primaryid$caseid$caseversion$i_f_code$event_dt$mfr_dt$init_fda_dt$fda_dt$rept_cod$auth_num$mfr_num$mfr_sndr$lit_ref$age$age_cod$age_grp$sex$e_sub$wt$wt_cod$rept_dt$to_mfr$occp_cod$reporter_country$occr_country
100046943$10004694$3$F$$20200924$20140312$20200928$EXP$$US-PFIZER INC-2014065112$PFIZER$$48$YR$$F$Y$57$KG$20200928$$LW$US$US
100048208$10004820$8$F$$20200821$20140312$20200825$EXP$$US-PFIZER INC-2014029927$PFIZER$$68$YR$$F$Y$$$20200825$$MD$US$US
100048232$10004823$2$F$$20200804$20140312$20200805$EXP$$US-PFIZER INC-2014066819$PFIZER$$$$E$F$Y$$$20200805$$LW$US$US
100049343$10004934$3$F$20080729$20200805$20140312$20200806$EXP$$US-PFIZER INC-2014066724$PFIZER$$65$YR$$F$Y$73$KG$20200806$$LW$US$US
100051353$10005135$3$F$20060922$20200923$20140312$20200925$EXP$$US-PFIZER INC-2014072143$PFIZER$$51$YR$$F$Y$63$KG$20200925$$LW$US$US
100051583$10005158$3$F$$20200804$20140312$20200805$EXP$$US-PFIZER INC-2014066722$PFIZER$$$$E$F$Y$$$20200805$$LW$US$US
100080813$10008081$3$F$2005$20200923$20140313$20200924$EXP$$US-PFIZER INC-2014067629$PFIZER$$60$YR$$F$Y$$$20200924$$LW$US$US
100084551$10008455$1$I$20140102$20140307$20140313$20140313$EXP$$US-JNJFOC-20140306769$PHARMACYCLICS$$$$$F$Y$42.18$KG$20140313$$MD$US$US
100089542$10008954$2$F$20120324$20200701$20140313$20200706$EXP$$JP-GILEAD-2014-0096507$GILEAD$$39$YR$A$M$Y$$$20200706$$MD$JP$JP
100100363$10010036$3$F$20130221$20200722$20140312$20200728$EXP$$US-INCYTE CORPORATION-2013IN000583$INCYTE$$$$$$Y$$$20200728$$MD$US$US
100116112$10011611$2$F$200105$20200922$20140314$20200924$EXP$$US-PFIZER INC-2014067103$PFIZER$$43$YR$$F$Y$68.03$KG$20200924$$LW$US$US
100117303$10011730$3$F$20061028$20200924$20140314$20200928$EXP$$US-PFIZER INC-2014067552$PFIZER$$44$YR$$F$Y$$$20200928$$LW$US$US
100117316$10011731$6$F$20051019$20200923$20140314$20200924$EXP$$US-PFIZER INC-2014067635$PFIZER$$56$YR$$F$Y$$$20200924$$LW$US$US
100117362$10011736$2$F$20110126$20200922$20140314$20200925$EXP$$US-PFIZER INC-2014067102$PFIZER$$54$YR$$F$Y$75$KG$20200925$$LW$US$US
100117413$10011741$3$F$20110308$20200923$20140314$20200925$EXP$$US-PFIZER INC-2014067597$PFIZER$$64$YR$$F$Y$$$20200925$$LW$US$US
100118292$10011829$2$F$2007$20200810$20140314$20200811$EXP$$US-PFIZER INC-2014067432$PFIZER$$53$YR$$F$Y$118$KG$20200811$$LW$US$US
100120042$10012004$2$F$2003$20200922$20140314$20200925$EXP$$US-PFIZER INC-2014067109$PFIZER$$54$YR$$F$Y$123$KG$20200925$$LW$US$US
100120622$10012062$2$F$$20200922$20140314$20200925$EXP$$US-PFIZER INC-2014068201$PFIZER$$79$YR$$F$Y$$$20200925$$LW$US$US
100121724$10012172$4$F$20140215$20140925$20140314$20141003$EXP$$PHHY2014PL027641$SANDOZ$$56$YR$$M$Y$$$20141003$$CN$PL$PL
100123912$10012391$2$F$$20200810$20140314$20200811$EXP$$US-PFIZER INC-2014071127$PFIZER$$64$YR$$F$Y$$$20200811$$LW$US$US
100128273$10012827$3$F$20140304$20150325$20140314$20150331$EXP$$AU-JNJFOC-20140305601$PHARMACYCLICS$$57$YR$A$F$Y$$$20150331$$MD$AU$AU
100136103$10013610$3$F$20140207$20140603$20140315$20140610$EXP$$GB-ROCHE-1361825$ROCHE$$78$YR$$F$Y$83$KG$20140610$$MD$GB$GB
100146483$10014648$3$F$2007$20200923$20140317$20200924$EXP$$US-PFIZER INC-2014067519$PFIZER$$68$YR$$F$Y$$$20200924$$LW$US$US
100147523$10014752$3$F$2009$20200920$20140317$20200923$EXP$$US-PFIZER INC-2014071269$PFIZER$$53$YR$$F$Y$54$KG$20200923$$LW$US$US
100147882$10014788$2$F$$20140307$20140317$20200701$EXP$$GR-JNJFOC-20140305144$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
100149182$10014918$2$F$201111$20200922$20140317$20200924$EXP$$US-PFIZER INC-2014069715$PFIZER$$75$YR$$F$Y$85.7$KG$20200924$$LW$US$US
100149283$10014928$3$F$2012$20200923$20140317$20200924$EXP$$US-PFIZER INC-2014069660$PFIZER$$69$YR$$F$Y$$$20200924$$LW$US$US
100150782$10015078$2$F$1997$20200924$20140317$20200928$EXP$$US-PFIZER INC-2014070340$PFIZER$$61$YR$$F$Y$73$KG$20200928$$LW$US$US
100150824$10015082$4$F$20140113$20150403$20140317$20150417$EXP$$US-JNJFOC-20140303008$JANSSEN$$42$YR$A$M$Y$42$KG$20150417$$MD$US$US
100160023$10016002$3$F$2008$20200923$20140317$20200924$EXP$$US-PFIZER INC-2014070939$PFIZER$$58$YR$$F$Y$98$KG$20200924$$LW$US$US
100160863$10016086$3$F$$20200923$20140317$20200925$EXP$$US-PFIZER INC-2014071868$PFIZER$$52$YR$$F$Y$$$20200925$$LW$US$US
100161263$10016126$3$F$1993$20200923$20140317$20200925$EXP$$US-PFIZER INC-2014071743$PFIZER$$43$YR$$F$Y$68.03$KG$20200925$$LW$US$US
100162753$10016275$3$F$2011$20200923$20140317$20200925$EXP$$US-PFIZER INC-2014071532$PFIZER$$68$YR$$F$Y$$$20200925$$LW$US$US
100162783$10016278$3$F$2009$20200923$20140317$20200925$EXP$$US-PFIZER INC-2014071637$PFIZER$$55$YR$$F$Y$$$20200925$$LW$US$US
100167549$10016754$9$F$20140212$20140703$20140318$20140711$EXP$$PHHY2014PL028976$SANDOZ$$55$YR$$M$Y$53$KG$20140711$$CN$PL$PL
100185904$10018590$4$F$2006$20200707$20140318$20200708$EXP$$US-PFIZER INC-2014071074$PFIZER$$48$YR$$F$Y$$$20200708$$LW$US$US
100186103$10018610$3$F$2017$20200923$20140318$20200925$EXP$$US-PFIZER INC-2014071034$PFIZER$$55$YR$$F$Y$$$20200925$$LW$US$US
100188503$10018850$3$F$201210$20200923$20140318$20200925$EXP$$US-PFIZER INC-2014071640$PFIZER$$54$YR$$F$Y$$$20200925$$LW$US$US
100188573$10018857$3$F$200909$20200923$20140318$20200924$EXP$$US-PFIZER INC-2014069499$PFIZER$$75$YR$$F$Y$59$KG$20200924$$LW$US$US
100192426$10019242$6$F$20131223$20140514$20140318$20140519$EXP$$US-JNJFOC-20140307391$PHARMACYCLICS$$65$YR$A$F$Y$70.5$KG$20140519$$MD$US$US
100192434$10019243$4$F$20140309$20140523$20140318$20140529$EXP$$BR-JNJFOC-20140307618$PHARMACYCLICS$$70$YR$E$F$Y$68$KG$20140529$$MD$BR$BR
100192792$10019279$2$F$2014$20200810$20140318$20200811$EXP$$US-PFIZER INC-2014072529$PFIZER$$80$YR$$F$Y$74.83$KG$20200811$$LW$US$US
100193261$10019326$1$I$$20140310$20140318$20140318$EXP$$ES-CUBIST PHARMACEUTICAL, INC.-2014CBST000404$CUBIST$MASEDA E, GANCEDO CH, LOPEZ?TOFINO A, RICA AS, GARCIA?BUJALANCE S, GILSANZ F. USE OF FIDAXOMICIN THROUGH A NASOGASTRIC TUBE FOR THE TREATMENT OF SEPTIC SHOCK CAUSED BY CLOSTRIDIUM DIFFICILE INFECTION IN A PATIENT WITH ORAL CANCER ADMITTED TO THE SURGICAL CRITICAL CARE UNIT. REV ESP QUIMIOTER. 2013?26(4):375?377$$$$$Y$$$20140318$$MD$ES$ES
100194922$10019492$2$F$$20200810$20140318$20200813$EXP$$US-PFIZER INC-2014071570$PFIZER$$$$A$F$Y$$$20200813$$LW$US$US
100206602$10020660$2$F$20100116$20140306$20140319$20140319$EXP$$GB-ROCHE-1357416$ROCHE$$76$YR$$F$Y$$$20140319$$MD$GB$GB
100215733$10021573$3$F$200412$20200826$20140319$20200827$EXP$$US-PFIZER INC-2014073332$PFIZER$$45$YR$$F$Y$82$KG$20200827$$LW$US$US
100215753$10021575$3$F$$20200929$20140319$20200930$EXP$$US-PFIZER INC-2014074003$PFIZER$$82$YR$$F$Y$$$20200930$$LW$US$US
100217713$10021771$3$F$200909$20200929$20140319$20200930$EXP$$US-PFIZER INC-2014069329$PFIZER$$60$YR$$F$Y$$$20200930$$LW$US$US
100217853$10021785$3$F$2004$20200929$20140319$20200930$EXP$$US-PFIZER INC-2014069340$PFIZER$$52$YR$$F$Y$83.9$KG$20200930$$LW$US$US
100219483$10021948$3$F$2010$20200923$20140319$20200925$EXP$$US-PFIZER INC-2014071500$PFIZER$$59$YR$$F$Y$91$KG$20200925$$LW$US$US
100219533$10021953$3$F$2012$20200923$20140319$20200925$EXP$$US-PFIZER INC-2014071155$PFIZER$$47$YR$$F$Y$$$20200925$$LW$US$US
100219543$10021954$3$F$$20200923$20140319$20200925$EXP$$US-PFIZER INC-2014071525$PFIZER$$$$A$F$Y$79.36$KG$20200925$$LW$US$US
100219803$10021980$3$F$2002$20200923$20140319$20200925$EXP$$US-PFIZER INC-2014071680$PFIZER$$53$YR$$F$Y$$$20200925$$LW$US$US
100220713$10022071$3$F$20110615$20200923$20140319$20200925$EXP$$US-PFIZER INC-2014071672$PFIZER$$74$YR$$F$Y$68.03$KG$20200925$$LW$US$US
100222754$10022275$4$F$201008$20200819$20140319$20200821$EXP$$US-PFIZER INC-2014073563$PFIZER$$61$YR$$F$Y$95.24$KG$20200821$$LW$US$US
100222833$10022283$3$F$20130710$20200806$20140319$20200810$EXP$$US-PFIZER INC-2014073546$PFIZER$$49$YR$$F$Y$49.89$KG$20200810$$LW$US$US
100222893$10022289$3$F$201003$20200805$20140319$20200806$EXP$$US-PFIZER INC-2014073527$PFIZER$$35$YR$$F$Y$95.69$KG$20200806$$LW$US$US
100223043$10022304$3$F$20060807$20200805$20140319$20200807$EXP$$US-PFIZER INC-2014073547$PFIZER$$58$YR$$F$Y$126.53$KG$20200807$$LW$US$US
100224235$10022423$5$F$20130910$20140603$20140319$20140611$EXP$$JP-PFIZER INC-2014073977$PFIZER$$64$YR$$M$Y$69$KG$20140610$$PH$JP$JP
100227933$10022793$3$F$20140308$20140509$20140319$20140516$EXP$$US-JNJFOC-20140309183$PHARMACYCLICS$$66$YR$E$F$Y$70.5$KG$20140516$$MD$US$US
1002310546$10023105$46$F$201401$20200915$20140320$20200928$EXP$$CA-ROCHE-1367988$ROCHE$$66$YR$$F$Y$$$20200928$$CN$CA$CA
100236782$10023678$2$F$$20140312$20140320$20200701$EXP$$GR-JNJFOC-20140307935$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
100238843$10023884$3$F$20121226$20200924$20140320$20200928$EXP$$US-PFIZER INC-2014074235$PFIZER$$61$YR$$F$Y$79.37$KG$20200928$$LW$US$US
100242743$10024274$3$F$2004$20200826$20140320$20200828$EXP$$US-PFIZER INC-2014073579$PFIZER$$64$YR$$F$Y$73$KG$20200828$$LW$US$US
100244083$10024408$3$F$$20200923$20140320$20200925$EXP$$US-PFIZER INC-2014071642$PFIZER$$55$YR$$F$Y$79$KG$20200925$$LW$US$US
100244593$10024459$3$F$20100309$20200819$20140320$20200820$EXP$$US-PFIZER INC-2014073584$PFIZER$$48$YR$$F$Y$79.37$KG$20200820$$LW$US$US
100246272$10024627$2$F$$20200924$20140320$20200928$EXP$$US-PFIZER INC-2014073585$PFIZER$$54$YR$$F$Y$$$20200928$$LW$US$US
100246363$10024636$3$F$20080516$20200826$20140320$20200827$EXP$$US-PFIZER INC-2014073537$PFIZER$$63$YR$$F$Y$76$KG$20200827$$LW$US$US
100247213$10024721$3$F$2012$20200924$20140320$20200928$EXP$$US-PFIZER INC-2014073586$PFIZER$$55$YR$$F$Y$82.54$KG$20200928$$LW$US$US
100248013$10024801$3$F$20110406$20200805$20140320$20200806$EXP$$US-PFIZER INC-2014073402$PFIZER$$53$YR$$F$Y$75.74$KG$20200806$$LW$US$US
100258322$10025832$2$F$20140207$20140603$20140320$20140617$EXP$GB-MHRA-ADR 22444313$GB-WATSON-2014-05056$WATSON$$78$YR$$F$Y$83$KG$20140617$$CN$GR$GB
100259323$10025932$3$F$20140306$20140409$20140320$20140416$EXP$$TR-JNJFOC-20140312676$PHARMACYCLICS$$61$YR$A$M$Y$54$KG$20140416$$MD$TR$TR
100264161$10026416$1$I$201311$20140312$20140321$20140321$EXP$$EC-ROCHE-1364577$ROCHE$$61$YR$$F$Y$$$20140321$$CN$EC$EC
100267172$10026717$2$F$20120621$20140523$20140321$20140530$EXP$$GB-ROCHE-1360931$ROCHE$$69$YR$$F$Y$$$20140530$$MD$GB$GB
100278545$10027854$5$F$2006$20200929$20140321$20200930$EXP$$US-PFIZER INC-2014064309$PFIZER$$52$YR$$F$Y$72.56$KG$20200930$$LW$US$US
100279704$10027970$4$F$20140304$20140423$20140321$20140501$EXP$$PHHY2014PL032020$SANDOZ$$67$YR$$F$Y$$$20140501$$CN$PL$PL
1002872120$10028721$20$F$20140317$20200924$20140321$20200930$EXP$$PHHY2014CA033801$NOVARTIS$$57$YR$$F$Y$$$20200930$$MD$CA$CA
100292121$10029212$1$I$$20140313$20140321$20140321$EXP$$PHHY2014KR033284$SANDOZ$$62$YR$$F$Y$$$20140321$$CN$COUNTRY NOT SPECIFIED$KR
100316791$10031679$1$I$$20140319$20140324$20140324$PER$$US-PFIZER INC-2014082388$PFIZER$$58$YR$$F$Y$$$20140324$$MD$US$US
100318853$10031885$3$F$2006$20200916$20140324$20200921$EXP$$US-PFIZER INC-2014065979$PFIZER$$60$YR$$F$Y$$$20200921$$LW$US$US
100323743$10032374$3$F$20111007$20200920$20140324$20200923$EXP$$US-PFIZER INC-2014066005$PFIZER$$67$YR$$F$Y$87.08$KG$20200923$$LW$US$US
100325953$10032595$3$F$2010$20200920$20140324$20200923$EXP$$US-PFIZER INC-2014066058$PFIZER$$54$YR$$F$Y$$$20200923$$LW$US$US
100326283$10032628$3$F$$20200923$20140324$20200925$EXP$$US-PFIZER INC-2014067696$PFIZER$$48$YR$$F$Y$$$20200925$$LW$US$US
100326393$10032639$3$F$20070712$20200923$20140324$20200928$EXP$$US-PFIZER INC-2014067693$PFIZER$$56$YR$$F$Y$68.03$KG$20200928$$LW$US$US
100326463$10032646$3$F$201301$20200923$20140324$20200925$EXP$$US-PFIZER INC-2014067698$PFIZER$$64$YR$$$Y$77.1$KG$20200925$$LW$US$US
100326953$10032695$3$F$20130716$20200805$20140324$20200806$EXP$$US-PFIZER INC-2014067763$PFIZER$$52$YR$$F$Y$$$20200806$$LW$US$US
100327853$10032785$3$F$201204$20200806$20140324$20200810$EXP$$US-PFIZER INC-2014067759$PFIZER$$44$YR$$F$Y$64$KG$20200810$$LW$US$US
100354871$10035487$1$I$$20140310$20140321$20140321$EXP$$2014CA00232$CIPLA$$$$$$N$$$20140314$N$HP$CA$
100384343$10038434$3$F$2003$20200923$20140326$20200925$EXP$$US-PFIZER INC-2014064414$PFIZER$$62$YR$$F$Y$$$20200925$$LW$US$US
100400326$10040032$6$F$20140317$20141223$20140326$20141231$EXP$$TR-JNJFOC-20140316322$PHARMACYCLICS$$79$YR$E$M$Y$69$KG$20141231$$MD$TR$TR
100400362$10040036$2$F$20120807$20140324$20140326$20140326$EXP$$US-JNJFOC-20121000257$PHARMACYCLICS$$61$YR$A$F$Y$52.4$KG$20140326$$MD$US$US
100400386$10040038$6$F$20140320$20150414$20140326$20150421$EXP$$GB-JNJFOC-20140315059$PHARMACYCLICS$$78$YR$E$M$Y$95.4$KG$20150421$$MD$GB$GB
100404513$10040451$3$F$20140311$20140401$20140327$20140410$EXP$$PHHY2014DE033041$SANDOZ$$79$YR$$M$Y$$$20140410$$CN$DE$DE
100407761$10040776$1$I$20140311$20140317$20140327$20140327$EXP$$PHHY2014DE032652$SANDOZ$$80$YR$$M$Y$$$20140327$$CN$DE$DE
100421952$10042195$2$F$20130601$20140320$20140327$20140327$EXP$$IE-JNJFOC-20130607987$PHARMACYCLICS$$79$YR$E$M$Y$72.8$KG$20140327$$MD$IE$IE
100425092$10042509$2$F$20140205$20140725$20140327$20140804$EXP$$PHHY2014ES035857$SANDOZ$$56$YR$$M$Y$$$20140804$$CN$ES$ES
100444454$10044445$4$F$20140317$20140806$20140328$20140809$EXP$$PHHO2014JP004116$NOVARTIS$$68$YR$$M$Y$61$KG$20140809$$MD$JP$JP
100447282$10044728$2$F$$20200811$20140328$20200819$EXP$$PT-ASTRAZENECA-2014SE19779$ASTRAZENECA$$25$YR$$F$Y$$$20200819$$HP$PT$PT
100450421$10045042$1$I$20130310$20140318$20140328$20140328$EXP$$PHHY2014US033684$SANDOZ$$42$YR$$M$Y$$$20140328$$CN$US$US
100453602$10045360$2$F$20131106$20140324$20140328$20140328$EXP$$BR-JNJFOC-20131108027$PHARMACYCLICS$$76$YR$E$M$Y$68$KG$20140328$$MD$BR$BR
1004541412$10045414$12$F$20140113$20200713$20140328$20200717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-20070124$BRISTOL MYERS SQUIBB$$61$YR$$M$Y$62$KG$20200717$$HP$US$US
100503048$10050304$8$F$20140314$20161122$20140401$20161202$EXP$$PHHY2014BE037540$SANDOZ$$72$YR$$F$Y$$$$$CN$BE$BE
100514792$10051479$2$F$20130521$20140325$20140401$20140401$EXP$$KR-JNJFOC-20130516142$PHARMACYCLICS$$74$YR$E$M$Y$60$KG$20140401$$MD$KR$KR
100531022$10053102$2$F$20140316$20140331$20140402$20140409$EXP$$PHHY2014FR039134$SANDOZ$$35$YR$$M$Y$$$20140409$$CN$FR$FR
100536873$10053687$3$F$20140324$20140418$20140402$20140424$EXP$$US-JNJFOC-20140317296$PHARMACYCLICS$$64$YR$A$M$Y$112.04$KG$20140424$$HP$US$US
100554742$10055474$2$F$$20200820$20140403$20200902$EXP$GB-002147023-PHFR2014GB002156$GB-LUPIN PHARMACEUTICALS INC.-E2B_00001870$LUPIN$$39$YR$$M$Y$$$20200902$$CN$GB$GB
100560278$10056027$8$F$20140303$20150921$20140403$20151012$EXP$$PL-JNJFOC-20140319011$JANSSEN$$28$YR$A$M$Y$71.1$KG$20151012$$CN$PL$PL
100570609$10057060$9$F$20140120$20200728$20140403$20200730$EXP$$US-PFIZER INC-2014094310$PFIZER$$59$YR$$M$Y$175$KG$20200730$$MD$US$US
100579131$10057913$1$I$$20140325$20140404$20140404$EXP$$PHHY2014FR037986$SANDOZ$$72$YR$$F$Y$$$20140404$$CN$FR$FR
100580313$10058031$3$F$20130312$20150708$20140404$20150716$EXP$$DE-JNJFOC-20140200651$JANSSEN$$46$YR$A$F$Y$79.2$KG$20150716$$MD$DE$DE
100603721$10060372$1$I$$20140327$20140404$20140404$EXP$$US-BAXTER-2014BAX015977$BAXTER$RAYMOND T, WIESEN J, REHM S, AURON M. CARBAPENEM?RESISTANT KLEBSIELLA PNEUMONIAE PROSTHETIC VALVE ENDOCARDITIS. INFECTIOUS DISEASES IN CLINICAL PRACTICE. 2014 JAN 01?22(2):113?115.$77$YR$$$Y$$$20140404$$HP$US$US
100606123$10060612$3$F$20140324$20140522$20140404$20140529$EXP$$SE-JNJFOC-20140318194$PHARMACYCLICS$$77$YR$E$M$Y$80.5$KG$20140529$$MD$SE$SE
100622291$10062229$1$I$$20140324$20140407$20140407$EXP$$US-MYLANLABS-2014S1006896$MYLAN$BONILLA IM, VARGAS?PINTO P, NISHIJIMA Y, PEDRAZA?TOSCANO A, HO H?T, LONG III VP, ET AL. IBANDRONATE AND VENTRICULAR ARRHYTHMIA RISK. J?CARDIOVASC?ELECTROPHYSIOL 2014? 25(3) 299?306$55$YR$A$F$Y$$$20140407$$HP$US$US
100637842$10063784$2$F$$20140829$20140408$20140903$EXP$$US-ROCHE-1371329$ROCHE$. IBANDRONIC ACID. VENTRICULAR ARRHYTHMIA: CASE REPORT.. REACTIONS 2014 JAN 01?1494:28?29.$55$YR$$F$Y$$$20140903$$HP$US$US
100645079$10064507$9$F$20120801$20200729$20140408$20200804$EXP$$JP-ASTELLAS-2014JP002987$ASTELLAS$$22$YR$$F$Y$51$KG$20200804$$MD$JP$JP
100654393$10065439$3$F$20140213$20140515$20140408$20140521$EXP$$FR-PFIZER INC-2014093527$PFIZER$$27$YR$$M$Y$$$20140521$$HP$FR$FR
1006548358$10065483$58$F$20121115$20200902$20140408$20200927$EXP$$PHHY2013CA013084$NOVARTIS$$47$YR$$M$Y$$$20200928$$HP$CA$CA
100663511$10066351$1$I$20130617$20130628$20140408$20140408$EXP$$HU-ACTAVIS-2013-25107$WATSON$$45$YR$$F$Y$$$20140408$$CN$HU$HU
100664063$10066406$3$F$20140331$20140502$20140408$20140507$EXP$$US-JNJFOC-20140402783$PHARMACYCLICS$$73$YR$E$M$Y$65$KG$20140507$$MD$US$US
100689012$10068901$2$F$20140327$20140417$20140409$20140428$PER$$JP-JNJFOC-20140405204$JANSSEN$$65$YR$A$F$Y$51$KG$20140428$$MD$JP$JP
100715797$10071579$7$F$20140205$20200730$20140410$20200801$EXP$$PHFR2014GB002278$NOVARTIS$$34$YR$$M$Y$$$20200801$$MD$GB$GB
100730192$10073019$2$F$20120226$20140403$20140411$20140411$EXP$$FR-JNJFOC-20120406946$JANSSEN$$45$YR$A$F$Y$41$KG$20140411$$MD$FR$FR
100735493$10073549$3$F$$20141124$20140411$20141126$EXP$$FR-JNJFOC-20140406341$PHARMACYCLICS$$$$E$M$Y$70$KG$20141126$$MD$FR$FR
1007380712$10073807$12$F$2010$20200910$20140411$20200916$EXP$$BR-ABBVIE-10P-020-0675843-00$ABBVIE$$$$$F$Y$72$KG$20200916$$CN$BR$BR
100738424$10073842$4$F$$20200907$20140413$20200915$EXP$$GB-MYLANLABS-2014S1007411$MYLAN$$$$$F$Y$$$20200915$$MD$GB$GB
100754803$10075480$3$F$20140328$20140501$20140414$20140509$EXP$$US-JNJFOC-20140401071$JANSSEN$$53$YR$A$F$Y$65$KG$20140509$$MD$US$US
100754932$10075493$2$F$20140123$20140404$20140414$20140414$EXP$$AU-JNJFOC-20130606643$JANSSEN$$29$YR$A$F$Y$$$20140414$$HP$AU$AU
100756102$10075610$2$F$20140311$20140423$20140414$20140502$PER$$FR-JNJFOC-20140404504$JANSSEN$$28$YR$A$F$Y$66$KG$20140502$$MD$FR$FR
100806533$10080653$3$F$2012$20200908$20140416$20200911$EXP$$PL-UCBSA-117837$UCB$BIEDRON A, KACINSKI M, SKOWRONEK?BALA B. STABBING HEADACHE IN AN 8?YEAR?OLD GIRL: PRIMARY OR DRUG INDUCED HEADACHE?. PEDIATRICS. 2014?133(4):E1068?71$8$YR$$F$Y$$$20200911$$MD$PL$PL
100808223$10080822$3$F$$20140505$20140416$20140509$EXP$$US-JNJFOC-20140407874$PHARMACYCLICS$$$$E$M$Y$73.94$KG$20140509$$HP$US$US
100813333$10081333$3$F$20140107$20200630$20140416$20200714$EXP$FR-AFSSAPS-ST20140296$FR-JNJFOC-20140402508$JOHNSON AND JOHNSON$$44$YR$$M$Y$80$KG$20200714$$MD$FR$FR
1008180511$10081805$11$F$20140330$20200630$20140416$20200714$EXP$$US-ACTELION-A-US2013-89344$ACTELION$$17$YR$$M$Y$67.12$KG$20200714$$HP$US$US
100818346$10081834$6$F$20130929$20200914$20140416$20200923$PER$$US-SA-2013SA100370$SANOFI AVENTIS$$50$YR$$M$Y$$$20200923$$CN$US$US
1008378212$10083782$12$F$20140317$20150227$20140417$20200810$EXP$$JP-ROCHE-1371409$ROCHE$$78$YR$$M$Y$64.45$KG$20200811$$MD$JP$JP
1008464913$10084649$13$F$201302$20200821$20140417$20200828$EXP$$US-SANOFI-AVENTIS-2013SA062305$SANOFI AVENTIS$$62$YR$$F$Y$$$20200828$$CN$US$US
100850913$10085091$3$F$20131121$20140618$20140417$20140626$EXP$$US-JNJFOC-20131116007$PHARMACYCLICS$$54$YR$A$M$Y$104$KG$20140626$$MD$US$US
100850934$10085093$4$F$20140307$20140918$20140417$20140926$EXP$$US-JNJFOC-20140411905$PHARMACYCLICS$$74$YR$E$M$Y$78.1$KG$20140926$$MD$US$US
100868095$10086809$5$F$20130712$20180130$20140418$20180205$EXP$$US-JNJFOC-20130711015$PHARMACYCLICS$BENNETT C , BERGER  JR, SARTOR O, CARSON KR, HRUSHESKY WJ, GEORGANTOPOULOS P, ET AL. PROGRESSIVE MULTI?FOCAL LEUCOENCEPHALOPATHY AMONG IBRUTINIB?TREATED PERSONS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA. BRITISH JOURNAL OF HAEMATOLOGY 2018?180 (2):286?308.$56$YR$A$F$Y$48.08$KG$20180205$$HP$US$US
1008695822$10086958$22$F$20140109$20200902$20140418$20200910$EXP$$PHHY2012CA123191$NOVARTIS$$51$YR$$M$Y$$$20200910$$HP$CA$CA
100872494$10087249$4$F$20140329$20140702$20140418$20140709$EXP$$PHHY2014IL043915$SANDOZ$$44$YR$$F$Y$$$20140709$$CN$IL$IL
100888124$10088812$4$F$20140213$20140827$20140421$20140904$EXP$$FR-JNJFOC-20140308345$JANSSEN$$78$YR$E$M$Y$$$20140904$$MD$FR$FR
100888814$10088881$4$F$20140302$20170801$20140421$20170810$EXP$$SE-JNJFOC-20140408768$JANSSEN$$80$YR$E$F$Y$68$KG$20170810$$MD$SE$SE
100903111$10090311$1$I$$20140410$20140421$20140421$EXP$$PHHY2014CN044358$SANDOZ$YANG S?H, ZHAN P, SUN M, ZHANG Y?P, MA N?L. PERFUSING CHEMOTHERAPY BY PERCUTANEOUS LUNG PUNCTURE IN THE TREATMENT OF EXTENSIVE DRUG RESISTANT PULMONARY TUBERCULOSIS. J?THORAC?DIS. 2012?4(6):624?628$24$YR$$F$Y$$$20140421$$HP$CN$CN
1009040619$10090406$19$F$201309$20200903$20140421$20200904$EXP$$US-PFIZER INC-2014109517$PFIZER$$47$YR$$F$Y$$$20200904$$MD$US$US
100995651$10099565$1$I$$20140414$20140423$20140423$EXP$$PHHY2014GB046615$SANDOZ$VAN HALSEMA C, HUMPHREYS S, BONINGTON A.. EXTENSIVELY DRUG?RESISTANT TUBERCULOSIS: EARLY ACCESS TO BEDAQUILINE FOR A UK PATIENT.. EUR RESPIR J. 2014?43 (1):292?294$28$YR$$F$Y$$$20140423$$HP$GB$GB
100999795$10099979$5$F$20140401$20200812$20140423$20200820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-20657763$BRISTOL MYERS SQUIBB$$84$YR$$M$Y$65$KG$20200820$$MD$JP$JP
101007342$10100734$2$F$20131030$20140416$20140423$20140423$EXP$$US-JNJFOC-20131103597$PHARMACYCLICS$$74$YR$E$M$Y$81.29$KG$20140423$$MD$US$US
101024553$10102455$3$F$20140325$20141203$20140424$20141215$EXP$$PHHY2014PL048412$SANDOZ$$69$YR$$F$Y$$$20141215$$CN$PL$PL
101036675$10103667$5$F$20140417$20140730$20140424$20140813$EXP$$FR-JNJFOC-20140415345$PHARMACYCLICS$$67$YR$E$M$Y$70$KG$20140813$$MD$FR$FR
101118453$10111845$3$F$20140404$20140714$20140425$20140721$EXP$$PHHY2014FR048712$SANDOZ$$68$YR$$F$Y$51$KG$20140721$$CN$FR$FR
101195091$10119509$1$I$20140329$20140417$20140425$20140425$EXP$$US-JNJFOC-20140416427$PHARMACYCLICS$$69$YR$E$F$Y$46.9$KG$20140425$$MD$US$US
101337399$10133739$9$F$2014$20200807$20140428$20200818$EXP$$US-SA-2014SA050658$SANOFI AVENTIS$$$$$M$Y$$$20200818$$CN$US$US
101358771$10135877$1$I$$20140414$20140429$20140429$EXP$$IT-ROCHE-1387284$ROCHE$MONDELLO P, PITINI V, ARRIGO C, MONDELLO S, MIAN M AND ALTAVILLA G NECROTIZING FASCIITIS AS A RARE COMPLICATION OF OSTEONECROSIS OF THE JAW IN A PATIENT WITH MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE: CASE REPORT AND REVIEW OF THE LITERATURE. SPRINGERPLUS 2014 MAR 05?3:123?127.$59$YR$$F$Y$$$20140429$$MD$IT$IT
101359761$10135976$1$I$201310$20140417$20140429$20140429$EXP$$US-ROCHE-1386288$ROCHE$$63$YR$$F$Y$$$20140429$$CN$US$US
101439581$10143958$1$I$20140220$20140415$20140430$20140430$EXP$$US-JNJFOC-20140419880$PHARMACYCLICS$$66$YR$E$M$Y$$$20140430$$MD$US$US
101440429$10144042$9$F$2004$20200723$20140430$20200804$EXP$$US-ABBVIE-14P-163-1228144-00$ABBVIE$$$$$F$Y$72.64$KG$20200803$$CN$US$US
101442501$10144250$1$I$20130825$20140422$20140430$20140430$EXP$$PHHY2014RU049445$SANDOZ$$49$YR$$F$Y$$$20140430$$CN$RU$RU
101443186$10144318$6$F$20131025$20200713$20140430$20200921$EXP$$JP-TAKEDA-2014TJP005378$TAKEDA$FUJISHIMA N, UCHIDA T, JUNG W C, GOH T Y, ANDO K, WANG C M ET AL.. OZOGAMICIN VERSUS STANDARD OF CARE IN ASIAN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2019?110(6):709?722$40$YR$$M$Y$64.8$KG$20200921$$MD$JP$JP
101450612$10145061$2$F$$20200831$20140501$20200902$EXP$$CA-009507513-1404CAN014551$MERCK$$59$YR$$M$Y$94.79$KG$20200902$$HP$CA$CA
101460006$10146000$6$F$20140329$20200716$20140501$20200728$EXP$$US-JNJFOC-20140404474$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20200728$$CN$US$US
101498034$10149803$4$F$20140423$20140714$20140502$20140724$EXP$$GB-JNJFOC-20140418722$PHARMACYCLICS$$55$YR$A$M$Y$89.4$KG$20140724$$MD$GB$GB
101510052$10151005$2$F$20140422$20140425$20140502$20140502$EXP$$JP-ASTELLAS-2014US004618$ASTELLAS$$69$YR$$M$Y$$$20140502$$CN$GB$JP
101515902$10151590$2$F$20140326$20140425$20140505$20140505$EXP$$PHHY2014TW040897$SANDOZ$$57$YR$$F$Y$$$20140505$$MD$TW$TW
101515933$10151593$3$F$$20200826$20140505$20200831$EXP$$PT-ROCHE-1394513$ROCHE$$61$YR$$F$Y$$$20200901$$HP$PT$PT
101523772$10152377$2$F$20140118$20140501$20140505$20140506$PER$$NL-JNJFOC-20140501118$JANSSEN$$75$YR$E$M$Y$80$KG$20140506$$MD$NL$NL
101532151$10153215$1$I$$20140425$20140505$20140505$EXP$$ALCN2014US002642$ALCON$$62$YR$$M$Y$$$20140505$$HP$US$US
101537598$10153759$8$F$201310$20190712$20140506$20190723$EXP$$CA-ROCHE-1297992$ROCHE$$68$YR$$M$Y$70.3$KG$20190723$$HP$CA$CA
101542905$10154290$5$F$20130915$20200310$20140506$20200803$EXP$$DE-JNJFOC-20140420505$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200803$$MD$DE$DE
1015531118$10155311$18$F$$20200806$20140506$20200812$EXP$$CA-PFIZER INC-2014123295$PFIZER$$73$YR$$F$Y$$$20200812$$HP$CA$CA
1015551610$10155516$10$F$201404$20200820$20140506$20200824$PER$$US-PFIZER INC-2014123254$PFIZER$$56$YR$$F$Y$67.12$KG$20200824$$MD$US$US
101570304$10157030$4$F$201404$20200917$20140507$20200922$PER$$US-PFIZER INC-2014122429$PFIZER$$58$YR$$M$Y$106.5$KG$20200922$$MD$US$US
101581032$10158103$2$F$20130622$20140505$20140507$20140507$EXP$$SE-JNJFOC-20130616548$PHARMACYCLICS$$58$YR$A$M$Y$78$KG$20140507$$MD$SE$SE
101606761$10160676$1$I$$20140428$20140508$20140508$EXP$$US-ROCHE-1393157$ROCHE$HONG D, GARRIDO?LAGUNA I, EKMEKCIOGLU S, FALCHOOK G, NAING A, WHELER J, FU S, MOULDER S, PIHA?PAUL S, TSIMBERIDOU A, WEN Y, CULOTTA K, ANDERES K, DAVIS D, LIU W, GEORGE G, CAMACHO L, PERCY S AND KURZROCK R. DUAL INHIBITION OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR PATHWAY: A PHASE 1 TRIAL EVALUATING BEVACIZUMAB AND AZD2171 (CEDIRANIB) IN PATIENTS WITH ADVANCED SOLID TUMORS. CANCER 2014 APR 17?:?.$$$$$Y$$$20140508$$MD$US$US
101608843$10160884$3$F$20131122$20161115$20140508$20161125$EXP$$PHHY2014MX054109$SANDOZ$$46$YR$$F$Y$$$20161125$$CN$MX$MX
101613194$10161319$4$F$201508$20200814$20140509$20200821$EXP$$BR-ROCHE-1344948$ROCHE$$44$YR$$F$Y$80$KG$20200821$$CN$BR$BR
101621902$10162190$2$F$$20200813$20140509$20200817$EXP$$CA-ROCHE-1398198$ROCHE$$$$$F$Y$$$20200817$$MD$CA$CA
101623575$10162357$5$F$2014$20200706$20140509$20200710$EXP$$US-SA-2014SA057163$SANOFI AVENTIS$$$$$$Y$$$20200710$$CN$US$US
101624001$10162400$1$I$$20140425$20140509$20140509$EXP$$GB-US-EMD SERONO, INC.-7289778$EMD SERONO INC$$$$$F$Y$$$20140509$$CN$GB$GB
101634468$10163446$8$F$20140227$20181123$20140509$20181203$EXP$$US-JNJFOC-20140304884$PHARMACYCLICS$PRIOTY I, CATHERINE D, LAUREN S, ADAM HK, SARAH B, SUNITA N, ET AL. IBRUTINIB ?INDUCED PNEUMONITIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.. BLOOD JOURNAL, AMERICAN SOCIETY OF HEMATOLOGY 2015?10:1182.$70$YR$E$F$Y$102$KG$20181203$$MD$US$US
101634572$10163457$2$F$20130622$20140506$20140509$20140509$EXP$$US-JNJFOC-20140501348$PHARMACYCLICS$$64$YR$A$M$Y$$$20140509$$MD$US$US
101634595$10163459$5$F$20140306$20140813$20140509$20140825$EXP$$GB-JNJFOC-20140505361$PHARMACYCLICS$$85$YR$E$M$Y$54.3$KG$20140825$$MD$GB$GB
1016635160$10166351$60$F$201401$20200703$20140512$20200707$EXP$$CA-ROCHE-1339281$ROCHE$$67$YR$$F$Y$70.7$KG$20200707$$CN$CA$CA
101677662$10167766$2$F$20121031$20140507$20140512$20140512$EXP$$US-JNJFOC-20121111071$PHARMACYCLICS$$54$YR$A$M$Y$70.4$KG$20140512$$MD$US$US
101679262$10167926$2$F$20130807$20140711$20140512$20140718$EXP$$PHHY2014GB055731$SANDOZ$$66$YR$$M$Y$$$20140718$$CN$GB$GB
101682403$10168240$3$F$20120903$20191007$20140512$20191017$EXP$$FR-009507513-1405FRA003799$MERCK$$70$YR$$M$Y$86$KG$20191017$$HP$FR$FR
101683632$10168363$2$F$20140421$20140528$20140513$20140607$EXP$$PHHY2014US054578$SANDOZ$$84$YR$$M$Y$$$20140608$$CN$US$US
101699573$10169957$3$F$20140421$20200804$20140513$20200814$EXP$$US-JNJFOC-20140504685$JOHNSON AND JOHNSON$$35$YR$A$F$Y$61.29$KG$20200814$$HP$US$US
101702584$10170258$4$F$20140426$20200831$20140513$20200907$EXP$$PHHY2014CA057038$NOVARTIS$$58$YR$$F$Y$$$20200907$$MD$CA$CA
101744162$10174416$2$F$20121229$20140509$20140515$20140515$EXP$$US-JNJFOC-20130101690$PHARMACYCLICS$$74$YR$E$M$Y$80.4$KG$20140515$$MD$US$US
101744365$10174436$5$F$20130411$20160108$20140515$20160119$EXP$$US-JNJFOC-20130416202$PHARMACYCLICS$PRIOTY I, CATHERINE D, LAUREN S, ADAM HK, SARAH B, SUNITA N, ET AL. IBRUTINIB?INDUCED PNEUMONITIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. BLOOD JOURNAL, AMERICAN SOCIETY OF HEMATOLOGY. 2015?10:1182.$70$YR$E$F$Y$$$20160119$$MD$US$US
1017624812$10176248$12$F$$20200715$20140516$20200717$PER$$US-PFIZER INC-2014133786$PFIZER$$53$YR$$F$Y$$$20200717$$MD$US$US
101785708$10178570$8$F$20120523$20200923$20140519$20200930$EXP$$US-SA-2014SA062879$SANOFI AVENTIS$$70$YR$$F$Y$62.59$KG$20200930$$PH$US$US
101815933$10181593$3$F$$20200629$20140519$20200709$PER$$US-PFIZER INC-2013339673$PFIZER$$58$YR$$F$Y$81.63$KG$20200709$$MD$US$US
101817743$10181774$3$F$20140508$20140528$20140519$20140605$EXP$$CN-JNJFOC-20140506824$PHARMACYCLICS$$55$YR$A$M$Y$86$KG$20140605$$MD$CN$CN
101846493$10184649$3$F$2012$20200806$20140521$20200819$EXP$$US-SHIRE-ALL1-2012-03557$SHIRE$$$$$F$Y$$$20200819$$MD$US$US
101853014$10185301$4$F$201305$20200807$20140521$20200811$PER$$US-PFIZER INC-2014135440$PFIZER$$52$YR$$F$Y$71$KG$20200811$$CN$US$US
1018707742$10187077$42$F$20131105$20200810$20140522$20200814$EXP$$CA-ROCHE-1301050$ROCHE$$73$YR$$M$Y$76$KG$20200814$$HP$CA$CA
101877911$10187791$1$I$$20140512$20140522$20140522$EXP$$US-ROCHE-1400943$ROCHE$YUN H, CURTIS J, GUO L, KILGORE M, MUNTNER P, SAAG K, MATTHEWS R, MORRISEY M, WRIGHT N, BECKER D AND DELZELL E. PATTERNS AND PREDICTORS OF OSTEOPOROSIS MEDICATION DISCONTINUATION AND SWITCHING AMONG MEDICARE BENEFICIARIES. BMC MUSCULOSKELETAL DISORDERS 2014 APR 01?15(1):1?12.$$$$$Y$$$20140522$$HP$US$US
101892392$10189239$2$F$$20200813$20140522$20200817$EXP$$PHHY2014PT058626$NOVARTIS$RIOS M. SEROTONIN SYNDROME AFTER SERTRALINE INTOXICATION. NASCER E CRESCER. 2012?21(3):206. NASCER E CRESCER. 2012?21(3):206$8$YR$$F$Y$$$20200817$$HP$PT$PT
101905285$10190528$5$F$201011$20200622$20140523$20200702$EXP$$PT-ROCHE-1406194$ROCHE$, NEVES I, MORAIS A, MAGALHAESA A BISPHOSPHONATE?ASSOCIATED OSTEONECROSIS OF THE JAWS IN LUNG CANCER PATIENTS. REVISTA PORTUGUESA DE PNEUMOLOGIA 2013?19(5):228?232.$59$YR$$M$Y$$$20200702$$HP$PT$PT
101921004$10192100$4$F$20130828$20150506$20140523$20150512$EXP$$UA-JNJFOC-20130816555$PHARMACYCLICS$$75$YR$E$M$Y$86$KG$20150512$$MD$UA$UA
101921272$10192127$2$F$20140415$20170721$20140523$20170725$EXP$$US-JNJFOC-20140510396$JANSSEN$$$$$M$Y$$$20170725$$MD$US$US
101962281$10196228$1$I$$20140516$20140520$20140520$EXP$$B0962899A$GLAXOSMITHKLINE$$$$$M$N$$$20140519$N$$IT$
101967091$10196709$1$I$20140211$20140516$20140527$20140527$EXP$$PT-PFIZER INC-2014142602$PFIZER$$88$YR$$F$Y$$$20140527$$PH$PT$PT
101988312$10198831$2$F$$20200707$20140527$20200721$EXP$$GB-NAPPMUNDI-GBR-2014-0018427$PURDUE$POLICOLA C, STOKES V, KARAVITAKI N, GROSSMAN A. ADRENAL INSUFFICIENCY IN ACUTE ORAL OPIATE THERAPY. ENDOCRINOLOGY AND METABOLIC DISEASES: CASE REPORTS. 2014?13?0071:1?3$18$YR$$M$Y$$$20200720$$MD$IT$IT
1020044029$10200440$29$F$20120730$20200619$20140528$20200703$EXP$$CA-ROCHE-1406066$ROCHE$$39$YR$$F$Y$106.58$KG$20200703$$MD$CA$CA
102007163$10200716$3$F$$20180313$20140528$20180327$EXP$$CZ-ROCHE-1406310$ROCHE$, PAVELKA T VYSKYT ATYPICKYCH ZLOMENIN U ANTIRESORPCNI LECBY, 4LETE SLEDOVANI. ABSTRACTS COLLECTION WINTER RHEUMATOLOGICAL DAYS 2018 2018?:31?32.$$$$$Y$$$20180327$$HP$CZ$CZ
102025982$10202598$2$F$20140515$20140603$20140528$20140611$EXP$$FR-JNJFOC-20140512732$PHARMACYCLICS$$75$YR$E$M$Y$69$KG$20140611$$MD$FR$FR
102026265$10202626$5$F$20140520$20180503$20140528$20180511$EXP$$US-JNJFOC-20140516951$PHARMACYCLICS$$73$YR$E$M$Y$85$KG$20180511$$MD$US$US
1020262811$10202628$11$F$20140414$20150805$20140528$20150811$EXP$$CA-JNJFOC-20140412100$PHARMACYCLICS$$79$YR$E$M$Y$82.5$KG$20150811$$MD$CA$CA
102034859$10203485$9$F$201304$20200424$20140529$20200922$EXP$$CA-ROCHE-1409356$ROCHE$$$$A$M$Y$$$20200922$$HP$CA$CA
102038965$10203896$5$F$2013$20200921$20140529$20200923$EXP$$US-009507513-1405USA013481$MERCK$$$$$M$Y$6.85$KG$20200923$$CN$IE$IE
102040903$10204090$3$F$20140328$20161122$20140529$20161130$EXP$$ES-SA-2014SA064881$AVENTIS$$66$YR$E$M$Y$$$20161130$$MD$ES$ES
102045513$10204551$3$F$201405$20200729$20140529$20200731$PER$$US-PFIZER INC-2014143423$PFIZER$$32$YR$$F$Y$$$20200731$$HP$US$US
102049091$10204909$1$I$20140521$20140522$20140529$20140529$EXP$$US-JNJFOC-20140515721$PHARMACYCLICS$$65$YR$A$F$Y$68$KG$20140529$$MD$US$US
102051401$10205140$1$I$20140414$20140520$20140529$20140529$EXP$$US-JNJFOC-20140518665$PHARMACYCLICS$$67$YR$E$M$Y$77.7$KG$20140529$$MD$US$US
102054421$10205442$1$I$20130713$20140519$20140529$20140529$EXP$$PHHY2014TW061980$SANDOZ$$33$YR$$F$Y$71.5$KG$20140529$$CN$TW$TW
1020642919$10206429$19$F$201112$20200819$20140530$20200827$EXP$$CA-ROCHE-1408363$ROCHE$$46$YR$$F$Y$$$20200827$$HP$CA$CA
102087554$10208755$4$F$20140523$20141021$20140530$20141027$EXP$$SE-JNJFOC-20140515884$PHARMACYCLICS$$77$YR$E$M$Y$81.5$KG$20141027$$MD$SE$SE
102087714$10208771$4$F$20140524$20140624$20140530$20140701$EXP$$US-JNJFOC-20140517525$PHARMACYCLICS$$61$YR$A$M$Y$105$KG$20140701$$MD$US$US
102134564$10213456$4$F$201405$20200814$20140603$20200820$EXP$$US-SA-2014SA062021$SANOFI AVENTIS$$$$$$Y$$$20200820$$HP$US$US
102139591$10213959$1$I$$20130725$20140603$20140603$EXP$$JP-JNJFOC-20140511165$JANSSEN$$$$$$Y$$$20140603$$MD$JP$JP
102139601$10213960$1$I$$20130725$20140603$20140603$EXP$$JP-JNJFOC-20140511183$JANSSEN$$$$$$Y$$$20140603$$MD$JP$JP
102139611$10213961$1$I$$20130725$20140603$20140603$EXP$$JP-JNJFOC-20140511184$JANSSEN$$$$$$Y$$$20140603$$MD$JP$JP
102148483$10214848$3$F$20130512$20140603$20140603$20140605$EXP$$RU-JNJFOC-20130508135$JANSSEN$$56$YR$A$F$Y$71$KG$20140605$$MD$RU$RU
102153106$10215310$6$F$20140506$20191002$20140603$20191017$EXP$$PHHO2014CA007117$NOVARTIS$$35$YR$$F$Y$90.2$KG$20191017$$HP$US$CA
102173084$10217308$4$F$2014$20200721$20140604$20200729$EXP$$CA-ABBVIE-14P-028-1242139-00$ABBVIE$$$$$F$Y$63.56$KG$20200729$$CN$CA$CA
1021844110$10218441$10$F$20140527$20200923$20140605$20200929$EXP$$PHHO2014ES007772$NOVARTIS$$40$YR$$F$Y$66.6$KG$20200929$$MD$ES$ES
102205582$10220558$2$F$$20140611$20140606$20140616$EXP$$TR-ROCHE-1412646$ROCHE$AVCI F, MERDIN A, GOKSU S AND COSKUN H. SEVERE HYPOCALCEMIA AFTER ORAL IBANDRONATE IN A PATIENT WITH METASTATIC BREAST CANCER: A CASE REPORT.. TURK ONKOLOJI DERGISI. 2014 JAN 01?29 (1):21?23.$47$YR$$F$Y$$$20140616$$HP$TR$TR
102223393$10222339$3$F$20140521$20140625$20140606$20140701$EXP$$US-JNJFOC-20140600857$ETHICON$$62$YR$A$F$Y$$$20140701$$MD$US$US
102224258$10222425$8$F$20140527$20150504$20140606$20150512$EXP$$IT-JNJFOC-20140604399$PHARMACYCLICS$$72$YR$E$M$Y$73.5$KG$20150512$$MD$IT$IT
102230071$10223007$1$I$20111211$20140528$20140607$20140607$EXP$$PHHY2014US066018$SANDOZ$$73$YR$$F$Y$$$20140608$$CN$US$US
102230141$10223014$1$I$20110804$20140528$20140607$20140607$EXP$$PHHY2014US066015$SANDOZ$$65$YR$$F$Y$$$20140608$$MD$US$US
102253957$10225395$7$F$20140505$20180202$20140609$20180207$EXP$$US-JNJFOC-20140605165$PHARMACYCLICS$$74$YR$E$F$Y$$$20180207$$MD$US$US
1022758761$10227587$61$F$20130723$20200917$20140610$20200930$EXP$$CA-ROCHE-1411673$ROCHE$$63$YR$$F$Y$$$20200930$$MD$CA$CA
102281004$10228100$4$F$20131014$20200921$20140610$20200928$EXP$$PHHY2014GB070235$NOVARTIS$$67$YR$$F$Y$63.8$KG$20200928$$MD$GB$GB
1023164231$10231642$31$F$20120505$20200721$20140611$20200729$EXP$$PHHY2012CA036601$NOVARTIS$$55$YR$$F$Y$$$20200729$$MD$CA$CA
102340403$10234040$3$F$20140530$20140702$20140612$20140710$EXP$$US-JNJFOC-20140607273$PHARMACYCLICS$$51$YR$A$F$Y$89.2$KG$20140710$$MD$US$US
102340427$10234042$7$F$20140430$20180226$20140612$20180301$EXP$$IT-JNJFOC-20140501042$PHARMACYCLICS$$74$YR$E$F$Y$$$20180301$$MD$IT$IT
102340836$10234083$6$F$19950101$20200715$20140612$20200716$EXP$$IE-ABBVIE-14P-229-1246597-00$ABBVIE$$0$YR$$M$Y$$$20200716$$CN$IE$IE
1023501114$10235011$14$F$20130221$20180920$20140613$20200824$EXP$$PHHY2013US099694$NOVARTIS$$59$YR$$F$Y$65.76$KG$20200824$$MD$US$US
102357252$10235725$2$F$20140527$20140716$20140613$20140722$EXP$$BR-JNJFOC-20140606243$PHARMACYCLICS$$71$YR$E$F$Y$68$KG$20140722$$MD$BR$BR
102361915$10236191$5$F$20140518$20150318$20140613$20150427$EXP$$PL-JNJFOC-20140513814$PHARMACYCLICS$$58$YR$A$F$Y$71$KG$20150427$$MD$PL$PL
1023653014$10236530$14$F$2012$20200916$20140613$20200921$PER$$US-PFIZER INC-2014162189$PFIZER$$61$YR$$F$Y$43$KG$20200921$$MD$US$US
102370042$10237004$2$F$20140603$20140716$20140613$20140724$EXP$$NZ-JNJFOC-20140609343$PHARMACYCLICS$$80$YR$E$M$Y$63$KG$20140724$$MD$NZ$NZ
102379561$10237956$1$I$20140516$20140603$20140616$20140616$EXP$$US-JNJFOC-20140602258$JANSSEN$$43$YR$A$F$Y$$$20140616$$MD$US$US
102381935$10238193$5$F$201210$20200305$20140616$20200730$EXP$$AT-RANBAXY-2014R1-82355$RANBAXY$$89$YR$$F$Y$68$KG$20200731$$HP$NL$AT
102384021$10238402$1$I$$20130725$20140616$20140616$EXP$$JP-JNJFOC-20140511186$JANSSEN$$$$$$Y$$$20140616$$MD$JP$JP
102386882$10238688$2$F$$20200911$20140616$20200917$EXP$$US-SA-2014SA076747$SANOFI AVENTIS$$$$$F$Y$$$20200917$$CN$US$US
102396053$10239605$3$F$20140318$20180329$20140616$20180412$EXP$$CN-JNJFOC-20140315578$PHARMACYCLICS$$54$YR$A$M$Y$86$KG$20180412$$MD$CN$CN
102421221$10242122$1$I$20131024$20140606$20140617$20140617$EXP$$PHHY2014GB070620$SANDOZ$$68$YR$$M$Y$$$20140617$$CN$GB$GB
102427779$10242777$9$F$$20200730$20140617$20200805$EXP$$PHHY2014PT072521$NOVARTIS$CALDEIRA L.. VARIOUS DRUGS COGNITIVE DECLINE, MYOCLONUS, HYPERREFLEXIA AND ATAXIA IN AN ELDERLY PATIENT: CASE REPORT.. REACTIONS WEEKLY. 2015?1548:263$68$YR$$F$Y$$$20200805$$HP$PT$PT
1024472110$10244721$10$F$2014$20200901$20140618$20200903$PER$$US-PFIZER INC-2014163155$PFIZER$$61$YR$$M$Y$80.5$KG$20200903$$MD$US$US
102494393$10249439$3$F$20130715$20200810$20140620$20200811$EXP$$PHHY2014FR075308$NOVARTIS$$72$YR$$M$Y$$$20200811$$HP$FR$FR
102527312$10252731$2$F$20140611$20140625$20140623$20140709$EXP$$US-JNJFOC-20140609864$PHARMACYCLICS$$70$YR$E$M$Y$78.02$KG$20140709$$MD$US$US
102534135$10253413$5$F$20140531$20200702$20140623$20200706$PER$$PHHY2014US076342$NOVARTIS$$48$YR$$F$Y$92$KG$20200706$$MD$US$US
102536345$10253634$5$F$20140618$20140905$20140623$20140918$PER$$GB-JNJFOC-20140614613$PHARMACYCLICS$$71$YR$E$M$Y$84.05$KG$20140911$$MD$GB$GB
102543162$10254316$2$F$$20140618$20140624$20140625$EXP$$GB-ROCHE-1419381$ROCHE$$47$YR$$F$Y$$$20140625$$MD$GB$GB
102572161$10257216$1$I$$20140609$20140620$20140620$EXP$$2014IT00546$CIPLA$$$$$$N$$$20140619$N$$IT$
102577057$10257705$7$F$20140605$20141115$20140625$20200714$EXP$$US-NOVOPROD-413487$NOVO NORDISK$$59$YR$$F$Y$81.18$KG$20200714$$MD$US$US
102613508$10261350$8$F$20140611$20151109$20140626$20151113$EXP$$FR-JNJFOC-20140608967$PHARMACYCLICS$$74$YR$E$M$Y$57$KG$20151113$$MD$FR$FR
102616761$10261676$1$I$$20140616$20140626$20140626$EXP$$PHHY2014PT075195$SANDOZ$RODRIGUES M, BRITO M, VILLAR M, CORREIA P. TREATMENT OF MULTIDRUG?RESISTANT AND EXTENSIVELY DRUG?RESISTANT TUBERCULOSIS IN ADOLESCENT PATIENTS.. THE PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2013?33 (6):657?659$17$YR$$M$Y$64$KG$20140626$$HP$PT$PT
102624063$10262406$3$F$20140614$20151216$20140626$20151223$EXP$$CN-JNJFOC-20140615853$PHARMACYCLICS$$72$YR$E$M$Y$60$KG$20151223$$MD$CN$CN
102647413$10264741$3$F$201301$20200806$20140627$20200904$PER$$US-SHIRE-US201402305$SHIRE$$31$YR$$F$Y$80$KG$20200904$$MD$US$US
102648142$10264814$2$F$20140331$20140624$20140627$20140708$PER$$GB-JNJFOC-20140614477$JANSSEN$$19$YR$A$F$Y$89$KG$20140708$$MD$GB$GB
102653676$10265367$6$F$20140516$20141210$20140627$20141222$EXP$$US-JNJFOC-20140612775$JANSSEN$$43$YR$A$F$Y$70.6$KG$20141222$$MD$US$US
102666281$10266628$1$I$$20140624$20140629$20140629$EXP$$PHHY2014BB079033$NOVARTIS$MUDARADDI R, KINTHALA S, RAMACHANDRA UB.. INTRA?OPERATIVE BRONCHOSPASM IN A PATIENT WHO WAS SCHEDULED FOR EMERGENCY CAESAREAN SECTION UNDER SPINAL ANAESTHESIA. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 2012?6(3):488?489$20$YR$$F$Y$$$20140702$$HP$BB$BB
1026684118$10266841$18$F$20170720$20200618$20140630$20200707$EXP$$CA-ROCHE-1426159$ROCHE$$41$YR$$F$Y$$$20200707$$CN$CA$CA
102682491$10268249$1$I$20130508$20140619$20140630$20140630$EXP$$US-CELGENEUS-163-21880-14063595$CELGENE$$67$YR$$M$Y$66.9$KG$20140630$$MD$US$US
102682869$10268286$9$F$20140614$20150429$20140630$20150511$EXP$$ES-JNJFOC-20140615604$JANSSEN$$66$YR$E$M$Y$$$20150511$$MD$ES$ES
102684583$10268458$3$F$$20150316$20140630$20150319$EXP$$IT-ELI_LILLY_AND_COMPANY-IT201406008986$ELI LILLY AND CO$$61$YR$$M$Y$65.4$KG$20150319$$CN$US$IT
1026921947$10269219$47$F$2013$20200917$20140701$20200921$EXP$$CA-ROCHE-1188671$ROCHE$$62$YR$$F$Y$58$KG$20200921$$HP$CA$CA
102700245$10270024$5$F$20140406$20151229$20140701$20160106$PER$$JP-JNJFOC-20140502718$JANSSEN$$66$YR$E$M$Y$69$KG$20160106$$MD$JP$JP
102717132$10271713$2$F$201401$20200908$20140701$20200915$PER$$US-SA-2014SA029070$SANOFI AVENTIS$$18$YR$$F$Y$$$20200915$$CN$US$US
102729762$10272976$2$F$201401$20200925$20140702$20200930$EXP$$DE-ASTRAZENECA-2014SE46711$ASTRAZENECA$$52$YR$$M$Y$87$KG$20200930$$$DE$DE
102779823$10277982$3$F$20140413$20141126$20140704$20141202$EXP$$US-JNJFOC-20140618319$JANSSEN$$81$YR$E$$Y$66.68$KG$20141202$$MD$US$US
102780334$10278033$4$F$20140623$20171018$20140704$20171027$EXP$$TR-JNJFOC-20140616436$PHARMACYCLICS$$68$YR$E$F$Y$68.5$KG$20171027$$MD$TR$TR
102782626$10278262$6$F$20200831$20200914$20140704$20200916$PER$$US-PFIZER INC-2014182745$PFIZER$$71$YR$$F$Y$73$KG$20200916$$CN$US$US
102783801$10278380$1$I$$20140627$20140704$20140704$EXP$$CH-ROCHE-1427171$ROCHE$PETKIN K, GRUNINGER P AND MEIER C. A FRACTURE ^WITH A MASSAGE^. SWISS MEDICAL FORUM 2014 JUN 25?14(26):506?508.$91$YR$$F$Y$$$20140704$$MD$CH$CH
102799315$10279931$5$F$20140520$20151029$20140707$20151102$EXP$$US-JNJFOC-20140618332$JANSSEN$$57$YR$A$F$Y$87.09$KG$20151102$$MD$US$US
102805012$10280501$2$F$$20200825$20140707$20200827$PER$$US-PFIZER INC-2014182687$PFIZER$$54$YR$$F$Y$85.26$KG$20200827$$CN$US$US
102850434$10285043$4$F$2020$20200910$20140708$20200915$EXP$$US-PFIZER INC-2014187482$PFIZER$$67$YR$$F$Y$104.33$KG$20200915$$CN$US$US
102851071$10285107$1$I$$20140701$20140708$20140708$EXP$$JP-PFIZER INC-2014183766$PFIZER$SATOSHI YAMAGUCHI. A CASE WITH MILD CHRONIC KIDNEY DISEASE OF INTRAOPERATIVE SUDDEN CARDIAC ARREST INDUCED BY SEVERE HYPERKALEMIA AND METABOLIC ACIDOSIS. ICU + CCU. 2014?38(5):331?335$79$YR$$M$Y$53$KG$20140708$$MD$JP$JP
1028518534$10285185$34$F$20140703$20200820$20140708$20200825$EXP$$CA-ROCHE-1267909$ROCHE$$49$YR$$F$Y$79$KG$20200825$$HP$CA$CA
102851952$10285195$2$F$20140425$20140627$20140708$20140708$PER$$FR-JNJFOC-20140500625$PHARMACYCLICS$$70$YR$E$M$Y$93$KG$20140708$$MD$FR$FR
102852045$10285204$5$F$201403$20200824$20140708$20200827$EXP$$US-SA-2014SA039870$SANOFI AVENTIS$$51$YR$$F$Y$$$20200827$$CN$US$US
1028637516$10286375$16$F$2013$20200805$20140709$20200807$EXP$$US-PFIZER INC-2014190883$PFIZER$$70$YR$$F$Y$66$KG$20200807$$HP$US$US
102872563$10287256$3$F$20140510$20140902$20140709$20140912$EXP$$DE-JNJFOC-20140705212$JANSSEN$$81$YR$E$M$Y$80$KG$20140912$$MD$DE$DE
102878603$10287860$3$F$20140513$20150903$20140709$20150909$EXP$$FR-BAYER-2014-083948$BAYER$$74$YR$E$M$Y$60$KG$20150909$$MD$FR$FR
102891314$10289131$4$F$$20200428$20140710$20200814$EXP$$CA-ROCHE-1430978$ROCHE$$77$YR$$F$Y$$$20200814$$HP$CA$CA
102894112$10289411$2$F$$20200701$20140710$20200705$EXP$$PHHY2014PT083263$NOVARTIS$$19$YR$$F$Y$$$20200706$$HP$PT$PT
102942342$10294234$2$F$201501$20200319$20140710$20200807$PER$$US-PURDUE-USA-2014-0111671$PURDUE$$60$YR$$F$Y$$$20200807$$CN$US$US
102948174$10294817$4$F$$20200224$20140710$20200807$PER$$US-PURDUE-USA-2014-0111924$PURDUE$$$$$F$Y$62.13$KG$20200807$$MD$US$US
102957202$10295720$2$F$201312$20200210$20140710$20200807$PER$$US-PURDUE-USA-2014-0115128$PURDUE$$55$YR$$F$Y$$$20200807$$MD$US$US
102985303$10298530$3$F$201307$20200821$20140711$20200828$EXP$$US-SANOFI-AVENTIS-2013SA075954$SANOFI AVENTIS$$66$YR$$F$Y$$$20200828$$CN$US$US
103013726$10301372$6$F$20140617$20141122$20140714$20141126$EXP$$FR-JNJFOC-20140704245$PHARMACYCLICS$$80$YR$E$M$Y$70$KG$20141126$$PH$FR$FR
103019475$10301947$5$F$$20200914$20140714$20200915$EXP$$PHHY2014BE043333$NOVARTIS$GILISSEN L, BOECKXSTAENS E, GEEBELEN J, GOOSSENS A. OCCUPATIONAL ALLERGIC CONTACT DERMATITIS FROM SYSTEMIC DRUGS. CONTACT DERMATITIS. 2020?82(1):24?30$44$YR$$F$Y$$$20200915$$HP$BE$BE
103043922$10304392$2$F$$20161227$20140715$20170110$EXP$$BB-RANBAXY-2014US-83299$RANBAXY$$20$YR$$F$Y$$$20170110$$CN$US$BB
103077412$10307741$2$F$2014$20200902$20140716$20200907$EXP$$US-SA-2014SA090633$SANOFI AVENTIS$$$$$$Y$$$20200907$$MD$US$US
103086221$10308622$1$I$$20140707$20140716$20140716$EXP$$HR-GLAXOSMITHKLINE-B1014211A$GLAXOSMITHKLINE$BROZOVIC G, SUNKO BM, HAFNER T, BEKAVAC I. ALLERGIC REACTION TO SUXAMETHONIUM DURING EMERGENCY CAESAREAN SECTION AND PSEUDOCHOLINESTERASE DEFICIENCY IN THE SAME PATIENT. WIEN KLIN WOCHENSCHR, 2014?$33$YR$$F$Y$$$20140716$$MD$HR$HR
103106313$10310631$3$F$$20200807$20140717$20200813$EXP$$GB-ROCHE-1030071$ROCHE$, DONEHOWER R, DAVIDENKO I, TJULANDIN S, DEPTALA A, HARRISON M, NIRNI S, LAKSHMAIAH, K, THOMAS A, JIANG Y, ZHU M, TANG R, ANDERSON A, DUBEY S, OLINER K AND LOH E. RILOTUMUMAB IN COMBINATION WITH EPIRUBICIN, CISPLATIN, AND CAPECITABINE AS FIRST?LINE TREATMENT FOR GASTRIC OR OESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA: AN OPEN?LABEL, DOSE DE?ESCALATION PHASE 1B STUDY AND A DOUBLE?BLIND, RANDOMISED PHASE 2. THE LANCET ONCOLOGY 2014 AUG?15:1?12.$$$$$Y$$$20200813$$MD$GB$GB
103121873$10312187$3$F$2009$20200622$20140718$20200702$EXP$$CA-ROCHE-1436298$ROCHE$$37$YR$$F$Y$$$20200702$$CN$CA$CA
103140722$10314072$2$F$20140505$20140711$20140718$20140718$EXP$$GB-JNJFOC-20140504628$PHARMACYCLICS$$69$YR$E$F$Y$60$KG$20140718$$MD$GB$GB
103280802$10328080$2$F$$20140721$20140721$20140730$EXP$$ES-ROCHE-1434313$ROCHE$CASADO E, VAZQUEZ I, LARROSA M, GARCIA?MANRIQUE M,GONZALEZ J AND GRATACOS J ATYPICAL FEMORAL FRACTURES: FROM THE PAIN WITHOUT FRACTURE TO THE FRACTURE WITHOUT PAIN. JOURNAL OF BONE AND MINERAL RESEARCH 2011 JAN 01?26 (SUP1):?.$$$$F$Y$$$20140730$$HP$ES$ES
103287183$10328718$3$F$20131122$20200723$20140721$20200727$EXP$$FR-PFIZER INC-2014201593$PFIZER$$56$YR$$M$Y$135$KG$20200727$$HP$FR$FR
103291658$10329165$8$F$201406$20200915$20140721$20200924$EXP$$PHHY2014AU086707$NOVARTIS$$68$YR$$M$Y$$$20200924$$MD$AU$AU
103295575$10329557$5$F$20140512$20140902$20140721$20140915$EXP$$DE-JNJFOC-20140701303$PHARMACYCLICS$$62$YR$A$M$Y$79$KG$20140915$$MD$DE$DE
103312754$10331275$4$F$20140415$20141127$20140722$20141204$PER$$AU-JNJFOC-20140417505$PHARMACYCLICS$$70$YR$E$F$Y$79.5$KG$20141204$$PH$AU$AU
103379946$10337994$6$F$20200801$20200901$20140724$20200904$EXP$$PHHY2014CA089356$NOVARTIS$$66$YR$$M$Y$$$20200904$$MD$CA$CA
103380661$10338066$1$I$20051112$20140716$20140724$20140724$EXP$$GB-ROCHE-1436677$ROCHE$$$$$M$Y$75$KG$20140724$$MD$GB$GB
103381215$10338121$5$F$20140701$20170801$20140724$20170810$EXP$$JP-JNJFOC-20140704695$JANSSEN$$84$YR$E$F$Y$48$KG$20170810$$MD$JP$JP
103381429$10338142$9$F$20140716$20141110$20140724$20141112$EXP$$BE-JNJFOC-20140714718$PHARMACYCLICS$$68$YR$E$F$Y$$$20141112$$MD$BE$BE
103394284$10339428$4$F$$20200924$20140724$20200929$PER$$US-PFIZER INC-2014206917$PFIZER$$71$YR$$F$Y$91.63$KG$20200929$$MD$US$US
103395861$10339586$1$I$20140708$20140715$20140724$20140724$EXP$$PHHY2014IT087113$SANDOZ$$45$YR$$M$Y$$$20140724$$CN$IT$IT
1034204736$10342047$36$F$2012$20200914$20140725$20200924$EXP$$CA-ROCHE-1425950$ROCHE$$51$YR$$F$Y$$$20200925$$HP$CA$CA
103430351$10343035$1$I$20140703$20140714$20140725$20140725$EXP$$FR-JNJFOC-20140709968$JANSSEN$$60$YR$A$M$Y$$$20140725$$MD$FR$FR
103431215$10343121$5$F$20140706$20140926$20140725$20141006$PER$$BE-JNJFOC-20140705082$PHARMACYCLICS$$72$YR$E$M$Y$75$KG$20141006$$MD$BE$BE
103431241$10343124$1$I$20140717$20140718$20140725$20140725$EXP$$DK-JNJFOC-20140715161$PHARMACYCLICS$$71$YR$E$M$Y$72$KG$20140731$$MD$DK$DK
103432083$10343208$3$F$20140327$20140725$20140725$20140807$EXP$$IT-JNJFOC-20140506495$PHARMACYCLICS$$85$YR$E$M$Y$68$KG$20140807$$MD$IT$IT
103444861$10344486$1$I$$20140716$20140728$20140728$EXP$$US-ROCHE-1439936$ROCHE$$75$YR$$F$Y$$$20140728$$CN$US$US
103453393$10345339$3$F$20140714$20140815$20140728$20140825$EXP$$US-JNJFOC-20140714901$JANSSEN$$52$YR$A$F$Y$81$KG$20140825$$MD$US$US
103458091$10345809$1$I$20140520$20140718$20140728$20140728$EXP$$PHHY2014FR089273$SANDOZ$$68$YR$$M$Y$$$20140728$$HP$FR$FR
103460812$10346081$2$F$20140717$20140725$20140728$20140807$EXP$$DE-JNJFOC-20140717076$PHARMACYCLICS$$56$YR$A$F$Y$56$KG$20140807$$MD$DE$DE
103462342$10346234$2$F$$20200709$20140728$20200715$EXP$$GB-ABBVIE-14P-167-1265448-00$ABBVIE$$1$DY$$M$Y$$$20200715$$CN$GB$GB
103471871$10347187$1$I$$20140720$20140729$20140729$EXP$$GB-ELI_LILLY_AND_COMPANY-GB201407009813$ELI LILLY AND CO$$$$A$$Y$$$20140728$$HP$GB$GB
103474283$10347428$3$F$201202$20200812$20140729$20200813$EXP$$US-PFIZER INC-2014208734$PFIZER$$63$YR$$M$Y$86$KG$20200813$$HP$US$US
103474703$10347470$3$F$20140212$20200720$20140729$20200803$EXP$$IE-SHIRE-IE201400546$SHIRE$$$$$$Y$$$20200803$$HP$IE$IE
103488626$10348862$6$F$20140710$20200727$20140729$20200731$EXP$$US-PFIZER INC-2014204200$PFIZER$SANDBORN, W.. INCIDENCE OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL DEVELOPMENT PROGRAMME. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2019?7 (8 SUPPL.):357$70$YR$$M$Y$90.7$KG$20200731$$HP$US$US
103510261$10351026$1$I$20140520$20140721$20140730$20140730$EXP$$FR-ASTRAZENECA-2014SE53152$ASTRAZENECA$$25155$DY$$M$Y$$$20140730$$MD$FR$FR
103511052$10351105$2$F$20140430$20200806$20140730$20200813$EXP$GB-MHRA-ADR 22612568$GB-ASTELLAS-2014EU010320$ASTELLAS$$67$YR$$F$Y$$$20200813$$MD$GB$GB
103530502$10353050$2$F$201305$20200616$20140730$20200727$PER$$US-ABBVIE-14P-163-1233454-00$ABBVIE$$41$YR$$F$Y$$$20200727$$CN$US$US
103554697$10355469$7$F$20140719$20160624$20140731$20160630$EXP$$AU-JNJFOC-20140716493$PHARMACYCLICS$$69$YR$E$M$Y$117$KG$20160630$$CN$AU$AU
103558737$10355873$7$F$$20200612$20140801$20200618$EXP$$CA-ROCHE-1442547$ROCHE$$64$YR$$F$Y$69$KG$20200618$$HP$CA$CA
103558796$10355879$6$F$20080515$20200714$20140801$20200716$EXP$$US-ROCHE-1401802$ROCHE$$37$YR$$M$Y$86.26$KG$20200716$$CN$US$US
103558841$10355884$1$I$20140717$20140728$20140801$20140801$EXP$GB-MHRA-TPP 13284778C414444YC1405596861600$GB-ROCHE-1441845$ROCHE$$75$YR$$F$Y$93$KG$20140801$$MD$GB$GB
103566381$10356638$1$I$20140707$20140724$20140801$20140801$EXP$$US-JNJFOC-20140717162$JANSSEN$$48$YR$A$M$Y$$$20140801$$MD$US$US
103568352$10356835$2$F$20140528$20200630$20140801$20200708$EXP$$PHHY2014ES093983$NOVARTIS$$52$YR$$F$Y$78$KG$20200708$$HP$COUNTRY NOT SPECIFIED$ES
103569372$10356937$2$F$20140611$20140721$20140801$20140801$EXP$$CN-JNJFOC-20140609912$PHARMACYCLICS$$45$YR$A$M$Y$70$KG$20140801$$MD$CN$CN
1035760129$10357601$29$F$20120312$20200807$20140801$20200812$EXP$$PHHY2014US044505$NOVARTIS$$53$YR$$F$Y$70.3$KG$20200812$$HP$US$US
103581351$10358135$1$I$20140520$20140718$20140801$20140801$EXP$$FR-JNJFOC-20140718420$JANSSEN$$68$YR$E$M$Y$$$20140801$$MD$FR$FR
103582173$10358217$3$F$$20200803$20140801$20200804$EXP$$US-PFIZER INC-2014214082$PFIZER$$57$YR$$M$Y$$$20200804$$CN$US$US
103590702$10359070$2$F$$20200914$20140804$20200928$EXP$$US-ROCHE-1441176$ROCHE$$$$$$Y$$$20200929$$HP$US$US
1035980817$10359808$17$F$2013$20200910$20140804$20200918$EXP$$PHHY2014CA058372$NOVARTIS$$61$YR$$M$Y$$$20200918$$CN$CA$CA
103604242$10360424$2$F$$20200706$20140804$20200708$PER$$US-PFIZER INC-2014216426$PFIZER$$71$YR$$F$Y$77.1$KG$20200708$$CN$US$US
103624651$10362465$1$I$20140331$20140728$20140805$20140805$EXP$$PHHY2014GB095687$SANDOZ$$62$YR$$M$Y$61$KG$20140805$$CN$GB$GB
1036288011$10362880$11$F$20140717$20200625$20140805$20200701$EXP$$JP-OTSUKA-JP-2014-16186$OTSUKA$$67$YR$$F$Y$46.2$KG$20200701$$MD$JP$JP
103664658$10366465$8$F$20140722$20170626$20140806$20170704$EXP$$US-JNJFOC-20140801299$PHARMACYCLICS$$51$YR$A$M$Y$78.6$KG$20170704$$MD$US$US
103691853$10369185$3$F$20140703$20140813$20140807$20140827$EXP$$FR-JNJFOC-20140707745$PHARMACYCLICS$$65$YR$A$M$Y$77$KG$20140827$$MD$FR$FR
103729893$10372989$3$F$20130411$20140828$20140808$20140911$EXP$$US-JNJFOC-20130413285$PHARMACYCLICS$$61$YR$A$M$Y$77.3$KG$20140911$$MD$US$US
103752483$10375248$3$F$20140729$20140828$20140811$20140903$EXP$$CN-JNJFOC-20140802727$PHARMACYCLICS$$58$YR$A$M$Y$86$KG$20140903$$MD$CN$CN
103755744$10375574$4$F$20140802$20150327$20140811$20150402$EXP$$GB-JNJFOC-20140804226$PHARMACYCLICS$$80$YR$E$F$Y$57.2$KG$20150402$$MD$GB$GB
1037705931$10377059$31$F$20130725$20200923$20140812$20200930$EXP$$CA-ROCHE-1254453$ROCHE$$65$YR$$F$Y$70$KG$20201001$$HP$CA$CA
1037889510$10378895$10$F$20120314$20180518$20140812$20180524$EXP$$MX-ACTELION-A-CH2013-80691$ACTELION$$43$YR$A$F$Y$73$KG$20180524$$MD$MX$MX
103824548$10382454$8$F$2014$20200831$20140813$20200904$EXP$$US-SA-2014SA056132$SANOFI AVENTIS$$58$YR$$F$Y$$$20200904$$CN$US$US
103828165$10382816$5$F$20141202$20200924$20140813$20200930$EXP$$US-SA-2013SA114305$SANOFI AVENTIS$$$$$$Y$$$20200930$$CN$US$US
103829293$10382929$3$F$20140325$20200714$20140813$20200721$EXP$$US-SA-2014SA040174$SANOFI AVENTIS$$31$YR$$M$Y$67.13$KG$20200721$$PH$US$US
103834362$10383436$2$F$20140207$20200805$20140814$20200811$EXP$$DE-ROCHE-1448629$ROCHE$$75$YR$$M$Y$$$20200811$$MD$DE$DE
1038414910$10384149$10$F$20140807$20200924$20140814$20200928$PER$$US-PFIZER INC-2014221583$PFIZER$$72$YR$$F$Y$73$KG$20200928$$MD$US$US
103882842$10388284$2$F$20140805$20140918$20140815$20140924$EXP$$CN-JNJFOC-20140809175$PHARMACYCLICS$$41$YR$A$F$Y$70$KG$20140924$$MD$CN$CN
103917914$10391791$4$F$$20200729$20140819$20200807$EXP$$US-ROCHE-1447951$ROCHE$$$$$$Y$$$20200807$$MD$US$US
1039223216$10392232$16$F$2014$20200916$20140819$20200924$EXP$$BR-ROCHE-1401352$ROCHE$$67$YR$$F$Y$86$KG$20200925$$HP$BR$BR
1039277260$10392772$60$F$2015$20200903$20140819$20200906$EXP$$CA-ROCHE-1448798$ROCHE$$77$YR$$F$Y$73$KG$20200907$$HP$CA$CA
103928075$10392807$5$F$2007$20200814$20140819$20200819$PER$$US-JNJFOC-20140814952$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20200819$$LW$US$US
1039375511$10393755$11$F$201407$20200917$20140819$20200922$EXP$$US-PFIZER INC-2014227153$PFIZER$$70$YR$$F$Y$70$KG$20200922$$MD$US$US
103971504$10397150$4$F$20130406$20141105$20140820$20141112$EXP$$US-JNJFOC-20130503845$PHARMACYCLICS$$58$YR$A$M$Y$98.2$KG$20141112$$MD$US$US
103971517$10397151$7$F$20140806$20150414$20140820$20150422$EXP$$AU-JNJFOC-20140810313$PHARMACYCLICS$$76$YR$E$M$Y$$$20150422$$MD$AU$AU
103983265$10398326$5$F$20140808$20140911$20140821$20140922$EXP$$ZA-JNJFOC-20140814241$JANSSEN$$36$YR$A$M$Y$83$KG$20140922$$MD$ZA$ZA
104001864$10400186$4$F$201408$20200817$20140821$20200821$EXP$$CA-SA-2014SA109174$SANOFI AVENTIS$$47$YR$$F$Y$$$20200821$$CN$CA$CA
104021664$10402166$4$F$20140808$20170801$20140822$20170810$EXP$$AR-JNJFOC-20140816392$JANSSEN$$71$YR$E$F$Y$59$KG$20170810$$MD$AR$AR
104030534$10403053$4$F$20140719$20140910$20140822$20140911$EXP$$CN-JNJFOC-20140715501$PHARMACYCLICS$$71$YR$E$M$Y$54$KG$20140911$$MD$CN$CN
104033413$10403341$3$F$20140710$20200629$20140822$20200707$EXP$$US-ROCHE-1435546$ROCHE$$66$YR$$F$Y$65.83$KG$20200708$$CN$US$US
104066582$10406658$2$F$20140814$20141126$20140825$20141209$PER$$US-JNJFOC-20140816618$JANSSEN$$63$YR$A$F$Y$82.1$KG$20141209$$MD$US$US
104070886$10407088$6$F$20140819$20200908$20140825$20200911$PER$$US-PFIZER INC-2014235662$PFIZER$$73$YR$$F$Y$86$KG$20200911$$HP$US$US
104075905$10407590$5$F$$20200820$20140825$20200824$PER$$US-PFIZER INC-2014235848$PFIZER$$47$YR$$F$Y$69$KG$20200824$$HP$US$US
104086203$10408620$3$F$20140501$20200820$20140826$20200902$EXP$GB-MHRA-EYC 00113816$GB-LUPIN PHARMACEUTICALS INC.-E2B_00002398$LUPIN$$62$YR$$M$Y$$$20200902$$CN$GB$GB
104096073$10409607$3$F$20090904$20200720$20140826$20200925$EXP$$GB-SHIRE-GB201405315$SHIRE$$$$$$Y$$$20200925$$MD$GB$GB
104105271$10410527$1$I$$20140818$20140826$20140826$EXP$$PHHY2014HR103553$SANDOZ$BROZOVIC G, MAZUL SUNKO B, HAFNER T, BEKAVAC I.. ALLERGIC REACTION TO SUXAMETHONIUM DURING EMERGENCY CAESAREAN SECTION AND PSEUDOCHOLINESTERASE DEFICIENCY IN THE SAME PATIENT.. WIENER KLINISCHE WOCHENSCHRIFT. 2014?126 (1314):435?8$33$YR$$F$Y$$$20140826$$HP$HR$HR
104123602$10412360$2$F$201006$20200618$20140827$20200827$PER$$US-LUPIN PHARMACEUTICALS INC.-E2B_00001311$LUPIN$$70$YR$$F$Y$69.84$KG$20200827$$MD$US$US
104128444$10412844$4$F$$20200928$20140827$20200929$EXP$$PHHY2014PT103379$NOVARTIS$$53$YR$$F$Y$$$20200929$$HP$PT$PT
104218013$10421801$3$F$$20200916$20140901$20200923$EXP$$GB-AUROBINDO-AUR-APL-2014-08957$AUROBINDO$AMLODIPINE/DOXAZOSIN/RAMIPRIL OVERDOSE?HYPOTENSION AND ACIDOSIS: CASE REPORT. 2015$58$YR$$M$Y$$$20200923$$HP$GB$GB
104226902$10422690$2$F$$20200713$20140902$20200721$EXP$$US-AUROBINDO-AUR-APL-2014-09172$AUROBINDO$BENAZEPRIL UPPER RESPIRATORY SYMPTOMS: 2 CASE REPORTS. 2014$78$YR$$M$Y$$$20200721$$HP$US$US
104226922$10422692$2$F$$20200713$20140902$20200723$EXP$$US-AUROBINDO-AUR-APL-2014-09165$AUROBINDO$BENAZEPRIL UPPER RESPIRATORY SYMPTOMS: 2 CASE REPORTS. 2014$67$YR$$M$Y$$$20200723$$HP$US$US
104226982$10422698$2$F$$20200722$20140902$20200730$EXP$$US-AUROBINDO-AUR-APL-2014-09226$AUROBINDO$$48$YR$$F$Y$92.6$KG$20200731$$HP$US$US
104227142$10422714$2$F$$20200907$20140902$20200911$EXP$$US-AUROBINDO-AUR-APL-2014-09219$AUROBINDO$$59$YR$$F$Y$$$20200911$$HP$US$US
104230572$10423057$2$F$$20140908$20140902$20140915$EXP$$IN-ROCHE-1457094$ROCHE$. IBANDRONIC ACID. BILATERAL ATYPICAL FEMORAL SHAFT FRACTURES: CASE REPORT.. REACTIONS 2014 JAN 01?1494:28?29.$58$YR$$F$Y$$$20140915$$HP$IN$IN
1042483611$10424836$11$F$20140911$20200914$20140902$20200918$EXP$$US-PFIZER INC-2014243931$PFIZER$$71$YR$$F$Y$$$20200918$$HP$US$US
104270533$10427053$3$F$20140824$20150206$20140903$20150218$EXP$$PHHO2014GB011739$NOVARTIS$$56$YR$$M$Y$77.3$KG$20150218$$HP$GB$GB
104294774$10429477$4$F$$20200813$20140904$20200814$PER$$US-PFIZER INC-2014243892$PFIZER$$49$YR$$F$Y$$$20200814$$MD$US$US
104302523$10430252$3$F$$20140910$20140904$20200821$EXP$$GB-CELGENEUS-167-21880-14044438$CELGENE$$$$$F$Y$50$KG$20200821$$HP$GB$GB
104306316$10430631$6$F$2011$20200724$20140904$20200729$EXP$$CA-ABBVIE-14K-028-1277691-00$ABBVIE$$$$$M$Y$$$20200729$$MD$CA$CA
104306493$10430649$3$F$2014$20200707$20140904$20200709$EXP$$US-PFIZER INC-2014245237$PFIZER$$70$YR$$F$Y$$$20200709$$CN$US$US
104307801$10430780$1$I$20130911$20140827$20140904$20140904$EXP$$US-CELGENEUS-163-21880-14085392$CELGENE$$68$YR$$M$Y$66.9$KG$20140904$$MD$US$US
104324033$10432403$3$F$$20200723$20140905$20200806$EXP$$NL-RANBAXY-2014R1-78440$RANBAXY$$82$YR$$M$Y$$$20200806$$HP$NL$NL
104358533$10435853$3$F$20130515$20140908$20140908$20140909$EXP$$DE-ROCHE-1438011$ROCHE$$70$YR$$F$Y$68$KG$20140909$$MD$DE$DE
104361379$10436137$9$F$$20200820$20140908$20200826$EXP$$JP-PFIZER INC-2014248727$PFIZER$OK, S.. LIPID EMULSION TREATMENT OF AMLODIPINE TOXICITY. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2020?45 (2):10.1111/JCPT.13119$73$YR$$M$Y$$$20200826$$MD$KR$JP
104375973$10437597$3$F$$20200803$20140908$20200810$EXP$$PT-MYLAN-2014M1002981$MYLAN$CALDEIRA L. VARIOUS DRUGS COGNITIVE DECLINE, MYOCLONUS, HYPERREFLEXIA AND ATAXIA IN AN ELDERLY PATIENT: CASE REPORT. REACTIONS WEEKLY. 2015?1548:263$68$YR$$F$Y$$$20200810$$MD$PT$PT
104412706$10441270$6$F$20140629$20200714$20140909$20200715$EXP$$US-PFIZER INC-2014246794$PFIZER$$71$YR$$F$Y$91$KG$20200715$$CN$US$US
104463943$10446394$3$F$20140819$20200713$20140911$20200717$EXP$$US-ROCHE-1459662$ROCHE$$73$YR$$F$Y$51.9$KG$20200717$$MD$US$US
1044811812$10448118$12$F$20120127$20200911$20140911$20200915$PER$$US-PFIZER INC-2014252347$PFIZER$$79$YR$$F$Y$81.63$KG$20200915$$CN$US$US
104492122$10449212$2$F$20140804$20141121$20140912$20141201$PER$$US-JNJFOC-20140909125$JANSSEN$$42$YR$A$M$Y$65.9$KG$20141201$$MD$US$US
104493533$10449353$3$F$20140829$20180315$20140912$20180323$EXP$$US-JNJFOC-20140905443$JANSSEN$$72$YR$E$F$Y$68.04$KG$20180323$$MD$US$US
104493572$10449357$2$F$20140828$20141014$20140912$20141027$PER$$IL-JNJFOC-20140906532$JANSSEN$$74$YR$E$M$Y$89.5$KG$20141027$$CN$CA$IL
104505175$10450517$5$F$2014$20200924$20140912$20200929$EXP$$US-SA-2014SA006359$SANOFI AVENTIS$$63$YR$$F$Y$58.96$KG$20200929$$CN$US$US
104523484$10452348$4$F$20140315$20200803$20140915$20200806$EXP$DE-BFARM-14101348$DE-UCBSA-118603$UCB$$22$YR$$F$Y$$$20200806$$HP$DE$DE
104564603$10456460$3$F$20140823$20150223$20140916$20150403$EXP$$US-JNJFOC-20140906789$JANSSEN$$78$YR$E$F$Y$$$20150403$$MD$US$US
104580882$10458088$2$F$$20200701$20140917$20200714$EXP$$FR-AUROBINDO-AUR-APL-2014-09569$AUROBINDO$$42$YR$$F$Y$$$20200714$$HP$FR$FR
104621186$10462118$6$F$2014$20200729$20140918$20200807$EXP$$CA-PFIZER INC-2014255995$PFIZER$$36$YR$$M$Y$91$KG$20200807$$LW$CA$CA
104663293$10466329$3$F$201401$20200914$20140922$20200922$EXP$$DE-AUROBINDO-AUR-APL-2014-06887$AUROBINDO$$52$YR$$M$Y$87$KG$20200922$$CN$DE$DE
104672974$10467297$4$F$20140307$20200825$20140922$20200827$PER$$US-JNJFOC-20140916325$JOHNSON AND JOHNSON$$79$YR$E$F$Y$66.28$KG$20200827$$CN$US$US
104680122$10468012$2$F$$20200701$20140922$20200706$PER$$US-PFIZER INC-2014257059$PFIZER$$69$YR$$M$Y$$$20200706$$MD$US$US
104693642$10469364$2$F$20130225$20140808$20140923$20140923$EXP$$AU-JNJFOC-20131117255$JANSSEN$$60$YR$A$F$Y$$$20140923$$MD$AU$AU
1046986413$10469864$13$F$20140826$20200819$20140923$20200901$EXP$$IN-INCYTE CORPORATION-2014IN002652$INCYTE$$$$$$Y$$$20200901$$HP$IN$IN
104717523$10471752$3$F$$20200824$20140923$20200826$EXP$$PHHY2014FR122018$NOVARTIS$$20$YR$$M$Y$$$20200826$$HP$FR$FR
104738935$10473893$5$F$20140721$20150304$20140924$20150311$EXP$$IT-JNJFOC-20140719949$PHARMACYCLICS$$70$YR$E$M$Y$83$KG$20150311$$MD$IT$IT
104758892$10475889$2$F$$20200706$20140925$20200711$EXP$$PHHY2014PT123007$NOVARTIS$ALMEIDA JP, LOPES A, BARBOSA MP. HYPERSENSITIVITY TO PROTON PUMP INHIBITORS ? A RARE CASE REPORT. REVISTA PORTUGUESA DE IMUNOALERGOLOGIA. 2016?24(1):31?6$39$YR$$F$Y$$$20200711$$HP$PT$PT
1047844715$10478447$15$F$2014$20200928$20140926$20200929$EXP$$US-PFIZER INC-2014263119$PFIZER$$61$YR$$F$Y$45$KG$20200929$$MD$US$US
1048002426$10480024$26$F$2013$20200831$20140929$20200907$EXP$$CA-ROCHE-1332993$ROCHE$$72$YR$$F$Y$102.1$KG$20200908$$MD$CA$CA
104803802$10480380$2$F$20120315$20140808$20140929$20140929$EXP$$IT-JNJFOC-20120308381$JANSSEN$$71$YR$E$M$Y$68$KG$20140929$$MD$IT$IT
104803922$10480392$2$F$$20200921$20140929$20200927$EXP$$US-AUROBINDO-AUR-APL-2014-10270$AUROBINDO$MINOCYCLINE: CONJUNCTIVAL PIGMENTATION: CASE REPORT. 2017$43$YR$$F$Y$$$20200928$$MD$US$US
104806784$10480678$4$F$2011$20200811$20140929$20200823$EXP$$BR-ELI_LILLY_AND_COMPANY-BR201409006647$ELI LILLY AND CO$$58$YR$$F$Y$98$KG$20200823$$CN$BR$BR
104808912$10480891$2$F$$20200909$20140929$20200918$EXP$$US-MYLANLABS-2014M1005605$MYLAN$THORNTON P. US SAFETY BRIEFS: FENTANYL PATCH FATALITIES LINKED TO BYSTANDER APATHY. WE ALL HAVE A ROLE IN PREVENTION!. J?PHARM?PRACT?RES 2013?43(4):300?301.$15$MON$$M$Y$$$20200918$$HP$AU$US
104821823$10482182$3$F$20140914$20200723$20140929$20200724$EXP$$PT-ASTRAZENECA-2014SE71823$ASTRAZENECA$$44$YR$$F$Y$$$20200724$$MD$PT$PT
104823823$10482382$3$F$20130627$20150708$20140929$20150716$EXP$$GB-JNJFOC-20140919704$JANSSEN$$45$YR$A$F$Y$66.3$KG$20150716$$MD$GB$GB
104827244$10482724$4$F$20140918$20141217$20140929$20141224$EXP$$CZ-JNJFOC-20140919290$PHARMACYCLICS$$73$YR$E$M$Y$81$KG$20141224$$MD$CZ$CZ
104841094$10484109$4$F$$20200915$20140930$20200916$PER$$US-PFIZER INC-2014265071$PFIZER$$57$YR$$M$Y$85.5$KG$20200916$$MD$US$US
104859146$10485914$6$F$$20200730$20141001$20200810$EXP$$NL-AUROBINDO-AUR-APL-2014-10401$AUROBINDO$VAN VEEN EJW, ET AL.. ANTIBACTERIALS:DRESS SYNDROME: CASE REPORT. REACTIONS WEEKLY. 2014?1521:P30$77$YR$$M$Y$$$20200810$$HP$NL$NL
104863707$10486370$7$F$20140921$20161027$20141001$20161108$EXP$$BR-JNJFOC-20140922275$PHARMACYCLICS$$51$YR$A$M$Y$$$20161108$$MD$BR$BR
104880961$10488096$1$I$20140917$20140925$20141002$20141002$EXP$$PHHY2014DE125904$SANDOZ$$65$YR$$M$Y$$$20141002$$CN$DE$DE
104882485$10488248$5$F$$20200810$20141002$20200812$EXP$$PHHY2014NL124238$NOVARTIS$VAN VEEN EJW. ANTIBACTERIALS: DRESS SYNDROME: CASE REPORT. REACTIONS WEEKLY. 2014?1521:30$77$YR$$M$Y$$$20200812$$HP$NL$NL
104888755$10488875$5$F$20140907$20150325$20141002$20150331$EXP$$GB-JNJFOC-20140909822$PHARMACYCLICS$$68$YR$E$F$Y$109.2$KG$20150331$$MD$GB$GB
104965582$10496558$2$F$20140924$20141028$20141005$20141105$EXP$$GB-JNJFOC-20140924275$PHARMACYCLICS$$87$YR$E$F$Y$55$KG$20141105$$MD$GB$GB
104974315$10497431$5$F$20130626$20200710$20141006$20200722$EXP$$NL-JNJFOC-20140109796$JOHNSON AND JOHNSON$$61$YR$$F$Y$80$KG$20200722$$HP$NL$NL
104978995$10497899$5$F$2013$20200914$20141006$20200922$PER$$US-JNJFOC-20141000908$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200922$$CN$US$US
104988686$10498868$6$F$$20200824$20141006$20200826$EXP$$US-PFIZER INC-2014270796$PFIZER$$66$YR$$F$Y$77$KG$20200826$$CN$US$US
105013572$10501357$2$F$20140914$20200723$20141007$20200731$EXP$$PT-JNJFOC-20141001654$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20200731$$MD$PT$PT
105022182$10502218$2$F$$20191007$20141007$20191021$EXP$$PHHY2014BR129354$NOVARTIS$$$$$M$Y$120$KG$20191021$$CN$COUNTRY NOT SPECIFIED$BR
105027469$10502746$9$F$20121126$20200710$20141007$20200722$EXP$$US-JNJFOC-20140609701$JOHNSON AND JOHNSON$$73$YR$$M$Y$111.23$KG$20200722$$MD$US$US
1050318365$10503183$65$F$201409$20200916$20141007$20200920$EXP$$CA-ROCHE-1446929$ROCHE$$64$YR$$F$Y$77$KG$20200921$$HP$CA$CA
1050606098$10506060$98$F$20151105$20200813$20141008$20200822$EXP$$PHHY2012CA020442$NOVARTIS$$67$YR$$F$Y$$$20200822$$MD$CA$CA
105065964$10506596$4$F$20140417$20200710$20141009$20200722$EXP$$US-JNJFOC-20141001585$JOHNSON AND JOHNSON$$55$YR$$M$Y$$$20200722$$HP$US$US
105080402$10508040$2$F$$20200226$20141009$20200709$PER$$US-ASTELLAS-2014US010568$ASTELLAS$$$$$M$Y$$$20200709$$CN$US$US
105094686$10509468$6$F$20140418$20150304$20141009$20150311$EXP$$PHHO2014KR007286$NOVARTIS$$51$YR$$F$Y$57$KG$20150311$$HP$KR$KR
105098642$10509864$2$F$20120922$20150302$20141010$20150305$EXP$$US-ROCHE-1470370$ROCHE$$61$YR$$F$Y$$$20150305$$LW$US$US
1051034612$10510346$12$F$20130306$20200710$20141010$20200722$EXP$$US-JNJFOC-20140110400$JOHNSON AND JOHNSON$$55$YR$$M$Y$$$20200722$$HP$US$US
105103487$10510348$7$F$20100410$20200710$20141010$20200722$EXP$$US-JNJFOC-20140110089$JOHNSON AND JOHNSON$$63$YR$$M$Y$120.54$KG$20200722$$HP$US$US
105120011$10512001$1$I$20130819$20140926$20141010$20141010$EXP$$US-JNJFOC-20141000591$JANSSEN$$45$YR$A$F$Y$62.6$KG$20141010$$MD$US$US
105132418$10513241$8$F$20121018$20200820$20141013$20200901$EXP$$US-JNJFOC-20140110477$JOHNSON AND JOHNSON$$61$YR$A$M$Y$85.7$KG$20200901$$MD$US$US
105132653$10513265$3$F$$20200714$20141013$20200716$EXP$$CA-LEO PHARMA-230045$LEO PHARM$$78$YR$$F$Y$$$20200716$$CN$CA$CA
105158222$10515822$2$F$$20200803$20141014$20200814$EXP$$NL-RANBAXY-2014RR-86475$RANBAXY$$77$YR$$M$Y$$$20200814$$HP$NL$NL
105168666$10516866$6$F$2014$20200825$20141014$20200908$EXP$$US-SA-2014SA040902$SANOFI AVENTIS$$$$$M$Y$115.6$KG$20200908$$CN$US$US
105169035$10516903$5$F$20141002$20151229$20141014$20160104$EXP$$RU-JNJFOC-20141004620$PHARMACYCLICS$$66$YR$E$F$Y$94$KG$20160104$$MD$RU$RU
105175847$10517584$7$F$20140901$20191028$20141014$20191112$EXP$$PHHO2014CA013343$NOVARTIS$$54$YR$$M$Y$84.2$KG$20191112$$HP$US$CA
1051818911$10518189$11$F$20130110$20200623$20141015$20200708$EXP$$IE-ALEXION PHARMACEUTICALS INC.-A201403897$ALEXION$$7$YR$$F$Y$26.3$KG$20200708$$CN$US$IE
105235014$10523501$4$F$2012$20200907$20141017$20200916$PER$$DE-AMGEN-DEUNI2014079826$AMGEN$KLEIN, A. LONG?TERM SURVEILLANCE OF BIOLOGIC THERAPIES IN SYSTEMIC?ONSET JUVENILE IDIOPATHIC ARTHRITIS: DATA FROM THE GERMAN BIKER REGISTRY.. RHEUMATOLOGY.. 2020?59(9):2287?2298$14$YR$T$M$Y$$$20200915$$HP$DE$DE
105244802$10524480$2$F$20141009$20180607$20141017$20180612$EXP$$ES-JNJFOC-20141008281$JANSSEN$$84$YR$E$M$Y$$$20180612$$MD$ES$ES
105246022$10524602$2$F$20141007$20141022$20141017$20141103$EXP$$US-JNJFOC-20141008250$PHARMACYCLICS$$71$YR$E$F$Y$$$20141103$$MD$US$US
105254292$10525429$2$F$20140930$20150129$20141017$20150202$EXP$$US-JNJFOC-20141011217$PHARMACYCLICS$$71$YR$E$M$Y$$$20150202$$MD$US$US
1052544121$10525441$21$F$201303$20191016$20141017$20191021$EXP$$PHHY2014BR132561$NOVARTIS$$74$YR$$F$Y$75$KG$20191021$$HP$BR$BR
105258659$10525865$9$F$20141009$20200923$20141017$20200928$EXP$$PHHO2014IT013813$NOVARTIS$$52$YR$$M$Y$92$KG$20200928$$HP$IT$IT
105280599$10528059$9$F$$20191127$20141020$20200807$EXP$$PHHY2014GB136022$NOVARTIS$$18$MON$$F$Y$2.27$KG$20200807$$HP$GB$GB
105311073$10531107$3$F$20140820$20200720$20141021$20200723$EXP$$US-GLAXOSMITHKLINE-US2014GSK005101$GLAXOSMITHKLINE$$42$YR$$F$Y$52.3$KG$20200723$$MD$US$US
105331541$10533154$1$I$201310$20141016$20141022$20141022$EXP$GB-MHRA-EYC 00115594$GB-ROCHE-1476065$ROCHE$$$$$M$Y$$$20141022$$MD$GB$GB
105337553$10533755$3$F$20140620$20141204$20141022$20141205$EXP$$PL-JNJFOC-20140617926$PHARMACYCLICS$$67$YR$E$M$Y$69$KG$20141205$$MD$PL$PL
105337652$10533765$2$F$$20200702$20141022$20200714$PER$$RO-AMGEN-ROUSP2014080307$AMGEN$BUCUR A.? DINCA O.? BUCUR M. B. ET AL.. EXTENSIVE OSTEONECROSIS OF THE MANDIBLE AFTER THERAPY WITH DENOSUMAB FOLLOWING BIPHOSPHONATES THERAPY. ACTA ENDOCRINOLOGICA (BUC). 2014?X (3):457?462$58$YR$A$M$Y$$$20200714$$HP$RO$RO
105380653$10538065$3$F$$20200707$20141023$20200709$EXP$$US-PFIZER INC-2014290782$PFIZER$$62$YR$$F$Y$79.16$KG$20200709$$CN$US$US
105392842$10539284$2$F$$20200813$20141023$20200816$EXP$$PHHY2014PT134452$NOVARTIS$$82$YR$$F$Y$$$20200816$$HP$PT$PT
1054101610$10541016$10$F$2014$20200702$20141024$20200710$EXP$$US-SA-2014SA080213$SANOFI AVENTIS$$55$YR$$F$Y$$$20200710$$CN$US$US
105417895$10541789$5$F$20140930$20141211$20141024$20141218$EXP$$NL-JNJFOC-20141002704$PHARMACYCLICS$$66$YR$E$F$Y$70$KG$20141218$$MD$NL$NL
1054179311$10541793$11$F$20141008$20160518$20141024$20160520$EXP$$TR-JNJFOC-20141005659$PHARMACYCLICS$$70$YR$E$F$Y$63.9$KG$20160520$$MD$TR$TR
105428372$10542837$2$F$$20200709$20141027$20200718$EXP$$US-AUROBINDO-AUR-APL-2014-11159$AUROBINDO$CEFAZOLIN/CEFDINIR:BULLOUS LESIONS: CASE REPORT. 2014$36$YR$$F$Y$$$20200718$$MD$US$US
105433402$10543340$2$F$201303$20141014$20141027$20141027$EXP$$IT-ROCHE-1473618$ROCHE$MANZON L, ETTORRE E, VISCOGLIOSI G, IPPOLITI S, FILIACI F, UNGARI C, FRATTO G AND AGRILLO A. BISPHOSPHONATE THERAPY AND OSTEONECROSIS OF THE JAW COMPLICATED WITH A TEMPORAL ABSCESS IN AN ELDERLY WOMAN WITH RHEUMATOID ARTHRITIS: A CASE REPORT. CLINICAL INTERVENTIONS IN AGING 2014 AUG 25?9:1409?1413.$68$YR$$F$Y$$$20141027$$HP$IT$IT
105438487$10543848$7$F$20140922$20200821$20141027$20200901$EXP$$JP-INCYTE CORPORATION-2014IN002927$INCYTE$$$$$$Y$$$20200901$$MD$JP$JP
105453282$10545328$2$F$$20200806$20141027$20200818$EXP$$DE-JNJFOC-20141010059$JOHNSON AND JOHNSON$ROIDER G, SACHS H, MUSSHOFF F, DAME T, SCHAEPER J, SCHWERER M, GRAW M, KRUEGER J. FIRST DETECTION OF ETHYLPHENIDATE IN HUMAN FATALITIES AFTER ETHYLPHENIDATE INTAKE. FORENSIC SCIENCE INTERNATIONAL. 2014?243:126129.$38$YR$A$M$Y$$$20200818$$HP$DE$DE
105492394$10549239$4$F$20140917$20180329$20141028$20180413$EXP$$JP-JNJFOC-20140919549$JOHNSON AND JOHNSON$$72$YR$E$M$Y$47.3$KG$20180413$$MD$JP$JP
105508672$10550867$2$F$$20200818$20141029$20200829$EXP$$PT-AUROBINDO-AUR-APL-2014-11270$AUROBINDO$$52$YR$$M$Y$$$20200829$$HP$PT$PT
105517507$10551750$7$F$$20200814$20141029$20200818$PER$$US-PFIZER INC-2014296514$PFIZER$$53$YR$$F$Y$$$20200818$$HP$US$US
105518935$10551893$5$F$$20200813$20141029$20200819$EXP$$US-PFIZER INC-2014295266$PFIZER$$63$YR$$F$Y$73$KG$20200819$$MD$US$US
105543665$10554366$5$F$$20150130$20141030$20200723$EXP$$JP-BAUSCH-BL-2014-007360$BAUSCH AND LOMB$$$$$$Y$$$20200723$$MD$JP$JP
1055533111$10555331$11$F$20140908$20200828$20141030$20200901$EXP$$JP-INCYTE CORPORATION-2014IN002711$INCYTE$$$$$$Y$$$20200901$$MD$JP$JP
105567326$10556732$6$F$20140820$20150318$20141031$20150428$EXP$$GR-JNJFOC-20140818882$PHARMACYCLICS$$76$YR$E$M$Y$74$KG$20150428$$MD$GR$GR
105599132$10559913$2$F$20140915$20141205$20141103$20141212$EXP$$CN-JNJFOC-20141015573$PHARMACYCLICS$$46$YR$A$M$Y$70$KG$20141212$$MD$CN$CN
105601755$10560175$5$F$1989$20200919$20141103$20200925$PER$$US-PFIZER INC-2014300984$PFIZER$$47$YR$$F$Y$68.95$KG$20200925$$MD$US$US
105602802$10560280$2$F$20141021$20141022$20141103$20200701$EXP$$GR-JNJFOC-20141015417$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
105603889$10560388$9$F$201410$20200820$20141103$20200831$EXP$$US-ASTELLAS-2014US016092$ASTELLAS$$71$YR$$M$Y$$$20200831$$CN$US$US
105604625$10560462$5$F$20200229$20200828$20141103$20200904$PER$$US-SA-2013SA104887$SANOFI AVENTIS$$$$$$Y$$$20200904$$HP$US$US
105608896$10560889$6$F$$20200909$20141103$20200916$EXP$$US-SA-2014SA144454$SANOFI AVENTIS$$$$$F$Y$$$20200916$$CN$US$US
105616273$10561627$3$F$20140912$20200604$20141103$20200701$EXP$$US-BIOMARINAP-US-2014-104507$BIOMARIN$$$$$M$Y$5.05$KG$20200701$$MD$US$US
1056402812$10564028$12$F$20141029$20200706$20141104$20200720$EXP$$IT-PFIZER INC-2014301589$PFIZER$SANDS, B.. THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS ? UPDATED RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM. GASTROENTEROLOGY. 2020?158 (6 SUPPL 1):S?1190$56$YR$$F$Y$67$KG$20200720$$MD$US$IT
105667491$10566749$1$I$201303$20141028$20141105$20141105$EXP$$IT-ROXANE LABORATORIES, INC.-2014-RO-01665RO$ROXANE$MANZON L,ETTORRE E,VISCOGLIOSI G,IPPOLITI S,ET AL. BISPHOSPHONATE THERAPY AND OSTEONECROSIS OF THE JAW COMPLICATED WITH A TEMPORAL ABSCESS IN AN ELDERLY WOMAN WITH RHEUMATOID ARTHRITIS: A CASE REPORT. CLINICAL INTERVENTIONS IN AGING 2014 AUG 25?9:1409?1413.$68$YR$$F$Y$$$20141105$$HP$COUNTRY NOT SPECIFIED$IT
105670272$10567027$2$F$20140916$20141108$20141105$20141125$EXP$$US-CELGENE-USA-2014104351$CELGENE$$58$YR$$M$Y$92.7$KG$20141125$$MD$US$US
105678813$10567881$3$F$$20200903$20141106$20200917$EXP$$FR-CIPLA LTD.-2014FR01621$CIPLA$$$$$$Y$$$20200917$$HP$FR$FR
105691161$10569116$1$I$$20141021$20141106$20141106$EXP$$US-JNJFOC-20141016310$JANSSEN$BENTON CB, THOMAS DA, YANG H, RAVANDI F, RYTTING M, O BRIEN S, ET AL. SAFETY AND CLINICAL ACTIVITY OF 5?AZA?2?DEOXYCYTIDINE (DECITABINE) WITH OR WITHOUT HYPER?CVAD IN RELAPSED/REFRACTORY ACUTE LYMPHOCYTIC LEUKAEMIA.. BRITISH JOURNAL OF HAEMATOLOGY 2014?167 (3):356?365.$$$$$Y$$$20141106$$MD$US$US
105698821$10569882$1$I$201204$20141030$20141107$20141107$EXP$$HU-ROCHE-1484239$ROCHE$BANHEGYI R, LACZO I, FULOP F, MELLAR E, CSIFFARI M, AND PIKO B. FULVESTRANT AND LONG?TERM PROGRESSION?FREE SURVIVAL: CASE REPORT OF OUR PATIENT WHO HAS METASTATIC BREAST CANCER. LAM (LEGE ARTIS MEDICINAE) 2014 JAN 01?24 (8?9):459?461.$70$YR$$F$Y$$$20141107$$MD$HU$HU
105735594$10573559$4$F$20141029$20141125$20141110$20141210$EXP$$CA-JNJFOC-20141101386$JANSSEN$$70$YR$E$M$Y$117$KG$20141210$$MD$CA$CA
105735663$10573566$3$F$20141029$20141202$20141110$20141210$EXP$$FR-JNJFOC-20141103665$PHARMACYCLICS$$64$YR$A$F$Y$56$KG$20141210$$MD$FR$FR
105737366$10573736$6$F$2013$20200817$20141110$20200821$EXP$$US-SA-2014SA140365$SANOFI AVENTIS$$53$YR$$M$Y$$$20200821$$CN$US$US
105737402$10573740$2$F$$20141030$20141110$20200701$EXP$$GR-JNJFOC-20141021397$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
105757467$10575746$7$F$201806$20200902$20141111$20200903$PER$$US-PFIZER INC-2014305972$PFIZER$$61$YR$$F$Y$77.11$KG$20200903$$HP$US$US
105764329$10576432$9$F$20141025$20200827$20141111$20200910$EXP$$JP-INCYTE CORPORATION-2014IN003339$INCYTE$$$$$$Y$$$20200910$$MD$JP$JP
105765252$10576525$2$F$201204$20141209$20141111$20141211$EXP$$HU-TEVA-520807ISR$TEVA$BANHEGYI R,LACZO I,CSIFFARI M,PIKO B,FULOP F,MELLAR E. FULVESTRANT AND LONG?TERM PROGRESSION?FREE SURVIVAL: THE CASE OF A METASTATIC BREAST CANCER PATIENT OF OURS. LAM (LEGE ARTIS MEDICINAE). 2014 SEP 17?2014/8?9:459?461.$68$YR$$F$Y$$$20141211$$MD$HU$HU
105781392$10578139$2$F$20130607$20200914$20141112$20200923$EXP$$DE-AUROBINDO-AUR-APL-2014-11702$AUROBINDO$$1$DY$$M$Y$3.01$KG$20200923$$CN$DE$DE
105787789$10578778$9$F$20141015$20200831$20141112$20200911$EXP$$JP-INCYTE CORPORATION-2014IN003139$INCYTE$$$$$$Y$$$20200911$$MD$JP$JP
105793075$10579307$5$F$20140729$20200904$20141112$20200916$EXP$$CO-JNJFOC-20141103644$JOHNSON AND JOHNSON$$34$YR$A$F$Y$$$20200916$$HP$CO$CO
105796304$10579630$4$F$20121106$20200628$20141112$20200706$PER$$US-JNJFOC-20141106326$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200706$$LW$US$US
1058003211$10580032$11$F$$20200909$20141112$20200918$EXP$$CA-PFIZER INC-2014309876$PFIZER$$54$YR$$F$Y$77$KG$20200918$$CN$CA$CA
105801275$10580127$5$F$201605$20200706$20141112$20200710$PER$$US-PFIZER INC-2014311696$PFIZER$$51$YR$$F$Y$77$KG$20200710$$CN$US$US
105821664$10582166$4$F$20141028$20141223$20141113$20150107$EXP$$GB-JNJFOC-20141106529$PHARMACYCLICS$$$$$$Y$$$20150105$$MD$GB$GB
105836995$10583699$5$F$20140930$20200710$20141114$20200722$EXP$$CA-JNJFOC-20141103641$JOHNSON AND JOHNSON$$60$YR$$F$Y$$$20200722$$HP$CA$CA
1058409110$10584091$10$F$201307$20200917$20141114$20200921$EXP$$US-PFIZER INC-2014312840$PFIZER$$81$YR$$F$Y$$$20200921$$MD$US$US
105846002$10584600$2$F$$20200824$20141114$20200826$EXP$$PHHY2014PT148074$NOVARTIS$$42$YR$$M$Y$$$20200826$$HP$PT$PT
105848347$10584834$7$F$$20200722$20141114$20200727$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-21577242$BRISTOL MYERS SQUIBB$LAREB.. STATINS AND MUSCLE RUPTURE.. LAREB QUARTERLY REPORT. 2014$73$YR$$F$Y$$$20200727$$HP$NL$NL
105850986$10585098$6$F$20141013$20150105$20141114$20150108$EXP$$KR-JNJFOC-20141009850$PHARMACYCLICS$$71$YR$E$M$Y$44.5$KG$20150108$$MD$KR$KR
105857262$10585726$2$F$20141001$20141031$20141114$20141114$EXP$$US-CELGENE-USA-2014101525$CELGENE$$56$YR$$M$Y$83.72$KG$20141114$$MD$US$US
105870765$10587076$5$F$20141026$20150316$20141117$20150319$EXP$$IT-JNJFOC-20141106178$PHARMACYCLICS$$72$YR$E$F$Y$58$KG$20150319$$CN$IT$IT
105870811$10587081$1$I$20140223$20141111$20141117$20141117$EXP$$US-JNJFOC-20141108440$PHARMACYCLICS$$70$YR$E$F$Y$73.63$KG$20141117$$MD$US$US
105872902$10587290$2$F$200905$20200806$20141117$20200813$EXP$$CA-ROCHE-1488552$ROCHE$$58$YR$$M$Y$74$KG$20200813$$HP$CA$CA
105887172$10588717$2$F$20130116$20141110$20141117$20200922$EXP$$US-GLAXOSMITHKLINE-US2014GSK022494$GLAXOSMITHKLINE$$32$YR$$F$Y$$$20200922$$CN$US$US
105902429$10590242$9$F$201411$20200807$20141118$20200812$PER$$US-PFIZER INC-2014316501$PFIZER$$57$YR$$M$Y$81$KG$20200812$$HP$US$US
105941513$10594151$3$F$$20200721$20141119$20200724$EXP$$TW-PFIZER INC-2014307971$PFIZER$HUANG, S.. CONCURRENCE OF UGT1A POLYMORPHISM AND END?STAGE RENAL DISEASE LEADS TO SEVERE TOXICITIES OF IRINOTECAN IN A PATIENT WITH METASTATIC COLON CANCER. TUMORI. 2011?97 (2):243?247$74$YR$$M$Y$$$20200724$$HP$TW$TW
105953632$10595363$2$F$$20200623$20141120$20200708$EXP$$TR-JNJFOC-20141104885$JOHNSON AND JOHNSON$ERDOGAN E, BOZYAKA I. DEVELOPMENT OF ACUTE HEPATOTOXICITY FOLLOWING THE FIRST DOSE OF PALIPERIDONE PALMITATE: A CASE REPORT. DUSUNEN ADAM THE JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES. 2020?33:92?95.$25$YR$$M$Y$$$20200708$$MD$TR$TR
106001264$10600126$4$F$20130702$20200709$20141122$20200713$EXP$$DE-DRREDDYS-GER/GER/14/0044480$DR REDDYS$$1$DY$N$M$Y$2.34$KG$20200713$$MD$DE$DE
106003081$10600308$1$I$$20141113$20141123$20141123$EXP$$JP-MYLANLABS-2014M1011656$MYLAN$EHARA D, YOSHIMI K, KUWATSUKA Y, TAKENAKA M, UTANI A. A CASE OF DRUG ERUPTION CAUSED BY INJECTABLE IBANDRONATE. J?DERMATOL 2014? 41 76 ABSTR. P?454$$$$$Y$$$20141123$$HP$JP$JP
106015343$10601534$3$F$20141111$20200701$20141124$20200713$EXP$$JP-NOVOPROD-429114$NOVO NORDISK$$56$YR$$F$Y$75$KG$20200713$$MD$JP$JP
106031399$10603139$9$F$201410$20200728$20141124$20200731$PER$$US-PFIZER INC-2014322171$PFIZER$$68$YR$$F$Y$$$20200731$$CN$US$US
1060315611$10603156$11$F$$20200914$20141124$20200916$PER$$US-PFIZER INC-2014093880$PFIZER$$50$YR$$M$Y$75$KG$20200916$$MD$US$US
106077034$10607703$4$F$2011$20200306$20141125$20200312$EXP$$PHHY2014AR154114$NOVARTIS$$$$$M$Y$$$20200312$$MD$AR$AR
1060995412$10609954$12$F$$20200810$20141126$20200811$EXP$$US-PFIZER INC-2014323469$PFIZER$$69$YR$$F$Y$$$20200811$$HP$US$US
106100802$10610080$2$F$$20200629$20141126$20200701$PER$$US-PFIZER INC-2014325083$PFIZER$$$$$F$Y$$$20200701$$HP$US$US
1061125710$10611257$10$F$20141104$20170515$20141126$20170523$EXP$$US-JNJFOC-20141115952$PHARMACYCLICS$$62$YR$A$F$Y$102.4$KG$20170523$$MD$US$US
106112585$10611258$5$F$20141117$20170926$20141126$20170929$EXP$$BR-JNJFOC-20141112896$PHARMACYCLICS$$56$YR$A$F$Y$43.7$KG$20170929$$CN$BR$BR
106143963$10614396$3$F$20130702$20200708$20141129$20200718$EXP$DE-BFARM-14349734$DE-ACCORD-027343$ACCORD$$1$DY$N$M$Y$2.34$KG$20200718$$MD$DE$DE
106144093$10614409$3$F$$20200810$20141129$20200821$EXP$$IT-AUROBINDO-AUR-APL-2014-12592$AUROBINDO$$68$YR$$F$Y$$$20200821$$HP$IT$IT
106144132$10614413$2$F$$20200921$20141129$20200928$EXP$$US-AUROBINDO-AUR-APL-2014-12561$AUROBINDO$$7$DEC$$F$Y$$$20200929$$MD$US$US
106144483$10614448$3$F$2013$20200821$20141129$20200904$EXP$$US-UCBSA-115642$UCB$$36$YR$$M$Y$73.5$KG$20200904$$MD$US$US
106146797$10614679$7$F$2013$20200706$20141130$20200707$EXP$$CA-ROCHE-1496772$ROCHE$$55$YR$$F$Y$$$20200707$$HP$CA$CA
106158675$10615867$5$F$20121120$20200816$20141201$20200824$EXP$$US-JNJFOC-20141115400$JOHNSON AND JOHNSON$$32$YR$A$M$Y$$$20200824$$CN$US$US
106160233$10616023$3$F$20140116$20200726$20141201$20200731$PER$$US-JNJFOC-20141113306$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200731$$HP$US$US
106168324$10616832$4$F$2014$20200827$20141201$20200901$PER$$US-JNJFOC-20141114019$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200901$$CN$US$US
106170174$10617017$4$F$20141126$20141207$20141201$20141212$EXP$$CN-JNJFOC-20141118964$PHARMACYCLICS$$72$YR$E$M$Y$63$KG$20141212$$MD$CN$CN
106174751$10617475$1$I$20141001$20141113$20141201$20141201$EXP$$PHHY2014US148799$SANDOZ$$$$$F$Y$71.4$KG$20141202$$CN$US$US
106187296$10618729$6$F$$20200803$20141202$20200805$EXP$$US-PFIZER INC-2014328715$PFIZER$$73$YR$$F$Y$78.02$KG$20200805$$CN$US$US
106188719$10618871$9$F$20140605$20160302$20141202$20160307$EXP$$MX-JNJFOC-20140610831$PHARMACYCLICS$$72$YR$E$M$Y$$$20160307$$MD$MX$MX
106191477$10619147$7$F$201311$20200730$20141202$20200806$EXP$$US-JNJFOC-20141117221$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20200806$$CN$US$US
106192755$10619275$5$F$2014$20200825$20141202$20200831$EXP$$US-SA-2014SA028359$SANOFI AVENTIS$$$$$$Y$$$20200831$$CN$US$US
106197146$10619714$6$F$20131111$20200726$20141202$20200731$PER$$US-JNJFOC-20141117190$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200731$$CN$US$US
106199831$10619983$1$I$20140922$20141119$20141202$20141202$EXP$$US-BAYER-2014-172672$BAYER$$$$$F$Y$71$KG$20141202$$CN$US$US
106211411$10621141$1$I$$20141124$20141203$20141203$EXP$$KR-ROCHE-1498372$ROCHE$KIM S, JEONG JB, KIM JW, KOH SJ KIM BG, LEE KL CHANG MS, IM JP, KANG HW AND SHIN CM CLINICAL AND ENDOSCOPIC CHARACTERISTICS OF DRUG?INDUCED ESOPHAGITIS. WORLD JOURNAL OF GASTROENTEROLOGY 2014 AUG 21?20 (31):10994?10999.$$$$$Y$$$20141203$$HP$KR$KR
106225799$10622579$9$F$20140715$20200916$20141203$20200918$EXP$$US-PFIZER INC-2014329366$PFIZER$$79$YR$$F$Y$68.03$KG$20200918$$CN$US$US
106236863$10623686$3$F$20141015$20141213$20141203$20141222$EXP$$US-JNJFOC-20141202109$PHARMACYCLICS$$$$$F$Y$67$KG$20141222$$MD$US$US
106236923$10623692$3$F$20140808$20141218$20141203$20141223$EXP$$KR-JNJFOC-20140810697$PHARMACYCLICS$$70$YR$E$M$Y$42.8$KG$20141223$$MD$KR$KR
106315884$10631588$4$F$2012$20200806$20141205$20200819$EXP$$IL-SHIRE-IL201400848$SHIRE$$$$$$Y$$$20200819$$MD$IL$IL
106317564$10631756$4$F$2012$20200806$20141205$20200819$EXP$$IL-SHIRE-IL201401017$SHIRE$$$$$$Y$$$20200819$$MD$IL$IL
106335207$10633520$7$F$20141120$20180627$20141205$20190117$EXP$$US-JNJFOC-20141116668$JANSSEN$$13$YR$C$F$Y$47.1$KG$20190117$$MD$US$US
1063389110$10633891$10$F$$20200814$20141205$20200819$EXP$$US-ASTELLAS-2014US014122$ASTELLAS$$$$$M$Y$$$20200819$$CN$US$US
106339023$10633902$3$F$20140717$20200707$20141205$20200720$EXP$$FR-JNJFOC-20141016957$JOHNSON AND JOHNSON$SELLE F, HEUDEL P, BESSARD A, POZET A, MEUNIER J, GLADIEFF L, LOTZ J, PROVANSAL M, AUGEREAU P, BERTON D, LAMICHHANE N, ORFEUVRE H, PAUTIER P, KALBACHER E, TAZI Y, SPAETH D. GINECO PROSPECTIVE NON?INTERVENTIONAL PROSPECTYON STUDY: TRABECTEDIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN FOR PLATINUM?SENSITIVE RECURRENT OVARIAN CANCER. ANTICANCER RESEARCH. 2020?40:3939?3945.$86$YR$$F$Y$$$20200720$$MD$FR$FR
1063627315$10636273$15$F$201409$20200821$20141206$20200830$EXP$$CA-ROCHE-1462731$ROCHE$$59$YR$$F$Y$77.18$KG$20200831$$HP$CA$CA
106371343$10637134$3$F$20141117$20150302$20141208$20150316$EXP$$FR-JNJFOC-20141116294$JANSSEN$$80$YR$E$M$Y$$$20150316$$MD$FR$FR
106376926$10637692$6$F$20141121$20200916$20141208$20200923$EXP$$PHHY2014CA157139$NOVARTIS$$50$YR$$F$Y$$$20200923$$CN$COUNTRY NOT SPECIFIED$CA
106399097$10639909$7$F$20141121$20200916$20141209$20200924$EXP$$CA-ROCHE-1504280$ROCHE$$50$YR$$F$Y$$$20200924$$CN$CA$CA
106416148$10641614$8$F$20140904$20191029$20141209$20200803$EXP$$DE-JNJFOC-20141113516$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200803$$MD$DE$DE
106416183$10641618$3$F$20121113$20200920$20141209$20200923$PER$$US-JNJFOC-20141202762$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200923$$CN$US$US
106420292$10642029$2$F$20140806$20141205$20141209$20141209$EXP$$PHHO2014SG010925$NOVARTIS$$65$YR$$F$Y$$$20141210$$HP$SG$SG
106422099$10642209$9$F$20141202$20181026$20141210$20181031$EXP$$US-ROCHE-1502637$ROCHE$$68$YR$$M$Y$100.7$KG$20181031$$MD$US$US
106428614$10642861$4$F$201411$20200730$20141210$20200803$PER$$US-PFIZER INC-2014334164$PFIZER$$54$YR$$F$Y$50$KG$20200803$$CN$US$US
106437845$10643784$5$F$$20200903$20141210$20200907$PER$$US-PFIZER INC-2014339079$PFIZER$$66$YR$$M$Y$83$KG$20200907$$CN$US$US
1064492226$10644922$26$F$201208$20200630$20141211$20200714$EXP$$CA-ROCHE-1262889$ROCHE$$64$YR$$M$Y$80$KG$20200714$$CN$CA$CA
106456062$10645606$2$F$20141111$20150312$20141211$20150323$EXP$$US-JNJFOC-20141203286$PHARMACYCLICS$$74$YR$E$M$Y$75.6$KG$20150323$$MD$US$US
106473453$10647345$3$F$2014$20200914$20141211$20200921$EXP$$PHHY2014CA162396$NOVARTIS$$48$YR$$F$Y$61$KG$20200921$$CN$COUNTRY NOT SPECIFIED$CA
106479071$10647907$1$I$20141111$20141201$20141212$20141212$EXP$DK-MYLANLABS-2014M1012237$DK-ACCORD-027391$ACCORD$$78$YR$E$M$Y$69$KG$20141212$$MD$DK$DK
106489262$10648926$2$F$$20200824$20141212$20200826$EXP$$PHHY2013PT163318$NOVARTIS$$42$YR$$M$Y$$$20200826$$HP$PT$PT
106496742$10649674$2$F$20141111$20141208$20141212$20141218$EXP$$DK-ACTAVIS-2014-26390$ACTAVIS$$78$YR$$M$Y$69$KG$20141218$$CN$DK$DK
106499019$10649901$9$F$20141014$20200827$20141212$20200910$EXP$$JP-INCYTE CORPORATION-2014IN003767$INCYTE$$$$$$Y$$$20200910$$MD$JP$JP
106508171$10650817$1$I$20140917$20141211$20141215$20141215$EXP$GB-MHRA-EYC 00117768$GB-ROCHE-1507591$ROCHE$$60$YR$$F$Y$$$20141215$$MD$GB$GB
106513971$10651397$1$I$20140728$20141203$20141215$20141215$EXP$$US-JNJFOC-20141208074$PHARMACYCLICS$$39$YR$A$M$Y$103.3$KG$20141215$$MD$US$US
106513995$10651399$5$F$20141120$20150731$20141215$20150807$EXP$$US-JNJFOC-20141207278$PHARMACYCLICS$$59$YR$A$F$Y$80$KG$20150807$$MD$US$US
106514012$10651401$2$F$20141121$20150518$20141215$20150522$EXP$$US-JNJFOC-20141208013$PHARMACYCLICS$$66$YR$E$M$Y$$$20150522$$MD$US$US
106526912$10652691$2$F$20141018$20141216$20141215$20141223$EXP$$US-JNJFOC-20141207238$PHARMACYCLICS$$66$YR$E$F$Y$43.5$KG$20141223$$MD$US$US
1065374645$10653746$45$F$20141105$20200903$20141216$20200918$EXP$$CA-ROCHE-1508095$ROCHE$$60$YR$$F$Y$92$KG$20200918$$MD$CA$CA
106539774$10653977$4$F$201411$20200908$20141216$20200921$EXP$$US-JNJFOC-20141204242$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200921$$CN$US$US
106552576$10655257$6$F$20141205$20150513$20141216$20150521$EXP$$GB-JNJFOC-20141207353$PHARMACYCLICS$$85$YR$E$F$Y$63.2$KG$20150521$$MD$GB$GB
106571529$10657152$9$F$201407$20200729$20141217$20200730$EXP$$FR-MERCK-1412FRA007081$MERCK$$48$YR$$M$Y$$$20200730$$PH$FR$FR
106578283$10657828$3$F$201408$20200831$20141217$20200910$PER$$US-EISAI MEDICAL RESEARCH-EC-2014-002257$EISAI$$62$YR$A$F$Y$$$20200910$$CN$US$US
106597983$10659798$3$F$20141114$20170228$20141217$20170309$EXP$$US-JNJFOC-20141207527$PHARMACYCLICS$LAMPSON BL, YU L, GLYNN RJ, BARRIENTOS JC, JACOBSEN ED, BANERJI V, ET AL. VENTRICULAR ARRHYTMIAS AND SUDDEN DEATH IN PATIENTS TAKING IBRUTINIB: VENTRICULAR ARRHYTHMIAS ON IBRUTINIB. BLOOD 2016.$61$YR$A$M$Y$122.5$KG$20170309$$MD$US$US
1066343911$10663439$11$F$201409$20200821$20141218$20200902$EXP$$CA-ROCHE-1510504$ROCHE$$33$YR$$F$Y$$$20200902$$CN$CA$CA
106638043$10663804$3$F$$20200810$20141219$20200821$EXP$$NL-AUROBINDO-AUR-APL-2014-13173$AUROBINDO$$43$YR$$M$Y$$$20200821$$HP$NL$NL
106641667$10664166$7$F$20141201$20150519$20141219$20150521$EXP$$IT-JNJFOC-20141211220$PHARMACYCLICS$$75$YR$E$M$Y$94$KG$20150521$$CN$IT$IT
106648991$10664899$1$I$20141208$20141217$20141219$20141219$EXP$$FR-BAYER-2014-186795$BAYER$$61$YR$A$M$Y$99$KG$20141219$$MD$FR$FR
106650044$10665004$4$F$20141203$20150619$20141219$20150701$EXP$$DE-JNJFOC-20141206045$JANSSEN$$48$YR$A$F$Y$79.6$KG$20150701$$MD$DE$DE
106650533$10665053$3$F$201405$20150224$20141219$20150311$EXP$$PHHY2014JP165504$NOVARTIS$$55$YR$$M$Y$82$KG$20150311$$CN$JP$JP
106659505$10665950$5$F$20141024$20160727$20141219$20160729$EXP$$KR-JNJFOC-20141101474$PHARMACYCLICS$$68$YR$E$M$Y$48.9$KG$20160729$$MD$KR$KR
106676164$10667616$4$F$20141110$20150921$20141222$20151002$EXP$$US-JNJFOC-20141205455$JANSSEN$$67$YR$E$M$Y$103$KG$20151002$$MD$US$US
106684662$10668466$2$F$20141202$20150113$20141222$20150121$EXP$$US-JNJFOC-20141213564$PHARMACYCLICS$$71$YR$E$M$Y$111.6$KG$20150121$$MD$US$US
1066937911$10669379$11$F$20140829$20200824$20141222$20200828$PER$$US-SANOFI-AVENTIS-2013SA042300$SANOFI AVENTIS$$$$$$Y$$$20200828$$CN$US$US
1067004614$10670046$14$F$20121219$20200915$20141223$20200924$EXP$$CA-ROCHE-1511391$ROCHE$$10$YR$$F$Y$$$20200924$$MD$CA$CA
106706701$10670670$1$I$20140829$20141213$20141223$20141223$EXP$$US-JNJFOC-20141215183$PHARMACYCLICS$$73$YR$E$M$Y$$$20141223$$MD$US$US
1067082014$10670820$14$F$20120423$20200713$20141223$20200716$EXP$$US-PFIZER INC-2014350639$PFIZER$$64$YR$$M$Y$77$KG$20200716$$MD$US$US
106715662$10671566$2$F$20141201$20190812$20141223$20190820$EXP$$US-JNJFOC-20141215084$JOHNSON AND JOHNSON$$59$YR$$F$Y$59$KG$20190820$$MD$US$US
106719556$10671955$6$F$201407$20200727$20141223$20200804$EXP$$FR-GILEAD-2014-0127724$GILEAD$$48$YR$A$M$Y$88$KG$20200804$$MD$FR$FR
106729423$10672942$3$F$20141208$20200812$20141223$20200814$PER$$US-AMGEN-USACT2014098540$AMGEN$$80$YR$E$F$Y$58.8$KG$20200814$$MD$US$US
106735783$10673578$3$F$20141102$20200129$20141224$20200206$EXP$$GB-ASTRAZENECA-2014SE84591$ASTRAZENECA$$38$YR$$F$Y$74$KG$20200206$$MD$GB$GB
106749888$10674988$8$F$2014$20200901$20141224$20200904$EXP$$US-SA-2014SA124590$SANOFI AVENTIS$$75$YR$$M$Y$$$20200904$$CN$US$US
106750876$10675087$6$F$20141208$20150709$20141224$20150712$EXP$$FR-JNJFOC-20141208349$PHARMACYCLICS$$65$YR$A$M$Y$71.5$KG$20150712$$MD$FR$FR
1067536311$10675363$11$F$$20200729$20141224$20200731$EXP$$US-PFIZER INC-2014356382$PFIZER$$85$YR$$F$Y$77$KG$20200731$$MD$US$US
1067652431$10676524$31$F$201404$20200917$20141226$20200925$EXP$$PHHY2014CA032890$NOVARTIS$$53$YR$$M$Y$$$20200925$$HP$CA$CA
1067787911$10677879$11$F$201306$20200716$20141229$20200722$PER$$BR-AMGEN-BRASP2014100458$AMGEN$$42$YR$A$F$Y$59$KG$20200722$$CN$BR$BR
106781946$10678194$6$F$2012$20200624$20141229$20200707$EXP$$US-MYLANLABS-2014M1014922$MYLAN$$77$YR$$F$Y$82$KG$20200707$$CN$US$US
106783922$10678392$2$F$20141210$20150106$20141229$20150109$EXP$$US-JNJFOC-20141213662$PHARMACYCLICS$$28$YR$A$M$Y$77.11$KG$20150109$$HP$US$US
106787814$10678781$4$F$20130104$20200831$20141229$20200915$EXP$$US-JNJFOC-20141218475$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200915$$CN$US$US
106787827$10678782$7$F$20131221$20200909$20141229$20200922$EXP$$US-JNJFOC-20141217039$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20200922$$HP$US$US
106787835$10678783$5$F$201312$20200701$20141229$20200707$PER$$US-JNJFOC-20141217100$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200707$$HP$US$US
1067928818$10679288$18$F$20150625$20200817$20141229$20200901$EXP$$CA-INCYTE CORPORATION-2013IN002396$INCYTE$$$$$$Y$$$20200901$$HP$CA$CA
106797815$10679781$5$F$20140608$20200629$20141229$20200702$PER$$US-JNJFOC-20141218201$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200702$$LW$US$US
1068016812$10680168$12$F$20141023$20200826$20141229$20200908$EXP$$JP-INCYTE CORPORATION-2014IN003978$INCYTE$$$$$$Y$$$20200908$$MD$JP$JP
1068225412$10682254$12$F$2014$20200915$20141230$20200917$EXP$$US-SA-2014SA161666$SANOFI AVENTIS$$$$$$Y$$$20200917$$CN$US$US
106857083$10685708$3$F$201412$20200921$20141231$20200924$PER$$US-PFIZER INC-2014361991$PFIZER$$59$YR$$F$Y$64.85$KG$20200924$$HP$US$US
106857424$10685742$4$F$20141123$20150129$20141231$20150206$EXP$$US-JNJFOC-20141207281$PHARMACYCLICS$$66$YR$E$M$Y$$$20150206$$MD$US$US
106865001$10686500$1$I$20141109$20141230$20150101$20150101$EXP$GB-MHRA-EYC 00118426$GB-ROCHE-1516351$ROCHE$$67$YR$$F$Y$67.12$KG$20150101$$CN$GB$GB
106866207$10686620$7$F$20140605$20160607$20150101$20200710$EXP$$FR-ROCHE-1516136$ROCHE$$64$YR$$M$Y$$$20200710$$MD$FR$FR
106873665$10687366$5$F$20140430$20160518$20150102$20160520$EXP$$PHHY2014AU078816$NOVARTIS$$21$YR$$F$Y$67$KG$20160520$$HP$AU$AU
106877533$10687753$3$F$20140812$20150313$20150102$20150327$EXP$$US-JNJFOC-20141215161$JANSSEN$$$$$$Y$$$20150327$$MD$US$US
106878444$10687844$4$F$2011$20200708$20150102$20200715$EXP$$US-SA-2014SA179364$SANOFI AVENTIS$$$$$F$Y$$$20200715$$CN$US$US
106878712$10687871$2$F$20141203$20150214$20150102$20150220$EXP$$US-JNJFOC-20141220180$PHARMACYCLICS$$71$YR$E$F$Y$63.2$KG$20150220$$MD$US$US
106878731$10687873$1$I$20141113$20141224$20150102$20150102$EXP$$US-JNJFOC-20141220178$PHARMACYCLICS$$60$YR$A$M$Y$$$20150102$$MD$US$US
106898703$10689870$3$F$$20200305$20150105$20200320$EXP$$ES-JNJFOC-20141218059$JOHNSON AND JOHNSON$ALVAREZ M, BARBARROJA?ESCUDERO J, ANTOLIN?AMERIGO D, RODRIGUEZ?RODRIGUEZ M, FERNANDEZ L, MEDINA I, BELLON T, SANCHEZ?GONZALEZ M. ERYTHEMA MULTIFORME INDUCED BY TRAMADOL: AN ALLERGY ASSESSMENT. J INVEST ALLERGOL CLIN IMMUNOL. 2020?30(4):1?7.$47$YR$$F$Y$$$20200320$$MD$ES$ES
106899204$10689920$4$F$20140101$20200914$20150105$20200925$EXP$$US-JNJFOC-20141218572$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200925$$CN$US$US
1069101913$10691019$13$F$201806$20200819$20150105$20200821$PER$$US-PFIZER INC-2014356122$PFIZER$$51$YR$$F$Y$60.77$KG$20200821$$MD$US$US
106930943$10693094$3$F$2013$20200803$20150106$20200804$EXP$$US-PFIZER INC-2014363516$PFIZER$$55$YR$$M$Y$113$KG$20200804$$CN$US$US
1069457338$10694573$38$F$20140417$20200629$20150107$20200701$EXP$$CA-ROCHE-1387659$ROCHE$$53$YR$$F$Y$48.81$KG$20200701$$HP$CA$CA
106975515$10697551$5$F$1974$20200824$20150108$20200826$EXP$$US-PFIZER INC-2015005483$PFIZER$$64$YR$$F$Y$58.51$KG$20200826$$CN$US$US
107000017$10700001$7$F$20141020$20151102$20150109$20151105$EXP$$IT-JNJFOC-20141108151$JANSSEN$$57$YR$A$M$Y$105$KG$20151105$$CN$GB$IT
107029521$10702952$1$I$20141109$20141230$20150110$20150110$EXP$GB-MHRA-EYC 00118426$GB-MYLANLABS-2015M1000115$MYLAN$$$$$$Y$$$20150110$$CN$GB$GB
107037819$10703781$9$F$2016$20200914$20150112$20200917$EXP$$US-PFIZER INC-2015011616$PFIZER$$71$YR$$F$Y$73$KG$20200917$$MD$US$US
107040376$10704037$6$F$201412$20200812$20150112$20200817$PER$$US-PFIZER INC-2015007441$PFIZER$$53$YR$$F$Y$48.53$KG$20200817$$HP$US$US
107040672$10704067$2$F$$20150105$20150112$20200708$EXP$$PHHY2015IT001302$NOVARTIS$CASTELNOVO A, ZAMBRELLI E, CANEVINI MP, CAVALLOTTI S, SCARONE S, D^AGOSTINO A. OCCIPITAL SEIZURES AND VISUAL PSEUDOHALLUCINATIONS ASSOCIATED WITH THE ADDITION OF BUPROPION TO CLOZAPINE: A CASE REPORT. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2014$33$YR$$M$Y$$$20200708$$HP$IT$IT
1070483315$10704833$15$F$$20200917$20141127$20200929$EXP$$CA-APOTEX-2014AP005774$APOTEX$$64$YR$$F$Y$69$KG$20200929$$CN$CA$CA
107076505$10707650$5$F$20140114$20200909$20150113$20200914$EXP$$US-JNJFOC-20150103396$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20200914$$HP$US$US
107093402$10709340$2$F$20140418$20200630$20150114$20200702$EXP$$IT-AUROBINDO-AUR-APL-2014-07472$AUROBINDO$$86$YR$$F$Y$$$20200702$$PH$IT$IT
1071271826$10712718$26$F$20130916$20200819$20150115$20200827$EXP$$CA-ROCHE-1520634$ROCHE$$44$YR$$F$Y$$$20200827$$CN$CA$CA
1071324521$10713245$21$F$20150107$20200713$20150115$20200717$EXP$$PHHY2015DE002788$NOVARTIS$$29$YR$$F$Y$62$KG$20200717$$HP$DE$DE
107135657$10713565$7$F$20141223$20180329$20150115$20180411$EXP$$CZ-JNJFOC-20150104606$PHARMACYCLICS$$75$YR$E$M$Y$79$KG$20180411$$MD$CZ$CZ
107138562$10713856$2$F$2005$20200701$20150115$20200703$EXP$$PHHY2015PT004265$NOVARTIS$$80$YR$$M$Y$$$20200703$$HP$PT$PT
107160124$10716012$4$F$$20200723$20150116$20200727$PER$$US-PFIZER INC-2015017321$PFIZER$$58$YR$$F$Y$74$KG$20200727$$MD$US$US
107169854$10716985$4$F$20141218$20180223$20150116$20180301$EXP$$US-JNJFOC-20150109394$PHARMACYCLICS$$62$YR$A$M$Y$112.1$KG$20180301$$HP$US$US
107176446$10717644$6$F$20150102$20200826$20150116$20200908$EXP$$JP-INCYTE CORPORATION-2015IN000037$INCYTE$$$$$$Y$$$20200908$$MD$JP$JP
107176806$10717680$6$F$20150112$20150423$20150116$20150427$EXP$$CN-JNJFOC-20150110119$PHARMACYCLICS$$65$YR$A$M$Y$76$KG$20150427$$MD$CN$CN
1071775413$10717754$13$F$$20200828$20150116$20200901$EXP$$US-PFIZER INC-2015018145$PFIZER$$50$YR$$F$Y$81$KG$20200901$$MD$US$US
107181242$10718124$2$F$20141216$20160426$20150117$20200813$EXP$$PHHY2014JP166769$NOVARTIS$$71$YR$$F$Y$$$20200813$$HP$JP$JP
1072049034$10720490$34$F$20100227$20200810$20150119$20200819$EXP$$PHHY2010CA13505$NOVARTIS$$64$YR$$F$Y$$$20200819$$CN$CA$CA
1072049933$10720499$33$F$201504$20200811$20150119$20200818$EXP$$PHHY2015CA005492$NOVARTIS$$65$YR$$M$Y$$$20200818$$HP$CA$CA
107218871$10721887$1$I$$20150105$20150120$20150120$EXP$$US-CIPLA LTD.-2015US00363$CIPLA$HOCHSTER H, UBOHA N, MESSERSMITH W, GOLD P, ONEIL B, COHEN D, DENLINGER C, COHEN S, LEICHMAN C, LEICHMAN L. PHASE II STUDY OF SELUMETINIB (AZD6244, ARRY?142886) PLUS IRINOTECAN AS SECOND?LINE THERAPY IN PATIENTS WITH K?RAS MUTATED COLORECTAL CANCER. CANCER CHEMOTHER PHARMACOL. 2015?75:17?23$$$$$Y$$$20150120$$HP$US$US
107236269$10723626$9$F$20141215$20200715$20150120$20200716$EXP$$US-PFIZER INC-2015023594$PFIZER$$62$YR$$F$Y$74$KG$20200716$$MD$US$US
107238871$10723887$1$I$$20150105$20150120$20150120$EXP$$US-CIPLA LTD.-2015US00386$CIPLA$HOCHSTER H, UBOHA N, MESSERSMITH W, GOLD P, ONEIL B, COHEN D, DENLINGER C, COHEN S, LEICHMAN C AND  LEICHMAN L. PHASE II STUDY OF SELUMETINIB (AZD6244, ARRY?142886) PLUS IRINOTECAN AS SECOND?LINE THERAPY IN PATIENTS WITH K?RAS MUTATED COLORECTAL CANCER. CANCER CHEMOTHER PHARMACOL. 2015?75:17 TO 23$$$$$Y$$$20150120$$HP$US$US
107247249$10724724$9$F$20150104$20170907$20150120$20170911$EXP$$US-JNJFOC-20150103434$JANSSEN$$63$YR$A$F$Y$48.5$KG$20170911$$MD$US$US
107272664$10727266$4$F$201301$20200811$20150121$20200821$EXP$$US-JNJFOC-20150110571$JOHNSON AND JOHNSON$$85$YR$E$F$Y$57.5$KG$20200821$$LW$US$US
107308727$10730872$7$F$201605$20200812$20150122$20200813$EXP$$US-PFIZER INC-2015027988$PFIZER$$52$YR$$F$Y$72.56$KG$20200813$$CN$US$US
107309344$10730934$4$F$20150114$20200810$20150122$20200813$EXP$$US-PFIZER INC-2015021156$PFIZER$$31$YR$$M$Y$$$20200813$$HP$US$US
107358944$10735894$4$F$201411$20200806$20150126$20200812$EXP$$US-ROCHE-1525768$ROCHE$$10$YR$$M$Y$52.2$KG$20200812$$MD$US$US
107391865$10739186$5$F$201411$20200820$20150126$20200821$EXP$$US-PFIZER INC-2015033171$PFIZER$$65$YR$$M$Y$96$KG$20200821$$CN$US$US
107408104$10740810$4$F$$20200716$20150127$20200717$PER$$US-PFIZER INC-2015032484$PFIZER$$54$YR$$F$Y$91$KG$20200717$$CN$US$US
107413856$10741385$6$F$201712$20200814$20150127$20200821$EXP$$US-SA-2014SA147871$SANOFI AVENTIS$$63$YR$$M$Y$$$20200821$$CN$US$US
1074161619$10741616$19$F$2011$20200806$20150127$20200810$EXP$$US-PFIZER INC-2015031957$PFIZER$$56$YR$$F$Y$86$KG$20200810$$HP$US$US
107422861$10742286$1$I$19960804$20150121$20150127$20150127$EXP$$DE-BAYER-2015-011744$BAYER$$34$YR$A$F$Y$$$20150127$$CN$US$US
107423461$10742346$1$I$20141209$20150117$20150127$20150127$EXP$$US-JNJFOC-20150117202$PHARMACYCLICS$$66$YR$E$M$Y$$$20150127$$MD$US$US
107443606$10744360$6$F$2007$20200706$20150128$20200708$EXP$$US-PFIZER INC-2015029702$PFIZER$$68$YR$$F$Y$81.63$KG$20200708$$CN$US$US
107444043$10744404$3$F$20141223$20150629$20150128$20150706$EXP$$GB-JNJFOC-20150115169$PHARMACYCLICS$$74$YR$E$M$Y$$$20150706$$HP$GB$GB
107460252$10746025$2$F$20141224$20150214$20150128$20150224$EXP$$US-JNJFOC-20150118253$PHARMACYCLICS$$73$YR$E$F$Y$$$20150224$$MD$US$US
107463832$10746383$2$F$20150123$20150206$20150128$20150212$EXP$$US-JNJFOC-20150118242$PHARMACYCLICS$$68$YR$E$M$Y$$$20150212$$MD$US$US
107471563$10747156$3$F$$20200728$20150129$20200806$EXP$$PT-ACCORD-028265$ACCORD$$68$YR$E$F$Y$$$20200806$$MD$PT$PT
107495186$10749518$6$F$20141121$20200924$20150129$20200930$EXP$$ES-ALEXION PHARMACEUTICALS INC.-A201500219$ALEXION$$4$YR$$F$Y$12$KG$20200930$$CN$ES$ES
107508515$10750851$5$F$20141219$20150813$20150130$20150819$EXP$$CA-JNJFOC-20150117077$JANSSEN$$33$YR$A$F$Y$57$KG$20150819$$MD$CA$CA
107510025$10751002$5$F$20130204$20200716$20150130$20200721$PER$$US-JNJFOC-20150117317$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200721$$CN$US$US
107512232$10751223$2$F$20140703$20200710$20150130$20200722$EXP$$US-JNJFOC-20150115160$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20200722$$HP$US$US
107521001$10752100$1$I$20141229$20150122$20150130$20150130$EXP$$US-JNJFOC-20150120393$PHARMACYCLICS$$84$YR$E$F$Y$$$20150130$$MD$US$US
107559333$10755933$3$F$19960804$20150325$20150202$20150327$EXP$$DE-ASTRAZENECA-2015SE08602$ASTRAZENECA$$34$YR$$F$Y$$$20150328$$CN$US$DE
107568694$10756869$4$F$20141216$20200706$20150203$20200709$EXP$$US-MERCK-1502USA000114$MERCK$$75$YR$$M$Y$$$20200709$$CN$US$US
107594563$10759456$3$F$201911$20200911$20150203$20200916$EXP$$US-JAZZ-2015-US-001212$JAZZ$$69$YR$$M$Y$92.97$KG$20200916$$HP$US$US
107603453$10760345$3$F$2014$20200904$20150204$20200915$EXP$$FR-ACCORD-028390$ACCORD$$40$YR$$F$Y$$$20200915$$CN$FR$FR
107608213$10760821$3$F$20141121$20200720$20150204$20200722$PER$$US-JNJFOC-20150119535$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200722$$CN$US$US
107608263$10760826$3$F$20140312$20200727$20150204$20200731$PER$$US-JNJFOC-20150120822$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200731$$CN$US$US
107609263$10760926$3$F$201305$20200916$20150204$20200929$EXP$$CA-JNJFOC-20150118657$JOHNSON AND JOHNSON$$30$YR$A$F$Y$70.5$KG$20200929$$CN$CA$CA
107613336$10761333$6$F$$20200927$20150204$20200929$PER$$US-PFIZER INC-2015043540$PFIZER$$50$YR$$M$Y$125$KG$20200929$$MD$US$US
107632644$10763264$4$F$20150118$20150420$20150204$20150427$EXP$$CN-JNJFOC-20150119118$PHARMACYCLICS$$41$YR$A$M$Y$67$KG$20150427$$MD$CN$CN
107650057$10765005$7$F$20150128$20200922$20150205$20200928$PER$$US-PFIZER INC-2015045767$PFIZER$$61$YR$$F$Y$90$KG$20200928$$MD$US$US
107667064$10766706$4$F$20131125$20200719$20150205$20200729$EXP$$US-JNJFOC-20150120847$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200729$$CN$US$US
107667213$10766721$3$F$$20150423$20150205$20200701$EXP$$GR-JNJFOC-20150118283$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
107684905$10768490$5$F$2012$20200720$20150206$20200722$PER$$CA-AMGEN-CANSP2014100252$AMGEN$$47$YR$A$F$Y$$$20200722$$CN$CA$CA
1076877810$10768778$10$F$20200410$20200810$20150206$20200813$EXP$$US-PFIZER INC-2015047736$PFIZER$$69$YR$$F$Y$70.75$KG$20200813$$CN$US$US
107700416$10770041$6$F$20141229$20160622$20150206$20160630$EXP$$FR-JNJFOC-20150203255$PHARMACYCLICS$$79$YR$E$F$Y$56$KG$20160630$$MD$FR$FR
107700484$10770048$4$F$2016$20200812$20150206$20200819$EXP$$BR-SA-2015SA013459$SANOFI AVENTIS$$$$$$Y$$$20200819$$MD$BR$BR
107769459$10776945$9$F$20140923$20200702$20150209$20200709$EXP$$PHHY2014AU159701$NOVARTIS$$39$YR$$M$Y$138$KG$20200709$$HP$AU$AU
107791463$10779146$3$F$20141102$20200820$20150210$20200824$PER$$US-JNJFOC-20150201738$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200824$$CN$US$US
107796602$10779660$2$F$$20200914$20150210$20200923$EXP$$DE-AUROBINDO-AUR-APL-2015-00915$AUROBINDO$$31$YR$$F$Y$84$KG$20200923$$CN$DE$DE
107797094$10779709$4$F$$20200924$20150210$20200930$EXP$$GB-AUROBINDO-AUR-APL-2015-01043$AUROBINDO$$49$YR$$F$Y$$$20201001$$MD$GB$GB
1078345512$10783455$12$F$20150112$20200713$20150210$20200722$EXP$$FR-GILEAD-2015-0136037$GILEAD$$61$YR$A$F$Y$76$KG$20200722$$MD$FR$FR
107845531$10784553$1$I$20150117$20150130$20150211$20150211$EXP$$US-PFIZER INC-2015052551$PFIZER$$67$YR$$M$Y$$$20150211$$MD$US$US
107851813$10785181$3$F$20150128$20150312$20150211$20200701$EXP$$GR-JNJFOC-20150120619$JOHNSON AND JOHNSON$$33$YR$$F$Y$52.21$KG$20200701$$CN$GR$GR
107851821$10785182$1$I$20140924$20140923$20150211$20150211$EXP$$US-JNJFOC-20140923940$JANSSEN$$40$YR$A$F$Y$55.6$KG$20150211$$MD$US$US
107865802$10786580$2$F$20141227$20150207$20150211$20150217$EXP$$US-JNJFOC-20150207136$PHARMACYCLICS$$87$YR$E$F$Y$51$KG$20150217$$MD$US$US
107866723$10786672$3$F$20150203$20150402$20150211$20150414$EXP$$JP-BAYER-2015-018889$BAYER$$58$YR$A$M$Y$66$KG$20150410$$MD$JP$JP
107868913$10786891$3$F$2014$20200728$20150211$20200921$PER$$US-JAZZ-2015-US-001722$JAZZ$$37$YR$$F$Y$$$20200921$$HP$US$US
107873351$10787335$1$I$20141203$20150205$20150211$20150211$EXP$GB-MHRA-EYC 00119572$GB-ROCHE-1534190$ROCHE$$66$YR$$F$Y$75$KG$20150212$$MD$GB$GB
1078752217$10787522$17$F$201408$20200707$20150212$20200710$EXP$$CA-ROCHE-1436029$ROCHE$$65$YR$$F$Y$51.3$KG$20200710$$MD$CA$CA
107875894$10787589$4$F$201411$20200730$20150212$20200805$PER$$BR-AMGEN-BRASP2015012713$AMGEN$$48$YR$A$M$Y$85$KG$20200805$$CN$BR$BR
107881376$10788137$6$F$2014$20200702$20150212$20200707$PER$$US-JNJFOC-20150202712$JOHNSON AND JOHNSON$$71$YR$$M$Y$104$KG$20200707$$CN$US$US
107886292$10788629$2$F$20140924$20150216$20150212$20150224$EXP$$US-JNJFOC-20150205558$PHARMACYCLICS$$67$YR$E$M$Y$97.52$KG$20150224$$MD$US$US
107896503$10789650$3$F$20150204$20150318$20150212$20150326$EXP$$US-JNJFOC-20150207178$PHARMACYCLICS$$80$YR$E$F$Y$51.7$KG$20150326$$MD$US$US
107936994$10793699$4$F$201408$20200830$20150213$20200902$PER$$US-JNJFOC-20150204353$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20200902$$LW$US$US
1079372413$10793724$13$F$2015$20200807$20150213$20200811$EXP$$US-PFIZER INC-2015055713$PFIZER$$82$YR$$F$Y$$$20200811$$MD$US$US
107941242$10794124$2$F$20150205$20150319$20150213$20150326$EXP$$US-JNJFOC-20150208577$PHARMACYCLICS$$75$YR$E$M$Y$70.76$KG$20150326$$MD$US$US
1079433513$10794335$13$F$2013$20200728$20150213$20200730$EXP$$US-PFIZER INC-2015050241$PFIZER$$65$YR$$F$Y$$$20200730$$CN$US$US
107944014$10794401$4$F$$20200825$20150213$20200827$EXP$$US-PFIZER INC-2015055227$PFIZER$$63$YR$$F$Y$53$KG$20200827$$CN$US$US
1079606813$10796068$13$F$20130802$20200820$20150216$20200825$EXP$$CA-ROCHE-1258942$ROCHE$$64$YR$$F$Y$100$KG$20200825$$HP$CA$CA
107962542$10796254$2$F$$20200720$20150216$20200731$EXP$$FR-ROCHE-1536097$ROCHE$, BOUABDALLAH K, BURRONI B, LAMY T, GRESSIN R, CARTRON G, THIEBLEMONT C, SARKOZY C, HAIOUN C, CASASNOVAS O, JOUBERT C, GYAN E, HERMINE O, LE GOUILL S SAFETY AND EFFICACY OF TEMSIROLIMUS IN COMBINATION WITH THREE DIFFERENT IMMUNO?CHEMOTHERAPY REGIMENS IN RELAPSE AND REFRACTORY MANTLE CELL LYMPHOMA, FINAL RESULTS OF THE T3 PHASE IB TRIAL OF THE LYSA. ANNALS OF HEMATOLOGY 2020?99 (8):1771?78.$$$$$Y$$$20200731$$MD$FR$FR
107971413$10797141$3$F$2019$20200814$20150216$20200823$PER$$US-ELI_LILLY_AND_COMPANY-US201501010013$ELI LILLY AND CO$$$$$F$Y$$$20200823$$CN$US$US
107980363$10798036$3$F$20090809$20200803$20150216$20200805$PER$$US-PFIZER INC-2015055506$PFIZER$$56$YR$$M$Y$71.66$KG$20200805$$CN$US$US
108016982$10801698$2$F$20141215$20150212$20150217$20150218$EXP$$US-JNJFOC-20150202271$PHARMACYCLICS$$55$YR$A$M$Y$$$20150218$$MD$US$US
108021845$10802184$5$F$20131001$20200809$20150217$20200813$PER$$US-JNJFOC-20150207277$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20200813$$CN$US$US
108030489$10803048$9$F$20141114$20200821$20150217$20200903$EXP$$JP-INCYTE CORPORATION-2015IN000164$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
108037964$10803796$4$F$20140521$20200624$20150217$20200703$EXP$$US-SA-2014SA173376$SANOFI AVENTIS$$52$YR$$F$Y$$$20200703$$CN$US$US
108186919$10818691$9$F$$20200909$20150218$20200914$EXP$$US-PFIZER INC-2015062780$PFIZER$$75$YR$$F$Y$45$KG$20200914$$MD$US$US
108303986$10830398$6$F$$20200807$20150219$20200811$PER$$US-PFIZER INC-2015060522$PFIZER$$$$$M$Y$110$KG$20200811$$HP$US$US
108304356$10830435$6$F$201301$20200916$20150219$20200923$EXP$$US-SANOFI-AVENTIS-2013SA008362$SANOFI AVENTIS$$$$$$Y$$$20200923$$CN$US$US
108304765$10830476$5$F$2013$20200727$20150219$20200731$PER$$US-JNJFOC-20150208619$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20200731$$CN$US$US
108422856$10842285$6$F$$20190730$20150220$20190805$PER$$US-PFIZER INC-2015060245$PFIZER$$45$YR$$F$Y$$$20190805$$MD$US$US
108443791$10844379$1$I$20150129$20150217$20150220$20150220$EXP$PT-INFARMED-N201502-741$PT-009507513-1502PRT007696$MERCK$$49$YR$$F$Y$63$KG$20150220$$PH$PT$PT
108444265$10844426$5$F$201301$20200903$20150220$20200909$PER$$US-JNJFOC-20150209638$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200909$$CN$US$US
108465924$10846592$4$F$20140314$20200827$20150220$20200910$EXP$$US-JNJFOC-20150212766$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200910$$CN$US$US
108610985$10861098$5$F$20120614$20160614$20150224$20160627$EXP$$MX-ACTELION-A-CH2013-92770$ACTELION$$53$YR$A$F$Y$45$KG$20160627$$MD$MX$MX
108613472$10861347$2$F$20140710$20170801$20150224$20170810$EXP$$JP-JNJFOC-20150211829$JANSSEN$$72$YR$E$M$Y$66$KG$20170810$$MD$JP$JP
108635372$10863537$2$F$20150215$20170721$20150224$20170726$EXP$$US-JNJFOC-20150214538$PHARMACYCLICS$$$$$F$Y$$$20170726$$MD$US$US
108635747$10863574$7$F$20150129$20200820$20150224$20200903$EXP$$JP-INCYTE CORPORATION-2015IN000744$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
108641587$10864158$7$F$$20200728$20150224$20200729$PER$$US-PFIZER INC-2015066513$PFIZER$$68$YR$$M$Y$106$KG$20200729$$CN$US$US
108662934$10866293$4$F$20141226$20200720$20150225$20200722$PER$$CA-AMGEN-CANSL2014101785$AMGEN$$52$YR$A$F$Y$115$KG$20200721$$HP$CA$CA
108701318$10870131$8$F$201411$20200831$20150226$20200903$EXP$$CA-009507513-1502CAN010703$MERCK$$60$YR$$F$Y$48$KG$20200903$$HP$CA$CA
108716942$10871694$2$F$20150203$20150402$20150226$20150410$EXP$$GB-JNJFOC-20150219085$PHARMACYCLICS$$86$YR$E$M$Y$$$20150410$$MD$GB$GB
108721106$10872110$6$F$20150218$20150922$20150226$20150928$PER$$US-JNJFOC-20150217694$PHARMACYCLICS$$75$YR$E$M$Y$70.76$KG$20150928$$MD$US$US
108728112$10872811$2$F$$20200820$20150227$20200826$PER$$US-AMGEN-USASP2015016782$AMGEN$$66$YR$E$M$Y$$$20200826$$MD$US$US
108732852$10873285$2$F$$20200707$20150227$20200720$EXP$$US-AUROBINDO-AUR-APL-2015-01602$AUROBINDO$$27$YR$$F$Y$$$20200720$$HP$US$US
108736195$10873619$5$F$201309$20200805$20150227$20200817$EXP$$US-JNJFOC-20150214675$JOHNSON AND JOHNSON$$55$YR$A$F$Y$90.7$KG$20200817$$HP$US$US
1087364411$10873644$11$F$201502$20200807$20150227$20200813$EXP$$JP-OTSUKA-JP-2015-11077$OTSUKA$$48$YR$$M$Y$65.8$KG$20200813$$MD$JP$JP
108736746$10873674$6$F$201302$20200722$20150227$20200731$EXP$$US-JNJFOC-20150218112$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200731$$CN$US$US
108737812$10873781$2$F$20150101$20150729$20150227$20150806$EXP$$US-MUNDIPHARMA DS AND PHARMACOVIGILANCE-USA-2015-0121293$PURDUE$$23$YR$$F$Y$45$KG$20150806$$MD$US$US
108751501$10875150$1$I$20100614$20150216$20150227$20150227$EXP$$CA-MYLANLABS-2015M1006547$MYLAN$AGLIETTA, M. A PHASE I DOSE EXCALATION TRIL OF TREMELIMUMAB (CP?675,206) IN COMBINATION WITH GEMCITABINE IN CHEMOTHERAPY?NAIVE PATIENTS WITH METASTATIC PANCREATIC CANCER. ANNALS OF ONCOLOGY. 02014? 25(9) 1750?1755.$$$$$Y$$$20150227$$HP$CA$CA
1087889812$10878898$12$F$20140906$20200811$20150302$20200813$EXP$$US-PFIZER INC-2015075682$PFIZER$$46$YR$$F$Y$50$KG$20200813$$HP$US$US
108789822$10878982$2$F$20141106$20150227$20150302$20150311$EXP$$PHHY2015ES021362$SANDOZ$$76$YR$$M$Y$$$20150311$$CN$ES$ES
1087992919$10879929$19$F$20140611$20200903$20150302$20200907$PER$$US-PFIZER INC-2015069594$PFIZER$$76$YR$$F$Y$79$KG$20200907$$MD$US$US
1088003249$10880032$49$F$20080117$20200811$20150302$20200819$EXP$$PHMT2008CA00492$NOVARTIS$$47$YR$$F$Y$55$KG$20200819$$CN$COUNTRY NOT SPECIFIED$CA
108805152$10880515$2$F$$20200921$20150303$20200927$EXP$$US-AUROBINDO-AUR-APL-2015-01599$AUROBINDO$$55$YR$$F$Y$$$20200928$$MD$US$US
108810535$10881053$5$F$20200728$20200729$20150303$20200731$PER$$US-PFIZER INC-2015075826$PFIZER$$78$YR$$F$Y$$$20200731$$CN$US$US
108822402$10882240$2$F$20141023$20200710$20150303$20200717$EXP$$FR-ASTELLAS-2015US006486$ASTELLAS$$59$YR$$M$Y$$$20200717$$HP$FR$FR
108828886$10882888$6$F$$20200702$20150303$20200707$PER$$US-PFIZER INC-2015074600$PFIZER$$77$YR$$M$Y$84$KG$20200707$$HP$US$US
1088363710$10883637$10$F$20150129$20200706$20150303$20200713$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-013142$BRISTOL MYERS SQUIBB$ASAMI Y, ET AL. A CASE OF NIVOLUMAB?INDUCED LEUKODERMA SHRINKING AND DISAPPEARING WITH ACCOMPANYING RECURRENCE OF MALIGNANT MELANOMA. THE 69TH ANNUAL MEETING OF THE WESTERN JAPAN DIVISION OF JDA. 2017?O?111$39$YR$$M$Y$60$KG$20200713$$MD$JP$JP
108852422$10885242$2$F$201406$20160426$20150304$20200818$EXP$$PHJP2015JP002300$NOVARTIS$$60$YR$$M$Y$53$KG$20200818$$HP$JP$JP
108869998$10886999$8$F$$20200825$20150304$20200826$PER$$US-PFIZER INC-2015074336$PFIZER$$63$YR$$M$Y$150$KG$20200826$$MD$US$US
108881769$10888176$9$F$20150129$20200908$20150304$20200915$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-012711$BRISTOL MYERS SQUIBB$YAMAUCHI I, ET AL.. CLINICAL FEATURES OF NIVOLUMAB?INDUCED THYROIDITIS:A CASE SERIES STUDY. THYROID. 2017?27(7):894?901$72$YR$$M$Y$53$KG$20200915$$MD$JP$JP
1089008013$10890080$13$F$20150225$20200805$20150305$20200807$PER$$US-PFIZER INC-2015076072$PFIZER$$32$YR$$M$Y$95$KG$20200807$$CN$US$US
1089112917$10891129$17$F$201502$20200826$20150305$20200908$EXP$$JP-INCYTE CORPORATION-2015IN000774$INCYTE$$$$$$Y$$$20200908$$HP$JP$JP
108912008$10891200$8$F$20150219$20200804$20150306$20200813$EXP$$FR-BEH-2015049321$CSL BEHRING$$45$YR$A$M$Y$$$20200813$$HP$FR$FR
1089174923$10891749$23$F$20150320$20200724$20150306$20200729$EXP$$US-SA-2015SA027489$SANOFI AVENTIS$$$$$$Y$$$20200729$$CN$US$US
108921795$10892179$5$F$201302$20200712$20150306$20200714$PER$$US-JNJFOC-20150300759$JOHNSON AND JOHNSON$$65$YR$$F$Y$$$20200714$$CN$US$US
108921903$10892190$3$F$20140116$20200922$20150306$20200928$PER$$US-JNJFOC-20150301422$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200928$$CN$US$US
108959799$10895979$9$F$201501$20200903$20150308$20200910$EXP$$PHHY2015CA024106$NOVARTIS$$76$YR$$F$Y$$$20200910$$CN$COUNTRY NOT SPECIFIED$CA
108972986$10897298$6$F$$20200626$20150309$20200701$PER$$US-PFIZER INC-2015081516$PFIZER$$79$YR$$F$Y$91$KG$20200701$$MD$US$US
108989234$10898923$4$F$20150226$20150423$20150309$20150430$EXP$$TW-JNJFOC-20150300387$JANSSEN$$31$YR$A$M$Y$103$KG$20150430$$MD$TW$TW
108989459$10898945$9$F$$20200923$20150309$20200928$EXP$$US-PFIZER INC-2015079726$PFIZER$$47$YR$$F$Y$$$20200928$$MD$US$US
109001822$10900182$2$F$20150129$20200914$20150310$20200921$EXP$$DE-AUROBINDO-AUR-APL-2015-01958$AUROBINDO$$85$YR$$F$Y$68$KG$20200921$$CN$DE$DE
109008551$10900855$1$I$$20150216$20150310$20150310$EXP$$US-PFIZER INC-2015082360$PFIZER$HOCHSTER, H.S.. PHASE II STUDY OF SELUMETINIB (AZD6244, ARRY?142886) PLUS IRINOTECAN AS SECOND?LINE THERAPY IN PATIENTS WITH K?RAS MUTATED COLORECTAL CANCER. CANCER CHEMOTHERAPY + PHARMACOLOGY. 2015?75(1):17?23$$$$$Y$$$20150310$$HP$US$US
109020393$10902039$3$F$201302$20200720$20150310$20200724$PER$$US-JNJFOC-20150305917$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200724$$CN$US$US
109030745$10903074$5$F$201411$20200918$20150311$20200925$PER$$BR-AMGEN-BRASP2014093804$AMGEN$$67$YR$E$M$Y$90$KG$20200925$$CN$BR$BR
109037661$10903766$1$I$$20150309$20150311$20150311$EXP$$KR-ROCHE-1550362$ROCHE$KIM H, JUNG H, KIM M, JOA K, KIM, YEO J, KWON S AND KIM C. SUCCESSFUL CONSERVATIVE TREATMENT: MULTIPLE ATYPICAL FRACTURES IN OSTEOPOROTIC PATIENTS AFTER BISPHOSPHATE MEDICATION: A UNIQUE CASE REPORT. MEDICINE 2015 FEB 13?94(5):E446?.$64$YR$$F$Y$$$20150311$$MD$KR$KR
109049243$10904924$3$F$20050916$20200916$20150311$20200922$EXP$$US-PFIZER INC-2015086790$PFIZER$$62$YR$$F$Y$95$KG$20200922$$LW$US$US
1090548311$10905483$11$F$$20200922$20150311$20200928$PER$$US-PFIZER INC-2015083097$PFIZER$$87$YR$$F$Y$66$KG$20200928$$MD$US$US
1090804911$10908049$11$F$$20200924$20150312$20200929$PER$$US-PFIZER INC-2015029957$PFIZER$$54$YR$$M$Y$$$20200929$$HP$US$US
109084233$10908423$3$F$200703$20200826$20150312$20200827$EXP$$US-PFIZER INC-2015086726$PFIZER$$56$YR$$F$Y$$$20200827$$LW$US$US
109108895$10910889$5$F$$20200922$20150312$20200925$EXP$$US-JAZZ-2015-US-000907$JAZZ$$$$$F$Y$$$20200925$$CN$US$US
109109211$10910921$1$I$20150103$20150115$20150312$20150312$EXP$$CA-JNJFOC-20150112592$PHARMACYCLICS$$76$YR$E$F$Y$56$KG$20150312$$MD$CA$CA
1091101010$10911010$10$F$20130411$20200715$20150312$20200723$EXP$$PHHY2012CA069532$NOVARTIS$$65$YR$$M$Y$116.55$KG$20200723$$HP$CA$CA
109112732$10911273$2$F$20140516$20160426$20150312$20200813$EXP$$PHJP2015JP002577$NOVARTIS$$60$YR$$M$Y$75$KG$20200813$$$JP$JP
109113272$10911327$2$F$2015$20200728$20150313$20200806$EXP$$CA-ROCHE-1524299$ROCHE$$$$$F$Y$$$20200807$$MD$CA$CA
109141586$10914158$6$F$2014$20200806$20150313$20200810$EXP$$US-PFIZER INC-2015086636$PFIZER$$81$YR$$F$Y$42$KG$20200810$$HP$US$US
109198903$10919890$3$F$20140609$20160725$20150317$20160726$EXP$$GB-ROCHE-1549187$ROCHE$$53$YR$$F$Y$$$20160726$$MD$GB$GB
1092018034$10920180$34$F$2015$20200710$20150317$20200717$EXP$$PHHY2015CA028279$NOVARTIS$$2$YR$$F$Y$$$20200717$$CN$COUNTRY NOT SPECIFIED$CA
1092018225$10920182$25$F$20140827$20200817$20150317$20200822$EXP$$PHHY2015US027053$NOVARTIS$$45$YR$$M$Y$73.92$KG$20200822$$MD$US$US
109210802$10921080$2$F$20150211$20150324$20150317$20150408$EXP$$AU-PFIZER INC-2015089312$PFIZER$$43$YR$$F$Y$$$20150408$$MD$AU$AU
1092309736$10923097$36$F$20100303$20200915$20150317$20200923$EXP$$PHHY2010CA15776$NOVARTIS$$55$YR$$M$Y$100$KG$20200923$$HP$CA$CA
1092334417$10923344$17$F$201410$20200807$20150318$20200814$EXP$$CA-ROCHE-1552626$ROCHE$$45$YR$$M$Y$$$20200814$$MD$CA$CA
109266054$10926605$4$F$20150310$20150417$20150318$20150423$EXP$$GB-JNJFOC-20150309950$PHARMACYCLICS$$82$YR$E$M$Y$77$KG$20150423$$MD$GB$GB
109273144$10927314$4$F$2014$20200821$20150318$20200826$EXP$$US-JAZZ-2015-US-000980$JAZZ$$$$$F$Y$54.42$KG$20200826$$HP$US$US
109278352$10927835$2$F$20150108$20160426$20150319$20200817$EXP$$PHJP2015JP002960$NOVARTIS$$59$YR$$M$Y$61$KG$20200817$$HP$JP$JP
1092833023$10928330$23$F$201009$20200824$20150319$20200828$EXP$$FR-009507513-1502FRA010804$MERCK$$19$YR$$M$Y$65$KG$20200828$$HP$FR$FR
109296032$10929603$2$F$$20150311$20150319$20150324$EXP$$ES-APOTEX-2015AP007317$APOTEX$RODRIGUEZ ARCAS MJ, GARCIA JIMENEZ E, CONESA ZAMORA P. CASE REPORT OF AN INTERACTION AMONGST OPIOIDS, SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND COX?2 INHIBITOR. ATEN?FARMACEUT. 2013?15(4):301?302$81$YR$$F$Y$$$20150324$$PH$ES$ES
109339561$10933956$1$I$$20150305$20150320$20150320$EXP$$ES-MYLANLABS-2015M1008790$MYLAN$RODRIGUEZ ARCAS MJ, GARCIA JIMENEZ E, CONESA ZAMORA P. CASE REPORT OF AN INTERACTION AMONGST OPIOIDS, SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND COX?2 INHIBITOR. ATEN?FARMACEUT 2013? 15(4):301?302.$$$$$Y$$$20150320$$PH$ES$ES
109341193$10934119$3$F$2008$20200713$20150320$20200716$PER$$US-JNJFOC-20140416192$JOHNSON AND JOHNSON$$$$$M$Y$$$20200716$$LW$US$US
109353296$10935329$6$F$20150217$20200824$20150320$20200904$EXP$$JP-INCYTE CORPORATION-2015IN001132$INCYTE$$$$$$Y$$$20200904$$CN$JP$JP
109441362$10944136$2$F$$20150413$20150323$20150416$EXP$$ES-AUROBINDO-AUR-APL-2015-02393$AUROBINDO$$81$YR$$F$Y$$$20150416$$HP$ES$ES
109445251$10944525$1$I$$20150316$20150323$20150323$EXP$$ES-TEVA-549006ISR$TEVA$RODRIGUEZ ARCAS MJ, GARCIA JIMENEZ E, CONESA ZAMORA P. CASE REPORT OF AN INTERACTION AMONGST OPIOIDS, SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND COX?2 INHIBITOR. ATEN?FARMACEUT 2013? 15(4):301?302.$81$YR$$F$Y$$$20150323$$PH$ES$ES
109446723$10944672$3$F$$20200826$20150323$20200828$PER$$US-PFIZER INC-2014220125$PFIZER$$41$YR$$F$Y$49$KG$20200828$$HP$US$US
109449414$10944941$4$F$$20150527$20150323$20200701$EXP$$GR-JNJFOC-20150308715$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
109456412$10945641$2$F$201310$20200728$20150323$20200731$EXP$$US-PFIZER INC-2015098960$PFIZER$$83$YR$$M$Y$75$KG$20200731$$MD$US$US
109456491$10945649$1$I$20121128$20150305$20150319$20150319$EXP$$2786995$HOSPIRA$$53$YR$A$F$N$$$20150318$N$HP$GB$
109464424$10946442$4$F$$20200909$20150323$20200911$EXP$$US-PFIZER INC-2015071285$PFIZER$$85$YR$$M$Y$$$20200911$$MD$US$US
109466143$10946614$3$F$20150310$20150415$20150323$20150416$EXP$$SG-SA-2015SA035647$AVENTIS$$58$YR$A$F$Y$$$20150416$$MD$SG$SG
109467693$10946769$3$F$20141107$20150402$20150323$20150406$EXP$$US-JNJFOC-20141117327$PHARMACYCLICS$$80$YR$E$M$Y$78.93$KG$20150406$$MD$US$US
109468313$10946831$3$F$$20200819$20150323$20200821$PER$$US-PFIZER INC-2015103710$PFIZER$$58$YR$$F$Y$68$KG$20200821$$CN$US$US
109468423$10946842$3$F$$20200918$20150323$20200923$PER$$US-PFIZER INC-2015097574$PFIZER$$47$YR$$M$Y$94.35$KG$20200923$$CN$US$US
109503553$10950355$3$F$20140912$20200818$20150324$20200828$EXP$$JP-KOWA-2014S1001235$KOWA PHARM$$$$$$Y$$$20200828$$MD$JP$JP
109522293$10952229$3$F$$20200624$20150325$20200704$PER$$US-AMGEN-USASP2015027647$AMGEN$HUSSAIN, N.. MALIGNANT CARCINOID TUMOR OF THE RECTUM IN A PATIENT WITH PSORIATIC ARTHRITIS TREATED WITH ETANERCEPT. J MED CASES. 2015?6(9):389?392$45$YR$A$F$Y$$$20200704$$HP$US$US
1095487528$10954875$28$F$20140827$20200731$20150325$20200808$EXP$$PHHY2014CA109807$NOVARTIS$$65$YR$$M$Y$$$20200808$$MD$CA$CA
109553302$10955330$2$F$20140308$20200701$20150326$20200715$EXP$$GB-AUROBINDO-AUR-APL-2014-07883$AUROBINDO$$59$YR$$F$Y$80$KG$20200715$$CN$GB$GB
1095533112$10955331$12$F$2014$20200709$20150326$20200714$EXP$$CA-ROCHE-1553566$ROCHE$$32$YR$$M$Y$104$KG$20200714$$CN$CA$CA
109587351$10958735$1$I$19960804$20150121$20150326$20150326$EXP$$US-BAYER-2015-011744$BAYER$$34$YR$A$F$Y$$$20150325$$CN$US$US
109606783$10960678$3$F$20150315$20150930$20150327$20151009$EXP$$JP-BAYER-2015-050675$BAYER$$62$YR$A$M$Y$73$KG$20151009$$MD$JP$JP
109619186$10961918$6$F$$20200720$20150327$20200723$PER$$CA-AMGEN-CANSP2015023284$AMGEN$$46$YR$A$M$Y$$$20200722$$CN$CA$CA
109667664$10966766$4$F$20150313$20150513$20150330$20200714$EXP$$US-NOVOPROD-442983$NOVO NORDISK$$74$YR$$F$Y$92.06$KG$20200714$$MD$US$US
109669544$10966954$4$F$20150318$20170316$20150330$20170324$EXP$$US-JNJFOC-20150320868$PHARMACYCLICS$$67$YR$E$M$Y$$$20170324$$MD$US$US
109683472$10968347$2$F$20150313$20150331$20150330$20150408$EXP$$CA-TEVA-551453USA$TEVA$$70$YR$$F$Y$$$20150408$$MD$CA$CA
109704252$10970425$2$F$2015$20200821$20150331$20200828$EXP$$US-SA-2015SA039935$SANOFI AVENTIS$$$$$M$Y$$$20200828$$CN$US$US
109719385$10971938$5$F$2007$20200625$20150331$20200702$PER$$US-JNJFOC-20130717680$JOHNSON AND JOHNSON$$$$$M$Y$$$20200702$$CN$US$US
109726343$10972634$3$F$20140805$20200624$20150331$20200706$PER$$US-JNJFOC-20140519651$JOHNSON AND JOHNSON$$48$YR$$M$Y$99.43$KG$20200706$$HP$US$US
109728453$10972845$3$F$200906$20200713$20150331$20200731$PER$$US-JNJFOC-20140213294$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20200731$$LW$US$US
109729573$10972957$3$F$2010$20200713$20150331$20200731$PER$$US-JNJFOC-20140106883$JOHNSON AND JOHNSON$$2$DEC$$M$Y$$$20200731$$CN$US$US
109737325$10973732$5$F$201403$20200910$20150401$20200923$EXP$$US-JNJFOC-20150321604$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20200923$$CN$US$US
109757236$10975723$6$F$201503$20200915$20150401$20200917$PER$$US-PFIZER INC-2015111004$PFIZER$$63$YR$$F$Y$111$KG$20200917$$HP$US$US
109783377$10978337$7$F$20150303$20200923$20150402$20200929$PER$$US-LUNDBECK-DKLU1109770$LUNDBECK$$78$YR$$F$Y$$$20200929$$MD$US$US
109788243$10978824$3$F$20140419$20200812$20150402$20200818$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-20668018$BRISTOL MYERS SQUIBB$$59$YR$$M$Y$100$KG$20200818$$HP$CA$CA
109789673$10978967$3$F$$20200825$20150402$20200828$PER$$US-PFIZER INC-2015111235$PFIZER$$57$YR$$F$Y$$$20200828$$HP$US$US
109800464$10980046$4$F$20150318$20170513$20150402$20170518$EXP$$CN-JNJFOC-20150316435$PHARMACYCLICS$$71$YR$E$F$Y$65$KG$20170518$$MD$CN$CN
1098206321$10982063$21$F$2013$20200626$20150403$20200703$EXP$$CA-ROCHE-1350337$ROCHE$$43$YR$$F$Y$54$KG$20200703$$HP$CA$CA
1098268014$10982680$14$F$$20200914$20150403$20200918$PER$$CA-AMGEN-CANSP2015031485$AMGEN$$65$YR$E$M$Y$$$20200918$$CN$CA$CA
1098277316$10982773$16$F$2011$20200902$20150403$20200911$EXP$$US-009507513-1504USA001266$MERCK$$$$$M$Y$86.17$KG$20200911$$MD$US$US
109836413$10983641$3$F$20150217$20150629$20150403$20150707$EXP$$US-JNJFOC-20150217673$PHARMACYCLICS$$61$YR$A$M$Y$81.01$KG$20150707$$MD$US$US
109839064$10983906$4$F$20130326$20200715$20150403$20200717$PER$$US-JNJFOC-20150400004$JOHNSON AND JOHNSON$$74$YR$$M$Y$$$20200717$$CN$US$US
109841059$10984105$9$F$20150220$20171013$20150403$20171017$EXP$$GB-JNJFOC-20150402322$PHARMACYCLICS$$69$YR$E$M$Y$111.4$KG$20171017$$MD$GB$GB
109891252$10989125$2$F$$20180806$20150406$20180809$EXP$$CH-CIPLA LTD.-2015CH02577$CIPLA$LAEMMLE A, HAHN D, HU L, RUFENACHT V, GAUTSCHI M, LEIBUNDGUT K ET AL.,. FATAL HYPERAMMONEMIA AND CARBAMOYL PHOSPHATE SYNTHETASE 1 (CPS1) DEFICIENCY FOLLOWING HIGH?DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION.. MOLECULAR GENETICS AND METABOLISM. 2015?114 (3):438 TO 444$$$$$Y$$$20180809$$HP$CH$CH
109898305$10989830$5$F$20140526$20200917$20150406$20200930$EXP$$CA-JNJFOC-20150400917$JOHNSON AND JOHNSON$$57$YR$A$M$Y$88.5$KG$20200930$$HP$CA$CA
109902752$10990275$2$F$$20200813$20150406$20200825$EXP$$CA-JNJFOC-20150319061$JOHNSON AND JOHNSON$$54$YR$A$F$Y$70$KG$20200825$$HP$CA$CA
109911244$10991124$4$F$20130811$20150709$20150406$20200922$PER$$JP-AMGEN-JPNCT2015032976$AMGEN$$57$YR$A$M$Y$94$KG$20200922$$HP$JP$JP
109912043$10991204$3$F$2001$20200731$20150406$20200805$PER$$US-JNJFOC-20150403986$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20200805$$LW$US$US
109915686$10991568$6$F$201411$20200901$20150406$20200915$EXP$$CA-JNJFOC-20150323608$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200915$$HP$CA$CA
1099320210$10993202$10$F$2014$20200810$20150407$20200813$EXP$$PHHY2014CA047249$NOVARTIS$$85$YR$$M$Y$$$20200814$$MD$CA$CA
109932452$10993245$2$F$$20200810$20150407$20200819$EXP$$US-AUROBINDO-AUR-APL-2015-02941$AUROBINDO$$36$YR$$M$Y$$$20200819$$HP$US$US
109951688$10995168$8$F$2014$20200714$20150407$20200716$EXP$$CA-PFIZER INC-2014308093$PFIZER$$43$YR$$F$Y$$$20200716$$HP$CA$CA
109959805$10995980$5$F$2009$20200624$20150407$20200706$PER$$US-JNJFOC-20121202163$JOHNSON AND JOHNSON$$$$$M$Y$111.23$KG$20200706$$CN$US$US
110014985$11001498$5$F$20150308$20200707$20150408$20200720$EXP$$FR-JNJFOC-20150404130$JOHNSON AND JOHNSON$SELLE F, HEUDEL P, BESSARD A, POZET A, MEUNIER J, GLADIEFF L, LOTZ J, PROVANSAL M, AUGEREAU P, BERTON D, LAMICHHANE N, ORFEUVRE H, PAUTIER P, KALBACHER E, TAZI Y, SPAETH D. GINECO PROSPECTIVE NON?INTERVENTIONAL PROSPECTYON STUDY: TRABECTEDIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN FOR PLATINUM?SENSITIVE RECURRENT OVARIAN CANCER. ANTICANCER RESEARCH. 2020?40:3939?3945.$75$YR$$F$Y$56$KG$20200720$$MD$FR$FR
110018048$11001804$8$F$201101$20200812$20150408$20200813$EXP$$US-PFIZER INC-2015120876$PFIZER$$54$YR$$M$Y$68$KG$20200813$$MD$US$US
1100310620$11003106$20$F$20141226$20200811$20150409$20200817$EXP$$PHHY2014CA170176$NOVARTIS$$61$YR$$M$Y$$$20200817$$CN$CA$CA
1100357214$11003572$14$F$2014$20200720$20150409$20200727$PER$$CA-AMGEN-CANSP2015033792$AMGEN$$69$YR$E$F$Y$$$20200727$$HP$CA$CA
110045103$11004510$3$F$20150327$20150721$20150409$20150729$EXP$$US-JNJFOC-20150401848$JANSSEN$$57$YR$A$F$Y$58.97$KG$20150729$$MD$US$US
110046843$11004684$3$F$201402$20200720$20150409$20200722$EXP$$CA-ABBVIE-15K-028-1373284-00$ABBVIE$$43$YR$$F$Y$$$20200722$$HP$CA$CA
110091887$11009188$7$F$201006$20200716$20150410$20200717$PER$$US-PFIZER INC-2015120196$PFIZER$$45$YR$$F$Y$117.9$KG$20200717$$MD$US$US
110094283$11009428$3$F$20150323$20150414$20150410$20200714$EXP$$US-NOVOPROD-444344$NOVO NORDISK$$71$YR$$M$Y$87.7$KG$20200714$$MD$US$US
110101967$11010196$7$F$20150402$20200717$20150410$20200722$EXP$$US-SA-2015SA044253$SANOFI AVENTIS$$$$$$Y$$$20200722$$HP$US$US
110105601$11010560$1$I$20150310$20150313$20150410$20150410$EXP$$US-PFIZER INC-2015110139$PFIZER$$68$YR$$M$Y$74$KG$20150410$$MD$US$US
1101084313$11010843$13$F$20160708$20200711$20150410$20200720$EXP$$PHHY2014CA055951$NOVARTIS$$45$YR$$M$Y$$$20200720$$CN$CA$CA
110137572$11013757$2$F$2013$20130610$20150412$20150526$PER$$US-JNJFOC-20130606870$JANSSEN$$$$E$F$Y$68.04$KG$20150526$$CN$US$US
1102019532$11020195$32$F$20120807$20200716$20150413$20200721$EXP$$CA-ROCHE-1137189$ROCHE$$46$YR$$F$Y$91$KG$20200721$$HP$CA$CA
110242305$11024230$5$F$$20200720$20150413$20200721$EXP$$CA-ABBVIE-15P-028-1372737-00$ABBVIE$$32$YR$$M$Y$53$KG$20200721$$HP$CA$CA
110242714$11024271$4$F$$20200629$20150414$20200706$EXP$$CA-AUROBINDO-AUR-APL-2015-03100$AUROBINDO$$45$YR$$$Y$$$20200706$$PH$CA$CA
110247891$11024789$1$I$20150310$20150408$20150414$20150414$EXP$$US-AUROBINDO-AUR-APL-2015-03215$AUROBINDO$$68$YR$$M$Y$74$KG$20150414$$MD$US$US
110247991$11024799$1$I$$20150326$20150410$20150410$EXP$$2015-07520$WATSON$$46$YR$$F$N$$$20150409$N$MD$FR$
110303681$11030368$1$I$$20150402$20150413$20150413$EXP$$US-H14001-15-00535$WESTWARD$$$$$F$N$$$20150410$N$$US$
110304893$11030489$3$F$$20200805$20150415$20200814$EXP$$US-SANOFI-AVENTIS-2013SA074362$SANOFI AVENTIS$$$$$$Y$$$20200814$$CN$US$US
110307114$11030711$4$F$20150210$20160720$20150415$20160728$EXP$$US-JNJFOC-20150309026$JANSSEN$$49$YR$$M$Y$125$KG$20160728$$MD$US$US
110320484$11032048$4$F$201512$20200818$20150415$20200827$EXP$$PHHY2015BR042518$NOVARTIS$$48$YR$$F$Y$70$KG$20200827$$CN$COUNTRY NOT SPECIFIED$BR
110324667$11032466$7$F$20140710$20200628$20150415$20200709$EXP$$US-JNJFOC-20141112541$JOHNSON AND JOHNSON$$89$YR$$M$Y$$$20200709$$CN$US$US
110326995$11032699$5$F$201303$20200728$20150415$20200804$EXP$$US-JNJFOC-20150118870$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200804$$CN$US$US
110328855$11032885$5$F$20121220$20200902$20150415$20200909$PER$$US-JNJFOC-20141214727$JOHNSON AND JOHNSON$$34$YR$A$F$Y$137.11$KG$20200909$$CN$US$US
110330454$11033045$4$F$20131128$20200716$20150415$20200728$EXP$$US-JNJFOC-20141211889$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200728$$CN$US$US
110332125$11033212$5$F$201410$20200728$20150415$20200731$PER$$US-JNJFOC-20150118841$JOHNSON AND JOHNSON$$23$YR$A$F$Y$$$20200731$$HP$US$US
110334455$11033445$5$F$2013$20200709$20150415$20200714$PER$$US-JNJFOC-20150309238$JOHNSON AND JOHNSON$$$$$F$Y$$$20200714$$HP$US$US
110335314$11033531$4$F$201403$20200625$20150415$20200708$EXP$$US-JNJFOC-20150307557$JOHNSON AND JOHNSON$$45$YR$$F$Y$$$20200708$$CN$US$US
110335846$11033584$6$F$201401$20200812$20150415$20200824$EXP$$US-JNJFOC-20150110987$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200824$$CN$US$US
110336934$11033693$4$F$20141007$20200903$20150415$20200909$PER$$US-JNJFOC-20150202683$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200909$$CN$US$US
110337706$11033770$6$F$20140924$20200706$20150415$20200709$PER$$US-JNJFOC-20150118923$JOHNSON AND JOHNSON$$66$YR$$M$Y$$$20200709$$CN$US$US
110338367$11033836$7$F$20141012$20200902$20150415$20200909$PER$$US-JNJFOC-20150118927$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200909$$CN$US$US
110341375$11034137$5$F$20131223$20200914$20150415$20200925$EXP$$US-JNJFOC-20141211831$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200925$$CN$US$US
110341904$11034190$4$F$20130309$20200810$20150415$20200813$PER$$US-JNJFOC-20150307906$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20200813$$LW$US$US
110344846$11034484$6$F$20140301$20200920$20150415$20200923$PER$$US-JNJFOC-20150217180$JOHNSON AND JOHNSON$$86$YR$E$M$Y$70.37$KG$20200923$$CN$US$US
110347906$11034790$6$F$20140918$20200722$20150415$20200731$PER$$US-JNJFOC-20150118850$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20200731$$CN$US$US
110348855$11034885$5$F$20140723$20200809$20150415$20200819$EXP$$US-JNJFOC-20150118866$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200819$$CN$US$US
110350464$11035046$4$F$2014$20200806$20150415$20200818$EXP$$US-JNJFOC-20150317445$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200818$$CN$US$US
110350985$11035098$5$F$20140226$20200805$20150415$20200813$PER$$US-JNJFOC-20150118846$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200813$$HP$US$US
110352734$11035273$4$F$20140326$20200915$20150415$20200917$PER$$US-JNJFOC-20150118892$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200917$$CN$US$US
110360144$11036014$4$F$20130106$20200819$20150415$20200821$PER$$US-JNJFOC-20150106909$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200821$$CN$US$US
110360155$11036015$5$F$20120909$20200908$20150415$20200921$EXP$$US-JNJFOC-20150110960$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200921$$LW$US$US
110373814$11037381$4$F$20140820$20200906$20150416$20200909$PER$$US-JNJFOC-20150407483$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200909$$LW$US$US
110374204$11037420$4$F$$20150526$20150416$20200701$EXP$$GR-JNJFOC-20150405633$JOHNSON AND JOHNSON$$$$E$M$Y$$$20200701$$MD$GR$GR
110389134$11038913$4$F$2012$20200811$20150416$20200819$PER$$US-JNJFOC-20150202794$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20200819$$LW$US$US
110389516$11038951$6$F$20131104$20200624$20150416$20200702$PER$$US-JNJFOC-20150301403$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200702$$CN$US$US
110390514$11039051$4$F$20140306$20200826$20150416$20200831$PER$$US-JNJFOC-20150305727$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200831$$HP$US$US
110396975$11039697$5$F$201301$20200818$20150416$20200824$PER$$US-JNJFOC-20141118127$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20200824$$CN$US$US
110398575$11039857$5$F$20141113$20200712$20150416$20200714$PER$$US-JNJFOC-20150117333$JOHNSON AND JOHNSON$$35$YR$$F$Y$$$20200714$$HP$US$US
110423279$11042327$9$F$20130503$20200830$20150416$20200911$EXP$$US-JNJFOC-20140501929$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20200911$$HP$US$US
110423834$11042383$4$F$20121225$20200803$20150416$20200805$PER$$US-JNJFOC-20150318420$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20200805$$CN$US$US
110425464$11042546$4$F$20140602$20200729$20150416$20200804$PER$$US-JNJFOC-20150118868$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20200804$$CN$US$US
110426104$11042610$4$F$20140914$20200712$20150416$20200717$PER$$US-JNJFOC-20150205185$JOHNSON AND JOHNSON$$42$YR$$M$Y$$$20200717$$HP$US$US
110426154$11042615$4$F$201403$20200629$20150416$20200706$PER$$US-JNJFOC-20150313440$JOHNSON AND JOHNSON$$28$YR$$F$Y$$$20200706$$CN$US$US
1104282317$11042823$17$F$20141105$20200728$20150417$20200806$EXP$$CA-ROCHE-1486983$ROCHE$$72$YR$$F$Y$$$20200806$$HP$CA$CA
110428432$11042843$2$F$$20150416$20150417$20150430$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-95553$RANBAXY$ASSAF AT, ZRNC TA, RIECKE B, WIKNER J, ZUSTIN J, FRIEDRICH RE, ET AL.. INTRAOPERATIVE EFFICIENCY OF FLUORESCENCE IMAGING BY VISUALLY ENHANCED LESION SCOPE (VELSCOPE) IN PATIENTS WITH BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW (BRONJ). J?CARDIOMAXILLOFAC?SURG. 2014?42(5):E157?E164$71$YR$$F$Y$$$20150430$$HP$DE$DE
110436484$11043648$4$F$20150321$20160720$20150417$20160729$EXP$$GB-JNJFOC-20150319704$JANSSEN$$28$YR$A$M$Y$104$KG$20160729$$MD$GB$GB
110447171$11044717$1$I$20150311$20150313$20150417$20150417$EXP$$DE-JNJFOC-20150309963$PHARMACYCLICS$$65$YR$A$M$Y$$$20150417$$MD$DE$DE
110447185$11044718$5$F$20150402$20150817$20150417$20150826$EXP$$US-JNJFOC-20150414472$PHARMACYCLICS$$72$YR$E$M$Y$$$20150826$$MD$US$US
1104677419$11046774$19$F$2007$20200629$20150420$20200707$PER$$CA-AMGEN-CANSP2015036531$AMGEN$$16$YR$T$F$Y$$$20200707$$MD$CA$CA
110489665$11048966$5$F$$20200902$20150420$20200903$PER$$US-PFIZER INC-2015131810$PFIZER$$52$YR$$F$Y$125$KG$20200903$$CN$US$US
110492947$11049294$7$F$$20200814$20150420$20200818$PER$$US-PFIZER INC-2015130693$PFIZER$$63$YR$$F$Y$63.27$KG$20200818$$MD$US$US
1105038810$11050388$10$F$20150407$20200910$20150421$20200918$PER$$AU-AMGEN-AUSCT2015035932$AMGEN$$12$YR$T$M$Y$39$KG$20200918$$HP$AU$AU
110521362$11052136$2$F$$20150409$20150421$20200701$EXP$$GR-JNJFOC-20150408672$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
110528024$11052802$4$F$$20200721$20150421$20200731$PER$$US-JNJFOC-20130803148$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20200731$$LW$US$US
110532573$11053257$3$F$$20200713$20150421$20200716$PER$$US-JNJFOC-20140105082$JOHNSON AND JOHNSON$$$$$M$Y$$$20200716$$LW$US$US
1105407513$11054075$13$F$20140806$20200901$20150422$20200910$EXP$$CA-ROCHE-1426946$ROCHE$$41$YR$$F$Y$$$20200911$$CN$CA$CA
110555168$11055516$8$F$$20200724$20150422$20200728$PER$$US-PFIZER INC-2015137465$PFIZER$$61$YR$$F$Y$$$20200728$$CN$US$US
110573803$11057380$3$F$201504$20200902$20150422$20200910$EXP$$US-LUNDBECK-DKLU1111424$LUNDBECK$$39$YR$$F$Y$91$KG$20200910$$CN$US$US
110604215$11060421$5$F$20150415$20150715$20150423$20150727$EXP$$DE-JNJFOC-20150419180$PHARMACYCLICS$$60$YR$A$M$Y$$$20150727$$MD$DE$DE
1106200416$11062004$16$F$201409$20200914$20150424$20200925$EXP$$CA-JNJFOC-20150414912$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200925$$HP$CA$CA
110620245$11062024$5$F$20130516$20200812$20150424$20200817$PER$$US-JNJFOC-20150416510$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200817$$CN$US$US
110681806$11068180$6$F$2001$20200915$20150427$20200917$PER$$US-JNJFOC-20150409593$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20200917$$CN$US$US
1106899218$11068992$18$F$20150326$20200709$20150427$20200722$EXP$$PHHY2015CA039010$NOVARTIS$$53$YR$$F$Y$$$20200722$$CN$CA$CA
110706591$11070659$1$I$20131126$20131126$20150427$20150427$EXP$$BR-JNJFOC-20131116811$PHARMACYCLICS$$77$YR$E$F$Y$56$KG$20150427$$MD$BR$BR
110706601$11070660$1$I$20140401$20140402$20150427$20150427$EXP$$PL-JNJFOC-20140403387$PHARMACYCLICS$$80$YR$E$M$Y$85.7$KG$20150427$$MD$PL$PL
110706611$11070661$1$I$20130907$20130912$20150427$20150427$EXP$$PL-JNJFOC-20130907679$PHARMACYCLICS$$59$YR$A$M$Y$93.5$KG$20150427$$HP$PL$PL
110711181$11071118$1$I$20150317$20150415$20150428$20150428$EXP$$US-JNJFOC-20150421510$PHARMACYCLICS$$71$YR$E$M$Y$98$KG$20150428$$MD$US$US
110715077$11071507$7$F$2015$20200924$20150428$20200929$PER$$US-PFIZER INC-2015121705$PFIZER$$52$YR$$M$Y$65$KG$20200929$$CN$US$US
110720233$11072023$3$F$$20200723$20150428$20200731$EXP$$ES-AUROBINDO-AUR-APL-2015-03715$AUROBINDO$$38$YR$$F$Y$$$20200731$$HP$ES$ES
110728121$11072812$1$I$20140604$20140605$20150428$20150428$EXP$$TR-JNJFOC-20140603677$PHARMACYCLICS$$66$YR$E$M$Y$73$KG$20150428$$MD$TR$TR
110729275$11072927$5$F$20140922$20151111$20150428$20151113$EXP$$TR-JNJFOC-20140922064$PHARMACYCLICS$$67$YR$E$M$Y$73$KG$20151113$$MD$TR$TR
110729285$11072928$5$F$20150414$20160516$20150428$20160520$EXP$$US-JNJFOC-20150420906$PHARMACYCLICS$$72$YR$E$M$Y$91.5$KG$20160520$$MD$US$US
110744071$11074407$1$I$$20150416$20150429$20150429$EXP$$DK-ROCHE-1567132$ROCHE$THORSTEINSSON A, LOMHOLT A AND EIKEN P. BISPHOSPHONATE?INDUCED OSTEONECROSIS OF THE EXTERNAL AUDITORY CANAL: A CASE REPORT. JOURNAL CLINICAL AND MEDICAL CASE REPORTS 2015 FEB 28?2(1):01?03.$76$YR$$F$Y$$$20150429$$HP$DK$DK
110745272$11074527$2$F$$20200616$20150429$20200701$EXP$$PT-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-96329$RANBAXY$$68$YR$$F$Y$$$20200701$$MD$PT$PT
110748672$11074867$2$F$$20150430$20150429$20150514$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-96460$RANBAXY$ESMAEILZADEH S, SEN EI, TUTBA A, DERNEK B, ESKIYURT N. DEVELOPMENT OF OSTEONECROSIS OF THE JAW IN A PATIENT RECEIVING ORAL BISPHOSPHONATES FOR OSTEOPOROSIS: A CASE REPORT. TURK OSTEOPOROZ DERGISI. 2014?20 (2):75?80$69$YR$$F$Y$$$20150514$$MD$TR$TR
110749921$11074992$1$I$20140113$20140114$20150429$20150429$EXP$$CA-JNJFOC-20140108340$PHARMACYCLICS$$71$YR$E$M$Y$62.2$KG$20150429$$MD$CA$CA
110749941$11074994$1$I$20130705$20130705$20150429$20150429$EXP$$UA-JNJFOC-20130705131$PHARMACYCLICS$$39$YR$A$F$Y$71.2$KG$20150429$$CN$UA$UA
110750517$11075051$7$F$201412$20200826$20150429$20200909$EXP$$US-JNJFOC-20150420518$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200909$$CN$US$US
110757859$11075785$9$F$201502$20200818$20150429$20200901$EXP$$JP-INCYTE CORPORATION-2015IN001764$INCYTE$$$$$$Y$$$20200901$$MD$JP$JP
110758653$11075865$3$F$20140625$20200902$20150429$20200911$EXP$$ES-AUROBINDO-AUR-APL-2015-03713$AUROBINDO$GARCIA SEVILLANO L.. MULTIPLE DRUGS VARIOUS TOXICITIES: CASE REPORT. REACTIONS WEEKLY. 2015?1547:200$66$YR$$F$Y$$$20200911$$HP$ES$ES
1107633811$11076338$11$F$20170914$20200727$20150429$20200729$EXP$$US-PFIZER INC-2015141539$PFIZER$$52$YR$$M$Y$105$KG$20200729$$CN$US$US
110777483$11077748$3$F$201005$20200901$20150430$20200909$EXP$$JP-ROCHE-718572$ROCHE$$65$YR$$M$Y$$$20200909$$HP$JP$JP
1107775728$11077757$28$F$20150416$20200916$20150430$20200930$EXP$$CA-ROCHE-1570993$ROCHE$$67$YR$$F$Y$$$20200930$$MD$CA$CA
1107779111$11077791$11$F$20150416$20200917$20150430$20200924$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-025357$BRISTOL MYERS SQUIBB$$51$YR$$F$Y$$$20200924$$CN$CO$CO
110777937$11077793$7$F$20200525$20200909$20150430$20200916$EXP$$CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-025417$BRISTOL MYERS SQUIBB$$58$YR$$M$Y$$$20200916$$CN$CO$CO
110781791$11078179$1$I$20140613$20140616$20150430$20150430$EXP$$TR-JNJFOC-20140610508$PHARMACYCLICS$$73$YR$E$M$Y$80$KG$20150430$$MD$TR$TR
110781801$11078180$1$I$20140922$20140924$20150430$20150430$EXP$$RU-JNJFOC-20140923193$PHARMACYCLICS$$65$YR$A$M$Y$80$KG$20150430$$MD$RU$RU
110781823$11078182$3$F$20130924$20150114$20150430$20150909$EXP$$GB-JNJFOC-20130916071$PHARMACYCLICS$$65$YR$A$M$Y$69$KG$20150909$$MD$GB$GB
110782393$11078239$3$F$20140504$20200811$20150430$20200817$PER$$US-JNJFOC-20150420147$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200817$$CN$US$US
110782593$11078259$3$F$20141031$20150519$20150430$20200701$EXP$$GR-JNJFOC-20141100503$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$MD$GR$GR
110792851$11079285$1$I$20140319$20140402$20150430$20150430$EXP$$DE-JNJFOC-20140401189$PHARMACYCLICS$$71$YR$E$F$Y$59.5$KG$20150430$$MD$DE$DE
110792861$11079286$1$I$20140502$20140502$20150430$20150430$EXP$$TR-JNJFOC-20140501143$PHARMACYCLICS$$73$YR$E$M$Y$81$KG$20150430$$MD$TR$TR
1107963011$11079630$11$F$20150305$20200903$20150430$20200916$EXP$$JP-INCYTE CORPORATION-2015IN001749$INCYTE$$$$$$Y$$$20200916$$MD$JP$JP
110800222$11080022$2$F$20141128$20190531$20150430$20190607$EXP$$CZ-JNJFOC-20141207613$PHARMACYCLICS$$67$YR$E$M$Y$74.1$KG$20190607$$MD$CZ$CZ
110814618$11081461$8$F$20150420$20200813$20150501$20200817$PER$$US-PFIZER INC-2015144360$PFIZER$$53$YR$$F$Y$$$20200817$$MD$US$US
110822952$11082295$2$F$201503$20200824$20150501$20200826$PER$$US-PFIZER INC-2015142482$PFIZER$$61$YR$$F$Y$63$KG$20200826$$CN$US$US
110824063$11082406$3$F$$20200914$20150501$20200916$PER$$US-PFIZER INC-2015141961$PFIZER$$77$YR$$F$Y$61$KG$20200916$$CN$US$US
110828055$11082805$5$F$20150413$20170328$20150501$20170404$EXP$$US-JNJFOC-20150420357$PHARMACYCLICS$$83$YR$E$F$Y$$$20170404$$MD$US$US
110836953$11083695$3$F$2010$20200731$20150501$20200812$EXP$$ES-JAZZ-JPI-P-012665$JAZZ$$40$YR$$F$Y$93.8$KG$20200812$$MD$ES$ES
110844167$11084416$7$F$$20200728$20150502$20200805$EXP$$PT-AUROBINDO-AUR-APL-2015-03877$AUROBINDO$$68$YR$$F$Y$$$20200805$$HP$PT$PT
110852665$11085266$5$F$201404$20200806$20150503$20200813$PER$$US-JNJFOC-20150406071$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200813$$CN$US$US
110853506$11085350$6$F$20140525$20200813$20150503$20200825$EXP$$US-JNJFOC-20141011652$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200825$$CN$US$US
110854114$11085411$4$F$20140407$20200709$20150503$20200713$PER$$US-JNJFOC-20150401124$JOHNSON AND JOHNSON$$93$YR$$F$Y$$$20200713$$CN$US$US
110862014$11086201$4$F$20130325$20200721$20150503$20200731$PER$$US-JNJFOC-20150321348$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20200731$$CN$US$US
110879855$11087985$5$F$20150227$20160426$20150504$20200816$EXP$$PHJP2015JP007020$NOVARTIS$$76$YR$$M$Y$54$KG$20200816$$HP$JP$JP
1108852725$11088527$25$F$2010$20200902$20150504$20200907$EXP$$US-PFIZER INC-2015120227$PFIZER$$57$YR$$F$Y$68$KG$20200907$$HP$US$US
1108913742$11089137$42$F$201401$20200713$20150505$20200717$EXP$$DE-ROCHE-1459359$ROCHE$$50$YR$$M$Y$90$KG$20200717$$MD$DE$DE
1108929723$11089297$23$F$20141201$20200417$20150505$20200922$EXP$$CA-ROCHE-1506537$ROCHE$$66$YR$$M$Y$97.5$KG$20200922$$MD$CA$CA
110898334$11089833$4$F$20150417$20160321$20150505$20160331$EXP$$US-JNJFOC-20150419072$JANSSEN$$46$YR$A$F$Y$96.6$KG$20160331$$MD$US$US
1109083716$11090837$16$F$$20200727$20150505$20200807$EXP$$CA-BAYER-2015-099605$BAYER$$64$YR$A$F$Y$69$KG$20200807$$HP$CA$CA
110908394$11090839$4$F$201406$20200708$20150505$20200713$PER$$US-JNJFOC-20150423164$JOHNSON AND JOHNSON$$80$YR$$F$Y$$$20200713$$CN$US$US
1109107114$11091071$14$F$$20200921$20150505$20200923$EXP$$US-PFIZER INC-2015144310$PFIZER$$63$YR$$F$Y$69$KG$20200923$$HP$US$US
110928354$11092835$4$F$20130420$20200827$20150506$20200901$PER$$US-JNJFOC-20150421904$JOHNSON AND JOHNSON$$86$YR$E$F$Y$72.64$KG$20200901$$CN$US$US
1109374111$11093741$11$F$20150312$20200805$20150506$20200814$EXP$$JP-PFIZER INC-2015096199$PFIZER$TAKAHASHI, M.. PALBOCICLIB?LETROZOLE AS FIRST?LINE TREATMENT FOR ADVANCED BREAST CANCER: UPDATED RESULTS FROM A JAPANESE PHASE 2 STUDY. CANCER MEDICINE. 2020?9 (14):4929?4940$73$YR$$F$Y$55$KG$20200814$$MD$JP$JP
110938694$11093869$4$F$20130427$20200921$20150506$20200923$EXP$$US-JNJFOC-20150423266$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200923$$HP$US$US
110939959$11093995$9$F$20150420$20200921$20150506$20200928$EXP$$GB-ROCHE-1572662$ROCHE$$46$YR$$F$Y$$$20200928$$MD$GB$GB
110945885$11094588$5$F$2014$20200713$20150506$20200715$PER$$US-PFIZER INC-2015141255$PFIZER$$59$YR$$M$Y$137$KG$20200715$$MD$US$US
1109461613$11094616$13$F$$20200923$20150506$20200928$PER$$US-PFIZER INC-2015147617$PFIZER$$69$YR$$F$Y$79$KG$20200928$$CN$US$US
110950582$11095058$2$F$$20200818$20150506$20200825$PER$$US-SA-2014SA038642$SANOFI AVENTIS$$$$$$Y$$$20200825$$CN$US$US
110965613$11096561$3$F$2015$20150507$20150507$20200701$EXP$$GR-JNJFOC-20150422292$JOHNSON AND JOHNSON$$$$E$F$Y$$$20200701$$CN$GR$GR
110977969$11097796$9$F$$20200819$20150507$20200821$PER$$US-PFIZER INC-2015149373$PFIZER$$73$YR$$F$Y$54$KG$20200821$$HP$US$US
110983313$11098331$3$F$20150426$20200429$20150507$20200507$EXP$$PHHY2015CA053531$NOVARTIS$$6$YR$$F$Y$$$20200507$$MD$CA$CA
110984294$11098429$4$F$20130412$20200903$20150507$20200909$PER$$US-JNJFOC-20150413318$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200909$$HP$US$US
110984616$11098461$6$F$201404$20200721$20150507$20200730$EXP$$US-JNJFOC-20150413290$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200730$$CN$US$US
110992983$11099298$3$F$2013$20200622$20150508$20200702$EXP$$US-JNJFOC-20150500922$JOHNSON AND JOHNSON$$$$$F$Y$$$20200702$$CN$US$US
110995192$11099519$2$F$201503$20150428$20150508$20200701$EXP$$GR-JNJFOC-20150424044$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
110997094$11099709$4$F$20150401$20171006$20150508$20171012$EXP$$US-JNJFOC-20150408752$PHARMACYCLICS$$70$YR$E$F$Y$112.7$KG$20171012$$MD$US$US
111005725$11100572$5$F$20140508$20200825$20150508$20200901$PER$$US-JNJFOC-20150501025$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200901$$CN$US$US
111013553$11101355$3$F$20130305$20200720$20150508$20200803$EXP$$US-SHIRE-US201503922$SHIRE$$23$MON$$M$Y$$$20200803$$MD$US$US
111014192$11101419$2$F$$20150520$20150508$20150525$EXP$$PHFR2015IE003610$NOVARTIS$$$$$F$Y$$$20150525$$MD$IE$IE
111026962$11102696$2$F$$20200731$20150511$20200804$PER$$CA-AMGEN-CANSL2015044761$AMGEN$$71$YR$E$F$Y$$$20200804$$MD$CA$CA
111027723$11102772$3$F$201410$20150520$20150511$20150603$EXP$$HU-ROCHE-1573375$ROCHE$$60$YR$$F$Y$85$KG$20150603$$MD$HU$HU
1110453917$11104539$17$F$20140419$20200728$20150511$20200730$EXP$$PHHY2015IT052559$NOVARTIS$$48$YR$$F$Y$70$KG$20200730$$HP$IT$IT
111047204$11104720$4$F$20191105$20200909$20150511$20200911$EXP$$US-PFIZER INC-2015158649$PFIZER$$85$YR$$F$Y$66.98$KG$20200911$$CN$US$US
1110516234$11105162$34$F$201411$20200728$20150511$20200731$EXP$$PHHY2011CA89391$NOVARTIS$$82$YR$$M$Y$$$20200731$$CN$CA$CA
111061802$11106180$2$F$20150425$20160610$20150512$20160622$EXP$$US-JNJFOC-20150423356$JANSSEN$$24$YR$A$M$Y$70$KG$20160622$$MD$US$US
111085952$11108595$2$F$20150327$20200918$20150513$20200928$EXP$$FR-ALEXION-A201501347$ALEXION$$63$YR$$M$Y$69.9$KG$20200928$$CN$FR$FR
1110870110$11108701$10$F$$20200629$20150513$20200706$PER$$CA-AMGEN-CANSP2015045489$AMGEN$$60$YR$A$F$Y$$$20200705$$HP$CA$CA
111108784$11110878$4$F$$20200902$20150513$20200904$PER$$US-PFIZER INC-2015156718$PFIZER$$64$YR$$M$Y$98$KG$20200904$$CN$US$US
111112023$11111202$3$F$20150505$20200824$20150513$20200825$PER$$US-PFIZER INC-2015158353$PFIZER$$85$YR$$F$Y$59$KG$20200825$$HP$US$US
111124102$11112410$2$F$20150502$20150504$20150514$20200714$EXP$$US-NOVOPROD-448373$NOVO NORDISK$$69$YR$$M$Y$112$KG$20200714$$MD$US$US
111141363$11114136$3$F$201505$20200806$20150514$20200813$EXP$$US-JAZZ-2015-US-006956$JAZZ$$51$YR$$F$Y$$$20200813$$CN$US$US
111151316$11115131$6$F$20071217$20200914$20150515$20200915$PER$$US-JNJFOC-20150506082$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20200915$$LW$US$US
111155132$11115513$2$F$$20200824$20150515$20200901$PER$$US-AMGEN-USASP2015046305$AMGEN$$57$YR$A$F$Y$$$20200901$$CN$US$US
111155479$11115547$9$F$20131028$20200806$20150515$20200818$EXP$$NL-AUROBINDO-AUR-APL-2015-04212$AUROBINDO$SARINIC VM.. INTERACTION BETWEEN ROSUVASTATIN AND TICAGRELOR RESULTING IN RHABDOMYOLYSIS. WHO PHARMACEUTICALS NEWSLETTER. 2018?3:10?14$78$YR$$M$Y$$$20200818$$HP$NL$NL
111157124$11115712$4$F$201503$20200825$20150515$20200831$EXP$$US-SA-2014SA032285$SANOFI AVENTIS$$64$YR$$F$Y$$$20200831$$PH$US$US
1111681416$11116814$16$F$20150226$20200806$20150515$20200812$EXP$$JP-OTSUKA-JP-2015-11922$OTSUKA$$56$YR$$M$Y$79.3$KG$20200812$$MD$JP$JP
111172965$11117296$5$F$20130402$20200730$20150515$20200809$EXP$$PHHY2015AU058774$NOVARTIS$$50$YR$$M$Y$90$KG$20200809$$MD$AU$AU
1111733313$11117333$13$F$20150416$20180503$20150515$20180512$EXP$$PHHY2014BR166514$NOVARTIS$$42$YR$$F$Y$57$KG$20180512$$HP$BR$BR
111187923$11118792$3$F$20130505$20200813$20150518$20200820$EXP$$US-JNJFOC-20150503941$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200820$$CN$US$US
111193433$11119343$3$F$20150213$20161215$20150518$20161220$EXP$$US-JNJFOC-20150505412$JANSSEN$$57$YR$A$F$Y$58.97$KG$20161220$$MD$US$US
111203729$11120372$9$F$2015$20200806$20150518$20200810$PER$$US-PFIZER INC-2015155833$PFIZER$$72$YR$$M$Y$109$KG$20200810$$HP$US$US
111220354$11122035$4$F$20150216$20160720$20150519$20160729$EXP$$PL-JNJFOC-20150510312$JANSSEN$$40$YR$A$M$Y$85$KG$20160729$$MD$PL$PL
111236484$11123648$4$F$20150512$20200807$20150519$20200812$EXP$$US-JAZZ-2015-US-007210$JAZZ$$46$YR$$M$Y$68.93$KG$20200812$$HP$US$US
1112488610$11124886$10$F$2009$20200813$20150520$20200819$EXP$$DE-ABBVIE-15K-062-1393193-00$ABBVIE$$66$YR$$F$Y$77$KG$20200819$$MD$DE$DE
111255848$11125584$8$F$$20200916$20150520$20200921$PER$$US-PFIZER INC-2015169099$PFIZER$$81$YR$$M$Y$78$KG$20200921$$MD$US$US
111260234$11126023$4$F$$20200715$20150520$20200717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-002956$BRISTOL MYERS SQUIBB$$9$DEC$$F$Y$$$20200717$$MD$JP$JP
1112607912$11126079$12$F$$20200914$20150520$20200921$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-023023$BRISTOL MYERS SQUIBB$$$$$F$Y$73$KG$20200921$$HP$CA$CA
111266691$11126669$1$I$$20150505$20150520$20150520$EXP$$JP-JNJFOC-20150503648$JANSSEN$NAKANISHI T, AOKI D, WATANABE Y, ANDO Y, TOMOTSUGU N, SATO Y, ET AL. A PHASE II CLINICAL TRIAL OF PEGYLATED LIPOSOMAL DOXORUBICIN AND CARBOPLATIN IN JAPANESE PATIENTS WITH PLATINUM?SENSITIVE RECURRENT OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER. JAPANESE JOURNAL OF CLINICAL ONCOLOGY 2015?45 (5):422?426.$$$$F$Y$$$20150520$$MD$JP$JP
111271231$11127123$1$I$$20150512$20150521$20150521$EXP$GB-MHRA-MIDB-55CB2EB2-0E83-466D-8B5A-5F481F153E8D$GB-ROCHE-1580463$ROCHE$$83$YR$$$Y$$$20150521$$PH$GB$GB
111278843$11127884$3$F$20150428$20150701$20150521$20150707$EXP$$US-JNJFOC-20150510349$JANSSEN$$57$YR$A$M$Y$65.8$KG$20150707$$MD$US$US
111283893$11128389$3$F$20140603$20200709$20150521$20200715$PER$$US-JNJFOC-20150509188$JOHNSON AND JOHNSON$$65$YR$$F$Y$108.05$KG$20200715$$CN$US$US
1112853211$11128532$11$F$20141126$20200902$20150521$20200915$EXP$$JP-INCYTE CORPORATION-2015IN002181$INCYTE$$$$$$Y$$$20200915$$MD$JP$JP
1112926814$11129268$14$F$$20200727$20150521$20200729$PER$$US-PFIZER INC-2015170397$PFIZER$$40$YR$$F$Y$$$20200729$$MD$US$US
111299532$11129953$2$F$20150420$20151023$20150521$20151102$EXP$$US-JNJFOC-20150419046$PHARMACYCLICS$$73$YR$E$M$Y$83.5$KG$20151102$$MD$US$US
111320953$11132095$3$F$20130314$20200908$20150522$20200921$EXP$$US-JNJFOC-20150509451$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20200921$$CN$US$US
111320963$11132096$3$F$20131017$20200706$20150522$20200717$EXP$$US-JNJFOC-20150509358$JOHNSON AND JOHNSON$$73$YR$$F$Y$$$20200717$$PH$US$US
111322953$11132295$3$F$2014$20200629$20150522$20200707$EXP$$US-SA-2014SA079778$SANOFI AVENTIS$$$$$F$Y$$$20200707$$HP$US$US
111323516$11132351$6$F$201911$20200924$20150522$20200929$EXP$$US-PFIZER INC-2015169360$PFIZER$$8$YR$$M$Y$39.1$KG$20200929$$MD$US$US
111324908$11132490$8$F$20150513$20170320$20150522$20170330$EXP$$US-JNJFOC-20150515572$PHARMACYCLICS$$58$YR$A$F$Y$$$20170330$$MD$US$US
111342273$11134227$3$F$20140929$20150520$20150524$20200714$EXP$$GR-JNJFOC-20150420354$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200714$$CN$GR$GR
111342693$11134269$3$F$20150506$20200803$20150524$20200817$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-032825$ELI LILLY AND CO$$77$YR$$M$Y$85$KG$20200817$$MD$DE$DE
111359582$11135958$2$F$$20200722$20150526$20200724$EXP$$US-PFIZER INC-2015172316$PFIZER$$65$YR$$F$Y$$$20200724$$MD$US$US
111384272$11138427$2$F$$20150525$20150527$20150608$EXP$$US-ROCHE-1583312$ROCHE$RIFAI A, POURTAHERI S, CARBONE A, CALLAGHAN J, STADLER C, RECORD N AND ISSA K. BILATERAL FEMUR FRACTURES ASSOCIATED WITH SHORT?TERM BISPHOSPHONATE USE. ORTHOPEDICS 2015 FEB 01?38 (2):E139?E142.$56$YR$$F$Y$$$20150608$$HP$US$US
111388604$11138860$4$F$$20200818$20150527$20200828$EXP$$US-AUROBINDO-AUR-APL-2015-04529$AUROBINDO$$74$YR$$M$Y$$$20200828$$HP$US$US
111409632$11140963$2$F$$20180905$20150527$20180919$EXP$$IT-JNJFOC-20150517908$JANSSEN$CURSI F. CASI CLINICI NEL DOLORE MUSCOLO?SCHELETRICO E NEUROPATICO. TAPENTADOLO PR IN UNA PAZIENTE ANZIANA CON DOLORE LOMBARE DA CIFOSCOLIOSI. MEDIFORMAT APR?2015?2:24?25.$86$YR$E$F$Y$$$20180917$$MD$IT$IT
1114239119$11142391$19$F$20150316$20200825$20150527$20200901$EXP$$PHHY2015US059279$NOVARTIS$$38$YR$$F$Y$62.14$KG$20200901$$HP$US$US
1114243713$11142437$13$F$20150503$20200818$20150527$20200821$EXP$$PHHY2013CA051698$NOVARTIS$$66$YR$$M$Y$$$20200821$$MD$CA$CA
111425132$11142513$2$F$$20200512$20150527$20200729$EXP$$US-PURDUE PHARMA-USA-2015-0123724$PURDUE$$67$YR$$M$Y$$$20200728$$HP$US$US
1114370015$11143700$15$F$201306$20200415$20150526$20200923$EXP$$CA-ROCHE-1583272$ROCHE$$62$YR$$F$Y$$$20200923$$MD$CA$CA
111467466$11146746$6$F$20150220$20200818$20150528$20200824$EXP$DE-EMA-DD-20191023-ABDUL_J-095941$GXKR2015DE002553$NOVARTIS$$$$N$M$Y$$$20200824$$HP$DE$DE
111467516$11146751$6$F$20150514$20161018$20150528$20200821$EXP$$PHHY2015US060657$NOVARTIS$$72$YR$$F$Y$$$20200821$$HP$US$US
111482776$11148277$6$F$2013$20200728$20150529$20200730$EXP$$US-PFIZER INC-2015175701$PFIZER$$58$YR$$F$Y$59$KG$20200730$$CN$US$US
111488183$11148818$3$F$20130217$20200804$20150529$20200814$EXP$$US-JNJFOC-20150514510$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200814$$LW$US$US
111513345$11151334$5$F$20150512$20160307$20150601$20160310$EXP$$US-JNJFOC-20150515280$PHARMACYCLICS$$70$YR$E$M$Y$$$20160310$$MD$US$US
111520733$11152073$3$F$201408$20200916$20150601$20200923$EXP$$US-SA-2014SA141274$SANOFI AVENTIS$$29$YR$$F$Y$$$20200923$$CN$US$US
111524195$11152419$5$F$20150408$20150703$20150601$20150708$EXP$$DE-JNJFOC-20150515749$JANSSEN$$49$YR$A$F$Y$80.6$KG$20150708$$MD$DE$DE
111551421$11155142$1$I$$20150519$20150602$20150602$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-98064$RANBAXY$$$$$$Y$$$20150602$$HP$GB$GB
111552387$11155238$7$F$$20200821$20150602$20200825$EXP$$US-PFIZER INC-2015181313$PFIZER$$41$YR$$F$Y$104$KG$20200825$$CN$US$US
111554252$11155425$2$F$20150525$20150525$20150602$20200701$EXP$$GR-JNJFOC-20150519225$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
111557301$11155730$1$I$$20150519$20150602$20150602$EXP$GB-MHRA-MIDB-55CB2EB2-0E83-466D-8B5A-5F481F153E8D$GB-MYLANLABS-2015M1016823$MYLAN$$$$$$Y$$$20150602$$PH$GB$GB
111563264$11156326$4$F$20140603$20191204$20150602$20200807$EXP$$GXKR2015DE002676$NOVARTIS$$8$MON$$F$Y$2.32$KG$20200807$$HP$DE$DE
111577474$11157747$4$F$20150430$20160713$20150603$20160720$EXP$$US-JNJFOC-20150516462$JANSSEN$$56$YR$A$F$Y$38$KG$20160720$$MD$US$US
111587518$11158751$8$F$2018$20200729$20150603$20200731$EXP$$US-PFIZER INC-2015182384$PFIZER$$41$YR$$F$Y$54$KG$20200731$$CN$US$US
111593234$11159323$4$F$20150209$20200713$20150603$20200724$EXP$$US-JNJFOC-20150521428$JOHNSON AND JOHNSON$$77$YR$$F$Y$$$20200724$$CN$US$US
111597899$11159789$9$F$20150206$20200722$20150603$20200805$EXP$$DE-INCYTE CORPORATION-2015IN002454$INCYTE$$$$$$Y$$$20200805$$MD$DE$DE
111603342$11160334$2$F$$20200730$20150604$20200806$PER$$US-SANOFI-AVENTIS-2013SA052351$SANOFI AVENTIS$$$$$$Y$$$20200806$$CN$US$US
111611142$11161114$2$F$$20200706$20150604$20200713$PER$$US-SA-2014SA080271$SANOFI AVENTIS$$$$$$Y$$$20200713$$CN$US$US
111611232$11161123$2$F$$20200908$20150604$20200915$PER$$US-SA-2014SA080371$SANOFI AVENTIS$$$$$$Y$$$20200915$$CN$US$US
111611342$11161134$2$F$2013$20200724$20150604$20200730$PER$$US-SA-2014SA074179$SANOFI AVENTIS$$$$$$Y$$$20200730$$CN$US$US
111640582$11164058$2$F$$20200824$20150604$20200831$PER$$US-SA-2014SA071324$SANOFI AVENTIS$$$$$$Y$$$20200831$$CN$US$US
111643025$11164302$5$F$20140604$20200819$20150604$20200821$PER$$US-JNJFOC-20150519193$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200821$$CN$US$US
111643884$11164388$4$F$20140310$20200916$20150604$20200929$EXP$$US-JNJFOC-20150521285$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200929$$CN$US$US
1116809638$11168096$38$F$2017$20200708$20150605$20200715$EXP$$PHHY2014CA038351$NOVARTIS$$49$YR$$F$Y$$$20200715$$CN$COUNTRY NOT SPECIFIED$CA
111685929$11168592$9$F$20141222$20170405$20150605$20200927$PER$$JP-AMGEN-JPNCT2015055084$AMGEN$$81$YR$E$M$Y$61$KG$20200927$$HP$JP$JP
111690645$11169064$5$F$201505$20200828$20150605$20200902$PER$$US-PFIZER INC-2015188334$PFIZER$$46$YR$$F$Y$$$20200902$$HP$US$US
111691845$11169184$5$F$20150528$20150723$20150605$20150727$PER$$US-JNJFOC-20150600975$PHARMACYCLICS$$60$YR$A$F$Y$65.77$KG$20150727$$HP$US$US
111701111$11170111$1$I$20130501$20150525$20150608$20150608$EXP$GB-MHRA-EYC 00123887$GB-ROCHE-1588821$ROCHE$$68$YR$$F$Y$66$KG$20150608$$MD$GB$GB
1117361918$11173619$18$F$$20200706$20150609$20200707$EXP$$CA-ROCHE-1589861$ROCHE$$53$YR$$M$Y$$$20200707$$HP$CA$CA
1117401610$11174016$10$F$20150514$20170823$20150609$20170829$EXP$$US-ROCHE-1581661$ROCHE$$64$YR$$F$Y$74.1$KG$20170829$$MD$US$US
111747363$11174736$3$F$201201$20200810$20150609$20200814$EXP$$BR-ROCHE-1587544$ROCHE$$43$YR$$F$Y$$$20200814$$MD$BR$BR
111749118$11174911$8$F$20151104$20200901$20150609$20200903$EXP$$US-PFIZER INC-2015190844$PFIZER$$61$YR$$F$Y$64$KG$20200903$$CN$US$US
111756685$11175668$5$F$20150603$20200714$20150609$20200719$EXP$$PHHY2015CA068245$NOVARTIS$$59$YR$$F$Y$$$20200719$$CN$COUNTRY NOT SPECIFIED$CA
111785802$11178580$2$F$$20200702$20150610$20200703$EXP$$PHHY2015PT066455$NOVARTIS$$15$YR$$M$Y$$$20200703$$HP$PT$PT
1117908316$11179083$16$F$20150528$20200728$20150610$20200730$EXP$$US-PFIZER INC-2015188607$PFIZER$$70$YR$$F$Y$86$KG$20200730$$HP$US$US
111800771$11180077$1$I$20130501$20150603$20150611$20150611$EXP$GB-MHRA-EYC 00123887$GB-TEVA-568291ACC$TEVA$$68$YR$$F$Y$66$KG$20150611$$MD$GB$GB
1118026016$11180260$16$F$2009$20200831$20150611$20200908$EXP$$DE-ROCHE-1592562$ROCHE$$59$YR$$M$Y$$$20200908$$CN$DE$DE
111806813$11180681$3$F$20141028$20200913$20150611$20200918$PER$$US-JNJFOC-20150605295$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20200918$$CN$US$US
1118130012$11181300$12$F$20150122$20200326$20150611$20200401$EXP$$PHHY2015CA012543$NOVARTIS$$63$YR$$M$Y$$$20200401$$CN$COUNTRY NOT SPECIFIED$CA
1118289210$11182892$10$F$201406$20200729$20150611$20200805$EXP$$US-ABBVIE-15K-163-1407406-00$ABBVIE$$70$YR$$F$Y$63.56$KG$20200805$$CN$US$US
1118294329$11182943$29$F$$20200707$20150611$20200710$EXP$$CA-PFIZER INC-2015191806$PFIZER$$72$YR$$F$Y$$$20200710$$MD$CA$CA
111843174$11184317$4$F$201306$20200916$20150612$20200929$EXP$$US-JNJFOC-20150606164$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20200929$$CN$US$US
111844653$11184465$3$F$20150529$20200812$20150612$20200818$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-037066$BRISTOL MYERS SQUIBB$$70$YR$$$Y$$$20200818$$MD$JP$JP
111853233$11185323$3$F$$20150827$20150612$20200701$EXP$$GR-JNJFOC-20150604203$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
111871243$11187124$3$F$20130615$20200916$20150615$20200929$EXP$$US-JNJFOC-20150506821$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200929$$CN$US$US
111871335$11187133$5$F$201312$20200816$20150615$20200827$EXP$$US-JNJFOC-20150507943$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200827$$CN$US$US
111872114$11187211$4$F$20141007$20200908$20150615$20200914$PER$$US-JNJFOC-20150505586$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20200914$$CN$US$US
111872213$11187221$3$F$20141101$20200902$20150615$20200909$PER$$US-JNJFOC-20150507953$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200909$$CN$US$US
111872395$11187239$5$F$20130604$20200816$20150615$20200819$PER$$US-JNJFOC-20150517123$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200819$$CN$US$US
111872414$11187241$4$F$20120529$20200908$20150615$20200914$PER$$US-JNJFOC-20150517122$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200914$$CN$US$US
111872423$11187242$3$F$201205$20200916$20150615$20200923$PER$$US-JNJFOC-20150516060$JOHNSON AND JOHNSON$$72$YR$E$M$Y$74.84$KG$20200923$$CN$US$US
111872885$11187288$5$F$201401$20200702$20150615$20200714$EXP$$US-JNJFOC-20150423231$JOHNSON AND JOHNSON$$78$YR$$F$Y$$$20200714$$CN$US$US
111873044$11187304$4$F$20140311$20200910$20150615$20200915$PER$$US-JNJFOC-20150507945$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200915$$CN$US$US
111873224$11187322$4$F$20120602$20200826$20150615$20200831$PER$$US-JNJFOC-20150517118$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200831$$CN$US$US
111873312$11187331$2$F$201402$20200809$20150615$20200813$PER$$US-JNJFOC-20150517124$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20200813$$HP$US$US
111873456$11187345$6$F$20140623$20200817$20150615$20200820$PER$$US-JNJFOC-20150520324$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200820$$CN$US$US
111873603$11187360$3$F$2012$20200812$20150615$20200817$PER$$US-JNJFOC-20150601770$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200817$$CN$US$US
111873983$11187398$3$F$20140517$20200823$20150615$20200831$PER$$US-JNJFOC-20150510050$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200831$$CN$US$US
111874303$11187430$3$F$20150318$20200723$20150615$20200728$PER$$US-JNJFOC-20150600174$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200728$$CN$US$US
111874334$11187433$4$F$20140621$20200805$20150615$20200807$PER$$US-JNJFOC-20150519831$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200807$$CN$US$US
111874774$11187477$4$F$20131220$20200825$20150615$20200827$PER$$US-JNJFOC-20150505578$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200827$$CN$US$US
111875023$11187502$3$F$20140307$20200714$20150615$20200717$PER$$US-JNJFOC-20150511255$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200717$$CN$US$US
111875583$11187558$3$F$20130822$20200727$20150615$20200805$EXP$$US-JNJFOC-20150500909$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20200805$$CN$US$US
111875667$11187566$7$F$2013$20200706$20150615$20200709$PER$$US-JNJFOC-20150505573$JOHNSON AND JOHNSON$$73$YR$$M$Y$$$20200709$$CN$US$US
111875735$11187573$5$F$20130313$20200810$20150615$20200817$PER$$US-JNJFOC-20150505582$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200817$$CN$US$US
111875744$11187574$4$F$201212$20200706$20150615$20200709$PER$$US-JNJFOC-20150505587$JOHNSON AND JOHNSON$$75$YR$$F$Y$$$20200709$$CN$US$US
111876433$11187643$3$F$20130608$20200802$20150615$20200804$PER$$US-JNJFOC-20150605418$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200804$$CN$US$US
111876575$11187657$5$F$20130502$20200630$20150615$20200706$PER$$US-JNJFOC-20150512519$JOHNSON AND JOHNSON$$82$YR$$F$Y$$$20200706$$CN$US$US
111900697$11190069$7$F$$20200915$20150615$20200917$PER$$US-PFIZER INC-2015196944$PFIZER$$66$YR$$M$Y$$$20200917$$CN$US$US
111913819$11191381$9$F$$20200916$20150616$20200920$EXP$$CA-ROCHE-1486264$ROCHE$$$$$M$Y$$$20200921$$MD$CA$CA
1119140118$11191401$18$F$$20200629$20150616$20200706$PER$$CA-AMGEN-CANSP2015056272$AMGEN$$72$YR$E$F$Y$$$20200706$$MD$CA$CA
1119272110$11192721$10$F$20150216$20200716$20150616$20200724$EXP$$PHHY2015DE056066$NOVARTIS$$59$YR$$F$Y$$$20200724$$HP$DE$DE
111941802$11194180$2$F$$20150610$20150616$20200701$EXP$$GR-JNJFOC-20150609931$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
1119425210$11194252$10$F$2015$20180622$20150616$20200831$EXP$$US-009507513-1506USA004779$MERCK$$59$YR$$M$Y$89.34$KG$20200831$$HP$US$US
111956196$11195619$6$F$1979$20200707$20150617$20200709$EXP$$US-PFIZER INC-2015200275$PFIZER$$28$YR$$F$Y$77$KG$20200709$$CN$US$US
111971764$11197176$4$F$$20200817$20150617$20200824$PER$$US-SA-2014SA087746$SANOFI AVENTIS$$$$$$Y$$$20200824$$HP$US$US
111973713$11197371$3$F$20150609$20180329$20150617$20180412$EXP$$CN-JNJFOC-20150608577$PHARMACYCLICS$$68$YR$E$F$Y$72$KG$20180412$$MD$CN$CN
111977022$11197702$2$F$20140110$20150608$20150617$20200714$EXP$$US-GILEAD-2015-0158000$GILEAD$$29$YR$A$F$Y$$$20200714$$HP$US$US
1119850314$11198503$14$F$$20200914$20150618$20200918$PER$$CA-AMGEN-CANSP2015012893$AMGEN$$67$YR$E$F$Y$$$20200917$$MD$CA$CA
111987062$11198706$2$F$$20150714$20150618$20150723$EXP$$TR-ROCHE-1594013$ROCHE$CELIK B. CORTICAL STRESS REACTION: 2 CASE REPORTS. TURKISH JOURNAL OF RHEUMATOLOGY 2015?1558:21?.$73$YR$$F$Y$$$20150723$$HP$TR$TR
111997654$11199765$4$F$201306$20200901$20150618$20200915$EXP$$US-JNJFOC-20150607287$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200915$$CN$US$US
112003682$11200368$2$F$20130613$20200825$20150618$20200828$EXP$$FR-ASTRAZENECA-2015SE57317$ASTRAZENECA$$65$YR$$M$Y$$$20200828$$MD$FR$FR
1120211637$11202116$37$F$20140620$20200817$20150619$20200822$EXP$$PHHY2014CA079720$NOVARTIS$$58$YR$$F$Y$$$20200822$$MD$CA$CA
1120248918$11202489$18$F$2015$20200909$20150619$20200911$EXP$$US-PFIZER INC-2015202473$PFIZER$$76$YR$$F$Y$95$KG$20200911$$MD$US$US
112025922$11202592$2$F$$20200713$20150619$20200713$PER$$US-PFIZER INC-2015203323$PFIZER$$64$YR$$F$Y$$$20200713$$MD$US$US
112048882$11204888$2$F$$20200725$20150622$20200810$EXP$$JP-ROCHE-1596878$ROCHE$, TAKEUCHI T, MIYASAKA N, SUMIDA T, MIMORI T, KOIKE T, ENDO K, MASHINO N AND YAMAMOTO K. EFFICACY AND SAFETY OF RITUXIMAB IN JAPANESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS INCLUDING LUPUS NEPHRITIS WHO ARE REFRACTORY TO CONVENTIONAL THERAPY.. MODERN RHEUMATOLOGY 2015 JUN 09?26 (1):80?6.$$$$$Y$$$20200810$$MD$JP$JP
112048922$11204892$2$F$$20200725$20150622$20200807$EXP$$JP-ROCHE-1594912$ROCHE$, TAKEUCHI T, MIYASAKA N, SUMIDA T, MIMORI T, KOIKE T, ENDO K, MASHINO N AND YAMAMOTO K. EFFICACY AND SAFETY OF RITUXIMAB IN JAPANESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS INCLUDING LUPUS NEPHRITIS WHO ARE REFRACTORY TO CONVENTIONAL THERAPY. MODERN RHEUMATOLOGY 2015 JUN 09?26 (1):80?6.$$$$$Y$$$20200807$$MD$JP$JP
112051882$11205188$2$F$20140704$20200802$20150622$20200806$PER$$US-JNJFOC-20150611200$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200806$$HP$US$US
112095289$11209528$9$F$20150616$20200914$20150622$20200921$EXP$$PHHY2015BR062237$NOVARTIS$$66$YR$$F$Y$69$KG$20200921$$MD$BR$BR
112109618$11210961$8$F$20150615$20200806$20150623$20200901$PER$$US-BIOMARINAP-US-2015-106664$BIOMARIN$$20$YR$$F$Y$71.2$KG$20200901$$PH$US$US
112110122$11211012$2$F$$20200725$20150623$20200807$EXP$$JP-ROCHE-1596877$ROCHE$, TAKEUCHI T, MIYASAKA N, SUMIDA T, MIMORI T, KOIKE T, ENDO K, MASHINO N AND YAMAMOTO K. EFFICACY AND SAFETY OF RITUXIMAB IN JAPANESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS INCLUDING LUPUS NEPHRITIS WHO ARE REFRACTORY TO CONVENTIONAL THERAPY.. MODERN RHEUMATOLOGY 2015 JUN 09?26 (1):80?6.$$$$$Y$$$20200807$$MD$JP$JP
112121742$11212174$2$F$20141216$20160720$20150623$20160729$EXP$$US-JNJFOC-20150202140$JANSSEN$$65$YR$A$F$Y$83$KG$20160729$$MD$US$US
1121298511$11212985$11$F$$20200911$20150623$20200915$PER$$US-PFIZER INC-2015205027$PFIZER$$54$YR$$F$Y$93$KG$20200915$$CN$US$US
1121498719$11214987$19$F$20141117$20200819$20150624$20200827$EXP$$PHHY2013CA072978$NOVARTIS$$54$YR$$F$Y$$$20200827$$CN$CA$CA
112154283$11215428$3$F$2003$20200831$20150624$20200909$EXP$$US-ELI_LILLY_AND_COMPANY-US201506007252$ELI LILLY AND CO$$$$$F$Y$$$20200909$$CN$US$US
1121564913$11215649$13$F$$20200713$20150624$20200715$EXP$$US-PFIZER INC-2015206793$PFIZER$$70$YR$$F$Y$57$KG$20200715$$HP$US$US
112163831$11216383$1$I$20150520$20150520$20150624$20150624$EXP$$GB-ASTRAZENECA-2015SE50550$ASTRAZENECA$$54$YR$$F$Y$$$20150624$$MD$GB$GB
112176713$11217671$3$F$$20200921$20150625$20200928$EXP$$US-AUROBINDO-AUR-APL-2015-05277$AUROBINDO$MINOCYCLINE:HYPERPIGMENTATION OF TYMPANIC MEMBRANE, SCLERA, TEETH AND PINNA: CASE REPORT. 2015$40$YR$$F$Y$$$20200929$$HP$US$US
112182203$11218220$3$F$20150528$20160816$20150625$20160826$EXP$$PHHY2015US076299$NOVARTIS$$62$YR$$F$Y$$$20160826$$CN$US$US
112187027$11218702$7$F$20150527$20180313$20150625$20200824$EXP$$JP-INCYTE CORPORATION-2015IN002744$INCYTE$$$$$$Y$$$20200824$$MD$JP$JP
112197062$11219706$2$F$2014$20150615$20150625$20200925$EXP$$US-GLAXOSMITHKLINE-US2015GSK089037$GLAXOSMITHKLINE$$$$$F$Y$$$20200925$$CN$US$US
112210796$11221079$6$F$20141023$20200727$20150626$20200730$EXP$$CA-ROCHE-1462845$ROCHE$$59$YR$$F$Y$82.6$KG$20200731$$HP$CA$CA
112255263$11225526$3$F$201306$20200726$20150629$20200731$PER$$US-JNJFOC-20150621633$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200731$$CN$US$US
112256009$11225600$9$F$$20200928$20150629$20200930$PER$$US-PFIZER INC-2015211671$PFIZER$$51$YR$$F$Y$$$20200930$$CN$US$US
112261863$11226186$3$F$$20200701$20150629$20200702$EXP$$PHHY2015IT074951$NOVARTIS$$45$YR$$M$Y$$$20200702$$HP$IT$IT
112267667$11226766$7$F$201504$20200724$20150630$20200731$PER$$US-SA-2015SA049465$SANOFI AVENTIS$$$$$$Y$$$20200731$$CN$US$US
112267825$11226782$5$F$201504$20200812$20150630$20200814$PER$$US-SA-2015SA051684$SANOFI AVENTIS$$$$$$Y$$$20200814$$CN$US$US
112291573$11229157$3$F$20151110$20200811$20150630$20200813$PER$$US-PFIZER INC-2015214453$PFIZER$$38$YR$$F$Y$$$20200813$$CN$US$US
112292914$11229291$4$F$20150618$20200831$20150630$20200903$EXP$$JP-PFIZER INC-2015217291$PFIZER$$45$YR$$F$Y$80.7$KG$20200903$$MD$JP$JP
112294931$11229493$1$I$$20150618$20150630$20150630$EXP$$PHHY2015TR075482$SANDOZ$TOGAY P, CELIK B, SOY BUGDAYCI D, PAKER N.. CORTICAL STRESS REACTION IN TWO PATIENTS ON BISPHOSPHONATE THERAPY: CASE REPORT.. TURK?J?RHEUMATOL. 2015?30(2):164?67$73$YR$$F$Y$$$20150630$$HP$TR$TR
112297267$11229726$7$F$20150618$20180329$20150630$20180412$EXP$$BR-JNJFOC-20150616380$PHARMACYCLICS$$77$YR$E$F$Y$58$KG$20180412$$MD$BR$BR
112301246$11230124$6$F$20150531$20200715$20150701$20200731$PER$$US-009507513-1506USA001293$MERCK$$54$YR$$F$Y$$$20200731$$PH$US$US
112313012$11231301$2$F$$20150623$20150701$20200701$EXP$$GR-JNJFOC-20150619442$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
1123139413$11231394$13$F$$20200720$20150701$20200723$PER$$CA-AMGEN-CANSP2015064666$AMGEN$$50$YR$A$F$Y$$$20200723$$CN$CA$CA
1123215211$11232152$11$F$2016$20200903$20150701$20200908$EXP$$US-PFIZER INC-2015219842$PFIZER$$56$YR$$F$Y$72$KG$20200908$$MD$US$US
112328509$11232850$9$F$2014$20200923$20150701$20200930$EXP$$US-JAZZ-2015-US-009605$JAZZ$$58$YR$$F$Y$$$20200930$$HP$US$US
1123294816$11232948$16$F$2014$20200820$20150701$20200825$EXP$$US-ACTELION-A-NJ2015-120333$ACTELION$$63$YR$$M$Y$74.83$KG$20200825$$HP$US$US
1123361116$11233611$16$F$2007$20200914$20150702$20200917$PER$$CA-AMGEN-CANSP2015064980$AMGEN$$46$YR$A$F$Y$$$20200917$$HP$CA$CA
112340813$11234081$3$F$$20150910$20150702$20200701$EXP$$GR-JNJFOC-20150622197$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
112342033$11234203$3$F$20140707$20200805$20150702$20200817$EXP$$US-JNJFOC-20150621611$JOHNSON AND JOHNSON$$37$YR$A$M$Y$$$20200817$$CN$US$US
112342143$11234214$3$F$20140605$20200906$20150702$20200918$EXP$$US-JNJFOC-20150619261$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200918$$LW$US$US
112354172$11235417$2$F$20150612$20150701$20150702$20150710$EXP$$US-JNJFOC-20150612929$JANSSEN$$71$YR$E$M$Y$113$KG$20150710$$MD$US$US
1123598519$11235985$19$F$2015$20191209$20150702$20191217$EXP$$US-INCYTE CORPORATION-2015IN002646$INCYTE$$$$$$Y$$$20191218$$CN$US$US
112360163$11236016$3$F$20150610$20161109$20150702$20161114$EXP$$PL-JNJFOC-20150620508$PHARMACYCLICS$$67$YR$E$M$Y$86.9$KG$20161114$$MD$PL$PL
112365012$11236501$2$F$201112$20200915$20150702$20200918$EXP$$PHHY2015BR078184$NOVARTIS$$73$YR$$M$Y$$$20200918$$MD$BR$BR
112371122$11237112$2$F$20131217$20150619$20150703$20150706$EXP$$JP-JNJFOC-20150615743$JANSSEN$$42$YR$A$M$Y$49.2$KG$20150706$$MD$JP$JP
112371764$11237176$4$F$20130426$20200629$20150703$20200706$PER$$US-JNJFOC-20150623179$JOHNSON AND JOHNSON$$75$YR$$M$Y$95.34$KG$20200706$$CN$US$US
1123874915$11238749$15$F$201506$20200723$20150706$20200730$EXP$$PHHY2011CA32882$NOVARTIS$$66$YR$$M$Y$$$20200730$$HP$CA$CA
112392022$11239202$2$F$$20200717$20150706$20200727$EXP$$ES-AUROBINDO-AUR-APL-2015-05686$AUROBINDO$$67$YR$$F$Y$$$20200727$$PH$ES$ES
112400544$11240054$4$F$$20200909$20150706$20200911$PER$$US-PFIZER INC-2015219884$PFIZER$$67$YR$$F$Y$$$20200911$$HP$US$US
112400985$11240098$5$F$$20200812$20150706$20200817$PER$$US-PFIZER INC-2015219991$PFIZER$$59$YR$$F$Y$$$20200817$$CN$US$US
112424849$11242484$9$F$$20200720$20150707$20200723$PER$$CA-AMGEN-CANSP2015065908$AMGEN$$62$YR$A$M$Y$$$20200723$$HP$CA$CA
1124403731$11244037$31$F$20130403$20200713$20150707$20200907$EXP$$CA-ROCHE-1249364$ROCHE$$69$YR$$F$Y$68$KG$20200907$$HP$CA$CA
112452606$11245260$6$F$201501$20200721$20150707$20200723$PER$$US-PFIZER INC-2015220062$PFIZER$$46$YR$$F$Y$105$KG$20200723$$MD$US$US
112455534$11245553$4$F$20150601$20200925$20150707$20200929$PER$$US-PFIZER INC-2015224653$PFIZER$$61$YR$$F$Y$$$20200929$$CN$US$US
112458147$11245814$7$F$2008$20200826$20150707$20200904$EXP$$US-EMD SERONO-234466J08USA$EMD SERONO INC$$38$YR$A$F$Y$82$KG$20200904$$CN$US$US
1124785915$11247859$15$F$20150602$20200716$20150708$20200717$EXP$$US-PFIZER INC-2015222839$PFIZER$$48$YR$$F$Y$99$KG$20200717$$MD$US$US
112508822$11250882$2$F$20150625$20150630$20150708$20200701$EXP$$GR-JNJFOC-20150701326$JOHNSON AND JOHNSON$$$$E$M$Y$$$20200701$$CN$GR$GR
112526635$11252663$5$F$20140627$20200630$20150708$20200713$EXP$$US-JNJFOC-20150703562$JOHNSON AND JOHNSON$$74$YR$$F$Y$$$20200713$$CN$US$US
1125340535$11253405$35$F$2014$20200807$20150709$20200814$EXP$$CA-ROCHE-1569139$ROCHE$$74$YR$$M$Y$$$20200814$$CN$CA$CA
112537921$11253792$1$I$$20150625$20150709$20150709$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-099930$RANBAXY$TOGAY P, CELIK B, SOY BUGDAYCI D, PAKER N. CORTICAL STRESS REACTION IN TWO PATIENTS ON BISPHOSPHONATE THERAPY: CASE REPORT. TURK?J?RHEUMATOL. 2015?30 (2):164?167$$$$$Y$$$20150709$$MD$TR$TR
112542323$11254232$3$F$20150320$20150909$20150709$20150929$PER$$BE-JNJFOC-20150319713$PHARMACYCLICS$$48$YR$A$M$Y$139$KG$20150929$$MD$BE$BE
112544004$11254400$4$F$2013$20200915$20150709$20200929$EXP$$US-JNJFOC-20150703382$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200929$$CN$US$US
112545652$11254565$2$F$20150425$20170801$20150709$20170815$EXP$$CZ-JNJFOC-20150611303$JANSSEN$$52$YR$A$M$Y$86$KG$20170815$$MD$CZ$CZ
112548612$11254861$2$F$$20200907$20150709$20200914$EXP$$US-AUROBINDO-AUR-APL-2015-05648$AUROBINDO$ANTIHYPERTENSIVES:ICHTHYOSIS?LIKE DRUG REACTION: CASE REPORT. 2015$73$YR$$M$Y$$$20200914$$MD$US$US
112551014$11255101$4$F$20141116$20200924$20150709$20200930$PER$$US-JNJFOC-20150704660$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200930$$CN$US$US
112555574$11255557$4$F$20140810$20200720$20150709$20200730$EXP$$US-JNJFOC-20150704620$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200730$$CN$US$US
112555613$11255561$3$F$20130706$20200805$20150709$20200811$PER$$US-JNJFOC-20150700877$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200811$$CN$US$US
112576671$11257667$1$I$$20141211$20150710$20150710$EXP$$AR-ROCHE-1599526$ROCHE$BRANCE M, PALATNIK M. SUBTROCHANTERIC FEMUR FRACTURE ASSOCIATED WITH CHRONIC BISPHOSPHONATE TREATMENT WITH GOOD RESPONSE TO RANELATE STRONTIUM . REVISTA ARGENTINA DE REUMATOLOGIA 2014?25:80?.$66$YR$$F$Y$$$20150710$$MD$AR$AR
1125772712$11257727$12$F$20150331$20200720$20150710$20200724$PER$$CA-AMGEN-CANSP2015061874$AMGEN$$46$YR$A$F$Y$$$20200724$$CN$CA$CA
1125930821$11259308$21$F$20141017$20200721$20150710$20200725$EXP$$PHHY2014CA138066$NOVARTIS$$54$YR$$F$Y$$$20200725$$PH$CA$CA
112594763$11259476$3$F$20150704$20200806$20150710$20200812$EXP$$US-PFIZER INC-2015227942$PFIZER$$36$YR$$F$Y$63$KG$20200812$$HP$US$US
112604761$11260476$1$I$20150629$20150703$20150710$20150710$EXP$$US-ASTRAZENECA-2015SE65504$ASTRAZENECA$$$$$F$Y$$$20150710$$MD$US$US
1126087915$11260879$15$F$201702$20200701$20150710$20200703$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK098504$GLAXOSMITHKLINE$$37$YR$$F$Y$74$KG$20200703$$CN$BR$BR
112617052$11261705$2$F$20131128$20200716$20150710$20200729$EXP$$US-BAYER-2014-188216$BAYER$$77$YR$E$M$Y$$$20200729$$CN$US$US
112627302$11262730$2$F$201505$20200727$20150710$20200807$PER$$US-PURDUE-USA-2015-0124096$PURDUE$$66$YR$$M$Y$$$20200807$$CN$US$US
112635107$11263510$7$F$201003$20200707$20150713$20200708$EXP$$CA-ROCHE-1606398$ROCHE$$16$YR$$F$Y$$$20200708$$CN$CA$CA
112652642$11265264$2$F$20141030$20150707$20150713$20200701$EXP$$GR-JNJFOC-20141218562$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
112661753$11266175$3$F$20140101$20200914$20150713$20200924$EXP$$US-BAYER-2015-000657$BAYER$$62$YR$A$F$Y$$$20200924$$CN$US$US
112664094$11266409$4$F$20150506$20200811$20150713$20200813$EXP$$US-PFIZER INC-2015229589$PFIZER$$70$YR$$F$Y$$$20200813$$HP$US$US
112673103$11267310$3$F$201507$20200811$20150713$20200817$EXP$$US-JAZZ-2015-US-010103$JAZZ$$52$YR$$F$Y$$$20200817$$HP$US$US
112683193$11268319$3$F$20150216$20200804$20150714$20200806$PER$$US-JNJFOC-20150621784$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200806$$CN$US$US
112683583$11268358$3$F$201504$20200720$20150714$20200730$EXP$$US-JNJFOC-20150704823$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20200730$$CN$US$US
112683674$11268367$4$F$20150214$20200706$20150714$20200709$PER$$US-JNJFOC-20150704912$JOHNSON AND JOHNSON$$70$YR$$M$Y$166.62$KG$20200709$$CN$US$US
112683684$11268368$4$F$20141118$20200729$20150714$20200803$PER$$US-JNJFOC-20150704932$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20200803$$HP$US$US
112683785$11268378$5$F$20150413$20200723$20150714$20200728$PER$$US-JNJFOC-20150705175$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20200728$$CN$US$US
112683835$11268383$5$F$201505$20200901$20150714$20200909$PER$$US-JNJFOC-20150705548$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200909$$HP$US$US
112684497$11268449$7$F$20140801$20200805$20150714$20200817$EXP$$US-JNJFOC-20150704840$JOHNSON AND JOHNSON$$73$YR$E$M$Y$74.91$KG$20200817$$CN$US$US
112684643$11268464$3$F$201502$20200914$20150714$20200918$PER$$US-JNJFOC-20150704924$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200918$$CN$US$US
112684664$11268466$4$F$201305$20200629$20150714$20200702$PER$$US-JNJFOC-20150616118$JOHNSON AND JOHNSON$$30$YR$$F$Y$$$20200702$$CN$US$US
112684903$11268490$3$F$20130801$20200707$20150714$20200713$PER$$US-JNJFOC-20150616659$JOHNSON AND JOHNSON$$68$YR$$F$Y$$$20200713$$CN$US$US
112685044$11268504$4$F$201409$20200910$20150714$20200914$EXP$$US-JNJFOC-20150621606$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20200914$$CN$US$US
112685375$11268537$5$F$201401$20200805$20150714$20200817$EXP$$US-JNJFOC-20150704864$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20200817$$CN$US$US
112685483$11268548$3$F$201310$20200720$20150714$20200722$PER$$US-JNJFOC-20150705921$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200722$$CN$US$US
112685983$11268598$3$F$201312$20200629$20150714$20200710$EXP$$US-JNJFOC-20150621603$JOHNSON AND JOHNSON$$33$YR$$F$Y$$$20200710$$CN$US$US
112686345$11268634$5$F$20141028$20200927$20150714$20200929$PER$$US-JNJFOC-20150705913$JOHNSON AND JOHNSON$$70$YR$E$M$Y$83.99$KG$20200929$$CN$US$US
112686873$11268687$3$F$201310$20200805$20150714$20200811$PER$$US-JNJFOC-20150621604$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200811$$CN$US$US
112686973$11268697$3$F$20141030$20200623$20150714$20200707$EXP$$US-JNJFOC-20150621610$JOHNSON AND JOHNSON$$81$YR$$F$Y$$$20200707$$CN$US$US
112687485$11268748$5$F$20150122$20200818$20150714$20200824$EXP$$US-JNJFOC-20150705680$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200824$$CN$US$US
112687553$11268755$3$F$20131006$20200823$20150714$20200827$PER$$US-JNJFOC-20150704473$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20200827$$CN$US$US
112687653$11268765$3$F$20150217$20200722$20150714$20200731$PER$$US-JNJFOC-20150610713$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20200731$$CN$US$US
112688406$11268840$6$F$201504$20200906$20150714$20200918$EXP$$US-JNJFOC-20150705732$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200918$$CN$US$US
112688466$11268846$6$F$20150417$20200917$20150714$20200921$PER$$US-JNJFOC-20150705520$JOHNSON AND JOHNSON$$58$YR$A$M$Y$61.74$KG$20200921$$CN$US$US
112688714$11268871$4$F$201502$20200916$20150714$20200921$PER$$US-JNJFOC-20150704835$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200921$$HP$US$US
112696726$11269672$6$F$20150418$20191029$20150714$20200807$EXP$$PHJP2015JP007290$NOVARTIS$$37$YR$$F$Y$55$KG$20200807$$HP$JP$JP
112699083$11269908$3$F$201407$20200729$20150714$20200805$PER$$US-JNJFOC-20150708055$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200805$$CN$US$US
112699322$11269932$2$F$20141007$20200903$20150714$20200909$EXP$$US-BAYER-2015-021334$BAYER$$85$YR$E$F$Y$$$20200909$$CN$US$US
1127014412$11270144$12$F$2008$20200709$20150714$20200710$EXP$$US-PFIZER INC-2015230922$PFIZER$$61$YR$$M$Y$$$20200710$$MD$US$US
112702591$11270259$1$I$20130602$20130614$20150714$20150714$EXP$$HU-JNJFOC-20130611144$JANSSEN$$47$YR$A$F$Y$35.2$KG$20150714$$MD$HU$HU
112702601$11270260$1$I$20140516$20140528$20150714$20150714$EXP$$HU-JNJFOC-20140600036$JANSSEN$$32$YR$A$M$Y$58$KG$20150714$$MD$HU$HU
112702615$11270261$5$F$20150130$20170418$20150714$20170424$EXP$$US-JNJFOC-20150203264$JANSSEN$$72$YR$E$F$Y$51$KG$20170424$$MD$US$US
112704171$11270417$1$I$20130130$20130325$20150714$20150714$EXP$$FR-JNJFOC-20130317150$JANSSEN$$27$YR$A$F$Y$44$KG$20150714$$MD$FR$FR
112713585$11271358$5$F$20130710$20200708$20150714$20200722$EXP$$US-BAYER-2013-095063$BAYER$$75$YR$E$M$Y$74.8$KG$20200722$$MD$US$US
1127257131$11272571$31$F$2015$20200121$20150715$20200127$EXP$$PHHY2015CA069220$NOVARTIS$$35$YR$$M$Y$$$20200127$$MD$CA$CA
112736334$11273633$4$F$2014$20200702$20150715$20200715$EXP$$US-BAYER-2015-021336$BAYER$$71$YR$E$M$Y$104$KG$20200715$$CN$US$US
112736956$11273695$6$F$20150707$20160720$20150715$20160729$EXP$$CA-JNJFOC-20150709266$JANSSEN$$50$YR$A$F$Y$73$KG$20160729$$MD$CA$CA
112737192$11273719$2$F$20130326$20200715$20150715$20200722$EXP$$US-BAYER-2015-112640$BAYER$$74$YR$E$M$Y$$$20200722$$CN$US$US
112740141$11274014$1$I$20121115$20121116$20150715$20150715$EXP$$JP-JNJFOC-20121110507$JANSSEN$$71$YR$E$F$Y$52.3$KG$20150715$$MD$JP$JP
1127491516$11274915$16$F$$20200914$20150716$20200921$PER$$CA-AMGEN-CANSP2015069595$AMGEN$$62$YR$A$F$Y$72.7$KG$20200920$$HP$CA$CA
112757931$11275793$1$I$20121224$20121226$20150716$20150716$EXP$$US-JNJFOC-20130100327$JANSSEN$$57$YR$A$M$Y$122.5$KG$20150716$$MD$US$US
112757941$11275794$1$I$20130904$20130911$20150716$20150716$EXP$$US-JNJFOC-20130908297$JANSSEN$$49$YR$A$M$Y$82.5$KG$20150716$$MD$US$US
112757951$11275795$1$I$20130507$20130508$20150716$20150716$EXP$$US-JNJFOC-20130506298$JANSSEN$$36$YR$A$F$Y$62.4$KG$20150716$$MD$US$US
112757971$11275797$1$I$20130107$20130115$20150716$20150716$EXP$$US-JNJFOC-20130110343$JANSSEN$$73$YR$E$F$Y$68.1$KG$20150716$$HP$US$US
112758081$11275808$1$I$20121124$20121130$20150716$20150716$EXP$$GB-JNJFOC-20121203305$JANSSEN$$36$YR$A$F$Y$64$KG$20150716$$MD$GB$GB
112758101$11275810$1$I$20130818$20130822$20150716$20150716$EXP$$DE-JNJFOC-20130813438$JANSSEN$$28$YR$A$F$Y$55.5$KG$20150716$$MD$DE$DE
112758111$11275811$1$I$20140207$20140217$20150716$20150716$EXP$$GB-JNJFOC-20140211993$JANSSEN$$53$YR$A$M$Y$64$KG$20150716$$MD$GB$GB
112761951$11276195$1$I$20130116$20130116$20150716$20150716$EXP$$AT-JNJFOC-20130110521$JANSSEN$$23$YR$A$F$Y$49.5$KG$20150716$$MD$AT$AT
112765821$11276582$1$I$20130123$20130123$20150716$20150716$EXP$$US-JNJFOC-20130116070$JANSSEN$$36$YR$A$M$Y$111$KG$20150716$$HP$US$US
112765831$11276583$1$I$20130123$20130226$20150716$20150716$EXP$$JP-JNJFOC-20130300822$JANSSEN$$19$YR$A$F$Y$39.7$KG$20150716$$MD$JP$JP
112765841$11276584$1$I$20130217$20130301$20150716$20150716$EXP$$NL-JNJFOC-20130302848$JANSSEN$$65$YR$A$M$Y$73$KG$20150716$$MD$NL$NL
112765851$11276585$1$I$20130303$20130314$20150716$20150716$EXP$$CA-JNJFOC-20130311151$JANSSEN$$25$YR$A$F$Y$51$KG$20150716$$MD$CA$CA
112765861$11276586$1$I$20130315$20130318$20150716$20150716$EXP$$JP-JNJFOC-20130313864$JANSSEN$$36$YR$A$F$Y$56.7$KG$20150716$$HP$JP$JP
112765871$11276587$1$I$20140126$20140128$20150716$20150716$EXP$$US-JNJFOC-20140200186$JANSSEN$$29$YR$A$F$Y$57.4$KG$20150716$$MD$US$US
112769261$11276926$1$I$20130513$20130528$20150716$20150716$EXP$$JP-JNJFOC-20130520231$JANSSEN$$36$YR$A$F$Y$53.3$KG$20150716$$MD$JP$JP
112769271$11276927$1$I$20140313$20140327$20150716$20150716$EXP$$HU-JNJFOC-20140319148$JANSSEN$$61$YR$A$M$Y$78$KG$20150716$$MD$HU$HU
112769281$11276928$1$I$20130614$20130628$20150716$20150716$EXP$$CA-JNJFOC-20130700850$JANSSEN$$36$YR$A$M$Y$84.5$KG$20150716$$MD$CA$CA
112769291$11276929$1$I$20130710$20130711$20150716$20150716$EXP$$NL-JNJFOC-20130708929$JANSSEN$$66$YR$E$M$Y$72$KG$20150716$$MD$NL$NL
112769301$11276930$1$I$20140819$20140820$20150716$20150716$EXP$$GB-JNJFOC-20140822091$JANSSEN$$35$YR$A$M$Y$60$KG$20150716$$MD$GB$GB
112769311$11276931$1$I$20140610$20140624$20150716$20150716$EXP$$GB-JNJFOC-20140619318$JANSSEN$$61$YR$A$F$Y$71.6$KG$20150716$$MD$GB$GB
112770231$11277023$1$I$20141016$20141021$20150716$20150716$EXP$$BR-JNJFOC-20141019783$JANSSEN$$75$YR$E$M$Y$84$KG$20150716$$MD$BR$BR
112770241$11277024$1$I$20141105$20141121$20150716$20150716$EXP$$FR-JNJFOC-20141118054$JANSSEN$$31$YR$A$F$Y$$$20150716$$MD$FR$FR
112770251$11277025$1$I$20141125$20141202$20150716$20150716$EXP$$DE-JNJFOC-20141205717$JANSSEN$$43$YR$A$F$Y$81.8$KG$20150716$$MD$DE$DE
112770281$11277028$1$I$20130711$20130715$20150716$20150716$EXP$$US-JNJFOC-20130711908$JANSSEN$$31$YR$A$F$Y$65.8$KG$20150716$$MD$US$US
112770291$11277029$1$I$20140602$20140808$20150716$20150716$EXP$$US-JNJFOC-20140812322$JANSSEN$$50$YR$A$F$Y$50.4$KG$20150716$$MD$US$US
112770301$11277030$1$I$20140917$20140924$20150716$20150716$EXP$$US-JNJFOC-20140926203$JANSSEN$$31$YR$A$M$Y$64.7$KG$20150716$$MD$US$US
112772541$11277254$1$I$20141202$20141217$20150716$20150716$EXP$$US-JNJFOC-20141212731$JANSSEN$$31$YR$A$M$Y$83.2$KG$20150716$$MD$US$US
112772551$11277255$1$I$20141229$20150101$20150716$20150716$EXP$$JP-JNJFOC-20150101282$JANSSEN$$30$YR$A$F$Y$40.9$KG$20150716$$MD$JP$JP
112772561$11277256$1$I$20131015$20131016$20150716$20150716$EXP$$US-JNJFOC-20131011900$JANSSEN$$73$YR$E$F$Y$67.1$KG$20150716$$MD$US$US
112772571$11277257$1$I$20140925$20141001$20150716$20150716$EXP$$FR-JNJFOC-20141006137$JANSSEN$$28$YR$A$F$Y$81$KG$20150716$$MD$FR$FR
112772581$11277258$1$I$20140730$20141022$20150716$20150716$EXP$$US-JNJFOC-20141019836$JANSSEN$$61$YR$A$M$Y$71.22$KG$20150716$$MD$US$US
1127734912$11277349$12$F$2015$20200827$20150716$20200910$EXP$$JP-INCYTE CORPORATION-2014IN002975$INCYTE$$$$$$Y$$$20200910$$MD$JP$JP
112777931$11277793$1$I$20131228$20140106$20150716$20150716$EXP$$CA-JNJFOC-20140104117$JANSSEN$$24$YR$A$M$Y$87$KG$20150716$$MD$CA$CA
112777941$11277794$1$I$20131119$20131119$20150716$20150716$EXP$$US-JNJFOC-20131113983$JANSSEN$$43$YR$A$M$Y$64.8$KG$20150716$$MD$US$US
112780764$11278076$4$F$2008$20200701$20150717$20200706$PER$$US-AMGEN-USASP2015070464$AMGEN$$56$YR$A$F$Y$$$20200706$$MD$US$US
112793931$11279393$1$I$20150405$20150529$20150717$20150717$EXP$$PL-JNJFOC-20150600387$JANSSEN$$61$YR$A$F$Y$71.4$KG$20150717$$MD$PL$PL
112793941$11279394$1$I$20140114$20140114$20150717$20150717$EXP$$DE-JNJFOC-20140110919$JANSSEN$$32$YR$A$F$Y$105$KG$20150717$$MD$DE$DE
112793951$11279395$1$I$20150117$20150211$20150717$20150717$EXP$$BR-JNJFOC-20150213639$JANSSEN$$76$YR$E$M$Y$84.2$KG$20150717$$MD$BR$BR
112793961$11279396$1$I$20150214$20150214$20150717$20150717$EXP$$RS-JNJFOC-20150214404$JANSSEN$$21$YR$A$M$Y$45$KG$20150717$$MD$RS$RS
112793987$11279398$7$F$20150629$20160427$20150717$20160503$EXP$$US-JNJFOC-20150700795$JANSSEN$$24$YR$A$M$Y$63.9$KG$20160503$$MD$US$US
112793991$11279399$1$I$20150104$20150105$20150717$20150717$EXP$$US-JNJFOC-20150103499$JANSSEN$$34$YR$A$F$Y$71.4$KG$20150717$$MD$US$US
112794004$11279400$4$F$20150624$20160523$20150717$20160531$EXP$$US-JNJFOC-20150621439$JANSSEN$$35$YR$A$F$Y$150.5$KG$20160531$$MD$US$US
112794802$11279480$2$F$20130823$20200727$20150717$20200807$EXP$$US-BAYER-2015-196456$BAYER$$53$YR$A$M$Y$$$20200807$$LW$US$US
112799854$11279985$4$F$20141010$20170106$20150717$20170111$EXP$$MY-BAXALTA-2015BAX013361$BAXALTA$$$$$$Y$$$20170110$$MD$MY$MY
112801423$11280142$3$F$20150126$20200727$20150717$20200803$EXP$$US-JNJFOC-20150606618$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20200803$$CN$US$US
112802572$11280257$2$F$20140603$20200819$20150717$20200821$PER$$US-JNJFOC-20150606585$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200821$$HP$US$US
112802634$11280263$4$F$20130618$20200629$20150717$20200706$PER$$US-JNJFOC-20150607214$JOHNSON AND JOHNSON$$82$YR$$F$Y$$$20200706$$CN$US$US
112803443$11280344$3$F$201306$20200726$20150717$20200731$PER$$US-JNJFOC-20150604581$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200731$$CN$US$US
112804523$11280452$3$F$201301$20200818$20150717$20200820$PER$$US-JNJFOC-20150608478$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20200820$$HP$US$US
112804873$11280487$3$F$201308$20200927$20150717$20200930$PER$$US-JNJFOC-20150705204$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20200930$$HP$US$US
112806253$11280625$3$F$20140826$20200811$20150717$20200821$EXP$$US-JNJFOC-20150605293$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20200821$$CN$US$US
112808183$11280818$3$F$201501$20200924$20150717$20200928$PER$$US-JNJFOC-20150604291$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200928$$CN$US$US
112808255$11280825$5$F$20130531$20200720$20150717$20200731$PER$$US-JNJFOC-20150607266$JOHNSON AND JOHNSON$$79$YR$E$F$Y$67.65$KG$20200731$$CN$US$US
112809204$11280920$4$F$2013$20200803$20150717$20200806$PER$$US-JNJFOC-20150607257$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200806$$CN$US$US
112809373$11280937$3$F$20131228$20200723$20150717$20200728$PER$$US-JNJFOC-20150604095$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200728$$LW$US$US
112810562$11281056$2$F$20140220$20160516$20150717$20160520$EXP$$GB-JNJFOC-20140309976$PHARMACYCLICS$$84$YR$E$M$Y$$$20160520$$MD$GB$GB
112811122$11281112$2$F$20120630$20200811$20150717$20200819$EXP$$US-BAYER-2015-021164$BAYER$$50$YR$A$M$Y$$$20200819$$LW$US$US
112811563$11281156$3$F$20140820$20200906$20150717$20200910$EXP$$US-BAYER-2015-136038$BAYER$$82$YR$E$M$Y$$$20200910$$HP$US$US
1128119712$11281197$12$F$$20200824$20150717$20200825$EXP$$US-PFIZER INC-2015234771$PFIZER$$70$YR$$F$Y$$$20200825$$HP$US$US
112829322$11282932$2$F$20150611$20170807$20150720$20170815$EXP$$US-JNJFOC-20150612728$PHARMACYCLICS$$61$YR$A$F$Y$$$20170815$$MD$US$US
112834644$11283464$4$F$$20200901$20150720$20200903$PER$$US-PFIZER INC-2015236622$PFIZER$$68$YR$$M$Y$$$20200903$$CN$US$US
112835604$11283560$4$F$20150603$20170608$20150720$20170614$EXP$$US-JNJFOC-20150619285$JANSSEN$$63$YR$A$F$Y$49$KG$20170614$$MD$US$US
112835641$11283564$1$I$20140925$20140929$20150720$20150720$EXP$$ZA-JNJFOC-20141004119$JANSSEN$$48$YR$A$F$Y$49$KG$20150720$$MD$ZA$ZA
112837212$11283721$2$F$20140306$20200826$20150720$20200828$EXP$$US-BAYER-2015-038735$BAYER$$68$YR$E$M$Y$$$20200828$$HP$US$US
112841255$11284125$5$F$20140424$20190904$20150720$20200819$PER$$US-AEGERION PHARMACEUTICAL INC.-AEGR000615$AEGERION$$37$YR$$F$Y$73.16$KG$20200819$$MD$US$US
112846794$11284679$4$F$20160330$20200211$20150720$20200819$PER$$US-AEGERION PHARMACEUTICAL INC.-AEGR001462$AEGERION$$60$YR$$M$Y$$$20200819$$MD$US$US
112849586$11284958$6$F$20140626$20200430$20150720$20200819$PER$$US-AEGERION PHARMACEUTICAL INC.-AEGR001384$AEGERION$$60$YR$$M$Y$$$20200819$$MD$US$US
112852702$11285270$2$F$20150516$20150806$20150720$20150811$EXP$$PHHO2015DE009317$NOVARTIS$$60$YR$$F$Y$$$20150811$$MD$DE$DE
112880482$11288048$2$F$20141102$20200820$20150721$20200825$EXP$$US-BAYER-2015-020002$BAYER$$59$YR$A$M$Y$$$20200825$$CN$US$US
112880734$11288073$4$F$20140710$20200628$20150721$20200708$EXP$$US-BAYER-2014-173185$BAYER$$89$YR$E$M$Y$$$20200708$$CN$US$US
112886383$11288638$3$F$$20200929$20150721$20200930$EXP$$US-PFIZER INC-2015004730$PFIZER$$61$YR$$F$Y$$$20200930$$CN$US$US
112889761$11288976$1$I$20150709$20150710$20150721$20150721$EXP$$US-JNJFOC-20150711410$JANSSEN$$84$YR$E$M$Y$68.49$KG$20150721$$MD$US$US
112891042$11289104$2$F$20121225$20200803$20150721$20200811$EXP$$US-BAYER-2015-076897$BAYER$$86$YR$E$M$Y$$$20200811$$HP$US$US
112895153$11289515$3$F$20140311$20200910$20150721$20200916$EXP$$US-BAYER-2015-253549$BAYER$$72$YR$E$M$Y$$$20200916$$HP$US$US
112898793$11289879$3$F$2013$20200914$20150721$20200924$EXP$$US-BAYER-2014-147783$BAYER$$69$YR$E$M$Y$$$20200924$$HP$US$US
112900284$11290028$4$F$20141216$20200924$20150721$20200930$EXP$$US-JAZZ-2014-US-016969$JAZZ$$45$YR$$F$Y$63.49$KG$20200930$$HP$US$US
1129038110$11290381$10$F$$20200707$20150722$20200707$EXP$$CA-ROCHE-1610671$ROCHE$$75$YR$$F$Y$$$20200707$$HP$CA$CA
112904163$11290416$3$F$2014$20200914$20150722$20200923$PER$$US-UNITED THERAPEUTICS-UNT-2014-005624$UNITED THERAPEUTICS$$$$$F$Y$69.39$KG$20200923$$CN$US$US
112906113$11290611$3$F$$20200724$20150722$20200727$EXP$$US-AUROBINDO-AUR-APL-2015-06237$AUROBINDO$MULTIPLE DRUGS SEROTONIN SYNDROME: CASE REPORT. 2015$41$YR$$F$Y$84$KG$20200727$$$COUNTRY NOT SPECIFIED$US
112920602$11292060$2$F$20140504$20200811$20150722$20200818$EXP$$US-BAYER-2015-181492$BAYER$$78$YR$E$F$Y$$$20200818$$CN$US$US
112928862$11292886$2$F$20140407$20200709$20150722$20200720$EXP$$US-BAYER-2015-113692$BAYER$$93$YR$E$F$Y$$$20200720$$CN$US$US
112929504$11292950$4$F$20130516$20200812$20150722$20200818$EXP$$US-BAYER-2015-169988$BAYER$$58$YR$A$F$Y$$$20200818$$CN$US$US
112931883$11293188$3$F$20150717$20200831$20150722$20200909$EXP$$BR-BIOMARINAP-BR-2015-106894$BIOMARIN$$11$YR$$F$Y$32.7$KG$20200909$$HP$BR$BR
112933552$11293355$2$F$20141101$20200902$20150722$20200908$EXP$$US-BAYER-2015-254405$BAYER$$64$YR$A$M$Y$$$20200908$$HP$US$US
112936229$11293622$9$F$20150501$20200707$20150722$20200720$EXP$$JP-INCYTE CORPORATION-2015IN002791$INCYTE$$$$$$Y$$$20200720$$MD$JP$JP
112949093$11294909$3$F$201506$20200626$20150723$20200702$EXP$$US-ROCHE-1610168$ROCHE$$47$YR$$M$Y$$$20200702$$MD$US$US
113015904$11301590$4$F$1998$20200921$20150722$20200928$PER$$US-ELI_LILLY_AND_COMPANY-US200908002886$ELI LILLY AND CO$$73$YR$$M$Y$$$20200928$$MD$US$US
113025253$11302525$3$F$20150210$20200819$20150723$20200824$PER$$US-JNJFOC-20150714555$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20200824$$HP$US$US
1130269515$11302695$15$F$20150710$20200827$20150723$20200907$EXP$$CA-ROCHE-1612329$ROCHE$$71$YR$$M$Y$$$20200907$$MD$CA$CA
113027523$11302752$3$F$201312$20200816$20150723$20200824$EXP$$US-BAYER-2015-253933$BAYER$$73$YR$E$M$Y$$$20200824$$CN$US$US
113031553$11303155$3$F$20141028$20200826$20150723$20200901$PER$$US-JNJFOC-20150714977$JOHNSON AND JOHNSON$$92$YR$E$F$Y$$$20200901$$HP$US$US
1130652211$11306522$11$F$20130201$20200922$20150723$20200928$EXP$$PHHY2015EC086798$NOVARTIS$$34$YR$$F$Y$$$20200928$$CN$EC$EC
1130658214$11306582$14$F$2014$20200804$20150723$20200807$EXP$$PHHY2014BR130324$NOVARTIS$$63$YR$$F$Y$57$KG$20200807$$CN$COUNTRY NOT SPECIFIED$BR
113071095$11307109$5$F$201211$20200910$20150723$20200914$EXP$$US-JNJFOC-20150715773$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200914$$CN$US$US
113079472$11307947$2$F$20130505$20200813$20150724$20200820$EXP$$US-BAYER-2015-244742$BAYER$$83$YR$E$F$Y$$$20200820$$CN$US$US
1130866419$11308664$19$F$$20200914$20150724$20200916$PER$$CA-AMGEN-CANSP2011017837$AMGEN$$52$YR$A$F$Y$98$KG$20200916$$HP$CA$CA
113091793$11309179$3$F$2014$20200630$20150724$20200703$EXP$$CA-PFIZER INC-2015058845$PFIZER$$58$YR$$M$Y$119$KG$20200703$$PH$CA$CA
113092252$11309225$2$F$20140603$20200709$20150724$20200720$EXP$$US-BAYER-2015-258187$BAYER$$65$YR$E$F$Y$108.05$KG$20200720$$CN$US$US
113101193$11310119$3$F$20150717$20150820$20150724$20150825$EXP$$TR-JNJFOC-20150717617$PHARMACYCLICS$$75$YR$E$M$Y$61.6$KG$20150825$$MD$TR$TR
1131094116$11310941$16$F$20150101$20200911$20150726$20200919$EXP$$DE-ROCHE-1612391$ROCHE$$60$YR$$F$Y$$$20200919$$CN$DE$DE
1131096030$11310960$30$F$20150914$20200915$20150726$20200923$EXP$$CA-ROCHE-1610105$ROCHE$$47$YR$$F$Y$58$KG$20200923$$HP$CA$CA
113114945$11311494$5$F$20150703$20150917$20150727$20150923$EXP$$US-JNJFOC-20150714991$JANSSEN$$68$YR$E$F$Y$$$20150923$$MD$US$US
113124542$11312454$2$F$$20200921$20150727$20200924$EXP$$PHHY2015PT087910$NOVARTIS$$39$YR$$F$Y$$$20200924$$HP$PT$PT
113154797$11315479$7$F$2015$20200810$20150728$20200818$EXP$$CA-ROCHE-1613817$ROCHE$$47$YR$$M$Y$$$20200818$$MD$CA$CA
113177082$11317708$2$F$20130217$20200804$20150728$20200813$EXP$$US-BAYER-2015-280034$BAYER$$71$YR$E$M$Y$$$20200813$$CN$US$US
113181922$11318192$2$F$$20200903$20150728$20200907$EXP$$PHHY2015FR089193$NOVARTIS$$60$YR$$M$Y$$$20200907$$HP$FR$FR
113183164$11318316$4$F$2013$20200921$20150728$20200925$EXP$$US-JAZZ-2015-US-010815$JAZZ$$$$$F$Y$$$20200925$$MD$US$US
113183362$11318336$2$F$20150717$20200902$20150728$20200903$PER$$US-LUNDBECK-DKLU2001861$LUNDBECK$$4$YR$$M$Y$$$20200903$$CN$US$US
1131947912$11319479$12$F$20121030$20200824$20150729$20200825$EXP$$PHHY2014US134441$NOVARTIS$$52$YR$$F$Y$$$20200825$$MD$US$US
1132007121$11320071$21$F$2015$20200210$20150729$20200721$EXP$$PHHY2015CA035739$NOVARTIS$$14$YR$$M$Y$$$20200721$$CN$CA$CA
113200912$11320091$2$F$20140307$20200825$20150729$20200828$EXP$$US-BAYER-2014-141436$BAYER$$79$YR$E$F$Y$66.28$KG$20200828$$CN$US$US
113201485$11320148$5$F$20121015$20200817$20150729$20200817$PER$$PHHY2013US099725$NOVARTIS$$43$YR$$F$Y$$$20200817$$MD$US$US
1132203718$11322037$18$F$2015$20200918$20150729$20200929$EXP$$US-SA-2015SA090742$SANOFI AVENTIS$$$$$$Y$$$20200929$$CN$US$US
1132353615$11323536$15$F$20111216$20200701$20150730$20200706$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN102901$VIIV$$52$YR$$M$Y$$$20200706$$CN$JP$JP
1132363615$11323636$15$F$20111216$20200701$20150730$20200706$EXP$$JP-GLAXOSMITHKLINE INC.-JP2015JPN102901$GLAXOSMITHKLINE$$52$YR$$M$Y$$$20200706$$CN$JP$JP
113238534$11323853$4$F$201009$20200908$20150730$20200925$EXP$$JP-ASTELLAS-2012JP004446$ASTELLAS$$39$YR$$F$Y$51$KG$20200925$$MD$JP$JP
113239843$11323984$3$F$20130721$20200625$20150730$20200708$EXP$$US-JNJFOC-20150712656$JOHNSON AND JOHNSON$$76$YR$$F$Y$$$20200708$$CN$US$US
113239958$11323995$8$F$20150706$20150727$20150730$20160826$EXP$$DE-JNJFOC-20150716701$PHARMACYCLICS$$68$YR$E$F$Y$$$20160826$$MD$DE$DE
113254503$11325450$3$F$20150727$20150928$20150730$20150930$EXP$$US-JNJFOC-20150722164$PHARMACYCLICS$$98$YR$E$M$Y$68.9$KG$20150930$$MD$US$US
1132624920$11326249$20$F$2014$20200918$20150731$20200928$PER$$CA-AMGEN-CANSP2015075697$AMGEN$$63$YR$A$F$Y$$$20200928$$MD$CA$CA
113262743$11326274$3$F$20130604$20200816$20150731$20200819$EXP$$US-BAYER-2015-279394$BAYER$$65$YR$E$M$Y$$$20200819$$HP$US$US
113270703$11327070$3$F$20150624$20151005$20150731$20151012$EXP$$PHHY2015FR088003$SANDOZ$$65$YR$$F$Y$$$20151012$$HP$FR$FR
113281042$11328104$2$F$20150723$20160617$20150731$20160623$EXP$$US-JNJFOC-20150718815$PHARMACYCLICS$$66$YR$E$M$Y$100$KG$20160623$$MD$US$US
1132997410$11329974$10$F$201211$20200812$20150803$20200813$EXP$$JP-VIIV HEALTHCARE ULC-JP2015JPN107326$VIIV$$67$YR$$M$Y$$$20200813$$CN$JP$JP
113306034$11330603$4$F$20150209$20200713$20150803$20200721$EXP$$US-BAYER-2015-300474$BAYER$$77$YR$E$F$Y$$$20200721$$HP$US$US
1133067910$11330679$10$F$201211$20200812$20150803$20200813$EXP$$JP-GLAXOSMITHKLINE-JP2015JPN107326$GLAXOSMITHKLINE$$67$YR$$M$Y$$$20200813$$CN$JP$JP
113338855$11333885$5$F$201904$20200819$20150803$20200821$PER$$US-PFIZER INC-2015243165$PFIZER$$63$YR$$F$Y$$$20200821$$CN$US$US
1133500926$11335009$26$F$20141109$20200914$20150804$20200928$EXP$$DE-ROCHE-ITM201411IM007553$ROCHE$$56$YR$$M$Y$96$KG$20200928$$CN$DE$DE
113362386$11336238$6$F$201412$20200826$20150804$20200831$EXP$$US-BAYER-2015-180303$BAYER$$67$YR$E$M$Y$$$20200831$$HP$US$US
113362972$11336297$2$F$2012$20200812$20150804$20200819$EXP$$US-BAYER-2015-324100$BAYER$$79$YR$E$M$Y$$$20200819$$HP$US$US
113363684$11336368$4$F$20150727$20200623$20150804$20200701$EXP$$US-ASTRAZENECA-2015SE73263$ASTRAZENECA$$17968$DY$$M$Y$$$20200701$$CN$US$US
113370954$11337095$4$F$20150308$20200618$20150804$20200701$EXP$$US-ACTELION-A-NJ2015-121796$ACTELION$$79$YR$$F$Y$$$20200701$$HP$US$US
113409643$11340964$3$F$20130822$20200816$20150805$20200827$EXP$$US-JNJFOC-20150716322$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200827$$CN$US$US
113409854$11340985$4$F$20140222$20200923$20150805$20200928$PER$$US-JNJFOC-20150720557$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200928$$CN$US$US
113410273$11341027$3$F$20140429$20200630$20150805$20200706$PER$$US-JNJFOC-20150718098$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20200706$$LW$US$US
113410884$11341088$4$F$20140818$20200915$20150805$20200918$PER$$US-JNJFOC-20150717044$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200918$$CN$US$US
113410973$11341097$3$F$20141009$20200715$20150805$20200717$PER$$US-JNJFOC-20150717883$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200717$$LW$US$US
113411033$11341103$3$F$20141006$20200903$20150805$20200909$PER$$US-JNJFOC-20150718107$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200909$$CN$US$US
113411894$11341189$4$F$20141009$20200712$20150805$20200721$EXP$$US-JNJFOC-20150714921$JOHNSON AND JOHNSON$$93$YR$$F$Y$$$20200721$$CN$US$US
113411924$11341192$4$F$201306$20200809$20150805$20200819$EXP$$US-JNJFOC-20150717052$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200819$$CN$US$US
113411963$11341196$3$F$20141129$20200721$20150805$20200724$PER$$US-JNJFOC-20150717876$JOHNSON AND JOHNSON$$95$YR$E$M$Y$$$20200724$$CN$US$US
113412254$11341225$4$F$201209$20200715$20150805$20200720$PER$$US-JNJFOC-20150722157$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200720$$CN$US$US
113412673$11341267$3$F$20140929$20200812$20150805$20200817$PER$$US-JNJFOC-20150714985$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200817$$CN$US$US
113412842$11341284$2$F$$20200702$20150805$20200709$PER$$US-JNJFOC-20150711493$JOHNSON AND JOHNSON$$$$$F$Y$$$20200709$$LW$US$US
113413825$11341382$5$F$2013$20200812$20150805$20200817$PER$$US-JNJFOC-20150717041$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20200817$$CN$US$US
113426494$11342649$4$F$201507$20200721$20150805$20200727$PER$$US-JAZZ-2015-US-011301$JAZZ$$40$YR$$F$Y$$$20200727$$HP$US$US
113431902$11343190$2$F$$20200902$20150806$20200914$EXP$$IT-LUPIN PHARMACEUTICALS INC.-2015-02331$LUPIN$$71$YR$$M$Y$$$20200914$$HP$IT$IT
1134338323$11343383$23$F$20140305$20200729$20150806$20200731$EXP$$BR-PFIZER INC-2014033892$PFIZER$$65$YR$$M$Y$95$KG$20200731$$CN$BR$BR
1134381633$11343816$33$F$201407$20200110$20150806$20200121$EXP$$PHHY2014CA092176$NOVARTIS$$80$YR$$F$Y$$$20200121$$CN$CA$CA
113442313$11344231$3$F$20141028$20200922$20150806$20200928$PER$$US-JNJFOC-20150722116$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200928$$CN$US$US
113442513$11344251$3$F$20140819$20200805$20150806$20200817$EXP$$US-JNJFOC-20150721518$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200817$$CN$US$US
113446033$11344603$3$F$201401$20200810$20150806$20200820$EXP$$IT-AUROBINDO-AUR-APL-2015-06724$AUROBINDO$$61$YR$$M$Y$$$20200820$$HP$IT$IT
113450237$11345023$7$F$20140623$20200817$20150806$20200820$EXP$$US-BAYER-2015-300446$BAYER$$79$YR$E$F$Y$$$20200820$$CN$US$US
113458104$11345810$4$F$20150725$20180321$20150806$20180323$EXP$$US-AMGEN-USASP2015078685$AMGEN$$72$YR$E$M$Y$$$20180323$$MD$US$US
113484059$11348405$9$F$201410$20200819$20150806$20200902$EXP$$JP-INCYTE CORPORATION-2015IN003859$INCYTE$$$$$$Y$$$20200902$$MD$JP$JP
113485004$11348500$4$F$2015$20200816$20150806$20200827$EXP$$US-JNJFOC-20150801556$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200827$$LW$US$US
113486415$11348641$5$F$20150201$20200911$20150806$20200922$EXP$$JP-INCYTE CORPORATION-2015IN000736$INCYTE$$$$$$Y$$$20200922$$MD$JP$JP
113488792$11348879$2$F$20150701$20150810$20150806$20150815$EXP$$FR-JNJFOC-20150720033$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20150815$$HP$FR$FR
1135003342$11350033$42$F$$20200914$20150807$20200924$EXP$$CA-PFIZER INC-2015262877$PFIZER$$58$YR$$M$Y$$$20200924$$CN$CA$CA
113501893$11350189$3$F$20130930$20200811$20150807$20200813$PER$$US-JNJFOC-20150803419$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200813$$CN$US$US
113502604$11350260$4$F$20150203$20200909$20150807$20200914$PER$$US-JNJFOC-20150803739$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200914$$CN$US$US
113504596$11350459$6$F$$20200806$20150807$20200810$PER$$US-PFIZER INC-2015254993$PFIZER$$64$YR$$F$Y$48$KG$20200810$$MD$US$US
113564954$11356495$4$F$201308$20200730$20150807$20200803$PER$$US-JNJFOC-20150800996$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20200803$$CN$US$US
113564995$11356499$5$F$201407$20200713$20150807$20200717$PER$$US-JNJFOC-20150804480$JOHNSON AND JOHNSON$$65$YR$$M$Y$$$20200717$$CN$US$US
113596746$11359674$6$F$20130113$20200715$20150808$20200717$PER$$PHEH2014US003332$NOVARTIS$$54$YR$$F$Y$58.5$KG$20200717$$CN$COUNTRY NOT SPECIFIED$US
113621583$11362158$3$F$201402$20200802$20150810$20200806$PER$$US-JNJFOC-20150805160$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200806$$CN$US$US
113624464$11362446$4$F$20130502$20200630$20150810$20200714$EXP$$US-BAYER-2015-258731$BAYER$$82$YR$E$F$Y$$$20200714$$HP$US$US
1136263816$11362638$16$F$$20200924$20150810$20200929$EXP$$CA-OTSUKA-2015_006993$OTSUKA$$9$YR$$M$Y$$$20200929$$HP$CA$CA
1136315113$11363151$13$F$20150127$20200709$20150811$20200710$EXP$$PHHY2015DE092570$NOVARTIS$$40$YR$$F$Y$75$KG$20200710$$MD$DE$DE
113631875$11363187$5$F$20120814$20200702$20150811$20200707$PER$$PHHY2013US102010$NOVARTIS$$30$YR$$M$Y$$$20200707$$MD$US$US
1136328817$11363288$17$F$201111$20200806$20150811$20200810$EXP$$CA-ROCHE-1619409$ROCHE$$62$YR$$F$Y$54.4$KG$20200811$$HP$CA$CA
113652004$11365200$4$F$20141009$20200712$20150811$20200721$EXP$$US-BAYER-2015-386397$BAYER$$94$YR$E$F$Y$$$20200721$$CN$US$US
113655189$11365518$9$F$20141003$20200820$20150811$20200903$EXP$$JP-INCYTE CORPORATION-2014IN003407$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
113656222$11365622$2$F$201501$20200924$20150811$20200928$EXP$$US-BAYER-2015-330531$BAYER$$76$YR$E$M$Y$$$20200928$$HP$US$US
113687123$11368712$3$F$$20200928$20150812$20200930$PER$$US-AMGEN-USASP2015081457$AMGEN$$67$YR$E$M$Y$$$20200930$$MD$US$US
1136875930$11368759$30$F$20130207$20200914$20150812$20200921$PER$$CA-AMGEN-CANSP2014104837$AMGEN$$57$YR$A$M$Y$$$20200920$$HP$CA$CA
113687805$11368780$5$F$20140909$20190121$20150812$20200824$PER$$PHHY2015US070639$NOVARTIS$$44$YR$$F$Y$$$20200824$$MD$US$US
113690223$11369022$3$F$200409$20200824$20150812$20200901$EXP$$PHEH2015US015024$NOVARTIS$$47$YR$$M$Y$$$20200901$$MD$US$US
113702262$11370226$2$F$20150126$20200727$20150812$20200803$EXP$$US-BAYER-2015-330510$BAYER$$56$YR$A$F$Y$$$20200803$$CN$US$US
1137440418$11374404$18$F$201401$20200720$20150813$20200930$PER$$CA-AMGEN-CANSP2014100327$AMGEN$$52$YR$A$F$Y$$$20200930$$MD$CA$CA
113754896$11375489$6$F$20131030$20200831$20150813$20200915$EXP$$US-JNJFOC-20150806390$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200915$$CN$US$US
113760632$11376063$2$F$$20151006$20150813$20151012$EXP$$GB-ELI_LILLY_AND_COMPANY-GB201508003571$ELI LILLY AND CO$$$$$M$Y$76.8$KG$20151009$$HP$GB$GB
113760661$11376066$1$I$$20150810$20150813$20150813$EXP$$GB-ELI_LILLY_AND_COMPANY-GB201508003572$ELI LILLY AND CO$$$$$$Y$$$20150813$$HP$GB$GB
113760672$11376067$2$F$20120621$20151006$20150813$20151009$EXP$$GB-ELI_LILLY_AND_COMPANY-GB201508003573$ELI LILLY AND CO$$74$YR$$M$Y$66.2$KG$20151009$$HP$GB$GB
113760682$11376068$2$F$$20151006$20150813$20151009$EXP$$GB-ELI_LILLY_AND_COMPANY-GB201508003570$ELI LILLY AND CO$$$$$M$Y$72.8$KG$20151009$$HP$GB$GB
113760711$11376071$1$I$$20150810$20150813$20150813$EXP$$GB-ELI_LILLY_AND_COMPANY-GB201508003439$ELI LILLY AND CO$$$$$$Y$$$20150812$$HP$GB$GB
1137629513$11376295$13$F$201506$20200801$20150813$20200807$EXP$$US-PFIZER INC-2015268235$PFIZER$$72$YR$$F$Y$58.96$KG$20200807$$MD$US$US
113768087$11376808$7$F$20150801$20160111$20150813$20160120$EXP$$AU-JNJFOC-20150808767$PHARMACYCLICS$$76$YR$E$M$Y$$$20160120$$MD$AU$AU
1138003537$11380035$37$F$20051005$20200912$20150814$20200917$EXP$$PHHY2013CA086553$NOVARTIS$$62$YR$$F$Y$$$20200917$$CN$CA$CA
113816034$11381603$4$F$20150721$20151009$20150814$20151014$EXP$$RU-JNJFOC-20150804742$PHARMACYCLICS$$62$YR$A$F$Y$75$KG$20151014$$MD$RU$RU
113818238$11381823$8$F$201407$20200827$20150814$20200911$EXP$$CA-UCBSA-2014022145$UCB$$33$YR$$F$Y$82$KG$20200911$$MD$CA$CA
113826714$11382671$4$F$$20200811$20150814$20200814$EXP$$US-PFIZER INC-2015268436$PFIZER$$56$YR$$M$Y$122$KG$20200814$$CN$US$US
113827143$11382714$3$F$201501$20200820$20150814$20200825$EXP$$US-JAZZ-2015-US-011844$JAZZ$$40$YR$$M$Y$83.9$KG$20200825$$HP$US$US
113828313$11382831$3$F$20121106$20200628$20150814$20200708$EXP$$US-BAYER-2014-167827$BAYER$$78$YR$E$M$Y$$$20200708$$LW$US$US
1138286729$11382867$29$F$$20200914$20150814$20200921$EXP$$CA-PFIZER INC-2015267393$PFIZER$$60$YR$$F$Y$$$20200921$$MD$CA$CA
113829293$11382929$3$F$2014$20200804$20150814$20200814$EXP$$US-JNJFOC-20150721911$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200814$$CN$US$US
113829686$11382968$6$F$2010$20200922$20150814$20200924$EXP$$US-PFIZER INC-2015266910$PFIZER$$57$YR$$F$Y$$$20200924$$MD$US$US
113859228$11385922$8$F$$20200707$20150817$20200709$EXP$$CA-ROCHE-1619365$ROCHE$$58$YR$$M$Y$$$20200709$$HP$COUNTRY NOT SPECIFIED$CA
113880348$11388034$8$F$20141202$20200827$20150817$20200910$EXP$$CA-UCBSA-2015025983$UCB$$4$YR$$M$Y$3.82$KG$20200910$$MD$CA$CA
113892605$11389260$5$F$20150810$20170103$20150817$20170110$EXP$$BR-JNJFOC-20150809863$PHARMACYCLICS$$64$YR$A$F$Y$62$KG$20170110$$MD$BR$BR
113893373$11389337$3$F$20140821$20200715$20150817$20200720$PER$$US-JNJFOC-20150809082$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200720$$LW$US$US
113914296$11391429$6$F$$20200729$20150818$20200811$EXP$$FR-ROCHE-1241782$ROCHE$$$$$F$Y$$$20200811$$HP$FR$FR
113914801$11391480$1$I$20141014$20141031$20150818$20150818$PER$$PHHY2014US142867$SANDOZ$$41$YR$$M$Y$$$20150818$$CN$US$US
113936247$11393624$7$F$2015$20200806$20150819$20200810$EXP$$FR-PFIZER INC-2015270040$PFIZER$$11$YR$$F$Y$38$KG$20200810$$HP$FR$FR
113943341$11394334$1$I$20150324$20150729$20150819$20150819$EXP$$IT-JNJFOC-20150723189$PHARMACYCLICS$$75$YR$E$M$Y$65$KG$20150819$$MD$IT$IT
113953874$11395387$4$F$201507$20200803$20150819$20200807$EXP$$AR-ABBVIE-15K-007-1445214-00$ABBVIE$$47$YR$$M$Y$$$20200807$$CN$AR$AR
113956473$11395647$3$F$20140618$20200716$20150819$20200721$PER$$US-JNJFOC-20150721519$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200721$$CN$US$US
113957035$11395703$5$F$20131108$20200825$20150819$20200908$EXP$$US-JNJFOC-20150806361$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200908$$CN$US$US
113957963$11395796$3$F$201210$20200811$20150819$20200817$PER$$US-JNJFOC-20150804941$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200817$$CN$US$US
113958754$11395875$4$F$2014$20200916$20150819$20200921$PER$$US-JNJFOC-20150801851$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200921$$CN$US$US
113958773$11395877$3$F$20141109$20200923$20150819$20200928$PER$$US-JNJFOC-20150805133$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200928$$CN$US$US
113958873$11395887$3$F$20130518$20200629$20150819$20200706$PER$$US-JNJFOC-20150806067$JOHNSON AND JOHNSON$$70$YR$$M$Y$$$20200706$$CN$US$US
113959623$11395962$3$F$2013$20200719$20150819$20200722$PER$$US-JNJFOC-20150805117$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200722$$CN$US$US
113959694$11395969$4$F$20140527$20200630$20150819$20200706$PER$$US-JNJFOC-20150805112$JOHNSON AND JOHNSON$$73$YR$$F$Y$$$20200706$$CN$US$US
113959765$11395976$5$F$20150402$20200811$20150819$20200817$PER$$US-JNJFOC-20150806334$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200817$$CN$US$US
113960004$11396000$4$F$201311$20200805$20150819$20200817$EXP$$US-JNJFOC-20150806994$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200817$$LW$US$US
113960683$11396068$3$F$20140728$20200916$20150819$20200929$EXP$$US-JNJFOC-20150723723$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200929$$CN$US$US
113961003$11396100$3$F$20130830$20200809$20150819$20200813$PER$$US-JNJFOC-20150802720$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200813$$CN$US$US
113961274$11396127$4$F$201309$20200908$20150819$20200915$PER$$US-JNJFOC-20150801204$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200915$$CN$US$US
113961323$11396132$3$F$20131021$20200825$20150819$20200908$EXP$$US-JNJFOC-20150805370$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200908$$CN$US$US
113961943$11396194$3$F$20141016$20200720$20150819$20200722$PER$$US-JNJFOC-20150803794$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200722$$CN$US$US
113962125$11396212$5$F$20130702$20200923$20150819$20200928$PER$$US-JNJFOC-20150805137$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200928$$CN$US$US
113962264$11396226$4$F$20130807$20200909$20150819$20200914$PER$$US-JNJFOC-20150806026$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200914$$CN$US$US
113962453$11396245$3$F$201212$20200906$20150819$20200914$PER$$US-JNJFOC-20150802143$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20200914$$CN$US$US
113962524$11396252$4$F$20140101$20200831$20150819$20200914$PER$$US-JNJFOC-20150803782$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200914$$CN$US$US
113962563$11396256$3$F$20131101$20200924$20150819$20200928$PER$$US-JNJFOC-20150803752$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200928$$CN$US$US
113962733$11396273$3$F$20130908$20200830$20150819$20200901$PER$$US-JNJFOC-20150801180$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200901$$CN$US$US
113962943$11396294$3$F$2013$20200809$20150819$20200819$EXP$$US-JNJFOC-20150805136$JOHNSON AND JOHNSON$$7$DEC$$M$Y$$$20200819$$CN$US$US
113963033$11396303$3$F$201504$20200915$20150819$20200917$PER$$US-JNJFOC-20150806398$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200917$$CN$US$US
113963163$11396316$3$F$20140124$20200824$20150819$20200827$PER$$US-JNJFOC-20150805342$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20200827$$CN$US$US
113963194$11396319$4$F$20130809$20200915$20150819$20200918$PER$$US-JNJFOC-20150806020$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200918$$CN$US$US
113963263$11396326$3$F$20150211$20200816$20150819$20200819$PER$$US-JNJFOC-20150723922$JOHNSON AND JOHNSON$$89$YR$E$M$Y$$$20200819$$LW$US$US
113963353$11396335$3$F$20140328$20200708$20150819$20200710$PER$$US-JNJFOC-20150803779$JOHNSON AND JOHNSON$$77$YR$$F$Y$$$20200710$$CN$US$US
113963392$11396339$2$F$20141007$20200706$20150819$20200709$PER$$US-JNJFOC-20150803765$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200709$$HP$US$US
113963994$11396399$4$F$20140513$20200924$20150819$20200929$PER$$US-JNJFOC-20150806199$JOHNSON AND JOHNSON$$77$YR$E$M$Y$120$KG$20200929$$CN$US$US
113964043$11396404$3$F$20140121$20200706$20150819$20200710$PER$$US-JNJFOC-20150723706$JOHNSON AND JOHNSON$$43$YR$$F$Y$$$20200710$$CN$US$US
113964074$11396407$4$F$20130815$20200719$20150819$20200722$PER$$US-JNJFOC-20150800964$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200722$$CN$US$US
113964294$11396429$4$F$20140821$20200722$20150819$20200731$PER$$US-JNJFOC-20150800204$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200731$$CN$US$US
113964304$11396430$4$F$2014$20200720$20150819$20200730$EXP$$US-JNJFOC-20150800963$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200730$$CN$US$US
113964344$11396434$4$F$20140805$20200719$20150819$20200724$PER$$US-JNJFOC-20150803757$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200724$$CN$US$US
113964395$11396439$5$F$20131217$20200823$20150819$20200825$PER$$US-JNJFOC-20150801749$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200825$$CN$US$US
113964912$11396491$2$F$20130219$20200903$20150819$20200909$PER$$US-JNJFOC-20150805113$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20200909$$HP$US$US
113965563$11396556$3$F$20121021$20200823$20150819$20200825$PER$$US-JNJFOC-20150804334$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200825$$HP$US$US
113965753$11396575$3$F$20140919$20200809$20150819$20200813$PER$$US-JNJFOC-20150804938$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200813$$CN$US$US
113965825$11396582$5$F$20141105$20200909$20150819$20200914$PER$$US-JNJFOC-20150806356$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200914$$CN$US$US
113973173$11397317$3$F$201506$20180607$20150819$20180611$EXP$$RU-JNJFOC-20150722383$JANSSEN$$58$YR$A$M$Y$92.8$KG$20180611$$MD$RU$RU
113973195$11397319$5$F$20141021$20160927$20150819$20160930$EXP$$GB-JNJFOC-20141017023$JANSSEN$$67$YR$E$F$Y$55.9$KG$20160930$$MD$GB$GB
113981199$11398119$9$F$2009$20200629$20150820$20200706$PER$$CA-AMGEN-CANSP2014106314$AMGEN$$46$YR$A$F$Y$$$20200706$$HP$CA$CA
113984005$11398400$5$F$$20200810$20150820$20200818$EXP$$PT-AUROBINDO-AUR-APL-2015-07322$AUROBINDO$$55$YR$$F$Y$$$20200818$$MD$PT$PT
113984652$11398465$2$F$20150811$20200814$20150820$20200821$PER$$PHEH2015US016200$NOVARTIS$$62$YR$$F$Y$$$20200821$$CN$COUNTRY NOT SPECIFIED$US
113992071$11399207$1$I$2013$20150814$20150820$20150820$EXP$$BR-ROCHE-1622550$ROCHE$$$$$F$Y$51$KG$20150820$$CN$BR$BR
114000345$11400034$5$F$20140912$20200727$20150820$20200804$PER$$PHHY2015US004621$NOVARTIS$$52$YR$$F$Y$$$20200804$$MD$US$US
114001353$11400135$3$F$20140714$20150811$20150820$20200613$EXP$$PHEH2015US015864$NOVARTIS$$20$YR$$M$Y$$$20200614$$PH$US$US
114002915$11400291$5$F$20130520$20200817$20150820$20200817$PER$$PHHY2014US070520$NOVARTIS$$45$YR$$F$Y$$$20200817$$MD$US$US
114012385$11401238$5$F$20121008$20200702$20150820$20200707$PER$$PHHY2013US098914$NOVARTIS$$41$YR$$F$Y$$$20200707$$MD$US$US
114027459$11402745$9$F$20121129$20200825$20150821$20200902$PER$$PHHY2014US070244$NOVARTIS$$42$YR$$F$Y$$$20200902$$MD$US$US
114036953$11403695$3$F$201312$20200909$20150821$20200914$PER$$US-JNJFOC-20150811534$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200914$$CN$US$US
1140534910$11405349$10$F$20141229$20191223$20150821$20200831$EXP$$JP-OTSUKA-2015_007683$OTSUKA$$55$YR$$F$Y$47.7$KG$20200831$$MD$JP$JP
114055936$11405593$6$F$20150817$20200911$20150821$20200915$PER$$US-PFIZER INC-2015276050$PFIZER$$67$YR$$F$Y$89.81$KG$20200915$$CN$US$US
114098943$11409894$3$F$$20200805$20150824$20200817$EXP$$CA-AUROBINDO-AUR-APL-2015-07336$AUROBINDO$MULTIPLE DRUGS:VARIOUS TOXICITIES: CASE REPORT. 2015$77$YR$$F$Y$$$20200817$$HP$CA$CA
114107782$11410778$2$F$20150615$20200605$20150824$20200818$EXP$$NL-GLAXOSMITHKLINE INC.-NL2015GSK118522$GLAXOSMITHKLINE$$18$YR$$F$Y$65$KG$20200818$$MD$NL$NL
114136523$11413652$3$F$20150225$20200805$20150824$20200817$EXP$$US-JNJFOC-20150812515$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200817$$CN$US$US
114136782$11413678$2$F$20141028$20200922$20150824$20200928$EXP$$US-BAYER-2015-394528$BAYER$$76$YR$E$F$Y$$$20200928$$HP$US$US
114172341$11417234$1$I$$20150812$20150825$20150825$EXP$$CN-MYLANLABS-2015M1028181$MYLAN$JIA N, CORMACK FC, XIE B, SHIUE Z, NAJAFIAN B, GRALOW JR. COLLAPSING FOCAL SEGMENTAL GLOMERULOSCLEROSIS FOLLOWING LONG?TERM TREATMENT WITH ORAL IBANDRONATE: CASE REPORT AND REVIEW OF LITERATURE. BMC?CAN 2015? 15:NO. 1.$$$$$Y$$$20150825$$HP$CN$CN
114185966$11418596$6$F$2014$20200720$20150826$20200723$PER$$CA-AMGEN-CANSP2014108289$AMGEN$$66$YR$E$F$Y$$$20200723$$HP$CA$CA
114193152$11419315$2$F$$20150818$20150826$20150902$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-102062$RANBAXY$JIA N, CORMACK FC, XIE B, SHIUE Z, NAJAFIAN B, GRALOW JR. COLLAPSING FOCAL SEGMENTAL GLOMERULOSCLEROSIS FOLLOWING LONG?TERM TREATMENT WITH ORAL IBANDRONATE: CASE REPORT AND REVIEW OF LITERATURE. BMC?CAN. 2015?15 (1)$$$$$Y$$$20150902$$MD$CN$CN
114201833$11420183$3$F$$20200726$20150826$20200804$PER$$US-JNJFOC-20150816312$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20200804$$LW$US$US
114209453$11420945$3$F$20150817$20150901$20150826$20150904$EXP$$CN-JNJFOC-20150813119$PHARMACYCLICS$$59$YR$A$F$Y$49$KG$20150904$$MD$CN$CN
1142118017$11421180$17$F$201508$20200625$20150826$20200701$EXP$$PHHY2013CA033466$NOVARTIS$$82$YR$$M$Y$$$20200701$$CN$CA$CA
114212582$11421258$2$F$2009$20200909$20150826$20200929$PER$$US-ELI_LILLY_AND_COMPANY-US201508007321$ELI LILLY AND CO$$$$$M$Y$$$20200929$$CN$US$US
114219592$11421959$2$F$20150615$20150907$20150827$20150921$EXP$$AT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-055121$BRISTOL MYERS SQUIBB$$75$YR$$F$Y$70$KG$20150921$$CN$AT$AT
1142225711$11422257$11$F$$20200914$20150827$20200916$PER$$CA-AMGEN-CANSP2015087213$AMGEN$$54$YR$A$M$Y$$$20200916$$CN$CA$CA
114225494$11422549$4$F$20150219$20160426$20150827$20200819$EXP$$JP-ROCHE-1626959$ROCHE$$11$YR$$F$Y$34$KG$20200819$$PH$JP$JP
114241273$11424127$3$F$20130820$20200901$20150827$20200909$PER$$US-JNJFOC-20150814938$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200909$$CN$US$US
114241322$11424132$2$F$201403$20200910$20150827$20200922$EXP$$US-BAYER-2015-093143$BAYER$$88$YR$E$M$Y$$$20200922$$HP$US$US
1142759412$11427594$12$F$20150615$20200819$20150827$20200825$PER$$US-SA-2015SA088421$SANOFI AVENTIS$$$$$$Y$$$20200825$$CN$US$US
114279351$11427935$1$I$$20150819$20150828$20150828$EXP$$US-CIPLA LTD.-2015US06790$CIPLA$KIM R, MAHIPAL A, SHIBATA D, SIEGEL E, SPRINGETT G, ALMHANNA K.ET.AL. PHASE I TRIAL OF COMBINATION OF FOLFIRI AND PASIREOTIDE, A SOMATOSTATIN ANALOGUE, IN ADVANCED GASTROINTESTINAL MALIGNANCIES. INVEST NEW DRUGS. 2015?1?7$$$$$Y$$$20150828$$HP$US$US
114279361$11427936$1$I$$20150819$20150828$20150828$EXP$$US-CIPLA LTD.-2015US06817$CIPLA$KIM R, MAHIPAL A, SHIBATA D, SIEGEL E, SPRINGETT G, ALMHANNA K.ET.AL. PHASE I TRIAL OF COMBINATION OF FOLFIRI AND PASIREOTIDE, A SOMATOSTATIN ANALOGUE, IN ADVANCED GASTROINTESTINAL MALIGNANCIES. INVEST NEW DRUGS. 2015?1?7$$$$$Y$$$20150828$$HP$US$US
114279371$11427937$1$I$$20150819$20150828$20150828$EXP$$US-CIPLA LTD.-2015US06815$CIPLA$KIM R, MAHIPAL A, SHIBATA D, SIEGEL E, SPRINGETT G, ALMHANNA K.ET.AL. PHASE I TRIAL OF COMBINATION OF FOLFIRI AND PASIREOTIDE, A SOMATOSTATIN ANALOGUE, IN ADVANCED GASTROINTESTINAL MALIGNANCIES. INVEST NEW DRUGS. 2015?1?7$$$$$Y$$$20150828$$HP$US$US
114279391$11427939$1$I$$20150819$20150828$20150828$EXP$$US-CIPLA LTD.-2015US06808$CIPLA$KIM R, MAHIPAL A, SHIBATA D, SIEGEL E, SPRINGETT G, ALMHANNA K.ET.AL. PHASE I TRIAL OF COMBINATION OF FOLFIRI AND PASIREOTIDE, A SOMATOSTATIN ANALOGUE, IN ADVANCED GASTROINTESTINAL MALIGNANCIES. INVEST NEW DRUGS. 2015?1?7$$$$$Y$$$20150828$$HP$US$US
114281745$11428174$5$F$20130226$20191118$20150828$20200824$PER$$PHHY2013US099120$NOVARTIS$$50$YR$$F$Y$$$20200824$$MD$US$US
114299953$11429995$3$F$20140910$20200917$20150828$20200930$EXP$$US-JNJFOC-20150816468$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20200930$$LW$US$US
1143064211$11430642$11$F$20150805$20191016$20150828$20191022$EXP$$PHHY2015CR103075$NOVARTIS$$75$YR$$F$Y$49$KG$20191022$$CN$COUNTRY NOT SPECIFIED$CR
114311796$11431179$6$F$2014$20200921$20150828$20200928$EXP$$PHHY2015CA103287$NOVARTIS$$29$YR$$M$Y$$$20200928$$CN$CA$CA
114321603$11432160$3$F$20121207$20200714$20150828$20200717$PER$$US-JNJFOC-20150819785$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200717$$CN$US$US
114324066$11432406$6$F$20150813$20170110$20150828$20170117$EXP$$US-JNJFOC-20150813979$PHARMACYCLICS$$76$YR$E$F$Y$57.14$KG$20170117$$MD$US$US
114326344$11432634$4$F$20141201$20200825$20150828$20200908$EXP$$JP-INCYTE CORPORATION-2015IN002921$INCYTE$$$$$$Y$$$20200908$$MD$JP$JP
114339411$11433941$1$I$$20150819$20150831$20150831$EXP$$US-CIPLA LTD.-2015US06767$CIPLA$KIM R, MAHIPAL A, SHIBATA D, SIEGEL E, SPRINGETT G, ALMHANNA K.ET.AL. PHASE I TRIAL OF COMBINATION OF FOLFIRI AND PASIREOTIDE, A SOMATOSTATIN ANALOGUE, IN ADVANCED GASTROINTESTINAL MALIGNANCIES. INVEST NEW DRUGS. 2015?1?7$$$$$Y$$$20150831$$HP$US$US
114368422$11436842$2$F$20060324$20200724$20150821$20200729$PER$$US-ELI_LILLY_AND_COMPANY-US200701000265$ELI LILLY AND CO$$52$YR$$M$Y$97.96$KG$20200729$$CN$US$US
114389773$11438977$3$F$2013$20170421$20150901$20170425$EXP$$CL-ACTELION-A-CH2015-116221$ACTELION$$36$YR$A$F$Y$100$KG$20170425$$MD$CL$CL
1143927453$11439274$53$F$2015$20200720$20150901$20200728$EXP$$CA-ROCHE-1628678$ROCHE$$57$YR$$M$Y$69$KG$20200729$$HP$CA$CA
114423428$11442342$8$F$201403$20200902$20150901$20200907$EXP$$DE-009507513-1508DEU012608$MERCK$$$$A$F$Y$100$KG$20200907$$CN$DE$DE
114423774$11442377$4$F$20130909$20200914$20150901$20200917$PER$$US-JNJFOC-20150821953$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20200917$$CN$US$US
114424611$11442461$1$I$2013$20150819$20150901$20150901$EXP$$CA-JNJFOC-20150814742$JANSSEN$$$$A$M$Y$$$20150901$$MD$CA$CA
114428011$11442801$1$I$20150105$20150824$20150901$20150901$EXP$$PHHY2015DK103197$SANDOZ$$57$YR$$M$Y$82$KG$20150901$$HP$DK$DK
114435952$11443595$2$F$20150821$20150919$20150901$20150921$EXP$$FR-ROCHE-1626946$ROCHE$$75$YR$$F$Y$68$KG$20150921$$MD$FR$FR
114436062$11443606$2$F$19870818$20200709$20150901$20200717$EXP$$FR-ABBVIE-15P-056-1454126-00$ABBVIE$$$$$F$Y$$$20200717$$LW$FR$FR
114444121$11444412$1$I$20080817$20080905$20150902$20150902$EXP$$JP-ROCHE-585335$ROCHE$$83$YR$$F$Y$45.2$KG$20150902$$MD$JP$JP
1144476711$11444767$11$F$20150818$20200629$20150902$20200703$PER$$CA-AMGEN-CANSP2015088930$AMGEN$$40$YR$A$F$Y$$$20200703$$HP$CA$CA
1144560315$11445603$15$F$20150731$20200907$20150902$20200911$EXP$$GB-ROCHE-1627636$ROCHE$$56$YR$$F$Y$$$20200911$$MD$GB$GB
114459925$11445992$5$F$20130823$20200818$20150902$20200820$EXP$$US-JNJFOC-20150900666$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200820$$CN$US$US
1145484022$11454840$22$F$20110108$20200831$20150903$20200903$EXP$$PHHY2015CO099346$NOVARTIS$$71$YR$$M$Y$76$KG$20200903$$HP$CO$CO
114565437$11456543$7$F$2011$20200924$20150903$20200930$EXP$$US-JAZZ-2015-US-012714$JAZZ$$$$$F$Y$$$20200930$$HP$US$US
1145717521$11457175$21$F$$20200914$20150904$20200921$PER$$CA-AMGEN-CANSP2015088317$AMGEN$$60$YR$A$F$Y$$$20200920$$CN$CA$CA
1145728213$11457282$13$F$$20200706$20150904$20200708$EXP$$CA-ROCHE-1626689$ROCHE$$$$$F$Y$$$20200708$$MD$CA$CA
114589567$11458956$7$F$20150806$20190926$20150904$20191002$EXP$$IL-JNJFOC-20150809643$JOHNSON AND JOHNSON$$73$YR$$M$Y$$$20191002$$MD$IL$IL
114589664$11458966$4$F$20151003$20151009$20150904$20200701$EXP$$GR-JNJFOC-20150821347$JOHNSON AND JOHNSON$$$$E$M$Y$$$20200701$$CN$GR$GR
114591132$11459113$2$F$201302$20200722$20150904$20200803$EXP$$US-BAYER-2015-030475$BAYER$$79$YR$E$M$Y$$$20200803$$CN$US$US
114596152$11459615$2$F$20141003$20200621$20150904$20200701$EXP$$US-BAYER-2014-191380$BAYER$$77$YR$E$M$Y$$$20200701$$LW$US$US
114598518$11459851$8$F$$20200914$20150904$20200924$EXP$$CA-TAKEDA-2015MPI004896$TAKEDA$$53$YR$$M$Y$100.3$KG$20200924$$MD$CA$CA
114600601$11460060$1$I$20130521$20130523$20150904$20150904$EXP$$KR-OTSUKA-JP-2013-11860$OTSUKA$$$$$$Y$$$20150904$$MD$KR$KR
114605222$11460522$2$F$2014$20200803$20150904$20200807$EXP$$US-JAZZ-2014-US-014098$JAZZ$$$$$F$Y$$$20200807$$HP$US$US
114668797$11466879$7$F$20170720$20200918$20150908$20200922$EXP$$BR-ROCHE-1630273$ROCHE$$38$YR$$F$Y$53$KG$20200922$$MD$BR$BR
1146725125$11467251$25$F$201008$20200805$20150908$20200814$EXP$$CA-ROCHE-1630022$ROCHE$$$$A$F$Y$$$20200814$$CN$CA$CA
114675863$11467586$3$F$20140710$20151214$20150908$20151222$EXP$$JP-ROCHE-1631094$ROCHE$$65$YR$$M$Y$58$KG$20151222$$MD$JP$JP
114679907$11467990$7$F$$20200803$20150908$20200804$PER$$US-PFIZER INC-2015286811$PFIZER$$68$YR$$F$Y$73$KG$20200804$$CN$US$US
114680674$11468067$4$F$$20200915$20150908$20200918$EXP$$US-PFIZER INC-2015295120$PFIZER$$$$A$F$Y$56$KG$20200918$$CN$US$US
114706183$11470618$3$F$20120529$20200908$20150908$20200911$EXP$$US-BAYER-2015-279590$BAYER$$75$YR$E$M$Y$$$20200911$$HP$US$US
114708442$11470844$2$F$201310$20200805$20150908$20200817$EXP$$US-BAYER-2015-368587$BAYER$$70$YR$E$M$Y$$$20200817$$CN$US$US
114730102$11473010$2$F$20140415$20200729$20150908$20200921$PER$$US-JAZZ-2014-US-004756$JAZZ$$24$YR$$M$Y$$$20200921$$HP$US$US
114731392$11473139$2$F$201410$20200518$20150908$20200820$PER$$US-JAZZ-2014-US-013983$JAZZ$$43$YR$$F$Y$111.1$KG$20200820$$$US$US
114734573$11473457$3$F$200912$20200626$20150908$20200701$EXP$$US-JAZZ-JPI-P-018765$JAZZ$$62$YR$$F$Y$84.09$KG$20200701$$MD$US$US
114735424$11473542$4$F$2015$20200807$20150908$20200812$EXP$$US-JAZZ-2015-US-007525$JAZZ$$$$$M$Y$92.97$KG$20200812$$HP$US$US
114737543$11473754$3$F$2011$20200720$20150908$20200921$PER$$US-JAZZ-2014-US-000066$JAZZ$$60$YR$$F$Y$39.49$KG$20200921$$MD$US$US
114738813$11473881$3$F$2012$20200901$20150908$20200909$EXP$$US-JAZZ-2013-US-001297$JAZZ$$46$YR$$F$Y$$$20200909$$HP$US$US
114742303$11474230$3$F$$20200910$20150908$20200916$EXP$$US-JAZZ-2012-US-000015$JAZZ$$$$$F$Y$$$20200916$$CN$US$US
114743784$11474378$4$F$20140717$20200710$20150908$20200921$PER$$FR-JAZZ-2014-FR-009629$JAZZ$$$$$$Y$$$20200921$$MD$FR$FR
114751137$11475113$7$F$20150812$20200914$20150908$20200918$PER$$CA-AMGEN-CANSP2015084414$AMGEN$$79$YR$E$F$Y$$$20200918$$HP$CA$CA
1147514532$11475145$32$F$20130603$20200910$20150908$20200920$EXP$$CA-ROCHE-1188683$ROCHE$$29$YR$$F$Y$77$KG$20200921$$HP$CA$CA
114764372$11476437$2$F$2015$20200529$20150909$20200820$PER$$US-JAZZ-2015-US-006662$JAZZ$$45$YR$$F$Y$$$20200820$$MD$US$US
114768482$11476848$2$F$2014$20200519$20150909$20200820$PER$$US-JAZZ-2014-US-009138$JAZZ$$$$$F$Y$$$20200820$$$US$US
114772173$11477217$3$F$2014$20200630$20150909$20200820$PER$$US-JAZZ-2014-US-010416$JAZZ$$37$YR$$F$Y$47.17$KG$20200820$$MD$US$US
114775453$11477545$3$F$2014$20200708$20150909$20200921$PER$$US-JAZZ-2014-US-010951$JAZZ$$$$$F$Y$$$20200921$$MD$US$US
114776263$11477626$3$F$$20200622$20150909$20200820$PER$$US-JAZZ-2014-US-009876$JAZZ$$$$$M$Y$$$20200820$$MD$US$US
114778262$11477826$2$F$2014$20200601$20150909$20200820$PER$$US-JAZZ-2014-US-011429$JAZZ$$$$$F$Y$$$20200820$$MD$US$US
114786394$11478639$4$F$20131217$20200823$20150909$20200826$EXP$$US-BAYER-2015-396319$BAYER$$65$YR$E$F$Y$$$20200826$$HP$US$US
114794162$11479416$2$F$201409$20200506$20150909$20200820$PER$$US-JAZZ-2014-US-012423$JAZZ$$44$YR$$F$Y$$$20200820$$CN$US$US
114795798$11479579$8$F$201507$20200708$20150909$20200715$EXP$$US-JAZZ-2015-US-010552$JAZZ$$23$YR$$M$Y$94$KG$20200715$$MD$US$US
114796712$11479671$2$F$201411$20200701$20150909$20200820$PER$$US-JAZZ-2014-US-015376$JAZZ$$30$YR$$F$Y$$$20200820$$MD$US$US
114799914$11479991$4$F$2013$20200810$20150909$20200817$EXP$$US-JAZZ-2014-US-014830$JAZZ$$$$$M$Y$83.9$KG$20200817$$HP$US$US
114808316$11480831$6$F$200905$20200908$20150909$20200909$EXP$$US-PFIZER INC-2015047207$PFIZER$$53$YR$$F$Y$83$KG$20200909$$CN$US$US
114812744$11481274$4$F$2010$20200916$20150909$20200923$EXP$$PHHY2015CA063355$NOVARTIS$$40$YR$$F$Y$$$20200923$$CN$COUNTRY NOT SPECIFIED$CA
114821282$11482128$2$F$$20200529$20150909$20200820$PER$$US-JAZZ-2014-US-016385$JAZZ$$$$$F$Y$$$20200820$$$US$US
114828412$11482841$2$F$2012$20200710$20150909$20200921$PER$$US-JAZZ-JPI-P-026123$JAZZ$$34$YR$$F$Y$$$20200921$$MD$US$US
114856614$11485661$4$F$2018$20200909$20150909$20200917$EXP$$US-JAZZ-2015-US-000303$JAZZ$$58$YR$$M$Y$$$20200917$$PH$US$US
114871582$11487158$2$F$$20200713$20150910$20200714$PER$$US-PFIZER INC-2015297050$PFIZER$$58$YR$$F$Y$$$20200714$$MD$US$US
114877142$11487714$2$F$$20200506$20150909$20200820$PER$$US-JAZZ-2015-US-002940$JAZZ$$$$$F$Y$74.83$KG$20200820$$$US$US
114881123$11488112$3$F$$20200728$20150909$20200921$PER$$US-JAZZ-2015-US-003468$JAZZ$$$$$F$Y$$$20200921$$HP$US$US
114891222$11489122$2$F$2010$20200625$20150909$20200820$PER$$US-JAZZ-2015-US-003638$JAZZ$$$$$M$Y$95.24$KG$20200820$$HP$US$US
1148977715$11489777$15$F$20150812$20200921$20150910$20200928$EXP$$CA-PFIZER INC-2015275679$PFIZER$$79$YR$$F$Y$$$20200928$$HP$CA$CA
114916785$11491678$5$F$20150901$20150929$20150910$20151006$EXP$$GB-JNJFOC-20150903070$PHARMACYCLICS$$65$YR$A$F$Y$$$20151006$$MD$GB$GB
114920233$11492023$3$F$20130925$20200726$20150910$20200730$PER$$US-JNJFOC-20150905067$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20200730$$CN$US$US
114921749$11492174$9$F$$20200122$20150910$20200129$EXP$$PHHY2015CA070257$NOVARTIS$$$$$M$Y$$$20200129$$CN$COUNTRY NOT SPECIFIED$CA
1149239416$11492394$16$F$20140925$20191008$20150910$20191031$EXP$$PHHY2014CA128928$NOVARTIS$$53$YR$$F$Y$$$20191031$$CN$COUNTRY NOT SPECIFIED$CA
1149614610$11496146$10$F$20141013$20200901$20150911$20200903$EXP$$CA-ROCHE-ITM201410IM007218$ROCHE$$72$YR$$F$Y$68.2$KG$20200904$$MD$CA$CA
114963662$11496366$2$F$20150515$20180521$20150911$20180529$EXP$$FR-JNJFOC-20150903813$JANSSEN$$63$YR$A$F$Y$68$KG$20180529$$MD$FR$FR
114965963$11496596$3$F$20150320$20200818$20150911$20200820$PER$$US-JNJFOC-20150812825$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200820$$LW$US$US
114966233$11496623$3$F$201502$20200719$20150911$20200722$PER$$US-JNJFOC-20150816431$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200722$$LW$US$US
114966243$11496624$3$F$20150503$20200729$20150911$20200731$PER$$US-JNJFOC-20150816454$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20200731$$LW$US$US
114966315$11496631$5$F$20130907$20200630$20150911$20200706$PER$$US-JNJFOC-20150820428$JOHNSON AND JOHNSON$$83$YR$$F$Y$$$20200706$$CN$US$US
114966354$11496635$4$F$201502$20200917$20150911$20200930$EXP$$US-JNJFOC-20150900862$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200930$$CN$US$US
114966454$11496645$4$F$20140811$20200722$20150911$20200731$EXP$$US-JNJFOC-20150824245$JOHNSON AND JOHNSON$$85$YR$E$F$Y$70$KG$20200731$$CN$US$US
114966613$11496661$3$F$20140629$20200826$20150911$20200831$PER$$US-JNJFOC-20150807304$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200831$$CN$US$US
114967823$11496782$3$F$201405$20200714$20150911$20200728$EXP$$US-JNJFOC-20150819787$JOHNSON AND JOHNSON$$66$YR$$M$Y$$$20200728$$CN$US$US
114968024$11496802$4$F$20131230$20200805$20150911$20200811$PER$$US-JNJFOC-20150903161$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200811$$CN$US$US
114968533$11496853$3$F$20130821$20200719$20150911$20200724$PER$$US-JNJFOC-20150816254$JOHNSON AND JOHNSON$$80$YR$E$F$Y$67.19$KG$20200724$$CN$US$US
114970233$11497023$3$F$20130510$20200819$20150911$20200824$PER$$US-JNJFOC-20150812167$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200824$$CN$US$US
114971164$11497116$4$F$20150820$20170226$20150911$20170306$EXP$$US-JNJFOC-20150907994$PHARMACYCLICS$$73$YR$E$M$Y$$$20170306$$MD$US$US
114971723$11497172$3$F$20130907$20200710$20150911$20200713$PER$$US-JNJFOC-20150905435$JOHNSON AND JOHNSON$$53$YR$$F$Y$$$20200713$$CN$US$US
114971993$11497199$3$F$20150116$20200726$20150911$20200730$PER$$US-JNJFOC-20150907645$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200730$$CN$US$US
114975232$11497523$2$F$20130714$20200726$20150911$20200810$EXP$$US-BAYER-2015-367625$BAYER$$76$YR$E$M$Y$$$20200810$$CN$US$US
114992587$11499258$7$F$20150723$20200916$20150913$20200922$PER$$ZA-AMGEN-ZAFCT2015093227$AMGEN$$59$YR$A$F$Y$69$KG$20200922$$MD$ZA$ZA
114993295$11499329$5$F$20150902$20180206$20150914$20180214$EXP$$JP-ROCHE-1633133$ROCHE$$80$YR$$F$Y$$$20180214$$MD$JP$JP
115001954$11500195$4$F$$20200803$20150914$20200805$EXP$$GB-PFIZER INC-2015305111$PFIZER$SEETOHUL, L.. NEFOPAM HYDROCHLORIDE: A FATAL OVERDOSE. JOURNAL OF ANALYTICAL TOXICOLOGY. 2015?39(6):486?489$37$YR$$M$Y$$$20200805$$MD$GB$GB
115005272$11500527$2$F$$20200713$20150914$20200714$PER$$US-PFIZER INC-2015302099$PFIZER$$50$YR$$F$Y$$$20200714$$CN$US$US
115017952$11501795$2$F$201407$20200729$20150914$20200811$EXP$$US-BAYER-2015-378104$BAYER$$73$YR$E$M$Y$$$20200811$$CN$US$US
1150225311$11502253$11$F$20150724$20200728$20150914$20200729$EXP$$PHHY2015IT109329$NOVARTIS$$49$YR$$F$Y$70$KG$20200729$$MD$IT$IT
115029773$11502977$3$F$20141210$20200728$20150914$20200804$EXP$$US-JNJFOC-20150909242$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200804$$CN$US$US
115043141$11504314$1$I$$20150831$20150915$20150915$EXP$$NG-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-102879$RANBAXY$LADAPO TA, NOURSE P, PILLAY K, FREAN J, BIRKHEAD M, POONSAMY B. MICROSPORIDIOSIS IN PEDIATRIC RENAL TRANSPLANT PATIENTS IN CAPE TOWN, SOUTH AFRICA: TWO CASE REPORTS. PEDIATR?TRANSPLANT. 2014?18(7):E220?6$$$$$Y$$$20150915$$HP$NG$NG
115083163$11508316$3$F$2014$20200917$20150915$20200930$EXP$$US-JNJFOC-20150909246$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20200930$$CN$US$US
115084172$11508417$2$F$20141224$20200824$20150915$20200825$PER$$PHHY2015US069132$NOVARTIS$$40$YR$$F$Y$59.86$KG$20200825$$HP$US$US
115111644$11511164$4$F$20150912$20200803$20150915$20200806$EXP$$CN-ASTRAZENECA-2015SE88812$ASTRAZENECA$$21968$DY$$M$Y$80$KG$20200806$$MD$CN$CN
115118982$11511898$2$F$$20200727$20150916$20200808$EXP$$TR-MACLEODS PHARMACEUTICALS US LTD-MAC2015001986$MACLEODS$$$$$$Y$$$20200808$$HP$TR$TR
115119502$11511950$2$F$$20200625$20150916$20200706$EXP$$DE-AUROBINDO-AUR-APL-2015-08069$AUROBINDO$$51$YR$$F$Y$$$20200706$$HP$DE$DE
1151378111$11513781$11$F$201607$20200713$20150916$20200715$PER$$US-PFIZER INC-2015295461$PFIZER$$58$YR$$F$Y$89$KG$20200715$$MD$US$US
115152323$11515232$3$F$2015$20200729$20150916$20200812$EXP$$US-INCYTE CORPORATION-2015IN004489$INCYTE$$$$$$Y$$$20200812$$CN$US$US
115152442$11515244$2$F$$20150909$20150916$20200701$EXP$$GR-JNJFOC-20150908315$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
115157552$11515755$2$F$2015$20150218$20150916$20200727$PER$$US-BAUSCH-BL-2015-003355$BAUSCH AND LOMB$$$$$$Y$67.19$KG$20200727$$PH$US$US
115162472$11516247$2$F$20150624$20151005$20150917$20151014$EXP$$FR-HOSPIRA-3001693$HOSPIRA$$65$YR$A$F$Y$$$20151014$$HP$FR$FR
1151732917$11517329$17$F$20150116$20200820$20150917$20200903$EXP$$JP-INCYTE CORPORATION-2015IN003287$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
115176133$11517613$3$F$$20200701$20150917$20200716$PER$$US-BAYER-2015-424977$BAYER$$63$YR$A$M$Y$$$20200716$$HP$US$US
115181232$11518123$2$F$20150701$20150911$20150917$20150921$EXP$$JP-JNJFOC-20150905964$JANSSEN$$64$YR$A$M$Y$97$KG$20150921$$MD$JP$JP
115182273$11518227$3$F$20140608$20200629$20150917$20200710$EXP$$US-BAYER-2014-190725$BAYER$$64$YR$A$F$Y$$$20200710$$LW$US$US
115183962$11518396$2$F$20131228$20200723$20150917$20200731$EXP$$US-BAYER-2015-329205$BAYER$$64$YR$A$M$Y$$$20200731$$LW$US$US
115184705$11518470$5$F$20150828$20151001$20150917$20151007$EXP$$US-JNJFOC-20150909338$JANSSEN$$48$YR$A$F$Y$30.8$KG$20151007$$MD$US$US
115188992$11518899$2$F$$20200714$20150917$20200717$EXP$$PHHY2015PT109543$NOVARTIS$MENDONCA M, LEITAO C, BARAHONA?CORREA B, LAMPREIA T. DOENCA DE TIQUES: UMA APRESENTACAO DE ESCLEROSE MULTIPLA PRIMARIA PROGRESSIVA. SINAPSE. 2014?14(2):106$55$YR$$F$Y$$$20200717$$HP$PT$PT
115203713$11520371$3$F$20150115$20200710$20150918$20200720$EXP$$JP-ROCHE-1635363$ROCHE$$5$YR$$F$Y$21$KG$20200720$$MD$JP$JP
115207406$11520740$6$F$$20200816$20150918$20200828$EXP$$CA-ELI_LILLY_AND_COMPANY-CA201509003400$ELI LILLY AND CO$$64$YR$$F$Y$69$KG$20200828$$HP$CA$CA
115215083$11521508$3$F$2011$20200821$20150918$20200824$EXP$$US-PFIZER INC-2015308320$PFIZER$$57$YR$$F$Y$$$20200824$$LW$US$US
115215713$11521571$3$F$201507$20200906$20150918$20200918$EXP$$US-JNJFOC-20150913112$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200918$$CN$US$US
115220714$11522071$4$F$20150916$20160901$20150918$20160908$EXP$$US-JNJFOC-20150914527$PHARMACYCLICS$$23$YR$A$F$Y$228.3$KG$20160908$$MD$US$US
115242936$11524293$6$F$20150825$20160302$20150918$20160307$EXP$$AU-JNJFOC-20150914515$PHARMACYCLICS$$82$YR$E$F$Y$65.1$KG$20160307$$MD$AU$AU
115252462$11525246$2$F$20150624$20150907$20150918$20150921$EXP$$FR-JNJFOC-20150912152$JANSSEN$$65$YR$A$F$Y$$$20150918$$MD$FR$FR
115253562$11525356$2$F$20150614$20151106$20150918$20151120$PER$$US-JNJFOC-20150612050$JANSSEN$$48$YR$A$F$Y$91$KG$20151120$$MD$US$US
115254003$11525400$3$F$20150823$20151014$20150918$20151019$EXP$$JP-JNJFOC-20150820060$PHARMACYCLICS$$53$YR$A$F$Y$49.1$KG$20151019$$MD$JP$JP
115315234$11531523$4$F$20150808$20200827$20150921$20200902$PER$$US-JNJFOC-20150915258$JOHNSON AND JOHNSON$$79$YR$E$F$Y$54.03$KG$20200902$$LW$US$US
1153197310$11531973$10$F$2015$20200921$20150921$20200924$EXP$$CA-PFIZER INC-2015300302$PFIZER$$69$YR$$M$Y$$$20200924$$HP$CA$CA
115330832$11533083$2$F$20131006$20200823$20150921$20200828$EXP$$US-BAYER-2015-376276$BAYER$$54$YR$A$F$Y$$$20200828$$CN$US$US
1153416722$11534167$22$F$201506$20200702$20150922$20200708$EXP$$CA-ROCHE-1637107$ROCHE$$23$YR$$F$Y$$$20200708$$MD$CA$CA
115375443$11537544$3$F$20140314$20200827$20150922$20200901$EXP$$US-BAYER-2015-026403$BAYER$$76$YR$E$M$Y$$$20200901$$CN$US$US
115378667$11537866$7$F$20150622$20200727$20150922$20200804$EXP$$CA-ALEXION PHARMACEUTICALS INC.-A201502420$ALEXION$$23$YR$$F$Y$56$KG$20200804$$CN$CA$CA
115381603$11538160$3$F$20140621$20200805$20150922$20200814$EXP$$US-BAYER-2015-304606$BAYER$$73$YR$E$F$Y$$$20200814$$CN$US$US
1153927011$11539270$11$F$20181130$20200825$20150923$20200827$EXP$$US-PFIZER INC-2015311118$PFIZER$$62$YR$$F$Y$54$KG$20200827$$MD$US$US
115407844$11540784$4$F$$20200714$20150923$20200715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-062092$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200715$$MD$CA$CA
115422946$11542294$6$F$$20200629$20150923$20200707$EXP$$CA-BAUSCH-BL-2015-021717$BAUSCH AND LOMB$VIVAS L, GOLD W, MANDELL D, WU P. AN 82?YEAR?OLD MAN WITH ATAXIA AND DYSARTHRIA. CMAJ. 2016?188(17?18):1251?1254. DOI:10.1503/CMAJ.150573$82$YR$$M$Y$$$20200707$$MD$CA$CA
1154391919$11543919$19$F$2017$20200817$20150924$20200911$EXP$$CA-ROCHE-GNE302571$ROCHE$$42$YR$$F$Y$65$KG$20200911$$CN$US$CA
115451092$11545109$2$F$20150915$20150924$20150924$20151001$PER$$AU-JNJFOC-20150915776$PHARMACYCLICS$$88$YR$E$M$Y$80$KG$20151001$$MD$AU$AU
115460092$11546009$2$F$$20200717$20150924$20200721$EXP$US-MLMSERVICE-20150915-0024934-1$US-PFIZER INC-2015313648$PFIZER$CORCORAN, J.. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH?DOSE INSULIN THERAPY: A CASE REPORT.. JOURNAL OF MEDICAL TOXICOLOGY. 2020?10.1007/S13181?020?00796?2$51$YR$$M$Y$100$KG$20200721$$HP$US$US
115466688$11546668$8$F$20150825$20160720$20150924$20160729$EXP$$PL-JNJFOC-20150912589$JANSSEN$$54$YR$A$M$Y$96$KG$20160729$$MD$PL$PL
115484792$11548479$2$F$20130522$20200622$20150924$20200703$EXP$$US-BAYER-2015-258469$BAYER$$81$YR$E$F$Y$$$20200703$$CN$US$US
115489731$11548973$1$I$$20150918$20150924$20150924$EXP$$DK-GLAXOSMITHKLINE-DK2015GSK136400$GLAXOSMITHKLINE$WENANDE E, ET AL.. POLYETHYLENE GLYCOLS (PEG) AND RELATED STRUCTURES: OVERLOOKED ALLERGENS IN THE PERIOPERATIVE SETTING.. A AND A CASE REPORTS. 2015?4?5:61?64$69$YR$$M$Y$$$20150924$$HP$DK$DK
115495637$11549563$7$F$2015$20200716$20150924$20200729$EXP$$US-INCYTE CORPORATION-2015IN002435$INCYTE$$$$$$Y$$$20200729$$CN$US$US
1155236213$11552362$13$F$201710$20200824$20150925$20200825$PER$$US-PFIZER INC-2015314185$PFIZER$$83$YR$$F$Y$68$KG$20200825$$MD$US$US
115523939$11552393$9$F$2013$20200709$20150925$20200713$EXP$$US-PFIZER INC-2015318794$PFIZER$$78$YR$$F$Y$$$20200713$$CN$US$US
115529283$11552928$3$F$20130901$20200901$20150925$20200909$PER$$US-JNJFOC-20150916097$JOHNSON AND JOHNSON$$73$YR$E$M$Y$93.7$KG$20200909$$HP$US$US
115550132$11555013$2$F$201306$20200901$20150925$20200908$EXP$$US-BAYER-2015-369765$BAYER$$66$YR$E$M$Y$$$20200908$$CN$US$US
115559882$11555988$2$F$$20200626$20150925$20200710$EXP$$PT-APOTEX-2015AP013093$APOTEX$$55$YR$$F$Y$$$20200710$$CN$PT$PT
115559922$11555992$2$F$20150210$20200819$20150925$20200825$EXP$$US-BAYER-2015-386109$BAYER$$52$YR$A$F$Y$$$20200825$$HP$US$US
115571094$11557109$4$F$20150913$20200715$20150925$20200717$EXP$$US-JAZZ-2015-US-014359$JAZZ$$43$YR$$M$Y$$$20200717$$MD$US$US
115579103$11557910$3$F$$20200803$20150928$20200814$EXP$$US-MACLEODS PHARMACEUTICALS US LTD-MAC2015002022$MACLEODS$$$$$$Y$$$20200814$$HP$US$US
115581573$11558157$3$F$$20200911$20150928$20200924$EXP$US-MLMSERVICE-20150915-0024934-1$US-CIPLA LTD.-2015US07618$CIPLA$$$$$$Y$$$20200924$$HP$US$US
115586011$11558601$1$I$$20121205$20150928$20150928$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-12SUNIBN02P$SUN$$67$YR$$F$Y$$$20150928$$PH$US$US
115620977$11562097$7$F$20150828$20200814$20150928$20200824$EXP$$PHHO2015FR014422$NOVARTIS$$67$YR$$F$Y$46$KG$20200824$$MD$FR$FR
115651355$11565135$5$F$2013$20200915$20150928$20200921$EXP$$US-JAZZ-2015-US-014499$JAZZ$$$$$M$Y$$$20200921$$CN$US$US
1156735619$11567356$19$F$20120301$20200707$20150929$20200709$EXP$$CA-ROCHE-1638076$ROCHE$$8$YR$$F$Y$64$KG$20200709$$MD$CA$CA
115694243$11569424$3$F$20131008$20200920$20150929$20200928$PER$$US-JNJFOC-20150923618$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200928$$CN$US$US
115695136$11569513$6$F$$20200805$20150929$20200806$EXP$$US-PFIZER INC-2015321625$PFIZER$$48$YR$$F$Y$$$20200806$$CN$US$US
115703918$11570391$8$F$20170313$20200818$20150929$20200901$EXP$$JP-INCYTE CORPORATION-2015IN004663$INCYTE$$$$$$Y$$$20200901$$MD$JP$JP
1157297621$11572976$21$F$$20181108$20150929$20200911$EXP$$GB-UCBSA-2015030418$UCB$$$$$F$Y$$$20200911$$HP$GB$GB
115733505$11573350$5$F$201409$20200827$20150929$20200915$EXP$$JP-INCYTE CORPORATION-2015IN004874$INCYTE$$$$$$Y$$$20200915$$MD$JP$JP
115747257$11574725$7$F$20130305$20200923$20150930$20200929$PER$$US-PFIZER INC-2015324148$PFIZER$$48$YR$$M$Y$122.4$KG$20200929$$CN$US$US
115778974$11577897$4$F$20150824$20160314$20150930$20160316$EXP$$CN-JNJFOC-20150922448$PHARMACYCLICS$$72$YR$E$M$Y$62$KG$20160316$$MD$CN$CN
115781192$11578119$2$F$20130930$20150921$20150930$20151020$EXP$$US-JNJFOC-20131000723$JANSSEN$$59$YR$A$M$Y$90.7$KG$20150930$$MD$US$US
115781202$11578120$2$F$20130701$20150921$20150930$20151020$EXP$$US-JNJFOC-20130904332$JANSSEN$$70$YR$E$M$Y$71.7$KG$20150930$$MD$US$US
115781222$11578122$2$F$20140211$20150921$20150930$20151020$EXP$$US-JNJFOC-20140213510$JANSSEN$$76$YR$E$M$Y$87.2$KG$20150930$$MD$US$US
115781232$11578123$2$F$20140323$20150921$20150930$20151020$EXP$$US-JNJFOC-20140316895$JANSSEN$$76$YR$E$M$Y$99.8$KG$20150930$$MD$US$US
115781262$11578126$2$F$20140512$20150921$20150930$20151020$EXP$$US-JNJFOC-20140517196$JANSSEN$$57$YR$A$F$Y$91.2$KG$20150930$$MD$US$US
115781272$11578127$2$F$20140404$20150921$20150930$20151020$EXP$$US-JNJFOC-20140410701$JANSSEN$$76$YR$E$M$Y$$$20150930$$MD$US$US
115781411$11578141$1$I$20141016$20141114$20150930$20150930$EXP$$US-JNJFOC-20141115483$JANSSEN$$76$YR$E$M$Y$87.2$KG$20150930$$MD$US$US
115781431$11578143$1$I$20141102$20141118$20150930$20150930$EXP$$US-JNJFOC-20141116958$JANSSEN$$60$YR$A$M$Y$88.5$KG$20150930$$MD$US$US
1158070918$11580709$18$F$201509$20200722$20150930$20200724$EXP$$CA-ABBVIE-15K-028-1471671-00$ABBVIE$$43$YR$$F$Y$$$20200724$$CN$CA$CA
115840291$11584029$1$I$20120721$20120917$20151001$20151001$EXP$$US-JNJFOC-20120907694$JANSSEN$$67$YR$E$M$Y$$$20151001$$HP$US$US
115840301$11584030$1$I$20121217$20130116$20151001$20151001$EXP$$US-JNJFOC-20130110475$JANSSEN$$69$YR$E$F$Y$100.7$KG$20151001$$MD$US$US
115840311$11584031$1$I$20130228$20130326$20151001$20151001$EXP$$US-JNJFOC-20130318088$JANSSEN$$60$YR$A$M$Y$$$20151001$$MD$US$US
115852802$11585280$2$F$20130314$20200908$20151001$20200911$EXP$$US-BAYER-2015-262732$BAYER$$89$YR$E$F$Y$$$20200911$$CN$US$US
115855191$11585519$1$I$20140522$20140609$20151001$20151001$EXP$$US-JNJFOC-20140609571$JANSSEN$$19$YR$A$M$Y$98.4$KG$20151001$$MD$US$US
115858601$11585860$1$I$20131017$20131019$20151001$20151001$EXP$$US-JNJFOC-20131014114$PHARMACYCLICS$$57$YR$A$F$Y$$$20151001$$MD$US$US
115891439$11589143$9$F$$20200716$20151002$20200720$PER$$US-PFIZER INC-2015327750$PFIZER$$61$YR$$F$Y$$$20200720$$MD$US$US
115893752$11589375$2$F$20150924$20151008$20151002$20151015$EXP$$CN-JNJFOC-20150924948$PHARMACYCLICS$$68$YR$E$F$Y$50$KG$20151015$$MD$CN$CN
115900523$11590052$3$F$20150831$20170104$20151002$20170112$EXP$$US-JNJFOC-20150925867$JANSSEN$$$$E$F$Y$$$20170112$$MD$US$US
1159069911$11590699$11$F$20150704$20200826$20151002$20200908$EXP$$JP-INCYTE CORPORATION-2015IN003660$INCYTE$$$$$$Y$$$20200908$$MD$JP$JP
115910442$11591044$2$F$$20200720$20151003$20200727$EXP$US-MLMSERVICE-20150915-0024934-1$US-ACCORD-034063$ACCORD$CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH?DOSE INSULIN THERAPY: A CASE REPORT. J MED TOXICOL. 2020?10.1007/ S13181?020?00796?2.$51$YR$$M$Y$100$KG$20200727$$HP$US$US
115932403$11593240$3$F$20150910$20170109$20151005$20170111$EXP$$US-JNJFOC-20150921120$JANSSEN$$4$YR$C$F$Y$20$KG$20170111$$MD$US$US
115941143$11594114$3$F$20140318$20200816$20151005$20200827$EXP$$US-JNJFOC-20150927555$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200827$$CN$US$US
115941154$11594115$4$F$20130607$20200720$20151005$20200724$PER$$US-JNJFOC-20150927551$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200724$$CN$US$US
115952093$11595209$3$F$$20191202$20151006$20191216$EXP$$GB-ROCHE-1639827$ROCHE$, VIRDEE P, EATOCK M, LORD S, FALK S, ANTHONEY A,  TURKINGTON R, GOFF M, ELHUSSEIN L, COLLINS L, LOVE S, MOSCHANDREAS J, AND MIDDLETON M DUAL ERB B INHIBITION IN OESOPHAGO?GASTRIC CANCER (DEBIOC): A PHASE I DOSE ESCALATING SAFETY STUDY AND RANDOMISED DOSE EXPANSION OF AZD8931 IN COMBINATION WITH OXALIPLATIN AND CAPECITABINE CHEMOTHERAPY IN PATIENTS WITH OESOPHAGOGASTRIC ADENOCARCINOMA. EUROPEAN JOURNAL OF CANCER ?124:131?41.$$$$$Y$$$20191216$$HP$GB$GB
1159625111$11596251$11$F$20150930$20200924$20151006$20200928$EXP$$DK-ROCHE-1641444$ROCHE$$69$YR$$M$Y$76.3$KG$20200928$$MD$DK$DK
115964943$11596494$3$F$20140708$20200913$20151006$20200922$PER$ES-AGEMED-006057341$ES-AMGEN-ESPSP2015102524$AMGEN$TOFE V.I.? BAGAN J. V.? BEGAN L.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$78$YR$E$F$Y$$$20200921$$HP$ES$ES
115965294$11596529$4$F$20140213$20200913$20151006$20200922$PER$ES-AGEMED-906056241$ES-AMGEN-ESPSP2015102527$AMGEN$TOFE V. I.? BAGAN J. V.? BAGAN L.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$59$YR$A$F$Y$$$20200921$$HP$ES$ES
115988832$11598883$2$F$20140618$20200716$20151006$20200723$EXP$$US-BAYER-2015-394272$BAYER$$74$YR$E$F$Y$$$20200723$$HP$US$US
115989052$11598905$2$F$20140222$20200923$20151006$20200930$EXP$$US-BAYER-2015-393490$BAYER$$81$YR$E$F$Y$$$20200930$$CN$US$US
115989403$11598940$3$F$2015$20200816$20151006$20200825$EXP$$US-BAYER-2015-395376$BAYER$$77$YR$E$M$Y$$$20200825$$LW$US$US
1159927530$11599275$30$F$201412$20200817$20151006$20200824$EXP$$US-ACTELION-A-NJ2015-124867$ACTELION$$42$YR$$F$Y$65.31$KG$20200824$$HP$US$US
1159938016$11599380$16$F$20150331$20200720$20151006$20200728$EXP$$CA-PFIZER INC-2015189436$PFIZER$$45$YR$$F$Y$$$20200728$$CN$CA$CA
116034583$11603458$3$F$20150624$20160418$20151007$20160421$EXP$$IT-ROCHE-1641726$ROCHE$$64$YR$$F$Y$$$20160421$$MD$IT$IT
116050188$11605018$8$F$201608$20200731$20151007$20200805$EXP$$US-PFIZER INC-2015330917$PFIZER$$70$YR$$M$Y$65$KG$20200805$$MD$US$US
116061524$11606152$4$F$20200630$20200701$20151007$20200713$EXP$$US-ACTELION-A-US2015-124990$ACTELION$$68$YR$$F$Y$96.15$KG$20200713$$MD$US$US
116077877$11607787$7$F$20150708$20170109$20151007$20170111$EXP$$RU-JNJFOC-20150712051$PHARMACYCLICS$$56$YR$A$M$Y$89.7$KG$20170111$$MD$RU$RU
1160784144$11607841$44$F$201509$20200623$20151007$20200703$EXP$$CA-JNJFOC-20150923280$JOHNSON AND JOHNSON$$41$YR$$F$Y$70$KG$20200703$$CN$CA$CA
116082584$11608258$4$F$20150928$20151009$20151007$20160321$EXP$$PL-JNJFOC-20151004522$JANSSEN$$60$YR$A$M$Y$78$KG$20160321$$MD$PL$PL
1160872924$11608729$24$F$20150801$20200623$20151007$20200707$EXP$$US-ACTELION PHARMACEUTICALS US, INC.-A-US2015-122587$ACTELION$$70$YR$$F$Y$77.1$KG$20200707$$HP$US$US
1160989146$11609891$46$F$2013$20200910$20151007$20200918$EXP$$CA-ROCHE-1643040$ROCHE$$68$YR$$F$Y$$$20200918$$MD$CA$CA
116102632$11610263$2$F$$20200921$20151008$20200928$EXP$$US-AUROBINDO-AUR-APL-2015-08805$AUROBINDO$$$$E$M$Y$$$20200928$$MD$US$US
116123073$11612307$3$F$20121224$20200908$20151008$20200914$PER$$US-JNJFOC-20151003491$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200914$$CN$US$US
116123303$11612330$3$F$20140513$20200913$20151008$20200922$PER$ES-AGEMED-206059341$ES-AMGEN-ESPSP2015104164$AMGEN$TOFE V.I.? BAGAN J. V.? BAGAN L.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$75$YR$E$F$Y$$$20200922$$HP$ES$ES
116124283$11612428$3$F$20131029$20200701$20151008$20200707$PER$$US-JNJFOC-20150908448$JOHNSON AND JOHNSON$$86$YR$$F$Y$$$20200707$$CN$US$US
116124373$11612437$3$F$20140510$20200924$20151008$20200929$PER$$US-JNJFOC-20150915098$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200929$$CN$US$US
116125064$11612506$4$F$20150319$20200709$20151008$20200716$PER$$US-JNJFOC-20150909238$JOHNSON AND JOHNSON$$55$YR$$F$Y$$$20200716$$CN$US$US
116125113$11612511$3$F$20120920$20200924$20151008$20200928$PER$$US-JNJFOC-20150912871$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200928$$CN$US$US
116125533$11612553$3$F$20140930$20200803$20151008$20200806$PER$$US-JNJFOC-20150907722$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200806$$CN$US$US
116125936$11612593$6$F$2013$20200723$20151008$20200731$EXP$$US-JNJFOC-20150919822$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200731$$HP$US$US
116126165$11612616$5$F$2012$20200914$20151008$20200917$PER$$US-JNJFOC-20150905786$JOHNSON AND JOHNSON$$92$YR$E$F$Y$57.2$KG$20200917$$CN$US$US
116126183$11612618$3$F$2015$20200901$20151008$20200909$PER$$US-JNJFOC-20150907652$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200909$$CN$US$US
116126214$11612621$4$F$20121201$20200922$20151008$20200928$PER$$US-JNJFOC-20150907438$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200928$$CN$US$US
116126235$11612623$5$F$20130901$20200729$20151008$20200731$PER$$US-JNJFOC-20150905436$JOHNSON AND JOHNSON$$81$YR$E$F$Y$77.1$KG$20200731$$CN$US$US
116126333$11612633$3$F$20140818$20200723$20151008$20200728$PER$$US-JNJFOC-20150907726$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200728$$CN$US$US
116126343$11612634$3$F$20131225$20200809$20151008$20200813$PER$$US-JNJFOC-20150908450$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200813$$CN$US$US
116126353$11612635$3$F$20131021$20200726$20151008$20200731$PER$$US-JNJFOC-20150908449$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200731$$CN$US$US
116126383$11612638$3$F$201402$20200721$20151008$20200724$PER$$US-JNJFOC-20150909404$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20200724$$CN$US$US
116126605$11612660$5$F$20121113$20200722$20151008$20200731$PER$$US-JNJFOC-20150919817$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200731$$CN$US$US
116128093$11612809$3$F$20131229$20200906$20151008$20200918$EXP$$US-JNJFOC-20150903666$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20200918$$CN$US$US
116128263$11612826$3$F$20141022$20200827$20151008$20200901$PER$$US-JNJFOC-20150907443$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200901$$CN$US$US
116128343$11612834$3$F$20131214$20200723$20151008$20200728$PER$$US-JNJFOC-20150908447$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200728$$CN$US$US
116129014$11612901$4$F$20121126$20200903$20151008$20200909$PER$$US-JNJFOC-20150907439$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200909$$CN$US$US
116129323$11612932$3$F$20131010$20200901$20151008$20200909$PER$$US-JNJFOC-20150922599$JOHNSON AND JOHNSON$$37$YR$A$F$Y$$$20200909$$CN$US$US
116131592$11613159$2$F$201312$20200723$20151008$20200728$PER$$US-JNJFOC-20150908444$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200728$$HP$US$US
116133153$11613315$3$F$20131003$20200721$20151008$20200722$PER$$US-JNJFOC-20150915047$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200722$$CN$US$US
116145533$11614553$3$F$20140423$20200913$20151009$20200922$PER$ES-AGEMED-106058341$ES-AMGEN-ESPSP2015104160$AMGEN$TOFE V. I.? BAGAN J.? BAGEN L. ET AL.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$73$YR$E$F$Y$$$20200922$$HP$ES$ES
116145543$11614554$3$F$20150114$20200913$20151009$20200922$PER$ES-AGEMED-406061341$ES-AMGEN-ESPSP2015104264$AMGEN$TOFE V. I.? BAGAN J. V.? BAGAN L.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$90$YR$E$F$Y$$$20200922$$HP$ES$ES
116146705$11614670$5$F$20150928$20160412$20151009$20160414$EXP$$FR-ROCHE-1641530$ROCHE$$77$YR$$M$Y$58.5$KG$20160414$$MD$FR$FR
116167123$11616712$3$F$2014$20200916$20151009$20200925$EXP$$US-BAYER-2015-398737$BAYER$$69$YR$E$M$Y$$$20200925$$CN$US$US
116167594$11616759$4$F$201407$20200713$20151009$20200727$EXP$$US-BAYER-2015-396451$BAYER$$65$YR$E$M$Y$$$20200727$$CN$US$US
1161685210$11616852$10$F$$20200831$20151009$20200915$EXP$$CA-JNJFOC-20151000741$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20200915$$HP$CA$CA
116170184$11617018$4$F$20130803$20200928$20151009$20200930$PER$$US-JNJFOC-20151003214$JOHNSON AND JOHNSON$$98$YR$E$M$Y$$$20200930$$CN$US$US
116174402$11617440$2$F$20130908$20200830$20151009$20200903$EXP$$US-BAYER-2015-397488$BAYER$$70$YR$E$M$Y$$$20200903$$CN$US$US
116177025$11617702$5$F$20141208$20200921$20151009$20200924$EXP$$US-JAZZ-2014-US-016417$JAZZ$$42$YR$$M$Y$85.72$KG$20200924$$HP$US$US
116177305$11617730$5$F$$20200923$20151009$20200925$EXP$$US-JAZZ-2015-US-015668$JAZZ$$$$$F$Y$$$20200925$$HP$US$US
1161828519$11618285$19$F$2014$20200903$20151011$20200910$EXP$$PHHY2010CA75795$NOVARTIS$$49$YR$$M$Y$$$20200910$$CN$CA$CA
116189114$11618911$4$F$$20200921$20151012$20200926$EXP$$CA-ABBVIE-15K-028-1477033-00$ABBVIE$$73$YR$$F$Y$$$20200926$$HP$CA$CA
1161901121$11619011$21$F$20151004$20200916$20151012$20200923$EXP$$PHHY2015CA121542$NOVARTIS$$61$YR$$M$Y$$$20200923$$CN$CA$CA
116197985$11619798$5$F$20130724$20200724$20151012$20200727$EXP$$JP-PFIZER INC-2015315798$PFIZER$$33$YR$$F$Y$50$KG$20200727$$MD$JP$JP
1161982012$11619820$12$F$2012$20200915$20151012$20200919$EXP$$CA-ABBVIE-15K-028-1477576-00$ABBVIE$$$$$F$Y$$$20200919$$HP$CA$CA
116199079$11619907$9$F$$20200803$20151012$20200804$EXP$$US-PFIZER INC-2015335887$PFIZER$$57$YR$$F$Y$$$20200804$$CN$US$US
116200503$11620050$3$F$20140821$20200722$20151012$20200731$EXP$$US-BAYER-2015-395659$BAYER$$87$YR$E$F$Y$$$20200731$$CN$US$US
116207537$11620753$7$F$$20200810$20151012$20200812$EXP$$US-PFIZER INC-2015341235$PFIZER$$43$YR$$F$Y$74$KG$20200812$$CN$US$US
116215033$11621503$3$F$20150810$20200714$20151013$20200717$EXP$$CA-ROCHE-1620457$ROCHE$$69$YR$$F$Y$49$KG$20200717$$HP$CA$CA
116218707$11621870$7$F$201509$20200708$20151013$20200714$EXP$$FR-LEO PHARMA-237541$LEO PHARM$EHRET M, VELTER C, TEBACHER M, BRUANT?RODIER C, CRIBIER B. RAPIDLY GROWING SQUAMOUS CELL CARCINOMA AFTER INGENOL MEBUTATE TREATMENT. ANN DERMATOL VENEREOL. 2018?.$75$YR$$M$Y$$$20200714$$MD$FR$FR
116242903$11624290$3$F$20150708$20200913$20151013$20200922$PER$ES-AGEMED-306060341$ES-AMGEN-ESPSP2015104246$AMGEN$TOFE V. I.? BAGAN J. V.? BAGAN L.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$62$YR$A$F$Y$$$20200922$$HP$ES$ES
1162451542$11624515$42$F$20150929$20200903$20151013$20200910$EXP$$PHHY2015CA123121$NOVARTIS$$61$YR$$M$Y$$$20200910$$CN$CA$CA
116253486$11625348$6$F$20121009$20200816$20151013$20200827$EXP$$US-JNJFOC-20151007727$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200827$$CN$US$US
1162561116$11625611$16$F$20150304$20200723$20151013$20200805$EXP$$US-ACTELION PHARMACEUTICALS US, INC.-A-US2015-114361$ACTELION$$51$YR$$F$Y$62.13$KG$20200805$$HP$US$US
1162612612$11626126$12$F$201407$20200716$20151013$20200720$PER$$US-PFIZER INC-2015337812$PFIZER$$70$YR$$F$Y$57$KG$20200720$$PH$US$US
116268666$11626866$6$F$2013$20200729$20151013$20200731$EXP$$US-PFIZER INC-2015339574$PFIZER$$76$YR$$F$Y$87.98$KG$20200731$$CN$US$US
1162778517$11627785$17$F$20130223$20200911$20151014$20200925$EXP$$CA-ROCHE-1645417$ROCHE$$65$YR$$F$Y$$$20200925$$CN$CA$CA
1162879310$11628793$10$F$20150912$20200715$20151014$20200720$EXP$$CA-PFIZER INC-2015335348$PFIZER$$58$YR$$F$Y$$$20200720$$HP$CA$CA
116295102$11629510$2$F$$20200828$20151014$20200904$EXP$$US-SA-2015SA160178$SANOFI AVENTIS$$$$$$Y$$$20200904$$CN$US$US
116296732$11629673$2$F$20140527$20200630$20151014$20200714$EXP$$US-BAYER-2015-398466$BAYER$$73$YR$E$F$Y$$$20200714$$CN$US$US
1163031810$11630318$10$F$20150902$20200806$20151014$20200813$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-070251$BRISTOL MYERS SQUIBB$$56$YR$$M$Y$$$20200813$$MD$DE$DE
116311774$11631177$4$F$2014$20200807$20151014$20200818$EXP$$US-JAZZ-2015-US-015995$JAZZ$$$$$M$Y$95$KG$20200818$$HP$US$US
1163154819$11631548$19$F$20141203$20200910$20151015$20200922$EXP$$CA-ROCHE-1645465$ROCHE$$72$YR$$F$Y$$$20200922$$MD$CA$CA
116323062$11632306$2$F$20150624$20160104$20151015$20160118$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-104177$RANBAXY$$$$$$Y$$$20160118$$HP$IT$IT
116325383$11632538$3$F$2014$20200715$20151015$20200717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-021087$BRISTOL MYERS SQUIBB$$80$YR$$F$Y$50$KG$20200717$$MD$JP$JP
1163273610$11632736$10$F$20150412$20200821$20151015$20200903$EXP$$JP-INCYTE CORPORATION-2015IN005185$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
116342542$11634254$2$F$20131021$20200825$20151015$20200902$EXP$$US-BAYER-2015-400419$BAYER$$60$YR$A$M$Y$$$20200902$$CN$US$US
116342732$11634273$2$F$201507$20200906$20151015$20200911$EXP$$US-BAYER-2015-426697$BAYER$$67$YR$E$M$Y$$$20200911$$CN$US$US
116343578$11634357$8$F$20150212$20200904$20151015$20200917$EXP$$JP-INCYTE CORPORATION-2015IN002065$INCYTE$$$$$$Y$$$20200917$$MD$JP$JP
116345953$11634595$3$F$20150920$20151028$20151015$20151102$EXP$$IL-JNJFOC-20151006287$PHARMACYCLICS$$71$YR$E$$Y$60$KG$20151102$$MD$IL$IL
116352913$11635291$3$F$2012$20200910$20151015$20200918$EXP$$BR-DSJP-DSU-2015-131847$DAIICHI$$$$$F$Y$$$20200918$$CN$BR$BR
1163585215$11635852$15$F$$20200629$20151016$20200919$PER$$CA-AMGEN-CANSP2015107863$AMGEN$$61$YR$A$M$Y$$$20200919$$HP$CA$CA
116370113$11637011$3$F$20150923$20160707$20151016$20160719$EXP$$US-JNJFOC-20151006972$JANSSEN$$25$YR$A$M$Y$61.2$KG$20160719$$MD$US$US
116372451$11637245$1$I$20150821$20150821$20151016$20151016$EXP$$AR-JNJFOC-20150816201$PHARMACYCLICS$$76$YR$E$M$Y$82$KG$20151016$$MD$AR$AR
116374402$11637440$2$F$$20200911$20151016$20200915$PER$$US-PFIZER INC-2015344579$PFIZER$$$$A$M$Y$$$20200915$$CN$US$US
116374724$11637472$4$F$$20200803$20151016$20200804$EXP$$US-PFIZER INC-2015085430$PFIZER$$74$YR$$M$Y$$$20200804$$CN$US$US
116376484$11637648$4$F$20150206$20200813$20151016$20200819$PER$$US-JNJFOC-20151011531$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200819$$CN$US$US
116376495$11637649$5$F$201505$20200716$20151016$20200728$EXP$$US-JNJFOC-20151011499$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200728$$CN$US$US
116378432$11637843$2$F$2013$20200809$20151016$20200817$EXP$$US-BAYER-2015-398865$BAYER$$7$DEC$E$M$Y$$$20200817$$CN$US$US
116378482$11637848$2$F$20140919$20200809$20151016$20200817$EXP$$US-BAYER-2015-398886$BAYER$$66$YR$E$F$Y$$$20200817$$CN$US$US
116381153$11638115$3$F$20130809$20200915$20151016$20200924$EXP$$US-BAYER-2015-400327$BAYER$$76$YR$E$F$Y$$$20200924$$CN$US$US
116381824$11638182$4$F$20130807$20200909$20151016$20200915$EXP$$US-BAYER-2015-400493$BAYER$$83$YR$E$F$Y$$$20200915$$CN$US$US
116383829$11638382$9$F$20141106$20200821$20151016$20200903$EXP$$JP-INCYTE CORPORATION-2015IN005213$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
116391415$11639141$5$F$$20200714$20151019$20200723$EXP$$US-AUROBINDO-AUR-APL-2015-09324$AUROBINDO$$51$YR$$M$Y$100$KG$20200723$$HP$US$US
1163919228$11639192$28$F$201510$20200717$20151019$20200721$EXP$$CA-ROCHE-1637398$ROCHE$$73$YR$$F$Y$$$20200722$$CN$CA$CA
1163975341$11639753$41$F$20150716$20200831$20151019$20200908$EXP$$PHHY2015CA075468$NOVARTIS$$82$YR$$M$Y$$$20200908$$MD$CA$CA
116400338$11640033$8$F$$20200925$20151019$20200929$EXP$$US-PFIZER INC-2015343981$PFIZER$$64$YR$$F$Y$$$20200929$$MD$US$US
116417844$11641784$4$F$20131218$20200630$20151019$20200714$EXP$$US-JNJFOC-20151011891$JOHNSON AND JOHNSON$$61$YR$$F$Y$$$20200714$$CN$US$US
116420292$11642029$2$F$20151007$20200701$20151019$20200708$EXP$$US-JAZZ-2015-US-013533$JAZZ$$41$YR$$M$Y$$$20200708$$MD$US$US
116428906$11642890$6$F$20180705$20200817$20151020$20200820$EXP$$CA-ROCHE-1648174$ROCHE$$61$YR$$M$Y$95.2$KG$20200820$$HP$CA$CA
116436152$11643615$2$F$$20151014$20151020$20200701$EXP$$GR-JNJFOC-20150611345$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
116447332$11644733$2$F$20140629$20200826$20151020$20200831$EXP$$US-BAYER-2015-401080$BAYER$$70$YR$E$M$Y$$$20200831$$CN$US$US
116449325$11644932$5$F$$20200813$20151020$20200817$PER$$US-PFIZER INC-2015347787$PFIZER$$62$YR$$F$Y$68$KG$20200817$$HP$US$US
116451643$11645164$3$F$20150910$20200803$20151020$20200810$EXP$$US-ENDO PHARMACEUTICALS INC.-2015-003309$ENDO$$29$YR$$M$Y$181.6$KG$20200810$$CN$US$US
116454603$11645460$3$F$20110128$20151113$20151020$20151118$EXP$$FR-PFIZER INC-2015348811$PFIZER$$63$YR$$F$Y$$$20151118$$HP$FR$FR
116473257$11647325$7$F$$20200710$20151021$20200718$EXP$$GB-AUROBINDO-AUR-APL-2015-09404$AUROBINDO$$80$YR$$F$Y$$$20200718$$HP$GB$GB
116477233$11647723$3$F$$20151023$20151021$20151104$EXP$$FR-ASTRAZENECA-2015SF00592$ASTRAZENECA$$$$$M$Y$$$20151104$$MD$FR$FR
116491612$11649161$2$F$$20160304$20151021$20200821$PER$$US-CELGENEUS-USA-2015103594$CELGENE$$$$$F$Y$$$20200821$$HP$US$US
116499762$11649976$2$F$20151013$20200730$20151021$20200807$EXP$$BR-BIOMARINAP-BR-2015-107776$BIOMARIN$$11$YR$$F$Y$33$KG$20200807$$MD$BR$BR
116501232$11650123$2$F$2010$20200622$20151021$20200923$EXP$$US-PURDUE PHARMA-USA-2015-0126469$PURDUE$$$$$M$Y$$$20200922$$CN$US$US
1165271217$11652712$17$F$2015$20200908$20151022$20200916$EXP$$US-SA-2015SA156517$SANOFI AVENTIS$$$$$$Y$$$20200916$$CN$US$US
116529783$11652978$3$F$20140805$20200719$20151022$20200730$EXP$$US-BAYER-2015-395979$BAYER$$66$YR$E$M$Y$$$20200730$$CN$US$US
116533798$11653379$8$F$20141028$20200727$20151022$20200803$EXP$$PHHY2014JP174754$NOVARTIS$$71$YR$$M$Y$42$KG$20200803$$$JP$JP
116545931$11654593$1$I$20120512$20120531$20151023$20151023$EXP$$US-BAYER-2012-057034$BAYER$$74$YR$E$M$Y$126.78$KG$20151023$$MD$US$US
116546142$11654614$2$F$$20200713$20151023$20200714$PER$$US-PFIZER INC-2015332694$PFIZER$$55$YR$$F$Y$$$20200714$$MD$US$US
1165471010$11654710$10$F$201509$20200714$20151023$20200716$EXP$$US-PFIZER INC-2015354579$PFIZER$$61$YR$$F$Y$73$KG$20200716$$MD$US$US
116549152$11654915$2$F$20150926$20151120$20151023$20151130$EXP$$JP-ROCHE-1649745$ROCHE$$88$YR$$F$Y$46$KG$20151201$$MD$JP$JP
116559122$11655912$2$F$$20200727$20151023$20200811$EXP$$US-IPCA LABORATORIES LIMITED-IPC201510-000687$IPCA$$$$$$Y$$$20200811$$HP$US$US
116561258$11656125$8$F$20151011$20180425$20151023$20180502$EXP$$JP-JNJFOC-20151008757$JANSSEN$$73$YR$E$M$Y$84.3$KG$20180502$$MD$JP$JP
116562226$11656222$6$F$20150930$20151124$20151023$20151202$EXP$$CA-TEVA-603006USA$TEVA$$53$YR$$M$Y$$$20151202$$MD$CA$CA
116565153$11656515$3$F$20151012$20160426$20151023$20160511$EXP$$US-JNJFOC-20151017641$PHARMACYCLICS$$59$YR$A$F$Y$$$20160511$$MD$US$US
116570455$11657045$5$F$202008$20200820$20151023$20200826$EXP$$US-JAZZ-2015-US-016927$JAZZ$$43$YR$$F$Y$97$KG$20200826$$MD$US$US
1165786410$11657864$10$F$20150821$20200710$20151023$20200715$EXP$$JP-ROCHE-1625320$ROCHE$$48$YR$$F$Y$49.6$KG$20200715$$MD$JP$JP
116585027$11658502$7$F$20151003$20200727$20151026$20200730$EXP$$NL-ROCHE-1646050$ROCHE$$53$YR$$F$Y$$$20200731$$MD$NL$NL
1165873215$11658732$15$F$201406$20200727$20151026$20200803$PER$$PHHY2015US005630$NOVARTIS$$33$YR$$F$Y$$$20200803$$HP$US$US
116595311$11659531$1$I$20151009$20151023$20151026$20151026$EXP$GB-MHRA-EYC 00129402$GB-ROCHE-1650306$ROCHE$$64$YR$$F$Y$53.52$KG$20151026$$CN$GB$GB
116617344$11661734$4$F$2014$20200715$20151026$20200721$EXP$$US-JAZZ-2015-US-016775$JAZZ$$$$$F$Y$56$KG$20200721$$MD$US$US
116617653$11661765$3$F$201201$20200910$20151026$20200915$EXP$$US-JAZZ-2015-US-017088$JAZZ$$31$YR$$F$Y$$$20200915$$HP$US$US
116620781$11662078$1$I$$20151013$20151026$20151026$EXP$$JP-MYLANLABS-2015M1036112$MYLAN$NAMBA M, HORIMASU Y, OKAMOTO Y, FUJITAKA K, HATTORI N, KOHNO N. A CASE OF EML4?ALK?POSITIVE LUNG ADENOCARCINOMA THAT WAS SUCCESSFULLY TREATED WITH ALECTINIB AFTER THE DISCONTINUATION OF CRIZOTINIB DUE TO DRUG?INDUCED EDEMA AND STASIS DERMATITIS. . HAIGAN 2015? 55(4):212?217.$$$$$Y$$$20151026$$HP$JP$JP
116624053$11662405$3$F$$20200731$20151027$20200812$EXP$$DK-BRISTOL-MYERS SQUIBB COMPANY-14936835$BRISTOL MYERS SQUIBB$$$$N$$Y$$$20200812$$HP$DK$DK
1166243425$11662434$25$F$20150728$20200718$20151027$20200728$EXP$$CA-ROCHE-1650800$ROCHE$$71$YR$$F$Y$$$20200728$$MD$CA$CA
1166348515$11663485$15$F$2014$20200903$20151027$20200909$EXP$$US-PFIZER INC-2015356892$PFIZER$$53$YR$$M$Y$98$KG$20200909$$HP$US$US
1166363125$11663631$25$F$20110317$20200922$20151027$20200929$EXP$$PHHY2012CA003378$NOVARTIS$$51$YR$$F$Y$$$20200929$$CN$COUNTRY NOT SPECIFIED$CA
116717251$11671725$1$I$20150413$20150512$20151028$20151028$PER$$PHHY2015US057986$NOVARTIS$$66$YR$$F$Y$53.1$KG$20151028$$CN$US$US
116724083$11672408$3$F$20140908$20200817$20151028$20200821$EXP$$PHJP2015JP018768$NOVARTIS$$75$YR$$F$Y$$$20200821$$MD$JP$JP
116742145$11674214$5$F$20150820$20200915$20151028$20200918$PER$$US-CELGENEUS-USA-2015103832$CELGENE$$74$YR$$F$Y$60.5$KG$20200918$$HP$US$US
116767292$11676729$2$F$20130830$20200809$20151028$20200817$EXP$$US-BAYER-2015-397866$BAYER$$64$YR$A$M$Y$$$20200817$$HP$US$US
116768282$11676828$2$F$201504$20200915$20151028$20200924$EXP$$US-BAYER-2015-399366$BAYER$$73$YR$E$M$Y$$$20200924$$HP$US$US
116772842$11677284$2$F$20151006$20160512$20151028$20160519$EXP$$DE-JNJFOC-20151011649$PHARMACYCLICS$$60$YR$A$M$Y$103$KG$20160519$$MD$DE$DE
116818093$11681809$3$F$20151017$20160801$20151029$20160824$EXP$$US-JNJFOC-20151021429$PHARMACYCLICS$$75$YR$E$M$Y$72$KG$20160824$$MD$US$US
116835282$11683528$2$F$20141013$20200921$20151029$20200925$EXP$$US-BAYER-2015-409688$BAYER$$85$YR$E$M$Y$$$20200925$$HP$US$US
116841183$11684118$3$F$20150807$20170801$20151029$20170815$EXP$$BR-JNJFOC-20150824425$JANSSEN$$90$YR$E$M$Y$53.5$KG$20170815$$MD$BR$BR
116849732$11684973$2$F$20151016$20151021$20151030$20151030$EXP$$US-NEXUS PHARMA-000001$NEXUS PHARMACEUTICALS$$45$YR$$M$Y$124$KG$20151030$$PH$US$US
116851325$11685132$5$F$20150101$20200819$20151030$20200819$PER$$PHHY2015US070828$NOVARTIS$$56$YR$$F$Y$$$20200819$$MD$US$US
1168545713$11685457$13$F$20150506$20200727$20151030$20200801$PER$$PHHY2015US099098$NOVARTIS$$45$YR$$F$Y$$$20200801$$MD$US$US
116864889$11686488$9$F$$20200825$20151030$20200825$EXP$$FR-009507513-1510FRA013864$MERCK$$71$YR$$M$Y$$$20200825$$HP$FR$FR
116865456$11686545$6$F$20150427$20200702$20151030$20200710$PER$$PHHY2015US123554$NOVARTIS$$40$YR$$F$Y$$$20200710$$MD$US$US
1168677415$11686774$15$F$20130517$20200702$20151030$20200707$EXP$$PHHY2014US083924$NOVARTIS$$28$YR$$M$Y$$$20200708$$MD$US$US
116870813$11687081$3$F$20140820$20200825$20151030$20200902$PER$$PHHY2015US121766$NOVARTIS$$32$YR$$F$Y$$$20200902$$MD$COUNTRY NOT SPECIFIED$US
116871095$11687109$5$F$20151019$20160518$20151030$20160525$EXP$$US-JNJFOC-20151023642$PHARMACYCLICS$$48$YR$A$F$Y$138.4$KG$20160525$$MD$US$US
116875378$11687537$8$F$20150310$20200826$20151030$20200908$EXP$$JP-INCYTE CORPORATION-2015IN005572$INCYTE$$$$$$Y$$$20200908$$MD$JP$JP
1168759813$11687598$13$F$$20200824$20151030$20200904$EXP$$PHEH2015US022080$NOVARTIS$$$$$M$Y$$$20200904$$MD$US$US
116877283$11687728$3$F$20121016$20200623$20151030$20200707$EXP$$US-JNJFOC-20151020122$JOHNSON AND JOHNSON$$59$YR$$M$Y$$$20200707$$CN$US$US
116877704$11687770$4$F$20151007$20170630$20151030$20170710$EXP$$US-JNJFOC-20151016387$PHARMACYCLICS$$31$YR$A$F$Y$62.3$KG$20170710$$MD$US$US
116877992$11687799$2$F$20150615$20200710$20151030$20200722$EXP$$US-JNJFOC-20151020160$JOHNSON AND JOHNSON$$85$YR$$M$Y$$$20200722$$HP$US$US
116880703$11688070$3$F$$20200812$20151030$20200817$EXP$$US-JAZZ-2015-US-017449$JAZZ$$$$$M$Y$$$20200817$$HP$US$US
116883155$11688315$5$F$20130724$20200702$20151031$20200706$EXP$$PHHY2014US070535$NOVARTIS$$36$YR$$F$Y$$$20200706$$MD$US$US
116887916$11688791$6$F$20150720$20200825$20151102$20200901$PER$$PHHY2015US123646$NOVARTIS$$55$YR$$F$Y$$$20200901$$MD$US$US
116906962$11690696$2$F$201405$20200714$20151102$20200724$EXP$$US-BAYER-2015-411148$BAYER$$66$YR$E$M$Y$$$20200724$$CN$US$US
116907825$11690782$5$F$20151018$20160505$20151102$20160513$EXP$$IT-JNJFOC-20151024416$JANSSEN$$14$YR$T$F$Y$75$KG$20160513$$MD$IT$IT
116907923$11690792$3$F$20130906$20200714$20151102$20200717$PER$$US-JNJFOC-20151023913$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200717$$CN$US$US
116908422$11690842$2$F$20140821$20151030$20151102$20151104$PER$$JP-JNJFOC-20140823250$PHARMACYCLICS$$73$YR$E$F$Y$70.5$KG$20151104$$MD$JP$JP
116921952$11692195$2$F$2009$20151105$20151103$20151112$EXP$$BR-ROCHE-1653313$ROCHE$. CLINICAL HETEROGENEITY OF ATYPICAL FRACTURES DURING PROLONGED USE OF BISPHOSPHONATES??RISK FACTORS AND BONE TURNOVER MARKERS. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA 2014?58 (8):855?861.$82$YR$$F$Y$$$20151112$$HP$BR$BR
116924372$11692437$2$F$20150203$20200909$20151103$20200911$EXP$$US-BAYER-2015-395775$BAYER$$80$YR$E$F$Y$$$20200911$$HP$US$US
116937352$11693735$2$F$20150815$20151202$20151103$20151212$EXP$$TW-ASTRAZENECA-2015SF04386$ASTRAZENECA$$23253$DY$$F$Y$52$KG$20151212$$MD$TW$TW
1169404712$11694047$12$F$20141120$20200826$20151103$20200908$EXP$$JP-INCYTE CORPORATION-2015IN003952$INCYTE$$$$$$Y$$$20200908$$MD$JP$JP
1169538313$11695383$13$F$$20200720$20151104$20200728$PER$$CA-AMGEN-CANSP2015115178$AMGEN$$39$YR$A$F$Y$$$20200728$$CN$CA$CA
1169545360$11695453$60$F$20150804$20200630$20151104$20200715$EXP$$PHHY2015CA100891$NOVARTIS$$68$YR$$M$Y$$$20200715$$HP$CA$CA
1169579610$11695796$10$F$$20200803$20151104$20200811$EXP$$PHEH2015US022025$NOVARTIS$$$$$M$Y$$$20200811$$MD$US$US
117014094$11701409$4$F$201409$20200701$20151105$20200714$EXP$$US-JNJFOC-20151101961$JOHNSON AND JOHNSON$$81$YR$$M$Y$69.46$KG$20200714$$CN$US$US
117015898$11701589$8$F$20131102$20200910$20151105$20200923$EXP$$JP-AEGERION PHARMACEUTICAL INC.-AEGR001656$AEGERION$$$$$$Y$$$20200923$$CN$JP$JP
117020691$11702069$1$I$20150608$20150618$20151105$20151105$EXP$$CZ-JNJFOC-20150615361$PHARMACYCLICS$$76$YR$E$F$Y$59$KG$20151105$$MD$CZ$CZ
117020731$11702073$1$I$20150331$20150408$20151105$20151105$EXP$$PL-JNJFOC-20150408897$PHARMACYCLICS$$61$YR$A$M$Y$105$KG$20151105$$MD$PL$PL
117025631$11702563$1$I$20151009$20151023$20151105$20151105$EXP$GB-MHRA-EYC 00129402$GB-WATSON-2015-23068$WATSON$$64$YR$$F$Y$53.52$KG$20151029$$CN$GB$GB
117026589$11702658$9$F$2015$20200925$20151105$20200929$PER$$US-PFIZER INC-2015358174$PFIZER$$70$YR$$M$Y$$$20200929$$MD$US$US
117040551$11704055$1$I$20151009$20151023$20151106$20151106$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-105516$RANBAXY$$$$$$Y$$$20151106$$HP$GB$GB
117041632$11704163$2$F$20141114$20200622$20151106$20200703$EXP$$US-BAYER-2015-421339$BAYER$$55$YR$A$M$Y$$$20200703$$CN$US$US
117041895$11704189$5$F$20150827$20200715$20151106$20200716$EXP$$PHHY2015NL123824$NOVARTIS$$29$YR$$F$Y$50$KG$20200716$$MD$NL$NL
117041965$11704196$5$F$2006$20200728$20151106$20200803$PER$$US-AMGEN-USASP2015116141$AMGEN$$52$YR$A$F$Y$$$20200803$$MD$US$US
117054331$11705433$1$I$20151009$20151023$20151106$20151106$EXP$GB-MHRA-EYC 00129402$GB-MYLANLABS-2015M1036933$MYLAN$$$$$$Y$$$20151106$$CN$GB$GB
117056083$11705608$3$F$20141024$20200913$20151106$20200924$EXP$$US-JNJFOC-20151103258$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20200924$$CN$US$US
117056437$11705643$7$F$20150804$20200709$20151106$20200716$EXP$$AU-PFIZER INC-2015368097$PFIZER$$55$YR$$F$Y$$$20200716$$HP$AU$AU
117059494$11705949$4$F$20150914$20160105$20151106$20160111$EXP$$DE-JNJFOC-20150919224$JANSSEN$$33$YR$A$F$Y$70$KG$20160111$$MD$DE$DE
117066025$11706602$5$F$20151024$20170508$20151106$20170512$EXP$$US-JNJFOC-20151105589$PHARMACYCLICS$$73$YR$E$F$Y$$$20170512$$MD$US$AU
117074353$11707435$3$F$2006$20200710$20151106$20200716$EXP$$US-JAZZ-JPI-P-014243$JAZZ$$$$$F$Y$$$20200716$$MD$US$US
117080531$11708053$1$I$$20151029$20151107$20151107$EXP$$GB-CIPLA LTD.-2015GB08363$CIPLA$SYMONDS R.P, GOURLEY C, DAVIDSON S, CARTY K, MCCARTNEY E, RAI D.ET.AL. CEDIRANIB COMBINED WITH CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH METASTATIC OR RECURRENT CERVICAL CANCER (CIRCCA): A RANDOMISED, DOUBLE?BLIND, PLACEBO?CONTROLLED PHASE 2 TRIAL. LANCET ONCOL. 2015?1?10$$$$$Y$$$20151107$$HP$GB$GB
117084211$11708421$1$I$$20151029$20151107$20151107$EXP$$GB-CIPLA LTD.-2015GB08396$CIPLA$SYMONDS R. P., GOURLEY C., DAVIDSON S., CARTY K., MCCARTNEY E., RAI D ET AL.. CEDIRANIB COMBINED WITH CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH METASTATIC OR RECURRENT CERVICAL CANCER (CIRCCA): A RANDOMISED, DOUBLE?BLIND, PLACEBO?CONTROLLED PHASE 2 TRIAL. LANCET ONCOL 2015. 2015?1 TO 10$$$$$Y$$$20151107$$HP$GB$GB
117084281$11708428$1$I$$20151029$20151107$20151107$EXP$$GB-CIPLA LTD.-2015GB08397$CIPLA$SYMONDS R. P., GOURLEY C., DAVIDSON S., CARTY K., MCCARTNEY E., RAI D ET AL.. CEDIRANIB COMBINED WITH CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH METASTATIC OR RECURRENT CERVICAL CANCER (CIRCCA): A RANDOMISED, DOUBLE?BLIND, PLACEBO?CONTROLLED PHASE 2 TRIAL. LANCET ONCOL 2015. 2015?1 TO 10$$$$$Y$$$20151107$$HP$GB$GB
1171309511$11713095$11$F$$20200817$20151109$20200828$EXP$$PHEH2015US022875$NOVARTIS$$$$$F$Y$72.11$KG$20200828$$MD$US$US
117136381$11713638$1$I$20120703$20151030$20151109$20151109$EXP$$US-JNJFOC-20151100678$JANSSEN$$62$YR$A$M$Y$$$20151109$$MD$US$US
1171389613$11713896$13$F$$20200908$20151109$20200922$EXP$$PHEH2015US022876$NOVARTIS$$$$$F$Y$$$20200922$$MD$US$US
117140776$11714077$6$F$$20200928$20151109$20200930$PER$$US-PFIZER INC-2015370098$PFIZER$$82$YR$$F$Y$$$20200930$$MD$US$US
117144603$11714460$3$F$20151022$20151123$20151109$20200714$EXP$$RU-NOVOPROD-468991$NOVO NORDISK$$65$YR$$F$Y$112$KG$20200714$$MD$RU$RU
117147572$11714757$2$F$$20151127$20151109$20151210$EXP$$JP-MYLANLABS-2015M1038569$MYLAN$OKADA Y, HAYASAKA T, CHIBA S, NISHINO R, ENDO Y, YAMAUCHI M. A CASE OF CESAREAN SECTION PRECEDED BY COIL EMBOLIZATION FOR SUBARACHNOID HEMORRHAGE UNDER GENERAL ANESTHESIA. MASUI 2015? 64(9):989?991.$$$$$Y$$$20151210$$HP$JP$JP
117153282$11715328$2$F$20140116$20200922$20151109$20200928$EXP$$US-BAYER-2015-034811$BAYER$$65$YR$E$M$Y$$$20200928$$HP$US$US
117157303$11715730$3$F$2014$20200720$20151109$20200731$EXP$$US-BAYER-2015-395778$BAYER$$67$YR$E$F$Y$$$20200731$$CN$US$US
117157494$11715749$4$F$20120612$20200923$20151109$20200929$PER$$US-JNJFOC-20151107926$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200929$$CN$US$US
117157693$11715769$3$F$20131104$20200811$20151109$20200821$EXP$$US-JNJFOC-20151101946$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200821$$CN$US$US
117157724$11715772$4$F$20131120$20200804$20151109$20200813$PER$$US-JNJFOC-20151107929$JOHNSON AND JOHNSON$$77$YR$E$M$Y$99.88$KG$20200813$$CN$US$US
117158353$11715835$3$F$20150921$20200730$20151109$20200731$EXP$$PL-PFIZER INC-2015379295$PFIZER$$56$YR$$F$Y$96$KG$20200731$$HP$PL$PL
117171262$11717126$2$F$$20200914$20151109$20200925$EXP$$CN-ELI_LILLY_AND_COMPANY-CN201510009846$ELI LILLY AND CO$WESTERBURG, C.ACICLOVIR OR VALACICLOVIR ? ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS.WHO PHARMACEUTICALS NEWSLETTER 2020?4:11?17.$$$$M$Y$56$KG$20200925$$HP$CN$CN
117178031$11717803$1$I$$20151029$20151110$20151110$EXP$$GB-CIPLA LTD.-2015GB08372$CIPLA$SYMONDS R.P, GOURLEY C, DAVIDSON S, CARTY K, MCCARTNEY E, RAI D.ET.AL. CEDIRANIB COMBINED WITH CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH METASTATIC OR RECURRENT CERVICAL CANCER (CIRCCA): A RANDOMISED, DOUBLE?BLIND, PLACEBO?CONTROLLED PHASE 2 TRIAL. LANCET ONCOL. 2015?1?10$$$$$Y$$$20151110$$HP$GB$GB
117186932$11718693$2$F$201302$20200629$20151109$20200706$EXP$$US-JAZZ-2013-US-002404$JAZZ$$50$YR$$M$Y$70$KG$20200706$$$US$US
117188554$11718855$4$F$20150928$20151117$20151110$20151125$EXP$$GB-JNJFOC-20150927063$JANSSEN$$72$YR$E$F$Y$58$KG$20151125$$HP$GB$GB
117208745$11720874$5$F$2011$20200812$20151110$20200817$EXP$$US-JAZZ-2015-US-018608$JAZZ$$$$$F$Y$99.32$KG$20200817$$MD$US$US
117211447$11721144$7$F$20151009$20200928$20151110$20200930$EXP$$CA-TAKEDA-2015TUS015531$TAKEDA$$55$YR$$M$Y$$$20200930$$MD$CA$CA
117212943$11721294$3$F$$20200831$20151111$20200915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-15386592$BRISTOL MYERS SQUIBB$LAKHI N, GOVIND A. IMPLANON FAILURE IN PATIENTS ON ANTIRETROVIRAL MEDICATION: THE IMPORTANCE OF DISCLOSURE. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE. 2010?36(3):181?2$33$YR$$F$Y$$$20200915$$MD$US$US
117215003$11721500$3$F$20131218$20200813$20151111$20200825$EXP$$US-JNJFOC-20151009529$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200825$$CN$US$US
117215643$11721564$3$F$20120713$20200806$20151111$20200817$EXP$$US-JNJFOC-20151006675$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20200817$$CN$US$US
117216063$11721606$3$F$20140818$20200727$20151111$20200803$EXP$$US-JNJFOC-20151024003$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200803$$CN$US$US
117216403$11721640$3$F$20150119$20200916$20151111$20200929$EXP$$US-JNJFOC-20151004287$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200929$$CN$US$US
117217523$11721752$3$F$20141015$20200927$20151111$20200929$PER$$US-JNJFOC-20151011338$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200929$$CN$US$US
117217653$11721765$3$F$20130720$20200630$20151111$20200707$PER$$US-JNJFOC-20151017775$JOHNSON AND JOHNSON$$92$YR$$M$Y$$$20200707$$HP$US$US
117218035$11721803$5$F$20141007$20200716$20151111$20200730$EXP$$US-JNJFOC-20151001342$JOHNSON AND JOHNSON$$84$YR$E$F$Y$69.01$KG$20200730$$CN$US$US
117218173$11721817$3$F$20131001$20200913$20151111$20200924$EXP$$US-JNJFOC-20151005901$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200924$$CN$US$US
117218713$11721871$3$F$20150505$20200701$20151111$20200706$PER$$US-JNJFOC-20151101826$JOHNSON AND JOHNSON$$46$YR$$F$Y$$$20200706$$HP$US$US
117218733$11721873$3$F$20130926$20200804$20151111$20200811$PER$$US-JNJFOC-20150927552$JOHNSON AND JOHNSON$$72$YR$E$F$Y$92.2$KG$20200811$$CN$US$US
117219033$11721903$3$F$20150216$20200702$20151111$20200706$PER$$US-JNJFOC-20151011388$JOHNSON AND JOHNSON$$84$YR$$M$Y$$$20200706$$CN$US$US
117219133$11721913$3$F$20140725$20200813$20151111$20200817$PER$$US-JNJFOC-20151012577$JOHNSON AND JOHNSON$$90$YR$E$M$Y$$$20200817$$CN$US$US
117219513$11721951$3$F$201502$20200714$20151111$20200716$PER$$US-JNJFOC-20151004285$JOHNSON AND JOHNSON$$49$YR$$F$Y$$$20200716$$CN$US$US
117219993$11721999$3$F$201407$20200630$20151111$20200714$EXP$$US-JNJFOC-20151011519$JOHNSON AND JOHNSON$$74$YR$$M$Y$$$20200714$$CN$US$US
117220053$11722005$3$F$20130701$20200915$20151111$20200918$PER$$US-JNJFOC-20151022263$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200918$$CN$US$US
117220373$11722037$3$F$20141012$20200727$20151111$20200731$PER$$US-JNJFOC-20151005748$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200731$$CN$US$US
117220403$11722040$3$F$20131004$20200628$20151111$20200702$PER$$US-JNJFOC-20151002788$JOHNSON AND JOHNSON$$92$YR$$M$Y$$$20200702$$CN$US$US
117220943$11722094$3$F$201311$20200830$20151111$20200901$PER$$US-JNJFOC-20151023901$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200901$$CN$US$US
117221013$11722101$3$F$20131119$20200723$20151111$20200728$PER$$US-JNJFOC-20151100654$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200728$$LW$US$US
117221213$11722121$3$F$20141002$20200719$20151111$20200722$PER$$US-JNJFOC-20151003791$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200722$$CN$US$US
117221403$11722140$3$F$20140810$20200625$20151111$20200702$PER$$US-JNJFOC-20151011399$JOHNSON AND JOHNSON$$68$YR$$F$Y$$$20200702$$CN$US$US
117221634$11722163$4$F$201301$20200721$20151111$20200724$PER$$US-JNJFOC-20151015262$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200724$$CN$US$US
117221733$11722173$3$F$2014$20200628$20151111$20200702$PER$$US-JNJFOC-20151019238$JOHNSON AND JOHNSON$$78$YR$$F$Y$$$20200702$$CN$US$US
117222063$11722206$3$F$20140102$20200803$20151111$20200807$PER$$US-JNJFOC-20151023910$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200807$$CN$US$US
117222255$11722225$5$F$20130507$20200726$20151111$20200730$PER$$US-JNJFOC-20151003003$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200730$$CN$US$US
117222273$11722227$3$F$20141023$20200924$20151111$20200929$PER$$US-JNJFOC-20151005764$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20200929$$CN$US$US
117222763$11722276$3$F$20140210$20200726$20151111$20200731$PER$$US-JNJFOC-20151023902$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200731$$CN$US$US
117222793$11722279$3$F$20131225$20200810$20151111$20200814$PER$$US-JNJFOC-20151101558$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200814$$LW$US$US
117224288$11722428$8$F$$20200923$20151111$20200930$EXP$$PHEH2015US022986$NOVARTIS$$$$$F$Y$$$20200930$$LW$US$US
117225488$11722548$8$F$$20200721$20151111$20200731$EXP$$PHHY2015CA131821$NOVARTIS$$$$$F$Y$$$20200731$$MD$CA$CA
1172266822$11722668$22$F$201301$20200827$20151111$20200901$EXP$$US-PFIZER INC-2015372624$PFIZER$$70$YR$$F$Y$$$20200901$$CN$US$US
117231234$11723123$4$F$$20200924$20151111$20200928$EXP$$US-PFIZER INC-2015368926$PFIZER$$56$YR$$M$Y$98$KG$20200928$$CN$US$US
117233377$11723337$7$F$20150422$20200819$20151111$20200902$EXP$$JP-INCYTE CORPORATION-2015IN005812$INCYTE$$$$$$Y$$$20200902$$MD$JP$JP
1172342124$11723421$24$F$2014$20200804$20151111$20200811$EXP$$PHHY2012CA038909$NOVARTIS$$48$YR$$F$Y$$$20200811$$CN$COUNTRY NOT SPECIFIED$CA
117238171$11723817$1$I$$20151028$20151111$20151111$EXP$$IE-MYLANLABS-2015M1038789$MYLAN$MURPHY CJ, MCCAUL CL, THORNTON PC. MATERNAL COLLAPSE SECONDARY TO AORTOCAVAL COMPRESSION. INT?J?OBSTET?ANESTH 2015? 24(4):393?394.$$$$$Y$$$20151111$$HP$IE$IE
117272674$11727267$4$F$20130714$20200623$20151112$20200706$EXP$$US-BAYER-2015-386252$BAYER$$76$YR$E$F$Y$$$20200706$$LW$US$US
117273465$11727346$5$F$$20200910$20151112$20200914$PER$$US-PFIZER INC-2015374312$PFIZER$$60$YR$$F$Y$63.5$KG$20200914$$CN$US$US
117274907$11727490$7$F$$20200729$20151112$20200731$EXP$$US-PFIZER INC-2015370915$PFIZER$$65$YR$$F$Y$104$KG$20200731$$MD$US$US
117275486$11727548$6$F$20151028$20200625$20151112$20200701$EXP$$US-SA-2015SA178922$SANOFI AVENTIS$$$$$$Y$$$20200701$$HP$US$US
117276383$11727638$3$F$20140721$20200928$20151112$20200930$PER$$US-JNJFOC-20151107660$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200930$$CN$US$US
117279456$11727945$6$F$20150510$20200901$20151112$20200915$EXP$$JP-INCYTE CORPORATION-2015IN005784$INCYTE$$$$$$Y$$$20200915$$HP$JP$JP
117284018$11728401$8$F$20151023$20180308$20151112$20180313$EXP$$US-JNJFOC-20151101482$JANSSEN$$84$YR$E$M$Y$79.47$KG$20180313$$MD$US$US
117288834$11728883$4$F$$20200813$20151112$20200818$EXP$$US-PFIZER INC-2015384791$PFIZER$ADLER, A.. SEROTONIN SYNDROME: THE POTENTIAL FOR A SEVERE REACTION BETWEEN COMMON PERIOPERATIVE MEDICATIONS AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS. A AND A CASE REPORTS. 2015?5(9):156?159$3$DEC$$M$Y$80$KG$20200818$$MD$US$US
117289675$11728967$5$F$20151009$20160331$20151112$20160408$EXP$$FR-JNJFOC-20151008594$PHARMACYCLICS$$76$YR$E$M$Y$69$KG$20160408$$MD$FR$FR
117334853$11733485$3$F$201411$20200729$20151113$20200805$EXP$$US-JNJFOC-20151111095$JOHNSON AND JOHNSON$$85$YR$E$M$Y$66$KG$20200805$$CN$US$US
117335027$11733502$7$F$$20180116$20151113$20200909$PER$$PHEH2015US023509$NOVARTIS$$$$$F$Y$$$20200909$$MD$US$US
117341272$11734127$2$F$$20151111$20151113$20151125$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-105992$RANBAXY$$$$$$Y$$$20151125$$HP$GB$GB
1173442223$11734422$23$F$$20200831$20151113$20200908$EXP$$PHEH2015US023443$NOVARTIS$$$$$F$Y$$$20200908$$LW$US$US
117352703$11735270$3$F$20131104$20200809$20151113$20200812$EXP$$US-JNJFOC-20151107729$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200812$$CN$US$US
117379514$11737951$4$F$20151002$20160302$20151113$20160308$EXP$$CZ-JNJFOC-20151113840$PHARMACYCLICS$$77$YR$E$F$Y$$$20160308$$MD$CZ$CZ
117391318$11739131$8$F$$20200826$20151113$20200902$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-17476250$BRISTOL MYERS SQUIBB$SUSMAN ED. EFAVIRENZ TIED TO NEUROLOGICAL BIRTH DEFECTS. CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS. 2013$$$$$Y$$$20200902$$HP$FR$FR
117417018$11741701$8$F$20151108$20160920$20151116$20160923$EXP$$FR-ROCHE-1659699$ROCHE$$77$YR$$M$Y$54$KG$20160923$$MD$FR$FR
117436892$11743689$2$F$20130510$20200819$20151116$20200825$EXP$$US-BAYER-2015-405089$BAYER$$84$YR$E$M$Y$$$20200825$$HP$US$US
117438143$11743814$3$F$20140505$20200810$20151116$20200819$EXP$$US-JNJFOC-20151115633$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200819$$CN$US$US
117438514$11743851$4$F$20150526$20200813$20151116$20200819$PER$$US-JNJFOC-20151115684$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200819$$CN$US$US
117438543$11743854$3$F$20150529$20200902$20151116$20200916$EXP$$US-JNJFOC-20151115690$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200916$$CN$US$US
117442282$11744228$2$F$20150719$20151105$20151116$20200924$PER$$US-CELGENEUS-USA-2015111992$CELGENE$$86$YR$$M$Y$77.63$KG$20200924$$HP$US$US
117443715$11744371$5$F$2013$20200723$20151116$20200731$EXP$$US-BAYER-2015-430407$BAYER$$77$YR$E$M$Y$$$20200731$$HP$US$US
1174538115$11745381$15$F$$20200629$20151117$20200703$PER$$CA-AMGEN-CANSP2015120647$AMGEN$$49$YR$A$F$Y$$$20200703$$CN$CA$CA
117458332$11745833$2$F$201508$20151201$20151117$20151215$EXP$$US-JNJFOC-20150808400$JANSSEN$$68$YR$E$M$Y$90.4$KG$20151215$$MD$US$US
1174588027$11745880$27$F$$20200706$20151117$20200714$EXP$$PHEH2015US023698$NOVARTIS$$$$$F$Y$$$20200714$$MD$US$US
117459312$11745931$2$F$20150830$20160325$20151117$20160405$EXP$$US-JNJFOC-20150901147$JANSSEN$$71$YR$E$F$Y$$$20160405$$MD$US$US
117459384$11745938$4$F$201508$20200226$20151117$20200303$EXP$$PHHY2015CA145896$NOVARTIS$$70$YR$$F$Y$$$20200303$$CN$CA$CA
117465293$11746529$3$F$20150828$20150901$20151117$20160208$PER$$PL-JNJFOC-20150903072$JANSSEN$$57$YR$A$F$Y$75$KG$20160208$$MD$PL$PL
117467153$11746715$3$F$20150917$20200624$20151117$20200703$EXP$$FR-TAKEDA-2015MPI007635$TAKEDA$$68$YR$$F$Y$75$KG$20200703$$HP$FR$FR
117485603$11748560$3$F$$20200710$20151117$20200720$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-18707349$BRISTOL MYERS SQUIBB$SUSMAN ED. EFAVIRENZ TIED TO NEUROLOGICAL BIRTH DEFECTS. CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS. 2013$$$N$$Y$$$20200720$$HP$FR$FR
117486531$11748653$1$I$$20151104$20151117$20151117$EXP$$GB-MYLANLABS-2015M1039935$MYLAN$AL?AZZANI WAK, EVANS L, SPEIGHT L, LEA?DAVIES M, STONE MD, LAU D, ET AL. HYPERPHARMACOTHERAPY IN AGEING CYSTIC FIBROSIS PATIENTS: THE FIRST REPORT OF AN ATYPICAL HIP FRACTURE. RESPIRAT?MED?CASE?REPORT 2015? 16:148?150.$$$$$Y$$$20151117$$HP$GB$GB
1174934267$11749342$67$F$201510$20200818$20151118$20200822$EXP$$PHHY2015CA145746$NOVARTIS$$37$YR$$M$Y$$$20200822$$MD$CA$CA
1174934711$11749347$11$F$$20200831$20151118$20200908$EXP$$PHEH2015US023857$NOVARTIS$$$$$M$Y$$$20200908$$MD$US$US
117496623$11749662$3$F$20140227$20200916$20151118$20200925$EXP$$US-BAYER-2015-470283$BAYER$$73$YR$E$M$Y$79.6$KG$20200925$$CN$US$US
117498344$11749834$4$F$20131030$20200831$20151118$20200908$EXP$$US-BAYER-2015-399783$BAYER$$70$YR$E$F$Y$$$20200908$$CN$US$US
117503924$11750392$4$F$$20200713$20151118$20200715$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-053880$BRISTOL MYERS SQUIBB$DERLON V, AUDIBERT G, BARBAUD A, MERTES PM. DRESS IN INTENSIVE CARE UNIT: A CHALLENGING DIAGNOSIS AND TREATMENT. ANNALES FRANCAISES D^ANESTHESIE ET DE REANIMATION. 2014?33(12):693?95$31$YR$$F$Y$$$20200715$$MD$FR$FR
117506832$11750683$2$F$$20200715$20151118$20200721$EXP$$BR-PFIZER INC-2015395836$PFIZER$$88$YR$$F$Y$$$20200721$$CN$BR$BR
117510121$11751012$1$I$20151012$20151014$20151118$20151118$EXP$$GB-JNJFOC-20151010202$JANSSEN$$80$YR$E$F$Y$75$KG$20151118$$MD$GB$GB
117514546$11751454$6$F$20151005$20161206$20151118$20161214$EXP$$US-JNJFOC-20151110542$JANSSEN$$75$YR$E$F$Y$65.4$KG$20161214$$MD$US$US
117518672$11751867$2$F$20151112$20170801$20151118$20170808$EXP$$BE-JNJFOC-20151118287$JANSSEN$$85$YR$E$M$Y$71$KG$20170808$$MD$BE$BE
1175204114$11752041$14$F$201306$20200727$20151118$20200804$EXP$$PHHY2013BR071823$NOVARTIS$$39$YR$$F$Y$67$KG$20200804$$MD$BR$BR
1175288515$11752885$15$F$20150713$20200914$20151119$20200917$PER$$CA-AMGEN-CANSP2015121181$AMGEN$$46$YR$A$F$Y$$$20200916$$MD$CA$CA
117533672$11753367$2$F$20150814$20151126$20151119$20151210$EXP$$GB-ASTRAZENECA-2015SF09884$ASTRAZENECA$$62$YR$$M$Y$72.9$KG$20151210$$MD$GB$GB
117547128$11754712$8$F$20141020$20200821$20151119$20200903$EXP$$JP-INCYTE CORPORATION-2015IN005919$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
117550541$11755054$1$I$20131218$20131219$20151119$20151119$EXP$$GB-JNJFOC-20131213873$JANSSEN$$45$YR$A$F$Y$57$KG$20151119$$MD$GB$GB
1175520510$11755205$10$F$2015$20200721$20151119$20200724$EXP$$US-INCYTE CORPORATION-2015IN005247$INCYTE$$$$$$Y$$$20200724$$CN$US$US
117554333$11755433$3$F$20121114$20200914$20151119$20200917$PER$$US-JNJFOC-20151118298$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200917$$CN$US$US
117555183$11755518$3$F$20131126$20200719$20151119$20200729$EXP$$US-JNJFOC-20151117514$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200729$$CN$US$US
117560167$11756016$7$F$20150112$20200714$20151119$20200722$EXP$$FR-PFIZER INC-2015383921$PFIZER$ALGALARRONDO, V.. IN BRIEF: SEVERE BRADYCARDIA WITH SOFOSBUVIR AND AMIODARONE. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS. 2015?57(1466):58$61$YR$$F$Y$76$KG$20200722$$MD$FR$FR
117565738$11756573$8$F$20150925$20200914$20151119$20200918$EXP$$CA-ROCHE-1642122$ROCHE$$83$YR$$M$Y$71.8$KG$20200918$$MD$CA$CA
117578981$11757898$1$I$20151103$20151116$20151120$20151120$EXP$$HU-JNJFOC-20151118718$JANSSEN$$71$YR$E$M$Y$71$KG$20151120$$MD$HU$HU
117583346$11758334$6$F$20151122$20200819$20151120$20200824$EXP$$US-PFIZER INC-2015398936$PFIZER$$68$YR$$F$Y$51.26$KG$20200824$$CN$US$US
117586332$11758633$2$F$20131029$20200701$20151120$20200715$EXP$$US-BAYER-2015-422682$BAYER$$86$YR$E$F$Y$$$20200715$$HP$US$US
117586652$11758665$2$F$20131003$20200721$20151120$20200727$EXP$$US-BAYER-2015-426782$BAYER$$77$YR$E$M$Y$$$20200727$$CN$US$US
117587852$11758785$2$F$20130701$20200915$20151120$20200924$EXP$$US-BAYER-2015-456963$BAYER$$74$YR$E$M$Y$$$20200924$$CN$US$US
117603695$11760369$5$F$$20151221$20151120$20200702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-079619$BRISTOL MYERS SQUIBB$$71$YR$$F$Y$$$20200702$$MD$JP$JP
117604922$11760492$2$F$20150112$20200716$20151120$20200720$EXP$$PHHY2015FR147489$NOVARTIS$ABRAMOWICZ M. IN BRIEF?SEVERE BRADYCARDIA WITH SOFOSBUVIR AND AMIODARONE. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS. 2015?57(10)$61$YR$$F$Y$76$KG$20200720$$HP$FR$FR
117605785$11760578$5$F$201312$20200909$20151120$20200914$EXP$$US-JNJFOC-20151117546$JOHNSON AND JOHNSON$$70$YR$E$M$Y$68.1$KG$20200914$$CN$US$US
117607607$11760760$7$F$2015$20200809$20151120$20200818$EXP$$US-JNJFOC-20151114480$JOHNSON AND JOHNSON$$59$YR$A$M$Y$98.52$KG$20200818$$CN$US$US
117615413$11761541$3$F$$20200626$20151120$20200703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-002537$BRISTOL MYERS SQUIBB$WATANABE T, TOKUMOTO Y, KOIZUMI Y, IMAI Y, YOSHIDA O, HIROOKA M, ET AL. A CASE OF ACUTE LIVER DYSFUNCTION WITHOUT ELEVATION OF ALT CAUSED BY TREATMENT WITH DACLATASVIR AND ASUNAPREVIR. THE JAPANSOCIETY OF HEPATOLOGY. 2015?56:109?112$$$$F$Y$51$KG$20200703$$HP$JP$JP
117625457$11762545$7$F$20151027$20200812$20151120$20200817$EXP$$US-JAZZ-2015-US-019419$JAZZ$$57$YR$$F$Y$49$KG$20200817$$$US$US
1176583021$11765830$21$F$20151118$20200819$20151121$20200824$EXP$$PHHY2015CO152101$NOVARTIS$$58$YR$$F$Y$63$KG$20200824$$HP$CO$CO
117662798$11766279$8$F$20131106$20200904$20151123$20200910$EXP$$CA-ROCHE-1356484$ROCHE$$51$YR$$F$Y$$$20200911$$PH$CA$CA
1176645731$11766457$31$F$20150902$20200811$20151123$20200826$EXP$$CA-ROCHE-GNE318259$ROCHE$$58$YR$$F$Y$$$20200826$$MD$CA$CA
117668084$11766808$4$F$$20200914$20151123$20200925$EXP$$CA-TAKEDA-2015MPI007830$TAKEDA$$$$$M$Y$$$20200925$$CN$CA$CA
1176689513$11766895$13$F$20150116$20200820$20151123$20200824$EXP$$PHJP2015JP006261$NOVARTIS$$64$YR$$M$Y$$$20200824$$MD$JP$JP
117674452$11767445$2$F$20151016$20170110$20151123$20170113$EXP$$PL-JNJFOC-20151021881$PHARMACYCLICS$$57$YR$A$M$Y$57$KG$20170113$$MD$PL$PL
117677091$11767709$1$I$20150919$20151001$20151123$20151123$EXP$$US-INCYTE CORPORATION-2015IN005001$INCYTE$$92$YR$$F$Y$$$20151123$$CN$US$US
117678936$11767893$6$F$20131203$20200825$20151123$20200828$PER$$US-JNJFOC-20151118777$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200828$$CN$US$US
1176878210$11768782$10$F$$20200719$20151123$20200721$EXP$$PHHY2015ES148434$NOVARTIS$$74$YR$$F$Y$$$20200721$$HP$ES$ES
117688423$11768842$3$F$$20200721$20151123$20200723$PER$$US-PFIZER INC-2015387690$PFIZER$$53$YR$$M$Y$82$KG$20200723$$CN$US$US
117695623$11769562$3$F$20150922$20180615$20151123$20180625$EXP$$US-VERTEX PHARMACEUTICALS-2015-005038$VERTEX$$34$YR$$F$Y$$$20180625$$HP$US$US
117706937$11770693$7$F$2015$20200809$20151123$20200817$EXP$$US-BAYER-2015-472839$BAYER$$59$YR$A$M$Y$98.52$KG$20200817$$CN$US$US
117729305$11772930$5$F$$20200316$20151124$20200323$EXP$$PHHY2015AU149709$NOVARTIS$$$$$M$Y$$$20200323$$MD$AU$AU
117733072$11773307$2$F$20131214$20200723$20151124$20200803$EXP$$US-BAYER-2015-421457$BAYER$$66$YR$E$F$Y$$$20200803$$HP$US$US
117737133$11773713$3$F$20140101$20200831$20151124$20200908$EXP$$US-BAYER-2015-396142$BAYER$$68$YR$E$F$Y$$$20200908$$CN$US$US
117742652$11774265$2$F$$20151120$20151124$20200701$EXP$$GR-JNJFOC-20151121940$JOHNSON AND JOHNSON$$$$E$M$Y$$$20200701$$CN$GR$GR
117764368$11776436$8$F$20151114$20181101$20151125$20181115$EXP$$US-ROCHE-1662875$ROCHE$$69$YR$$F$Y$53.3$KG$20181115$$MD$US$US
117776595$11777659$5$F$2014$20200714$20151125$20200716$EXP$$PHHY2015BE152355$NOVARTIS$$33$YR$$F$Y$$$20200716$$CN$BE$BE
117776802$11777680$2$F$$20200824$20151125$20200901$EXP$$JP-TEVA-611531ISR$TEVA$MAEDA O. LONG?TERM MULTIDISCIPLINARY TREATMENT INCLUDING PROTON THERAPY FOR A RECURRENT LOW?GRADE ENDOMETRIAL STROMAL SARCOMA AND PATHOLOGICALLY PROMINENT EPITHELIAL DIFFERENTIATION: AN AUTOPSY CASE REPORT.. BMC WOMEN^S HEALTH 20. 2020 JUL 25?.$$$$F$Y$$$20200901$$HP$JP$JP
117787772$11778777$2$F$$20200715$20151125$20200723$EXP$$CA-MYLANLABS-2015M1041865$MYLAN$DIAZ?PALLARES C, LEE H, LUIDER J, DUGGAN P, NERI P, TAY J, ET AL. CYCLOPHOSPHAMIDE, BORTEZOMIB AND DEXAMETHASONE (CYBORD) FOR THE TREATMENT OF NEWLY DIAGNOSED AL AMYLOIDOSIS: IMPACT OF RESPONSE ON SURVIVAL OUTCOMES. CLIN?LYMPHOMA?MYELOMA?LEUK 2020?20(6):394?399.$$$$$Y$$$20200723$$HP$CA$CA
117789513$11778951$3$F$20140311$20200908$20151125$20200914$PER$$US-JNJFOC-20151123453$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200914$$CN$US$US
117791242$11779124$2$F$201511$20151123$20151125$20200701$EXP$$GR-JNJFOC-20151122564$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
1177931124$11779311$24$F$20120306$20200501$20151125$20200506$EXP$$PHHY2012CA021236$NOVARTIS$$47$YR$$M$Y$$$20200506$$HP$CA$CA
117799915$11779991$5$F$20151110$20160202$20151125$20160210$EXP$$NL-JNJFOC-20151113724$JOHNSON AND JOHNSON$$77$YR$E$M$Y$72.5$KG$20160210$$MD$NL$NL
1178069138$11780691$38$F$2015$20200707$20151126$20200710$EXP$$CA-ROCHE-1667249$ROCHE$$17$YR$$F$Y$$$20200710$$CN$CA$CA
117810523$11781052$3$F$$20200813$20151126$20200820$EXP$$US-DRREDDYS-USA/USA/15/0054326$DR REDDYS$ADLER A, CHARNIN J, QURAISHI S. SEROTONIN SYNDROME: THE POTENTIAL FOR A SEVERE REACTION BETWEEN COMMON PERIOPERATIVE MEDICATIONS AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS. A A CASE REP. 2015?5(9):156?59. DOI:10.1213/XAA.0000000000000217$25$YR$A$M$Y$80$KG$20200820$$MD$US$US
117814692$11781469$2$F$20150522$20151218$20151126$20151229$PER$$KR-JNJFOC-20150516937$JANSSEN$$61$YR$A$M$Y$56.6$KG$20151229$$MD$KR$KR
117814701$11781470$1$I$20151117$20151118$20151126$20151126$EXP$$US-JNJFOC-20151118903$JANSSEN$$59$YR$A$M$Y$54$KG$20151126$$MD$US$US
117816572$11781657$2$F$20150929$20160205$20151126$20160218$EXP$$AU-JNJFOC-20151104693$JANSSEN$$64$YR$A$M$Y$110$KG$20160218$$MD$AU$AU
117823039$11782303$9$F$$20200922$20151127$20200927$EXP$$CA-ROCHE-1667732$ROCHE$$64$YR$$F$Y$69$KG$20200928$$HP$CA$CA
1178275415$11782754$15$F$2015$20200811$20151127$20200813$EXP$$US-PFIZER INC-2015406045$PFIZER$$60$YR$$F$Y$81$KG$20200813$$MD$US$US
117839396$11783939$6$F$$20200727$20151128$20200810$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-106614$RANBAXY$$80$YR$$F$Y$$$20200810$$HP$NL$GB
117849917$11784991$7$F$$20180502$20151130$20180508$EXP$$BR-ROCHE-1666633$ROCHE$$$$$F$Y$45$KG$20180508$$CN$BR$BR
117854502$11785450$2$F$$20200702$20151130$20200706$PER$$US-PFIZER INC-2015394621$PFIZER$$66$YR$$M$Y$$$20200706$$MD$US$US
117871203$11787120$3$F$20150307$20200920$20151130$20200928$PER$$US-JNJFOC-20151125828$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200928$$CN$US$US
1178727813$11787278$13$F$20150820$20200714$20151130$20200717$EXP$$CA-TAKEDA-2015TUS012330$TAKEDA$$47$YR$$F$Y$$$20200717$$HP$CA$CA
117874957$11787495$7$F$2015$20200903$20151130$20200908$EXP$$US-SA-2015SA178388$SANOFI AVENTIS$$$$$$Y$$$20200908$$CN$US$US
117876764$11787676$4$F$2013$20200710$20151130$20200715$EXP$$US-JAZZ-2015-US-020096$JAZZ$$$$$F$Y$$$20200715$$MD$US$US
117877155$11787715$5$F$$20200828$20151130$20200831$EXP$$PHHY2015GB152434$NOVARTIS$MALIK BH, HAMID P, KHAN S, GUPTA D, ISLAM M. CORRELATION BETWEEN DONEPEZIL AND QTC PROLONGATION AND TORSADES DE POINTES: A VERY RARE PHENOMENON. CUREUS. 2019?11(12):E6451$83$YR$$F$Y$$$20200831$$HP$GB$GB
117877585$11787758$5$F$20151103$20161118$20151130$20161124$EXP$$JP-JNJFOC-20151105503$JANSSEN$$74$YR$E$F$Y$50.2$KG$20161124$$MD$JP$JP
1178870214$11788702$14$F$20151029$20200626$20151201$20200710$EXP$$CA-ROCHE-1670618$ROCHE$$65$YR$$M$Y$95$KG$20200710$$CN$CA$CA
1178896347$11788963$47$F$20151112$20200818$20151201$20200824$EXP$$PHHY2015CA151030$NOVARTIS$$61$YR$$F$Y$$$20200824$$MD$CA$CA
117889711$11788971$1$I$20141023$20151123$20151201$20151201$EXP$$PHHY2015CN156111$NOVARTIS$LEI Z, JIAN?WEI W. CASE ANALYSIS OF OSTEONECROSIS OF THE JAW ASSOCIATED WITH BISPHOSPHONATES. WORLD LATEST MEDICINE INFORMATION. 2015?15(42)$67$YR$$F$Y$$$20151201$$HP$CN$CN
117897922$11789792$2$F$20140818$20200915$20151201$20200924$EXP$$US-BAYER-2015-386520$BAYER$$82$YR$E$M$Y$$$20200924$$CN$US$US
117898606$11789860$6$F$20151120$20170303$20151201$20170310$EXP$$US-JNJFOC-20151124554$PHARMACYCLICS$$71$YR$E$F$Y$63$KG$20170310$$MD$US$US
117907376$11790737$6$F$$20200831$20151201$20200902$EXP$$US-PFIZER INC-2014306190$PFIZER$$80$YR$$F$Y$94.8$KG$20200902$$CN$US$US
117917384$11791738$4$F$201310$20200628$20151201$20200702$PER$$US-JNJFOC-20151127142$JOHNSON AND JOHNSON$$49$YR$$F$Y$$$20200702$$CN$US$US
117919861$11791986$1$I$20150630$20150702$20151201$20151201$EXP$$FR-JNJFOC-20150702128$JANSSEN$$69$YR$E$F$Y$65$KG$20151201$$MD$FR$FR
117920103$11792010$3$F$$20200717$20151201$20200721$EXP$$PHHY2015FR152115$NOVARTIS$DERLON V. AZTREONAM/PANTOPRAZOLE DRESS SYNDROME: CASE REPORT.. REACTION WEEKLY. 2015?1577:55$31$YR$$F$Y$$$20200721$$HP$NL$FR
117928844$11792884$4$F$20150327$20161024$20151202$20161107$EXP$$JP-ROCHE-1668394$ROCHE$$68$YR$$M$Y$70$KG$20161107$$MD$JP$JP
117931272$11793127$2$F$20141002$20200719$20151202$20200724$EXP$$US-BAYER-2015-439179$BAYER$$70$YR$E$F$Y$$$20200724$$CN$US$US
117939445$11793944$5$F$20090406$20200811$20151202$20200821$EXP$$JP-009507513-1511JPN015429$MERCK$$61$YR$$M$Y$74$KG$20200821$$CN$JP$JP
117940073$11794007$3$F$$20200624$20151202$20200701$EXP$$FR-SA-2015SA199333$SANOFI AVENTIS$GHIRINGHELLI F, VINCENT J, BELTJENS F, BENGRINE L, LADOIRE S. FLUOROURACIL, LEUCOVORIN AND IRINOTECAN ASSOCIATED WITH AFLIBERCEPT CAN INDUCE MICROSCOPIC COLITIS IN METASTATIC COLORECTAL CANCER PATIENTS.. INVEST NEW DRUGS.. 2015?33(6):1263?6$$$$$Y$$$20200701$$MD$FR$FR
117941862$11794186$2$F$20151103$20160706$20151202$20160713$EXP$$GB-JNJFOC-20151112541$JANSSEN$$68$YR$E$F$Y$71.6$KG$20160713$$MD$GB$GB
117942144$11794214$4$F$$20160301$20151202$20160405$EXP$$GB-AUROBINDO-AUR-APL-2015-10818$AUROBINDO$$54$YR$$M$Y$$$20160405$$HP$GB$GB
117942552$11794255$2$F$20151007$20160707$20151202$20160715$EXP$$CA-JNJFOC-20151120521$JANSSEN$$61$YR$A$F$Y$55$KG$20160715$$MD$CA$CA
117942626$11794262$6$F$2015$20200706$20151202$20200713$EXP$$US-SA-2015SA164384$SANOFI AVENTIS$$$$$M$Y$$$20200713$$CN$US$US
117942826$11794282$6$F$$20200718$20151202$20200727$EXP$$FR-AUROBINDO-AUR-APL-2015-10805$AUROBINDO$$31$YR$$F$Y$$$20200727$$HP$FR$FR
117951061$11795106$1$I$20151105$20151106$20151202$20151202$EXP$$US-JNJFOC-20151108432$JANSSEN$$41$YR$A$M$Y$61.8$KG$20151202$$MD$US$US
117962125$11796212$5$F$20151127$20160831$20151203$20160914$EXP$$CA-ROCHE-1671341$ROCHE$$84$YR$$M$Y$63.5$KG$20160914$$MD$CA$CA
117980041$11798004$1$I$200312$20040322$20151203$20151203$EXP$$CA-JNJFOC-20040305316$JANSSEN$$48$YR$A$M$Y$$$20151203$$MD$CA$CA
117981015$11798101$5$F$20151022$20151119$20151203$20160712$EXP$$NZ-JNJFOC-20151123824$JANSSEN$$60$YR$A$F$Y$55.2$KG$20160712$$MD$NZ$NZ
117982863$11798286$3$F$20151002$20151216$20151203$20151222$EXP$$RU-JNJFOC-20151002775$JANSSEN$$62$YR$A$F$Y$85$KG$20151222$$MD$RU$RU
117982873$11798287$3$F$20150915$20160225$20151203$20160229$EXP$$ZA-JNJFOC-20150916742$JANSSEN$$75$YR$E$F$Y$84$KG$20160229$$MD$ZA$ZA
117998103$11799810$3$F$2012$20200916$20151203$20200921$EXP$$US-JAZZ-2015-US-020516$JAZZ$$$$$M$Y$$$20200921$$HP$US$US
117998242$11799824$2$F$20151120$20160325$20151203$20160405$EXP$$PL-JNJFOC-20151124100$JANSSEN$$66$YR$E$M$Y$63$KG$20160405$$MD$PL$PL
117998307$11799830$7$F$20151030$20190116$20151203$20190125$EXP$$DE-JNJFOC-20151124116$PHARMACYCLICS$CHENG C, WORONOW D, NAYERNAMA A, WROBLEWSKI T, JONES CS. IBRUTINIB?ASSOCIATED VENTRICULAR ARRHYTHMIA IN THE FDA ADVERSE EVENT REPORTING SYSTEM. LEUKEMIA + LYMPHOMA 2018?59 (NO 12):3016?3017.$77$YR$E$M$Y$68$KG$20190125$$MD$DE$DE
1180020719$11800207$19$F$$20200720$20151203$20200723$PER$$CA-AMGEN-KDL279454$AMGEN$$53$YR$A$F$Y$$$20200723$$CN$CA$CA
1180068716$11800687$16$F$201307$20200915$20151204$20200924$EXP$$CA-ROCHE-1671688$ROCHE$$71$YR$$F$Y$$$20200924$$MD$CA$CA
118007907$11800790$7$F$20180121$20200714$20151204$20200715$EXP$$US-PFIZER INC-2015406991$PFIZER$$68$YR$$F$Y$71.2$KG$20200715$$MD$US$US
118009243$11800924$3$F$2015$20200227$20151204$20200803$EXP$$DE-JNJFOC-20151202341$JOHNSON AND JOHNSON$$51$YR$A$M$Y$66$KG$20200803$$MD$DE$DE
118009751$11800975$1$I$20151124$20151125$20151204$20151204$EXP$$IL-JNJFOC-20151125096$PHARMACYCLICS$$78$YR$E$M$Y$68.8$KG$20151204$$MD$IL$IL
118012672$11801267$2$F$2020$20200817$20151204$20200819$PER$$US-PFIZER INC-2015419760$PFIZER$$73$YR$$F$Y$$$20200819$$HP$US$US
118013352$11801335$2$F$20151122$20151207$20151204$20151211$EXP$$PHHO2015US019785$NOVARTIS$$49$YR$$F$Y$54.4$KG$20151211$$MD$US$US
1180193014$11801930$14$F$$20200629$20151204$20200707$EXP$$CA-PFIZER INC-2015411810$PFIZER$$71$YR$$F$Y$$$20200707$$HP$CA$CA
118039028$11803902$8$F$20151121$20170622$20151204$20170629$EXP$$JP-JNJFOC-20151122840$JANSSEN$$69$YR$E$M$Y$55.8$KG$20170629$$MD$JP$JP
118056642$11805664$2$F$2015$20200807$20151207$20200812$PER$$US-AMGEN-USASP2015127807$AMGEN$$74$YR$E$M$Y$$$20200812$$MD$US$US
1180606215$11806062$15$F$20151201$20200921$20151207$20200928$EXP$$PHHY2015CA158998$NOVARTIS$$50$YR$$M$Y$$$20200928$$CN$COUNTRY NOT SPECIFIED$CA
118064622$11806462$2$F$20151010$20151202$20151207$20151215$EXP$$GB-JNJFOC-20151010246$JANSSEN$$65$YR$A$M$Y$89.5$KG$20151215$$MD$GB$GB
118069012$11806901$2$F$201309$20200804$20151207$20200814$EXP$$US-BAYER-2015-436522$BAYER$$72$YR$E$F$Y$92.2$KG$20200814$$CN$US$US
118069532$11806953$2$F$$20200904$20151207$20200908$PER$$US-PFIZER INC-2015407260$PFIZER$$55$YR$$M$Y$$$20200908$$MD$US$US
118069683$11806968$3$F$20131003$20160620$20151207$20160628$EXP$$US-JNJFOC-20151203131$JANSSEN$$24$YR$A$M$Y$77.6$KG$20160628$$MD$US$US
118075953$11807595$3$F$20131211$20200802$20151207$20200810$EXP$$US-JNJFOC-20151203656$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200810$$CN$US$US
118076883$11807688$3$F$20141001$20200712$20151207$20200715$PER$$US-JNJFOC-20151204870$JOHNSON AND JOHNSON$$62$YR$$M$Y$$$20200715$$LW$US$US
118079064$11807906$4$F$20151124$20160720$20151207$20160728$EXP$$PL-JNJFOC-20151126077$JANSSEN$$27$YR$A$M$Y$84$KG$20160728$$MD$PL$PL
118079076$11807907$6$F$20150908$20181108$20151207$20181114$EXP$$US-JNJFOC-20150919311$JANSSEN$$77$YR$E$F$Y$65.2$KG$20181114$$MD$US$US
118091044$11809104$4$F$$20200710$20151207$20200715$PER$$US-JAZZ-2015-US-020806$JAZZ$$$$$F$Y$$$20200715$$MD$US$US
118105494$11810549$4$F$20151202$20160601$20151208$20160605$EXP$$PL-JNJFOC-20151203476$JANSSEN$$60$YR$A$M$Y$79$KG$20160605$$MD$PL$PL
118106222$11810622$2$F$20151130$20160202$20151208$20160204$EXP$$IT-PFIZER INC-2015425682$PFIZER$$81$YR$$F$Y$$$20160204$$MD$IT$IT
118106613$11810661$3$F$20151113$20160509$20151208$20160516$EXP$$US-ELI_LILLY_AND_COMPANY-US201511008577$ELI LILLY AND CO$$29$YR$$F$Y$$$20160513$$CN$US$US
1181083614$11810836$14$F$$20200622$20151208$20200701$EXP$$CA-OTSUKA-2015_016174$OTSUKA$$41$YR$$F$Y$$$20200701$$CN$CA$CA
118112792$11811279$2$F$20141012$20200727$20151208$20200811$EXP$$US-BAYER-2015-440256$BAYER$$83$YR$E$F$Y$$$20200811$$CN$US$US
118113898$11811389$8$F$201802$20200708$20151208$20200716$EXP$$US-PFIZER INC-2015410388$PFIZER$$43$YR$$F$Y$76$KG$20200716$$CN$US$US
118121023$11812102$3$F$20131206$20200824$20151208$20200828$PER$$US-JNJFOC-20151205224$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200828$$LW$US$US
118121063$11812106$3$F$20141203$20200729$20151208$20200803$PER$$US-JNJFOC-20151205293$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200803$$CN$US$US
1181267226$11812672$26$F$20151125$20200513$20151208$20200921$EXP$$CA-ROCHE-1674495$ROCHE$$68$YR$$M$Y$$$20200921$$CN$CA$CA
1181349332$11813493$32$F$20130911$20200918$20151209$20200924$EXP$$PHHY2012CA016234$NOVARTIS$$68$YR$$M$Y$68.02$KG$20200925$$PH$CA$CA
118136142$11813614$2$F$2015$20200901$20151209$20200904$EXP$$US-BAYER-2015-420604$BAYER$$65$YR$E$F$Y$$$20200904$$CN$US$US
118143184$11814318$4$F$20151120$20160113$20151209$20160916$EXP$$RU-JNJFOC-20151121943$JANSSEN$$49$YR$A$F$Y$75$KG$20160916$$MD$RU$RU
118152864$11815286$4$F$20141230$20200920$20151209$20200923$PER$$US-JNJFOC-20151205852$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200923$$CN$US$US
118153292$11815329$2$F$20150116$20200726$20151209$20200810$EXP$$US-BAYER-2015-420744$BAYER$$80$YR$E$M$Y$$$20200810$$CN$US$US
118203102$11820310$2$F$20131001$20200913$20151210$20200923$EXP$$US-BAYER-2015-441049$BAYER$$76$YR$E$M$Y$$$20200923$$CN$US$US
118225614$11822561$4$F$20141024$20200623$20151210$20200702$EXP$$PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-083293$BRISTOL MYERS SQUIBB$ARAUJO R, BATISTA S, SOUSA M, SANTIAGO B. POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME IN AN 18?YEAR?OLD PUERPERAL HIV PATIENT ON ANTIRETROVIRAL THERAPY. EUROPEAN JOURNAL OF NEUROLOGY. 2015?22(SUPPL 1):484?828$18$YR$$F$Y$$$20200702$$MD$PT$PT
118231742$11823174$2$F$$20200910$20151210$20200918$EXP$$CA-BAYER-2015-003998$BAYER$$62$YR$A$F$Y$86$KG$20200918$$HP$US$CA
118238175$11823817$5$F$$20200624$20151210$20200702$EXP$$FR-BAUSCH-BL-2015-029105$BAUSCH AND LOMB$GHIRINGHELLI F, VINCENT J, BELTJENS F, BENGRINE L, LADOIRE S. FLUOROURACIL, LEUCOVORIN AND IRINOTECAN ASSOCIATED WITH AFLIBERCEPT CAN INDUCE MICROSCOPIC COLITIS IN METASTATIC COLORECTAL CANCER PATIENTS. INVESTIGATIONAL NEW DRUGS. 2015 OCT 22?33:1263?1266. DOI:10.1007/S10637?015?0295?6$59$YR$$M$Y$$$20200702$$MD$FR$FR
118238625$11823862$5$F$$20200701$20151210$20200714$EXP$$FR-BAUSCH-BL-2015-029103$BAUSCH AND LOMB$GHIRINGHELLI F, VINCENT J, BELTJENS F, BENGRINE L, LADOIRE S. FLUOROURACIL, LEUCOVORIN AND IRINOTECAN ASSOCIATED WITH AFLIBERCEPT CAN INDUCE MICROSCOPIC COLITIS IN METASTATIC COLORECTAL CANCER PATIENTS. INVESTIGATIONAL NEW DRUGS. 2015 OCT 22?33(6):1263?1266. DOI:10.1007/S10637?015?0295?6$34$YR$$M$Y$$$20200714$$MD$FR$FR
118267925$11826792$5$F$20151111$20160119$20151211$20200714$EXP$$US-NOVOPROD-471528$NOVO NORDISK$$66$YR$$F$Y$118$KG$20200714$$MD$US$US
118271024$11827102$4$F$201505$20200716$20151211$20200730$EXP$$US-BAYER-2015-446280$BAYER$$63$YR$A$F$Y$$$20200730$$CN$US$US
118275795$11827579$5$F$20141119$20200727$20151211$20200803$EXP$$PHHY2015US158489$NOVARTIS$$47$YR$$F$Y$$$20200803$$MD$US$US
118282253$11828225$3$F$20151130$20160127$20151211$20160205$EXP$$US-JNJFOC-20151209063$PHARMACYCLICS$$19$YR$A$F$Y$53.2$KG$20160205$$MD$US$US
118286812$11828681$2$F$20151111$20160908$20151211$20160919$EXP$$US-JNJFOC-20151113732$JANSSEN$$51$YR$A$M$Y$75$KG$20160919$$MD$US$US
118288682$11828868$2$F$$20200915$20151211$20200922$EXP$$JP-PFIZER INC-2015433578$PFIZER$HAYASHI, Y.. A CHILD CASE OF GENERALIZED CRYPTOGENIC EPILEPSY MANIFESTING SEVERE ABNORMAL ELECTROENCEPHALOGRAM SUCCESSFULLY TREATED WITH ETHOSUXIMIDE.. THE 45TH MEETING OF THE JAPANESE SOCIETY OF CLINICAL NEUROPHYSIOLOGY. 2015?43(5):378$3$YR$$F$Y$$$20200922$$MD$JP$JP
118288762$11828876$2$F$$20200802$20151211$20200813$EXP$$CA-APOTEX-2015AP015175$APOTEX$$$$$M$Y$2$KG$20200813$$HP$CA$CA
118306842$11830684$2$F$$20200810$20151214$20200818$EXP$$PT-JNJFOC-20151203095$JOHNSON AND JOHNSON$GOMES S, GAGO C, CAMPOS A, GOUVEIA C, NOBREGA S. CHOLESTATIC JAUNDICE  WHERE DID IT START. ACTAPEDIATRPORT. 2015?46 (4):66?184.$12$YR$T$F$Y$$$20200818$$HP$PT$PT
1183085538$11830855$38$F$20141119$20200622$20151214$20200706$EXP$$CA-ROCHE-1675990$ROCHE$$53$YR$$F$Y$$$20200706$$MD$CA$CA
118312136$11831213$6$F$20150801$20200702$20151214$20200707$PER$$PHHY2015US159857$NOVARTIS$$60$YR$$M$Y$$$20200707$$MD$US$US
118317399$11831739$9$F$$20200728$20151214$20200730$EXP$$US-PFIZER INC-2015421946$PFIZER$$58$YR$$F$Y$52.16$KG$20200730$$CN$US$US
118321332$11832133$2$F$20151116$20160429$20151214$20160506$EXP$$US-JNJFOC-20151203060$JANSSEN$$54$YR$A$F$Y$83.01$KG$20160506$$MD$US$US
118322853$11832285$3$F$20150916$20200618$20151214$20200701$EXP$$US-ACTELION-A-NJ2015-126149$ACTELION$$67$YR$$M$Y$$$20200701$$HP$US$US
1183255622$11832556$22$F$20100701$20200901$20151214$20200911$EXP$$PHHY2014CA037354$NOVARTIS$$54$YR$$F$Y$$$20200911$$MD$CA$CA
118331537$11833153$7$F$20151206$20160427$20151214$20160429$EXP$$JP-JNJFOC-20151206662$JANSSEN$$38$YR$A$M$Y$51.1$KG$20160429$$MD$JP$JP
118335582$11833558$2$F$20150112$20191211$20151214$20200915$PER$$US-PERRIGO-15US010997$PERRIGO$$67$YR$$F$Y$63.49$KG$20200915$$CN$US$US
1183379010$11833790$10$F$20141210$20200728$20151214$20200730$EXP$GB-EMA-DD-20180219-TANEJAEVHP-174757$PHFR2014GB008905$NOVARTIS$$41$YR$$F$Y$$$20200730$$HP$GB$GB
118341504$11834150$4$F$20130711$20200811$20151214$20200821$EXP$$US-JNJFOC-20151116415$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200821$$CN$US$US
118341516$11834151$6$F$201004$20200721$20151214$20200731$PER$$US-JNJFOC-20151116416$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200731$$CN$US$US
118341523$11834152$3$F$20140227$20200916$20151214$20200921$PER$$US-JNJFOC-20151116561$JOHNSON AND JOHNSON$$73$YR$E$M$Y$79.6$KG$20200921$$CN$US$US
118341715$11834171$5$F$201402$20200712$20151214$20200721$EXP$$US-JNJFOC-20151117541$JOHNSON AND JOHNSON$$61$YR$$M$Y$145.2$KG$20200721$$CN$US$US
118341803$11834180$3$F$20150326$20200908$20151214$20200914$PER$$US-JNJFOC-20151119169$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20200914$$CN$US$US
118341943$11834194$3$F$20150426$20200910$20151214$20200915$PER$$US-JNJFOC-20151119179$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200915$$CN$US$US
118341985$11834198$5$F$20150120$20200826$20151214$20200901$PER$$US-JNJFOC-20151119160$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200901$$CN$US$US
118342303$11834230$3$F$20141117$20200809$20151214$20200813$PER$$US-JNJFOC-20151119967$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200813$$CN$US$US
118342463$11834246$3$F$20150329$20200820$20151214$20200901$EXP$$US-JNJFOC-20151119982$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200901$$CN$US$US
118342683$11834268$3$F$201311$20200629$20151214$20200702$PER$$US-JNJFOC-20151121826$JOHNSON AND JOHNSON$$72$YR$$M$Y$$$20200702$$LW$US$US
118342983$11834298$3$F$20140117$20200921$20151214$20200930$EXP$$US-JNJFOC-20151125825$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20200930$$CN$US$US
118343064$11834306$4$F$20130407$20200920$20151214$20200922$PER$$US-JNJFOC-20151126833$JOHNSON AND JOHNSON$$75$YR$E$M$Y$105.33$KG$20200922$$CN$US$US
118343253$11834325$3$F$20131224$20200701$20151214$20200706$PER$$US-JNJFOC-20151201107$JOHNSON AND JOHNSON$$77$YR$$M$Y$$$20200706$$HP$US$US
118343493$11834349$3$F$201411$20200803$20151214$20200807$EXP$$US-JNJFOC-20151203496$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200807$$CN$US$US
118343535$11834353$5$F$20131117$20200630$20151214$20200714$EXP$$US-JNJFOC-20151119929$JOHNSON AND JOHNSON$$53$YR$$M$Y$$$20200714$$CN$US$US
118343623$11834362$3$F$20141204$20200722$20151214$20200731$PER$$US-JNJFOC-20151202084$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200731$$CN$US$US
118343743$11834374$3$F$20150116$20200727$20151214$20200731$PER$$US-JNJFOC-20151205174$JOHNSON AND JOHNSON$$91$YR$E$M$Y$$$20200731$$CN$US$US
118343793$11834379$3$F$20140830$20200917$20151214$20200921$PER$$US-JNJFOC-20151124886$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200921$$CN$US$US
118343833$11834383$3$F$201301$20200707$20151214$20200713$EXP$$US-JNJFOC-20151124901$JOHNSON AND JOHNSON$$81$YR$$M$Y$$$20200713$$CN$US$US
118343905$11834390$5$F$20140701$20200712$20151214$20200721$EXP$$US-JNJFOC-20151124895$JOHNSON AND JOHNSON$$57$YR$$M$Y$$$20200721$$CN$US$US
118343934$11834393$4$F$20140826$20200726$20151214$20200730$PER$$US-JNJFOC-20151124916$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200730$$CN$US$US
118343944$11834394$4$F$201403$20200927$20151214$20200930$PER$$US-JNJFOC-20151124892$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200930$$HP$US$US
118343963$11834396$3$F$20130724$20200629$20151214$20200706$PER$$US-JNJFOC-20151124936$JOHNSON AND JOHNSON$$60$YR$$F$Y$$$20200706$$CN$US$US
118344053$11834405$3$F$20140914$20200707$20151214$20200713$PER$$US-JNJFOC-20151124941$JOHNSON AND JOHNSON$$81$YR$$F$Y$$$20200713$$CN$US$US
118344064$11834406$4$F$20140401$20200628$20151214$20200709$EXP$$US-JNJFOC-20151124942$JOHNSON AND JOHNSON$$79$YR$$F$Y$$$20200709$$CN$US$US
118344193$11834419$3$F$20140803$20200709$20151214$20200713$PER$$US-JNJFOC-20151124888$JOHNSON AND JOHNSON$$67$YR$$F$Y$$$20200713$$CN$US$US
118345233$11834523$3$F$20131202$20200820$20151214$20200825$EXP$$US-JNJFOC-20151205826$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20200825$$CN$US$US
118345423$11834542$3$F$201401$20200908$20151214$20200921$EXP$$US-JNJFOC-20151205835$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200921$$CN$US$US
118346073$11834607$3$F$20150210$20200830$20151214$20200901$PER$$US-JNJFOC-20151117629$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200901$$CN$US$US
118347653$11834765$3$F$20150223$20200813$20151215$20200825$EXP$$US-JNJFOC-20151103261$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200825$$HP$US$US
118348354$11834835$4$F$20140611$20200820$20151215$20200901$EXP$$US-JNJFOC-20151104475$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200901$$CN$US$US
118348802$11834880$2$F$201311$20200727$20151215$20200731$PER$$US-JNJFOC-20151103886$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200731$$HP$US$US
118348843$11834884$3$F$201405$20200712$20151215$20200715$PER$$US-JNJFOC-20151103951$JOHNSON AND JOHNSON$$72$YR$$F$Y$$$20200715$$CN$US$US
118348873$11834887$3$F$20140808$20200712$20151215$20200714$PER$$US-JNJFOC-20151103954$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200714$$CN$US$US
118348923$11834892$3$F$20140410$20200914$20151215$20200917$PER$$US-JNJFOC-20151103539$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20200917$$CN$US$US
118349063$11834906$3$F$20140908$20200726$20151215$20200729$PER$$US-JNJFOC-20151108433$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200729$$CN$US$US
118349283$11834928$3$F$20131120$20200806$20151215$20200811$PER$$US-JNJFOC-20151110522$JOHNSON AND JOHNSON$$80$YR$E$M$Y$87.99$KG$20200811$$LW$US$US
118349393$11834939$3$F$20140102$20200921$20151215$20200928$PER$$US-JNJFOC-20151109882$JOHNSON AND JOHNSON$$57$YR$A$F$Y$80.36$KG$20200928$$LW$US$US
118349434$11834943$4$F$20140308$20200728$20151215$20200731$PER$$US-JNJFOC-20151114619$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200731$$CN$US$US
118349512$11834951$2$F$20130921$20200813$20151215$20200820$PER$$US-JNJFOC-20151110423$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200820$$HP$US$US
118349642$11834964$2$F$201409$20200903$20151215$20200909$PER$$US-JNJFOC-20151115944$JOHNSON AND JOHNSON$$63$YR$A$F$Y$83.3$KG$20200909$$HP$US$US
118353482$11835348$2$F$$20200921$20151215$20200928$EXP$$US-AUROBINDO-AUR-APL-2015-11304$AUROBINDO$$33$YR$$M$Y$$$20200928$$HP$US$US
118354882$11835488$2$F$20131004$20200628$20151215$20200710$EXP$$US-BAYER-2015-440725$BAYER$$92$YR$E$M$Y$$$20200710$$CN$US$US
118371282$11837128$2$F$20150529$20200902$20151215$20200908$EXP$$US-BAYER-2015-469066$BAYER$$73$YR$E$F$Y$$$20200908$$CN$US$US
118379423$11837942$3$F$20151202$20151204$20151215$20160404$EXP$$IT-JNJFOC-20151205937$JANSSEN$$76$YR$E$F$Y$86$KG$20160404$$MD$IT$IT
118393372$11839337$2$F$20150828$20200727$20151216$20200805$PER$$PHHY2015US159859$NOVARTIS$$58$YR$$F$Y$$$20200805$$MD$US$US
1183949815$11839498$15$F$20150930$20200702$20151216$20200713$EXP$$PHHY2015CA119952$NOVARTIS$$63$YR$$M$Y$$$20200714$$CN$CA$CA
118416934$11841693$4$F$20150821$20160323$20151216$20160331$EXP$$AU-JNJFOC-20150818168$JANSSEN$$78$YR$E$M$Y$76$KG$20160331$$MD$AU$AU
1184267024$11842670$24$F$$20200731$20151216$20200807$EXP$$ES-PFIZER INC-2015449406$PFIZER$$74$YR$$F$Y$$$20200807$$CN$FR$ES
118427073$11842707$3$F$$20200724$20151216$20200804$EXP$$ES-ASTRAZENECA-2015SF23834$ASTRAZENECA$$74$YR$$F$Y$$$20200804$$HP$ES$ES
118430143$11843014$3$F$2015$20200713$20151216$20200714$PER$$US-PFIZER INC-2015443068$PFIZER$$55$YR$$F$Y$$$20200714$$CN$US$US
118444182$11844418$2$F$20150216$20200702$20151217$20200715$EXP$$US-BAYER-2015-445252$BAYER$$84$YR$E$M$Y$$$20200715$$CN$US$US
118447082$11844708$2$F$20140810$20200625$20151217$20200708$EXP$$US-BAYER-2015-445291$BAYER$$68$YR$E$F$Y$$$20200708$$CN$US$US
118457347$11845734$7$F$20151210$20180115$20151217$20180116$EXP$$US-JNJFOC-20151211584$JANSSEN$$71$YR$E$F$Y$71.67$KG$20180116$$MD$US$US
118480105$11848010$5$F$$20200824$20151217$20200827$EXP$$US-JAZZ-2015-US-021453$JAZZ$$$$$M$Y$$$20200827$$CN$US$US
118482828$11848282$8$F$$20200907$20151217$20200908$EXP$$CA-ROCHE-1678516$ROCHE$$18$YR$$F$Y$$$20200908$$HP$CA$CA
118484753$11848475$3$F$$20200921$20151218$20200930$EXP$$DE-ROCHE-1676611$ROCHE$$$$$$Y$$$20200930$$HP$DE$DE
118484833$11848483$3$F$$20200921$20151218$20200930$EXP$$DE-ROCHE-1678985$ROCHE$$$$$$Y$$$20200930$$HP$DE$DE
118497474$11849747$4$F$20151001$20200810$20151218$20200818$EXP$$US-BIOGEN-2015BI155558$BIOGEN$$43$YR$$F$Y$$$20200818$$MD$US$US
118527709$11852770$9$F$20150120$20200915$20151218$20200923$EXP$$JP-INCYTE CORPORATION-2015IN006509$INCYTE$$$$$$Y$$$20200923$$MD$JP$JP
1185295815$11852958$15$F$$20200731$20151218$20200805$EXP$$ES-SA-2015SA214444$SANOFI AVENTIS$ISIDORO?GARCIA M, SANCHEZ?MARTIN A, GARCIA?BERROCAL B, ROMAN?CURTO C.. PRIMUN NON NOCERE, POLYPHARMACY AND PHARMACOGENETICS.. PHARMACOGENOMICS. 2015?16(17):1903?5$$$$$Y$$$20200805$$MD$ES$ES
118534272$11853427$2$F$20010322$20200910$20151218$20200921$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-10850311$BRISTOL MYERS SQUIBB$$0$DY$$M$Y$3.24$KG$20200921$$HP$US$US
118537792$11853779$2$F$$20200623$20151219$20200703$PER$$US-009507513-1512USA008213$MERCK$$10$YR$$F$Y$$$20200703$$MD$US$US
1185608723$11856087$23$F$20151127$20200922$20151221$20200929$EXP$$PHHY2015CA120340$NOVARTIS$$64$YR$$F$Y$$$20200929$$CN$COUNTRY NOT SPECIFIED$CA
118570044$11857004$4$F$$20200716$20151221$20200724$EXP$ES-MLMSERVICE-20151209-0103683-1$ES-GALDERMA-ES15009045$GALDERMA$HEALTH AUTHORITY, ISIDORO?GARCIA M. PRIMUN NON NOCERE, POLYPHARMACY AND PHARMACOGENETICS. PHARMACOGENOMICS. 2015?16 (17):1903?1905.$74$YR$$F$Y$$$20200724$$HP$ES$ES
118572104$11857210$4$F$2017$20200903$20151221$20200904$PER$$US-PFIZER INC-2015412056$PFIZER$$70$YR$$F$Y$77$KG$20200904$$CN$US$US
118583413$11858341$3$F$20150304$20160125$20151222$20171221$EXP$$US-ROCHE-1558915$ROCHE$$82$YR$$F$Y$47.1$KG$20171221$$MD$US$US
1185862910$11858629$10$F$$20200629$20151222$20200712$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2007-000002$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200712$$MD$FR$FR
118586643$11858664$3$F$20010322$20200916$20151222$20200918$EXP$$US-009507513-01050823$MERCK$$1$DY$$M$Y$3.24$KG$20200918$$CN$US$US
118587494$11858749$4$F$20141002$20160622$20151222$20160704$EXP$$JP-ROCHE-1667324$ROCHE$$38$YR$$F$Y$50$KG$20160704$$MD$JP$JP
118587692$11858769$2$F$$20200921$20151222$20200928$EXP$$US-AUROBINDO-AUR-APL-2015-11540$AUROBINDO$$17$YR$$F$Y$$$20200929$$MD$US$US
118593447$11859344$7$F$2014$20200910$20151221$20200915$EXP$$US-JAZZ-2015-US-021824$JAZZ$$$$$M$Y$139.68$KG$20200915$$CN$US$US
118600063$11860006$3$F$20151127$20200623$20151222$20200701$EXP$$GB-AUROBINDO-AUR-APL-2015-11635$AUROBINDO$$59$YR$$F$Y$$$20200701$$CN$GB$GB
118607404$11860740$4$F$2015$20200325$20151222$20200401$EXP$$PHHY2015CA149862$NOVARTIS$$47$YR$$F$Y$$$20200401$$CN$COUNTRY NOT SPECIFIED$CA
118613151$11861315$1$I$$20130510$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00190$AVANIR$$51$YR$$F$Y$$$20151222$$CN$US$US
118613161$11861316$1$I$201305$20130531$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00202$AVANIR$$74$YR$$F$Y$$$20151222$$CN$US$US
118613171$11861317$1$I$$20130502$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00187$AVANIR$$25$YR$$F$Y$$$20151222$$CN$US$US
118613191$11861319$1$I$2013$20130619$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00211$AVANIR$$$$$M$Y$$$20151222$$CN$US$US
118613221$11861322$1$I$$20130515$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00191$AVANIR$$44$YR$$M$Y$$$20151222$$CN$US$US
118613281$11861328$1$I$$20130528$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00200$AVANIR$$56$YR$$F$Y$$$20151222$$CN$US$US
118613321$11861332$1$I$201305$20130628$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00218$AVANIR$$44$YR$$F$Y$$$20151222$$CN$US$US
118613391$11861339$1$I$$20130517$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00195$AVANIR$$53$YR$$F$Y$$$20151222$$CN$US$US
118613501$11861350$1$I$2013$20130712$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00220$AVANIR$$74$YR$$M$Y$$$20151222$$CN$US$US
118613511$11861351$1$I$2013$20130805$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00225$AVANIR$$67$YR$$M$Y$$$20151222$$CN$US$US
118613591$11861359$1$I$2013$20130903$20151222$20151222$PER$$US-AVANIR PHARMACEUTICALS, INC.-2013NUEUSA00238$AVANIR$$54$YR$$M$Y$$$20151222$$CN$US$US
118615241$11861524$1$I$$20151209$20151222$20151222$EXP$$US-MYLANLABS-2015M1046008$MYLAN$GERARDI DM, MURPHY TK, TOUFEXIS M, HANKS C. SEROTONERGIC OR ANTICHOLINERGIC TOXIDROME: CASE REPORT OF A 9?YEAR?OLD GIRL. PEDIATR?EMERG?CARE 2015? 31(12):846?50.$$$$$Y$$$20151221$$HP$US$US
118615793$11861579$3$F$2015$20200717$20151222$20200730$EXP$$JP-JNJFOC-20151216930$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20200730$$MD$JP$JP
118615843$11861584$3$F$$20160426$20151222$20200701$EXP$$GR-JNJFOC-20151217230$JOHNSON AND JOHNSON$$$$E$M$Y$$$20200701$$CN$GR$GR
118621127$11862112$7$F$20150323$20200915$20151222$20200924$EXP$$US-BIOGEN-2015BI052465$BIOGEN$$38$YR$$M$Y$107.5$KG$20200924$$CN$US$US
118627481$11862748$1$I$20150521$20150522$20151223$20151223$EXP$$UA-ACTELION-A-CH2015-118479$ACTELION$$40$YR$A$F$Y$63.7$KG$20151223$$MD$UA$UA
118628621$11862862$1$I$20151005$20151119$20151223$20151223$EXP$$IT-ROCHE-1665005$ROCHE$$45$YR$$F$Y$$$20151223$$MD$IT$IT
118630478$11863047$8$F$$20200626$20151223$20200710$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2015RR-108227$RANBAXY$$74$YR$$F$Y$$$20200710$$HP$NL$ES
1186359511$11863595$11$F$2014$20200804$20151223$20200811$EXP$$PHHY2014CA154360$NOVARTIS$$43$YR$$F$Y$$$20200811$$CN$CA$CA
118639162$11863916$2$F$20151209$20160118$20151223$20160127$EXP$$DE-JNJFOC-20151208691$JANSSEN$$66$YR$E$M$Y$74.5$KG$20160127$$MD$DE$DE
118642816$11864281$6$F$2019$20200831$20151223$20200902$EXP$$US-PFIZER INC-2015459748$PFIZER$$52$YR$$F$Y$127$KG$20200902$$CN$US$US
1186429310$11864293$10$F$$20200701$20151223$20200710$EXP$$ES-BAUSCH-BL-2015-030558$BAUSCH AND LOMB$ISIDORO?GARCIA M, SANCHEZ?MARTIN A, GARCIA?BERROCAL B, ROMAN?CURTO C. PRIMUN NON NOCERE, POLYPHARMACY AND PHARMACOGENETICS. PHARMACOGENOMICS. 2015?16(17):1903?1905. DOI:10.2217/PGS.15.137$74$YR$$F$Y$$$20200710$$MD$ES$ES
118645252$11864525$2$F$$20200708$20151223$20200717$EXP$$CA-JNJFOC-20151219212$JOHNSON AND JOHNSON$$$$$M$Y$$$20200717$$HP$CA$CA
118646851$11864685$1$I$$20151208$20151223$20151223$EXP$$US-JNJFOC-20151208650$JOHNSON AND JOHNSON$GERARDI DM, MURPHY TK, TOUFEXIS M, HANKS C. SEROTONERGIC OR ANTICHOLINERGIC TOXIDROME: CASE REPORT OF A 9?YEAR?OLD GIRL.. PEDIATRIC EMERGENCY CARE 12?DEC?2015?31 (12):846?850.$9$YR$C$F$Y$$$20151223$$HP$US$US
1186495611$11864956$11$F$20151130$20200701$20151223$20200707$EXP$$US-PFIZER INC-2015459918$PFIZER$$61$YR$$F$Y$81.19$KG$20200707$$HP$US$US
1186559743$11865597$43$F$2015$20200720$20151223$20200730$EXP$$CA-PFIZER INC-2012292491$PFIZER$$61$YR$$F$Y$61$KG$20200730$$MD$CA$CA
118656302$11865630$2$F$20150618$20200827$20151223$20200902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-043603$BRISTOL MYERS SQUIBB$$71$YR$$F$Y$46$KG$20200902$$MD$JP$JP
118667453$11866745$3$F$20151116$20160115$20151224$20160126$EXP$$US-ROCHE-1662694$ROCHE$$43$YR$$F$Y$56.3$KG$20160126$$MD$US$US
118668604$11866860$4$F$201509$20200320$20151224$20200327$EXP$$PHHY2015CA166716$NOVARTIS$$57$YR$$F$Y$$$20200327$$CN$COUNTRY NOT SPECIFIED$CA
1186707010$11867070$10$F$20131101$20200831$20151224$20200909$EXP$$US-BIOGEN-2015BI00164777$BIOGEN$$55$YR$$F$Y$$$20200909$$CN$US$US
118671525$11867152$5$F$20131030$20200821$20151224$20200902$EXP$NL-LRB-211253$NL-JNJFOC-20151219577$JOHNSON AND JOHNSON$$18$YR$A$M$Y$130$KG$20200902$$CN$NL$NL
118677245$11867724$5$F$20150301$20200823$20151224$20200903$EXP$$US-JNJFOC-20151218983$JOHNSON AND JOHNSON$$90$YR$E$M$Y$$$20200903$$CN$US$US
118677263$11867726$3$F$20140115$20200730$20151224$20200806$EXP$$US-JNJFOC-20151218982$JOHNSON AND JOHNSON$$92$YR$E$F$Y$$$20200806$$HP$US$US
118677964$11867796$4$F$201310$20200720$20151224$20200729$EXP$$FR-ARIAD PHARMACEUTICALS, INC-2015FR005895$TAKEDA$$14$YR$$F$Y$52.1$KG$20200729$$MD$FR$FR
118678113$11867811$3$F$20151125$20160128$20151224$20160205$EXP$$FR-JNJFOC-20151127134$JANSSEN$$60$YR$A$M$Y$90$KG$20160205$$MD$FR$FR
118678321$11867832$1$I$20151023$20151217$20151224$20151224$EXP$$FR-JNJFOC-20151219342$JANSSEN$$67$YR$E$M$Y$$$20151224$$MD$FR$FR
118680032$11868003$2$F$20151104$20160112$20151224$20160118$EXP$$FR-JNJFOC-20151105557$PHARMACYCLICS$$69$YR$E$M$Y$53$KG$20160118$$MD$FR$FR
118683916$11868391$6$F$$20200730$20151224$20200806$EXP$$CA-ABBVIE-15K-028-1524163-00$ABBVIE$$43$YR$$F$Y$$$20200806$$CN$CA$CA
1186940816$11869408$16$F$20150623$20200825$20151227$20200901$EXP$$PHHY2015US099102$NOVARTIS$$42$YR$$F$Y$$$20200901$$MD$US$US
118695912$11869591$2$F$20150201$20160106$20151228$20160114$EXP$$BR-ROCHE-1553567$ROCHE$$$$$M$Y$$$20160114$$MD$BR$BR
1187110911$11871109$11$F$20141224$20200715$20151228$20200721$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN180189$VIIV$$4$DEC$$M$Y$$$20200721$$CN$JP$JP
118719223$11871922$3$F$20151212$20160523$20151228$20160531$EXP$$GB-JNJFOC-20151219599$PHARMACYCLICS$$57$YR$A$F$Y$57.5$KG$20160531$$MD$GB$GB
118723724$11872372$4$F$1989$20200902$20151228$20200904$EXP$$US-PFIZER INC-2015465865$PFIZER$$28$YR$$M$Y$$$20200904$$HP$US$US
118724245$11872424$5$F$20151123$20160211$20151228$20200714$EXP$$US-NOVOPROD-473942$NOVO NORDISK$$77$YR$$F$Y$60.4$KG$20200714$$MD$US$US
118728579$11872857$9$F$$20200924$20151228$20200929$PER$$US-PFIZER INC-2015435568$PFIZER$$38$YR$$F$Y$170.1$KG$20200929$$MD$US$US
118728848$11872884$8$F$20150630$20200710$20151228$20200722$EXP$$NL-JNJFOC-20151218722$JOHNSON AND JOHNSON$$48$YR$$M$Y$93$KG$20200722$$HP$NL$NL
118729128$11872912$8$F$$20200701$20151228$20200706$PER$$US-PFIZER INC-2015457935$PFIZER$$45$YR$$M$Y$86$KG$20200706$$CN$US$US
118730634$11873063$4$F$20140724$20200906$20151228$20200914$PER$$US-JNJFOC-20151221242$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200914$$HP$US$US
118734819$11873481$9$F$201512$20200730$20151228$20200803$EXP$$US-JAZZ-2015-US-021878$JAZZ$$45$YR$$F$Y$$$20200803$$HP$US$US
118738493$11873849$3$F$20150620$20160309$20151229$20160311$EXP$$JP-ROCHE-1684368$ROCHE$$74$YR$$F$Y$57$KG$20160311$$MD$JP$JP
118743832$11874383$2$F$20150927$20160426$20151229$20200818$EXP$$JP-ROCHE-1685135$ROCHE$$80$YR$$F$Y$$$20200818$$PH$JP$JP
118744594$11874459$4$F$$20200722$20151229$20200731$EXP$ES-MLMSERVICE-20151209-0103683-1$ES-ACCORD-036570$ACCORD$$74$YR$E$F$Y$$$20200731$$CN$ES$ES
118752272$11875227$2$F$20150420$20200825$20151229$20200901$PER$$PHHY2015US123701$NOVARTIS$$39$YR$$F$Y$$$20200901$$MD$US$US
118756951$11875695$1$I$$20151221$20151229$20151229$EXP$$US-TEVA-620896USA$TEVA$GERARDI DM, MURPHY TK, TOUFEXIS M, HANKS C. SEROTONERGIC OR ANTICHOLINERGIC TOXIDROME: CASE REPORT OF A 9?YEAR?OLD GIRL. PEDIATR?EMERG?CARE 2015?31(12):846?50.$9$YR$$F$Y$$$20151229$$HP$US$US
118762323$11876232$3$F$20151124$20151218$20151229$20160216$EXP$$CH-JNJFOC-20151125613$JANSSEN$$74$YR$E$F$Y$53$KG$20160216$$HP$CH$CH
118763454$11876345$4$F$20150526$20200820$20151229$20200903$EXP$$JP-INCYTE CORPORATION-2015IN006850$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
118775124$11877512$4$F$2015$20200924$20151230$20200930$EXP$$US-JAZZ-2015-US-022396$JAZZ$$$$$F$Y$$$20200930$$HP$US$US
118777283$11877728$3$F$20150313$20200817$20151230$20200817$PER$$PHHY2015US070626$NOVARTIS$$48$YR$$F$Y$$$20200818$$MD$US$US
118782683$11878268$3$F$20151009$20160415$20151230$20160422$EXP$$JP-ROCHE-1686133$ROCHE$$53$YR$$F$Y$49$KG$20160422$$MD$JP$JP
1187875911$11878759$11$F$$20200914$20151230$20200925$EXP$$CA-JNJFOC-20151223430$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20200925$$CN$CA$CA
118797372$11879737$2$F$20151130$20200430$20151230$20200819$PER$$US-AEGERION PHARMACEUTICAL INC.-AEGR002285$AEGERION$$67$YR$$F$Y$$$20200819$$MD$US$US
118802142$11880214$2$F$20140102$20200803$20151230$20200813$EXP$$US-BAYER-2015-459006$BAYER$$82$YR$E$M$Y$$$20200813$$HP$US$US
118803623$11880362$3$F$201405$20200623$20151230$20200701$EXP$$US-BIOGEN-2014BI060742$BIOGEN$$60$YR$$F$Y$$$20200701$$CN$US$US
118804202$11880420$2$F$20151214$20160103$20151230$20160106$EXP$$IL-JNJFOC-20151222591$PHARMACYCLICS$$64$YR$A$F$Y$64.6$KG$20160106$$MD$IL$IL
118811842$11881184$2$F$20150325$20160210$20151231$20160218$EXP$$JP-ROCHE-1686111$ROCHE$$83$YR$$M$Y$59$KG$20160218$$MD$JP$JP
118815392$11881539$2$F$20150524$20160218$20151231$20160226$EXP$$JP-ROCHE-1686334$ROCHE$$76$YR$$M$Y$63$KG$20160226$$MD$JP$JP
118818172$11881817$2$F$20141120$20160606$20151231$20160614$EXP$$JP-ROCHE-1686160$ROCHE$$79$YR$$M$Y$55$KG$20160614$$MD$JP$JP
118819842$11881984$2$F$20140818$20200727$20151231$20200807$EXP$$US-BAYER-2015-458962$BAYER$$80$YR$E$M$Y$$$20200807$$CN$US$US
118820183$11882018$3$F$20151216$20160106$20151231$20160112$EXP$$US-JNJFOC-20151224155$JANSSEN$$59$YR$A$F$Y$78$KG$20160112$$MD$US$US
118826543$11882654$3$F$2014$20200706$20151231$20200717$EXP$$US-JNJFOC-20151223416$JOHNSON AND JOHNSON$$$$$M$Y$$$20200717$$CN$US$US
118835083$11883508$3$F$20130104$20200902$20151231$20200909$EXP$$PHHO2013FR001861$NOVARTIS$$34$YR$$M$Y$70$KG$20200909$$HP$NL$FR
1188438564$11884385$64$F$201408$20200921$20160103$20200926$EXP$$PHHY2014CA077639$NOVARTIS$$64$YR$$M$Y$$$20200927$$HP$CA$CA
118849762$11884976$2$F$201311$20200830$20160104$20200903$EXP$$US-BAYER-2015-458793$BAYER$$81$YR$E$F$Y$$$20200903$$CN$US$US
118854422$11885442$2$F$20131211$20200802$20160104$20200812$EXP$$US-BAYER-2015-482799$BAYER$$83$YR$E$F$Y$$$20200812$$CN$US$US
118861002$11886100$2$F$$20200713$20160104$20200714$PER$$US-PFIZER INC-2015439286$PFIZER$$52$YR$$M$Y$$$20200714$$MD$US$US
118876217$11887621$7$F$20140723$20200727$20160105$20200804$PER$$PHHY2015US004618$NOVARTIS$$39$YR$$F$Y$$$20200805$$MD$US$US
118883032$11888303$2$F$20131119$20200723$20160105$20200731$EXP$$US-BAYER-2015-459989$BAYER$$82$YR$E$F$Y$$$20200731$$LW$US$US
118886772$11888677$2$F$20140830$20200917$20160105$20200925$EXP$$US-BAYER-2015-477435$BAYER$$77$YR$E$F$Y$$$20200925$$CN$US$US
118887855$11888785$5$F$20150506$20160923$20160105$20160927$EXP$$CN-JNJFOC-20151224697$JANSSEN$$42$YR$A$F$Y$50$KG$20160927$$MD$CN$CN
118888843$11888884$3$F$201410$20200831$20160105$20200915$EXP$$US-JNJFOC-20160100730$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200915$$CN$US$US
118888874$11888887$4$F$20141220$20200827$20160105$20200901$PER$$US-JNJFOC-20160100736$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200901$$CN$US$US
118888982$11888898$2$F$20140803$20200709$20160105$20200721$EXP$$US-BAYER-2015-477588$BAYER$$67$YR$E$F$Y$$$20200721$$HP$US$US
1188896210$11888962$10$F$201510$20200630$20160105$20200702$PER$$US-PFIZER INC-2015465628$PFIZER$$62$YR$$F$Y$74$KG$20200702$$CN$US$US
118896972$11889697$2$F$20140725$20200813$20160105$20200818$EXP$$US-BAYER-2015-448164$BAYER$$90$YR$E$M$Y$$$20200818$$CN$US$US
118916482$11891648$2$F$20131008$20200920$20160106$20200925$EXP$$US-BAYER-2015-432647$BAYER$$73$YR$E$F$Y$$$20200925$$CN$US$US
1189187224$11891872$24$F$20151223$20200701$20160106$20200715$EXP$$US-ACTELION PHARMACEUTICALS US, INC.-A-US2015-129373$ACTELION$$47$YR$$F$Y$113.38$KG$20200715$$MD$US$US
1189244929$11892449$29$F$20150925$20200728$20160106$20200803$EXP$$PHHY2015CA118020$NOVARTIS$$74$YR$$F$Y$$$20200803$$CN$CA$CA
1189281312$11892813$12$F$$20200818$20160106$20200818$EXP$$US-PFIZER INC-2015388526$PFIZER$$44$YR$$M$Y$$$20200818$$HP$US$US
1189359026$11893590$26$F$201804$20200805$20160106$20200814$EXP$$US-ACTELION PHARMACEUTICALS US, INC.-A-US2015-127621$ACTELION$$57$YR$$F$Y$63.49$KG$20200814$$HP$US$US
1189391534$11893915$34$F$20150720$20200724$20160107$20200806$EXP$$CA-ROCHE-1689916$ROCHE$$79$YR$$F$Y$$$20200806$$MD$CA$CA
118947723$11894772$3$F$20141204$20160314$20160107$20160321$EXP$$JP-ROCHE-1507966$ROCHE$$77$YR$$F$Y$42$KG$20160321$$MD$JP$JP
118963232$11896323$2$F$201405$20200712$20160107$20200722$EXP$$US-BAYER-2015-464459$BAYER$$72$YR$E$F$Y$$$20200722$$CN$US$US
118968691$11896869$1$I$$20140410$20160107$20160107$EXP$$US-GLAXOSMITHKLINE-B0986081A$GLAXOSMITHKLINE$GERARDI DM, MURPHY TK, TOUFEXIS M, HANKS C. SEROTONERGIC OR ANTICHOLINERGIC TOXIDROME: CASE REPORT OF A 9?YEAR?OLD GIRL. PEDIATRIC EMERGENCY CARE. 2015?31 (NUMBER 12):846?850$9$YR$$F$Y$$$20160107$$HP$COUNTRY NOT SPECIFIED$US
1189764810$11897648$10$F$2015$20200707$20160108$20200715$EXP$$CA-ROCHE-1690436$ROCHE$$58$YR$$F$Y$$$20200715$$HP$CA$CA
118985692$11898569$2$F$20141024$20200913$20160108$20200923$EXP$$US-BAYER-2015-463140$BAYER$$52$YR$A$M$Y$$$20200923$$CN$US$US
119003922$11900392$2$F$20150910$20151222$20160108$20160121$EXP$$UA-JNJFOC-20150913273$JANSSEN$$55$YR$A$F$Y$84$KG$20160121$$MD$UA$UA
119018797$11901879$7$F$20120219$20200916$20160108$20200918$EXP$$US-PFIZER INC-2016002433$PFIZER$$70$YR$$F$Y$$$20200918$$MD$US$US
119050066$11905006$6$F$201206$20200715$20160108$20200729$EXP$$US-JNJFOC-20160101544$JOHNSON AND JOHNSON$$56$YR$$M$Y$$$20200729$$CN$US$US
119050104$11905010$4$F$201401$20200910$20160108$20200923$EXP$$US-JNJFOC-20160100861$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200923$$CN$US$US
119058552$11905855$2$F$$20160113$20160111$20160121$EXP$$GB-ROCHE-1691027$ROCHE$. HYPERPHARMACOTHERAPY IN AGEING CYSTIC FIBROSIS PATIENTS: THE FIRST REPORT OF AN ATYPICAL HIP FRACTURE. RESPIRATORY MEDICINE CASE REPORTS 2015?16:148?150.$54$YR$$M$Y$$$20160121$$HP$GB$GB
1190654614$11906546$14$F$20150813$20200917$20160111$20200920$EXP$$PHHY2015CA099882$NOVARTIS$$53$YR$$M$Y$$$20200920$$CN$COUNTRY NOT SPECIFIED$CA
119070582$11907058$2$F$20131120$20200804$20160111$20200814$EXP$$US-BAYER-2015-463065$BAYER$$77$YR$E$M$Y$99.88$KG$20200814$$CN$US$US
119074554$11907455$4$F$201505$20180521$20160111$20180529$EXP$$FR-JNJFOC-20160102295$JANSSEN$$72$YR$E$F$Y$62$KG$20180529$$HP$FR$FR
119074591$11907459$1$I$20150414$20150709$20160111$20160111$EXP$$HU-JNJFOC-20150708158$JANSSEN$$50$YR$A$F$Y$81$KG$20160111$$MD$HU$HU
119074604$11907460$4$F$20150722$20160620$20160111$20160711$EXP$$CA-JNJFOC-20150723256$JANSSEN$$26$YR$A$M$Y$52.1$KG$20160711$$MD$CA$CA
119074613$11907461$3$F$20151002$20160510$20160111$20160518$EXP$$DE-JNJFOC-20151024572$JANSSEN$$54$YR$A$M$Y$88$KG$20160518$$MD$DE$DE
119074621$11907462$1$I$20150705$20150810$20160111$20160111$EXP$$AT-JNJFOC-20150809167$JANSSEN$$30$YR$A$M$Y$54$KG$20160111$$MD$AT$AT
119074631$11907463$1$I$20150703$20150710$20160111$20160111$EXP$$US-JNJFOC-20150709724$JANSSEN$$45$YR$A$M$Y$75.4$KG$20160111$$MD$US$US
119074646$11907464$6$F$20150720$20170331$20160111$20170404$EXP$$US-JNJFOC-20150716932$JANSSEN$$63$YR$A$F$Y$49$KG$20170404$$MD$US$US
119074651$11907465$1$I$20150709$20150920$20160111$20160111$EXP$$IL-JNJFOC-20150920683$JANSSEN$$42$YR$A$M$Y$81$KG$20160111$$MD$IL$IL
119074665$11907466$5$F$20150729$20160627$20160111$20160630$EXP$$CA-JNJFOC-20150922999$JANSSEN$$26$YR$A$M$Y$52$KG$20160630$$MD$CA$CA
119077242$11907724$2$F$20120612$20200923$20160111$20200930$EXP$$US-BAYER-2015-463067$BAYER$$80$YR$E$M$Y$$$20200930$$LW$US$US
119078442$11907844$2$F$20141215$20200720$20160111$20200730$EXP$$US-JNJFOC-20151208383$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20200730$$CN$US$US
1190904813$11909048$13$F$$20200713$20160111$20200714$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-092211$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200714$$PH$CA$CA
119095812$11909581$2$F$$20160113$20160112$20160125$EXP$$US-ROCHE-1692922$ROCHE$MOWRY J, SPYKER D, BROOKS D, MCMILLAN N AND SCHAUBEN J. 2014 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 32ND ANNUAL REPORT. CLINICAL TOXICOLOGY 2015 DEC 01?53 (10):962?1147.$86$YR$$F$Y$$$20160125$$PH$US$US
119096314$11909631$4$F$20151127$20170307$20160112$20170316$EXP$$TW-ROCHE-1670583$ROCHE$$49$YR$$M$Y$69.5$KG$20170316$$MD$TW$TW
119101527$11910152$7$F$20151216$20200805$20160112$20200807$EXP$$US-PFIZER INC-2014097243$PFIZER$$38$YR$$F$Y$$$20200807$$MD$US$US
1191017410$11910174$10$F$$20200917$20160112$20200921$EXP$$US-PFIZER INC-2015477841$PFIZER$$60$YR$$F$Y$86.17$KG$20200921$$HP$US$US
1191020011$11910200$11$F$201510$20200805$20160112$20200807$PER$$US-PFIZER INC-2015476513$PFIZER$$38$YR$$M$Y$77$KG$20200807$$HP$US$US
119108072$11910807$2$F$20151231$20160530$20160112$20160608$EXP$$IT-JNJFOC-20160106944$JANSSEN$$66$YR$E$F$Y$$$20160608$$MD$IT$IT
119110317$11911031$7$F$20150330$20200902$20160112$20200915$EXP$$JP-INCYTE CORPORATION-2015IN006989$INCYTE$$$$$$Y$$$20200915$$MD$JP$JP
1191137714$11911377$14$F$20150911$20200702$20160112$20200709$EXP$$PHHY2016US001354$NOVARTIS$$41$YR$$F$Y$61$KG$20200709$$CN$US$US
119114271$11911427$1$I$20151230$20160104$20160112$20160112$EXP$$US-JNJFOC-20160101835$JANSSEN$$60$YR$A$M$Y$111.2$KG$20160112$$MD$US$US
119119573$11911957$3$F$20151113$20200804$20160112$20200812$EXP$$US-TEVA-625023USA$TEVA$$56$YR$A$F$Y$73.55$KG$20200812$$MD$US$US
1191369413$11913694$13$F$$20200812$20160113$20200813$PER$$US-PFIZER INC-2016003961$PFIZER$$44$YR$$F$Y$86$KG$20200813$$CN$US$US
1191370013$11913700$13$F$20170114$20200714$20160113$20200715$EXP$$US-PFIZER INC-2016006388$PFIZER$$53$YR$$M$Y$113$KG$20200715$$MD$US$US
119137905$11913790$5$F$20151110$20200804$20160113$20200812$EXP$$US-BAXTER-2016BAX000883$BAXTER$$56$YR$$F$Y$73.55$KG$20200812$$MD$US$US
1191420710$11914207$10$F$202001$20200903$20160113$20200904$EXP$$US-PFIZER INC-2015161888$PFIZER$$27$YR$$M$Y$102$KG$20200904$$MD$US$US
119142529$11914252$9$F$20151113$20200814$20160113$20200825$EXP$$DE-BAXALTA-2016BLT000107$SHIRE$$$$$$Y$$$20200825$$MD$DE$DE
119144115$11914411$5$F$2015$20200812$20160113$20200824$EXP$$US-JNJFOC-20160108032$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200824$$CN$US$US
119150345$11915034$5$F$20151210$20200701$20160113$20200715$EXP$$ES-ROCHE-1693089$ROCHE$$70$YR$$F$Y$$$20200715$$MD$ES$ES
1191531619$11915316$19$F$20130717$20200922$20160114$20200930$EXP$$CA-ROCHE-1692996$ROCHE$$56$YR$$M$Y$$$20201001$$HP$CA$CA
1191632927$11916329$27$F$$20200818$20160114$20200821$EXP$$CA-PFIZER INC-2016013581$PFIZER$$84$YR$$F$Y$$$20200821$$MD$CA$CA
119168382$11916838$2$F$$20200713$20160114$20200714$PER$$US-PFIZER INC-2015460120$PFIZER$$79$YR$$F$Y$$$20200714$$MD$US$US
119182424$11918242$4$F$20160112$20160610$20160114$20160622$EXP$$US-ROCHE-1694521$ROCHE$$67$YR$$M$Y$97.3$KG$20160622$$MD$US$US
119190255$11919025$5$F$20140208$20200809$20160115$20200813$PER$$US-JNJFOC-20151218734$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20200813$$LW$US$US
119190433$11919043$3$F$20131113$20200913$20160115$20200915$PER$$US-JNJFOC-20160100351$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20200915$$LW$US$US
119190454$11919045$4$F$20140505$20200906$20160115$20200914$PER$$US-JNJFOC-20160100515$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200914$$LW$US$US
119191213$11919121$3$F$20140427$20200908$20160115$20200915$PER$$US-JNJFOC-20151207379$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20200915$$CN$US$US
119191523$11919152$3$F$20140520$20200726$20160115$20200730$EXP$$US-JNJFOC-20151212683$JOHNSON AND JOHNSON$$89$YR$E$M$Y$$$20200730$$CN$US$US
119191644$11919164$4$F$201312$20200928$20160115$20200930$PER$$US-JNJFOC-20151213292$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20200930$$CN$US$US
119191984$11919198$4$F$20130228$20200810$20160115$20200817$PER$$US-JNJFOC-20151218756$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20200817$$CN$US$US
119192193$11919219$3$F$20140219$20200713$20160115$20200715$PER$$US-JNJFOC-20151221187$JOHNSON AND JOHNSON$$81$YR$$M$Y$$$20200715$$LW$US$US
119192223$11919222$3$F$20150322$20200910$20160115$20200914$PER$$US-JNJFOC-20151218133$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200914$$CN$US$US
119192323$11919232$3$F$20140108$20200708$20160115$20200713$PER$$US-JNJFOC-20151220942$JOHNSON AND JOHNSON$$65$YR$$M$Y$$$20200713$$CN$US$US
119192384$11919238$4$F$20150312$20200902$20160115$20200914$PER$$US-JNJFOC-20151223318$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200914$$CN$US$US
119192524$11919252$4$F$20150201$20200628$20160115$20200706$PER$$US-JNJFOC-20151223186$JOHNSON AND JOHNSON$$84$YR$$F$Y$$$20200706$$CN$US$US
119192603$11919260$3$F$20140112$20200727$20160115$20200731$PER$$US-JNJFOC-20151223415$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200731$$CN$US$US
119192673$11919267$3$F$20131230$20200806$20160115$20200813$PER$$US-JNJFOC-20151223445$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200813$$CN$US$US
119193045$11919304$5$F$20140203$20200727$20160115$20200731$PER$$US-JNJFOC-20160100125$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20200731$$CN$US$US
119193103$11919310$3$F$20140311$20200819$20160115$20200824$PER$$US-JNJFOC-20151225251$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200824$$CN$US$US
119193143$11919314$3$F$20141227$20200818$20160115$20200831$EXP$$US-JNJFOC-20160100133$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200831$$CN$US$US
119193163$11919316$3$F$20141008$20200630$20160115$20200706$PER$$US-JNJFOC-20160100130$JOHNSON AND JOHNSON$$46$YR$$M$Y$$$20200706$$CN$US$US
119193684$11919368$4$F$20140325$20200820$20160115$20200824$PER$$US-JNJFOC-20160100520$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20200824$$LW$US$US
119193714$11919371$4$F$20140219$20200806$20160115$20200811$PER$$US-JNJFOC-20160100433$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200811$$CN$US$US
119194703$11919470$3$F$20130608$20200722$20160115$20200731$PER$$US-JNJFOC-20160100764$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200731$$CN$US$US
119194853$11919485$3$F$201302$20200630$20160115$20200707$PER$$US-JNJFOC-20160101350$JOHNSON AND JOHNSON$$59$YR$$M$Y$$$20200707$$CN$US$US
119194904$11919490$4$F$20141029$20200901$20160115$20200909$PER$$US-JNJFOC-20160101318$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200909$$CN$GB$US
119195393$11919539$3$F$201508$20200713$20160115$20200717$PER$$US-JNJFOC-20151220885$JOHNSON AND JOHNSON$$80$YR$$M$Y$$$20200717$$CN$US$US
119195523$11919552$3$F$20140219$20200909$20160115$20200914$PER$$US-JNJFOC-20160100990$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200914$$CN$US$US
119197253$11919725$3$F$20151230$20160805$20160115$20160812$EXP$$GB-ASTRAZENECA-2016SE02415$ASTRAZENECA$$24383$DY$$F$Y$66.4$KG$20160813$$MD$GB$GB
119200815$11920081$5$F$20160107$20161214$20160115$20161221$EXP$$ES-JNJFOC-20160107068$PHARMACYCLICS$$68$YR$E$F$Y$67.5$KG$20161221$$MD$ES$ES
119205316$11920531$6$F$20130429$20200728$20160115$20200803$PER$$US-JNJFOC-20160108030$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200803$$CN$US$US
119207565$11920756$5$F$$20191104$20160115$20200709$PER$$US-ASTELLAS-2015US030089$ASTELLAS$$$$$F$Y$$$20200709$$CN$US$US
119215967$11921596$7$F$20151223$20180607$20160115$20180613$EXP$$AR-JNJFOC-20160106539$JANSSEN$$73$YR$E$F$Y$68$KG$20180613$$MD$AR$AR
1192221323$11922213$23$F$$20200728$20160115$20200804$EXP$$CA-PFIZER INC-2016017452$PFIZER$$64$YR$$F$Y$$$20200804$$HP$CA$CA
119223602$11922360$2$F$2007$20200904$20160115$20200908$EXP$$US-PFIZER INC-2016012065$PFIZER$$54$YR$$F$Y$$$20200908$$CN$US$US
1192301911$11923019$11$F$20151022$20200819$20160117$20200902$EXP$$JP-INCYTE CORPORATION-2016IN000065$INCYTE$$$$$$Y$$$20200902$$MD$JP$JP
119233337$11923333$7$F$$20200731$20160118$20200731$EXP$$CA-ABBVIE-16K-028-1539178-00$ABBVIE$$$$$F$Y$$$20200731$$MD$CA$CA
119234491$11923449$1$I$$20160108$20160118$20160118$EXP$$US-ROCHE-1692085$ROCHE$$$$$$Y$$$20160118$$MD$US$US
119234526$11923452$6$F$2008$20200630$20160118$20200707$EXP$$CA-ABBVIE-16K-028-1539284-00$ABBVIE$$$$$F$Y$$$20200707$$MD$CA$CA
119235313$11923531$3$F$$20200701$20160118$20200703$EXP$$CA-ABBVIE-16K-028-1539429-00$ABBVIE$$36$YR$$M$Y$$$20200703$$MD$CA$CA
119240286$11924028$6$F$20151111$20161025$20160118$20161103$EXP$$US-JNJFOC-20160109760$PHARMACYCLICS$$50$YR$A$F$Y$63.87$KG$20161103$$MD$US$US
119240308$11924030$8$F$20160105$20171018$20160118$20171019$EXP$$TR-JNJFOC-20160110045$PHARMACYCLICS$$64$YR$A$M$Y$$$20171019$$MD$TR$TR
119240362$11924036$2$F$20160104$20160505$20160118$20160513$EXP$$US-JNJFOC-20160108651$PHARMACYCLICS$$70$YR$E$M$Y$$$20160513$$MD$US$US
119247094$11924709$4$F$20151228$20160330$20160118$20160407$EXP$$CZ-JNJFOC-20160110937$PHARMACYCLICS$$74$YR$E$M$Y$$$20160407$$MD$CZ$CZ
119251402$11925140$2$F$$20200403$20160118$20200812$PER$$US-009507513-1512USA012482$MERCK$$39$YR$$F$Y$$$20200812$$HP$US$US
119251562$11925156$2$F$$20200403$20160118$20200812$PER$$US-009507513-1601USA005146$MERCK$MATHUR R, ZHANG Y, GRIMMER M, HONG C, BERGER M, MOLINARO A, ET AL. MGMT PROMOTER METHYLATION LEVEL IN NEWLY DIAGNOSED LOW?GRADE GLIOMA IS A PREDICTOR OF HYPERMUTATION AT RECURRENCE. NEURO?ONCOLOGY. 2020$28$YR$$M$Y$$$20200812$$HP$US$US
119251852$11925185$2$F$$20200403$20160118$20200812$PER$$US-009507513-1601USA005147$MERCK$MATHUR R, ZHANG Y, GRIMMER M, HONG C, BERGER M, MOLINARO A, ET AL. MGMT PROMOTER METHYLATION LEVEL IN NEWLY DIAGNOSED LOW?GRADE GLIOMA IS A PREDICTOR OF HYPERMUTATION AT RECURRENCE. NEURO?ONCOLOGY. 2020$41$YR$$F$Y$$$20200812$$HP$US$US
119252782$11925278$2$F$$20200403$20160118$20200812$PER$$US-009507513-1601USA005148$MERCK$MATHUR R, ZHANG Y, GRIMMER M, HONG C, BERGER M, MOLINARO A, ET AL. MGMT PROMOTER METHYLATION LEVEL IN NEWLY DIAGNOSED LOW?GRADE GLIOMA IS A PREDICTOR OF HYPERMUTATION AT RECURRENCE. NEURO?ONCOLOGY. 2020$49$YR$$M$Y$$$20200812$$HP$US$US
119253522$11925352$2$F$$20200403$20160118$20200812$PER$$US-009507513-1601USA005149$MERCK$MATHUR R, ZHANG Y, GRIMMER M, HONG C, BERGER M, MOLINARO A, ET AL. MGMT PROMOTER METHYLATION LEVEL IN NEWLY DIAGNOSED LOW?GRADE GLIOMA IS A PREDICTOR OF HYPERMUTATION AT RECURRENCE. NEURO?ONCOLOGY. 2020$27$YR$$M$Y$$$20200812$$HP$US$US
119259152$11925915$2$F$$20200410$20160119$20200416$EXP$$CA-ROCHE-1695785$ROCHE$$54$YR$$F$Y$$$20200416$$CN$CA$CA
119267106$11926710$6$F$20151221$20160509$20160119$20160513$EXP$$FR-JNJFOC-20160107402$JANSSEN$$81$YR$E$M$Y$$$20160513$$MD$FR$FR
1192721213$11927212$13$F$2015$20200921$20160119$20200925$EXP$$US-SA-2015SA190677$SANOFI AVENTIS$$$$$$Y$$$20200925$$CN$US$US
119272658$11927265$8$F$201512$20200706$20160119$20200713$EXP$$US-SA-2016SA000735$SANOFI AVENTIS$$$$$$Y$$$20200713$$CN$US$US
1192739214$11927392$14$F$$20200723$20160119$20200806$EXP$$US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2014-107131$ACTELION$$$$$F$Y$86.17$KG$20200806$$HP$US$US
119279112$11927911$2$F$20150830$20160112$20160119$20160129$EXP$$US-JNJFOC-20150906491$JANSSEN$$60$YR$A$F$Y$53.52$KG$20160129$$MD$US$US
119281185$11928118$5$F$20150810$20200903$20160119$20200917$EXP$$JP-INCYTE CORPORATION-2016IN000162$INCYTE$$$$$$Y$$$20200917$$MD$JP$JP
1192827014$11928270$14$F$20150228$20200817$20160119$20200901$EXP$$JP-INCYTE CORPORATION-2015IN004952$INCYTE$$$$$$Y$$$20200901$$MD$JP$JP
1192859229$11928592$29$F$201309$20200206$20160119$20200217$EXP$$PHHY2013CA099777$NOVARTIS$$60$YR$$M$Y$$$20200217$$MD$CA$CA
119291992$11929199$2$F$20151128$20200730$20160120$20200803$PER$$US-CELGENEUS-USA-2016012944$CELGENE$$57$YR$$M$Y$135.29$KG$20200803$$HP$US$US
119295834$11929583$4$F$20150629$20160624$20160120$20160629$EXP$$JP-ROCHE-1696800$ROCHE$$52$YR$$F$Y$53$KG$20160629$$MD$JP$JP
119296373$11929637$3$F$201401$20200812$20160120$20200819$EXP$$US-BAYER-2015-010441$BAYER$$76$YR$E$M$Y$$$20200819$$HP$US$US
119298751$11929875$1$I$20150713$20150714$20160120$20160120$EXP$$JP-ROCHE-1609867$ROCHE$$63$YR$$F$Y$62$KG$20160120$$MD$JP$JP
119314083$11931408$3$F$20150630$20200623$20160120$20200706$EXP$$US-INCYTE CORPORATION-2015IN004791$INCYTE$$$$$$Y$$$20200706$$CN$US$US
119314568$11931456$8$F$202002$20200909$20160120$20200919$EXP$$US-INCYTE CORPORATION-2015IN005709$INCYTE$$$$$$Y$$$20200920$$CN$US$US
119317227$11931722$7$F$20151129$20180328$20160120$20180403$EXP$$FR-JNJFOC-20160112473$JANSSEN$$81$YR$E$M$Y$79$KG$20180403$$MD$FR$FR
119317919$11931791$9$F$202007$20200803$20160120$20200910$PER$$US-INCYTE CORPORATION-2015IN005719$INCYTE$$$$$$Y$$$20200910$$CN$US$US
1193216513$11932165$13$F$20150228$20200817$20160120$20200825$EXP$$PHJP2015JP016300$NOVARTIS$$80$YR$$M$Y$63$KG$20200825$$MD$JP$JP
1193222925$11932229$25$F$2015$20200728$20160120$20200803$EXP$$NL-ASTELLAS-2016US001878$ASTELLAS$$92$YR$$M$Y$$$20200803$$CN$NL$NL
119326964$11932696$4$F$201509$20200624$20160120$20200703$PER$$PHEH2016US001259$NOVARTIS$$30$YR$$F$Y$$$20200703$$CN$COUNTRY NOT SPECIFIED$US
1193323217$11933232$17$F$$20200728$20160121$20200731$PER$$CA-AMGEN-CANSP2016004828$AMGEN$$64$YR$A$F$Y$$$20200731$$HP$CA$CA
119333263$11933326$3$F$20150109$20161227$20160121$20161230$EXP$$JP-ROCHE-1567281$ROCHE$$68$YR$$M$Y$86$KG$20161230$$MD$JP$JP
1193449310$11934493$10$F$20160217$20191030$20160121$20191106$EXP$$PHHY2015CA152752$NOVARTIS$$42$YR$$M$Y$$$20191106$$CN$CA$CA
119348843$11934884$3$F$20131001$20200823$20160121$20200903$EXP$$US-JNJFOC-20160112169$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200903$$CN$US$US
119350567$11935056$7$F$20151214$20200721$20160121$20200727$EXP$$US-SA-2015SA215309$SANOFI AVENTIS$$$$$$Y$$$20200727$$HP$US$US
119352642$11935264$2$F$20150902$20180521$20160121$20180523$EXP$$FR-JNJFOC-20151220592$JANSSEN$$76$YR$E$F$Y$49$KG$20180523$$MD$FR$FR
119365915$11936591$5$F$$20200828$20160121$20200901$EXP$$CA-PFIZER INC-2015318758$PFIZER$$59$YR$$F$Y$$$20200901$$HP$CA$CA
119369363$11936936$3$F$20151214$20160322$20160121$20160331$EXP$$ES-JNJFOC-20151213084$JANSSEN$$73$YR$E$M$Y$70$KG$20160331$$MD$ES$ES
1193706913$11937069$13$F$2019$20200629$20160121$20200710$EXP$$US-ACTELION PHARMACEUTICALS US, INC.-A-US2015-117750$ACTELION$$$$$F$Y$94.79$KG$20200710$$HP$US$US
119374742$11937474$2$F$$20200903$20160121$20200907$PER$$US-BIOGEN-2016BI00167734$BIOGEN$$$$$F$Y$$$20200907$$CN$US$US
119376189$11937618$9$F$$20200722$20160122$20200728$EXP$$CA-009507513-1601CAN007640$MERCK$$54$YR$$M$Y$$$20200728$$CN$CA$CA
1193787612$11937876$12$F$20150603$20200812$20160122$20200818$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-003019$BRISTOL MYERS SQUIBB$YANAGISAWA H, ET AL. A PATIENT WITH LEFT FEMORAL MALIGNANT MELANOMA WHO EXPERIENCED EATING DISORDER CAUSED BY GASTRITIS AFTER NIVOLUMAB WAS SWITCHED TO IPILIMUMAB. 33RD ANNUAL MEETING OF THE JAPANESE SKIN CANCER SOCIETY. 2017?161$53$YR$$F$Y$50.7$KG$20200818$$MD$JP$JP
119379882$11937988$2$F$20150116$20200612$20160122$20200617$EXP$$CA-009507513-1601CAN007685$MERCK$$83$YR$$F$Y$54$KG$20200617$$MD$CA$CA
1193930023$11939300$23$F$201601$20200807$20160122$20200813$PER$$US-ACTELION PHARMACEUTICALS US, INC.-A-US2016-130076$ACTELION$$41$YR$$M$Y$99.77$KG$20200813$$HP$US$US
119396516$11939651$6$F$201306$20200805$20160122$20200807$PER$$US-JNJFOC-20160110915$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20200807$$HP$US$US
119397022$11939702$2$F$20121114$20200914$20160122$20200916$EXP$$US-BAYER-2015-471463$BAYER$$78$YR$E$M$Y$$$20200916$$CN$US$US
119414362$11941436$2$F$20071227$20200902$20160122$20200911$EXP$$US-BIOGEN-2008BI000013$BIOGEN$$47$YR$$F$Y$134.84$KG$20200911$$CN$US$US
119421381$11942138$1$I$$20160120$20160125$20160125$EXP$$DE-ROCHE-1698097$ROCHE$$$$E$F$Y$61$KG$20160125$$MD$DE$DE
119447932$11944793$2$F$20150927$20160309$20160125$20160318$EXP$$US-JNJFOC-20160108851$JANSSEN$$77$YR$E$F$Y$65.77$KG$20160318$$MD$US$US
119449138$11944913$8$F$20190912$20200921$20160125$20200925$PER$$US-PFIZER INC-2016015671$PFIZER$$68$YR$$M$Y$63$KG$20200925$$MD$US$US
119449934$11944993$4$F$20131117$20200630$20160125$20200715$EXP$$US-BAYER-2015-474207$BAYER$$53$YR$A$M$Y$$$20200715$$CN$US$US
119452082$11945208$2$F$20151111$20160405$20160125$20160413$EXP$$GB-JNJFOC-20151209060$PHARMACYCLICS$$77$YR$E$M$Y$$$20160413$$MD$GB$GB
119452265$11945226$5$F$20160113$20161019$20160125$20161027$EXP$$US-JNJFOC-20160115927$PHARMACYCLICS$$71$YR$E$M$Y$$$20161027$$MD$US$US
119485763$11948576$3$F$20150915$20200816$20160125$20200825$EXP$$ALCN2015CA005852$NOVARTIS$$81$YR$$F$Y$$$20200825$$HP$US$CA
119488378$11948837$8$F$20160121$20171206$20160125$20171213$EXP$$DE-JNJFOC-20160118527$JANSSEN$$78$YR$E$M$Y$64$KG$20171213$$MD$DE$DE
119493744$11949374$4$F$20140217$20200812$20160125$20200817$PER$$US-JNJFOC-20160116590$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200817$$CN$US$US
119510332$11951033$2$F$20150505$20200701$20160126$20200715$EXP$$US-BAYER-2015-461855$BAYER$$46$YR$A$F$Y$$$20200715$$HP$US$US
119521394$11952139$4$F$201601$20200723$20160126$20200727$PER$$US-BIOGEN-2016BI00176552$BIOGEN$$42$YR$$M$Y$$$20200727$$CN$US$US
1195356511$11953565$11$F$20160121$20170706$20160126$20170712$EXP$$ES-JNJFOC-20160119329$JANSSEN$$76$YR$E$M$Y$82$KG$20170712$$MD$ES$ES
119571942$11957194$2$F$20151207$20160211$20160126$20160217$PER$$US-JNJFOC-20151223395$JANSSEN$$53$YR$A$M$Y$74.2$KG$20160217$$MD$US$US
119574326$11957432$6$F$201601$20200710$20160126$20200716$EXP$$US-JAZZ-2016-US-000946$JAZZ$$60$YR$$M$Y$$$20200716$$MD$US$US
119575094$11957509$4$F$$20200720$20160126$20200723$EXP$$US-JAZZ-2016-US-001000$JAZZ$$$$$F$Y$$$20200723$$CN$US$US
119578472$11957847$2$F$20130501$20200721$20160126$20200724$EXP$$FR-BIOMARINAP-FR-2015-108410$BIOMARIN$$30$YR$$M$Y$55$KG$20200724$$MD$FR$FR
119619149$11961914$9$F$20160113$20170308$20160126$20170317$EXP$$DE-ROCHE-1696835$ROCHE$$64$YR$$M$Y$85$KG$20170317$$MD$DE$DE
1196206429$11962064$29$F$2015$20200720$20160126$20200725$PER$$CA-AMGEN-CANSP2012074066$AMGEN$$63$YR$A$F$Y$61$KG$20200725$$MD$CA$CA
119650191$11965019$1$I$$20160119$20160127$20160127$EXP$$DE-DRREDDYS-GER/GER/16/0065480$DR REDDYS$$$$E$F$Y$61$KG$20160127$$MD$DE$DE
119656453$11965645$3$F$$20160808$20160127$20160811$EXP$$PHHY2016GB009051$NOVARTIS$DE SOUZA MC, STEPAVOI G. CASE REPORT: BEWARE THE SILVER NITRATE STICK ? A RISK FACTOR FOR BISPHOSPHONATE?RELATED OSTEONECROSIS OF THE JAW (BRONJ). DENTAL UPDATE. 2015?42 (8):735?43$61$YR$$M$Y$$$20160811$$HP$GB$GB
119658952$11965895$2$F$20150426$20200910$20160127$20200916$EXP$$US-BAYER-2015-474185$BAYER$$67$YR$E$M$Y$$$20200916$$CN$US$US
119659712$11965971$2$F$20140311$20200908$20160127$20200914$EXP$$US-BAYER-2015-476474$BAYER$$60$YR$A$M$Y$$$20200914$$HP$US$US
119665332$11966533$2$F$20150223$20200813$20160127$20200819$EXP$$US-BAYER-2015-463409$BAYER$$64$YR$A$M$Y$$$20200819$$CN$US$US
119670142$11967014$2$F$2015$20200825$20160127$20200901$PER$$US-009507513-1601USA009324$MERCK$$80$YR$$F$Y$$$20200901$$CN$US$US
1196831721$11968317$21$F$20141126$20200915$20160128$20200925$EXP$$CA-ROCHE-1700204$ROCHE$$65$YR$$F$Y$$$20200925$$CN$CA$CA
119688282$11968828$2$F$$20200729$20160128$20200804$EXP$$GB-DRREDDYS-USA/UKI/15/0053339$DR REDDYS$VOHRA A. QUETIAPINE INDUCED RESTLESS LEGS SYNDROME: A SERIES OF FOUR CASES. ASIAN J PSYCHIATR. 2015?8:UNKNOWN?UNKNOWN.$43$YR$A$F$Y$$$20200804$$MD$GB$GB
119697374$11969737$4$F$20150120$20200826$20160128$20200901$EXP$$US-BAYER-2015-474163$BAYER$$73$YR$E$F$Y$$$20200901$$CN$US$US
119697562$11969756$2$F$$20160128$20160128$20160202$EXP$$US-ROCHE-1701642$ROCHE$$$$$$Y$$$20160202$$MD$US$US
119701045$11970104$5$F$$20200729$20160128$20200813$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-110432$RANBAXY$$43$YR$$F$Y$$$20200813$$HP$GB$GB
119719074$11971907$4$F$20150706$20160125$20160128$20200908$EXP$$DE-GLAXOSMITHKLINE-DE2016GSK009757$GLAXOSMITHKLINE$$46$YR$$F$Y$47$KG$20200908$$MD$DE$DE
1197203110$11972031$10$F$20151028$20200818$20160128$20200904$EXP$$PHJP2016JP001063$NOVARTIS$$57$YR$$M$Y$65$KG$20200904$$MD$JP$JP
119720844$11972084$4$F$201302$20200908$20160128$20200921$EXP$$US-JNJFOC-20160116258$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200921$$CN$US$US
1197274311$11972743$11$F$20160118$20170718$20160128$20170727$EXP$$JP-JNJFOC-20160120013$JANSSEN$$89$YR$E$M$Y$55.2$KG$20170727$$MD$JP$JP
119765662$11976566$2$F$20151025$20160127$20160129$20171221$EXP$$US-ROCHE-1664415$ROCHE$$34$YR$$F$Y$124$KG$20171221$$MD$US$US
119768554$11976855$4$F$$20200915$20160129$20200921$EXP$$CA-TEVA-629759ACC$TEVA$$9$YR$C$F$Y$$$20200921$$MD$CA$CA
119773435$11977343$5$F$20151218$20200630$20160129$20200707$EXP$$MX-PFIZER INC-2016030167$PFIZER$$70$YR$$F$Y$83$KG$20200707$$MD$MX$MX
119774242$11977424$2$F$20140214$20200720$20160129$20200730$EXP$$US-JNJFOC-20160121626$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200730$$HP$US$US
119782552$11978255$2$F$20130724$20200629$20160129$20200714$EXP$$US-BAYER-2015-477549$BAYER$$60$YR$A$F$Y$$$20200714$$CN$US$US
119815854$11981585$4$F$20151030$20200703$20160131$20200709$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-092570$BRISTOL MYERS SQUIBB$$93$YR$$F$Y$$$20200709$$MD$JP$JP
119820022$11982002$2$F$$20200820$20160201$20200902$EXP$$VN-CIPLA LTD.-2016VN00297$CIPLA$$$$$$Y$$$20200902$$HP$VN$VN
119823453$11982345$3$F$20141205$20161208$20160201$20161220$EXP$$JP-ROCHE-1646047$ROCHE$$66$YR$$M$Y$57$KG$20161220$$MD$JP$JP
119823872$11982387$2$F$20150329$20200820$20160201$20200827$EXP$$US-BAYER-2015-473845$BAYER$$64$YR$A$M$Y$$$20200827$$CN$US$US
119824292$11982429$2$F$$20200820$20160201$20200902$EXP$$VN-CIPLA LTD.-2016VN00305$CIPLA$$$$$$Y$$$20200902$$HP$VN$VN
119824811$11982481$1$I$$20160118$20160201$20160201$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-110353$RANBAXY$$$$$$Y$$$20160201$$HP$DE$DE
119827323$11982732$3$F$20160110$20160510$20160201$20160517$EXP$$RO-JNJFOC-20160117951$JANSSEN$$77$YR$E$M$Y$$$20160517$$MD$RO$RO
119827482$11982748$2$F$201301$20200707$20160201$20200721$EXP$$US-BAYER-2015-477442$BAYER$$81$YR$E$M$Y$$$20200721$$HP$US$US
119828102$11982810$2$F$20160113$20160202$20160201$20160211$EXP$$FR-JNJFOC-20160111187$JANSSEN$$50$YR$A$F$Y$63$KG$20160211$$MD$FR$FR
119835096$11983509$6$F$20160117$20170505$20160201$20170511$EXP$$US-JNJFOC-20160121459$PHARMACYCLICS$$74$YR$E$F$Y$$$20170511$$MD$US$US
119836983$11983698$3$F$20151118$20170425$20160201$20170504$EXP$$US-JNJFOC-20151202069$PHARMACYCLICS$$82$YR$E$M$Y$$$20170504$$MD$US$US
1198406821$11984068$21$F$20151111$20200826$20160201$20200908$EXP$$PHHY2012CA059738$NOVARTIS$$59$YR$$F$Y$$$20200908$$CN$CA$CA
119845012$11984501$2$F$20140124$20200827$20160201$20200910$EXP$$US-JNJFOC-20141208396$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20200910$$LW$US$US
119845024$11984502$4$F$201402$20200909$20160201$20200922$EXP$$US-JNJFOC-20160119190$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200922$$CN$US$US
119847113$11984711$3$F$2015$20200828$20160201$20200908$EXP$$US-BIOGEN-2015BI137095$BIOGEN$$$$$F$Y$95.79$KG$20200908$$CN$US$US
1198636618$11986366$18$F$$20200917$20160202$20200924$EXP$$CA-009507513-1601CAN011883$MERCK$$84$YR$$F$Y$$$20200924$$PH$CA$CA
119875272$11987527$2$F$$20200728$20160202$20200731$EXP$$CA-009507513-1107USA02130$MERCK$$62$YR$$M$Y$92.25$KG$20200731$$HP$CA$CA
119875961$11987596$1$I$$20160119$20160202$20160202$EXP$$DE-AUROBINDO-AUR-APL-2016-00556$AUROBINDO$$$$$F$Y$61$KG$20160202$$MD$DE$DE
1198769210$11987692$10$F$$20200909$20160202$20200914$EXP$$CA-ROCHE-1702404$ROCHE$$64$YR$$F$Y$$$20200914$$HP$CA$CA
119878494$11987849$4$F$$20200717$20160202$20200724$EXP$$GB-AUROBINDO-AUR-APL-2015-06543$AUROBINDO$$43$YR$$F$Y$$$20200724$$HP$GB$GB
119878825$11987882$5$F$20130503$20200830$20160202$20200904$EXP$$US-BAYER-2014-066346$BAYER$$41$YR$A$M$Y$$$20200904$$HP$US$US
119879272$11987927$2$F$$20200728$20160202$20200731$EXP$$CA-009507513-1601CAN010810$MERCK$$69$YR$$M$Y$$$20200731$$CN$CA$CA
119879783$11987978$3$F$20151203$20200727$20160202$20200803$EXP$$PHJP2016JP002081$NOVARTIS$$54$YR$$M$Y$$$20200803$$MD$JP$JP
119883723$11988372$3$F$20151229$20170823$20160202$20170828$EXP$$US-JNJFOC-20160123373$JANSSEN$$77$YR$E$F$Y$79.83$KG$20170828$$CN$US$US
119884401$11988440$1$I$$20160118$20160202$20160202$EXP$$ES-WARNER CHILCOTT, LLC-1047189$WARNER CHILCOTT$$82$YR$$F$Y$$$20160202$$MD$ES$ES
119886803$11988680$3$F$20150622$20200910$20160202$20200914$PER$$US-JNJFOC-20160109879$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20200914$$CN$US$US
119888989$11988898$9$F$201503$20200730$20160202$20200807$EXP$$PHHY2016BR013091$NOVARTIS$$61$YR$$F$Y$82$KG$20200807$$MD$BR$BR
119893122$11989312$2$F$20151015$20200902$20160202$20200911$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004432$BRISTOL MYERS SQUIBB$$56$YR$$M$Y$89.81$KG$20200911$$CN$US$US
119895104$11989510$4$F$20160118$20200717$20160202$20200724$EXP$$PHHY2016EC013444$NOVARTIS$$74$YR$$M$Y$$$20200724$$CN$COUNTRY NOT SPECIFIED$EC
1198951712$11989517$12$F$20131013$20200707$20160202$20200717$EXP$$PHHY2013IL117888$NOVARTIS$$72$YR$$F$Y$39$KG$20200717$$CN$IL$IL
1199103313$11991033$13$F$$20200706$20160202$20200715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004939$BRISTOL MYERS SQUIBB$$54$YR$$M$Y$$$20200715$$CN$CA$CA
119933433$11993343$3$F$$20200708$20160203$20200716$EXP$$GB-ACCORD-031871$ACCORD$$43$YR$$F$Y$$$20200716$$MD$GB$GB
1199352821$11993528$21$F$2015$20200825$20160203$20200828$EXP$$US-PFIZER INC-2016052883$PFIZER$$48$YR$$F$Y$73$KG$20200828$$MD$US$US
119937243$11993724$3$F$201404$20200806$20160203$20200818$EXP$$US-BAYER-2015-129829$BAYER$$73$YR$E$M$Y$$$20200818$$LW$US$US
119941412$11994141$2$F$20150621$20160210$20160203$20160212$EXP$$SE-JNJFOC-20150617536$JANSSEN$$43$YR$A$M$Y$75$KG$20160212$$MD$SE$SE
119948553$11994855$3$F$20160119$20160209$20160203$20200701$EXP$$GR-JNJFOC-20160123592$JOHNSON AND JOHNSON$$$$E$M$Y$$$20200701$$CN$GR$GR
1199627213$11996272$13$F$20150804$20200720$20160203$20200724$EXP$$US-ACTELION-A-US2015-123126$ACTELION$$75$YR$$M$Y$$$20200724$$HP$US$US
119973885$11997388$5$F$20110630$20170807$20160203$20200926$PER$$JP-AMGEN-JPNCT2013093936$AMGEN$$62$YR$A$M$Y$70$KG$20200925$$HP$JP$JP
119994042$11999404$2$F$$20180926$20160204$20181003$EXP$$DE-ROCHE-1703503$ROCHE$$73$YR$$F$Y$61$KG$20181003$$MD$DE$DE
119996341$11999634$1$I$$20160121$20160204$20160204$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-110663$RANBAXY$$$$$$Y$$$20160204$$HP$GB$GB
1199978716$11999787$16$F$20150805$20200916$20160204$20200921$EXP$$CA-ROCHE-1618751$ROCHE$$61$YR$$M$Y$$$20200921$$HP$CA$CA
120000132$12000013$2$F$20160119$20160205$20160204$20160217$EXP$$ES-ROCHE-1697908$ROCHE$$85$YR$$F$Y$72$KG$20160217$$MD$ES$ES
120008447$12000844$7$F$20160126$20160524$20160204$20160531$EXP$$ES-JNJFOC-20160201578$JANSSEN$$72$YR$E$M$Y$100$KG$20160531$$MD$ES$ES
120014804$12001480$4$F$20200622$20200623$20160204$20200702$EXP$$PHHY2013US129255$NOVARTIS$$75$YR$$F$Y$$$20200702$$MD$US$US
120056912$12005691$2$F$$20200901$20160204$20200909$EXP$$JP-OTSUKA-2016_002687$OTSUKA$TAKAI Y, KAJIMA Y. EXAMINATION OF MEDICATION MANAGEMENT SUMMARY AND CONTROL OF PATIENT EVENTS. JAPANESE JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES. 2020?46(8):446?451$8$DEC$$M$Y$$$20200909$$PH$JP$JP
120092482$12009248$2$F$20141217$20160222$20160205$20160226$EXP$$JP-ROCHE-1523844$ROCHE$SAKAKIBARA J, SAKAKIBARA JUN AND MORIMOTO M, ET AL. 7 THERAPEUTIC EXPERIENCE OF ALECTINIB FOR EML4?ALK FUSION GENE?POSITIVE LUNG CANCER IN A TREATED CASE WITH CRIZOTINIB AT OUR DEPARTMENT. ABSTRACTS OF THE 95TH LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT SECTIONAL MEETING OF HOKKAIDO MEDICAL CONGRESS 2015 OCT 24?14:?.$44$YR$$F$Y$50$KG$20160226$$MD$JP$JP
1201024215$12010242$15$F$201404$20200909$20160205$20200916$EXP$$JP-GLAXOSMITHKLINE-JP2016JPN012091$GLAXOSMITHKLINE$$$$$M$Y$$$20200916$$CN$JP$JP
120108814$12010881$4$F$20160128$20160331$20160205$20160405$EXP$$BR-JNJFOC-20160124622$JANSSEN$$60$YR$A$F$Y$90$KG$20160405$$MD$BR$BR
120121675$12012167$5$F$20141202$20160624$20160205$20160629$EXP$$AU-JNJFOC-20141203508$JANSSEN$$53$YR$A$M$Y$101.8$KG$20160629$$MD$AU$AU
1201217613$12012176$13$F$20160131$20160706$20160205$20160714$EXP$$KR-JNJFOC-20160201544$JANSSEN$$70$YR$E$M$Y$73$KG$20160714$$MD$KR$KR
1201281915$12012819$15$F$201404$20200909$20160205$20200916$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2016JPN012091$VIIV$$$$$M$Y$$$20200916$$CN$JP$JP
120141662$12014166$2$F$20140117$20200921$20160205$20200930$EXP$$US-BAYER-2015-478384$BAYER$$61$YR$A$F$Y$$$20200930$$CN$US$US
120142912$12014291$2$F$20150116$20200727$20160205$20200811$EXP$$US-BAYER-2015-483915$BAYER$$91$YR$E$M$Y$$$20200811$$CN$US$US
120202801$12020280$1$I$$20160122$20160206$20160206$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-111073$RANBAXY$$45$YR$$F$Y$$$20160206$$HP$GB$ES
120368967$12036896$7$F$20150720$20200623$20160208$20200708$EXP$$IT-AEGERION PHARMACEUTICALS INC-AEGR002253$AEGERION$$$$$$Y$$$20200708$$HP$IT$IT
1203751624$12037516$24$F$201506$20200817$20160208$20200825$EXP$$PHHY2015CA076388$NOVARTIS$$65$YR$$F$Y$$$20200825$$HP$CA$CA
1204027937$12040279$37$F$$20200914$20160208$20200921$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK160212$GLAXOSMITHKLINE$$$$$F$Y$64$KG$20200921$$CN$BR$BR
120411077$12041107$7$F$$20200729$20160208$20200731$PER$$US-PFIZER INC-2016070934$PFIZER$$56$YR$$F$Y$$$20200731$$CN$US$US
120420177$12042017$7$F$20160202$20200824$20160208$20200824$EXP$$PHHY2016US015948$NOVARTIS$$57$YR$$F$Y$93.88$KG$20200824$$MD$US$US
120443333$12044333$3$F$20140412$20200824$20160208$20200826$PER$$US-JNJFOC-20160206052$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200826$$CN$US$US
120452953$12045295$3$F$20140225$20200805$20160208$20200811$PER$$US-JNJFOC-20160206009$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200811$$CN$US$US
120453605$12045360$5$F$20160131$20170418$20160208$20170427$EXP$$NL-JNJFOC-20160205124$JANSSEN$$14$YR$T$M$Y$42.9$KG$20170427$$MD$NL$NL
120470225$12047022$5$F$20140924$20160824$20160209$20160901$EXP$$JP-ROCHE-1492388$ROCHE$IWASHIRO N, FUJIWARA AKI, AND DOMEN HIROMITSU A CASE OF BRAIN METASTASES AND LIVER METASTASES FROM POSTOPERATIVE ANAPLASTIC LYMPHOMA KINASE?POSITIVE LUNG CANCER WHERE ALECTINIB WAS EFFECTIVE AFTER THE EXPRESSION OF RESISTANCE TO CRIZOTINIB. JAPANESE JOURNAL OF LUNG CANCER/? ABSTRACTS OF THE 56TH ANNUAL MEETING OF THE JAPAN LUNG CANCER SOCIETY / THE 56TH ANNUAL MEETING OF THE JAPAN LUNG CANCER SOCIETY 2015 NOV?:658?.$74$YR$$F$Y$44$KG$20160901$$MD$JP$JP
120473742$12047374$2$F$20200812$20200813$20160209$20200818$PER$$US-BIOGEN-2016BI00179691$BIOGEN$$55$YR$$F$Y$$$20200818$$CN$US$US
120475932$12047593$2$F$$20160222$20160209$20160226$EXP$$AT-ROCHE-1706416$ROCHE$BROZEK W, REICHARDT D, ZWERINA J, DIMAI H, KLAUSHOFER K AND ZWETTLER E. ANTIRESORPTIVE THERAPY AND RISK OF MORTALITY AND REFRACTURE IN OSTEOPOROSIS?RELATED HIP FRACTURE: A NATIONWIDE STUDY.. OSTEOPOROSIS INTERNATIONAL 2016 JAN 01?27(1):387?396.$$$$$Y$$$20160226$$HP$AT$AT
120519472$12051947$2$F$20141001$20200712$20160209$20200722$EXP$$US-BAYER-2015-483606$BAYER$$62$YR$A$M$Y$$$20200722$$LW$US$US
120532962$12053296$2$F$201411$20200803$20160209$20200813$EXP$$US-BAYER-2015-482803$BAYER$$81$YR$E$F$Y$$$20200813$$CN$US$US
120533003$12053300$3$F$20160109$20160203$20160209$20200910$EXP$$US-CELGENEUS-USA-2016020423$CELGENE$$63$YR$$M$Y$$$20200910$$PH$US$US
120551053$12055105$3$F$20151203$20200806$20160209$20200813$PER$$PHEH2016US002747$NOVARTIS$$48$YR$$F$Y$$$20200813$$MD$US$US
120583653$12058365$3$F$201511$20200908$20160210$20200915$PER$$US-BIOGEN-2016BI00181777$BIOGEN$$35$YR$$M$Y$$$20200915$$CN$US$US
120592322$12059232$2$F$20131202$20200820$20160210$20200825$EXP$$US-BAYER-2015-484533$BAYER$$63$YR$A$M$Y$$$20200825$$CN$US$US
120596242$12059624$2$F$20140520$20200726$20160210$20200804$EXP$$US-BAYER-2015-490639$BAYER$$89$YR$E$M$Y$$$20200804$$CN$US$US
120598331$12059833$1$I$$20160201$20160210$20160210$EXP$$2016-000239$WARNER CHILCOTT$JOURNAL: ANNALS OF THE RHEUMATIC DISEASES?AUTHOR: MERINO MELENDEZ L, LLORENTE I, GARCIA E, GARCIA?VICUNA R, CASTANEDA SANZ S?TITLE: ATYPICAL FEMORAL FRACTURES AFTER TREATMENT WITH BISPHOSPHONATES AND DENOSUMAB IN INFLAMMATORY AND SENILE OSTEOPOROSIS?VOLUME: 74(2) YEAR: 2015 PAGES: 762?763$82$YR$$F$Y$$$20160210$$MD$ES$ES
120599985$12059998$5$F$$20200713$20160210$20200723$EXP$$FR-TEVA-634084ISR$TEVA$LELIEVRE B. SEVERE POISONING WITH NAPROXEN CAUSING COAGULOPATHY. BASIC?CLIN?PHARMACOL?TOXICOL. 2020?126(5):458?463.$58$YR$$F$Y$$$20200723$$HP$FR$FR
1206059711$12060597$11$F$2006$20200803$20160210$20200804$PER$$US-PFIZER INC-2016075238$PFIZER$$56$YR$$M$Y$122$KG$20200804$$MD$US$US
120617745$12061774$5$F$20160118$20200805$20160210$20200827$EXP$$US-LUNDBECK-DKLU2009087$LUNDBECK$$63$YR$$F$Y$$$20200828$$CN$US$US
120668532$12066853$2$F$20141204$20200722$20160211$20200731$EXP$$US-BAYER-2015-483290$BAYER$$73$YR$E$M$Y$$$20200731$$CN$US$US
120693732$12069373$2$F$$20200916$20160211$20200928$EXP$$US-APOTEX-2016AP006489$APOTEX$$$$$$Y$$$20200928$$CN$GB$US
120700202$12070020$2$F$$20200716$20160211$20200723$EXP$$CA-FRI-1000082464$ALLERGAN$$$$$M$Y$$$20200723$$MD$CA$CA
120701973$12070197$3$F$20140306$20200715$20160211$20200717$PER$$US-JNJFOC-20160208508$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200717$$CN$US$US
120701995$12070199$5$F$201506$20200810$20160211$20200813$PER$$US-JNJFOC-20160206426$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200813$$CN$US$US
120702853$12070285$3$F$2013$20200806$20160211$20200813$PER$$US-JNJFOC-20160208616$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200813$$LW$US$US
120710265$12071026$5$F$2015$20200831$20160211$20200903$EXP$$US-JAZZ-2016-US-002043$JAZZ$$47$YR$$F$Y$$$20200903$$HP$US$US
120714702$12071470$2$F$2012$20200625$20160211$20200706$EXP$$BE-AUROBINDO-AUR-APL-2016-01160$AUROBINDO$VAN WIJNENDAELE R, ET AL.. ANTIPSYCHOTICS : TARDIVE DYSKINESIA: 4 CASE REPORTS. REACTIONS WEEKLY. 2016?1583:128$$$$F$Y$$$20200706$$HP$BE$BE
120715052$12071505$2$F$2011$20200625$20160211$20200707$EXP$$BE-AUROBINDO-AUR-APL-2016-01159$AUROBINDO$ANTIPSYCHOTICS.TARDIVE DYSKINESIA: 4 CASE REPORTS.. 2016$$$E$F$Y$$$20200707$$HP$BE$BE
120715972$12071597$2$F$20040701$20200901$20160212$20200907$PER$$US-AMGEN-USASL2016014310$AMGEN$$43$YR$A$F$Y$$$20200907$$MD$US$US
120721779$12072177$9$F$2016$20200803$20160212$20200806$EXP$$CA-ROCHE-1659576$ROCHE$$69$YR$$F$Y$$$20200807$$MD$CA$CA
1207228223$12072282$23$F$2014$20200317$20160212$20200323$EXP$$PHHY2015CA143204$NOVARTIS$$28$YR$$F$Y$$$20200323$$CN$COUNTRY NOT SPECIFIED$CA
1207243111$12072431$11$F$20160126$20200914$20160212$20200917$PER$$CA-AMGEN-CANSP2016015699$AMGEN$$55$YR$A$M$Y$$$20200917$$HP$CA$CA
120724602$12072460$2$F$201401$20200908$20160212$20200911$EXP$$US-BAYER-2015-484733$BAYER$$58$YR$A$F$Y$$$20200911$$CN$US$US
120727321$12072732$1$I$$20160129$20160212$20160212$EXP$$US-AUROBINDO-AUR-APL-2016-01101$AUROBINDO$WOLIN EA, ET AL.. ALENDRONIC ACID/IBANDRONIC ACID ATYPICAL SUBTROCHANTERIC FEMUR FRACTURE: CASE REPORT. REACTIONS WEEKLY. 2016?1583:52$76$YR$$F$Y$$$20160212$$HP$US$US
120734875$12073487$5$F$20160126$20200803$20160212$20200814$EXP$$US-ACTELION-A-NJ2016-131230$ACTELION$$74$YR$$F$Y$$$20200814$$HP$US$US
120735504$12073550$4$F$20150301$20200809$20160212$20200814$PER$$US-JNJFOC-20160204570$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200814$$CN$US$US
120736183$12073618$3$F$20140128$20200709$20160212$20200721$EXP$$US-JNJFOC-20160205845$JOHNSON AND JOHNSON$$39$YR$$M$Y$$$20200721$$CN$US$US
120738272$12073827$2$F$20131206$20200824$20160212$20200828$EXP$$US-BAYER-2015-483919$BAYER$$69$YR$E$F$Y$$$20200828$$LW$US$US
120743852$12074385$2$F$20141203$20200729$20160212$20200811$EXP$$US-BAYER-2015-484547$BAYER$$74$YR$E$M$Y$$$20200811$$CN$US$US
1207470924$12074709$24$F$201410$20200910$20160212$20200915$EXP$$PHHY2010CA80150$NOVARTIS$$73$YR$$F$Y$$$20200915$$HP$CA$CA
120752443$12075244$3$F$20160205$20160216$20160212$20160224$EXP$$US-ASTRAZENECA-2016SE13528$ASTRAZENECA$$54$YR$$F$Y$$$20160224$$MD$US$US
120753911$12075391$1$I$$20160129$20160213$20160213$EXP$$ES-AUROBINDO-AUR-APL-2016-01327$AUROBINDO$$45$YR$$F$Y$$$20160210$$MD$ES$ES
1207682910$12076829$10$F$$20200720$20160215$20200801$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-111597$RANBAXY$$58$YR$$F$Y$$$20200801$$HP$NL$FR
120768402$12076840$2$F$20131224$20200701$20160215$20200715$EXP$$US-BAYER-2015-480920$BAYER$$77$YR$E$M$Y$$$20200715$$HP$US$US
120769323$12076932$3$F$20160122$20160307$20160215$20160317$PER$$US-JNJFOC-20160205120$JANSSEN$$62$YR$A$M$Y$$$20160317$$MD$US$US
120775247$12077524$7$F$20160201$20200821$20160215$20200825$EXP$$US-PFIZER INC-2016077637$PFIZER$$65$YR$$M$Y$92$KG$20200825$$CN$US$US
120786737$12078673$7$F$$20200716$20160216$20200718$EXP$$ES-AUROBINDO-AUR-APL-2016-01164$AUROBINDO$$74$YR$$F$Y$$$20200718$$MD$ES$ES
120788352$12078835$2$F$20150914$20200716$20160216$20200725$EXP$PT-EMA-DD-20200706-BANAVALLI_M-145040$PHHY2016PT017095$NOVARTIS$$61$YR$$F$Y$61$KG$20200725$$HP$PT$PT
120796568$12079656$8$F$$20200727$20160216$20200729$EXP$$US-PFIZER INC-2016088306$PFIZER$$62$YR$$F$Y$$$20200729$$MD$US$US
120806722$12080672$2$F$$20200722$20160216$20200731$EXP$$US-AUROBINDO-AUR-APL-2016-01119$AUROBINDO$$16$YR$$F$Y$59$KG$20200731$$MD$US$US
120807775$12080777$5$F$20130625$20200702$20160216$20200710$PER$$PHHY2014US083957$NOVARTIS$$47$YR$$F$Y$$$20200710$$MD$US$US
120808548$12080854$8$F$2011$20200903$20160216$20200908$EXP$$US-JAZZ-2016-US-002245$JAZZ$$78$YR$$F$Y$53$KG$20200908$$HP$US$US
120811447$12081144$7$F$20160208$20170404$20160216$20170407$EXP$$US-JNJFOC-20160207848$JANSSEN$$74$YR$E$F$Y$71.67$KG$20170407$$MD$US$US
1208175810$12081758$10$F$201502$20200730$20160216$20200806$EXP$$PHHY2016AR020595$NOVARTIS$$35$YR$$F$Y$$$20200806$$CN$COUNTRY NOT SPECIFIED$AR
120830216$12083021$6$F$$20200713$20160217$20200714$PER$$US-PFIZER INC-2016078048$PFIZER$$58$YR$$F$Y$$$20200714$$HP$US$US
120838023$12083802$3$F$20160205$20160304$20160217$20160314$EXP$$US-JNJFOC-20160211074$PHARMACYCLICS$$80$YR$E$M$Y$103.76$KG$20160314$$MD$US$US
120839024$12083902$4$F$20140730$20200831$20160217$20200908$EXP$$US-BAYER-2016-013131$BAYER$$69$YR$E$M$Y$108.8$KG$20200908$$HP$US$US
120844488$12084448$8$F$20140504$20200702$20160217$20200707$PER$$PHHY2015US158866$NOVARTIS$$51$YR$$F$Y$$$20200707$$MD$US$US
120854574$12085457$4$F$20150920$20170801$20160217$20170815$EXP$$CO-JNJFOC-20151209482$JANSSEN$$93$YR$E$F$Y$70$KG$20170815$$MD$CO$CO
120855312$12085531$2$F$20150301$20160720$20160217$20160728$EXP$$DE-JNJFOC-20150604087$JANSSEN$$53$YR$A$M$Y$98.2$KG$20160728$$MD$DE$DE
120858984$12085898$4$F$20140805$20200702$20160217$20200710$PER$$PHHY2015US098160$NOVARTIS$$44$YR$$F$Y$$$20200710$$MD$US$US
1208593625$12085936$25$F$201503$20200629$20160217$20200709$EXP$$CA-PFIZER INC-2015167344$PFIZER$$55$YR$$F$Y$87$KG$20200709$$MD$CA$CA
1208843614$12088436$14$F$20121106$20200623$20160218$20200701$EXP$$CA-ROCHE-1712586$ROCHE$$42$YR$$F$Y$75$KG$20200701$$HP$JP$CA
120884752$12088475$2$F$20160202$20160307$20160218$20160314$EXP$$TR-ROCHE-1710691$ROCHE$$62$YR$$M$Y$104$KG$20160314$$MD$TR$TR
120888455$12088845$5$F$201505$20200716$20160218$20200724$EXP$$JP-ROCHE-1685126$ROCHE$$14$YR$$M$Y$59.1$KG$20200724$$MD$JP$JP
120891653$12089165$3$F$20140227$20200727$20160218$20200804$EXP$$PHHY2016US019537$NOVARTIS$$42$YR$$F$Y$$$20200804$$MD$US$US
120893957$12089395$7$F$20160107$20180612$20160218$20180621$EXP$$GB-JNJFOC-20160108419$JANSSEN$$71$YR$E$M$Y$90$KG$20180621$$MD$GB$GB
120893965$12089396$5$F$20160206$20160316$20160218$20160325$EXP$$US-JNJFOC-20160207760$JANSSEN$$71$YR$E$M$Y$104$KG$20160325$$MD$US$US
120895496$12089549$6$F$201601$20200713$20160218$20200715$PER$$US-PFIZER INC-2016049737$PFIZER$$63$YR$$F$Y$69.4$KG$20200715$$CN$US$US
120909044$12090904$4$F$20150712$20160802$20160218$20160804$EXP$$NL-JNJFOC-20150709904$JANSSEN$$62$YR$A$M$Y$67$KG$20160804$$MD$NL$NL
120910093$12091009$3$F$201404$20200728$20160218$20200811$EXP$$US-BAYER-2016-019062$BAYER$$82$YR$E$F$Y$$$20200811$$HP$US$US
1209149726$12091497$26$F$$20200720$20160218$20200728$EXP$$CA-PFIZER INC-2016085227$PFIZER$$65$YR$$F$Y$$$20200728$$HP$CA$CA
120920305$12092030$5$F$20151109$20170222$20160219$20170228$EXP$$JP-ROCHE-1711737$ROCHE$$72$YR$$M$Y$54$KG$20170228$$MD$JP$JP
120940445$12094044$5$F$20160206$20170425$20160219$20170503$EXP$$US-JNJFOC-20160207662$JANSSEN$$55$YR$A$M$Y$86$KG$20170503$$MD$US$US
120944466$12094446$6$F$20150701$20200827$20160219$20200904$EXP$$US-BIOGEN-2016BI00189368$BIOGEN$$55$YR$$F$Y$$$20200904$$CN$US$US
120947735$12094773$5$F$20150212$20200921$20160219$20200928$PER$$US-JNJFOC-20160217457$JOHNSON AND JOHNSON$$49$YR$A$F$Y$114.8$KG$20200928$$HP$US$US
120949164$12094916$4$F$201207$20200721$20160219$20200731$PER$$US-JNJFOC-20160217442$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200731$$CN$US$US
120949184$12094918$4$F$20140410$20200806$20160219$20200811$PER$$US-JNJFOC-20160217444$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200811$$CN$US$US
120949906$12094990$6$F$20151210$20200831$20160219$20200914$PER$$US-JNJFOC-20160217398$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200914$$CN$US$US
120949924$12094992$4$F$20150201$20200903$20160219$20200914$PER$$US-JNJFOC-20160217403$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20200914$$CN$US$US
120950014$12095001$4$F$20140521$20200716$20160219$20200728$EXP$$US-JNJFOC-20160217409$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200728$$CN$US$US
120950124$12095012$4$F$20140103$20200816$20160219$20200827$EXP$$US-JNJFOC-20160217419$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200827$$CN$US$US
120950146$12095014$6$F$20141214$20200817$20160219$20200820$PER$$US-JNJFOC-20160217422$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200820$$CN$US$US
120950218$12095021$8$F$20150331$20200719$20160219$20200729$EXP$$US-JNJFOC-20160217424$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200729$$CN$US$US
120950284$12095028$4$F$$20200701$20160219$20200707$EXP$$PHHY2016CA020630$NOVARTIS$$14$MON$$F$Y$$$20200707$$HP$CA$CA
120950424$12095042$4$F$20150403$20200707$20160219$20200713$PER$$US-JNJFOC-20160217436$JOHNSON AND JOHNSON$$91$YR$$M$Y$$$20200713$$CN$US$US
120952452$12095245$2$F$20160213$20200830$20160219$20200902$EXP$$US-ASTRAZENECA-2016SE17435$ASTRAZENECA$$15070$DY$$F$Y$60.6$KG$20200902$$MD$US$US
1209544815$12095448$15$F$20160125$20200820$20160219$20200826$EXP$$GB-SA-2016SA028120$SANOFI AVENTIS$$$$$$Y$$$20200826$$HP$GB$GB
120954984$12095498$4$F$$20200626$20160219$20200701$EXP$$GB-ABBVIE-16P-167-1564993-00$ABBVIE$$75$YR$$F$Y$$$20200701$$CN$GB$GB
120955214$12095521$4$F$2013$20200902$20160219$20200910$EXP$$US-BIOGEN-2013BI100265$BIOGEN$$42$YR$$F$Y$$$20200910$$CN$US$US
120955874$12095587$4$F$20160208$20200812$20160219$20200817$PER$$US-JAZZ-2016-US-002796$JAZZ$$52$YR$$F$Y$101.59$KG$20200817$$HP$US$US
1209859412$12098594$12$F$20150904$20200820$20160222$20200826$EXP$$CA-ROCHE-1637460$ROCHE$$70$YR$$M$Y$68$KG$20200826$$MD$CA$CA
120997297$12099729$7$F$20140826$20190923$20160222$20191021$EXP$$PHHY2014US139883$NOVARTIS$$56$YR$$F$Y$101.3$KG$20191021$$MD$US$US
121007206$12100720$6$F$20160207$20161213$20160222$20161219$EXP$$US-JNJFOC-20160216239$JANSSEN$$45$YR$A$F$Y$96.3$KG$20161219$$MD$US$US
121007465$12100746$5$F$20141006$20170213$20160222$20170216$EXP$$AU-JNJFOC-20141005650$JANSSEN$$31$YR$A$F$Y$71$KG$20170216$$MD$AU$AU
1210101617$12101016$17$F$20140428$20200807$20160222$20200819$EXP$$US-ACTELION-A-NJ2014-98517$ACTELION$$62$YR$$F$Y$61.22$KG$20200819$$HP$US$US
121010752$12101075$2$F$20150312$20200902$20160222$20200911$EXP$$US-BAYER-2015-497592$BAYER$$63$YR$A$F$Y$$$20200911$$HP$US$US
121041388$12104138$8$F$201403$20200702$20160223$20200706$EXP$$PHJP2016JP001712$NOVARTIS$$59$YR$$F$Y$53$KG$20200706$$HP$JP$JP
121042383$12104238$3$F$$20190715$20160223$20190725$EXP$$ES-ROCHE-1703079$ROCHE$. UNKNOWN. REV OSTEOPOROS METAB MINER 2015?7(3):13?46.$82$YR$$F$Y$$$20190725$$MD$ES$ES
121048438$12104843$8$F$$20200714$20160223$20200716$PER$$US-PFIZER INC-2016057974$PFIZER$$44$YR$$F$Y$$$20200716$$HP$US$US
121048522$12104852$2$F$$20200713$20160223$20200714$PER$$US-PFIZER INC-2016052529$PFIZER$$64$YR$$F$Y$$$20200714$$CN$US$US
121050324$12105032$4$F$20140412$20200922$20160223$20200928$PER$$US-JNJFOC-20160219487$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200928$$CN$US$US
121059979$12105997$9$F$$20200928$20160223$20200930$EXP$$US-ARIAD-2014US004171$TAKEDA$$$$$F$Y$$$20200930$$HP$US$US
1210626717$12106267$17$F$20141226$20200831$20160128$20200911$EXP$$JP-INCYTE CORPORATION-2015IN001690$INCYTE$$$$$$Y$$$20200911$$MD$JP$JP
121063173$12106317$3$F$$20200731$20160223$20200805$EXP$CN-MLMSERVICE-20160208-0145760-1$CN-TAKEDA-2016MPI001128$TAKEDA$HAO H, LIU Y, ZHAO S, FANG B. BORTEZOMIB IN COMBINATION WITH DEXAMETHASONE IN THE TREATMENT OF MULTIPLE MYELOMA INDUCED RHABDOMYOLYSIS: A CASE REPORT. ZHONGHUA XUEYEXUE ZAZHI. 2015?36(3):253$63$YR$$M$Y$$$20200805$$MD$CN$CN
1210910811$12109108$11$F$2012$20200925$20160224$20200929$EXP$$PHHY2016BR018138$NOVARTIS$$57$YR$$M$Y$82$KG$20200930$$MD$BR$BR
1210927611$12109276$11$F$$20200731$20160224$20200803$EXP$$US-PFIZER INC-2016104930$PFIZER$$83$YR$$F$Y$$$20200803$$CN$US$US
121100083$12110008$3$F$201412$20200621$20160224$20200706$EXP$$US-BAYER-2015-479612$BAYER$$67$YR$E$M$Y$$$20200706$$HP$US$US
121104453$12110445$3$F$20120224$20200910$20160224$20200916$EXP$$US-BAYER-2016-008032$BAYER$$79$YR$E$F$Y$$$20200916$$CN$US$US
1211105012$12111050$12$F$20160204$20170811$20160224$20170818$EXP$$GB-JNJFOC-20160217995$PHARMACYCLICS$$50$YR$A$M$Y$76$KG$20170818$$MD$GB$GB
121148465$12114846$5$F$20160211$20200915$20160225$20200917$EXP$$GB-SA-2016SA033402$SANOFI AVENTIS$$51$YR$$F$Y$60$KG$20200917$$MD$GB$GB
121168193$12116819$3$F$$20200709$20160225$20200716$EXP$$GB-LUNDBECK-DKLU2010401$LUNDBECK$$75$YR$$F$Y$$$20200716$$HP$GB$GB
121193673$12119367$3$F$2015$20200726$20160226$20200803$EXP$$US-JNJFOC-20160221159$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20200803$$CN$US$US
121193683$12119368$3$F$20140518$20200915$20160226$20200929$EXP$$US-JNJFOC-20160220847$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200929$$CN$US$US
121193783$12119378$3$F$201511$20200813$20160226$20200825$EXP$$US-JNJFOC-20160220897$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200825$$HP$US$US
121193794$12119379$4$F$201402$20200728$20160226$20200731$PER$$US-JNJFOC-20160220934$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200731$$CN$US$US
121198402$12119840$2$F$20150322$20200910$20160226$20200914$EXP$$US-BAYER-2015-496129$BAYER$$79$YR$E$F$Y$$$20200914$$CN$US$US
1212014111$12120141$11$F$2015$20200729$20160226$20200731$PER$$US-PFIZER INC-2016082266$PFIZER$$59$YR$$F$Y$$$20200731$$MD$US$US
121222987$12122298$7$F$2013$20200116$20160226$20200123$EXP$$PHHY2013CA047399$NOVARTIS$$73$YR$$M$Y$$$20200123$$HP$CA$CA
1212230524$12122305$24$F$20151219$20200904$20160226$20200910$EXP$$PHHY2015CA172640$NOVARTIS$$61$YR$$F$Y$$$20200911$$MD$CA$CA
1212444535$12124445$35$F$20160401$20200922$20160229$20200923$EXP$$CN-ROCHE-1717581$ROCHE$$58$YR$$M$Y$62$KG$20200924$$MD$CN$CN
121256294$12125629$4$F$20140324$20200902$20160229$20200904$EXP$$US-BAYER-2016-038630$BAYER$$73$YR$E$F$Y$$$20200904$$LW$US$US
121266312$12126631$2$F$2015$20200713$20160229$20200728$EXP$$IN-CIPLA LTD.-2016IN01517$CIPLA$$$$$$Y$$$20200728$$HP$IN$IN
121270593$12127059$3$F$20131015$20200913$20160229$20200922$PER$ES-AGEMED-706180241$ES-AMGEN-ESPSP2016022485$AMGEN$TOFE V. I.? BAGAN J. V.? BAGAN L.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$55$YR$A$F$Y$$$20200922$$HP$ES$ES
121272373$12127237$3$F$20160201$20200713$20160229$20200720$EXP$FR-AFSSAPS-ST20160165$FR-FRI-1000082874$ALLERGAN$$$$$F$Y$77$KG$20200720$$PH$FR$FR
121273693$12127369$3$F$20150710$20200913$20160229$20200922$PER$ES-AGEMED-006183341$ES-AMGEN-ESPSP2016022480$AMGEN$TOFE V. I.? BAGAN J.? BAGAN L.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$77$YR$E$F$Y$$$20200922$$HP$ES$ES
121273823$12127382$3$F$20151018$20200913$20160229$20200922$PER$ES-AGEMED-906182241$ES-AMGEN-ESPSP2016022504$AMGEN$TOFE V. I.? BAGAN J. V.? BAGAN L.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$86$YR$E$F$Y$$$20200922$$HP$ES$ES
1213037910$12130379$10$F$$20200710$20160229$20200710$EXP$$CA-ROCHE-1717281$ROCHE$$$$$M$Y$$$20200710$$MD$CA$CA
121305535$12130553$5$F$20150522$20200924$20160301$20200928$PER$$US-JNJFOC-20160116127$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200928$$CN$US$US
121305564$12130556$4$F$201501$20200722$20160301$20200731$PER$$US-JNJFOC-20160116129$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200731$$CN$US$US
121305694$12130569$4$F$20150121$20200810$20160301$20200813$PER$$US-JNJFOC-20160116136$JOHNSON AND JOHNSON$$94$YR$E$F$Y$$$20200813$$HP$US$US
121306563$12130656$3$F$20140116$20200818$20160301$20200820$PER$$US-JNJFOC-20160120425$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200820$$CN$US$US
121306754$12130675$4$F$20140730$20200817$20160301$20200820$PER$$US-JNJFOC-20160116219$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20200820$$CN$US$US
121306815$12130681$5$F$20131102$20200622$20160301$20200702$EXP$$US-JNJFOC-20160120804$JOHNSON AND JOHNSON$$80$YR$$M$Y$$$20200702$$CN$US$US
121306843$12130684$3$F$201403$20200811$20160301$20200821$EXP$$US-JNJFOC-20160120806$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200821$$CN$US$US
121306983$12130698$3$F$20130214$20200709$20160301$20200715$PER$$US-JNJFOC-20160121627$JOHNSON AND JOHNSON$$80$YR$$F$Y$$$20200715$$HP$US$US
121307143$12130714$3$F$20140205$20200924$20160301$20200930$PER$$US-JNJFOC-20160121628$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20200930$$CN$US$US
121309124$12130912$4$F$20140215$20200712$20160301$20200714$PER$$US-JNJFOC-20160121622$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200714$$CN$US$US
121309433$12130943$3$F$20150819$20200806$20160301$20200811$PER$$US-JNJFOC-20160206972$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200811$$HP$US$US
121309443$12130944$3$F$20120224$20200910$20160301$20200914$PER$$US-JNJFOC-20160108752$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200914$$CN$US$US
121309653$12130965$3$F$20130605$20200721$20160301$20200731$PER$$US-JNJFOC-20160213569$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200731$$CN$US$US
121309994$12130999$4$F$20140214$20200728$20160301$20200731$PER$$US-JNJFOC-20160216270$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200731$$CN$US$US
121310014$12131001$4$F$20140219$20200817$20160301$20200819$PER$$US-JNJFOC-20160216699$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200819$$CN$US$US
121310233$12131023$3$F$2013$20200715$20160301$20200717$PER$$US-JNJFOC-20160124682$JOHNSON AND JOHNSON$$$$$F$Y$$$20200717$$CN$US$US
121310244$12131024$4$F$201411$20200920$20160301$20200928$PER$$US-JNJFOC-20160124684$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200928$$CN$US$US
121311114$12131111$4$F$20140513$20200707$20160301$20200720$EXP$$US-JNJFOC-20160123140$JOHNSON AND JOHNSON$$65$YR$$M$Y$$$20200720$$HP$US$US
121311163$12131116$3$F$20141023$20200701$20160301$20200706$PER$$US-JNJFOC-20160202588$JOHNSON AND JOHNSON$$76$YR$$F$Y$$$20200706$$CN$US$US
121311193$12131119$3$F$20150425$20200715$20160301$20200720$PER$$US-JNJFOC-20160202587$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20200720$$HP$US$US
121311753$12131175$3$F$201412$20200819$20160301$20200824$PER$$US-JNJFOC-20160115983$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200824$$HP$US$US
121312173$12131217$3$F$20140425$20200630$20160301$20200706$PER$$US-JNJFOC-20160206309$JOHNSON AND JOHNSON$$83$YR$$F$Y$$$20200706$$CN$US$US
121312203$12131220$3$F$20140411$20200830$20160301$20200901$PER$$US-JNJFOC-20160206312$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200901$$CN$US$US
121312213$12131221$3$F$20140621$20200805$20160301$20200811$PER$$US-JNJFOC-20160206313$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20200811$$HP$US$US
121312253$12131225$3$F$20140726$20200903$20160301$20200914$PER$$US-JNJFOC-20160206131$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200914$$CN$US$US
121312344$12131234$4$F$201306$20200921$20160301$20200923$PER$$US-JNJFOC-20160203204$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200923$$CN$US$US
121312453$12131245$3$F$20150921$20200818$20160301$20200821$PER$$US-JNJFOC-20160206634$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200821$$CN$US$US
121312493$12131249$3$F$20150918$20200906$20160301$20200918$EXP$$US-JNJFOC-20160206632$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200918$$CN$US$US
121313014$12131301$4$F$2014$20200906$20160301$20200914$PER$$US-JNJFOC-20160213199$JOHNSON AND JOHNSON$$86$YR$E$M$Y$112.76$KG$20200914$$CN$US$US
121313086$12131308$6$F$20160218$20160413$20160301$20160420$EXP$$UA-JNJFOC-20160218867$JANSSEN$$33$YR$A$M$Y$95.2$KG$20160420$$MD$UA$UA
121313174$12131317$4$F$20150226$20200719$20160301$20200722$PER$$US-JNJFOC-20160208796$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200722$$CN$US$US
121313223$12131322$3$F$201404$20200728$20160301$20200803$PER$$US-JNJFOC-20160122283$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200803$$CN$US$US
121315564$12131556$4$F$20150206$20200716$20160301$20200721$PER$$US-JNJFOC-20160206126$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20200721$$CN$US$US
121315863$12131586$3$F$20140624$20200819$20160301$20200825$PER$$US-JNJFOC-20160208507$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200825$$CN$US$US
121315873$12131587$3$F$201404$20200902$20160301$20200909$PER$$US-JNJFOC-20160208509$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200909$$CN$US$US
121315945$12131594$5$F$20140612$20200806$20160301$20200817$EXP$$US-JNJFOC-20160206422$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20200817$$CN$US$US
121317953$12131795$3$F$20150923$20200805$20160301$20200807$PER$$US-JNJFOC-20160206914$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200807$$CN$US$US
121317974$12131797$4$F$201405$20200916$20160301$20200922$PER$$US-JNJFOC-20160222361$JOHNSON AND JOHNSON$$91$YR$E$M$Y$$$20200922$$CN$US$US
121319065$12131906$5$F$201503$20200929$20160301$20200930$PER$$US-JNJFOC-20160205130$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200930$$CN$US$US
121319424$12131942$4$F$20121014$20200823$20160301$20200825$PER$$US-JNJFOC-20160208783$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200825$$CN$US$US
121319443$12131944$3$F$20140730$20200831$20160301$20200914$PER$$US-JNJFOC-20160116152$JOHNSON AND JOHNSON$$69$YR$E$M$Y$108.8$KG$20200914$$HP$US$US
121319754$12131975$4$F$20131224$20200729$20160301$20200803$PER$$US-JNJFOC-20160213897$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200803$$LW$US$US
121319875$12131987$5$F$20140211$20200813$20160301$20200820$PER$$US-JNJFOC-20160213907$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20200820$$CN$US$US
121320203$12132020$3$F$20140724$20200920$20160301$20200923$PER$$US-JNJFOC-20160214867$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200923$$CN$US$US
121321533$12132153$3$F$20150417$20200730$20160301$20200806$EXP$$US-JNJFOC-20160214043$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200806$$CN$US$US
1213227711$12132277$11$F$20141227$20200821$20160301$20200903$EXP$$JP-INCYTE CORPORATION-2015IN006150$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
121324523$12132452$3$F$20140223$20200702$20160301$20200714$EXP$$US-JNJFOC-20160220221$JOHNSON AND JOHNSON$$77$YR$$M$Y$$$20200714$$HP$US$US
121326853$12132685$3$F$20150202$20200728$20160301$20200731$PER$$US-JNJFOC-20160203417$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200731$$CN$US$US
121329764$12132976$4$F$20140602$20200825$20160301$20200908$EXP$$US-JNJFOC-20160108023$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200908$$CN$US$US
121330914$12133091$4$F$20140703$20200805$20160301$20200811$PER$$US-JNJFOC-20160112673$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200811$$CN$US$US
121331433$12133143$3$F$201503$20200628$20160301$20200709$EXP$$US-JNJFOC-20160116045$JOHNSON AND JOHNSON$$79$YR$$F$Y$$$20200709$$CN$US$US
121331763$12133176$3$F$20150414$20160516$20160301$20160523$EXP$$JP-ROCHE-1718436$ROCHE$$78$YR$$F$Y$61$KG$20160523$$MD$JP$JP
1213337522$12133375$22$F$$20200720$20160301$20200723$PER$$CA-AMGEN-CANSP2016018438$AMGEN$$65$YR$E$F$Y$$$20200723$$CN$CA$CA
121335293$12133529$3$F$20141218$20161013$20160301$20161020$EXP$$JP-ROCHE-1625325$ROCHE$$79$YR$$M$Y$63$KG$20161020$$MD$JP$JP
121336432$12133643$2$F$$20160223$20160301$20200930$EXP$$PHHY2016GB024628$NOVARTIS$$42$YR$$F$Y$$$20200930$$HP$GB$GB
121341233$12134123$3$F$20160105$20160405$20160301$20160411$EXP$$US-ROCHE-1692340$ROCHE$$39$YR$$M$Y$68.6$KG$20160411$$MD$US$US
121350607$12135060$7$F$201602$20200708$20160301$20200713$EXP$$US-JAZZ-2016-US-003497$JAZZ$$58$YR$$F$Y$70.3$KG$20200713$$MD$US$US
1213508525$12135085$25$F$201602$20200817$20160301$20200823$EXP$$US-ACTELION-A-NJ2016-131949$ACTELION$$20$YR$$F$Y$$$20200823$$HP$US$US
1213522522$12135225$22$F$2016$20200901$20160301$20200908$EXP$$PHHY2016CA026246$NOVARTIS$$84$YR$$M$Y$$$20200908$$MD$CA$CA
121354021$12135402$1$I$$20160225$20160302$20160302$EXP$$ES-ROCHE-1718502$ROCHE$LEON VAZQUEZ F, BONIS J, BRYANT CEREZO V, HERRERO HERNANDEZ S, JAMART SANCHEZ L AND DIAZ HOLGADO A. PREVENTION OF OSTEOPOROTIC FRACTURE IN SPAIN: USE OF DRUGS BEFORE AND AFTER A HIP FRACTURE. REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL 2015?7 (2):54?62.$$$$$Y$$$20160302$$HP$ES$ES
121358873$12135887$3$F$$20200913$20160302$20200923$PER$ES-AGEMED-806181241$ES-AMGEN-ESPSP2016022486$AMGEN$TOFE V. I.? BAGAN J.? BAGAN L.. OSTEONECROSIS OF THE JAWS ASSOCIATED WITH DENOSUMAB: STUDY OF CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN A SERIES OF CLINICAL CASES. ORAL MEDICINE AND PATHOLOGY. 2020?12 (7):E676?81$82$YR$E$F$Y$$$20200923$$HP$ES$ES
121373514$12137351$4$F$20160119$20161207$20160302$20161214$EXP$$ES-TEVA-630516ACC$TEVA$$85$YR$$F$Y$$$20161214$$MD$ES$ES
121373894$12137389$4$F$20080215$20200908$20160302$20200914$EXP$$JP-ASTELLAS-2008JP003688$ASTELLAS$$37$YR$$F$Y$56$KG$20200914$$MD$JP$JP
121374812$12137481$2$F$2016$20200817$20160302$20200824$EXP$$DE-ABBVIE-16K-062-1568634-00$ABBVIE$$$$$F$Y$$$20200824$$CN$DE$DE
121375161$12137516$1$I$20150824$20150825$20160302$20160302$EXP$$US-JNJFOC-20150819418$JANSSEN$$66$YR$E$F$Y$62$KG$20160302$$MD$US$US
121375172$12137517$2$F$20151027$20160419$20160302$20160429$EXP$$US-JNJFOC-20151118504$JANSSEN$$79$YR$E$M$Y$78.02$KG$20160429$$MD$US$US
121375185$12137518$5$F$20151223$20160615$20160302$20160619$EXP$$US-JNJFOC-20151223672$JANSSEN$$70$YR$E$M$Y$81$KG$20160619$$MD$US$US
121375192$12137519$2$F$20160103$20160505$20160302$20160516$EXP$$US-JNJFOC-20160102492$JANSSEN$$68$YR$E$M$Y$$$20160516$$MD$US$US
121375202$12137520$2$F$20150828$20160111$20160302$20160408$EXP$$US-JNJFOC-20150924816$JANSSEN$$81$YR$E$M$Y$102.06$KG$20160408$$MD$US$US
121375212$12137521$2$F$20151202$20160513$20160302$20160519$EXP$$US-JNJFOC-20151206455$JANSSEN$$46$YR$A$M$Y$61$KG$20160519$$MD$US$US
121375221$12137522$1$I$20151002$20160120$20160302$20160302$EXP$$US-JNJFOC-20151118492$JANSSEN$$68$YR$E$F$Y$54$KG$20160302$$MD$US$US
121375233$12137523$3$F$20160207$20160222$20160302$20160408$EXP$$IT-JNJFOC-20160208627$JANSSEN$$81$YR$E$M$Y$112$KG$20160408$$MD$IT$IT
1213754514$12137545$14$F$201602$20200826$20160302$20200831$EXP$$US-PFIZER INC-2016028956$PFIZER$$70$YR$$F$Y$80.73$KG$20200831$$MD$US$US
121384517$12138451$7$F$1993$20200924$20160302$20200929$PER$$US-PFIZER INC-2016122754$PFIZER$$23$YR$$M$Y$79.38$KG$20200929$$MD$US$US
121387442$12138744$2$F$20150320$20160226$20160302$20160308$EXP$$CA-JNJFOC-20150322203$JANSSEN$$58$YR$A$F$Y$103$KG$20160308$$MD$CA$CA
1213946917$12139469$17$F$20121119$20200922$20160303$20200924$EXP$$CA-ROCHE-1162790$ROCHE$$43$YR$$F$Y$70$KG$20200924$$HP$CA$CA
121407165$12140716$5$F$20160212$20160331$20160303$20170606$EXP$$UA-JNJFOC-20160302365$JANSSEN$$54$YR$A$M$Y$86.3$KG$20170606$$MD$UA$UA
121410484$12141048$4$F$$20200904$20160303$20200908$PER$$US-PFIZER INC-2016108351$PFIZER$$79$YR$$F$Y$$$20200908$$MD$US$US
121411365$12141136$5$F$20160216$20161103$20160303$20161108$EXP$$TR-JNJFOC-20160216260$PHARMACYCLICS$$64$YR$A$M$Y$84$KG$20161108$$MD$TR$TR
1214206610$12142066$10$F$20150219$20200824$20160303$20200904$EXP$$JP-INCYTE CORPORATION-2015IN004442$INCYTE$$$$$$Y$$$20200904$$MD$JP$JP
121432013$12143201$3$F$20160109$20160426$20160304$20200816$EXP$$PHJP2016JP004310$NOVARTIS$$68$YR$$F$Y$46$KG$20200816$$HP$JP$JP
121433822$12143382$2$F$201411$20160330$20160304$20160407$EXP$$JP-ROCHE-1523383$ROCHE$$61$YR$$M$Y$42$KG$20160407$$MD$JP$JP
121440241$12144024$1$I$20150623$20151028$20160304$20160304$EXP$$JP-ROCHE-1656253$ROCHE$$85$YR$$M$Y$47$KG$20160304$$MD$JP$JP
121445522$12144552$2$F$20140219$20200909$20160304$20200914$EXP$$US-BAYER-2016-002674$BAYER$$65$YR$E$M$Y$$$20200914$$CN$US$US
121454333$12145433$3$F$20160217$20160613$20160304$20160622$EXP$$CA-JNJFOC-20160221409$JANSSEN$$35$YR$A$F$Y$50.5$KG$20160622$$MD$CA$CA
121459381$12145938$1$I$20160226$20160229$20160304$20160304$EXP$$US-JNJFOC-20160300420$JANSSEN$$42$YR$A$F$Y$91.9$KG$20160304$$MD$US$US
121473354$12147335$4$F$2015$20200629$20160304$20200706$PER$$CA-AMGEN-CANSP2016026213$AMGEN$$38$YR$A$F$Y$$$20200706$$HP$CA$CA
121473561$12147356$1$I$20141130$20160225$20160304$20160304$EXP$ES-AGEMED-109637344$ES-BAYER-2016-037313$BAYER$$72$YR$E$F$Y$$$20160304$$MD$ES$ES
1214739317$12147393$17$F$201411$20200901$20160304$20200902$EXP$$US-PFIZER INC-2016078686$PFIZER$$64$YR$$M$Y$100$KG$20200902$$CN$US$US
121475364$12147536$4$F$20160225$20160608$20160304$20160617$EXP$$FR-JNJFOC-20160227347$JANSSEN$$62$YR$A$M$Y$73.8$KG$20160617$$MD$FR$FR
121481413$12148141$3$F$20160125$20200715$20160304$20200717$PER$$US-PFIZER INC-2016079646$PFIZER$$62$YR$$F$Y$76.38$KG$20200717$$CN$US$US
121514112$12151411$2$F$19801122$20200714$20160304$20200723$EXP$$FR-ABBVIE-16P-056-1575191-00$ABBVIE$$$$N$F$Y$2.68$KG$20200723$$HP$FR$FR
121543272$12154327$2$F$20140516$20200623$20160307$20200706$EXP$$US-BAYER-2016-001331$BAYER$$75$YR$E$M$Y$$$20200706$$CN$US$US
121544142$12154414$2$F$$20200713$20160307$20200714$PER$$US-PFIZER INC-2016081154$PFIZER$$65$YR$$F$Y$$$20200714$$MD$US$US
1215459512$12154595$12$F$2017$20200812$20160307$20200820$EXP$$PHHY2016CA026139$NOVARTIS$$$$$M$Y$$$20200820$$CN$CA$CA
1215499010$12154990$10$F$20160227$20170217$20160307$20170221$EXP$$GB-JNJFOC-20160301600$JANSSEN$$65$YR$A$F$Y$71$KG$20170221$$MD$GB$GB
121554753$12155475$3$F$201309$20200830$20160307$20200911$EXP$$US-JNJFOC-20160303012$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200911$$CN$US$US
121557276$12155727$6$F$20160209$20170830$20160307$20170912$EXP$$US-PFIZER INC-2016135846$PFIZER$$74$YR$$M$Y$68$KG$20170912$$MD$US$US
121559985$12155998$5$F$20150830$20160329$20160307$20160920$EXP$$US-JNJFOC-20150900070$JANSSEN$$74$YR$E$M$Y$79.37$KG$20160920$$MD$US$US
121574252$12157425$2$F$20150415$20160902$20160308$20160913$EXP$$JP-ROCHE-1721941$ROCHE$$62$YR$$F$Y$61$KG$20160913$$MD$JP$JP
121582333$12158233$3$F$20160205$20200703$20160308$20200709$EXP$$FR-ELI_LILLY_AND_COMPANY-FR201602008389$ELI LILLY AND CO$$29$YR$$F$Y$100$KG$20200709$$MD$FR$FR
121584492$12158449$2$F$201410$20200831$20160308$20200908$EXP$$US-BAYER-2016-001337$BAYER$$87$YR$E$F$Y$$$20200908$$CN$US$US
121589982$12158998$2$F$20160304$20160314$20160308$20160315$EXP$$CO-ROCHE-1722501$ROCHE$$73$YR$$F$Y$$$20160315$$CN$CO$CO
1215903815$12159038$15$F$201505$20200915$20160308$20200930$EXP$$GB-ROCHE-1718214$ROCHE$$31$YR$$F$Y$$$20201001$$HP$GB$GB
121602682$12160268$2$F$1980$20200714$20160308$20200722$EXP$FR-AFSSAPS-ST20160169$FR-LUNDBECK-DKLU2010916$LUNDBECK$$$$$F$Y$3$KG$20200722$$MD$FR$FR
121604712$12160471$2$F$20131230$20200806$20160308$20200814$EXP$$US-BAYER-2015-498795$BAYER$$79$YR$E$M$Y$$$20200814$$CN$US$US
121605182$12160518$2$F$20141008$20200630$20160308$20200714$EXP$$US-BAYER-2016-001104$BAYER$$46$YR$A$M$Y$$$20200714$$HP$US$US
121609836$12160983$6$F$201512$20200810$20160308$20200812$EXP$$US-PFIZER INC-2016142088$PFIZER$$60$YR$$F$Y$66.68$KG$20200812$$CN$US$US
121610794$12161079$4$F$$20200919$20160308$20200923$EXP$$US-INCYTE CORPORATION-2016IN001263$INCYTE$$$$$$Y$$$20200923$$CN$US$US
121611858$12161185$8$F$$20200722$20160308$20200730$EXP$$DE-PFIZER INC-2016143729$PFIZER$WAGNER, F.. THE BLUE CHILD. THORACIC AND CARDIOVASCULAR SURGEON. 2016?64 (SUPPL 2):10.1055/S?0036?1571935$13$YR$$M$Y$32$KG$20200730$$HP$DE$DE
1216150231$12161502$31$F$201411$20200908$20160309$20200911$EXP$$CA-ROCHE-1498769$ROCHE$$68$YR$$F$Y$79$KG$20200911$$HP$CA$CA
121616342$12161634$2$F$$20200804$20160309$20200807$PER$$US-BIOGEN-2016BI00194743$BIOGEN$$$$$F$Y$$$20200807$$CN$US$US
121621523$12162152$3$F$20140203$20200727$20160309$20200811$EXP$$US-BAYER-2016-000696$BAYER$$58$YR$A$M$Y$$$20200811$$CN$US$US
121621944$12162194$4$F$201501$20200722$20160309$20200804$EXP$$US-BAYER-2016-013165$BAYER$$76$YR$E$M$Y$$$20200804$$CN$US$US
121625022$12162502$2$F$$20200630$20160309$20200701$PER$$US-PFIZER INC-2016085316$PFIZER$$53$YR$$F$Y$60.33$KG$20200701$$CN$US$US
121653523$12165352$3$F$20160226$20180110$20160309$20180116$EXP$$US-JNJFOC-20160303963$PHARMACYCLICS$$80$YR$E$M$Y$78.5$KG$20180116$$MD$US$US
121655404$12165540$4$F$20140831$20200715$20160309$20200729$EXP$$FR-INCYTE CORPORATION-2016IN001309$INCYTE$$$$$$Y$$$20200729$$HP$FR$FR
121657704$12165770$4$F$201511$20180622$20160309$20180702$EXP$$PHHY2015AR098082$NOVARTIS$$39$YR$$F$Y$$$20180702$$CN$COUNTRY NOT SPECIFIED$AR
121665146$12166514$6$F$20080515$20200714$20160309$20200720$EXP$$PHHY2011US121518$NOVARTIS$$37$YR$$M$Y$86.26$KG$20200720$$CN$US$US
121667159$12166715$9$F$2014$20200724$20160310$20200813$EXP$$CA-ROCHE-1459906$ROCHE$$75$YR$$F$Y$$$20200813$$CN$CA$CA
121670212$12167021$2$F$20200629$20200701$20160310$20200713$EXP$$US-ACCORD-038581$ACCORD$$56$YR$$F$Y$$$20200713$$HP$US$US
121681786$12168178$6$F$20141126$20200818$20160310$20200901$EXP$$JP-INCYTE CORPORATION-2015IN003597$INCYTE$$$$$$Y$$$20200901$$MD$JP$JP
121685015$12168501$5$F$201403$20200707$20160310$20200716$EXP$$US-JNJFOC-20160307607$JOHNSON AND JOHNSON$$68$YR$$M$Y$$$20200716$$CN$US$US
121690522$12169052$2$F$20160210$20200615$20160310$20200715$PER$$US-ELI_LILLY_AND_COMPANY-US201602004551$ELI LILLY AND CO$$65$YR$$F$Y$$$20200715$$CN$US$US
121693732$12169373$2$F$201507$20200227$20160310$20200818$PER$$US-OTSUKA-2015_017440$OTSUKA$$60$YR$$M$Y$$$20200818$$CN$US$US
1217033931$12170339$31$F$201511$20200915$20160311$20200923$EXP$$CA-ROCHE-1723618$ROCHE$$66$YR$$F$Y$$$20200923$$MD$CA$CA
121713242$12171324$2$F$$20200713$20160311$20200714$PER$$US-PFIZER INC-2016095091$PFIZER$$46$YR$$F$Y$63$KG$20200714$$CN$US$US
1217208510$12172085$10$F$20150107$20200702$20160311$20200709$PER$$PHHY2016US008196$NOVARTIS$$37$YR$$M$Y$99.79$KG$20200710$$HP$US$US
121727661$12172766$1$I$$20160302$20160311$20160311$EXP$$JP-MYLANLABS-2016M1010637$MYLAN$NISHIO M, HORIIKE A, NOKIHARA H, HORINOUCHI H, NAKAMICHI S, WAKUI H, ET AL. PHASE I STUDY OF THE ANTI?MET ANTIBODY ONARTUZUMAB IN PATIENTS WITH SOLID TUMORS AND MET?POSITIVE LUNG CANCER. INVEST?NEW?DRUGS 2015?33(3):632?40.$$$$$Y$$$20160311$$HP$JP$JP
121732186$12173218$6$F$20150921$20180130$20160311$20200715$EXP$BE-EMA-DD-20171229-SANDEVHP-110736$PHHO2015BE014821$NOVARTIS$$67$YR$$M$Y$100$KG$20200715$$HP$BE$BE
121736893$12173689$3$F$20141006$20200714$20160311$20200720$EXP$$PHHY2016FR033228$NOVARTIS$$66$YR$$M$Y$74$KG$20200720$$HP$FR$FR
121737253$12173725$3$F$20150825$20170217$20160314$20170221$EXP$$PL-ROCHE-1638165$ROCHE$$42$YR$$F$Y$59$KG$20170221$$MD$PL$PL
121738374$12173837$4$F$20141208$20161018$20160314$20161026$EXP$$JP-ROCHE-1662772$ROCHE$$74$YR$$M$Y$77$KG$20161026$$MD$JP$JP
121738432$12173843$2$F$$20200818$20160314$20200828$EXP$$US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022257$GLENMARK$$44$YR$$M$Y$$$20200828$$MD$US$US
121738847$12173884$7$F$20130101$20200702$20160314$20200707$PER$$PHHY2014US134706$NOVARTIS$$46$YR$$F$Y$$$20200708$$MD$US$US
121745244$12174524$4$F$$20200819$20160312$20200827$EXP$$US-AUROBINDO-AUR-APL-2016-03269$AUROBINDO$$38$YR$$M$Y$91.2$KG$20200827$$MD$US$US
121745583$12174558$3$F$20141002$20160425$20160312$20160502$EXP$$JP-ROCHE-1594040$ROCHE$$68$YR$$M$Y$72$KG$20160502$$MD$JP$JP
1217499715$12174997$15$F$20160203$20170801$20160314$20170809$EXP$$GB-JNJFOC-20160206998$JANSSEN$$68$YR$E$F$Y$93$KG$20170809$$MD$GB$GB
121749981$12174998$1$I$20151120$20160301$20160314$20160314$EXP$$US-JNJFOC-20160306037$JANSSEN$$82$YR$E$F$Y$55$KG$20160314$$MD$US$US
121749995$12174999$5$F$20160229$20171107$20160314$20171116$EXP$$BE-JNJFOC-20160306200$JANSSEN$$74$YR$E$M$Y$78$KG$20171116$$MD$BE$BE
121755573$12175557$3$F$20160208$20170228$20160314$20170306$EXP$$JP-JNJFOC-20160212135$PHARMACYCLICS$$62$YR$A$F$Y$69.5$KG$20170306$$MD$JP$JP
121773903$12177390$3$F$20110711$20200723$20160314$20200803$EXP$$CA-JNJFOC-20160311657$JOHNSON AND JOHNSON$$61$YR$A$M$Y$97$KG$20200803$$HP$CA$CA
121775696$12177569$6$F$20160307$20200717$20160314$20200722$EXP$$US-PFIZER INC-2016151110$PFIZER$$74$YR$$F$Y$66$KG$20200722$$HP$US$US
121777412$12177741$2$F$20151006$20160407$20160315$20160415$EXP$$JP-ROCHE-1651416$ROCHE$$59$YR$$M$Y$$$20160415$$MD$JP$JP
121778152$12177815$2$F$$20200706$20160314$20200709$EXP$$PHHY2016FR031427$NOVARTIS$$72$YR$$M$Y$$$20200709$$HP$FR$FR
121778193$12177819$3$F$$20200706$20160314$20200713$EXP$$PHHY2016FR034079$NOVARTIS$$42$YR$$M$Y$$$20200713$$HP$FR$FR
121784563$12178456$3$F$20140830$20200708$20160315$20200721$EXP$$US-BAYER-2016-037664$BAYER$$66$YR$E$F$Y$$$20200721$$CN$US$US
1217951515$12179515$15$F$201503$20200630$20160315$20200702$PER$$US-PFIZER INC-2016143897$PFIZER$$52$YR$$F$Y$$$20200702$$PH$US$US
121799983$12179998$3$F$$20200713$20160315$20200714$PER$$US-PFIZER INC-2016098936$PFIZER$$65$YR$$F$Y$$$20200714$$CN$US$US
121810562$12181056$2$F$20150120$20200924$20160315$20200930$EXP$$US-BAYER-2016-028174$BAYER$$72$YR$E$M$Y$$$20200930$$CN$US$US
121828232$12182823$2$F$20160226$20160414$20160316$20160421$EXP$$CA-ROCHE-1722844$ROCHE$$82$YR$$F$Y$$$20160421$$MD$CA$CA
121837633$12183763$3$F$20160301$20170323$20160316$20170329$EXP$$US-PFIZER INC-2016154925$PFIZER$$69$YR$$M$Y$65.7$KG$20170329$$MD$US$US
121846483$12184648$3$F$20160307$20160504$20160316$20160513$EXP$$US-JNJFOC-20160313750$PHARMACYCLICS$$79$YR$E$F$Y$$$20160513$$MD$US$US
121851462$12185146$2$F$202005$20200819$20160316$20200824$PER$$US-PFIZER INC-2016108679$PFIZER$$65$YR$$F$Y$63.58$KG$20200824$$HP$US$US
121872034$12187203$4$F$$20200909$20160317$20200918$EXP$$US-ACORDA-ACO_122225_2016$ACORDA$$$$$F$Y$$$20200918$$CN$US$US
121887398$12188739$8$F$20150728$20200727$20160317$20200801$PER$$PHHY2016US019346$NOVARTIS$$62$YR$$F$Y$$$20200801$$MD$US$US
1218895010$12188950$10$F$20150901$20200702$20160317$20200709$PER$$PHHY2016US032395$NOVARTIS$$62$YR$$F$Y$$$20200710$$MD$US$US
121895662$12189566$2$F$$20160321$20160318$20160324$EXP$$ES-ROCHE-1726920$ROCHE$SELGA J, NUNEZ JH, MINGUELL J, LALANZA M AND GARRIDO M SIMULTANEOUS BILATERAL ATYPICAL FEMORAL FRACTURE IN A PATIENT RECEIVING DENOSUMAB: CASE REPORT AND LITERATURE REVIEW. OSTEOPOROS INT 2016?27:827?832.$62$YR$$F$Y$$$20160324$$HP$ES$ES
1219077310$12190773$10$F$20160224$20161018$20160318$20161021$EXP$$US-JNJFOC-20160310826$JANSSEN$$78$YR$E$F$Y$57$KG$20161021$$MD$US$US
121911354$12191135$4$F$20160120$20200902$20160318$20200904$EXP$$CA-PFIZER INC-2016160500$PFIZER$$65$YR$$F$Y$100$KG$20200904$$MD$CA$CA
121911443$12191144$3$F$201602$20200904$20160318$20200908$EXP$$US-PFIZER INC-2016161424$PFIZER$$62$YR$$F$Y$$$20200908$$CN$US$US
121915954$12191595$4$F$20140323$20200716$20160318$20200720$PER$$US-JNJFOC-20160315704$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20200720$$CN$US$US
121916941$12191694$1$I$20160128$20160129$20160318$20160318$PER$$CZ-JNJFOC-20160206257$PHARMACYCLICS$$80$YR$E$M$Y$$$20160318$$MD$CZ$CZ
121918377$12191837$7$F$201601$20200804$20160318$20200806$PER$$US-PFIZER INC-2016160199$PFIZER$$74$YR$$M$Y$66$KG$20200806$$MD$US$US
1219201013$12192010$13$F$2016$20200811$20160318$20200814$EXP$$US-SA-2016SA053445$SANOFI AVENTIS$$$$$$Y$$$20200814$$CN$US$US
121921932$12192193$2$F$201302$20200908$20160318$20200914$EXP$$US-BAYER-2016-017278$BAYER$$76$YR$E$F$Y$$$20200914$$CN$US$US
121925317$12192531$7$F$20150930$20200810$20160318$20200818$EXP$$US-BIOGEN-2016BI00202341$BIOGEN$$58$YR$$F$Y$62.2$KG$20200818$$MD$US$US
121938149$12193814$9$F$20141229$20200728$20160321$20200806$EXP$$CA-ROCHE-1727213$ROCHE$$68$YR$$M$Y$$$20200806$$MD$CA$CA
121941404$12194140$4$F$20150305$20160617$20160321$20160621$EXP$$JP-ROCHE-1658166$ROCHE$$62$YR$$F$Y$55$KG$20160621$$MD$JP$JP
121944373$12194437$3$F$20140730$20200817$20160321$20200821$EXP$$US-BAYER-2016-017277$BAYER$$88$YR$E$F$Y$$$20200821$$CN$US$US
1219459915$12194599$15$F$2014$20200922$20160321$20200928$EXP$$PHHY2014CA109642$NOVARTIS$$78$YR$$F$Y$$$20200928$$CN$CA$CA
121954881$12195488$1$I$20160201$20160224$20160321$20160321$EXP$$CH-JNJFOC-20160315916$JANSSEN$$74$YR$E$F$Y$$$20160321$$MD$CH$CH
121975397$12197539$7$F$20160216$20200714$20160322$20200715$EXP$$US-PFIZER INC-2016163266$PFIZER$$63$YR$$M$Y$82.99$KG$20200715$$HP$US$US
121988443$12198844$3$F$20140602$20200825$20160322$20200828$EXP$$US-BAYER-2016-007140$BAYER$$73$YR$E$M$Y$$$20200828$$CN$US$US
121991875$12199187$5$F$20130429$20200728$20160322$20200811$EXP$$US-BAYER-2016-009031$BAYER$$55$YR$A$M$Y$$$20200811$$CN$US$US
121992142$12199214$2$F$20160313$20200306$20160322$20200831$EXP$$US-ROCHE-1726671$ROCHE$$69$YR$$F$Y$85.9$KG$20200901$$MD$US$US
121992752$12199275$2$F$201512$20160315$20160322$20200914$EXP$$AU-JNJFOC-20160315064$JOHNSON AND JOHNSON$$16$YR$T$F$Y$$$20200914$$CN$AU$AU
121994088$12199408$8$F$2015$20200821$20160322$20200825$PER$$US-PFIZER INC-2016140020$PFIZER$$68$YR$$F$Y$59$KG$20200825$$CN$US$US
122021221$12202122$1$I$20160304$20160316$20160323$20160323$EXP$GB-MHRA-TPP23814697C125484YC1457350884074$GB-ROCHE-1727268$ROCHE$$82$YR$$F$Y$61$KG$20160323$$MD$GB$GB
122022161$12202216$1$I$$20150723$20160322$20160322$EXP$$FR-B. BRAUN MEDICAL INC.-1049445$B BRAUN$$50$YR$$M$Y$$$20160322$$MD$FR$FR
122023583$12202358$3$F$$20200810$20160322$20200817$EXP$$PHHY2016NI037626$NOVARTIS$$$$$F$Y$$$20200817$$CN$COUNTRY NOT SPECIFIED$NI
122026948$12202694$8$F$20150919$20200707$20160322$20200710$EXP$$US-VERTEX PHARMACEUTICALS-2016-001722$VERTEX$$13$YR$$F$Y$$$20200710$$CN$US$US
122030824$12203082$4$F$20160312$20190205$20160323$20190213$EXP$$US-ROCHE-1726800$ROCHE$$49$YR$$M$Y$73.9$KG$20190213$$MD$US$US
122034253$12203425$3$F$20140505$20200906$20160323$20200911$EXP$$US-BAYER-2016-002451$BAYER$$56$YR$A$M$Y$$$20200911$$LW$US$US
1220343824$12203438$24$F$20200626$20200824$20160323$20200828$EXP$$PHHY2016CR036668$NOVARTIS$$54$YR$$F$Y$91.16$KG$20200828$$CN$COUNTRY NOT SPECIFIED$CR
122036244$12203624$4$F$2015$20200812$20160323$20200820$EXP$$US-BAYER-2016-007340$BAYER$$81$YR$E$M$Y$$$20200820$$CN$US$US
122036782$12203678$2$F$201503$20200628$20160323$20200710$EXP$$US-BAYER-2016-012796$BAYER$$79$YR$E$F$Y$$$20200710$$CN$US$US
122044152$12204415$2$F$201910$20200701$20160323$20200709$PER$$US-AMGEN-USASL2016033058$AMGEN$$70$YR$E$F$Y$$$20200709$$MD$US$US
122044702$12204470$2$F$201602$20200831$20160323$20200903$PER$$US-ELI_LILLY_AND_COMPANY-US201603004330$ELI LILLY AND CO$$59$YR$$F$Y$$$20200903$$CN$US$US
122045008$12204500$8$F$20160310$20161027$20160323$20161103$EXP$$DE-JNJFOC-20160313682$JANSSEN$$55$YR$A$F$Y$$$20161103$$MD$DE$DE
1220505413$12205054$13$F$20160510$20190606$20160323$20200723$EXP$$PHHY2016CO036674$NOVARTIS$$60$YR$$M$Y$75$KG$20200723$$CN$CO$CO
122051621$12205162$1$I$20150511$20150512$20160323$20160323$EXP$$JP-JNJFOC-20150509955$JANSSEN$$60$YR$A$M$Y$58$KG$20160323$$MD$JP$JP
122053952$12205395$2$F$2013$20200715$20160323$20200723$EXP$$US-BAYER-2016-019708$BAYER$$80$YR$E$F$Y$$$20200723$$CN$US$US
122065142$12206514$2$F$$20200713$20160324$20200714$PER$$US-PFIZER INC-2016143628$PFIZER$$67$YR$$F$Y$$$20200714$$MD$US$US
122066372$12206637$2$F$201411$20200920$20160324$20200925$EXP$$US-BAYER-2016-019707$BAYER$$71$YR$E$F$Y$$$20200925$$CN$US$US
1220779924$12207799$24$F$20160226$20200925$20160324$20200929$EXP$$US-TAKEDA-2016MPI001971$TAKEDA$$82$YR$$F$Y$$$20200929$$CN$US$US
122083621$12208362$1$I$20141203$20160317$20160324$20160324$EXP$ES-AGEMED-009844444$ES-BAYER-2016-052775$BAYER$$87$YR$E$M$Y$$$20160324$$MD$ES$ES
122095685$12209568$5$F$20160303$20200807$20160324$20200812$PER$$US-BIOGEN-2016BI00204402$BIOGEN$$63$YR$$F$Y$$$20200812$$HP$US$US
1220965326$12209653$26$F$2013$20200904$20160325$20200909$EXP$$CA-ROCHE-1213265$ROCHE$$80$YR$$F$Y$66$KG$20200909$$HP$CA$CA
122100302$12210030$2$F$20160225$20160421$20160325$20160427$EXP$$NL-ROCHE-1728930$ROCHE$$71$YR$$F$Y$$$20160427$$MD$NL$NL
122106842$12210684$2$F$20160310$20160406$20160325$20160415$EXP$$JP-JNJFOC-20160320069$JANSSEN$$61$YR$A$M$Y$58.3$KG$20160415$$MD$JP$JP
122106857$12210685$7$F$20160229$20181113$20160325$20181116$EXP$$GB-JNJFOC-20160304330$JANSSEN$$72$YR$E$F$Y$82$KG$20181116$$MD$GB$GB
122106861$12210686$1$I$20150627$20150701$20160325$20160325$EXP$$JP-JNJFOC-20150704203$JANSSEN$$60$YR$A$M$Y$55$KG$20160325$$MD$JP$JP
122111889$12211188$9$F$20150518$20200806$20160325$20200810$EXP$$JP-OTSUKA-2016_006748$OTSUKA$$45$YR$$M$Y$68.2$KG$20200810$$MD$JP$JP
1221200913$12212009$13$F$2016$20200908$20160325$20200911$EXP$$US-SA-2016SA037813$SANOFI AVENTIS$$$$$$Y$$$20200911$$CN$US$US
122120407$12212040$7$F$201501$20200807$20160325$20200811$PER$$US-PFIZER INC-2016138215$PFIZER$$60$YR$$F$Y$60$KG$20200811$$HP$US$US
1221214513$12212145$13$F$201506$20200901$20160325$20200901$EXP$$FR-PFIZER INC-2015244581$PFIZER$$72$YR$$M$Y$$$20200901$$MD$FR$FR
1221232016$12212320$16$F$2016$20200828$20160325$20200909$EXP$$CL-BIOMARINAP-CL-2016-109333$BIOMARIN$$6$YR$$M$Y$22$KG$20200909$$HP$CL$CL
1221262320$12212623$20$F$201511$20200904$20160328$20200916$EXP$$CA-ROCHE-1731284$ROCHE$$55$YR$$M$Y$$$20200916$$MD$CA$CA
122130413$12213041$3$F$20110707$20170925$20160328$20200911$EXP$$CL-BRISTOL-MYERS SQUIBB COMPANY-19502020$BRISTOL MYERS SQUIBB$$39$YR$$F$Y$$$20200911$$CN$CL$CL
122137503$12213750$3$F$20150206$20200716$20160328$20200728$EXP$$US-BAYER-2016-026476$BAYER$$63$YR$A$M$Y$$$20200728$$CN$US$US
122138022$12213802$2$F$20150923$20200805$20160328$20200814$EXP$$US-BAYER-2016-027752$BAYER$$66$YR$E$M$Y$$$20200814$$CN$US$US
122143762$12214376$2$F$20160318$20160503$20160328$20160509$EXP$$KR-JNJFOC-20160323445$PHARMACYCLICS$$73$YR$E$M$Y$$$20160509$$MD$KR$KR
122144743$12214474$3$F$201506$20161102$20160328$20161115$EXP$$FI-ROCHE-1636770$ROCHE$$63$YR$$M$Y$$$20161115$$MD$FI$FI
122145195$12214519$5$F$20080312$20200710$20160328$20200716$EXP$$FR-ABBVIE-16P-056-1592178-00$ABBVIE$$0$DY$$F$Y$2.6$KG$20200716$$HP$FR$FR
122145208$12214520$8$F$200812$20200722$20160328$20200727$EXP$$FR-ABBVIE-16P-056-1592095-00$ABBVIE$$8$MON$$F$Y$3$KG$20200727$$LW$FR$FR
122148165$12214816$5$F$$20200727$20160328$20200805$EXP$$SE-JNJFOC-20160316954$JOHNSON AND JOHNSON$BROMS G, KIELER H, EKBOM A, GISSLER M, HELLGREN K, LEINONEN M, PEDERSEN L, CHMITT?EGENOLF M, SORENSEN H, GRANATH F. PAEDIATRIC INFECTIONS IN THE FIRST 3 YEARS OF LIFE AFTER MATERNAL ANTI?TNF TREATMENT DURING PREGNANCY. ALIMENT PHARM THER. 2020 JUL 24?.$$$I$$Y$$$20200805$$MD$SE$SE
122155901$12215590$1$I$20140609$20140611$20160328$20160328$EXP$$US-JNJFOC-20140608592$JANSSEN$$64$YR$A$F$Y$94.5$KG$20160328$$MD$US$US
122158192$12215819$2$F$2012$20200819$20160328$20200903$EXP$$US-JAZZ-JPI-P-024962$JAZZ$$15$YR$$M$Y$102.27$KG$20200903$$MD$US$US
1221616512$12216165$12$F$201511$20200904$20160329$20200920$EXP$$CA-ROCHE-1732689$ROCHE$$76$YR$$F$Y$$$20200921$$CN$CA$CA
1221695937$12216959$37$F$201509$20200818$20160329$20200826$EXP$$PHHY2015CA057753$NOVARTIS$$75$YR$$F$Y$54.42$KG$20200826$$MD$CA$CA
122171983$12217198$3$F$20160208$20160506$20160329$20200702$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-013277$BRISTOL MYERS SQUIBB$$92$YR$$M$Y$58$KG$20200702$$PH$JP$JP
122179876$12217987$6$F$$20200608$20160329$20200706$PER$$US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-125690$ACTELION$$$$$F$Y$$$20200706$$PH$US$US
122186687$12218668$7$F$20160315$20180402$20160329$20180406$EXP$$CN-JNJFOC-20160316280$JANSSEN$$65$YR$A$F$Y$59$KG$20180406$$MD$CN$CN
122199602$12219960$2$F$201507$20200627$20160330$20200706$EXP$$FR-BEH-2016060469$CSL BEHRING$$35$YR$A$F$Y$60$KG$20200706$$MD$FR$FR
122205881$12220588$1$I$20160304$20160316$20160330$20160330$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-113925$RANBAXY$$82$YR$$F$Y$61$KG$20160330$$HP$GB$GB
122208188$12220818$8$F$$20200921$20160330$20200925$PER$$US-PFIZER INC-2016160611$PFIZER$$60$YR$$M$Y$$$20200925$$CN$US$US
122209119$12220911$9$F$20160325$20200814$20160330$20200819$PER$$US-PFIZER INC-2016181934$PFIZER$$78$YR$$F$Y$59$KG$20200819$$MD$US$US
122209723$12220972$3$F$20160114$20200703$20160330$20200709$PER$$ES-AMGEN-ESPSP2016017441$AMGEN$$51$YR$A$M$Y$101$KG$20200709$$HP$ES$ES
122211063$12221106$3$F$20160212$20200904$20160330$20200909$PER$$US-TAKEDA-2016MPI002241$TAKEDA$$56$YR$$F$Y$$$20200909$$PH$US$US
1222136129$12221361$29$F$20170901$20200825$20160330$20200827$PER$$US-PFIZER INC-2016042912$PFIZER$$76$YR$$F$Y$74$KG$20200827$$HP$US$US
122222232$12222223$2$F$2015$20200915$20160330$20200923$PER$$US-MYLANLABS-2015M1029812$MYLAN$$$$$F$Y$$$20200923$$CN$US$US
122224874$12222487$4$F$20151108$20181116$20160330$20181122$EXP$$FR-JNJFOC-20160222711$PHARMACYCLICS$$77$YR$E$M$Y$65$KG$20181122$$MD$FR$FR
1222249216$12222492$16$F$20160321$20180417$20160330$20180426$EXP$$ES-JNJFOC-20160320897$JANSSEN$$82$YR$E$M$Y$70.8$KG$20180426$$MD$ES$ES
122235052$12223505$2$F$$20200922$20160330$20200929$EXP$$US-JNJFOC-20160321335$JOHNSON AND JOHNSON$$28$YR$A$F$Y$$$20200929$$HP$US$US
1222433512$12224335$12$F$20140724$20200915$20160331$20200925$EXP$$CA-ROCHE-1733268$ROCHE$$35$YR$$M$Y$$$20200925$$CN$CA$CA
1222434627$12224346$27$F$$20200914$20160331$20200917$PER$$CA-AMGEN-CANSP2015029495$AMGEN$$75$YR$E$F$Y$$$20200917$$HP$CA$CA
122249844$12224984$4$F$$20200807$20160331$20200814$EXP$$US-ROCHE-1731326$ROCHE$$$$N$$Y$$$20200814$$HP$RU$RU
122255622$12225562$2$F$20160321$20160331$20160331$20160411$EXP$$IT-JNJFOC-20160321247$JANSSEN$$67$YR$E$F$Y$62$KG$20160411$$MD$IT$IT
122266322$12226632$2$F$2014$20200407$20160331$20200703$EXP$$US-PURDUE-USA-2016-0129887$PURDUE$$60$YR$$M$Y$$$20200703$$MD$US$US
122267705$12226770$5$F$20160323$20170324$20160331$20170328$EXP$$US-JNJFOC-20160327411$PHARMACYCLICS$$73$YR$E$F$Y$41$KG$20170328$$MD$US$US
122272232$12227223$2$F$201602$20200630$20160331$20200702$EXP$NL-LRB-215445$NL-PFIZER INC-2016178178$PFIZER$$43$YR$$F$Y$$$20200702$$PH$NL$NL
122272517$12227251$7$F$2018$20200803$20160331$20200804$EXP$$US-PFIZER INC-2016148718$PFIZER$$82$YR$$F$Y$$$20200804$$MD$US$US
122274075$12227407$5$F$20160220$20200706$20160331$20200717$EXP$ES-AGEMED-237193344$PHHY2016ES041839$NOVARTIS$$26$YR$$F$Y$$$20200717$$HP$ES$ES
1222772112$12227721$12$F$20151111$20200721$20160401$20200804$EXP$$CA-ROCHE-1733758$ROCHE$$64$YR$$F$Y$$$20200803$$CN$CA$CA
122282952$12228295$2$F$201310$20200720$20160401$20200724$EXP$$US-BAYER-2015-375417$BAYER$$70$YR$E$M$Y$$$20200724$$HP$US$US
122286464$12228646$4$F$20150522$20200813$20160401$20200819$PER$$US-JNJFOC-20160302601$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20200819$$HP$US$US
122286495$12228649$5$F$201511$20200706$20160401$20200710$EXP$$US-JNJFOC-20160302603$JOHNSON AND JOHNSON$$53$YR$$M$Y$$$20200710$$CN$US$US
122286514$12228651$4$F$20151108$20200811$20160401$20200817$PER$$US-JNJFOC-20160302606$JOHNSON AND JOHNSON$$71$YR$E$M$Y$122.4$KG$20200817$$CN$US$US
122286634$12228663$4$F$20150915$20200721$20160401$20200724$PER$$US-JNJFOC-20160302558$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200724$$HP$US$US
122286724$12228672$4$F$2015$20200712$20160401$20200721$EXP$$US-JNJFOC-20160301505$JOHNSON AND JOHNSON$$29$YR$$M$Y$$$20200721$$CN$US$US
122286863$12228686$3$F$201503$20200811$20160401$20200813$PER$$US-JNJFOC-20160302424$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200813$$CN$US$US
122286914$12228691$4$F$201505$20200720$20160401$20200724$PER$$US-JNJFOC-20160301433$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200724$$HP$US$US
122286955$12228695$5$F$20151001$20200723$20160401$20200731$PER$$US-JNJFOC-20160301440$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200731$$HP$US$US
122287044$12228704$4$F$20150803$20200903$20160401$20200909$PER$$US-JNJFOC-20160302538$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200909$$HP$US$US
122287253$12228725$3$F$20150508$20200716$20160401$20200720$PER$$US-JNJFOC-20160302546$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200720$$CN$US$US
122287464$12228746$4$F$20141204$20200701$20160401$20200706$PER$$US-JNJFOC-20160303014$JOHNSON AND JOHNSON$$87$YR$$M$Y$$$20200706$$CN$US$US
122287703$12228770$3$F$201407$20200629$20160401$20200702$PER$$US-JNJFOC-20160304064$JOHNSON AND JOHNSON$$53$YR$$F$Y$$$20200702$$LW$US$US
122287743$12228774$3$F$20150318$20200826$20160401$20200831$PER$$US-JNJFOC-20160225556$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200831$$CN$US$US
122287764$12228776$4$F$20140611$20200623$20160401$20200707$EXP$$US-JNJFOC-20160304235$JOHNSON AND JOHNSON$$68$YR$$M$Y$$$20200707$$CN$US$US
122287913$12228791$3$F$20140809$20200817$20160401$20200828$EXP$$US-JNJFOC-20160304058$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20200828$$LW$US$US
122288093$12228809$3$F$20140615$20200713$20160401$20200716$PER$$US-JNJFOC-20160301893$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200716$$CN$US$US
122288914$12228891$4$F$20151120$20200916$20160401$20200921$PER$$US-JNJFOC-20160301329$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200921$$CN$US$US
122289112$12228911$2$F$20130422$20200917$20160401$20200922$PER$$US-JNJFOC-20160304320$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200922$$HP$US$US
122289183$12228918$3$F$20150423$20200701$20160401$20200706$PER$$US-JNJFOC-20160304359$JOHNSON AND JOHNSON$$74$YR$$M$Y$$$20200706$$LW$US$US
122290024$12229002$4$F$201509$20200914$20160401$20200917$PER$$US-JNJFOC-20160301416$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200917$$HP$US$US
122290136$12229013$6$F$201510$20200909$20160401$20200918$PER$$US-JNJFOC-20160301426$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200918$$CN$US$US
122290484$12229048$4$F$20150206$20200914$20160401$20200918$PER$$US-JNJFOC-20160301369$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20200918$$CN$US$US
122291654$12229165$4$F$20150531$20200913$20160401$20200922$PER$$US-JNJFOC-20160303162$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200922$$CN$US$US
122291664$12229166$4$F$20130802$20200902$20160401$20200914$PER$$US-JNJFOC-20160303163$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20200914$$CN$US$US
122292645$12229264$5$F$20150526$20200819$20160401$20200825$PER$$US-JNJFOC-20160302575$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20200825$$CN$US$US
122292913$12229291$3$F$201403$20200809$20160401$20200813$PER$$US-JNJFOC-20160301816$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200813$$HP$US$US
122293035$12229303$5$F$$20200818$20160401$20200831$EXP$$US-JNJFOC-20160302544$JOHNSON AND JOHNSON$$$$E$F$Y$$$20200831$$CN$US$US
122293202$12229320$2$F$20141011$20200810$20160401$20200814$PER$$US-JNJFOC-20160302590$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20200814$$HP$US$US
122293294$12229329$4$F$2015$20200803$20160401$20200806$PER$$US-JNJFOC-20160302648$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20200806$$CN$US$US
122293624$12229362$4$F$20150519$20200817$20160401$20200824$PER$$US-JNJFOC-20160302624$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200824$$CN$US$US
122293734$12229373$4$F$201503$20200824$20160401$20200831$PER$$US-JNJFOC-20160302631$JOHNSON AND JOHNSON$$78$YR$E$M$Y$132.45$KG$20200831$$CN$US$US
122293905$12229390$5$F$201509$20200917$20160401$20200922$PER$$US-JNJFOC-20160302487$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200922$$CN$US$US
122293914$12229391$4$F$20151023$20200623$20160401$20200702$PER$$US-JNJFOC-20160302488$JOHNSON AND JOHNSON$$73$YR$$M$Y$$$20200702$$HP$US$US
122294154$12229415$4$F$20150721$20200806$20160401$20200813$PER$$US-JNJFOC-20160302510$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200813$$CN$US$US
122294543$12229454$3$F$20140325$20200802$20160401$20200804$PER$$US-JNJFOC-20160314399$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200804$$CN$US$US
122295324$12229532$4$F$20150630$20200809$20160401$20200817$PER$$US-JNJFOC-20160306114$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20200817$$HP$US$US
122296194$12229619$4$F$201402$20200716$20160401$20200721$PER$$US-JNJFOC-20160306195$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20200721$$CN$US$US
122296223$12229622$3$F$20150609$20200908$20160401$20200914$PER$$US-JNJFOC-20160306172$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200914$$CN$US$US
122296263$12229626$3$F$20150127$20200901$20160401$20200903$PER$$US-JNJFOC-20160306115$JOHNSON AND JOHNSON$$92$YR$E$M$Y$$$20200903$$CN$US$US
122296424$12229642$4$F$20150504$20200811$20160401$20200813$PER$$US-JNJFOC-20160320871$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200813$$CN$US$US
122296904$12229690$4$F$201411$20200712$20160401$20200715$PER$$US-JNJFOC-20160312886$JOHNSON AND JOHNSON$$63$YR$$M$Y$$$20200715$$CN$US$US
122297013$12229701$3$F$20150519$20200830$20160401$20200902$PER$$US-JNJFOC-20160312811$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200902$$CN$US$US
122297223$12229722$3$F$20140601$20200922$20160401$20200928$PER$$US-JNJFOC-20160320876$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200928$$CN$US$US
122297363$12229736$3$F$201404$20200914$20160401$20200925$EXP$$US-JNJFOC-20160319733$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200925$$CN$US$US
122297543$12229754$3$F$20140821$20200902$20160401$20200909$PER$$US-JNJFOC-20160301555$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200909$$CN$US$US
122297783$12229778$3$F$201502$20200629$20160401$20200706$PER$$US-JNJFOC-20160312892$JOHNSON AND JOHNSON$$42$YR$$F$Y$$$20200706$$CN$US$US
122298223$12229822$3$F$20140523$20200820$20160401$20200901$EXP$$US-JNJFOC-20160307164$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200901$$CN$US$US
122298233$12229823$3$F$201404$20200831$20160401$20200902$PER$$US-JNJFOC-20160307166$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200902$$CN$US$US
122298263$12229826$3$F$201312$20200826$20160401$20200831$PER$$US-JNJFOC-20160308245$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200831$$CN$US$US
122298273$12229827$3$F$201306$20200917$20160401$20200922$PER$$US-JNJFOC-20160308246$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200922$$CN$US$US
122298293$12229829$3$F$20140303$20200823$20160401$20200825$PER$$US-JNJFOC-20160303644$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20200825$$CN$US$US
122299143$12229914$3$F$20160125$20200902$20160401$20200909$PER$$US-JNJFOC-20160300447$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200909$$HP$US$US
122299373$12229937$3$F$201401$20200908$20160401$20200914$PER$$US-JNJFOC-20160309757$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200914$$CN$US$US
122299893$12229989$3$F$20140429$20200906$20160401$20200914$PER$$US-JNJFOC-20160315701$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200914$$CN$US$US
122300063$12230006$3$F$20130201$20200707$20160401$20200710$PER$$US-JNJFOC-20160315921$JOHNSON AND JOHNSON$$74$YR$$F$Y$$$20200710$$CN$US$US
122300303$12230030$3$F$201503$20200720$20160401$20200724$PER$$US-JNJFOC-20160316881$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20200724$$CN$US$US
122301075$12230107$5$F$201401$20200827$20160401$20200910$EXP$$US-JNJFOC-20160307009$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200910$$HP$US$US
122301104$12230110$4$F$2014$20200723$20160401$20200731$PER$$US-JNJFOC-20160309720$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200731$$CN$US$US
122301723$12230172$3$F$20131028$20200909$20160401$20200922$EXP$$US-JNJFOC-20160311036$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200922$$CN$US$US
122301813$12230181$3$F$20150314$20200713$20160401$20200716$PER$$US-JNJFOC-20160310942$JOHNSON AND JOHNSON$$62$YR$$F$Y$$$20200716$$CN$US$US
122302763$12230276$3$F$20140830$20200708$20160401$20200714$PER$$US-JNJFOC-20160221158$JOHNSON AND JOHNSON$$66$YR$$F$Y$$$20200714$$CN$US$US
122302813$12230281$3$F$201409$20200811$20160401$20200813$PER$$US-JNJFOC-20160311042$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20200813$$CN$US$US
122303183$12230318$3$F$20140204$20200730$20160401$20200803$PER$$US-JNJFOC-20160208613$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20200803$$CN$US$US
122303192$12230319$2$F$20150120$20200924$20160401$20200929$PER$$US-JNJFOC-20160206983$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200929$$CN$US$US
122305053$12230505$3$F$201305$20200810$20160401$20200813$PER$$US-JNJFOC-20160223918$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200813$$CN$US$US
122305073$12230507$3$F$20140309$20200630$20160401$20200706$PER$$US-JNJFOC-20160223916$JOHNSON AND JOHNSON$$66$YR$$M$Y$$$20200706$$CN$US$US
122305214$12230521$4$F$20140324$20200902$20160401$20200909$PER$$US-JNJFOC-20160219201$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200909$$CN$US$US
122305523$12230552$3$F$20140924$20200903$20160401$20200909$PER$$US-JNJFOC-20160226604$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200909$$CN$US$US
122306604$12230660$4$F$$20200807$20160401$20200814$EXP$$US-ROCHE-1733658$ROCHE$$$$N$$Y$$$20200814$$HP$RU$RU
122306993$12230699$3$F$201309$20200913$20160401$20200918$PER$$US-JNJFOC-20160226692$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200918$$CN$US$US
122307232$12230723$2$F$20130831$20200709$20160401$20200713$PER$$US-JNJFOC-20160223044$JOHNSON AND JOHNSON$$55$YR$$M$Y$$$20200713$$CN$US$US
122307403$12230740$3$F$201503$20200722$20160401$20200731$PER$$US-JNJFOC-20160301279$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200731$$CN$US$US
122307583$12230758$3$F$201308$20200730$20160401$20200803$PER$$US-JNJFOC-20160301296$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200803$$CN$US$US
122308054$12230805$4$F$20150120$20200921$20160401$20200923$PER$$US-JNJFOC-20160301370$JOHNSON AND JOHNSON$$71$YR$E$M$Y$83.46$KG$20200923$$CN$US$US
122308065$12230806$5$F$20150505$20200819$20160401$20200901$EXP$$US-JNJFOC-20160301371$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20200901$$CN$US$US
122310214$12231021$4$F$20160218$20160415$20160401$20160426$EXP$$US-JNJFOC-20160222799$JANSSEN$$76$YR$E$F$Y$61.5$KG$20160426$$MD$US$US
122315063$12231506$3$F$201501$20200721$20160401$20200731$EXP$$US-JNJFOC-20160317078$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200731$$CN$US$US
122315173$12231517$3$F$201411$20200721$20160401$20200731$PER$$US-JNJFOC-20160318782$JOHNSON AND JOHNSON$$77$YR$E$M$Y$70.29$KG$20200731$$CN$US$US
122315224$12231522$4$F$201405$20200824$20160401$20200827$PER$$US-JNJFOC-20160319875$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200827$$CN$US$US
122315303$12231530$3$F$201404$20200625$20160401$20200706$PER$$US-JNJFOC-20160319880$JOHNSON AND JOHNSON$$57$YR$$M$Y$$$20200706$$CN$US$US
122315354$12231535$4$F$201403$20200909$20160401$20200915$PER$$US-JNJFOC-20160319881$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200915$$CN$US$US
122315393$12231539$3$F$2014$20200622$20160401$20200702$EXP$$US-JNJFOC-20160316879$JOHNSON AND JOHNSON$$83$YR$$F$Y$$$20200702$$CN$US$US
122319145$12231914$5$F$20160321$20161205$20160401$20161208$EXP$$US-JNJFOC-20160330070$PHARMACYCLICS$$64$YR$A$F$Y$$$20161208$$MD$US$US
122326005$12232600$5$F$20150623$20200709$20160401$20200715$EXP$$US-BIOGEN-2015BI076095$BIOGEN$$34$YR$$F$Y$83.91$KG$20200715$$CN$US$US
122336762$12233676$2$F$20131001$20200823$20160404$20200827$EXP$$US-BAYER-2016-012385$BAYER$$68$YR$E$F$Y$$$20200827$$LW$US$US
122337382$12233738$2$F$$20200727$20160404$20200729$PER$$US-AMGEN-USASL2016038852$AMGEN$$50$YR$A$F$Y$$$20200728$$HP$US$US
1223379213$12233792$13$F$2012$20200219$20160404$20200225$EXP$$PHHY2012CA123946$NOVARTIS$$29$YR$$F$Y$$$20200225$$MD$CA$CA
122339042$12233904$2$F$20160315$20160404$20160404$20160413$EXP$$US-JNJFOC-20160323714$JANSSEN$$71$YR$E$M$Y$114$KG$20160413$$MD$US$US
1223424016$12234240$16$F$201304$20200708$20160404$20200710$EXP$$US-PFIZER INC-2016169246$PFIZER$$71$YR$$F$Y$59$KG$20200710$$MD$US$US
122342742$12234274$2$F$201402$20200909$20160404$20200918$EXP$$US-BAYER-2016-019332$BAYER$$75$YR$E$M$Y$$$20200918$$CN$US$US
122357152$12235715$2$F$20150417$20200730$20160404$20200811$EXP$$US-BAYER-2016-033542$BAYER$$76$YR$E$M$Y$$$20200811$$CN$US$US
122365438$12236543$8$F$2015$20200827$20160405$20200910$EXP$$AR-ROCHE-1632687$ROCHE$$42$YR$$M$Y$$$20200910$$CN$AR$AR
122365728$12236572$8$F$$20200701$20160405$20200714$EXP$$ES-AUROBINDO-AUR-APL-2016-04079$AUROBINDO$REV ESP GERIATR GERONTOL. 2015$71$YR$$F$Y$$$20200714$$HP$ES$ES
122368952$12236895$2$F$20160329$20160503$20160405$20160512$EXP$$US-ROCHE-1734806$ROCHE$$64$YR$$F$Y$110.32$KG$20160512$$MD$US$US
122374237$12237423$7$F$2013$20200707$20160405$20200710$EXP$$CA-ROCHE-1217703$ROCHE$$$$$F$Y$58.06$KG$20200710$$CN$CA$CA
122377431$12237743$1$I$$20160328$20160405$20160405$EXP$$HR-ROCHE-1735025$ROCHE$VRDOLJAK E, GORE M, LEYMAN S, SZCZYLIK C, KHARKEVICH G, SCHOFFSKI P, TORDAY L, MARDIAK J, ZHANG K, SAJBEN P AND SELLA A. BISPHOSPHONATES IN PATIENTS WITH RENAL CELL CARCINOMA AND BONE METASTASES: A SUNITINIB GLOBAL EXPANDED?ACCESS TRIAL SUBANALYSIS.. FUTURE ONCOLOGY 2015?11(20):2831?2840.$$$$$Y$$$20160405$$HP$HR$HR
122380109$12238010$9$F$20160314$20200708$20160405$20200717$EXP$$BR-JNJFOC-20160322374$JOHNSON AND JOHNSON$$84$YR$$M$Y$69.8$KG$20200717$$MD$BR$BR
122394492$12239449$2$F$20160404$20200821$20160405$20200826$PER$$US-009507513-1604USA002153$MERCK$$26$YR$$F$Y$$$20200826$$HP$US$US
122394823$12239482$3$F$20160318$20160720$20160405$20160729$EXP$$TW-JNJFOC-20160327793$JANSSEN$$51$YR$A$M$Y$80$KG$20160729$$MD$TW$TW
122395534$12239553$4$F$$20160328$20160405$20200925$EXP$$US-JAZZ-2016-US-005868$JAZZ$$$$$M$Y$$$20200925$$CN$US$US
1224004622$12240046$22$F$20160115$20200806$20160405$20200812$EXP$$PHHY2016US042656$NOVARTIS$$42$YR$$F$Y$59.41$KG$20200812$$HP$US$US
122411733$12241173$3$F$20150314$20200713$20160406$20200723$EXP$$US-BAYER-2016-049142$BAYER$$62$YR$A$F$Y$$$20200723$$CN$US$US
122412232$12241223$2$F$$20200902$20160406$20200911$EXP$$ES-AUROBINDO-AUR-APL-2016-04296$AUROBINDO$$74$YR$$F$Y$$$20200911$$MD$ES$ES
122413884$12241388$4$F$20160304$20200818$20160406$20200820$PER$$US-PFIZER INC-2016153061$PFIZER$$60$YR$$M$Y$113$KG$20200820$$MD$US$US
122414932$12241493$2$F$$20200722$20160406$20200727$EXP$$CA-BAXTER-2016BAX017805$BAXTER$$$$$F$Y$$$20200727$$HP$CA$CA
122415346$12241534$6$F$20160329$20200917$20160406$20200921$PER$$US-PFIZER INC-2016191977$PFIZER$$76$YR$$F$Y$58.97$KG$20200921$$CN$US$US
122422514$12242251$4$F$20160324$20160512$20160406$20160523$EXP$$KR-JNJFOC-20160323396$JANSSEN$$66$YR$E$F$Y$$$20160523$$MD$KR$KR
122422522$12242252$2$F$20150825$20160630$20160406$20160706$EXP$$JP-JNJFOC-20150904854$JANSSEN$$68$YR$E$F$Y$52$KG$20160706$$MD$JP$JP
122423083$12242308$3$F$20131224$20200816$20160406$20200827$EXP$$US-JNJFOC-20160402236$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200827$$CN$US$US
1224242610$12242426$10$F$20141013$20200821$20160406$20200826$EXP$$PHHY2014CL159032$NOVARTIS$$19$YR$$F$Y$$$20200826$$MD$CL$CL
122424404$12242440$4$F$$20200818$20160406$20200821$EXP$$PHHY2016BR037060$NOVARTIS$$$$$F$Y$74$KG$20200821$$CN$BR$BR
122425848$12242584$8$F$201603$20200805$20160406$20200811$EXP$$US-SA-2016SA054538$SANOFI AVENTIS$$$$$$Y$$$20200811$$HP$US$US
122434468$12243446$8$F$20150522$20200907$20160406$20200918$EXP$$JP-INCYTE CORPORATION-2016IN001901$INCYTE$$$$$$Y$$$20200918$$MD$JP$JP
122446919$12244691$9$F$2004$20200720$20160407$20200723$PER$$CA-AMGEN-CANSP2016041934$AMGEN$$52$YR$A$F$Y$$$20200723$$CN$CA$CA
122447934$12244793$4$F$201506$20200810$20160407$20200818$EXP$$US-BAYER-2016-027291$BAYER$$82$YR$E$M$Y$$$20200818$$CN$US$US
122450972$12245097$2$F$2014$20160328$20160407$20200728$EXP$$CN-BAYER-2016-061492$BAYER$LI YINGHUI, HANG YONGFU, LIANG YAN. ACUTE TUBULAR?INTERSTITIAL NEPHROPATHY (ATIN) CAUSED BY MOXIFLOXACIN AND LEVOFLOXACIN. ADVERSE DRUG REACTIONS JOURNAL(ADRJ),. 2016?VOL18.NO.1:P71$31$YR$A$M$Y$$$20200728$$MD$CN$CN
122453024$12245302$4$F$$20200812$20160407$20200817$PER$$US-PFIZER INC-2016167644$PFIZER$$86$YR$$F$Y$54.4$KG$20200817$$CN$US$US
122461757$12246175$7$F$2015$20200812$20160407$20200817$EXP$$CA-PFIZER INC-2015166636$PFIZER$$59$YR$$F$Y$$$20200817$$MD$CA$CA
122463045$12246304$5$F$20160325$20160714$20160407$20160719$EXP$$US-JNJFOC-20160400662$JANSSEN$$73$YR$E$F$Y$63.5$KG$20160719$$MD$US$US
122466623$12246662$3$F$20140513$20200707$20160407$20200721$EXP$$US-BAYER-2016-022914$BAYER$$65$YR$E$M$Y$$$20200721$$CN$US$US
122474371$12247437$1$I$20140930$20160325$20160407$20160407$EXP$$CA-CELGENE-CAN-2016037078$CELGENE$$66$YR$$M$Y$91.3$KG$20160407$$MD$CA$CA
122474903$12247490$3$F$$20200820$20160407$20200828$EXP$$US-BIOGEN-2016BI00216436$BIOGEN$$$$$F$Y$78.09$KG$20200828$$CN$US$US
1224755111$12247551$11$F$201506$20200914$20160407$20200921$PER$$CA-AMGEN-CANSP2016042951$AMGEN$$59$YR$A$F$Y$$$20200921$$CN$CA$CA
122486942$12248694$2$F$20140425$20200630$20160408$20200714$EXP$$US-BAYER-2016-025338$BAYER$$83$YR$E$F$Y$$$20200714$$CN$US$US
122491545$12249154$5$F$$20200702$20160408$20200706$EXP$$US-PFIZER INC-2016194416$PFIZER$$69$YR$$F$Y$$$20200706$$MD$US$US
122492802$12249280$2$F$20160329$20160419$20160408$20160427$EXP$$US-JNJFOC-20160405624$PHARMACYCLICS$$51$YR$A$M$Y$41.14$KG$20160427$$MD$US$US
122494675$12249467$5$F$20151017$20180220$20160408$20180228$EXP$$CA-JNJFOC-20151013989$PHARMACYCLICS$$77$YR$E$F$Y$72$KG$20180228$$MD$CA$CA
1224991115$12249911$15$F$2016$20200914$20160408$20200922$EXP$$CA-PFIZER INC-2016193745$PFIZER$$59$YR$$F$Y$$$20200922$$CN$CA$CA
122502042$12250204$2$F$20150818$20170801$20160408$20170816$EXP$$BR-JNJFOC-20151116905$JANSSEN$$72$YR$E$M$Y$75.8$KG$20170816$$MD$BR$BR
122502051$12250205$1$I$20151109$20151126$20160408$20160408$EXP$$SE-JNJFOC-20151125548$PHARMACYCLICS$$72$YR$E$M$Y$90.5$KG$20160408$$MD$SE$SE
122502061$12250206$1$I$20151117$20151118$20160408$20160408$EXP$$JP-JNJFOC-20151120872$PHARMACYCLICS$$67$YR$E$F$Y$147.4$KG$20160408$$MD$JP$JP
122502072$12250207$2$F$20160107$20180329$20160408$20180412$EXP$$CN-JNJFOC-20160120103$PHARMACYCLICS$$68$YR$E$M$Y$50$KG$20180412$$MD$CN$CN
122502081$12250208$1$I$20151115$20151228$20160408$20160408$EXP$$TR-JNJFOC-20151223362$PHARMACYCLICS$$65$YR$A$M$Y$60$KG$20160408$$MD$TR$TR
122502979$12250297$9$F$20200120$20200831$20160408$20200910$EXP$$PHHY2015CA151047$NOVARTIS$$75$YR$$M$Y$$$20200910$$MD$CA$CA
122506235$12250623$5$F$$20200716$20160408$20200726$EXP$$US-BIOGEN-2016BI00211900$BIOGEN$$$$$F$Y$$$20200726$$MD$US$US
122513343$12251334$3$F$2006$20200915$20160410$20200918$PER$$US-JNJFOC-20160319554$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20200918$$CN$US$US
122537841$12253784$1$I$20150627$20150701$20160411$20160411$EXP$$US-JNJFOC-20150701358$JANSSEN$$55$YR$A$F$Y$88.3$KG$20160411$$MD$US$US
122537873$12253787$3$F$20160401$20170221$20160411$20170224$EXP$$DE-JNJFOC-20160403288$JANSSEN$$67$YR$E$M$Y$80$KG$20170224$$MD$DE$DE
1225411928$12254119$28$F$2016$20200818$20160411$20200831$EXP$$US-SA-2016SA060293$SANOFI AVENTIS$$$$$$Y$$$20200831$$HP$US$US
122543802$12254380$2$F$20160326$20170627$20160411$20170705$EXP$$ES-JNJFOC-20160403822$JANSSEN$$73$YR$E$F$Y$70$KG$20170705$$MD$ES$ES
122544373$12254437$3$F$201603$20160415$20160411$20200701$EXP$$GR-JNJFOC-20160403063$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
122549112$12254911$2$F$2017$20200814$20160411$20200816$EXP$$CA-ABBVIE-16K-028-1600493-00$ABBVIE$$46$YR$$F$Y$$$20200816$$CN$CA$CA
122549202$12254920$2$F$$20200901$20160411$20200904$EXP$$US-JAZZ-2016-US-006475$JAZZ$$$$$F$Y$96$KG$20200904$$HP$US$US
122549304$12254930$4$F$2008$20200817$20160411$20200820$EXP$$US-JAZZ-2016-US-006438$JAZZ$$$$$M$Y$$$20200820$$HP$US$US
122565057$12256505$7$F$$20191127$20160412$20191205$EXP$$PHHY2015CA167718$NOVARTIS$$$$$F$Y$$$20191205$$CN$CA$CA
122569523$12256952$3$F$20160406$20160426$20160412$20160429$EXP$$UA-JNJFOC-20160407596$JANSSEN$$62$YR$A$F$Y$52$KG$20160429$$MD$UA$UA
122569532$12256953$2$F$20160402$20160405$20160412$20171122$EXP$$AT-JNJFOC-20160404724$JANSSEN$$73$YR$E$F$Y$63$KG$20171122$$MD$AT$AT
122571954$12257195$4$F$201508$20200630$20160412$20200708$EXP$$US-SA-2015SA129265$SANOFI AVENTIS$$58$YR$$F$Y$$$20200708$$CN$US$US
122572972$12257297$2$F$201404$20200902$20160412$20200908$EXP$$US-BAYER-2016-027211$BAYER$$72$YR$E$M$Y$$$20200908$$HP$US$US
122574702$12257470$2$F$20140624$20200819$20160412$20200827$EXP$$US-BAYER-2016-027214$BAYER$$58$YR$A$F$Y$$$20200827$$CN$US$US
122595922$12259592$2$F$$20200710$20160412$20200717$PER$$US-SA-2015SA099568$SANOFI AVENTIS$$$$$$Y$$$20200717$$CN$US$US
122605737$12260573$7$F$20170418$20200918$20160412$20200924$PER$$US-SA-2016SA052827$SANOFI AVENTIS$$$$$$Y$$$20200924$$CN$US$US
122611103$12261110$3$F$20160118$20200828$20160412$20200907$EXP$$US-INCYTE CORPORATION-2016IN000533$INCYTE$$$$$$Y$$$20200907$$MD$US$US
122614862$12261486$2$F$20140225$20200805$20160413$20200813$EXP$$US-BAYER-2016-024941$BAYER$$68$YR$E$F$Y$$$20200813$$CN$US$US
122620379$12262037$9$F$201604$20200428$20160413$20200916$PER$$US-AMGEN-USASL2016042921$AMGEN$$76$YR$E$M$Y$$$20200916$$MD$US$US
1226206321$12262063$21$F$20160209$20200807$20160413$20200812$EXP$$CA-ROCHE-1709474$ROCHE$$59$YR$$F$Y$$$20200812$$CN$CA$CA
122623917$12262391$7$F$$20200629$20160413$20200703$PER$$CA-AMGEN-CANSP2016044235$AMGEN$$58$YR$A$M$Y$$$20200703$$HP$CA$CA
122624973$12262497$3$F$20151117$20160819$20160413$20160823$EXP$$KR-ROCHE-1663346$ROCHE$$74$YR$$M$Y$56.3$KG$20160823$$MD$KR$KR
122632292$12263229$2$F$20160204$20160727$20160413$20160803$EXP$$CA-JNJFOC-20160404287$JANSSEN$$75$YR$E$M$Y$95$KG$20160803$$MD$CA$CA
122656372$12265637$2$F$$20200915$20160413$20200915$EXP$$CA-BAYER-2016-070721$BAYER$$$$$F$Y$$$20200915$$HP$CA$CA
122676523$12267652$3$F$201311$20200623$20160414$20200707$EXP$$US-JNJFOC-20160410998$JOHNSON AND JOHNSON$$70$YR$$F$Y$$$20200707$$CN$US$US
122676553$12267655$3$F$2014$20200817$20160414$20200820$PER$$US-JNJFOC-20160410936$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200820$$CN$US$US
122680872$12268087$2$F$201603$20200717$20160414$20200724$EXP$$US-SA-2016SA065613$SANOFI AVENTIS$$$$$$Y$$$20200724$$CN$US$US
122694122$12269412$2$F$20121220$20200810$20160414$20200819$EXP$$US-JNJFOC-20140302017$JOHNSON AND JOHNSON$$65$YR$E$F$Y$62.2$KG$20200819$$HP$US$US
122694142$12269414$2$F$20120706$20200710$20160414$20200722$EXP$$US-JNJFOC-20140110211$JOHNSON AND JOHNSON$$74$YR$$M$Y$$$20200722$$HP$US$US
1226998214$12269982$14$F$20161220$20200917$20160415$20200925$EXP$$CA-ROCHE-1733450$ROCHE$$61$YR$$M$Y$72.9$KG$20200925$$MD$CA$CA
1227047512$12270475$12$F$20151228$20190912$20160415$20200825$EXP$$PHHY2016US048609$NOVARTIS$$45$YR$$F$Y$64.8$KG$20200825$$MD$US$US
122705723$12270572$3$F$20151225$20200820$20160415$20200827$EXP$$PHEH2016US008557$NOVARTIS$$68$YR$$F$Y$54$KG$20200827$$HP$US$US
1227063316$12270633$16$F$20160315$20200724$20160415$20200727$PER$$US-PFIZER INC-2016169183$PFIZER$$76$YR$$F$Y$66$KG$20200727$$HP$US$US
122710182$12271018$2$F$20150918$20200906$20160415$20200910$EXP$$US-BAYER-2016-028403$BAYER$$68$YR$E$F$Y$$$20200910$$CN$US$US
122710965$12271096$5$F$20160324$20200910$20160415$20200914$EXP$$CA-ROCHE-1661916$ROCHE$$57$YR$$M$Y$$$20200915$$MD$CA$CA
122711162$12271116$2$F$201601$20200828$20160415$20200902$EXP$$FR-PFIZER INC-2016209811$PFIZER$$32$YR$$F$Y$58$KG$20200902$$HP$FR$FR
122713966$12271396$6$F$20141119$20200702$20160415$20200708$PER$$PHHY2015US028462$NOVARTIS$$46$YR$$F$Y$$$20200709$$MD$US$US
122723602$12272360$2$F$2015$20200902$20160415$20200904$EXP$$US-SA-2015SA199861$SANOFI AVENTIS$$$$$F$Y$$$20200904$$CN$US$US
122723684$12272368$4$F$20160307$20170719$20160415$20170727$EXP$$GB-JNJFOC-20160314209$JANSSEN$$79$YR$E$F$Y$76$KG$20170727$$MD$GB$GB
122724527$12272452$7$F$20160405$20200710$20160415$20200722$EXP$$US-JNJFOC-20160410065$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200722$$HP$US$US
122725533$12272553$3$F$20160404$20160901$20160415$20160907$EXP$$GB-JNJFOC-20160411003$PHARMACYCLICS$$85$YR$E$M$Y$60.1$KG$20160907$$MD$GB$GB
122733773$12273377$3$F$20160403$20160518$20160415$20160525$EXP$$US-JNJFOC-20160407452$JANSSEN$$59$YR$A$M$Y$83$KG$20160525$$MD$US$US
122763153$12276315$3$F$20160405$20160414$20160418$20160425$EXP$$FR-JNJFOC-20160408716$JANSSEN$$45$YR$A$M$Y$84$KG$20160425$$MD$FR$FR
122775863$12277586$3$F$20160407$20160422$20160418$20160428$EXP$$FI-JNJFOC-20160409193$JANSSEN$$68$YR$E$F$Y$55$KG$20160428$$MD$FI$FI
1227810610$12278106$10$F$20151113$20200515$20160418$20200924$PER$$PHHY2015US157890$NOVARTIS$$26$YR$$F$Y$$$20200924$$MD$US$US
1227815913$12278159$13$F$20121002$20200702$20160418$20200709$PER$$PHHY2015US005719$NOVARTIS$$46$YR$$F$Y$$$20200709$$MD$US$US
122790134$12279013$4$F$20120815$20200702$20160418$20200706$PER$$PHHY2013US102687$NOVARTIS$$60$YR$$F$Y$$$20200706$$MD$US$US
122791342$12279134$2$F$2009$20200916$20160418$20200923$EXP$$PHHY2016PL047578$NOVARTIS$$69$YR$$F$Y$$$20200923$$MD$PL$PL
122798253$12279825$3$F$20151230$20200627$20160418$20200709$EXP$$US-ACTELION-A-US2016-129591$ACTELION$$44$YR$$F$Y$$$20200709$$MD$US$US
122798714$12279871$4$F$2014$20200901$20160418$20200904$EXP$$US-JAZZ-2016-US-006805$JAZZ$$$$$F$Y$$$20200904$$HP$US$US
122809825$12280982$5$F$201410$20200920$20160419$20200923$PER$$US-JNJFOC-20160412954$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200923$$CN$US$US
122810504$12281050$4$F$20140717$20200715$20160419$20200724$PER$$US-JNJFOC-20160416298$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200724$$CN$US$US
122822275$12282227$5$F$20160414$20160526$20160419$20160531$EXP$$TR-JNJFOC-20160414678$PHARMACYCLICS$$67$YR$E$M$Y$76$KG$20160531$$MD$TR$TR
122849614$12284961$4$F$$20200629$20160420$20200704$PER$$CA-AMGEN-CANSP2016048021$AMGEN$$55$YR$A$F$Y$$$20200704$$HP$CA$CA
122853557$12285355$7$F$201504$20200901$20160420$20200909$EXP$$CA-ROCHE-1744210$ROCHE$$60$YR$$F$Y$$$20200909$$MD$CA$CA
122857143$12285714$3$F$$20200422$20160420$20200721$EXP$$US-PURDUE-USA-2016-0130287$PURDUE$$$$$F$Y$59$KG$20200721$$MD$US$US
122863464$12286346$4$F$$20200831$20160420$20200902$PER$$US-PFIZER INC-2016203775$PFIZER$$65$YR$$F$Y$$$20200902$$CN$US$US
122879203$12287920$3$F$$20200804$20160420$20200806$EXP$$US-JAZZ-2015-US-011011$JAZZ$$$$$F$Y$$$20200806$$MD$US$US
122880842$12288084$2$F$201409$20200702$20160420$20200921$PER$$US-JAZZ-2015-US-011125$JAZZ$$12$YR$$F$Y$$$20200921$$CN$US$US
122891286$12289128$6$F$20150618$20161227$20160421$20200722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-029405$BRISTOL MYERS SQUIBB$$86$YR$$M$Y$$$20200722$$MD$JP$JP
122897233$12289723$3$F$$20200723$20160421$20200805$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2016-01536$LUPIN$$$$N$$Y$.06$KG$20200805$$HP$DE$DE
122899243$12289924$3$F$20150120$20160809$20160421$20160819$EXP$$JP-ROCHE-1567140$ROCHE$$67$YR$$F$Y$59$KG$20160819$$MD$JP$JP
1229013117$12290131$17$F$$20200729$20160421$20200731$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK011740$GLAXOSMITHKLINE$$$$$F$Y$82$KG$20200731$$CN$BR$BR
1229035311$12290353$11$F$2012$20200818$20160421$20200820$EXP$$US-PFIZER INC-2016217490$PFIZER$$49$YR$$F$Y$82$KG$20200820$$MD$US$US
122904342$12290434$2$F$20140918$20200623$20160421$20200706$EXP$$ZA-CIPLA LTD.-2016ZA03710$CIPLA$VAN DER LAAN LE, SCHAAF HS, SOLOMONS R, WILLEMSE M, MOHAMED N, BABOOLAL SO ET AL.. PROBABLE LEVOFLOXACIN?ASSOCIATED SECONDARY INTRACRANIAL HYPERTENSION IN A CHILD WITH MULTIDRUG?RESISTANT TUBERCULOSIS. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2016?35 (6):706?708$$$$$Y$$$20200706$$HP$ZA$ZA
122907516$12290751$6$F$20160310$20200415$20160421$20200423$EXP$$US-ABBVIE-16P-163-1582093-00$ABBVIE$$49$YR$$M$Y$75.5$KG$20200423$$MD$US$US
122909673$12290967$3$F$$20160415$20160421$20200701$EXP$$GR-JNJFOC-20160404550$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
122909953$12290995$3$F$20140115$20200818$20160421$20200820$PER$$US-JNJFOC-20160417106$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200820$$CN$US$US
122909972$12290997$2$F$20150317$20160505$20160421$20160511$EXP$$ES-JNJFOC-20150314273$JANSSEN$$56$YR$A$M$Y$74$KG$20160511$$MD$ES$ES
1229100615$12291006$15$F$$20200813$20160421$20200818$PER$$US-PFIZER INC-2016172335$PFIZER$$68$YR$$M$Y$115$KG$20200818$$MD$US$US
122911005$12291100$5$F$20160412$20160615$20160421$20160627$EXP$$US-JNJFOC-20160418100$PHARMACYCLICS$$31$YR$A$M$Y$128.2$KG$20160627$$MD$US$US
122914509$12291450$9$F$1998$20200713$20160421$20200716$EXP$$FR-ABBVIE-16P-056-1610164-00$ABBVIE$$$$$M$Y$$$20200715$$HP$FR$FR
122919579$12291957$9$F$20160331$20200630$20160421$20200706$EXP$$CA-TAKEDA-2016TUS006412$TAKEDA$$38$YR$$F$Y$$$20200706$$CN$CA$CA
122934292$12293429$2$F$20150807$20200828$20160421$20200904$EXP$$FR-CELGENEUS-FRA-2015085260$CELGENE$$77$YR$$M$Y$77$KG$20200904$$HP$FR$FR
122936733$12293673$3$F$20160407$20200831$20160421$20200904$EXP$$DE-GILEAD-2016-0208874$GILEAD$$54$YR$A$M$Y$90.6$KG$20200904$$CN$DE$DE
122939145$12293914$5$F$20160310$20200415$20160422$20200417$EXP$$US-ROCHE-1725254$ROCHE$$49$YR$$M$Y$75.5$KG$20200417$$MD$US$US
122941723$12294172$3$F$20090322$20200720$20160422$20200803$EXP$$AR-SHIRE-AR201604713$SHIRE$$$$$$Y$$$20200803$$MD$AR$AR
122943966$12294396$6$F$$20200818$20160422$20200825$EXP$$BR-ROCHE-1729335$ROCHE$$$$A$F$Y$75$KG$20200825$$CN$BR$BR
122946812$12294681$2$F$20130429$20200625$20160422$20200708$EXP$$US-BAYER-2016-033291$BAYER$$72$YR$E$M$Y$$$20200708$$HP$US$US
1229484410$12294844$10$F$2016$20200916$20160422$20200918$EXP$$US-PFIZER INC-2016226285$PFIZER$$70$YR$$M$Y$64$KG$20200918$$CN$US$US
122948507$12294850$7$F$20050330$20200907$20160422$20200911$EXP$$JP-VIIV HEALTHCARE LIMITED-A200902503$VIIV$$35$YR$$M$Y$$$20200911$$CN$US$JP
122950617$12295061$7$F$20050330$20200907$20160422$20200911$EXP$$JP-GLAXOSMITHKLINE-A200902503$GLAXOSMITHKLINE$$35$YR$$M$Y$$$20200911$$CN$US$JP
122960292$12296029$2$F$2009$20200625$20160422$20200922$EXP$$US-PURDUE PHARMA-USA-2016-0128498$PURDUE$$58$YR$$M$Y$$$20200922$$CN$US$US
122972901$12297290$1$I$20160208$20160411$20160422$20160422$EXP$$EC-JNJFOC-20160417225$JANSSEN$$66$YR$E$M$Y$90$KG$20160422$$MD$EC$EC
122973242$12297324$2$F$20160412$20160608$20160422$20160621$EXP$$GB-JNJFOC-20160420502$PHARMACYCLICS$$87$YR$E$M$Y$$$20160621$$MD$GB$GB
122979097$12297909$7$F$2014$20200901$20160422$20200904$PER$$US-PFIZER INC-2016205988$PFIZER$$78$YR$$M$Y$102$KG$20200904$$MD$US$US
1229791710$12297917$10$F$2008$20200818$20160422$20200821$PER$$US-PFIZER INC-2016214065$PFIZER$$60$YR$$F$Y$99$KG$20200821$$MD$US$US
1229821233$12298212$33$F$2008$20200914$20160423$20200918$PER$$CA-AMGEN-CANSP2016050673$AMGEN$$53$YR$A$F$Y$$$20200918$$HP$CA$CA
122984683$12298468$3$F$20160207$20200713$20160424$20200717$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-012956$BRISTOL MYERS SQUIBB$$79$YR$$F$Y$40$KG$20200717$$MD$JP$JP
122987494$12298749$4$F$20101021$20200707$20160425$20200710$EXP$$BR-ROCHE-701006$ROCHE$$18$YR$$F$Y$65$KG$20200710$$MD$BR$BR
122988826$12298882$6$F$$20200802$20160425$20200810$EXP$$CA-ROCHE-1745502$ROCHE$$$$$M$Y$$$20200810$$MD$CA$CA
122989373$12298937$3$F$20160325$20200828$20160425$20200904$EXP$$IN-ROCHE-1738279$ROCHE$$45$YR$$M$Y$77.8$KG$20200904$$MD$IN$IN
122989842$12298984$2$F$20151006$20160609$20160425$20160616$EXP$$JP-ROCHE-1710570$ROCHE$$74$YR$$F$Y$48$KG$20160616$$MD$JP$JP
122994277$12299427$7$F$$20200629$20160425$20200706$PER$$CA-AMGEN-CANSP2016051438$AMGEN$$56$YR$A$F$Y$$$20200705$$HP$CA$CA
122995933$12299593$3$F$20160331$20200901$20160425$20200903$PER$$US-PFIZER INC-2016213777$PFIZER$$51$YR$$M$Y$68.49$KG$20200903$$HP$US$US
1229966029$12299660$29$F$20160418$20200922$20160425$20200924$EXP$$US-PFIZER INC-2016228376$PFIZER$$69$YR$$F$Y$106$KG$20200924$$MD$US$US
123004311$12300431$1$I$20160313$20160422$20160425$20160425$EXP$$PT-JNJFOC-20160421281$PHARMACYCLICS$$65$YR$A$$Y$55.2$KG$20160425$$MD$PT$PT
123009302$12300930$2$F$20150806$20160527$20160425$20160606$EXP$$JP-ROCHE-1632452$ROCHE$$85$YR$$M$Y$51$KG$20160606$$MD$JP$JP
1230107019$12301070$19$F$20170511$20200803$20160425$20200814$EXP$$US-ACTELION-A-NJ2016-135003$ACTELION$$60$YR$$F$Y$70.3$KG$20200814$$HP$US$US
123011285$12301128$5$F$20160308$20170823$20160425$20170901$EXP$$DK-JNJFOC-20160400499$JANSSEN$$68$YR$E$M$Y$91$KG$20170901$$MD$DK$DK
123011683$12301168$3$F$20160419$20160811$20160425$20160812$EXP$$KR-JNJFOC-20160420816$PHARMACYCLICS$$85$YR$E$M$Y$55$KG$20160812$$MD$KR$KR
1230182124$12301821$24$F$2016$20200722$20160425$20200728$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK146600$GLAXOSMITHKLINE$$40$YR$$F$Y$80$KG$20200728$$CN$BR$BR
123021388$12302138$8$F$20160408$20170404$20160425$20170413$EXP$$US-JNJFOC-20160416797$JANSSEN$$67$YR$E$F$Y$58.9$KG$20170412$$MD$US$US
1230227447$12302274$47$F$2008$20200914$20160425$20200921$EXP$$CA-PFIZER INC-2016221150$PFIZER$$53$YR$$F$Y$$$20200921$$MD$CA$CA
123027415$12302741$5$F$$20200629$20160425$20200706$PER$$CA-AMGEN-CANSP2015013791$AMGEN$$41$YR$A$F$Y$$$20200706$$CN$CA$CA
123028368$12302836$8$F$$20200629$20160426$20200705$PER$$CA-AMGEN-CANSP2016051354$AMGEN$$55$YR$A$F$Y$87$KG$20200705$$HP$CA$CA
123035073$12303507$3$F$$20200731$20160426$20200803$PER$$US-JNJFOC-20160411033$JOHNSON AND JOHNSON$$$$T$M$Y$$$20200803$$LW$US$US
1230466913$12304669$13$F$20150212$20200720$20160426$20200723$PER$$CA-AMGEN-CANSP2015013797$AMGEN$$54$YR$A$F$Y$$$20200723$$CN$CA$CA
123051762$12305176$2$F$$20200817$20160426$20200820$EXP$$CA-BAXTER-2016BAX020150$BAXTER$$65$YR$$F$Y$$$20200820$$HP$CA$CA
123055632$12305563$2$F$20160404$20200622$20160426$20200701$EXP$$JP-ACTELION-A-CH2016-134965$ACTELION$$69$YR$$M$Y$$$20200701$$MD$JP$JP
123058522$12305852$2$F$2015$20200708$20160426$20200717$EXP$$US-ELI_LILLY_AND_COMPANY-US201604006151$ELI LILLY AND CO$$$$$M$Y$$$20200717$$CN$US$US
123060517$12306051$7$F$$20200728$20160426$20200805$PER$$CA-AMGEN-CANSP2016051977$AMGEN$$$$$F$Y$$$20200805$$HP$CA$CA
1230633311$12306333$11$F$2016$20200722$20160426$20200731$EXP$$US-SA-2016SA066866$SANOFI AVENTIS$$$$$$Y$$$20200731$$LW$US$US
123063623$12306362$3$F$20151218$20200627$20160426$20200702$PER$$IT-SA-2016SA081199$SANOFI AVENTIS$$23$YR$$F$Y$60$KG$20200702$$MD$IT$IT
123069083$12306908$3$F$20140214$20200728$20160426$20200807$EXP$$US-BAYER-2016-035966$BAYER$$71$YR$E$M$Y$$$20200807$$CN$US$US
123082925$12308292$5$F$$20200819$20160426$20200824$EXP$$US-JAZZ-2016-US-007333$JAZZ$$$$$F$Y$$$20200824$$HP$US$US
123087302$12308730$2$F$20150528$20160628$20160427$20160701$EXP$$JP-ROCHE-1658965$ROCHE$$65$YR$$F$Y$41$KG$20160701$$MD$JP$JP
123088252$12308825$2$F$$20200701$20160427$20200707$PER$$US-AMGEN-USASL2016051044$AMGEN$$56$YR$A$F$Y$$$20200707$$MD$US$US
123091281$12309128$1$I$20150503$20160418$20160427$20160427$EXP$$NL-ROCHE-1744090$ROCHE$$60$YR$$$Y$$$20160427$$MD$NL$NL
1230948111$12309481$11$F$2007$20200728$20160427$20200729$PER$$US-PFIZER INC-2016208777$PFIZER$$67$YR$$F$Y$56$KG$20200729$$MD$US$US
123096288$12309628$8$F$20160421$20171024$20160427$20171025$EXP$$IL-JNJFOC-20160422786$PHARMACYCLICS$$47$YR$A$M$Y$63$KG$20171025$$MD$IL$IL
123110743$12311074$3$F$20160414$20160715$20160427$20160720$EXP$$PL-JNJFOC-20160420661$PHARMACYCLICS$$47$YR$A$M$Y$82$KG$20160720$$MD$PL$PL
123112133$12311213$3$F$20150419$20200713$20160427$20200716$PER$$US-JNJFOC-20160419534$JOHNSON AND JOHNSON$$73$YR$$M$Y$$$20200716$$LW$US$US
123112902$12311290$2$F$20140309$20200630$20160427$20200714$EXP$$US-BAYER-2016-038427$BAYER$$66$YR$E$M$Y$$$20200714$$CN$US$US
123113442$12311344$2$F$201407$20200629$20160427$20200710$EXP$$US-BAYER-2016-043821$BAYER$$53$YR$A$F$Y$$$20200710$$LW$US$US
123116682$12311668$2$F$20160225$20200814$20160427$20200824$EXP$$DE-BIOGEN-2016BI00228014$BIOGEN$$21$YR$$F$Y$$$20200823$$CN$DE$DE
123121013$12312101$3$F$20151125$20200803$20160427$20200812$EXP$$CA-BIOGEN-2015BI158821$BIOGEN$$41$YR$$F$Y$$$20200811$$CN$CA$CA
1231249412$12312494$12$F$20090209$20200914$20160428$20200917$PER$$CA-AMGEN-CANSP2016039095$AMGEN$$50$YR$A$M$Y$$$20200917$$HP$CA$CA
123129312$12312931$2$F$20150327$20160615$20160428$20160622$EXP$$JP-ROCHE-1720368$ROCHE$$38$YR$$M$Y$70$KG$20160622$$MD$JP$JP
123131696$12313169$6$F$20151223$20200704$20160428$20200709$EXP$$GB-CELGENEUS-GBR-2016015918$CELGENE$$78$YR$$M$Y$$$20200709$$HP$GB$GB
123131784$12313178$4$F$20141031$20200701$20160428$20200714$EXP$$NL-AUROBINDO-AUR-APL-2016-05462$AUROBINDO$$45$YR$$F$Y$$$20200714$$MD$NL$NL
123132317$12313231$7$F$20160201$20200827$20160428$20200901$EXP$$CA-CELGENEUS-CAN-2016021398$CELGENE$$83$YR$$F$Y$55.3$KG$20200901$$MD$CA$CA
1231328113$12313281$13$F$2014$20200901$20160428$20200903$EXP$$US-PFIZER INC-2016221992$PFIZER$$63$YR$$F$Y$63.5$KG$20200903$$MD$US$US
123134475$12313447$5$F$20080122$20200629$20160428$20200708$EXP$$US-PURDUE-USA-2008-0031449$PURDUE$$28$YR$$M$Y$$$20200708$$CN$US$US
123135287$12313528$7$F$20150928$20200815$20160428$20200909$EXP$$PHHO2015RO015459$NOVARTIS$$75$YR$$M$Y$84$KG$20200909$$MD$RO$RO
123136209$12313620$9$F$$20200629$20160428$20200707$EXP$$CA-PFIZER INC-2016231208$PFIZER$$56$YR$$F$Y$$$20200707$$HP$CA$CA
123142882$12314288$2$F$20160417$20160426$20160428$20160505$EXP$$JP-JNJFOC-20160421852$JANSSEN$$74$YR$E$F$Y$46.9$KG$20160505$$MD$JP$JP
123144652$12314465$2$F$201305$20200810$20160428$20200817$EXP$$US-BAYER-2016-038430$BAYER$$73$YR$E$M$Y$$$20200817$$HP$US$US
123151952$12315195$2$F$20140924$20200903$20160428$20200909$EXP$$US-BAYER-2016-039890$BAYER$$62$YR$A$M$Y$$$20200909$$CN$US$US
123152713$12315271$3$F$201408$20200831$20160428$20200903$EXP$$US-JNJFOC-20160416303$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200903$$CN$US$US
1231560616$12315606$16$F$20160407$20200724$20160428$20200819$PER$$US-ACTELION PHARMACEUTICALS US, INC.-A-US2016-134669$ACTELION$$67$YR$$F$Y$57.14$KG$20200819$$HP$US$US
1231575417$12315754$17$F$$20200728$20160428$20200805$EXP$$PHHY2016GT055689$NOVARTIS$$82$YR$$F$Y$$$20200805$$CN$GT$GT
123163167$12316316$7$F$20151016$20200728$20160428$20200806$EXP$$CA-ROCHE-1748574$ROCHE$$56$YR$$F$Y$$$20200806$$MD$CA$CA
123173307$12317330$7$F$2016$20170405$20160429$20200817$EXP$$DE-UCBSA-2016014353$UCB$$$$$M$Y$97$KG$20200817$$MD$DE$DE
123174088$12317408$8$F$$20200828$20160429$20200901$PER$$US-PFIZER INC-2016198352$PFIZER$$82$YR$$F$Y$$$20200901$$MD$US$US
123175277$12317527$7$F$202008$20200925$20160429$20200929$EXP$$US-PFIZER INC-2016235106$PFIZER$$54$YR$$F$Y$54$KG$20200929$$CN$US$US
123175834$12317583$4$F$20160405$20160606$20160429$20160615$EXP$$FR-JNJFOC-20160405152$JANSSEN$$62$YR$A$M$Y$71.1$KG$20160615$$MD$FR$FR
123175844$12317584$4$F$20160415$20160513$20160429$20160519$EXP$$FR-JNJFOC-20160418334$JANSSEN$$62$YR$A$M$Y$71.1$KG$20160519$$MD$FR$FR
123177423$12317742$3$F$2013$20200408$20160429$20200717$EXP$$US-MUNDIPHARMA DS AND PHARMACOVIGILANCE-USA-2016-0130508$PURDUE$$$$$F$Y$53.61$KG$20200717$$MD$US$US
123180302$12318030$2$F$$20200907$20160429$20200911$EXP$$NO-009507513-1604NOR018030$MERCK$BREIVIK H, FROST J, LOKKEN TN, SLORDAL L.. POST MORTEM TISSUE DISTRIBUTION OF QUETIAPINE IN FORENSIC AUTOPSIES.. FORENSIC SCIENCE INTERNATIONAL. 2020?315:110413$51$YR$$F$Y$$$20200911$$HP$NO$NO
123182982$12318298$2$F$20160413$20160913$20160429$20160921$EXP$$US-JNJFOC-20160420504$PHARMACYCLICS$$69$YR$E$M$Y$$$20160921$$MD$US$US
123185632$12318563$2$F$20131028$20200909$20160429$20200918$EXP$$US-BAYER-2016-049036$BAYER$$77$YR$E$M$Y$$$20200918$$CN$US$US
123187952$12318795$2$F$201604$20200918$20160429$20200925$EXP$$US-SA-2016SA080348$SANOFI AVENTIS$$$$$$Y$$$20200925$$CN$US$US
1232109313$12321093$13$F$$20200720$20160502$20200723$PER$$CA-AMGEN-CANSP2016054589$AMGEN$$55$YR$A$F$Y$$$20200723$$HP$CA$CA
123214163$12321416$3$F$20141014$20170217$20160502$20170223$EXP$$JP-ROCHE-1487167$ROCHE$UYAMA H, TASAKI M, KOYAMA N, HONTSU S, ET AL. STUDY ON USEFULNESS OF ALECTINIB FOR LUNG CANCER AFTER ADMINISTRATION OF CRIZOTINIB. ANNALS OF THE JAPANESE RESPIRATORY SOCIETY? PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE JAPANESE RESPIRATORY SOCIETY? FROM 08 APR 2016 TO 10 APR 2016? KYOTO?CITY, KYOTO. MAR 2016. 5(S):243 2016 MAR?5(S):243?.$67$YR$$F$Y$46$KG$20170223$$MD$JP$JP
1232153416$12321534$16$F$$20200914$20160502$20200918$PER$$CA-AMGEN-CANSP2016054557$AMGEN$$53$YR$A$M$Y$$$20200918$$HP$CA$CA
123224442$12322444$2$F$20130117$20200915$20160502$20200929$EXP$$US-JNJFOC-20160305041$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200929$$CN$US$US
1232252517$12322525$17$F$20160421$20180627$20160502$20180629$EXP$$AU-JNJFOC-20160422608$JANSSEN$$70$YR$E$F$Y$72.4$KG$20180629$$MD$AU$AU
123225265$12322526$5$F$20160421$20170529$20160502$20170607$EXP$$FR-JNJFOC-20160422636$JANSSEN$$59$YR$A$F$Y$69$KG$20170607$$MD$FR$FR
123227074$12322707$4$F$$20200727$20160502$20200728$PER$$US-PFIZER INC-2016224347$PFIZER$$75$YR$$F$Y$$$20200728$$CN$US$US
123236772$12323677$2$F$20150202$20200728$20160502$20200807$EXP$$US-BAYER-2016-025881$BAYER$$66$YR$E$F$Y$$$20200807$$CN$US$US
123238467$12323846$7$F$$20200914$20160502$20200918$PER$$CA-AMGEN-CANSP2016053912$AMGEN$$58$YR$A$F$Y$$$20200918$$HP$CA$CA
123238661$12323866$1$I$20160421$20160421$20160502$20160502$EXP$$DE-JNJFOC-20160420608$JANSSEN$$7$DEC$E$M$Y$73$KG$20160502$$MD$DE$DE
123251992$12325199$2$F$$20200730$20160502$20200807$EXP$$CA-009507513-1604CAN017156$MERCK$$$$$F$Y$$$20200807$$HP$CA$CA
123257645$12325764$5$F$$20200724$20160503$20200805$EXP$$GB-LUPIN PHARMACEUTICALS INC.-2015-02170$LUPIN$VOHRA A. QUETIAPINE INDUCED RESTLESS LEGS SYNDROME: A SERIES OF FOUR CASES. ASIAN JOURNAL OF PSYCHIATRY. 2015?16:73?74$43$YR$$F$Y$$$20200805$$MD$GB$GB
123268502$12326850$2$F$$20200730$20160503$20200803$EXP$$CA-009507513-1604CAN017236$MERCK$$55$YR$$M$Y$$$20200803$$HP$CA$CA
123270242$12327024$2$F$$20200819$20160503$20200824$PER$$US-PFIZER INC-2016240485$PFIZER$$47$YR$$F$Y$106.58$KG$20200824$$CN$US$US
1232839419$12328394$19$F$20160407$20200706$20160503$20200710$EXP$$CA-PFIZER INC-2016213277$PFIZER$$69$YR$$F$Y$$$20200710$$HP$CA$CA
123290142$12329014$2$F$20160423$20160510$20160503$20160517$EXP$$FR-JNJFOC-20160423384$JANSSEN$$39$YR$A$M$Y$75.4$KG$20160517$$MD$FR$FR
123290482$12329048$2$F$20150609$20200908$20160503$20200911$EXP$$US-BAYER-2016-046095$BAYER$$77$YR$E$M$Y$$$20200911$$HP$US$US
123290712$12329071$2$F$201309$20200830$20160503$20200908$EXP$$US-BAYER-2016-043873$BAYER$$80$YR$E$F$Y$$$20200908$$CN$US$US
123296484$12329648$4$F$20160325$20200730$20160503$20200810$EXP$$US-BIOGEN-2016BI00231699$BIOGEN$$65$YR$$F$Y$$$20200810$$MD$US$US
123297637$12329763$7$F$2016$20200908$20160503$20200910$EXP$$CA-TAKEDA-2016TUS007465$TAKEDA$$32$YR$$F$Y$$$20200910$$MD$CA$CA
1232981810$12329818$10$F$$20200720$20160503$20200723$PER$$CA-AMGEN-CANSP2016055555$AMGEN$$$$$F$Y$$$20200723$$HP$CA$CA
123299696$12329969$6$F$$20200804$20160504$20200807$EXP$CA-HEALTHCANADA-000654097$CA-009507513-1605CAN001462$MERCK$$83$YR$$F$Y$$$20200807$$CN$CA$CA
1233035012$12330350$12$F$$20200720$20160504$20200723$PER$$CA-AMGEN-CANSP2016054181$AMGEN$$79$YR$E$F$Y$$$20200723$$CN$CA$CA
123303866$12330386$6$F$20150527$20200727$20160504$20200801$PER$$PHHY2016US019375$NOVARTIS$$29$YR$$F$Y$$$20200801$$MD$US$US
123307883$12330788$3$F$201405$20200916$20160504$20200925$EXP$$US-BAYER-2016-040601$BAYER$$91$YR$E$M$Y$$$20200925$$CN$US$US
1233097315$12330973$15$F$$20200720$20160504$20200723$PER$$CA-AMGEN-CANSP2016053953$AMGEN$$$$$F$Y$$$20200722$$CN$CA$CA
1233116621$12331166$21$F$2016$20200914$20160504$20200930$PER$$CA-AMGEN-CANSP2016054169$AMGEN$$56$YR$A$F$Y$$$20200930$$CN$CA$CA
1233179422$12331794$22$F$20160321$20200903$20160504$20200911$EXP$$BE-CELGENEUS-BEL-2016035783$CELGENE$$56$YR$$F$Y$127$KG$20200911$$MD$BE$BE
1233264510$12332645$10$F$20160410$20200709$20160504$20200713$EXP$$US-PFIZER INC-2016230773$PFIZER$$77$YR$$F$Y$58$KG$20200713$$CN$US$US
123344383$12334438$3$F$20160426$20161014$20160504$20161021$EXP$$PL-JNJFOC-20160427371$PHARMACYCLICS$$81$YR$E$M$Y$77$KG$20161021$$MD$PL$PL
123348333$12334833$3$F$$20200824$20160504$20200829$PER$$US-CELGENEUS-USA-2016050134$CELGENE$$$$$M$Y$70$KG$20200829$$MD$US$US
123352562$12335256$2$F$20160425$20200914$20160504$20200916$PER$$US-ELI_LILLY_AND_COMPANY-US201604010290$ELI LILLY AND CO$$80$YR$$F$Y$$$20200916$$CN$US$US
123352863$12335286$3$F$$20200715$20160504$20200723$EXP$$US-JAZZ-2016-US-007868$JAZZ$$$$$F$Y$$$20200723$$CN$US$US
1233541518$12335415$18$F$2013$20200713$20160504$20200727$PER$$CA-AMGEN-CANSP2016055292$AMGEN$$58$YR$A$F$Y$$$20200727$$CN$CA$CA
1233625111$12336251$11$F$201406$20200825$20160505$20200904$EXP$$FR-UCBSA-2016015800$UCB$$1$YR$$M$Y$3.18$KG$20200904$$HP$FR$FR
1233669424$12336694$24$F$$20200914$20160505$20200918$PER$$CA-AMGEN-CANSP2015094586$AMGEN$$41$YR$A$F$Y$90$KG$20200918$$HP$CA$CA
123368673$12336867$3$F$20150604$20200823$20160505$20200903$EXP$$US-JNJFOC-20160500269$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20200903$$CN$US$US
1233714713$12337147$13$F$20160422$20200813$20160505$20200819$EXP$$PHHY2016PA061228$NOVARTIS$$44$YR$$F$Y$86$KG$20200819$$CN$COUNTRY NOT SPECIFIED$PA
123371532$12337153$2$F$$20200828$20160505$20200901$EXP$$DE-ROCHE-1752022$ROCHE$, MCCLANAHAN F, SCHONING T, SCHWARZBICH M, CREMER M, DITTRICH T, HO A AND WITZENS?HARIG M MINIMAL RENAL TOXICITY AFTER RITUXIMAB DHAP WITH A MODIFIED CISPLATIN APPLICATION SCHEME IN PATIENTS WITH RELAPSED AND REFRACTORY DIFFUSE LARGE B?CELL LYMPHOMA.. BLOOD 2015?126 (23):1506?.$$$$$Y$$$20200901$$HP$DE$DE
123372486$12337248$6$F$201510$20200917$20160505$20200925$EXP$$PHHY2016CA047441$NOVARTIS$$57$YR$$F$Y$$$20200926$$CN$COUNTRY NOT SPECIFIED$CA
123374873$12337487$3$F$$20200629$20160505$20200705$PER$$CA-AMGEN-CANSP2016053941$AMGEN$$67$YR$E$M$Y$$$20200705$$HP$CA$CA
123381862$12338186$2$F$20151102$20200828$20160505$20200903$EXP$$CA-CELGENEUS-CAN-2015123244$CELGENE$$70$YR$$M$Y$80.9$KG$20200903$$MD$CA$CA
123383552$12338355$2$F$20160422$20180509$20160505$20180517$EXP$$US-JNJFOC-20160424472$JANSSEN$$61$YR$A$M$Y$104$KG$20180517$$MD$US$US
123388382$12338838$2$F$2015$20200629$20160505$20200820$PER$$US-JAZZ-2015-US-012524$JAZZ$$35$YR$$F$Y$61.22$KG$20200820$$MD$US$US
1233890424$12338904$24$F$$20200914$20160505$20200921$EXP$$CA-PFIZER INC-2016241427$PFIZER$$53$YR$$M$Y$$$20200921$$CN$CA$CA
123394022$12339402$2$F$201508$20200610$20160505$20200820$PER$$US-JAZZ-2015-US-012841$JAZZ$$39$YR$$F$Y$73.47$KG$20200820$$MD$US$US
123397495$12339749$5$F$$20200914$20160506$20200917$PER$$CA-AMGEN-CANSP2016056844$AMGEN$$56$YR$A$F$Y$$$20200917$$HP$CA$CA
1233981114$12339811$14$F$$20200629$20160506$20200707$PER$$CA-AMGEN-CANSP2016056726$AMGEN$$$$$F$Y$$$20200707$$CN$CA$CA
1233998643$12339986$43$F$20160104$20200826$20160506$20200903$EXP$$CA-ROCHE-1753265$ROCHE$$68$YR$$M$Y$$$20200903$$MD$CA$CA
123406863$12340686$3$F$20160405$20160511$20160506$20160519$EXP$$GB-JNJFOC-20160409568$JANSSEN$$60$YR$A$M$Y$71$KG$20160519$$MD$GB$GB
123406892$12340689$2$F$$20200826$20160506$20200903$EXP$$DE-AUROBINDO-AUR-APL-2016-04587$AUROBINDO$$53$YR$$F$Y$75$KG$20200903$$HP$DE$DE
123407522$12340752$2$F$20150127$20200901$20160506$20200904$EXP$$US-BAYER-2016-046096$BAYER$$92$YR$E$M$Y$$$20200904$$CN$US$US
123407534$12340753$4$F$201402$20200716$20160506$20200730$EXP$$US-BAYER-2016-046093$BAYER$$59$YR$A$F$Y$$$20200730$$CN$US$US
123409996$12340999$6$F$201111$20200909$20160506$20200917$EXP$$US-ASTRAZENECA-2016SE48974$ASTRAZENECA$$51$YR$$F$Y$$$20200917$$CN$CA$CA
1234150735$12341507$35$F$20160206$20200910$20160506$20200917$EXP$$PHHY2016CA003462$NOVARTIS$$79$YR$$M$Y$$$20200917$$HP$CA$CA
123418653$12341865$3$F$20140428$20200827$20160506$20200910$EXP$$US-JNJFOC-20160501540$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200910$$CN$US$US
123426743$12342674$3$F$20160420$20160830$20160506$20160907$EXP$$PHHO2016DE006458$NOVARTIS$$45$YR$$F$Y$89$KG$20160907$$MD$DE$DE
123427574$12342757$4$F$20160418$20160923$20160506$20161003$EXP$$US-JNJFOC-20160424206$PHARMACYCLICS$$61$YR$A$F$Y$61.22$KG$20161003$$MD$US$US
1234344319$12343443$19$F$$20200827$20160506$20200901$PER$$US-PFIZER INC-2016203730$PFIZER$$72$YR$$F$Y$$$20200901$$CN$US$US
123439053$12343905$3$F$2015$20200921$20160507$20200923$PER$$US-JNJFOC-20160411176$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200923$$CN$US$US
123439163$12343916$3$F$20140408$20200628$20160507$20200706$PER$$US-JNJFOC-20160409139$JOHNSON AND JOHNSON$$51$YR$$M$Y$$$20200706$$HP$US$US
123439324$12343932$4$F$2016$20200908$20160507$20200914$PER$$US-JNJFOC-20160411197$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200914$$CN$US$US
123439363$12343936$3$F$20130204$20200917$20160507$20200921$PER$$US-JNJFOC-20160409967$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200921$$CN$US$US
123439422$12343942$2$F$20150523$20200818$20160507$20200824$PER$$US-JNJFOC-20160411188$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200824$$HP$US$US
123439823$12343982$3$F$2014$20200707$20160507$20200714$PER$$US-JNJFOC-20160409396$JOHNSON AND JOHNSON$$71$YR$$F$Y$$$20200714$$CN$US$US
123440023$12344002$3$F$20150926$20200903$20160507$20200916$EXP$$US-JNJFOC-20160414348$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200916$$CN$US$US
123440043$12344004$3$F$201503$20200924$20160507$20200928$PER$$US-JNJFOC-20160414350$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200928$$CN$US$US
123440073$12344007$3$F$201209$20200727$20160507$20200731$PER$$US-JNJFOC-20160414347$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200731$$CN$US$US
123440103$12344010$3$F$20150713$20200713$20160507$20200715$PER$$US-JNJFOC-20160414344$JOHNSON AND JOHNSON$$66$YR$$F$Y$$$20200715$$CN$US$US
123440113$12344011$3$F$201502$20200709$20160507$20200715$PER$$US-JNJFOC-20160414341$JOHNSON AND JOHNSON$$72$YR$$M$Y$$$20200715$$LW$US$US
123440483$12344048$3$F$201304$20200629$20160507$20200702$PER$$US-JNJFOC-20160324648$JOHNSON AND JOHNSON$$65$YR$$M$Y$$$20200702$$CN$US$US
123440544$12344054$4$F$20150623$20200722$20160507$20200803$EXP$$US-JNJFOC-20160206130$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20200803$$CN$US$US
123440915$12344091$5$F$201505$20200913$20160507$20200917$PER$$US-JNJFOC-20160416206$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20200917$$CN$US$US
123440955$12344095$5$F$20151012$20200730$20160507$20200806$EXP$$US-JNJFOC-20160416215$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200806$$CN$US$US
123441484$12344148$4$F$20140203$20200625$20160507$20200708$EXP$$US-JNJFOC-20160320905$JOHNSON AND JOHNSON$$79$YR$$F$Y$$$20200708$$CN$US$US
123441953$12344195$3$F$201206$20200805$20160507$20200807$PER$$US-JNJFOC-20160328238$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200807$$CN$US$US
123442052$12344205$2$F$201404$20200830$20160507$20200903$PER$$US-JNJFOC-20160328683$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200903$$HP$US$US
123442143$12344214$3$F$201505$20200906$20160507$20200914$PER$$US-JNJFOC-20160400038$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20200914$$LW$US$US
123442273$12344227$3$F$20140711$20200927$20160507$20200930$PER$$US-JNJFOC-20160400039$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200930$$LW$US$US
123442293$12344229$3$F$20140629$20200820$20160507$20200826$PER$$US-JNJFOC-20160400040$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200826$$CN$US$US
123442583$12344258$3$F$201502$20200629$20160507$20200710$EXP$$US-JNJFOC-20160330114$JOHNSON AND JOHNSON$$85$YR$$M$Y$$$20200710$$CN$US$US
123443082$12344308$2$F$20140418$20200922$20160507$20200928$PER$$US-JNJFOC-20160421537$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200928$$LW$US$US
123443104$12344310$4$F$20140915$20200823$20160507$20200825$PER$$US-JNJFOC-20160426414$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200825$$CN$US$US
123443203$12344320$3$F$201409$20200818$20160507$20200821$PER$$US-JNJFOC-20160426433$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20200821$$CN$US$US
123443223$12344322$3$F$20131207$20200623$20160507$20200702$PER$$US-JNJFOC-20160426421$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200702$$CN$US$US
123443323$12344332$3$F$201407$20200729$20160507$20200803$PER$$US-JNJFOC-20160426425$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200803$$CN$US$US
123443413$12344341$3$F$20150614$20200916$20160507$20200918$PER$$US-JNJFOC-20160426436$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20200918$$CN$US$US
123443613$12344361$3$F$20150623$20200802$20160507$20200805$PER$$US-JNJFOC-20160402653$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200805$$CN$US$US
123443673$12344367$3$F$20140703$20200715$20160507$20200717$PER$$US-JNJFOC-20160402663$JOHNSON AND JOHNSON$$83$YR$$M$Y$71.67$KG$20200717$$CN$US$US
123443683$12344368$3$F$20150103$20200714$20160507$20200728$EXP$$US-JNJFOC-20160402664$JOHNSON AND JOHNSON$$70$YR$$M$Y$$$20200728$$LW$US$US
123443883$12344388$3$F$20130205$20200825$20160507$20200827$PER$$US-JNJFOC-20160402704$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200827$$CN$US$US
123443993$12344399$3$F$20141010$20200802$20160507$20200804$PER$$US-JNJFOC-20160402070$JOHNSON AND JOHNSON$$71$YR$E$M$Y$93.4$KG$20200804$$CN$US$US
123444124$12344412$4$F$2014$20200716$20160507$20200730$EXP$$US-JNJFOC-20160404608$JOHNSON AND JOHNSON$$77$YR$E$M$Y$97.88$KG$20200730$$CN$US$US
123444222$12344422$2$F$20150622$20200701$20160507$20200706$PER$$US-JNJFOC-20160404112$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200706$$CN$US$US
123444264$12344426$4$F$20150830$20200714$20160507$20200717$PER$$US-JNJFOC-20160402752$JOHNSON AND JOHNSON$$70$YR$$M$Y$80.74$KG$20200717$$LW$US$US
123444403$12344440$3$F$20141107$20200824$20160507$20200907$EXP$$US-JNJFOC-20160402702$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200907$$CN$US$US
123444614$12344461$4$F$20140514$20200628$20160507$20200702$PER$$US-JNJFOC-20160420641$JOHNSON AND JOHNSON$$62$YR$$F$Y$$$20200702$$CN$US$US
123444654$12344465$4$F$20140928$20200720$20160507$20200722$PER$$US-JNJFOC-20160426444$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20200722$$CN$US$US
123445053$12344505$3$F$201406$20200806$20160507$20200817$EXP$$US-JNJFOC-20160404401$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20200817$$CN$US$US
123445244$12344524$4$F$20140414$20200716$20160507$20200722$PER$$US-JNJFOC-20160404610$JOHNSON AND JOHNSON$$77$YR$E$M$Y$113.05$KG$20200722$$HP$US$US
123445403$12344540$3$F$201501$20200715$20160507$20200729$EXP$$US-JNJFOC-20160404637$JOHNSON AND JOHNSON$$67$YR$E$M$Y$145.28$KG$20200729$$CN$US$US
123445903$12344590$3$F$201409$20200823$20160507$20200903$EXP$$US-JNJFOC-20160404656$JOHNSON AND JOHNSON$$56$YR$A$F$Y$122.58$KG$20200903$$CN$US$US
123445953$12344595$3$F$201411$20200922$20160507$20200928$PER$$US-JNJFOC-20160403008$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200928$$CN$US$US
123446143$12344614$3$F$201411$20200726$20160507$20200730$PER$$US-JNJFOC-20160403059$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200730$$CN$US$US
123446613$12344661$3$F$201511$20200712$20160507$20200717$PER$$US-JNJFOC-20160416283$JOHNSON AND JOHNSON$$82$YR$$M$Y$85.96$KG$20200717$$HP$US$US
123446623$12344662$3$F$20160201$20200714$20160507$20200717$PER$$US-JNJFOC-20160416284$JOHNSON AND JOHNSON$$72$YR$$F$Y$114.6$KG$20200717$$CN$US$US
123446715$12344671$5$F$201510$20200909$20160507$20200914$EXP$$US-JNJFOC-20160416231$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200914$$CN$US$US
123446744$12344674$4$F$20141008$20200809$20160507$20200814$PER$$US-JNJFOC-20160416233$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20200814$$CN$US$US
123446944$12344694$4$F$20151218$20200722$20160507$20200731$PER$$US-JNJFOC-20160416247$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200731$$HP$US$US
123446974$12344697$4$F$201510$20200721$20160507$20200731$PER$$US-JNJFOC-20160416250$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200731$$CN$US$US
123447034$12344703$4$F$201509$20200913$20160507$20200918$PER$$US-JNJFOC-20160416203$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20200918$$CN$US$US
123447163$12344716$3$F$201601$20200901$20160507$20200909$PER$$US-JNJFOC-20160416194$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200909$$CN$US$US
123447234$12344723$4$F$201403$20200902$20160507$20200909$PER$$US-JNJFOC-20160328588$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200909$$CN$US$US
123447393$12344739$3$F$20140731$20200714$20160507$20200717$PER$$US-JNJFOC-20160416305$JOHNSON AND JOHNSON$$81$YR$$F$Y$$$20200717$$CN$US$US
123447483$12344748$3$F$20130401$20200804$20160507$20200811$PER$$US-JNJFOC-20160416315$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20200811$$CN$US$US
123447553$12344755$3$F$201408$20200817$20160507$20200820$PER$$US-JNJFOC-20160416302$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200820$$CN$US$US
123447804$12344780$4$F$201501$20200809$20160507$20200818$EXP$$US-JNJFOC-20160416211$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200818$$CN$US$US
123447973$12344797$3$F$20130520$20200830$20160507$20200901$PER$$US-JNJFOC-20160416299$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20200901$$CN$US$US
123448424$12344842$4$F$20150608$20200825$20160507$20200828$PER$$US-JNJFOC-20160416149$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20200828$$CN$US$US
123448434$12344843$4$F$20151022$20200813$20160507$20200817$PER$$US-JNJFOC-20160416150$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20200817$$CN$US$US
123448444$12344844$4$F$20160219$20200902$20160507$20200909$PER$$US-JNJFOC-20160416161$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200909$$CN$US$US
123448544$12344854$4$F$2012$20200709$20160507$20200715$PER$$US-JNJFOC-20160416171$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200715$$HP$US$US
123448634$12344863$4$F$20160303$20200826$20160507$20200901$EXP$$US-JNJFOC-20160416183$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20200901$$CN$US$US
123448673$12344867$3$F$20151216$20200923$20160507$20200928$PER$$US-JNJFOC-20160416187$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200928$$CN$US$US
123448883$12344888$3$F$201506$20200823$20160507$20200826$PER$$US-JNJFOC-20160416359$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200826$$CN$US$US
123449164$12344916$4$F$20140917$20200816$20160507$20200819$PER$$US-JNJFOC-20160417108$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200819$$CN$US$US
123449313$12344931$3$F$20150628$20200813$20160507$20200820$PER$$US-JNJFOC-20160414331$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20200820$$CN$US$US
123450043$12345004$3$F$20140510$20200811$20160507$20200821$EXP$$US-JNJFOC-20160420580$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200821$$CN$US$US
123450073$12345007$3$F$201204$20200804$20160507$20200806$PER$$US-JNJFOC-20160422757$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200806$$CN$US$US
123450122$12345012$2$F$20140424$20200720$20160507$20200724$PER$$US-JNJFOC-20160412822$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20200724$$CN$US$US
123450163$12345016$3$F$20140423$20200819$20160507$20200824$PER$$US-JNJFOC-20160413293$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20200824$$CN$US$US
123450464$12345046$4$F$20140327$20200804$20160507$20200814$EXP$$US-JNJFOC-20160416978$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200814$$CN$US$US
123450533$12345053$3$F$2016$20200727$20160507$20200731$PER$$US-JNJFOC-20160418322$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200731$$CN$US$US
123450573$12345057$3$F$20140529$20200721$20160507$20200731$PER$$US-JNJFOC-20160417212$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20200731$$LW$US$US
123450903$12345090$3$F$20140831$20200914$20160507$20200918$PER$$US-JNJFOC-20160423113$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20200918$$LW$US$US
123450913$12345091$3$F$20140828$20200913$20160507$20200915$PER$$US-JNJFOC-20160423114$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200915$$LW$US$US
123451113$12345111$3$F$20151112$20200920$20160507$20200923$EXP$$US-JNJFOC-20160424304$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200923$$CN$US$US
123451262$12345126$2$F$201302$20200701$20160507$20200706$PER$$US-JNJFOC-20160311040$JOHNSON AND JOHNSON$$73$YR$$M$Y$$$20200706$$CN$US$US
123451403$12345140$3$F$20150807$20200629$20160507$20200702$PER$$US-JNJFOC-20160424341$JOHNSON AND JOHNSON$$53$YR$$M$Y$$$20200702$$CN$US$US
123451433$12345143$3$F$20150515$20200803$20160507$20200812$EXP$$US-JNJFOC-20160425493$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200812$$CN$US$US
123451483$12345148$3$F$20150515$20200810$20160507$20200814$PER$$US-JNJFOC-20160425496$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200814$$CN$US$US
123451663$12345166$3$F$20141216$20200730$20160507$20200805$PER$$US-JNJFOC-20160422919$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200805$$CN$US$US
123452043$12345204$3$F$20150702$20200914$20160507$20200925$EXP$$US-JNJFOC-20160409171$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200925$$CN$US$US
123452183$12345218$3$F$20141005$20200629$20160507$20200706$PER$$US-JNJFOC-20160409164$JOHNSON AND JOHNSON$$51$YR$$F$Y$$$20200706$$CN$US$US
123452453$12345245$3$F$201508$20200824$20160507$20200907$EXP$$US-JNJFOC-20160409968$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200907$$HP$US$US
123452644$12345264$4$F$2015$20200803$20160507$20200806$PER$$US-JNJFOC-20160409969$JOHNSON AND JOHNSON$$7$DEC$E$F$Y$$$20200806$$CN$US$US
123452693$12345269$3$F$2015$20200624$20160507$20200702$PER$$US-JNJFOC-20160411181$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200702$$HP$US$US
123452743$12345274$3$F$201505$20200716$20160507$20200720$PER$$US-JNJFOC-20160411172$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200720$$CN$US$US
123456991$12345699$1$I$20151008$20151109$20160509$20160509$EXP$$US-ROCHE-1659669$ROCHE$$58$YR$$M$Y$92$KG$20160509$$MD$US$US
123469842$12346984$2$F$20150318$20200826$20160509$20200831$EXP$$US-BAYER-2016-043816$BAYER$$85$YR$E$M$Y$$$20200831$$CN$US$US
1234722910$12347229$10$F$2016$20200908$20160509$20200915$EXP$$CA-PFIZER INC-2016243994$PFIZER$$32$YR$$F$Y$$$20200915$$CN$CA$CA
123483975$12348397$5$F$2015$20200722$20160509$20200730$EXP$$US-SA-2015SA209278$SANOFI AVENTIS$$65$YR$$F$Y$68.49$KG$20200730$$HP$US$US
123485889$12348588$9$F$$20200803$20160509$20200813$PER$$US-ACTELION-A-US2016-135665$ACTELION$$$$$M$Y$117.01$KG$20200813$$MD$US$US
123488745$12348874$5$F$$20200820$20160509$20200828$EXP$$PHHY2016CO061780$NOVARTIS$$$$$F$Y$68$KG$20200828$$CN$COUNTRY NOT SPECIFIED$CO
123495972$12349597$2$F$$20200813$20160510$20200824$EXP$$US-AUROBINDO-AUR-APL-2016-00547$AUROBINDO$$25$YR$$M$Y$80$KG$20200824$$MD$US$US
123500792$12350079$2$F$20160503$20160506$20160510$20160516$EXP$$JP-ROCHE-1753713$ROCHE$$65$YR$$M$Y$$$20160516$$MD$JP$JP
123506822$12350682$2$F$20160430$20190913$20160510$20200909$EXP$$CA-JNJFOC-20160505104$JOHNSON AND JOHNSON$$16$YR$T$F$Y$38.1$KG$20200909$$HP$CA$CA
123508502$12350850$2$F$20160414$20200703$20160510$20200714$EXP$NO-NOMAADVRE-RELISSO-2016-21845$NO-NOVOPROD-490050$NOVO NORDISK$$63$YR$$F$Y$$$20200714$$MD$NO$NO
123518402$12351840$2$F$20160504$20160509$20160510$20160516$EXP$$ES-JNJFOC-20160507275$PHARMACYCLICS$$64$YR$A$F$Y$73$KG$20160516$$MD$ES$ES
123518542$12351854$2$F$201304$20200629$20160510$20200708$EXP$$US-BAYER-2016-059226$BAYER$$65$YR$E$M$Y$$$20200708$$CN$US$US
123520169$12352016$9$F$20150314$20200826$20160510$20200903$PER$$US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-28392BI$BOEHRINGER INGELHEIM$$77$YR$E$F$Y$108.86$KG$20200827$$CN$US$US
123522242$12352224$2$F$20140519$20200819$20160510$20200828$EXP$$PHHY2014CA065272$NOVARTIS$$54$YR$$M$Y$$$20200828$$CN$COUNTRY NOT SPECIFIED$CA
123522783$12352278$3$F$201508$20200724$20160510$20200729$EXP$$FR-PFIZER INC-2015298173$PFIZER$$60$YR$$M$Y$97$KG$20200729$$MD$FR$FR
123527884$12352788$4$F$20160225$20180523$20160510$20180525$EXP$$FR-JNJFOC-20160501649$JANSSEN$$73$YR$E$M$Y$72$KG$20180525$$MD$FR$FR
123531273$12353127$3$F$20110103$20200707$20160510$20200714$EXP$$US-BIOGEN-2011BI027228$BIOGEN$$62$YR$$F$Y$75.82$KG$20200714$$MD$US$US
123531759$12353175$9$F$2012$20200629$20160510$20200709$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-033370$BRISTOL MYERS SQUIBB$HLEYHEL M, GOUJON S, DELTEIL C, VASILJEVIC A, LUZZI S, STEPHAN JL, ET AL. RISK OF CANCER IN CHILDREN EXPOSED TO DIDANOSINE IN UTERO. AIDS. 2016?30(8):1245?56$11$YR$$M$Y$$$20200709$$MD$FR$FR
123542912$12354291$2$F$20160401$20160503$20160511$20200729$EXP$$NL-009507513-1605NLD004380$MERCK$$63$YR$$F$Y$$$20200729$$HP$NL$NL
123549152$12354915$2$F$$20200722$20160511$20200727$EXP$$IT-VIIV HEALTHCARE LIMITED-IT2016GSK064907$VIIV$PEZZANI MD, RESNATI C, DI CRISTO V, RIVA A, GERVASONI C. ABACAVIR?INDUCED LIVER TOXICITY. THE BRAZILIAN JOURNAL OF INFECTIOUS DISEASES. 2016?20(5):502?504$33$YR$$F$Y$$$20200727$$HP$IT$IT
1235497913$12354979$13$F$20150512$20200814$20160511$20200820$EXP$$JP-OTSUKA-2016_007936AA$OTSUKA$$55$YR$$M$Y$63.7$KG$20200820$$MD$JP$JP
123549953$12354995$3$F$20160504$20200828$20160511$20200902$EXP$$IN-ROCHE-1753970$ROCHE$$45$YR$$M$Y$77.8$KG$20200902$$MD$IN$IN
1235507233$12355072$33$F$20150729$20200914$20160511$20200921$EXP$$CA-PFIZER INC-2015306460$PFIZER$$41$YR$$F$Y$90$KG$20200921$$CN$CA$CA
1235512022$12355120$22$F$20180413$20200806$20160511$20200810$EXP$$US-PFIZER INC-2016079225$PFIZER$$57$YR$$F$Y$88$KG$20200810$$PH$US$US
123559517$12355951$7$F$2016$20200909$20160511$20200914$EXP$$US-JAZZ-2016-US-008429$JAZZ$$$$$M$Y$$$20200914$$CN$US$US
123561121$12356112$1$I$20160427$20160503$20160511$20160511$EXP$$DE-JNJFOC-20160505486$JANSSEN$$64$YR$A$F$Y$$$20160511$$MD$DE$DE
123563742$12356374$2$F$20140624$20200916$20160511$20200929$EXP$$US-JNJFOC-20160315932$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20200929$$CN$US$US
123565463$12356546$3$F$$20200819$20160511$20200827$EXP$$PHHY2016PA045474$NOVARTIS$$78$YR$$F$Y$$$20200827$$MD$PA$PA
123566887$12356688$7$F$$20200728$20160511$20200804$PER$$US-SA-2015SA128971$SANOFI AVENTIS$$$$$$Y$$$20200804$$CN$US$US
1235711610$12357116$10$F$2014$20200728$20160511$20200806$EXP$FR-ANSM-BR20160249$FR-LUNDBECK-DKLU2013615$LUNDBECK$$1$DY$$M$Y$3$KG$20200806$$HP$FR$FR
123589373$12358937$3$F$201404$20200831$20160512$20200903$EXP$$US-BAYER-2016-047159$BAYER$$72$YR$E$M$Y$$$20200903$$CN$US$US
123593622$12359362$2$F$$20160512$20160512$20160519$EXP$$KR-JNJFOC-20160504894$JANSSEN$$74$YR$E$M$Y$44.4$KG$20160519$$MD$KR$KR
123595879$12359587$9$F$20150611$20200824$20160512$20200904$EXP$$JP-INCYTE CORPORATION-2016IN002621$INCYTE$$$$$$Y$$$20200904$$MD$JP$JP
123602041$12360204$1$I$20160506$20160506$20160512$20160512$EXP$$RU-JNJFOC-20160507957$JANSSEN$$54$YR$A$F$Y$$$20160512$$MD$RU$RU
123604313$12360431$3$F$201411$20200721$20160512$20200804$EXP$$US-BAYER-2016-058141$BAYER$$77$YR$E$M$Y$70.29$KG$20200804$$CN$US$US
123604582$12360458$2$F$20160504$20160630$20160512$20160711$EXP$$US-JNJFOC-20160505384$JANSSEN$$37$YR$A$F$Y$48$KG$20160711$$MD$US$US
123622195$12362219$5$F$201407$20200624$20160512$20200707$EXP$$US-JNJFOC-20160508199$JOHNSON AND JOHNSON$$88$YR$$F$Y$$$20200707$$CN$US$US
1236422110$12364221$10$F$20160414$20200814$20160513$20200826$EXP$$US-JNJFOC-20160506459$JOHNSON AND JOHNSON$$83$YR$E$M$Y$83.2$KG$20200826$$MD$US$US
123642321$12364232$1$I$20151029$20160506$20160512$20160512$EXP$$BE-SA-2016SA090843$AVENTIS$$19$YR$A$M$Y$$$20160512$$MD$BE$BE
1236564435$12365644$35$F$20131127$20200824$20160513$20200831$EXP$$CA-ROCHE-1756124$ROCHE$$67$YR$$F$Y$$$20200831$$MD$CA$CA
123675721$12367572$1$I$20150730$20151021$20160513$20160513$EXP$$US-JNJFOC-20151016982$JANSSEN$$52$YR$A$F$Y$49$KG$20160513$$MD$US$US
123678707$12367870$7$F$$20200909$20160513$20200915$PER$$US-AMGEN-USASP2016058574$AMGEN$$60$YR$A$F$Y$62.6$KG$20200915$$MD$US$US
123680933$12368093$3$F$20160429$20160622$20160513$20160630$EXP$$US-JNJFOC-20160512332$PHARMACYCLICS$$65$YR$A$F$Y$$$20160630$$MD$US$US
1237099724$12370997$24$F$2016$20200720$20160516$20200723$PER$$CA-AMGEN-CANSP2016061225$AMGEN$$65$YR$E$F$Y$$$20200723$$HP$CA$CA
1237277230$12372772$30$F$2016$20200916$20160516$20200924$EXP$$PHHY2016CA007008$NOVARTIS$$77$YR$$M$Y$$$20200924$$MD$CA$CA
123733407$12373340$7$F$20160506$20180615$20160516$20180622$EXP$$FR-JNJFOC-20160508653$JANSSEN$$45$YR$A$M$Y$86$KG$20180622$$MD$FR$FR
123733425$12373342$5$F$20160506$20170217$20160516$20170223$EXP$$DE-JNJFOC-20160509856$JANSSEN$$71$YR$E$F$Y$70$KG$20170223$$MD$DE$DE
123733447$12373344$7$F$20160426$20181114$20160516$20181116$EXP$$AR-JNJFOC-20160510342$JANSSEN$$73$YR$E$F$Y$67$KG$20181116$$MD$AR$AR
123733456$12373345$6$F$20160430$20160707$20160516$20160715$EXP$$FR-JNJFOC-20160505330$JANSSEN$$83$YR$E$M$Y$99.1$KG$20160715$$MD$FR$FR
123733972$12373397$2$F$20160506$20160517$20160516$20160531$EXP$$US-JNJFOC-20160511405$PHARMACYCLICS$$67$YR$E$M$Y$83.01$KG$20160531$$MD$US$US
1237353422$12373534$22$F$20141202$20180911$20160516$20200816$EXP$$PHHY2014CA159553$NOVARTIS$$75$YR$$F$Y$$$20200816$$CN$CA$CA
123746742$12374674$2$F$$20200518$20160517$20200820$PER$$US-JAZZ-2015-US-014079$JAZZ$$$$$M$Y$$$20200820$$$US$US
123752052$12375205$2$F$2015$20200513$20160517$20200820$PER$$US-JAZZ-2015-US-014176$JAZZ$$$$$M$Y$88.43$KG$20200820$$$US$US
123752742$12375274$2$F$$20200622$20160517$20200820$PER$$US-JAZZ-2015-US-014329$JAZZ$$$$$F$Y$$$20200820$$MD$US$US
123753282$12375328$2$F$201311$20200916$20160517$20200918$EXP$$BR-PFIZER INC-2016253374$PFIZER$$82$YR$$M$Y$75$KG$20200918$$CN$BR$BR
123753361$12375336$1$I$$20160111$20160517$20160517$EXP$$KR-ROCHE-1695421$ROCHE$KOH J, MYONG J, JUNG S, LEE J, KWOK S, PARK S AND JU J. ATYPICAL FEMORAL FRACTURE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BISPHOSPHONATES: A NESTED CASE?CONTROL STUDY.. ARTHRITIS AND RHEUMATOLOGY 2016 JAN 01?68 (1):77?82.$68$YR$$F$Y$$$20160517$$HP$KR$KR
1237575919$12375759$19$F$20030205$20200914$20160517$20200923$EXP$$CA-PFIZER INC-HQWYE674925FEB03$PFIZER$$49$YR$$F$Y$73$KG$20200923$$HP$CA$CA
123757962$12375796$2$F$201509$20200727$20160517$20200921$PER$$US-JAZZ-2015-US-014023$JAZZ$$58$YR$$F$Y$$$20200921$$HP$US$US
123768182$12376818$2$F$$20160506$20160517$20200701$EXP$$GR-JNJFOC-20160507180$JOHNSON AND JOHNSON$$$$E$M$Y$$$20200701$$CN$GR$GR
123768203$12376820$3$F$20160425$20170316$20160517$20170322$EXP$$US-JNJFOC-20160507254$JANSSEN$$55$YR$A$M$Y$97.1$KG$20170322$$MD$US$US
123768212$12376821$2$F$20160327$20160623$20160517$20160725$EXP$$US-JNJFOC-20160509610$JANSSEN$$36$YR$A$F$Y$$$20160725$$MD$US$US
123772072$12377207$2$F$20160428$20160524$20160517$20160606$EXP$$PHHO2016US006830$NOVARTIS$$48$YR$$M$Y$84.4$KG$20160606$$MD$US$US
123773983$12377398$3$F$201906$20200729$20160517$20200730$EXP$$BR-PFIZER INC-2016218461$PFIZER$$80$YR$$F$Y$63$KG$20200730$$CN$BR$BR
1237739939$12377399$39$F$2016$20200720$20160517$20200727$EXP$$CA-PFIZER INC-2016252940$PFIZER$$71$YR$$F$Y$$$20200727$$HP$CA$CA
123777236$12377723$6$F$$20200916$20160517$20200918$EXP$$US-PFIZER INC-2016260571$PFIZER$$58$YR$$F$Y$64$KG$20200918$$HP$US$US
123786319$12378631$9$F$20160504$20200902$20160517$20200904$EXP$$CA-TAKEDA-2016TUS007915$TAKEDA$$55$YR$$F$Y$$$20200904$$HP$CA$CA
123792624$12379262$4$F$20160413$20160803$20160517$20160811$EXP$$FR-JNJFOC-20160512711$JANSSEN$$73$YR$E$F$Y$79$KG$20160811$$MD$FR$FR
123792631$12379263$1$I$20130731$20131123$20160517$20160517$EXP$$DE-JNJFOC-20131115484$JANSSEN$$69$YR$E$F$Y$66$KG$20160517$$MD$DE$DE
123797603$12379760$3$F$20140924$20160817$20160518$20160823$EXP$$JP-ROCHE-1658025$ROCHE$$61$YR$$F$Y$53$KG$20160823$$MD$JP$JP
123807883$12380788$3$F$20140423$20200819$20160518$20200825$EXP$$US-BAYER-2016-077432$BAYER$$60$YR$A$F$Y$$$20200825$$CN$US$US
123808889$12380888$9$F$2013$20200626$20160518$20200715$EXP$$PHHY2016BR068169$NOVARTIS$$56$YR$$F$Y$88$KG$20200715$$MD$BR$BR
1238124529$12381245$29$F$2016$20200720$20160518$20200724$PER$$CA-AMGEN-CANSP2016061262$AMGEN$$71$YR$E$F$Y$$$20200724$$CN$CA$CA
123812554$12381255$4$F$20160420$20200723$20160518$20200729$EXP$$GB-SA-2016SA090933$SANOFI AVENTIS$$46$YR$$F$Y$64.5$KG$20200729$$MD$GB$GB
123813157$12381315$7$F$2016$20200731$20160518$20200805$EXP$$US-SA-2016SA054060$SANOFI AVENTIS$$$$$$Y$$$20200805$$CN$US$US
123815844$12381584$4$F$20160531$20200706$20160518$20200708$EXP$$US-TAKEDA-2016MPI004176$TAKEDA$$72$YR$$M$Y$87.08$KG$20200708$$CN$US$US
123820421$12382042$1$I$20160420$20160421$20160518$20160518$EXP$$US-JNJFOC-20160421795$JANSSEN$$67$YR$E$F$Y$78.1$KG$20160518$$MD$US$US
1238227611$12382276$11$F$20160326$20170426$20160518$20170502$EXP$$GB-JNJFOC-20160515313$PHARMACYCLICS$$84$YR$E$M$Y$$$20170502$$MD$GB$GB
123829714$12382971$4$F$$20200629$20160518$20200706$PER$$US-JAZZ-2016-US-008772$JAZZ$$$$$F$Y$$$20200706$$CN$US$US
1238365625$12383656$25$F$20130410$20200903$20160519$20200904$EXP$$DE-ROCHE-1611753$ROCHE$$67$YR$$F$Y$82$KG$20200904$$MD$DE$DE
123846482$12384648$2$F$$20200713$20160519$20200714$PER$$US-PFIZER INC-2016242377$PFIZER$$79$YR$$F$Y$$$20200714$$MD$US$US
123854452$12385445$2$F$20160310$20160511$20160519$20160524$EXP$$PHHY2016ES064678$NOVARTIS$$55$YR$$F$Y$$$20160524$$CN$ES$ES
1238547410$12385474$10$F$2016$20191121$20160519$20191127$EXP$$PHHY2016AR068913$NOVARTIS$$69$YR$$F$Y$$$$$HP$AR$AR
123861132$12386113$2$F$20150310$20160524$20160519$20160531$EXP$$US-JNJFOC-20150408102$JANSSEN$$7$YR$C$M$Y$20.9$KG$20160531$$MD$US$US
1238652513$12386525$13$F$2015$20200727$20160519$20200803$EXP$$US-JAZZ-2016-US-008868$JAZZ$$65$YR$$F$Y$122.5$KG$20200803$$MD$US$US
123866293$12386629$3$F$201407$20200831$20160519$20200908$EXP$$US-BIOGEN-2016BI00239647$BIOGEN$$50$YR$$F$Y$$$20200908$$CN$US$US
123868292$12386829$2$F$20160505$20160603$20160519$20160614$EXP$$GB-JNJFOC-20160513037$JANSSEN$$65$YR$A$F$Y$61.5$KG$20160614$$MD$GB$GB
123868306$12386830$6$F$20160505$20161118$20160519$20161123$EXP$$IT-JNJFOC-20160510230$JANSSEN$$76$YR$E$F$Y$72$KG$20161123$$MD$IT$IT
123875132$12387513$2$F$$20200924$20160520$20200930$EXP$$ES-AUROBINDO-AUR-APL-2016-06170$AUROBINDO$$18$YR$$F$Y$$$20201001$$HP$ES$ES
1238804842$12388048$42$F$20160412$20200914$20160520$20200923$EXP$$CA-ROCHE-1759231$ROCHE$$70$YR$$F$Y$93$KG$20200923$$MD$CA$CA
123890681$12389068$1$I$20130910$20130923$20160520$20160520$EXP$$DE-JNJFOC-20130913806$JANSSEN$$75$YR$E$F$Y$65$KG$20160520$$MD$DE$DE
123901482$12390148$2$F$20160510$20160518$20160520$20160531$EXP$$JP-JNJFOC-20160512455$JANSSEN$$69$YR$E$F$Y$62$KG$20160531$$MD$JP$JP
123907486$12390748$6$F$201603$20200727$20160520$20200803$EXP$$US-JNJFOC-20160513846$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200803$$CN$US$US
123914155$12391415$5$F$2015$20200721$20160520$20200727$EXP$$US-JAZZ-2016-US-009136$JAZZ$$$$$F$Y$$$20200727$$HP$US$US
123915793$12391579$3$F$$20200818$20160521$20200829$EXP$$ES-AUROBINDO-AUR-APL-2016-06039$AUROBINDO$$61$YR$$F$Y$$$20200829$$HP$ES$ES
123924053$12392405$3$F$2003$20200911$20160523$20200916$EXP$$US-JAZZ-2015-US-014607$JAZZ$$$$$F$Y$77.55$KG$20200916$$HP$US$US
123925124$12392512$4$F$20160105$20200806$20160523$20200812$EXP$$PHHO2016FR007076$NOVARTIS$$52$YR$$F$Y$40$KG$20200812$$MD$FR$FR
1239251425$12392514$25$F$2010$20200826$20160523$20200905$EXP$$PHHY2014BR162994$NOVARTIS$$60$YR$$F$Y$78$KG$20200905$$MD$BR$BR
123925279$12392527$9$F$201512$20200717$20160523$20200725$EXP$$PHHY2015CA147328$NOVARTIS$$62$YR$$F$Y$$$20200725$$HP$CA$CA
123927734$12392773$4$F$20160302$20160815$20160523$20160822$EXP$$CA-ROCHE-1721958$ROCHE$$84$YR$$F$Y$50.6$KG$20160822$$MD$CA$CA
123928842$12392884$2$F$20150924$20200721$20160523$20200921$PER$$US-JAZZ-2015-US-014770$JAZZ$$37$YR$$F$Y$83.9$KG$20200921$$HP$US$US
123938753$12393875$3$F$$20200713$20160523$20200714$PER$$US-PFIZER INC-2016265074$PFIZER$$52$YR$$F$Y$$$20200714$$HP$US$US
123939827$12393982$7$F$20160321$20200826$20160523$20200909$EXP$$SK-JNJFOC-20160517551$JOHNSON AND JOHNSON$$64$YR$A$F$Y$85$KG$20200909$$HP$SK$SK
123952232$12395223$2$F$$20200901$20160523$20200909$EXP$$GB-MYLANLABS-2016M1020993$MYLAN$SHEIKH M, NELSON?PIERCY C, DULEY J, FLORIN T, ANSARI A.. SUCCESSFUL PREGNANCIES WITH THIOPURINE?ALLOPURINOL CO?THERAPY FOR INFLAMMATORY BOWEL DISEASE. J?CROHN^S?COLITIS. INTERNET?DOC. 2015?9(8):680?4$31$YR$$F$Y$$$20200909$$HP$GB$GB
123952389$12395238$9$F$$20200717$20160523$20200720$EXP$$US-PFIZER INC-2016270964$PFIZER$$68$YR$$F$Y$55$KG$20200720$$MD$US$US
123958253$12395825$3$F$201604$20200831$20160523$20200903$EXP$$CA-TAKEDA-2016TUS008145$TAKEDA$$37$YR$$F$Y$$$20200903$$CN$CA$CA
123981523$12398152$3$F$20151018$20160613$20160524$20161109$EXP$$US-JNJFOC-20151018671$JANSSEN$$82$YR$E$M$Y$$$20161109$$MD$US$US
123985394$12398539$4$F$20131217$20200824$20160524$20200907$EXP$$US-JNJFOC-20160520207$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200907$$CN$US$US
123993112$12399311$2$F$201605$20160523$20160524$20160526$EXP$$SE-JNJFOC-20160517980$JANSSEN$$57$YR$A$M$Y$$$20160526$$MD$SE$SE
123993122$12399312$2$F$20160502$20160607$20160524$20160610$EXP$$GB-JNJFOC-20160504279$JANSSEN$$72$YR$E$M$Y$53.8$KG$20160610$$MD$GB$GB
123997343$12399734$3$F$$20200723$20160524$20200728$EXP$$PHHY2016NI071479$NOVARTIS$$$$$M$Y$$$20200728$$CN$COUNTRY NOT SPECIFIED$NI
1239975815$12399758$15$F$20160421$20200618$20160524$20200701$EXP$$US-ACTELION-A-US2016-135978$ACTELION$$61$YR$$F$Y$68.03$KG$20200701$$HP$US$US
1239977510$12399775$10$F$20150731$20200825$20160524$20200902$EXP$$US-SA-2015SA116439$SANOFI AVENTIS$$66$YR$$M$Y$$$20200902$$CN$US$US
1240010113$12400101$13$F$20160517$20200617$20160524$20200701$EXP$$US-ACTELION-A-US2016-136692$ACTELION$$67$YR$$F$Y$$$20200701$$HP$US$US
124010443$12401044$3$F$201507$20200914$20160525$20200921$PER$$US-SA-2015SA143382$SANOFI AVENTIS$$$$$$Y$$$20200921$$CN$US$US
1240127516$12401275$16$F$20160519$20170629$20160525$20170707$EXP$$JP-JNJFOC-20160520537$JANSSEN$$80$YR$E$M$Y$45$KG$20170707$$MD$JP$JP
124015232$12401523$2$F$201408$20200817$20160525$20200824$EXP$$US-BAYER-2016-073962$BAYER$$79$YR$E$M$Y$$$20200824$$CN$US$US
124016562$12401656$2$F$20131018$20200625$20160525$20200701$EXP$$US-BAYER-2016-073971$BAYER$$78$YR$E$M$Y$$$20200701$$CN$US$US
124023103$12402310$3$F$$20200901$20160525$20200908$PER$$US-SA-2016SA026084$SANOFI AVENTIS$$$$$$Y$$$20200908$$CN$US$US
124024803$12402480$3$F$2015$20200706$20160525$20200707$EXP$$US-PFIZER INC-2016265634$PFIZER$$60$YR$$M$Y$$$20200707$$CN$US$US
1240254212$12402542$12$F$2016$20200630$20160525$20200702$EXP$$US-PFIZER INC-2016268202$PFIZER$$56$YR$$F$Y$73$KG$20200702$$MD$US$US
124025945$12402594$5$F$201603$20200918$20160525$20200925$PER$$US-SA-2016SA060262$SANOFI AVENTIS$$$$$$Y$$$20200925$$CN$US$US
124026215$12402621$5$F$$20200716$20160525$20200717$EXP$$FR-ABBVIE-16P-056-1635251-00$ABBVIE$$$$$M$Y$$$20200717$$CN$FR$US
124029844$12402984$4$F$$20200701$20160525$20200713$EXP$$FR-ABBVIE-16P-056-1635347-00$ABBVIE$$$$I$M$Y$$$20200713$$CN$FR$FR
124030572$12403057$2$F$$20200402$20160525$20200501$PER$$PHHY2014US159241$NOVARTIS$$$$$F$Y$$$20200501$$CN$COUNTRY NOT SPECIFIED$US
124038202$12403820$2$F$201509$20200507$20160525$20200820$PER$$US-JAZZ-2015-US-015238$JAZZ$$33$YR$$F$Y$79.37$KG$20200820$$$US$US
124038295$12403829$5$F$201411$20200712$20160525$20200724$EXP$$US-BAYER-2016-050635$BAYER$$63$YR$A$M$Y$$$20200724$$CN$US$US
124042633$12404263$3$F$199903$20200701$20160525$20200713$EXP$$FR-ABBVIE-16P-056-1635271-00$ABBVIE$$$$I$M$Y$$$20200713$$CN$FR$FR
124042794$12404279$4$F$20140214$20200730$20160525$20200803$PER$$US-JNJFOC-20160522192$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200803$$CN$US$US
124049055$12404905$5$F$$20200814$20160525$20200820$PER$$US-PFIZER INC-2016270055$PFIZER$$70$YR$$F$Y$131.54$KG$20200820$$CN$US$US
1240557214$12405572$14$F$$20200720$20160526$20200727$PER$$CA-AMGEN-CANSP2016063959$AMGEN$$75$YR$E$F$Y$56$KG$20200726$$CN$CA$CA
124059162$12405916$2$F$20160508$20200717$20160526$20200722$EXP$$IT-ROCHE-1763335$ROCHE$$60$YR$$M$Y$68$KG$20200722$$MD$IT$IT
124061321$12406132$1$I$$20160523$20160526$20160526$EXP$$NL-ROCHE-1763808$ROCHE$COLOMA P, DE RIDDER M, BEZEMER I, HERINGS R, GINI R, PECCHIOLI S, SCOTTI L, RIJNBEEK P, MOSSEVELD M, VAN DER LEI J, TRIFIRO G AND STURKENBOOM M. RISK OF CARDIAC VALVULOPATHY WITH USE OF BISPHOSPHONATES: A POPULATION?BASED, MULTICOUNTRY CASE?CONTROL STUDY . OSTEOPOROSIS INTERNATIONAL 2016 MAY 01?27.5:1857?1867.$$$$$Y$$$20160526$$HP$NL$NL
124064208$12406420$8$F$$20200909$20160526$20200911$PER$$US-PFIZER INC-2016275359$PFIZER$$59$YR$$F$Y$$$20200911$$HP$US$US
124065612$12406561$2$F$20160429$20160623$20160526$20160629$EXP$$FR-JNJFOC-20160520771$PHARMACYCLICS$$74$YR$E$M$Y$83$KG$20160629$$MD$FR$FR
124065854$12406585$4$F$20160518$20160812$20160526$20160820$EXP$$US-ROCHE-1761232$ROCHE$$65$YR$$F$Y$92.9$KG$20160820$$MD$US$US
124069493$12406949$3$F$201505$20200519$20160526$20200820$PER$$US-JAZZ-2015-US-015667$JAZZ$$25$YR$$F$Y$$$20200820$$HP$US$US
124069753$12406975$3$F$2013$20200814$20160526$20200821$EXP$$US-JAZZ-2015-US-015537$JAZZ$$$$$F$Y$$$20200821$$HP$US$US
124069884$12406988$4$F$20140421$20200906$20160526$20200914$PER$$US-JNJFOC-20160523801$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200914$$CN$US$US
124071849$12407184$9$F$201604$20200717$20160526$20200727$EXP$$US-SA-2016SA096409$SANOFI AVENTIS$$$$$$Y$$$20200727$$CN$US$US
124073273$12407327$3$F$$20190730$20160526$20200701$EXP$$GR-JNJFOC-20160519046$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
1240791421$12407914$21$F$2019$20200828$20160526$20200902$EXP$$PHHY2016CA070945$NOVARTIS$$44$YR$$F$Y$$$20200902$$CN$COUNTRY NOT SPECIFIED$CA
124080763$12408076$3$F$20160323$20170420$20160526$20170427$EXP$$US-JNJFOC-20160516650$JANSSEN$$64$YR$A$M$Y$83.92$KG$20170427$$MD$US$US
124081303$12408130$3$F$$20200820$20160526$20200825$EXP$$JP-PFIZER INC-2016273382$PFIZER$KAGEYAMA, H.. SPECIAL ISSUE: THYROID AND SKIN CASE (17) PART 3. DRUG?INDUCED THYROID DYSFUNCTION, THYROID?ASSOCIATED OPHTHALMOPATHY (SWELLING OF EYELID) DUE TO AMIODARONE HYDROCHLORIDE. VISUAL DERMATOLOGY. 2020?19:828?830$62$YR$$F$Y$$$20200825$$MD$JP$JP
124082992$12408299$2$F$20090612$20200928$20160526$20200929$PER$$US-PFIZER INC-2016274691$PFIZER$$61$YR$$F$Y$$$20200929$$MD$US$US
124087383$12408738$3$F$20141006$20161110$20160526$20161117$EXP$$JP-ROCHE-1764073$ROCHE$$73$YR$$F$Y$46$KG$20161117$$MD$JP$JP
124095992$12409599$2$F$$20200729$20160526$20200921$PER$$US-JAZZ-2015-US-015725$JAZZ$$$$$M$Y$$$20200921$$HP$US$US
124113174$12411317$4$F$20160523$20160718$20160527$20160727$EXP$$DE-ROCHE-1764116$ROCHE$$65$YR$$F$Y$60.5$KG$20160727$$MD$DE$DE
124114883$12411488$3$F$$20200729$20160527$20200806$PER$$US-BIOGEN-2016BI00236948$BIOGEN$$$$$F$Y$$$20200806$$CN$US$US
124115052$12411505$2$F$201601$20200806$20160527$20200811$PER$$US-BIOGEN-2016BI00236725$BIOGEN$$34$YR$$M$Y$$$20200811$$CN$US$US
124117712$12411771$2$F$20160501$20160524$20160527$20160601$EXP$$US-JNJFOC-20160520233$JANSSEN$$68$YR$E$M$Y$104.3$KG$20160601$$MD$US$US
124117821$12411782$1$I$20151216$20160518$20160527$20160527$EXP$$US-JNJFOC-20160519419$JANSSEN$$70$YR$E$M$Y$69$KG$20160527$$MD$US$US
124117852$12411785$2$F$20160513$20160525$20160527$20160603$EXP$$FR-JNJFOC-20160518688$JANSSEN$$60$YR$A$M$Y$83$KG$20160603$$MD$FR$FR
124122314$12412231$4$F$20130926$20200924$20160527$20200928$PER$$US-JNJFOC-20160523492$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200928$$LW$US$US
124123085$12412308$5$F$201501$20200729$20160527$20200731$PER$$US-JNJFOC-20160524376$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20200731$$CN$US$US
124123095$12412309$5$F$20150619$20200908$20160527$20200914$PER$$US-JNJFOC-20160525724$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200914$$CN$US$US
124123504$12412350$4$F$201401$20200824$20160527$20200831$EXP$$US-JNJFOC-20160522895$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200831$$CN$US$US
1241237110$12412371$10$F$20150827$20200901$20160527$20200915$EXP$$JP-INCYTE CORPORATION-2016IN003138$INCYTE$$$$$$Y$$$20200915$$MD$JP$JP
124124038$12412403$8$F$$20200803$20160527$20200805$EXP$$CA-PFIZER INC-2015227262$PFIZER$$68$YR$$F$Y$$$20200805$$HP$CA$CA
124128723$12412872$3$F$$20200825$20160527$20200827$PER$$US-PFIZER INC-2016275201$PFIZER$$51$YR$$F$Y$$$20200827$$HP$US$US
124129053$12412905$3$F$201411$20200731$20160527$20200805$EXP$$US-JAZZ-2016-US-009519$JAZZ$$53$YR$$F$Y$$$20200805$$CN$US$US
124133892$12413389$2$F$$20200707$20160527$20200715$EXP$$DK-MYLANLABS-2016M1020847$MYLAN$$25$YR$$M$Y$$$20200715$$HP$DK$DK
124135438$12413543$8$F$20160420$20171115$20160527$20171117$EXP$$FR-JNJFOC-20160521693$JANSSEN$$75$YR$E$M$Y$89$KG$20171117$$MD$FR$FR
124135442$12413544$2$F$20160202$20160617$20160527$20160624$EXP$$GB-JNJFOC-20160205169$JANSSEN$$77$YR$E$M$Y$81$KG$20160624$$MD$GB$GB
124135461$12413546$1$I$20141018$20141020$20160527$20160527$EXP$$ES-JNJFOC-20141014210$JANSSEN$$83$YR$E$F$Y$66$KG$20160527$$MD$ES$ES
124138366$12413836$6$F$$20200511$20160527$20200827$PER$$PHEH2016US013254$NOVARTIS$$$$$F$Y$$$20200827$$HP$US$US
124138862$12413886$2$F$$20200520$20160527$20200921$PER$$US-JAZZ-2015-US-016261$JAZZ$$$$$F$Y$$$20200921$$MD$US$US
124139887$12413988$7$F$2016$20200722$20160527$20200728$EXP$$US-JAZZ-2016-US-009575$JAZZ$$41$YR$$F$Y$$$20200728$$CN$US$US
124153803$12415380$3$F$2018$20200812$20160530$20200817$PER$$US-PFIZER INC-2016279945$PFIZER$$51$YR$$F$Y$71.21$KG$20200817$$HP$US$US
124159339$12415933$9$F$20160422$20200722$20160530$20200724$EXP$$CA-PFIZER INC-2016249400$PFIZER$$82$YR$$F$Y$$$20200724$$HP$CA$CA
124162932$12416293$2$F$20160220$20170424$20160530$20170427$EXP$$GB-ROCHE-1716530$ROCHE$$68$YR$$M$Y$79.9$KG$20170427$$MD$GB$GB
124168383$12416838$3$F$$20200805$20160530$20200807$EXP$$US-PFIZER INC-2016280298$PFIZER$$76$YR$$F$Y$$$20200807$$HP$US$US
124169752$12416975$2$F$$20130723$20160530$20200701$EXP$$GR-JNJFOC-20130716245$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$CN$GR$GR
1241762212$12417622$12$F$20150824$20200805$20160530$20200809$EXP$$PHHY2016US071264$NOVARTIS$$58$YR$$F$Y$104.5$KG$20200809$$HP$US$US
124176378$12417637$8$F$2014$20190207$20160530$20190215$EXP$$PHHY2016BR074009$NOVARTIS$$71$YR$$F$Y$80$KG$20190216$$MD$BR$BR
124180974$12418097$4$F$20160504$20200827$20160531$20200904$PER$$US-BIOGEN-2016BI00236390$BIOGEN$$55$YR$$F$Y$$$20200904$$CN$US$US
124191722$12419172$2$F$$20200723$20160531$20200921$PER$$US-JAZZ-2015-US-016421$JAZZ$$$$$M$Y$$$20200921$$HP$US$US
1241951420$12419514$20$F$$20200720$20160531$20200729$EXP$$CA-PFIZER INC-2016264085$PFIZER$$75$YR$$F$Y$56$KG$20200729$$MD$CA$CA
124202413$12420241$3$F$$20200713$20160531$20200921$PER$$US-JAZZ-2015-US-016641$JAZZ$$$$$F$Y$86.62$KG$20200921$$MD$US$US
1242024812$12420248$12$F$20160519$20180413$20160531$20180424$EXP$$BE-JNJFOC-20160521146$JANSSEN$$82$YR$E$M$Y$94.7$KG$20180424$$MD$BE$BE
124202514$12420251$4$F$20160108$20160606$20160531$20160614$EXP$$ZA-JNJFOC-20160521017$JANSSEN$$50$YR$A$F$Y$51$KG$20160614$$MD$ZA$ZA
124202982$12420298$2$F$2014$20150428$20160531$20200701$EXP$$GR-JNJFOC-20150304354$JOHNSON AND JOHNSON$$$$E$F$Y$$$20200701$$CN$GR$GR
124203253$12420325$3$F$$20200911$20160531$20200918$EXP$$PT-PFIZER INC-2016275699$PFIZER$OLIVEIRA, J.. STUNNED MYOCARDIUM AFTER AN ANESTHETIC PROCEDURE IN A PEDIATRIC PATIENT?CASE REPORT. REVISTA PORTUGUESA DE CARDIOLOGIA. 2016?35(6):E1?375.E5$14$YR$$F$Y$$$20200918$$MD$PT$PT
124203759$12420375$9$F$20160521$20160919$20160531$20160922$EXP$$FR-JNJFOC-20160524518$JANSSEN$$72$YR$E$M$Y$80$KG$20160922$$HP$FR$FR
124207094$12420709$4$F$201410$20200719$20160531$20200722$PER$$US-JNJFOC-20160526276$JOHNSON AND JOHNSON$$73$YR$E$M$Y$73.09$KG$20200722$$CN$US$US
124207104$12420710$4$F$20140407$20200729$20160531$20200805$EXP$$US-JNJFOC-20160526198$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20200805$$CN$US$US
124214073$12421407$3$F$20151126$20160909$20160531$20160914$EXP$$NL-JNJFOC-20160527236$JANSSEN$$66$YR$E$M$Y$$$20160914$$MD$NL$NL
1242177512$12421775$12$F$$20200909$20160531$20200910$EXP$$US-PFIZER INC-2016280414$PFIZER$$67$YR$$F$Y$57$KG$20200910$$CN$US$US
124225979$12422597$9$F$$20200715$20160601$20200720$EXP$$CA-ROCHE-1766629$ROCHE$$71$YR$$F$Y$$$20200720$$HP$CA$CA
124230755$12423075$5$F$20160525$20200630$20160601$20200701$EXP$$US-PFIZER INC-2016278754$PFIZER$$76$YR$$F$Y$52$KG$20200701$$CN$US$US
124231552$12423155$2$F$201503$20200720$20160601$20200727$EXP$$US-BAYER-2016-053740$BAYER$$55$YR$A$F$Y$$$20200727$$CN$US$US
124232463$12423246$3$F$20160327$20200717$20160601$20200724$PER$$PL-AMGEN-POLCT2016068578$AMGEN$$66$YR$E$F$Y$84$KG$20200724$$HP$PL$PL
124246554$12424655$4$F$20130820$20200727$20160601$20200730$EXP$$GB-SA-2016SA090853$SANOFI AVENTIS$$$$$$Y$$$20200730$$MD$GB$GB
124248706$12424870$6$F$20160525$20171009$20160601$20171016$EXP$$US-ROCHE-1765262$ROCHE$$87$YR$$M$Y$75$KG$20171016$$MD$US$US
124259182$12425918$2$F$20130401$20200804$20160601$20200814$EXP$$US-BAYER-2016-074104$BAYER$$57$YR$A$F$Y$$$20200814$$HP$US$US
124263013$12426301$3$F$2015$20200803$20160601$20200812$EXP$$US-JNJFOC-20160522128$JOHNSON AND JOHNSON$$62$YR$A$M$Y$71.1$KG$20200812$$CN$US$US
124264185$12426418$5$F$20140904$20200806$20160601$20200811$PER$$US-JNJFOC-20160527840$JOHNSON AND JOHNSON$$67$YR$E$F$Y$76$KG$20200811$$CN$US$US
124264314$12426431$4$F$20140930$20200805$20160601$20200817$EXP$$US-JNJFOC-20160528576$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20200817$$CN$US$US
124264653$12426465$3$F$20141205$20200630$20160601$20200706$PER$$US-JNJFOC-20160527735$JOHNSON AND JOHNSON$$75$YR$$M$Y$$$20200706$$CN$US$US
124268492$12426849$2$F$$20200722$20160601$20200727$EXP$$US-JAZZ-2016-US-009749$JAZZ$$$$$F$Y$$$20200727$$HP$US$US
124271887$12427188$7$F$20160223$20161122$20160601$20200722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-033310$BRISTOL MYERS SQUIBB$$80$YR$$$Y$52$KG$20200722$$PH$JP$JP
124281124$12428112$4$F$20141118$20200811$20160602$20200817$EXP$$PHHY2016US075620$NOVARTIS$$43$YR$$F$Y$81.63$KG$20200817$$MD$US$US
124282736$12428273$6$F$20160326$20200826$20160602$20200902$EXP$$FR-CELGENEUS-FRA-2016048136$CELGENE$$85$YR$$M$Y$45$KG$20200902$$HP$FR$FR
124287795$12428779$5$F$2016$20200602$20160602$20200708$PER$$US-INCYTE CORPORATION-2016IN003085$INCYTE$$$$$$Y$$$20200708$$CN$US$US
1242880028$12428800$28$F$20160623$20200717$20160602$20200722$EXP$$PHHY2016CA074938$NOVARTIS$$48$YR$$M$Y$$$20200722$$CN$COUNTRY NOT SPECIFIED$CA
124288012$12428801$2$F$$20160601$20160602$20160610$EXP$$PHHO2016BE007667$NOVARTIS$$$$$F$Y$82.35$KG$20160610$$MD$BE$BE
124289082$12428908$2$F$20160522$20160609$20160602$20160617$EXP$$ES-JNJFOC-20160522048$JANSSEN$$69$YR$E$M$Y$70$KG$20160617$$MD$ES$ES
124289091$12428909$1$I$20160521$20160524$20160602$20160602$EXP$$DE-JNJFOC-20160521634$JANSSEN$$77$YR$E$F$Y$67$KG$20160602$$MD$DE$DE
124293355$12429335$5$F$20140121$20200719$20160602$20200729$EXP$$US-JNJFOC-20160528569$JOHNSON AND JOHNSON$$91$YR$E$F$Y$$$20200729$$CN$US$US
124293462$12429346$2$F$20130923$20200914$20160602$20200925$EXP$SE-MPA-2016-003133$SE-JNJFOC-20160529245$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200925$$MD$SE$SE
124293565$12429356$5$F$20140603$20200804$20160602$20200807$PER$$US-JNJFOC-20160527067$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200807$$CN$US$US
124295742$12429574$2$F$20160524$20200627$20160602$20200702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041365$BRISTOL MYERS SQUIBB$$43$YR$$F$Y$74.7$KG$20200702$$HP$US$US
124300293$12430029$3$F$20160522$20170206$20160602$20170210$EXP$$US-JNJFOC-20160527286$PHARMACYCLICS$$37$YR$A$F$Y$$$20170210$$MD$US$US
1243003111$12430031$11$F$20160426$20181011$20160602$20181018$EXP$$AT-JNJFOC-20160504250$JANSSEN$$76$YR$E$F$Y$87$KG$20181018$$MD$AT$AT
124303593$12430359$3$F$201312$20200701$20160602$20200706$EXP$$US-JAZZ-2016-US-009848$JAZZ$$42$YR$$M$Y$$$20200706$$CN$US$US
1243095816$12430958$16$F$20160526$20200629$20160603$20200708$PER$$CA-AMGEN-CANSP2016069625$AMGEN$$72$YR$E$M$Y$$$20200708$$CN$CA$CA
124313502$12431350$2$F$$20200505$20160603$20200820$PER$$US-JAZZ-2015-US-017243$JAZZ$$$$$F$Y$$$20200820$$$US$US
124314032$12431403$2$F$$20200511$20160603$20200820$PER$$US-JAZZ-2015-US-017588$JAZZ$$$$$F$Y$$$20200820$$$US$US
124316274$12431627$4$F$20150114$20160902$20160603$20200804$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-062338$BRISTOL MYERS SQUIBB$$69$YR$$M$Y$$$20200804$$MD$JP$JP
124317791$12431779$1$I$$20160519$20160603$20160603$EXP$$CZ-ACCORD-041120$ACCORD$POKORNA P. PERTUZUMAB IN THE TREATMENT OF BREAST CANCER. FARMAKOTERAPIE. 2016 12(2) 267?268.$44$YR$$F$Y$$$20160603$$MD$CZ$CZ
124318876$12431887$6$F$20160506$20200820$20160603$20200829$EXP$$PHHY2016CO066331$NOVARTIS$$48$YR$$M$Y$70$KG$20200829$$CN$CO$CO
124324753$12432475$3$F$201501$20200721$20160603$20200810$EXP$$US-BAYER-2016-057987$BAYER$$83$YR$E$M$Y$$$20200810$$HP$US$US
124325643$12432564$3$F$20160518$20161111$20160603$20161118$EXP$$US-TEVA-665421ACC$TEVA$$65$YR$$F$Y$$$20161118$$MD$US$US
124330885$12433088$5$F$20160524$20170427$20160603$20170504$EXP$$FR-JNJFOC-20160524077$JANSSEN$$56$YR$A$F$Y$70$KG$20170504$$MD$FR$FR
124330903$12433090$3$F$20160514$20160615$20160603$20160623$EXP$$JP-JNJFOC-20160520676$JANSSEN$$89$YR$E$M$Y$59.3$KG$20160623$$MD$JP$JP
124334368$12433436$8$F$201608$20200708$20160603$20200714$EXP$$PHHY2016PA000816$NOVARTIS$$62$YR$$M$Y$89.34$KG$20200714$$CN$COUNTRY NOT SPECIFIED$PA
124336216$12433621$6$F$20160525$20171009$20160603$20171017$EXP$$US-ABBVIE-16P-163-1638532-00$ABBVIE$$87$YR$$M$Y$75$KG$20171017$$MD$US$US
124338443$12433844$3$F$20160504$20160613$20160603$20160620$EXP$$US-JNJFOC-20160505756$JANSSEN$$74$YR$E$F$Y$84.82$KG$20160620$$MD$US$US
124338502$12433850$2$F$201408$20200831$20160603$20200904$EXP$$US-BAYER-2016-075290$BAYER$$85$YR$E$M$Y$$$20200904$$CN$US$US
124362262$12436226$2$F$20160410$20160726$20160605$20160729$EXP$$FR-JNJFOC-20160410331$JANSSEN$$75$YR$E$M$Y$$$20160729$$MD$FR$FR
124362286$12436228$6$F$20160426$20160727$20160605$20160802$EXP$$AU-JNJFOC-20160507816$JANSSEN$$73$YR$E$M$Y$69.2$KG$20160802$$MD$AU$AU
124364677$12436467$7$F$20151119$20200914$20160606$20200917$PER$$CA-AMGEN-CANSP2016071044$AMGEN$$83$YR$E$F$Y$$$20200917$$MD$CA$CA
124375126$12437512$6$F$201312$20200902$20160606$20200907$EXP$$PHJP2016JP014656$NOVARTIS$$17$YR$$M$Y$54$KG$20200907$$$JP$JP
124376533$12437653$3$F$20160522$20160624$20160606$20160630$EXP$$ES-JNJFOC-20160524270$PHARMACYCLICS$$63$YR$A$M$Y$$$20160630$$MD$ES$ES
124377133$12437713$3$F$20160512$20170322$20160606$20170328$EXP$$SE-JNJFOC-20160601064$PHARMACYCLICS$$68$YR$E$F$Y$$$20170328$$MD$SE$SE
124381605$12438160$5$F$20151116$20161115$20160606$20161118$EXP$$ES-JNJFOC-20160225320$JANSSEN$$56$YR$A$F$Y$81$KG$20161118$$MD$ES$ES
124385916$12438591$6$F$2014$20200804$20160606$20200806$EXP$$US-PFIZER INC-2016285007$PFIZER$$52$YR$$F$Y$99$KG$20200806$$HP$US$US
124386412$12438641$2$F$$20200512$20160606$20200820$PER$$US-JAZZ-2015-US-018236$JAZZ$$$$$M$Y$$$20200820$$$US$US
124388333$12438833$3$F$201405$20200625$20160606$20200708$EXP$$US-BAYER-2016-075783$BAYER$$61$YR$A$M$Y$$$20200708$$CN$US$US
124391952$12439195$2$F$$20200925$20160606$20200929$PER$$US-PFIZER INC-2016274692$PFIZER$$$$$F$Y$$$20200929$$MD$US$US
124392603$12439260$3$F$2008$20200910$20160606$20200914$PER$$US-AMGEN-USASL2016071470$AMGEN$$77$YR$E$F$Y$$$20200914$$MD$US$US
124394933$12439493$3$F$20140215$20200712$20160606$20200721$EXP$$US-BAYER-2016-017891$BAYER$$78$YR$E$M$Y$$$20200721$$CN$US$US
124406454$12440645$4$F$$20200805$20160606$20200813$EXP$$BR-BIOMARINAP-BR-2016-109965$BIOMARIN$$8$YR$$F$Y$$$20200813$$HP$BR$BR
1244076034$12440760$34$F$201604$20200917$20160606$20200924$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-042673$BRISTOL MYERS SQUIBB$$70$YR$$F$Y$$$20200924$$HP$CA$CA
124408502$12440850$2$F$20141210$20160714$20160607$20160721$EXP$$JP-ROCHE-1765504$ROCHE$$78$YR$$F$Y$$$20160721$$MD$JP$JP
124410584$12441058$4$F$20160316$20200719$20160607$20200805$EXP$$CA-ROCHE-1769176$ROCHE$$42$YR$$F$Y$$$20200805$$CN$CA$CA
124412285$12441228$5$F$201505$20200721$20160607$20200725$EXP$$DE-009507513-1606DEU001856$MERCK$ATTARAN?BANDARABADI M, KALBASI ANARAKI P, GWINNER W, HALLER H.. 73?JAHRIGEN PATIENT EINE UNERWARTETE WIRKUNG. ARZTEWOCHE. 2016?12?3$73$YR$$M$Y$$$20200725$$HP$DE$DE
124412952$12441295$2$F$20160405$20160721$20160607$20160802$EXP$$US-ROCHE-1738075$ROCHE$$71$YR$$F$Y$79.9$KG$20160802$$MD$US$US
124416634$12441663$4$F$$20200716$20160607$20200729$EXP$$DE-LUPIN PHARMACEUTICALS INC.-2016-02416$LUPIN$$73$YR$$M$Y$$$20200729$$CN$GB$DE
124416714$12441671$4$F$2015$20200812$20160607$20200821$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-043485$BRISTOL MYERS SQUIBB$$61$YR$$M$Y$87.5$KG$20200821$$MD$US$US
124417485$12441748$5$F$2013$20200910$20160607$20200917$EXP$$CA-ROCHE-1770763$ROCHE$$63$YR$$F$Y$57$KG$20200917$$MD$CA$CA
124427174$12442717$4$F$20160122$20200727$20160607$20200811$EXP$$JP-INCYTE CORPORATION-2016IN003236$INCYTE$$$$$$Y$$$20200811$$MD$JP$JP
124431657$12443165$7$F$20150110$20200918$20160607$20200922$EXP$$CA-PFIZER INC-2015038700$PFIZER$$33$YR$$F$Y$$$20200922$$MD$CA$CA
124432173$12443217$3$F$20160401$20180724$20160607$20180727$EXP$$PL-JNJFOC-20160602831$PHARMACYCLICS$$81$YR$E$M$Y$74.8$KG$20180727$$MD$PL$PL
124432371$12443237$1$I$20160530$20160601$20160607$20160607$EXP$$IT-JNJFOC-20160602315$JANSSEN$$67$YR$E$F$Y$68$KG$20160607$$MD$IT$IT
1244338710$12443387$10$F$$20200914$20160607$20200921$EXP$$CA-PFIZER INC-2016285136$PFIZER$$83$YR$$F$Y$$$20200921$$HP$CA$CA
124435992$12443599$2$F$20160516$20160614$20160607$20160621$EXP$$CN-JNJFOC-20160516846$PHARMACYCLICS$$49$YR$A$M$Y$79$KG$20160621$$MD$CN$CN
124453124$12445312$4$F$20160529$20161117$20160607$20161121$EXP$$AU-JNJFOC-20160529240$JANSSEN$$83$YR$E$M$Y$70$KG$20161121$$MD$AU$AU
124455778$12445577$8$F$201510$20200911$20160608$20200922$EXP$$US-JNJFOC-20160425336$JOHNSON AND JOHNSON$$38$YR$A$M$Y$$$20200922$$LW$US$US
124455926$12445592$6$F$2008$20200814$20160608$20200820$PER$$US-JNJFOC-20150812358$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20200820$$LW$US$US
124462504$12446250$4$F$20160603$20160808$20160608$20160811$EXP$$TR-ROCHE-1770073$ROCHE$$56$YR$$M$Y$71.5$KG$20160811$$MD$TR$TR
124467215$12446721$5$F$$20200724$20160608$20200728$PER$$US-PFIZER INC-2016025244$PFIZER$$55$YR$$F$Y$$$20200728$$MD$US$US
1244737621$12447376$21$F$2000$20200723$20160608$20200727$EXP$$US-PFIZER INC-2016260265$PFIZER$$51$YR$$F$Y$79$KG$20200727$$CN$US$US
124476533$12447653$3$F$$20200708$20160608$20200720$EXP$$US-SA-2016SA105101$SANOFI AVENTIS$PARK M, NGUYEN V, DEBORD J. A TWIST OF FATE.. JOURNAL OF GENERAL INTERNAL MEDICINE. 2016?31:2(1):S533?S534$$$$$Y$$$20200720$$HP$US$US
1244798910$12447989$10$F$201605$20200914$20160608$20200921$EXP$$CA-PFIZER INC-2016284711$PFIZER$$78$YR$$F$Y$$$20200921$$HP$CA$CA
124485122$12448512$2$F$$20200727$20160608$20200804$EXP$$GB-ALLERGAN-1658797US$ALLERGAN$BERMAN SS, SABAT JS. MYCOTIC ANEURYSM OF THE DISTAL THORACIC AORTA AFTER BOTULINUM TOXIN INJECTION FOR ESOPHAGEAL DYSMOTILITY. JOURNAL OF VASCULAR SURGERY CASES AND INNOVATIVE TECHNIQUES. 2020?6(3):388?91$$$$F$Y$$$20200804$$MD$US$GB
124485162$12448516$2$F$20160601$20160722$20160608$20160725$EXP$$US-JNJFOC-20160602998$JANSSEN$$59$YR$A$F$Y$51$KG$20160725$$MD$US$US
124487551$12448755$1$I$20160529$20160531$20160608$20160608$EXP$$BE-JNJFOC-20160604826$JANSSEN$$61$YR$A$M$Y$56$KG$20160608$$MD$BE$BE
1244877610$12448776$10$F$20151009$20200722$20160608$20200805$EXP$$JP-INCYTE CORPORATION-2016IN003266$INCYTE$$$$$$Y$$$20200805$$PH$JP$JP
124488111$12448811$1$I$20160603$20160603$20160608$20160608$EXP$$JP-JNJFOC-20160603657$JANSSEN$$69$YR$E$$Y$59.8$KG$20160608$$MD$JP$JP
124491822$12449182$2$F$20071026$20200928$20160608$20200929$PER$$US-PFIZER INC-2016274690$PFIZER$$59$YR$$F$Y$$$20200929$$MD$US$US
124505201$12450520$1$I$$20160607$20160609$20160609$EXP$$US-ROCHE-1771488$ROCHE$$$$$$Y$$$20160609$$CN$US$US
124514473$12451447$3$F$$20200805$20160609$20200811$PER$$US-JAZZ-2016-US-010261$JAZZ$$$$$M$Y$$$20200811$$CN$US$US
124519702$12451970$2$F$2009$20200526$20160609$20200820$PER$$US-JAZZ-2015-US-018986$JAZZ$$$$$M$Y$64.4$KG$20200820$$MD$US$US
124520163$12452016$3$F$$20200715$20160609$20200720$PER$$US-JAZZ-2015-US-018844$JAZZ$$$$$F$Y$$$20200720$$$US$US
124527043$12452704$3$F$20131001$20200809$20160609$20200817$EXP$$US-BAYER-2015-023091$BAYER$$54$YR$A$F$Y$$$20200817$$CN$US$US
124527885$12452788$5$F$20140923$20200708$20160609$20200713$PER$$US-JNJFOC-20160603762$JOHNSON AND JOHNSON$$74$YR$$M$Y$$$20200713$$CN$US$US
124531122$12453112$2$F$20160531$20200911$20160609$20200915$PER$$US-ELI_LILLY_AND_COMPANY-US201606002249$ELI LILLY AND CO$$$$$F$Y$$$20200915$$CN$US$US
124531295$12453129$5$F$$20180226$20160609$20200916$EXP$$FR-BAUSCH-BL-2016-013358$BAUSCH AND LOMB$PENIT A, BEMER P, BESSON J, CAZET L, BOURIGAULT C, JUVIN M. COMMUNITY?ACQUIRED CLOSTRIDIUM DIFFICILE INFECTIONS. MEDECINE ET MALADIES INFECTIEUSES. 2016?46(3):131?139.$79$YR$$F$Y$$$20200916$$HP$FR$FR
124539139$12453913$9$F$20160307$20200722$20160609$20200725$EXP$$PHHY2016DE066418$NOVARTIS$$$$A$M$Y$85$KG$20200725$$HP$DE$DE
124539792$12453979$2$F$$20200820$20160610$20200902$EXP$$US-CIPLA LTD.-2016US06857$CIPLA$PETTUS JH, MCNABB B, ECKEL RH, SKYLER JS, DHALLA A, GUAN S ET AL.. EFFECT OF RANOLAZINE ON GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH EITHER GLIMEPIRIDE OR METFORMIN. DIABETES, OBESITY AND METABOLISM. 2016?18 (5):463 TO 474$$$$$Y$$$20200902$$HP$US$US
124540964$12454096$4$F$20150608$20160701$20160610$20160706$EXP$$JP-ROCHE-1596276$ROCHE$OURA N, SUGIYAMA M, SHINOHARA K, ET AL. A CASE OF ALECTINIB?ASSOCIATED GRADE 4 NEUTROPENIA THAT WAS MANAGED WITH A DOSE REDUCTION IN ACCORDANCE WITH THE CRITERIA OF THE AF?001JP TRIAL. JAPANESE JOURNAL OF LUNG CANCER 2016 APR?56(2):119?123.$43$YR$$F$Y$61$KG$20160706$$MD$JP$JP
124541217$12454121$7$F$20160505$20200706$20160610$20200708$EXP$$CA-ROCHE-1771508$ROCHE$$69$YR$$F$Y$$$20200708$$HP$CA$CA
124550567$12455056$7$F$20160523$20161222$20160610$20161227$EXP$$US-JNJFOC-20160600926$JANSSEN$$38$YR$A$M$Y$87.7$KG$20161227$$MD$US$US
124550833$12455083$3$F$20160529$20160623$20160610$20160630$EXP$$AT-JNJFOC-20160529381$JANSSEN$$69$YR$E$M$Y$84$KG$20160630$$MD$AT$AT
124550864$12455086$4$F$20160530$20161117$20160610$20161123$EXP$$US-JNJFOC-20160607108$PHARMACYCLICS$$73$YR$E$M$Y$$$20161123$$MD$US$US
124552025$12455202$5$F$20160519$20200722$20160610$20200729$EXP$$PHHY2016NL079435$NOVARTIS$$65$YR$$F$Y$$$20200729$$CN$COUNTRY NOT SPECIFIED$NL
124558094$12455809$4$F$20160605$20160606$20160610$20160701$EXP$$US-JNJFOC-20160605421$JANSSEN$$60$YR$A$M$Y$112$KG$20160701$$MD$US$US
124558423$12455842$3$F$20151126$20200113$20160610$20200722$EXP$$FI-ROCHE-1770835$ROCHE$$25$YR$$F$Y$$$20200722$$MD$FI$FI
124558574$12455857$4$F$20160515$20160903$20160610$20160909$EXP$$JP-JNJFOC-20160529117$JANSSEN$$27$YR$A$M$Y$65.8$KG$20160909$$MD$JP$JP
124558772$12455877$2$F$20110805$20200917$20160610$20200928$EXP$$US-NOVOPROD-495420$NOVO NORDISK$$57$YR$$M$Y$102.49$KG$20200928$$LW$US$US
124562033$12456203$3$F$20160330$20161121$20160610$20161125$EXP$$GB-JNJFOC-20160604057$JANSSEN$$28$YR$A$M$Y$$$20161125$$HP$GB$GB
124563613$12456361$3$F$2018$20200825$20160610$20200908$EXP$$CO-INCYTE CORPORATION-2015IN005926$INCYTE$$$$$$Y$$$20200908$$CN$CO$CO
124568045$12456804$5$F$20141008$20200706$20160610$20200717$EXP$$US-JNJFOC-20160602606$JOHNSON AND JOHNSON$$91$YR$$F$Y$$$20200717$$LW$US$US
124571348$12457134$8$F$20151026$20200727$20160610$20200804$EXP$$PHJP2015JP023476$NOVARTIS$$56$YR$$M$Y$80$KG$20200804$$HP$JP$JP
124577922$12457792$2$F$201305$20200731$20160611$20200807$EXP$$US-BIOGEN-2015BI014943$BIOGEN$$62$YR$$F$Y$$$20200807$$MD$US$US
1245780512$12457805$12$F$201509$20200914$20160611$20200917$PER$$CA-AMGEN-CANSP2016074269$AMGEN$$61$YR$A$F$Y$$$20200917$$HP$CA$CA
124581263$12458126$3$F$$20200708$20160613$20200721$EXP$$US-CIPLA LTD.-2016US06578$CIPLA$PARK M, NGUYEN V, DEBORD J. A TWIST OF FATE. JOURNAL OF GENERAL INTERNAL MEDICINE. 2016?31:2 (SUPPL 1):S533 TO S534$$$$$Y$$$20200721$$HP$US$US
124585442$12458544$2$F$$20200608$20160613$20200820$PER$$US-JAZZ-2015-US-019448$JAZZ$$$$$F$Y$$$20200820$$MD$US$US
124585802$12458580$2$F$201208$20200706$20160613$20200921$PER$$US-JAZZ-2015-US-019514$JAZZ$$45$YR$$F$Y$48.98$KG$20200921$$MD$US$US
124586162$12458616$2$F$$20200521$20160613$20200820$PER$$US-JAZZ-2015-US-019416$JAZZ$$$$$F$Y$$$20200820$$CN$US$US
124586612$12458661$2$F$2015$20200622$20160613$20200820$PER$$US-JAZZ-2015-US-019028$JAZZ$$$$$F$Y$$$20200820$$MD$US$US
1245876513$12458765$13$F$20151112$20200910$20160613$20200918$EXP$$GB-ROCHE-1762999$ROCHE$$54$YR$$F$Y$$$20200918$$MD$GB$GB
1245927825$12459278$25$F$20160426$20200915$20160613$20200924$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-022610$BRISTOL MYERS SQUIBB$$72$YR$$F$Y$$$20200924$$CN$CA$CA
124599552$12459955$2$F$20160531$20160713$20160613$20160722$EXP$$US-JNJFOC-20160601779$JANSSEN$$56$YR$A$F$Y$58$KG$20160722$$MD$US$US
124600999$12460099$9$F$201605$20200821$20160613$20200825$EXP$$US-PFIZER INC-2016219760$PFIZER$$60$YR$$F$Y$110.2$KG$20200825$$CN$US$US
124610093$12461009$3$F$$20200708$20160613$20200714$EXP$$CA-UCBSA-2016021264$UCB$$44$YR$$F$Y$$$20200715$$MD$CA$CA
124610485$12461048$5$F$20160518$20200803$20160613$20200811$EXP$$DE-BIOGEN-2016BI00247284$BIOGEN$$32$YR$$F$Y$$$20200811$$CN$DE$DE
1246121213$12461212$13$F$201606$20200914$20160613$20200922$PER$$US-INCYTE CORPORATION-2016IN003350$INCYTE$$$$$$Y$$$20200922$$CN$US$US
124615735$12461573$5$F$$20200904$20160613$20200908$EXP$$US-TAKEDA-2016TUS009438$TAKEDA$$$$$M$Y$81.63$KG$20200908$$CN$US$US
124621213$12462121$3$F$20160603$20200917$20160613$20200929$EXP$$US-ABBVIE-16P-163-1647829-00$ABBVIE$$69$YR$$F$Y$$$20200928$$MD$US$US
124623458$12462345$8$F$20160529$20180226$20160613$20180302$EXP$$US-JNJFOC-20160601560$JANSSEN$$84$YR$E$M$Y$86.5$KG$20180302$$MD$US$US
124625832$12462583$2$F$201603$20160729$20160614$20160808$EXP$$GB-ABBVIE-16K-167-1649454-00$ABBVIE$$56$YR$$M$Y$$$20160808$$MD$GB$GB
124637164$12463716$4$F$20160601$20200801$20160614$20200804$PER$$US-PFIZER INC-2016297758$PFIZER$$56$YR$$F$Y$$$20200804$$HP$US$US
124638882$12463888$2$F$20140810$20200720$20160614$20200730$EXP$$US-BAYER-2015-375574$BAYER$$74$YR$E$M$Y$$$20200730$$HP$US$US
124638892$12463889$2$F$20140924$20200706$20160614$20200716$EXP$$US-BAYER-2015-021454$BAYER$$66$YR$E$M$Y$$$20200716$$HP$US$US
124639007$12463900$7$F$$20200102$20160614$20200107$EXP$$PHHY2016IT080287$NOVARTIS$$86$YR$$F$Y$$$20200107$$HP$IT$IT
1246390312$12463903$12$F$20160601$20200720$20160614$20200724$PER$$CA-AMGEN-CANSP2016074503$AMGEN$$58$YR$A$M$Y$$$20200724$$MD$CA$CA
124643093$12464309$3$F$$20200708$20160614$20200715$EXP$$US-DRREDDYS-USA/USA/16/0080605$DR REDDYS$PARK M, NGUYEN V, DEBORD J. A TWIST OF FATE. J GEN INTERN MED. 2016?31:2(1):S533?4.$45$YR$A$M$Y$$$20200715$$HP$US$US
1246467120$12464671$20$F$$20200626$20160614$20200709$EXP$$US-ACTELION-A-NJ2015-121779$ACTELION$$$$$F$Y$72.56$KG$20200709$$HP$US$US
124648094$12464809$4$F$$20200707$20160614$20200708$PER$$US-PFIZER INC-2016286593$PFIZER$$75$YR$$F$Y$$$20200708$$MD$US$US
124648972$12464897$2$F$20160531$20160613$20160614$20160622$EXP$$GB-JNJFOC-20160604781$JANSSEN$$55$YR$A$M$Y$96$KG$20160622$$MD$GB$GB
124652018$12465201$8$F$201604$20200820$20160614$20200825$PER$$US-PFIZER INC-2016272192$PFIZER$$64$YR$$F$Y$66$KG$20200825$$CN$US$US
124655474$12465547$4$F$20121118$20200712$20160614$20200721$EXP$$US-JNJFOC-20160519107$JOHNSON AND JOHNSON$$76$YR$$F$Y$61.29$KG$20200721$$CN$US$US
124655792$12465579$2$F$201407$20200729$20160614$20200811$EXP$$US-BAYER-2016-083606$BAYER$$75$YR$E$M$Y$$$20200811$$HP$US$US
124658343$12465834$3$F$201403$20200902$20160614$20200909$EXP$$US-BAYER-2016-065875$BAYER$$77$YR$E$F$Y$$$20200909$$CN$US$US
124659284$12465928$4$F$2016$20200724$20160614$20200730$EXP$$US-SA-2016SA092928$SANOFI AVENTIS$$$$$$Y$$$20200730$$CN$US$US
1246649219$12466492$19$F$201208$20200813$20160615$20200826$EXP$$CA-ROCHE-1775252$ROCHE$$71$YR$$F$Y$$$20200826$$MD$CA$CA
124669838$12466983$8$F$20160530$20200716$20160615$20200721$EXP$$PHHY2016CA081502$NOVARTIS$$38$YR$$F$Y$$$20200721$$MD$CA$CA
124675642$12467564$2$F$201411$20200726$20160615$20200730$EXP$$US-BAYER-2016-067941$BAYER$$78$YR$E$M$Y$$$20200730$$HP$US$US
124678928$12467892$8$F$201605$20200709$20160615$20200715$EXP$$US-JAZZ-2016-US-010635$JAZZ$$47$YR$$F$Y$$$20200715$$MD$US$US
124681644$12468164$4$F$20160525$20160721$20160615$20160729$EXP$$US-JNJFOC-20160601040$PHARMACYCLICS$$63$YR$A$F$Y$65.5$KG$20160729$$MD$US$US
124683334$12468333$4$F$20140610$20200830$20160615$20200902$PER$$US-JNJFOC-20160607510$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200902$$CN$US$US
124690283$12469028$3$F$$20200708$20160615$20200714$EXP$$US-PFIZER INC-2016297355$PFIZER$PARK, M.. A TWIST OF FATE. JOURNAL OF GENERAL INTERNAL MEDICINE. 2016?31 (2 SUPPL. 1):S533?S534$45$YR$$M$Y$$$20200714$$HP$US$US
124690619$12469061$9$F$$20191217$20160615$20191227$EXP$IT-EMA-DD-20190819-KHARE_I-134625$IT-PURDUE PHARMA-GBR-2016-0036949$PURDUE$FLAVIO C.. TAPENTADOLE PR IN AN OLD PATIENT WITH LUMBAR PAIN DUE TO KYPHOSCOLIOSIS.. MEDIFORMAT. 2015?2:24?5$86$YR$$F$Y$$$20191227$$HP$IT$IT
124692064$12469206$4$F$20131015$20200820$20160615$20200901$EXP$$US-JNJFOC-20160606896$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200901$$CN$US$US
124696183$12469618$3$F$20160607$20170510$20160615$20170519$EXP$$FR-JNJFOC-20160609069$JANSSEN$$63$YR$A$F$Y$70$KG$20170519$$MD$FR$FR
1247039611$12470396$11$F$$20200629$20160616$20200706$PER$$CA-AMGEN-CANSP2016074646$AMGEN$$60$YR$A$F$Y$$$20200706$$MD$CA$CA
124707723$12470772$3$F$20150423$20190419$20160616$20200824$PER$$PHHY2015US070645$NOVARTIS$$50$YR$$F$Y$$$20200824$$MD$US$US
124711949$12471194$9$F$20160426$20200723$20160616$20200728$EXP$$DE-ROCHE-1756888$ROCHE$$75$YR$$M$Y$123$KG$20200728$$MD$DE$DE
124721331$12472133$1$I$20130411$20160311$20160616$20160616$EXP$$PL-JNJFOC-20160313693$JANSSEN$$53$YR$A$M$Y$67$KG$20160616$$MD$PL$PL
124727483$12472748$3$F$$20200909$20160616$20200915$PER$$US-JAZZ-2015-US-020001$JAZZ$$$$$M$Y$$$20200915$$HP$US$US
124729332$12472933$2$F$20150713$20200713$20160616$20200722$EXP$$US-BAYER-2016-072720$BAYER$$66$YR$E$F$Y$$$20200722$$CN$US$US
124738612$12473861$2$F$201503$20200811$20160616$20200818$EXP$$US-BAYER-2016-043459$BAYER$$81$YR$E$M$Y$$$20200818$$CN$US$US
1247409814$12474098$14$F$2016$20200722$20160616$20200728$EXP$$CA-TAKEDA-2016TUS009863$TAKEDA$$70$YR$$M$Y$75$KG$20200728$$HP$CA$CA
124741982$12474198$2$F$$20200708$20160616$20200715$EXP$US-MLMSERVICE-20160603-0307094-1$US-JNJFOC-20160612076$JOHNSON AND JOHNSON$DEBORD J, NGUYEN V, PARK M. A TWIST OF FATE. JOURNAL OF GENERAL INTERNAL MEDICINE. 2016?31 (2 SUPPL.1):S533?S534.$45$YR$$M$Y$$$20200715$$HP$US$US
124742692$12474269$2$F$20160603$20160804$20160617$20160811$EXP$$TR-TEVA-668756ACC$TEVA$$56$YR$$M$Y$$$20160811$$MD$TR$TR
124746442$12474644$2$F$$20200708$20160617$20200721$EXP$US-MLMSERVICE-20160603-0307094-1$US-LUPIN PHARMACEUTICALS INC.-2016-02595$LUPIN$$45$YR$$M$Y$$$20200721$$HP$US$US
124757232$12475723$2$F$20141211$20160801$20160617$20160808$EXP$$JP-ROCHE-1607879$ROCHE$$60$YR$$F$Y$45$KG$20160808$$MD$JP$JP
124758762$12475876$2$F$201503$20200924$20160617$20200928$EXP$$US-BAYER-2016-072535$BAYER$$81$YR$E$F$Y$$$20200928$$CN$US$US
124758832$12475883$2$F$20150702$20200914$20160617$20200917$EXP$$US-BAYER-2016-069337$BAYER$$78$YR$E$M$Y$$$20200917$$CN$US$US
124760635$12476063$5$F$20040809$20200918$20160617$20200925$EXP$$ES-ABBVIE-16P-144-1654590-00$ABBVIE$$0$YR$$M$Y$$$20200925$$LW$ES$ES
124762642$12476264$2$F$$20200820$20160617$20200902$EXP$$US-CIPLA LTD.-2016US07171$CIPLA$$$$$$Y$$$20200902$$HP$US$PE
124762692$12476269$2$F$$20200820$20160617$20200903$EXP$$US-CIPLA LTD.-2016US06890$CIPLA$$$$$$Y$$$20200903$$HP$US$PE
124763855$12476385$5$F$20151222$20170524$20160617$20170531$EXP$$JP-ROCHE-1775526$ROCHE$$81$YR$$F$Y$$$20170531$$MD$JP$JP
124765098$12476509$8$F$20151125$20200727$20160617$20200801$PER$$PHHY2016US082742$NOVARTIS$$51$YR$$F$Y$$$20200801$$MD$US$US
124766875$12476687$5$F$20160501$20160722$20160617$20160801$EXP$$US-PFIZER INC-2016261692$PFIZER$$63$YR$$M$Y$93.8$KG$20160801$$MD$US$US
124773152$12477315$2$F$20150727$20160614$20160617$20200722$PER$$PHHY2016US083103$NOVARTIS$$63$YR$$F$Y$$$20200722$$MD$US$US
124774014$12477401$4$F$20160611$20200525$20160617$20200603$EXP$$NL-JNJFOC-20160612892$JOHNSON AND JOHNSON$$59$YR$$F$Y$65.2$KG$20200603$$MD$NL$NL
124774029$12477402$9$F$20160526$20170822$20160617$20170825$EXP$$AU-JNJFOC-20160608013$JANSSEN$$77$YR$E$M$Y$72$KG$20170825$$MD$AU$AU
124774495$12477449$5$F$$20200707$20160617$20200714$EXP$$ES-BIOGEN-2015BI081291$BIOGEN$$$$$F$Y$$$20200714$$MD$ES$ES
1247755425$12477554$25$F$20151221$20200203$20160617$20200210$EXP$$PHHY2015CA169582$NOVARTIS$$59$YR$$F$Y$$$20200210$$CN$CA$CA
124775902$12477590$2$F$20140204$20200730$20160617$20200811$EXP$$US-BAYER-2016-028187$BAYER$$89$YR$E$F$Y$$$20200811$$CN$US$US
124781688$12478168$8$F$201410$20191210$20160617$20191217$EXP$$PHHY2015CA118706$NOVARTIS$$47$YR$$F$Y$$$20191217$$HP$CA$CA
124783762$12478376$2$F$20140807$20200702$20160618$20200709$PER$$PHHY2015US028740$NOVARTIS$$56$YR$$F$Y$$$20200709$$MD$US$US
124784094$12478409$4$F$201111$20200804$20160618$20200814$EXP$$US-JNJFOC-20160609554$JOHNSON AND JOHNSON$$82$YR$E$F$Y$34.05$KG$20200814$$CN$US$US
1247841915$12478419$15$F$20160601$20171113$20160618$20171116$EXP$$US-JNJFOC-20160606147$JANSSEN$$77$YR$E$F$Y$77.11$KG$20171116$$MD$US$US
124784265$12478426$5$F$20150903$20200909$20160618$20200914$EXP$$US-JNJFOC-20160610256$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200914$$CN$US$US
124785688$12478568$8$F$20160603$20160923$20160619$20160927$EXP$$DE-JNJFOC-20160609474$JANSSEN$$53$YR$A$F$Y$82$KG$20160927$$MD$DE$DE
124792942$12479294$2$F$$20200702$20160620$20200921$PER$$US-JAZZ-2015-US-020468$JAZZ$$$$$F$Y$$$20200921$$MD$US$US
124803322$12480332$2$F$201505$20200716$20160620$20200724$EXP$$US-BAYER-2016-070796$BAYER$$64$YR$A$M$Y$$$20200724$$HP$US$US
124803444$12480344$4$F$$20190220$20160620$20190302$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-118735$RANBAXY$$51$YR$$F$Y$$$20190302$$HP$ES$ES
124810515$12481051$5$F$201603$20200727$20160620$20200806$EXP$$US-BAYER-2016-098290$BAYER$$57$YR$A$M$Y$$$20200806$$CN$US$US
124811212$12481121$2$F$201502$20200709$20160620$20200721$EXP$$US-BAYER-2016-072730$BAYER$$72$YR$E$M$Y$$$20200721$$LW$US$US
124812701$12481270$1$I$20160517$20160607$20160620$20160620$EXP$$US-JNJFOC-20160610308$JANSSEN$$38$YR$A$M$Y$95$KG$20160620$$MD$US$US
124813333$12481333$3$F$2016$20200908$20160620$20200911$EXP$$US-BAYER-2016-070869$BAYER$$70$YR$E$M$Y$$$20200911$$CN$US$US
124821913$12482191$3$F$20140728$20200727$20160620$20200803$EXP$$PHHY2016US019567$NOVARTIS$$35$YR$$F$Y$$$20200803$$MD$US$US
124830596$12483059$6$F$20140309$20200702$20160620$20200706$EXP$$PHHY2014US045158$NOVARTIS$$30$YR$$F$Y$$$20200706$$HP$US$US
124833816$12483381$6$F$20150309$20200727$20160621$20200803$PER$$PHHY2016US082448$NOVARTIS$$27$YR$$F$Y$$$20200803$$MD$US$US
124834517$12483451$7$F$20151020$20200702$20160621$20200706$EXP$$PHHY2016US082718$NOVARTIS$$46$YR$$F$Y$$$20200706$$MD$US$US
124837158$12483715$8$F$20151005$20200702$20160621$20200709$EXP$$PHHY2016US082570$NOVARTIS$$50$YR$$F$Y$$$20200709$$MD$US$US
124845803$12484580$3$F$201311$20200623$20160621$20200703$EXP$$US-BAYER-2016-071235$BAYER$$70$YR$E$F$Y$$$20200703$$CN$US$US
124846012$12484601$2$F$20130201$20200707$20160621$20200717$EXP$$US-BAYER-2016-053106$BAYER$$74$YR$E$F$Y$$$20200717$$CN$US$US
124852744$12485274$4$F$20141225$20200817$20160621$20200901$EXP$$JP-INCYTE CORPORATION-2015IN001767$INCYTE$$$$$$Y$$$20200901$$MD$JP$JP
124853766$12485376$6$F$$20200918$20160621$20200923$EXP$$AU-PFIZER INC-2016307456$PFIZER$ADLER, N.. PIPERACILLIN?TAZOBACTAM?INDUCED LINEAR IGA BULLOUS DERMATOSIS PRESENTING CLINICALLY AS STEVENS?JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS OVERLAP. CLINICAL + EXPERIMENTAL DERMATOLOGY. 2017?42 (3):299?302$47$YR$$M$Y$$$20200923$$HP$AU$AU
124855972$12485597$2$F$20160529$20160627$20160621$20160705$EXP$$US-JNJFOC-20160613324$PHARMACYCLICS$$77$YR$E$F$Y$71.2$KG$20160705$$MD$US$US
124861733$12486173$3$F$2016$20200730$20160621$20200808$EXP$$PHHY2016AU084794$NOVARTIS$$$$$F$Y$$$20200808$$HP$AU$AU
124871652$12487165$2$F$$20160614$20160622$20161214$EXP$$IT-ROCHE-1756116$ROCHE$FUSCO V, PORTA C, SAIA G, PAGLINO C, BETTINI G, SCOLETTA M, BONACINA R, VESCOVI P, MERIGO E, LO RE G, GUGLIELMINI P, DI FEDE O, CAMPISI G AND BEDOGNI A. OSTEONECROSIS OF THE JAW IN PATIENTS WITH METASTATIC RENAL CELL CANCER TREATED WITH BISPHOSPHONATES AND TARGETED AGENTS: RESULTS OF AN ITALIAN MULTICENTER STUDY AND REVIEW OF THE LITERATURE.. CLINICAL GENITOURINARY CANCER. 2015?13 (4):287?294.$59$YR$$M$Y$$$20161214$$MD$IT$IT
124878071$12487807$1$I$20160503$20160615$20160622$20160622$EXP$GB-MHRA-EYC 00140947$PHFR2016GB004999$NOVARTIS$$64$YR$$F$Y$$$20160622$$HP$GB$GB
124891222$12489122$2$F$20160613$20160627$20160622$20160706$EXP$$ES-JNJFOC-20160613038$JANSSEN$$70$YR$E$F$Y$$$20160706$$MD$ES$ES
124891513$12489151$3$F$20151023$20200913$20160622$20200916$EXP$$US-BAYER-2016-119272$BAYER$$99$YR$E$F$Y$$$20200916$$CN$US$US
124892692$12489269$2$F$20160503$20160627$20160622$20160704$EXP$$GB-AMGEN-GBRSP2016078112$AMGEN$$64$YR$A$F$Y$$$20160704$$HP$GB$GB
124894654$12489465$4$F$20130907$20200830$20160622$20200911$EXP$$US-JNJFOC-20160604094$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200911$$CN$US$US
1248957223$12489572$23$F$20160421$20191207$20160622$20191212$EXP$$PHHY2016CA057207$NOVARTIS$$41$YR$$F$Y$$$20191212$$HP$CA$CA
124896282$12489628$2$F$$20160616$20160622$20200701$EXP$$GR-JNJFOC-20160615252$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
124908124$12490812$4$F$201602$20200821$20160622$20200828$EXP$$DE-BIOGEN-2016BI00207474$BIOGEN$$68$YR$$F$Y$$$20200828$$CN$DE$DE
124915505$12491550$5$F$201501$20200720$20160623$20200731$EXP$$US-JNJFOC-20160615149$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200731$$CN$US$US
1249156712$12491567$12$F$201602$20200709$20160623$20200713$PER$$US-PFIZER INC-2016203841$PFIZER$$71$YR$$F$Y$89.81$KG$20200713$$MD$US$US
124918853$12491885$3$F$20160607$20161130$20160623$20161208$EXP$$US-JNJFOC-20160615029$PHARMACYCLICS$$77$YR$E$F$Y$104.5$KG$20161208$$MD$US$US
124920491$12492049$1$I$$20160616$20160623$20160623$EXP$$US-ROCHE-1778435$ROCHE$$$$$M$Y$$$20160623$$MD$US$US
124921874$12492187$4$F$2016$20160729$20160623$20200921$PER$$US-CELGENEUS-USA-2016064842$CELGENE$$$$$M$Y$$$20200921$$HP$US$US
124923128$12492312$8$F$2016$20200721$20160623$20200724$EXP$$US-SA-2016SA105667$SANOFI AVENTIS$$$$$$Y$$$20200724$$CN$US$US
124923197$12492319$7$F$201605$20200715$20160623$20200721$EXP$$US-SA-2016SA103529$SANOFI AVENTIS$$$$$$Y$$$20200721$$MD$US$US
124928782$12492878$2$F$20160329$20160725$20160623$20160801$EXP$$FR-JNJFOC-20160417311$JANSSEN$$79$YR$E$M$Y$85$KG$20160801$$MD$FR$FR
124931723$12493172$3$F$20150715$20200701$20160623$20200715$EXP$$US-BAYER-2016-107607$BAYER$$82$YR$E$M$Y$$$20200715$$CN$US$US
124936953$12493695$3$F$20160617$20160713$20160623$20160715$EXP$$ES-JNJFOC-20160618470$JANSSEN$$71$YR$E$M$Y$$$20160715$$MD$ES$ES
124937286$12493728$6$F$20160406$20200923$20160623$20200929$EXP$$US-SA-2016SA115597$SANOFI AVENTIS$$$$$$Y$$$20200929$$MD$US$US
1249429315$12494293$15$F$2000$20200720$20160623$20200725$EXP$$PHHY2016ZA084563$NOVARTIS$$$$$F$Y$67$KG$20200725$$HP$ZA$ZA
124943332$12494333$2$F$20160331$20200902$20160623$20200908$EXP$$US-LUNDBECK-DKLU2004209$LUNDBECK$$6$YR$$F$Y$$$20200909$$MD$US$US
1249442311$12494423$11$F$$20200824$20160623$20200831$EXP$$US-JAZZ-2016-US-011272$JAZZ$$$$$F$Y$$$20200831$$CN$US$US
1249444417$12494444$17$F$$20200720$20160623$20200723$PER$$CA-AMGEN-CANSP2016078553$AMGEN$$62$YR$A$F$Y$$$20200723$$HP$CA$CA
124948787$12494878$7$F$2016$20200915$20160624$20200923$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-049131$BRISTOL MYERS SQUIBB$$$$$M$Y$90$KG$20200923$$MD$DE$DE
124950452$12495045$2$F$20160503$20160627$20160624$20160705$EXP$GB-MHRA-EYC 00140947$GB-DRREDDYS-GER/UKI/16/0080753$DR REDDYS$$64$YR$$F$Y$$$20160705$$HP$GB$GB
1249517322$12495173$22$F$20140403$20200703$20160624$20200715$EXP$$PHHY2012CA115890$NOVARTIS$$70$YR$$M$Y$$$20200715$$MD$CA$CA
124952528$12495252$8$F$2013$20200903$20160624$20200911$PER$$US-PFIZER INC-2016288607$PFIZER$$84$YR$$F$Y$53.97$KG$20200911$$HP$US$US
124959343$12495934$3$F$20160503$20160803$20160624$20160809$EXP$$GB-ROCHE-1782617$ROCHE$$64$YR$$F$Y$$$20160809$$HP$GB$GB
124966645$12496664$5$F$20160526$20200728$20160624$20200810$EXP$$US-ACTELION-A-US2015-118686$ACTELION$$49$YR$$M$Y$68.48$KG$20200810$$HP$US$US
124973652$12497365$2$F$201603$20160810$20160624$20160817$EXP$$GB-MYLANLABS-2016M1025163$MYLAN$$$$$$Y$$$20160817$$MD$GB$GB
124974795$12497479$5$F$20160619$20170404$20160624$20170411$EXP$$US-JNJFOC-20160620311$PHARMACYCLICS$$72$YR$E$M$Y$$$20170411$$MD$US$US
124994913$12499491$3$F$201605$20160831$20160627$20160906$EXP$$PHHY2016CO087212$NOVARTIS$$52$YR$$F$Y$46$KG$20160906$$CN$COUNTRY NOT SPECIFIED$CO
125002372$12500237$2$F$20140811$20160628$20160627$20160705$EXP$$FR-JNJFOC-20141016568$JANSSEN$$33$YR$A$F$Y$59$KG$20160705$$HP$FR$FR
1250036313$12500363$13$F$2015$20200831$20160627$20200901$PER$$US-PFIZER INC-2016291266$PFIZER$$67$YR$$F$Y$118$KG$20200901$$MD$US$US
1250040215$12500402$15$F$1994$20200817$20160627$20200819$EXP$$US-PFIZER INC-2016273540$PFIZER$$62$YR$$F$Y$63$KG$20200819$$MD$US$US
125010421$12501042$1$I$20070408$20160615$20160627$20160627$EXP$$US-JNJFOC-20160615219$JANSSEN$$67$YR$E$F$Y$104.8$KG$20160627$$HP$US$US
125012805$12501280$5$F$20190829$20200916$20160627$20200918$EXP$$US-PFIZER INC-2016291998$PFIZER$$52$YR$$M$Y$113.4$KG$20200918$$CN$US$US
125028592$12502859$2$F$20141122$20160808$20160628$20160817$EXP$$JP-ROCHE-1597486$ROCHE$$70$YR$$F$Y$73$KG$20160817$$MD$JP$JP
125030899$12503089$9$F$$20200720$20160628$20200724$PER$$CA-AMGEN-CANSP2016082381$AMGEN$$46$YR$A$F$Y$$$20200724$$HP$CA$CA
125037133$12503713$3$F$20200605$20200805$20160628$20200805$PER$$US-BIOGEN-2016BI00256257$BIOGEN$$41$YR$$F$Y$$$20200805$$CN$US$US
1250385414$12503854$14$F$2016$20200722$20160628$20200730$EXP$$CA-PFIZER INC-2016305602$PFIZER$$70$YR$$M$Y$75$KG$20200730$$HP$CA$CA
125044733$12504473$3$F$20160615$20160707$20160628$20160715$EXP$$US-JNJFOC-20160620751$PHARMACYCLICS$$61$YR$A$F$Y$$$20160715$$MD$US$US
125055454$12505545$4$F$20160218$20200924$20160628$20200930$EXP$$PHHY2016CA026471$NOVARTIS$$58$YR$$F$Y$$$20200930$$MD$COUNTRY NOT SPECIFIED$CA
125055672$12505567$2$F$20160606$20160920$20160628$20160929$EXP$$GB-JNJFOC-20160620000$JANSSEN$$63$YR$A$M$Y$70$KG$20160929$$MD$GB$GB
125056353$12505635$3$F$$20200820$20160628$20200923$PER$$US-INCYTE CORPORATION-2016IN003688$INCYTE$$$$$$Y$$$20200923$$CN$US$US
1250584910$12505849$10$F$20141022$20200901$20160628$20200915$EXP$$JP-INCYTE CORPORATION-2014IN003435$INCYTE$$$$$$Y$$$20200915$$MD$JP$JP
1250756214$12507562$14$F$20140626$20200903$20160629$20200920$EXP$$CA-ROCHE-1785119$ROCHE$$61$YR$$M$Y$$$20200921$$MD$CA$CA
1250787621$12507876$21$F$20160617$20200914$20160629$20200919$PER$$CA-AMGEN-CANSP2016083007$AMGEN$$60$YR$A$F$Y$$$20200919$$MD$CA$CA
125091265$12509126$5$F$20150817$20200720$20160629$20200724$EXP$$IT-PFIZER INC-2016319274$PFIZER$POGLIANI, D.. NONCONVULSIVE STATUS EPILEPTICUS DUE TO FENTANYL INTOXICATION IN HEMODIALYSED PATIENTS: TWO CASE REPORTS AND REVIEW OF THE LITERATURE. GIORNALE ITALIANO DI NEFROLOGIA. 2016?33(3).$77$YR$$M$Y$$$20200724$$MD$IT$IT
125105883$12510588$3$F$20160615$20170530$20160629$20170531$EXP$$CA-PFIZER INC-2016316088$PFIZER$$55$YR$$M$Y$$$20170531$$MD$CA$CA
125116281$12511628$1$I$20160412$20160617$20160630$20160630$EXP$$US-ROCHE-1778455$ROCHE$$71$YR$$F$Y$80.8$KG$20160630$$MD$US$US
125117073$12511707$3$F$20140815$20200721$20160630$20200731$PER$$US-JNJFOC-20160603798$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200731$$CN$US$US
125117084$12511708$4$F$20151031$20200628$20160630$20200702$PER$$US-JNJFOC-20160605452$JOHNSON AND JOHNSON$$64$YR$$M$Y$$$20200702$$CN$US$US
125117105$12511710$5$F$20140418$20200628$20160630$20200707$EXP$$US-JNJFOC-20160607302$JOHNSON AND JOHNSON$$70$YR$$M$Y$$$20200707$$CN$US$US
125117143$12511714$3$F$20160208$20200709$20160630$20200713$PER$$US-JNJFOC-20160605698$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200713$$CN$US$US
125117393$12511739$3$F$201512$20200811$20160630$20200813$PER$$US-JNJFOC-20160522557$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200813$$LW$US$US
125117413$12511741$3$F$201212$20200723$20160630$20200730$PER$$US-JNJFOC-20160604124$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200730$$CN$US$US
125117503$12511750$3$F$20160403$20200809$20160630$20200813$PER$$US-JNJFOC-20160522879$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200813$$CN$US$US
125117533$12511753$3$F$20120126$20200924$20160630$20200930$PER$$US-JNJFOC-20160523066$JOHNSON AND JOHNSON$$80$YR$E$F$Y$66.28$KG$20200930$$CN$US$US
125117573$12511757$3$F$20140816$20200810$20160630$20200813$PER$$US-JNJFOC-20160524144$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200813$$CN$US$US
125117904$12511790$4$F$20150728$20200818$20160630$20200824$PER$$US-JNJFOC-20160523837$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20200824$$LW$US$US
125118073$12511807$3$F$201509$20200823$20160630$20200903$EXP$$US-JNJFOC-20160602440$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200903$$CN$US$US
125118143$12511814$3$F$20151207$20200915$20160630$20200918$PER$$US-JNJFOC-20160605176$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20200918$$CN$US$US
125118333$12511833$3$F$20151118$20200818$20160630$20200824$PER$$US-JNJFOC-20160605190$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200824$$CN$US$US
125118643$12511864$3$F$201412$20200727$20160630$20200731$PER$$US-JNJFOC-20160611654$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200731$$CN$US$US
125118753$12511875$3$F$20140827$20200716$20160630$20200721$PER$$US-JNJFOC-20160606906$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20200721$$CN$US$US
125118943$12511894$3$F$20151122$20200623$20160630$20200707$EXP$$US-JNJFOC-20160522214$JOHNSON AND JOHNSON$$61$YR$$M$Y$86$KG$20200707$$CN$US$US
125118973$12511897$3$F$20140810$20200630$20160630$20200706$PER$$US-JNJFOC-20160509656$JOHNSON AND JOHNSON$$79$YR$$F$Y$56$KG$20200706$$CN$US$US
125119393$12511939$3$F$2014$20200625$20160630$20200702$PER$$US-JNJFOC-20160605354$JOHNSON AND JOHNSON$$$$$M$Y$$$20200702$$CN$US$US
125119454$12511945$4$F$20141012$20200708$20160630$20200713$PER$$US-JNJFOC-20160524584$JOHNSON AND JOHNSON$$51$YR$$F$Y$$$20200713$$CN$US$US
125119943$12511994$3$F$20150513$20200913$20160630$20200924$EXP$$US-JNJFOC-20160520111$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200924$$HP$US$US
125119993$12511999$3$F$20140525$20200713$20160630$20200724$EXP$$US-JNJFOC-20160521889$JOHNSON AND JOHNSON$$77$YR$$M$Y$$$20200724$$CN$US$US
125120293$12512029$3$F$2014$20200825$20160630$20200827$PER$$US-JNJFOC-20160522573$JOHNSON AND JOHNSON$$77$YR$E$M$Y$115.77$KG$20200827$$CN$US$US
125120603$12512060$3$F$201408$20200715$20160630$20200720$PER$$US-JNJFOC-20160509642$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200720$$CN$US$US
125120824$12512082$4$F$201212$20200802$20160630$20200804$PER$$US-JNJFOC-20160524591$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200804$$CN$US$US
125120902$12512090$2$F$201502$20200729$20160630$20200803$PER$$US-JNJFOC-20160511878$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200803$$HP$US$US
125121033$12512103$3$F$20131217$20200716$20160630$20200720$PER$$US-JNJFOC-20160509720$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200720$$CN$US$US
125121113$12512111$3$F$20151008$20200728$20160630$20200731$PER$$US-JNJFOC-20160517560$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20200731$$CN$US$US
125121282$12512128$2$F$20130211$20200714$20160630$20200717$PER$$US-JNJFOC-20160314535$JOHNSON AND JOHNSON$$62$YR$$M$Y$$$20200717$$CN$US$US
125121293$12512129$3$F$20140826$20200923$20160630$20200928$PER$$US-JNJFOC-20160509643$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20200928$$CN$US$US
125121356$12512135$6$F$20140915$20200827$20160630$20200901$PER$$US-JNJFOC-20160611002$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200901$$CN$US$US
125121443$12512144$3$F$20141025$20200628$20160630$20200702$PER$$US-JNJFOC-20160522200$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200702$$CN$US$US
125121813$12512181$3$F$20150411$20200820$20160630$20200824$PER$$US-JNJFOC-20160610319$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20200824$$CN$US$US
125121853$12512185$3$F$20140919$20200922$20160630$20200928$PER$$US-JNJFOC-20160612433$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200928$$CN$US$US
125121923$12512192$3$F$20140818$20200812$20160630$20200825$EXP$$US-JNJFOC-20160526173$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20200825$$LW$US$US
125122023$12512202$3$F$201408$20200628$20160630$20200706$PER$$US-JNJFOC-20160606909$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20200706$$CN$US$US
125122433$12512243$3$F$20140722$20200701$20160630$20200706$PER$$US-JNJFOC-20160611448$JOHNSON AND JOHNSON$$51$YR$$F$Y$120$KG$20200706$$CN$US$US
125122513$12512251$3$F$20141101$20200728$20160630$20200731$PER$$US-JNJFOC-20160603326$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200731$$CN$US$US
125122673$12512267$3$F$20150729$20200908$20160630$20200914$PER$$US-JNJFOC-20160523847$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200914$$LW$US$US
125122705$12512270$5$F$201501$20200623$20160630$20200707$EXP$$US-JNJFOC-20160523851$JOHNSON AND JOHNSON$$84$YR$$M$Y$$$20200707$$LW$US$US
125122823$12512282$3$F$20150412$20200706$20160630$20200710$PER$$US-JNJFOC-20160525165$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200710$$CN$US$US
125122863$12512286$3$F$201507$20200812$20160630$20200825$EXP$$US-JNJFOC-20160527838$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200825$$CN$US$US
125122903$12512290$3$F$20130322$20200714$20160630$20200716$PER$$US-JNJFOC-20160527765$JOHNSON AND JOHNSON$$79$YR$$F$Y$$$20200716$$CN$US$US
125122923$12512292$3$F$201602$20200811$20160630$20200817$PER$$US-JNJFOC-20160522950$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200817$$HP$US$US
125123053$12512305$3$F$201504$20200909$20160630$20200914$PER$$US-JNJFOC-20160525983$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200914$$CN$US$US
125123323$12512332$3$F$20141214$20200819$20160630$20200821$PER$$US-JNJFOC-20160520950$JOHNSON AND JOHNSON$$71$YR$E$M$Y$92.62$KG$20200821$$CN$US$US
125123353$12512335$3$F$20150717$20200809$20160630$20200813$PER$$US-JNJFOC-20160612432$JOHNSON AND JOHNSON$$43$YR$A$M$Y$$$20200813$$CN$US$US
125123575$12512357$5$F$20150211$20200726$20160630$20200731$PER$$US-JNJFOC-20160508597$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200731$$CN$US$US
125123873$12512387$3$F$20150525$20200818$20160630$20200821$PER$$US-JNJFOC-20160523446$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200821$$CN$US$US
125123883$12512388$3$F$20150715$20200701$20160630$20200706$PER$$US-JNJFOC-20160527973$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20200706$$CN$US$US
125123943$12512394$3$F$20130613$20200818$20160630$20200821$PER$$US-JNJFOC-20160528548$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200821$$CN$US$US
125123973$12512397$3$F$201505$20200811$20160630$20200814$PER$$US-JNJFOC-20160528565$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200814$$CN$US$US
125124243$12512424$3$F$20150601$20200726$20160630$20200730$PER$$US-JNJFOC-20160600192$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20200730$$HP$US$US
125124393$12512439$3$F$20140621$20200917$20160630$20200921$PER$$US-JNJFOC-20160517562$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200921$$CN$US$US
125124403$12512440$3$F$20141028$20200629$20160630$20200702$PER$$US-JNJFOC-20160520112$JOHNSON AND JOHNSON$$67$YR$$F$Y$59.02$KG$20200702$$CN$US$US
125124543$12512454$3$F$20141228$20200806$20160630$20200818$EXP$$US-JNJFOC-20160525288$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200818$$CN$US$US
125124663$12512466$3$F$201505$20200625$20160630$20200702$PER$$US-JNJFOC-20160524030$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200702$$HP$US$US
125124893$12512489$3$F$20140928$20200726$20160630$20200731$PER$$US-JNJFOC-20160525315$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20200731$$CN$US$US
125124913$12512491$3$F$20140630$20200628$20160630$20200702$PER$$US-JNJFOC-20160512477$JOHNSON AND JOHNSON$$75$YR$$F$Y$50.85$KG$20200702$$CN$US$US
125124924$12512492$4$F$20150926$20200803$20160630$20200806$PER$$US-JNJFOC-20160525316$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200806$$CN$US$US
125124943$12512494$3$F$20140703$20200707$20160630$20200709$PER$$US-JNJFOC-20160610400$JOHNSON AND JOHNSON$$74$YR$$M$Y$$$20200709$$CN$US$US
125125565$12512556$5$F$20150316$20200720$20160630$20200731$EXP$$US-JNJFOC-20160512471$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200731$$CN$US$US
125125613$12512561$3$F$201502$20200713$20160630$20200717$PER$$US-JNJFOC-20160528544$JOHNSON AND JOHNSON$$86$YR$$M$Y$$$20200717$$CN$US$US
125125833$12512583$3$F$20140620$20200818$20160630$20200824$PER$$US-JNJFOC-20160505358$JOHNSON AND JOHNSON$$94$YR$E$F$Y$$$20200824$$LW$US$US
125126152$12512615$2$F$20150624$20200818$20160630$20200820$PER$$US-JNJFOC-20160314756$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200820$$CN$US$US
125126473$12512647$3$F$20121006$20200820$20160630$20200901$EXP$$US-JNJFOC-20160506993$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20200901$$CN$US$US
125126763$12512676$3$F$20140427$20200820$20160630$20200825$PER$$US-JNJFOC-20160605883$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200825$$CN$US$US
125126823$12512682$3$F$20141117$20200624$20160630$20200707$EXP$$US-JNJFOC-20160606833$JOHNSON AND JOHNSON$$84$YR$$M$Y$$$20200707$$CN$US$US
125126963$12512696$3$F$20150916$20200916$20160630$20200929$EXP$$US-JNJFOC-20160522177$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200929$$CN$US$US
125127143$12512714$3$F$20141117$20200728$20160630$20200731$PER$$US-JNJFOC-20160516498$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20200731$$CN$US$US
125127274$12512727$4$F$201406$20200809$20160630$20200813$PER$$US-JNJFOC-20160508203$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200813$$CN$US$US
125127764$12512776$4$F$20150709$20200820$20160630$20200824$PER$$US-JNJFOC-20160519823$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200824$$CN$US$US
125128014$12512801$4$F$20141227$20200812$20160630$20200817$PER$$US-JNJFOC-20160509647$JOHNSON AND JOHNSON$$72$YR$E$F$Y$123$KG$20200817$$CN$US$US
125128073$12512807$3$F$20150104$20200708$20160630$20200714$PER$$US-JNJFOC-20160510596$JOHNSON AND JOHNSON$$36$YR$$F$Y$$$20200714$$CN$US$US
125128552$12512855$2$F$201409$20200720$20160630$20200731$PER$$US-JNJFOC-20160409173$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20200731$$CN$US$US
125129773$12512977$3$F$20141003$20200910$20160630$20200915$PER$$US-JNJFOC-20160510613$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200915$$CN$US$US
125130243$12513024$3$F$201309$20200628$20160630$20200709$EXP$$US-JNJFOC-20160513837$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20200709$$LW$US$US
125130283$12513028$3$F$20140904$20200906$20160630$20200914$PER$$US-JNJFOC-20160514066$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20200914$$CN$US$US
125130303$12513030$3$F$20140512$20200915$20160630$20200918$PER$$US-JNJFOC-20160514902$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200918$$LW$US$US
125130393$12513039$3$F$20140829$20200824$20160630$20200826$PER$$US-JNJFOC-20160524500$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200826$$CN$US$US
125131094$12513109$4$F$20141108$20200818$20160630$20200824$PER$$US-JNJFOC-20160522222$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20200824$$CN$US$US
125131824$12513182$4$F$201510$20200827$20160630$20200901$PER$$US-JNJFOC-20160525832$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200901$$CN$US$US
125131833$12513183$3$F$20150102$20200823$20160630$20200825$PER$$US-JNJFOC-20160526190$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200825$$CN$US$US
125131913$12513191$3$F$20140508$20200721$20160630$20200730$EXP$$US-JNJFOC-20160524345$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20200730$$CN$US$US
125131984$12513198$4$F$20150211$20200802$20160630$20200810$EXP$$US-JNJFOC-20160526301$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200810$$CN$US$US
125132133$12513213$3$F$2013$20200819$20160630$20200901$EXP$$US-JNJFOC-20160524428$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200901$$CN$US$US
125132423$12513242$3$F$20140613$20200629$20160630$20200706$PER$$US-JNJFOC-20160525392$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200706$$CN$US$US
125132443$12513244$3$F$20151014$20200713$20160630$20200717$PER$$US-JNJFOC-20160525606$JOHNSON AND JOHNSON$$80$YR$$M$Y$$$20200717$$CN$US$US
125132514$12513251$4$F$20150923$20200817$20160630$20200828$EXP$$US-JNJFOC-20160525293$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200828$$CN$US$US
125132614$12513261$4$F$20140508$20200720$20160630$20200722$PER$$US-JNJFOC-20160523292$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200722$$HP$US$US
125132674$12513267$4$F$20150710$20200903$20160630$20200909$PER$$US-JNJFOC-20160525308$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200909$$CN$US$US
125132813$12513281$3$F$201509$20200906$20160630$20200914$PER$$US-JNJFOC-20160524336$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200914$$CN$US$US
125132843$12513284$3$F$20150914$20200810$20160630$20200817$PER$$US-JNJFOC-20160525312$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20200817$$CN$US$US
125132923$12513292$3$F$20141101$20200906$20160630$20200914$PER$$US-JNJFOC-20160524540$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200914$$CN$US$US
125133263$12513326$3$F$20141202$20200823$20160630$20200826$PER$$US-JNJFOC-20160520139$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200826$$CN$US$US
125133293$12513329$3$F$20150508$20200629$20160630$20200706$PER$$US-JNJFOC-20160524431$JOHNSON AND JOHNSON$$62$YR$$M$Y$$$20200706$$CN$US$US
125133384$12513338$4$F$20140716$20200827$20160630$20200901$PER$$US-JNJFOC-20160525630$JOHNSON AND JOHNSON$$76$YR$E$F$Y$103.06$KG$20200901$$CN$US$US
125133583$12513358$3$F$20150828$20200716$20160630$20200722$PER$$US-JNJFOC-20160521454$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200722$$CN$US$US
125133603$12513360$3$F$201511$20200824$20160630$20200827$PER$$US-JNJFOC-20160521456$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200827$$CN$US$US
125133705$12513370$5$F$20150315$20200818$20160630$20200820$PER$$US-JNJFOC-20160523294$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200820$$LW$US$US
125133833$12513383$3$F$20150915$20200816$20160630$20200820$PER$$US-JNJFOC-20160520847$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200820$$HP$US$US
125134223$12513422$3$F$20150928$20200730$20160630$20200803$PER$$US-JNJFOC-20160524109$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200803$$CN$US$US
125134483$12513448$3$F$201511$20200824$20160630$20200827$PER$$US-JNJFOC-20160521415$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200827$$CN$US$US
125134584$12513458$4$F$201506$20200630$20160630$20200706$PER$$US-JNJFOC-20160525833$JOHNSON AND JOHNSON$$65$YR$$F$Y$$$20200706$$CN$US$US
125134613$12513461$3$F$20151112$20200817$20160630$20200821$PER$$US-JNJFOC-20160526197$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200821$$CN$US$US
125134653$12513465$3$F$20150331$20200723$20160630$20200731$PER$$US-JNJFOC-20160525888$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200731$$CN$US$US
125135063$12513506$3$F$20151214$20200909$20160630$20200914$EXP$$US-JNJFOC-20160526270$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20200914$$CN$US$US
125135083$12513508$3$F$20150612$20200813$20160630$20200819$PER$$US-JNJFOC-20160524433$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200819$$CN$US$US
125135555$12513555$5$F$20150518$20200727$20160630$20200731$PER$$US-JNJFOC-20160523214$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200731$$CN$US$US
125135563$12513556$3$F$201409$20200715$20160630$20200727$EXP$$US-JNJFOC-20160524440$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200727$$CN$US$US
125136323$12513632$3$F$20131101$20200810$20160630$20200813$PER$$US-JNJFOC-20160524778$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200813$$CN$US$US
125136453$12513645$3$F$20140505$20200825$20160630$20200827$PER$$US-JNJFOC-20160525297$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20200827$$CN$US$US
125136633$12513663$3$F$20140525$20200707$20160630$20200716$EXP$$US-JNJFOC-20160525734$JOHNSON AND JOHNSON$$79$YR$$F$Y$81.72$KG$20200716$$CN$US$US
125136806$12513680$6$F$20150127$20200702$20160630$20200714$EXP$$US-JNJFOC-20160527837$JOHNSON AND JOHNSON$$61$YR$$M$Y$$$20200714$$CN$US$US
125137084$12513708$4$F$20141024$20200917$20160630$20200930$EXP$$US-JNJFOC-20160520922$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200930$$CN$US$US
125137093$12513709$3$F$20150929$20200817$20160630$20200820$PER$$US-JNJFOC-20160521416$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200820$$CN$US$US
125137183$12513718$3$F$20150427$20200625$20160630$20200702$PER$$US-JNJFOC-20160521436$JOHNSON AND JOHNSON$$86$YR$$M$Y$$$20200702$$CN$US$US
125137253$12513725$3$F$20151222$20200719$20160630$20200722$PER$$US-JNJFOC-20160522938$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200722$$CN$US$US
125137303$12513730$3$F$201509$20200903$20160630$20200909$PER$$US-JNJFOC-20160522954$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20200909$$CN$US$US
125137343$12513734$3$F$20141108$20200908$20160630$20200918$PER$$US-JNJFOC-20160522642$JOHNSON AND JOHNSON$$80$YR$E$M$Y$80.81$KG$20200918$$CN$US$US
125137403$12513740$3$F$20151203$20200909$20160630$20200914$PER$$US-JNJFOC-20160522644$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200914$$CN$US$US
125137635$12513763$5$F$20150325$20200707$20160630$20200714$PER$$US-JNJFOC-20160528054$JOHNSON AND JOHNSON$$74$YR$$F$Y$$$20200714$$CN$US$US
125137665$12513766$5$F$20130412$20200802$20160630$20200805$PER$$US-JNJFOC-20160528058$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20200805$$CN$US$US
125137815$12513781$5$F$201407$20200716$20160630$20200720$PER$$US-JNJFOC-20160528076$JOHNSON AND JOHNSON$$52$YR$A$M$Y$129$KG$20200720$$CN$US$US
125138155$12513815$5$F$20151030$20200817$20160630$20200820$PER$$US-JNJFOC-20160523306$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200820$$CN$US$US
125138283$12513828$3$F$2015$20200922$20160630$20200928$PER$$US-JNJFOC-20160524158$JOHNSON AND JOHNSON$$64$YR$A$F$Y$131$KG$20200928$$CN$US$US
125138484$12513848$4$F$201312$20200901$20160630$20200914$PER$$US-JNJFOC-20160524586$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200914$$CN$US$US
125138513$12513851$3$F$20150128$20200913$20160630$20200917$PER$$US-JNJFOC-20160521443$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20200917$$CN$US$US
125138543$12513854$3$F$20150602$20200707$20160630$20200709$PER$$US-JNJFOC-20160521448$JOHNSON AND JOHNSON$$75$YR$$M$Y$64.47$KG$20200709$$CN$US$US
125138643$12513864$3$F$20160109$20200702$20160630$20200706$PER$$US-JNJFOC-20160524122$JOHNSON AND JOHNSON$$76$YR$$M$Y$$$20200706$$CN$US$US
125138663$12513866$3$F$201511$20200920$20160630$20200923$PER$$US-JNJFOC-20160524123$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200923$$CN$US$US
125138744$12513874$4$F$20160302$20200709$20160630$20200713$PER$$US-JNJFOC-20160522577$JOHNSON AND JOHNSON$$67$YR$$F$Y$$$20200713$$CN$US$US
125138883$12513888$3$F$20150420$20200812$20160630$20200817$PER$$US-JNJFOC-20160524132$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200817$$CN$US$US
125138896$12513889$6$F$201412$20200903$20160630$20200916$EXP$$US-JNJFOC-20160524639$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200916$$CN$US$US
125138915$12513891$5$F$20150303$20200730$20160630$20200804$PER$$US-JNJFOC-20160522590$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200804$$LW$US$US
125138973$12513897$3$F$20150418$20200917$20160630$20200922$PER$$US-JNJFOC-20160524130$JOHNSON AND JOHNSON$$68$YR$E$F$Y$56.3$KG$20200922$$CN$US$US
125138993$12513899$3$F$20150611$20200805$20160630$20200813$PER$$US-JNJFOC-20160521410$JOHNSON AND JOHNSON$$81$YR$E$M$Y$99.88$KG$20200813$$CN$US$US
125139143$12513914$3$F$2014$20200908$20160630$20200914$PER$$US-JNJFOC-20160524117$JOHNSON AND JOHNSON$$85$YR$E$F$Y$120$KG$20200914$$CN$US$US
125139163$12513916$3$F$20150825$20200721$20160630$20200731$PER$$US-JNJFOC-20160524131$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200731$$CN$US$US
125139173$12513917$3$F$20150623$20200723$20160630$20200730$PER$$US-JNJFOC-20160522652$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200730$$CN$US$US
125139233$12513923$3$F$201307$20200712$20160630$20200716$EXP$$US-JNJFOC-20160522657$JOHNSON AND JOHNSON$$76$YR$$F$Y$$$20200716$$CN$US$US
125139363$12513936$3$F$20150725$20200906$20160630$20200914$PER$$US-JNJFOC-20160524119$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200914$$CN$US$US
125139663$12513966$3$F$20140314$20200915$20160630$20200918$PER$$US-JNJFOC-20160528571$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200918$$CN$US$US
125139673$12513967$3$F$201411$20200906$20160630$20200914$PER$$US-JNJFOC-20160528574$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200914$$CN$US$US
125139733$12513973$3$F$20140923$20200723$20160630$20200730$PER$$US-JNJFOC-20160527725$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200730$$CN$US$US
125139743$12513974$3$F$20150519$20200825$20160630$20200827$PER$$US-JNJFOC-20160527727$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200827$$CN$US$US
125139833$12513983$3$F$20150627$20200630$20160630$20200706$PER$$US-JNJFOC-20160528000$JOHNSON AND JOHNSON$$95$YR$$F$Y$$$20200706$$CN$US$US
125139873$12513987$3$F$201507$20200819$20160630$20200824$PER$$US-JNJFOC-20160528006$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20200824$$CN$US$US
125139953$12513995$3$F$201409$20200817$20160630$20200824$PER$$US-JNJFOC-20160528012$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200824$$CN$US$US
125140005$12514000$5$F$20140923$20200927$20160630$20200930$PER$$US-JNJFOC-20160528820$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200930$$CN$US$US
125140013$12514001$3$F$201409$20200921$20160630$20200923$PER$$US-JNJFOC-20160527730$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20200923$$CN$US$US
125140213$12514021$3$F$20141017$20200902$20160630$20200916$EXP$$US-JNJFOC-20160527945$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200916$$CN$US$US
125140243$12514024$3$F$20120613$20200803$20160630$20200812$EXP$$US-JNJFOC-20160527902$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200812$$CN$US$US
125140254$12514025$4$F$20141208$20200909$20160630$20200914$PER$$US-JNJFOC-20160527750$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200914$$HP$US$US
125140263$12514026$3$F$20141217$20200901$20160630$20200903$EXP$$US-JNJFOC-20160527904$JOHNSON AND JOHNSON$$78$YR$E$M$Y$70.82$KG$20200903$$CN$US$US
125140383$12514038$3$F$20151120$20200825$20160630$20200908$EXP$$US-JNJFOC-20160527909$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20200908$$CN$US$US
125140664$12514066$4$F$20141010$20200628$20160630$20200709$EXP$$US-JNJFOC-20160528097$JOHNSON AND JOHNSON$$92$YR$$F$Y$$$20200709$$CN$US$US
125141163$12514116$3$F$20131117$20200811$20160630$20200814$PER$$US-JNJFOC-20160522662$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20200814$$CN$US$US
125141215$12514121$5$F$201506$20200910$20160630$20200923$EXP$$US-JNJFOC-20160522566$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200923$$CN$US$US
125141253$12514125$3$F$20121108$20200727$20160630$20200803$EXP$$US-JNJFOC-20160524174$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200803$$CN$US$US
125141273$12514127$3$F$20141010$20200729$20160630$20200805$PER$$US-JNJFOC-20160525164$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20200805$$CN$US$US
125141313$12514131$3$F$20150607$20200903$20160630$20200909$PER$$US-JNJFOC-20160524173$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200909$$CN$US$US
125141393$12514139$3$F$20150922$20200713$20160630$20200720$PER$$US-JNJFOC-20160525321$JOHNSON AND JOHNSON$$64$YR$A$M$Y$99.15$KG$20200720$$CN$US$US
125141483$12514148$3$F$20141017$20200826$20160630$20200831$PER$$US-JNJFOC-20160522667$JOHNSON AND JOHNSON$$74$YR$E$M$Y$92.9$KG$20200831$$CN$US$US
125141623$12514162$3$F$20140409$20200906$20160630$20200914$PER$$US-JNJFOC-20160522671$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200914$$CN$US$US
125141783$12514178$3$F$20141222$20200628$20160630$20200702$PER$$US-JNJFOC-20160528538$JOHNSON AND JOHNSON$$65$YR$$M$Y$$$20200702$$HP$US$US
125141996$12514199$6$F$201405$20200623$20160630$20200707$EXP$$US-JNJFOC-20160528051$JOHNSON AND JOHNSON$$77$YR$$M$Y$79$KG$20200707$$HP$US$US
125142263$12514226$3$F$20150331$20200806$20160630$20200811$PER$$US-JNJFOC-20160525142$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20200811$$CN$US$US
125142593$12514259$3$F$20150430$20200921$20160630$20200923$PER$$US-JNJFOC-20160522700$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200923$$CN$US$US
125142803$12514280$3$F$201601$20200701$20160630$20200707$PER$$US-JNJFOC-20160524928$JOHNSON AND JOHNSON$$46$YR$$F$Y$$$20200707$$HP$US$US
125142903$12514290$3$F$20140527$20200826$20160630$20200831$PER$$US-JNJFOC-20160524770$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20200831$$CN$US$US
125143193$12514319$3$F$20151129$20200910$20160630$20200915$PER$$US-JNJFOC-20160522883$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20200915$$CN$US$US
125143303$12514330$3$F$20140707$20200715$20160630$20200717$PER$$US-JNJFOC-20160524327$JOHNSON AND JOHNSON$$52$YR$$F$Y$$$20200717$$CN$US$US
125143335$12514333$5$F$2013$20200921$20160630$20200923$EXP$$US-JNJFOC-20160522589$JOHNSON AND JOHNSON$$9$DEC$E$M$Y$$$20200923$$LW$US$US
125143373$12514337$3$F$20150216$20200924$20160630$20200928$PER$$US-JNJFOC-20160527788$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200928$$CN$US$US
125143704$12514370$4$F$20141203$20200824$20160630$20200827$PER$$US-JNJFOC-20160527928$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200827$$CN$US$US
125143873$12514387$3$F$20140405$20200827$20160630$20200901$PER$$US-JNJFOC-20160527978$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200901$$CN$US$US
125143973$12514397$3$F$20130824$20200908$20160630$20200914$PER$$US-JNJFOC-20160527946$JOHNSON AND JOHNSON$$44$YR$A$F$Y$89.5$KG$20200914$$CN$US$US
125144013$12514401$3$F$201601$20200806$20160630$20200813$PER$$US-JNJFOC-20160527947$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200813$$CN$US$US
125144063$12514406$3$F$2015$20200818$20160630$20200824$EXP$$US-JNJFOC-20160527967$JOHNSON AND JOHNSON$$61$YR$A$F$Y$66.28$KG$20200824$$CN$US$US
125144103$12514410$3$F$20140523$20200809$20160630$20200818$EXP$$US-JNJFOC-20160527968$JOHNSON AND JOHNSON$$45$YR$A$M$Y$$$20200818$$CN$US$US
125144223$12514422$3$F$201212$20200825$20160630$20200908$EXP$$US-JNJFOC-20160528631$JOHNSON AND JOHNSON$$92$YR$E$F$Y$$$20200908$$CN$US$US
125144313$12514431$3$F$20151013$20200721$20160630$20200724$PER$$US-JNJFOC-20160528004$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200724$$CN$US$US
125144353$12514435$3$F$20150207$20200906$20160630$20200914$PER$$US-JNJFOC-20160528345$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200914$$CN$US$US
125144393$12514439$3$F$201509$20200818$20160630$20200831$EXP$$US-JNJFOC-20160528346$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200831$$CN$US$US
125144543$12514454$3$F$20141222$20200730$20160630$20200806$EXP$$US-JNJFOC-20160528533$JOHNSON AND JOHNSON$$24$YR$A$F$Y$$$20200806$$CN$US$US
125144764$12514476$4$F$20140224$20200901$20160630$20200903$PER$$US-JNJFOC-20160528049$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20200903$$CN$US$US
125145293$12514529$3$F$20160301$20200719$20160630$20200729$EXP$$US-JNJFOC-20160522939$JOHNSON AND JOHNSON$$86$YR$E$M$Y$90.8$KG$20200729$$CN$US$US
125145314$12514531$4$F$20150108$20200803$20160630$20200806$PER$$US-JNJFOC-20160523534$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200806$$CN$US$US
125145326$12514532$6$F$20141124$20200923$20160630$20200928$PER$$US-JNJFOC-20160523535$JOHNSON AND JOHNSON$$43$YR$A$M$Y$76.2$KG$20200928$$CN$US$US
125145463$12514546$3$F$20151115$20200706$20160630$20200709$PER$$US-JNJFOC-20160522942$JOHNSON AND JOHNSON$$76$YR$$M$Y$$$20200709$$CN$US$US
125145505$12514550$5$F$20150304$20200826$20160630$20200828$PER$$US-JNJFOC-20160523539$JOHNSON AND JOHNSON$$80$YR$E$F$Y$90.72$KG$20200828$$CN$US$US
125145604$12514560$4$F$20150513$20200630$20160630$20200714$EXP$$US-JNJFOC-20160522803$JOHNSON AND JOHNSON$$85$YR$$M$Y$$$20200714$$CN$US$US
125145643$12514564$3$F$20160217$20200707$20160630$20200713$PER$$US-JNJFOC-20160522946$JOHNSON AND JOHNSON$$67$YR$$F$Y$61.6$KG$20200713$$HP$US$US
125145735$12514573$5$F$201401$20200827$20160630$20200831$PER$$US-JNJFOC-20160523220$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200831$$CN$US$US
125145843$12514584$3$F$20141111$20200702$20160630$20200707$PER$$US-JNJFOC-20160525151$JOHNSON AND JOHNSON$$73$YR$$M$Y$83.54$KG$20200707$$HP$US$US
125146302$12514630$2$F$20150414$20160805$20160630$20160912$PER$$US-JNJFOC-20160524151$JANSSEN$$85$YR$E$M$Y$$$20160912$$CN$US$US
125146383$12514638$3$F$20150814$20200908$20160630$20200914$PER$$US-JNJFOC-20160524139$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200914$$CN$US$US
125146514$12514651$4$F$201602$20200630$20160630$20200706$PER$$US-JNJFOC-20160523228$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200706$$CN$US$US
125146933$12514693$3$F$20140619$20200714$20160630$20200717$PER$$US-JNJFOC-20160524775$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20200717$$CN$US$US
125146953$12514695$3$F$201307$20200826$20160630$20200831$PER$$US-JNJFOC-20160524781$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200831$$CN$US$US
125147133$12514713$3$F$20150414$20200729$20160630$20200805$PER$$US-JNJFOC-20160524546$JOHNSON AND JOHNSON$$91$YR$E$F$Y$$$20200805$$CN$US$US
125147163$12514716$3$F$20140608$20200928$20160630$20200930$PER$$US-JNJFOC-20160522738$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200930$$LW$US$US
125147324$12514732$4$F$201303$20200729$20160630$20200803$EXP$$US-JNJFOC-20160522376$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200803$$CN$US$US
125147914$12514791$4$F$201101$20200722$20160630$20200731$PER$$US-JNJFOC-20160529494$JOHNSON AND JOHNSON$$77$YR$E$M$Y$119.8$KG$20200731$$LW$US$US
125148404$12514840$4$F$20140918$20200721$20160630$20200730$EXP$$US-JNJFOC-20160522741$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200730$$CN$US$US
125148453$12514845$3$F$20150625$20200810$20160630$20200813$PER$$US-JNJFOC-20160526023$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20200813$$CN$US$US
125148514$12514851$4$F$20151228$20200916$20160630$20200921$PER$$US-JNJFOC-20160524667$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200921$$CN$US$US
125148533$12514853$3$F$20150826$20200816$20160630$20200820$PER$$US-JNJFOC-20160525972$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200820$$CN$US$US
125148563$12514856$3$F$20141223$20200628$20160630$20200709$EXP$$US-JNJFOC-20160523057$JOHNSON AND JOHNSON$$86$YR$$F$Y$$$20200709$$CN$US$US
125148603$12514860$3$F$20150727$20200908$20160630$20200914$PER$$US-JNJFOC-20160525975$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200914$$CN$US$US
125148684$12514868$4$F$20130823$20200803$20160630$20200812$EXP$$US-JNJFOC-20160526014$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20200812$$CN$US$US
125148813$12514881$3$F$20150718$20200831$20160630$20200903$PER$$US-JNJFOC-20160522873$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200903$$CN$US$US
125149064$12514906$4$F$20151019$20200806$20160630$20200813$PER$$US-JNJFOC-20160523308$JOHNSON AND JOHNSON$$68$YR$E$M$Y$102.88$KG$20200813$$LW$US$US
125149213$12514921$3$F$20140615$20200831$20160630$20200903$EXP$$US-JNJFOC-20160524771$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200903$$CN$US$US
125149313$12514931$3$F$20150601$20200727$20160630$20200731$PER$$US-JNJFOC-20160525290$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200731$$CN$US$US
125149653$12514965$3$F$20121014$20200712$20160630$20200714$PER$$US-JNJFOC-20160522805$JOHNSON AND JOHNSON$$67$YR$$M$Y$$$20200714$$CN$US$US
125149753$12514975$3$F$20140628$20200818$20160630$20200821$PER$$US-JNJFOC-20160525388$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20200821$$CN$US$US
125149803$12514980$3$F$20150306$20200719$20160630$20200722$PER$$US-JNJFOC-20160524349$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20200722$$CN$US$US
125149923$12514992$3$F$201202$20200628$20160630$20200702$PER$$US-JNJFOC-20160522798$JOHNSON AND JOHNSON$$84$YR$$M$Y$$$20200702$$CN$US$US
125149963$12514996$3$F$20160221$20200622$20160630$20200702$EXP$$US-JNJFOC-20160524338$JOHNSON AND JOHNSON$$75$YR$$F$Y$$$20200702$$CN$US$US
125150103$12515010$3$F$201601$20200811$20160630$20200821$EXP$$US-JNJFOC-20160525301$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20200821$$CN$US$US
125150113$12515011$3$F$20150627$20200721$20160630$20200731$PER$$US-JNJFOC-20160525302$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200731$$CN$US$US
125150153$12515015$3$F$20150328$20200707$20160630$20200713$PER$$US-JNJFOC-20160525303$JOHNSON AND JOHNSON$$69$YR$$F$Y$$$20200713$$CN$US$US
125150233$12515023$3$F$20141218$20200629$20160630$20200710$EXP$$US-JNJFOC-20160604911$JOHNSON AND JOHNSON$$95$YR$$F$Y$$$20200710$$CN$US$US
125150451$12515045$1$I$20150324$20150408$20160630$20160630$EXP$$JP-ROCHE-1564232$ROCHE$$48$YR$$M$Y$74$KG$20160630$$MD$JP$JP
125150733$12515073$3$F$20141225$20200720$20160630$20200724$PER$$US-JNJFOC-20160604924$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20200724$$CN$US$US
125150753$12515075$3$F$20140718$20200825$20160630$20200828$PER$$US-JNJFOC-20160604926$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200828$$CN$US$US
125150894$12515089$4$F$20140630$20200811$20160630$20200817$PER$$US-JNJFOC-20160604173$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200817$$CN$US$US
125151025$12515102$5$F$20141203$20200708$20160630$20200717$EXP$$US-JNJFOC-20160604944$JOHNSON AND JOHNSON$$63$YR$$F$Y$$$20200717$$CN$US$US
125151194$12515119$4$F$20160418$20200915$20160630$20200929$EXP$$US-JNJFOC-20160520696$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200929$$CN$US$US
125151424$12515142$4$F$2015$20200727$20160630$20200731$PER$$US-JNJFOC-20160515401$JOHNSON AND JOHNSON$$32$YR$A$F$Y$$$20200731$$CN$US$US
125151484$12515148$4$F$20140604$20200726$20160630$20200730$PER$$US-JNJFOC-20160601191$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200730$$CN$US$US
125151583$12515158$3$F$201411$20200831$20160630$20200902$PER$$US-JNJFOC-20160510597$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200902$$CN$US$US
125151623$12515162$3$F$20151105$20200825$20160630$20200828$PER$$US-JNJFOC-20160520967$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20200828$$CN$US$US
125151693$12515169$3$F$20151007$20200818$20160630$20200831$EXP$$US-JNJFOC-20160606690$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200831$$CN$US$US
125151703$12515170$3$F$20151119$20200921$20160630$20200928$PER$$US-JNJFOC-20160509727$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200928$$CN$US$US
125151733$12515173$3$F$201406$20200624$20160630$20200707$EXP$$US-JNJFOC-20160602576$JOHNSON AND JOHNSON$$81$YR$$M$Y$70.37$KG$20200707$$CN$US$US
125151754$12515175$4$F$20130103$20200630$20160630$20200706$PER$$US-JNJFOC-20160508204$JOHNSON AND JOHNSON$$77$YR$$M$Y$70.37$KG$20200706$$CN$US$US
125152213$12515221$3$F$20140523$20200803$20160630$20200805$PER$$US-JNJFOC-20160425732$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200805$$CN$US$US
125152233$12515223$3$F$20141002$20200816$20160630$20200820$PER$$US-JNJFOC-20160427034$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20200820$$CN$US$US
125152243$12515224$3$F$20140428$20200810$20160630$20200813$PER$$US-JNJFOC-20160427035$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200813$$CN$US$US
125152535$12515253$5$F$20140505$20200630$20160630$20200706$PER$$US-JNJFOC-20160425776$JOHNSON AND JOHNSON$$76$YR$$M$Y$$$20200706$$LW$US$US
125152832$12515283$2$F$$20200713$20160630$20200724$EXP$$TR-MACLEODS PHARMACEUTICALS US LTD-MAC2016002858$MACLEODS$$$$$$Y$$$20200724$$HP$GB$TR
125153713$12515371$3$F$20140828$20200916$20160630$20200921$PER$$US-JNJFOC-20160516539$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200921$$CN$US$US
125153915$12515391$5$F$20160205$20200805$20160630$20200811$PER$$US-JNJFOC-20160520699$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200811$$CN$US$US
125154054$12515405$4$F$201408$20200831$20160630$20200914$PER$$US-JNJFOC-20160521170$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200914$$LW$US$US
125154303$12515430$3$F$20130507$20200719$20160630$20200722$PER$$US-JNJFOC-20160502779$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20200722$$CN$US$US
125154593$12515459$3$F$20150428$20200709$20160630$20200717$PER$$US-JNJFOC-20160501473$JOHNSON AND JOHNSON$$50$YR$$F$Y$$$20200717$$CN$US$US
125154893$12515489$3$F$201510$20200913$20160630$20200917$PER$$US-JNJFOC-20160507089$JOHNSON AND JOHNSON$$80$YR$E$F$Y$72.64$KG$20200917$$CN$US$US
125154923$12515492$3$F$20141114$20200722$20160630$20200731$PER$$US-JNJFOC-20160507738$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20200731$$CN$US$US
125154933$12515493$3$F$20160108$20200820$20160630$20200824$PER$$US-JNJFOC-20160520697$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200824$$CN$US$US
125155313$12515531$3$F$201506$20200810$20160630$20200813$PER$$US-JNJFOC-20160502951$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200813$$CN$US$US
125155393$12515539$3$F$20141207$20200920$20160630$20200922$PER$$US-JNJFOC-20160500155$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200922$$CN$US$US
125155453$12515545$3$F$20141002$20200805$20160630$20200807$PER$$US-JNJFOC-20160502863$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20200807$$CN$US$US
125155523$12515552$3$F$20150217$20200715$20160630$20200721$PER$$US-JNJFOC-20160502851$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200721$$CN$US$US
125155853$12515585$3$F$201509$20200923$20160630$20200928$PER$$US-JNJFOC-20160502877$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200928$$CN$US$US
125155873$12515587$3$F$20140929$20200727$20160630$20200803$EXP$$US-JNJFOC-20160503978$JOHNSON AND JOHNSON$$91$YR$E$F$Y$$$20200803$$CN$US$US
125155903$12515590$3$F$20150628$20200830$20160630$20200901$PER$$US-JNJFOC-20160502865$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200901$$CN$US$US
125156223$12515622$3$F$20151214$20200913$20160630$20200915$PER$$US-JNJFOC-20160502857$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20200915$$CN$US$US
125156563$12515656$3$F$2015$20200916$20160630$20200921$PER$$US-JNJFOC-20160604130$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20200921$$CN$US$US
125156634$12515663$4$F$20160509$20200908$20160630$20200914$PER$$US-JNJFOC-20160528326$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200914$$CN$US$US
125156673$12515667$3$F$20140921$20200819$20160630$20200825$PER$$US-JNJFOC-20160604230$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200825$$CN$US$US
125156783$12515678$3$F$20140604$20200823$20160630$20200825$PER$$US-JNJFOC-20160512520$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20200825$$CN$US$US
125157033$12515703$3$F$20140615$20200727$20160630$20200731$PER$$US-JNJFOC-20160612128$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200731$$CN$US$US
125157153$12515715$3$F$20150226$20200629$20160630$20200706$PER$$US-JNJFOC-20160604219$JOHNSON AND JOHNSON$$65$YR$$F$Y$$$20200706$$CN$US$US
125157383$12515738$3$F$201410$20200719$20160630$20200722$PER$$US-JNJFOC-20160606443$JOHNSON AND JOHNSON$$39$YR$A$M$Y$$$20200722$$CN$US$US
125157432$12515743$2$F$201404$20200707$20160630$20200713$PER$$US-JNJFOC-20160500215$JOHNSON AND JOHNSON$$48$YR$$F$Y$$$20200713$$CN$US$US
125157453$12515745$3$F$20140103$20200906$20160630$20200909$PER$$US-JNJFOC-20160523056$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20200909$$CN$US$US
125157673$12515767$3$F$20140815$20200927$20160630$20200930$PER$$US-JNJFOC-20160523065$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200930$$CN$US$US
125158023$12515802$3$F$2015$20200706$20160630$20200708$PER$$US-JNJFOC-20160523458$JOHNSON AND JOHNSON$$$$$F$Y$$$20200708$$CN$US$US
125158563$12515856$3$F$20140707$20200630$20160630$20200714$EXP$$US-JNJFOC-20160523406$JOHNSON AND JOHNSON$$68$YR$$M$Y$$$20200714$$CN$US$US
125158613$12515861$3$F$201511$20200816$20160630$20200820$PER$$US-JNJFOC-20160522243$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200820$$CN$US$US
125158913$12515891$3$F$20140911$20200630$20160630$20200706$PER$$US-JNJFOC-20160523427$JOHNSON AND JOHNSON$$68$YR$$M$Y$$$20200706$$CN$US$US
125159063$12515906$3$F$20140710$20200818$20160630$20200820$PER$$US-JNJFOC-20160523436$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200820$$CN$US$US
125159314$12515931$4$F$20151119$20200908$20160630$20200914$PER$$US-JNJFOC-20160521329$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20200914$$HP$US$US
125159593$12515959$3$F$20150311$20200622$20160630$20200702$EXP$$US-JNJFOC-20160515367$JOHNSON AND JOHNSON$$61$YR$$M$Y$$$20200702$$CN$US$US
125159993$12515999$3$F$20150124$20200625$20160630$20200706$PER$$US-JNJFOC-20160521779$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200706$$CN$US$US
125160093$12516009$3$F$201501$20200630$20160630$20200706$PER$$US-JNJFOC-20160516630$JOHNSON AND JOHNSON$$50$YR$$F$Y$97.61$KG$20200706$$CN$US$US
125160103$12516010$3$F$201306$20200827$20160630$20200901$PER$$US-JNJFOC-20160516632$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200901$$CN$US$US
125160253$12516025$3$F$201505$20200709$20160630$20200721$EXP$$US-JNJFOC-20160509207$JOHNSON AND JOHNSON$$73$YR$$F$Y$$$20200721$$CN$US$US
125160883$12516088$3$F$20141113$20200920$20160630$20200923$PER$$US-JNJFOC-20160605361$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20200923$$CN$US$US
125160893$12516089$3$F$20151023$20200913$20160630$20200915$PER$$US-JNJFOC-20160608750$JOHNSON AND JOHNSON$$99$YR$E$F$Y$$$20200915$$CN$US$US
125161164$12516116$4$F$20140121$20200902$20160630$20200916$EXP$$US-JNJFOC-20160524799$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200916$$CN$US$US
125161363$12516136$3$F$20140823$20200722$20160630$20200731$PER$$US-JNJFOC-20160604202$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200731$$CN$US$US
125161653$12516165$3$F$20141020$20200809$20160630$20200813$PER$$US-JNJFOC-20160610406$JOHNSON AND JOHNSON$$63$YR$A$F$Y$99.79$KG$20200813$$CN$US$US
125161773$12516177$3$F$20151231$20200823$20160630$20200827$PER$$US-JNJFOC-20160524121$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200827$$CN$US$US
125162013$12516201$3$F$20140224$20200727$20160630$20200731$PER$$US-JNJFOC-20160508213$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200731$$CN$US$US
125162274$12516227$4$F$20150701$20200819$20160630$20200821$PER$$US-JNJFOC-20160618641$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200821$$CN$US$US
125162363$12516236$3$F$201407$20200702$20160630$20200708$EXP$$US-JNJFOC-20160618643$JOHNSON AND JOHNSON$$54$YR$$M$Y$$$20200708$$CN$US$US
125162373$12516237$3$F$20130927$20200713$20160630$20200716$PER$$US-JNJFOC-20160618644$JOHNSON AND JOHNSON$$52$YR$$M$Y$$$20200716$$CN$US$US
125162413$12516241$3$F$20150415$20200903$20160630$20200909$PER$$US-JNJFOC-20160521894$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200909$$CN$US$US
125162513$12516251$3$F$20150520$20200813$20160630$20200820$PER$$US-JNJFOC-20160521940$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200820$$CN$US$US
125162683$12516268$3$F$20150309$20200806$20160630$20200818$EXP$$US-JNJFOC-20160523403$JOHNSON AND JOHNSON$$68$YR$E$M$Y$117.59$KG$20200818$$CN$US$US
125163073$12516307$3$F$20150820$20200915$20160630$20200929$EXP$$US-JNJFOC-20160521327$JOHNSON AND JOHNSON$$79$YR$E$M$Y$90.62$KG$20200929$$CN$US$US
125163394$12516339$4$F$20120517$20200702$20160630$20200710$PER$$US-JNJFOC-20160508212$JOHNSON AND JOHNSON$$62$YR$$M$Y$104.32$KG$20200710$$CN$US$US
125163463$12516346$3$F$20140226$20200817$20160630$20200820$PER$$US-JNJFOC-20160618653$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200820$$CN$US$US
125164303$12516430$3$F$20140707$20200827$20160630$20200901$PER$$US-JNJFOC-20160507003$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200901$$CN$US$US
125164324$12516432$4$F$20140617$20200909$20160630$20200922$EXP$$US-JNJFOC-20160507010$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200922$$CN$US$US
125164423$12516442$3$F$201508$20200629$20160630$20200706$PER$$US-JNJFOC-20160521176$JOHNSON AND JOHNSON$$75$YR$$M$Y$$$20200706$$LW$US$US
125164473$12516447$3$F$20130919$20200909$20160630$20200914$PER$$US-JNJFOC-20160507597$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200914$$CN$US$US
125164494$12516449$4$F$20140808$20200629$20160630$20200706$PER$$US-JNJFOC-20160522229$JOHNSON AND JOHNSON$$82$YR$$M$Y$105.33$KG$20200706$$CN$US$US
125164704$12516470$4$F$201507$20200723$20160630$20200731$EXP$$US-JNJFOC-20160522380$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200731$$CN$US$US
125164784$12516478$4$F$20150725$20200813$20160630$20200817$PER$$US-JNJFOC-20160522374$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200817$$CN$US$US
125167971$12516797$1$I$20160503$20160615$20160630$20160630$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119319$RANBAXY$$64$YR$$F$Y$$$20160630$$HP$GB$GB
125174603$12517460$3$F$$20190222$20160630$20190308$EXP$$ES-ROCHE-1785348$ROCHE$GUILLENA S, MARTIN GUILLEN S, HURTADO GARCIA R AND ALVAREZ CIENFUEGOS A. UVEITIS DUE TO BISPHOSPHONATES: A RARE SIDE EFFECT?.. REUMATOLOGIA CLINICA 2016?12(2):119?.$51$YR$$F$Y$$$20190308$$MD$ES$ES
1251755712$12517557$12$F$20160603$20170724$20160630$20170728$EXP$$IT-JNJFOC-20160609020$JANSSEN$$75$YR$E$M$Y$71$KG$20170728$$MD$IT$IT
125175949$12517594$9$F$20160205$20200821$20160630$20200827$EXP$$PHHY2016CL088658$NOVARTIS$$58$YR$$F$Y$69.5$KG$20200827$$MD$CL$CL
1251765610$12517656$10$F$20151020$20200808$20160630$20200826$EXP$$PHHY2015CO045179$NOVARTIS$$50$YR$$F$Y$59$KG$20200826$$CN$COUNTRY NOT SPECIFIED$CO
125181062$12518106$2$F$2015$20200710$20160630$20200722$EXP$$US-ELI_LILLY_AND_COMPANY-US201606009795$ELI LILLY AND CO$$$$$F$Y$$$20200722$$CN$US$US
125200604$12520060$4$F$$20200713$20160630$20200715$PER$$US-PFIZER INC-2016323801$PFIZER$$60$YR$$F$Y$$$20200715$$PH$US$US
125201503$12520150$3$F$20160617$20160708$20160630$20160718$EXP$$GB-JNJFOC-20160625679$JANSSEN$$70$YR$E$M$Y$63.4$KG$20160718$$MD$GB$GB
125201622$12520162$2$F$201406$20200924$20160630$20200930$EXP$$US-BAYER-2015-456952$BAYER$$69$YR$E$F$Y$$$20200930$$CN$US$US
125201793$12520179$3$F$20160413$20160720$20160630$20160729$EXP$$DE-JNJFOC-20160416659$JANSSEN$$56$YR$A$M$Y$76.9$KG$20160729$$MD$DE$DE
125207562$12520756$2$F$20140827$20200716$20160701$20200727$EXP$$US-BAYER-2016-117831$BAYER$$63$YR$A$M$Y$$$20200727$$CN$US$US
125211748$12521174$8$F$20070514$20200908$20160701$20200911$EXP$$JP-ASTELLAS-2009JP000299$ASTELLAS$$18$YR$$F$Y$49$KG$20200911$$MD$JP$JP
125211991$12521199$1$I$20160412$20160628$20160701$20160701$EXP$$US-ASTELLAS-2016US025303$ASTELLAS$$71$YR$$F$Y$$$20160701$$CN$GB$US
125216262$12521626$2$F$2016$20200715$20160701$20200720$EXP$$CA-ABBVIE-16K-028-1665319-00$ABBVIE$$$$$F$Y$$$20200720$$CN$CA$CA
125216884$12521688$4$F$20160112$20200825$20160701$20200828$EXP$$BE-CELGENEUS-BEL-2016012416$CELGENE$$62$YR$$F$Y$55$KG$20200828$$MD$BE$BE
125217832$12521783$2$F$2013$20200909$20160701$20200917$EXP$$US-ABBVIE-16K-163-1597455-00$ABBVIE$$$$$F$Y$72.64$KG$20200916$$CN$US$US
125218802$12521880$2$F$20140613$20200629$20160701$20200714$EXP$$US-BAYER-2016-104990$BAYER$$69$YR$E$M$Y$$$20200714$$CN$US$US
125219754$12521975$4$F$201406$20200917$20160701$20200928$EXP$$US-JNJFOC-20160622593$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200928$$CN$US$US
125221364$12522136$4$F$20160523$20200811$20160701$20200820$EXP$$US-BIOGEN-2016BI00259471$BIOGEN$$54$YR$$F$Y$$$20200820$$CN$US$US
1252227520$12522275$20$F$20160623$20191001$20160701$20191015$EXP$$PHHY2016CO055860$NOVARTIS$$67$YR$$F$Y$46$KG$20191015$$CN$COUNTRY NOT SPECIFIED$CO
1252230616$12522306$16$F$20160611$20180308$20160701$20180312$EXP$$NZ-JNJFOC-20160625031$JANSSEN$$58$YR$A$M$Y$112$KG$20180312$$MD$NZ$NZ
125224641$12522464$1$I$$20160621$20160701$20160701$EXP$$FR-GLAXOSMITHKLINE-FR2014GSK055293$GLAXOSMITHKLINE$RENET S, CLOSON A, BROCHET MS, BUSSIERES JF, BOUCHER M. INCREASE IN TRANSAMINASE LEVELS FOLLOWING THE USE OF RALTEGRAVIR IN A WOMAN WITH A HIGH HIV VIRAL LOAD AT 35 WEEKS OF PREGNANCY.. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA. 2013?35 (1):68?72$$$I$M$Y$3.17$KG$20160701$$$COUNTRY NOT SPECIFIED$FR
125230894$12523089$4$F$20160622$20200129$20160701$20200211$EXP$$GB-ASTRAZENECA-2016SE69946$ASTRAZENECA$$24515$DY$$F$Y$51.1$KG$20200211$$MD$GB$GB
1252309818$12523098$18$F$20160512$20200806$20160701$20200813$EXP$$PHHY2016DE090677$NOVARTIS$$$$E$F$Y$65$KG$20200813$$MD$DE$DE
125234076$12523407$6$F$20150114$20200805$20160703$20200808$EXP$$PHHY2015US175952$NOVARTIS$$65$YR$$M$Y$$$20200808$$MD$US$US
1252360613$12523606$13$F$20150127$20200819$20160703$20200824$EXP$$PHHY2015US175948$NOVARTIS$$31$YR$$F$Y$112.47$KG$20200824$$MD$US$US
125237687$12523768$7$F$$20200629$20160704$20200706$PER$$CA-AMGEN-CANSP2016084270$AMGEN$$49$YR$A$F$Y$$$20200706$$CN$CA$CA
125238092$12523809$2$F$$20200625$20160704$20200704$EXP$$PT-ACCORD-041988$ACCORD$$17$YR$T$F$Y$$$20200704$$MD$PT$PT
125252241$12525224$1$I$20160417$20160418$20160704$20160704$EXP$$ES-JNJFOC-20160424220$PHARMACYCLICS$$75$YR$E$M$Y$60$KG$20160704$$MD$ES$ES
125255064$12525506$4$F$20141115$20200814$20160704$20200818$EXP$$PHHY2014US184544$NOVARTIS$$46$YR$$M$Y$84$KG$20200818$$MD$US$US
125265111$12526511$1$I$20160503$20160627$20160705$20160705$EXP$$PHFR2016GB005312$NOVARTIS$$64$YR$$F$Y$$$20160705$$HP$GB$GB
125268374$12526837$4$F$$20200807$20160705$20200820$PER$$US-BAYER-2016-126303$BAYER$$$$A$F$Y$100.68$KG$20200820$$LW$US$US
125270833$12527083$3$F$20120517$20200702$20160705$20200716$EXP$$US-BAYER-2016-092741$BAYER$$62$YR$A$M$Y$104.32$KG$20200716$$HP$US$US
125272611$12527261$1$I$$20160621$20160705$20160705$EXP$$FR-VIIV HEALTHCARE LIMITED-FR2014GSK055293$VIIV$RENET S, CLOSON A, BROCHET MS, BUSSIERES JF, BOUCHER M. INCREASE IN TRANSAMINASE LEVELS FOLLOWING THE USE OF RALTEGRAVIR IN A WOMAN WITH A HIGH HIV VIRAL LOAD AT 35 WEEKS OF PREGNANCY.. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA. 2013?35 (1):68?72$$$I$M$Y$3.17$KG$20160705$$$COUNTRY NOT SPECIFIED$FR
125272679$12527267$9$F$20150511$20200909$20160705$20200916$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2016JPN092059$VIIV$$5$DEC$$M$Y$$$20200916$$CN$JP$JP
125275498$12527549$8$F$2013$20200909$20160705$20200923$EXP$$CA-ROCHE-1626363$ROCHE$$58$YR$$F$Y$$$20200923$$CN$CA$CA
1252764511$12527645$11$F$201603$20200901$20160705$20200903$EXP$$US-PFIZER INC-2016320547$PFIZER$$68$YR$$F$Y$72.2$KG$20200903$$MD$US$US
1252816218$12528162$18$F$20160516$20200918$20160705$20200927$EXP$$CA-SA-2016SA100648$SANOFI AVENTIS$$$$$$Y$$$20200928$$HP$CA$CA
125281764$12528176$4$F$20160629$20160812$20160705$20160822$EXP$$FR-JNJFOC-20160627135$JANSSEN$$64$YR$A$M$Y$83$KG$20160822$$MD$FR$FR
125283285$12528328$5$F$2016$20200713$20160705$20200724$EXP$$JP-SHIRE-JP201608012$SHIRE$IWAMURO, M.? URATA, H.? TANAK, T.? KAWANO, S.? KAWAHARA, Y.? ET AL.. PATTERN OF GASTRIC LANTHANUM DEPOSITION BASED ON THE PRESENCE OR ABSENCE OF MUCOSAL ATROPHY. GASTROENTEROLOGICAL ENDOSCOPY. 2020?62(6):648?690$75$YR$$F$Y$$$20200724$$$COUNTRY NOT SPECIFIED$JP
125288312$12528831$2$F$20160619$20160706$20160705$20160715$EXP$$US-JNJFOC-20160620183$PHARMACYCLICS$$65$YR$A$F$Y$$$20160715$$MD$US$US
125301708$12530170$8$F$201611$20200701$20160706$20200706$EXP$$US-PFIZER INC-2016062485$PFIZER$$55$YR$$M$Y$95$KG$20200706$$MD$US$US
125312676$12531267$6$F$20160529$20180308$20160706$20180315$EXP$$IT-JNJFOC-20160600337$JANSSEN$$72$YR$E$M$Y$$$20180315$$CN$IT$IT
125313104$12531310$4$F$20160624$20170214$20160706$20170217$EXP$$AU-JNJFOC-20160625661$PHARMACYCLICS$$73$YR$E$M$Y$$$20170217$$MD$AU$AU
125321782$12532178$2$F$$20200824$20160706$20200831$EXP$$US-SA-2016SA121521$SANOFI AVENTIS$$$$$$Y$$$20200831$$CN$US$US
125323742$12532374$2$F$$20200629$20160706$20200708$EXP$$PT-MYLANLABS-2016M1027313$MYLAN$CRUZ S, MOREIRA AR, NEVES J, SEGURADO J, BRAZ F.. MIOPIZACAO AGUDA INDUZIDA POR TOPIRAMATO?CASO CLINICO.. 13 CONGRESSO PORTUGUES DE DIABETES? MEDICO NEWS.. 2017?37?40$17$YR$$F$Y$$$20200708$$MD$PT$PT
125347482$12534748$2$F$$20200622$20160706$20200706$EXP$IL-MLMSERVICE-20160616-0322873-1$IL-ALKEM LABORATORIES LIMITED-IL-ALKEM-2016-00045$ALKEM$$69$YR$$M$Y$$$20200706$$HP$GB$IL
125356197$12535619$7$F$2007$20200619$20160707$20200701$EXP$$PT-AUROBINDO-AUR-APL-2014-10265$AUROBINDO$ALMEIDA JP, LOPES A, BARBOSA M.. A CASE REPORT OF DELAYED HYPERSENSITIVITY TO ALL PPIS. REVISTA PORTUGUESA DE IMUNOALERGOLOGIA. 2016?24(1):31?6$39$YR$$F$Y$$$20200701$$HP$PT$PT
125370001$12537000$1$I$20160624$20160624$20160707$20160707$EXP$$US-JNJFOC-20160624453$JANSSEN$$25$YR$A$M$Y$$$20160707$$MD$US$US
125370011$12537001$1$I$20160618$20160624$20160707$20160707$EXP$$US-JNJFOC-20160624825$JANSSEN$$22$YR$A$M$Y$$$20160707$$MD$US$US
1253704611$12537046$11$F$20151101$20200707$20160707$20200710$PER$$US-PFIZER INC-2016314302$PFIZER$$42$YR$$M$Y$$$20200710$$MD$US$US
1253712110$12537121$10$F$20150828$20200903$20160707$20200916$EXP$$JP-JNJFOC-20160702158$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200916$$MD$JP$JP
125371782$12537178$2$F$201511$20200914$20160707$20200917$EXP$$US-JAZZ-2015-US-022772$JAZZ$$25$YR$$F$Y$$$20200917$$HP$US$US
125372032$12537203$2$F$201507$20200731$20160707$20200804$EXP$$US-JAZZ-2015-US-022704$JAZZ$$62$YR$$F$Y$52.15$KG$20200804$$HP$US$US
125372933$12537293$3$F$20160624$20161102$20160707$20161110$EXP$$US-JNJFOC-20160626009$PHARMACYCLICS$$79$YR$E$F$Y$67$KG$20161110$$MD$US$US
125377176$12537717$6$F$$20200707$20160707$20200714$EXP$$US-ARIAD PHARMACEUTICALS, INC-2016US006397$TAKEDA$$$$$F$Y$70$KG$20200714$$CN$US$US
125380683$12538068$3$F$$20200629$20160707$20200702$EXP$$US-JAZZ-2016-US-012192$JAZZ$$$$$F$Y$$$20200702$$CN$US$US
1253814714$12538147$14$F$2015$20200625$20160707$20200708$EXP$$US-BIOMARINAP-US-2016-109332$BIOMARIN$$14$YR$$F$Y$39.91$KG$20200708$$HP$US$US
1253883716$12538837$16$F$$20200914$20160708$20200918$PER$$CA-AMGEN-CANSP2016070695$AMGEN$$23$YR$A$F$Y$$$20200917$$HP$CA$CA
125408984$12540898$4$F$20140926$20200904$20160708$20200916$EXP$$JP-INCYTE CORPORATION-2016IN004161$INCYTE$$$$$$Y$$$20200916$$MD$JP$JP
125410803$12541080$3$F$20140731$20200921$20160708$20200928$PER$$US-JNJFOC-20160627611$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200928$$CN$US$US
125412264$12541226$4$F$20160629$20160914$20160708$20160922$EXP$$ES-JNJFOC-20160700489$PHARMACYCLICS$$64$YR$A$F$Y$71$KG$20160922$$MD$ES$ES
125413244$12541324$4$F$20160629$20170428$20160708$20170503$EXP$$FR-JNJFOC-20160705103$JANSSEN$$52$YR$A$F$Y$63$KG$20170503$$MD$FR$FR
125420104$12542010$4$F$$20200722$20160708$20200813$PER$$US-ACTELION-A-NJ2016-138831$ACTELION$$$$$F$Y$49.89$KG$20200813$$HP$US$US
125420643$12542064$3$F$20160622$20160818$20160708$20160822$EXP$$TW-PFIZER INC-2016330758$PFIZER$$47$YR$$M$Y$$$20160822$$MD$TW$TW
125431524$12543152$4$F$20140903$20200707$20160711$20200709$EXP$$BR-ROCHE-1461508$ROCHE$$60$YR$$F$Y$56$KG$20200709$$CN$BR$BR
125436464$12543646$4$F$2015$20200803$20160711$20200807$EXP$$US-JAZZ-2016-US-000368$JAZZ$$$$$F$Y$58.96$KG$20200807$$MD$US$US
125437134$12543713$4$F$$20200611$20160711$20200820$PER$$US-JAZZ-2016-US-000098$JAZZ$$$$$F$Y$77$KG$20200820$$CN$US$US
125443365$12544336$5$F$$20200611$20160711$20200616$EXP$$PHHY2015CO091793$NOVARTIS$$$$$F$Y$80$KG$20200616$$CN$CO$CO
125443598$12544359$8$F$$20200901$20160711$20200903$PER$$US-PFIZER INC-2016305988$PFIZER$$64$YR$$M$Y$$$20200903$$MD$US$US
125447251$12544725$1$I$20160614$20160616$20160711$20160711$EXP$$FR-ROCHE-1777750$ROCHE$$65$YR$$M$Y$84.1$KG$20160711$$MD$FR$FR
125451032$12545103$2$F$20160621$20160708$20160711$20160715$EXP$$US-JNJFOC-20160706680$PHARMACYCLICS$$71$YR$E$M$Y$$$20160715$$MD$US$US
125451182$12545118$2$F$20150707$20200731$20160711$20200811$EXP$$ES-CELGENEUS-ESP-2016066286$CELGENE$$57$YR$$F$Y$115.5$KG$20200811$$HP$ES$ES
125454574$12545457$4$F$20160428$20180524$20160711$20180529$EXP$$GR-JNJFOC-20160706004$JANSSEN$$88$YR$E$F$Y$$$20180529$$MD$GR$GR
125461362$12546136$2$F$20130205$20200825$20160711$20200827$EXP$$US-BAYER-2016-066804$BAYER$$75$YR$E$F$Y$$$20200827$$CN$US$US
125462333$12546233$3$F$20150916$20200916$20160711$20200925$EXP$$US-BAYER-2016-117008$BAYER$$77$YR$E$M$Y$$$20200925$$CN$US$US
125462642$12546264$2$F$20160519$20160630$20160711$20200701$EXP$$GR-JNJFOC-20160700237$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
125474671$12547467$1$I$$20160707$20160711$20160711$EXP$$GB-ROCHE-1790784$ROCHE$$51$YR$$F$Y$$$20160712$$MD$GB$GB
125480143$12548014$3$F$$20190828$20160712$20200130$EXP$$CA-BAUSCH-BL-2016-016022$BAUSCH AND LOMB$$$$$F$Y$$$20200130$$CN$CA$CA
125489101$12548910$1$I$20160426$20160630$20160712$20160712$EXP$$AU-JNJFOC-20160702550$JANSSEN$$69$YR$E$M$Y$$$20160712$$MD$AU$AU
125491352$12549135$2$F$2015$20200803$20160712$20200813$EXP$$US-BAYER-2016-070675$BAYER$$7$DEC$E$F$Y$$$20200813$$CN$US$US
125492922$12549292$2$F$20140619$20200621$20160712$20200701$EXP$$US-BAYER-2016-087024$BAYER$$69$YR$E$F$Y$$$20200701$$HP$US$US
125499617$12549961$7$F$20160701$20160824$20160712$20161006$EXP$$US-JNJFOC-20160702892$JANSSEN$$57$YR$A$F$Y$74.1$KG$20161006$$MD$US$US
125500017$12550001$7$F$201601$20200817$20160712$20200819$EXP$$US-PFIZER INC-2016334632$PFIZER$$58$YR$$F$Y$42.64$KG$20200819$$CN$US$US
125507269$12550726$9$F$20160627$20200713$20160712$20200721$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-056236$BRISTOL MYERS SQUIBB$SUGIMOTO T, ET AL. A CASE OF MALIGNANT MELANOMA WITH METASTASIS TO GASTROINTESTINAL TRACT WHERE DETAILED ENDOSCOPIC OBSERVATION WAS PERFORMED. THE 108TH REGULAR MEETING OF THE HOKURIKU BRANCH OF THE JAPAN GASTROENTEROLOGICA. 2016?33$79$YR$$M$Y$45$KG$20200721$$MD$JP$JP
125520367$12552036$7$F$201909$20200221$20160713$20200227$EXP$$PHHY2014CA094560$NOVARTIS$$68$YR$$F$Y$$$20200227$$CN$COUNTRY NOT SPECIFIED$CA
125523534$12552353$4$F$$20190828$20160713$20200205$EXP$$CA-GLAXOSMITHKLINE-CA2016GSK099380$GLAXOSMITHKLINE$$$$$F$Y$$$20200205$$CN$CA$CA
125531383$12553138$3$F$20160525$20160921$20160713$20160928$EXP$$ZA-JNJFOC-20160706503$JANSSEN$$43$YR$A$F$Y$61$KG$20160928$$MD$ZA$ZA
125533232$12553323$2$F$20160628$20161007$20160713$20161018$EXP$$PL-JNJFOC-20160704051$PHARMACYCLICS$$67$YR$E$F$Y$59.7$KG$20161018$$MD$PL$PL
125533542$12553354$2$F$20140929$20200727$20160713$20200805$EXP$$US-BAYER-2016-088356$BAYER$$91$YR$E$F$Y$$$20200805$$CN$US$US
125549383$12554938$3$F$$20200707$20160713$20200713$EXP$$US-BIOGEN-2016BI00263785$BIOGEN$$$$$F$Y$$$20200713$$CN$US$US
125552663$12555266$3$F$20150715$20200823$20160714$20200825$PER$$US-JNJFOC-20160705572$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200825$$CN$US$US
125553651$12555365$1$I$$20160629$20160714$20160714$EXP$$IT-CIPLA LTD.-2016IT09543$CIPLA$AGLIETTA M, BARONE C, SAWYER MB, MOORE MJ, MILLER WH JR, BAGALA C ET AL.,. A PHASE I DOSE ESCALATION TRIAL OF TREMELIMUMAB (CP?675,206) IN COMBINATION WITH GEMCITABINE IN CHEMOTHERAPY?NAIVE PATIENTS WITH METASTATIC PANCREATIC CANCER. ANNALS OF ONCOLOGY. 2014?25(9):1750 TO 1755$$$$$Y$$$20160714$$HP$IT$IT
125553691$12555369$1$I$$20160629$20160714$20160714$EXP$$IT-CIPLA LTD.-2016IT09531$CIPLA$AGLIETTA M, BARONE C, SAWYER MB, MOORE MJ, MILLER WH, BAGALA C ET AL.,. A PHASE I DOSE ESCALATION TRIAL OF TREMELIMUMAB (CP?675,206) IN COMBINATION WITH GEMCITABINE IN CHEMOTHERAPY?NAIVE PATIENTS WITH METASTATIC PANCREATIC CANCER. ANNALS OF ONCOLOGY. 2014?25:1750 TO 1755$$$$$Y$$$20160714$$HP$IT$IT
1255568010$12555680$10$F$2010$20200914$20160714$20200916$PER$$US-PFIZER INC-2016336251$PFIZER$$69$YR$$F$Y$43$KG$20200916$$MD$US$US
125557014$12555701$4$F$$20200720$20160714$20200721$EXP$$US-PFIZER INC-2016307821$PFIZER$$64$YR$$F$Y$$$20200721$$CN$US$US
125557264$12555726$4$F$$20200713$20160714$20200715$PER$$US-PFIZER INC-2016326514$PFIZER$$51$YR$$F$Y$$$20200715$$MD$US$US
125558361$12555836$1$I$$20140609$20160714$20160714$EXP$$IT-CIPLA LTD.-2014IT00546$CIPLA$AGLIETTA M, BARONE C, SAWYER MB, MOORE MJ, MILLER WH JR, BAGALA C ET AL.,. A PHASE I DOSE?ESCALATION TRIAL OF TREMELIMUMAB (CP?675,206) IN COMBINATION WITH GEMCITABINE IN CHEMOTHERAPY?NAIVE PATIENTS WITH METASTATIC PANCREATIC CANCER. ANNALS OF ONCOLOGY. 2014?25 (9):1750 TO 1755$$$$$Y$$$20160714$$HP$IT$IT
125562322$12556232$2$F$201512$20200729$20160714$20200803$EXP$$CA-PFIZER INC-2015459426$PFIZER$$57$YR$$F$Y$$$20200803$$HP$CA$CA
125564021$12556402$1$I$$20160629$20160714$20160714$EXP$$IT-CIPLA LTD.-2016IT09518$CIPLA$AGLIETTA M, BARONE C, SAWYER MB, MOORE MJ, MILLER WH, BAGALA C ET AL.,. A PHASE I DOSE ESCALATION TRIAL OF TREMELIMUMAB (CP?675,206) IN COMBINATION WITH GEMCITABINE IN CHEMOTHERAPY?NAIVE PATIENTS WITH METASTATIC PANCREATIC CANCER. ANNALS OF ONCOLOGY. 2016?25 (9):1750 TO 1755$$$$$Y$$$20160714$$HP$IT$IT
125564861$12556486$1$I$20150624$20150907$20160714$20160714$EXP$$FR-PFIZER INC-3001693$PFIZER$$65$YR$$F$Y$$$20160714$$CN$FR$FR
125568082$12556808$2$F$2015$20200818$20160714$20200826$EXP$$US-BAYER-2016-107670$BAYER$$61$YR$A$F$Y$66.28$KG$20200826$$CN$US$US
125575664$12557566$4$F$20160206$20200715$20160714$20200727$EXP$$ES-ASTELLAS-2016US027063$ASTELLAS$$60$YR$$M$Y$$$20200727$$CN$GB$ES
1255762618$12557626$18$F$20160625$20180618$20160714$20180627$EXP$$FR-JNJFOC-20160700586$JANSSEN$$67$YR$E$M$Y$70$KG$20180627$$MD$FR$FR
125579759$12557975$9$F$$20200807$20160714$20200812$EXP$$US-JAZZ-2016-US-000877$JAZZ$$$$$F$Y$117.46$KG$20200812$$HP$US$US
125580012$12558001$2$F$$20200720$20160714$20200921$PER$$US-JAZZ-2016-US-000481$JAZZ$$$$$F$Y$$$20200921$$CN$US$US
125592643$12559264$3$F$20140610$20200816$20160715$20200819$PER$$US-JNJFOC-20160709222$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200819$$CN$US$US
125595732$12559573$2$F$20150720$20191016$20160715$20191024$EXP$$PHHY2015CA076195$NOVARTIS$$50$YR$$F$Y$$$20191025$$CN$COUNTRY NOT SPECIFIED$CA
125614223$12561422$3$F$201301$20200721$20160715$20200729$EXP$$US-BAYER-2015-456430$BAYER$$76$YR$E$M$Y$$$20200729$$CN$US$US
125621498$12562149$8$F$20160224$20170222$20160715$20170302$EXP$$FR-JNJFOC-20160227868$JANSSEN$$67$YR$E$M$Y$96$KG$20170302$$MD$FR$FR
125622303$12562230$3$F$201406$20200917$20160715$20200925$EXP$$US-BAYER-2016-130305$BAYER$$83$YR$E$M$Y$$$20200925$$HP$US$US
1256350811$12563508$11$F$$20200629$20160715$20200706$PER$$CA-AMGEN-CANSP2016091090$AMGEN$$55$YR$A$F$Y$$$20200706$$HP$CA$CA
125635874$12563587$4$F$20160707$20200924$20160715$20200929$EXP$$US-JAZZ-2016-US-012720$JAZZ$$50$YR$$M$Y$$$20200929$$HP$US$US
1256388811$12563888$11$F$$20200629$20160716$20200707$PER$$CA-AMGEN-CANSP2016092280$AMGEN$$45$YR$A$F$Y$115$KG$20200707$$HP$CA$CA
125640213$12564021$3$F$$20200818$20160718$20200829$EXP$$US-AUROBINDO-AUR-APL-2016-08928$AUROBINDO$LEE J, ET AL.. LISINOPRIL/LOSARTAN CUTANEOUS PEMPHIGUS VEGETANS AND ORAL PEMPHIGUS VULGARIS: CASE REPORT. REACTIONS WEEKLY. 2016?1608:174$74$YR$$M$Y$$$20200829$$HP$US$US
1256412610$12564126$10$F$$20200629$20160718$20200707$PER$$CA-AMGEN-CANSP2016090901$AMGEN$$33$YR$A$F$Y$$$20200707$$HP$CA$CA
125646782$12564678$2$F$2010$20200811$20160718$20200814$EXP$$US-JAZZ-2016-US-000927$JAZZ$$$$$F$Y$$$20200814$$MD$US$US
125653383$12565338$3$F$20160708$20160909$20160718$20160913$EXP$$SE-JNJFOC-20160710274$JANSSEN$$67$YR$E$F$Y$77$KG$20160913$$MD$SE$SE
125655612$12565561$2$F$20141117$20200624$20160718$20200708$EXP$$US-BAYER-2016-116936$BAYER$$84$YR$E$M$Y$$$20200708$$CN$US$US
125657001$12565700$1$I$20160704$20160705$20160718$20160718$EXP$$CA-PFIZER INC-2016342251$PFIZER$$65$YR$$F$Y$$$20160718$$MD$CA$CA
125662091$12566209$1$I$20160512$20160618$20160718$20160718$EXP$$US-JNJFOC-20160617853$JANSSEN$$80$YR$E$F$Y$94$KG$20160718$$MD$US$US
125675163$12567516$3$F$$20200511$20160718$20200709$PER$$US-ASTELLAS-2016US025293$ASTELLAS$$$$A$M$Y$$$20200709$$CN$US$US
125684295$12568429$5$F$20150717$20200916$20160718$20200917$EXP$$US-BIOGEN-2016BI00264131$BIOGEN$$53$YR$$M$Y$64.01$KG$20200917$$CN$US$US
125689923$12568992$3$F$$20200727$20160719$20200728$EXP$$CA-ABBVIE-16K-028-1675501-00$ABBVIE$$53$YR$$M$Y$$$20200728$$CN$CA$CA
125691442$12569144$2$F$20140103$20200922$20160719$20200925$EXP$$US-BAYER-2015-460692$BAYER$$76$YR$E$M$Y$$$20200925$$CN$US$US
125694492$12569449$2$F$201407$20200823$20160719$20200903$EXP$$US-JNJFOC-20160700222$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200903$$CN$US$US
125700304$12570030$4$F$2016$20200924$20160719$20200929$PER$$US-PFIZER INC-2016344180$PFIZER$$63$YR$$F$Y$71$KG$20200929$$PH$US$US
1257041611$12570416$11$F$20080617$20200629$20160719$20200708$EXP$$CA-PFIZER INC-CA-WYE-H04658008$PFIZER$$45$YR$$F$Y$115$KG$20200708$$HP$CA$CA
125705605$12570560$5$F$20160701$20170623$20160719$20170629$EXP$$DE-PFIZER INC-2016344951$PFIZER$$53$YR$$M$Y$104$KG$20170629$$MD$DE$DE
1257057010$12570570$10$F$20140611$20200715$20160719$20200721$EXP$$JP-OTSUKA-JP-2014-20074$OTSUKA$$44$YR$$M$Y$71.9$KG$20200721$$MD$JP$JP
1257097812$12570978$12$F$2007$20200914$20160719$20200921$PER$$CA-AMGEN-CANSP2015119458$AMGEN$$41$YR$A$F$Y$$$20200921$$MD$CA$CA
1257115226$12571152$26$F$$20200925$20160719$20200928$EXP$$CA-PFIZER INC-2016324063$PFIZER$$85$YR$$M$Y$$$20200928$$HP$CA$CA
125715054$12571505$4$F$20160705$20200908$20160719$20200911$EXP$$CA-TAKEDA-2016TUS011816$TAKEDA$$50$YR$$F$Y$$$20200911$$MD$CA$CA
125721863$12572186$3$F$2014$20200817$20160719$20200824$EXP$$US-BAYER-2016-071330$BAYER$$72$YR$E$F$Y$$$20200824$$CN$US$US
1257223412$12572234$12$F$$20200629$20160719$20200707$EXP$$CA-PFIZER INC-2016348552$PFIZER$$33$YR$$F$Y$$$20200707$$HP$CA$CA
125725471$12572547$1$I$20160708$20160718$20160720$20160720$EXP$GB-MHRA-TPP6334938C1233142YC1467970542515$GB-ROCHE-1797132$ROCHE$$79$YR$$F$Y$58$KG$20160720$$MD$GB$GB
1257285213$12572852$13$F$2013$20200914$20160720$20200917$PER$$CA-AMGEN-CANSP2015113554$AMGEN$$76$YR$E$F$Y$$$20200916$$CN$CA$CA
125735463$12573546$3$F$$20200702$20160720$20200706$PER$$US-PFIZER INC-2016318628$PFIZER$$65$YR$$F$Y$$$20200706$$MD$US$US
125737543$12573754$3$F$$20200814$20160720$20200818$PER$$US-PFIZER INC-2016345216$PFIZER$$64$YR$$F$Y$$$20200818$$MD$US$US
1257375712$12573757$12$F$201607$20200727$20160720$20200728$EXP$$US-PFIZER INC-2016350525$PFIZER$$73$YR$$F$Y$64$KG$20200728$$CN$US$US
1257384626$12573846$26$F$2015$20200701$20160720$20200702$EXP$$CA-PFIZER INC-2016000793$PFIZER$$44$YR$$F$Y$$$20200702$$CN$CA$CA
125738922$12573892$2$F$201204$20200804$20160720$20200813$EXP$$US-BAYER-2016-081166$BAYER$$73$YR$E$F$Y$$$20200813$$CN$US$US
125739842$12573984$2$F$20160620$20160711$20160720$20160726$EXP$$RU-JNJFOC-20160618746$JANSSEN$$63$YR$A$F$Y$97.5$KG$20160726$$MD$RU$RU
125743783$12574378$3$F$20160229$20170421$20160720$20170428$EXP$$US-JNJFOC-20160401172$JANSSEN$$52$YR$A$M$Y$91$KG$20170428$$MD$US$US
125774723$12577472$3$F$201607$20200803$20160720$20200806$EXP$$US-JAZZ-2016-US-013014$JAZZ$$42$YR$$F$Y$$$20200806$$HP$US$US
125781663$12578166$3$F$20160707$20200709$20160721$20200717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000156$ACADIA PHARMACEUTICALS$$72$YR$$M$Y$68$KG$20200717$$HP$US$US
125787521$12578752$1$I$$20160707$20160721$20160721$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120570$RANBAXY$$51$YR$$F$Y$$$20160721$$HP$GB$GB
1257925715$12579257$15$F$201611$20200922$20160721$20200929$EXP$$CA-PFIZER INC-2016352411$PFIZER$$37$YR$$F$Y$$$20200929$$HP$CA$CA
125796932$12579693$2$F$20150311$20200622$20160721$20200706$EXP$$US-BAYER-2016-098913$BAYER$$61$YR$A$M$Y$$$20200706$$CN$US$US
125797143$12579714$3$F$20140628$20200818$20160721$20200824$EXP$$US-BAYER-2016-104134$BAYER$$53$YR$A$M$Y$$$20200824$$CN$US$US
125798513$12579851$3$F$2014$20200117$20160721$20200125$EXP$$PHHY2016AR092463$NOVARTIS$$$$$F$Y$$$20200125$$CN$COUNTRY NOT SPECIFIED$AR
125799146$12579914$6$F$20160425$20160923$20160721$20160930$EXP$$JP-ROCHE-1794704$ROCHE$$52$YR$$F$Y$$$20160930$$MD$JP$JP
1258064818$12580648$18$F$2007$20200922$20160721$20200923$EXP$$CA-PFIZER INC-2015383958$PFIZER$$41$YR$$F$Y$$$20200923$$CN$CA$CA
125807808$12580780$8$F$20151230$20200807$20160721$20200810$EXP$$US-PFIZER INC-2016351051$PFIZER$$68$YR$$F$Y$61$KG$20200810$$CN$US$US
125808805$12580880$5$F$20160712$20160811$20160721$20160817$EXP$$CH-JNJFOC-20160711631$JANSSEN$$5$DEC$A$F$Y$68$KG$20160817$$MD$CH$CH
125808873$12580887$3$F$20160701$20160801$20160721$20160805$EXP$$GB-PFIZER INC-2016339238$PFIZER$$71$YR$$F$Y$59.7$KG$20160805$$MD$GB$GB
125809454$12580945$4$F$20160612$20160830$20160721$20160906$EXP$$US-JNJFOC-20160615027$PHARMACYCLICS$$69$YR$E$M$Y$98$KG$20160906$$MD$US$US
125810468$12581046$8$F$201512$20200907$20160721$20200919$EXP$$JP-INCYTE CORPORATION-2016IN004348$INCYTE$$$$$$Y$$$20200919$$MD$JP$JP
125820252$12582025$2$F$20160705$20160826$20160722$20160904$EXP$$FR-ROCHE-1791998$ROCHE$$76$YR$$M$Y$70$KG$20160904$$MD$FR$FR
125820671$12582067$1$I$201407$20160704$20160722$20160722$EXP$GB-MHRA-ADR 23544912$GB-ACCORD-042247$ACCORD$$52$YR$$F$Y$$$20160722$$MD$GB$GB
1258253817$12582538$17$F$201606$20200714$20160722$20200723$EXP$$PHHY2016CA086482$NOVARTIS$$51$YR$$M$Y$$$20200723$$HP$CA$CA
125827642$12582764$2$F$20160324$20200325$20160722$20200722$PER$$US-FRI-1000084371$ALLERGAN$$80$YR$$F$Y$$$20200722$$CN$US$US
125829961$12582996$1$I$20160617$20160713$20160722$20160722$EXP$$US-JNJFOC-20160711695$JANSSEN$$$$$$Y$99.7$KG$20160722$$MD$US$US
125830043$12583004$3$F$20160705$20170223$20160722$20170302$EXP$$US-JNJFOC-20160715762$PHARMACYCLICS$$68$YR$E$F$Y$52$KG$20170302$$MD$US$US
125830056$12583005$6$F$$20200702$20160722$20200710$EXP$$US-BIOGEN-2016BI00267481$BIOGEN$$$$$M$Y$$$20200710$$MD$US$US
125833583$12583358$3$F$20150725$20200813$20160722$20200818$EXP$$US-BAYER-2016-100963$BAYER$$81$YR$E$M$Y$$$20200818$$HP$US$US
1258339717$12583397$17$F$2013$20200914$20160722$20200920$EXP$$CA-PFIZER INC-2015363640$PFIZER$$76$YR$$F$Y$$$20200920$$CN$CA$CA
125834793$12583479$3$F$$20200904$20160722$20200924$PER$$US-INCYTE CORPORATION-2016IN004264$INCYTE$$$$$$Y$$$20200924$$CN$US$US
125839744$12583974$4$F$20141114$20200811$20160722$20200812$EXP$$PHHY2016DE099773$NOVARTIS$$$$A$F$Y$$$20200812$$MD$DE$DE
125839786$12583978$6$F$20160710$20170427$20160722$20170509$EXP$$GB-JNJFOC-20160717227$ETHICON$$38$YR$A$F$Y$$$20170509$$CN$US$GB
125840376$12584037$6$F$20160501$20200825$20160722$20200903$PER$$PHHY2016US099422$NOVARTIS$$30$YR$$F$Y$$$20200903$$MD$US$US
125864824$12586482$4$F$20160208$20200803$20160725$20200805$PER$$US-PFIZER INC-2016313546$PFIZER$$79$YR$$F$Y$61$KG$20200805$$CN$US$US
125865123$12586512$3$F$2004$20200811$20160725$20200813$PER$$US-PFIZER INC-2016320338$PFIZER$$48$YR$$F$Y$91$KG$20200813$$CN$US$US
1258651312$12586513$12$F$20160628$20200803$20160725$20200805$PER$$US-PFIZER INC-2016323613$PFIZER$$67$YR$$F$Y$$$20200805$$HP$US$US
1258686011$12586860$11$F$2014$20200821$20160725$20200824$EXP$$US-PFIZER INC-2016352717$PFIZER$$65$YR$$F$Y$89$KG$20200824$$MD$US$US
125870004$12587000$4$F$20160708$20161025$20160725$20161102$EXP$$AT-JNJFOC-20160712719$JANSSEN$$49$YR$A$F$Y$69$KG$20161102$$MD$AT$AT
1258700618$12587006$18$F$201604$20200706$20160725$20200720$EXP$$CA-ROCHE-1799664$ROCHE$$60$YR$$F$Y$$$20200720$$CN$CA$CA
1258705010$12587050$10$F$20160630$20180411$20160725$20180416$EXP$$CA-ROCHE-1789583$ROCHE$$82$YR$$M$Y$53$KG$20180416$$MD$CA$CA
125871964$12587196$4$F$20160205$20200805$20160725$20200814$EXP$$US-BAYER-2016-100920$BAYER$$63$YR$A$F$Y$$$20200814$$CN$US$US
125872362$12587236$2$F$20160108$20200820$20160725$20200825$EXP$$US-BAYER-2016-100934$BAYER$$71$YR$E$F$Y$$$20200825$$HP$US$US
125874621$12587462$1$I$20160330$20160331$20160725$20160725$EXP$$CA-PFIZER INC-2016199603$PFIZER$$73$YR$$F$Y$$$20160725$$MD$CA$CA
125876342$12587634$2$F$201504$20200623$20160725$20200703$EXP$$US-BAYER-2016-105168$BAYER$$68$YR$E$M$Y$$$20200703$$CN$US$US
125876642$12587664$2$F$20150207$20200906$20160725$20200911$EXP$$US-BAYER-2016-107703$BAYER$$75$YR$E$F$Y$$$20200911$$CN$US$US
125879904$12587990$4$F$20140902$20200820$20160725$20200826$PER$$US-JNJFOC-20160714976$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20200826$$CN$US$US
125879913$12587991$3$F$20140702$20200831$20160725$20200903$EXP$$US-JNJFOC-20160715019$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200903$$CN$US$US
125880953$12588095$3$F$201407$20200702$20160725$20200716$EXP$$US-BAYER-2016-122677$BAYER$$54$YR$A$M$Y$$$20200716$$CN$US$US
125882953$12588295$3$F$2014$20200825$20160725$20200902$EXP$$US-JNJFOC-20160517853$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20200902$$CN$US$US
125899814$12589981$4$F$201407$20200709$20160725$20200720$EXP$$US-JNJFOC-20160715827$JOHNSON AND JOHNSON$$72$YR$$M$Y$$$20200720$$CN$US$US
125899823$12589982$3$F$20130702$20200712$20160725$20200714$PER$$US-JNJFOC-20160716178$JOHNSON AND JOHNSON$$89$YR$$F$Y$$$20200714$$CN$US$US
1259033626$12590336$26$F$20170107$20200805$20160725$20200817$PER$$US-ACTELION-A-US2016-139746$ACTELION$$65$YR$$F$Y$55.33$KG$20200817$$HP$US$US
125904227$12590422$7$F$2020$20200708$20160725$20200709$EXP$$US-JAZZ-2016-US-013440$JAZZ$$64$YR$$F$Y$$$20200709$$PH$US$US
125905666$12590566$6$F$20160721$20200731$20160725$20200803$EXP$$HU-ASTRAZENECA-2016SE79973$ASTRAZENECA$$15658$DY$$F$Y$$$20200803$$MD$GB$GB
125925389$12592538$9$F$$20200701$20160726$20200702$EXP$$PHEH2016US018264$NOVARTIS$$$$$F$Y$$$20200703$$CN$US$US
125925666$12592566$6$F$20160720$20190823$20160726$20190829$EXP$$JP-JNJFOC-20160720656$JOHNSON AND JOHNSON$$46$YR$$M$Y$62$KG$20190829$$MD$JP$JP
125926442$12592644$2$F$$20200714$20160726$20200821$PER$$US-INCYTE CORPORATION-2016IN004455$INCYTE$$$$$$Y$$$20200821$$CN$US$US
125926677$12592667$7$F$2016$20200828$20160726$20200901$PER$$US-PFIZER INC-2016323247$PFIZER$$54$YR$$F$Y$90.72$KG$20200901$$HP$US$US
125927782$12592778$2$F$20160403$20200809$20160726$20200814$EXP$$US-BAYER-2016-103187$BAYER$$83$YR$E$M$Y$$$20200814$$CN$US$US
125929622$12592962$2$F$20130828$20200628$20160726$20200708$EXP$$US-BAYER-2016-136974$BAYER$$75$YR$E$F$Y$$$20200708$$HP$US$US
125931353$12593135$3$F$$20200818$20160726$20200825$EXP$$PT-MYLANLABS-2016M1030022$MYLAN$VIANA S, GARCIA T.N, CALADO N, MAGALHAES M.F, SOLES I, ESCOTO V ET AL.. IATROGENIC DEMYELINATING EFFECT OF ANTI?DEPRESSIVE AGENTS. POSTER PRESENTED DURING THE 22ND CONGRESS OF INTERNAL MEDICINE (VIANA DO CASTELO. 2016?23:419$71$YR$$F$Y$$$20200825$$HP$PT$PT
125932612$12593261$2$F$20151014$20160726$20160726$20160803$EXP$$US-JNJFOC-20160719976$JANSSEN$$59$YR$A$F$Y$100$KG$20160803$$MD$US$US
125961272$12596127$2$F$$20200820$20160726$20200827$EXP$$US-ABBVIE-16P-163-1681478-00$ABBVIE$$$$$$Y$$$20200827$$MD$US$US
125970436$12597043$6$F$201502$20200827$20160726$20200910$EXP$$JP-INCYTE CORPORATION-2016IN004631$INCYTE$$$$$$Y$$$20200910$$MD$JP$JP
125973824$12597382$4$F$20160717$20161215$20160726$20161222$EXP$$GB-JNJFOC-20160717760$JANSSEN$$76$YR$E$M$Y$70$KG$20161222$$MD$GB$GB
125976156$12597615$6$F$20150526$20200716$20160726$20200728$EXP$$US-JNJFOC-20160624549$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200728$$CN$US$US
125982233$12598223$3$F$201503$20200917$20160726$20200923$PER$$US-JNJFOC-20160626778$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200923$$CN$US$US
125983295$12598329$5$F$20160715$20200811$20160726$20200814$EXP$$JP-GILEAD-2016-0224640$GILEAD$$77$YR$E$M$Y$62.9$KG$20200814$$MD$JP$JP
125983682$12598368$2$F$20160630$20170314$20160726$20170322$EXP$$CA-ABBVIE-16P-028-1669218-00$ABBVIE$$82$YR$$M$Y$55$KG$20170322$$MD$CA$CA
1259840916$12598409$16$F$20150713$20200914$20160726$20200921$EXP$$CA-PFIZER INC-2015389516$PFIZER$$46$YR$$F$Y$$$20200921$$MD$CA$CA
125993963$12599396$3$F$201407$20200909$20160727$20200914$PER$$US-JNJFOC-20160717079$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20200914$$CN$US$US
1260006210$12600062$10$F$20160714$20200716$20160727$20200724$EXP$$PHHY2016CA099882$NOVARTIS$$62$YR$$M$Y$90$KG$20200724$$HP$CA$CA
126007077$12600707$7$F$201608$20200708$20160727$20200711$EXP$$CA-TAKEDA-2016TUS012992$TAKEDA$$62$YR$$F$Y$92$KG$20200711$$CN$CA$CA
126009932$12600993$2$F$20160712$20160722$20160728$20160728$EXP$$JP-ROCHE-1799017$ROCHE$$61$YR$$F$Y$47$KG$20160728$$MD$JP$JP
126012663$12601266$3$F$201606$20200706$20160728$20200710$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055285$BRISTOL MYERS SQUIBB$ONO K, ET AL. A CASE OF FULMINANT TYPE 1 DIABETES MELLITUS CAUSED BY NIVOLUMAB THERAPY FOR LUNG ADENOCARCINOMA. 53RD KINKI REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY. 2016?120$65$YR$$M$Y$$$20200710$$MD$JP$JP
126018532$12601853$2$F$20160714$20161129$20160728$20161220$EXP$$IT-JNJFOC-20160717458$PHARMACYCLICS$$76$YR$E$F$Y$61$KG$20161220$$MD$IT$IT
126020158$12602015$8$F$2016$20200903$20160728$20200908$EXP$$US-PFIZER INC-2016000551$PFIZER$$57$YR$$M$Y$61.22$KG$20200908$$MD$US$US
126020836$12602083$6$F$$20200630$20160728$20200701$EXP$$US-PFIZER INC-2016338882$PFIZER$$38$YR$$F$Y$98.88$KG$20200701$$HP$US$US
126034846$12603484$6$F$20160619$20200604$20160728$20200616$EXP$$IL-JNJFOC-20160721424$JOHNSON AND JOHNSON$$75$YR$$M$Y$80$KG$20200616$$MD$IL$IL
126038733$12603873$3$F$20130820$20200923$20160728$20200928$PER$$US-JNJFOC-20160717171$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200928$$CN$US$US
126038764$12603876$4$F$20141123$20180322$20160728$20180327$EXP$$GB-JNJFOC-20141119520$JANSSEN$$47$YR$A$F$Y$110$KG$20180327$$MD$GB$GB
126039081$12603908$1$I$20160130$20160209$20160728$20160728$EXP$$DE-JNJFOC-20160207798$JANSSEN$$23$YR$A$F$Y$54$KG$20160728$$MD$DE$DE
1260506711$12605067$11$F$$20200914$20160728$20200921$PER$$CA-AMGEN-CANSP2016096856$AMGEN$$18$YR$A$F$Y$$$20200921$$MD$CA$CA
126056563$12605656$3$F$20160530$20161110$20160727$20161121$EXP$$GB2016K3504SPO$KRKA DD NOVO MESTO$$71$YR$$M$N$$$20161117$N$$GB$
126059296$12605929$6$F$20150507$20200727$20160729$20200813$PER$$JP-AMGEN-JPNCT2016098045$AMGEN$$87$YR$E$M$Y$$$20200813$$MD$JP$JP
1260612916$12606129$16$F$20160726$20200710$20160729$20200714$PER$$US-PFIZER INC-2016363456$PFIZER$$63$YR$$F$Y$$$20200714$$PH$US$US
126065143$12606514$3$F$201411$20200906$20160729$20200911$EXP$$US-BAYER-2016-106751$BAYER$$83$YR$E$F$Y$$$20200911$$CN$US$US
126073472$12607347$2$F$$20200706$20160729$20200709$PER$$US-PFIZER INC-2016366898$PFIZER$$44$YR$$F$Y$190.51$KG$20200709$$CN$US$US
1260755013$12607550$13$F$20160713$20180125$20160729$20180130$EXP$$FR-JNJFOC-20160724048$JANSSEN$$82$YR$E$M$Y$98$KG$20180130$$MD$FR$FR
1260763910$12607639$10$F$20160327$20200701$20160729$20200714$EXP$$US-INCYTE CORPORATION-2016IN004565$INCYTE$$$$$$Y$$$20200714$$CN$US$US
126076423$12607642$3$F$20160719$20170915$20160729$20170922$EXP$$AU-JNJFOC-20160724021$PHARMACYCLICS$$74$YR$E$M$Y$$$20170922$$MD$AU$AU
126076492$12607649$2$F$20160721$20160727$20160729$20160803$EXP$$FR-JNJFOC-20160722374$JANSSEN$$69$YR$E$M$Y$60$KG$20160803$$MD$FR$FR
126078199$12607819$9$F$201512$20200720$20160729$20200723$PER$$CA-AMGEN-CANSP2016097103$AMGEN$$64$YR$A$F$Y$$$20200722$$CN$CA$CA
126078534$12607853$4$F$20160722$20160822$20160729$20160826$EXP$$UA-JNJFOC-20160719051$PHARMACYCLICS$$71$YR$E$M$Y$70$KG$20160826$$MD$UA$UA
126079641$12607964$1$I$$20160720$20160729$20160729$EXP$$PHHY2016TR102248$NOVARTIS$EMRAL R, AYDOGAN BI, UYSAL AR, CORAPCIOGLU D. INVASIVE AND RECURRENT ACTH?PRODUCING PITUITARY MACROADENOMA. ENDOCRINE REVIEWS. 2014?35$29$YR$$M$Y$$$20160729$$HP$TR$TR
1260916611$12609166$11$F$2020$20200707$20160731$20200714$EXP$$CA-UCBSA-2016028099$UCB$$73$YR$$F$Y$$$20200714$$CN$CA$CA
1260916910$12609169$10$F$201705$20200811$20160731$20200819$EXP$$PHHY2016ZA020724$NOVARTIS$$41$YR$$F$Y$$$20200819$$CN$ZA$ZA
126095082$12609508$2$F$20151110$20181029$20160801$20181101$EXP$$US-ROCHE-1661649$ROCHE$$72$YR$$F$Y$57.2$KG$20181101$$MD$US$US
1260953111$12609531$11$F$201512$20200720$20160801$20200727$EXP$$CA-PFIZER INC-2016362505$PFIZER$$64$YR$$F$Y$$$20200727$$CN$CA$CA
126101081$12610108$1$I$20160708$20160718$20160801$20160801$EXP$GB-MHRA-TPP6334938C1233142YC1467970542515$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-121130$RANBAXY$$$$$$Y$$$20160801$$HP$GB$GB
1261012231$12610122$31$F$2016$20200123$20160801$20200129$EXP$$PHHY2016CA104286$NOVARTIS$$50$YR$$F$Y$$$20200129$$CN$COUNTRY NOT SPECIFIED$CA
126101382$12610138$2$F$20121008$20161122$20160801$20161206$EXP$$US-ROCHE-1805762$ROCHE$CHEN F, LI R, LALL A, KIM S, HIRSH D AND SCHWECHTER E ATYPICAL VANCOUVER TYPE?C PERIPROSTHETIC FRACTURE COMPLICATED BY NON?UNION [ARTICLE NUMBER E44]. THE JOURNAL OF BONE AND JOINT SURGERY CASE CONNECTOR 2015 MAY 27?5(2):1?5.$69$YR$$F$Y$$$20161206$$MD$US$US
126106085$12610608$5$F$201607$20200717$20160801$20200723$EXP$$US-SA-2016SA136761$SANOFI AVENTIS$$$$$$Y$$$20200723$$CN$US$US
1261065414$12610654$14$F$20151023$20200702$20160801$20200707$EXP$$JP-OTSUKA-2016_004955$OTSUKA$$37$YR$$F$Y$61.3$KG$20200707$$MD$JP$JP
1261080211$12610802$11$F$201606$20200928$20160801$20200930$EXP$$US-PFIZER INC-2016332491$PFIZER$$93$YR$$F$Y$66$KG$20200930$$CN$US$US
126108073$12610807$3$F$201606$20200902$20160801$20200904$PER$$US-PFIZER INC-2016334658$PFIZER$$70$YR$$M$Y$77.1$KG$20200904$$CN$US$US
126109163$12610916$3$F$201211$20200701$20160801$20200714$EXP$$US-JNJFOC-20160528550$JOHNSON AND JOHNSON$$81$YR$$M$Y$$$20200714$$CN$US$US
126110119$12611011$9$F$1993$20200814$20160801$20200827$PER$$US-PFIZER INC-2016362810$PFIZER$$25$YR$$F$Y$59.41$KG$20200827$$CN$US$US
126111346$12611134$6$F$2016$20200731$20160801$20200804$EXP$$US-SA-2016SA137818$SANOFI AVENTIS$$$$$$Y$$$20200804$$MD$US$US
126111443$12611144$3$F$20151013$20200721$20160801$20200727$EXP$$US-BAYER-2016-107815$BAYER$$77$YR$E$M$Y$$$20200727$$HP$US$US
126111923$12611192$3$F$201411$20200924$20160801$20200930$EXP$$US-BAYER-2016-109936$BAYER$$76$YR$E$F$Y$90.72$KG$20200930$$CN$US$US
126114843$12611484$3$F$201211$20200701$20160801$20200716$EXP$$US-BAYER-2016-120040$BAYER$$81$YR$E$M$Y$$$20200716$$HP$US$US
126115695$12611569$5$F$$20200723$20160801$20200805$EXP$$CA-PURDUE PHARMA-CAN-2016-0006921$PURDUE$$29$YR$$F$Y$$$20200804$$CN$CA$CA
126115882$12611588$2$F$201502$20200713$20160801$20200723$EXP$$US-BAYER-2016-107476$BAYER$$86$YR$E$M$Y$$$20200723$$CN$US$US
126117535$12611753$5$F$20160626$20180206$20160801$20180209$EXP$$US-JNJFOC-20160722807$PHARMACYCLICS$$86$YR$E$F$Y$$$20180209$$MD$US$US
126120262$12612026$2$F$20141015$20200830$20160801$20200911$EXP$$US-JNJFOC-20160521776$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200911$$CN$US$US
126120592$12612059$2$F$20150914$20170801$20160801$20170815$EXP$$AR-JNJFOC-20151010158$JANSSEN$$65$YR$A$M$Y$103$KG$20170815$$MD$AR$AR
1261220615$12612206$15$F$20150510$20200831$20160801$20200907$EXP$$PHHY2015CA089484$NOVARTIS$$39$YR$$F$Y$$$20200907$$MD$CA$CA
1261227518$12612275$18$F$$20200914$20160801$20200922$EXP$$CA-PFIZER INC-2016367129$PFIZER$$18$YR$$F$Y$$$20200922$$HP$CA$CA
126124233$12612423$3$F$20130823$20200803$20160801$20200813$EXP$$US-BAYER-2016-103371$BAYER$$63$YR$A$M$Y$$$20200813$$CN$US$US
1261263215$12612632$15$F$20150725$20200720$20160801$20200723$EXP$$US-ALLERGAN-1664412US$ALLERGAN$$$$$F$Y$67.6$KG$20200723$$MD$BR$US
126126939$12612693$9$F$$20200629$20160801$20200706$PER$$CA-AMGEN-CANSP2015128883$AMGEN$$71$YR$E$F$Y$$$20200706$$CN$CA$CA
126127406$12612740$6$F$$20200730$20160801$20200803$PER$$US-AMGEN-USASL2016096661$AMGEN$$11$YR$C$F$Y$$$20200803$$MD$US$US
126131181$12613118$1$I$$20160719$20160802$20160802$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-121207$RANBAXY$$69$YR$$F$Y$$$20160802$$HP$GB$US
1261365324$12613653$24$F$2015$20191220$20160802$20200108$EXP$$PHHY2015CA086395$NOVARTIS$$33$YR$$F$Y$$$20200108$$CN$COUNTRY NOT SPECIFIED$CA
126137715$12613771$5$F$$20200821$20160802$20200826$PER$$US-TAKEDA-2016MPI006683$TAKEDA$$$$$M$Y$$$20200826$$CN$US$US
126138978$12613897$8$F$20160718$20200811$20160802$20200813$PER$$US-PFIZER INC-2016354161$PFIZER$$72$YR$$F$Y$83$KG$20200813$$CN$US$US
126139524$12613952$4$F$201606$20200908$20160802$20200909$PER$$US-PFIZER INC-2016363401$PFIZER$$72$YR$$F$Y$77.11$KG$20200909$$CN$US$US
1261411310$12614113$10$F$20151119$20200728$20160802$20200803$EXP$$CN-ASTELLAS-2015JP023435AA$ASTELLAS$$77$YR$$M$Y$58$KG$20200803$$MD$CN$CN
126142233$12614223$3$F$20160728$20200727$20160802$20200803$EXP$$PHHY2016CA105268$NOVARTIS$$31$YR$$F$Y$$$20200803$$HP$CA$CA
126147081$12614708$1$I$$20160427$20160802$20160802$EXP$$CH-JNJFOC-20160426070$JANSSEN$$48$YR$A$F$Y$76.6$KG$20160802$$MD$CH$CH
126153642$12615364$2$F$20150515$20200803$20160802$20200813$EXP$$US-BAYER-2016-083078$BAYER$$79$YR$E$F$Y$$$20200813$$CN$US$US
126155572$12615557$2$F$201308$20200702$20160802$20200716$EXP$$US-BAYER-2016-083117$BAYER$$71$YR$E$M$Y$$$20200716$$HP$US$US
126158323$12615832$3$F$201409$20200817$20160802$20200824$EXP$$US-BAYER-2016-106893$BAYER$$57$YR$A$M$Y$$$20200824$$CN$US$US
126159502$12615950$2$F$20150214$20200706$20160802$20200717$EXP$$US-BAYER-2015-375358$BAYER$$70$YR$E$M$Y$166.62$KG$20200717$$CN$US$US
126164653$12616465$3$F$$20200928$20160802$20200929$PER$$US-PFIZER INC-2016102219$PFIZER$$$$$F$Y$$$20200929$$CN$US$US
126167503$12616750$3$F$$20160725$20160802$20200827$EXP$$US-TEVA-680308USA$TEVA$PETUKHOVA TA, MAVERAKIS E, HO B, SHARON VR. UROGYNECOLOGIC COMPLICATIONS IN STEVENS?JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: PRESENTATION OF A CASE AND RECOMMENDATIONS FOR MANAGEMENT. JAAD?CASE?REP 2016?2(3):202?205.$28$YR$A$F$Y$$$20200827$$MD$US$US
126169975$12616997$5$F$2016$20200908$20160803$20200914$EXP$$US-JAZZ-2016-US-014078$JAZZ$$$$$F$Y$$$20200914$$HP$US$US
126178525$12617852$5$F$20200716$20200721$20160803$20200723$PER$$US-PFIZER INC-2016363561$PFIZER$$67$YR$$F$Y$56$KG$20200723$$MD$US$US
126179521$12617952$1$I$20150901$20150903$20160803$20160803$EXP$$DE-ROCHE-1630674$ROCHE$$48$YR$$M$Y$$$20160803$$MD$DE$DE
126190754$12619075$4$F$20150618$20200901$20160803$20200914$PER$$US-JNJFOC-20160723096$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200914$$CN$US$US
126190764$12619076$4$F$20141017$20200630$20160803$20200706$PER$$US-JNJFOC-20160723139$JOHNSON AND JOHNSON$$92$YR$$F$Y$$$20200706$$CN$US$US
126191143$12619114$3$F$20160715$20200714$20160803$20200821$PER$$US-INCYTE CORPORATION-2016IN004572$INCYTE$$$$$$Y$$$20200821$$CN$US$US
1261948711$12619487$11$F$20160707$20200707$20160803$20200708$EXP$$US-PFIZER INC-2016283069$PFIZER$$86$YR$$F$Y$62$KG$20200708$$MD$US$US
1261994110$12619941$10$F$20160718$20180426$20160803$20180509$EXP$$FR-JNJFOC-20160725236$JANSSEN$$76$YR$E$M$Y$76$KG$20180509$$MD$FR$FR
126217472$12621747$2$F$$20200716$20160804$20200724$PER$$US-ASTRAZENECA-2016SE58815$ASTRAZENECA$$82$YR$$F$Y$63$KG$20200724$$$US$US
126222722$12622272$2$F$201409$20200921$20160804$20200925$EXP$$US-BAYER-2016-106899$BAYER$$30$YR$A$F$Y$$$20200925$$CN$US$US
126224344$12622434$4$F$20200311$20200814$20160804$20200819$EXP$$PHHY2016CA105063$NOVARTIS$$75$YR$$M$Y$$$20200819$$CN$COUNTRY NOT SPECIFIED$CA
126229461$12622946$1$I$20131101$20131202$20160804$20160804$EXP$$DE-JNJFOC-20131200340$JANSSEN$$66$YR$E$F$Y$74$KG$20160804$$MD$DE$DE
126230726$12623072$6$F$20160712$20170522$20160804$20170531$EXP$$FR-JNJFOC-20160800715$JANSSEN$$82$YR$E$F$Y$58$KG$20170531$$MD$FR$FR
126230761$12623076$1$I$20160211$20160212$20160804$20160804$EXP$$US-JNJFOC-20160214035$JANSSEN$$33$YR$A$M$Y$81.19$KG$20160804$$MD$US$US
126231123$12623112$3$F$20160606$20200819$20160804$20200901$EXP$$US-JNJFOC-20160801793$JOHNSON AND JOHNSON$$65$YR$E$M$Y$88.53$KG$20200901$$MD$US$US
126233463$12623346$3$F$20141104$20200812$20160804$20200825$EXP$$US-JNJFOC-20160616704$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200825$$CN$US$US
126251712$12625171$2$F$20150413$20200723$20160805$20200730$EXP$$US-BAYER-2015-375668$BAYER$$57$YR$A$F$Y$$$20200730$$CN$US$US
126254293$12625429$3$F$20160628$20200917$20160805$20200930$EXP$$FR-JNJFOC-20160802010$JOHNSON AND JOHNSON$$94$YR$E$F$Y$43$KG$20200930$$HP$FR$FR
126259892$12625989$2$F$20150122$20200818$20160805$20200825$EXP$$US-BAYER-2015-375621$BAYER$$85$YR$E$F$Y$$$20200825$$CN$US$US
126261013$12626101$3$F$20160725$20170424$20160805$20170502$EXP$$GB-JNJFOC-20160800349$JANSSEN$$63$YR$A$M$Y$70$KG$20170502$$MD$GB$GB
126263243$12626324$3$F$20150625$20160704$20160805$20200722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-037343$BRISTOL MYERS SQUIBB$$92$YR$$F$Y$44$KG$20200722$$MD$JP$JP
126265175$12626517$5$F$$20200903$20160805$20200907$PER$$US-PFIZER INC-2016353464$PFIZER$$60$YR$$F$Y$74.83$KG$20200907$$MD$US$US
1262652512$12626525$12$F$2015$20200730$20160805$20200803$PER$$US-PFIZER INC-2016374467$PFIZER$$68$YR$$M$Y$100$KG$20200803$$MD$US$US
126265763$12626576$3$F$20140802$20200825$20160805$20200908$EXP$$US-JNJFOC-20160801228$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200908$$CN$US$US
126269298$12626929$8$F$20160719$20191009$20160805$20191022$EXP$$FR-ROCHE-1806746$ROCHE$$59$YR$$F$Y$79$KG$20191023$$MD$FR$FR
126274615$12627461$5$F$$20200727$20160805$20200730$EXP$$US-INCYTE CORPORATION-2016IN004658$INCYTE$$$$$$Y$$$20200731$$MD$US$US
126274947$12627494$7$F$20160717$20160921$20160805$20160926$EXP$$KR-PFIZER INC-2016366831$PFIZER$$56$YR$$M$Y$$$20160926$$MD$KR$KR
126280371$12628037$1$I$$20160802$20160807$20160807$EXP$$US-ROCHE-1808125$ROCHE$$$$$F$Y$$$20160808$$CN$US$US
126281588$12628158$8$F$20160725$20200723$20160808$20200724$EXP$$DE-ROCHE-1808874$ROCHE$$42$YR$$F$Y$51$KG$20200724$$MD$DE$DE
126282562$12628256$2$F$20141222$20160912$20160808$20160920$EXP$$JP-ROCHE-1631078$ROCHE$$60$YR$$F$Y$39$KG$20160920$$MD$JP$JP
126284022$12628402$2$F$$20200605$20160808$20200820$PER$$US-JAZZ-2016-US-003953$JAZZ$$$$$F$Y$69.39$KG$20200820$$MD$US$US
126285154$12628515$4$F$2016$20200702$20160808$20200707$EXP$$US-JAZZ-2016-US-004382$JAZZ$$$$$F$Y$$$20200707$$CN$US$US
126285932$12628593$2$F$201602$20200518$20160808$20200820$PER$$US-JAZZ-2016-US-003934$JAZZ$$46$YR$$F$Y$45$KG$20200820$$HP$US$US
126286082$12628608$2$F$2011$20200501$20160808$20200820$PER$$US-JAZZ-2016-US-004010$JAZZ$$$$$F$Y$97.05$KG$20200820$$$US$US
126293213$12629321$3$F$20160315$20160830$20160808$20161214$EXP$$JP-ROCHE-1810050$ROCHE$$87$YR$$F$Y$$$20161214$$MD$JP$JP
126293852$12629385$2$F$20160727$20160802$20160808$20160811$EXP$$JP-ROCHE-1806832$ROCHE$$52$YR$$M$Y$$$20160811$$MD$JP$JP
126295173$12629517$3$F$20160624$20200914$20160808$20200925$PER$$US-CELGENEUS-USA-2016071285$CELGENE$$61$YR$$M$Y$70.82$KG$20200925$$MD$US$US
126298294$12629829$4$F$20140103$20200825$20160808$20200828$EXP$$US-BAYER-2016-106822$BAYER$$64$YR$A$M$Y$$$20200828$$CN$US$US
126301133$12630113$3$F$201101$20200722$20160808$20200729$EXP$$US-BAYER-2016-110841$BAYER$$77$YR$E$M$Y$119.8$KG$20200729$$LW$US$US
126302372$12630237$2$F$20150908$20200825$20160808$20200903$EXP$$US-BAYER-2016-150776$BAYER$$76$YR$E$M$Y$$$20200903$$HP$US$US
126303662$12630366$2$F$20151214$20200913$20160808$20200916$EXP$$US-BAYER-2016-088566$BAYER$$46$YR$A$M$Y$$$20200916$$CN$US$US
126303722$12630372$2$F$20140923$20200723$20160808$20200729$EXP$$US-BAYER-2016-106797$BAYER$$70$YR$E$M$Y$$$20200729$$LW$US$US
126305681$12630568$1$I$20160704$20160705$20160808$20160808$EXP$$JP-JNJFOC-20160708156$JANSSEN$$$$$$Y$$$20160808$$MD$JP$JP
126305892$12630589$2$F$2016$20200727$20160808$20200803$EXP$$US-BAYER-2016-078069$BAYER$$71$YR$E$M$Y$$$20200803$$CN$US$US
126333704$12633370$4$F$2014$20170109$20160809$20170120$EXP$$BY-ACTELION-A-CH2016-140244$ACTELION$$55$YR$A$F$Y$63$KG$20170120$$MD$BY$BY
126336432$12633643$2$F$20140723$20200809$20160809$20200817$EXP$$US-BAYER-2015-019562$BAYER$$69$YR$E$M$Y$$$20200817$$CN$US$US
1263438324$12634383$24$F$20160418$20200804$20160808$20200811$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK086557$GLAXOSMITHKLINE$$46$YR$$F$Y$78$KG$20200811$$CN$BR$BR
126345492$12634549$2$F$20150428$20200709$20160809$20200721$EXP$$US-BAYER-2016-087660$BAYER$$50$YR$A$F$Y$$$20200721$$CN$US$US
126346142$12634614$2$F$20141002$20200805$20160809$20200814$EXP$$US-BAYER-2016-088026$BAYER$$57$YR$A$F$Y$$$20200814$$CN$US$US
126346319$12634631$9$F$2013$20200629$20160809$20200707$PER$$CA-AMGEN-CANSP2016099056$AMGEN$$77$YR$E$M$Y$$$20200707$$HP$CA$CA
126346972$12634697$2$F$20150628$20200830$20160809$20200902$EXP$$US-BAYER-2016-088373$BAYER$$67$YR$E$M$Y$$$20200902$$CN$US$US
126348555$12634855$5$F$$20200713$20160809$20200715$PER$$US-PFIZER INC-2016341882$PFIZER$$67$YR$$F$Y$$$20200715$$MD$US$US
1263512311$12635123$11$F$201605$20200717$20160809$20200721$PER$$US-PFIZER INC-2016335918$PFIZER$$55$YR$$M$Y$91$KG$20200721$$CN$US$US
126352011$12635201$1$I$20160727$20160728$20160809$20160809$EXP$$ES-JNJFOC-20160803126$PHARMACYCLICS$$75$YR$E$M$Y$59$KG$20160809$$MD$ES$ES
126354923$12635492$3$F$20150609$20200625$20160809$20200708$EXP$$US-JNJFOC-20160804106$JOHNSON AND JOHNSON$$66$YR$$M$Y$$$20200708$$CN$US$US
1263566710$12635667$10$F$$20200629$20160809$20200704$PER$$CA-AMGEN-CANSP2016101720$AMGEN$$49$YR$A$F$Y$$$20200704$$CN$CA$CA
126356842$12635684$2$F$20130919$20200909$20160809$20200914$EXP$$US-BAYER-2016-093117$BAYER$$69$YR$E$F$Y$$$20200914$$CN$US$US
126358695$12635869$5$F$20160711$20200807$20160809$20200813$EXP$$FR-CELGENEUS-FRA-2016077146$CELGENE$$77$YR$$M$Y$73$KG$20200813$$MD$FR$FR
126363817$12636381$7$F$20160209$20200813$20160809$20200821$EXP$$CA-ROCHE-1810380$ROCHE$$43$YR$$M$Y$$$20200821$$CN$CA$CA
126387473$12638747$3$F$20121119$20200916$20160809$20200921$EXP$$PHHO2013PL015261$NOVARTIS$$9$YR$$F$Y$20.5$KG$20200921$$MD$PL$PL
126391617$12639161$7$F$20160227$20200211$20160810$20200812$EXP$$CA-ROCHE-1809806$ROCHE$$54$YR$$F$Y$$$20200812$$CN$CA$CA
1263935846$12639358$46$F$20121204$20200103$20160810$20200807$EXP$$PHEH2016US019856$NOVARTIS$$29$YR$$F$Y$$$20200807$$MD$US$US
1263987814$12639878$14$F$$20200805$20160810$20200817$EXP$$PHHY2015US131781$NOVARTIS$$$$$M$Y$$$20200817$$LW$US$US
1264009610$12640096$10$F$$20200805$20160810$20200813$PER$$PHHY2016US105184$NOVARTIS$$$$$F$Y$65.76$KG$20200813$$CN$US$US
1264060611$12640606$11$F$$20200902$20160810$20200908$EXP$$US-PFIZER INC-2016370902$PFIZER$$39$YR$$F$Y$57$KG$20200908$$HP$US$US
126411533$12641153$3$F$20140603$20200831$20160810$20200908$EXP$$US-BAYER-2016-123644$BAYER$$89$YR$E$M$Y$$$20200908$$CN$US$US
126411561$12641156$1$I$20160504$20160505$20160810$20160810$EXP$$RU-JNJFOC-20160506458$JANSSEN$$50$YR$A$M$Y$112.4$KG$20160810$$MD$RU$RU
126412456$12641245$6$F$$20200701$20160810$20200709$EXP$$US-PFIZER INC-2016358762$PFIZER$$66$YR$$F$Y$45.81$KG$20200709$$MD$US$US
126418532$12641853$2$F$201501$20200913$20160810$20200924$EXP$$US-JNJFOC-20160709271$JOHNSON AND JOHNSON$$21$YR$A$F$Y$$$20200924$$CN$US$US
126427289$12642728$9$F$2011$20200729$20160810$20200731$PER$$US-AMGEN-USASL2016101824$AMGEN$$42$YR$A$F$Y$$$20200730$$CN$US$US
126429054$12642905$4$F$201607$20200629$20160811$20200703$PER$$CA-AMGEN-CANSP2016102459$AMGEN$$65$YR$E$F$Y$70$KG$20200703$$CN$CA$CA
1264295218$12642952$18$F$$20200914$20160811$20200921$PER$$CA-AMGEN-CANSP2016102398$AMGEN$$47$YR$A$F$Y$$$20200921$$MD$CA$CA
1264385112$12643851$12$F$$20200629$20160811$20200708$EXP$$CA-PFIZER INC-2016368442$PFIZER$$77$YR$$M$Y$$$20200708$$MD$CA$CA
1264399426$12643994$26$F$1999$20200914$20160811$20200922$EXP$$CA-PFIZER INC-2016377290$PFIZER$$47$YR$$F$Y$$$20200922$$CN$CA$CA
126439982$12643998$2$F$20140810$20200630$20160811$20200714$EXP$$US-BAYER-2016-092582$BAYER$$79$YR$E$F$Y$56$KG$20200714$$HP$US$US
126443963$12644396$3$F$20160125$20200802$20160811$20200812$EXP$$US-BAYER-2016-130595$BAYER$$73$YR$E$M$Y$$$20200812$$HP$US$US
126444262$12644426$2$F$201508$20200817$20160811$20200820$EXP$$US-BAYER-2016-150602$BAYER$$86$YR$E$F$Y$$$20200820$$CN$US$US
1264491428$12644914$28$F$2007$20200811$20160811$20200814$EXP$$US-PFIZER INC-2016374437$PFIZER$$56$YR$$M$Y$82.54$KG$20200814$$CN$US$US
126451562$12645156$2$F$20160705$20161111$20160811$20161119$EXP$$CA-TEVA-684229ACC$TEVA$$60$YR$$F$Y$$$20161119$$MD$CA$CA
126451675$12645167$5$F$201511$20200706$20160811$20200710$PER$$US-JNJFOC-20160804141$JOHNSON AND JOHNSON$$73$YR$$M$Y$$$20200710$$CN$US$US
126454432$12645443$2$F$201401$20200908$20160811$20200911$EXP$$US-BAYER-2016-048246$BAYER$$72$YR$E$M$Y$$$20200911$$CN$US$US
126456818$12645681$8$F$$20200917$20160811$20200922$EXP$$CA-GLAXOSMITHKLINE-CA2016GSK112187$GLAXOSMITHKLINE$$$$$F$Y$$$20200922$$CN$CA$CA
126463361$12646336$1$I$20160614$20160802$20160812$20160812$EXP$$FR-BAXTER-2016BAX041234$BAXTER$$65$YR$$M$Y$$$20160811$$HP$FR$FR
126463411$12646341$1$I$20151108$20160802$20160812$20160812$EXP$$FR-BAXTER-2016BAX041243$BAXTER$$77$YR$$M$Y$$$20160811$$HP$FR$FR
126463433$12646343$3$F$20160705$20170330$20160812$20170410$EXP$$FR-BAXTER-2016BAX041237$BAXTER$$76$YR$$M$Y$$$20170410$$MD$FR$FR
126463481$12646348$1$I$20150821$20160802$20160812$20160812$EXP$$FR-BAXTER-2016BAX041245$BAXTER$$75$YR$$F$Y$$$20160811$$MD$FR$FR
126468938$12646893$8$F$20150529$20200729$20160812$20200807$EXP$$CA-ROCHE-1809774$ROCHE$$55$YR$$F$Y$$$20200807$$HP$CA$CA
126474362$12647436$2$F$20131217$20200716$20160812$20200727$EXP$$US-BAYER-2016-093257$BAYER$$77$YR$E$F$Y$$$20200727$$CN$US$US
126483798$12648379$8$F$20160530$20200609$20160812$20200701$EXP$$AU-CELGENEUS-AUS-2016060006$CELGENE$$49$YR$$M$Y$$$20200701$$HP$AU$AU
126485102$12648510$2$F$20140615$20200727$20160812$20200806$EXP$$US-BAYER-2016-121499$BAYER$$77$YR$E$F$Y$$$20200806$$CN$US$US
126486383$12648638$3$F$20151002$20200819$20160812$20200825$EXP$$US-BAYER-2016-139171$BAYER$$74$YR$E$F$Y$$$20200825$$CN$US$US
126486392$12648639$2$F$20141113$20200920$20160812$20200925$EXP$$US-BAYER-2016-122230$BAYER$$58$YR$A$M$Y$$$20200925$$CN$US$US
126486477$12648647$7$F$20160722$20200831$20160812$20200908$EXP$$FR-CELGENEUS-FRA-2016080319$CELGENE$$67$YR$$F$Y$69$KG$20200908$$HP$FR$FR
126489163$12648916$3$F$20160729$20160906$20160812$20160914$EXP$$US-JNJFOC-20160807337$PHARMACYCLICS$$71$YR$E$M$Y$$$20160914$$MD$US$US
126489172$12648917$2$F$20160413$20160919$20160812$20160928$EXP$$IT-JNJFOC-20160425369$PHARMACYCLICS$$79$YR$E$M$Y$63$KG$20160928$$MD$IT$IT
126490644$12649064$4$F$20160608$20200917$20160812$20200930$EXP$$FR-JNJFOC-20160809488$JOHNSON AND JOHNSON$$94$YR$E$F$Y$43$KG$20200930$$MD$FR$FR
126494936$12649493$6$F$20160805$20161004$20160812$20161014$EXP$$ES-JNJFOC-20160805695$JANSSEN$$68$YR$E$F$Y$60$KG$20161014$$MD$ES$ES
126497498$12649749$8$F$2016$20200819$20160812$20200824$EXP$$US-JAZZ-2016-US-014930$JAZZ$$$$$M$Y$$$20200824$$HP$US$US
126499062$12649906$2$F$20160303$20200624$20160813$20200707$EXP$$US-JNJFOC-20160705939$JOHNSON AND JOHNSON$$77$YR$$F$Y$$$20200707$$CN$US$US
126499702$12649970$2$F$$20200914$20160813$20200924$EXP$$CA-AUROBINDO-AUR-APL-2016-10121$AUROBINDO$NATARAJ J, ET AL.. RISPERIDONE/QUETIAPINE RABBIT SYNDROME: CASE REPORT. REACTIONS WEEKLY. 2016?1612:177$11$YR$$F$Y$$$20200924$$HP$CA$CA
126503092$12650309$2$F$20150126$20200730$20160814$20200806$EXP$$US-JNJFOC-20160619545$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20200806$$CN$US$US
1265043014$12650430$14$F$$20200629$20160814$20200706$PER$$CA-AMGEN-CANSP2016089419$AMGEN$$51$YR$A$M$Y$$$20200706$$CN$CA$CA
126506063$12650606$3$F$$20200706$20160815$20200713$PER$$US-BIOGEN-2016BI00276358$BIOGEN$$$$$F$Y$$$20200713$$CN$US$US
126507094$12650709$4$F$20151218$20181010$20160815$20181016$EXP$$US-ROCHE-1680545$ROCHE$$36$YR$$M$Y$95.7$KG$20181016$$MD$US$US
126510542$12651054$2$F$$20200506$20160815$20200820$PER$$US-JAZZ-2016-US-005445$JAZZ$$$$$M$Y$81.63$KG$20200820$$CN$US$US
126511018$12651101$8$F$20160810$20200706$20160815$20200713$PER$$US-BIOGEN-2016BI00277107$BIOGEN$$44$YR$$F$Y$$$20200713$$CN$US$US
126511874$12651187$4$F$$20200812$20160815$20200812$PER$$US-BIOGEN-2016BI00278002$BIOGEN$$$$$M$Y$$$20200812$$CN$US$US
126514012$12651401$2$F$20150126$20200730$20160815$20200811$EXP$$US-BAYER-2016-123254$BAYER$$61$YR$A$F$Y$$$20200811$$CN$US$US
126515712$12651571$2$F$20150226$20200629$20160815$20200710$EXP$$US-BAYER-2016-121786$BAYER$$65$YR$E$F$Y$$$20200710$$CN$US$US
126518527$12651852$7$F$20160331$20180406$20160815$20180409$EXP$$US-JNJFOC-20160810478$JANSSEN$$72$YR$E$F$Y$116$KG$20180409$$MD$US$US
126520252$12652025$2$F$2015$20200706$20160815$20200716$EXP$$US-BAYER-2016-102035$BAYER$$77$YR$E$F$Y$$$20200716$$HP$US$US
126525944$12652594$4$F$$20200828$20160815$20200901$PER$$US-PFIZER INC-2016385767$PFIZER$$66$YR$$M$Y$$$20200901$$MD$US$US
126527903$12652790$3$F$$20200717$20160815$20200727$EXP$$CA-APOTEX-2016AP010338$APOTEX$$73$YR$$F$Y$$$20200727$$HP$CA$CA
126528852$12652885$2$F$20150120$20200921$20160815$20200924$EXP$$US-BAYER-2016-041836$BAYER$$71$YR$E$M$Y$83.46$KG$20200924$$HP$US$US
126533272$12653327$2$F$$20200817$20160815$20200824$EXP$$US-ABBVIE-16P-163-1696946-00$ABBVIE$$$$$F$Y$$$20200824$$CN$US$US
126536632$12653663$2$F$$20170728$20160815$20170801$EXP$GB-MHRA-ADR 23595375$GB-ROCHE-1813328$ROCHE$$68$YR$$F$Y$68$KG$20170801$$CN$GB$GB
126538433$12653843$3$F$20190807$20200701$20160816$20200707$PER$$US-BIOGEN-2016BI00269854$BIOGEN$$53$YR$$F$Y$$$20200707$$MD$US$US
126539486$12653948$6$F$2016$20200623$20160816$20200703$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000325$ACADIA PHARMACEUTICALS$$70$YR$$F$Y$$$20200703$$CN$US$US
126544263$12654426$3$F$20160303$20200826$20160816$20200901$EXP$$US-BAYER-2016-075172$BAYER$$42$YR$A$F$Y$$$20200901$$HP$US$US
1265449545$12654495$45$F$20170519$20200824$20160816$20200827$EXP$$PHHY2016CO111394$NOVARTIS$$48$YR$$F$Y$74$KG$20200827$$HP$CO$CO
1265456639$12654566$39$F$$20200928$20160816$20200930$EXP$$PHHY2015US133640$NOVARTIS$$$$$F$Y$$$20200930$$LW$US$US
126546932$12654693$2$F$20150309$20200806$20160816$20200817$EXP$$US-BAYER-2016-101926$BAYER$$68$YR$E$M$Y$117.59$KG$20200817$$CN$US$US
126551692$12655169$2$F$20150525$20200818$20160816$20200824$EXP$$US-BAYER-2016-101847$BAYER$$68$YR$E$F$Y$$$20200824$$CN$US$US
126552222$12655222$2$F$20160803$20160907$20160816$20160915$EXP$$IT-JNJFOC-20160808204$JANSSEN$$70$YR$E$F$Y$$$20160915$$MD$IT$IT
126552614$12655261$4$F$$20191213$20160816$20200701$EXP$$US-SA-2016SA145845$SANOFI AVENTIS$$$$$$Y$$$20200701$$CN$US$US
126554499$12655449$9$F$$20200721$20160816$20200727$EXP$$US-JAZZ-2016-US-015020$JAZZ$$$$$F$Y$$$20200727$$CN$US$US
126554562$12655456$2$F$20121108$20200727$20160816$20200803$EXP$$US-BAYER-2016-102796$BAYER$$68$YR$E$M$Y$$$20200803$$CN$US$US
126554782$12655478$2$F$20150607$20200903$20160816$20200909$EXP$$US-BAYER-2016-102848$BAYER$$79$YR$E$M$Y$$$20200909$$CN$US$US
126555212$12655521$2$F$20151225$20200624$20160816$20200706$EXP$$US-BAYER-2016-103084$BAYER$$61$YR$A$M$Y$$$20200706$$CN$US$US
126558512$12655851$2$F$20160810$20200801$20160816$20200804$PER$$US-PFIZER INC-2016387714$PFIZER$$48$YR$$F$Y$$$20200804$$MD$US$US
126559702$12655970$2$F$20141101$20200728$20160816$20200807$EXP$$US-BAYER-2016-116608$BAYER$$72$YR$E$F$Y$$$20200807$$HP$US$US
126559712$12655971$2$F$20160303$20200624$20160816$20200706$EXP$$US-BAYER-2016-138155$BAYER$$77$YR$E$F$Y$$$20200706$$CN$US$US
126560782$12656078$2$F$201603$20200630$20160816$20200715$EXP$$US-BAYER-2016-139042$BAYER$$79$YR$E$F$Y$$$20200715$$CN$US$US
126560792$12656079$2$F$20140815$20200721$20160816$20200730$EXP$$US-BAYER-2016-116687$BAYER$$69$YR$E$M$Y$$$20200730$$HP$US$US
126576754$12657675$4$F$20160727$20161111$20160816$20161118$EXP$$UA-JNJFOC-20160803587$JANSSEN$$56$YR$A$M$Y$100$KG$20161118$$MD$UA$UA
1265776113$12657761$13$F$201804$20200713$20160816$20200724$EXP$$US-ACTELION-A-NJ2016-140647$ACTELION$$73$YR$$F$Y$83.45$KG$20200724$$MD$US$US
126583592$12658359$2$F$20160111$20190906$20160817$20190919$EXP$$US-ROCHE-1693756$ROCHE$$50$YR$$M$Y$77.5$KG$20190919$$MD$US$US
126588732$12658873$2$F$20160802$20160802$20160817$20200701$EXP$$GR-JNJFOC-20150504323$JOHNSON AND JOHNSON$$$$E$M$Y$$$20200701$$CN$GR$GR
126589743$12658974$3$F$2016$20191118$20160817$20200707$EXP$$US-SA-2016SA145982$SANOFI AVENTIS$$$$$$Y$$$20200707$$CN$US$US
126589892$12658989$2$F$20131120$20200806$20160817$20200814$EXP$$US-BAYER-2015-466833$BAYER$$80$YR$E$M$Y$87.99$KG$20200814$$LW$US$US
126590292$12659029$2$F$201308$20200730$20160817$20200811$EXP$$US-BAYER-2016-041577$BAYER$$79$YR$E$M$Y$$$20200811$$HP$US$US
1265916227$12659162$27$F$2006$20200810$20160817$20200812$EXP$$US-PFIZER INC-2016366847$PFIZER$$68$YR$$F$Y$79$KG$20200812$$CN$US$US
126591682$12659168$2$F$20151203$20200909$20160817$20200914$EXP$$US-BAYER-2016-102943$BAYER$$62$YR$A$M$Y$$$20200914$$HP$US$US
126592892$12659289$2$F$20141108$20200908$20160817$20200917$EXP$$US-BAYER-2016-102975$BAYER$$80$YR$E$M$Y$80.81$KG$20200917$$CN$US$US
126593932$12659393$2$F$201511$20200824$20160817$20200827$EXP$$US-BAYER-2016-102715$BAYER$$69$YR$E$M$Y$$$20200827$$HP$US$US
1265959719$12659597$19$F$2016$20200904$20160817$20200908$EXP$$CA-PFIZER INC-2016384972$PFIZER$$62$YR$$F$Y$$$20200908$$MD$CA$CA
126596579$12659657$9$F$20141025$20200817$20160817$20200831$EXP$$JP-INCYTE CORPORATION-2016IN004791$INCYTE$$$$$$Y$$$20200831$$MD$JP$JP
126596905$12659690$5$F$20160404$20200804$20160817$20200804$EXP$$PHHY2016US111004$NOVARTIS$$54$YR$$F$Y$72$KG$20200804$$CN$US$US
1265999316$12659993$16$F$$20200629$20160817$20200707$EXP$$CA-PFIZER INC-2016335872$PFIZER$$51$YR$$M$Y$$$20200707$$CN$CA$CA
126605222$12660522$2$F$20150903$20200702$20160817$20200715$EXP$$US-JNJFOC-20160619551$JOHNSON AND JOHNSON$$77$YR$$F$Y$$$20200715$$CN$US$US
126616265$12661626$5$F$20140821$20200805$20160817$20200807$PER$$US-PFIZER INC-2016388696$PFIZER$$55$YR$$M$Y$$$20200807$$HP$US$US
1266185012$12661850$12$F$2015$20200807$20160817$20200811$EXP$$US-PFIZER INC-2016387075$PFIZER$$59$YR$$F$Y$82$KG$20200811$$HP$US$US
126618838$12661883$8$F$20150810$20200820$20160817$20200903$EXP$$JP-INCYTE CORPORATION-2016IN001171$INCYTE$$$$$$Y$$$20200903$$MD$JP$JP
126622303$12662230$3$F$201607$20200630$20160817$20200702$EXP$$US-JAZZ-2016-US-015121$JAZZ$$20$YR$$F$Y$$$20200702$$MD$US$US
126622326$12662232$6$F$2016$20160930$20160817$20200929$EXP$$US-JAZZ-2016-US-015327$JAZZ$$56$YR$$M$Y$$$20200929$$MD$US$US
126622502$12662250$2$F$20150601$20200830$20160817$20200911$EXP$$US-JNJFOC-20160524545$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20200911$$CN$US$US
126622922$12662292$2$F$20160801$20160810$20160817$20160819$EXP$$BE-JNJFOC-20160812016$JANSSEN$$64$YR$A$M$Y$76$KG$20160819$$MD$BE$BE
126622937$12662293$7$F$20160531$20181017$20160817$20181022$EXP$$AT-JNJFOC-20160616619$JANSSEN$$76$YR$E$F$Y$81$KG$20181022$$MD$AT$AT
126624031$12662403$1$I$2016$20160809$20160817$20160817$EXP$$AU-009507513-1608AUS006068$MERCK$$$$$F$Y$$$20160817$$HP$AU$AU
126632233$12663223$3$F$20150926$20200803$20160818$20200813$EXP$$US-BAYER-2016-104853$BAYER$$81$YR$E$M$Y$$$20200813$$LW$US$US
126632762$12663276$2$F$20140409$20200906$20160818$20200910$EXP$$US-BAYER-2016-102966$BAYER$$75$YR$E$M$Y$$$20200910$$CN$US$US
126636503$12663650$3$F$20160701$20200727$20160818$20200806$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000082$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$97$KG$20200806$$CN$US$US
126637749$12663774$9$F$2016$20200720$20160818$20200730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000173$ACADIA PHARMACEUTICALS$$79$YR$$M$Y$$$20200730$$CN$US$US
1266393110$12663931$10$F$20160216$20200723$20160818$20200729$EXP$$US-PFIZER INC-2016386939$PFIZER$$52$YR$$F$Y$68$KG$20200729$$CN$US$US
126648102$12664810$2$F$20140717$20200715$20160818$20200727$EXP$$US-BAYER-2016-073867$BAYER$$73$YR$E$F$Y$$$20200727$$CN$US$US
126649492$12664949$2$F$20151120$20200623$20160818$20200703$EXP$$US-BAYER-2016-102402$BAYER$$67$YR$E$M$Y$$$20200703$$CN$US$US
126649682$12664968$2$F$20140410$20200902$20160818$20200909$EXP$$US-BAYER-2016-155134$BAYER$$74$YR$E$M$Y$$$20200909$$CN$US$US
126650183$12665018$3$F$20150306$20200719$20160818$20200727$EXP$$US-BAYER-2016-104210$BAYER$$51$YR$A$F$Y$$$20200727$$CN$US$US
1266523314$12665233$14$F$20160802$20200902$20160818$20200915$EXP$$JP-INCYTE CORPORATION-2016IN004894$INCYTE$$$$$$Y$$$20200915$$MD$JP$JP
126652993$12665299$3$F$201607$20200813$20160818$20200903$PER$$US-LUNDBECK-DKLU2016758$LUNDBECK$$78$YR$$M$Y$$$20200903$$MD$US$US
126653082$12665308$2$F$20160221$20200622$20160818$20200701$EXP$$US-BAYER-2016-104877$BAYER$$75$YR$E$F$Y$$$20200701$$HP$US$US
126654512$12665451$2$F$20160729$20160816$20160818$20160823$EXP$$US-JNJFOC-20160800769$PHARMACYCLICS$$82$YR$E$M$Y$71$KG$20160823$$MD$US$US
1266548324$12665483$24$F$20151214$20200728$20160818$20200810$EXP$$US-ACTELION-A-US2015-129061$ACTELION$$79$YR$$F$Y$68.03$KG$20200810$$HP$US$US
126657522$12665752$2$F$20160804$20160824$20160818$20160826$EXP$$IL-JNJFOC-20160805388$PHARMACYCLICS$$65$YR$A$F$Y$64.6$KG$20160826$$MD$IL$IL
126660763$12666076$3$F$$20200710$20160818$20200921$PER$$US-JAZZ-2016-US-005570$JAZZ$$$$$F$Y$$$20200921$$MD$US$US
126666383$12666638$3$F$$20160819$20160819$20161214$EXP$$DE-ROCHE-1814842$ROCHE$MINCKWITZ G, REIMER T, POTENBERG J, CONRAD B, SCHURER U, EIDTMANN H, JUST M, PAEPKE S AND STICKELER E THE PHASE III ICE STUDY: ADJUVANT IBANDRONATE WITH OR WITHOUT CAPECITABINE IN ELDERLY PATIENTS WITH MODERATE OR HIGH RISK EARLY BREAST CANCER. (ABSTRACT S3?04). CANCER RESEARCH 2015 MAY 01?75(SUPP:9):?.$$$E$$Y$$$20161214$$HP$DE$DE
126677781$12667778$1$I$20150414$20160518$20160819$20160819$EXP$$US-BAYER-2016-104415$BAYER$$85$YR$E$M$Y$$$20160819$$CN$US$US
126678233$12667823$3$F$20160808$20170125$20160819$20170202$EXP$$IT-JNJFOC-20160812597$PHARMACYCLICS$$62$YR$A$F$Y$$$20170202$$MD$IT$IT
126680692$12668069$2$F$20140505$20200825$20160819$20200828$EXP$$US-BAYER-2016-105350$BAYER$$58$YR$A$M$Y$$$20200828$$CN$US$US
126683267$12668326$7$F$201608$20200803$20160819$20200808$EXP$$PHHY2016CA113655$NOVARTIS$$35$YR$$F$Y$$$20200808$$CN$CA$CA
126689682$12668968$2$F$20150601$20200727$20160819$20200807$EXP$$US-BAYER-2016-104117$BAYER$$85$YR$E$F$Y$$$20200807$$HP$US$US
126689852$12668985$2$F$20160811$20160812$20160819$20160825$EXP$$FR-JNJFOC-20160814179$JANSSEN$$59$YR$A$F$Y$71$KG$20160825$$MD$FR$FR
126690365$12669036$5$F$2012$20200831$20160819$20200906$EXP$NL-LRB-202313$NL-009507513-1508NLD003323$MERCK$$71$YR$$M$Y$79$KG$20200906$$HP$NL$NL
126691142$12669114$2$F$20150511$20200625$20160819$20200708$EXP$$US-BAYER-2016-126919$BAYER$$63$YR$A$M$Y$$$20200708$$CN$US$US
126691682$12669168$2$F$20140120$20200906$20160819$20200910$EXP$$US-BAYER-2016-130287$BAYER$$73$YR$E$M$Y$$$20200910$$CN$US$US
126693126$12669312$6$F$2015$20200729$20160819$20200730$EXP$$US-PFIZER INC-2016388678$PFIZER$$62$YR$$F$Y$73$KG$20200730$$MD$US$US
126694213$12669421$3$F$2016$20191110$20160819$20191120$EXP$$PHHY2016CA021426$NOVARTIS$$46$YR$$F$Y$$$20191120$$HP$CA$CA
126696172$12669617$2$F$20150611$20200805$20160819$20200813$EXP$$US-BAYER-2016-102783$BAYER$$81$YR$E$M$Y$99.88$KG$20200813$$CN$US$US
1266999018$12669990$18$F$20160707$20200720$20160821$20200723$PER$$CA-AMGEN-CANSP2016107257$AMGEN$$67$YR$E$F$Y$$$20200723$$CN$CA$CA
126701662$12670166$2$F$2016$20200805$20160821$20200807$PER$$US-BIOGEN-2016BI00280541$BIOGEN$$$$$M$Y$$$20200807$$CN$US$US
1267068515$12670685$15$F$$20200720$20160822$20200728$PER$$CA-AMGEN-CANSP2015042116$AMGEN$$42$YR$A$F$Y$$$20200728$$MD$CA$CA
126708012$12670801$2$F$$20200722$20160822$20200921$PER$$US-JAZZ-2016-US-006136$JAZZ$$$$$F$Y$$$20200921$$CN$US$US
126709684$12670968$4$F$201502$20200810$20160822$20200817$EXP$$US-JAZZ-2016-US-006172$JAZZ$$34$YR$$F$Y$$$20200817$$CN$US$US
126711863$12671186$3$F$$20200803$20160822$20200812$EXP$$FR-AUROBINDO-AUR-APL-2016-10497$AUROBINDO$$27$YR$$F$Y$$$20200812$$HP$FR$FR
126714387$12671438$7$F$20160810$20200707$20160822$20200713$EXP$$PHHY2016CA112272$NOVARTIS$$56$YR$$M$Y$$$20200713$$PH$CA$CA
126719457$12671945$7$F$20150515$20200714$20160822$20200717$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2016JPN118859$VIIV$$55$YR$$M$Y$$$20200717$$CN$JP$JP
126719582$12671958$2$F$201503$20200824$20160822$20200831$EXP$$US-BAYER-2016-043029$BAYER$$78$YR$E$M$Y$132.45$KG$20200831$$HP$US$US
126729786$12672978$6$F$2016$20200911$20160822$20200916$EXP$$CA-PFIZER INC-2016389882$PFIZER$$74$YR$$F$Y$$$20200916$$HP$CA$CA
1267308823$12673088$23$F$201603$20200713$20160822$20200720$EXP$$PHHY2016CA038348$NOVARTIS$$52$YR$$F$Y$$$20200720$$MD$CA$CA
126732674$12673267$4$F$20150610$20200702$20160822$20200709$PER$$PHHY2016US113044$NOVARTIS$$63$YR$$F$Y$$$20200710$$MD$US$US
126735103$12673510$3$F$20150211$20200802$20160822$20200812$EXP$$US-BAYER-2016-104180$BAYER$$80$YR$E$M$Y$$$20200812$$HP$US$US
126737902$12673790$2$F$20141217$20200915$20160822$20200924$EXP$$US-BAYER-2016-127922$BAYER$$78$YR$E$F$Y$$$20200924$$CN$US$US
126739352$12673935$2$F$$20200701$20160822$20200706$PER$$US-BEH-2016071510$CSL BEHRING$$4$YR$C$M$Y$16$KG$20200706$$CN$US$US
126739872$12673987$2$F$$20200909$20160822$20200922$EXP$$US-APOTEX-2016AP010613$APOTEX$THORNTON P. US SAFETY BRIEFS: FENTANYL PATCH FATALITIES LINKED TO BYSTANDER APATHY. WE ALL HAVE A ROLE IN PREVENTION. JOURNAL OF PHARMACY PRACTICE AND RESEARCH. 2013?43(4):300?301$15$MON$$M$Y$$$20200922$$HP$US$US
126749189$12674918$9$F$$20200706$20160823$20200709$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0935$ORION$$51$YR$$M$Y$$$20200709$$MD$CA$CA
1267514418$12675144$18$F$201503$20200629$20160823$20200706$PER$$CA-AMGEN-CANSL2015044183$AMGEN$$55$YR$A$F$Y$87$KG$20200706$$MD$CA$CA
126751783$12675178$3$F$$20200514$20160823$20200824$EXP$$CA-ROCHE-1630664$ROCHE$$49$YR$$F$Y$$$20200824$$HP$CA$CA
126757202$12675720$2$F$$20200520$20160823$20200820$PER$$US-JAZZ-2016-US-006570$JAZZ$$$$$M$Y$$$20200820$$HP$US$US
1267643419$12676434$19$F$$20200629$20160823$20200706$PER$$CA-AMGEN-CANSP2016108897$AMGEN$$54$YR$A$M$Y$$$20200706$$HP$CA$CA
126767587$12676758$7$F$20150821$20200702$20160823$20200707$PER$$PHHY2015US159881$NOVARTIS$$49$YR$$F$Y$$$20200707$$MD$US$US
126770082$12677008$2$F$201212$20200825$20160823$20200828$EXP$$US-BAYER-2016-107699$BAYER$$92$YR$E$F$Y$$$20200828$$CN$US$US
126772535$12677253$5$F$20160801$20180321$20160823$20180330$EXP$$AU-JNJFOC-20160804669$JANSSEN$$80$YR$E$M$Y$72$KG$20180330$$MD$AU$AU
126774642$12677464$2$F$20140828$20200916$20160823$20200925$EXP$$US-BAYER-2016-097434$BAYER$$81$YR$E$M$Y$$$20200925$$CN$US$US
126776933$12677693$3$F$$20200804$20160823$20200817$EXP$$US-INCYTE CORPORATION-2016IN005057$INCYTE$$$$$$Y$$$20200817$$CN$US$US
126777552$12677755$2$F$20151120$20200916$20160823$20200925$EXP$$US-BAYER-2016-041894$BAYER$$60$YR$A$M$Y$$$20200925$$CN$US$US
126778474$12677847$4$F$20140801$20200805$20160823$20200814$EXP$$US-BAYER-2015-374594$BAYER$$73$YR$E$M$Y$74.91$KG$20200814$$CN$US$US
126780434$12678043$4$F$2015$20200811$20160823$20200819$EXP$$US-BIOGEN-2016BI00281637$BIOGEN$$$$$M$Y$$$20200819$$HP$US$US
126780852$12678085$2$F$201509$20200823$20160823$20200826$EXP$$US-BAYER-2016-116529$BAYER$$68$YR$E$M$Y$$$20200826$$CN$US$US
126782096$12678209$6$F$2015$20200831$20160823$20200904$EXP$$US-ABBVIE-16K-163-1703641-00$ABBVIE$$$$$F$Y$$$20200904$$CN$US$US
126785296$12678529$6$F$20160802$20200522$20160823$20200526$EXP$$PHHY2016CA115075$NOVARTIS$$66$YR$$M$Y$$$20200527$$CN$CA$CA
126786272$12678627$2$F$2016$20200909$20160823$20200917$EXP$$BR-BIOGEN-2016BI00281373$BIOGEN$$$$$F$Y$$$20200917$$CN$BR$BR
126787456$12678745$6$F$$20200629$20160824$20200706$PER$$CA-AMGEN-CANSP2016109206$AMGEN$$60$YR$A$F$Y$$$20200706$$HP$CA$CA
126789263$12678926$3$F$$20200727$20160824$20200805$EXP$$RU-ROCHE-1819057$ROCHE$, VOROBYEV V, GEMDZHIAN E, DUBROVIN E, NESTEROVA E, KAPLANOV K, VOLODICHEVA E, ZHEREBTSOVA V AND KRAVCHENKO S RISK ? ADAPTED INTENSIVE INDUCTION THERAPY, AUTOLOGOUS STEM CELL TRANSPLANTATION, AND RITUXIMAB MAINTENANCE ALLOW TO REACH A HIGH 7?YEAR SURVIVAL RATE IN PATIENTS WITH MANTLE CELL LYMPHOMA. TERAPEVTICHESKII ARKHIV 2019?91 (7):?.$$$$$Y$$$20200805$$MD$RU$RU
126790807$12679080$7$F$20120801$20180130$20160824$20180213$EXP$$CN-ACTELION-A-CH2016-140893$ACTELION$$21$YR$A$M$Y$79$KG$20180213$$MD$CN$CN
126793123$12679312$3$F$20041104$20180502$20160824$20180514$EXP$DE-BFARM-08008921$DE-BAYER-2016-162574$BAYER$$71$YR$E$F$Y$$$20180514$$CN$US$DE
126797175$12679717$5$F$$20180304$20160824$20180422$EXP$$CA-APOTEX-2016AP010627$APOTEX$$57$YR$$M$Y$90$KG$20180314$$CN$CA$CA
126797533$12679753$3$F$$20200824$20160824$20200827$EXP$$PHHY2016PT114199$NOVARTIS$BRANQUINHO D, RAMOS?ANDRADE D, ELVAS L, AMARO P, FERREIRA M, SOFIA C. DRUG INDUCED ACUTE PANCREATITIS AND PSEUDOANEURYSMS: AN OMINOUS COMBINATION.. PORTUGUESE JOURNALOF GASTROENTEROLOGY. 2016?23(6):309?13$40$YR$$F$Y$$$20200827$$HP$PT$PT
126804256$12680425$6$F$201608$20200701$20160824$20200706$EXP$$US-PFIZER INC-2016392926$PFIZER$$52$YR$$F$Y$$$20200706$$HP$US$US
1268129411$12681294$11$F$2013$20200828$20160824$20200902$PER$$US-009507513-1608USA008197$MERCK$$60$YR$$M$Y$$$20200902$$PH$US$US
126813722$12681372$2$F$201412$20200813$20160824$20200825$EXP$$US-JNJFOC-20160711589$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200825$$CN$US$US
126814042$12681404$2$F$2014$20200707$20160824$20200721$EXP$$US-BAYER-2016-071639$BAYER$$71$YR$E$F$Y$$$20200721$$CN$US$US
126818282$12681828$2$F$20140829$20200824$20160824$20200827$EXP$$US-BAYER-2016-102112$BAYER$$70$YR$E$F$Y$$$20200827$$CN$US$US
126819147$12681914$7$F$$20200807$20160824$20200818$PER$$US-ACTELION-A-US2016-141280$ACTELION$$$$$M$Y$71.2$KG$20200818$$MD$US$US
1268199730$12681997$30$F$$20200629$20160824$20200707$EXP$$CA-PFIZER INC-2016400589$PFIZER$$54$YR$$M$Y$$$20200707$$MD$CA$CA
1268237510$12682375$10$F$$20200720$20160825$20200723$PER$$CA-AMGEN-CANSP2016108931$AMGEN$$$$$F$Y$$$20200723$$HP$CA$CA
126827816$12682781$6$F$20160803$20200813$20160825$20200826$EXP$GB-MHRA-EYC 00143637$GB-MACLEODS PHARMACEUTICALS US LTD-MAC2016003010$MACLEODS$$$$$$Y$$$20200826$$CN$GB$GB
126827964$12682796$4$F$201601$20200807$20160825$20200810$EXP$$US-ROCHE-1721613$ROCHE$$70$YR$$F$Y$$$20200811$$MD$US$US
126837421$12683742$1$I$20151116$20151117$20160825$20160825$EXP$$DE-JNJFOC-20151118687$JANSSEN$$76$YR$E$F$Y$63$KG$20160825$$MD$DE$DE
126839102$12683910$2$F$20141028$20200629$20160825$20200710$EXP$$US-BAYER-2016-099870$BAYER$$67$YR$E$F$Y$59.02$KG$20200710$$CN$US$US
126840022$12684002$2$F$20160811$20160816$20160825$20200701$EXP$$GR-JNJFOC-20150824194$JOHNSON AND JOHNSON$$$$E$F$Y$$$20200701$$CN$GR$GR
126843342$12684334$2$F$20150814$20200908$20160825$20200911$EXP$$US-BAYER-2016-104374$BAYER$$76$YR$E$F$Y$$$20200911$$HP$US$US
126844534$12684453$4$F$20150316$20200720$20160825$20200727$EXP$$US-BAYER-2016-096428$BAYER$$57$YR$A$M$Y$99.77$KG$20200727$$HP$US$US
126844562$12684456$2$F$20140703$20200707$20160825$20200717$EXP$$US-BAYER-2016-120544$BAYER$$74$YR$E$M$Y$$$20200717$$CN$US$US
126846612$12684661$2$F$201309$20200913$20160825$20200917$EXP$$US-BAYER-2016-040640$BAYER$$73$YR$E$F$Y$$$20200917$$CN$US$US
1268469212$12684692$12$F$20150515$20200714$20160825$20200727$EXP$$JP-JNJFOC-20160818269$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200727$$MD$JP$JP
126847062$12684706$2$F$$20170728$20160825$20170811$EXP$GB-MHRA-ADR 23595375$GB-TEVA-685570ACC$TEVA$$68$YR$$F$Y$68$KG$20170811$$CN$GB$GB
126848702$12684870$2$F$20140921$20200819$20160825$20200826$EXP$$US-BAYER-2016-121063$BAYER$$85$YR$E$F$Y$$$20200826$$CN$US$US
126850002$12685000$2$F$20160615$20160825$20160825$20160829$EXP$$IT-JNJFOC-20160627511$JANSSEN$$65$YR$A$M$Y$74$KG$20160829$$CN$IT$IT
126850402$12685040$2$F$201212$20200723$20160825$20200730$EXP$$US-BAYER-2016-120900$BAYER$$77$YR$E$M$Y$$$20200730$$CN$US$US
1268506618$12685066$18$F$$20200629$20160825$20200706$PER$$CA-AMGEN-CANSP2016109223$AMGEN$$55$YR$A$F$Y$$$20200706$$HP$CA$CA
1268507413$12685074$13$F$20160815$20200710$20160825$20200721$EXP$$US-INCYTE CORPORATION-2016IN004811$INCYTE$$$$$$Y$$$20200722$$CN$US$US
126851023$12685102$3$F$$20200713$20160825$20200724$EXP$$CA-JNJFOC-20160802817$JOHNSON AND JOHNSON$$63$YR$A$M$Y$103$KG$20200724$$HP$CA$CA
126851672$12685167$2$F$201404$20200712$20160825$20200722$EXP$$US-BAYER-2016-134454$BAYER$$86$YR$E$F$Y$63.11$KG$20200722$$CN$US$US
126851882$12685188$2$F$20130702$20200712$20160825$20200721$EXP$$US-BAYER-2016-144605$BAYER$$89$YR$E$F$Y$$$20200721$$CN$US$US
126861905$12686190$5$F$$20200716$20160825$20200721$EXP$$PHHY2016CA115872$NOVARTIS$$$$$F$Y$$$20200721$$CN$CA$CA
1268661018$12686610$18$F$20160803$20200814$20160825$20200817$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069995$BRISTOL MYERS SQUIBB$$69$YR$$F$Y$101$KG$20200817$$PH$GB$GB
126867855$12686785$5$F$201510$20200630$20160825$20200702$EXP$$US-JAZZ-2016-US-007237$JAZZ$$20$YR$$F$Y$$$20200702$$CN$US$US
126869023$12686902$3$F$2014$20200812$20160825$20200825$PER$$US-JAZZ-2016-US-006844$JAZZ$$49$YR$$F$Y$$$20200825$$HP$US$US
126884862$12688486$2$F$20151222$20200719$20160826$20200727$EXP$$US-BAYER-2016-102456$BAYER$$57$YR$A$M$Y$$$20200727$$CN$US$US
126885303$12688530$3$F$$20200626$20160826$20200820$PER$$US-CIPLA LTD.-2016US07208$CIPLA$$$$$$Y$$$20200820$$HP$US$US
1268920712$12689207$12$F$$20200921$20160826$20200925$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1434$ORION$$62$YR$$F$Y$73$KG$20200925$$MD$CA$CA
126892581$12689258$1$I$20160813$20160815$20160826$20160826$EXP$$ZA-JNJFOC-20160813559$JANSSEN$$63$YR$A$F$Y$77.2$KG$20160826$$MD$ZA$ZA
1268930513$12689305$13$F$$20200706$20160826$20200709$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1444$ORION$$54$YR$$M$Y$$$20200709$$MD$CA$CA
126895331$12689533$1$I$$20160812$20160826$20160826$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122457$RANBAXY$$68$YR$$F$Y$68$KG$20160826$$HP$GB$GB
126896129$12689612$9$F$20150401$20200714$20160826$20200721$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2016JPN121032$VIIV$$42$YR$$M$Y$$$20200721$$CN$JP$JP
1268961311$12689613$11$F$20110824$20200701$20160826$20200706$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2016JPN122087$VIIV$$48$YR$$M$Y$$$20200706$$CN$JP$JP
126898502$12689850$2$F$20140620$20200818$20160826$20200824$EXP$$US-BAYER-2016-090279$BAYER$$94$YR$E$F$Y$$$20200824$$LW$US$US
126901753$12690175$3$F$20141108$20200818$20160826$20200824$EXP$$US-BAYER-2016-101151$BAYER$$86$YR$E$M$Y$$$20200824$$CN$US$US
1269020017$12690200$17$F$$20200914$20160826$20200917$PER$$CA-AMGEN-CANSP2016107911$AMGEN$$42$YR$A$F$Y$81$KG$20200917$$CN$CA$CA
126904303$12690430$3$F$20141019$20200916$20160826$20200923$PER$$US-JNJFOC-20160816788$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200923$$CN$US$US
126906713$12690671$3$F$20160509$20200908$20160826$20200911$EXP$$US-BAYER-2016-108509$BAYER$$74$YR$E$M$Y$$$20200911$$CN$US$US
126906722$12690672$2$F$20141223$20200628$20160826$20200708$EXP$$US-BAYER-2016-103754$BAYER$$86$YR$E$F$Y$$$20200708$$CN$US$US
126906772$12690677$2$F$20131023$20200621$20160826$20200701$EXP$$US-BAYER-2016-103757$BAYER$$70$YR$E$M$Y$$$20200701$$CN$US$US
126906962$12690696$2$F$201111$20200804$20160826$20200813$EXP$$US-BAYER-2016-120056$BAYER$$82$YR$E$F$Y$34.05$KG$20200813$$CN$US$US
1269099020$12690990$20$F$20101004$20200916$20160826$20200924$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1432$ORION$$52$YR$$F$Y$98$KG$20200924$$MD$CA$CA
126911673$12691167$3$F$20160821$20171023$20160826$20171025$EXP$$IL-JNJFOC-20160817534$PHARMACYCLICS$$72$YR$E$F$Y$56$KG$20171025$$MD$IL$IL
1269142020$12691420$20$F$$20200629$20160826$20200708$EXP$$CA-PFIZER INC-2016405201$PFIZER$$55$YR$$F$Y$$$20200708$$HP$CA$CA
126915482$12691548$2$F$20160705$20160829$20160826$20160830$EXP$$NO-JNJFOC-20160712740$JANSSEN$$61$YR$A$M$Y$80$KG$20160830$$MD$NO$NO
126915593$12691559$3$F$20150517$20200720$20160826$20200731$EXP$$US-JNJFOC-20160821679$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200731$$CN$US$US
126919682$12691968$2$F$201506$20200928$20160827$20200930$PER$$US-AMGEN-USASL2016106767$AMGEN$$65$YR$E$M$Y$$$20200929$$MD$US$US
126924663$12692466$3$F$20160617$20160928$20160829$20161214$EXP$$JP-ROCHE-1820621$ROCHE$$75$YR$$F$Y$49$KG$20161214$$MD$JP$JP
126928032$12692803$2$F$20160816$20160901$20160829$20160901$EXP$$GB-BEH-2016072863$CSL BEHRING$$75$YR$E$M$Y$$$20160901$$MD$GB$GB
1269295018$12692950$18$F$2016$20200813$20160829$20200819$EXP$$PHHY2016CA112377$NOVARTIS$$$$$M$Y$$$20200819$$CN$COUNTRY NOT SPECIFIED$CA
126932497$12693249$7$F$20160524$20180228$20160829$20180314$EXP$$IT-ROCHE-1767615$ROCHE$$79$YR$$M$Y$79$KG$20180314$$MD$IT$IT
126932692$12693269$2$F$2016$20200902$20160829$20200916$EXP$$CA-JNJFOC-20160817978$JOHNSON AND JOHNSON$$7$YR$C$F$Y$22$KG$20200916$$HP$CA$CA
126933486$12693348$6$F$2011$20200922$20160829$20200925$EXP$$US-PFIZER INC-2016401694$PFIZER$$70$YR$$F$Y$48$KG$20200925$$CN$US$US
126942143$12694214$3$F$201412$20200915$20160829$20200924$EXP$$US-BAYER-2016-167154$BAYER$$55$YR$A$F$Y$$$20200924$$CN$US$US
126943532$12694353$2$F$201311$20200915$20160829$20200924$EXP$$US-BAYER-2016-167601$BAYER$$65$YR$E$F$Y$$$20200924$$CN$US$US
126944272$12694427$2$F$20150729$20200908$20160829$20200914$EXP$$US-BAYER-2016-101846$BAYER$$80$YR$E$M$Y$$$20200914$$CN$US$US
126946592$12694659$2$F$20140919$20200922$20160829$20200928$EXP$$US-BAYER-2016-120026$BAYER$$78$YR$E$F$Y$$$20200928$$HP$US$US
126946832$12694683$2$F$20131211$20200922$20160829$20200928$EXP$$US-BAYER-2016-134846$BAYER$$74$YR$E$F$Y$$$20200928$$CN$US$US
1269489717$12694897$17$F$$20200914$20160829$20200918$EXP$$CA-PFIZER INC-2016406528$PFIZER$$42$YR$$F$Y$81$KG$20200918$$CN$CA$CA
126953583$12695358$3$F$$20200920$20160829$20200923$EXP$$US-JNJFOC-20160821360$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200923$$CN$US$US
1269550018$12695500$18$F$2013$20200724$20160829$20200724$EXP$$CA-PFIZER INC-2016245898$PFIZER$$58$YR$$F$Y$$$20200724$$MD$US$CA
126956722$12695672$2$F$20160808$20160831$20160829$20160912$EXP$$US-JNJFOC-20160823100$PHARMACYCLICS$$69$YR$E$F$Y$$$20160912$$MD$US$US
1269650815$12696508$15$F$201503$20200706$20160830$20200714$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1477$ORION$$55$YR$$F$Y$87$KG$20200714$$MD$CA$CA
1269688714$12696887$14$F$$20200921$20160830$20200924$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1453$ORION$$60$YR$$F$Y$$$20200924$$MD$CA$CA
1269741712$12697417$12$F$202003$20200827$20160830$20200831$PER$$US-PFIZER INC-2016278630$PFIZER$$65$YR$$F$Y$$$20200831$$MD$US$US
126976334$12697633$4$F$20150909$20200402$20160830$20200407$EXP$$PHHY2015CA110769$NOVARTIS$$79$YR$$M$Y$$$20200407$$HP$CA$CA
1269769310$12697693$10$F$20130215$20200715$20160830$20200721$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN119440$VIIV$$5$DEC$$M$Y$$$20200721$$CN$JP$JP
126979469$12697946$9$F$$20200805$20160830$20200817$EXP$$PHHY2015US127635$NOVARTIS$$$$$M$Y$$$20200817$$MD$US$US
126987119$12698711$9$F$$20200908$20160830$20200916$EXP$$PHHY2015US127104$NOVARTIS$$$$$F$Y$$$20200916$$CN$US$US
126995423$12699542$3$F$20140909$20200709$20160830$20200720$EXP$$US-JNJFOC-20160822832$JOHNSON AND JOHNSON$$82$YR$$M$Y$69.4$KG$20200720$$CN$US$US
126995454$12699545$4$F$20140524$20200916$20160830$20200929$EXP$$US-JNJFOC-20160823317$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200929$$CN$US$US
126995852$12699585$2$F$20160820$20170728$20160830$20170804$EXP$$FR-JNJFOC-20160821501$JANSSEN$$51$YR$A$M$Y$90$KG$20170804$$MD$FR$FR
126996202$12699620$2$F$201502$20200902$20160830$20200916$EXP$$US-JNJFOC-20160618850$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200916$$CN$US$US
126998587$12699858$7$F$20150622$20200914$20160830$20200921$EXP$$DE-GILEAD-2015-0173670$GILEAD$$56$YR$A$F$Y$80$KG$20200921$$CN$DE$DE
1270004017$12700040$17$F$2016$20200916$20160830$20200917$EXP$$CA-TAKEDA-2016TUS014832$TAKEDA$$59$YR$$F$Y$$$20200917$$HP$CA$CA
127003403$12700340$3$F$20151115$20200916$20160830$20200923$PER$$US-SA-2015SA194558$SANOFI AVENTIS$$$$$$Y$$$20200923$$HP$US$US
127004452$12700445$2$F$$20200630$20160830$20200709$PER$$US-SA-2016SA031404$SANOFI AVENTIS$$$$$$Y$$$20200709$$MD$US$US
127007125$12700712$5$F$$20200806$20160830$20200812$EXP$$US-JAZZ-2016-US-016101$JAZZ$$$$$F$Y$$$20200812$$HP$US$US
127009159$12700915$9$F$2016$20200908$20160830$20200915$EXP$$PHHY2016PA118763$NOVARTIS$$57$YR$$M$Y$96.6$KG$20200915$$CN$COUNTRY NOT SPECIFIED$PA
1270157113$12701571$13$F$$20200714$20160831$20200720$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1493$ORION$$$$$F$Y$$$20200720$$MD$CA$CA
1270161320$12701613$20$F$2015$20200725$20160831$20200805$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1490$ORION$$61$YR$$F$Y$$$20200805$$MD$CA$CA
127019125$12701912$5$F$201608$20200604$20160831$20200820$PER$$US-JAZZ-2016-US-007520$JAZZ$$24$YR$$M$Y$$$20200820$$MD$US$US
1270202019$12702020$19$F$$20200921$20160831$20200930$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1482$ORION$$58$YR$$M$Y$$$20200930$$MD$CA$CA
127020523$12702052$3$F$$20200807$20160831$20200818$EXP$$US-ROCHE-1822901$ROCHE$$$$$F$Y$$$20200819$$CN$US$US
127022582$12702258$2$F$$20200819$20160831$20200821$PER$$US-AMGEN-USASL2016111164$AMGEN$$56$YR$A$F$Y$$$20200821$$CN$US$US
127023093$12702309$3$F$$20200918$20160831$20200922$PER$$US-PFIZER INC-2016407146$PFIZER$$70$YR$$F$Y$$$20200922$$CN$US$US
127032046$12703204$6$F$$20200629$20160831$20200707$EXP$$CA-PFIZER INC-2016404361$PFIZER$$69$YR$$F$Y$$$20200707$$HP$CA$CA
127032062$12703206$2$F$20130507$20200719$20160831$20200727$EXP$$US-BAYER-2016-087385$BAYER$$58$YR$A$M$Y$$$20200727$$CN$US$US
127032663$12703266$3$F$2013$20200819$20160831$20200825$EXP$$US-BAYER-2016-104143$BAYER$$74$YR$E$M$Y$$$20200825$$CN$US$US
127033536$12703353$6$F$20160726$20181001$20160831$20181008$EXP$$FR-JNJFOC-20160822941$JANSSEN$$70$YR$E$M$Y$77$KG$20181008$$MD$FR$FR
1270337815$12703378$15$F$20140617$20200701$20160831$20200714$EXP$$JP-JNJFOC-20160824209$JOHNSON AND JOHNSON$$62$YR$$M$Y$$$20200714$$MD$JP$JP
127036332$12703633$2$F$201507$20200708$20160831$20200717$EXP$$US-BAYER-2016-131799$BAYER$$80$YR$E$M$Y$$$20200717$$CN$US$US
1270369011$12703690$11$F$2005$20200715$20160831$20200716$PER$$US-PFIZER INC-2016410779$PFIZER$$68$YR$$M$Y$63$KG$20200716$$MD$US$US
127037882$12703788$2$F$20151112$20200817$20160831$20200824$EXP$$US-BAYER-2016-104558$BAYER$$71$YR$E$M$Y$$$20200824$$CN$US$US
127039452$12703945$2$F$20140407$20200729$20160831$20200811$EXP$$US-BAYER-2016-104832$BAYER$$53$YR$A$M$Y$$$20200811$$HP$US$US
127039642$12703964$2$F$20160210$20200702$20160831$20200812$PER$$US-INCYTE CORPORATION-2016IN004020$INCYTE$$$$$$Y$$$20200812$$CN$US$US
127040152$12704015$2$F$20140818$20200812$20160831$20200820$EXP$$US-BAYER-2016-104843$BAYER$$46$YR$A$M$Y$$$20200820$$CN$US$US
127040953$12704095$3$F$201509$20200819$20160831$20200824$PER$$US-JNJFOC-20160821385$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20200824$$CN$US$US
127041192$12704119$2$F$20140709$20200805$20160831$20200813$EXP$$US-BAYER-2016-131788$BAYER$$72$YR$E$M$Y$$$20200813$$CN$US$US
127042102$12704210$2$F$20141225$20200720$20160831$20200727$EXP$$US-BAYER-2016-112646$BAYER$$88$YR$E$F$Y$$$20200727$$CN$US$US
127042462$12704246$2$F$20140305$20200720$20160831$20200731$EXP$$US-JNJFOC-20160609814$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200731$$CN$US$US
127043892$12704389$2$F$20141204$20200917$20160831$20200925$EXP$$US-BAYER-2016-169313$BAYER$$65$YR$E$F$Y$$$20200925$$CN$US$US
1270466917$12704669$17$F$20160623$20200909$20160831$20200915$EXP$$CA-TAKEDA-2016TUS015019$TAKEDA$$37$YR$$M$Y$$$20200915$$MD$CA$CA
127051165$12705116$5$F$2016$20200902$20160831$20200910$EXP$$US-JAZZ-2016-US-016317$JAZZ$$45$YR$$F$Y$$$20200910$$CN$US$US
1270559713$12705597$13$F$2011$20200708$20160901$20200728$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1521$ORION$$58$YR$$F$Y$$$20200728$$MD$CA$CA
1270573712$12705737$12$F$$20200917$20160901$20200923$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1512$ORION$$42$YR$$F$Y$81$KG$20200923$$HP$CA$CA
1270648512$12706485$12$F$201608$20200810$20160901$20200812$PER$$US-PFIZER INC-2016408168$PFIZER$$77$YR$$F$Y$91$KG$20200812$$MD$US$US
1270657110$12706571$10$F$20150410$20200713$20160901$20200724$EXP$$JP-JNJFOC-20160824227$JOHNSON AND JOHNSON$$63$YR$$M$Y$$$20200724$$MD$JP$JP
1270673716$12706737$16$F$20160506$20200717$20160901$20200723$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-036498$BRISTOL MYERS SQUIBB$$59$YR$$F$Y$$$20200723$$CN$CA$CA
127069585$12706958$5$F$$20200817$20160901$20200825$EXP$$PHEH2016US021879$NOVARTIS$$$$$M$Y$$$20200825$$CN$US$US
127070459$12707045$9$F$20160416$20200710$20160901$20200717$EXP$$PHHY2016EC119367$NOVARTIS$$59$YR$$M$Y$$$20200717$$HP$EC$EC
127073742$12707374$2$F$20140703$20200715$20160901$20200723$EXP$$US-BAYER-2016-066657$BAYER$$83$YR$E$M$Y$71.67$KG$20200723$$CN$US$US
127074662$12707466$2$F$20140512$20200915$20160901$20200924$EXP$$US-BAYER-2016-098041$BAYER$$69$YR$E$M$Y$$$20200924$$LW$US$US
127077502$12707750$2$F$20140305$20200720$20160901$20200727$EXP$$US-BAYER-2016-128437$BAYER$$70$YR$E$M$Y$$$20200727$$HP$US$US
127097793$12709779$3$F$2014$20200708$20160902$20200716$EXP$$US-BIOGEN-2016BI00285522$BIOGEN$$$$$F$Y$$$20200716$$CN$US$US
127097993$12709799$3$F$201608$20200814$20160901$20200825$EXP$$GR-ROCHE-1824185$ROCHE$$$$A$M$Y$$$20200826$$MD$GR$GR
127106725$12710672$5$F$2015$20200727$20160902$20200731$EXP$$US-JAZZ-2016-US-016450$JAZZ$$$$$F$Y$$$20200731$$HP$US$US
127106862$12710686$2$F$20140624$20200707$20160902$20200720$EXP$$US-BAYER-2016-148895$BAYER$$73$YR$E$M$Y$$$20200720$$CN$US$US
127112387$12711238$7$F$2016$20200910$20160902$20200916$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1551$ORION$$32$YR$$F$Y$$$20200916$$MD$CA$CA
127113004$12711300$4$F$2014$20200813$20160902$20200821$EXP$$US-BIOGEN-2016BI00285529$BIOGEN$$$$$F$Y$$$20200821$$HP$US$US
127113332$12711333$2$F$20140621$20200917$20160902$20200925$EXP$$US-BAYER-2016-098750$BAYER$$65$YR$E$F$Y$$$20200925$$CN$US$US
127113382$12711338$2$F$20151214$20200909$20160902$20200914$EXP$$US-BAYER-2016-104701$BAYER$$58$YR$A$M$Y$$$20200914$$CN$US$US
127114048$12711404$8$F$2012$20200918$20160902$20200922$EXP$$US-PFIZER INC-2016411180$PFIZER$$68$YR$$F$Y$93$KG$20200922$$MD$US$US
127120448$12712044$8$F$20151224$20180525$20160902$20200923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-071973$BRISTOL MYERS SQUIBB$$71$YR$$M$Y$$$20200923$$HP$JP$JP
127120652$12712065$2$F$20150715$20200823$20160902$20200827$EXP$$US-BAYER-2016-137566$BAYER$$76$YR$E$F$Y$$$20200827$$CN$US$US
1271224813$12712248$13$F$2016$20200714$20160902$20200721$EXP$$US-SA-2016SA133214$SANOFI AVENTIS$$$$$$Y$$$20200721$$HP$US$US
127123803$12712380$3$F$2015$20200629$20160902$20200707$EXP$$CA-PFIZER INC-2016130276$PFIZER$$38$YR$$F$Y$$$20200707$$HP$CA$CA
127128016$12712801$6$F$20160727$20171023$20160902$20171030$EXP$$KR-JNJFOC-20160810216$PHARMACYCLICS$$64$YR$A$M$Y$52$KG$20171030$$MD$KR$KR
127128023$12712802$3$F$20160825$20170123$20160902$20170202$EXP$$KR-JNJFOC-20160827256$PHARMACYCLICS$$57$YR$A$M$Y$$$20170202$$MD$KR$KR
1271420213$12714202$13$F$20160806$20200717$20160905$20200721$EXP$$DE-ROCHE-1779932$ROCHE$$54$YR$$F$Y$70$KG$20200722$$MD$DE$DE
1271422612$12714226$12$F$$20200630$20160905$20200702$PER$$US-PFIZER INC-2016417314$PFIZER$$45$YR$$F$Y$79$KG$20200702$$PH$US$US
127147423$12714742$3$F$20160826$20160907$20160905$20160909$EXP$$GB-JNJFOC-20160826995$JANSSEN$$69$YR$E$M$Y$$$20160909$$MD$GB$GB
127147813$12714781$3$F$20130913$20200830$20160905$20200902$PER$$US-JNJFOC-20160827130$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200902$$CN$US$US
127154493$12715449$3$F$2015$20200731$20160906$20200807$PER$$US-AMGEN-USASP2016114581$AMGEN$$70$YR$E$F$Y$$$20200807$$MD$US$US
127161775$12716177$5$F$2012$20200911$20160906$20200917$EXP$$CA-ROCHE-1140040$ROCHE$$60$YR$$F$Y$93.4$KG$20200917$$MD$CA$CA
127162321$12716232$1$I$$20160829$20160906$20160906$EXP$$PHEH2016US022051$NOVARTIS$$$$$F$Y$$$20160906$$CN$US$US
127171885$12717188$5$F$20160615$20161012$20160906$20161020$EXP$$BE-JNJFOC-20160616944$JANSSEN$$68$YR$E$M$Y$83$KG$20161020$$MD$BE$BE
1271723313$12717233$13$F$20151006$20200915$20160906$20200921$EXP$$JP-OTSUKA-2016_021302$OTSUKA$$58$YR$$F$Y$59$KG$20200921$$MD$JP$JP
127172492$12717249$2$F$201412$20200622$20160906$20200701$EXP$$US-BAYER-2016-107673$BAYER$$78$YR$E$F$Y$$$20200701$$CN$US$US
127172601$12717260$1$I$20160807$20160808$20160906$20160906$EXP$$KR-JNJFOC-20160815066$PHARMACYCLICS$$69$YR$E$M$Y$$$20160906$$MD$KR$KR
127175714$12717571$4$F$20151027$20180329$20160906$20180411$EXP$$GB-JNJFOC-20151022917$PHARMACYCLICS$$61$YR$A$F$Y$57.8$KG$20180411$$MD$GB$GB
127177921$12717792$1$I$20160808$20160812$20160906$20160906$EXP$$JP-PFIZER INC-2016400169$PFIZER$$38$YR$$M$Y$60.1$KG$20160906$$MD$JP$JP
127178192$12717819$2$F$20160824$20160929$20160906$20161010$EXP$$CA-PFIZER INC-2016416953$PFIZER$$65$YR$$F$Y$$$20161010$$MD$CA$CA
127193822$12719382$2$F$$20200915$20160907$20200925$EXP$$CA-APOTEX-2016AP011027$APOTEX$$77$YR$$F$Y$70$KG$20200925$$CN$CA$CA
127194484$12719448$4$F$20160809$20200626$20160907$20200702$EXP$$DE-BIOGEN-2016BI00286059$BIOGEN$$61$YR$$F$Y$75$KG$20200702$$CN$DE$DE
1272022110$12720221$10$F$201612$20200715$20160907$20200717$PER$$US-PFIZER INC-2016420541$PFIZER$$58$YR$$F$Y$$$20200717$$HP$US$US
127208925$12720892$5$F$20160819$20161019$20160907$20161026$EXP$$US-JNJFOC-20160825385$JANSSEN$$43$YR$A$F$Y$72$KG$20161026$$MD$US$US
127210002$12721000$2$F$201501$20200729$20160907$20200811$EXP$$US-BAYER-2016-103435$BAYER$$88$YR$E$F$Y$$$20200811$$CN$US$US
127215942$12721594$2$F$20140604$20200726$20160907$20200730$EXP$$US-BAYER-2016-113300$BAYER$$64$YR$A$M$Y$$$20200730$$LW$US$US
127223282$12722328$2$F$2013$20200727$20160907$20200805$EXP$$US-BIOGEN-2015BI102846$BIOGEN$$62$YR$$F$Y$$$20200804$$CN$US$US
127235136$12723513$6$F$20160901$20200707$20160908$20200709$PER$$US-PFIZER INC-2016421158$PFIZER$$58$YR$$F$Y$68$KG$20200709$$HP$US$US
127238602$12723860$2$F$20160829$20200706$20160908$20200714$EXP$$US-SA-2016SA163683$SANOFI AVENTIS$$$$$$Y$$$20200714$$CN$US$US
127240952$12724095$2$F$20130725$20200714$20160908$20200727$EXP$$US-JNJFOC-20160728476$JOHNSON AND JOHNSON$$65$YR$$M$Y$$$20200727$$CN$US$US
127245542$12724554$2$F$201507$20200812$20160908$20200819$EXP$$US-BAYER-2016-107374$BAYER$$68$YR$E$M$Y$$$20200819$$CN$US$US
127251652$12725165$2$F$20160820$20161004$20160908$20161021$EXP$$FI-JNJFOC-20160827109$JANSSEN$$57$YR$A$F$Y$$$20161021$$HP$FI$FI
127262175$12726217$5$F$2016$20200715$20160908$20200722$EXP$$US-SA-2016SA119086$SANOFI AVENTIS$$$$$$Y$$$20200722$$CN$US$US
1272645510$12726455$10$F$20160825$20170727$20160908$20170801$EXP$$FR-ROCHE-1823183$ROCHE$$72$YR$$M$Y$77$KG$20170801$$MD$FR$FR
1272680918$12726809$18$F$20160810$20200807$20160908$20200819$PER$$US-ACTELION-A-US2016-141740$ACTELION$$81$YR$$F$Y$$$20200819$$MD$US$US
1272724512$12727245$12$F$201605$20200701$20160909$20200709$EXP$$CA-ROCHE-1827571$ROCHE$$47$YR$$F$Y$$$20200709$$MD$CA$CA
127278427$12727842$7$F$$20200630$20160909$20200703$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-072673$BRISTOL MYERS SQUIBB$$46$YR$$F$Y$80$KG$20200703$$CN$CA$CA
127283205$12728320$5$F$20160428$20200706$20160909$20200721$EXP$$KR-OTSUKA-2016_018879$OTSUKA$$$$$$Y$$$20200721$$MD$KR$KR
127283242$12728324$2$F$201606$20200811$20160909$20200818$EXP$$US-SA-2016SA162179$SANOFI AVENTIS$$49$YR$$M$Y$$$20200818$$CN$US$US
127283752$12728375$2$F$20150108$20200803$20160909$20200813$EXP$$US-BAYER-2016-103711$BAYER$$75$YR$E$M$Y$$$20200813$$CN$US$US
127288749$12728874$9$F$20160821$20180327$20160909$20180406$EXP$$US-JNJFOC-20160905671$JANSSEN$$75$YR$E$M$Y$103.87$KG$20180406$$MD$US$US
1272902415$12729024$15$F$20181105$20200910$20160909$20200914$EXP$$CA-TAKEDA-2016TUS015642$TAKEDA$$72$YR$$M$Y$$$20200914$$HP$CA$CA
1272907411$12729074$11$F$20160705$20200819$20160909$20200821$EXP$$CA-TAKEDA-2016TUS012100$TAKEDA$$45$YR$$F$Y$$$20200821$$HP$CA$CA
127291702$12729170$2$F$20160831$20160909$20160909$20160916$EXP$$TR-JNJFOC-20160902419$PHARMACYCLICS$$53$YR$A$F$Y$52.1$KG$20160916$$MD$TR$TR
127300082$12730008$2$F$$20160919$20160909$20160923$EXP$$RO-PFIZER INC-2016419876$PFIZER$GALESANU, CORINA. ATYPICAL FEMORAL FRACTURES AFTER LONG?TERM BISPHOPHONATE THERAPY: CASE REPORT. REVISTA MEDICO?CHIRURGICALA A SOCIETATII DE MEDICI SI NATURALISTI DIN IASI. 2016?1:120: 114?118$77$YR$$F$Y$$$20160923$$MD$RO$RO
1273015119$12730151$19$F$20160825$20200730$20160909$20200812$EXP$$US-ACTELION-A-US2016-141592$ACTELION$$60$YR$$M$Y$124.26$KG$20200812$$HP$US$US
127302281$12730228$1$I$20151028$20151029$20160909$20160909$EXP$$GB-SA-2016SA071225$AVENTIS$$66$YR$$F$Y$68.4$KG$20160909$$MD$GB$GB
127302301$12730230$1$I$20151230$20160108$20160909$20160909$EXP$$GB-SA-2016SA071985$AVENTIS$$66$YR$$F$Y$66.4$KG$20160909$$MD$GB$GB
127304404$12730440$4$F$$20200924$20160909$20200930$EXP$$US-JAZZ-2016-US-017003$JAZZ$$$$$M$Y$$$20200930$$HP$US$US
127315783$12731578$3$F$201512$20200810$20160912$20200814$PER$$US-JNJFOC-20160625785$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200814$$CN$US$US
127315972$12731597$2$F$20151101$20200628$20160912$20200706$PER$$US-JNJFOC-20160700948$JOHNSON AND JOHNSON$$58$YR$$M$Y$$$20200706$$CN$US$US
127316053$12731605$3$F$201406$20200706$20160912$20200709$PER$$US-JNJFOC-20160621694$JOHNSON AND JOHNSON$$80$YR$$M$Y$90.72$KG$20200709$$CN$US$US
127316125$12731612$5$F$2015$20200914$20160912$20200924$EXP$$US-JNJFOC-20160618564$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200924$$LW$US$US
127316136$12731613$6$F$201501$20200909$20160912$20200914$EXP$$US-JNJFOC-20160618625$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20200914$$HP$US$US
127316262$12731626$2$F$201502$20200903$20160912$20200909$PER$$US-JNJFOC-20160623478$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200909$$HP$US$US
127317023$12731702$3$F$20140803$20200902$20160912$20200909$PER$$US-JNJFOC-20160804782$JOHNSON AND JOHNSON$$85$YR$E$M$Y$69.46$KG$20200909$$LW$US$US
127317063$12731706$3$F$20140731$20200915$20160912$20200922$PER$$US-JNJFOC-20160804308$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20200922$$CN$US$US
127317793$12731779$3$F$20150408$20200906$20160912$20200914$PER$$US-JNJFOC-20160728482$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200914$$HP$US$US
127317863$12731786$3$F$201604$20200823$20160912$20200828$PER$$US-JNJFOC-20160803039$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200828$$CN$US$US
127318122$12731812$2$F$20151006$20200706$20160912$20200710$PER$$US-JNJFOC-20160706039$JOHNSON AND JOHNSON$$75$YR$$M$Y$$$20200710$$CN$US$US
127318203$12731820$3$F$20150518$20200726$20160912$20200731$PER$$US-JNJFOC-20160814018$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200731$$CN$US$US
127318222$12731822$2$F$20150526$20200831$20160912$20200902$PER$$US-JNJFOC-20160709082$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200902$$CN$US$US
127318653$12731865$3$F$20141029$20200914$20160912$20200917$PER$$US-JNJFOC-20160816785$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200917$$CN$US$US
127318686$12731868$6$F$20150910$20200708$20160912$20200713$PER$$US-JNJFOC-20160818538$JOHNSON AND JOHNSON$$85$YR$$F$Y$$$20200713$$CN$US$US
127318792$12731879$2$F$20150813$20200629$20160912$20200706$PER$$US-JNJFOC-20160626824$JOHNSON AND JOHNSON$$65$YR$$M$Y$95.25$KG$20200706$$CN$US$US
127319092$12731909$2$F$20151117$20200715$20160912$20200720$PER$$US-JNJFOC-20160619552$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20200720$$CN$US$US
127319113$12731911$3$F$201402$20200924$20160912$20200929$PER$$US-JNJFOC-20160805379$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20200929$$CN$US$US
127320232$12732023$2$F$201511$20200707$20160912$20200710$PER$$US-JNJFOC-20160625790$JOHNSON AND JOHNSON$$51$YR$$F$Y$$$20200710$$CN$US$US
127320622$12732062$2$F$20160309$20200917$20160912$20200921$PER$$US-JNJFOC-20160616992$JOHNSON AND JOHNSON$$44$YR$A$M$Y$136.08$KG$20200921$$HP$US$US
127320652$12732065$2$F$20151214$20200830$20160912$20200911$EXP$$US-JNJFOC-20160703946$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200911$$CN$US$US
127320732$12732073$2$F$20131211$20200922$20160912$20200928$PER$$US-JNJFOC-20160705172$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200928$$CN$US$US
127320923$12732092$3$F$201308$20200825$20160912$20200827$PER$$US-JNJFOC-20160601391$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200827$$CN$US$US
127321072$12732107$2$F$201603$20200709$20160912$20200713$PER$$US-JNJFOC-20160618136$JOHNSON AND JOHNSON$$85$YR$$M$Y$95.62$KG$20200713$$CN$US$US
127321563$12732156$3$F$20150905$20200923$20160912$20200928$PER$$US-JNJFOC-20160620233$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200928$$CN$US$US
127322133$12732213$3$F$20141103$20200917$20160912$20200921$PER$$US-JNJFOC-20160619404$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200921$$CN$US$US
127322514$12732251$4$F$2016$20200715$20160912$20200721$PER$$US-JNJFOC-20160815342$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200721$$CN$US$US
127323132$12732313$2$F$20141217$20200915$20160912$20200918$PER$$US-JNJFOC-20160620225$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200918$$CN$US$US
127324213$12732421$3$F$201503$20200628$20160912$20200702$PER$$US-JNJFOC-20160818402$JOHNSON AND JOHNSON$$86$YR$$F$Y$54.8$KG$20200702$$CN$US$US
127324233$12732423$3$F$201408$20200921$20160912$20200923$PER$$US-JNJFOC-20160818696$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200923$$CN$US$US
127324872$12732487$2$F$201311$20200915$20160912$20200918$PER$$US-JNJFOC-20160822098$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200918$$CN$US$US
127324933$12732493$3$F$201412$20200915$20160912$20200921$PER$$US-JNJFOC-20160820812$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20200921$$CN$US$US
127325112$12732511$2$F$20150210$20200927$20160912$20200930$PER$$US-JNJFOC-20160623319$JOHNSON AND JOHNSON$$83$YR$E$F$Y$120.75$KG$20200930$$CN$US$US
127325192$12732519$2$F$20160407$20200720$20160912$20200731$PER$$US-JNJFOC-20160623315$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200731$$CN$US$US
127325502$12732550$2$F$20150324$20200728$20160912$20200803$PER$$US-JNJFOC-20160510611$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20200803$$CN$US$US
127325592$12732559$2$F$20140406$20200624$20160912$20200702$PER$$US-JNJFOC-20160604081$JOHNSON AND JOHNSON$$38$YR$$F$Y$$$20200702$$CN$US$US
127325833$12732583$3$F$20151014$20200701$20160912$20200706$PER$$US-JNJFOC-20160814162$JOHNSON AND JOHNSON$$69$YR$$F$Y$$$20200706$$CN$US$US
127326164$12732616$4$F$20150207$20200831$20160912$20200903$PER$$US-JNJFOC-20160604328$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200903$$CN$US$US
127326203$12732620$3$F$20121003$20200811$20160912$20200817$PER$$US-JNJFOC-20160522820$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200817$$CN$US$US
127327052$12732705$2$F$201407$20200713$20160912$20200717$PER$$US-JNJFOC-20160617151$JOHNSON AND JOHNSON$$49$YR$$F$Y$$$20200717$$CN$US$US
127327463$12732746$3$F$20150708$20200722$20160912$20200731$PER$$US-JNJFOC-20160625750$JOHNSON AND JOHNSON$$78$YR$E$F$Y$58$KG$20200731$$CN$US$US
127327606$12732760$6$F$20141023$20200901$20160912$20200914$PER$$US-JNJFOC-20160822988$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200914$$CN$US$US
127329662$12732966$2$F$201404$20200712$20160912$20200717$PER$$US-JNJFOC-20160705251$JOHNSON AND JOHNSON$$86$YR$$F$Y$63.11$KG$20200717$$CN$US$US
127329992$12732999$2$F$201507$20200708$20160912$20200709$PER$$US-JNJFOC-20160700197$JOHNSON AND JOHNSON$$80$YR$$M$Y$$$20200709$$CN$US$US
127330323$12733032$3$F$20160204$20200921$20160912$20200928$PER$$US-JNJFOC-20160825332$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200928$$CN$US$US
127330332$12733033$2$F$20150516$20200707$20160912$20200710$PER$$US-JNJFOC-20160711445$JOHNSON AND JOHNSON$$53$YR$$M$Y$68.2$KG$20200710$$LW$US$US
127330462$12733046$2$F$20150828$20200720$20160912$20200722$PER$$US-JNJFOC-20160622903$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200722$$CN$US$US
127330572$12733057$2$F$20140806$20200820$20160912$20200824$PER$$US-JNJFOC-20160624578$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20200824$$CN$US$US
127330863$12733086$3$F$20131221$20200920$20160912$20200928$PER$$US-JNJFOC-20160823499$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200928$$CN$US$US
127330992$12733099$2$F$20141204$20200917$20160912$20200922$PER$$US-JNJFOC-20160821211$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200922$$CN$US$US
127331313$12733131$3$F$20150117$20200921$20160912$20200928$PER$$US-JNJFOC-20160822414$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200928$$CN$US$US
127331343$12733134$3$F$20150721$20200715$20160912$20200720$PER$$US-JNJFOC-20160822365$JOHNSON AND JOHNSON$$84$YR$E$F$Y$62.7$KG$20200720$$CN$US$US
127331522$12733152$2$F$20140709$20200805$20160912$20200807$PER$$US-JNJFOC-20160624914$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200807$$CN$US$US
127332993$12733299$3$F$201311$20200906$20160912$20200914$PER$$US-JNJFOC-20160721114$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200914$$CN$US$US
127333023$12733302$3$F$20140818$20200802$20160912$20200805$PER$$US-JNJFOC-20160721230$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200805$$CN$US$US
127333283$12733328$3$F$20140801$20200812$20160912$20200817$PER$$US-JNJFOC-20160721250$JOHNSON AND JOHNSON$$33$YR$A$F$Y$$$20200817$$CN$US$US
127333392$12733339$2$F$201508$20200817$20160912$20200820$PER$$US-JNJFOC-20160721372$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200820$$CN$US$US
127333467$12733346$7$F$20160723$20200812$20160912$20200818$EXP$$US-BAUSCH-BL-2016-021351$BAUSCH AND LOMB$$75$YR$$F$Y$57.2$KG$20200818$$CN$US$US
127333843$12733384$3$F$201404$20200923$20160912$20200928$PER$$US-JNJFOC-20160805506$JOHNSON AND JOHNSON$$82$YR$E$M$Y$57$KG$20200928$$CN$US$US
127334083$12733408$3$F$20151002$20200819$20160912$20200824$PER$$US-JNJFOC-20160625618$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200824$$CN$US$US
127334103$12733410$3$F$20150628$20200716$20160912$20200720$PER$$US-JNJFOC-20160806373$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20200720$$CN$US$US
127334322$12733432$2$F$201603$20200630$20160912$20200706$PER$$US-JNJFOC-20160705763$JOHNSON AND JOHNSON$$79$YR$$F$Y$$$20200706$$CN$US$US
127334442$12733444$2$F$201411$20200924$20160912$20200928$PER$$US-JNJFOC-20160528555$JOHNSON AND JOHNSON$$76$YR$E$F$Y$90.72$KG$20200928$$CN$US$US
127334602$12733460$2$F$20141031$20200804$20160912$20200811$PER$$US-JNJFOC-20160808620$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200811$$CN$US$US
127334932$12733493$2$F$20140624$20200707$20160912$20200713$PER$$US-JNJFOC-20160721727$JOHNSON AND JOHNSON$$73$YR$$M$Y$$$20200713$$CN$US$US
127335453$12733545$3$F$20140905$20200708$20160912$20200713$PER$$US-JNJFOC-20160823623$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200713$$HP$US$US
127336372$12733637$2$F$201308$20200702$20160912$20200709$PER$$US-JNJFOC-20160425500$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200709$$CN$US$US
127336943$12733694$3$F$20140904$20200923$20160912$20200928$PER$$US-JNJFOC-20160825363$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200928$$CN$US$US
127337252$12733725$2$F$20140128$20200629$20160912$20200706$PER$$US-JNJFOC-20160528554$JOHNSON AND JOHNSON$$71$YR$$F$Y$$$20200706$$CN$US$US
127337382$12733738$2$F$20151026$20200924$20160912$20200928$PER$$US-JNJFOC-20160704259$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200928$$CN$US$US
127337612$12733761$2$F$20140603$20200831$20160912$20200914$PER$$US-JNJFOC-20160619543$JOHNSON AND JOHNSON$$89$YR$E$M$Y$$$20200914$$CN$US$US
127337942$12733794$2$F$201311$20200728$20160912$20200804$PER$$US-JNJFOC-20160510600$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20200804$$HP$US$US
127338603$12733860$3$F$20150308$20200908$20160912$20200914$PER$$US-JNJFOC-20160900221$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200914$$CN$US$US
127338776$12733877$6$F$$20200706$20160912$20200707$EXP$$CA-ROCHE-1826490$ROCHE$$34$YR$$M$Y$$$20200707$$HP$CA$CA
127339055$12733905$5$F$20140527$20200726$20160912$20200730$PER$$US-JNJFOC-20160901408$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200730$$CN$US$US
127339182$12733918$2$F$20140627$20200701$20160912$20200714$EXP$$US-JNJFOC-20160622869$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200714$$CN$US$US
127339253$12733925$3$F$20160204$20200816$20160912$20200819$PER$$US-JNJFOC-20160609652$JOHNSON AND JOHNSON$$75$YR$E$F$Y$89.36$KG$20200819$$CN$US$US
127339502$12733950$2$F$20160125$20200802$20160912$20200805$PER$$US-JNJFOC-20160625781$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200805$$CN$US$US
127341092$12734109$2$F$201202$20200721$20160912$20200724$PER$$US-JNJFOC-20160620330$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200724$$CN$US$US
127341193$12734119$3$F$20130512$20200908$20160912$20200914$PER$$US-JNJFOC-20160810185$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200914$$CN$US$US
127341203$12734120$3$F$20140808$20200722$20160912$20200731$PER$$US-JNJFOC-20160810183$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200731$$CN$US$US
127341283$12734128$3$F$20150309$20200816$20160912$20200819$PER$$US-JNJFOC-20160722761$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200819$$CN$US$US
127341293$12734129$3$F$20150425$20200920$20160912$20200922$PER$$US-JNJFOC-20160722889$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200922$$CN$US$US
127341563$12734156$3$F$20150923$20200913$20160912$20200921$PER$$US-JNJFOC-20160724162$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200921$$CN$US$US
127341592$12734159$2$F$20140801$20200827$20160912$20200831$PER$$US-JNJFOC-20160803214$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20200831$$CN$US$US
127341833$12734183$3$F$20140524$20200924$20160912$20200929$PER$$US-JNJFOC-20160812314$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200929$$HP$US$US
127342793$12734279$3$F$201505$20200824$20160912$20200827$PER$$US-JNJFOC-20160701260$JOHNSON AND JOHNSON$$79$YR$E$M$Y$110.9$KG$20200827$$CN$US$US
127343102$12734310$2$F$20150511$20200625$20160912$20200702$PER$$US-JNJFOC-20160618281$JOHNSON AND JOHNSON$$63$YR$$M$Y$$$20200702$$CN$US$US
127343152$12734315$2$F$20140410$20200902$20160912$20200909$PER$$US-JNJFOC-20160803763$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200909$$CN$US$US
127343162$12734316$2$F$20130816$20200803$20160912$20200805$PER$$US-JNJFOC-20160808252$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200805$$CN$US$US
127343262$12734326$2$F$20140912$20200909$20160912$20200914$PER$$US-JNJFOC-20160617150$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200914$$CN$US$US
127344104$12734410$4$F$201410$20200915$20160912$20200921$PER$$US-JNJFOC-20160700946$JOHNSON AND JOHNSON$$40$YR$A$M$Y$$$20200921$$CN$US$US
127344992$12734499$2$F$20141023$20200902$20160912$20200909$PER$$US-JNJFOC-20160620327$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20200909$$CN$US$US
127345022$12734502$2$F$20140120$20200906$20160912$20200914$PER$$US-JNJFOC-20160627400$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200914$$CN$US$US
127346623$12734662$3$F$20150702$20200903$20160912$20200909$PER$$US-JNJFOC-20160701311$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200909$$CN$US$US
127346804$12734680$4$F$201602$20200715$20160912$20200727$EXP$$US-JNJFOC-20160618198$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200727$$CN$US$US
127347193$12734719$3$F$20140506$20200702$20160912$20200707$PER$$US-JNJFOC-20160721740$JOHNSON AND JOHNSON$$81$YR$$M$Y$$$20200707$$CN$US$US
127348294$12734829$4$F$20141011$20200915$20160912$20200927$EXP$$US-JNJFOC-20160617162$JOHNSON AND JOHNSON$$89$YR$E$M$Y$$$20200927$$CN$US$US
127348553$12734855$3$F$20140725$20200706$20160912$20200717$EXP$$US-JNJFOC-20160719832$JOHNSON AND JOHNSON$$76$YR$$M$Y$$$20200717$$CN$US$US
127348572$12734857$2$F$201410$20200811$20160912$20200817$PER$$US-JNJFOC-20160719867$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200817$$CN$US$US
127349903$12734990$3$F$201602$20200923$20160912$20200928$PER$$US-JNJFOC-20160709204$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200928$$CN$US$US
127350104$12735010$4$F$20120101$20200701$20160912$20200707$PER$$US-JNJFOC-20160712631$JOHNSON AND JOHNSON$$46$YR$$F$Y$$$20200707$$LW$US$US
127350673$12735067$3$F$20130320$20200909$20160912$20200922$EXP$$US-JNJFOC-20160710208$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200922$$CN$US$US
127351174$12735117$4$F$20140103$20200825$20160912$20200827$PER$$US-JNJFOC-20160527742$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200827$$CN$US$US
127351182$12735118$2$F$20150629$20200729$20160912$20200731$PER$$US-JNJFOC-20160610435$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200731$$CN$US$US
127351224$12735122$4$F$201406$20200810$20160912$20200813$PER$$US-JNJFOC-20160800834$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200813$$CN$US$US
127351692$12735169$2$F$20130828$20200628$20160912$20200702$PER$$US-JNJFOC-20160618465$JOHNSON AND JOHNSON$$75$YR$$F$Y$$$20200702$$CN$US$US
127351973$12735197$3$F$20141118$20200913$20160912$20200917$PER$$US-JNJFOC-20160717099$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200917$$CN$US$US
127351983$12735198$3$F$20140810$20200804$20160912$20200807$PER$$US-JNJFOC-20160717156$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200807$$CN$US$US
127352233$12735223$3$F$20150711$20200827$20160912$20200901$PER$$US-JNJFOC-20160717144$JOHNSON AND JOHNSON$$69$YR$E$M$Y$130.75$KG$20200901$$CN$US$US
127353092$12735309$2$F$20150908$20200825$20160912$20200903$PER$$US-JNJFOC-20160724189$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200903$$CN$US$US
127353283$12735328$3$F$20150811$20200928$20160912$20200930$PER$$US-JNJFOC-20160801268$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200930$$CN$US$US
127359762$12735976$2$F$20150711$20200827$20160912$20200902$EXP$$US-BAYER-2016-145380$BAYER$$69$YR$E$M$Y$130.75$KG$20200902$$HP$US$US
127360783$12736078$3$F$$20200709$20160912$20200715$EXP$$US-PFIZER INC-2016357643$PFIZER$$68$YR$$F$Y$$$20200715$$MD$US$US
127361256$12736125$6$F$20160824$20200707$20160912$20200710$PER$$US-PFIZER INC-2016421350$PFIZER$$72$YR$$M$Y$$$20200710$$HP$US$US
127361542$12736154$2$F$20160722$20200806$20160913$20200810$EXP$$JP-ROCHE-1828327$ROCHE$$67$YR$$F$Y$52$KG$20200810$$MD$JP$JP
127363862$12736386$2$F$20160728$20161003$20160912$20161012$EXP$$US-JNJFOC-20160803121$PHARMACYCLICS$$46$YR$A$F$Y$$$20161012$$MD$US$US
127366384$12736638$4$F$$20200713$20160913$20200717$PER$$US-JNJFOC-20160808218$JOHNSON AND JOHNSON$$67$YR$$F$Y$$$20200717$$MD$US$US
127368261$12736826$1$I$$20160830$20160912$20160912$EXP$$US-CELGENEUS-USA-2016088100$CELGENE$DE SOUZA. RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB ALONE OR CEDIRANIB PLUS LENALIDOMIDE IN IODINE 131?REFRACTORY DIFFERENTIATED THYROID CANCER (DTC): A UNIVERSITY OF CHICAGO PHASE 2 CONSORTIUM TRIAL.. JOURNAL OF CLINICAL ONCOLOGY. 2016 MAY?.$$$$$Y$$$20160912$$HP$US$US
1273697219$12736972$19$F$$20200914$20160912$20200921$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-073069$BRISTOL MYERS SQUIBB$$74$YR$$F$Y$$$20200921$$CN$CA$CA
1273710814$12737108$14$F$20150617$20200916$20160913$20200924$EXP$$CA-ROCHE-1827996$ROCHE$$61$YR$$F$Y$$$20200924$$HP$CA$CA
1273715810$12737158$10$F$20160901$20171004$20160912$20171009$EXP$$IT-JNJFOC-20160908418$PHARMACYCLICS$$63$YR$A$F$Y$$$20171009$$MD$IT$IT
127376425$12737642$5$F$20160825$20161124$20160913$20161202$EXP$$FR-ABBVIE-16P-056-1715141-00$ABBVIE$$72$YR$$M$Y$71$KG$20161202$$MD$FR$FR
127378143$12737814$3$F$20160629$20161101$20160913$20161114$EXP$$FR-JNJFOC-20160807590$JANSSEN$$68$YR$E$F$Y$56$KG$20161114$$MD$FR$FR
127383767$12738376$7$F$201609$20200817$20160913$20200819$PER$$US-PFIZER INC-2016396936$PFIZER$$64$YR$$M$Y$72$KG$20200819$$MD$US$US
127386205$12738620$5$F$2016$20200720$20160913$20200728$EXP$$US-SA-2016SA155727$SANOFI AVENTIS$$58$YR$$F$Y$$$20200728$$CN$US$US
127389242$12738924$2$F$20160829$20181010$20160913$20181016$EXP$$FR-JNJFOC-20160905612$JANSSEN$$56$YR$A$F$Y$53$KG$20181016$$MD$FR$FR
127390061$12739006$1$I$20160408$20160503$20160912$20160912$EXP$$US-JNJFOC-20160510919$PHARMACYCLICS$$83$YR$E$M$Y$$$20160912$$MD$US$US
127390074$12739007$4$F$20160804$20161125$20160912$20161129$EXP$$IL-JNJFOC-20160805361$PHARMACYCLICS$$51$YR$A$M$Y$95$KG$20161129$$MD$IL$IL
127397033$12739703$3$F$201509$20200624$20160913$20200707$EXP$$US-JNJFOC-20160910280$JOHNSON AND JOHNSON$$84$YR$$F$Y$51.6$KG$20200707$$CN$US$US
127398682$12739868$2$F$20160904$20160923$20160913$20160930$EXP$$CH-JNJFOC-20160907340$JANSSEN$$62$YR$A$F$Y$82$KG$20160930$$MD$CH$CH
1274139214$12741392$14$F$$20200828$20160914$20200901$PER$$US-PFIZER INC-2016427691$PFIZER$$64$YR$$F$Y$64$KG$20200901$$CN$US$US
1274142213$12741422$13$F$20171230$20200912$20160914$20200916$EXP$$US-PFIZER INC-2016426500$PFIZER$$65$YR$$F$Y$88$KG$20200916$$MD$US$US
127422802$12742280$2$F$20131224$20200729$20160914$20200811$EXP$$US-BAYER-2016-032651$BAYER$$62$YR$A$M$Y$$$20200811$$LW$US$US
127426171$12742617$1$I$20160829$20160902$20160914$20160914$EXP$$US-JNJFOC-20160907065$PHARMACYCLICS$$71$YR$E$F$Y$57.3$KG$20160914$$MD$US$US
127440462$12744046$2$F$2016$20200717$20160914$20200722$PER$$US-009507513-1609USA003265$MERCK$$68$YR$$M$Y$$$20200722$$CN$US$US
127452123$12745212$3$F$$20200914$20160915$20200924$EXP$$CA-APOTEX-2016AP011372$APOTEX$$$$$$Y$$$20200924$$CN$CA$CA
127457044$12745704$4$F$20160824$20161214$20160915$20161221$EXP$$US-JNJFOC-20160903322$JANSSEN$$53$YR$A$F$Y$82$KG$20161221$$MD$US$US
127462234$12746223$4$F$20160908$20161005$20160915$20161007$EXP$$US-JNJFOC-20160911385$JANSSEN$$67$YR$E$F$Y$$$20161007$$MD$US$US
127463315$12746331$5$F$20160817$20170803$20160915$20170810$EXP$$CA-PFIZER INC-2016400683$PFIZER$$74$YR$$F$Y$$$20170810$$MD$CA$CA
127470975$12747097$5$F$20160620$20200907$20160915$20200919$EXP$$JP-INCYTE CORPORATION-2016IN003680$INCYTE$$$$$$Y$$$20200919$$MD$JP$JP
127480142$12748014$2$F$20151228$20200916$20160915$20200925$EXP$$US-BAYER-2016-105400$BAYER$$65$YR$E$M$Y$$$20200925$$HP$US$US
127481903$12748190$3$F$20160722$20200807$20160915$20200816$EXP$$PHJP2016JP026077$NOVARTIS$$67$YR$$F$Y$52$KG$20200816$$CN$JP$JP
1274820013$12748200$13$F$20160525$20200810$20160915$20200812$EXP$$US-ASTELLAS-2016US033536$ASTELLAS$$85$YR$$M$Y$$$20200812$$CN$US$US
1274886214$12748862$14$F$201608$20200708$20160915$20200710$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-018369$BRISTOL MYERS SQUIBB$$51$YR$$F$Y$$$20200710$$HP$CA$CA
127505552$12750555$2$F$20130512$20200908$20160916$20200911$EXP$$US-BAYER-2016-159916$BAYER$$76$YR$E$M$Y$$$20200911$$CN$US$US
1275066816$12750668$16$F$20170316$20200727$20160916$20200807$PER$$US-ACTELION-A-NJ2016-142127$ACTELION$$52$YR$$M$Y$71.2$KG$20200807$$HP$US$US
127527154$12752715$4$F$$20200915$20160916$20200916$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-073613$BRISTOL MYERS SQUIBB$$81$YR$$M$Y$$$20200916$$MD$CA$CA
127532721$12753272$1$I$20150617$20150618$20160916$20160916$EXP$$DE-ROCHE-1596813$ROCHE$$53$YR$$M$Y$$$20160916$$MD$DE$DE
127533516$12753351$6$F$201511$20200626$20160915$20200706$EXP$$US-ASTELLAS-2015US041494$ASTELLAS$$88$YR$$M$Y$$$20200706$$CN$US$US
1275360710$12753607$10$F$20170114$20200729$20160916$20200803$EXP$$US-PFIZER INC-2016433788$PFIZER$$45$YR$$F$Y$160$KG$20200803$$HP$US$US
127540335$12754033$5$F$20180226$20200819$20160915$20200831$EXP$$US-ASTELLAS-2015US046253$ASTELLAS$$73$YR$$M$Y$$$20200831$$CN$US$US
1275437814$12754378$14$F$2007$20200907$20160916$20200914$EXP$GB-EMA-DD-20180801-DEEPAKEVHPDD-095300$PHFR2016GB007346$NOVARTIS$$36$YR$$F$Y$$$20200914$$MD$GB$GB
127550372$12755037$2$F$201505$20200828$20160916$20200904$EXP$$US-ASTELLAS-2016US030448$ASTELLAS$$48$YR$$F$Y$$$20200904$$CN$US$US
127556922$12755692$2$F$20140506$20200702$20160916$20200716$EXP$$US-BAYER-2016-148938$BAYER$$82$YR$E$M$Y$$$20200716$$CN$US$US
127558184$12755818$4$F$20150127$20200702$20160916$20200716$EXP$$US-BAYER-2016-105815$BAYER$$61$YR$A$M$Y$$$20200716$$CN$US$US
127560235$12756023$5$F$20160829$20161109$20160916$20161115$EXP$$TR-JNJFOC-20160827434$PHARMACYCLICS$$71$YR$E$M$Y$75$KG$20161115$$MD$TR$TR
127560373$12756037$3$F$20140917$20200816$20160916$20200819$EXP$$US-BAYER-2016-076430$BAYER$$74$YR$E$F$Y$$$20200819$$CN$US$US
127567892$12756789$2$F$$20200820$20160917$20200829$EXP$$ES-AUROBINDO-AUR-APL-2016-11683$AUROBINDO$$78$YR$$M$Y$$$20200829$$HP$ES$ES
127575862$12757586$2$F$20160116$20200730$20160919$20200804$EXP$$CA-009507513-1609CAN006633$MERCK$$52$YR$$M$Y$95.24$KG$20200804$$HP$CA$CA
127587514$12758751$4$F$20150515$20200921$20160919$20200925$EXP$$PHHY2015NL087506$NOVARTIS$$72$YR$$F$Y$$$20200925$$MD$NL$NL
127594241$12759424$1$I$20160820$20160915$20160919$20160919$EXP$$PL-JNJFOC-20160914475$PHARMACYCLICS$$81$YR$E$M$Y$75.2$KG$20160919$$MD$PL$PL
127596068$12759606$8$F$20160215$20200710$20160919$20200710$EXP$$PHHY2016CA127706$NOVARTIS$$62$YR$$F$Y$60.7$KG$20200710$$MD$CA$CA
127597912$12759791$2$F$20160912$20160919$20160919$20160923$EXP$$AR-JNJFOC-20160913463$PHARMACYCLICS$$63$YR$A$F$Y$76$KG$20160923$$MD$AR$AR
127601483$12760148$3$F$201404$20200721$20160919$20200731$PER$$US-JNJFOC-20160918475$JOHNSON AND JOHNSON$$64$YR$A$M$Y$72.5$KG$20200731$$CN$US$US
1276047914$12760479$14$F$20150529$20200708$20160919$20200722$EXP$$US-ACTELION-A-US2016-142331$ACTELION$$69$YR$$M$Y$61.22$KG$20200722$$MD$US$US
127608663$12760866$3$F$20160820$20200824$20160919$20200825$EXP$$US-ACTELION-A-NJ2016-142102$ACTELION$$39$YR$$F$Y$$$20200825$$HP$US$US
127609683$12760968$3$F$$20200807$20160919$20200818$EXP$$US-BAXTER-2016BAX047213$BAXTER$MOJADDI M, HOVNANIANS N, KAUFMANN M, HILL J. MACROSCOPIC T?WAVE ALTERNANS: AN UNUSUAL COMPANION OF QT PROLONGATION. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2016 APR 05?67(13):1265?1265.$55$YR$$F$Y$$$20200818$$HP$US$US
127615444$12761544$4$F$201604$20200722$20160920$20200724$EXP$$US-ABBVIE-16K-163-1727359-00$ABBVIE$$41$YR$$F$Y$76.27$KG$20200724$$CN$US$US
1276157114$12761571$14$F$2016$20200715$20160920$20200723$EXP$$PHHY2016CA019812$NOVARTIS$$53$YR$$M$Y$$$20200723$$HP$CA$CA
127627342$12762734$2$F$20130426$20160914$20160920$20160922$EXP$$DE-JNJFOC-20140509157$JANSSEN$$53$YR$A$F$Y$75$KG$20160922$$HP$DE$DE
127627882$12762788$2$F$201309$20200628$20160920$20200708$EXP$$US-BAYER-2016-098341$BAYER$$82$YR$E$M$Y$$$20200708$$CN$US$US
127634177$12763417$7$F$20160910$20171205$20160920$20171218$EXP$$CN-JNJFOC-20160915548$JANSSEN$$33$YR$A$F$Y$79$KG$20171218$$MD$CN$CN
127634893$12763489$3$F$20160807$20161004$20160920$20161006$EXP$$CA-JNJFOC-20160818271$JANSSEN$$78$YR$E$F$Y$91.16$KG$20161006$$MD$CA$CA
127641092$12764109$2$F$20140716$20200827$20160920$20200902$EXP$$US-BAYER-2016-105334$BAYER$$76$YR$E$F$Y$103.06$KG$20200902$$CN$US$US
127642286$12764228$6$F$2013$20200911$20160920$20200916$EXP$$US-JAZZ-2016-US-017790$JAZZ$$28$YR$$M$Y$$$20200916$$HP$US$US
1276475524$12764755$24$F$$20200921$20160921$20200929$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076425$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200929$$CN$CA$CA
127653816$12765381$6$F$$20200923$20160921$20200929$PER$$US-PFIZER INC-2016436218$PFIZER$$71$YR$$F$Y$$$20200929$$CN$US$US
127653931$12765393$1$I$$20160909$20160921$20160921$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-124506$RANBAXY$$66$YR$$F$Y$$$20160921$$HP$GB$ES
127655063$12765506$3$F$$20190823$20160921$20200903$PER$$US-CIPLA LTD.-2016US17014$CIPLA$$$$$$Y$$$20200903$$MD$US$US
127656553$12765655$3$F$201505$20200709$20160921$20200720$EXP$$US-JNJFOC-20160900018$JOHNSON AND JOHNSON$$53$YR$$F$Y$$$20200720$$CN$US$US
127656564$12765656$4$F$201402$20200702$20160921$20200706$PER$$US-JNJFOC-20160900253$JOHNSON AND JOHNSON$$66$YR$$M$Y$$$20200706$$HP$US$US
127656923$12765692$3$F$20140826$20200624$20160921$20200706$PER$$US-JNJFOC-20160903747$JOHNSON AND JOHNSON$$66$YR$$M$Y$$$20200706$$CN$US$US
127656973$12765697$3$F$20141010$20200810$20160921$20200819$EXP$$US-JNJFOC-20160906747$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20200819$$CN$US$US
127657193$12765719$3$F$20151011$20200713$20160921$20200716$PER$$US-JNJFOC-20160903736$JOHNSON AND JOHNSON$$63$YR$$M$Y$114.3$KG$20200716$$CN$US$US
127657643$12765764$3$F$20150608$20200917$20160921$20200922$PER$$US-JNJFOC-20160902479$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200922$$HP$US$US
127657953$12765795$3$F$20160427$20200927$20160921$20200929$PER$$US-JNJFOC-20160908239$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20200929$$CN$US$US
127657984$12765798$4$F$201603$20200826$20160921$20200909$EXP$$US-JNJFOC-20160908016$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200909$$CN$US$US
127658082$12765808$2$F$20151002$20200715$20160921$20200720$PER$$US-JNJFOC-20160908161$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200720$$HP$US$US
127658113$12765811$3$F$20141027$20200712$20160921$20200714$PER$$US-JNJFOC-20160906834$JOHNSON AND JOHNSON$$70$YR$$F$Y$$$20200714$$CN$US$US
127658123$12765812$3$F$201409$20200722$20160921$20200731$PER$$US-JNJFOC-20160909402$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200731$$CN$US$US
127658233$12765823$3$F$20140915$20200922$20160921$20200928$PER$$US-JNJFOC-20160910283$JOHNSON AND JOHNSON$$49$YR$A$F$Y$$$20200928$$CN$US$US
127658485$12765848$5$F$20150119$20200719$20160921$20200729$EXP$$US-JNJFOC-20160910277$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20200729$$CN$US$US
127658513$12765851$3$F$20140326$20200629$20160921$20200706$PER$$US-JNJFOC-20160911006$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200706$$CN$US$US
127658803$12765880$3$F$20130828$20200831$20160921$20200903$PER$$US-JNJFOC-20160910747$JOHNSON AND JOHNSON$$76$YR$E$M$Y$83.5$KG$20200903$$CN$US$US
127658854$12765885$4$F$20150522$20200902$20160921$20200909$PER$$US-JNJFOC-20160910269$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200909$$CN$US$US
127659863$12765986$3$F$20140916$20200908$20160921$20200914$PER$$US-JNJFOC-20160910631$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200914$$CN$US$US
127660063$12766006$3$F$20140813$20200701$20160921$20200713$EXP$$US-JNJFOC-20160913079$JOHNSON AND JOHNSON$$45$YR$$M$Y$$$20200713$$CN$US$US
127660153$12766015$3$F$20140831$20200910$20160921$20200918$PER$$US-JNJFOC-20160913633$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200918$$HP$US$US
127660213$12766021$3$F$20160906$20161121$20160921$20161129$EXP$$US-JNJFOC-20160915158$JANSSEN$$55$YR$A$M$Y$93.9$KG$20161129$$MD$US$US
127661993$12766199$3$F$201403$20200916$20160921$20200921$PER$$US-JNJFOC-20160918267$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200921$$CN$US$US
127666882$12766688$2$F$20160905$20160927$20160921$20161007$EXP$$CA-PFIZER INC-2016434487$PFIZER$$70$YR$$M$Y$$$20161007$$MD$CA$CA
1276679812$12766798$12$F$$20200818$20160921$20200824$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076609$BRISTOL MYERS SQUIBB$$56$YR$$F$Y$$$20200824$$MD$CA$CA
127669996$12766999$6$F$20160826$20200624$20160921$20200707$EXP$$FR-ASTELLAS-2016US036034$ASTELLAS$$83$YR$$M$Y$$$20200707$$MD$FR$FR
1276721118$12767211$18$F$20160222$20200626$20160921$20200701$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-015691$BRISTOL MYERS SQUIBB$$65$YR$$M$Y$$$20200701$$CN$CA$CA
127672524$12767252$4$F$20160909$20190722$20160921$20200803$EXP$$GR-JNJFOC-20160913958$JOHNSON AND JOHNSON$$63$YR$A$F$Y$$$20200803$$MD$GR$GR
127672765$12767276$5$F$20150625$20200817$20160921$20200819$EXP$$PHHY2013CA113952$NOVARTIS$$80$YR$$F$Y$$$20200819$$HP$CA$CA
1276772410$12767724$10$F$$20200713$20160921$20200717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076689$BRISTOL MYERS SQUIBB$$60$YR$$F$Y$$$20200717$$MD$CA$CA
1276949220$12769492$20$F$$20200922$20160921$20200929$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076352$BRISTOL MYERS SQUIBB$$$$$M$Y$89$KG$20200929$$MD$CA$CA
127695542$12769554$2$F$$20161026$20160922$20161104$EXP$$ES-ROCHE-1832646$ROCHE$JALIL?ABUMALHAM D, HURTADO CELOTTI D, BUESA BAREZ J, RUBIO ALONSO L AND MARTINEZ?GONZALEZ J INFLUENCE OF ORAL BISPHOSPHONATES IN PATIENTS WITH DENTAL IMPLANTS [POSTER 13]. MEDICINA ORAL, PATOLOGIA ORAL Y CIRUGIA BUCAL. 2015 JUN 01?20(SUP1):S35?.$66$YR$$F$Y$$$20161104$$MD$ES$ES
1276988615$12769886$15$F$$20200819$20160922$20200827$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076654$BRISTOL MYERS SQUIBB$$62$YR$$F$Y$72$KG$20200827$$MD$CA$CA
127706618$12770661$8$F$20160910$20181010$20160922$20181018$EXP$$GB-JNJFOC-20160915688$JANSSEN$$80$YR$E$F$Y$75$KG$20181018$$MD$GB$GB
127707484$12770748$4$F$20160519$20200710$20160922$20200722$EXP$$US-JNJFOC-20160920399$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20200722$$HP$US$US
127712045$12771204$5$F$$20200902$20160922$20200911$EXP$$CA-APOTEX-2016AP011878$APOTEX$$$$$F$Y$$$20200911$$CN$CA$CA
1277126814$12771268$14$F$$20200723$20160922$20200728$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076851$BRISTOL MYERS SQUIBB$$43$YR$$F$Y$$$20200728$$CN$CA$CA
1277126912$12771269$12$F$$20200715$20160922$20200720$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076855$BRISTOL MYERS SQUIBB$$65$YR$$M$Y$$$20200720$$MD$CA$CA
127715945$12771594$5$F$$20200915$20160922$20200923$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076774$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200923$$MD$CA$CA
127717717$12771771$7$F$$20200814$20160922$20200820$PER$$US-PFIZER INC-2016440654$PFIZER$$73$YR$$F$Y$60$KG$20200820$$MD$US$US
127721552$12772155$2$F$20140803$20200902$20160922$20200908$EXP$$US-BAYER-2016-154391$BAYER$$85$YR$E$M$Y$69.46$KG$20200908$$LW$US$US
127724087$12772408$7$F$$20200922$20160922$20200923$EXP$$US-PFIZER INC-2016440869$PFIZER$$79$YR$$M$Y$$$20200923$$MD$US$US
127727133$12772713$3$F$20160914$20161007$20160922$20161014$EXP$$US-JNJFOC-20160919614$JANSSEN$$60$YR$A$F$Y$116$KG$20161014$$MD$US$US
1277354620$12773546$20$F$$20200625$20160923$20200701$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076599$BRISTOL MYERS SQUIBB$$64$YR$$F$Y$$$20200701$$CN$CA$CA
127742412$12774241$2$F$20160411$20200723$20160923$20200806$EXP$NL-LRB-225062$NL-TEVA-693422ACC$TEVA$$57$YR$A$F$Y$97$KG$20200806$$MD$NL$NL
127742887$12774288$7$F$2005$20200922$20160923$20200924$EXP$$US-PFIZER INC-2016445015$PFIZER$$51$YR$$F$Y$102$KG$20200924$$HP$US$US
127743471$12774347$1$I$20160812$20160912$20160923$20160923$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-124297$RANBAXY$$54$YR$$F$Y$54.9$KG$20160923$$HP$GB$GB
127754094$12775409$4$F$20160909$20170125$20160923$20170125$EXP$$CA-PFIZER INC-2016440371$PFIZER$$74$YR$$F$Y$$$20170125$$MD$CA$CA
127754293$12775429$3$F$20160914$20161102$20160923$20161110$EXP$$US-JNJFOC-20160917308$PHARMACYCLICS$$79$YR$E$F$Y$67$KG$20161110$$MD$US$US
127762814$12776281$4$F$2014$20200922$20160923$20200929$EXP$$US-JNJFOC-20160918518$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$99.88$KG$20200929$$CN$US$US
1277651616$12776516$16$F$$20200922$20160923$20200929$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076363$BRISTOL MYERS SQUIBB$$74$YR$$M$Y$$$20200929$$CN$CA$CA
127765177$12776517$7$F$$20200626$20160923$20200702$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076645$BRISTOL MYERS SQUIBB$$50$YR$$F$Y$$$20200702$$CN$CA$CA
127769505$12776950$5$F$2013$20200924$20160923$20200930$EXP$$US-JAZZ-2016-US-018245$JAZZ$$$$$M$Y$$$20200930$$HP$US$US
127770464$12777046$4$F$20160916$20191030$20160923$20191106$EXP$$GB-ASTRAZENECA-2016SF00763$ASTRAZENECA$$20860$DY$$M$Y$120.6$KG$20191106$$MD$GB$GB
127778854$12777885$4$F$$20200813$20160924$20200820$PER$$US-JAZZ-2016-US-010807$JAZZ$$$$$F$Y$$$20200820$$HP$US$US
127784613$12778461$3$F$$20200817$20160926$20200817$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-077013$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200817$$CN$US$US
127785483$12778548$3$F$20160909$20200724$20160926$20200808$PER$$PHHY2016US131627$NOVARTIS$$49$YR$$F$Y$83.54$KG$20200808$$CN$COUNTRY NOT SPECIFIED$US
1277947410$12779474$10$F$20140131$20200702$20160926$20200709$EXP$$PHHY2016CA019556$NOVARTIS$$45$YR$$F$Y$$$20200710$$MD$CA$CA
127797507$12779750$7$F$2014$20200707$20160926$20200708$EXP$$US-PFIZER INC-2016444436$PFIZER$$54$YR$$M$Y$99.34$KG$20200708$$MD$US$US
1278124218$12781242$18$F$2015$20200824$20160926$20200829$EXP$$PHHY2015CA109453$NOVARTIS$$70$YR$$F$Y$$$20200829$$MD$CA$CA
1278141312$12781413$12$F$201609$20200709$20160926$20200714$EXP$$US-SA-2016SA175347$SANOFI AVENTIS$$49$YR$$F$Y$$$20200714$$HP$US$US
127821842$12782184$2$F$20150303$20161102$20160927$20161114$EXP$$JP-ROCHE-1833444$ROCHE$$77$YR$$F$Y$59$KG$20161114$$MD$JP$JP
127822602$12782260$2$F$$20200902$20160927$20200914$EXP$$JP-LUPIN PHARMACEUTICALS INC.-2016-04297$LUPIN$$75$YR$$F$Y$$$20200914$$MD$JP$JP
127827948$12782794$8$F$$20200826$20160927$20200907$EXP$$CA-APOTEX-2016AP012086$APOTEX$$46$YR$$F$Y$$$20200907$$CN$CA$CA
127829876$12782987$6$F$$20200731$20160927$20200804$PER$$US-PFIZER INC-2016447523$PFIZER$$77$YR$$F$Y$$$20200804$$CN$US$US
127830237$12783023$7$F$201801$20200908$20160927$20200909$EXP$$US-PFIZER INC-2016449439$PFIZER$$74$YR$$F$Y$63$KG$20200909$$MD$US$US
127832883$12783288$3$F$$20161020$20160927$20161024$EXP$$BR-ROCHE-1810984$ROCHE$$38$YR$$M$Y$84.7$KG$20161024$$MD$BR$BR
1278382610$12783826$10$F$20150413$20200812$20160927$20200813$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN107353$VIIV$$48$YR$$M$Y$$$20200813$$CN$JP$JP
127840202$12784020$2$F$20160605$20200724$20160927$20200727$EXP$$US-GLAXOSMITHKLINE-US2016GSK138863$GLAXOSMITHKLINE$$85$YR$$F$Y$61$KG$20200727$$MD$US$US
127840495$12784049$5$F$20160912$20200824$20160927$20200907$EXP$$AU-JNJFOC-20160913984$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200907$$CN$AU$AU
127842711$12784271$1$I$20160219$20160222$20160927$20160927$EXP$$US-JNJFOC-20160225042$PHARMACYCLICS$$69$YR$A$M$Y$$$20160927$$MD$US$US
127856485$12785648$5$F$20160909$20180124$20160927$20180129$EXP$$US-JNJFOC-20160915257$JANSSEN$$57$YR$A$F$Y$84$KG$20180129$$MD$US$US
127867453$12786745$3$F$20150407$20200811$20160927$20200814$EXP$$AU-PFIZER INC-2016442461$PFIZER$$2$YR$$M$Y$12.8$KG$20200814$$HP$AU$AU
1278741810$12787418$10$F$20160920$20200811$20160928$20200814$EXP$$GB-UCBSA-2016037062$UCB$$24$YR$$F$Y$$$20200814$$HP$GB$GB
127893512$12789351$2$F$2014$20200825$20160928$20200828$EXP$$US-BAYER-2016-103003$BAYER$$77$YR$E$M$Y$115.77$KG$20200828$$CN$US$US
1278996413$12789964$13$F$$20200914$20160928$20200918$EXP$$CA-PFIZER INC-2015283341$PFIZER$$54$YR$$M$Y$$$20200918$$CN$CA$CA
1279005815$12790058$15$F$2016$20200909$20160928$20200914$EXP$$PHHY2016CA081553$NOVARTIS$$72$YR$$M$Y$$$20200914$$CN$COUNTRY NOT SPECIFIED$CA
127904873$12790487$3$F$201603$20200909$20160929$20200918$EXP$$US-BIOGEN-2016BI00294935$BIOGEN$$60$YR$$M$Y$$$20200918$$MD$US$US
127907313$12790731$3$F$20160802$20200806$20160929$20200817$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-078448$BRISTOL MYERS SQUIBB$$63$YR$$F$Y$$$20200817$$CN$BR$BR
127910338$12791033$8$F$2016$20200821$20160929$20200825$EXP$$US-PFIZER INC-2016452423$PFIZER$$66$YR$$F$Y$73$KG$20200825$$HP$US$US
127919233$12791923$3$F$$20200515$20160929$20200820$PER$$US-JAZZ-2016-US-011469$JAZZ$$$$$F$Y$$$20200820$$$US$US
127938142$12793814$2$F$$20200710$20160929$20200921$PER$$US-JAZZ-2016-US-011783$JAZZ$$$$$F$Y$$$20200921$$HP$US$US
1279524618$12795246$18$F$2014$20200807$20160929$20200812$PER$$US-PFIZER INC-2016447059$PFIZER$$73$YR$$F$Y$$$20200812$$CN$US$US
127952542$12795254$2$F$$20200731$20160929$20200804$PER$$US-PFIZER INC-2016098478$PFIZER$$71$YR$$F$Y$$$20200804$$MD$US$US
1279549017$12795490$17$F$20160915$20200706$20160929$20200717$EXP$$US-ACTELION-A-US2016-142642$ACTELION$$88$YR$$F$Y$$$20200717$$HP$US$US
127958726$12795872$6$F$20150603$20200720$20160929$20200730$EXP$$CA-JNJFOC-20160923592$JOHNSON AND JOHNSON$$53$YR$A$F$Y$$$20200730$$CN$CA$CA
127973889$12797388$9$F$20160405$20200626$20160930$20200702$EXP$$PHHO2016FR013837$NOVARTIS$$53$YR$$M$Y$70$KG$20200702$$HP$FR$FR
127982966$12798296$6$F$$20200723$20160930$20200804$EXP$$CA-APOTEX-2016AP012482$APOTEX$$31$YR$$F$Y$71$KG$20200804$$CN$CA$CA
1279866811$12798668$11$F$$20200916$20160930$20200924$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1847$ORION$$66$YR$$M$Y$$$20200924$$MD$CA$CA
127987073$12798707$3$F$201606$20191114$20160930$20191127$EXP$$PHHY2016CA078706$NOVARTIS$$45$YR$$F$Y$$$20191127$$CN$COUNTRY NOT SPECIFIED$CA
127987722$12798772$2$F$$20160926$20160930$20161007$EXP$$ES-AUROBINDO-AUR-APL-2016-11933$AUROBINDO$$66$YR$$F$Y$$$20161007$$MD$ES$ES
127991332$12799133$2$F$20160916$20161024$20160930$20161025$EXP$$IT-JNJFOC-20160923493$JANSSEN$$68$YR$E$F$Y$$$20161025$$MD$IT$IT
1279916616$12799166$16$F$2013$20200910$20160930$20200916$EXP$$PHHY2016ZA133890$NOVARTIS$$$$$M$Y$60$KG$20200916$$MD$ZA$ZA
127992152$12799215$2$F$20131021$20200710$20160930$20200722$EXP$$US-JNJFOC-20160926558$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20200722$$HP$US$US
127992724$12799272$4$F$201406$20200902$20160930$20200910$EXP$$FR-ASTRAZENECA-2016SF02698$ASTRAZENECA$$66$YR$$M$Y$158$KG$20200910$$CN$FR$FR
127998476$12799847$6$F$20160830$20160927$20160930$20171122$EXP$$EE-JNJFOC-20160928914$JANSSEN$$71$YR$E$M$Y$68$KG$20171122$$CN$EE$EE
128008993$12800899$3$F$20160914$20200821$20161002$20200822$EXP$$PHHY2016AU134993$NOVARTIS$$37$YR$$F$Y$50$KG$20200822$$MD$AU$AU
1280104345$12801043$45$F$20160628$20200909$20161003$20200918$EXP$$CA-ROCHE-1836972$ROCHE$$15$YR$$F$Y$$$20200918$$CN$CA$CA
128013406$12801340$6$F$20160926$20181009$20161003$20181012$EXP$$FR-ROCHE-1837251$ROCHE$$83$YR$$F$Y$73$KG$20181012$$MD$FR$FR
128016303$12801630$3$F$$20190805$20161003$20190808$PER$$US-PFIZER INC-2016457521$PFIZER$$65$YR$$F$Y$$$20190808$$MD$US$US
128017423$12801742$3$F$$20200622$20161003$20200702$EXP$$US-AUROBINDO-AUR-APL-2016-10680$AUROBINDO$$3$MON$$$Y$6.1$KG$20200702$$MD$US$US
1280184811$12801848$11$F$20160418$20200921$20161003$20200925$EXP$$PHHY2016DE106616$NOVARTIS$$51$YR$$F$Y$92$KG$20200925$$HP$DE$DE
128022922$12802292$2$F$201604$20200812$20161003$20200817$EXP$$US-JAZZ-2016-US-012404$JAZZ$$83$YR$$F$Y$$$20200817$$HP$US$US
128033263$12803326$3$F$20160921$20170118$20161003$20170127$EXP$$IL-JNJFOC-20160929914$PHARMACYCLICS$$77$YR$E$M$Y$$$20170127$$MD$IL$IL
1280401313$12804013$13$F$20160914$20180123$20161003$20180125$EXP$$US-JNJFOC-20160925350$JANSSEN$$40$YR$A$F$Y$74.4$KG$20180125$$MD$US$US
128053331$12805333$1$I$20160912$20160913$20161004$20161004$EXP$$US-ROCHE-1829909$ROCHE$$50$YR$$M$Y$90.7$KG$20161004$$MD$US$US
128066312$12806631$2$F$201602$20200923$20161004$20200928$EXP$$US-BAYER-2016-141821$BAYER$$66$YR$E$F$Y$$$20200928$$CN$US$US
128072292$12807229$2$F$20140110$20161013$20161004$20161019$EXP$$DE-JNJFOC-20140106841$JANSSEN$$66$YR$E$F$Y$73$KG$20161019$$MD$DE$DE
128073883$12807388$3$F$20160912$20170112$20161004$20170119$EXP$$NZ-JNJFOC-20160930478$JANSSEN$$58$YR$A$M$Y$112.5$KG$20170119$$MD$NZ$NZ
128073925$12807392$5$F$20160617$20161206$20161004$20161208$EXP$$US-JNJFOC-20160930254$JANSSEN$$73$YR$E$M$Y$99.79$KG$20161208$$MD$US$US
128086133$12808613$3$F$20140918$20200804$20161004$20200814$EXP$$US-JNJFOC-20161001588$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200814$$CN$US$US
128092183$12809218$3$F$20160725$20200624$20161004$20200702$EXP$$NL-ASTRAZENECA-2016SF02694$ASTRAZENECA$$19764$DY$$F$Y$$$20200702$$MD$NL$NL
1280942511$12809425$11$F$20160903$20200807$20161005$20200812$EXP$$CA-TAKEDA-2016TUS017672$TAKEDA$$63$YR$$M$Y$$$20200812$$CN$CA$CA
128100745$12810074$5$F$1977$20200924$20161005$20200928$EXP$$US-PFIZER INC-2016456687$PFIZER$$78$YR$$F$Y$$$20200928$$CN$US$US
128104523$12810452$3$F$$20200729$20161005$20200809$EXP$$CA-UCBSA-2016037901$UCB$$45$YR$$F$Y$97$KG$20200809$$HP$CA$CA
128112122$12811212$2$F$20140810$20200804$20161005$20200813$EXP$$US-BAYER-2016-144869$BAYER$$78$YR$E$F$Y$$$20200813$$CN$US$US
128114565$12811456$5$F$2016$20200626$20161005$20200701$EXP$$US-SA-2016SA174372$SANOFI AVENTIS$$$$$$Y$$$20200701$$HP$US$US
128117854$12811785$4$F$20160918$20161013$20161005$20170412$EXP$$GB-JNJFOC-20160924750$JANSSEN$$67$YR$E$M$Y$65.2$KG$20170412$$MD$GB$GB
128126035$12812603$5$F$20160202$20161220$20161005$20170104$EXP$$GB-JNJFOC-20160929319$PHARMACYCLICS$$60$YR$A$M$Y$136$KG$20170104$$MD$GB$GB
128127211$12812721$1$I$20160809$20160927$20161005$20161005$EXP$$IT-JNJFOC-20160927957$JANSSEN$$59$YR$A$M$Y$$$20161005$$CN$IT$IT
128127226$12812722$6$F$20160907$20170222$20161005$20170224$EXP$$GB-JNJFOC-20160930837$JANSSEN$$76$YR$E$M$Y$63$KG$20170224$$HP$GB$GB
128127293$12812729$3$F$20160906$20161223$20161005$20161230$EXP$$TR-JNJFOC-20161002994$PHARMACYCLICS$$51$YR$A$F$Y$$$20161230$$MD$TR$TR
1281285318$12812853$18$F$2015$20200806$20161005$20200811$EXP$$CA-PFIZER INC-2016464804$PFIZER$$58$YR$$F$Y$64$KG$20200811$$MD$CA$CA
128154219$12815421$9$F$20160926$20190516$20161005$20190522$EXP$$GB-JNJFOC-20160930047$JANSSEN$$65$YR$A$M$Y$68.2$KG$20190522$$MD$GB$GB
128157734$12815773$4$F$201504$20200809$20161005$20200813$PER$$US-JNJFOC-20161001951$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200813$$HP$US$US
128159462$12815946$2$F$$20200825$20161006$20200914$PER$$US-AMGEN-USASP2016136322$AMGEN$$56$YR$A$M$Y$$$20200914$$MD$US$US
128188045$12818804$5$F$20151130$20200910$20161006$20200919$EXP$$JP-UNITED THERAPEUTICS-UNT-2016-014190$UNITED THERAPEUTICS$$42$YR$$F$Y$49.8$KG$20200919$$CN$JP$JP
128191351$12819135$1$I$20160711$20160712$20161006$20161006$EXP$$CA-PFIZER INC-2016354630$PFIZER$$65$YR$$M$Y$$$20161006$$MD$CA$CA
128206993$12820699$3$F$201703$20200923$20161007$20200928$EXP$$US-JAZZ-2016-US-019126$JAZZ$$53$YR$$F$Y$$$20200928$$HP$US$US
128207724$12820772$4$F$20141105$20200727$20161006$20200731$PER$$US-JNJFOC-20161001631$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200731$$CN$US$US
128207741$12820774$1$I$20160914$20160914$20161006$20161006$EXP$$AR-JNJFOC-20160915810$JANSSEN$$70$YR$E$M$Y$$$20161006$$MD$AR$AR
1282132620$12821326$20$F$20160927$20180920$20161006$20180927$EXP$$FR-JNJFOC-20160929357$JANSSEN$$76$YR$E$M$Y$74.2$KG$20180927$$MD$FR$FR
1282142210$12821422$10$F$$20200917$20161007$20200929$EXP$$CA-APOTEX-2016AP012794$APOTEX$$$$$F$Y$$$20200929$$CN$CA$CA
128219167$12821916$7$F$2016$20200728$20161006$20200803$EXP$$US-SA-2016SA181034$SANOFI AVENTIS$$$$$$Y$$$20200803$$PH$US$US
1282263710$12822637$10$F$201609$20200701$20161007$20200702$PER$$US-PFIZER INC-2016465565$PFIZER$$71$YR$$F$Y$$$20200702$$HP$US$US
1282308825$12823088$25$F$20150127$20200707$20161007$20200716$EXP$$PHHY2011CA37575$NOVARTIS$$74$YR$$F$Y$$$20200716$$CN$CA$CA
128230953$12823095$3$F$20160924$20180705$20161006$20180712$EXP$$FR-JNJFOC-20160929688$JANSSEN$$83$YR$E$M$Y$96$KG$20180712$$MD$FR$FR
128247052$12824705$2$F$201403$20200916$20161006$20200925$EXP$$US-BAYER-2016-181636$BAYER$$79$YR$E$M$Y$$$20200925$$LW$US$US
128255036$12825503$6$F$20160923$20181112$20161007$20181119$EXP$$ES-JNJFOC-20160928100$JANSSEN$$80$YR$E$M$Y$97$KG$20181119$$MD$ES$ES
1282551313$12825513$13$F$$20200710$20161006$20200714$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK144027$GLAXOSMITHKLINE$$$$$F$Y$55$KG$20200714$$CN$BR$BR
128255926$12825592$6$F$20160926$20181009$20161007$20181017$EXP$$FR-ABBVIE-16P-056-1744589-00$ABBVIE$$83$YR$$F$Y$73$KG$20181017$$HP$FR$FR
128262172$12826217$2$F$$20200724$20161006$20200921$PER$$US-JAZZ-2016-US-012590$JAZZ$$$$$F$Y$$$20200921$$HP$US$US
128275386$12827538$6$F$20160928$20180327$20161007$20180406$EXP$$FR-JNJFOC-20161000054$JANSSEN$$68$YR$E$F$Y$69$KG$20180406$$MD$FR$FR
128280006$12828000$6$F$20160921$20161220$20161007$20170105$EXP$$US-JNJFOC-20160930629$PHARMACYCLICS$$79$YR$E$M$Y$$$20170105$$MD$US$US
128281076$12828107$6$F$201609$20200804$20161007$20200807$EXP$$US-SA-2016SA172926$SANOFI AVENTIS$$$$$$Y$$$20200807$$MD$US$US
128284453$12828445$3$F$20131115$20200714$20161007$20200727$EXP$$US-JNJFOC-20161001630$JOHNSON AND JOHNSON$$71$YR$$F$Y$$$20200727$$CN$US$US
128285586$12828558$6$F$20150925$20200826$20161007$20200901$EXP$$US-SA-2015SA153660$SANOFI AVENTIS$$$$$$Y$$$20200901$$PH$US$US
128286232$12828623$2$F$20151120$20200908$20161007$20200911$PER$$US-SA-2015SA202055$SANOFI AVENTIS$$$$$$Y$$$20200911$$PH$US$US
128295973$12829597$3$F$2016$20200805$20161007$20200813$PER$$US-SA-2016SA068131$SANOFI AVENTIS$$$$$$Y$$$20200813$$CN$US$US
128299352$12829935$2$F$20200821$20200821$20161007$20200827$PER$$US-SA-2016SA082255$SANOFI AVENTIS$$68$YR$$F$Y$$$20200827$$CN$US$US
128299392$12829939$2$F$201603$20200717$20161007$20200724$PER$$US-SA-2016SA083060$SANOFI AVENTIS$$58$YR$$F$Y$$$20200724$$CN$US$US
128299982$12829998$2$F$$20200910$20161007$20200915$PER$$US-SA-2016SA139265$SANOFI AVENTIS$$$$$$Y$$$20200915$$MD$US$US
128302595$12830259$5$F$2016$20200821$20161007$20200827$EXP$$US-SA-2016SA161163$SANOFI AVENTIS$$49$YR$$M$Y$$$20200827$$MD$US$US
128306032$12830603$2$F$20130226$20200803$20161007$20200806$PER$$US-SANOFI-AVENTIS-2013SA023822$SANOFI AVENTIS$$45$YR$$F$Y$99.79$KG$20200806$$CN$US$US
128306092$12830609$2$F$201909$20200923$20161007$20200929$EXP$$US-SANOFI-AVENTIS-2013SA041694$SANOFI AVENTIS$$47$YR$$F$Y$$$20200929$$CN$US$US
128308977$12830897$7$F$$20160930$20161007$20200923$PER$$US-JAZZ-2016-US-019320$JAZZ$$$$$M$Y$$$20200923$$HP$US$US
1283196513$12831965$13$F$2015$20200807$20161010$20200821$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1920$ORION$$60$YR$$F$Y$64$KG$20200821$$MD$CA$CA
1283209213$12832092$13$F$20160420$20200910$20161010$20200919$EXP$$PHHY2016DE125612$NOVARTIS$$61$YR$$M$Y$88$KG$20200919$$HP$DE$DE
1283296315$12832963$15$F$20160723$20180827$20161010$20180903$EXP$$TR-ROCHE-1802738$ROCHE$$60$YR$$M$Y$78$KG$20180903$$MD$TR$TR
128336362$12833636$2$F$20161002$20161020$20161010$20161102$EXP$$MX-JNJFOC-20161004607$JANSSEN$$81$YR$E$M$Y$53.5$KG$20161102$$MD$MX$MX
128336373$12833637$3$F$20161002$20161011$20161010$20161014$EXP$$ES-JNJFOC-20161004318$JANSSEN$$60$YR$A$M$Y$$$20161014$$MD$ES$ES
128337925$12833792$5$F$$20200715$20161010$20200719$EXP$$PHHY2016FR136945$NOVARTIS$$6$MON$$M$Y$3.11$KG$20200719$$HP$FR$FR
128338735$12833873$5$F$20161001$20161115$20161010$20161124$EXP$$RU-JNJFOC-20161005257$JANSSEN$$35$YR$A$M$Y$107$KG$20161124$$MD$RU$RU
128340094$12834009$4$F$20161003$20171228$20161010$20180102$EXP$$IT-JNJFOC-20161004235$PHARMACYCLICS$$73$YR$E$F$Y$40$KG$20180102$$MD$IT$IT
128345157$12834515$7$F$$20200713$20161010$20200715$EXP$$CA-PFIZER INC-2016334025$PFIZER$$68$YR$$F$Y$$$20200715$$HP$CA$CA
1283507010$12835070$10$F$20101103$20200910$20161010$20200916$EXP$$US-BIOGEN-2010BI040246$BIOGEN$STEFOSKI D, BALABANOV R, WAHEED R, KO M, KORALNIK I, MORALES F. TREATMENT OF NATALIZUMAB?ASSOCIATED PML WITH FILGRASTIM. DOI: 10.1002/ACN3.776. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2019?1?9.$38$YR$$F$Y$$$20200916$$MD$US$US
1283517218$12835172$18$F$20160329$20200812$20161011$20200820$EXP$$CA-ROCHE-1840576$ROCHE$$68$YR$$F$Y$$$20200820$$MD$CA$CA
128353683$12835368$3$F$20150407$20170117$20161011$20170130$EXP$$JP-ROCHE-1691531$ROCHE$$75$YR$$M$Y$61$KG$20170130$$MD$JP$JP
1283585017$12835850$17$F$201710$20200707$20161011$20200714$EXP$$NL-ABBVIE-16K-114-1718015-00$ABBVIE$$76$YR$$M$Y$$$20200714$$HP$NL$NL
128366993$12836699$3$F$20160921$20181023$20161011$20181103$EXP$$US-ROCHE-1836076$ROCHE$$41$YR$$F$Y$80.36$KG$20181103$$MD$US$US
1283775631$12837756$31$F$20160824$20200303$20161012$20200921$EXP$$CA-ROCHE-1840218$ROCHE$$$$E$M$Y$$$20200921$$CN$CA$CA
1283816215$12838162$15$F$201305$20200730$20161012$20200805$EXP$$PHHY2009CA21616$NOVARTIS$$57$YR$$F$Y$$$20200805$$MD$CA$CA
128381786$12838178$6$F$20160927$20200626$20161012$20200701$EXP$$PHHY2016IN137477$NOVARTIS$$58$YR$$M$Y$$$20200701$$MD$IN$IN
128382527$12838252$7$F$20151222$20200728$20161012$20200803$EXP$$PHHY2016CA051128$NOVARTIS$$52$YR$$F$Y$$$20200803$$CN$CA$CA
128385043$12838504$3$F$201209$20200914$20161012$20200921$PER$$CA-AMGEN-CANSP2016137966$AMGEN$$72$YR$E$F$Y$$$20200921$$HP$CA$CA
128390005$12839000$5$F$202003$20200728$20161012$20200731$EXP$$US-PFIZER INC-2016366810$PFIZER$$79$YR$$F$Y$$$20200731$$MD$US$US
128397076$12839707$6$F$$20200805$20161012$20200807$PER$$US-PFIZER INC-2016474290$PFIZER$$52$YR$$M$Y$$$20200807$$CN$US$US
128398783$12839878$3$F$20160924$20161129$20161012$20161201$EXP$$CA-PFIZER INC-2016458473$PFIZER$$61$YR$$F$Y$$$20161201$$MD$CA$CA
128398872$12839887$2$F$20160928$20161104$20161012$20161114$EXP$$KR-PFIZER INC-2016460408$PFIZER$$81$YR$$M$Y$$$20161114$$MD$KR$KR
1284022318$12840223$18$F$$20200806$20161012$20200811$EXP$$CA-PFIZER INC-2016469513$PFIZER$WONG, J.. CUTANEOUS SQUAMOUS CELL CARCINOMA IN TWO PEDIATRIC LUNG TRANSPLANT PATIENTS ON PROLONGED VORICONAZOLE TREATMENT. PEDIATRIC TRANSPLANTATION. 2014?18 (6):E200?E207$10$YR$$M$Y$$$20200811$$MD$CA$CA
1284026624$12840266$24$F$20160831$20200820$20161012$20200825$EXP$$CA-TAKEDA-2016TUS015756$TAKEDA$$55$YR$$M$Y$$$20200825$$HP$CA$CA
128405986$12840598$6$F$201608$20200928$20161012$20200930$PER$$US-PFIZER INC-2016474692$PFIZER$$66$YR$$F$Y$97$KG$20200930$$CN$US$US
1284145713$12841457$13$F$20141019$20200811$20161012$20200816$EXP$$PHHO2016US014260$NOVARTIS$$51$YR$$F$Y$75.28$KG$20200816$$MD$US$US
128415114$12841511$4$F$20161001$20161102$20161012$20161110$EXP$$US-JNJFOC-20161001666$JANSSEN$$73$YR$E$M$Y$87$KG$20161110$$MD$US$US
128424875$12842487$5$F$$20200707$20161013$20200722$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-125805$RANBAXY$$$$I$M$Y$3$KG$20200722$$HP$NL$FR
128428037$12842803$7$F$20161010$20200702$20161013$20200709$30DAY$$US-PFIZER INC-2016476318$PFIZER$$9$YR$$F$Y$$$20200709$$CN$US$US
128428723$12842872$3$F$$20200723$20161013$20200728$PER$$US-BIOGEN-2016BI00303312$BIOGEN$$$$$F$Y$$$20200728$$HP$US$US
128430955$12843095$5$F$201604$20200811$20161013$20200818$PER$$PHEH2016US026218$NOVARTIS$$$$A$F$Y$65.7$KG$20200818$$CN$US$US
128433853$12843385$3$F$20160922$20200804$20161013$20200806$EXP$$GR-CELGENEUS-GRC-2016100551$CELGENE$$81$YR$$M$Y$80$KG$20200806$$HP$GR$GR
128436152$12843615$2$F$201509$20200917$20161013$20200923$EXP$$US-BAYER-2016-043100$BAYER$$69$YR$E$F$Y$$$20200923$$HP$US$US
128436553$12843655$3$F$20150619$20200922$20161013$20200928$PER$$US-JNJFOC-20161008089$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200928$$CN$US$US
1284376613$12843766$13$F$20160903$20200807$20161013$20200814$EXP$$CA-PFIZER INC-2016464823$PFIZER$$63$YR$$M$Y$$$20200814$$MD$CA$CA
128438683$12843868$3$F$20160826$20161205$20161013$20161212$EXP$$SE-JNJFOC-20161009038$PHARMACYCLICS$$68$YR$E$F$Y$$$20161212$$MD$SE$SE
128438695$12843869$5$F$20160921$20170620$20161013$20170623$EXP$$PL-JNJFOC-20161005995$PHARMACYCLICS$$71$YR$E$M$Y$94$KG$20170623$$MD$PL$PL
128443582$12844358$2$F$201311$20191018$20161013$20191031$EXP$$PHHY2014CA002923$NOVARTIS$$63$YR$$F$Y$$$20191031$$MD$CA$CA
128445255$12844525$5$F$20151029$20200904$20161013$20200917$EXP$$JP-INCYTE CORPORATION-2015IN005749$INCYTE$$$$$$Y$$$20200917$$MD$JP$JP
1284468224$12844682$24$F$2013$20200722$20161013$20200729$EXP$$US-BIOGEN-2016BI00303433$BIOGEN$$60$YR$$M$Y$$$20200729$$MD$US$US
128453512$12845351$2$F$20160617$20200730$20161013$20200921$PER$$US-JAZZ-2016-US-013502$JAZZ$$33$YR$$F$Y$$$20200921$$HP$US$US
128454112$12845411$2$F$2016$20200615$20161013$20200820$PER$$US-JAZZ-2016-US-013506$JAZZ$$$$$F$Y$97.51$KG$20200820$$MD$US$US
128456455$12845645$5$F$200310$20200723$20161013$20200729$EXP$$FR-GLAXOSMITHKLINE-FR2014GSK055337$GLAXOSMITHKLINE$$50$YR$$M$Y$$$20200729$$CN$FR$FR
128461038$12846103$8$F$2016$20200909$20161014$20200917$EXP$$US-JAZZ-2016-US-019655$JAZZ$$$$$M$Y$$$20200917$$PH$US$US
128461486$12846148$6$F$201608$20200728$20161014$20200805$EXP$$US-BIOGEN-2016BI00303415$BIOGEN$$54$YR$$F$Y$$$20200805$$CN$US$US
1284885211$12848852$11$F$201608$20200901$20161014$20200910$EXP$$US-BIOGEN-2016BI00303899$BIOGEN$$42$YR$$F$Y$$$20200910$$HP$US$US
128491353$12849135$3$F$20161004$20200828$20161014$20200902$EXP$$GB-PFIZER INC-2016473720$PFIZER$$$$$$Y$$$20200902$$HP$GB$GB
128502877$12850287$7$F$$20200720$20161014$20200729$EXP$$CA-APOTEX-2016AP012926$APOTEX$$51$YR$$F$Y$$$20200729$$HP$CA$CA
128518524$12851852$4$F$2016$20200720$20161017$20200728$EXP$$BR-BAYER-2016-196116$BAYER$$63$YR$A$M$Y$$$20200728$$CN$BR$BR
128524503$12852450$3$F$20160930$20170421$20161017$20170501$EXP$$US-JNJFOC-20161011797$JANSSEN$$60$YR$A$M$Y$$$20170501$$HP$US$US
128528194$12852819$4$F$20161003$20161201$20161017$20161205$EXP$GB-MHRA-EYC 00146514$GB-009507513-1610GBR008242$MERCK$$17$YR$$M$Y$66.5$KG$20161205$$MD$GB$GB
128532624$12853262$4$F$20160930$20161206$20161017$20161209$EXP$$US-JNJFOC-20161006801$JANSSEN$$39$YR$A$F$Y$65.9$KG$20161209$$MD$US$US
128532632$12853263$2$F$2016$20200616$20161017$20200820$PER$$US-JAZZ-2016-US-014195$JAZZ$$$$$F$Y$$$20200820$$CN$US$US
128534083$12853408$3$F$$20200708$20161017$20200716$EXP$$US-BIOGEN-2016BI00303467$BIOGEN$$$$$M$Y$$$20200716$$MD$US$US
1285375632$12853756$32$F$201608$20200825$20161017$20200901$EXP$$PHHY2016CA122927$NOVARTIS$$75$YR$$M$Y$$$20200901$$CN$COUNTRY NOT SPECIFIED$CA
128537634$12853763$4$F$201605$20200916$20161017$20200922$EXP$$DE-BIOGEN-2016BI00304769$BIOGEN$$55$YR$$F$Y$$$20200922$$HP$DE$DE
1285387814$12853878$14$F$2014$20200910$20161017$20200925$EXP$$PHHY2015BR093893$NOVARTIS$$65$YR$$F$Y$80$KG$20200925$$HP$BR$BR
128541813$12854181$3$F$20140603$20200804$20161017$20200813$EXP$$US-BAYER-2016-108274$BAYER$$70$YR$E$M$Y$$$20200813$$CN$US$US
1285435827$12854358$27$F$20160408$20200921$20161017$20200924$EXP$$PHHY2016CA048557$NOVARTIS$$59$YR$$M$Y$$$20200925$$MD$CA$CA
128547647$12854764$7$F$$20200914$20161017$20200924$EXP$$CA-APOTEX-2016AP012836$APOTEX$$55$YR$$F$Y$$$20200924$$CN$CA$CA
1285510712$12855107$12$F$20161011$20181011$20161017$20181015$EXP$$FR-JNJFOC-20161005203$JANSSEN$$81$YR$E$M$Y$96$KG$20181015$$MD$FR$FR
128565476$12856547$6$F$20160728$20200729$20161018$20200803$EXP$$PHHY2016DE140754$NOVARTIS$$$$A$M$Y$80$KG$20200803$$CN$DE$DE
128567303$12856730$3$F$20161009$20161123$20161018$20161202$EXP$$PHHO2016US015023$NOVARTIS$$28$YR$$F$Y$84.9$KG$20161202$$HP$US$US
128569386$12856938$6$F$201609$20200824$20161018$20200826$PER$$US-PFIZER INC-2016482587$PFIZER$$62$YR$$M$Y$74$KG$20200826$$MD$US$US
128569986$12856998$6$F$$20200728$20161018$20200811$EXP$$CZ-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-126130$RANBAXY$$60$YR$$M$Y$$$20200811$$HP$NL$CZ
128570547$12857054$7$F$20161011$20200910$20161018$20200916$EXP$$JP-ASTELLAS-2016JP017141$ASTELLAS$MURATA M, TAKIZAWA I, MARUYAMA R, KASAHARA T, HARA N, TOMITA Y.. A CASE OF G4 THROMBOCYTOPENIA DUE TO ENZALUTAMIDE.. THE 381TH THE JAPANESE UROLOGICAL ASSOCIATION, NIIGATA BRANCH, PROGRAM/ABSTRACTS. 2017$76$YR$$M$Y$$$20200916$$MD$JP$JP
128578162$12857816$2$F$20150914$20200813$20161018$20200818$EXP$$US-SA-2015SA151918$SANOFI AVENTIS$$42$YR$$F$Y$$$20200818$$HP$US$US
128580512$12858051$2$F$20160201$20200818$20161018$20200820$EXP$$US-SA-2016SA039624$SANOFI AVENTIS$$57$YR$$M$Y$$$20200820$$MD$US$US
128582723$12858272$3$F$20161012$20161018$20161018$20161021$EXP$$PL-JNJFOC-20161012052$JANSSEN$$62$YR$A$M$Y$70$KG$20161021$$MD$PL$PL
128582731$12858273$1$I$20160909$20160916$20161018$20161018$EXP$$US-JNJFOC-20160928951$JANSSEN$$60$YR$A$M$Y$$$20161018$$HP$US$US
128592034$12859203$4$F$20131121$20161028$20161018$20161103$EXP$$CO-JNJFOC-20140215632$JANSSEN$$84$YR$E$F$Y$61$KG$20161103$$MD$CO$CO
128592685$12859268$5$F$20161004$20161214$20161018$20161220$EXP$$US-JNJFOC-20161008201$JANSSEN$$55$YR$A$M$Y$83.46$KG$20161220$$MD$US$US
128606606$12860660$6$F$20160925$20170726$20161019$20170808$EXP$$US-PFIZER INC-2016480216$PFIZER$$67$YR$$M$Y$$$20170808$$MD$US$US
128617904$12861790$4$F$20160226$20161121$20161019$20161125$EXP$$FR-JNJFOC-20161010861$PHARMACYCLICS$$44$YR$A$F$Y$$$20161125$$MD$FR$FR
128620822$12862082$2$F$20150515$20200818$20161019$20200831$EXP$$CA-JNJFOC-20161010222$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20200831$$CN$CA$CA
128625226$12862522$6$F$20161007$20170421$20161019$20200715$EXP$$DE-CELGENEUS-DEU-2016102496$CELGENE$$79$YR$$F$Y$77$KG$20200715$$HP$DE$DE
128625501$12862550$1$I$20160611$20161007$20161019$20161019$EXP$$CA-PFIZER INC-2016481932$PFIZER$$62$YR$$F$Y$$$20161019$$MD$CA$CA
128625965$12862596$5$F$20161012$20170707$20161019$20170714$EXP$$US-JNJFOC-20161015917$PHARMACYCLICS$$43$YR$A$M$Y$61.2$KG$20170714$$MD$US$US
128628362$12862836$2$F$20160929$20161122$20161019$20161128$EXP$$IT-JNJFOC-20161010931$JANSSEN$$$$$M$Y$70$KG$20161128$$CN$IT$IT
128628631$12862863$1$I$20151116$20151124$20161019$20161019$EXP$$DE-JNJFOC-20151123269$JANSSEN$$78$YR$E$F$Y$78$KG$20161019$$MD$DE$DE
1286286810$12862868$10$F$20150714$20200709$20161019$20200715$EXP$$JP-OTSUKA-2016_022184$OTSUKA$$50$YR$$F$Y$61$KG$20200715$$MD$JP$JP
128630375$12863037$5$F$201609$20200717$20161019$20200721$PER$$US-PFIZER INC-2016487980$PFIZER$$64$YR$$M$Y$90.7$KG$20200721$$CN$US$US
128637844$12863784$4$F$$20200724$20161019$20200727$EXP$$PHHY2016CZ140648$NOVARTIS$$70$YR$$F$Y$$$20200727$$HP$CZ$CZ
128638396$12863839$6$F$20160609$20200626$20161019$20200702$EXP$$JP-ACTELION-A-US2016-144032$ACTELION$$20$YR$$F$Y$48.1$KG$20200702$$HP$DE$JP
128641874$12864187$4$F$20140626$20200911$20161020$20200921$EXP$$CA-ROCHE-1842734$ROCHE$$59$YR$$F$Y$$$20200921$$CN$CA$CA
128643446$12864344$6$F$$20200707$20161020$20200713$EXP$$CA-ROCHE-1717965$ROCHE$$$$$F$Y$76$KG$20200714$$HP$CA$CA
128651764$12865176$4$F$2017$20200831$20161020$20200905$EXP$$PHHY2015CA120863$NOVARTIS$$$$$F$Y$$$20200905$$HP$CA$CA
128653584$12865358$4$F$20161010$20161128$20161020$20161130$EXP$$PT-JNJFOC-20161014251$JANSSEN$$70$YR$E$M$Y$$$20161130$$MD$PT$PT
128658148$12865814$8$F$201609$20200630$20161020$20200702$PER$$US-PFIZER INC-2016487142$PFIZER$$68$YR$$F$Y$68.04$KG$20200702$$CN$US$US
128669285$12866928$5$F$20160926$20161201$20161020$20161208$EXP$GB-MHRA-EYC 00146514$GB-PFIZER INC-2016481951$PFIZER$$17$YR$$M$Y$66.5$KG$20161208$$MD$GB$GB
128669972$12866997$2$F$201405$20200602$20161020$20200820$PER$$US-JAZZ-2014-US-007736$JAZZ$$24$YR$$F$Y$$$20200820$$CN$US$US
128690252$12869025$2$F$$20200911$20161021$20200918$PER$$US-PFIZER INC-2016488363$PFIZER$$47$YR$$F$Y$$$20200918$$HP$US$US
128690383$12869038$3$F$201910$20200729$20161021$20200731$EXP$$US-PFIZER INC-2016489311$PFIZER$$77$YR$$F$Y$55.34$KG$20200731$$HP$US$US
128693526$12869352$6$F$20161008$20200721$20161021$20200723$EXP$$PHHO2016CN014997$NOVARTIS$$31$YR$$M$Y$60$KG$20200723$$MD$CN$CN
128695122$12869512$2$F$$20200708$20161021$20200715$EXP$$PHHY2016DO144521$NOVARTIS$$98$YR$$F$Y$$$20200715$$CN$COUNTRY NOT SPECIFIED$DO
128700794$12870079$4$F$$20200818$20161021$20200821$EXP$$CA-GLAXOSMITHKLINE-CA2016GSK062252$GLAXOSMITHKLINE$$$$$F$Y$$$20200821$$CN$CA$CA
128702202$12870220$2$F$20160118$20200923$20161021$20200929$EXP$$US-PFIZER INC-3176581$PFIZER$$42$YR$$F$Y$58$KG$20200929$$MD$US$US
128713814$12871381$4$F$20200118$20200701$20161020$20200703$EXP$$US-ABBVIE-16K-163-1755178-00$ABBVIE$$59$YR$$M$Y$63.56$KG$20200703$$CN$US$US
128714056$12871405$6$F$20101124$20200604$20161021$20200825$EXP$$US-NAPPMUNDI-USA-2016-0131102$PURDUE$$70$YR$$M$Y$220$KG$20200825$$CN$US$US
128716587$12871658$7$F$20160627$20200727$20161021$20200803$PER$$PHHY2016US143919$NOVARTIS$$51$YR$$F$Y$$$20200803$$MD$US$US
1287227721$12872277$21$F$2015$20200619$20161021$20200706$EXP$$CA-ROCHE-1844343$ROCHE$$78$YR$$F$Y$$$20200706$$CN$CA$CA
128732391$12873239$1$I$20160728$20161011$20161021$20161021$EXP$$FR-SA-2016SA187975$AVENTIS$$76$YR$E$F$Y$$$20161021$$HP$FR$FR
128746674$12874667$4$F$2006$20200829$20161021$20200901$PER$$US-TAKEDA-2016TUS018957$TAKEDA$$$$$M$Y$61.22$KG$20200901$$CN$US$US
128748005$12874800$5$F$20161012$20170913$20161022$20170918$EXP$$US-ROCHE-1842168$ROCHE$$75$YR$$M$Y$67.5$KG$20170918$$MD$US$US
128755427$12875542$7$F$20160706$20200908$20161024$20200916$EXP$$CA-ROCHE-1844997$ROCHE$$51$YR$$M$Y$$$20200917$$MD$CA$CA
128757932$12875793$2$F$$20200520$20161024$20200820$PER$$US-JAZZ-2016-US-015184$JAZZ$$$$$F$Y$$$20200820$$$US$US
128758118$12875811$8$F$2014$20200727$20161024$20200730$EXP$$US-JAZZ-2016-US-014611$JAZZ$$$$$F$Y$$$20200730$$HP$US$US
128759632$12875963$2$F$$20200723$20161024$20200921$PER$$US-JAZZ-2016-US-015177$JAZZ$$$$$M$Y$$$20200921$$HP$US$US
128763975$12876397$5$F$20161014$20170223$20161024$20170227$EXP$$SE-JNJFOC-20161015566$JANSSEN$$77$YR$E$M$Y$84.9$KG$20170227$$MD$SE$SE
128775338$12877533$8$F$20160501$20200702$20161024$20200708$PER$$PHHY2016US099556$NOVARTIS$$50$YR$$F$Y$$$20200708$$MD$US$US
128775544$12877554$4$F$20160531$20200702$20161024$20200710$PER$$PHHY2016US143937$NOVARTIS$$48$YR$$F$Y$$$20200711$$MD$US$US
128776344$12877634$4$F$20160601$20200727$20161024$20200804$PER$$PHHY2016US143877$NOVARTIS$$54$YR$$F$Y$$$20200805$$MD$US$US
128779962$12877996$2$F$20160722$20200727$20161024$20200805$PER$$PHHY2016US143884$NOVARTIS$$36$YR$$F$Y$$$20200805$$MD$US$US
128780458$12878045$8$F$201511$20200923$20161024$20200930$EXP$$US-SA-2015SA194792$SANOFI AVENTIS$$$$$$Y$$$20200930$$CN$US$US
128780933$12878093$3$F$20161010$20161123$20161024$20161130$EXP$$RU-JNJFOC-20161012295$JANSSEN$$38$YR$A$F$Y$58.7$KG$20161130$$MD$RU$RU
128783004$12878300$4$F$$20200712$20161024$20200715$PER$$US-JNJFOC-20161018248$JOHNSON AND JOHNSON$$$$$M$Y$$$20200715$$CN$US$US
128783652$12878365$2$F$2015$20200629$20161024$20200710$EXP$$US-JNJFOC-20161019366$JOHNSON AND JOHNSON$$$$$M$Y$$$20200710$$CN$US$US
128783685$12878368$5$F$201501$20200701$20161024$20200706$PER$$US-JNJFOC-20161019369$JOHNSON AND JOHNSON$$70$YR$$M$Y$$$20200706$$CN$US$US
128784143$12878414$3$F$20150806$20200628$20161024$20200707$EXP$$US-JNJFOC-20161020231$JOHNSON AND JOHNSON$$74$YR$$M$Y$$$20200707$$CN$US$US
128787402$12878740$2$F$20160609$20200629$20161024$20200702$EXP$$NL-SA-2016SA193776$SANOFI AVENTIS$$68$YR$$F$Y$59$KG$20200702$$CN$NL$NL
128789143$12878914$3$F$20161003$20161201$20161024$20161209$EXP$$GB-MUNDIPHARMA DS AND PHARMACOVIGILANCE-GBR-2016-0041186$PURDUE$$17$YR$$M$Y$66.5$KG$20161209$$MD$GB$GB
128792428$12879242$8$F$20160406$20200727$20161025$20200803$PER$$PHHY2015US158988$NOVARTIS$$26$YR$$F$Y$$$20200803$$MD$US$US
128793304$12879330$4$F$20130415$20200727$20161025$20200804$PER$$PHHY2016US143973$NOVARTIS$$46$YR$$F$Y$$$20200805$$MD$US$US
128795233$12879523$3$F$20160909$20181101$20161025$20181114$EXP$$US-ROCHE-1833635$ROCHE$$63$YR$$F$Y$70.82$KG$20181114$$MD$US$US
128805482$12880548$2$F$20161007$20161103$20161025$20161116$EXP$$US-PFIZER INC-2016494013$PFIZER$$63$YR$$F$Y$50.3$KG$20161116$$MD$US$US
128805571$12880557$1$I$20160706$20160706$20161025$20161025$EXP$$CA-PFIZER INC-2016344072$PFIZER$$65$YR$$M$Y$$$20161025$$MD$CA$CA
128818564$12881856$4$F$1990$20200706$20161025$20200713$PER$$US-JNJFOC-20160902759$JOHNSON AND JOHNSON$$$$$M$Y$$$20200713$$LW$US$US
1288192115$12881921$15$F$$20200806$20161025$20200818$EXP$$CA-APOTEX-2016AP013278$APOTEX$$61$YR$$F$Y$$$20200818$$CN$CA$CA
128819561$12881956$1$I$20160929$20160929$20161025$20161025$EXP$$NL-JNJFOC-20160930151$JANSSEN$$71$YR$E$M$Y$80$KG$20161025$$MD$NL$NL
128822581$12882258$1$I$20160726$20161013$20161025$20161025$EXP$$PHEH2016US026640$NOVARTIS$$58$YR$$F$Y$98$KG$20161025$$CN$US$US
128824832$12882483$2$F$20151216$20171205$20161025$20171218$EXP$$CN-JNJFOC-20151215412$JANSSEN$$52$YR$A$F$Y$74$KG$20171218$$MD$CN$CN
128827212$12882721$2$F$201408$20200803$20161025$20200812$EXP$$US-JNJFOC-20161004799$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20200812$$CN$US$US
128828062$12882806$2$F$20151019$20200806$20161025$20200813$EXP$$US-BAYER-2016-103763$BAYER$$68$YR$E$M$Y$102.88$KG$20200813$$LW$US$US
128828738$12882873$8$F$2016$20200723$20161025$20200729$EXP$$US-SA-2016SA167456$SANOFI AVENTIS$$$$$$Y$$$20200729$$CN$US$US
128828954$12882895$4$F$20141023$20200901$20161025$20200904$EXP$$US-BAYER-2016-168907$BAYER$$81$YR$E$F$Y$$$20200904$$CN$US$US
128830213$12883021$3$F$201608$20200701$20161025$20200709$PER$$US-SA-2016SA163541$SANOFI AVENTIS$$$$$$Y$$$20200709$$MD$US$US
128830442$12883044$2$F$20141017$20200630$20161025$20200715$EXP$$US-BAYER-2016-150585$BAYER$$92$YR$E$F$Y$$$20200715$$CN$US$US
128833212$12883321$2$F$20161003$20161201$20161025$20161209$EXP$$GB-BAUSCH-BL-2016-025264$BAUSCH AND LOMB$$17$YR$$M$Y$66.5$KG$20161209$$MD$GB$GB
128835806$12883580$6$F$$20200813$20161025$20200817$EXP$$US-JAZZ-2016-US-020446$JAZZ$$$$$M$Y$$$20200817$$HP$US$US
128837515$12883751$5$F$$20200826$20161026$20200907$EXP$$CA-APOTEX-2016AP013303$APOTEX$$53$YR$$F$Y$$$20200907$$CN$CA$CA
128838182$12883818$2$F$2013$20200714$20161026$20200722$EXP$$PT-BAXTER-2016BAX053763$BAXTER$$35$YR$$F$Y$$$20200722$$CN$PT$PT
128852744$12885274$4$F$$20200903$20161026$20200921$EXP$$CA-PURDUE PHARMA-CAN-2015-0006005$PURDUE$$$$$F$Y$$$20200921$$CN$CA$CA
128860974$12886097$4$F$20161015$20180416$20161026$20180430$EXP$$BE-JNJFOC-20161016758$JANSSEN$$63$YR$A$F$Y$101$KG$20180430$$MD$BE$BE
128865045$12886504$5$F$20161015$20170310$20161026$20170317$EXP$$RU-JNJFOC-20161021042$JANSSEN$$51$YR$A$F$Y$81$KG$20170317$$MD$RU$RU
128866253$12886625$3$F$201411$20200831$20161026$20200903$EXP$$US-JNJFOC-20161020174$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200903$$CN$US$US
128875752$12887575$2$F$$20200908$20161026$20200911$EXP$$US-JAZZ-2016-US-020716$JAZZ$$$$$M$Y$$$20200911$$CN$US$US
128880625$12888062$5$F$20131205$20200710$20161027$20200715$EXP$$CA-ROCHE-1308729$ROCHE$$62$YR$$F$Y$57.2$KG$20200716$$HP$CA$CA
128880674$12888067$4$F$20150401$20170310$20161027$20170320$EXP$$JP-ROCHE-1672898$ROCHE$$74$YR$$F$Y$38$KG$20170320$$MD$JP$JP
1288812211$12888122$11$F$20160803$20200828$20161027$20200903$EXP$GB-MHRA-EYC 00146972$GB-ROCHE-1846324$ROCHE$$42$YR$$F$Y$98$KG$20200904$$MD$GB$GB
1288864919$12888649$19$F$20160913$20200901$20161027$20200904$EXP$$PHHY2016DE146853$NOVARTIS$$65$YR$$M$Y$62$KG$20200904$$CN$COUNTRY NOT SPECIFIED$DE
128887115$12888711$5$F$$20200908$20161027$20200915$EXP$$US-BIOGEN-2016BI00308088$BIOGEN$$$$$M$Y$$$20200915$$MD$US$US
128888045$12888804$5$F$20161010$20200812$20161027$20200814$PER$$US-PFIZER INC-2016496717$PFIZER$$66$YR$$F$Y$61$KG$20200814$$HP$US$US
128889275$12888927$5$F$20161012$20171117$20161027$20171123$EXP$$BR-JNJFOC-20161016067$JANSSEN$$68$YR$E$F$Y$43.5$KG$20171123$$MD$BR$BR
128894779$12889477$9$F$20160919$20180111$20161027$20180117$EXP$$FR-JNJFOC-20161014597$JANSSEN$$65$YR$A$M$Y$74$KG$20180117$$MD$FR$FR
128894783$12889478$3$F$20161007$20181011$20161027$20181015$EXP$$FR-JNJFOC-20161015675$JANSSEN$$61$YR$A$F$Y$50$KG$20181015$$MD$FR$FR
128895533$12889553$3$F$201604$20200629$20161027$20200702$PER$$US-PFIZER INC-2016496737$PFIZER$$57$YR$$M$Y$125$KG$20200702$$CN$US$US
128897493$12889749$3$F$20160918$20161117$20161027$20161123$EXP$$IL-JNJFOC-20161024097$PHARMACYCLICS$$79$YR$E$M$Y$$$20161123$$MD$IL$IL
1288978213$12889782$13$F$$20200709$20161027$20200716$EXP$$CA-APOTEX-2016AP013285$APOTEX$$64$YR$$F$Y$$$20200716$$CN$CA$CA
128905913$12890591$3$F$2016$20200707$20161027$20200921$PER$$US-JAZZ-2016-US-015697$JAZZ$$$$$F$Y$$$20200921$$MD$US$US
128906772$12890677$2$F$2016$20200707$20161027$20200921$PER$$US-JAZZ-2016-US-015931$JAZZ$$29$YR$$F$Y$$$20200921$$MD$US$US
128907162$12890716$2$F$$20200512$20161027$20200820$PER$$US-JAZZ-2016-US-015784$JAZZ$$$$$F$Y$$$20200820$$CN$US$US
128907202$12890720$2$F$2015$20200720$20161027$20200921$PER$$US-JAZZ-2016-US-015427$JAZZ$$$$$F$Y$$$20200921$$MD$US$US
128909929$12890992$9$F$20160222$20200807$20161027$20200817$EXP$$CA-APOTEX-2016AP013491$APOTEX$$65$YR$E$M$Y$$$20200817$$CN$US$CA
128910356$12891035$6$F$$20200824$20161027$20200903$EXP$$CA-APOTEX-2016AP013489$APOTEX$$$$$M$Y$$$20200903$$HP$CA$CA
128916304$12891630$4$F$$20200807$20161028$20200818$EXP$$CA-APOTEX-2016AP013462$APOTEX$$43$YR$$F$Y$$$20200818$$CN$CA$CA
128919507$12891950$7$F$$20200825$20161028$20200904$EXP$$CA-APOPHARMA INC-2016AP013468$APOTEX$$$$$M$Y$$$20200904$$CN$CA$CA
128925662$12892566$2$F$20161012$20200911$20161028$20200915$PER$$US-PFIZER INC-2016502391$PFIZER$$51$YR$$F$Y$70.3$KG$20200915$$HP$US$US
128926812$12892681$2$F$$20200820$20161028$20200902$EXP$$GB-CIPLA LTD.-2016US20054$CIPLA$$$$$$Y$$$20200902$$HP$ES$GB
128927472$12892747$2$F$$20200820$20161028$20200903$EXP$$GB-CIPLA LTD.-2016US20049$CIPLA$$$$$$Y$$$20200903$$HP$ES$GB
128929326$12892932$6$F$$20200916$20161028$20200921$EXP$$US-PFIZER INC-2016151044$PFIZER$$72$YR$$M$Y$$$20200921$$MD$US$US
128930061$12893006$1$I$20150226$20150817$20161028$20161028$EXP$$JP-ROCHE-1630667$ROCHE$$66$YR$$M$Y$47$KG$20161028$$MD$JP$JP
128939614$12893961$4$F$20161018$20170511$20161028$20170518$EXP$$GB-JNJFOC-20161018923$PHARMACYCLICS$$51$YR$A$M$Y$76$KG$20170518$$MD$GB$GB
128943807$12894380$7$F$20161023$20181030$20161028$20181113$EXP$$US-ROCHE-1847489$ROCHE$$59$YR$$F$Y$67.1$KG$20181113$$MD$US$US
128944213$12894421$3$F$20141014$20170130$20161028$20170206$EXP$$US-JNJFOC-20141012122$JANSSEN$$70$YR$E$M$Y$83.9$KG$20170206$$MD$US$US
1289523316$12895233$16$F$$20200804$20161029$20200807$EXP$$US-ASTRAZENECA-2016SF12590$ASTRAZENECA$$84$YR$$F$Y$$$20200807$$MD$CA$CA
128968555$12896855$5$F$20150702$20200820$20161031$20200825$EXP$$US-ASTRAZENECA-2016SF10528$ASTRAZENECA$$26880$DY$$M$Y$$$20200825$$$US$US
1289766910$12897669$10$F$$20200812$20161031$20200819$EXP$$CA-ASTELLAS-2016US041772$ASTELLAS$$45$YR$$F$Y$$$20200819$$HP$CA$CA
128978382$12897838$2$F$20161006$20161207$20161031$20161216$EXP$$GB-JNJFOC-20161007864$JANSSEN$$57$YR$A$F$Y$54$KG$20161216$$MD$GB$GB
128981345$12898134$5$F$20160924$20170601$20161031$20170612$EXP$$US-JNJFOC-20161018679$JANSSEN$$79$YR$E$M$Y$$$20170612$$MD$US$US
128982105$12898210$5$F$20160925$20161212$20161031$20161216$EXP$$DE-JNJFOC-20161019357$JANSSEN$$44$YR$A$F$Y$66.6$KG$20161216$$MD$DE$DE
128982243$12898224$3$F$201609$20200729$20161031$20200806$EXP$$US-BIOGEN-2016BI00310896$BIOGEN$$47$YR$$F$Y$$$20200806$$CN$US$UZ
128989992$12898999$2$F$20150406$20161215$20161101$20161226$EXP$$JP-ROCHE-1549390$ROCHE$$71$YR$$F$Y$43$KG$20161226$$MD$JP$JP
128990042$12899004$2$F$2013$20200629$20161101$20200708$EXP$$NL-BAXTER-2016BAX054411$BAXTER$$68$YR$$F$Y$59$KG$20200708$$CN$NL$NL
1289927912$12899279$12$F$20150301$20200825$20161101$20200827$EXP$$DE-ROCHE-1844357$ROCHE$$54$YR$$F$Y$91$KG$20200828$$MD$DE$DE
128997267$12899726$7$F$201609$20200806$20161101$20200810$PER$$US-PFIZER INC-2016505925$PFIZER$$77$YR$$F$Y$53$KG$20200810$$CN$US$US
128999762$12899976$2$F$20140926$20200715$20161101$20200727$EXP$$US-BAYER-2016-198845$BAYER$$56$YR$A$F$Y$$$20200727$$HP$US$US
129003736$12900373$6$F$20161026$20200720$20161101$20200723$EXP$$ES-TAKEDA-2016MPI009374$TAKEDA$$64$YR$$M$Y$69$KG$20200723$$MD$ES$ES
129005096$12900509$6$F$20160618$20170221$20161101$20170301$EXP$$DE-JNJFOC-20161024974$JANSSEN$$77$YR$E$F$Y$52$KG$20170301$$MD$DE$DE
129009383$12900938$3$F$20161021$20161108$20161101$20161116$EXP$$GB-JNJFOC-20161023986$JANSSEN$$70$YR$E$M$Y$77$KG$20161116$$MD$GB$GB
1290162924$12901629$24$F$20160913$20200722$20161102$20200730$EXP$$CA-ROCHE-1849502$ROCHE$$63$YR$$F$Y$$$20200730$$MD$CA$CA
1290185313$12901853$13$F$$20200814$20161102$20200821$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091205$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200821$$HP$CA$CA
129018762$12901876$2$F$$20200820$20161102$20200903$EXP$$GB-CIPLA LTD.-2016US20057$CIPLA$$$$$$Y$$$20200903$$HP$ES$GB
129019262$12901926$2$F$$20200820$20161102$20200902$EXP$$GB-CIPLA LTD.-2016US20058$CIPLA$$$$$$Y$$$20200902$$HP$ES$GB
129035543$12903554$3$F$201310$20200707$20161102$20200716$EXP$$US-JNJFOC-20161026633$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200716$$CN$US$US
129046774$12904677$4$F$20161011$20200804$20161102$20200811$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-071243$BOEHRINGER INGELHEIM$MURATA M, TAKIZAWA I, MARUYAMA R, KASAHARA T, HARA N, TOMITA Y. ENZALUTAMIDE?INDUCED SEVERE THROMBOCYTOPENIA COMPLICATED BY A SEIZURE IN A 76?YEAR?OLD MAN WITH CASTRATION?RESISTANT PROSTATE CANCER. IJU CASE REPORTS. 2018?2(1):9?11.$76$YR$$M$Y$$$20200811$$MD$JP$JP
1290484118$12904841$18$F$2016$20200624$20161102$20200708$EXP$$US-ACTELION-A-NJ2016-143755$ACTELION$$$$$F$Y$60.32$KG$20200708$$HP$US$US
1290486917$12904869$17$F$20161026$20200622$20161102$20200706$EXP$$US-ACTELION-A-US2016-144841$ACTELION$$62$YR$$F$Y$86.17$KG$20200706$$HP$US$US
129066792$12906679$2$F$20130308$20200219$20161103$20200909$EXP$$CA-JNJFOC-20161024133$JOHNSON AND JOHNSON$$14$YR$T$F$Y$$$20200909$$HP$CA$CA
129069362$12906936$2$F$20131113$20200913$20161103$20200917$EXP$$US-BAYER-2016-001523$BAYER$$38$YR$A$F$Y$$$20200917$$CN$US$US
129069655$12906965$5$F$20160916$20200724$20161103$20200728$EXP$$CA-PFIZER INC-2016449033$PFIZER$$60$YR$$F$Y$$$20200728$$HP$CA$CA
129076113$12907611$3$F$201610$20200810$20161103$20200813$EXP$$US-SA-2016SA192316$SANOFI AVENTIS$$$$$$Y$$$20200813$$CN$US$US
129076652$12907665$2$F$$20200708$20161103$20200710$EXP$$US-ASTELLAS-2016US042884$ASTELLAS$OLIVER N, LUONG T, TCHAKAROV A, ABDELRAHIM M, MULANOVICH VE, KONTOYIANNIS DP ET AL. DISSEMINATED CRYPTOCOCCAL INFECTION IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS: A RARE CAUSE OF ACUTE KIDNEY INJURY. BONE MARROW TRANSPLANTATION. 2016?51(10):1301?4$31$YR$$M$Y$$$20200710$$HP$US$US
1290814055$12908140$55$F$20160510$20200827$20161103$20200907$EXP$$PHHY2012CA091745$NOVARTIS$$79$YR$$F$Y$$$20200907$$MD$CA$CA
129089782$12908978$2$F$$20200529$20161103$20200820$PER$$US-JAZZ-2016-US-016697$JAZZ$$$$$F$Y$$$20200820$$MD$US$US
129100184$12910018$4$F$201603$20200623$20161104$20200707$EXP$$US-JNJFOC-20161019400$JOHNSON AND JOHNSON$$72$YR$$M$Y$$$20200707$$CN$US$US
129100385$12910038$5$F$20160316$20200827$20161104$20200901$PER$$US-JNJFOC-20161018151$JOHNSON AND JOHNSON$$64$YR$A$M$Y$119.86$KG$20200901$$CN$US$US
129100404$12910040$4$F$20160119$20200827$20161104$20200902$PER$$US-JNJFOC-20161019464$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20200902$$CN$US$US
129101342$12910134$2$F$20141218$20200922$20161104$20200928$PER$$US-JNJFOC-20161019845$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200928$$CN$US$US
129101493$12910149$3$F$20130912$20200908$20161104$20200914$PER$$US-JNJFOC-20161020135$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20200914$$CN$US$US
129101513$12910151$3$F$20150312$20200831$20161104$20200902$PER$$US-JNJFOC-20161019813$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200902$$CN$US$US
129101523$12910152$3$F$20140802$20200818$20161104$20200824$PER$$US-JNJFOC-20161020140$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200824$$CN$US$US
129102946$12910294$6$F$201403$20200915$20161104$20200929$EXP$$US-JNJFOC-20161020246$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200929$$CN$US$US
129103003$12910300$3$F$20150112$20200702$20161104$20200708$PER$$US-JNJFOC-20161021685$JOHNSON AND JOHNSON$$84$YR$$F$Y$$$20200708$$CN$US$US
129103463$12910346$3$F$20150814$20200825$20161104$20200827$PER$$US-JNJFOC-20160922564$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200827$$CN$US$US
129104273$12910427$3$F$20160331$20200820$20161104$20200825$PER$$US-JNJFOC-20160926118$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200825$$CN$US$US
129104353$12910435$3$F$20150908$20200816$20161104$20200820$PER$$US-JNJFOC-20160925769$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200820$$CN$US$US
129104493$12910449$3$F$20150318$20200715$20161104$20200721$PER$$US-JNJFOC-20160926168$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200721$$CN$US$US
129104553$12910455$3$F$20121204$20200702$20161104$20200706$PER$$US-JNJFOC-20160926415$JOHNSON AND JOHNSON$$72$YR$$F$Y$$$20200706$$CN$US$US
129105073$12910507$3$F$20150117$20200816$20161104$20200827$EXP$$US-JNJFOC-20160929074$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200827$$CN$US$US
129105183$12910518$3$F$20150128$20200804$20161104$20200811$PER$$US-JNJFOC-20160929118$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200811$$LW$US$US
129105524$12910552$4$F$201602$20200802$20161104$20200806$PER$$US-JNJFOC-20161002080$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200806$$CN$US$US
129105613$12910561$3$F$20141224$20200728$20161104$20200804$EXP$$US-JNJFOC-20161002052$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200804$$HP$US$US
129105633$12910563$3$F$20140130$20200910$20161104$20200915$PER$$US-JNJFOC-20161002003$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200915$$HP$US$US
129105823$12910582$3$F$201401$20200830$20161104$20200902$PER$$US-JNJFOC-20161002983$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200902$$HP$US$US
129106143$12910614$3$F$201509$20200917$20161104$20200922$PER$$US-JNJFOC-20160930278$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200922$$CN$US$US
129106173$12910617$3$F$201411$20200812$20161104$20200814$PER$$US-JNJFOC-20160930318$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200814$$CN$US$US
129106273$12910627$3$F$20131005$20200819$20161104$20200821$PER$$US-JNJFOC-20161000690$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200821$$CN$US$US
129106533$12910653$3$F$201408$20200708$20161104$20200715$PER$$US-JNJFOC-20161001369$JOHNSON AND JOHNSON$$36$YR$$M$Y$$$20200715$$CN$US$US
129107063$12910706$3$F$20131013$20200817$20161104$20200820$PER$$US-JNJFOC-20161004762$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200820$$CN$US$US
129107353$12910735$3$F$20150327$20200813$20161104$20200825$EXP$$US-JNJFOC-20161005463$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200825$$LW$US$US
129107374$12910737$4$F$20141201$20200721$20161104$20200731$PER$$US-JNJFOC-20161006988$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200731$$CN$US$US
129107493$12910749$3$F$20141103$20200730$20161104$20200803$PER$$US-JNJFOC-20161007146$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20200803$$CN$US$US
129107613$12910761$3$F$20140903$20200730$20161104$20200806$EXP$$US-JNJFOC-20161007689$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200806$$LW$US$US
129108514$12910851$4$F$20141022$20200921$20161104$20200928$PER$$US-JNJFOC-20161012558$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200928$$CN$US$US
129108853$12910885$3$F$20141018$20200802$20161104$20200810$EXP$$US-JNJFOC-20161014837$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200810$$HP$US$US
129109434$12910943$4$F$20150522$20200827$20161104$20200902$PER$$US-JNJFOC-20161018990$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200902$$CN$US$US
129109543$12910954$3$F$20140830$20200916$20161104$20200918$PER$$US-JNJFOC-20161022606$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20200918$$CN$US$US
129109804$12910980$4$F$201310$20200706$20161104$20200710$PER$$US-JNJFOC-20161012189$JOHNSON AND JOHNSON$$86$YR$$M$Y$$$20200710$$CN$US$US
129113363$12911336$3$F$20151219$20200720$20161104$20200731$PER$$US-JNJFOC-20161022690$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200731$$CN$US$US
129113563$12911356$3$F$20150206$20200813$20161104$20200817$PER$$US-JNJFOC-20161022835$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200817$$CN$US$US
129113592$12911359$2$F$20140720$20200922$20161104$20200928$PER$$US-JNJFOC-20161022935$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200928$$CN$US$US
129114164$12911416$4$F$20160222$20200715$20161104$20200721$PER$$US-JNJFOC-20161019193$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200721$$CN$US$US
129114213$12911421$3$F$20160630$20200908$20161104$20200914$PER$$US-JNJFOC-20161019302$JOHNSON AND JOHNSON$$72$YR$E$M$Y$95$KG$20200914$$HP$US$US
129114313$12911431$3$F$201504$20200802$20161104$20200806$PER$$US-JNJFOC-20161024953$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200806$$HP$US$US
129114442$12911444$2$F$20140926$20200715$20161104$20200721$PER$$US-JNJFOC-20161011792$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20200721$$CN$US$US
129114868$12911486$8$F$$20200917$20161104$20200924$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-048399$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200924$$MD$CA$CA
129115522$12911552$2$F$20150404$20161206$20161104$20170106$EXP$$JP-ROCHE-1672839$ROCHE$$72$YR$$M$Y$53$KG$20170106$$MD$JP$JP
129116593$12911659$3$F$20140414$20200716$20161104$20200724$EXP$$US-BAYER-2016-067158$BAYER$$77$YR$E$M$Y$113.05$KG$20200724$$HP$US$US
129121146$12912114$6$F$$20200914$20161104$20200925$EXP$$CA-JNJFOC-20160308952$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20200925$$CN$CA$CA
1291261615$12912616$15$F$20161022$20181114$20161104$20181119$EXP$$US-JNJFOC-20161024426$JANSSEN$$71$YR$E$F$Y$104$KG$20181119$$MD$US$US
129126858$12912685$8$F$20160906$20171006$20161104$20171030$EXP$$JP-PFIZER INC-2016433693$PFIZER$$56$YR$$F$Y$$$20171030$$MD$JP$JP
129128248$12912824$8$F$201603$20200917$20161104$20200924$PER$$US-PFIZER INC-2016229973$PFIZER$$67$YR$$F$Y$117$KG$20200924$$MD$US$US
129129933$12912993$3$F$20161101$20161107$20161104$20161114$EXP$$ES-JNJFOC-20161101891$PHARMACYCLICS$$79$YR$E$F$Y$$$20161114$$MD$ES$ES
129131936$12913193$6$F$$20200630$20161104$20200702$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091703$BRISTOL MYERS SQUIBB$$55$YR$$F$Y$$$20200702$$CN$CA$CA
129132518$12913251$8$F$20160801$20200729$20161104$20200811$EXP$$US-ACTELION-A-NJ2016-144705$ACTELION$$56$YR$$M$Y$$$20200811$$CN$US$US
129132905$12913290$5$F$$20200629$20161104$20200702$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091775$BRISTOL MYERS SQUIBB$$68$YR$$F$Y$$$20200702$$HP$CA$CA
1291329119$12913291$19$F$20160617$20200818$20161104$20200824$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-092198$BRISTOL MYERS SQUIBB$$60$YR$$F$Y$$$20200824$$MD$CA$CA
1291330610$12913306$10$F$$20200914$20161104$20200921$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091788$BRISTOL MYERS SQUIBB$$57$YR$$F$Y$$$20200921$$MD$CA$CA
1291369714$12913697$14$F$$20200625$20161104$20200701$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091509$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200701$$HP$CA$CA
129137045$12913704$5$F$$20200923$20161104$20200930$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091698$BRISTOL MYERS SQUIBB$$$$$F$Y$70$KG$20200930$$HP$CA$CA
1291372826$12913728$26$F$$20200709$20161106$20200713$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091701$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20200713$$MD$CA$CA
129138226$12913822$6$F$$20200625$20161104$20200701$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091876$BRISTOL MYERS SQUIBB$$15$YR$$F$Y$$$20200701$$CN$CA$CA
129139344$12913934$4$F$$20200625$20161104$20200701$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091622$BRISTOL MYERS SQUIBB$$60$YR$$F$Y$$$20200701$$CN$CA$CA
1291427312$12914273$12$F$$20200720$20161106$20200724$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-092845$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200724$$HP$CA$CA
129142868$12914286$8$F$$20200715$20161106$20200717$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091799$BRISTOL MYERS SQUIBB$$45$YR$$F$Y$76$KG$20200717$$HP$CA$CA
1291429117$12914291$17$F$20160526$20200917$20161106$20200925$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-092038$BRISTOL MYERS SQUIBB$$72$YR$$M$Y$$$20200925$$MD$CA$CA
1291429223$12914292$23$F$$20200914$20161106$20200921$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-092847$BRISTOL MYERS SQUIBB$$63$YR$$F$Y$$$20200921$$HP$CA$CA
129142993$12914299$3$F$$20200625$20161106$20200828$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091819$BRISTOL MYERS SQUIBB$$57$YR$$F$Y$$$20200828$$HP$CA$CA
1291577816$12915778$16$F$20161031$20200519$20161106$20200821$EXP$$CA-ROCHE-1850664$ROCHE$$73$YR$$F$Y$61$KG$20200821$$MD$CA$CA
129160743$12916074$3$F$$20200909$20161104$20200916$EXP$$CA-APOTEX-2016AP013690$APOTEX$$37$YR$$F$Y$$$20200916$$CN$CA$CA
129164838$12916483$8$F$$20200625$20161107$20200701$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091700$BRISTOL MYERS SQUIBB$$59$YR$$F$Y$$$20200701$$CN$CA$CA
129164913$12916491$3$F$20150108$20170116$20161107$20170126$EXP$$JP-ROCHE-1848891$ROCHE$$53$YR$$F$Y$69$KG$20170126$$MD$JP$JP
129167702$12916770$2$F$201409$20200722$20161107$20200731$EXP$$US-BAYER-2016-177353$BAYER$$64$YR$A$F$Y$$$20200731$$CN$US$US
129167872$12916787$2$F$2016$20200602$20161107$20200820$PER$$US-JAZZ-2016-US-017459$JAZZ$$$$$F$Y$60.77$KG$20200820$$MD$US$US
129171282$12917128$2$F$201603$20200826$20161107$20200902$EXP$$US-BAYER-2016-177214$BAYER$$87$YR$E$F$Y$$$20200902$$HP$US$US
129172482$12917248$2$F$2014$20200629$20161107$20200820$PER$$US-JAZZ-2016-US-017577$JAZZ$$$$$M$Y$$$20200820$$MD$US$US
1291742014$12917420$14$F$20181118$20200717$20161107$20200730$EXP$$US-ACTELION-A-US2016-133870$ACTELION$$46$YR$$F$Y$55.78$KG$20200730$$HP$US$US
129174275$12917427$5$F$2018$20200915$20161107$20200918$PER$$US-PFIZER INC-2016514720$PFIZER$$42$YR$$F$Y$97$KG$20200918$$HP$US$US
129175444$12917544$4$F$$20200625$20161107$20200702$EXP$GB-MHRA-ADR 23694900$PHHY2016GB148858$NOVARTIS$$$$I$F$Y$$$20200702$$CN$GB$GB
129194262$12919426$2$F$$20200911$20161108$20200923$EXP$$CA-APOTEX-2016AP013910$APOTEX$$69$YR$$F$Y$62$KG$20200923$$CN$CA$CA
129197324$12919732$4$F$$20190809$20161108$20190815$PER$$US-PFIZER INC-2016514475$PFIZER$$$$$F$Y$$$20190815$$MD$US$US
129204514$12920451$4$F$$20200911$20161108$20200920$EXP$$PHHY2012CA041631$NOVARTIS$$$$$M$Y$$$20200920$$MD$CA$CA
129206872$12920687$2$F$20140904$20200923$20161107$20200928$EXP$$US-BAYER-2016-171485$BAYER$$87$YR$E$F$Y$$$20200928$$CN$US$US
129213553$12921355$3$F$2014$20161025$20161108$20200701$EXP$$GR-JNJFOC-20161023318$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
129216223$12921622$3$F$2016$20200702$20161108$20200710$EXP$$US-BIOGEN-2016BI00314309$BIOGEN$$$$$F$Y$$$20200710$$CN$US$US
129227772$12922777$2$F$201501$20200715$20161109$20200724$EXP$$US-BAYER-2016-067149$BAYER$$67$YR$E$M$Y$145.28$KG$20200724$$CN$US$US
129234152$12923415$2$F$202008$20200820$20161109$20200826$PER$$US-AMGEN-USASL2016144443$AMGEN$$65$YR$E$F$Y$$$20200826$$MD$US$US
129237461$12923746$1$I$20161003$20161102$20161109$20161109$EXP$$GB-BAUSCH-BL-2016-027031$BAUSCH AND LOMB$$17$YR$$M$Y$66.5$KG$20161109$$MD$GB$GB
129239834$12923983$4$F$20161102$20170117$20161108$20170126$EXP$$BE-JNJFOC-20161108148$PHARMACYCLICS$$66$YR$E$F$Y$$$20170126$$MD$BE$BE
129240951$12924095$1$I$$20161104$20161109$20161109$EXP$$PHEH2016US028920$NOVARTIS$$$$$$Y$$$20161109$$CN$COUNTRY NOT SPECIFIED$US
129243522$12924352$2$F$$20190412$20161109$20190419$EXP$$PHHY2016GR152513$NOVARTIS$$68$YR$$F$Y$$$20190419$$HP$GR$GR
129246643$12924664$3$F$2014$20200804$20161108$20200811$PER$$US-JNJFOC-20161104901$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200811$$CN$US$US
129246686$12924668$6$F$20161020$20180522$20161108$20180531$EXP$$ES-JNJFOC-20161023673$PHARMACYCLICS$$67$YR$E$F$Y$57$KG$20180531$$MD$ES$ES
129260452$12926045$2$F$20161101$20161118$20161109$20161123$EXP$$CA-JNJFOC-20161105903$JANSSEN$$73$YR$E$F$Y$61$KG$20161123$$MD$CA$CA
1292619212$12926192$12$F$20160919$20200804$20161109$20200806$EXP$$GR-CELGENEUS-GRC-2016100544$CELGENE$$72$YR$$F$Y$70$KG$20200806$$HP$GR$GR
129262323$12926232$3$F$20161026$20161130$20161109$20161209$EXP$$NZ-JNJFOC-20161104501$PHARMACYCLICS$$63$YR$A$M$Y$$$20161209$$MD$NZ$NZ
1292624911$12926249$11$F$20161024$20200807$20161109$20200812$EXP$$PHHO2016US016126$NOVARTIS$$57$YR$$M$Y$78.5$KG$20200812$$MD$US$US
129263312$12926331$2$F$$20161101$20161109$20200701$EXP$$GR-JNJFOC-20161103524$JOHNSON AND JOHNSON$$7$DEC$$M$Y$$$20200701$$CN$GR$GR
129263513$12926351$3$F$20161027$20200914$20161109$20200922$EXP$$US-BIOGEN-2016BI00313856$BIOGEN$$61$YR$$F$Y$$$20200922$$CN$US$US
129270984$12927098$4$F$$20200812$20161109$20200817$EXP$$US-PFIZER INC-2016516562$PFIZER$$71$YR$$F$Y$127.9$KG$20200817$$CN$US$US
129279832$12927983$2$F$20161015$20200911$20161110$20200924$EXP$$NO-ROCHE-1851959$ROCHE$$83$YR$$F$Y$67$KG$20200924$$MD$NO$NO
1292888822$12928888$22$F$$20200921$20161110$20200929$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091881$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200929$$HP$CA$CA
1292888920$12928889$20$F$$20200924$20161110$20200930$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091709$BRISTOL MYERS SQUIBB$$66$YR$$F$Y$$$20200930$$MD$CA$CA
129301572$12930157$2$F$20140802$20200818$20161110$20200824$EXP$$US-BAYER-2016-204620$BAYER$$65$YR$E$F$Y$$$20200824$$CN$US$US
129303743$12930374$3$F$2013$20200910$20161110$20200923$EXP$$CA-JNJFOC-20161103350$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$144$KG$20200923$$HP$CA$CA
129304394$12930439$4$F$201411$20200819$20161110$20200901$EXP$$US-JNJFOC-20161107702$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20200901$$CN$US$US
129307174$12930717$4$F$$20200207$20161110$20200713$PER$$US-VANDA PHARMACEUTICALS, INC-2016TASUS001386$VANDA PHARMACEUTICALS$$$$$M$Y$$$20200713$$HP$US$US
129310932$12931093$2$F$$20200505$20161110$20200820$PER$$US-JAZZ-2016-US-017917$JAZZ$$$$$M$Y$$$20200820$$$US$US
129318828$12931882$8$F$20161024$20180220$20161111$20180226$EXP$$CZ-ROCHE-1849529$ROCHE$$72$YR$$F$Y$42$KG$20180226$$MD$CZ$CZ
1293232015$12932320$15$F$20181015$20200714$20161111$20200720$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-070073$BRISTOL MYERS SQUIBB$$65$YR$$F$Y$$$20200720$$HP$GB$GB
129324951$12932495$1$I$20150317$20150401$20161111$20161111$EXP$$JP-ROCHE-1561037$ROCHE$$64$YR$$F$Y$57$KG$20161111$$MD$JP$JP
129326211$12932621$1$I$20161025$20161025$20161111$20161111$EXP$$BE-FERRINGPH-2016FE05741$FERRING$$$$$$Y$$$20161111$$MD$BE$BE
129331193$12933119$3$F$$20200707$20161111$20200709$EXP$$GB-PFIZER INC-2016520721$PFIZER$SICE, P.. TEICOPLANIN HYPERSENSITIVITY DURING ANAESTHESIA AND SURGERY. BR J CLIN PHARMACOL. 2019?85(4):854?6$63$YR$$M$Y$$$20200709$$MD$GB$GB
129331812$12933181$2$F$20160926$20170330$20161111$20170410$EXP$$PL-TEVA-709074ISR$TEVA$$70$YR$$M$Y$$$20170410$$MD$PL$PL
129332472$12933247$2$F$20140513$20200707$20161111$20200709$EXP$$GB-PFIZER INC-2016520820$PFIZER$SICE, P.. TEICOPLANIN HYPERSENSITIVITY DURING ANAESTHESIA AND SURGERY. BR J CLIN PHARMACOL. 2019?85:854?6$62$YR$$F$Y$$$20200709$$MD$GB$GB
129334182$12933418$2$F$20130324$20200707$20161111$20200710$EXP$$GB-PFIZER INC-2016520828$PFIZER$SICE, P.. TEICOPLANIN HYPERSENSITIVITY DURING ANAESTHESIA AND SURGERY. BR J CLIN PHARMACOL. 2019?85(4):854?6$46$YR$$F$Y$$$20200710$$MD$GB$GB
129339734$12933973$4$F$20161108$20200824$20161111$20200831$PER$$PHEH2016US029566$NOVARTIS$$35$YR$$F$Y$$$20200831$$CN$COUNTRY NOT SPECIFIED$US
129354452$12935445$2$F$2014$20200727$20161114$20200921$PER$$US-JAZZ-2016-US-018777$JAZZ$$$$$M$Y$$$20200921$$HP$US$US
129355231$12935523$1$I$2015$20151015$20161114$20161114$EXP$$FI-ROCHE-1647293$ROCHE$$45$YR$$M$Y$110$KG$20161114$$MD$FI$FI
129368722$12936872$2$F$20131002$20200707$20161114$20200710$EXP$$GB-PFIZER INC-2016523088$PFIZER$SICE, P.. TEICOPLANIN HYPERSENSITIVITY DURING ANAESTHESIA AND SURGERY. BR J CLIN PHARMACOL. 2019?85:854?6$67$YR$$F$Y$$$20200710$$MD$GB$GB
129369022$12936902$2$F$20131112$20200707$20161114$20200710$EXP$$GB-PFIZER INC-2016523112$PFIZER$SICE, P.. TEICOPLANIN HYPERSENSITIVITY DURING ANAESTHESIA AND SURGERY. BR J CLIN PHARMACOL. 2019?85:854?856$74$YR$$M$Y$$$20200710$$MD$GB$GB
129372268$12937226$8$F$2016$20200722$20161114$20200729$PER$$US-PFIZER INC-2016521681$PFIZER$$79$YR$$M$Y$$$20200729$$HP$US$US
129374243$12937424$3$F$$20200702$20161114$20200707$PER$$US-PFIZER INC-2016523768$PFIZER$$72$YR$$F$Y$$$20200707$$CN$US$US
129378446$12937844$6$F$20141210$20200811$20161114$20200813$EXP$$US-PFIZER INC-2016334989$PFIZER$$57$YR$$F$Y$81.63$KG$20200813$$MD$US$US
129381073$12938107$3$F$201608$20200801$20161114$20200826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000828$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$63$KG$20200826$$CN$US$US
129381503$12938150$3$F$201602$20200802$20161114$20200812$EXP$$US-BAYER-2016-192466$BAYER$$68$YR$E$M$Y$$$20200812$$CN$US$US
129381773$12938177$3$F$2016$20200831$20161114$20200910$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000948$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20200910$$MD$US$US
129382251$12938225$1$I$$20161108$20161114$20161114$EXP$$JP-JNJFOC-20161109975$JANSSEN$SASAOKA S, MATSUI T, HANE Y, ABE J, UEDA N, MOTOOKA Y, ET AL. TIME?TO?ONSET ANALYSIS OF DRUG?INDUCED LONG QT SYNDROME BASED ON A SPONTANEOUS REPORTING SYSTEM FOR ADVERSE DRUG EVENTS. PLOS ONE 2016?11 (10).$$$$$Y$$$20161114$$HP$JP$JP
129382572$12938257$2$F$20160913$20200915$20161114$20200925$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000990$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20200925$$MD$US$US
129383364$12938336$4$F$201609$20200908$20161114$20200918$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000807$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$73$KG$20200918$$CN$US$US
129385254$12938525$4$F$2016$20200901$20161114$20200911$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000410$ACADIA PHARMACEUTICALS$$61$YR$$M$Y$$$20200911$$CN$US$US
129391545$12939154$5$F$20160728$20200911$20161114$20200921$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-000502$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$75$KG$20200921$$MD$US$US
129393315$12939331$5$F$2016$20200805$20161114$20200814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-001093$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$72$KG$20200814$$MD$US$US
1293952816$12939528$16$F$2016$20200629$20161114$20200707$EXP$$CA-PFIZER INC-2016521754$PFIZER$$67$YR$$F$Y$$$20200707$$HP$CA$CA
129408903$12940890$3$F$2009$20200827$20161115$20200901$PER$$US-JNJFOC-20161103720$JOHNSON AND JOHNSON$$2$DEC$A$M$Y$$$20200901$$CN$US$US
129412493$12941249$3$F$20110621$20200706$20161115$20200710$PER$$US-JNJFOC-20161103646$JOHNSON AND JOHNSON$$17$YR$$M$Y$$$20200710$$LW$US$US
129414264$12941426$4$F$201403$20200706$20161115$20200709$PER$$US-JNJFOC-20161103723$JOHNSON AND JOHNSON$$18$YR$$M$Y$$$20200709$$LW$US$US
129415601$12941560$1$I$20141006$20141212$20161115$20161115$EXP$$JP-ROCHE-1511334$ROCHE$$35$YR$$M$Y$73$KG$20161115$$MD$JP$JP
129419723$12941972$3$F$201201$20200918$20161114$20200930$EXP$$US-JAZZ-JPI-P-019501$JAZZ$$34$YR$$F$Y$113.4$KG$20200930$$HP$US$US
129420394$12942039$4$F$2009$20200706$20161115$20200709$PER$$US-JNJFOC-20161104417$JOHNSON AND JOHNSON$$8$YR$$M$Y$$$20200709$$LW$US$US
129428745$12942874$5$F$201412$20200812$20161115$20200825$EXP$$US-JNJFOC-20161111271$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200825$$CN$US$US
129443482$12944348$2$F$20161105$20161114$20161115$20161122$EXP$$JP-JNJFOC-20161107394$JANSSEN$$75$YR$E$M$Y$63.3$KG$20161122$$MD$JP$JP
129443873$12944387$3$F$20161017$20161110$20161115$20161121$EXP$$IT-JNJFOC-20161113223$JANSSEN$$50$YR$A$F$Y$$$20161121$$MD$IT$IT
129444535$12944453$5$F$2016$20200902$20161115$20200910$EXP$$US-JAZZ-2016-US-022111$JAZZ$$$$$F$Y$113.4$KG$20200910$$HP$US$US
1294567710$12945677$10$F$$20200914$20161116$20200918$PER$$CA-AMGEN-CANSP2016157990$AMGEN$$24$YR$A$F$Y$$$20200918$$HP$CA$CA
1294572022$12945720$22$F$20151207$20200810$20161115$20200817$EXP$$GB-MYLANLABS-2016M1039616$MYLAN$$46$YR$$M$Y$$$20200817$$MD$GB$GB
1294587712$12945877$12$F$$20200629$20161116$20200703$PER$$CA-AMGEN-CANSP2016158750$AMGEN$$67$YR$E$F$Y$$$20200703$$HP$CA$CA
1294692912$12946929$12$F$20160921$20200924$20161116$20200928$EXP$$US-PFIZER INC-2016527160$PFIZER$$79$YR$$F$Y$91$KG$20200928$$MD$US$US
129472439$12947243$9$F$20160901$20200916$20161116$20200918$EXP$$GB-ABBVIE-16P-167-1779528-00$ABBVIE$$35$YR$$F$Y$$$20200918$$MD$GB$GB
129477952$12947795$2$F$20150112$20161202$20161117$20161206$EXP$$IE-ROCHE-1524871$ROCHE$$36$YR$$F$Y$61.3$KG$20161206$$MD$IE$IE
129486311$12948631$1$I$20160305$20160307$20161116$20161116$EXP$$UA-JNJFOC-20160314437$JANSSEN$$40$YR$A$M$Y$64$KG$20161116$$MD$UA$UA
129486321$12948632$1$I$20160403$20160405$20161116$20161116$EXP$$RU-JNJFOC-20160406619$JANSSEN$$31$YR$A$M$Y$70.5$KG$20161116$$MD$RU$RU
129486331$12948633$1$I$20150821$20150824$20161116$20161116$EXP$$RU-JNJFOC-20150820132$JANSSEN$$40$YR$A$M$Y$105$KG$20161116$$MD$RU$RU
129486341$12948634$1$I$20160614$20160614$20161116$20161116$EXP$$RU-JNJFOC-20160615158$JANSSEN$$41$YR$A$M$Y$103$KG$20161116$$MD$RU$RU
129487714$12948771$4$F$20161107$20161206$20161116$20161212$EXP$$NZ-JNJFOC-20161109496$PHARMACYCLICS$$80$YR$E$M$Y$$$20161212$$MD$NZ$NZ
129488417$12948841$7$F$20161107$20200803$20161116$20200810$EXP$$CZ-TAKEDA-2016MPI009799$TAKEDA$MAISNAR V, POUR L, SPICKA I, OZCAN M, TURGUT M, HAJEK R.. INITIAL PHASE 2 RESULTS OF IBRUTINIB COMBINED WITH BORTEZOMIB/DEXAMETHASONE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA. HAEMATOLOGICA. 2017?102(2):267$57$YR$$M$Y$113$KG$20200810$$MD$CZ$CZ
129497934$12949793$4$F$$20200630$20161117$20200707$EXP$$PHHY2016CR066160$NOVARTIS$$$$$F$Y$67$KG$20200708$$MD$CR$CR
129500062$12950006$2$F$20150518$20200726$20161117$20200731$EXP$$US-BAYER-2016-165348$BAYER$$57$YR$A$M$Y$$$20200731$$CN$US$US
1295003925$12950039$25$F$20141104$20200709$20161117$20200717$EXP$$US-JNJFOC-20161108556$JOHNSON AND JOHNSON$$6$YR$$F$Y$38.9$KG$20200717$$LW$US$US
129500441$12950044$1$I$20160628$20160804$20161117$20161117$EXP$$GB-TEVA-684215ACC$TEVA$$75$YR$$M$Y$$$20161117$$MD$GB$GB
129502104$12950210$4$F$20161107$20180111$20161116$20180119$EXP$$FR-JNJFOC-20161108796$JANSSEN$$65$YR$A$M$Y$65$KG$20180119$$MD$FR$FR
129502462$12950246$2$F$20140115$20200818$20161117$20200824$EXP$$US-BAYER-2016-076956$BAYER$$73$YR$E$M$Y$$$20200824$$CN$US$US
129502614$12950261$4$F$20130503$20200812$20161117$20200820$EXP$$US-BIOGEN-2013BI045043$BIOGEN$$47$YR$$M$Y$93.07$KG$20200820$$CN$US$US
129502963$12950296$3$F$20160925$20170321$20161117$20170329$EXP$$GB-JNJFOC-20161001854$PHARMACYCLICS$$87$YR$E$F$Y$$$20170329$$MD$GB$GB
1295043020$12950430$20$F$20160923$20200716$20161116$20200730$EXP$$US-ACTELION-A-NJ2016-138325$ACTELION$$49$YR$$F$Y$$$20200730$$HP$US$US
129513641$12951364$1$I$20150702$20150706$20161117$20161117$EXP$$FR-JNJFOC-20150714570$JANSSEN$$37$YR$A$M$Y$64$KG$20161117$$HP$FR$FR
129515945$12951594$5$F$20161029$20200915$20161117$20200921$EXP$$DE-CELGENEUS-DEU-2016111994$CELGENE$$68$YR$$M$Y$$$20200921$$HP$DE$DE
129517772$12951777$2$F$$20200924$20161117$20200929$EXP$$NL-ROCHE-1853546$ROCHE$, BRAUN K, GELEIJNS K, JANSEN F AND VAN R RISKS AND BENEFITS OF RITUXIMAB IN THE TREATMENT OF HASHIMOTO ENCEPHALOPATHY IN CHILDREN: TWO CASE REPORTS AND A MINI REVIEW. PEDIATRIC NEUROLOGY 2016 SEP 20?:1?4.$12$YR$$M$Y$$$20200929$$MD$NL$NL
129523746$12952374$6$F$2011$20200819$20161117$20200826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-096624$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200826$$CN$CA$CA
129527213$12952721$3$F$2016$20200806$20161117$20200814$PER$$US-SA-2016SA165395$SANOFI AVENTIS$$$$$$Y$$$20200814$$CN$US$US
129528407$12952840$7$F$20160721$20200818$20161117$20200825$EXP$$PHHY2016CA120231$NOVARTIS$$37$YR$$F$Y$$$20200825$$PH$CA$CA
129532922$12953292$2$F$20160420$20200818$20161117$20200828$EXP$$US-TAKEDA-2016MPI003328$TAKEDA$$58$YR$$M$Y$78$KG$20200828$$MD$US$US
129534755$12953475$5$F$20161108$20161216$20161117$20161222$EXP$$FR-ABBVIE-16P-056-1779808-00$ABBVIE$$75$YR$$M$Y$62$KG$20161222$$MD$FR$FR
129539318$12953931$8$F$20160404$20200727$20161118$20200810$EXP$$CA-ROCHE-1855931$ROCHE$$45$YR$$F$Y$$$20200810$$HP$CA$CA
129543057$12954305$7$F$20161108$20170925$20161118$20170928$EXP$$US-ROCHE-1854277$ROCHE$$72$YR$$F$Y$65.2$KG$20170929$$MD$US$US
129550297$12955029$7$F$20161107$20170222$20161118$20170302$EXP$$GB-JNJFOC-20161117044$JANSSEN$$85$YR$E$M$Y$61$KG$20170302$$MD$GB$GB
129550315$12955031$5$F$20160110$20170124$20161118$20170201$EXP$$US-JNJFOC-20161117786$JANSSEN$$30$YR$$F$Y$48.54$KG$20170201$$MD$US$US
129550771$12955077$1$I$20161007$20161103$20161118$20161118$EXP$$US-ALVOGEN-2016-ALVOGEN-086814$ALVOGEN$$63$YR$$F$Y$50.3$KG$20161118$$MD$US$US
129564622$12956462$2$F$20161027$20170221$20161118$20170301$EXP$$IL-JNJFOC-20161024204$JANSSEN$$61$YR$A$F$Y$$$20170301$$MD$IL$IL
129569834$12956983$4$F$201205$20200910$20161118$20200915$PER$$US-JNJFOC-20161117227$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200915$$CN$US$US
129574393$12957439$3$F$20161113$20170410$20161118$20170417$EXP$$CA-JNJFOC-20161115682$JANSSEN$$54$YR$A$M$Y$109.3$KG$20170417$$MD$CA$CA
129593051$12959305$1$I$20150622$20150624$20161121$20161121$EXP$$HK-ROCHE-1599085$ROCHE$$52$YR$$F$Y$46$KG$20161121$$MD$HK$HK
129594693$12959469$3$F$201811$20200813$20161121$20200820$PER$$US-AMGEN-USASP2016161096$AMGEN$$71$YR$E$F$Y$$$20200820$$MD$US$US
129600971$12960097$1$I$$20161107$20161121$20161121$EXP$$AT-ROCHE-1856492$ROCHE$PECHERSTORFER M, HERRMANN Z, BODY J?J, MANEGOLD C, DEGARDIN M, CLEMENS M, THURLIMANN B, TUBIANA?HULIN M, STEINHAUER E, VAN EIJKEREN M, HUSS H?J AND THIEBAUD D RANDOMIZED PHASE II TRIAL COMPARING DIFFERENT DOSES OF THE BISPHOSPHONATE IBANDRONATE IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY . JOURNAL OF CLINICAL ONCOLOGY 1996 JAN?14(1):268?276.$$$$$Y$$$20161121$$MD$AT$AT
129612844$12961284$4$F$2016$20200910$20161121$20200915$PER$$US-PFIZER INC-2016537985$PFIZER$$11$YR$$M$Y$$$20200915$$CN$US$US
129615229$12961522$9$F$201512$20200820$20161121$20200830$EXP$$US-UCBSA-2016043625$UCB$$21$YR$$F$Y$72$KG$20200831$$CN$US$US
129618297$12961829$7$F$20161110$20200910$20161121$20200916$EXP$$US-PFIZER INC-2016529035$PFIZER$$55$YR$$M$Y$81$KG$20200916$$HP$US$US
129621978$12962197$8$F$201610$20190722$20161121$20200803$EXP$$GR-JNJFOC-20161117004$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20200803$$MD$GR$GR
129632888$12963288$8$F$$20200827$20161122$20200909$PER$$PHEH2016US030519$NOVARTIS$$$$$F$Y$$$20200909$$MD$US$US
1296350420$12963504$20$F$20140321$20200722$20161122$20200730$EXP$$CA-ROCHE-1857057$ROCHE$$60$YR$$F$Y$$$20200730$$CN$CA$CA
129636307$12963630$7$F$2016$20200914$20161122$20200918$PER$$CA-AMGEN-CANSP2016163519$AMGEN$$59$YR$A$F$Y$$$20200918$$MD$CA$CA
129639233$12963923$3$F$$20200730$20161122$20200804$EXP$$CA-009507513-1611CAN007618$MERCK$$$$$M$Y$$$20200804$$CN$DK$CA
129639529$12963952$9$F$20160808$20200731$20161122$20200807$EXP$$PHHY2016DE124300$NOVARTIS$$$$A$M$Y$125$KG$20200807$$HP$DE$DE
129639586$12963958$6$F$20200917$20200921$20161122$20200930$EXP$$PHHY2016BR072845$NOVARTIS$$73$YR$$F$Y$88$KG$20200930$$CN$BR$BR
129639727$12963972$7$F$20140716$20200821$20161122$20200829$EXP$$PHHY2015CO064648$NOVARTIS$$50$YR$$F$Y$58$KG$20200830$$CN$COUNTRY NOT SPECIFIED$CO
1296415619$12964156$19$F$20160310$20200623$20161122$20200701$EXP$$PHHY2016CA034937$NOVARTIS$$71$YR$$F$Y$$$20200701$$HP$CA$CA
129642945$12964294$5$F$$20200928$20161122$20200930$EXP$$US-PFIZER INC-2016538990$PFIZER$$53$YR$$F$Y$$$20200930$$HP$US$US
129643505$12964350$5$F$201610$20200626$20161122$20200701$PER$$US-PFIZER INC-2016478916$PFIZER$$69$YR$$F$Y$95.25$KG$20200701$$MD$US$US
129645122$12964512$2$F$20141103$20200917$20161122$20200925$EXP$$US-BAYER-2016-124912$BAYER$$78$YR$E$M$Y$$$20200925$$CN$US$US
129645343$12964534$3$F$20160927$20200907$20161122$20200916$EXP$$DE-BIOGEN-2016BI00319735$BIOGEN$$0$DY$$M$Y$2.44$KG$20200916$$CN$DE$DE
1296511213$12965112$13$F$2016$20200907$20161122$20200915$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-098912$BRISTOL MYERS SQUIBB$YAMAMOTO A, ET AL. A CASE OF LUNG ADENOCARCINOMA WITH IMMUNE?RELATED CHOLANGITIS CAUSED BY NIVOLUMAB. 56TH CHUGOKU?SHIKOKU BRANCH CONGRESS OF THE JAPAN LUNG CANCER SOCIETY. 2017?102$55$YR$$M$Y$70$KG$20200915$$MD$JP$JP
129654619$12965461$9$F$201602$20200903$20161122$20200907$EXP$$CA-TAKEDA-2016TUS005111$TAKEDA$$70$YR$$M$Y$$$20200907$$HP$CA$CA
1296549413$12965494$13$F$201610$20200703$20161122$20200709$EXP$$BR-TAKEDA-2016TUS021026$TAKEDA$$61$YR$$F$Y$70.9$KG$20200709$$CN$BR$BR
129655177$12965517$7$F$20161108$20180217$20161122$20180228$EXP$$BR-JNJFOC-20161112772$JANSSEN$$69$YR$E$M$Y$72.5$KG$20180228$$MD$BR$BR
1296652011$12966520$11$F$20161115$20200819$20161122$20200825$EXP$$GB-MYLANLABS-2016M1050070$MYLAN$$54$YR$$M$Y$$$20200825$$MD$GB$GB
129674204$12967420$4$F$201509$20190912$20161123$20190918$EXP$$DE-ROCHE-1635604$ROCHE$$55$YR$$M$Y$125$KG$20190918$$MD$DE$DE
129676367$12967636$7$F$$20200827$20161123$20200910$EXP$$PHEH2016US030520$NOVARTIS$$$$$M$Y$$$20200910$$MD$US$US
129687573$12968757$3$F$20161111$20200813$20161123$20200828$EXP$$GB-UCBSA-2016043770$UCB$$$$A$M$Y$$$20200828$$HP$GB$GB
129695109$12969510$9$F$20160913$20200730$20161123$20200813$EXP$$US-ACTELION-A-US2016-141555$ACTELION$$53$YR$$F$Y$83.9$KG$20200813$$HP$US$US
129698626$12969862$6$F$20160730$20170908$20161123$20170912$EXP$$AU-JNJFOC-20161117625$JANSSEN$$45$YR$A$F$Y$75$KG$20170912$$MD$AU$AU
129701313$12970131$3$F$201504$20200629$20161123$20200710$EXP$$US-JNJFOC-20160916338$JOHNSON AND JOHNSON$$72$YR$$F$Y$$$20200710$$CN$US$US
129701955$12970195$5$F$20070907$20200724$20161123$20200730$EXP$$TN-SA-2016SA211743$SANOFI AVENTIS$SALOUAGE I, EL AIDLI S, KASTALLI S, DAGHFOUS R, LAKHAL M.. FATAL KOUNIS SYNDROME WITH STENT THROMBOSIS SECONDARY TO AMOXICILLIN/CLAVULANIC ACID USE: A CASE REPORT AND LITERATURE REVIEW.. THERAPIE. 2016?71 (6):535?539$58$YR$$F$Y$$$20200730$$HP$TN$TN
129703476$12970347$6$F$20161116$20170626$20161123$20170628$EXP$$IE-JNJFOC-20161124043$JANSSEN$$60$YR$A$M$Y$$$20170628$$CN$IE$IE
129706586$12970658$6$F$20161113$20170406$20161123$20170413$EXP$$ES-JNJFOC-20161121131$JANSSEN$$72$YR$E$M$Y$72$KG$20170413$$MD$ES$ES
129707387$12970738$7$F$$20200717$20161123$20200727$EXP$$CA-APOTEX-2016AP014712$APOTEX$$83$YR$$F$Y$$$20200727$$CN$CA$CA
129709042$12970904$2$F$2013$20200812$20161123$20200820$PER$$US-JAZZ-2014-US-015151$JAZZ$$$$$M$Y$92.97$KG$20200820$$MD$US$US
129709252$12970925$2$F$$20200707$20161123$20200921$PER$$US-JAZZ-2014-US-006513$JAZZ$$$$$F$Y$$$20200921$$MD$US$US
129710752$12971075$2$F$2015$20200701$20161123$20200921$PER$$US-JAZZ-2015-US-008003$JAZZ$$$$$M$Y$$$20200921$$CN$US$US
129713082$12971308$2$F$$20200522$20161123$20200820$PER$$US-JAZZ-2016-US-019661$JAZZ$$$$$F$Y$$$20200820$$MD$US$US
129721523$12972152$3$F$$20200715$20161124$20200721$EXP$$AU-ORION CORPORATION ORION PHARMA-TREX2016-2387$ORION$MAYALL B. HAEMOPOIETIC TOXICITY AND LOWDOSE METHOTREXATE. MED J AUSTRALIA. 1992?156(6):440.$68$YR$$F$Y$$$20200721$$$COUNTRY NOT SPECIFIED$AU
129729233$12972923$3$F$202008$20200807$20161124$20200811$PER$$US-PFIZER INC-2016541030$PFIZER$$63$YR$$F$Y$84.37$KG$20200811$$CN$US$US
129730403$12973040$3$F$20161028$20170311$20161124$20170316$EXP$$US-ASTRAZENECA-2016SF24031$ASTRAZENECA$$832$MON$$F$Y$76.5$KG$20170316$$MD$US$US
129733763$12973376$3$F$20161021$20170421$20161124$20170428$EXP$$PL-JNJFOC-20161023272$JANSSEN$$36$YR$A$F$Y$76.8$KG$20170428$$MD$PL$PL
129733784$12973378$4$F$20161117$20170421$20161124$20170428$EXP$$BY-JNJFOC-20161121815$JANSSEN$$44$YR$A$F$Y$82.4$KG$20170428$$MD$BY$BY
129734321$12973432$1$I$20161103$20161104$20161124$20161124$EXP$$KR-JNJFOC-20161109390$PHARMACYCLICS$$74$YR$E$M$Y$$$20161124$$MD$KR$KR
129735126$12973512$6$F$20140901$20200702$20161124$20200709$PER$$PHHY2014US135995$NOVARTIS$$42$YR$$M$Y$74.8$KG$20200709$$MD$US$US
129736471$12973647$1$I$20160907$20160907$20161124$20161124$EXP$$JP-JNJFOC-20160908233$JANSSEN$$80$YR$E$M$Y$52.7$KG$20161124$$MD$JP$JP
1297399517$12973995$17$F$$20200720$20161124$20200723$PER$$CA-AMGEN-CANSP2016163638$AMGEN$$63$YR$A$F$Y$$$20200723$$MD$CA$CA
129742395$12974239$5$F$$20200914$20161125$20200922$PER$$CA-AMGEN-CANSP2016164388$AMGEN$$66$YR$E$F$Y$$$20200922$$HP$CA$CA
129755621$12975562$1$I$20160310$20161118$20161125$20161125$EXP$$IL-JNJFOC-20161120996$JANSSEN$$35$YR$A$M$Y$$$20161125$$CN$GB$IL
129755971$12975597$1$I$20161115$20161116$20161125$20161125$EXP$$US-JNJFOC-20161122638$PHARMACYCLICS$$61$YR$A$F$Y$$$20161125$$MD$US$US
129756002$12975600$2$F$20151125$20161128$20161125$20161202$EXP$$CA-JNJFOC-20161124539$PHARMACYCLICS$$67$YR$E$M$Y$76$KG$20161202$$MD$CA$CA
129759291$12975929$1$I$20161102$20161117$20161125$20161125$EXP$$TW-ASTRAZENECA-2016SF23308$ASTRAZENECA$$28135$DY$$F$Y$39$KG$20161126$$MD$TW$TW
129776582$12977658$2$F$$20200919$20161128$20200922$PER$$US-AMGEN-USASL2016157264$AMGEN$$83$YR$E$M$Y$$$20200922$$MD$US$US
129780924$12978092$4$F$201605$20200904$20161128$20200908$EXP$$FR-PFIZER INC-2016541699$PFIZER$$64$YR$$M$Y$84$KG$20200908$$MD$FR$FR
129781279$12978127$9$F$$20200730$20161128$20200803$PER$$US-PFIZER INC-2016332932$PFIZER$$62$YR$$F$Y$$$20200803$$MD$US$US
129785229$12978522$9$F$$20200805$20161128$20200810$PER$$US-PFIZER INC-2016546783$PFIZER$$70$YR$$M$Y$104$KG$20200810$$MD$US$US
129786062$12978606$2$F$20161114$20161128$20161128$20161207$EXP$$US-JNJFOC-20161119381$JANSSEN$$41$YR$A$F$Y$77$KG$20161207$$MD$US$US
129786075$12978607$5$F$20161111$20170418$20161128$20170424$EXP$$US-JNJFOC-20161121022$JANSSEN$$25$YR$A$F$Y$96$KG$20170424$$MD$US$US
129786894$12978689$4$F$$20200803$20161128$20200806$PER$$US-PFIZER INC-2016551519$PFIZER$$66$YR$$F$Y$$$20200806$$CN$US$US
129789981$12978998$1$I$20160411$20160427$20161128$20161128$EXP$$UA-JNJFOC-20160425171$JANSSEN$$82$YR$E$F$Y$77$KG$20161128$$MD$UA$UA
1297965817$12979658$17$F$$20200910$20161128$20200917$EXP$$PHEH2016US030800$NOVARTIS$$$$$M$Y$$$20200917$$CN$COUNTRY NOT SPECIFIED$US
129802697$12980269$7$F$20160606$20200907$20161128$20200919$EXP$$JP-INCYTE CORPORATION-2016IN003514$INCYTE$$$$$$Y$$$20200919$$MD$JP$JP
129807815$12980781$5$F$$20200722$20161128$20200727$PER$$US-PFIZER INC-2016543651$PFIZER$$$$$F$Y$$$20200727$$HP$US$US
129808125$12980812$5$F$201511$20200917$20161128$20200922$EXP$$US-JAZZ-2016-US-022923$JAZZ$$39$YR$$M$Y$79.37$KG$20200922$$CN$US$US
129814099$12981409$9$F$20161111$20200707$20161129$20200708$EXP$$IT-ROCHE-1860160$ROCHE$$65$YR$$F$Y$$$20200709$$MD$IT$IT
129828957$12982895$7$F$$20171120$20161129$20200918$EXP$$CA-APOTEX-2016AP014814$APOTEX$$42$YR$$F$Y$81$KG$20200918$$CN$CA$CA
129836133$12983613$3$F$20161120$20161221$20161129$20161227$EXP$$IL-JNJFOC-20161123442$PHARMACYCLICS$$81$YR$E$M$Y$70$KG$20161227$$MD$IL$IL
129842479$12984247$9$F$20150822$20200902$20161129$20200910$EXP$$JP-OTSUKA-2016_003888$OTSUKA$$58$YR$$F$Y$56.2$KG$20200910$$MD$JP$JP
129844423$12984442$3$F$$20200724$20161129$20200731$EXP$FR-EMA-20170804-NEGIEVPROD-133829669$FR-DSJP-DSE-2016-139401$DAIICHI$REYNAUD C, EYSSERIC?GUERIN H, BONADONA A, BARTOLI M, BARRET A, CANDILLE C, ET AL.. TOXIC DEATH CAUSED BY AMLODIPIN AND OLMESARTAN: A CASE REPORT WITH PHARMACOBEZOARD. TOXICOLOGIE ANALYTIQUE ET CLINIQUE. 2016?28 (4):286?293$$$$$Y$$$20200731$$MD$FR$FR
129848783$12984878$3$F$20160811$20200612$20161129$20200910$EXP$$US-PURDUE-USA-2016-0133904$PURDUE$$50$YR$$F$Y$$$20200910$$CN$US$US
129850566$12985056$6$F$$20200909$20161129$20200918$EXP$$CA-APOTEX-2016AP014805$APOTEX$$52$YR$$M$Y$$$20200918$$HP$CA$CA
129850604$12985060$4$F$2016$20200925$20161129$20200930$PER$$US-JAZZ-2016-US-022634$JAZZ$$$$$F$Y$$$20200930$$CN$US$US
129853185$12985318$5$F$$20200824$20161130$20200825$EXP$$CA-ROCHE-1859492$ROCHE$$79$YR$$F$Y$$$20200825$$MD$CA$CA
129870302$12987030$2$F$20161120$20161231$20161130$20170106$EXP$$IL-JNJFOC-20161124361$JANSSEN$$66$YR$E$M$Y$90$KG$20170106$$MD$IL$IL
129873413$12987341$3$F$20160415$20190711$20161130$20200909$EXP$$FR-JNJFOC-20161128959$JOHNSON AND JOHNSON$$16$YR$T$F$Y$66$KG$20200909$$MD$FR$FR
129873963$12987396$3$F$20141022$20200921$20161130$20200925$EXP$$US-BAYER-2016-200655$BAYER$$80$YR$E$F$Y$$$20200925$$CN$US$US
129882305$12988230$5$F$20161108$20161227$20161130$20170106$EXP$$AU-JNJFOC-20161129094$PHARMACYCLICS$$74$YR$E$M$Y$$$20170106$$MD$AU$AU
1298834811$12988348$11$F$20161120$20200908$20161130$20200912$EXP$$PHHY2016PA162670$NOVARTIS$$68$YR$$F$Y$60.32$KG$20200913$$MD$PA$PA
129899464$12989946$4$F$$20200715$20161201$20200717$PER$$US-PFIZER INC-2016552041$PFIZER$$$$$M$Y$$$20200717$$MD$US$US
129903162$12990316$2$F$20140409$20200722$20161201$20200731$EXP$$US-BAYER-2016-225687$BAYER$$81$YR$E$F$Y$$$20200731$$CN$US$US
129904444$12990444$4$F$20160315$20200827$20161201$20200909$EXP$$US-CELGENEUS-USA-2016036657$CELGENE$$57$YR$$M$Y$78$KG$20200909$$MD$US$US
129908132$12990813$2$F$20140813$20200913$20161201$20200924$EXP$$US-JNJFOC-20161114934$JOHNSON AND JOHNSON$$51$YR$A$M$Y$74.84$KG$20200924$$CN$US$US
1299158313$12991583$13$F$200902$20200909$20161201$20200911$EXP$$US-PFIZER INC-2016559113$PFIZER$$38$YR$$F$Y$63$KG$20200911$$CN$US$US
129916824$12991682$4$F$201604$20200910$20161201$20200918$EXP$$CZ-ARIAD-2016CZ007343$TAKEDA$$65$YR$$F$Y$$$20200918$$MD$CZ$CZ
1299241826$12992418$26$F$20161123$20200629$20161202$20200713$EXP$$CA-ROCHE-1862239$ROCHE$$53$YR$$F$Y$$$20200714$$CN$CA$CA
129926466$12992646$6$F$20161119$20200729$20161202$20200803$EXP$$CN-ROCHE-1858948$ROCHE$$59$YR$$M$Y$55$KG$20200803$$MD$CN$CN
129929983$12992998$3$F$$20200818$20161202$20200829$EXP$$US-AUROBINDO-AUR-APL-2016-14532$AUROBINDO$SACCO KA, MOUSA OY, WANG MH. CHRONIC ABDOMINAL PAIN AND CUTANEOUS SWELLING.. GASTEROENTEROLOGY. 2017?153:651?2$51$YR$$M$Y$$$20200829$$MD$US$US
1299396614$12993966$14$F$$20200701$20161202$20200703$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-101553$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200703$$CN$GB$GB
129941275$12994127$5$F$$20200810$20161202$20200812$PER$$US-PFIZER INC-2016558929$PFIZER$$63$YR$$F$Y$$$20200812$$CN$US$US
129947612$12994761$2$F$20140905$20200624$20161202$20200706$EXP$$US-BAYER-2016-172966$BAYER$$64$YR$A$F$Y$$$20200706$$CN$US$US
1299477114$12994771$14$F$20161123$20200622$20161202$20200706$EXP$$US-ACTELION-A-NJ2016-146292$ACTELION$$53$YR$$F$Y$$$20200706$$HP$US$US
129949791$12994979$1$I$20160107$20160111$20161202$20161202$EXP$$US-JNJFOC-20160108808$JANSSEN$$74$YR$E$M$Y$74.6$KG$20161202$$MD$US$US
129951058$12995105$8$F$201905$20200804$20161202$20200807$EXP$$US-PFIZER INC-2016552032$PFIZER$$78$YR$$M$Y$83$KG$20200807$$CN$US$US
1299521810$12995218$10$F$20161013$20200812$20161202$20200821$PER$$CO-AMGEN-COLSL2016151568$AMGEN$$36$YR$A$F$Y$56$KG$20200821$$MD$CO$CO
129970874$12997087$4$F$20161101$20170410$20161205$20170424$EXP$$KR-PFIZER INC-2016519365$PFIZER$$63$MON$$M$Y$$$20170424$$MD$KR$KR
1299793116$12997931$16$F$20160905$20200803$20161205$20200810$EXP$$GB-MYLANLABS-2016M1038823$MYLAN$$56$YR$$M$Y$$$20200810$$MD$GB$GB
129979853$12997985$3$F$$20200811$20161205$20200813$EXP$$JP-PFIZER INC-2016557064$PFIZER$SUETA, D. A DESTABILIZED CASE OF STABLE EFFORT ANGINA PECTORIS INDUCED BY LOW?DOSE ADENOSINE TRIPHOSPHATE. JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2016?55 (22):3291?3294$79$YR$$M$Y$49.1$KG$20200813$$MD$JP$JP
129980262$12998026$2$F$20150128$20200804$20161205$20200814$EXP$$US-BAYER-2016-190139$BAYER$$79$YR$E$M$Y$$$20200814$$LW$US$US
129982682$12998268$2$F$20151011$20200713$20161205$20200722$EXP$$US-BAYER-2016-175502$BAYER$$63$YR$A$M$Y$114.3$KG$20200722$$CN$US$US
1299831310$12998313$10$F$$20200925$20161205$20200930$PER$$US-PFIZER INC-2016053264$PFIZER$$59$YR$$F$Y$78$KG$20200930$$MD$US$US
129987444$12998744$4$F$20161026$20200720$20161205$20200724$EXP$$ES-CELGENEUS-ESP-2016108498$CELGENE$$64$YR$$M$Y$69$KG$20200724$$MD$ES$ES
129987785$12998778$5$F$201610$20170920$20161205$20170922$EXP$$GB-JNJFOC-20161200300$PHARMACYCLICS$$68$YR$E$M$Y$88$KG$20170922$$CN$GB$GB
129994014$12999401$4$F$$20200811$20161205$20200820$EXP$$JP-BAUSCH-BL-2016-030425$BAUSCH AND LOMB$SUETA D, KOJIMA S, IZUMIYA Y, YAMAMURO M, KAIKITA K, HOKIMOTO S, OGAWA H. A DESTABILIZED CASE OF STABLE EFFORT ANGINA PECTORIS INDUCED BY LOW?DOSE ADENOSINE TRIPHOSPHATE. INTERNAL MEDICINE. 2016?55 (22):3291?3294. DOI:10.2169/INTERNALMEDICINE.55.7234$79$YR$$M$Y$49.1$KG$20200820$$MD$JP$JP
129994491$12999449$1$I$20160119$20160125$20161205$20161205$EXP$$FR-JNJFOC-20160122870$JANSSEN$$86$YR$E$M$Y$100$KG$20161205$$MD$FR$FR
129994647$12999464$7$F$20161017$20200918$20161205$20200923$EXP$$GB-MYLANLABS-2016M1044972$MYLAN$$38$YR$$M$Y$$$20200923$$CN$GB$GB
129996023$12999602$3$F$20150815$20200813$20161205$20200825$EXP$$US-JNJFOC-20161202024$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20200825$$CN$US$US
1299960512$12999605$12$F$20161125$20171228$20161205$20171229$EXP$$FR-JNJFOC-20161130326$JANSSEN$$45$YR$A$F$Y$67$KG$20171229$$MD$FR$FR
129999574$12999957$4$F$20160815$20200724$20161205$20200729$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-067821$BRISTOL MYERS SQUIBB$$48$YR$$M$Y$112.8$KG$20200729$$HP$GB$GB
1300017519$13000175$19$F$201611$20200908$20161205$20200916$EXP$$CA-ROCHE-1863461$ROCHE$$34$YR$$F$Y$91$KG$20200916$$MD$CA$CA
130009103$13000910$3$F$20160419$20200623$20161206$20200708$EXP$$IT-AEGERION PHARMACEUTICALS INC-AEGR002855$AEGERION$$$$$$Y$$$20200708$$MD$IT$IT
130012717$13001271$7$F$$20200715$20161206$20200717$PER$$US-PFIZER INC-2016264949$PFIZER$$61$YR$$M$Y$89$KG$20200717$$MD$US$US
130013487$13001348$7$F$2016$20200922$20161206$20200926$EXP$$PHHO2016FR017508$NOVARTIS$$66$YR$$M$Y$$$20200926$$MD$FR$FR
130015323$13001532$3$F$$20200722$20161206$20200724$PER$$US-PFIZER INC-2016556905$PFIZER$$52$YR$$F$Y$$$20200724$$MD$US$US
130017962$13001796$2$F$20161123$20161202$20161206$20161213$EXP$$CA-PFIZER INC-2016560338$PFIZER$$76$YR$$M$Y$$$20161213$$MD$CA$CA
130018311$13001831$1$I$$20161125$20161206$20161206$EXP$$US-PFIZER INC-2016555246$PFIZER$$7$DEC$$F$Y$$$20161206$$MD$US$US
130023044$13002304$4$F$20161126$20170301$20161206$20170306$EXP$$US-JNJFOC-20161202625$PHARMACYCLICS$$57$YR$A$M$Y$71.5$KG$20170306$$MD$US$US
130023553$13002355$3$F$2016$20200803$20161206$20200807$EXP$$US-SA-2016SA014018$SANOFI AVENTIS$$$$$M$Y$$$20200807$$CN$US$US
130025321$13002532$1$I$20150110$20150701$20161206$20161206$EXP$$US-JNJFOC-20150704440$JANSSEN$$49$YR$A$F$Y$63.7$KG$20161206$$MD$US$US
130026562$13002656$2$F$20150220$20200825$20161206$20200827$EXP$$US-BAYER-2016-219475$BAYER$$72$YR$E$M$Y$$$20200827$$HP$US$US
130030314$13003031$4$F$20161117$20161221$20161206$20161228$EXP$$US-JNJFOC-20161127722$JANSSEN$$25$YR$A$M$Y$$$20161228$$MD$US$US
130031571$13003157$1$I$20160817$20161202$20161206$20161206$EXP$$GB-FRESENIUS KABI-FK201609476$FRESENIUS KABI$$48$YR$$M$Y$68.8$KG$20161206$$HP$GB$GB
130036118$13003611$8$F$20161025$20180810$20161206$20180820$EXP$$US-JNJFOC-20161127709$JANSSEN$$78$YR$E$M$Y$88$KG$20180820$$MD$US$US
130036908$13003690$8$F$20170402$20200727$20161206$20200806$EXP$$US-ACTELION-A-US2016-132723$ACTELION$$64$YR$$F$Y$49.89$KG$20200806$$HP$US$US
1300584911$13005849$11$F$2016$20200912$20161207$20200922$EXP$$DE-INCYTE CORPORATION-2016IN007752$INCYTE$$$$$$Y$$$20200922$$MD$DE$DE
130062314$13006231$4$F$20141226$20200903$20161207$20200917$EXP$$JP-INCYTE CORPORATION-2016IN007707$INCYTE$$$$$$Y$$$20200917$$MD$JP$JP
130062965$13006296$5$F$$20200820$20161207$20200824$PER$$US-PFIZER INC-2016568535$PFIZER$$63$YR$$F$Y$77.11$KG$20200824$$CN$US$US
130063305$13006330$5$F$20160415$20200205$20161207$20200803$EXP$$DE-JNJFOC-20160723995$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20200803$$MD$DE$DE
130064517$13006451$7$F$20161111$20170426$20161207$20170504$EXP$$RU-JNJFOC-20161115871$PHARMACYCLICS$$73$YR$E$M$Y$$$20170504$$MD$RU$RU
130066963$13006696$3$F$20160204$20200608$20161207$20200710$EXP$$PT-BAYER-2016-232129$BAYER$$58$YR$A$F$Y$$$20200710$$HP$NL$PT
130067124$13006712$4$F$201609$20200626$20161207$20200713$PER$$US-ASTRAZENECA-2016SF25368$ASTRAZENECA$$$$$F$Y$$$20200713$$CN$US$US
1300674216$13006742$16$F$$20200807$20161207$20200819$EXP$$CA-APOTEX-2016AP015239$APOTEX$$53$YR$$F$Y$$$20200819$$MD$CA$CA
130068001$13006800$1$I$20160817$20161202$20161207$20161207$EXP$$GB-009507513-1612GBR001592$MERCK$$48$YR$$M$Y$68.8$KG$20161207$$CN$IE$GB
130068106$13006810$6$F$20161110$20200811$20161207$20200814$EXP$$CA-OTSUKA-2016_026954$OTSUKA$$48$YR$$F$Y$56$KG$20200814$$CN$CA$CA
130070751$13007075$1$I$20160817$20161202$20161207$20161207$EXP$$GB-PFIZER INC-2016562951$PFIZER$$48$YR$$M$Y$68.8$KG$20161207$$HP$GB$GB
1300735521$13007355$21$F$20161129$20200901$20161207$20200909$EXP$$IE-MYLANLABS-2016M1053572$MYLAN$$55$YR$$M$Y$$$20200909$$MD$IE$IE
130087884$13008788$4$F$20140324$20200623$20161208$20200708$EXP$$IT-AEGERION PHARMACEUTICALS INC-AEGR002856$AEGERION$$$$$$Y$$$20200708$$MD$IT$IT
130091153$13009115$3$F$$20200910$20161208$20200918$EXP$$CA-APOTEX-2016AP015219$APOTEX$$28$YR$$F$Y$$$20200918$$CN$CA$CA
130091584$13009158$4$F$20160809$20180521$20161208$20180529$EXP$$FR-JNJFOC-20160811263$JANSSEN$$78$YR$E$M$Y$78$KG$20180529$$MD$FR$FR
130091647$13009164$7$F$$20200910$20161208$20200922$EXP$$CA-APOTEX-2016AP015217$APOTEX$$49$YR$$F$Y$$$20200922$$CN$CA$CA
1300919511$13009195$11$F$2015$20200626$20161208$20200707$EXP$$US-NOVOPROD-521559$NOVO NORDISK$$57$YR$$M$Y$120.18$KG$20200707$$CN$US$US
130092362$13009236$2$F$20141204$20200701$20161208$20200716$EXP$$US-BAYER-2016-043734$BAYER$$87$YR$E$M$Y$$$20200716$$CN$US$US
130096202$13009620$2$F$201301$20200722$20161208$20200731$EXP$$US-JNJFOC-20161104630$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200731$$CN$US$US
130096682$13009668$2$F$$20200831$20161208$20200907$PER$$US-CELGENEUS-USA-2016118907$CELGENE$$$$$M$Y$$$20200907$$CN$US$US
130097773$13009777$3$F$20131221$20200920$20161208$20200925$EXP$$US-BAYER-2016-169326$BAYER$$85$YR$E$F$Y$$$20200925$$CN$US$US
130098073$13009807$3$F$2005$20200720$20161208$20200727$PER$$US-AMGEN-USASL2016169329$AMGEN$$61$YR$A$F$Y$$$20200727$$MD$US$US
1300989714$13009897$14$F$2016$20200916$20161208$20200921$EXP$$US-SA-2016SA220419$SANOFI AVENTIS$$$$$$Y$$$20200921$$CN$US$US
1300991111$13009911$11$F$20161115$20200922$20161208$20200928$EXP$$PHHY2016IL165685$NOVARTIS$$73$YR$$F$Y$$$20200928$$CN$IL$IL
130099751$13009975$1$I$$20161130$20161208$20161208$EXP$$US-009507513-1612USA001380$MERCK$$$$$$Y$$$20161208$$HP$US$US
130100541$13010054$1$I$20160817$20161202$20161208$20161208$EXP$$GB-BAUSCH-BL-2016-031027$BAUSCH AND LOMB$$48$YR$$M$Y$68.8$KG$20161208$$HP$GB$GB
130103672$13010367$2$F$$20200713$20161208$20200715$PER$$US-PFIZER INC-2016557108$PFIZER$$65$YR$$F$Y$$$20200715$$MD$US$US
130110211$13011021$1$I$20160309$20161201$20161208$20161208$EXP$$US-MERRIMACK PHARMACEUTICALS, INC.-MER-2016-000172$MERRIMACK PHARMACEUTICALS$$$$$$Y$$$20161208$$MD$US$US
130128943$13012894$3$F$2013$20200921$20161209$20200925$EXP$$US-BAYER-2016-103079$BAYER$$9$DEC$E$M$Y$$$20200925$$CN$US$US
130132714$13013271$4$F$20161126$20161229$20161209$20170123$EXP$$FR-JNJFOC-20161203028$JANSSEN$$67$YR$E$F$Y$60.7$KG$20170123$$MD$FR$FR
130134371$13013437$1$I$20160817$20161202$20161209$20161209$EXP$$GB-GLAXOSMITHKLINE-GB2016179021$GLAXOSMITHKLINE$$48$YR$$M$Y$68.8$KG$20161209$$HP$GB$GB
130134893$13013489$3$F$20161028$20170530$20161209$20170531$EXP$$IT-JNJFOC-20161130524$JANSSEN$$85$YR$E$F$Y$$$20170531$$MD$IT$IT
130135052$13013505$2$F$$20200723$20161209$20200805$EXP$$US-INCYTE CORPORATION-2016IN007762$INCYTE$$$$$$Y$$$20200805$$CN$US$US
130137316$13013731$6$F$2016$20200717$20161209$20200722$EXP$$CA-TAKEDA-2016TUS021669$TAKEDA$$25$YR$$F$Y$$$20200722$$CN$CA$CA
130138702$13013870$2$F$$20200707$20161209$20200722$EXP$IR-MLMSERVICE-20161121-0506813-1$IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2016-00345$ALKEM$$22$MON$$M$Y$$$20200722$$HP$US$IR
130143393$13014339$3$F$20161111$20180829$20161209$20180907$EXP$$IT-JNJFOC-20161123294$JANSSEN$$74$YR$E$M$Y$50$KG$20180907$$CN$IT$IT
130143413$13014341$3$F$20160711$20161213$20161209$20161222$EXP$$TR-JNJFOC-20161203833$JANSSEN$$69$YR$E$F$Y$77.6$KG$20161222$$MD$TR$TR
130144581$13014458$1$I$20160817$20161202$20161209$20161209$EXP$$GB-MYLANLABS-2016M1054329$MYLAN$$$$$$Y$$$20161209$$MD$GB$GB
130146307$13014630$7$F$20091202$20200923$20161209$20200928$PER$$US-PFIZER INC-2016568601$PFIZER$$47$YR$$F$Y$$$20200928$$MD$US$US
130146895$13014689$5$F$$20200706$20161209$20200713$EXP$$US-BAUSCH-BL-2016-031065$BAUSCH AND LOMB$OLIVER N, LUONG T, TCHAKAROV A, ABDELRAHIM M, MULANOVICH V, KONTOYIANNIS D, SAMUELS J, GLASS W, JONES R, KEBRIAEI P, ABUDAYYEH A. DISSEMINATED CRYPTOCOCCAL INFECTION IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS: A RARE CAUSE OF ACUTE KIDNEY INJURY. BONE MARROW TRANSPLANTATION. 2016 MAY 09?51(10):1301?1304. DOI:10.1038/BMT.2016.120?$31$YR$$M$Y$$$20200713$$MD$US$US
130148655$13014865$5$F$$20200803$20161209$20200806$EXP$$PHHY2016FR165138$NOVARTIS$$63$YR$$F$Y$$$20200806$$HP$FR$FR
1301560211$13015602$11$F$20161123$20171016$20161212$20171025$EXP$$KR-ROCHE-1859332$ROCHE$$48$YR$$F$Y$59.8$KG$20171025$$MD$KR$KR
130159403$13015940$3$F$20141103$20200809$20161212$20200818$EXP$$US-JNJFOC-20161100933$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200818$$CN$US$US
130159473$13015947$3$F$20160214$20200715$20161212$20200717$PER$$US-JNJFOC-20161100988$JOHNSON AND JOHNSON$$87$YR$$F$Y$$$20200717$$CN$US$US
130159523$13015952$3$F$20150929$20200824$20161212$20200831$PER$$US-JNJFOC-20161101461$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20200831$$LW$US$US
130159993$13015999$3$F$20141203$20200909$20161212$20200914$PER$$US-JNJFOC-20161104122$JOHNSON AND JOHNSON$$67$YR$E$M$Y$114.86$KG$20200914$$CN$US$US
130160156$13016015$6$F$201411$20200910$20161212$20200914$PER$$US-JNJFOC-20161105126$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200914$$CN$US$US
130160493$13016049$3$F$20150220$20200825$20161212$20200827$PER$$US-JNJFOC-20161114734$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200827$$CN$US$US
130160563$13016056$3$F$20140924$20200625$20161212$20200708$EXP$$US-JNJFOC-20161115639$JOHNSON AND JOHNSON$$79$YR$$M$Y$$$20200708$$CN$US$US
130161133$13016113$3$F$201501$20200716$20161212$20200728$EXP$$US-JNJFOC-20161117740$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200728$$CN$US$US
130161233$13016123$3$F$20141116$20200622$20161212$20200702$EXP$$US-JNJFOC-20161119346$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200702$$CN$US$US
130161473$13016147$3$F$20151122$20200715$20161212$20200717$PER$$US-JNJFOC-20161118487$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200717$$CN$US$US
130161643$13016164$3$F$20150205$20200625$20161212$20200708$EXP$$US-JNJFOC-20161120864$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200708$$CN$US$US
130161684$13016168$4$F$20150319$20200901$20161212$20200914$PER$$US-JNJFOC-20161121265$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200914$$CN$US$US
130161784$13016178$4$F$20150117$20200816$20161212$20200827$EXP$$US-JNJFOC-20161119419$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200827$$CN$US$US
130162324$13016232$4$F$201309$20200910$20161212$20200922$EXP$$US-JNJFOC-20161123748$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200922$$CN$US$US
130162533$13016253$3$F$20141205$20200914$20161212$20200917$PER$$US-JNJFOC-20161124578$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200917$$CN$US$US
130162873$13016287$3$F$20141128$20200729$20161212$20200731$PER$$US-JNJFOC-20161125668$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20200731$$CN$US$US
130163003$13016300$3$F$201507$20200903$20161212$20200914$PER$$US-JNJFOC-20161127081$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200914$$CN$US$US
130163313$13016331$3$F$20141128$20200716$20161212$20200721$PER$$US-JNJFOC-20161126981$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200721$$CN$US$US
130163693$13016369$3$F$20141205$20200819$20161212$20200824$PER$$US-JNJFOC-20161129349$JOHNSON AND JOHNSON$$71$YR$E$F$Y$96.62$KG$20200824$$HP$US$US
130163862$13016386$2$F$20140409$20200722$20161212$20200731$PER$$US-JNJFOC-20161124839$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200731$$CN$US$US
130164453$13016445$3$F$20160316$20200915$20161212$20200917$PER$$US-JNJFOC-20161106797$JOHNSON AND JOHNSON$$57$YR$A$F$Y$$$20200917$$CN$US$US
130164663$13016466$3$F$20151114$20200818$20161212$20200820$PER$$US-JNJFOC-20161108584$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200820$$LW$US$US
130164703$13016470$3$F$20130403$20200811$20161212$20200814$PER$$US-JNJFOC-20161108577$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20200814$$CN$US$US
130165063$13016506$3$F$20150618$20200817$20161212$20200820$PER$$US-JNJFOC-20161109768$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20200820$$CN$US$US
130165273$13016527$3$F$20141017$20200806$20161212$20200818$EXP$$US-JNJFOC-20161110448$JOHNSON AND JOHNSON$$47$YR$A$F$Y$90.8$KG$20200818$$CN$US$US
130165303$13016530$3$F$20140801$20200906$20161212$20200914$PER$$US-JNJFOC-20161110584$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200914$$CN$US$US
130165433$13016543$3$F$201311$20200809$20161212$20200813$PER$$US-JNJFOC-20161111239$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20200813$$CN$US$US
130165913$13016591$3$F$20141209$20200824$20161212$20200827$PER$$US-JNJFOC-20161113134$JOHNSON AND JOHNSON$$72$YR$E$M$Y$87.17$KG$20200827$$CN$US$US
130170911$13017091$1$I$20160817$20161202$20161212$20161212$EXP$GB-BAXTER-2016BAX044578$GB-GLENMARK GENERICS (EUROPE) LTD.-2016GMK025294$GLENMARK$$$$$$Y$$$20161212$$HP$GB$GB
130174262$13017426$2$F$20160504$20161212$20161212$20161219$EXP$$TR-JNJFOC-20160508461$JANSSEN$$78$YR$E$F$Y$55$KG$20161219$$MD$TR$TR
130175172$13017517$2$F$$20200821$20161212$20200826$PER$$US-PFIZER INC-2016562235$PFIZER$$64$YR$$F$Y$$$20200826$$MD$US$US
130175325$13017532$5$F$$20200910$20161212$20200915$PER$$US-PFIZER INC-2016564478$PFIZER$$70$YR$$F$Y$$$20200915$$CN$US$US
130177784$13017778$4$F$$20200922$20161212$20200924$PER$$US-PFIZER INC-2016572752$PFIZER$$61$YR$$F$Y$112.5$KG$20200924$$MD$US$US
130178064$13017806$4$F$2016$20200909$20161212$20200918$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-001481$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20200918$$CN$US$US
130180332$13018033$2$F$201301$20200722$20161212$20200803$EXP$$US-BAYER-2016-213362$BAYER$$82$YR$E$M$Y$$$20200803$$CN$US$US
130183973$13018397$3$F$20160916$20200708$20161212$20200714$EXP$$US-SA-2016SA222273$SANOFI AVENTIS$$34$YR$$F$Y$92.53$KG$20200714$$MD$US$US
130184012$13018401$2$F$20161129$20170123$20161212$20170202$EXP$$US-JNJFOC-20161201834$JANSSEN$$25$YR$A$M$Y$77.8$KG$20170202$$MD$US$US
130190756$13019075$6$F$$20191008$20161212$20191028$EXP$$PHHY2016BR168716$NOVARTIS$$$$$F$Y$58$KG$20191028$$MD$BR$BR
130200771$13020077$1$I$20160817$20161202$20161212$20161212$EXP$$GB-MUNDIPHARMA DS AND PHARMACOVIGILANCE-GBR-2016-0042162$PURDUE$$48$YR$$M$Y$68.8$KG$20161205$$HP$GB$GB
130201361$13020136$1$I$20160523$20161202$20161212$20161212$EXP$$PHEH2016US031749$NOVARTIS$$59$YR$$M$Y$$$20161212$$CN$US$US
130202252$13020225$2$F$20161108$20170131$20161212$20170204$EXP$$US-TEVA-718960ACC$TEVA$$72$YR$$F$Y$$$20170204$$MD$US$US
130202271$13020227$1$I$20160217$20161201$20161212$20161212$EXP$$US-TEVA-718961ACC$TEVA$$61$YR$$F$Y$$$20161210$$MD$US$US
130202303$13020230$3$F$20161018$20170223$20161212$20170228$EXP$$ES-TEVA-718955ACC$TEVA$$44$YR$$F$Y$$$20170301$$MD$ES$ES
130203671$13020367$1$I$20160817$20161202$20161212$20161212$EXP$$PHFR2016GB009588$NOVARTIS$$48$YR$$M$Y$68.8$KG$20161212$$HP$GB$GB
130204273$13020427$3$F$20161118$20161220$20161212$20170103$EXP$$BE-JNJFOC-20161209055$ETHICON$$58$YR$A$F$Y$$$20170103$$HP$BE$BE
1302059115$13020591$15$F$2016$20200923$20161212$20200928$EXP$$US-SA-2016SA225096$SANOFI AVENTIS$$$$$$Y$$$20200928$$MD$US$US
130207003$13020700$3$F$20161128$20170127$20161212$20170130$EXP$$JP-ASTRAZENECA-2016SF30830$ASTRAZENECA$$75$YR$$M$Y$60$KG$20170130$$MD$JP$JP
130213706$13021370$6$F$20160709$20200918$20161213$20200928$EXP$$FR-ALEXION-A201609598$ALEXION$$11$MON$$F$Y$11.6$KG$20200928$$CN$FR$FR
130215914$13021591$4$F$20151014$20200623$20161213$20200708$EXP$$IT-AEGERION PHARMACEUTICALS INC-AEGR002426$AEGERION$$$$$$Y$$$20200708$$MD$IT$IT
130216786$13021678$6$F$20160704$20200918$20161213$20200925$EXP$$FR-ALEXION PHARMACEUTICALS INC.-A201609595$ALEXION$$6$MON$$F$Y$12.5$KG$20200925$$CN$AU$FR
130219702$13021970$2$F$20160914$20170927$20161213$20171002$EXP$$US-ROCHE-1830083$ROCHE$$61$YR$$F$Y$55.5$KG$20171002$$MD$US$US
130220163$13022016$3$F$$20200706$20161213$20200714$EXP$$US-DRREDDYS-USA/USA/16/0085496$DR REDDYS$OLIVER N, LUONG T, TCHAKAROV A, ABDELRAHIM M, MULANOVICH V, KONTOYIANNIS D, JONES R, SAMUELS J, GLASS W, ABUDAYYEN A. DISSEMINATED CRYPTOCOCCAL INFECTION IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS: A RARE CAUSE OF ACUTE KIDNEY INJURY. BONE MARROW TRANSPLANT. 2016?51(10):1301?4.$31$YR$A$M$Y$$$20200714$$MD$US$US
130222138$13022213$8$F$201609$20200715$20161213$20200717$PER$$US-PFIZER INC-2016568951$PFIZER$$67$YR$$F$Y$64.85$KG$20200717$$MD$US$US
130224282$13022428$2$F$$20200717$20161213$20200722$PER$$US-BIOGEN-2016BI00327444$BIOGEN$$$$$F$Y$$$20200722$$CN$US$US
130224705$13022470$5$F$201506$20200914$20161213$20200916$PER$$US-EISAI MEDICAL RESEARCH-EC-2015-008399$EISAI$$66$YR$E$F$Y$$$20200916$$CN$US$US
130240773$13024077$3$F$20160330$20170424$20161213$20170502$EXP$$FR-JNJFOC-20160413436$JANSSEN$$68$YR$E$M$Y$87$KG$20170502$$MD$FR$FR
1302449115$13024491$15$F$20161004$20200731$20161213$20200814$EXP$$US-ACTELION-A-US2016-145121$ACTELION$$62$YR$$M$Y$65.31$KG$20200814$$HP$US$US
130245387$13024538$7$F$20160816$20200918$20161213$20200925$EXP$$FR-ALEXION PHARMACEUTICALS INC.-A201609702$ALEXION$$2$MON$$F$Y$$$20200925$$CN$AU$FR
130250101$13025010$1$I$20160817$20161202$20161213$20161213$EXP$$GB-JNJFOC-20161202129$JOHNSON AND JOHNSON$$48$YR$A$M$Y$68.8$KG$20161213$$HP$GB$GB
130253712$13025371$2$F$20160615$20200901$20161214$20200914$EXP$$FR-BAUSCH-BL-2016-031059$BAUSCH AND LOMB$$54$YR$$M$Y$75$KG$20200914$$HP$FR$FR
130260383$13026038$3$F$2009$20200716$20161214$20200720$PER$$US-JNJFOC-20161128637$JOHNSON AND JOHNSON$$2$DEC$A$M$Y$$$20200720$$LW$US$US
130260394$13026039$4$F$2009$20200716$20161214$20200724$PER$$US-JNJFOC-20161128638$JOHNSON AND JOHNSON$$$$T$M$Y$$$20200724$$LW$US$US
130260434$13026043$4$F$2013$20200716$20161214$20200722$PER$$US-JNJFOC-20161128632$JOHNSON AND JOHNSON$$2$DEC$A$M$Y$$$20200722$$LW$US$US
130263372$13026337$2$F$$20200903$20161214$20200908$PER$$US-BIOGEN-2016BI00329318$BIOGEN$$$$$F$Y$$$20200908$$CN$US$US
130266875$13026687$5$F$20161201$20170329$20161214$20170406$EXP$$GB-JNJFOC-20161207174$JANSSEN$$67$YR$E$M$Y$94$KG$20170406$$MD$GB$GB
1302690121$13026901$21$F$20160620$20200709$20161214$20200717$EXP$$CA-CELLTRION INC.-2016CA010684$CELLTRION$$$$$$Y$$$20200717$$HP$CA$CA
1302755014$13027550$14$F$20160720$20200829$20161214$20200902$EXP$$NL-ABBVIE-16K-114-1687729-00$ABBVIE$$63$YR$$F$Y$$$20200901$$CN$NL$NL
130276273$13027627$3$F$20161118$20170216$20161214$20170222$EXP$$US-JNJFOC-20161209580$PHARMACYCLICS$$83$YR$E$M$Y$40.6$KG$20170222$$MD$US$US
130276621$13027662$1$I$20160817$20161202$20161214$20161214$EXP$$GB-TEVA-717908ACC$TEVA$$48$YR$$M$Y$68.8$KG$20161214$$MD$GB$GB
130277364$13027736$4$F$20160928$20170518$20161214$20170522$EXP$$BE-JNJFOC-20161208251$PHARMACYCLICS$$71$YR$E$M$Y$78$KG$20170522$$MD$BE$BE
130279056$13027905$6$F$$20200727$20161214$20200803$PER$$US-PFIZER INC-2016574597$PFIZER$$47$YR$$F$Y$85.28$KG$20200803$$CN$US$US
130280405$13028040$5$F$$20200720$20161214$20200722$PER$$US-PFIZER INC-2016571332$PFIZER$$69$YR$$F$Y$$$20200722$$CN$US$US
130280916$13028091$6$F$20160812$20190924$20161214$20191004$EXP$$US-PFIZER INC-2016403258$PFIZER$$71$YR$$M$Y$71.7$KG$20191004$$MD$US$US
1302851615$13028516$15$F$$20200706$20161214$20200712$EXP$$PHHY2016CA170200$NOVARTIS$$45$YR$$F$Y$$$20200712$$HP$CA$CA
130291992$13029199$2$F$20160817$20161202$20161215$20161218$EXP$$GB-DEXPHARM-20162358$DEXCEL$$48$YR$A$M$Y$68.8$KG$20161215$$MD$GB$GB
130292565$13029256$5$F$$20200909$20161215$20200915$EXP$$US-BIOGEN-2016BI00330611$BIOGEN$$$$$M$Y$$$20200915$$CN$US$US
130300623$13030062$3$F$$20200701$20161215$20200705$EXP$$PHHY2016PT169300$NOVARTIS$FACEIRA A, PEREIRA S. REV PORT HIPERT RISCO CARDIOVASC. POLUICAO ATMOSFERICA E HIPERTENSAO. 2014?43:26$75$YR$$F$Y$$$20200706$$HP$PT$PT
130304613$13030461$3$F$$20200708$20161215$20200713$EXP$$CA-BIOVITRUM-2016CA1081$BIOVITRUM$$$$$F$Y$$$20200713$$CN$CA$CA
130306287$13030628$7$F$20161119$20200826$20161215$20200902$EXP$$US-BIOGEN-2016BI00330264$BIOGEN$$60$YR$$F$Y$$$20200902$$CN$US$US
130310322$13031032$2$F$201502$20200716$20161215$20200722$EXP$$CA-ALLERGAN-1000083354$ALLERGAN$$$$$F$Y$69.39$KG$20200722$$CN$CA$CA
130310613$13031061$3$F$20160511$20200710$20161215$20200722$EXP$$US-JNJFOC-20161211502$JOHNSON AND JOHNSON$$68$YR$$F$Y$$$20200722$$HP$US$US
130312473$13031247$3$F$2010$20200826$20161215$20200904$EXP$$US-009507513-1612USA002743$MERCK$$$$$M$Y$$$20200904$$HP$US$US
130317672$13031767$2$F$$20200721$20161215$20200723$EXP$$CA-ABBVIE-16K-028-1600466-00$ABBVIE$$54$YR$$M$Y$$$20200723$$HP$CA$CA
1303244814$13032448$14$F$201504$20200910$20161215$20200918$EXP$$US-INCYTE CORPORATION-2016IN007875$INCYTE$$$$$$Y$$$20200918$$CN$US$US
1303280534$13032805$34$F$201607$20200618$20161215$20200701$EXP$$US-ACTELION-A-NJ2016-133225$ACTELION$$60$YR$$F$Y$94.33$KG$20200701$$HP$US$US
1303281628$13032816$28$F$20161208$20200702$20161215$20200716$EXP$$US-ACTELION-A-NJ2016-146895$ACTELION$$52$YR$$F$Y$74.38$KG$20200716$$HP$US$US
130335828$13033582$8$F$201611$20200709$20161216$20200717$EXP$$CA-BIOGEN-2016BI00330189$BIOGEN$$47$YR$$F$Y$$$20200717$$CN$CA$CA
130344451$13034445$1$I$20160817$20161202$20161216$20161216$EXP$$GB-AUROBINDO-AUR-APL-2016-15181$AUROBINDO$$48$YR$$M$Y$68.8$KG$20161216$$HP$GB$GB
130350352$13035035$2$F$20140801$20200906$20161216$20200911$EXP$$US-BAYER-2016-216700$BAYER$$73$YR$E$M$Y$$$20200911$$CN$US$US
130357518$13035751$8$F$201611$20200824$20161216$20200826$PER$$US-PFIZER INC-2016547597$PFIZER$$99$YR$$F$Y$95$KG$20200826$$CN$US$US
1303682415$13036824$15$F$$20200916$20161216$20200924$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-105759$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200924$$MD$CA$CA
130371945$13037194$5$F$20130225$20200825$20161216$20200901$EXP$$PHHY2012CA023343$NOVARTIS$$27$YR$$M$Y$$$20200901$$CN$COUNTRY NOT SPECIFIED$CA
130385628$13038562$8$F$20161209$20170316$20161219$20170320$EXP$$KR-ROCHE-1868341$ROCHE$$47$YR$$F$Y$57.6$KG$20170320$$MD$KR$KR
130386319$13038631$9$F$20150925$20200710$20161219$20200724$EXP$$JP-AEGERION PHARMACEUTICAL INC.-AEGR002391$AEGERION$$$$$$Y$$$20200724$$CN$JP$JP
1303863510$13038635$10$F$20151228$20200629$20161219$20200714$EXP$$JP-AEGERION PHARMACEUTICAL INC.-AEGR002872$AEGERION$$$$$$Y$$$20200714$$CN$JP$JP
130393122$13039312$2$F$$20200914$20161219$20200923$EXP$$FR-ROCHE-1670061$ROCHE$, ALAMI N, MORENO C, POL S, KARATAPANIS S, GSCHWANTLER M, HORSMANS Y, ELEFSINIOTIS I, LARREY D,  FERRARI C, RIZZETTO M, ORLANDINI A, CALLEJA J, BRUNO S, SCHNELL G, QAQISH R, REDMAN R, PILOT?MATIAS T, KOPECKY?BROMBERG S, YU Y AND MOBASHERY N OMBITASVIR/PARITAPREVIR/RITONAVIR PLUS RIBAVIRIN FOR 24 WEEKS IN PATIENTS WITH HCV GT4 AND COMPENSATED CIRRHOSIS (AGATE?I PART II). HEALTH SCIENCE REPORTS 2018?2 (3):1?9.$$$$$Y$$$20200923$$MD$FR$FR
130400988$13040098$8$F$$20200820$20161219$20200825$EXP$$FR-SA-2016SA216624$SANOFI AVENTIS$REYNAUD C, EYSSERIC?GUERIN H, BONADONA A, BARTOLI M, BARRET A, CANDILLE C ET AL.. TOXIC DEATH CAUSED BY AMLODIPIN AND OLMESARTAN: A CASE REPORT WITH PHARMACOBEZOARD.. TOXICOLOGIE ANALYTIQUE ET CLINIQUE. 2016?28(4):286?293$$$$$Y$$$20200825$$HP$FR$FR
130403252$13040325$2$F$20161206$20170123$20161219$20170202$EXP$$CA-PFIZER INC-2016580847$PFIZER$$70$YR$$M$Y$$$20170202$$MD$CA$CA
1304039815$13040398$15$F$2018$20200701$20161219$20200703$EXP$$US-PFIZER INC-2016586896$PFIZER$$58$YR$$F$Y$127$KG$20200703$$MD$US$US
130407436$13040743$6$F$2016$20200707$20161219$20200710$EXP$$CA-PFIZER INC-2016579792$PFIZER$$53$YR$$F$Y$$$20200710$$HP$CA$CA
1304093136$13040931$36$F$2017$20200804$20161219$20200812$EXP$$CA-CELLTRION INC.-2016CA013598$CELLTRION$$$$$$Y$$$20200812$$HP$CA$CA
130422854$13042285$4$F$20161206$20161209$20161219$20170317$EXP$$US-JNJFOC-20161210997$JANSSEN$$50$YR$A$F$Y$77.11$KG$20170317$$MD$US$US
130423313$13042331$3$F$20141231$20200702$20161219$20200706$PER$$US-JNJFOC-20161215562$JOHNSON AND JOHNSON$$75$YR$$M$Y$$$20200706$$CN$US$US
130423575$13042357$5$F$20161121$20170131$20161219$20170206$EXP$$CA-JNJFOC-20161209553$JANSSEN$$45$YR$A$M$Y$74$KG$20170206$$MD$CA$CA
130424562$13042456$2$F$20120515$20200730$20161219$20200805$PER$$US-CELGENEUS-USA-2016124675$CELGENE$$64$YR$$M$Y$106.24$KG$20200805$$HP$US$US
130426518$13042651$8$F$200301$20200720$20161219$20200722$EXP$$CA-PFIZER INC-2016586619$PFIZER$WALKER, G.. AN UNUSUAL CASE OF RABIES ENCEPHALITIS. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2016?43(6):852?855$52$YR$$M$Y$$$20200722$$MD$CA$CA
1304285513$13042855$13$F$20161211$20200820$20161219$20200825$PER$$US-ACTELION-A-NJ2016-147053$ACTELION$$60$YR$$F$Y$86.62$KG$20200825$$HP$US$US
130429244$13042924$4$F$20161117$20200730$20161219$20200807$PER$$US-JAZZ-2016-US-022911$JAZZ$$63$YR$$F$Y$$$20200807$$HP$US$US
130429262$13042926$2$F$$20200703$20161219$20200921$PER$$FR-JAZZ-2016-FR-023268$JAZZ$$$$$$Y$$$20200921$$MD$FR$FR
130443424$13044342$4$F$$20200720$20161220$20200729$EXP$$CA-APOTEX-2016AP015603$APOTEX$$$$$$Y$$$20200729$$HP$CA$CA
130455141$13045514$1$I$2016$20160921$20161220$20161220$EXP$$CA-BAYER-2016-184634$BAYER$$23$YR$A$F$Y$$$20161220$$MD$CA$CA
130456041$13045604$1$I$20161017$20161024$20161220$20161220$EXP$$TR-BAYER-2016-205433$BAYER$$35$YR$A$F$Y$$$20161220$$CN$TR$TR
130456051$13045605$1$I$20160708$20160907$20161220$20161220$EXP$$CH-BAYER-2016-178064$BAYER$$29$YR$A$F$Y$$$20161220$$MD$CH$CH
130456061$13045606$1$I$201611$20161121$20161220$20161220$EXP$$NO-BAYER-2016-222260$BAYER$$49$YR$A$F$Y$80$KG$20161220$$MD$NO$NO
130458905$13045890$5$F$20161214$20170104$20161220$20170106$EXP$$GB-JNJFOC-20161214542$JANSSEN$$75$YR$E$F$Y$55$KG$20170106$$MD$GB$GB
130458925$13045892$5$F$20161006$20180704$20161220$20180712$EXP$$GB-JNJFOC-20161011120$JANSSEN$$75$YR$E$M$Y$71$KG$20180712$$MD$GB$GB
130461963$13046196$3$F$$20200731$20161220$20200806$PER$$US-PFIZER INC-2016577975$PFIZER$$69$YR$$F$Y$$$20200806$$CN$US$US
130467422$13046742$2$F$20131202$20200913$20161220$20200924$EXP$$US-JNJFOC-20161202585$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200924$$CN$US$US
130468291$13046829$1$I$20161128$20161129$20161220$20161220$EXP$$CA-JNJFOC-20161202691$JANSSEN$$71$YR$E$F$Y$72.8$KG$20161220$$MD$CA$CA
1304683010$13046830$10$F$20161210$20181025$20161220$20181029$EXP$$US-JNJFOC-20161211794$JANSSEN$$74$YR$E$M$Y$71$KG$20181029$$HP$US$US
130471815$13047181$5$F$20161213$20200720$20161220$20200828$PER$$US-INCYTE CORPORATION-2016IN007991$INCYTE$$$$$$Y$$$20200828$$CN$US$US
130479092$13047909$2$F$$20200928$20161220$20200930$PER$$US-PFIZER INC-2016577599$PFIZER$$$$$F$Y$$$20200930$$HP$US$US
1304852517$13048525$17$F$20160504$20200717$20161220$20200723$EXP$$CA-ROCHE-1869185$ROCHE$$29$YR$$F$Y$70$KG$20200723$$MD$CA$CA
130490141$13049014$1$I$20161213$20161216$20161221$20161221$EXP$$NL-JNJFOC-20161215001$JANSSEN$$$$E$F$Y$49.3$KG$20161221$$MD$NL$NL
1304942413$13049424$13$F$20160407$20200629$20161221$20200702$PER$$CA-AMGEN-CANSP2016048704$AMGEN$$69$YR$E$F$Y$$$20200702$$HP$CA$CA
130494411$13049441$1$I$20140103$20161207$20161221$20161221$EXP$386695$IT-ACCORD-046637$ACCORD$$75$YR$$M$Y$$$20161221$$HP$DE$IT
130505775$13050577$5$F$20161130$20170207$20161221$20170210$EXP$$PT-JNJFOC-20161201754$PHARMACYCLICS$$80$YR$E$M$Y$56.4$KG$20170210$$MD$PT$PT
130505923$13050592$3$F$20161128$20170105$20161221$20170111$EXP$$ES-JNJFOC-20161208734$PHARMACYCLICS$$67$YR$E$F$Y$51.1$KG$20170111$$MD$ES$ES
1305102114$13051021$14$F$$20200820$20161221$20200825$PER$$US-PFIZER INC-2016516257$PFIZER$$60$YR$$F$Y$86.18$KG$20200825$$MD$US$US
130517107$13051710$7$F$201607$20200928$20161221$20200930$EXP$$US-PFIZER INC-2016370475$PFIZER$$70$YR$$F$Y$77.1$KG$20200930$$CN$US$US
130521264$13052126$4$F$20161215$20200917$20161221$20200923$EXP$$GB-MYLANLABS-2016M1056158$MYLAN$$60$YR$$M$Y$$$20200923$$MD$GB$GB
130523328$13052332$8$F$20161019$20200619$20161221$20200702$EXP$$US-ACTELION-A-US2016-143553$ACTELION$$77$YR$$F$Y$107.94$KG$20200702$$HP$US$US
130532567$13053256$7$F$$20200911$20161222$20200925$EXP$$CA-APOTEX-2016AP015639$APOTEX$$71$YR$$F$Y$68$KG$20200925$$CN$CA$CA
130533627$13053362$7$F$20160918$20191025$20161222$20191101$EXP$$US-ROCHE-1837581$ROCHE$$57$YR$$F$Y$53.7$KG$20191101$$MD$US$US
130537516$13053751$6$F$$20200808$20161222$20200819$EXP$$CA-APOTEX-2016AP015691$APOTEX$$61$YR$$M$Y$$$20200819$$CN$CA$CA
1305428513$13054285$13$F$$20200826$20161222$20200907$EXP$$CA-APOTEX-2016AP015721$APOTEX$$$$$F$Y$$$20200907$$CN$CA$CA
130543242$13054324$2$F$20161205$20200626$20161222$20200707$EXP$$NZ-ELI_LILLY_AND_COMPANY-NZ201612005551$ELI LILLY AND CO$$43$YR$$M$Y$$$20200707$$HP$NZ$NZ
1305455217$13054552$17$F$2016$20200826$20161222$20200928$EXP$$CA-CELLTRION INC.-2016CA013112$CELLTRION$$$$$$Y$$$20200929$$HP$CA$CA
130550369$13055036$9$F$201612$20200910$20161222$20200918$EXP$$JP-ARIAD PHARMACEUTICALS, INC-2016JP007471$TAKEDA$$47$YR$$M$Y$61.5$KG$20200918$$MD$JP$JP
130551952$13055195$2$F$20161209$20170104$20161222$20170111$EXP$$JP-JNJFOC-20161215298$JANSSEN$$65$YR$A$F$Y$48.3$KG$20170111$$MD$JP$JP
1305561310$13055613$10$F$2016$20200806$20161222$20200818$EXP$$US-INCYTE CORPORATION-2016IN007952$INCYTE$$$$$$Y$$$20200818$$CN$US$US
130557981$13055798$1$I$20161120$20161205$20161222$20161222$EXP$$IL-JNJFOC-20161205966$JANSSEN$$74$YR$E$F$Y$$$20161222$$MD$IL$IL
130562281$13056228$1$I$20160726$20160928$20161222$20161222$PER$$US-NAPPMUNDI-USA-2016-0133957$PURDUE$$58$YR$$F$Y$98.5$KG$20161222$$MD$US$US
130562953$13056295$3$F$$20200803$20161222$20200814$EXP$$CA-APOTEX-2016AP015786$APOTEX$$48$YR$$F$Y$$$20200814$$CN$CA$CA
130564984$13056498$4$F$20160720$20170913$20161222$20170918$EXP$$US-ROCHE-1838808$ROCHE$$56$YR$$M$Y$124.5$KG$20170918$$MD$US$US
1305673421$13056734$21$F$201804$20200827$20161222$20200908$EXP$$US-BIOMARINAP-US-2016-109231$BIOMARIN$$40$YR$$F$Y$$$20200908$$CN$US$US
130572761$13057276$1$I$20160817$20161207$20161223$20161223$EXP$$GB-INTERNATIONAL MEDICATION SYSTEMS, LIMITED-1061221$INTERNATIONAL MEDICATION SYSTEM$$48$YR$$M$Y$$$20161223$$$GB$GB
130574126$13057412$6$F$$20200806$20161223$20200818$EXP$$CA-APOTEX-2016AP015703$APOTEX$$53$YR$$F$Y$$$20200818$$CN$CA$CA
130574303$13057430$3$F$$20200703$20161223$20200709$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-2686$ORION$$58$YR$$M$Y$$$20200709$$HP$CA$CA
130575537$13057553$7$F$$20200828$20161223$20200908$EXP$$CA-APOTEX-2016AP015696$APOTEX$$18$YR$$F$Y$$$20200908$$HP$CA$CA
130575604$13057560$4$F$20160812$20191009$20161223$20191015$EXP$$US-009507513-1612USA009688$MERCK$$71$YR$$M$Y$71.7$KG$20191015$$CN$US$US
130576609$13057660$9$F$$20200807$20161223$20200817$EXP$$CA-APOTEX-2016AP015709$APOTEX$$69$YR$$F$Y$$$20200817$$CN$CA$CA
130577809$13057780$9$F$$20200807$20161223$20200818$EXP$$CA-APOTEX-2016AP015710$APOTEX$$65$YR$$F$Y$$$20200818$$CN$CA$CA
1305781113$13057811$13$F$$20200723$20161223$20200730$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0494$ORION$$$$A$F$Y$$$20200730$$MD$CA$CA
130579138$13057913$8$F$2008$20200910$20161223$20200922$EXP$$CA-APOTEX-2016AP015712$APOTEX$$$$A$F$Y$$$20200922$$CN$CA$CA
1305805711$13058057$11$F$$20200817$20161223$20200825$EXP$$CA-APOTEX-2016AP015766$APOTEX$$65$YR$$F$Y$$$20200825$$HP$CA$CA
130582479$13058247$9$F$$20200629$20161223$20200703$PER$$CA-AMGEN-CANSP2016081001$AMGEN$$70$YR$E$F$Y$$$20200703$$HP$CA$CA
130582991$13058299$1$I$$20161219$20161223$20161223$EXP$$AT-ROCHE-1869963$ROCHE$, ETSCHMAIER A, FERLITSCH M, MAIERON A, HAMETNER S, HORVATITS T, PATERNOSTRO R, SALZL P, REIBERGER T, PECK?RADOSAVLJEVIC M, QUEHENBERGER P, HOFER H, TRAUNER M, FERENCI P AND FERLITSCH A. VON WILLEBRAND FACTOR ANTIGEN (VWF?AG): A NON?INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SERIOUS ADVERSE EVENTS IN HCV PATIENTS WITH INTERFERON TRIPLE THERAPY. DIGESTIVE AND LIVER DISEASE 2016 OCT 01?48 (10):1194?1199.$$$$$Y$$$20161223$$HP$AT$AT
130583357$13058335$7$F$2012$20191126$20161223$20191203$EXP$$PHHY2012CA082420$NOVARTIS$$25$YR$$M$Y$$$20191203$$HP$CA$CA
130583684$13058368$4$F$$20200811$20161223$20200814$PER$$US-PFIZER INC-2016583522$PFIZER$$27$YR$$F$Y$$$20200814$$HP$US$US
130583997$13058399$7$F$$20200728$20161223$20200805$EXP$$CA-APOTEX-2016AP015757$APOTEX$$65$YR$$F$Y$$$20200805$$CN$CA$CA
130584045$13058404$5$F$20161201$20200706$20161223$20200708$PER$$US-PFIZER INC-2016586857$PFIZER$$66$YR$$F$Y$102$KG$20200708$$HP$US$US
1305843210$13058432$10$F$201611$20200824$20161223$20200826$PER$$US-PFIZER INC-2016593508$PFIZER$$62$YR$$F$Y$107$KG$20200826$$MD$US$US
130584358$13058435$8$F$$20200917$20161223$20200929$EXP$$CA-APOTEX-2016AP015741$APOTEX$$73$YR$$F$Y$$$20200929$$CN$CA$CA
130585235$13058523$5$F$$20200728$20161223$20200806$EXP$$CA-APOTEX-2016AP015797$APOTEX$$24$YR$$F$Y$$$20200806$$CN$CA$CA
130587318$13058731$8$F$20160722$20200814$20161223$20200821$EXP$$GB-ROCHE-1836249$ROCHE$$33$YR$$F$Y$$$20200821$$MD$GB$GB
130587497$13058749$7$F$$20200709$20161223$20200721$EXP$$CA-APOTEX-2016AP015733$APOTEX$$40$YR$$F$Y$75$KG$20200721$$CN$CA$CA
1305881010$13058810$10$F$$20200918$20161223$20200930$EXP$$CA-APOTEX-2016AP015763$APOTEX$$74$YR$$F$Y$$$20200930$$HP$CA$CA
1305884511$13058845$11$F$$20200824$20161223$20200903$EXP$$CA-APOTEX-2016AP015768$APOTEX$$75$YR$$F$Y$56$KG$20200903$$HP$CA$CA
1305885314$13058853$14$F$$20200831$20161223$20200909$EXP$$CA-APOTEX-2016AP015743$APOTEX$$79$YR$$F$Y$$$20200909$$CN$CA$CA
130589918$13058991$8$F$$20200807$20161223$20200818$EXP$$CA-APOTEX-2016AP015722$APOTEX$$55$YR$$F$Y$87$KG$20200818$$CN$CA$CA
130590164$13059016$4$F$$20200827$20161223$20200908$EXP$$CA-APOTEX-2016AP015756$APOTEX$$66$YR$$F$Y$$$20200908$$CN$CA$CA
130590198$13059019$8$F$$20200630$20161223$20200709$EXP$$CA-APOTEX-2016AP015792$APOTEX$$57$YR$$M$Y$$$20200709$$CN$CA$CA
130590409$13059040$9$F$$20200820$20161223$20200831$EXP$$CA-APOTEX-2016AP015749$APOTEX$$72$YR$$F$Y$$$20200831$$MD$CA$CA
130590844$13059084$4$F$2016$20200825$20161223$20200828$EXP$$US-JAZZ-2016-US-021021$JAZZ$$$$$F$Y$$$20200828$$HP$US$US
130591236$13059123$6$F$$20200720$20161223$20200804$PER$$CA-AMGEN-CANSP2016178588$AMGEN$$$$$F$Y$$$20200804$$HP$CA$CA
130591666$13059166$6$F$$20200808$20161223$20200820$EXP$$CA-APOTEX-2016AP015754$APOTEX$$60$YR$$F$Y$$$20200820$$CN$CA$CA
130591964$13059196$4$F$$20200828$20161223$20200909$EXP$$CA-APOTEX-2016AP015840$APOTEX$$$$$F$Y$$$20200909$$CN$CA$CA
130592051$13059205$1$I$20150508$20161212$20161223$20161223$EXP$$US-JNJFOC-20161213088$JANSSEN$$79$YR$E$F$Y$44$KG$20161223$$MD$US$US
130592097$13059209$7$F$$20200808$20161223$20200819$EXP$$CA-APOTEX-2016AP015767$APOTEX$$$$$F$Y$$$20200819$$HP$CA$CA
130593238$13059323$8$F$20160923$20200825$20161223$20200829$PER$$PHHY2016US175813$NOVARTIS$$41$YR$$F$Y$$$20200829$$MD$US$US
130594048$13059404$8$F$$20200820$20161223$20200901$EXP$$CA-APOTEX-2016AP015718$APOTEX$$41$YR$$M$Y$90$KG$20200901$$CN$CA$CA
130594102$13059410$2$F$2003$20200721$20161223$20200728$EXP$$CA-ASTELLAS-2016US049950$ASTELLAS$WALKER G, THIESSEN B, GRAEB D, MOORE GRW, MACKENZIE IRA. AN UNUSUAL CASE OF RABIES ENCEPHALITIS. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2016?43(6):852?5$52$YR$$M$Y$$$20200728$$MD$CA$CA
130595376$13059537$6$F$$20200803$20161223$20200813$EXP$$CA-APOTEX-2016AP015776$APOTEX$$16$YR$$F$Y$$$20200813$$CN$CA$CA
1305956211$13059562$11$F$$20200808$20161223$20200819$EXP$$CA-APOTEX-2016AP015791$APOTEX$$63$YR$$F$Y$$$20200819$$CN$CA$CA
130596344$13059634$4$F$20150104$20200827$20161223$20200901$PER$$US-JNJFOC-20161217882$JOHNSON AND JOHNSON$$91$YR$E$M$Y$$$20200901$$CN$US$US
130596413$13059641$3$F$20141201$20200910$20161223$20200914$PER$$US-JNJFOC-20161218685$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200914$$CN$US$US
130597889$13059788$9$F$$20200807$20161223$20200820$EXP$$CA-APOTEX-2016AP015748$APOTEX$$57$YR$$M$Y$$$20200820$$CN$CA$CA
130602995$13060299$5$F$$20200831$20161223$20200908$EXP$$CA-APOTEX-2016AP015844$APOTEX$$$$$F$Y$$$20200908$$HP$CA$CA
130609167$13060916$7$F$2011$20200813$20161225$20200824$EXP$$US-ABBVIE-16P-163-1565912-00$ABBVIE$$89$YR$$M$Y$$$20200823$$MD$US$US
130618431$13061843$1$I$$20161219$20161226$20161226$EXP$$US-ROCHE-1870906$ROCHE$$39$YR$$F$Y$$$20161226$$HP$US$US
1306208417$13062084$17$F$20161120$20200630$20161226$20200702$EXP$$CA-TAKEDA-2016TUS021430$TAKEDA$$63$YR$$M$Y$$$20200703$$HP$CA$CA
130623432$13062343$2$F$$20200731$20161226$20200810$PER$$US-ASTRAZENECA-2016SF35267$ASTRAZENECA$$69$YR$$F$Y$$$20200810$$CN$US$US
130629442$13062944$2$F$$20200701$20161227$20200715$EXP$$US-AUROBINDO-AUR-APL-2016-15605$AUROBINDO$$72$YR$$M$Y$$$20200715$$HP$US$US
1306331814$13063318$14$F$201604$20200724$20161227$20200729$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0861$ORION$$71$YR$$F$Y$$$20200729$$MD$CA$CA
130633582$13063358$2$F$$20200821$20161227$20200827$PER$$AR-AMGEN-ARGSP2016182491$AMGEN$$68$YR$E$F$Y$$$20200827$$CN$AR$AR
130634198$13063419$8$F$20160407$20200708$20161227$20200714$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0803$ORION$$69$YR$$F$Y$$$20200714$$MD$CA$CA
130634666$13063466$6$F$201605$20200917$20161227$20200925$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0485$ORION$$78$YR$$F$Y$$$20200925$$MD$CA$CA
130642713$13064271$3$F$$20200806$20161227$20200811$EXP$$PHHY2016CA178385$NOVARTIS$$$$$M$Y$$$20200811$$PH$CA$CA
1306429113$13064291$13$F$20190115$20200720$20161227$20200725$PER$$CA-AMGEN-CANSP2016182566$AMGEN$$64$YR$A$F$Y$$$20200725$$HP$CA$CA
130643925$13064392$5$F$201510$20200827$20161227$20200910$EXP$$US-JNJFOC-20161220156$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20200910$$LW$US$US
130649527$13064952$7$F$$20200629$20161227$20200710$EXP$$CA-JNJFOC-20161217720$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200710$$CN$CA$CA
130651318$13065131$8$F$20161118$20170130$20161227$20170208$EXP$$US-JNJFOC-20161123570$PHARMACYCLICS$$69$YR$E$M$Y$101.6$KG$20170208$$MD$US$US
130652446$13065244$6$F$$20200918$20161227$20200929$EXP$$JP-PFIZER INC-2016590545$PFIZER$TOMIDA, E.. CAUSATIVE DRUG DETECTION BY DRUG?INDUCED LYMPHOCYTE STIMULATION TEST IN DRUG?INDUCED LINEAR IGA BULLOUS DERMATOSIS. BRITISH JOURNAL OF DERMATOLOGY. 2016?175 (5):1106?1108$72$YR$$F$Y$$$20200929$$MD$JP$JP
130654436$13065443$6$F$$20200629$20161227$20200708$EXP$$CA-PFIZER INC-2016322235$PFIZER$$49$YR$$F$Y$$$20200708$$CN$CA$CA
130656019$13065601$9$F$2013$20200629$20161227$20200707$EXP$$CA-PFIZER INC-2016311611$PFIZER$$70$YR$$F$Y$$$20200707$$HP$CA$CA
130660652$13066065$2$F$201311$20200809$20161227$20200814$EXP$$US-BAYER-2016-217122$BAYER$$55$YR$A$F$Y$$$20200814$$CN$US$US
130661848$13066184$8$F$20160601$20200720$20161227$20200727$EXP$$CA-PFIZER INC-2016294889$PFIZER$$58$YR$$M$Y$$$20200727$$MD$CA$CA
130662742$13066274$2$F$20161220$20161220$20161227$20200701$EXP$$GR-JNJFOC-20161217106$JOHNSON AND JOHNSON$$$$A$F$Y$$$20200701$$CN$GR$GR
130667259$13066725$9$F$201611$20200831$20161227$20200902$PER$$US-PFIZER INC-2016112140$PFIZER$$52$YR$$F$Y$$$20200902$$MD$US$US
130687362$13068736$2$F$20141028$20200622$20161228$20200701$EXP$$US-BAYER-2016-187949$BAYER$$67$YR$E$M$Y$$$20200701$$CN$US$US
130687835$13068783$5$F$2016$20200824$20161228$20200907$EXP$$CA-JNJFOC-20161203380$JOHNSON AND JOHNSON$$60$YR$A$M$Y$66$KG$20200907$$CN$CA$CA
130690682$13069068$2$F$20150117$20200816$20161228$20200820$EXP$$US-BAYER-2016-190007$BAYER$$84$YR$E$M$Y$$$20200820$$CN$US$US
1306964818$13069648$18$F$201612$20200723$20161228$20200730$EXP$$CA-TAKEDA-2016TUS022956$TAKEDA$$42$YR$$F$Y$$$20200730$$HP$CA$CA
130697022$13069702$2$F$20140830$20200916$20161228$20200925$EXP$$US-BAYER-2016-206186$BAYER$$52$YR$A$M$Y$$$20200925$$CN$US$US
130697262$13069726$2$F$20141209$20200824$20161228$20200827$EXP$$US-BAYER-2016-217410$BAYER$$72$YR$E$M$Y$87.17$KG$20200827$$CN$US$US
130697282$13069728$2$F$20150206$20200813$20161228$20200820$EXP$$US-BAYER-2016-207152$BAYER$$69$YR$E$F$Y$$$20200820$$CN$US$US
130700976$13070097$6$F$20161206$20200804$20161228$20200804$PER$$PHHY2016US178574$NOVARTIS$$33$YR$$F$Y$112.3$KG$20200804$$MD$US$US
130702713$13070271$3$F$$20161227$20161228$20200731$PER$$US-AMGEN-USASP2016183481$AMGEN$SZ USMANI. CARDIAC COMPLICATIONS IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH CARFILZOMIB. BLOOD CANCER JOURNAL. 2015?5:E272$$$$$Y$$$20200731$$HP$US$US
130707999$13070799$9$F$20090209$20200917$20161229$20200925$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-2790$ORION$$50$YR$$M$Y$$$20200925$$MD$CA$CA
1307095512$13070955$12$F$$20200908$20161229$20200910$EXP$$PHEH2016US033836$NOVARTIS$$$$$F$Y$$$20200910$$CN$US$US
130709715$13070971$5$F$20160425$20200825$20161229$20200901$PER$$PHHY2016US176137$NOVARTIS$$48$YR$$M$Y$$$20200901$$MD$US$US
1307119143$13071191$43$F$2016$20200921$20161229$20200929$EXP$$CA-CELLTRION INC.-2016CA014179$CELLTRION$$$$$$Y$$$20200929$$HP$CA$CA
130712555$13071255$5$F$20161206$20180710$20161229$20180720$EXP$$IT-JNJFOC-20161220588$JANSSEN$$77$YR$E$M$Y$80$KG$20180720$$MD$IT$IT
130715289$13071528$9$F$$20200828$20161229$20200901$PER$$US-PFIZER INC-2016602805$PFIZER$$62$YR$$M$Y$$$20200901$$CN$US$US
130718482$13071848$2$F$20141103$20200809$20161229$20200820$EXP$$US-BAYER-2016-211113$BAYER$$80$YR$E$M$Y$$$20200820$$CN$US$US
130718502$13071850$2$F$20131005$20200819$20161229$20200824$EXP$$US-BAYER-2016-191327$BAYER$$72$YR$E$M$Y$$$20200824$$CN$US$US
130719492$13071949$2$F$20140924$20200625$20161229$20200708$EXP$$US-BAYER-2016-219547$BAYER$$79$YR$E$M$Y$$$20200708$$CN$US$US
1307224025$13072240$25$F$201701$20200715$20161229$20200729$EXP$$US-ACTELION-A-US2016-147506$ACTELION$$64$YR$$M$Y$85.71$KG$20200729$$HP$US$US
130724864$13072486$4$F$20151023$20200702$20161229$20200716$PER$$PHHY2015US157823$NOVARTIS$$56$YR$$M$Y$$$20200716$$MD$US$US
130725883$13072588$3$F$200910$20200725$20161229$20200730$PER$$US-SA-2016SA168363$SANOFI AVENTIS$$$$$$Y$$$20200730$$LW$US$US
130726463$13072646$3$F$20120201$20200801$20161229$20200806$PER$$US-SA-2016SA190471$SANOFI AVENTIS$$$$$$Y$$$20200806$$LW$US$US
130727064$13072706$4$F$20130401$20200819$20161229$20200826$PER$$US-SA-2016SA199647$SANOFI AVENTIS$$$$$$Y$$$20200826$$LW$US$US
130728913$13072891$3$F$20150227$20200630$20161229$20200706$PER$$US-SA-2016SA218178$SANOFI AVENTIS$$$$$$Y$$$20200706$$LW$US$US
1307292521$13072925$21$F$20160207$20200921$20161229$20200923$EXP$$US-PFIZER INC-2016602691$PFIZER$$63$YR$$F$Y$66$KG$20200923$$MD$US$US
130731534$13073153$4$F$$20200701$20161229$20200703$EXP$$US-PFIZER INC-2016592122$PFIZER$$26$YR$$F$Y$$$20200703$$CN$US$US
130732512$13073251$2$F$20160812$20170616$20161229$20170623$EXP$$US-JNJFOC-20161224949$JANSSEN$$71$YR$E$M$Y$71.71$KG$20170623$$MD$US$US
130732592$13073259$2$F$20161219$20170104$20161229$20170112$EXP$$US-JNJFOC-20161223607$PHARMACYCLICS$$75$YR$E$F$Y$107.9$KG$20170112$$MD$US$US
130735066$13073506$6$F$20160918$20191101$20161229$20191106$EXP$$US-CELGENEUS-USA-2016102034$CELGENE$$57$YR$$F$Y$$$20191106$$HP$US$US
130736264$13073626$4$F$20161221$20170731$20161229$20170808$EXP$$JP-JNJFOC-20161220399$JANSSEN$$90$YR$E$M$Y$50.1$KG$20170808$$MD$JP$JP
130743838$13074383$8$F$20130131$20200716$20161230$20200721$EXP$$CA-ROCHE-1183212$ROCHE$$77$YR$$M$Y$78.5$KG$20200721$$HP$CA$CA
130743959$13074395$9$F$2016$20200921$20161230$20200928$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-2791$ORION$$59$YR$$F$Y$$$20200928$$HP$CA$CA
130748985$13074898$5$F$2016$20200817$20161230$20200819$PER$$US-PFIZER INC-2016462856$PFIZER$$78$YR$$F$Y$75$KG$20200819$$MD$US$US
130750887$13075088$7$F$20160601$20200724$20161230$20200729$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0547$ORION$$58$YR$$M$Y$$$20200729$$MD$CA$CA
130751697$13075169$7$F$20160421$20200813$20161230$20200817$EXP$$PHHY2016US179685$NOVARTIS$$51$YR$$F$Y$105.5$KG$20200817$$CN$US$US
130753522$13075352$2$F$20140918$20200804$20161230$20200814$EXP$$US-BAYER-2016-192049$BAYER$$72$YR$E$M$Y$$$20200814$$CN$US$US
130754736$13075473$6$F$20161220$20200713$20161230$20200717$EXP$$US-PFIZER INC-2016594280$PFIZER$$84$YR$$M$Y$64.13$KG$20200717$$HP$US$US
130756542$13075654$2$F$20161215$20161226$20161230$20170105$EXP$$PT-JNJFOC-20161222608$JANSSEN$$73$YR$E$F$Y$60$KG$20170105$$MD$PT$PT
130763625$13076362$5$F$20161128$20180404$20161230$20190213$EXP$$AR-JNJFOC-20161217461$JANSSEN$$34$YR$A$F$Y$55$KG$20190213$$MD$AR$AR
130765482$13076548$2$F$20161221$20170104$20161230$20170113$EXP$$US-JNJFOC-20161225789$PHARMACYCLICS$$58$YR$A$M$Y$$$20170113$$MD$US$US
130769894$13076989$4$F$$20200723$20161230$20200724$EXP$$US-PFIZER INC-2016590167$PFIZER$$67$YR$$F$Y$73.47$KG$20200724$$CN$US$US
1307700010$13077000$10$F$20161206$20200816$20161230$20200820$EXP$$CZ-BIOGEN-2016BI00328821$BIOGEN$VANECKOVA M, MARTINKOVA A, TUPY R, FIEDLER J, STETKAROVA I, MEDOVA E, VACHOVA M, GRUNERMELOVA M, MELUZINOVA E, ADAMKOVA J, KUBALE J, TALABOVA M, HORAKOVA D, HAVRDOVA E, MARKOVA J. THE SPECTRUM OF MRI FINDINGS OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN PATIENTS WITH MULTIPLE SCLEROSIS IN THE CZECH REPUBLIC. DOI: 10.14735/AMCSNN2019381.. CESK SLOV NEUROL N. 2019?4:381?390.$29$YR$$M$Y$$$20200820$$MD$CZ$CZ
130770606$13077060$6$F$20161130$20180927$20161230$20181003$EXP$$FR-JNJFOC-20161221135$JANSSEN$$76$YR$E$F$Y$62.3$KG$20181003$$MD$FR$FR
130780716$13078071$6$F$20161220$20170404$20170102$20170413$EXP$$JP-ROCHE-1873307$ROCHE$$38$YR$$F$Y$57$KG$20170413$$MD$JP$JP
1307860124$13078601$24$F$20161205$20200804$20170102$20200811$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107984$BRISTOL MYERS SQUIBB$NISHIMAKI M. A CASE OF HYPONATREMIA AND DEPRESSED LEVEL OF CONSCIOUSNESS CAUSED BY IPILIMUMAB FOR MALIGNANT MELANOMA. 69TH ANNUAL MEETING OF THE WESTERN JAPAN DIVISION OF JDA IN KUMAMOTO 2017. 2017?0?109$63$YR$$F$Y$50$KG$20200811$$MD$JP$JP
130797152$13079715$2$F$$20200901$20170103$20200910$EXP$$CA-APOTEX-2016AP016057$APOTEX$$57$YR$$F$Y$$$20200910$$PH$CA$CA
130797525$13079752$5$F$20161123$20200814$20170103$20200818$EXP$$CA-TAKEDA-2016TUS021278$TAKEDA$$37$YR$$M$Y$$$20200818$$MD$CA$CA
130800952$13080095$2$F$20140131$20200922$20170103$20200925$EXP$$US-BAYER-2015-399627$BAYER$$76$YR$E$M$Y$$$20200925$$CN$US$US
130810313$13081031$3$F$20161201$20200626$20170103$20200701$PER$$US-PFIZER INC-2016601189$PFIZER$$72$YR$$M$Y$$$20200701$$CN$US$US
130811282$13081128$2$F$20150619$20200922$20170103$20200925$EXP$$US-BAYER-2016-197924$BAYER$$75$YR$E$M$Y$$$20200925$$CN$US$US
130816576$13081657$6$F$2008$20200818$20170103$20200820$EXP$$US-PFIZER INC-2016598166$PFIZER$$38$YR$$F$Y$49.9$KG$20200820$$CN$US$US
130816731$13081673$1$I$20161201$20161227$20170103$20170103$EXP$$FR-PFIZER INC-2016600208$PFIZER$$69$YR$$M$Y$$$20170103$$HP$FR$FR
130816892$13081689$2$F$$20200630$20170103$20200820$PER$$US-JAZZ-2016-US-024619$JAZZ$$$$$M$Y$$$20200820$$HP$US$US
130817672$13081767$2$F$$20200827$20170103$20200831$PER$$US-PFIZER INC-2016592984$PFIZER$$59$YR$$F$Y$$$20200831$$CN$US$US
130821009$13082100$9$F$20181106$20200721$20170103$20200724$EXP$$PHHY2016CA023189$NOVARTIS$$80$YR$$M$Y$$$20200724$$CN$COUNTRY NOT SPECIFIED$CA
130826926$13082692$6$F$201612$20191022$20170103$20191030$EXP$$PHHY2016CA180161$NOVARTIS$$48$YR$$M$Y$$$20191030$$HP$CA$CA
130833172$13083317$2$F$2016$20200827$20170104$20200904$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-001720$ACADIA PHARMACEUTICALS$$$$$F$Y$61$KG$20200904$$MD$US$US
130834565$13083456$5$F$20161227$20200709$20170104$20200713$EXP$$KR-ABBVIE-17K-090-1827793-00$ABBVIE$$60$YR$$M$Y$50.6$KG$20200713$$MD$KR$KR
130839802$13083980$2$F$$20200803$20170104$20200811$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-111798$BRISTOL MYERS SQUIBB$JUNG K, ZENG X, BILUSIC M.. NIVOLUMAB?ASSOCIATED ACUTE GLOMERULONEPHRITIS: A CASE REPORT AND LITERATURE REVIEW. BMC NEPHROLOGY. 2016?17(1):1?6$70$YR$$M$Y$$$20200811$$MD$US$US
1308465513$13084655$13$F$$20200706$20170104$20200707$EXP$$US-PFIZER INC-2016601837$PFIZER$$73$YR$$F$Y$$$20200707$$CN$US$US
130849383$13084938$3$F$20161227$20171201$20170104$20171208$EXP$$FR-JNJFOC-20161223491$JANSSEN$$47$YR$A$F$Y$90$KG$20171208$$MD$FR$FR
1308511510$13085115$10$F$20161118$20200812$20170104$20200817$EXP$$US-PFIZER INC-2016603464$PFIZER$$66$YR$$F$Y$82$KG$20200817$$HP$US$US
130856015$13085601$5$F$201809$20200810$20170104$20200812$EXP$$US-PFIZER INC-2017000768$PFIZER$$79$YR$$F$Y$86$KG$20200812$$CN$US$US
1308560211$13085602$11$F$201607$20200917$20170104$20200922$PER$$US-PFIZER INC-2017002250$PFIZER$$44$YR$$F$Y$$$20200922$$MD$US$US
130860993$13086099$3$F$20160619$20170106$20170104$20200709$EXP$$TR-CELGENEUS-TUR-2016127300$CELGENE$$71$YR$$F$Y$60$KG$20200709$$HP$TR$TR
130864382$13086438$2$F$$20200806$20170104$20200818$EXP$$US-ACTELION-A-US2016-147694$ACTELION$$$$$F$Y$95.24$KG$20200818$$MD$US$US
1308647224$13086472$24$F$$20200818$20170104$20200822$EXP$$US-ACTELION-A-NJ2016-147743$ACTELION$$$$$F$Y$104.31$KG$20200822$$HP$US$US
130872476$13087247$6$F$201612$20200831$20170105$20200907$EXP$$US-BAUSCH-BL-2017-000015$BAUSCH AND LOMB$$80$YR$$F$Y$76.27$KG$20200907$$CN$US$US
1308737413$13087374$13$F$20150728$20200924$20170105$20200930$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0949$ORION$$67$YR$$F$Y$$$20200930$$MD$CA$CA
130875712$13087571$2$F$$20200715$20170105$20200721$EXP$$AU-ORION CORPORATION ORION PHARMA-TREX2017-0074$ORION$MAYALL B, PARKIN J. HAEMOPOIETIC TOXICITY AND LOW?DOSE METHOTREXATE. MED J AUST. 2020 MAR 16?156(6):440.$55$YR$$F$Y$$$20200721$$$COUNTRY NOT SPECIFIED$AU
130875972$13087597$2$F$$20200715$20170105$20200724$EXP$$AU-ORION CORPORATION ORION PHARMA-TREX2017-0073$ORION$MAYALL B, PARKIN J. HAEMOPOIETIC TOXICITY AND LOW?DOSE METHOTREXATE. MED J AUST. 1992 MAR 16?156 (6):440.$43$YR$$M$Y$$$20200724$$$COUNTRY NOT SPECIFIED$AU
130883131$13088313$1$I$20161226$20161228$20170105$20170105$EXP$$GB-JNJFOC-20161225908$JANSSEN$$29$YR$A$F$Y$50$KG$20170105$$MD$GB$GB
130883983$13088398$3$F$20160921$20190107$20170105$20190108$EXP$$AT-JNJFOC-20161227029$JANSSEN$$33$YR$A$M$Y$79.5$KG$20190108$$MD$AT$AT
130883992$13088399$2$F$20161227$20180810$20170105$20180820$EXP$$US-JNJFOC-20170100652$JANSSEN$$63$YR$A$F$Y$58.06$KG$20180820$$MD$US$US
130886695$13088669$5$F$2014$20170214$20170105$20170217$EXP$$US-JNJFOC-20161226038$JANSSEN$$74$YR$E$F$Y$92.53$KG$20170217$$CN$US$US
130886754$13088675$4$F$20140918$20200721$20170105$20200724$PER$$US-JNJFOC-20170102027$JOHNSON AND JOHNSON$$59$YR$A$F$Y$63.56$KG$20200724$$CN$US$US
130889592$13088959$2$F$$20200715$20170105$20200717$EXP$$AU-PFIZER INC-2016604538$PFIZER$MAYALL, B.. HAEMOPOIETIC TOXICITY AND LOW?DOSE METHOTREXATE. MEDICAL JOURNAL OF AUSTRALIA. 1992?156 (6):440$43$YR$$M$Y$$$20200717$$MD$AU$AU
130892632$13089263$2$F$20161220$20170920$20170105$20170927$EXP$$FR-JNJFOC-20161223422$JANSSEN$$56$YR$A$F$Y$77$KG$20170927$$MD$FR$FR
130895605$13089560$5$F$$20200702$20170105$20200706$PER$$US-PFIZER INC-2017004247$PFIZER$$66$YR$$M$Y$71$KG$20200706$$MD$US$US
130895742$13089574$2$F$201606$20200716$20170105$20200720$PER$$US-PFIZER INC-2017004222$PFIZER$$45$YR$$M$Y$94.8$KG$20200720$$CN$US$US
1309087618$13090876$18$F$20150922$20200901$20170106$20200904$EXP$$CA-ROCHE-1637968$ROCHE$$61$YR$$F$Y$$$20200904$$CN$CA$CA
130931542$13093154$2$F$20161227$20170109$20170106$20170116$EXP$$GB-JNJFOC-20161227019$JANSSEN$$75$YR$E$M$Y$54$KG$20170116$$MD$GB$GB
130932868$13093286$8$F$$20200810$20170106$20200813$EXP$$AU-PFIZER INC-2017004390$PFIZER$TABET, E.. OPIOID?INDUCED HYPOADRENALISM RESULTING IN FASTING HYPOGLYCAEMIA. BMJ CASE REPORTS. 2019?12 (12):10.1136/BCR?2019?230551$18$YR$$F$Y$46$KG$20200813$$HP$AU$AU
130938043$13093804$3$F$20150104$20200827$20170106$20200901$EXP$$US-BAYER-2016-243814$BAYER$$91$YR$E$M$Y$$$20200901$$CN$US$US
130940675$13094067$5$F$2016$20200713$20170106$20200715$PER$$US-PFIZER INC-2017001912$PFIZER$$59$YR$$F$Y$86$KG$20200715$$CN$US$US
130944187$13094418$7$F$$20200713$20170106$20200715$PER$$US-PFIZER INC-2017005925$PFIZER$$69$YR$$F$Y$$$20200715$$MD$US$US
130946906$13094690$6$F$20161230$20200807$20170106$20200812$EXP$$US-PFIZER INC-2017004265$PFIZER$$76$YR$$F$Y$70.75$KG$20200812$$HP$US$US
130947583$13094758$3$F$$20200909$20170106$20200916$EXP$$CA-APOTEX-2016AP015216$APOTEX$$71$YR$$F$Y$$$20200916$$HP$CA$CA
130950174$13095017$4$F$201612$20200922$20170106$20200928$EXP$$FR-EXELIXIS-XL18417007899$EXELIXIS$$61$YR$$M$Y$46$KG$20200928$$MD$FR$FR
130967492$13096749$2$F$20160627$20190716$20170109$20200827$EXP$$ES-TEVA-726508ISR$TEVA$$51$YR$A$F$Y$$$20200827$$MD$ES$ES
130968672$13096867$2$F$20161115$20170111$20170109$20170111$EXP$$IT-ROCHE-1876853$ROCHE$$85$YR$$F$Y$59$KG$20170112$$MD$IT$IT
130970464$13097046$4$F$20161208$20200807$20170109$20200811$PER$$US-PFIZER INC-2017007183$PFIZER$$65$YR$$F$Y$98$KG$20200811$$MD$US$US
130979415$13097941$5$F$20170104$20200810$20170109$20200821$PER$$PHEH2017US000824$NOVARTIS$$45$YR$$F$Y$$$20200821$$HP$US$US
130983816$13098381$6$F$20161221$20200903$20170109$20200911$EXP$$US-INCYTE CORPORATION-2016IN008353$INCYTE$$$$$$Y$$$20200911$$CN$US$US
130985193$13098519$3$F$20161230$20170817$20170109$20170821$EXP$$PL-JNJFOC-20170101865$PHARMACYCLICS$$15$YR$T$M$Y$57$KG$20170821$$MD$PL$PL
130986778$13098677$8$F$20161229$20171207$20170109$20171214$EXP$$US-JNJFOC-20170105834$PHARMACYCLICS$$71$YR$E$M$Y$103.1$KG$20171214$$MD$US$US
130991331$13099133$1$I$20161221$20170103$20170109$20170109$EXP$$PL-JNJFOC-20170101983$JANSSEN$$58$YR$A$F$Y$100$KG$20170109$$MD$PL$PL
1309932015$13099320$15$F$20161231$20200909$20170109$20200914$EXP$$NL-ABBVIE-17P-114-1834697-00$ABBVIE$$70$YR$$M$Y$69$KG$20200914$$CN$NL$NL
131001673$13100167$3$F$201701$20200917$20170110$20200923$EXP$$US-RECKITT BENCKISER HEALTHCARE INT LIMITED-RB-80312-2017$RECKITT BENCKISER$$37$YR$$F$Y$$$20200923$$CN$US$US
131010457$13101045$7$F$20161221$20200903$20170110$20200910$EXP$$PHHY2016US182404$NOVARTIS$$66$YR$$F$Y$$$20200910$$CN$US$US
131015037$13101503$7$F$20161212$20170707$20170110$20170721$EXP$$ES-CELGENEUS-ESP-2016126148$CELGENE$$83$YR$$F$Y$$$20170721$$HP$ES$ES
131019305$13101930$5$F$201611$20200804$20170110$20200807$EXP$$US-PFIZER INC-2017002681$PFIZER$$42$YR$$F$Y$$$20200807$$HP$US$US
131020723$13102072$3$F$20150114$20200628$20170110$20200702$PER$$US-JNJFOC-20170106570$JOHNSON AND JOHNSON$$56$YR$$F$Y$$$20200702$$HP$US$US
131025197$13102519$7$F$20161123$20200810$20170110$20200812$EXP$$CA-TAKEDA-2017TUS000337$TAKEDA$$52$YR$$M$Y$$$20200812$$MD$CA$CA
1310286918$13102869$18$F$20160822$20200731$20170110$20200813$EXP$$US-ACTELION-A-US2016-141630$ACTELION$$66$YR$$F$Y$52.61$KG$20200813$$HP$US$US
131031533$13103153$3$F$201601$20200918$20170110$20200923$PER$$US-JAZZ-2016-US-024984$JAZZ$$36$YR$$F$Y$$$20200923$$CN$US$US
131035239$13103523$9$F$20160509$20200424$20170111$20200817$EXP$$CA-ROCHE-1876554$ROCHE$$71$YR$$F$Y$$$20200818$$HP$CA$CA
131040992$13104099$2$F$$20170120$20170111$20170124$EXP$$BE-ROCHE-1877044$ROCHE$BODY J, LICHINITSER M, ANDREEVA N, BUDDE M AND BERGSTROM B. SAFETY OF AN INTRAVENOUS (I.V.) DOSE OF IBANDRONATE FOLLOWED BY DAILY ORAL DOSING IN METASTATIC BONE DISEASE: RESULTS OF AN OPEN?LABEL STUDY . JOURNAL OF CLINICAL ONCOLOGY 2004?22 (14_S):735?.$$$$$Y$$$20170124$$HP$BE$BE
131042537$13104253$7$F$201407$20200714$20170111$20200724$PER$$US-AMGEN-USASP2016148517$AMGEN$$61$YR$A$F$Y$70$KG$20200723$$MD$US$US
131047744$13104774$4$F$$20200730$20170111$20200803$PER$$US-PFIZER INC-2016060519$PFIZER$$66$YR$$F$Y$68$KG$20200803$$MD$US$US
131048226$13104822$6$F$201701$20200921$20170111$20200924$PER$$US-PFIZER INC-2017009834$PFIZER$$6$MON$$M$Y$$$20200924$$HP$US$US
1310535310$13105353$10$F$$20200813$20170111$20200817$PER$$US-PFIZER INC-2017006268$PFIZER$$73$YR$$F$Y$$$20200817$$MD$US$US
131057234$13105723$4$F$20170104$20180105$20170111$20180109$EXP$$BR-JNJFOC-20170104684$JANSSEN$$81$YR$E$F$Y$38.1$KG$20180109$$MD$BR$BR
131061527$13106152$7$F$20161209$20200720$20170111$20200721$PER$$US-PFIZER INC-2017007803$PFIZER$$61$YR$$M$Y$95.25$KG$20200721$$MD$US$US
131064392$13106439$2$F$$20170105$20170111$20200701$EXP$$GR-JNJFOC-20170107572$JOHNSON AND JOHNSON$$$$E$F$Y$$$20200701$$CN$GR$GR
131065424$13106542$4$F$20161125$20200611$20170111$20200615$PER$$US-CELGENEUS-USA-2017012025$CELGENE$$64$YR$$F$Y$70.9$KG$20200615$$MD$US$US
131065648$13106564$8$F$20161124$20200625$20170111$20200709$EXP$$US-ACTELION-A-US2016-147501$ACTELION$$60$YR$$F$Y$$$20200709$$HP$US$US
131091884$13109188$4$F$$20200629$20170112$20200710$EXP$$CA-JNJFOC-20170105848$JOHNSON AND JOHNSON$$$$$M$Y$$$20200710$$HP$CA$CA
131095285$13109528$5$F$20160126$20200624$20170112$20200702$EXP$$US-ASTRAZENECA-2017SE02005$ASTRAZENECA$$32$YR$$M$Y$96.2$KG$20200702$$$US$US
1311132617$13111326$17$F$201611$20200821$20170112$20200825$EXP$$US-ACTELION-A-US2017-148216$ACTELION$$42$YR$$F$Y$$$20200825$$HP$US$US
1311175221$13111752$21$F$$20200707$20170113$20200709$EXP$$CA-ROCHE-1876541$ROCHE$$$$$F$Y$$$20200709$$HP$CA$CA
131131225$13113122$5$F$$20200914$20170113$20200922$PER$$CA-AMGEN-CANSP2017001862$AMGEN$$58$YR$A$F$Y$$$20200922$$HP$CA$CA
1311313318$13113133$18$F$2013$20200723$20170113$20200731$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0862$ORION$$65$YR$$F$Y$$$20200731$$MD$CA$CA
131132832$13113283$2$F$20151030$20200817$20170113$20200824$EXP$$US-BAYER-2016-103276$BAYER$$67$YR$E$M$Y$$$20200824$$CN$US$US
131133722$13113372$2$F$2016$20200729$20170113$20200807$EXP$$FR-009507513-1701FRA004984$MERCK$$69$YR$$M$Y$$$20200807$$HP$FR$FR
131134225$13113422$5$F$$20200706$20170113$20200708$EXP$$US-PFIZER INC-2017013901$PFIZER$$68$YR$$F$Y$$$20200708$$CN$US$US
131136182$13113618$2$F$20141128$20200716$20170113$20200723$EXP$$US-BAYER-2016-225812$BAYER$$78$YR$E$F$Y$$$20200723$$CN$US$US
131140023$13114002$3$F$20170103$20190130$20170113$20190205$EXP$$AU-JNJFOC-20170110078$PHARMACYCLICS$$63$YR$A$F$Y$$$20190205$$MD$AU$AU
131142572$13114257$2$F$$20200911$20170113$20200915$PER$$US-PFIZER INC-2017013958$PFIZER$$$$A$F$Y$$$20200915$$MD$US$US
131143254$13114325$4$F$2009$20200727$20170113$20200729$EXP$$US-PFIZER INC-2017016246$PFIZER$$67$YR$$F$Y$49.9$KG$20200729$$CN$US$US
131144776$13114477$6$F$20170103$20170929$20170113$20171006$EXP$$US-JNJFOC-20170110297$PHARMACYCLICS$$66$YR$E$M$Y$$$20171006$$MD$US$US
131145107$13114510$7$F$201401$20200730$20170113$20200805$EXP$$PHJP2016JP028457$NOVARTIS$$69$YR$$M$Y$46.5$KG$20200805$$HP$JP$JP
131155542$13115554$2$F$$20200817$20170114$20200825$EXP$$CA-BAXTER-2017BAX000675$BAXTER$$65$YR$$F$Y$$$20200825$$HP$CA$CA
131155663$13115566$3$F$$20200817$20170114$20200820$EXP$$CA-BAXTER-2017BAX000680$BAXTER$$65$YR$$F$Y$$$20200820$$HP$CA$CA
131164456$13116445$6$F$$20190220$20170116$20200720$EXP$$CA-BAUSCH-BL-2017-001069$BAUSCH AND LOMB$$74$YR$$F$Y$$$20200720$$HP$CA$CA
131166282$13116628$2$F$20120326$20200907$20170116$20200922$EXP$$FR-ROCHE-1058754$ROCHE$$44$YR$$F$Y$63$KG$20200922$$MD$FR$FR
1311670311$13116703$11$F$201608$20200717$20170116$20200722$EXP$$DE-ROCHE-1829713$ROCHE$$77$YR$$M$Y$$$20200722$$CN$DE$DE
1311681610$13116816$10$F$$20200716$20170116$20200720$PER$$US-PFIZER INC-2017015915$PFIZER$$69$YR$$F$Y$$$20200720$$CN$US$US
131168793$13116879$3$F$20160912$20200908$20170116$20200911$PER$$US-PFIZER INC-2017016457$PFIZER$$57$YR$$F$Y$65$KG$20200911$$HP$US$US
131169502$13116950$2$F$$20200810$20170116$20200819$EXP$$FR-AUROBINDO-AUR-APL-2016-15206$AUROBINDO$$72$YR$$M$Y$$$20200819$$HP$FR$FR
1311836428$13118364$28$F$20150729$20200914$20170116$20200924$EXP$$CA-CELLTRION INC.-2015CA012467$CELLTRION$$$$$$Y$$$20200924$$CN$CA$CA
1311849136$13118491$36$F$20130603$20200921$20170116$20200928$EXP$$AU-MYLANLABS-2017M1002455$MYLAN$$53$YR$$M$Y$$$20200928$$PH$AU$AU
131188938$13118893$8$F$20170104$20200827$20170116$20200907$PER$$PHEH2017US001647$NOVARTIS$$19$YR$$M$Y$$$20200907$$MD$US$US
1311952826$13119528$26$F$201405$20200807$20170116$20200813$EXP$$CA-ROCHE-1879732$ROCHE$$51$YR$$F$Y$$$20200813$$MD$CA$CA
1311974814$13119748$14$F$201711$20200804$20170117$20200807$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-001989$BRISTOL MYERS SQUIBB$$56$YR$$F$Y$$$20200807$$CN$GB$GB
131197833$13119783$3$F$$20200707$20170117$20200713$EXP$$CA-ROCHE-1880380$ROCHE$$$$$F$Y$$$20200713$$MD$CA$CA
131205573$13120557$3$F$$20200710$20170117$20200713$PER$$US-PFIZER INC-2016003920$PFIZER$$52$YR$$F$Y$$$20200713$$HP$US$US
131206506$13120650$6$F$200603$20200724$20170117$20200728$PER$$US-PFIZER INC-2017012640$PFIZER$$57$YR$$F$Y$$$20200728$$CN$US$US
131206827$13120682$7$F$201111$20200917$20170117$20200923$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-0188$ORION$$51$YR$$F$Y$$$20200923$$HP$CA$CA
131207214$13120721$4$F$201610$20200825$20170117$20200828$EXP$$DE-ROCHE-1880444$ROCHE$$15$YR$$M$Y$$$20200828$$MD$DE$DE
131207328$13120732$8$F$201609$20200813$20170117$20200819$EXP$$PHHY2016CA133471$NOVARTIS$$48$YR$$M$Y$$$20200820$$CN$COUNTRY NOT SPECIFIED$CA
131211105$13121110$5$F$20161202$20190404$20170117$20200706$PER$$US-ASTRAZENECA-2017SE02604$ASTRAZENECA$$25658$DY$$F$Y$80.7$KG$20200706$$CN$US$US
131212849$13121284$9$F$20161223$20200630$20170117$20200714$EXP$$US-JNJFOC-20170108703$JOHNSON AND JOHNSON$$64$YR$$M$Y$100.33$KG$20200714$$MD$US$US
1312136636$13121366$36$F$201707$20200716$20170117$20200730$EXP$$US-ACTELION-A-NJ2017-148210$ACTELION$$57$YR$$F$Y$53.06$KG$20200730$$HP$US$US
131216485$13121648$5$F$$20200914$20170117$20200923$EXP$$CA-PFIZER INC-2017017327$PFIZER$$58$YR$$F$Y$$$20200923$$CN$CA$CA
1312258914$13122589$14$F$$20200922$20170117$20200928$EXP$$CA-TAKEDA-2017TUS000820$TAKEDA$$64$YR$$M$Y$$$20200928$$MD$CA$CA
1312274911$13122749$11$F$201707$20200824$20170117$20200828$EXP$$US-ASTELLAS-2016US049939$ASTELLAS$$89$YR$$M$Y$$$20200828$$CN$US$US
131230242$13123024$2$F$20161126$20170119$20170117$20170127$EXP$$ES-JNJFOC-20161204256$JANSSEN$$66$YR$E$F$Y$58$KG$20170127$$MD$ES$ES
131230252$13123025$2$F$20161202$20170203$20170117$20170206$EXP$$TR-JNJFOC-20170111366$JANSSEN$$50$YR$A$F$Y$$$20170206$$MD$TR$TR
131231033$13123103$3$F$$20200727$20170117$20200729$EXP$$PHHY2017NL003902$NOVARTIS$WOLVETANG T, HORST MT, RINEKE J ET AL.. MULTIPLE DRUGS: SEROTONIN SYNDROME: CASE REPORT.. REACTION WEEKLY. 2017?1634:197$64$YR$$F$Y$$$20200729$$HP$NL$NL
131236414$13123641$4$F$201209$20180410$20170117$20180424$EXP$$PHHY2017DE005155$ALCON$$66$YR$$M$Y$$$20180424$$HP$DE$DE
131238894$13123889$4$F$2015$20200818$20170118$20200821$EXP$$CA-ROCHE-1620513$ROCHE$$$$$M$Y$108.9$KG$20200821$$HP$CA$CA
131240432$13124043$2$F$20160115$20180109$20170118$20200725$PER$$JP-AMGEN-JPNCT2017008091$AMGEN$$86$YR$E$M$Y$$$20200725$$HP$JP$JP
131240521$13124052$1$I$20161115$20170109$20170118$20170118$EXP$391235$IT-ACCORD-047471$ACCORD$$85$YR$$F$Y$59$KG$20170118$$MD$IT$IT
1312444610$13124446$10$F$$20200901$20170118$20200904$PER$$US-PFIZER INC-2017020016$PFIZER$$65$YR$$M$Y$$$20200904$$MD$US$US
131249142$13124914$2$F$20160406$20170123$20170118$20170207$EXP$$UA-US WORLDMEDS, LLC-USW201611-000817$US WORLDMEDS$$62$YR$$F$Y$49.3$KG$20170207$$MD$UA$UA
1312515410$13125154$10$F$2017$20200702$20170118$20200710$EXP$$CA-PFIZER INC-2017021757$PFIZER$$63$YR$$F$Y$$$20200710$$CN$CA$CA
131251581$13125158$1$I$20161231$20170104$20170118$20170118$EXP$$CA-PFIZER INC-2017014383$PFIZER$$36$YR$$M$Y$$$20170118$$MD$CA$CA
131251627$13125162$7$F$20160606$20200820$20170118$20200824$EXP$$CA-PFIZER INC-2016326712$PFIZER$$50$YR$$F$Y$$$20200824$$HP$CA$CA
131251713$13125171$3$F$201612$20200827$20170118$20200831$EXP$$US-PFIZER INC-2017013623$PFIZER$$58$YR$$M$Y$133.81$KG$20200831$$MD$US$US
131259622$13125962$2$F$201609$20190913$20170118$20200701$EXP$$GR-JNJFOC-20161015713$JOHNSON AND JOHNSON$$$$E$F$Y$$$20200701$$CN$GR$GR
1312599728$13125997$28$F$20170110$20200807$20170118$20200814$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK017485$GLAXOSMITHKLINE$$64$YR$$F$Y$78$KG$20200814$$CN$BR$BR
131264745$13126474$5$F$2015$20200710$20170118$20200714$PER$$US-PFIZER INC-2017019980$PFIZER$$71$YR$$F$Y$73$KG$20200714$$CN$US$US
131287774$13128777$4$F$20130529$20200903$20170119$20200907$EXP$$CA-ROCHE-1231822$ROCHE$$47$YR$$F$Y$81.6$KG$20200908$$HP$CA$CA
1312878114$13128781$14$F$$20200720$20170119$20200729$PER$$CA-AMGEN-CANSP2017005116$AMGEN$$60$YR$A$F$Y$$$20200729$$MD$CA$CA
1312949615$13129496$15$F$20161114$20200819$20170119$20200821$EXP$$CA-TAKEDA-2017TUS000828$TAKEDA$$44$YR$$F$Y$$$20200821$$HP$CA$CA
131297182$13129718$2$F$$20200717$20170119$20200721$EXP$$US-PFIZER INC-2017019964$PFIZER$$$$$F$Y$$$20200721$$CN$US$US
131304813$13130481$3$F$201609$20170321$20170119$20170323$EXP$$AT-JNJFOC-20161224904$PHARMACYCLICS$$74$YR$E$M$Y$$$20170323$$MD$AT$AT
131305345$13130534$5$F$20150304$20200818$20170119$20200901$EXP$$JP-INCYTE CORPORATION-2015IN005288$INCYTE$$$$$$Y$$$20200901$$MD$US$JP
131310284$13131028$4$F$20140723$20170306$20170119$20200721$EXP$$TR-CELGENEUS-TUR-2014112902$CELGENE$$61$YR$$M$Y$75$KG$20200721$$MD$TR$TR
131313022$13131302$2$F$20170112$20170117$20170119$20170123$EXP$$IT-JNJFOC-20170114399$JANSSEN$$60$YR$A$F$Y$91$KG$20170123$$MD$IT$DE
131314623$13131462$3$F$$20200722$20170119$20200727$PER$$US-PFIZER INC-2017022186$PFIZER$$62$YR$$F$Y$$$20200727$$CN$US$US
131315791$13131579$1$I$$20170109$20170119$20170119$EXP$$GB-TEVA-730427ISR$TEVA$CORDEN E, HIGGINS E, SMITH C. ^^HYPERCALCAEMIA?INDUCED KIDNEY INJURY CAUSED BY THE VITAMIN D ANALOGUE CALCITRIOL FOR PSORIASIS: A NOTE OF CAUTION WHEN PRESCRIBING TOPICAL TREATMENT. CLIN?EXP?DERMATOL 2016?41(8):899?901.$55$YR$$M$Y$$$20170119$$MD$GB$GB
131315961$13131596$1$I$20161020$20161020$20170119$20170119$EXP$$HU-JNJFOC-20161019244$JANSSEN$$72$YR$E$M$Y$76$KG$20170119$$MD$HU$HU
131321073$13132107$3$F$2003$20200904$20170119$20200910$EXP$$US-JAZZ-2017-US-000516$JAZZ$$$$$F$Y$$$20200910$$CN$US$US
131321092$13132109$2$F$$20200922$20170119$20200930$PER$$US-JAZZ-2017-US-000582$JAZZ$$$$$F$Y$$$20200930$$CN$US$US
131322664$13132266$4$F$20141005$20200629$20170120$20200706$PER$$US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-003422$BOEHRINGER INGELHEIM$$83$YR$$F$Y$61.69$KG$20200706$$CN$US$US
131326155$13132615$5$F$$20200922$20170120$20200925$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-0240$ORION$$58$YR$$F$Y$$$20200925$$CN$CA$CA
131327803$13132780$3$F$$20200831$20170120$20200913$EXP$$AU-LUPIN PHARMACEUTICALS INC.-2017-00248$LUPIN$$18$YR$$F$Y$46$KG$20200913$$HP$AU$AU
1313281912$13132819$12$F$$20200729$20170120$20200806$EXP$$ES-009507513-1701ESP004354$MERCK$ALMORZA T, MUNOZ?HERNANDEZ M, LALUEZA A.. ERTAPENEM?INDUCED NEUROLOGICAL TOXICITY IN A PATIENT WITH STAGE IV CHRONIC KIDNEY DISEASE. ENFERM LNFECC MICROBIAL CLIN. 2017?35(9):607?8$73$YR$$M$Y$$$20200806$$HP$ES$ES
131333062$13133306$2$F$20161223$20170201$20170120$20170206$EXP$$US-JNJFOC-20170110566$JANSSEN$$65$YR$A$M$Y$113.4$KG$20170206$$MD$US$US
1313369825$13133698$25$F$201610$20200713$20170120$20200721$EXP$$US-INCYTE CORPORATION-2016IN008354$INCYTE$$$$$$Y$$$20200721$$CN$US$US
131339155$13133915$5$F$20170108$20171005$20170120$20171013$EXP$$CN-JNJFOC-20170115895$PHARMACYCLICS$$69$YR$E$M$Y$$$20171013$$MD$CN$CN
131339164$13133916$4$F$20170107$20170301$20170120$20170303$EXP$$IL-JNJFOC-20170106144$PHARMACYCLICS$$81$YR$E$M$Y$70$KG$20170303$$MD$IL$IL
131363426$13136342$6$F$201604$20200806$20170121$20200807$EXP$$CA-ABBVIE-16K-028-1644573-00$ABBVIE$$70$YR$$F$Y$$$20200807$$MD$CA$CA
1313703313$13137033$13$F$20160809$20200722$20170123$20200729$EXP$$IT-ROCHE-1882660$ROCHE$$70$YR$$M$Y$83$KG$20200729$$MD$IT$IT
1313748325$13137483$25$F$20140301$20200909$20170123$20200927$EXP$$CA-ROCHE-1882290$ROCHE$$47$YR$$M$Y$$$20200927$$MD$CA$CA
131375376$13137537$6$F$$20200810$20170123$20200812$EXP$$CA-009507513-1701CAN009061$MERCK$$60$YR$$F$Y$$$20200812$$CN$CA$CA
1313907214$13139072$14$F$20170103$20200909$20170123$20200914$EXP$$PHHY2017DE007310$NOVARTIS$$$$A$F$Y$$$20200914$$HP$DE$DE
131391152$13139115$2$F$$20200910$20170123$20200918$EXP$$US-BAYER-2017-010732$BAYER$$16$YR$T$M$Y$$$20200918$$HP$US$US
131391522$13139152$2$F$201611$20200831$20170123$20200901$EXP$$US-KOWA-17US000068$KOWA PHARM$$$$$$Y$$$20200901$$HP$US$US
131391589$13139158$9$F$20160309$20200714$20170123$20200721$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-020265$BRISTOL MYERS SQUIBB$IWAMA S. WS1?3:A CASE OF PITUITARY DISPRDER BY ADMINISTRATION OF NIBORMAB. THE 45TH ANNUAL MEETING OF THE JAPAN SOCIETY FOR CLONICAL IMMUNOLOGY. 2017$49$YR$$F$Y$47$KG$20200721$$MD$JP$JP
1313917419$13139174$19$F$20101004$20200914$20170123$20200918$EXP$$CA-PFIZER INC-2011246063$PFIZER$$52$YR$$F$Y$98$KG$20200918$$MD$CA$CA
131391952$13139195$2$F$20160428$20200720$20170123$20200727$EXP$$US-BAYER-2016-242465$BAYER$$70$YR$E$M$Y$$$20200727$$CN$US$US
131396834$13139683$4$F$20161223$20200716$20170123$20200717$PER$$US-PFIZER INC-2017027316$PFIZER$$59$YR$$F$Y$66$KG$20200717$$CN$US$US
131399651$13139965$1$I$20170109$20170117$20170123$20170123$EXP$$RU-JNJFOC-20170115583$JANSSEN$$47$YR$A$M$Y$65$KG$20170123$$MD$RU$RU
131403494$13140349$4$F$$20200903$20170123$20200904$PER$$US-PFIZER INC-2016197205$PFIZER$$57$YR$$M$Y$$$20200904$$MD$US$US
131404533$13140453$3$F$20161227$20170522$20170123$20170526$EXP$$PL-JNJFOC-20170112332$JANSSEN$$38$YR$A$F$Y$69$KG$20170526$$MD$PL$PL
131404568$13140456$8$F$20161229$20170403$20170123$20170406$EXP$$DE-JNJFOC-20170110621$JANSSEN$$62$YR$A$F$Y$70$KG$20170406$$MD$DE$DE
1314056410$13140564$10$F$20160919$20200825$20170123$20200901$PER$$PHHY2017US008479$NOVARTIS$$47$YR$$F$Y$$$20200901$$MD$US$US
131409125$13140912$5$F$20131101$20200813$20170123$20200825$EXP$$US-JNJFOC-20170120010$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200825$$CN$US$US
131409922$13140992$2$F$201502$20200818$20170123$20200831$EXP$$US-JNJFOC-20170102443$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200831$$CN$US$US
131414491$13141449$1$I$20161208$20170116$20170123$20170123$EXP$$DK-JNJFOC-20170117371$JANSSEN$$69$YR$E$F$Y$54$KG$20170123$$MD$DK$DK
131421951$13142195$1$I$20160930$20161003$20170124$20170124$EXP$$BY-US WORLDMEDS, LLC-USW201610-000683$US WORLDMEDS$$56$YR$$F$Y$79$KG$20170123$$MD$BY$BY
131434562$13143456$2$F$20140624$20200913$20170124$20200923$EXP$$US-BAYER-2017-005111$BAYER$$80$YR$E$F$Y$$$20200923$$CN$US$US
1314346410$13143464$10$F$201612$20200824$20170124$20200828$PER$$US-JAZZ-2017-US-000633$JAZZ$$31$YR$$F$Y$$$20200828$$HP$US$US
131440786$13144078$6$F$201511$20200903$20170124$20200910$EXP$$US-ABBVIE-16K-163-1798330-00$ABBVIE$$59$YR$$F$Y$90.8$KG$20200909$$CN$US$US
131443402$13144340$2$F$$20171017$20170124$20171030$EXP$$CN-ROCHE-1883361$ROCHE$ZHAI Y, WANG H, WU Y, CHANG Y, WANG L, WANG Q ET AL SUCCESSFUL MAINTENANCE THERAPY WITH ORAL ETOPOSIDE FOLLOWING FIRST?LINE THERAPY IN AN ELDERLY WOMAN WITH EXTENSIVE?STAGE SCLC: A CASE REPORT AND LITERATURE REVIEW.. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 2016?9 (11):22502?22509.$88$YR$$F$Y$$$20171030$$MD$CN$CN
131444274$13144427$4$F$$20170207$20170124$20200701$EXP$$GR-JNJFOC-20170117197$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200701$$HP$GR$GR
131445014$13144501$4$F$20160612$20180614$20170124$20180618$EXP$$ES-JNJFOC-20160613568$JANSSEN$$57$YR$A$F$Y$80.2$KG$20180618$$MD$ES$ES
131446724$13144672$4$F$20150119$20200723$20170124$20200728$PER$$US-JNJFOC-20170121277$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200728$$CN$US$US
131446812$13144681$2$F$20140624$20200913$20170124$20200924$EXP$$US-JNJFOC-20170106613$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200924$$CN$US$US
131449494$13144949$4$F$20160519$20180221$20170124$20180227$EXP$$US-JNJFOC-20160601374$PHARMACYCLICS$$71$YR$E$M$Y$69.2$KG$20180227$$MD$US$US
131451743$13145174$3$F$$20200923$20170124$20200929$EXP$$US-AUROBINDO-AUR-APL-2017-16196$AUROBINDO$NAFCILLIN/TACROLIMUS INTERACTION: REDUCED TACROLIMUS LEVEL: CASE REPORT. 2017$13$YR$$M$Y$$$20200930$$HP$US$US
1314525242$13145252$42$F$201701$20200901$20170124$20200924$EXP$$CA-CELLTRION INC.-2017CA000732$CELLTRION$$$$$$Y$$$20200924$$HP$CA$CA
1314566557$13145665$57$F$2016$20200817$20170124$20200823$EXP$$US-ACTELION-A-NJ2017-148873$ACTELION$$48$YR$$F$Y$81.63$KG$20200823$$HP$US$US
131462719$13146271$9$F$$20200918$20170125$20200925$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-004064$BRISTOL MYERS SQUIBB$$77$YR$$M$Y$$$20200925$$CN$CA$CA
131463532$13146353$2$F$20161214$20200804$20170125$20200805$PER$$PHHY2017US010077$NOVARTIS$$54$YR$$M$Y$68.03$KG$20200805$$MD$US$US
131464033$13146403$3$F$20160918$20200923$20170125$20200929$PER$$US-CELGENEUS-USA-2017014922$CELGENE$$60$YR$$F$Y$67$KG$20200929$$HP$US$US
131464929$13146492$9$F$20161027$20200605$20170124$20200908$EXP$$PHHY2017CA008782$NOVARTIS$$73$YR$$M$Y$$$20200908$$MD$CA$CA
131468859$13146885$9$F$20161226$20170911$20170125$20170914$EXP$$FR-ROCHE-1883080$ROCHE$$71$YR$$M$Y$57$KG$20170914$$MD$FR$FR
1314726611$13147266$11$F$$20200923$20170125$20200930$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005239$BRISTOL MYERS SQUIBB$$52$YR$$F$Y$$$20200930$$CN$CA$CA
131486822$13148682$2$F$$20200923$20170125$20200928$PER$$US-PFIZER INC-2017029982$PFIZER$$78$YR$$F$Y$$$20200928$$CN$US$US
131492517$13149251$7$F$20150806$20200515$20170125$20200707$PER$$PHHY2016US032202$NOVARTIS$$53$YR$$M$Y$$$20200707$$MD$US$US
131493455$13149345$5$F$20161206$20200706$20170125$20200713$EXP$$US-ASTELLAS-2016US048844$ASTELLAS$$79$YR$$M$Y$$$20200713$$CN$US$US
131495282$13149528$2$F$201612$20200716$20170125$20200724$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-001747$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20200724$$MD$US$US
131496512$13149651$2$F$20160608$20170301$20170125$20170303$EXP$$RU-JNJFOC-20170119797$JANSSEN$$77$YR$E$F$Y$50$KG$20170303$$MD$RU$RU
131504454$13150445$4$F$$20200714$20170125$20200715$PER$$US-PFIZER INC-2017034540$PFIZER$$62$YR$$F$Y$$$20200715$$MD$US$US
1315173413$13151734$13$F$$20200806$20170125$20200810$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005497$BRISTOL MYERS SQUIBB$$47$YR$$F$Y$$$20200810$$HP$CA$CA
1315180811$13151808$11$F$20180922$20200701$20170125$20200715$PER$$US-ACTELION-A-US2014-109898$ACTELION$$79$YR$$F$Y$44.9$KG$20200715$$HP$US$US
131529515$13152951$5$F$$20200721$20170126$20200724$EXP$$CA-ABBVIE-17K-028-1848651-00$ABBVIE$$60$YR$$F$Y$$$20200724$$CN$CA$CA
131529959$13152995$9$F$$20200605$20170126$20200716$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-004692$BRISTOL MYERS SQUIBB$$57$YR$$F$Y$$$20200716$$CN$CA$CA
131530678$13153067$8$F$$20200917$20170126$20200924$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-004893$BRISTOL MYERS SQUIBB$$43$YR$$F$Y$$$20200924$$HP$CA$CA
1315311810$13153118$10$F$$20200918$20170126$20200925$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005291$BRISTOL MYERS SQUIBB$$48$YR$$F$Y$$$20200925$$CN$CA$CA
1315318819$13153188$19$F$20160707$20200818$20170126$20200825$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005845$BRISTOL MYERS SQUIBB$$67$YR$$F$Y$$$20200825$$CN$CA$CA
131531927$13153192$7$F$$20200629$20170126$20200702$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005886$BRISTOL MYERS SQUIBB$$64$YR$$F$Y$$$20200702$$CN$CA$CA
1315319413$13153194$13$F$$20200807$20170126$20200813$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005442$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200813$$HP$CA$CA
131539581$13153958$1$I$20140722$20140729$20170126$20170126$EXP$$GB-JNJFOC-20140720249$JANSSEN$$52$YR$A$M$Y$96$KG$20170126$$HP$GB$GB
131539606$13153960$6$F$20170107$20180627$20170126$20180705$EXP$$AU-JNJFOC-20170109344$JANSSEN$$69$YR$E$M$Y$86$KG$20180705$$MD$AU$AU
1315579521$13155795$21$F$20161125$20200706$20170126$20200709$EXP$$CA-TAKEDA-2017TUS001473$TAKEDA$$33$YR$$F$Y$$$20200709$$HP$CA$CA
1315628913$13156289$13$F$20170116$20200819$20170126$20200820$EXP$$BE-PFIZER INC-2017030537$PFIZER$$69$YR$$F$Y$56$KG$20200820$$HP$BE$BE
131565364$13156536$4$F$$20200820$20170126$20200825$EXP$$US-ACTELION-A-NJ2017-149077$ACTELION$$$$$F$Y$$$20200825$$HP$US$US
131570933$13157093$3$F$20140414$20170515$20170127$20200807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-003382$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200807$$LW$US$US
131575822$13157582$2$F$20160223$20200702$20170127$20200709$PER$$PHHY2016US084201$NOVARTIS$$50$YR$$F$Y$$$20200710$$MD$US$US
131580227$13158022$7$F$$20200812$20170127$20200817$EXP$$US-PFIZER INC-2017034931$PFIZER$$59$YR$$M$Y$$$20200817$$CN$US$US
131583152$13158315$2$F$20140717$20200624$20170127$20200706$EXP$$US-BAYER-2016-067083$BAYER$$71$YR$E$F$Y$62.65$KG$20200706$$CN$US$US
131586341$13158634$1$I$20140821$20140901$20170127$20170127$EXP$$FR-JNJFOC-20140903995$JANSSEN$$73$YR$E$F$Y$84$KG$20170127$$HP$FR$FR
131586351$13158635$1$I$20140912$20140917$20170127$20170127$EXP$$US-JNJFOC-20140918256$JANSSEN$$68$YR$E$F$Y$84.7$KG$20170127$$MD$US$US
1315873915$13158739$15$F$201611$20200728$20170127$20200730$EXP$$CA-TAKEDA-2017TUS001663$TAKEDA$$47$YR$$F$Y$60$KG$20200730$$HP$CA$CA
1315892215$13158922$15$F$2007$20200918$20170127$20200925$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005391$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200925$$HP$CA$CA
1315893214$13158932$14$F$$20200630$20170127$20200706$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005744$BRISTOL MYERS SQUIBB$$71$YR$$F$Y$$$20200706$$CN$CA$CA
131597523$13159752$3$F$2008$20200721$20170127$20200730$EXP$$US-ABBVIE-17K-163-1847013-00$ABBVIE$$69$YR$$F$Y$82.17$KG$20200730$$CN$US$US
131599945$13159994$5$F$20161226$20170203$20170127$20170210$EXP$$FR-ABBVIE-17P-056-1848494-00$ABBVIE$$71$YR$$M$Y$58$KG$20170210$$HP$COUNTRY NOT SPECIFIED$FR
131601662$13160166$2$F$$20200805$20170127$20200807$EXP$$US-PFIZER INC-2017032444$PFIZER$$74$YR$$M$Y$$$20200807$$CN$US$US
131601713$13160171$3$F$20170108$20200707$20170127$20200720$EXP$$US-INCYTE CORPORATION-2017IN000105$INCYTE$$$$$$Y$$$20200720$$CN$US$US
131602753$13160275$3$F$$20200806$20170127$20200820$EXP$$US-BIOMARINAP-US-2017-112587$BIOMARIN$$15$YR$$M$Y$$$20200820$$MD$US$US
131613535$13161353$5$F$20170117$20190314$20170130$20200716$EXP$$CO-ROCHE-1886373$ROCHE$$57$YR$$M$Y$84$KG$20200716$$HP$CO$CO
131620396$13162039$6$F$$20200824$20170130$20200826$PER$$US-PFIZER INC-2016256825$PFIZER$$68$YR$$F$Y$$$20200826$$HP$US$US
131623343$13162334$3$F$20190125$20200714$20170130$20200718$EXP$$PHHY2017CA009523$NOVARTIS$$61$YR$$M$Y$$$20200718$$HP$CA$CA
131626717$13162671$7$F$20160525$20200806$20170130$20200807$EXP$$CA-ABBVIE-16K-028-1777383-00$ABBVIE$$63$YR$$F$Y$$$20200806$$HP$COUNTRY NOT SPECIFIED$CA
131626732$13162673$2$F$201507$20200903$20170130$20200909$EXP$$US-BAYER-2016-225815$BAYER$$72$YR$E$F$Y$$$20200909$$CN$US$US
131626841$13162684$1$I$20141023$20141107$20170130$20170130$EXP$$FR-JNJFOC-20141108312$JANSSEN$$63$YR$A$M$Y$59$KG$20170130$$HP$FR$FR
131626887$13162688$7$F$20161212$20170822$20170130$20170830$EXP$$US-JNJFOC-20161215584$JANSSEN$$78$YR$E$F$Y$59$KG$20170830$$MD$US$US
131633418$13163341$8$F$20170112$20200911$20170130$20200915$EXP$$US-PFIZER INC-2016174359$PFIZER$$42$YR$$M$Y$84$KG$20200915$$MD$US$US
131641293$13164129$3$F$$20170130$20170130$20200701$EXP$$GR-JNJFOC-20170123554$JOHNSON AND JOHNSON$$60$YR$$M$Y$$$20200701$$CN$GR$GR
131642168$13164216$8$F$20170124$20200706$20170130$20200713$EXP$$GB-MYLANLABS-2017M1004846$MYLAN$$43$YR$$M$Y$$$20200713$$MD$GB$GB
131642666$13164266$6$F$20140530$20200809$20170130$20200818$EXP$$US-JNJFOC-20170125615$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200818$$CN$US$US
131646635$13164663$5$F$$20200914$20170130$20200917$PER$$US-JAZZ-2017-US-000640$JAZZ$$$$$F$Y$$$20200917$$HP$US$US
131658913$13165891$3$F$$20200915$20170131$20200923$EXP$$CA-TEVA-734156ACC$TEVA$$61$YR$A$F$Y$66$KG$20200923$$HP$CA$CA
131659408$13165940$8$F$2003$20200914$20170131$20200917$PER$$CA-AMGEN-CANSP2017014229$AMGEN$$48$YR$A$F$Y$$$20200917$$CN$CA$CA
131660958$13166095$8$F$$20200707$20170131$20200709$EXP$$CA-ROCHE-1885399$ROCHE$$34$YR$$M$Y$$$20200709$$MD$CA$CA
1316633710$13166337$10$F$20170125$20200629$20170131$20200707$PER$$CA-AMGEN-CANSP2017014736$AMGEN$$57$YR$A$M$Y$$$20200707$$HP$CA$CA
131675364$13167536$4$F$20170508$20200914$20170131$20200916$PER$$US-PFIZER INC-2017039039$PFIZER$$40$YR$$M$Y$$$20200916$$CN$US$US
131675657$13167565$7$F$201701$20200914$20170131$20200916$EXP$$US-PFIZER INC-2017041102$PFIZER$$80$YR$$F$Y$68.03$KG$20200916$$CN$US$US
131678617$13167861$7$F$$20200915$20170131$20200922$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005498$BRISTOL MYERS SQUIBB$$59$YR$$F$Y$58$KG$20200922$$HP$CA$CA
131680554$13168055$4$F$2014$20200716$20170131$20200720$PER$$US-JNJFOC-20170126139$JOHNSON AND JOHNSON$$7$DEC$E$M$Y$$$20200720$$CN$US$US
131683063$13168306$3$F$20170120$20170317$20170131$20170322$EXP$$TR-JNJFOC-20170119327$PHARMACYCLICS$$59$YR$A$M$Y$90$KG$20170322$$MD$TR$TR
131683528$13168352$8$F$20161121$20181010$20170131$20181012$EXP$$US-ROCHE-1867574$ROCHE$$46$YR$$F$Y$75.5$KG$20181013$$MD$US$US
1316928013$13169280$13$F$$20200914$20170201$20200921$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005325$BRISTOL MYERS SQUIBB$$78$YR$$F$Y$$$20200921$$CN$CA$CA
131704522$13170452$2$F$20160729$20180525$20170201$20200922$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-102558$BRISTOL MYERS SQUIBB$$83$YR$$F$Y$$$20200922$$MD$JP$JP
131720563$13172056$3$F$2016$20200922$20170131$20200928$EXP$$PT-009507513-1611PRT002581$MERCK$$70$YR$$M$Y$$$20200928$$MD$PT$PT
1317575511$13175755$11$F$20151029$20200722$20170201$20200731$EXP$$JP-PFIZER INC-2017039376$PFIZER$$35$YR$$F$Y$45$KG$20200731$$MD$JP$JP
131758434$13175843$4$F$2015$20200817$20170201$20200821$EXP$$IT-BIOGEN-2017BI00346584$BIOGEN$DE MERCANTI S, GNED D, MATTA M, IUDICELLO M, FRANCHIN E, CLERICO M. ATYPICAL MULTIPLE SCLEROSIS LESIONS OR PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY LESIONS: THAT IS THE QUESTION.DOI: 10.1177/2324709620939802. JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS. 2020?8:1?4.$$$$F$Y$$$20200821$$MD$IT$IT
131761598$13176159$8$F$20160724$20200812$20170201$20200818$EXP$$JP-PFIZER INC-2016461348$PFIZER$$69$YR$$M$Y$56$KG$20200818$$MD$JP$JP
1317620010$13176200$10$F$$20200630$20170201$20200712$EXP$$PHEH2017US003269$NOVARTIS$$$$$F$Y$$$20200712$$CN$US$US
131765643$13176564$3$F$201512$20200830$20170201$20200902$PER$$US-JNJFOC-20170128134$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200902$$CN$US$US
131769442$13176944$2$F$$20170124$20170201$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-00792$VIFOR$$71$YR$E$F$Y$$$20200715$$CN$US$US
131780945$13178094$5$F$2013$20200729$20170202$20200811$EXP$$BE-SUN PHARMACEUTICAL INDUSTRIES LTD-2017R1-132640$RANBAXY$$61$YR$$M$Y$$$20200811$$HP$NL$BE
131787088$13178708$8$F$$20200708$20170202$20200721$EXP$$CA-ROCHE-1886825$ROCHE$$$$$F$Y$$$20200722$$CN$CA$CA
1317920015$13179200$15$F$20161222$20200709$20170202$20200710$EXP$$PHHY2016DE180620$NOVARTIS$$74$YR$$M$Y$80$KG$20200710$$HP$DE$DE
131795862$13179586$2$F$201302$20200712$20170202$20200721$EXP$$US-BAYER-2015-034802$BAYER$$65$YR$E$F$Y$$$20200721$$CN$US$US
131804123$13180412$3$F$201612$20200617$20170202$20200813$PER$$US-TEVA-733344ACC$TEVA$$56$YR$A$F$Y$$$20200814$$PH$US$US
131805403$13180540$3$F$$20200908$20170202$20200915$EXP$$PHHY2017CA011860$NOVARTIS$$45$YR$$F$Y$$$20200915$$HP$CA$CA
131817863$13181786$3$F$20161116$20170411$20170202$20180705$EXP$$DE-JNJFOC-20170118471$JANSSEN$$26$YR$A$F$Y$52$KG$20180705$$MD$DE$DE
131820761$13182076$1$I$20150515$20150518$20170202$20170202$EXP$$GB-JNJFOC-20150513420$JANSSEN$$64$YR$A$M$Y$74.2$KG$20170202$$HP$GB$GB
131820773$13182077$3$F$20170116$20171120$20170202$20171128$EXP$$FR-JNJFOC-20170117462$JANSSEN$$59$YR$A$F$Y$74$KG$20171128$$MD$FR$FR
1318237015$13182370$15$F$20151115$20200730$20170203$20200805$EXP$$CA-ABBVIE-17K-028-1856140-00$ABBVIE$$61$YR$$F$Y$$$20200805$$CN$CA$CA
1318249312$13182493$12$F$201610$20200813$20170203$20200818$EXP$$US-PFIZER INC-2017042388$PFIZER$$56$YR$$F$Y$35.83$KG$20200818$$HP$US$US
131825722$13182572$2$F$$20200713$20170203$20200715$PER$$US-PFIZER INC-2017043400$PFIZER$$68$YR$$F$Y$$$20200715$$HP$US$US
131826874$13182687$4$F$201908$20200721$20170203$20200723$EXP$$US-PFIZER INC-2017045478$PFIZER$$56$YR$$F$Y$$$20200722$$HP$US$US
131827048$13182704$8$F$$20200729$20170203$20200731$EXP$$US-PFIZER INC-2017045128$PFIZER$$88$YR$$F$Y$$$20200731$$HP$US$US
131828505$13182850$5$F$20161216$20200824$20170203$20200903$EXP$$PT-SUNOVION-2017SUN000339$SUNOVION$$$$$$Y$$$20200903$$CN$PT$DE
131829272$13182927$2$F$201411$20200831$20170203$20200903$EXP$$US-BAYER-2016-205896$BAYER$$56$YR$A$M$Y$$$20200903$$CN$US$US
131829973$13182997$3$F$$20171024$20170203$20171108$EXP$$CN-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-132535$RANBAXY$$88$YR$$F$Y$$$20171108$$HP$CN$CN
1318391712$13183917$12$F$20170123$20191011$20170203$20191016$EXP$$FR-ROCHE-1884399$ROCHE$$72$YR$$F$Y$50$KG$20191016$$MD$FR$FR
131843163$13184316$3$F$201701$20200904$20170203$20200908$EXP$$FR-ROCHE-1888731$ROCHE$$63$YR$$F$Y$71$KG$20200908$$MD$FR$FR
131844853$13184485$3$F$20161104$20200723$20170203$20200728$PER$$DE-EISAI MEDICAL RESEARCH-EC-2016-022954$EISAI$$63$YR$A$F$Y$55$KG$20200728$$MD$DE$DE
131845792$13184579$2$F$201612$20170210$20170203$20170217$EXP$$DK-JNJFOC-20170109629$JANSSEN$$70$YR$E$F$Y$53$KG$20170217$$MD$DK$DK
131847081$13184708$1$I$20170108$20170120$20170203$20170203$EXP$$US-US WORLDMEDS, LLC-USW201701-000135$US WORLDMEDS$$78$YR$$M$Y$58.9$KG$20170202$$MD$US$US
131849655$13184965$5$F$20170124$20170807$20170203$20170815$EXP$$CZ-JNJFOC-20170201705$PHARMACYCLICS$$76$YR$E$F$Y$$$20170815$$MD$CZ$CZ
131853391$13185339$1$I$20160203$20160208$20170203$20170203$EXP$$US-US WORLDMEDS, LLC-USW201602-000216$US WORLDMEDS$$75$YR$$M$Y$76.7$KG$20170203$$MD$US$US
131853491$13185349$1$I$20160801$20160905$20170203$20170203$EXP$$UA-US WORLDMEDS, LLC-USW201609-000631$US WORLDMEDS$$64$YR$$M$Y$61.1$KG$20170203$$HP$UA$UA
131853994$13185399$4$F$20170117$20170714$20170203$20170721$EXP$$NL-JNJFOC-20170126664$JANSSEN$$73$YR$E$M$Y$110$KG$20170721$$MD$NL$NL
1318543111$13185431$11$F$20170123$20180927$20170203$20181004$EXP$$FR-ABBVIE-17P-056-1852044-00$ABBVIE$$72$YR$$F$Y$43$KG$20181004$$MD$FR$FR
131855273$13185527$3$F$20161128$20170417$20170203$20170427$EXP$$JP-PFIZER INC-2016577426$PFIZER$$75$YR$$M$Y$60$KG$20170427$$MD$JP$JP
131855745$13185574$5$F$20161111$20200918$20170203$20200923$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-007031$BRISTOL MYERS SQUIBB$$42$YR$$F$Y$58$KG$20200923$$HP$US$US
131877167$13187716$7$F$2016$20200825$20170206$20200827$EXP$$US-PFIZER INC-2017047673$PFIZER$$85$YR$$F$Y$51.26$KG$20200827$$MD$US$US
1318792910$13187929$10$F$$20200713$20170206$20200722$EXP$$PHEH2017US003270$NOVARTIS$$$$$M$Y$$$20200722$$CN$US$US
1318805914$13188059$14$F$$20200724$20170206$20200807$EXP$$CA-GLENMARK PHARMACEUTICALS-2017GMK026159$GLENMARK$$$$$$Y$$$20200807$$HP$CA$CA
131891764$13189176$4$F$20141023$20170302$20170206$20170309$EXP$$US-JNJFOC-20141020201$JANSSEN$$68$YR$E$F$Y$85.2$KG$20170309$$MD$US$US
131893185$13189318$5$F$2016$20200804$20170206$20200807$EXP$$US-JAZZ-2017-US-001398$JAZZ$$$$$F$Y$$$20200807$$HP$US$US
131894639$13189463$9$F$20161102$20200103$20170206$20200108$EXP$$PHHY2016CA148171$NOVARTIS$$55$YR$$M$Y$$$20200108$$CN$COUNTRY NOT SPECIFIED$CA
131898323$13189832$3$F$20161018$20170616$20170206$20170626$EXP$$US-JNJFOC-20161017593$JANSSEN$$66$YR$E$M$Y$94$KG$20170626$$MD$US$US
131898404$13189840$4$F$20170130$20170728$20170206$20170801$EXP$$BE-JNJFOC-20170200206$PHARMACYCLICS$$63$YR$A$M$Y$61$KG$20170801$$MD$BE$BE
131898874$13189887$4$F$20121025$20200221$20170206$20200803$EXP$$DE-JNJFOC-20130718328$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20200803$$MD$DE$DE
131901855$13190185$5$F$20140131$20200628$20170206$20200702$PER$$US-JNJFOC-20170203163$JOHNSON AND JOHNSON$$86$YR$$F$Y$100.1$KG$20200702$$CN$US$US
131903201$13190320$1$I$201606$20170126$20170206$20170206$EXP$$DE-JNJFOC-20170124008$JANSSEN$$$$N$M$Y$3.78$KG$20170206$$MD$DE$DE
131903594$13190359$4$F$$20200814$20170206$20200818$EXP$$US-PFIZER INC-2017049271$PFIZER$$73$YR$$F$Y$$$20200818$$CN$US$US
131905984$13190598$4$F$201608$20200810$20170206$20200813$EXP$$US-JAZZ-2017-US-001604$JAZZ$$46$YR$$M$Y$$$20200813$$HP$US$US
131915742$13191574$2$F$$20200918$20170207$20200924$EXP$$US-AUROBINDO-AUR-APL-2017-29367$AUROBINDO$$$$$$Y$$$20200924$$HP$US$US
131915792$13191579$2$F$$20200918$20170207$20200924$EXP$$US-AUROBINDO-AUR-APL-2017-29430$AUROBINDO$$$$$$Y$$$20200924$$HP$US$US
131917412$13191741$2$F$20151008$20170303$20170207$20170307$EXP$$CR-ROCHE-1644768$ROCHE$$49$YR$$F$Y$83$KG$20170307$$MD$CR$CR
131921152$13192115$2$F$20161114$20170316$20170207$20170321$EXP$$FR-ROCHE-1855960$ROCHE$$66$YR$$F$Y$67.3$KG$20170321$$MD$FR$FR
131924004$13192400$4$F$20160722$20200902$20170207$20200904$EXP$$PHJP2017JP004009$NOVARTIS$$79$YR$$M$Y$$$20200904$$$JP$JP
131925949$13192594$9$F$$20200902$20170207$20200916$EXP$$CA-INCYTE CORPORATION-2017IN000638$INCYTE$$$$$$Y$$$20200916$$CN$CA$CA
1319283516$13192835$16$F$20161019$20200915$20170207$20200923$EXP$$CO-INCYTE CORPORATION-2016IN006772$INCYTE$$$$$$Y$$$20200923$$CN$CO$CO
131932605$13193260$5$F$$20200806$20170207$20200811$EXP$$US-PFIZER INC-2017047822$PFIZER$COLBURN, S.. THE COST OF SEEKING AN EDGE: RECURRENT RENAL INFARCTION IN SETTING OF RECREATIONAL USE OF ANABOLIC STEROIDS. ANNALS OF MEDICINE AND SURGERY. 2017?14:25?28$43$YR$$M$Y$$$20200811$$HP$US$US
131939707$13193970$7$F$20170110$20200916$20170207$20200921$EXP$$CA-TAKEDA-2017TUS002532$TAKEDA$$33$YR$$M$Y$$$20200921$$MD$CA$CA
131944444$13194444$4$F$201701$20200722$20170207$20200820$PER$$US-JAZZ-2016-US-024110$JAZZ$$14$YR$$M$Y$$$20200820$$HP$US$US
131946506$13194650$6$F$20170204$20170422$20170207$20191212$EXP$$US-ROCHE-1890197$ROCHE$$68$YR$$F$Y$66.7$KG$20191212$$MD$US$US
1319527621$13195276$21$F$20160606$20200806$20170208$20200819$EXP$$CA-ROCHE-1889780$ROCHE$$71$YR$$M$Y$87$KG$20200819$$MD$CA$CA
131957301$13195730$1$I$20150723$20150724$20170208$20170208$EXP$$SG-ROCHE-1613592$ROCHE$$49$YR$$M$Y$72.1$KG$20170208$$MD$SG$SG
131959952$13195995$2$F$$20200721$20170208$20200724$PER$$US-BIOGEN-2017BI00352345$BIOGEN$$$$$M$Y$$$20200724$$CN$US$US
131959962$13195996$2$F$20170127$20170214$20170208$20170222$EXP$$JP-ROCHE-1887755$ROCHE$$13$YR$$M$Y$74$KG$20170222$$MD$JP$JP
131961296$13196129$6$F$20170413$20200911$20170208$20200917$EXP$$PHHY2017IN019393$NOVARTIS$$51$YR$$F$Y$65$KG$20200917$$MD$IN$IN
131961999$13196199$9$F$20170126$20200429$20170208$20200501$EXP$$AU-ROCHE-1888320$ROCHE$$60$YR$$F$Y$56.5$KG$20200501$$MD$AU$AU
131966569$13196656$9$F$201701$20200630$20170208$20200702$EXP$$US-PFIZER INC-2017055843$PFIZER$$79$YR$$F$Y$70$KG$20200702$$MD$US$US
1319755423$13197554$23$F$20151026$20200908$20170208$20200914$EXP$$US-PFIZER INC-2017056057$PFIZER$$28$YR$$M$Y$$$20200914$$LW$US$US
1319757227$13197572$27$F$20091230$20200821$20170208$20200825$EXP$$US-PFIZER INC-2017056055$PFIZER$$60$YR$$M$Y$$$20200825$$LW$US$US
1319781018$13197810$18$F$20060522$20200908$20170208$20200914$EXP$$US-PFIZER INC-2017056060$PFIZER$$42$YR$$M$Y$$$20200914$$LW$US$US
132013022$13201302$2$F$201701$20170202$20170209$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-01317$VIFOR$$45$YR$A$F$Y$$$20200715$$PH$US$US
132013082$13201308$2$F$20170201$20170201$20170209$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-01260$VIFOR$$58$YR$A$F$Y$$$20200715$$HP$US$US
1320235210$13202352$10$F$2018$20200828$20170209$20200901$PER$$US-PFIZER INC-2017054968$PFIZER$$62$YR$$F$Y$72$KG$20200901$$MD$US$US
132033469$13203346$9$F$2016$20200728$20170209$20200805$EXP$$PHHY2016CA131604$NOVARTIS$$60$YR$$M$Y$$$20200805$$CN$COUNTRY NOT SPECIFIED$CA
132036863$13203686$3$F$20170120$20170221$20170209$20170224$EXP$$NL-PFIZER INC-2017032912$PFIZER$$$$$F$Y$68$KG$20170224$$HP$NL$NL
132039782$13203978$2$F$20170131$20191022$20170208$20200909$EXP$$CA-JNJFOC-20170203360$JOHNSON AND JOHNSON$$17$YR$T$M$Y$87.7$KG$20200909$$HP$CA$CA
132061171$13206117$1$I$20160916$20170202$20170209$20170209$EXP$$BE-JNJFOC-20170207851$PHARMACYCLICS$$9$DEC$E$M$Y$$$20170209$$MD$BE$BE
132080555$13208055$5$F$20170203$20180329$20170209$20180403$EXP$$US-JNJFOC-20170205440$JANSSEN$$53$YR$A$F$Y$86.2$KG$20180403$$MD$US$US
132093277$13209327$7$F$20160908$20200917$20170209$20200922$PER$$US-PFIZER INC-2016433532$PFIZER$$63$YR$$F$Y$136$KG$20200922$$CN$US$US
132105782$13210578$2$F$$20200629$20170210$20200703$EXP$$CA-SA-2017SA020159$SANOFI AVENTIS$$$$$$Y$$$20200703$$MD$CA$CA
132112972$13211297$2$F$$20200921$20170210$20200925$PER$$US-PFIZER INC-2017060479$PFIZER$$61$YR$$F$Y$68$KG$20200925$$CN$US$US
132119833$13211983$3$F$201612$20170222$20170210$20200701$EXP$$GR-JNJFOC-20170203246$JOHNSON AND JOHNSON$$52$YR$$F$Y$$$20200701$$CN$GR$GR
132127674$13212767$4$F$20161120$20200630$20170210$20200703$EXP$$US-ROCHE-1890389$ROCHE$$63$YR$$M$Y$72.5$KG$20200703$$MD$US$US
132143532$13214353$2$F$201610$20200821$20170210$20200826$EXP$$FR-PFIZER INC-2017050324$PFIZER$$62$YR$$M$Y$$$20200826$$MD$FR$FR
132161118$13216111$8$F$201606$20200831$20170210$20200903$EXP$$NO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-010325$BRISTOL MYERS SQUIBB$$45$YR$$M$Y$$$20200903$$CN$NO$NO
132165985$13216598$5$F$$20200916$20170210$20200920$EXP$$CA-ROCHE-1889952$ROCHE$$$$$F$Y$$$20200921$$HP$CA$CA
132185993$13218599$3$F$20160523$20200811$20170210$20200825$EXP$$US-ACORDA-ACO_125835_2016$ACORDA$$54$YR$$F$Y$$$20200825$$CN$US$US
1321911924$13219119$24$F$20141126$20200715$20170210$20200825$EXP$$CA-ROCHE-1891382$ROCHE$$68$YR$$M$Y$$$20200825$$MD$CA$CA
132200424$13220042$4$F$$20200909$20170210$20200918$EXP$$CA-APOTEX-2017AP006228$APOTEX$$35$YR$$F$Y$$$20200918$$CN$CA$CA
132200735$13220073$5$F$$20200908$20170210$20200911$EXP$$CA-ROCHE-1891879$ROCHE$$42$YR$$F$Y$$$20200912$$HP$CA$CA
132203033$13220303$3$F$20170117$20170418$20170210$20170421$EXP$$HK-ROCHE-1890369$ROCHE$$57$YR$$F$Y$52.2$KG$20170421$$MD$HK$HK
132204522$13220452$2$F$$20170725$20170210$20170801$EXP$$US-JNJFOC-20160210802$JANSSEN$BARTLETT NL, CHEN AI, KOLIBABA KS, LAMY  T, JONES  S, HIRATA J, ET AL. LYMPHOMA: THERAPY WITH BIOLOGIC AGENTS, EXCLUDING PRE ? CLINICAL MODELS. BARTLETT NL, CHEN  I, KOLIBABA  S, LAMY  T, JONES  S, HIRATA J, ET AL. POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (R?CHP) FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B?CELL LYMPHOMA (DLBCL): PRELIMINARY RESULTS OF A PHASE IB DOSE?ESCALATION. BLOOD 2015?126 (23):2726.$$$$$Y$$$20170801$$MD$US$US
132233054$13223305$4$F$201802$20200717$20170212$20200730$EXP$$US-ACORDA-ACO_125351_2016$ACORDA$$56$YR$$F$Y$52.15$KG$20200730$$CN$US$US
132243964$13224396$4$F$$20200910$20170212$20200914$PER$$US-BIOGEN-2017BI00354315$BIOGEN$$$$$F$Y$$$20200914$$CN$US$US
132247623$13224762$3$F$$20200909$20170213$20200914$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-010786$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200914$$CN$US$US
132255444$13225544$4$F$$20200909$20170213$20200915$EXP$$CA-APOTEX-2017AP006389$APOTEX$$54$YR$$M$Y$$$20200915$$CN$CA$CA
132263072$13226307$2$F$$20200923$20170213$20200928$EXP$$BE-TAKEDA-2017TUS002161$TAKEDA$$43$YR$$M$Y$64.8$KG$20200928$$MD$BE$BE
132266992$13226699$2$F$20170130$20170207$20170213$20170216$EXP$$IT-JNJFOC-20170206020$JANSSEN$$69$YR$E$F$Y$$$20170216$$MD$IT$IT
132267303$13226730$3$F$20161228$20170312$20170213$20170321$EXP$$GB-JNJFOC-20170208876$JANSSEN$$65$YR$A$F$Y$101.4$KG$20170321$$HP$GB$GB
132273866$13227386$6$F$20160906$20171103$20170213$20171107$EXP$$US-JNJFOC-20160908158$PHARMACYCLICS$$79$YR$E$M$Y$61$KG$20171107$$MD$US$US
1322742921$13227429$21$F$2017$20200910$20170213$20200918$EXP$$US-INCYTE CORPORATION-2017IN000728$INCYTE$$$$$$Y$$$20200918$$CN$US$US
132284495$13228449$5$F$201609$20200612$20170213$20200824$EXP$$US-ROCHE-1850436$ROCHE$$63$YR$$F$Y$55.39$KG$20200825$$CN$US$US
132287136$13228713$6$F$20170207$20200818$20170213$20200825$EXP$$IE-MYLANLABS-2017M1008561$MYLAN$$31$YR$$M$Y$$$20200825$$MD$IE$IE
132288956$13228895$6$F$$20200807$20170213$20200812$EXP$$CA-ROCHE-1832720$ROCHE$$37$YR$$F$Y$$$20200812$$HP$CA$CA
1322896712$13228967$12$F$2015$20200803$20170213$20200811$EXP$$CA-ROCHE-1892661$ROCHE$$64$YR$$F$Y$$$20200811$$CN$CA$CA
132293054$13229305$4$F$$20200811$20170214$20200814$PER$$US-BIOGEN-2017BI00354968$BIOGEN$$$$$F$Y$$$20200814$$CN$US$US
132294573$13229457$3$F$$20200629$20170214$20200710$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-133099$RANBAXY$$93$YR$$$Y$$$20200710$$HP$NL$GB
132301122$13230112$2$F$20150331$20170308$20170214$20170313$EXP$$KR-ROCHE-1560670$ROCHE$$61$YR$$M$Y$67.8$KG$20170313$$MD$KR$KR
1323021915$13230219$15$F$20160603$20200810$20170214$20200818$EXP$$PHHY2016CA090442$NOVARTIS$$39$YR$$M$Y$125$KG$20200818$$HP$CA$CA
132302613$13230261$3$F$20131113$20200916$20170214$20200925$EXP$$US-BAYER-2013-157835$BAYER$$80$YR$E$F$Y$77.11$KG$20200925$$CN$US$US
132304763$13230476$3$F$20161227$20200721$20170214$20200727$EXP$$TW-PFIZER INC-2017010196$PFIZER$$69$YR$$F$Y$72.5$KG$20200727$$MD$TW$TW
132312813$13231281$3$F$20130411$20200802$20170214$20200810$EXP$$US-JNJFOC-20170212080$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200810$$CN$US$US
132315192$13231519$2$F$20160527$20200910$20170214$20200925$PER$$US-AMAG PHARMACEUTICALS, INC.-AMAG201601833$AMAG$$30$YR$A$F$Y$66.21$KG$20200925$$$US$US
132315763$13231576$3$F$201509$20200914$20170214$20200918$PER$$US-EISAI MEDICAL RESEARCH-EC-2015-010645$EISAI$$61$YR$A$F$Y$73$KG$20200918$$MD$US$US
132321633$13232163$3$F$201611$20200828$20170214$20200903$EXP$$CA-CELGENEUS-CAN-2016123475$CELGENE$$72$YR$$F$Y$75$KG$20200903$$MD$CA$CA
1323286010$13232860$10$F$201701$20200909$20170214$20200916$EXP$$NL-ABBVIE-17P-114-1872447-00$ABBVIE$$65$YR$$F$Y$50$KG$20200915$$HP$NL$NL
132331044$13233104$4$F$2013$20200707$20170215$20200714$EXP$$US-BIOGEN-2017BI00357596$BIOGEN$$$$$F$Y$$$20200714$$CN$US$US
132344592$13234459$2$F$20161202$20180404$20170215$20180412$EXP$$ES-JNJFOC-20161217349$JANSSEN$$44$YR$A$F$Y$60$KG$20180412$$MD$ES$ES
132344601$13234460$1$I$20170105$20170109$20170215$20170215$EXP$$GB-JNJFOC-20170108616$JANSSEN$$75$YR$E$F$Y$90.6$KG$20170215$$MD$GB$GB
132344785$13234478$5$F$20160404$20200812$20170215$20200817$PER$$US-JNJFOC-20170212687$JOHNSON AND JOHNSON$$82$YR$E$M$Y$75.91$KG$20200817$$CN$US$US
132345904$13234590$4$F$$20200903$20170215$20200907$EXP$$US-PFIZER INC-2017061478$PFIZER$$71$YR$$F$Y$$$20200907$$CN$US$US
132346194$13234619$4$F$$20200730$20170215$20200803$PER$$US-PFIZER INC-2017061549$PFIZER$$53$YR$$F$Y$$$20200803$$HP$US$US
132349948$13234994$8$F$20151022$20170830$20170215$20170907$EXP$$ES-JNJFOC-20151020178$JANSSEN$$71$YR$E$M$Y$70$KG$20170907$$MD$ES$ES
132354517$13235451$7$F$2016$20200731$20170215$20200731$EXP$$US-PFIZER INC-2017061750$PFIZER$$63$YR$$F$Y$81.54$KG$20200731$$CN$US$US
132367441$13236744$1$I$20170116$20170117$20170215$20170215$EXP$$CA-PFIZER INC-2017030917$PFIZER$$54$YR$$M$Y$76$KG$20170215$$MD$CA$CA
1323696210$13236962$10$F$20161214$20200908$20170215$20200924$EXP$$US-INCYTE CORPORATION-2017IN000876$INCYTE$$$$$$Y$$$20200925$$CN$US$US
132394643$13239464$3$F$20170126$20170321$20170216$20170323$EXP$$ES-JNJFOC-20170208171$JANSSEN$$52$YR$A$F$Y$91.2$KG$20170323$$MD$ES$ES
132395044$13239504$4$F$201404$20200715$20170216$20200727$EXP$$US-JNJFOC-20170213385$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20200727$$CN$US$US
132397393$13239739$3$F$20161028$20171026$20170216$20171030$EXP$$US-JNJFOC-20161106554$PHARMACYCLICS$$39$YR$A$F$Y$45$KG$20171030$$MD$US$US
1323994419$13239944$19$F$2018$20200921$20170216$20200925$PER$$US-PFIZER INC-2017067913$PFIZER$$79$YR$$F$Y$77$KG$20200925$$CN$US$US
1323998311$13239983$11$F$$20200729$20170216$20200731$PER$$US-PFIZER INC-2017070400$PFIZER$$64$YR$$F$Y$76$KG$20200731$$MD$US$US
132405762$13240576$2$F$20170130$20170217$20170216$20170307$EXP$$US-JNJFOC-20170204030$JANSSEN$$85$YR$E$M$Y$$$20170307$$MD$US$US
132413693$13241369$3$F$20170208$20170322$20170216$20170324$EXP$$US-ASTRAZENECA-2017SE16222$ASTRAZENECA$$55$YR$$F$Y$51$KG$20170324$$MD$US$US
132414083$13241408$3$F$20170204$20170307$20170216$20170321$EXP$$US-ASTRAZENECA-2017SE17542$ASTRAZENECA$$51$YR$$F$Y$54.5$KG$20170321$$MD$US$US
132428959$13242895$9$F$$20200731$20170216$20200803$EXP$$CA-ABBVIE-17P-028-1876032-00$ABBVIE$$$$$F$Y$$$20200803$$CN$CA$CA
1324363434$13243634$34$F$20131114$20200805$20170216$20200814$EXP$$US-ACTELION-A-US2013-91467$ACTELION$$56$YR$$F$Y$79.37$KG$20200814$$HP$US$US
132438572$13243857$2$F$20141008$20200706$20170217$20200717$EXP$$US-BAYER-2016-114893$BAYER$$91$YR$E$F$Y$$$20200717$$CN$US$US
132443332$13244333$2$F$20141116$20200622$20170217$20200703$EXP$$US-BAYER-2016-221611$BAYER$$78$YR$E$M$Y$$$20200703$$CN$US$US
132444575$13244457$5$F$$20200803$20170217$20200811$EXP$$CA-APOTEX-2017AP006744$APOTEX$$$$$F$Y$$$20200811$$HP$CA$CA
1324446311$13244463$11$F$20150729$20200731$20170217$20200804$EXP$$CA-TAKEDA-2016TUS000831$TAKEDA$$65$YR$$F$Y$$$20200804$$HP$CA$CA
132449317$13244931$7$F$20170129$20200327$20170216$20200817$EXP$$CA-ROCHE-1894064$ROCHE$$40$YR$$F$Y$$$20200817$$MD$CA$CA
132456372$13245637$2$F$20161115$20170207$20170217$20170217$EXP$IT-MINISAL02-391235$IT-TEVA-729731ACC$TEVA$$85$YR$$F$Y$59$KG$20170217$$MD$IT$IT
132457622$13245762$2$F$20170208$20170222$20170217$20170303$EXP$$US-JNJFOC-20170214885$PHARMACYCLICS$$45$YR$A$F$Y$55.7$KG$20170303$$MD$US$US
132458407$13245840$7$F$$20200707$20170217$20200710$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1026$ORION$$39$YR$$F$Y$$$20200710$$MD$CA$CA
132458441$13245844$1$I$20161215$20170209$20170217$20170217$EXP$$CH-JNJFOC-20170209589$JANSSEN$$61$YR$A$M$Y$83$KG$20170217$$MD$CH$CH
132459384$13245938$4$F$20161228$20200817$20170217$20200828$PER$$IN-AMGEN-INDNI2017024798$AMGEN$KHANDPUR, S.. A PRELIMINARY PROSPECTIVE NON?RANDOMIZED CONTROLLED TRIAL TO COMPARE THE EFFICACY OF SUBCUTANEOUS ETANERCEPT VERSUS ORAL METHOTREXATE IN MODERATE?TO?SEVERE CHRONIC PLAQUE PSORIASIS AND CORRELATION OF RESPONSE WITH T HELPER (TH) 1, TH2, TH17 AND T REGULATORY CYTOKINE PATTERNS.. INDIAN JOURNAL OF DERMATOLOGY, VENEREOLOGY AND LEPROLOGY. 2020?86 (4):441?445$34$YR$A$M$Y$58$KG$20200827$$HP$IN$IN
132461913$13246191$3$F$$20200917$20170217$20200929$EXP$$CA-APOTEX-2017AP006577$APOTEX$$53$YR$$F$Y$60$KG$20200929$$CN$CA$CA
132474635$13247463$5$F$20170208$20200817$20170217$20200820$EXP$$CA-TAKEDA-2017TUS003324$TAKEDA$$44$YR$$M$Y$$$20200820$$HP$CA$CA
132477304$13247730$4$F$2016$20200922$20170217$20200929$EXP$$FI-ABBVIE-17P-055-1874113-00$ABBVIE$$77$YR$$F$Y$42$KG$20200928$$CN$FI$FI
132504815$13250481$5$F$$20200807$20170219$20200820$EXP$$CA-APOTEX-2017AP006555$APOTEX$$69$YR$$F$Y$$$20200820$$CN$CA$CA
132508434$13250843$4$F$20170209$20200723$20170220$20200728$PER$$US-BIOGEN-2017BI00356909$BIOGEN$$61$YR$$M$Y$$$20200728$$CN$US$US
132513118$13251311$8$F$$20200901$20170220$20200911$EXP$$CA-APOTEX-2017AP006578$APOTEX$$45$YR$$F$Y$$$20200911$$CN$CA$CA
1325133519$13251335$19$F$$20200731$20170220$20200812$EXP$$CA-APOTEX-2017AP006763$APOTEX$$71$YR$$F$Y$$$20200812$$HP$CA$CA
1325144810$13251448$10$F$$20200918$20170220$20200930$EXP$$CA-APOTEX-2017AP006660$APOTEX$$$$$F$Y$$$20200930$$CN$CA$CA
132515337$13251533$7$F$$20200824$20170220$20200903$EXP$$CA-APOTEX-2017AP006675$APOTEX$$53$YR$$F$Y$$$20200903$$MD$CA$CA
132515412$13251541$2$F$20160911$20170210$20170220$20200713$EXP$$JP-VIFOR (INTERNATIONAL) INC.-VIT-2017-00608$VIFOR$$74$YR$E$M$Y$63.7$KG$20200713$$MD$JP$JP
132515909$13251590$9$F$$20200826$20170220$20200907$EXP$$CA-APOTEX-2017AP006777$APOTEX$$71$YR$$F$Y$$$20200907$$CN$CA$CA
132516176$13251617$6$F$$20200807$20170220$20200819$EXP$$CA-APOTEX-2017AP006643$APOTEX$$$$$M$Y$$$20200819$$CN$CA$CA
132516886$13251688$6$F$20170301$20200706$20170220$20200710$PER$$US-PFIZER INC-2016487946$PFIZER$$50$YR$$F$Y$84$KG$20200710$$CN$US$US
132522902$13252290$2$F$20170211$20170306$20170220$20170314$EXP$$FR-JNJFOC-20170214152$JANSSEN$$63$YR$A$F$Y$51$KG$20170314$$MD$FR$FR
132527642$13252764$2$F$2016$20200715$20170220$20200807$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-001267$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20200807$$MD$US$US
132534143$13253414$3$F$2016$20200629$20170220$20200724$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2016-001275$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20200724$$MD$US$US
132536152$13253615$2$F$201701$20200717$20170220$20200727$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-001977$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$45$KG$20200727$$MD$US$US
1325429210$13254292$10$F$$20200825$20170221$20200903$EXP$$CA-APOTEX-2017AP006753$APOTEX$$51$YR$$M$Y$$$20200903$$HP$CA$CA
132543305$13254330$5$F$$20200831$20170221$20200909$EXP$$CA-APOTEX-2017AP006769$APOTEX$$75$YR$$F$Y$$$20200909$$CN$CA$CA
132547042$13254704$2$F$20150512$20170301$20170221$20170306$EXP$$TH-ROCHE-1592468$ROCHE$$47$YR$$F$Y$43.8$KG$20170306$$MD$TH$TH
1325474612$13254746$12$F$201505$20200917$20170221$20200929$EXP$$CA-APOTEX-2017AP006614$APOTEX$$45$YR$$F$Y$$$20200929$$CN$CA$CA
132548325$13254832$5$F$20150615$20171128$20170221$20171212$EXP$$US-ROCHE-1620241$ROCHE$$52$YR$$M$Y$93.3$KG$20171212$$MD$US$US
1325499311$13254993$11$F$$20200722$20170221$20200803$EXP$$CA-APOTEX-2017AP006561$APOTEX$$75$YR$$F$Y$$$20200803$$CN$CA$CA
132550352$13255035$2$F$201408$20200828$20170221$20200904$EXP$$PHHY2014CA054984$NOVARTIS$$38$YR$$F$Y$$$20200904$$CN$COUNTRY NOT SPECIFIED$CA
132562748$13256274$8$F$20161013$20200807$20170221$20200813$EXP$$CA-TAKEDA-2015TUS015633$TAKEDA$$26$YR$$F$Y$$$20200813$$CN$CA$CA
132573722$13257372$2$F$$20200807$20170221$20200820$EXP$$US-ELI_LILLY_AND_COMPANY-US201702006807$ELI LILLY AND CO$COLBURN S, CHILDERS WK, CHACON A, SWAILES A, AHMED FM, SAHI R..THE COST OF SEEKING AN EDGE: RECURRENT RENAL INFARCTION IN SETTING OF RECREATIONAL USE OF ANABOLIC STEROIDS..ANNALS OF MEDICINE AND SURGERY 2017?14:25?28.$43$YR$$M$Y$$$20200820$$HP$US$US
132574532$13257453$2$F$20170119$20170302$20170221$20170602$EXP$$US-US WORLDMEDS, LLC-USW201702-000233$US WORLDMEDS$$60$YR$$M$Y$81.6$KG$20170602$$HP$US$US
132574785$13257478$5$F$20170209$20200731$20170221$20200807$EXP$$US-SA-2017SA026393$SANOFI AVENTIS$$$$$$Y$$$20200807$$MD$US$US
1325752110$13257521$10$F$$20200624$20170221$20200706$EXP$IT-MINISAL02-396082$IT-MYLANLABS-2017M1010562$MYLAN$$65$YR$$F$Y$$$20200706$$MD$IT$IT
1325755910$13257559$10$F$$20200813$20170221$20200818$EXP$$US-JAZZ-2017-US-001526$JAZZ$$$$$F$Y$$$20200818$$CN$US$US
132575776$13257577$6$F$2017$20200623$20170221$20200730$PER$$US-INCYTE CORPORATION-2017IN000977$INCYTE$$$$$$Y$$$20200730$$CN$US$US
1325938432$13259384$32$F$201612$20200714$20170222$20200716$PER$$US-PFIZER INC-2016481413$PFIZER$$53$YR$$F$Y$77$KG$20200716$$CN$US$US
132594309$13259430$9$F$2017$20200909$20170222$20200914$PER$$US-PFIZER INC-2017077608$PFIZER$$69$YR$$F$Y$91$KG$20200914$$CN$US$US
132598045$13259804$5$F$20170109$20170320$20170222$20170323$EXP$$PHHY2017DE024516$NOVARTIS$$$$A$M$Y$96$KG$20170323$$CN$DE$DE
132605526$13260552$6$F$20170118$20170621$20170222$20180604$EXP$$RU-JNJFOC-20170121004$JANSSEN$$17$YR$T$F$Y$45$KG$20180604$$MD$RU$RU
132606402$13260640$2$F$20170209$20170314$20170222$20170316$EXP$$CZ-JNJFOC-20170217468$PHARMACYCLICS$$80$YR$E$M$Y$66$KG$20170316$$MD$CZ$CZ
132607162$13260716$2$F$20170202$20170217$20170222$20170301$EXP$$CA-PFIZER INC-2017078747$PFIZER$$76$YR$$M$Y$$$20170301$$MD$CA$CA
1326135915$13261359$15$F$201701$20200902$20170222$20200903$EXP$$US-PFIZER INC-2017075459$PFIZER$$60$YR$$F$Y$104$KG$20200903$$MD$US$US
132617407$13261740$7$F$20170213$20170628$20170222$20170630$EXP$$UA-JNJFOC-20170217822$JANSSEN$$57$YR$A$M$Y$63.8$KG$20170630$$MD$UA$UA
132618337$13261833$7$F$20170212$20180110$20170222$20180112$EXP$$IL-JNJFOC-20170218336$JANSSEN$$53$YR$A$F$Y$50$KG$20180112$$MD$IL$IL
132618963$13261896$3$F$20170117$20171023$20170222$20171026$EXP$$US-JNJFOC-20170121536$PHARMACYCLICS$$39$YR$A$F$Y$45$KG$20171026$$MD$US$US
132619902$13261990$2$F$201702$20170207$20170222$20200715$PER$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-01443$VIFOR$$78$YR$E$F$Y$$$20200715$$CN$US$US
132626552$13262655$2$F$20170123$20170224$20170223$20170303$EXP$$TW-ASTRAZENECA-2017SE18287$ASTRAZENECA$$28140$DY$$F$Y$$$20170303$$MD$TW$TW
132631752$13263175$2$F$201701$20200707$20170223$20200715$PER$$US-AMGEN-USASP2017026238$AMGEN$$45$YR$A$F$Y$$$20200715$$CN$US$US
132639134$13263913$4$F$$20200629$20170223$20200701$PER$$US-PFIZER INC-2017079137$PFIZER$$53$YR$$F$Y$$$20200701$$CN$US$US
132647261$13264726$1$I$$20170209$20170223$20170223$EXP$$US-MYLANLABS-2017M1010083$MYLAN$FORERO?TORRES A, KOLIBABA KS, LAMY T, JONES S, LEE C, SHARMAN J. POLATUZUMAB VEDOTIN COMBINED WITH OBINUTUZUMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (G?CHP) FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B?CELL LYMPHOMA (DLBCL): PRELIMINARY RESULTS OF A PHASE IB/II DOSE?ESCALATION STUDY. BLOOD 2016?128(2):1856.$$$$$Y$$$20170223$$HP$US$US
132655751$13265575$1$I$$20170209$20170223$20170223$EXP$$US-MYLANLABS-2017M1010128$MYLAN$FORERO?TORRES A, KOLIBABA KS, LAMY T, JONES S, LEE C, SHARMAN J. POLATUZUMAB VEDOTIN COMBINED WITH OBINUTUZUMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (G?CHP) FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B?CELL LYMPHOMA (DLBCL): PRELIMINARY RESULTS OF A PHASE IB/II DOSE?ESCALATION STUDY. BLOOD 2016?128(2):1856.$$$$$Y$$$20170223$$HP$US$US
132656291$13265629$1$I$$20170209$20170223$20170223$EXP$$US-MYLANLABS-2017M1010130$MYLAN$FORERO?TORRES A, KOLIBABA KS, LAMY T, JONES S, LEE C, SHARMAN J. POLATUZUMAB VEDOTIN COMBINED WITH OBINUTUZUMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (G?CHP) FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B?CELL LYMPHOMA (DLBCL): PRELIMINARY RESULTS OF A PHASE IB/II DOSE?ESCALATION STUDY. BLOOD 2016?128(2):1856.$$$$$Y$$$20170223$$HP$US$US
1326606434$13266064$34$F$2016$20200909$20170223$20200919$EXP$$US-INCYTE CORPORATION-2017IN001157$INCYTE$$$$$$Y$$$20200920$$CN$US$US
132661073$13266107$3$F$20170211$20200902$20170223$20200908$EXP$$US-LUNDBECK-DKLU2026756$LUNDBECK$$64$YR$$M$Y$$$20200908$$MD$US$US
132661704$13266170$4$F$20200615$20200702$20170223$20200710$EXP$$US-ACTELION-A-US2017-150141$ACTELION$$72$YR$$M$Y$68.03$KG$20200710$$MD$US$US
132664322$13266432$2$F$$20170213$20170223$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-01649$VIFOR$$57$YR$A$M$Y$$$20200715$$CN$US$US
132664342$13266434$2$F$$20170213$20170223$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-01483$VIFOR$$87$YR$E$F$Y$$$20200715$$CN$US$US
132664402$13266440$2$F$20170210$20170210$20170223$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-01628$VIFOR$$67$YR$E$M$Y$$$20200715$$CN$US$US
132678852$13267885$2$F$20200801$20200803$20170224$20200810$PER$$US-AMGEN-USASL2017028017$AMGEN$$70$YR$E$M$Y$$$20200810$$MD$US$US
132681958$13268195$8$F$20170208$20200819$20170224$20200824$EXP$$JP-PFIZER INC-2017078998$PFIZER$$74$YR$$M$Y$$$20200824$$HP$JP$JP
132683792$13268379$2$F$20140330$20200623$20170224$20200706$EXP$$US-BAYER-2016-232861$BAYER$$60$YR$A$M$Y$$$20200706$$CN$US$US
132689445$13268944$5$F$20170214$20170622$20170224$20170628$EXP$$RU-ROCHE-1896424$ROCHE$$54$YR$$M$Y$59$KG$20170628$$MD$RU$RU
132689464$13268946$4$F$20160215$20200721$20170224$20200724$EXP$$JP-OTSUKA-2016_004467$OTSUKA$$53$YR$$F$Y$50$KG$20200724$$MD$JP$JP
132698927$13269892$7$F$20160912$20181005$20170224$20181011$EXP$$FR-JNJFOC-20160921087$JANSSEN$$69$YR$E$M$Y$60$KG$20181011$$MD$FR$FR
1326990415$13269904$15$F$20161110$20200903$20170224$20200910$EXP$$PHHY2017DE027295$NOVARTIS$$48$YR$$M$Y$77$KG$20200910$$CN$DE$DE
132699863$13269986$3$F$20150319$20200927$20170224$20200930$PER$$US-JNJFOC-20170222224$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200930$$LW$US$US
1327011624$13270116$24$F$20170207$20200724$20170224$20200729$EXP$$JP-CELGENEUS-JPN-2017027675$CELGENE$$59$YR$$M$Y$$$20200729$$MD$JP$JP
132711671$13271167$1$I$$20170216$20170226$20170226$EXP$$PHHY2017SG029438$NOVARTIS$$34$YR$$F$Y$$$20170227$$CN$SG$SG
132713062$13271306$2$F$$20200113$20170226$20200720$EXP$$CA-ROCHE-1898404$ROCHE$$62$YR$$F$Y$72$KG$20200720$$MD$CA$CA
132726479$13272647$9$F$20170220$20200903$20170227$20200908$PER$$US-PFIZER INC-2017077266$PFIZER$$59$YR$$F$Y$$$20200908$$HP$US$US
132727404$13272740$4$F$$20200728$20170227$20200803$PER$$US-PFIZER INC-2016506942$PFIZER$$79$YR$$F$Y$$$20200803$$CN$US$US
132733832$13273383$2$F$20170217$20170302$20170227$20170307$EXP$$US-JNJFOC-20170222054$PHARMACYCLICS$$75$YR$E$M$Y$72.2$KG$20170307$$MD$US$US
132738755$13273875$5$F$20170204$20181002$20170227$20181008$EXP$$US-JNJFOC-20170210781$PHARMACYCLICS$$69$YR$E$M$Y$$$20181008$$MD$US$US
132744993$13274499$3$F$20160429$20200720$20170227$20200731$EXP$$IN-INCYTE CORPORATION-2016IN003288$INCYTE$$$$$$Y$$$20200731$$CN$IN$IN
1327484514$13274845$14$F$20151014$20200617$20170227$20200701$EXP$$US-ACTELION-A-US2016-147269$ACTELION$$67$YR$$F$Y$82.54$KG$20200701$$HP$US$US
132753272$13275327$2$F$$20200817$20170228$20200820$EXP$$CA-BAXTER-2017BAX008377$BAXTER$$$$$F$Y$$$20200820$$CN$CA$CA
132758551$13275855$1$I$20130303$20141004$20170228$20170228$PER$$PHHY2014US132644$NOVARTIS$$58$YR$$F$Y$$$20170228$$CN$US$US
132761075$13276107$5$F$$20200720$20170228$20200723$PER$$CA-AMGEN-CANSP2017029597$AMGEN$$$$A$F$Y$90$KG$20200723$$HP$CA$CA
1327610811$13276108$11$F$20120713$20200701$20170228$20200706$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN102192$VIIV$$60$YR$$M$Y$$$20200706$$CN$JP$JP
1327640918$13276409$18$F$20150921$20191211$20170228$20191224$EXP$$PHHY2015CA076028$NOVARTIS$$65$YR$$F$Y$$$20191224$$MD$CA$CA
132771334$13277133$4$F$20170211$20200710$20170228$20200716$EXP$$PL-PFIZER INC-2017073836$PFIZER$$63$YR$$F$Y$86$KG$20200716$$HP$PL$PL
132777433$13277743$3$F$20170205$20170428$20170228$20170505$EXP$$IL-JNJFOC-20170210792$PHARMACYCLICS$$70$YR$E$F$Y$54$KG$20170505$$MD$IL$IL
132778988$13277898$8$F$2017$20200702$20170228$20200708$EXP$$CA-TAKEDA-2017TUS000823$TAKEDA$$63$YR$$F$Y$$$20200708$$MD$CA$CA
132779797$13277979$7$F$$20200702$20170228$20200706$PER$$US-PFIZER INC-2017082897$PFIZER$$60$YR$$M$Y$$$20200706$$CN$US$US
132780164$13278016$4$F$$20200721$20170228$20200723$PER$$US-PFIZER INC-2017084833$PFIZER$$58$YR$$F$Y$$$20200723$$CN$US$US
132784542$13278454$2$F$20161213$20170303$20170228$20170316$EXP$$TW-PFIZER INC-2016598107$PFIZER$$60$YR$$M$Y$$$20170316$$MD$TW$TW
132786791$13278679$1$I$$20170215$20170228$20170228$EXP$$US-MYLANLABS-2017M1011884$MYLAN$JALILIAN L, DELGADO UPEGUI C, FERREIRA R, SIMMONS L, CILIBERTO C. INTRAOPERATIVE TREATMENT OF FETAL ASYSTOLE AFTER ENDOVASCULAR REPAIR OF AORTIC COARCTATION IN A PREGNANT WOMAN WITH MITRAL STENOSIS. A?A?CASE?REP 2016?6(6):150?3.$$$$$Y$$$20170228$$MD$US$US
132788035$13278803$5$F$20170130$20200804$20170228$20200807$PER$$US-ACTELION-A-US2017-150063$ACTELION$$72$YR$$M$Y$$$20200807$$MD$US$US
132788066$13278806$6$F$20151117$20200811$20170228$20200819$PER$$US-ACTELION-A-NJ2017-150267$ACTELION$$65$YR$$F$Y$$$20200819$$MD$US$US
132788462$13278846$2$F$201702$20170220$20170228$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-01953$VIFOR$$79$YR$E$M$Y$$$20200715$$PH$US$US
132804591$13280459$1$I$20151211$20170216$20170301$20170301$EXP$$IT-ROCHE-1895315$ROCHE$$29$YR$$F$Y$48$KG$20170301$$MD$IT$IT
132811123$13281112$3$F$$20200430$20170301$20200821$EXP$$CA-ROCHE-1898409$ROCHE$$57$YR$$F$Y$$$20200821$$HP$CA$CA
132817823$13281782$3$F$2005$20200916$20170301$20200918$EXP$$US-PFIZER INC-2017083727$PFIZER$$42$YR$$M$Y$$$20200918$$CN$US$US
1328214712$13282147$12$F$201701$20200727$20170301$20200803$EXP$$PHHY2017CA011010$NOVARTIS$$36$YR$$F$Y$$$20200803$$CN$COUNTRY NOT SPECIFIED$CA
132844324$13284432$4$F$20170216$20190308$20170301$20190315$EXP$$IL-JNJFOC-20170300280$PHARMACYCLICS$$64$YR$A$M$Y$$$20190315$$MD$IL$IL
132845962$13284596$2$F$20170207$20170313$20170301$20170320$EXP$$US-JNJFOC-20170222795$PHARMACYCLICS$$82$YR$E$M$Y$81$KG$20170320$$MD$US$US
132847362$13284736$2$F$201508$20200719$20170301$20200729$EXP$$US-JNJFOC-20161220765$JOHNSON AND JOHNSON$$89$YR$E$M$Y$$$20200729$$CN$US$US
132847372$13284737$2$F$20140528$20200715$20170301$20200727$EXP$$US-JNJFOC-20170200595$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200727$$CN$US$US
132849392$13284939$2$F$201508$20200719$20170301$20200728$EXP$$US-BAYER-2016-244639$BAYER$$89$YR$E$M$Y$$$20200728$$CN$US$US
1328495415$13284954$15$F$2017$20200702$20170301$20200715$EXP$$US-INCYTE CORPORATION-2017IN001205$INCYTE$$$$$$Y$$$20200715$$CN$US$US
132850462$13285046$2$F$$20200727$20170301$20200731$EXP$$CZ-MYLANLABS-2017M1012286$MYLAN$KARVUNIDIS T, HARAZIM M, RADEJ J, NOVAK I, HORAK J, MATEJOVIC M. LACTIC ACIDOSIS ASSOCIATED WITH METFORMIN ? MINI?REVIEW ON THE CASE REPORTS.. ANESTEZIOL?INTENZ?MED. 2016?27(4):243?251$70$YR$$F$Y$$$20200731$$HP$CZ$CZ
132855084$13285508$4$F$2017$20170224$20170301$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-01813$VIFOR$$56$YR$A$M$Y$$$20200715$$CN$US$US
132867112$13286711$2$F$2015$20200801$20170301$20200811$EXP$$US-BIOGEN-2017BI00363531$BIOGEN$$$$$M$Y$$$20200811$$CN$US$US
132876038$13287603$8$F$2017$20200908$20170302$20200912$EXP$$PHHY2017CA011070$NOVARTIS$$70$YR$$M$Y$$$20200912$$CN$COUNTRY NOT SPECIFIED$CA
132878026$13287802$6$F$2015$20200919$20170302$20200925$PER$$PHHY2015US087606$NOVARTIS$$70$YR$$M$Y$$$20200925$$CN$US$US
132879442$13287944$2$F$$20200817$20170302$20200820$EXP$$CA-BAXTER-2017BAX008933$BAXTER$$66$YR$$F$Y$80$KG$20200820$$HP$CA$CA
1328808510$13288085$10$F$$20200914$20170302$20200917$PER$$CA-AMGEN-CANSP2017030438$AMGEN$$44$YR$A$F$Y$$$20200917$$CN$CA$CA
132886114$13288611$4$F$$20200701$20170302$20200702$PER$$US-PFIZER INC-2017079065$PFIZER$$67$YR$$F$Y$$$20200702$$CN$US$US
132887058$13288705$8$F$201701$20200916$20170302$20200918$PER$$US-PFIZER INC-2017090056$PFIZER$$61$YR$$F$Y$$$20200918$$CN$US$US
132900966$13290096$6$F$20170223$20200803$20170303$20200806$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-017753$BRISTOL MYERS SQUIBB$SAKAMOTO N.. A STUDY ON CLINICAL CHARACTERISTICS OF 7 CASES OF NON?SMALL CELL LUNG CANCER COMPLICATED WITH DRUG?INDUCED LUNG DISORDER AFTER NIVOLUMAB ADMINISTRATION.. THE JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE.. 2018?107(S):105$70$YR$$M$Y$$$20200806$$MD$JP$JP
132902885$13290288$5$F$20170103$20171213$20170302$20171226$EXP$$US-JNJFOC-20170210445$JANSSEN$$84$YR$E$F$Y$64.41$KG$20171226$$MD$US$US
1329078721$13290787$21$F$2017$20200806$20170302$20200818$EXP$$US-INCYTE CORPORATION-2017IN001261$INCYTE$$$$$$Y$$$20200818$$CN$US$US
132922143$13292214$3$F$20170203$20170303$20170303$20170308$EXP$$US-JNJFOC-20170301339$JANSSEN$$77$YR$E$F$Y$90$KG$20170308$$MD$US$US
1329262610$13292626$10$F$2016$20200915$20170303$20200918$EXP$$US-PFIZER INC-2017092178$PFIZER$$56$YR$$F$Y$$$20200918$$MD$US$US
132927529$13292752$9$F$$20200831$20170303$20200907$EXP$$PHEH2017US006449$NOVARTIS$$$$$F$Y$$$20200907$$MD$US$US
1329286810$13292868$10$F$2001$20200810$20170303$20200813$EXP$$DE-009507513-1702DEU011068$MERCK$$29$YR$$M$Y$$$20200813$$MD$DE$DE
132929744$13292974$4$F$20150421$20200921$20170303$20200923$PER$$US-JNJFOC-20161203814$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200923$$LW$US$US
132930503$13293050$3$F$20160512$20200707$20170303$20200710$PER$$US-JNJFOC-20170104583$JOHNSON AND JOHNSON$$73$YR$$F$Y$$$20200710$$LW$US$US
132930563$13293056$3$F$20120520$20200909$20170303$20200914$PER$$US-JNJFOC-20170104380$JOHNSON AND JOHNSON$$67$YR$E$M$Y$118.04$KG$20200914$$CN$US$US
132930572$13293057$2$F$20160519$20200901$20170303$20200914$PER$$US-JNJFOC-20161004695$JOHNSON AND JOHNSON$$55$YR$A$M$Y$136.08$KG$20200914$$CN$US$US
132930623$13293062$3$F$20150124$20200920$20170303$20200923$EXP$$US-JNJFOC-20170105432$JOHNSON AND JOHNSON$$76$YR$E$M$Y$91$KG$20200923$$CN$US$US
132931733$13293173$3$F$201509$20200727$20170303$20200731$PER$$US-JNJFOC-20170114603$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200731$$CN$US$US
132931813$13293181$3$F$20150109$20200908$20170303$20200914$PER$$US-JNJFOC-20170115270$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200914$$CN$US$US
132932142$13293214$2$F$20120529$20200817$20170303$20200824$PER$$US-JNJFOC-20161225831$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20200824$$CN$US$US
132932432$13293243$2$F$20160428$20200720$20170303$20200724$PER$$US-JNJFOC-20161217944$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200724$$CN$US$US
132932633$13293263$3$F$2013$20200708$20170303$20200717$EXP$$US-JNJFOC-20170120033$JOHNSON AND JOHNSON$$66$YR$$F$Y$$$20200717$$CN$US$US
132932693$13293269$3$F$20160423$20200723$20170303$20200728$PER$$US-JNJFOC-20170119939$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200728$$CN$US$US
132932713$13293271$3$F$20160415$20200927$20170303$20200929$PER$$US-JNJFOC-20170119992$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200929$$CN$US$US
132933073$13293307$3$F$201503$20200805$20170303$20200813$PER$$US-JNJFOC-20170121420$JOHNSON AND JOHNSON$$65$YR$$F$Y$$$20200813$$CN$US$US
132933893$13293389$3$F$201206$20200818$20170303$20200821$PER$$US-JNJFOC-20170124585$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20200821$$CN$US$US
132934053$13293405$3$F$20151102$20200730$20170303$20200806$EXP$$US-JNJFOC-20170125601$JOHNSON AND JOHNSON$$94$YR$E$F$Y$$$20200806$$CN$US$US
132934073$13293407$3$F$20140901$20200802$20170303$20200810$EXP$$US-JNJFOC-20170125611$JOHNSON AND JOHNSON$$38$YR$A$F$Y$$$20200810$$CN$US$US
132934563$13293456$3$F$20151024$20200924$20170303$20200928$PER$$US-JNJFOC-20170125945$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200928$$CN$US$US
132934683$13293468$3$F$201505$20200810$20170303$20200813$PER$$US-JNJFOC-20170126229$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20200813$$CN$US$US
132934733$13293473$3$F$20160804$20200716$20170303$20200721$PER$$US-JNJFOC-20170126154$JOHNSON AND JOHNSON$$62$YR$A$M$Y$153.45$KG$20200721$$CN$US$US
132934894$13293489$4$F$20140413$20200830$20170303$20200911$EXP$$US-JNJFOC-20170127241$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200911$$CN$US$US
132934902$13293490$2$F$201605$20200804$20170303$20200806$PER$$US-JNJFOC-20161210012$JOHNSON AND JOHNSON$$71$YR$E$M$Y$88.98$KG$20200806$$CN$US$US
132935753$13293575$3$F$201401$20200721$20170303$20200731$PER$$US-JNJFOC-20170200347$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200731$$CN$US$US
132936143$13293614$3$F$201512$20200826$20170303$20200831$PER$$US-JNJFOC-20170201590$JOHNSON AND JOHNSON$$67$YR$E$M$Y$139.09$KG$20200831$$LW$US$US
132936422$13293642$2$F$201503$20200830$20170303$20200902$PER$$US-JNJFOC-20161222542$JOHNSON AND JOHNSON$$49$YR$A$F$Y$162.39$KG$20200902$$CN$US$US
132936643$13293664$3$F$20150102$20200806$20170303$20200818$EXP$$US-JNJFOC-20161225885$JOHNSON AND JOHNSON$$94$YR$E$F$Y$54.4$KG$20200818$$CN$US$US
132940785$13294078$5$F$20170131$20170412$20170303$20180228$EXP$$AU-BAXALTA-2017BLT001439$SHIRE$$41$YR$$M$Y$$$20180226$$MD$AU$AU
132943464$13294346$4$F$2017$20170607$20170303$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-02163$VIFOR$$84$YR$E$M$Y$$$20200715$$PH$US$US
132943563$13294356$3$F$20170217$20170227$20170303$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-02235$VIFOR$$56$YR$A$M$Y$$$20200715$$PH$US$US
132944581$13294458$1$I$20170217$20170220$20170303$20170303$EXP$$DE-JNJFOC-20170302055$JANSSEN$$53$YR$A$M$Y$83$KG$20170303$$MD$DE$DE
132944622$13294462$2$F$20140921$20200803$20170303$20200805$PER$$US-JNJFOC-20161201683$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200805$$CN$US$US
132944643$13294464$3$F$20141204$20200810$20170303$20200819$EXP$$US-JNJFOC-20161204286$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20200819$$CN$US$US
132944862$13294486$2$F$20141028$20200719$20170303$20200721$PER$$US-JNJFOC-20160907360$JOHNSON AND JOHNSON$$30$YR$A$F$Y$$$20200721$$LW$US$US
132945172$13294517$2$F$20150101$20200827$20170303$20200831$PER$$US-JNJFOC-20161209744$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20200831$$HP$US$US
132945453$13294545$3$F$201501$20200908$20170303$20200914$PER$$US-JNJFOC-20161205119$JOHNSON AND JOHNSON$$60$YR$A$M$Y$87.17$KG$20200914$$CN$US$US
132947162$13294716$2$F$201412$20200628$20170303$20200702$PER$$US-JNJFOC-20161205009$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200702$$HP$US$US
132947363$13294736$3$F$20150412$20200813$20170303$20200819$PER$$US-JNJFOC-20170206412$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200819$$CN$US$US
132947612$13294761$2$F$20141206$20200804$20170303$20200806$PER$$US-JNJFOC-20161209670$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200806$$CN$US$US
132947994$13294799$4$F$20150225$20200709$20170303$20200714$PER$$US-JNJFOC-20170209751$JOHNSON AND JOHNSON$$59$YR$$F$Y$$$20200714$$CN$US$US
132948003$13294800$3$F$20130207$20200714$20170303$20200717$PER$$US-JNJFOC-20170210296$JOHNSON AND JOHNSON$$41$YR$$F$Y$$$20200717$$CN$US$US
132948183$13294818$3$F$201501$20200916$20170303$20200929$EXP$$US-JNJFOC-20170211164$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200929$$CN$US$US
132948223$13294822$3$F$20140624$20200714$20170303$20200717$PER$$US-JNJFOC-20170211091$JOHNSON AND JOHNSON$$85$YR$$M$Y$$$20200717$$CN$US$US
132948482$13294848$2$F$20150622$20200803$20170303$20200805$PER$$US-JNJFOC-20161214930$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200805$$CN$US$US
132948614$13294861$4$F$201310$20200803$20170303$20200806$PER$$US-JNJFOC-20170213001$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20200806$$CN$US$US
132948662$13294866$2$F$20160421$20200903$20170303$20200914$PER$$US-JNJFOC-20170203079$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200914$$HP$US$US
132948683$13294868$3$F$20141010$20200824$20170303$20200827$PER$$US-JNJFOC-20170213194$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20200827$$CN$US$US
132948873$13294887$3$F$20130212$20200729$20170303$20200805$EXP$$US-JNJFOC-20170212834$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200805$$CN$US$US
132949172$13294917$2$F$20141219$20200902$20170303$20200909$PER$$US-JNJFOC-20161217657$JOHNSON AND JOHNSON$$86$YR$E$M$Y$$$20200909$$CN$US$US
132949564$13294956$4$F$20130116$20200824$20170303$20200827$PER$$US-JNJFOC-20170215178$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200827$$CN$US$US
132949943$13294994$3$F$201512$20200727$20170303$20200731$PER$$US-JNJFOC-20170218245$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200731$$CN$US$US
132950813$13295081$3$F$20160819$20200816$20170303$20200819$PER$$US-JNJFOC-20170204333$JOHNSON AND JOHNSON$$48$YR$A$M$Y$$$20200819$$CN$US$US
132951082$13295108$2$F$20140217$20200820$20170303$20200824$PER$$US-JNJFOC-20170213328$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200824$$CN$US$US
132951372$13295137$2$F$20160623$20200906$20170303$20200909$PER$$US-JNJFOC-20170210305$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20200909$$CN$US$US
132951403$13295140$3$F$20160714$20200803$20170303$20200805$PER$$US-JNJFOC-20170219603$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200805$$CN$US$US
132952283$13295228$3$F$20140305$20200820$20170303$20200825$PER$$US-JNJFOC-20161214931$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200825$$CN$US$US
132952983$13295298$3$F$20140719$20200813$20170303$20200819$PER$$US-JNJFOC-20161217947$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200819$$CN$US$US
132953044$13295304$4$F$20131018$20200706$20170303$20200713$PER$$US-JNJFOC-20161217946$JOHNSON AND JOHNSON$$34$YR$$F$Y$$$20200713$$CN$US$US
132953533$13295353$3$F$20160306$20200922$20170303$20200928$PER$$US-JNJFOC-20161221029$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200928$$CN$US$US
132953653$13295365$3$F$20130410$20200906$20170303$20200914$PER$$US-JNJFOC-20161222721$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200914$$CN$US$US
132953863$13295386$3$F$201411$20200720$20170303$20200724$PER$$US-JNJFOC-20161224238$JOHNSON AND JOHNSON$$64$YR$A$F$Y$120$KG$20200724$$CN$US$US
132953894$13295389$4$F$20151223$20200812$20170303$20200819$PER$$US-JNJFOC-20161224288$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20200819$$CN$US$US
132953903$13295390$3$F$20150830$20200706$20170303$20200717$EXP$$US-JNJFOC-20161224083$JOHNSON AND JOHNSON$$97$YR$$F$Y$$$20200717$$CN$US$US
132954093$13295409$3$F$20150814$20200924$20170303$20200930$PER$$US-JNJFOC-20170106566$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200930$$CN$US$US
132954293$13295429$3$F$20160421$20200831$20170303$20200902$PER$$US-JNJFOC-20170109668$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20200902$$CN$US$US
132955934$13295593$4$F$20170222$20170427$20170303$20170502$EXP$$GB-JNJFOC-20170226441$JANSSEN$$79$YR$E$M$Y$42.28$KG$20170502$$MD$GB$GB
132958624$13295862$4$F$20170214$20200922$20170303$20200929$PER$$US-JAZZ-2017-US-002836$JAZZ$$36$YR$$F$Y$$$20200929$$HP$US$US
132958669$13295866$9$F$2016$20200901$20170303$20200909$EXP$$US-BIOGEN-2017BI00366008$BIOGEN$$$$$F$Y$$$20200908$$HP$US$US
132959454$13295945$4$F$$20200817$20170303$20200824$EXP$$PHHY2017CA030470$NOVARTIS$$$$$F$Y$$$20200824$$CN$COUNTRY NOT SPECIFIED$CA
1329689711$13296897$11$F$$20200817$20170306$20200820$PER$$PHEH2017US006612$NOVARTIS$$$$$F$Y$$$20200820$$MD$US$US
132971353$13297135$3$F$$20200629$20170306$20200706$PER$$CA-AMGEN-CANSP2016112986$AMGEN$$69$YR$E$F$Y$$$20200706$$CN$CA$CA
132974796$13297479$6$F$201512$20200723$20170306$20200729$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1173$ORION$$64$YR$$F$Y$$$20200729$$MD$CA$CA
1329761811$13297618$11$F$20200526$20200706$20170306$20200707$EXP$$US-PFIZER INC-2017090040$PFIZER$$52$YR$$F$Y$108$KG$20200707$$MD$US$US
132983402$13298340$2$F$201501$20200908$20170306$20200911$EXP$$US-BAYER-2016-236451$BAYER$$60$YR$A$M$Y$87.17$KG$20200911$$CN$US$US
132984472$13298447$2$F$201403$20200727$20170306$20200803$EXP$$US-BIOGEN-2017BI00365919$BIOGEN$$63$YR$$F$Y$$$20200803$$CN$US$US
132986163$13298616$3$F$$20200625$20170306$20200701$EXP$$FR-PFIZER INC-2015310733$PFIZER$$31$YR$$F$Y$$$20200701$$CN$FR$FR
132988864$13298886$4$F$20150330$20200702$20170306$20200715$EXP$$US-JNJFOC-20170303537$JOHNSON AND JOHNSON$$58$YR$$F$Y$$$20200715$$CN$US$US
132990487$13299048$7$F$20150326$20200824$20170306$20200907$EXP$$DE-INCYTE CORPORATION-2017IN001570$INCYTE$$$$$$Y$$$20200907$$MD$DE$DE
132991805$13299180$5$F$2004$20200717$20170306$20200728$EXP$$US-BIOGEN-2008BI025295$BIOGEN$$56$YR$$F$Y$65.38$KG$20200728$$HP$US$US
132992432$13299243$2$F$20161004$20170315$20170306$20170323$EXP$$CZ-JNJFOC-20170110616$JANSSEN$$72$YR$E$M$Y$81$KG$20170323$$MD$CZ$CZ
132995279$13299527$9$F$$20200629$20170306$20200707$EXP$$CA-PFIZER INC-2016375688$PFIZER$$$$$F$Y$$$20200707$$CN$CA$CA
132998209$13299820$9$F$201902$20200724$20170306$20200806$EXP$$US-ACTELION-A-NJ2017-150572$ACTELION$$51$YR$$F$Y$58.96$KG$20200806$$HP$US$US
132999352$13299935$2$F$$20200911$20170306$20200915$PER$$US-PFIZER INC-2017091145$PFIZER$$62$YR$$F$Y$$$20200915$$MD$US$US
132999363$13299936$3$F$$20200925$20170306$20200929$PER$$US-PFIZER INC-2017098800$PFIZER$$67$YR$$F$Y$$$20200929$$MD$US$US
133012817$13301281$7$F$$20200927$20170307$20200929$PER$$US-PFIZER INC-2017094302$PFIZER$$78$YR$$F$Y$75$KG$20200929$$MD$US$US
133014168$13301416$8$F$20080617$20200707$20170307$20200713$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0946$ORION$$45$YR$$F$Y$115$KG$20200713$$HP$CA$CA
133022832$13302283$2$F$20160512$20200707$20170307$20200720$EXP$$US-BAYER-2017-003673$BAYER$$73$YR$E$F$Y$$$20200720$$LW$US$US
133026307$13302630$7$F$20170227$20170726$20170307$20170803$EXP$$RS-JNJFOC-20170300677$JANSSEN$$67$YR$E$F$Y$65$KG$20170803$$MD$RS$RS
133026647$13302664$7$F$201608$20200914$20170307$20200917$EXP$NO-NOMAADVRE-RELISV-2017-23478$NO-SA-2017SA034170$SANOFI AVENTIS$$$$$$Y$$$20200917$$MD$NO$NO
1330273410$13302734$10$F$20170105$20180525$20170307$20200923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-019216$BRISTOL MYERS SQUIBB$SAITO K, ET AL. A CASE OF MALIGNANT MELANOMA WITH DELIRIUM SYMPTOMS RESULTING IN A DIAGNOSIS OF ACTH HYPOSECRETION UNDER OPDIVO THERAPY. 2018?90$77$YR$$F$Y$$$20200923$$HP$JP$JP
133028331$13302833$1$I$20151110$20170227$20170307$20170307$EXP$ES-AGEMED-405527340$ES-AMGEN-ESPSP2017032221$AMGEN$$70$YR$E$F$Y$$$20170307$$HP$ES$ES
1330403414$13304034$14$F$20161027$20200909$20170307$20200911$EXP$$PHHY2017DE010026$NOVARTIS$$68$YR$$F$Y$55$KG$20200911$$CN$DE$DE
133042034$13304203$4$F$20160412$20181101$20170308$20181115$EXP$$US-ROCHE-1903254$ROCHE$$58$YR$$F$Y$62.65$KG$20181115$$MD$US$US
133042817$13304281$7$F$20170221$20200728$20170308$20200805$EXP$$TW-ACTELION-A-CH2017-150256$ACTELION$$41$YR$$M$Y$$$20200805$$CN$TW$TW
133047367$13304736$7$F$20160223$20200812$20170308$20200824$EXP$$US-DRREDDYS-USA/USA/16/0083421$DR REDDYS$$78$YR$E$F$Y$77$KG$20200824$$MD$US$US
133051316$13305131$6$F$201910$20200819$20170308$20200825$EXP$$PHHY2017CA030045$NOVARTIS$$64$YR$$M$Y$$$20200825$$HP$CA$CA
133051512$13305151$2$F$20200622$20200804$20170308$20200806$EXP$$US-PFIZER INC-2017093168$PFIZER$$42$YR$$F$Y$$$20200806$$HP$US$US
133058894$13305889$4$F$$20200928$20170308$20200929$PER$$US-AMGEN-USASL2017030118$AMGEN$$32$YR$A$F$Y$$$20200929$$MD$US$US
1330698116$13306981$16$F$20161231$20191021$20170308$20200817$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-018584$BRISTOL MYERS SQUIBB$$63$YR$$F$Y$$$20200817$$HP$DE$DE
133072174$13307217$4$F$2017$20200812$20170308$20200814$EXP$$US-SA-2017SA036729$SANOFI AVENTIS$$$$$$Y$$$20200814$$CN$US$US
133093802$13309380$2$F$20160912$20170307$20170309$20170313$EXP$$US-JNJFOC-20160919742$PHARMACYCLICS$$77$YR$E$F$Y$107.2$KG$20170313$$MD$US$US
133104298$13310429$8$F$201407$20200629$20170309$20200710$EXP$$US-JNJFOC-20170202926$JOHNSON AND JOHNSON$$14$YR$$M$Y$$$20200710$$LW$US$US
133116337$13311633$7$F$20131011$20200828$20170309$20200902$PER$$US-JNJFOC-20170304292$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20200902$$LW$US$US
133125051$13312505$1$I$20161127$20170301$20170309$20170309$EXP$$US-G+W LABS-GW2017US000092$G AND W LAB$$$$$$Y$$$20170309$$HP$US$US
1331254912$13312549$12$F$20170220$20200816$20170309$20200820$EXP$$CZ-BIOGEN-2017BI00368305$BIOGEN$VANECKOVA M, MARTINKOVA A, TUPY R, FIEDLER J, STETKAROVA I, MEDOVA E, VACHOVA M, GRUNERMELOVA M, MELUZINOVA E, ADAMKOVA J, KUBALE J, TALABOVA M, HORAKOVA D, HAVRDOVA E, MARKOVA J. THE SPECTRUM OF MRI FINDINGS OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN PATIENTS WITH MULTIPLE SCLEROSIS IN THE CZECH REPUBLIC. DOI: 10.14735/AMCSNN2019381.. CESK SLOV NEUROL N. 2019?4:381?390.$53$YR$$F$Y$$$20200820$$MD$CZ$CZ
133128803$13312880$3$F$20170301$20180907$20170309$20180920$EXP$$BE-JNJFOC-20170305293$JANSSEN$$57$YR$A$F$Y$69.8$KG$20180913$$MD$BE$BE
133131216$13313121$6$F$$20200911$20170309$20200917$EXP$$US-BIOGEN-2017BI00367921$BIOGEN$$$$$F$Y$$$20200917$$CN$US$US
133131812$13313181$2$F$20170218$20200820$20170309$20200901$EXP$$FI-JNJFOC-20170307740$JOHNSON AND JOHNSON$$93$YR$E$M$Y$$$20200901$$MD$FI$FI
133137622$13313762$2$F$20160518$20170327$20170309$20170406$EXP$$FR-JNJFOC-20160526073$JANSSEN$$70$YR$E$F$Y$60$KG$20170406$$MD$FR$FR
133140053$13314005$3$F$20161013$20200810$20170309$20200820$EXP$$US-TEVA-745505USA$TEVA$$46$YR$A$F$Y$50$KG$20200820$$MD$US$US
133142783$13314278$3$F$20170227$20170309$20170309$20170317$EXP$$GB-JNJFOC-20170303507$JANSSEN$$64$YR$A$F$Y$64$KG$20170317$$MD$GB$GB
133143284$13314328$4$F$$20200819$20170309$20200825$PER$$US-JAZZ-2017-US-002928$JAZZ$$$$$M$Y$$$20200825$$MD$US$US
133144825$13314482$5$F$20170223$20200622$20170309$20200706$EXP$$US-ACTELION-A-NJ2017-150769$ACTELION$$47$YR$$F$Y$81.63$KG$20200706$$HP$US$US
1331449725$13314497$25$F$201702$20200908$20170309$20200911$EXP$$PHHY2017CA034348$NOVARTIS$$77$YR$$M$Y$$$20200911$$CN$COUNTRY NOT SPECIFIED$CA
133145142$13314514$2$F$20150302$20200816$20170309$20200820$EXP$$US-BAYER-2017-046467$BAYER$$82$YR$E$M$Y$$$20200820$$CN$US$US
133145973$13314597$3$F$20170228$20170329$20170309$20170406$EXP$$PL-JNJFOC-20170305277$JANSSEN$$80$YR$E$F$Y$64$KG$20170406$$MD$PL$PL
133168291$13316829$1$I$20160810$20161116$20170310$20170310$EXP$$MX-ACTELION-A-CH2016-145763$ACTELION$$42$YR$A$F$Y$64.5$KG$20170310$$MD$MX$MX
133192415$13319241$5$F$$20200710$20170309$20200710$EXP$$CA-ROCHE-1902165$ROCHE$$55$YR$$F$Y$$$20200710$$CN$CA$CA
1331936719$13319367$19$F$20140203$20200908$20170310$20200915$EXP$$PHHY2014CA015339$NOVARTIS$$78$YR$$F$Y$$$20200915$$HP$CA$CA
1331958516$13319585$16$F$1999$20200921$20170309$20200924$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1336$ORION$$47$YR$$F$Y$$$20200924$$MD$CA$CA
133208102$13320810$2$F$20130410$20200906$20170310$20200911$EXP$$US-BAYER-2016-245465$BAYER$$80$YR$E$F$Y$$$20200911$$HP$US$US
133209061$13320906$1$I$20161216$20161221$20170309$20170309$EXP$$JP-ROCHE-1880440$ROCHE$$68$YR$$F$Y$57$KG$20170309$$MD$JP$JP
1332139212$13321392$12$F$$20200817$20170309$20200821$EXP$$PHEH2017US006615$NOVARTIS$$$$$M$Y$$$20200821$$MD$US$US
133219879$13321987$9$F$20170306$20200810$20170310$20200817$EXP$$GB-MYLANLABS-2017M1014595$MYLAN$$32$YR$$M$Y$$$20200817$$MD$GB$GB
133220104$13322010$4$F$20170110$20200728$20170310$20200803$EXP$$GB-MYLANLABS-2017M1003101$MYLAN$$41$YR$$F$Y$$$20200803$$MD$GB$GB
133220894$13322089$4$F$2017$20200720$20170310$20200727$EXP$$US-SA-2017SA038504$SANOFI AVENTIS$$$$$F$Y$$$20200727$$HP$US$US
133222262$13322226$2$F$20151102$20200730$20170310$20200811$EXP$$US-BAYER-2017-017466$BAYER$$94$YR$E$F$Y$$$20200811$$CN$US$US
133229672$13322967$2$F$20150815$20200813$20170309$20200819$EXP$$US-BAYER-2016-230234$BAYER$$88$YR$E$M$Y$$$20200819$$CN$US$US
1332331915$13323319$15$F$20160801$20200914$20170310$20200918$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-020300$BRISTOL MYERS SQUIBB$$28$YR$$M$Y$$$20200918$$HP$CA$CA
133251967$13325196$7$F$20180821$20200730$20170310$20200813$EXP$$US-ACTELION-A-US2017-151000$ACTELION$$54$YR$$F$Y$131.52$KG$20200813$$HP$US$US
133290606$13329060$6$F$20151113$20200910$20170313$20200918$EXP$$AU-BIOGEN-2016BI00184214$BIOGEN$$67$YR$$F$Y$$$20200918$$CN$AU$AU
133293301$13329330$1$I$20170208$20170308$20170313$20170313$EXP$$AU-JNJFOC-20170310528$PHARMACYCLICS$$73$YR$E$M$Y$$$20170313$$MD$AU$AU
1332960710$13329607$10$F$$20200806$20170313$20200813$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK057166$GLAXOSMITHKLINE$$$$$F$Y$87$KG$20200813$$CN$BR$BR
133296763$13329676$3$F$20150812$20200717$20170313$20200729$EXP$$US-INCYTE CORPORATION-2017IN001818$INCYTE$$$$$$Y$$$20200729$$CN$US$US
133298254$13329825$4$F$20170215$20170607$20170313$20170614$EXP$$HU-JNJFOC-20170304711$JANSSEN$$29$YR$A$F$Y$63$KG$20170614$$MD$HU$HU
133300053$13330005$3$F$1991$20200928$20170313$20200930$EXP$$US-PFIZER INC-2017102656$PFIZER$$59$YR$$F$Y$$$20200930$$CN$US$US
133300325$13330032$5$F$$20200908$20170313$20200910$PER$$US-PFIZER INC-2017103721$PFIZER$$56$YR$$F$Y$$$20200910$$HP$US$US
133327445$13332744$5$F$$20200626$20170314$20200702$PER$$US-PFIZER INC-2017102303$PFIZER$$79$YR$$F$Y$$$20200702$$CN$US$US
133328884$13332888$4$F$$20200908$20170314$20200911$PER$$US-PFIZER INC-2017103725$PFIZER$$56$YR$$F$Y$$$20200911$$HP$US$US
133331959$13333195$9$F$20120920$20200625$20170313$20200707$EXP$$GB-MYLANLABS-2016M1031539$MYLAN$$57$YR$$M$Y$$$20200707$$MD$GB$GB
133341642$13334164$2$F$200812$20200706$20170313$20200713$EXP$$US-BIOGEN-2008BI033337$BIOGEN$$46$YR$$M$Y$$$20200713$$CN$US$US
1333433011$13334330$11$F$2020$20200710$20170313$20200714$EXP$$NL-ABBVIE-17P-114-1903111-00$ABBVIE$$66$YR$$M$Y$86.5$KG$20200714$$CN$US$NL
1333456712$13334567$12$F$2016$20200630$20170314$20200701$EXP$$US-PFIZER INC-2016557055$PFIZER$$66$YR$$F$Y$$$20200701$$HP$US$US
133355336$13335533$6$F$20150101$20200909$20170314$20200911$EXP$$PHHY2016CO105662$NOVARTIS$$62$YR$$M$Y$68$KG$20200911$$CN$CO$CO
133361436$13336143$6$F$20160404$20200618$20170314$20200702$EXP$$US-ACTELION-A-NJ2017-150752$ACTELION$$51$YR$$F$Y$$$20200702$$MD$US$US
133365688$13336568$8$F$20170222$20200914$20170315$20200925$EXP$$IT-AUROBINDO-AUR-APL-2017-31034$AUROBINDO$$24$YR$$F$Y$$$20200925$$HP$IT$IT
133366507$13336650$7$F$20170204$20200707$20170314$20200713$EXP$$US-JAZZ-2017-US-002154$JAZZ$$52$YR$$F$Y$$$20200713$$CN$US$US
133367182$13336718$2$F$201701$20200629$20170314$20200820$PER$$US-JAZZ-2016-US-024307$JAZZ$$40$YR$$F$Y$$$20200820$$HP$US$US
133375897$13337589$7$F$2015$20200910$20170315$20200915$EXP$$US-BIOGEN-2017BI00372049$BIOGEN$$$$$F$Y$$$20200915$$CN$US$US
133376834$13337683$4$F$$20200805$20170315$20200810$EXP$$US-PFIZER INC-2016543643$PFIZER$$57$YR$$F$Y$$$20200810$$MD$US$US
133377826$13337782$6$F$2016$20200805$20170315$20200806$PER$$US-TAKEDA-2017MPI001920$TAKEDA$$$$$F$Y$$$20200806$$CN$US$US
133385217$13338521$7$F$2017$20200625$20170315$20200701$EXP$$US-SA-2017SA042093$SANOFI AVENTIS$$$$$$Y$$$20200701$$HP$US$US
133395932$13339593$2$F$201612$20200701$20170315$20200709$EXP$FR-AFSSAPS-RN20170287$PHHY2017FR034601$NOVARTIS$$82$YR$$F$Y$$$20200709$$HP$FR$FR
133395977$13339597$7$F$201612$20200625$20170315$20200703$EXP$$GXKR2017DE000709$NOVARTIS$$13$YR$$F$Y$70.3$KG$20200703$$HP$DE$DE
1333971413$13339714$13$F$20171023$20200723$20170315$20200804$EXP$$US-BIOMARINAP-US-2017-113104$BIOMARIN$$17$YR$$F$Y$38.1$KG$20200804$$HP$US$US
1333995425$13339954$25$F$20170307$20200717$20170316$20200724$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-020728$BRISTOL MYERS SQUIBB$$63$YR$$M$Y$$$20200724$$CN$CA$CA
133402301$13340230$1$I$20170227$20170306$20170316$20170316$EXP$$DE-ROCHE-1903246$ROCHE$$76$YR$$M$Y$61$KG$20170316$$MD$DE$DE
1334041211$13340412$11$F$$20200629$20170316$20200701$PER$$US-PFIZER INC-2017109131$PFIZER$$51$YR$$M$Y$104$KG$20200701$$MD$US$US
133404178$13340417$8$F$$20200904$20170316$20200908$PER$$US-PFIZER INC-2017107265$PFIZER$$81$YR$$F$Y$68$KG$20200908$$CN$US$US
133406151$13340615$1$I$20161201$20161208$20170316$20170316$EXP$$JP-ROCHE-1875856$ROCHE$$68$YR$$M$Y$61$KG$20170316$$MD$JP$JP
133414914$13341491$4$F$20160129$20200722$20170316$20200729$EXP$$US-ROCHE-1711735$ROCHE$$78$YR$$F$Y$$$20200729$$CN$US$US
133428313$13342831$3$F$20170307$20170619$20170316$20170628$EXP$$FR-JNJFOC-20170309676$JANSSEN$$60$YR$A$F$Y$74.3$KG$20170628$$MD$FR$FR
133428654$13342865$4$F$$20200904$20170316$20200908$PER$$US-PFIZER INC-2017107428$PFIZER$$69$YR$$F$Y$$$20200908$$CN$US$US
133436554$13343655$4$F$$20200727$20170316$20200731$EXP$$US-JAZZ-2017-US-002234$JAZZ$$$$$M$Y$$$20200731$$CN$US$US
133444468$13344446$8$F$20170307$20180725$20170317$20180731$EXP$$CN-ROCHE-1903883$ROCHE$$64$YR$$F$Y$48$KG$20180731$$MD$CN$CN
133446012$13344601$2$F$$20200818$20170317$20200901$EXP$$US-GLENMARK PHARMACEUTICALS-2017GMK026746$GLENMARK$$$$E$M$Y$$$20200901$$HP$US$US
133446203$13344620$3$F$20161221$20200109$20170317$20200122$EXP$$ZA-BEH-2017077423$CSL BEHRING$$18$MON$I$M$Y$$$20200122$$CN$DE$ZA
133454436$13345443$6$F$20161201$20200109$20170317$20200122$EXP$$IT-BEH-2016076088$CSL BEHRING$$2$YR$C$M$Y$12.5$KG$20200122$$CN$US$IT
1334561710$13345617$10$F$201505$20200803$20170317$20200811$EXP$$GB-ROCHE-1614575$ROCHE$$79$YR$$F$Y$$$20200811$$MD$GB$GB
133459873$13345987$3$F$20160831$20170801$20170317$20170815$EXP$$JP-JNJFOC-20161200401$JANSSEN$$68$YR$E$M$Y$68$KG$20170815$$MD$JP$JP
133466628$13346662$8$F$2017$20200731$20170317$20200805$EXP$$US-SA-2017SA011914$SANOFI AVENTIS$$$$$$Y$$$20200805$$HP$US$US
133474725$13347472$5$F$20170304$20170509$20170317$20170518$EXP$$GB-JNJFOC-20170317444$PHARMACYCLICS$$56$YR$A$M$Y$$$20170518$$MD$GB$GB
133481762$13348176$2$F$$20200626$20170318$20200704$PER$$US-AMGEN-USASL2017038057$AMGEN$$66$YR$E$F$Y$$$20200704$$CN$US$US
133491138$13349113$8$F$$20200630$20170320$20200709$PER$$PHEH2017US008096$NOVARTIS$$$$$F$Y$45.35$KG$20200709$$LW$US$US
133496095$13349609$5$F$201412$20200714$20170320$20200716$EXP$$PHHY2017SK041887$NOVARTIS$$27$YR$$F$Y$50$KG$20200716$$MD$SK$SK
133498731$13349873$1$I$20140214$20151103$20170320$20170320$EXP$$US-ASTELLAS-2015US041141$ASTELLAS$$65$YR$$M$Y$$$20170320$$CN$US$US
133500031$13350003$1$I$20170305$20170307$20170320$20170320$EXP$$CA-PFIZER INC-2017115699$PFIZER$$70$YR$$F$Y$$$20170320$$MD$CA$CA
133504374$13350437$4$F$2009$20200715$20170320$20200724$EXP$$US-BIOGEN-2017BI00373912$BIOGEN$$$$$F$Y$$$20200724$$CN$US$US
133505055$13350505$5$F$20160831$20200901$20170320$20200908$EXP$$US-BAUSCH-BL-2017-006784$BAUSCH AND LOMB$$68$YR$$M$Y$147.55$KG$20200908$$CN$US$US
133507023$13350702$3$F$20150912$20200713$20170320$20200716$PER$$US-JNJFOC-20170316215$JOHNSON AND JOHNSON$$69$YR$$F$Y$$$20200716$$CN$US$US
133508527$13350852$7$F$20170308$20200107$20170320$20200110$PER$$PHEH2017US007759$NOVARTIS$$4$YR$$M$Y$$$20200110$$CN$US$US
133508685$13350868$5$F$201504$20200623$20170320$20200707$EXP$$US-JNJFOC-20170319188$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200707$$CN$US$US
133510723$13351072$3$F$$20200727$20170320$20200729$EXP$$US-PFIZER INC-2017111857$PFIZER$$63$YR$$M$Y$$$20200729$$MD$US$US
133514233$13351423$3$F$2013$20200903$20170320$20200907$EXP$$US-PFIZER INC-2017112896$PFIZER$$60$YR$$F$Y$132$KG$20200907$$CN$US$US
133515122$13351512$2$F$20161212$20200818$20170320$20200825$EXP$$FR-ABBVIE-17P-056-1913441-00$ABBVIE$$76$YR$$F$Y$$$20200825$$HP$FR$FR
133526752$13352675$2$F$$20200629$20170320$20200702$PER$$US-JAZZ-2017-US-003622$JAZZ$$$$$F$Y$$$20200702$$MD$US$US
133530181$13353018$1$I$20160901$20161128$20170321$20170321$EXP$$GB-TEVA-718189ACC$TEVA$$72$YR$$M$Y$$$20170321$$MD$GB$GB
133538567$13353856$7$F$201701$20200921$20170321$20200923$EXP$$US-PFIZER INC-2017113590$PFIZER$$73$YR$$F$Y$91.63$KG$20200923$$HP$US$US
133539384$13353938$4$F$$20200628$20170321$20200701$PER$$US-PFIZER INC-2017116184$PFIZER$$62$YR$$F$Y$$$20200701$$MD$US$US
133547086$13354708$6$F$20160101$20200722$20170321$20200729$EXP$$US-GLAXOSMITHKLINE-US2017GSK036135$GLAXOSMITHKLINE$$47$YR$$M$Y$77.8$KG$20200729$$MD$US$US
1335475910$13354759$10$F$$20200915$20170321$20200928$EXP$$PHEH2017US007968$NOVARTIS$$$$$M$Y$$$20200928$$CN$US$US
133549215$13354921$5$F$$20200824$20170321$20200828$EXP$$PHEH2017US007881$NOVARTIS$$$$$F$Y$$$20200828$$CN$US$US
133549229$13354922$9$F$$20200728$20170321$20200730$EXP$$PHEH2017US008097$NOVARTIS$$$$$M$Y$$$20200730$$LW$US$US
133550036$13355003$6$F$2015$20200618$20170321$20200910$EXP$$PHHY2017ZA041724$NOVARTIS$$$$$M$Y$$$20200910$$CN$ZA$ZA
133552233$13355223$3$F$20140918$20200721$20170321$20200728$EXP$$US-BAYER-2017-002393$BAYER$$59$YR$A$F$Y$63.56$KG$20200728$$CN$US$US
133553303$13355330$3$F$20170310$20170523$20170321$20170602$EXP$$US-JNJFOC-20170314013$JANSSEN$$69$YR$E$M$Y$66.5$KG$20170602$$HP$US$US
133553311$13355331$1$I$20170118$20170204$20170321$20170321$EXP$$US-JNJFOC-20170206335$JANSSEN$$$$$M$Y$$$20170321$$MD$US$US
133554634$13355463$4$F$$20200728$20170321$20200730$PER$$US-PFIZER INC-2017118872$PFIZER$$64$YR$$F$Y$$$20200730$$CN$US$US
133558135$13355813$5$F$20170224$20170425$20170321$20170428$EXP$$BR-JNJFOC-20170318447$JANSSEN$$68$YR$E$M$Y$69$KG$20170428$$MD$BR$BR
133558487$13355848$7$F$20170317$20200821$20170321$20200828$PER$$PHEH2017US008312$NOVARTIS$$31$YR$$F$Y$60$KG$20200828$$CN$COUNTRY NOT SPECIFIED$US
133562392$13356239$2$F$20170227$20170321$20170321$20170323$EXP$$FR-JNJFOC-20170316282$JANSSEN$$78$YR$E$F$Y$$$20170323$$MD$FR$FR
133562954$13356295$4$F$20170202$20170728$20170321$20170803$EXP$$US-JNJFOC-20170317182$JANSSEN$$43$YR$A$F$Y$51.3$KG$20170803$$MD$US$US
133580554$13358055$4$F$$20200918$20170322$20200929$EXP$$CA-APOTEX-2017AP008460$APOTEX$$$$$F$Y$$$20200929$$HP$CA$CA
133583923$13358392$3$F$20160608$20200915$20170322$20200924$EXP$$PHHY2017FR040901$NOVARTIS$$68$YR$$F$Y$70$KG$20200924$$MD$FR$FR
133586809$13358680$9$F$$20200803$20170322$20200810$PER$$PHEH2017US008459$NOVARTIS$$$$$F$Y$49.89$KG$20200810$$MD$US$US
133591014$13359101$4$F$20160317$20200710$20170322$20200717$PER$$US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-016496$BOEHRINGER INGELHEIM$$73$YR$$M$Y$$$20200717$$CN$US$US
133591702$13359170$2$F$2017$20200824$20170322$20200903$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002657$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20200903$$HP$US$US
133593832$13359383$2$F$$20200721$20170322$20200727$PER$$PHEH2017US008217$NOVARTIS$$$$$F$Y$$$20200727$$HP$US$US
133595037$13359503$7$F$20150825$20200722$20170322$20200724$EXP$$PHHY2016US019389$NOVARTIS$$55$YR$$F$Y$179.32$KG$20200724$$MD$US$US
133599023$13359902$3$F$20161230$20190815$20170322$20200924$PER$$US-CELGENEUS-USA-2017034492$CELGENE$$61$YR$$M$Y$87.62$KG$20200924$$HP$US$US
133599488$13359948$8$F$$20200713$20170322$20200717$EXP$E2B_00512546$CA-SA-2017SA042969$SANOFI AVENTIS$$$$$$Y$$$20200717$$MD$CA$CA
1336033018$13360330$18$F$20170301$20200921$20170322$20200923$EXP$$US-INCYTE CORPORATION-2017IN001869$INCYTE$$$$$$Y$$$20200923$$CN$US$US
133606062$13360606$2$F$201505$20200810$20170322$20200817$EXP$$US-BAYER-2017-018410$BAYER$$47$YR$A$M$Y$$$20200817$$CN$US$US
1336064920$13360649$20$F$$20200714$20170322$20200727$EXP$$US-ACTELION-A-US2017-151298$ACTELION$$$$$M$Y$77.1$KG$20200727$$HP$US$US
1336065624$13360656$24$F$201802$20200713$20170322$20200724$EXP$$US-ACTELION-A-US2016-146665$ACTELION$$44$YR$$F$Y$78.01$KG$20200724$$HP$US$US
133610938$13361093$8$F$20170123$20200914$20170322$20200916$EXP$$US-TAKEDA-2017MPI002171$TAKEDA$$52$YR$$F$Y$118$KG$20200916$$MD$US$US
133625086$13362508$6$F$20090420$20200929$20170323$20200930$PER$$US-PFIZER INC-2017119855$PFIZER$$75$YR$$M$Y$$$20200930$$MD$US$US
133625877$13362587$7$F$201705$20200911$20170323$20200915$PER$$US-PFIZER INC-2017123180$PFIZER$$70$YR$$F$Y$90$KG$20200915$$CN$US$US
1336264311$13362643$11$F$20171113$20200708$20170323$20200710$EXP$$US-PFIZER INC-2017127378$PFIZER$$77$YR$$F$Y$96$KG$20200710$$MD$US$US
1336337415$13363374$15$F$$20200803$20170323$20200811$EXP$$PHEH2017US008460$NOVARTIS$$$$$M$Y$$$20200811$$MD$US$US
133634134$13363413$4$F$20150330$20200909$20170323$20200911$EXP$$RS-PFIZER INC-2017124958$PFIZER$$42$YR$$F$Y$$$20200911$$MD$RS$RS
1336401119$13364011$19$F$2017$20200626$20170323$20200708$EXP$$US-INCYTE CORPORATION-2017IN001912$INCYTE$$$$$$Y$$$20200708$$CN$US$US
133644672$13364467$2$F$20160429$20200912$20170323$20200916$EXP$$CA-TAKEDA-2016TUS007695$TAKEDA$$59$YR$$F$Y$$$20200916$$HP$CA$CA
133648596$13364859$6$F$20170123$20200702$20170323$20200709$PER$$PHHY2017US043801$NOVARTIS$$47$YR$$F$Y$$$20200710$$MD$US$US
133651252$13365125$2$F$20150206$20200709$20170323$20200721$EXP$$US-BAYER-2017-012603$BAYER$$79$YR$E$M$Y$$$20200721$$CN$US$US
1336619618$13366196$18$F$20150921$20191231$20170323$20200108$EXP$$PHHY2015CA119802$NOVARTIS$$53$YR$$F$Y$$$20200108$$HP$CA$CA
1336628011$13366280$11$F$2017$20200722$20170323$20200804$PER$$US-ACTELION-A-NJ2017-151487$ACTELION$$68$YR$$F$Y$$$20200804$$MD$US$US
133668493$13366849$3$F$20150721$20200727$20170324$20200805$PER$$PHHY2017US043024$NOVARTIS$$43$YR$$F$Y$$$20200805$$MD$US$US
1336762712$13367627$12$F$20161114$20200702$20170324$20200708$EXP$$PHHY2016US175421$NOVARTIS$$53$YR$$F$Y$$$20200708$$MD$US$US
133689772$13368977$2$F$20170315$20170424$20170324$20170427$EXP$$GB-ASTRAZENECA-2017SE29364$ASTRAZENECA$$80$YR$$F$Y$$$20170427$$MD$DE$DE
133691979$13369197$9$F$$20200630$20170324$20200703$EXP$$PHJP2017JP009374$NOVARTIS$$$$N$M$Y$2.38$KG$20200704$$HP$JP$JP
133704771$13370477$1$I$20170109$20170117$20170324$20170324$EXP$$DE-JNJFOC-20170116049$JANSSEN$$78$YR$E$M$Y$98$KG$20170324$$MD$DE$DE
133714474$13371447$4$F$2016$20200701$20170324$20200706$EXP$$US-JAZZ-2017-US-003385$JAZZ$$$$$M$Y$$$20200706$$HP$US$US
133732444$13373244$4$F$20170321$20200924$20170327$20200928$EXP$$DE-ROCHE-1910252$ROCHE$$53$YR$$F$Y$60$KG$20200928$$MD$DE$DE
133732892$13373289$2$F$20160429$20200912$20170327$20200921$EXP$$CA-PFIZER INC-2016247307$PFIZER$$59$YR$$F$Y$$$20200921$$HP$US$CA
133742833$13374283$3$F$20170315$20170502$20170327$20170504$EXP$$KR-JNJFOC-20170320060$JANSSEN$$30$YR$A$M$Y$83$KG$20170504$$MD$KR$KR
133744842$13374484$2$F$201509$20200727$20170327$20200806$EXP$$US-BAYER-2017-009960$BAYER$$84$YR$E$M$Y$$$20200806$$CN$US$US
133745462$13374546$2$F$20161013$20170421$20170327$20170428$EXP$$DK-JNJFOC-20161008598$JANSSEN$$67$YR$E$M$Y$84$KG$20170428$$MD$DK$DK
133750289$13375028$9$F$2014$20200701$20170327$20200710$EXP$$US-PFIZER INC-2017128156$PFIZER$$65$YR$$F$Y$86$KG$20200710$$MD$US$US
1337591111$13375911$11$F$20170303$20200630$20170328$20200714$EXP$$US-ACTELION-A-US2017-151129$ACTELION$$78$YR$$M$Y$$$20200714$$MD$US$US
133762695$13376269$5$F$$20200629$20170328$20200706$PER$$CA-AMGEN-CANSP2017045609$AMGEN$$50$YR$A$F$Y$168$KG$20200706$$HP$CA$CA
133769622$13376962$2$F$20161012$20180326$20170328$20180409$EXP$$FR-AUROBINDO-AUR-APL-2017-31577$AUROBINDO$$49$YR$$M$Y$$$20180409$$CN$FR$FR
133777454$13377745$4$F$2015$20200706$20170328$20200708$EXP$$US-PFIZER INC-2016570664$PFIZER$$67$YR$$F$Y$61.22$KG$20200708$$CN$US$US
133777855$13377785$5$F$2017$20200805$20170328$20200806$PER$$US-BAYER-2017-055933$BAYER$$23$YR$A$F$Y$104.5$KG$20200806$$HP$US$US
133803016$13380301$6$F$$20200731$20170329$20200731$EXP$$CA-ABBVIE-17K-028-1909275-00$ABBVIE$$$$$F$Y$$$20200731$$MD$CA$CA
133803236$13380323$6$F$20170323$20170928$20170329$20171006$EXP$$CZ-BAXTER-2017BAX013676$BAXTER$$50$YR$$M$Y$98$KG$20171006$$MD$CZ$CZ
133803443$13380344$3$F$$20200715$20170329$20200727$EXP$$CA-APOTEX-2017AP008645$APOTEX$$72$YR$$F$Y$$$20200727$$CN$CA$CA
133803632$13380363$2$F$$20200629$20170328$20200703$EXP$$CA-APOTEX-2017AP008520$APOTEX$$$$$$Y$$$20200703$$CN$CA$CA
133811414$13381141$4$F$20191123$20200810$20170329$20200812$PER$$US-PFIZER INC-2017134524$PFIZER$$69$YR$$F$Y$72.57$KG$20200812$$CN$US$US
133813601$13381360$1$I$20141104$20150707$20170329$20170329$EXP$$JP-ROCHE-1608044$ROCHE$$83$YR$$F$Y$35$KG$20170329$$MD$JP$JP
133816205$13381620$5$F$$20180723$20170329$20200820$EXP$$ES-ROCHE-1912251$ROCHE$SENIN A, BROQUETAS T, LENS S, CANETE N, LONDONO M, FERRARO M ET AL APLASTIC ANEMIA AND SEVERE MYELOSUPPRESSION WITH BOCEPREVIR OR SIMEPREVIR?CONTAINING HEPATITIS C VIRUS TREATMENT.. ANNALS OF HEPATOLOGY. 2017?16(2):312?317.$58$YR$$M$Y$$$20200820$$MD$ES$ES
133818102$13381810$2$F$$20200828$20170329$20200901$EXP$$PHHY2017PT041144$NOVARTIS$$39$YR$$M$Y$$$20200901$$HP$PT$PT
133818884$13381888$4$F$20160405$20200917$20170329$20200919$EXP$$PHHO2017US001850$NOVARTIS$$53$YR$$F$Y$93$KG$20200919$$HP$US$US
133820401$13382040$1$I$$20170320$20170329$20170329$EXP$$PHHY2017CZ043185$NOVARTIS$POSPISKOVA M, KOHOUTEK M. KARCINOM PRSU?CHRONICKE ONEMOCNENI? ANTI HER2 TERAPIE. KLIN ONKOLOGIE. 2016?29(2)$$$E$F$Y$$$20170329$$HP$CZ$CZ
133820433$13382043$3$F$20170227$20200709$20170329$20200713$EXP$$KR-ABBVIE-17P-090-1919029-00$ABBVIE$$60$YR$$M$Y$55$KG$20200713$$MD$KR$KR
1338214410$13382144$10$F$20160426$20200910$20170329$20200912$EXP$$PHHY2016DE067553$NOVARTIS$$77$YR$$M$Y$95$KG$20200912$$HP$DE$DE
133825513$13382551$3$F$20160624$20200727$20170329$20200804$PER$$PHHY2017US043731$NOVARTIS$$37$YR$$F$Y$$$20200805$$MD$US$US
1338258210$13382582$10$F$20161220$20200702$20170329$20200707$PER$$PHHY2017US043724$NOVARTIS$$28$YR$$F$Y$$$20200707$$MD$US$US
133829342$13382934$2$F$201610$20200821$20170329$20200827$EXP$$US-JAZZ-2017-US-003754$JAZZ$$47$YR$$F$Y$$$20200827$$HP$US$US
133829919$13382991$9$F$20170323$20200630$20170329$20200810$PER$$US-INCYTE CORPORATION-2017IN002012$INCYTE$$$$$$Y$$$20200810$$CN$US$US
133829938$13382993$8$F$20170314$20200817$20170329$20200820$PER$$US-INCYTE CORPORATION-2017IN002072$INCYTE$$$$$$Y$$$20200820$$CN$US$US
133830259$13383025$9$F$20160913$20200803$20170329$20200814$EXP$$JP-INCYTE CORPORATION-2017IN002344$INCYTE$$$$$$Y$$$20200814$$MD$JP$JP
133833607$13383360$7$F$20151210$20200825$20170329$20200903$PER$$US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-017563$BOEHRINGER INGELHEIM$$64$YR$A$F$Y$105.9$KG$20200826$$CN$US$US
133843424$13384342$4$F$$20200908$20170329$20200916$EXP$$PL-MYLANLABS-2017M1018732$MYLAN$WORON J, SIWEK M. SEROTONIN SYNDROME AND BLEEDING FROM THE GASTROINTESTINAL TRACT DURING PHARMACOTHERAPY COURSE IN A PATIENT SUFFERING FROM DEPRESSION WITH CO?OCCURRING DISEASES AND COMPLICATIONS.. MEDYCYNA PRAKTYCZNA PSYCHIATRIA. 2019?3:62?3$56$YR$$F$Y$$$20200916$$HP$PL$PL
1338490714$13384907$14$F$201705$20200923$20170329$20200928$PER$$US-PFIZER INC-2017132920$PFIZER$$79$YR$$F$Y$91$KG$20200928$$MD$US$US
133849377$13384937$7$F$201604$20200716$20170329$20200717$PER$$US-PFIZER INC-2015146436$PFIZER$$64$YR$$F$Y$$$20200717$$MD$US$US
133869597$13386959$7$F$$20200909$20170330$20200922$EXP$$PHEH2017US008895$NOVARTIS$$$$$F$Y$$$20200922$$CN$US$US
133877206$13387720$6$F$202008$20200814$20170330$20200822$EXP$$US-ACTELION-A-NJ2017-151650$ACTELION$$77$YR$$F$Y$114.29$KG$20200822$$HP$US$US
133883982$13388398$2$F$20151222$20200916$20170330$20200925$EXP$$US-BAYER-2017-048571$BAYER$$74$YR$E$M$Y$$$20200925$$CN$US$US
1338893121$13388931$21$F$20160504$20200802$20170330$20200810$EXP$$CA-CELLTRION INC.-2017CA003740$CELLTRION$$$$$$Y$$$20200810$$HP$CA$CA
1338913020$13389130$20$F$20160722$20200818$20170331$20200828$EXP$$CA-ROCHE-1914493$ROCHE$$43$YR$$F$Y$$$20200828$$MD$CA$CA
1339040815$13390408$15$F$20200511$20200720$20170331$20200722$EXP$$US-PFIZER INC-2016585592$PFIZER$$65$YR$$F$Y$104.33$KG$20200722$$MD$US$US
133908303$13390830$3$F$20161221$20200907$20170331$20200910$EXP$$ES-ROCHE-1912988$ROCHE$$50$YR$$F$Y$84$KG$20200910$$MD$ES$ES
133923721$13392372$1$I$20170310$20170316$20170331$20170331$EXP$$BE-JNJFOC-20170318470$JANSSEN$$57$YR$A$M$Y$$$20170331$$MD$BE$BE
133926611$13392661$1$I$20170317$20170324$20170331$20170331$EXP$$BE-JNJFOC-20170332525$JANSSEN$$69$YR$E$M$Y$65$KG$20170331$$MD$BE$BE
133928052$13392805$2$F$20170310$20200625$20170331$20200702$PER$$CO-AMGEN-COLSL2017047718$AMGEN$$66$YR$E$M$Y$$$20200702$$MD$CO$CO
133928223$13392822$3$F$20170321$20170503$20170331$20170508$EXP$$DE-JNJFOC-20170328016$JANSSEN$$5$DEC$A$M$Y$71$KG$20170508$$MD$DE$DE
133930643$13393064$3$F$20170310$20180212$20170331$20180221$EXP$$TR-JNJFOC-20170318662$PHARMACYCLICS$$80$YR$E$F$Y$$$20180221$$MD$TR$TR
1339316713$13393167$13$F$20170208$20200901$20170331$20200910$EXP$$PHHY2017DE048290$NOVARTIS$$49$YR$$F$Y$64$KG$20200910$$HP$DE$DE
133932102$13393210$2$F$20170307$20170619$20170331$20170628$EXP$$FR-JNJFOC-20170309199$JANSSEN$$57$YR$A$M$Y$110$KG$20170628$$MD$FR$FR
1339376412$13393764$12$F$$20200922$20170331$20200929$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-068945$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200929$$CN$CA$CA
133939605$13393960$5$F$$20200911$20170331$20200923$EXP$$CA-APOTEX-2017AP008909$APOTEX$$50$YR$$F$Y$$$20200923$$CN$CA$CA
133952112$13395211$2$F$2017$20200916$20170403$20200922$EXP$$CA-ABBVIE-17P-028-1916662-00$ABBVIE$$$$$F$Y$$$20200922$$CN$CA$CA
133952934$13395293$4$F$$20200706$20170403$20200709$PER$$US-PFIZER INC-2017141650$PFIZER$$70$YR$$F$Y$$$20200709$$CN$US$US
133955637$13395563$7$F$20170302$20200807$20170403$20200819$EXP$$IN-INCYTE CORPORATION-2017IN002473$INCYTE$$$$$$Y$$$20200819$$CN$IN$IN
133956566$13395656$6$F$$20200921$20170403$20200924$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-1003$ORION$$46$YR$$F$Y$$$20200924$$MD$CA$CA
1339609828$13396098$28$F$20170324$20200903$20170403$20200904$EXP$$DE-EISAI MEDICAL RESEARCH-EC-2017-026284$EISAI$$57$YR$A$F$Y$57.5$KG$20200904$$MD$DE$DE
133969573$13396957$3$F$201702$20200706$20170403$20200715$EXP$$FR-TAKEDA-2017MPI002956$TAKEDA$$66$YR$$M$Y$$$20200715$$HP$FR$FR
133972369$13397236$9$F$20170330$20200727$20170403$20200731$EXP$$US-INCYTE CORPORATION-2017IN002235$INCYTE$$$$$$Y$$$20200731$$CN$US$US
133976074$13397607$4$F$20161216$20170425$20170403$20170427$EXP$$NL-JNJFOC-20161216248$JANSSEN$$59$YR$A$M$Y$116$KG$20170427$$MD$NL$NL
133978195$13397819$5$F$20150326$20200811$20170403$20200821$EXP$$US-JNJFOC-20170330068$JOHNSON AND JOHNSON$$42$YR$A$F$Y$$$20200821$$CN$US$US
133980263$13398026$3$F$20160116$20200914$20170403$20200917$PER$$US-JNJFOC-20170333719$JOHNSON AND JOHNSON$$69$YR$E$M$Y$$$20200917$$CN$US$US
133980792$13398079$2$F$20170309$20170323$20170403$20170411$EXP$$US-JNJFOC-20170314207$JANSSEN$$75$YR$$M$Y$85.4$KG$20170411$$MD$US$US
133981176$13398117$6$F$20170105$20200504$20170403$20200506$EXP$$PHHO2017TR005639$NOVARTIS$$46$YR$$M$Y$107.2$KG$20200506$$HP$COUNTRY NOT SPECIFIED$TR
1339841820$13398418$20$F$201605$20200810$20170403$20200819$EXP$$US-ACTELION-A-NJ2016-136822$ACTELION$$61$YR$$M$Y$103.86$KG$20200819$$HP$US$US
133986029$13398602$9$F$20170731$20190218$20170403$20200814$EXP$$JP-009507513-1703JPN003019J$MERCK$KOMADA F,NAKAYAMA Y, TAKARA K. ?NOTE? ANALYSIS OF TIME?TO?ONSET AND ONSET?PATTERN OF INTERSTITIAL LUNG DISEASE AFTER THE ADMINISTRATION OF MONOCLONAL ANTIBODY AGENTS. YAKUGAKU ZASSHI. 2018?138:1587?1594$77$YR$$F$Y$51$KG$20200814$$HP$JP$JP
133988053$13398805$3$F$$20200915$20170403$20200923$EXP$$CA-TEVA-755468ACC$TEVA$$3$YR$C$M$Y$14$KG$20200923$$PH$CA$CA
1339894418$13398944$18$F$2016$20200831$20170404$20200907$EXP$$PHHY2016CA109964$NOVARTIS$$62$YR$$M$Y$$$20200907$$CN$CA$CA
134000714$13400071$4$F$2017$20200828$20170404$20200906$EXP$$US-BIOGEN-2017BI00381186$BIOGEN$$41$YR$$F$Y$$$20200906$$CN$US$US
134001988$13400198$8$F$201612$20200828$20170404$20200831$EXP$$US-PFIZER INC-2017143949$PFIZER$$60$YR$$F$Y$58.96$KG$20200831$$MD$US$US
134013852$13401385$2$F$20161107$20170405$20170404$20170410$EXP$$PL-JNJFOC-20161115272$JANSSEN$$70$YR$E$M$Y$78$KG$20170410$$MD$PL$PL
134014333$13401433$3$F$$20200914$20170404$20200921$EXP$$PT-BAYER-2017-057673$BAYER$$27$YR$A$F$Y$83$KG$20200921$$CN$PT$PT
134016083$13401608$3$F$20170328$20170419$20170404$20170421$EXP$$AU-JNJFOC-20170333393$PHARMACYCLICS$$72$YR$E$M$Y$81.1$KG$20170421$$MD$AU$AU
134021334$13402133$4$F$20140403$20200831$20170404$20200914$PER$$US-JNJFOC-20170333536$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200914$$CN$US$US
134022192$13402219$2$F$20170327$20170406$20170404$20170410$EXP$$DK-JNJFOC-20170400036$JANSSEN$$52$YR$A$F$Y$$$20170410$$MD$DK$DK
134026195$13402619$5$F$$20200804$20170404$20200814$EXP$$US-ACTELION-A-NJ2017-151714$ACTELION$$$$$F$Y$$$20200814$$MD$US$US
1340263614$13402636$14$F$201710$20200803$20170404$20200814$EXP$$US-ACTELION-A-NJ2017-151883$ACTELION$$67$YR$$F$Y$82.09$KG$20200814$$HP$US$US
1340266027$13402660$27$F$20170226$20200815$20170404$20200823$EXP$$US-ACTELION-A-US2017-150797$ACTELION$$57$YR$$F$Y$45.35$KG$20200823$$HP$US$US
134029532$13402953$2$F$201603$20200131$20170404$20200207$EXP$$US-ROCHE-1756667$ROCHE$$30$YR$$F$Y$$$20200208$$CN$US$US
134041822$13404182$2$F$201509$20200812$20170405$20200817$EXP$$DE-ROCHE-1911672$ROCHE$$$$$F$Y$$$20200817$$MD$DE$DE
134051461$13405146$1$I$201609$20161020$20170405$20170405$EXP$$AT-JNJFOC-20161018562$PHARMACYCLICS$$74$YR$E$M$Y$72$KG$20170405$$MD$AT$AT
134055577$13405557$7$F$20170329$20200914$20170405$20200916$EXP$$US-CELGENEUS-USA-20170400510$CELGENE$$70$YR$$M$Y$75$KG$20200916$$CN$US$US
1340580916$13405809$16$F$$20200824$20170405$20200826$EXP$$US-PFIZER INC-2017145600$PFIZER$$59$YR$$F$Y$$$20200826$$CN$US$US
134058279$13405827$9$F$$20200708$20170405$20200710$PER$$US-PFIZER INC-2017146971$PFIZER$$53$YR$$M$Y$113$KG$20200710$$CN$US$US
134062934$13406293$4$F$20150223$20200706$20170405$20200709$PER$$US-JNJFOC-20170401553$JOHNSON AND JOHNSON$$85$YR$$F$Y$$$20200709$$CN$US$US
134062963$13406296$3$F$20130623$20200820$20170405$20200824$PER$$US-JNJFOC-20170401876$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200824$$CN$US$US
134064992$13406499$2$F$201501$20200916$20170405$20200925$EXP$$US-BAYER-2017-028970$BAYER$$69$YR$E$F$Y$$$20200925$$HP$US$US
134071474$13407147$4$F$$20200921$20170405$20200928$EXP$$US-ABBVIE-17P-163-1924918-00$ABBVIE$$$$$M$Y$$$20200928$$CN$US$US
134073525$13407352$5$F$2014$20200804$20170405$20200807$EXP$$US-JAZZ-2017-US-004217$JAZZ$$$$$F$Y$$$20200807$$HP$US$US
134080843$13408084$3$F$$20200922$20170406$20200930$EXP$$GB-MACLEODS PHARMACEUTICALS US LTD-MAC2017004630$MACLEODS$$$$$$Y$$$20200930$$CN$IN$GB
1340820910$13408209$10$F$20170223$20200721$20170406$20200727$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-028353$BRISTOL MYERS SQUIBB$$54$YR$$F$Y$$$20200727$$MD$CA$CA
134101263$13410126$3$F$20161228$20200806$20170406$20200813$EXP$$PHHY2017AR049528$NOVARTIS$$61$YR$$F$Y$$$20200813$$CN$AR$AR
134102373$13410237$3$F$2016$20200812$20170406$20200816$EXP$$CA-ROCHE-1857534$ROCHE$$38$YR$$F$Y$69$KG$20200817$$MD$CA$CA
134102504$13410250$4$F$20170316$20200821$20170406$20200831$EXP$$NL-JNJFOC-20170401927$JOHNSON AND JOHNSON$$32$YR$A$F$Y$90$KG$20200831$$CN$NL$NL
134124662$13412466$2$F$20070420$20200706$20170406$20200709$PER$$US-JNJFOC-20170302628$JOHNSON AND JOHNSON$$10$YR$$M$Y$$$20200709$$LW$US$US
1341302010$13413020$10$F$$20200804$20170406$20200812$EXP$$US-BIOGEN-2017BI00382993$BIOGEN$$$$$F$Y$$$20200812$$CN$US$US
134131212$13413121$2$F$$20200818$20170407$20200819$EXP$$PT-VIIV HEALTHCARE LIMITED-PT2017048674$VIIV$CAROLINO F, SANTOS N, PINEIRO C, SANTOS AS, SOARES P, SARMENTO A,ET AL. PREVALENCE OF ABACAVIR?ASSOCIATED HYPERSENSITIVITY SYNDROME AND HLA?B*5701 ALLELE IN A PORTUGUESE HIV?POSITIVE POPULATION. PORTO BIOMEDICAL JOURNAL. 2017?2(2):59?62$27$YR$$M$Y$$$20200819$$MD$PT$PT
134131243$13413124$3$F$$20200818$20170407$20200819$EXP$$PT-VIIV HEALTHCARE LIMITED-PT2017048673$VIIV$CAROLINO F, SANTOS N, PINEIRO C, SANTOS AS, SOARES P, SARMENTO A,ET AL.PREVALENCE OF ABACAVIR?ASSOCIATED HYPERSENSITIVITY SYNDROME AND HLA?B*5701 ALLELE IN A PORTUGUESE HIV?POSITIVE POPULATION. PORTO BIOMEDICAL JOURNAL. 2017?2(2):59?62$51$YR$$F$Y$$$20200819$$MD$PT$PT
134131302$13413130$2$F$$20200818$20170407$20200819$EXP$$PT-VIIV HEALTHCARE LIMITED-PT2017048670$VIIV$CAROLINO F, SANTOS N, PINEIRO C, SANTOS AS, SOARES P, SARMENTO A,ET AL. PREVALENCE OF ABACAVIR?ASSOCIATED HYPERSENSITIVITY SYNDROME AND HLA?B*5701 ALLELE IN A PORTUGUESE HIV?POSITIVE POPULATION. PORTO BIOMEDICAL JOURNAL. 2017?2(2):59?62$63$YR$$M$Y$$$20200819$$MD$PT$PT
134131332$13413133$2$F$$20200818$20170407$20200819$EXP$$PT-VIIV HEALTHCARE LIMITED-PT2017048671$VIIV$CAROLINO F, SANTOS N, PINEIRO C, SANTOS AS, SOARES P, SARMENTO A,ET AL.PREVALENCE OF ABACAVIR?ASSOCIATED HYPERSENSITIVITY SYNDROME AND HLA?B*5701 ALLELE IN A PORTUGUESE HIV?POSITIVE POPULATION. PORTO BIOMEDICAL JOURNAL. 2017?2(2):59?62$45$YR$$M$Y$$$20200819$$MD$PT$PT
134131352$13413135$2$F$$20200818$20170407$20200819$EXP$$PT-VIIV HEALTHCARE LIMITED-PT2017048672$VIIV$CAROLINO F, SANTOS N, PINEIRO C, SANTOS AS, SOARES P, SARMENTO A,ET AL. PREVALENCE OF ABACAVIR?ASSOCIATED HYPERSENSITIVITY SYNDROME AND HLA?B*5701 ALLELE IN A PORTUGUESE HIV?POSITIVE POPULATION. PORTO BIOMEDICAL JOURNAL. 2017?2(2):59?62$59$YR$$M$Y$$$20200819$$MD$PT$PT
134131442$13413144$2$F$$20200818$20170407$20200819$EXP$$PT-VIIV HEALTHCARE LIMITED-PT2017048667$VIIV$CAROLINO F, SANTOS N, PINEIRO C, SANTOS AS, SOARES P, SARMENTO A ET AL. PREVALENCE OF ABACAVIR?ASSOCIATED HYPERSENSITIVITY SYNDROME AND HLA?B*5701 ALLELE IN A PORTUGUESE HIV?POSITIVE POPULATION. PORTO BIOMEDICAL JOURNAL. 2017?2(2):59?62.$35$YR$$M$Y$$$20200819$$MD$PT$PT
134131452$13413145$2$F$$20200818$20170407$20200819$EXP$$PT-VIIV HEALTHCARE LIMITED-PT2017048668$VIIV$CAROLINO F, SANTOS N, PINEIRO C, SANTOS AS, SOARES P, SARMENTO A,ET AL. PREVALENCE OF ABACAVIR?ASSOCIATED HYPERSENSITIVITY SYNDROME AND HLA?B*5701 ALLELE IN A PORTUGUESE HIV?POSITIVE POPULATION. PORTO BIOMEDICAL JOURNAL. 2017?2(2):59?62.$36$YR$$F$Y$$$20200819$$MD$PT$PT
1341355311$13413553$11$F$20160114$20200804$20170407$20200819$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-027987$BRISTOL MYERS SQUIBB$$52$YR$$M$Y$$$20200819$$MD$DE$DE
134135943$13413594$3$F$20110225$20200624$20170406$20200716$PER$$US-JNJFOC-20170317930$JOHNSON AND JOHNSON$$20$YR$$M$Y$$$20200716$$CN$US$US
134151755$13415175$5$F$20151022$20190802$20170407$20200803$EXP$$DE-JNJFOC-20150717502$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200803$$MD$DE$DE
134153283$13415328$3$F$2017$20200722$20170406$20200727$EXP$$CA-PFIZER INC-2017146756$PFIZER$$34$YR$$M$Y$$$20200727$$MD$CA$CA
1341537111$13415371$11$F$2010$20200904$20170406$20200917$EXP$$US-ACORDA-ACO_136061_2017$ACORDA$$$$$F$Y$$$20200917$$CN$US$US
134154111$13415411$1$I$$20170328$20170406$20170406$EXP$$US-SA-2017SA058166$AVENTIS$BENDELL JC, HOCHSTER H, HART LL, FIRDAUS I, MACE JR, MCFARLANE JJ, ET AL. A PHASE II RANDOMIZED TRIAL (GO27827) OF FIRST LINE FOLFOX PLUS BEVACIZUMAB WITH OR WITHOUT THE MET INHIBITOR ONARTUZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER. THE ONCOLOGIST 2017 MAR 1?22(3):264?71.$$$A$$Y$$$20170406$$HP$US$US
1341578623$13415786$23$F$20161121$20200317$20170406$20200320$EXP$$PHHY2016CA161390$NOVARTIS$$52$YR$$F$Y$$$20200320$$PH$CA$CA
134158053$13415805$3$F$20150705$20200903$20170406$20200916$EXP$$US-JNJFOC-20170403341$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200916$$CN$US$US
134161452$13416145$2$F$20160316$20200622$20170406$20200702$EXP$$US-JNJFOC-20170304676$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20200702$$CN$US$US
134166169$13416616$9$F$20170213$20200831$20170406$20200903$EXP$$CA-CELGENEUS-CAN-20170310497$CELGENE$$77$YR$$M$Y$71.8$KG$20200903$$MD$CA$CA
134166171$13416617$1$I$20170306$20170331$20170407$20170407$EXP$$ALCN2017FR002447$NOVARTIS$$88$YR$$F$Y$$$20170407$$HP$FR$FR
134169411$13416941$1$I$20170302$20170306$20170406$20170406$EXP$$GB-JNJFOC-20170309750$JANSSEN$$48$YR$A$F$Y$85.5$KG$20170406$$MD$GB$GB
134181306$13418130$6$F$201608$20200807$20170407$20200812$EXP$$US-JAZZ-2017-US-004274$JAZZ$$46$YR$$F$Y$$$20200812$$HP$US$US
134181344$13418134$4$F$20170402$20200708$20170407$20200714$EXP$$IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-029521$BRISTOL MYERS SQUIBB$$47$YR$$F$Y$64$KG$20200714$$HP$IT$IT
134181819$13418181$9$F$201703$20200901$20170406$20200911$EXP$$US-ASTELLAS-2017US009618$ASTELLAS$$76$YR$$M$Y$$$20200911$$CN$US$US
1341826916$13418269$16$F$20170330$20200922$20170407$20200925$EXP$$CA-TAKEDA-2017TUS007276$TAKEDA$$47$YR$$F$Y$$$20200925$$HP$CA$CA
134184282$13418428$2$F$20170216$20200709$20170406$20200716$EXP$FR-AFSSAPS-BR20170235$FR-SA-2017SA055123$SANOFI AVENTIS$$78$YR$$F$Y$$$20200716$$MD$FR$FR
134185072$13418507$2$F$$20200925$20170408$20200929$PER$$US-AMGEN-USASL2017050836$AMGEN$$53$YR$A$F$Y$$$20200929$$CN$US$US
1342112112$13421121$12$F$2014$20200901$20170410$20200908$EXP$$US-ABBVIE-17K-163-1933442-00$ABBVIE$$$$$M$Y$68.1$KG$20200908$$CN$US$US
1342189111$13421891$11$F$2016$20200817$20170410$20200819$EXP$$US-PFIZER INC-2017148343$PFIZER$$68$YR$$F$Y$97$KG$20200819$$MD$US$US
134227042$13422704$2$F$20170306$20180104$20170410$20180110$EXP$$FR-ALLERGAN-1713093US$ALLERGAN$$88$YR$$F$Y$54$KG$20180110$$MD$COUNTRY NOT SPECIFIED$FR
134234113$13423411$3$F$20170330$20170602$20170410$20170609$EXP$$US-JNJFOC-20170401039$PHARMACYCLICS$$84$YR$E$M$Y$58.1$KG$20170609$$MD$US$US
134234592$13423459$2$F$20151019$20170712$20170410$20170717$EXP$$US-JNJFOC-20151104710$PHARMACYCLICS$$49$YR$A$M$Y$$$20170717$$MD$US$US
134238672$13423867$2$F$2020$20200731$20170410$20200804$EXP$$US-009507513-1704USA002255$MERCK$$78$YR$$F$Y$$$20200804$$CN$US$US
134241622$13424162$2$F$20160221$20200817$20170410$20200820$EXP$$US-BAYER-2017-066663$BAYER$$68$YR$E$M$Y$$$20200820$$CN$US$US
134243917$13424391$7$F$20170222$20170703$20170410$20170707$EXP$$AU-JNJFOC-20170406051$JANSSEN$$69$YR$E$F$Y$82.1$KG$20170707$$MD$AU$AU
134245388$13424538$8$F$20170321$20200915$20170410$20200922$EXP$$FR-CELGENEUS-FRA-2017038515$CELGENE$$69$YR$$F$Y$48$KG$20200922$$HP$FR$FR
134250213$13425021$3$F$$20200914$20170410$20200924$EXP$$GB-IPCA LABORATORIES LIMITED-IPC201703-000381$IPCA$$$$$$Y$$$20200924$$HP$GB$GB
134251913$13425191$3$F$20151018$20200603$20170411$20200819$PER$$US-CIPLA LTD.-2017US04314$CIPLA$$$$$$Y$$$20200819$$HP$US$US
134253265$13425326$5$F$2013$20200803$20170411$20200811$EXP$$BR-BIOGEN-2017BI00385620$BIOGEN$$$$$F$Y$$$20200811$$CN$BR$BR
134268345$13426834$5$F$201511$20200807$20170411$20200811$EXP$$US-PFIZER INC-2017153880$PFIZER$$62$YR$$M$Y$85.28$KG$20200811$$CN$US$US
134268434$13426843$4$F$$20200812$20170411$20200817$PER$$US-PFIZER INC-2017152002$PFIZER$$75$YR$$F$Y$$$20200817$$MD$US$US
134276984$13427698$4$F$20170226$20171024$20170411$20171024$EXP$$IL-JNJFOC-20170401881$PHARMACYCLICS$$55$YR$A$M$Y$112$KG$20171024$$MD$IL$IL
134276992$13427699$2$F$20170403$20170411$20170411$20170417$EXP$$ES-JNJFOC-20170404223$PHARMACYCLICS$$75$YR$E$M$Y$$$20170417$$MD$ES$ES
134286065$13428606$5$F$$20200803$20170411$20200811$PER$$PHEH2017US010519$NOVARTIS$$$$$F$Y$72.56$KG$20200811$$CN$US$US
134295285$13429528$5$F$200712$20200825$20170411$20200828$EXP$$DE-BIOGEN-2017BI00386047$BIOGEN$$48$YR$$M$Y$$$20200828$$$DE$DE
134301732$13430173$2$F$20170406$20180216$20170412$20180301$EXP$$AU-ROCHE-1918869$ROCHE$$67$YR$$M$Y$$$20180301$$MD$AU$AU
134304413$13430441$3$F$$20200925$20170412$20200929$PER$$US-PFIZER INC-2017154722$PFIZER$$64$YR$$F$Y$$$20200929$$CN$US$US
134307016$13430701$6$F$2014$20200914$20170412$20200918$PER$$CA-AMGEN-CANSP2017054419$AMGEN$$59$YR$A$F$Y$$$20200918$$CN$CA$CA
1343104711$13431047$11$F$$20200803$20170412$20200811$EXP$$PHEH2017US010520$NOVARTIS$$$$$M$Y$$$20200811$$CN$US$US
134314403$13431440$3$F$20150726$20200712$20170412$20200715$PER$$US-JNJFOC-20170332199$JOHNSON AND JOHNSON$$79$YR$$F$Y$$$20200715$$CN$US$US
134314923$13431492$3$F$20160215$20200712$20170412$20200715$PER$$US-JNJFOC-20170400318$JOHNSON AND JOHNSON$$72$YR$$F$Y$$$20200715$$CN$US$US
134315083$13431508$3$F$20160518$20200816$20170412$20200820$PER$$US-JNJFOC-20170334646$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200820$$CN$US$US
134315613$13431561$3$F$20140627$20200805$20170412$20200813$PER$$US-JNJFOC-20170401924$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20200813$$CN$US$US
134315673$13431567$3$F$201406$20200817$20170412$20200819$PER$$US-JNJFOC-20170403064$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200819$$CN$US$US
134315862$13431586$2$F$20150321$20200914$20170412$20200921$PER$$US-JNJFOC-20170303972$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200921$$CN$US$US
134316013$13431601$3$F$20140518$20200721$20170412$20200731$PER$$US-JNJFOC-20170403430$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200731$$CN$US$US
134316473$13431647$3$F$20150305$20200923$20170412$20200928$PER$$US-JNJFOC-20170225326$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200928$$CN$US$US
134316752$13431675$2$F$20160221$20200817$20170412$20200820$PER$$US-JNJFOC-20170403261$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200820$$CN$US$US
134316783$13431678$3$F$20150427$20200802$20170412$20200805$PER$$US-JNJFOC-20170404514$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200805$$CN$US$US
134317014$13431701$4$F$2014$20200903$20170412$20200916$EXP$$US-JNJFOC-20170300048$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20200916$$HP$US$US
134317533$13431753$3$F$20150327$20200714$20170412$20200717$PER$$US-JNJFOC-20170303929$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200717$$CN$US$US
134317543$13431754$3$F$201405$20200721$20170412$20200731$PER$$US-JNJFOC-20170303334$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200731$$CN$US$US
134317583$13431758$3$F$20150326$20200806$20170412$20200811$PER$$US-JNJFOC-20170305084$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200811$$CN$US$US
134318223$13431822$3$F$201609$20200817$20170412$20200828$EXP$$US-JNJFOC-20170305618$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20200828$$CN$US$US
134318493$13431849$3$F$20140422$20200916$20170412$20200927$EXP$$US-JNJFOC-20170303181$JOHNSON AND JOHNSON$$34$YR$A$F$Y$72.64$KG$20200928$$CN$US$US
134318733$13431873$3$F$20150222$20200712$20170412$20200715$PER$$US-JNJFOC-20170307565$JOHNSON AND JOHNSON$$32$YR$$F$Y$$$20200715$$CN$US$US
134318763$13431876$3$F$20150303$20200819$20170412$20200824$PER$$US-JNJFOC-20170307634$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200824$$CN$US$US
134318832$13431883$2$F$20150302$20200816$20170412$20200820$PER$$US-JNJFOC-20170307074$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200820$$CN$US$US
134318853$13431885$3$F$20140417$20200628$20170412$20200702$PER$$US-JNJFOC-20170309099$JOHNSON AND JOHNSON$$79$YR$$M$Y$$$20200702$$CN$US$US
134319193$13431919$3$F$20150316$20200728$20170412$20200731$PER$$US-JNJFOC-20170309225$JOHNSON AND JOHNSON$$66$YR$E$M$Y$153.13$KG$20200731$$CN$US$US
134319213$13431921$3$F$20160712$20200914$20170412$20200923$PER$$US-JNJFOC-20170309111$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200923$$CN$US$US
134319223$13431922$3$F$20150304$20200927$20170412$20200930$PER$$US-JNJFOC-20170309195$JOHNSON AND JOHNSON$$39$YR$A$F$Y$$$20200930$$HP$US$US
134319483$13431948$3$F$2015$20200708$20170412$20200713$PER$$US-JNJFOC-20170310482$JOHNSON AND JOHNSON$$59$YR$$M$Y$$$20200713$$CN$US$US
134319865$13431986$5$F$20160822$20200819$20170412$20200824$PER$$US-JNJFOC-20170312083$JOHNSON AND JOHNSON$$31$YR$A$F$Y$$$20200824$$HP$US$US
134319883$13431988$3$F$20150323$20200723$20170412$20200730$PER$$US-JNJFOC-20170312223$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200730$$CN$US$US
134319943$13431994$3$F$2013$20200923$20170412$20200928$PER$$US-JNJFOC-20170312619$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200928$$CN$US$US
134319992$13431999$2$F$20140823$20200917$20170412$20200923$PER$$US-JNJFOC-20170304174$JOHNSON AND JOHNSON$$61$YR$A$F$Y$$$20200923$$CN$US$US
134320044$13432004$4$F$201407$20200818$20170412$20200831$EXP$$US-JNJFOC-20170312534$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200831$$CN$US$US
134320333$13432033$3$F$20131222$20200802$20170412$20200804$PER$$US-JNJFOC-20170314150$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200804$$CN$US$US
134320653$13432065$3$F$20141001$20200804$20170412$20200814$EXP$$US-JNJFOC-20170315549$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200814$$CN$US$US
134320663$13432066$3$F$201407$20200923$20170412$20200928$PER$$US-JNJFOC-20170315586$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200928$$CN$US$US
134320703$13432070$3$F$20140911$20200702$20170412$20200709$PER$$US-JNJFOC-20170316801$JOHNSON AND JOHNSON$$91$YR$$F$Y$$$20200709$$CN$US$US
134321077$13432107$7$F$20150126$20200622$20170412$20200702$EXP$$US-JNJFOC-20170319335$JOHNSON AND JOHNSON$$56$YR$$F$Y$$$20200702$$LW$US$US
134321203$13432120$3$F$201308$20200903$20170412$20200914$PER$$US-JNJFOC-20170318905$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200914$$CN$US$US
134321223$13432122$3$F$20140930$20200927$20170412$20200929$PER$$US-JNJFOC-20170318875$JOHNSON AND JOHNSON$$80$YR$E$F$Y$59.47$KG$20200929$$CN$US$US
134321553$13432155$3$F$20150317$20200628$20170412$20200706$PER$$US-JNJFOC-20170319675$JOHNSON AND JOHNSON$$40$YR$$F$Y$$$20200706$$CN$US$US
134321594$13432159$4$F$20130318$20200726$20170412$20200731$EXP$$US-JNJFOC-20170319897$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20200731$$CN$US$US
134321693$13432169$3$F$20140809$20200716$20170412$20200724$PER$$US-JNJFOC-20170319650$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200724$$CN$US$US
134321913$13432191$3$F$20160220$20200722$20170412$20200731$PER$$US-JNJFOC-20170319694$JOHNSON AND JOHNSON$$75$YR$E$M$Y$145$KG$20200731$$CN$US$US
134322253$13432225$3$F$20150318$20200702$20170412$20200706$PER$$US-JNJFOC-20170321618$JOHNSON AND JOHNSON$$76$YR$$M$Y$$$20200706$$CN$US$US
134322272$13432227$2$F$20150206$20200709$20170412$20200715$PER$$US-JNJFOC-20170118129$JOHNSON AND JOHNSON$$79$YR$$M$Y$$$20200715$$CN$US$US
134322392$13432239$2$F$20140716$20200722$20170412$20200731$PER$$US-JNJFOC-20170304724$JOHNSON AND JOHNSON$$50$YR$A$M$Y$$$20200731$$CN$US$US
134322573$13432257$3$F$201407$20200916$20170412$20200918$PER$$US-JNJFOC-20170322617$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200918$$CN$US$US
134322673$13432267$3$F$201603$20200917$20170412$20200930$EXP$$US-JNJFOC-20170324301$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200930$$CN$US$US
134322713$13432271$3$F$20161220$20200816$20170412$20200820$PER$$US-JNJFOC-20170325402$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200820$$CN$US$US
134322923$13432292$3$F$20160820$20200720$20170412$20200724$PER$$US-JNJFOC-20170326053$JOHNSON AND JOHNSON$$82$YR$E$F$Y$66.2$KG$20200724$$CN$US$US
134323023$13432302$3$F$20161026$20200812$20170412$20200819$PER$$US-JNJFOC-20170323745$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200819$$HP$US$US
134323283$13432328$3$F$20161108$20200719$20170412$20200722$PER$$US-JNJFOC-20170328469$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20200722$$CN$US$US
134323323$13432332$3$F$20140215$20200806$20170412$20200813$PER$$US-JNJFOC-20170327367$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200813$$CN$US$US
134323353$13432335$3$F$20150905$20200920$20170412$20200921$PER$$US-JNJFOC-20170327858$JOHNSON AND JOHNSON$$95$YR$E$M$Y$$$20200921$$CN$US$US
134323853$13432385$3$F$20160101$20200902$20170412$20200909$PER$$US-JNJFOC-20170329978$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200909$$LW$US$US
134324072$13432407$2$F$20151222$20200916$20170412$20200918$PER$$US-JNJFOC-20170312886$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200918$$CN$US$US
134324183$13432418$3$F$201503$20200901$20170412$20200914$PER$$US-JNJFOC-20170331310$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200914$$CN$US$US
134324883$13432488$3$F$$20200716$20170412$20200728$EXP$$US-JNJFOC-20170332209$JOHNSON AND JOHNSON$$$$$F$Y$$$20200728$$LW$US$US
134324892$13432489$2$F$20150302$20200716$20170412$20200720$PER$$US-JNJFOC-20170326036$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200720$$CN$US$US
134324903$13432490$3$F$20151208$20200903$20170412$20200914$PER$$US-JNJFOC-20170332210$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200914$$CN$US$US
134332023$13433202$3$F$201606$20200715$20170412$20200728$EXP$$US-ACTELION-A-US2016-134637$ACTELION$$66$YR$$F$Y$61.22$KG$20200728$$MD$US$US
134332162$13433216$2$F$20170315$20170505$20170412$20170512$EXP$$FR-JNJFOC-20170407053$JANSSEN$$67$YR$E$M$Y$96$KG$20170512$$MD$FR$FR
134334604$13433460$4$F$20200215$20200825$20170412$20200904$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-030102$BRISTOL MYERS SQUIBB$$68$YR$$M$Y$$$20200904$$CN$US$US
134338122$13433812$2$F$20170301$20170519$20170412$20200724$EXP$$FR-SHIRE-FR201706721$SHIRE$$$$$$Y$$$20200724$$HP$FR$FR
134339187$13433918$7$F$20170321$20180306$20170412$20180312$EXP$$JP-JNJFOC-20170408839$JANSSEN$$29$YR$A$F$Y$45$KG$20180312$$MD$JP$JP
134342762$13434276$2$F$20170326$20200730$20170413$20200805$EXP$$US-SA-2017SA061536$SANOFI AVENTIS$$$$$$Y$$$20200805$$CN$US$US
134345052$13434505$2$F$$20200713$20170413$20200715$PER$$US-PFIZER INC-2017149829$PFIZER$$52$YR$$F$Y$$$20200715$$HP$US$US
134348694$13434869$4$F$2017$20200707$20170413$20200713$EXP$$US-JAZZ-2017-US-004562$JAZZ$$$$$F$Y$$$20200713$$CN$US$US
134361961$13436196$1$I$20150206$20150210$20170413$20170413$EXP$$DK-JNJFOC-20150207897$JANSSEN$$67$YR$E$M$Y$86$KG$20170413$$MD$DK$DK
134380862$13438086$2$F$20160215$20200712$20170413$20200721$EXP$$US-BAYER-2017-064521$BAYER$$72$YR$E$F$Y$$$20200721$$CN$US$US
1343816618$13438166$18$F$20181214$20200908$20170413$20200916$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-010627$BRISTOL MYERS SQUIBB$$85$YR$$F$Y$$$20200916$$HP$CA$CA
134387322$13438732$2$F$20170306$20180108$20170413$20180116$EXP$$FR-MALLINCKRODT-T201701506$MALLINCKRODT$$88$YR$$F$Y$54$KG$20180116$$CN$US$FR
134393391$13439339$1$I$20160720$20170407$20170413$20170413$EXP$$US-TEVA-760191ACC$TEVA$$56$YR$$M$Y$$$20170413$$MD$US$US
134398069$13439806$9$F$20170220$20200807$20170413$20200817$EXP$$JP-ARIAD PHARMACEUTICALS, INC-2017JP008068$TAKEDA$MURAKAMI N, KUBOTA A, WATANABE Y, FUJIWARA S, SHIMOMURA T, NAKAHARA R, ET AL. A CASE OF CHRONIC MYELOID LEUKEMIA COMPLICATED WITH HEMOLYTIC ANEMIA ASSOCIATED TO PONATINIB. THE 81ST ANNUAL MEETING OF THE JAPANESE SOCIETY OF HEMATOLOGY. 2019?00:S317$70$YR$$F$Y$$$20200817$$PH$JP$JP
1344040819$13440408$19$F$201701$20200915$20170413$20200924$EXP$$CA-ROCHE-1918678$ROCHE$$59$YR$$F$Y$$$20200924$$MD$CA$CA
134410226$13441022$6$F$2017$20200903$20170413$20200908$EXP$$US-JAZZ-2017-US-004639$JAZZ$$$$$M$Y$$$20200908$$CN$US$US
134411813$13441181$3$F$$20200811$20170413$20200813$EXP$$US-ABBVIE-17K-163-1872519-00$ABBVIE$$$$$F$Y$75.82$KG$20200813$$HP$US$US
134414073$13441407$3$F$20170214$20200706$20170413$20200716$EXP$BR20170235$FR-ACCORD-050154$ACCORD$$78$YR$$F$Y$$$20200716$$MD$FR$FR
134414469$13441446$9$F$20160607$20200921$20170413$20200924$EXP$$CA-TAKEDA-2017TUS001175$TAKEDA$$14$YR$$F$Y$$$20200924$$HP$CA$CA
134414842$13441484$2$F$$20180115$20170413$20180118$EXP$$JP-ROCHE-1919368$ROCHE$KENMOTSU H, IWAMA E, GOTO Y, HARADA T, TSUMURA S, SAKASHITA H, MORI Y, NAKAGAKI N, FUJITA Y, SEIKE M, BESSHO A, ONO M, OKAZAKI A, AKAMATSU H, MORINAGA R, USHIJIMA S, SHIMOSE T, TOKUNAGA S, HAMADA A, YAMAMOTO N, NAKANISHI Y, SUGIO K AND OKAMOTO I. ALECTINIB FOR PATIENTS WITH ALK REARRANGEMENT?POSITIVE NON?SMALL CELL LUNG CANCER AND A POOR PERFORMANCE STATUS. JOURNAL OF THORACIC O 2017 NOV?12 (11:S2):S1952?.$74$YR$$F$Y$$$20180118$$MD$JP$JP
134415437$13441543$7$F$$20200813$20170413$20200821$EXP$$FR-ROCHE-1918304$ROCHE$$$$$$Y$$$20200821$$MD$FR$FR
134416204$13441620$4$F$$20191107$20170413$20191118$EXP$$JP-ROCHE-1917696$ROCHE$$$$$$Y$$$20191118$$HP$JP$JP
134416751$13441675$1$I$2009$20170329$20170413$20170413$EXP$$RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-138031$RANBAXY$VASILIU C, CARSOTE M, VALEA A, ALBU SE. MULTIPLE FRAGILITY FRACTURES DURING MENOPAUSE ? WHAT THERAPEUTIC SOLUTIONS DO WE HAVE?. GINECOLOGIA.RO. 2017?1(15):71$79$YR$$F$Y$$$20170413$$HP$RO$RO
134419976$13441997$6$F$2017$20200903$20170413$20200914$PER$$US-INCYTE CORPORATION-2017IN002578$INCYTE$$$$$$Y$$$20200914$$CN$US$US
134423615$13442361$5$F$$20200720$20170413$20200721$PER$$US-PFIZER INC-2017163243$PFIZER$$56$YR$$F$Y$$$20200721$$MD$US$US
134427269$13442726$9$F$20170324$20200922$20170414$20200928$PER$$US-PFIZER INC-2017157306$PFIZER$$54$YR$$F$Y$$$20200928$$CN$US$US
1344289612$13442896$12$F$20170330$20200805$20170414$20200807$EXP$$PHHY2017DE053610$NOVARTIS$$79$YR$$M$Y$70$KG$20200807$$HP$DE$DE
134430403$13443040$3$F$20170406$20180730$20170414$20180731$EXP$$FR-JNJFOC-20170408735$JANSSEN$$68$YR$E$F$Y$48$KG$20180731$$MD$FR$FR
134433622$13443362$2$F$20160419$20200708$20170414$20200716$EXP$$US-TAKEDA-2017TUS007633$TAKEDA$$60$YR$$M$Y$$$20200716$$CN$US$US
134442339$13444233$9$F$2016$20200720$20170414$20200729$EXP$$CA-PFIZER INC-2017123119$PFIZER$$56$YR$$F$Y$$$20200729$$HP$CA$CA
134459043$13445904$3$F$$20200818$20170417$20200827$EXP$$CA-AUROBINDO-AUR-APL-2017-32487$AUROBINDO$$74$YR$$F$Y$$$20200827$$HP$CA$CA
134466193$13446619$3$F$201511$20200709$20170417$20200713$PER$$US-EISAI MEDICAL RESEARCH-EC-2015-011769$EISAI$$60$YR$A$F$Y$$$20200713$$CN$US$US
134469507$13446950$7$F$2017$20200928$20170417$20200929$PER$$US-PFIZER INC-2017159785$PFIZER$$73$YR$$M$Y$88$KG$20200929$$CN$US$US
134471715$13447171$5$F$201703$20200826$20170417$20200902$EXP$$PHHY2017CA054669$NOVARTIS$$50$YR$$F$Y$$$20200902$$CN$COUNTRY NOT SPECIFIED$CA
134471744$13447174$4$F$20151002$20170818$20170417$20200921$PER$$JP-AMGEN-JPNCT2017058637$AMGEN$$83$YR$E$M$Y$64$KG$20200921$$HP$JP$JP
134474319$13447431$9$F$$20200918$20170417$20200922$EXP$$US-PFIZER INC-2017165509$PFIZER$$68$YR$$F$Y$69$KG$20200922$$CN$US$US
134478417$13447841$7$F$2016$20200720$20170417$20200724$PER$$CA-AMGEN-CANSP2017056165$AMGEN$$56$YR$A$F$Y$$$20200724$$CN$CA$CA
134481109$13448110$9$F$2016$20200720$20170417$20200730$EXP$$CA-CELLTRION INC.-2017CA004750$CELLTRION$$$$$$Y$$$20200730$$HP$CA$CA
134484783$13448478$3$F$20170308$20170815$20170417$20170824$EXP$$US-JNJFOC-20170314290$JANSSEN$$83$YR$E$M$Y$$$20170824$$MD$US$US
1344898811$13448988$11$F$20170330$20200812$20170417$20200817$EXP$$CA-TAKEDA-2017TUS007538$TAKEDA$$80$YR$$F$Y$$$20200817$$HP$CA$CA
134490212$13449021$2$F$20170131$20170419$20170417$20170421$EXP$$BR-JNJFOC-20170416574$JANSSEN$$58$YR$A$M$Y$$$20170421$$MD$BR$BR
134491129$13449112$9$F$2017$20200812$20170417$20200814$PER$$US-PFIZER INC-2017085508$PFIZER$$78$YR$$F$Y$88$KG$20200814$$MD$US$US
134495982$13449598$2$F$20151110$20170509$20170417$20170517$EXP$$CZ-PFIZER INC-2017158210$PFIZER$$71$YR$$M$Y$$$20170517$$MD$CZ$CZ
134496286$13449628$6$F$20170403$20200824$20170417$20200825$EXP$$US-ACTELION-A-US2017-152540$ACTELION$$43$YR$$F$Y$$$20200825$$MD$US$US
134508963$13450896$3$F$201401$20200905$20170418$20200918$EXP$$IT-MACLEODS PHARMACEUTICALS US LTD-MAC2017004685$MACLEODS$$$$$$Y$$$20200918$$HP$IT$IT
134509043$13450904$3$F$$20171024$20170418$20171101$EXP$$AU-ROCHE-1920653$ROCHE$$$$$F$Y$$$20171101$$MD$AU$AU
134512052$13451205$2$F$20170330$20170623$20170418$20170630$EXP$$DE-JNJFOC-20170417148$JANSSEN$$53$YR$A$M$Y$$$20170630$$HP$DE$DE
134516317$13451631$7$F$2017$20200821$20170418$20200824$EXP$$US-PFIZER INC-2017161562$PFIZER$$76$YR$$F$Y$$$20200824$$CN$US$US
134516363$13451636$3$F$201703$20200713$20170418$20200716$PER$$US-PFIZER INC-2017159138$PFIZER$$42$YR$$F$Y$90.72$KG$20200716$$CN$US$US
134516917$13451691$7$F$20160726$20200911$20170418$20200921$EXP$$GB-AUROBINDO-AUR-APL-2017-32200$AUROBINDO$$36$YR$$F$Y$94.2$KG$20200921$$CN$GB$GB
134517768$13451776$8$F$20180202$20200908$20170418$20200910$PER$$US-PFIZER INC-2017164029$PFIZER$$77$YR$$F$Y$70.31$KG$20200910$$HP$US$US
1345264721$13452647$21$F$201704$20200806$20170418$20200812$EXP$$NL-ABBVIE-17K-114-1944010-00$ABBVIE$$73$YR$$M$Y$54$KG$20200812$$HP$NL$NL
134527943$13452794$3$F$20170325$20180102$20170418$20180103$EXP$$US-PFIZER INC-2017154983$PFIZER$$14$YR$$F$Y$47$KG$20180103$$HP$US$US
1345312615$13453126$15$F$20150416$20200702$20170418$20200709$EXP$$PHHY2016US019094$NOVARTIS$$40$YR$$F$Y$61.68$KG$20200709$$HP$US$US
1345317725$13453177$25$F$201608$20200922$20170418$20200930$EXP$$NL-ABBVIE-17K-114-1944960-00$ABBVIE$$59$YR$$F$Y$44$KG$20200930$$HP$NL$NL
134544428$13454442$8$F$2012$20200812$20170418$20200825$EXP$$US-JAZZ-2017-US-003454$JAZZ$$$$$F$Y$$$20200825$$MD$US$US
134548351$13454835$1$I$20160416$20160418$20170418$20170418$EXP$$US-JNJFOC-20160419714$PHARMACYCLICS$$67$YR$E$M$Y$85.9$KG$20170418$$MD$US$US
134548942$13454894$2$F$$20200713$20170418$20200716$PER$$US-PFIZER INC-2017161038$PFIZER$$61$YR$$F$Y$$$20200716$$MD$US$US
134549552$13454955$2$F$20170330$20170414$20170418$20170426$EXP$$JP-PFIZER INC-2017163547$PFIZER$$83$YR$$F$Y$$$20170426$$MD$JP$JP
1345532117$13455321$17$F$2015$20200710$20170419$20200714$EXP$$US-PFIZER INC-2017164179$PFIZER$$58$YR$$F$Y$57$KG$20200714$$MD$US$US
134555032$13455503$2$F$20130623$20200820$20170418$20200825$EXP$$US-BAYER-2017-065813$BAYER$$68$YR$E$M$Y$$$20200825$$CN$US$US
134555052$13455505$2$F$20150427$20200802$20170418$20200812$EXP$$US-BAYER-2017-068918$BAYER$$71$YR$E$M$Y$$$20200812$$CN$US$US
134556867$13455686$7$F$$20200812$20170418$20200821$EXP$$US-ACTELION-A-US2017-152586$ACTELION$$$$$F$Y$65.76$KG$20200821$$HP$US$US
134564954$13456495$4$F$19991102$20200630$20170418$20200707$EXP$$FR-ABBVIE-17P-056-1905990-00$ABBVIE$$$$N$M$Y$$$20200706$$HP$FR$FR
134567769$13456776$9$F$20161010$20200702$20170418$20200709$EXP$$PHHY2017US057560$NOVARTIS$$23$YR$$F$Y$$$20200710$$MD$US$US
134574612$13457461$2$F$20140518$20200721$20170419$20200728$EXP$$US-BAYER-2017-066602$BAYER$$72$YR$E$M$Y$$$20200728$$CN$US$US
134574933$13457493$3$F$20170325$20180404$20170419$20190213$EXP$$AU-JNJFOC-20170331588$JANSSEN$$67$YR$E$F$Y$68$KG$20190213$$MD$AU$AU
134576042$13457604$2$F$20120520$20200909$20170419$20200914$EXP$$US-BAYER-2017-003855$BAYER$$67$YR$E$M$Y$118.04$KG$20200914$$CN$US$US
134581782$13458178$2$F$$20200724$20170419$20200804$EXP$$GR-ACCORD-047541$ACCORD$RIZOS E, GERASIMOU C, DOUZENIS A, PAPAGEORGIOU C. CARDIOTOXICITY ASSOCIATE WITH CLOZAPINE, A POTENT HYPOTHESIS OF IMMUNOMODULATION BY CLOZAPINE: A CASE REPORT.. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2017,267(1):S63$31$YR$$M$Y$$$20200804$$MD$GR$GR
134584446$13458444$6$F$20170409$20170706$20170419$20170713$EXP$$US-JNJFOC-20170413790$JANSSEN$$63$YR$A$M$Y$104$KG$20170713$$MD$US$US
1345857411$13458574$11$F$20140703$20200702$20170419$20200709$PER$$PHHY2014US134261$NOVARTIS$$39$YR$$F$Y$$$20200709$$MD$US$US
134589686$13458968$6$F$$20200902$20170419$20200910$PER$$PHEH2017US011377$NOVARTIS$$$$$M$Y$$$20200910$$CN$COUNTRY NOT SPECIFIED$US
134589974$13458997$4$F$20170307$20200702$20170419$20200709$PER$$PHHY2017US057745$NOVARTIS$$47$YR$$F$Y$$$20200710$$MD$US$US
134594083$13459408$3$F$200610$20200807$20170419$20200817$EXP$$US-ACTELION-A-US2006-13668$ACTELION$$59$YR$$F$Y$53.06$KG$20200817$$HP$US$US
134601783$13460178$3$F$20170408$20181031$20170420$20181102$EXP$$US-JNJFOC-20170413286$JANSSEN$$49$YR$A$F$Y$83$KG$20181102$$MD$US$US
134603864$13460386$4$F$20130410$20200710$20170420$20200722$EXP$$CA-JNJFOC-20170417041$JOHNSON AND JOHNSON$$65$YR$$M$Y$$$20200722$$HP$CA$CA
134611032$13461103$2$F$$20200714$20170420$20200720$EXP$$PHJP2017JP012636$NOVARTIS$$$$$$Y$$$20200720$$MD$JP$JP
134614082$13461408$2$F$20170415$20200922$20170420$20200929$EXP$$US-ASTELLAS-2017US014937$ASTELLAS$$68$YR$$M$Y$$$20200929$$CN$US$US
134618664$13461866$4$F$$20200802$20170420$20200803$EXP$$GB-PFIZER INC-2017172253$PFIZER$$$$$F$Y$1.8$KG$20200803$$HP$GB$GB
1346238610$13462386$10$F$2017$20200715$20170420$20200824$PER$$US-INCYTE CORPORATION-2017IN001989$INCYTE$$$$$$Y$$$20200824$$CN$US$US
134625932$13462593$2$F$$20200925$20170420$20200929$EXP$$ES-SA-2017SA071772$SANOFI AVENTIS$RAMIREZ A, ABRIL JC, CANO J.. DRESS SYNDROME DUE TO ANTIBIOTIC THERAPY OF OSTEOARTICULAR INFECTIONS IN CHILDREN: TWO CASE REPORTS.. REV ESP CIR ORTOP TRAUMATOL.. 2015?59(5):360?4$8$YR$$M$Y$$$20200929$$MD$ES$ES
134626444$13462644$4$F$2017$20200714$20170420$20200721$EXP$$US-SA-2017SA052455$SANOFI AVENTIS$$$$$$Y$$$20200721$$CN$US$US
1346279114$13462791$14$F$2014$20200817$20170420$20200820$EXP$$US-PFIZER INC-2017088580$PFIZER$$45$YR$$F$Y$75$KG$20200820$$CN$US$US
134635849$13463584$9$F$20170412$20200817$20170420$20200825$EXP$$US-ACTELION-A-US2017-152465$ACTELION$$51$YR$$F$Y$83.9$KG$20200825$$HP$US$US
134651497$13465149$7$F$20111203$20200820$20170421$20200827$EXP$$US-ABBVIE-12P-163-0906270-00$ABBVIE$$64$YR$$F$Y$68.1$KG$20200827$$CN$US$US
134658824$13465882$4$F$20150307$20200815$20170421$20200818$EXP$$CA-ROCHE-ITM201503IM011452$ROCHE$$76$YR$$M$Y$88.2$KG$20200818$$MD$CA$CA
134665957$13466595$7$F$20170224$20171220$20170421$20200818$EXP$$JP-009507513-1704JPN010055$MERCK$$53$YR$$M$Y$68$KG$20200818$$CN$JP$JP
1346751111$13467511$11$F$20170412$20200826$20170421$20200828$EXP$$GB-PFIZER INC-2017173688$PFIZER$NASH, P.. SAFETY AND EFFICACY OF TOFACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: INTERIM ANALYSIS OF OPAL BALANCE, AN OPEN?LABEL, LONG?TERM EXTENSION STUDY.. RHEUMATOLOGY AND THERAPY. 2020?7 (3):553?580$57$YR$$M$Y$81$KG$20200828$$HP$AU$GB
134679134$13467913$4$F$20161007$20180514$20170421$20180522$EXP$$GB-JNJFOC-20170421039$JANSSEN$$70$YR$E$F$Y$66.4$KG$20180522$$MD$GB$GB
134681991$13468199$1$I$20170413$20170414$20170421$20170421$EXP$$BE-JNJFOC-20170416078$PHARMACYCLICS$$72$YR$E$M$Y$85$KG$20170421$$MD$BE$BE
134682174$13468217$4$F$20170329$20180530$20170421$20180604$EXP$$US-JNJFOC-20170418865$JANSSEN$$5$YR$C$M$Y$24.5$KG$20180604$$MD$US$US
134682973$13468297$3$F$201409$20200719$20170421$20200722$PER$$US-JNJFOC-20170420753$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200722$$CN$US$US
134685524$13468552$4$F$20160628$20200917$20170421$20200923$PER$$US-JNJFOC-20170420696$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200923$$HP$US$US
134692457$13469245$7$F$20170412$20200717$20170421$20200721$EXP$$JP-GILEAD-2017-0267955$GILEAD$$76$YR$E$M$Y$47.6$KG$20200721$$MD$JP$JP
134709053$13470905$3$F$20140221$20200805$20170424$20200807$PER$$US-JNJFOC-20170422608$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200807$$CN$US$US
134719649$13471964$9$F$20170401$20200821$20170424$20200824$EXP$$US-PFIZER INC-2017179325$PFIZER$$76$YR$$M$Y$94.35$KG$20200824$$MD$US$US
134719862$13471986$2$F$$20200720$20170424$20200722$PER$$US-PFIZER INC-2017177640$PFIZER$$74$YR$$F$Y$$$20200722$$CN$US$US
134726932$13472693$2$F$$20200730$20170424$20200805$EXP$$PHEH2017US011778$NOVARTIS$$$$$M$Y$$$20200805$$MD$US$US
134727094$13472709$4$F$201607$20200924$20170424$20200928$PER$$US-JNJFOC-20170422671$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200928$$CN$US$US
134730083$13473008$3$F$201704$20200708$20170424$20200708$PER$$US-BIOGEN-2017BI00389147$BIOGEN$$55$YR$$F$Y$$$20200708$$CN$US$US
134730563$13473056$3$F$$20200915$20170424$20200917$EXP$$IT-PFIZER INC-2017176642$PFIZER$$6$YR$$F$Y$$$20200917$$HP$IT$IT
134731352$13473135$2$F$$20200612$20170424$20200715$EXP$$ES-VALIDUS PHARMACEUTICALS LLC-ES-2017VAL000638$VALIDUS$RAMIIREZ A, ABRIL JC, CANO J.. DRESS SYNDROME DUE TO ANTIBIOTIC THERAPY OF OSTEOARTICULAR INFECTIONS IN CHILDREN: TWO CASE REPORTS.. REV ESP CIR ORTOP TRAUMATOL. 2015?59(5):360?4$$$$$Y$$$20200715$$MD$ES$ES
1347525715$13475257$15$F$20170223$20191129$20170424$20200816$EXP$$PHHY2017US060000$NOVARTIS$$5$YR$$F$Y$23.1$KG$20200816$$HP$US$US
1347586711$13475867$11$F$20120920$20200831$20170425$20200907$EXP$$PHHY2012CA083127$NOVARTIS$$78$YR$$M$Y$$$20200907$$HP$CA$CA
134765295$13476529$5$F$20170406$20200706$20170425$20200717$EXP$$US-PFIZER INC-2017175026$PFIZER$$74$YR$$F$Y$48.53$KG$20200717$$HP$US$US
134773973$13477397$3$F$2001$20200930$20170425$20200930$PER$$US-BIOGEN-2017BI00390923$BIOGEN$$59$YR$$F$Y$$$20200930$$CN$US$US
134777773$13477777$3$F$201601$20200630$20170425$20200714$EXP$$US-JNJFOC-20170424930$JOHNSON AND JOHNSON$$80$YR$$F$Y$$$20200714$$CN$US$US
134782018$13478201$8$F$20170321$20181029$20170425$20200814$EXP$$JP-009507513-1703JPN002243J$MERCK$$72$YR$$M$Y$57$KG$20200814$$CN$JP$JP
134782702$13478270$2$F$20160928$20200630$20170425$20200708$EXP$$US-ROCHE-1880224$ROCHE$$55$YR$$M$Y$107$KG$20200708$$MD$US$US
134789113$13478911$3$F$20161012$20190524$20170425$20190603$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-034887$BRISTOL MYERS SQUIBB$$49$YR$$M$Y$93$KG$20190603$$MD$FR$FR
134790391$13479039$1$I$20110109$20110606$20170425$20170425$EXP$$IL-JNJFOC-20170406630$JANSSEN$$57$YR$A$M$Y$84.35$KG$20170425$$MD$IL$IL
134795472$13479547$2$F$20160609$20180528$20170424$20180612$EXP$$PL-BAXALTA-2017BLT003159$SHIRE$$36$YR$$M$Y$$$20180612$$MD$PL$PL
134795561$13479556$1$I$20160928$20170412$20170424$20170424$EXP$$PL-BAXALTA-2017BLT003163$BAXALTA$$42$YR$$M$Y$99.5$KG$20170424$$MD$PL$PL
134796461$13479646$1$I$20160719$20170412$20170424$20170424$EXP$$US-BAXALTA-2017BLT003161$BAXALTA$$23$YR$$M$Y$$$20170424$$MD$US$US
134797581$13479758$1$I$20161002$20170412$20170424$20170424$EXP$$US-BAXALTA-2017BLT003166$BAXALTA$$13$YR$$M$Y$49.5$KG$20170424$$MD$US$US
134799683$13479968$3$F$20170403$20200630$20170425$20200702$EXP$NL-LRB-237823$NL-PFIZER INC-2017177766$PFIZER$$56$YR$$F$Y$90$KG$20200702$$CN$NL$NL
134805472$13480547$2$F$20161218$20170420$20170425$20170501$EXP$$CH-JNJFOC-20170106209$JANSSEN$$53$YR$A$F$Y$59$KG$20170501$$MD$CH$CH
134806775$13480677$5$F$20170412$20200813$20170425$20200821$EXP$$US-ACTELION-A-US2017-152863$ACTELION$$7$YR$$M$Y$$$20200821$$HP$US$US
1348067920$13480679$20$F$$20200718$20170425$20200730$EXP$$US-ACTELION-A-US2016-143736$ACTELION$$$$$F$Y$63.95$KG$20200730$$HP$US$US
134809918$13480991$8$F$2017$20200703$20170425$20200709$EXP$$CA-TAKEDA-2017TUS008390$TAKEDA$$47$YR$$F$Y$$$20200709$$HP$CA$CA
134841053$13484105$3$F$20160818$20200909$20170425$20200914$PER$$US-JNJFOC-20170423290$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200914$$CN$US$US
134843869$13484386$9$F$201608$20200708$20170426$20200714$EXP$$PHHY2017CA058949$NOVARTIS$$53$YR$$F$Y$$$20200714$$CN$COUNTRY NOT SPECIFIED$CA
134844589$13484458$9$F$20160927$20200917$20170426$20200925$EXP$$PHHY2016CA148710$NOVARTIS$$65$YR$$F$Y$$$20200925$$CN$COUNTRY NOT SPECIFIED$CA
134847512$13484751$2$F$$20200827$20170426$20200831$PER$$US-PFIZER INC-2015084714$PFIZER$$$$$M$Y$$$20200831$$CN$US$US
134862342$13486234$2$F$20160713$20170421$20170426$20170428$EXP$$PL-JNJFOC-20160806393$JANSSEN$$39$YR$A$M$Y$87$KG$20170428$$MD$PL$PL
134862352$13486235$2$F$20161004$20170421$20170426$20170428$EXP$$LT-JNJFOC-20161022647$JANSSEN$$40$YR$A$M$Y$92$KG$20170428$$MD$LT$LT
134862362$13486236$2$F$20160125$20170421$20170426$20170428$EXP$$LT-JNJFOC-20160403382$JANSSEN$$48$YR$A$F$Y$$$20170428$$MD$LT$LT
134862782$13486278$2$F$20160409$20170421$20170426$20170428$EXP$$RU-JNJFOC-20160416355$JANSSEN$$44$YR$A$M$Y$81.4$KG$20170428$$MD$RU$RU
134862792$13486279$2$F$20160203$20170421$20170426$20170428$EXP$$RU-JNJFOC-20160316908$JANSSEN$$55$YR$A$M$Y$83.5$KG$20170428$$MD$RU$RU
134862802$13486280$2$F$20160421$20170421$20170426$20170428$EXP$$US-JNJFOC-20160800683$JANSSEN$$52$YR$A$M$Y$91$KG$20170428$$MD$US$US
134862812$13486281$2$F$20160831$20170421$20170426$20170428$EXP$$US-JNJFOC-20160917267$JANSSEN$$54$YR$A$M$Y$163$KG$20170428$$MD$US$US
134862822$13486282$2$F$20161205$20170421$20170426$20170428$EXP$$RU-JNJFOC-20170122993$JANSSEN$$52$YR$A$F$Y$94.3$KG$20170428$$MD$RU$RU
134862832$13486283$2$F$20160621$20170421$20170426$20170428$EXP$$UA-JNJFOC-20160622963$JANSSEN$$30$YR$A$M$Y$82$KG$20170428$$MD$UA$UA
1348636622$13486366$22$F$2019$20200909$20170426$20200926$EXP$$CA-CELLTRION INC.-2017CA005163$CELLTRION$$$$$$Y$$$20200926$$HP$CA$CA
134865308$13486530$8$F$20170424$20181009$20170426$20190719$EXP$$US-ROCHE-1925687$ROCHE$$78$YR$$F$Y$68.4$KG$20190719$$MD$US$US
134865672$13486567$2$F$201403$20200721$20170426$20200724$PER$$US-JNJFOC-20170418177$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20200724$$CN$US$US
134866503$13486650$3$F$$20200716$20170426$20200720$PER$$US-PFIZER INC-2017182865$PFIZER$$$$$M$Y$$$20200720$$CN$US$US
134870151$13487015$1$I$$20170416$20170426$20170426$EXP$$CA-ELI_LILLY_AND_COMPANY-CA201704007410$ELI LILLY AND CO$$$$A$$Y$$$20170426$$CN$GB$CA
134882339$13488233$9$F$20160404$20200821$20170426$20200825$EXP$$US-ACTELION-A-NJ2016-136901$ACTELION$$1$YR$$M$Y$12.25$KG$20200825$$HP$US$US
134886434$13488643$4$F$20170327$20200710$20170427$20200720$EXP$$JP-ACTELION-A-CH2017-153123$ACTELION$$48$YR$$M$Y$79$KG$20200720$$MD$JP$JP
134890302$13489030$2$F$20170417$20200914$20170427$20200922$EXP$$IT-AUROBINDO-AUR-APL-2017-33130$AUROBINDO$$58$YR$$F$Y$$$20200922$$MD$IT$IT
134892898$13489289$8$F$20181005$20200824$20170427$20200826$EXP$$US-PFIZER INC-2017179077$PFIZER$$66$YR$$F$Y$79$KG$20200826$$MD$US$US
134898144$13489814$4$F$200903$20200826$20170426$20200903$EXP$$US-JAZZ-2014-US-005994$JAZZ$$61$YR$$F$Y$$$20200903$$MD$US$US
1349011012$13490110$12$F$201610$20200728$20170426$20200803$EXP$$PHHY2016CA145608$NOVARTIS$$62$YR$$M$Y$122$KG$20200803$$MD$CA$CA
134903334$13490333$4$F$2014$20200701$20170427$20200710$EXP$$US-BIOGEN-2017BI00390273$BIOGEN$$$$$F$Y$78.54$KG$20200710$$CN$US$US
134911723$13491172$3$F$201501$20200706$20170427$20200709$PER$$US-JNJFOC-20170417440$JOHNSON AND JOHNSON$$52$YR$$M$Y$108.96$KG$20200709$$CN$US$US
134914224$13491422$4$F$20170419$20170911$20170427$20170915$EXP$$RU-JNJFOC-20170424590$JANSSEN$$46$YR$A$F$Y$51$KG$20170915$$MD$RU$RU
134915063$13491506$3$F$20150903$20200728$20170427$20200731$EXP$$DE-DRREDDYS-USA/GER/17/0089506$DR REDDYS$JOCHIM A, GEMPT J, DESCHAUER M, BERNKOPF K, SCHWARZ J, KIRSCHKE J, HASLINGER B. STATUS EPILEPTICUS AFTER SUBTHALAMIC DEEP BRAIN STIMULATION SURGERY IN A PATIENT WITH PARKINSON^S DISEASE. WORLD NEUROSURG. 2016?96:614.E1?E6.$72$YR$E$F$Y$$$20200731$$MD$DE$DE
134917733$13491773$3$F$$20200821$20170427$20200821$PER$$US-BIOGEN-2017BI00391100$BIOGEN$$$$$F$Y$$$20200821$$CN$US$US
134921263$13492126$3$F$20200603$20200916$20170427$20200924$EXP$$PHHY2017AR061632$NOVARTIS$$13$YR$$M$Y$$$20200924$$CN$COUNTRY NOT SPECIFIED$AR
134921651$13492165$1$I$20160602$20160602$20170427$20170427$EXP$$BE-JNJFOC-20160608411$PHARMACYCLICS$$51$YR$A$M$Y$$$20170427$$MD$BE$BE
134922563$13492256$3$F$2016$20200720$20170427$20200722$PER$$US-PFIZER INC-2017180557$PFIZER$$74$YR$$F$Y$$$20200722$$MD$US$US
134922592$13492259$2$F$$20170410$20170427$20200716$PER$$US-ASTRAZENECA-2017SE40763$ASTRAZENECA$$61$YR$$F$Y$$$20200716$$$US$US
134922867$13492286$7$F$20160920$20200805$20170427$20200807$PER$$US-PFIZER INC-2017125432$PFIZER$$55$YR$$F$Y$91$KG$20200807$$MD$US$US
1349283430$13492834$30$F$201711$20200902$20170427$20200905$EXP$$PHHY2015CR102611$NOVARTIS$$62$YR$$M$Y$70$KG$20200905$$CN$CR$CR
134928367$13492836$7$F$20170412$20171103$20170427$20171110$EXP$$US-JNJFOC-20170422242$JANSSEN$$61$YR$A$M$Y$70.1$KG$20171110$$MD$US$US
134928669$13492866$9$F$$20200817$20170427$20200822$EXP$$PHEH2017US012177$NOVARTIS$$$$$M$Y$$$20200822$$CN$US$US
134943234$13494323$4$F$20150903$20200724$20170428$20200731$EXP$$DE-AUROBINDO-AUR-APL-2017-33141$AUROBINDO$$72$YR$$F$Y$$$20200731$$MD$DE$DE
134950414$13495041$4$F$20170320$20170821$20170428$20170830$EXP$$JP-ROCHE-1923281$ROCHE$$66$YR$$M$Y$49$KG$20170830$$MD$JP$JP
134961516$13496151$6$F$20160421$20170828$20170428$20200713$EXP$$IT-TEVA-763281ACC$TEVA$$67$YR$$M$Y$131$KG$20200713$$MD$IT$IT
134963682$13496368$2$F$2010$20200811$20170428$20200814$EXP$$FR-ABBVIE-17P-056-1958020-00$ABBVIE$$8$YR$$F$Y$$$20200814$$MD$FR$FR
134965341$13496534$1$I$$20170419$20170428$20170428$EXP$$PHEH2017US011831$NOVARTIS$$$$$M$Y$$$20170428$$CN$COUNTRY NOT SPECIFIED$US
134968686$13496868$6$F$$20200420$20170428$20200824$EXP$$PHHY2017PA062641$NOVARTIS$$$$$F$Y$54$KG$20200824$$CN$COUNTRY NOT SPECIFIED$PA
134969852$13496985$2$F$20170221$20170523$20170428$20170602$EXP$$US-JNJFOC-20170224217$JANSSEN$$$$$M$Y$$$20170602$$MD$US$US
134971546$13497154$6$F$20151020$20200819$20170428$20200902$EXP$$JP-INCYTE CORPORATION-2017IN003161$INCYTE$$$$$$Y$$$20200902$$MD$JP$JP
134972304$13497230$4$F$20131005$20200712$20170428$20200721$EXP$$US-JNJFOC-20170425830$JOHNSON AND JOHNSON$$66$YR$$F$Y$$$20200721$$CN$US$US
134972773$13497277$3$F$20170117$20170703$20170428$20170705$EXP$$US-JNJFOC-20170119555$JANSSEN$$50$YR$A$F$Y$70.76$KG$20170705$$MD$US$US
134975874$13497587$4$F$20170410$20200826$20170428$20200831$PER$$US-PFIZER INC-2017183754$PFIZER$$70$YR$$F$Y$$$20200831$$MD$US$US
1349788610$13497886$10$F$20170120$20200629$20170428$20200703$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-106468$BRISTOL MYERS SQUIBB$$76$YR$$F$Y$$$20200703$$HP$CA$CA
134985994$13498599$4$F$$20200723$20170501$20200728$EXP$$US-PFIZER INC-2017181833$PFIZER$$73$YR$$F$Y$$$20200728$$CN$US$US
134987385$13498738$5$F$20150903$20200728$20170501$20200811$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-139323$RANBAXY$$72$YR$$F$Y$$$20200811$$HP$NL$DE
1349916511$13499165$11$F$20170329$20180814$20170501$20180817$EXP$$FR-JNJFOC-20170424738$JANSSEN$$86$YR$E$M$Y$67$KG$20180817$$HP$FR$FR
134991957$13499195$7$F$20170419$20181018$20170501$20181026$EXP$$US-JNJFOC-20170424701$JANSSEN$$73$YR$E$M$Y$66.23$KG$20181026$$HP$US$US
134993973$13499397$3$F$20160724$20200630$20170501$20200704$EXP$$US-ROCHE-1914598$ROCHE$$62$YR$$F$Y$53$KG$20200704$$MD$US$US
134994645$13499464$5$F$20170425$20180406$20170501$20180413$EXP$$US-JNJFOC-20170427381$PHARMACYCLICS$$86$YR$E$F$Y$57.61$KG$20180413$$MD$US$US
135003003$13500300$3$F$201704$20200914$20170501$20200921$EXP$$US-SA-2017SA076709$SANOFI AVENTIS$$$$$$Y$$$20200921$$MD$US$US
135004152$13500415$2$F$20140822$20170502$20170501$20170503$EXP$$US-JNJFOC-20140824761$JANSSEN$$66$YR$E$M$Y$77$KG$20170503$$MD$US$US
135005928$13500592$8$F$$20200720$20170501$20200724$EXP$$CA-PFIZER INC-2017185903$PFIZER$$51$YR$$F$Y$$$20200724$$HP$CA$CA
135015435$13501543$5$F$$20200804$20170501$20200814$EXP$$JP-ALXN-A201704395AA$ALEXION$$$$$$Y$$$20200814$$CN$JP$JP
135028056$13502805$6$F$20150819$20200625$20170502$20200701$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN062760$VIIV$$5$DEC$$M$Y$$$20200701$$CN$JP$JP
135028666$13502866$6$F$20150819$20200625$20170502$20200701$EXP$$JP-GLAXOSMITHKLINE-JP2017JPN062760$GLAXOSMITHKLINE$$5$DEC$$M$Y$$$20200701$$CN$JP$JP
135032873$13503287$3$F$201709$20200910$20170502$20200915$PER$$US-PFIZER INC-2017188405$PFIZER$$59$YR$$F$Y$$$20200915$$CN$US$US
135045596$13504559$6$F$$20200731$20170502$20200811$EXP$$US-IMPAX LABORATORIES, INC-2017-IPXL-00691$AMNEAL$$$$$F$Y$58$KG$20200811$$MD$US$US
135052175$13505217$5$F$2017$20200804$20170502$20200805$EXP$$CA-TAKEDA-2017TUS009171$TAKEDA$$51$YR$$F$Y$$$20200805$$PH$CA$CA
135078153$13507815$3$F$$20200629$20170503$20200706$PER$$US-PFIZER INC-2015170696$PFIZER$$47$YR$$F$Y$$$20200706$$MD$US$US
1350855911$13508559$11$F$20170421$20190621$20170503$20190628$EXP$$CA-ASTRAZENECA-2017SE43020$ASTRAZENECA$$771$MON$$M$Y$$$20190628$$MD$CA$CA
135087052$13508705$2$F$201608$20200821$20170503$20200916$PER$$US-ASTRAZENECA-2016SF12517$ASTRAZENECA$$892$MON$$M$Y$83$KG$20200916$$CN$US$US
135101593$13510159$3$F$20170403$20170608$20170503$20170616$EXP$$BE-ASTRAZENECA-2017SE35228$ASTRAZENECA$$66$YR$$M$Y$58$KG$20170616$$MD$BE$BE
135103913$13510391$3$F$20161202$20171226$20170503$20180103$EXP$$GB-ASTRAZENECA-2016SF35728$ASTRAZENECA$$18341$DY$$M$Y$$$20180103$$MD$GB$GB
135105742$13510574$2$F$20170425$20170901$20170503$20170907$EXP$$NL-ASTRAZENECA-2017SE43599$ASTRAZENECA$$70$YR$$M$Y$93.7$KG$20170907$$MD$NL$NL
135106432$13510643$2$F$20170421$20200618$20170503$20200701$EXP$$CA-ACTELION-A-US2017-152337$ACTELION$$49$YR$$F$Y$63.49$KG$20200701$$HP$CA$CA
135109775$13510977$5$F$$20200918$20170503$20200929$EXP$$CA-APOTEX-2017AP011209$APOTEX$$26$YR$$F$Y$63$KG$20200929$$CN$CA$CA
135112475$13511247$5$F$$20200921$20170503$20200925$EXP$$GB-BIOGEN-2017BI00379781$BIOGEN$$$$$F$Y$$$20200925$$CN$GB$GB
135118637$13511863$7$F$2016$20200819$20170504$20200826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-097001$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200826$$MD$CA$CA
135119166$13511916$6$F$$20200903$20170504$20200907$EXP$$US-PFIZER INC-2017155040$PFIZER$$36$YR$$F$Y$$$20200907$$HP$US$US
135120045$13512004$5$F$2017$20200609$20170504$20200703$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003171$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$97$KG$20200703$$MD$US$US
135120132$13512013$2$F$$20200113$20170504$20200714$EXP$$CA-ROCHE-1930061$ROCHE$$57$YR$$F$Y$$$20200714$$CN$CA$CA
135121484$13512148$4$F$$20200723$20170504$20200728$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-1264$ORION$$51$YR$$F$Y$$$20200728$$HP$CA$CA
135121623$13512162$3$F$20170425$20170515$20170504$20170522$EXP$$US-JNJFOC-20170501308$PHARMACYCLICS$$66$YR$E$M$Y$$$20170522$$MD$US$US
135127039$13512703$9$F$2017$20200805$20170504$20200814$EXP$$US-SA-2017SA078321$SANOFI AVENTIS$$$$$$Y$$$20200814$$CN$US$US
135128241$13512824$1$I$20140621$20140624$20170504$20170504$EXP$$US-JNJFOC-20140618437$JANSSEN$$66$YR$E$M$Y$75$KG$20170504$$MD$US$US
135139678$13513967$8$F$20160901$20200911$20170504$20200917$EXP$$US-PFIZER INC-2017192886$PFIZER$$46$YR$$F$Y$$$20200917$$CN$US$US
135143966$13514396$6$F$20170421$20181018$20170504$20181023$EXP$$CN-JNJFOC-20170429222$JANSSEN$$76$YR$E$M$Y$80$KG$20181023$$MD$CN$CN
135146924$13514692$4$F$$20200724$20170504$20200731$EXP$$FR-ASTELLAS-2017US016685$ASTELLAS$BRUNET M, LELIEVRE B, JEGOU F, ABBARA C, TURCANT A, ROUX GL, ET AL. ENZALUTAMIDE (XTANDI) AND ANALYTICAL INTERFERENCE DURING THE DETERMINATION OF DIGOXIN. CLINICAL TOXICOLOGY. 2017?55(5):388$84$YR$$M$Y$$$20200731$$HP$FR$FR
135150901$13515090$1$I$20140804$20140805$20170504$20170504$EXP$$US-JNJFOC-20140804630$JANSSEN$$66$YR$E$M$Y$76$KG$20170504$$MD$US$US
135151972$13515197$2$F$20170426$20170504$20170504$20170509$EXP$$CA-ASTRAZENECA-2017SE46346$ASTRAZENECA$$68$YR$$F$Y$$$20170510$$MD$CA$CA
135152816$13515281$6$F$20170416$20181127$20170504$20181204$EXP$$AT-ASTRAZENECA-2017SE41033$ASTRAZENECA$$28331$DY$$M$Y$$$20181204$$MD$AT$AT
135153746$13515374$6$F$20170426$20190228$20170504$20190308$EXP$$US-ASTRAZENECA-2017SE46036$ASTRAZENECA$FONTECILLA NATALIA, KHANNA TRISHA, AUDREY?CLAIRE, ANTONOV NINA, GESKIN LARISA. BULLOUS PEMPHIGOID ASSOCIATED WITH A NEW COMBINATION CHECKPOINT INHIBITOR IMMUNOTHERAPY.. JOURNAL OF DRUGS IN DERMATOLOGY. 2019?18(1):103?104.$23765$DY$$F$Y$$$20190308$$MD$US$US
1351618214$13516182$14$F$20161116$20200908$20170505$20200915$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038679$BRISTOL MYERS SQUIBB$FURUKAWA R, ET AL. ONSET SITUTATION OF COLITIS DUE TO ANTI PD?1 ANTIBODY IN OUR HOSPITAL. THE 98TH HOKKAIDO MEDICAL CONGRESS OF THE JAPANESE SOCIETY OF GASTROENTEROLOGY. 2018?150$52$YR$$M$Y$63$KG$20200915$$MD$JP$JP
135164602$13516460$2$F$20170415$20170614$20170505$20170616$EXP$$CA-ASTRAZENECA-2017SE46348$ASTRAZENECA$$70$YR$$F$Y$$$20170616$$MD$CA$CA
135167262$13516726$2$F$$20170529$20170505$20170602$EXP$$HK-ROCHE-1930859$ROCHE$$$$$$Y$$$20170602$$MD$HK$HK
135168182$13516818$2$F$$20200720$20170505$20200722$PER$$US-PFIZER INC-2017188678$PFIZER$$67$YR$$M$Y$$$20200722$$CN$US$US
135170925$13517092$5$F$$20200819$20170505$20200826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038596$BRISTOL MYERS SQUIBB$$52$YR$$F$Y$$$20200826$$CN$CA$CA
135171528$13517152$8$F$$20200915$20170505$20200916$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-101466$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200916$$MD$CA$CA
1351715514$13517155$14$F$$20200710$20170505$20200715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038230$BRISTOL MYERS SQUIBB$$52$YR$$F$Y$$$20200715$$CN$CA$CA
1351717111$13517171$11$F$$20200814$20170505$20200901$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038205$BRISTOL MYERS SQUIBB$$43$YR$$F$Y$$$20200901$$CN$CA$CA
1351769213$13517692$13$F$$20200811$20170505$20200813$PER$$US-PFIZER INC-2017199380$PFIZER$$61$YR$$F$Y$75.3$KG$20200813$$MD$US$US
135179382$13517938$2$F$$20200729$20170505$20200731$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK063810$GLAXOSMITHKLINE$$$$$M$Y$$$20200731$$CN$CA$CA
135183622$13518362$2$F$20160711$20170427$20170505$20170515$EXP$$JP-ASTRAZENECA-2016SE83003$ASTRAZENECA$$26396$DY$$M$Y$$$20170515$$MD$JP$JP
1351836923$13518369$23$F$20170416$20190123$20170505$20190125$EXP$$US-JNJFOC-20170421253$JANSSEN$$78$YR$E$M$Y$64$KG$20190125$$MD$US$US
135183831$13518383$1$I$20161013$20161013$20170505$20170505$EXP$$DE-ASTRAZENECA-2016SF10113$ASTRAZENECA$$46$YR$$F$Y$$$20170505$$MD$DE$DE
135185964$13518596$4$F$20150407$20200624$20170505$20200702$PER$$US-JNJFOC-20170503325$JOHNSON AND JOHNSON$$73$YR$$F$Y$$$20200702$$CN$US$US
135186108$13518610$8$F$2015$20180525$20170505$20200923$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038693$BRISTOL MYERS SQUIBB$TAKAHASHI H, ET AL. THREE CASES WHERE VEMURAFENIB WAS ADMINISTERED FOR MALIGNANT MELANOMA. RINSHO DERMA. 2017?59(4):513?7$82$YR$$M$Y$54$KG$20200923$$MD$JP$JP
135188359$13518835$9$F$$20200630$20170505$20200701$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052264$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200701$$MD$CA$CA
135191111$13519111$1$I$20160411$20160412$20170505$20170505$EXP$$IT-ASTRAZENECA-2016SE40539$ASTRAZENECA$$27019$DY$$M$Y$$$20170505$$MD$IT$IT
135191343$13519134$3$F$20160523$20170613$20170505$20170615$EXP$$FR-ASTRAZENECA-2016SE55934$ASTRAZENECA$$25135$DY$$F$Y$$$20170615$$MD$FR$FR
1351932413$13519324$13$F$20171112$20200715$20170505$20200722$PER$$US-PFIZER INC-2017199196$PFIZER$$58$YR$$F$Y$104.3$KG$20200722$$HP$US$US
135193939$13519393$9$F$$20200914$20170505$20200922$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038017$BRISTOL MYERS SQUIBB$$63$YR$$F$Y$$$20200922$$MD$CA$CA
135194163$13519416$3$F$$20200915$20170505$20200923$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038266$BRISTOL MYERS SQUIBB$$$$$M$Y$66$KG$20200923$$MD$CA$CA
135195994$13519599$4$F$$20200918$20170505$20200928$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038053$BRISTOL MYERS SQUIBB$$60$YR$$F$Y$$$20200928$$CN$CA$CA
135197575$13519757$5$F$$20200916$20170506$20200923$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038156$BRISTOL MYERS SQUIBB$$69$YR$$M$Y$$$20200923$$CN$CA$CA
1351978611$13519786$11$F$$20200915$20170506$20200922$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038198$BRISTOL MYERS SQUIBB$$$$$M$Y$113$KG$20200922$$HP$CA$CA
1351984815$13519848$15$F$$20200629$20170506$20200702$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-000478$BRISTOL MYERS SQUIBB$$56$YR$$M$Y$$$20200702$$HP$CA$CA
1351988612$13519886$12$F$$20200916$20170506$20200923$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-037981$BRISTOL MYERS SQUIBB$$40$YR$$F$Y$$$20200923$$MD$CA$CA
135199273$13519927$3$F$$20200807$20170506$20200811$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038095$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200811$$CN$CA$CA
135199326$13519932$6$F$$20200722$20170506$20200727$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038081$BRISTOL MYERS SQUIBB$$42$YR$$F$Y$81$KG$20200727$$MD$CA$CA
135201613$13520161$3$F$20170423$20170531$20170507$20170606$EXP$$CZ-BAXTER-2017BAX019030$BAXTER$$38$YR$$F$Y$95$KG$20170606$$MD$CZ$CZ
1352036610$13520366$10$F$20160919$20200813$20170507$20200819$EXP$$GB-MYLANLABS-2016M1041198$MYLAN$$31$YR$$M$Y$$$20200819$$HP$GB$GB
135212726$13521272$6$F$$20200709$20170508$20200714$PER$$US-PFIZER INC-2017192842$PFIZER$$69$YR$$F$Y$70$KG$20200714$$CN$US$US
135216475$13521647$5$F$2017$20200713$20170508$20200716$PER$$US-AMGEN-USASP2017069076$AMGEN$$62$YR$A$M$Y$$$20200716$$HP$US$US
1352179118$13521791$18$F$201704$20200727$20170508$20200810$EXP$$US-INCYTE CORPORATION-2017IN003289$INCYTE$$$$$$Y$$$20200810$$CN$US$US
135226045$13522604$5$F$20140812$20200809$20170508$20200818$EXP$$US-JNJFOC-20170505756$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200818$$CN$US$US
135230302$13523030$2$F$20170422$20180619$20170508$20180622$EXP$$AU-ASTRAZENECA-2017SE48409$ASTRAZENECA$$17045$DY$$F$Y$$$20180622$$MD$AU$AU
135233081$13523308$1$I$20170309$20170309$20170508$20170508$EXP$$TW-ASTRAZENECA-2017SE25740$ASTRAZENECA$$56$YR$$M$Y$53.5$KG$20170508$$MD$TW$TW
135233311$13523331$1$I$20160426$20160613$20170508$20170508$EXP$$DE-ASTRAZENECA-2016SE65032$ASTRAZENECA$$921$MON$$F$Y$$$20170508$$MD$DE$DE
135239508$13523950$8$F$20170415$20200504$20170508$20200505$EXP$$PHHO2017CO007478$NOVARTIS$$53$YR$$F$Y$80$KG$20200505$$HP$BR$CO
135240241$13524024$1$I$20160812$20160830$20170508$20170508$EXP$$US-ASTRAZENECA-2016SE93583$ASTRAZENECA$$57$YR$$M$Y$123.2$KG$20170508$$MD$US$US
135241884$13524188$4$F$20170425$20180724$20170508$20180731$EXP$$US-JNJFOC-20170506227$JANSSEN$$50$YR$A$M$Y$$$20180731$$MD$US$US
135257349$13525734$9$F$20170403$20200624$20170509$20200701$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038842$BRISTOL MYERS SQUIBB$$73$YR$$F$Y$$$20200701$$CN$CA$CA
1352579914$13525799$14$F$201303$20200709$20170509$20200717$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-037847$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20200717$$MD$FR$FR
135260993$13526099$3$F$20170329$20180816$20170509$20180824$EXP$$CA-ASTRAZENECA-2017SE33831$ASTRAZENECA$$23870$DY$$M$Y$$$20180824$$MD$CA$CA
135262421$13526242$1$I$$20170503$20170509$20170509$EXP$$US-ROCHE-1931919$ROCHE$KAMIYA?MATSUOKA C, PAKER A, CHIN L, YOUSSEF A, TUMMALA S AND LOGHIN M POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN CANCER PATIENTS: A SINGLE INSTITUTION RETROSPECTIVE STUDY. J NEUROONCOL 2016?128:75?84.$$$$$Y$$$20170509$$HP$US$US
1352634321$13526343$21$F$20170404$20200713$20170509$20200720$EXP$$CA-TAKEDA-2017TUS009836$TAKEDA$$43$YR$$F$Y$65$KG$20200720$$HP$CA$CA
135264753$13526475$3$F$$20200824$20170509$20200903$EXP$$CA-ROCHE-1931776$ROCHE$$69$YR$$F$Y$$$20200903$$HP$CA$CA
135272196$13527219$6$F$20170501$20170620$20170509$20170627$EXP$$JP-JNJFOC-20170501090$JANSSEN$$51$YR$A$F$Y$48$KG$20170627$$MD$JP$JP
1352733518$13527335$18$F$20170414$20200817$20170509$20200820$EXP$$LT-SA-2017SA079780$SANOFI AVENTIS$$$$$$Y$$$20200820$$MD$LT$LT
135275182$13527518$2$F$20161123$20170510$20170509$20170517$EXP$$US-JNJFOC-20170505500$PHARMACYCLICS$$73$YR$E$M$Y$116.4$KG$20170517$$MD$US$US
135280513$13528051$3$F$$20200709$20170509$20200731$EXP$$AU-MYLANLABS-2017M1027554$MYLAN$RICHARDS S, TORRE L, LAWTHER B. BUPRENORPHINE?RELATED COMPLICATIONS IN ELDERLY HOSPITALISED PATIENTS: A CASE SERIES. ANAESTH?INTENSIVE?CARE 2017?45(2):256?261.$91$YR$$M$Y$$$20200731$$MD$AU$AU
135284382$13528438$2$F$20170322$20200408$20170509$20200416$EXP$$CA-ASTRAZENECA-2017SE31432$ASTRAZENECA$$71$YR$$M$Y$$$20200416$$MD$CA$CA
135289844$13528984$4$F$20170411$20200702$20170509$20200707$EXP$$US-JAZZ-2017-US-005766$JAZZ$$34$YR$$F$Y$$$20200707$$MD$US$US
1353045423$13530454$23$F$20170417$20200904$20170509$20200910$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-040478$BRISTOL MYERS SQUIBB$$70$YR$$F$Y$47$KG$20200910$$CN$CA$CA
135311212$13531121$2$F$$20200911$20170510$20200923$EXP$$CA-APOTEX-2017AP011489$APOTEX$$69$YR$$F$Y$80$KG$20200923$$CN$CA$CA
1353148915$13531489$15$F$20170412$20200908$20170510$20200910$EXP$$CA-TAKEDA-2017TUS008259$TAKEDA$$67$YR$$M$Y$$$20200910$$HP$CA$CA
135323723$13532372$3$F$20111209$20200529$20170510$20200701$EXP$$PHHY2017DE065287$NOVARTIS$$$$A$M$Y$$$20200701$$MD$DE$DE
135324625$13532462$5$F$20170426$20171201$20170510$20171207$EXP$$KR-PFIZER INC-2017199200$PFIZER$$82$YR$$M$Y$$$20171207$$MD$KR$KR
135324853$13532485$3$F$$20200713$20170510$20200716$EXP$$US-JAZZ-2017-US-005806$JAZZ$$$$$F$Y$$$20200716$$CN$US$US
135324874$13532487$4$F$2017$20200826$20170510$20200831$EXP$$US-JAZZ-2017-US-005814$JAZZ$$$$$M$Y$$$20200831$$HP$US$US
135331567$13533156$7$F$20161213$20180626$20170510$20180703$EXP$$JP-ASTRAZENECA-2017SE35872$ASTRAZENECA$$21961$DY$$M$Y$$$20180703$$MD$JP$JP
135333378$13533337$8$F$20170430$20180416$20170510$20180419$EXP$$KR-JNJFOC-20170500814$JANSSEN$$44$YR$A$F$Y$54$KG$20180419$$MD$KR$KR
135333463$13533346$3$F$$20200804$20170510$20200814$EXP$$DE-JNJFOC-20170508063$JOHNSON AND JOHNSON$$$$E$F$Y$$$20200814$$MD$DE$DE
135334172$13533417$2$F$20170504$20171020$20170510$20171026$EXP$$PL-JNJFOC-20170507408$PHARMACYCLICS$$65$YR$A$M$Y$71$KG$20171026$$MD$PL$PL
135334961$13533496$1$I$20150615$20150701$20170510$20170510$EXP$$US-JNJFOC-20150703780$JANSSEN$$88$YR$E$M$Y$77.11$KG$20170510$$MD$US$US
135334973$13533497$3$F$2012$20200917$20170510$20200928$EXP$$CA-JNJFOC-20170506438$JOHNSON AND JOHNSON$$30$YR$A$F$Y$44.44$KG$20200928$$HP$CA$CA
1353366921$13533669$21$F$201503$20200707$20170510$20200721$EXP$$US-ACTELION-A-NJ2015-115216$ACTELION$$37$YR$$F$Y$83.9$KG$20200721$$HP$US$US
135337402$13533740$2$F$20150223$20200709$20170510$20200720$EXP$$US-BAYER-2017-088080$BAYER$$75$YR$E$F$Y$$$20200720$$CN$US$US
135337552$13533755$2$F$201409$20200719$20170510$20200727$EXP$$US-BAYER-2017-077325$BAYER$$68$YR$E$M$Y$$$20200727$$CN$US$US
135345923$13534592$3$F$201212$20200729$20170511$20200805$EXP$$US-BIOGEN-2017BI00398847$BIOGEN$$29$YR$$F$Y$$$20200805$$CN$US$US
135354775$13535477$5$F$20130918$20200707$20170511$20200710$PER$$US-BIOGEN-2013BI097949$BIOGEN$$53$YR$$F$Y$$$20200710$$CN$US$US
135356645$13535664$5$F$201501$20200907$20170511$20200919$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-140130$RANBAXY$$$$$M$Y$$$20200919$$HP$IT$IT
135359518$13535951$8$F$$20200630$20170511$20200702$PER$$US-PFIZER INC-2017135287$PFIZER$$64$YR$$F$Y$83$KG$20200702$$MD$US$US
1353650126$13536501$26$F$20180124$20200803$20170511$20200810$EXP$$CA-CELLTRION INC.-2017CA005808$CELLTRION$$$$$$Y$$$20200811$$HP$CA$CA
135368229$13536822$9$F$20170128$20200914$20170511$20200916$EXP$$PHHY2017DE066773$NOVARTIS$$55$YR$$M$Y$79$KG$20200916$$HP$DE$DE
135370245$13537024$5$F$20160806$20190315$20170511$20190318$EXP$$CL-ASTRAZENECA-2016SE86002$ASTRAZENECA$$28276$DY$$F$Y$$$20190318$$MD$CL$CL
135370826$13537082$6$F$2006$20200506$20170511$20200729$EXP$$US-MUNDIPHARMA DS AND PHARMACOVIGILANCE-USA-2017-0138763$PURDUE$$58$YR$$M$Y$75.28$KG$20200729$$CN$US$US
135370832$13537083$2$F$20161130$20170808$20170511$20170809$EXP$$TR-ASTRAZENECA-2016SF27859$ASTRAZENECA$$20716$DY$$M$Y$$$20170809$$MD$TR$TR
135372345$13537234$5$F$20170419$20200728$20170511$20200731$EXP$$GR-CELGENEUS-GRC-20170409122$CELGENE$$72$YR$$F$Y$68$KG$20200731$$HP$GR$GR
135372587$13537258$7$F$$20200820$20170511$20200825$EXP$$US-PFIZER INC-2017172599$PFIZER$BANKER, K.. COMPULSIVE GABAPENTIN ABUSE DESPITE LACK OF DESIRABLE EFFECTS: A CASE REPORT. JOURNAL OF SUBSTANCE USE. 2017?22 (6):661?663$51$YR$$M$Y$$$20200825$$HP$US$US
135376813$13537681$3$F$$20170608$20170511$20200803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-041434$BRISTOL MYERS SQUIBB$YU WY?H, BHUTANI T, KORNIK R, PINCUS LB, MAURO T, ROSENBLUM MD ET AL. WARFARIN?ASSOCIATED NONUREMIC CALCIPHYLAXIS. JAMA DERMATOLOGY. 2017?153:309?14$58$YR$$F$Y$$$20200803$$HP$US$US
135377283$13537728$3$F$20170204$20200629$20170511$20200710$EXP$$US-ACTELION-A-NJ2017-149752$ACTELION$$72$YR$$F$Y$87.08$KG$20200710$$MD$US$US
135380958$13538095$8$F$20120605$20200724$20170512$20200802$EXP$$BR-BIOGEN-2017BI00400188$BIOGEN$$33$YR$$F$Y$$$20200802$$CN$BR$BR
135380975$13538097$5$F$2016$20200811$20170512$20200814$EXP$$US-ABBVIE-17K-163-1913208-00$ABBVIE$$68$YR$$F$Y$79$KG$20200814$$CN$US$US
135381737$13538173$7$F$20141013$20200724$20170512$20200804$EXP$$BR-BIOGEN-2017BI00400201$BIOGEN$$36$YR$$F$Y$$$20200804$$CN$BR$BR
135383594$13538359$4$F$20180717$20200903$20170512$20200911$EXP$$US-ASTRAZENECA-2017SE48929$ASTRAZENECA$$62$YR$$F$Y$123.4$KG$20200911$$$US$US
135394603$13539460$3$F$$20200910$20170512$20200915$PER$$US-PFIZER INC-2017206421$PFIZER$$71$YR$$F$Y$$$20200915$$CN$US$US
135395814$13539581$4$F$20120710$20200917$20170512$20200929$EXP$$CA-JNJFOC-20170507138$JOHNSON AND JOHNSON$$30$YR$A$F$Y$132$KG$20200930$$MD$CA$CA
135409392$13540939$2$F$20160615$20171017$20170512$20171025$EXP$$US-ASTRAZENECA-2017SE50892$ASTRAZENECA$$66$YR$$M$Y$97.9$KG$20171025$$MD$US$US
135409472$13540947$2$F$20170228$20170706$20170512$20170711$EXP$$FR-ASTRAZENECA-2017SE24245$ASTRAZENECA$$48$YR$$M$Y$89$KG$20170711$$MD$FR$FR
135409582$13540958$2$F$20170214$20190627$20170512$20190628$EXP$$TR-ASTRAZENECA-2017SE18926$ASTRAZENECA$$26762$DY$$M$Y$$$20190628$$MD$TR$TR
135411712$13541171$2$F$20170407$20170906$20170512$20170908$EXP$$IL-ASTRAZENECA-2017SE37044$ASTRAZENECA$$23843$DY$$M$Y$$$20170908$$MD$IL$IL
135414331$13541433$1$I$20160309$20160309$20170512$20170512$EXP$$FR-ASTRAZENECA-2016SE26727$ASTRAZENECA$$21007$DY$$M$Y$64$KG$20170512$$MD$FR$FR
135416747$13541674$7$F$2016$20200709$20170512$20200715$EXP$$US-SA-2016SA172680$SANOFI AVENTIS$$$$$$Y$$$20200715$$HP$US$US
135439022$13543902$2$F$$20200904$20170515$20200909$PER$$US-ELI_LILLY_AND_COMPANY-US201705003352$ELI LILLY AND CO$$$$$F$Y$$$20200909$$CN$US$US
1354457916$13544579$16$F$201808$20200916$20170515$20200923$EXP$$PHHY2017CA069730$NOVARTIS$$69$YR$$M$Y$$$20200923$$CN$CA$CA
1354468711$13544687$11$F$20170117$20200831$20170515$20200910$EXP$$US-ASTELLAS-2017US003224$ASTELLAS$$78$YR$$M$Y$$$20200910$$CN$US$US
135451283$13545128$3$F$20170509$20170613$20170515$20170614$EXP$$ES-ASTRAZENECA-2017SE50359$ASTRAZENECA$$49$YR$$M$Y$68$KG$20170614$$MD$ES$ES
135456632$13545663$2$F$$20200713$20170515$20200716$PER$$US-PFIZER INC-2017208599$PFIZER$$$$$F$Y$$$20200716$$CN$US$US
135458272$13545827$2$F$$20170503$20170515$20200803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038965$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200803$$CN$US$US
135460241$13546024$1$I$1999$20160901$20170515$20170515$EXP$$US-WARNER CHILCOTT-2016-002062$ALLERGAN$$66$YR$$F$Y$$$20170515$$CN$JP$US
135466011$13546601$1$I$20160519$20160602$20170515$20170515$EXP$$KR-ASTRAZENECA-2016SE59822$ASTRAZENECA$$858$MON$$F$Y$$$20170515$$MD$KR$KR
135466063$13546606$3$F$20170102$20170824$20170515$20170901$EXP$$MY-JNJFOC-20170104631$JANSSEN$$68$YR$E$M$Y$79$KG$20170901$$MD$MY$MY
1354661713$13546617$13$F$20170310$20180125$20170515$20180202$EXP$$UA-ASTRAZENECA-2017SE51087$ASTRAZENECA$$18827$DY$$M$Y$$$20180202$$MD$UA$UA
135466655$13546665$5$F$20170403$20190807$20170515$20190814$EXP$$GB-ASTRAZENECA-2017SE47184$ASTRAZENECA$$21756$DY$$M$Y$$$20190814$$MD$GB$GB
135467361$13546736$1$I$20170307$20170308$20170515$20170515$EXP$$US-ASTRAZENECA-2017SE25645$ASTRAZENECA$$64$YR$$M$Y$$$20170515$$MD$US$US
135467622$13546762$2$F$20160316$20170523$20170515$20170525$EXP$$UA-ASTRAZENECA-2016SE32770$ASTRAZENECA$$16719$DY$$M$Y$$$20170525$$MD$UA$UA
135472364$13547236$4$F$201605$20200618$20170515$20200701$EXP$$US-ACTELION-A-NJ2016-142055$ACTELION$$57$YR$$M$Y$79.37$KG$20200701$$MD$US$US
135475952$13547595$2$F$$20200810$20170515$20200813$PER$$US-BIOGEN-2017BI00399573$BIOGEN$$$$$F$Y$$$20200813$$CN$US$US
135476923$13547692$3$F$20130812$20200423$20170515$20200428$EXP$$PHHY2013CA089586$NOVARTIS$$64$YR$$F$Y$$$20200428$$CN$CA$CA
135478934$13547893$4$F$20200827$20200827$20170516$20200924$PER$$US-ELI_LILLY_AND_COMPANY-US201705001801$ELI LILLY AND CO$$63$YR$$M$Y$$$20200924$$CN$US$US
135479802$13547980$2$F$20170106$20170717$20170516$20170720$EXP$$NL-ROCHE-1931058$ROCHE$$59$YR$$F$Y$100$KG$20170720$$MD$NL$NL
135487796$13548779$6$F$$20200714$20170516$20200722$EXP$$CA-APOTEX-2017AP011695$APOTEX$$58$YR$$M$Y$$$20200722$$CN$CA$CA
135492365$13549236$5$F$20170415$20180227$20170516$20180305$EXP$$CZ-ROCHE-1933969$ROCHE$$73$YR$$M$Y$75$KG$20180305$$MD$CZ$CZ
135492732$13549273$2$F$20170410$20170925$20170516$20170929$EXP$$HU-ASTRAZENECA-2017SE39138$ASTRAZENECA$$64$YR$$M$Y$69$KG$20170929$$MD$HU$HU
135493455$13549345$5$F$20170320$20180927$20170516$20181001$EXP$$CL-ASTRAZENECA-2017SE30618$ASTRAZENECA$$30541$DY$$M$Y$$$20181001$$MD$CL$CL
135493907$13549390$7$F$201705$20200720$20170516$20200725$PER$$CA-AMGEN-CANSP2017071781$AMGEN$$50$YR$A$F$Y$$$20200725$$HP$CA$CA
135496541$13549654$1$I$20170426$20170505$20170516$20170516$EXP$$DE-ROCHE-1932269$ROCHE$$69$YR$$M$Y$80$KG$20170516$$MD$DE$DE
135497577$13549757$7$F$$20180912$20170516$20180924$PER$$PHEH2017US014562$NOVARTIS$$$$$F$Y$$$20180924$$CN$COUNTRY NOT SPECIFIED$US
135509232$13550923$2$F$20170505$20170519$20170516$20170525$EXP$$CA-PFIZER INC-2017209609$PFIZER$$67$YR$$M$Y$$$20170525$$MD$CA$CA
135510022$13551002$2$F$20170508$20170616$20170516$20170621$EXP$$GB-JNJFOC-20170510528$PHARMACYCLICS$$71$YR$E$M$Y$$$20170621$$MD$GB$GB
135511242$13551124$2$F$201612$20200925$20170516$20200929$EXP$$FR-PFIZER INC-2017209481$PFIZER$$52$YR$$M$Y$106$KG$20200929$$MD$FR$FR
135512722$13551272$2$F$20170504$20170515$20170516$20170523$EXP$$FR-ASTRAZENECA-2017SE50734$ASTRAZENECA$$18939$DY$$M$Y$$$20170523$$MD$FR$FR
135513712$13551371$2$F$20170402$20170825$20170516$20170828$EXP$$BR-ASTRAZENECA-2017SE36341$ASTRAZENECA$$19249$DY$$M$Y$$$20170828$$MD$BR$BR
135516053$13551605$3$F$$20181003$20170516$20181011$EXP$$PT-BAUSCH-BL-2017-014648$BAUSCH AND LOMB$ROCHA G, FLOR?DE?LIMA F, AZEVEDO I, GUIMARAES H. SEVERE BRONCHOPULMONARY DYSPLASIA WITH LARGE PNEUMATOCELES IN AN EXTREME PRETERM NEWBORN. PORTUGUESE JOURNAL OF PULMONOLOGY. 2017?23(3):170?172.$$$N$M$Y$.58$KG$20181011$$MD$PT$PT
135517487$13551748$7$F$20160503$20200630$20170516$20200706$EXP$$CA-TAKEDA-2016TUS008197$TAKEDA$$55$YR$$F$Y$$$20200706$$HP$CA$CA
135524201$13552420$1$I$20160411$20160412$20170517$20170517$EXP$$ES-ASTRAZENECA-2016SE39157$ASTRAZENECA$$25054$DY$$M$Y$$$20170517$$MD$ES$ES
135526661$13552666$1$I$20160525$20160525$20170517$20170517$EXP$$VN-ASTRAZENECA-2016SE57358$ASTRAZENECA$$19398$DY$$M$Y$$$20170517$$MD$VN$VN
135527485$13552748$5$F$20140707$20200910$20170517$20200915$EXP$$US-ASTRAZENECA-2017SE49958$ASTRAZENECA$$24958$DY$$M$Y$92.1$KG$20200915$$$US$US
135529002$13552900$2$F$20170501$20170517$20170517$20170519$EXP$$PH-ROCHE-1935777$ROCHE$$81$YR$$M$Y$$$20170519$$CN$PH$PH
135530504$13553050$4$F$$20200706$20170517$20200713$EXP$$US-PFIZER INC-2017215095$PFIZER$$$$$F$Y$86.17$KG$20200713$$CN$US$US
135533467$13553346$7$F$20170510$20200714$20170517$20200717$EXP$$CA-ROCHE-1936246$ROCHE$$64$YR$$F$Y$$$20200717$$MD$CA$CA
135534047$13553404$7$F$20170831$20200917$20170517$20200925$EXP$$CA-ROCHE-1935668$ROCHE$$38$YR$$F$Y$$$20200925$$CN$CA$CA
1355444416$13554444$16$F$20170418$20200701$20170517$20200706$EXP$$ES-ROCHE-1934858$ROCHE$$84$YR$$M$Y$75$KG$20200706$$MD$ES$ES
135547122$13554712$2$F$20170510$20170515$20170517$20170524$EXP$$CN-JNJFOC-20170514666$PHARMACYCLICS$$88$YR$E$M$Y$$$20170524$$MD$CN$CN
1355484015$13554840$15$F$202006$20200706$20170517$20200717$EXP$$US-ACTELION-A-NJ2016-139773$ACTELION$$66$YR$$F$Y$120.18$KG$20200717$$HP$US$US
135550446$13555044$6$F$20170509$20171003$20170517$20171010$EXP$$IL-ASTRAZENECA-2017SE50470$ASTRAZENECA$$70$YR$$M$Y$61$KG$20171010$$MD$IL$IL
135550732$13555073$2$F$20160311$20170614$20170517$20170622$EXP$$AU-ASTRAZENECA-2016SE34009$ASTRAZENECA$$28855$DY$$M$Y$$$20170622$$MD$AU$AU
135553656$13555365$6$F$20170508$20180104$20170517$20180108$EXP$$ES-BAXTER-2017BAX020861$BAXTER$$46$YR$$M$Y$70.3$KG$20180108$$HP$ES$ES
135554673$13555467$3$F$20170326$20170609$20170517$20170619$EXP$$GB-JNJFOC-20170404212$PHARMACYCLICS$$71$YR$E$M$Y$107.5$KG$20170619$$MD$GB$GB
135556953$13555695$3$F$2020$20200914$20170517$20200921$PER$$US-AMGEN-USASL2017072433$AMGEN$$60$YR$A$F$Y$$$20200920$$MD$US$US
135557447$13555744$7$F$201701$20200707$20170517$20200717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002399$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$50$KG$20200717$$MD$US$US
135562244$13556224$4$F$2017$20200814$20170517$20200824$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002505$ACADIA PHARMACEUTICALS$$61$YR$$F$Y$$$20200824$$HP$US$US
135562832$13556283$2$F$201701$20200727$20170517$20200803$PER$$US-SA-2017SA008281$SANOFI AVENTIS$$$$$$Y$$$20200803$$CN$US$US
135568719$13556871$9$F$20170217$20200629$20170517$20200709$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002535$ACADIA PHARMACEUTICALS$$65$YR$$M$Y$74$KG$20200709$$CN$US$US
135570104$13557010$4$F$20170316$20200819$20170517$20200828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002691$ACADIA PHARMACEUTICALS$$67$YR$$M$Y$$$20200828$$MD$US$US
135570928$13557092$8$F$2017$20200708$20170517$20200717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002744$ACADIA PHARMACEUTICALS$$85$YR$$M$Y$91$KG$20200717$$HP$US$US
135573954$13557395$4$F$201703$20200914$20170517$20200924$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002923$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20200924$$CN$US$US
135575147$13557514$7$F$2017$20200729$20170517$20200807$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002982$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20200807$$CN$US$US
135575323$13557532$3$F$2017$20200612$20170517$20200707$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002437$ACADIA PHARMACEUTICALS$$74$YR$$M$Y$$$20200707$$MD$US$US
135576643$13557664$3$F$20190710$20200714$20170517$20200807$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003076$ACADIA PHARMACEUTICALS$$81$YR$$F$Y$$$20200807$$MD$US$US
135576801$13557680$1$I$20161122$20170412$20170518$20170518$EXP$$CA-PFIZER INC-2017180125$PFIZER$$74$YR$$F$Y$$$20170518$$MD$CA$CA
1355772810$13557728$10$F$$20200915$20170518$20200917$EXP$$US-PFIZER INC-2017212769$PFIZER$$71$YR$$F$Y$49$KG$20200917$$HP$US$US
135580976$13558097$6$F$20170418$20200730$20170517$20200807$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003274$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20200807$$MD$US$US
135588523$13558852$3$F$20161126$20171013$20170518$20171016$EXP$$JP-ASTRAZENECA-2016SF26281$ASTRAZENECA$$28907$DY$$M$Y$$$20171016$$MD$JP$JP
135588692$13558869$2$F$20160423$20170608$20170518$20170609$EXP$$US-ASTRAZENECA-2016SE45813$ASTRAZENECA$$25526$DY$$F$Y$$$20170609$$MD$US$US
135591651$13559165$1$I$$20170511$20170518$20170518$EXP$$CN-ROCHE-1936029$ROCHE$ZHANG W, ZHANG Y, LI P, RHODESM S,  WANG Y,  XUE X, DONG Y, DING W, SHEN Y AND  ZHANG B ADMINISTRATION OF SODIUM IBANDRONATE IN THE TREATMENT OF COMPLICATED GIANT CELL TUMOR OF THE SPINE. SPINE 2011 AUG 01?36 (17):E1166?E1172.$33$YR$$F$Y$$$20170518$$MD$CN$CN
135594484$13559448$4$F$20170407$20170721$20170518$20170724$EXP$$PH-ASTRAZENECA-2017SE53108$ASTRAZENECA$$49$YR$$M$Y$$$20170724$$MD$PH$PH
135596373$13559637$3$F$20160627$20200823$20170518$20200903$EXP$$US-JNJFOC-20170504197$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200903$$CN$US$US
135598564$13559856$4$F$20170511$20180125$20170518$20180126$EXP$$CN-ASTRAZENECA-2017SE51210$ASTRAZENECA$$15856$DY$$M$Y$$$20180126$$MD$CN$CN
1356004914$13560049$14$F$20170322$20200625$20170518$20200701$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-038718$BRISTOL MYERS SQUIBB$$72$YR$$F$Y$$$20200701$$HP$CA$CA
135600984$13560098$4$F$20160821$20180815$20170518$20180824$EXP$$NL-ASTRAZENECA-2016SE90204$ASTRAZENECA$$958$MON$$F$Y$$$20180824$$MD$NL$NL
135601991$13560199$1$I$20160124$20140125$20170518$20170518$EXP$$NL-ASTRAZENECA-2016SE08670$ASTRAZENECA$$816$MON$$M$Y$$$20170518$$MD$NL$NL
1356075615$13560756$15$F$20170509$20200905$20170518$20200909$EXP$$JP-ABBVIE-17K-087-1977405-00$ABBVIE$$70$YR$$F$Y$49$KG$20200909$$MD$JP$JP
135611781$13561178$1$I$20160426$20160427$20170518$20170518$EXP$$RU-ASTRAZENECA-2016SE46511$ASTRAZENECA$$26523$DY$$F$Y$$$20170518$$MD$RU$RU
135616095$13561609$5$F$20170421$20200921$20170518$20200929$EXP$$ES-ALLERGAN-1720312US$ALLERGAN$$$$$F$Y$60$KG$20200929$$HP$ES$ES
135619214$13561921$4$F$20170110$20200702$20170518$20200710$PER$$PHHY2017US071652$NOVARTIS$$39$YR$$F$Y$$$20200711$$MD$US$US
135621797$13562179$7$F$20170504$20200811$20170519$20200819$PER$$CO-AMGEN-COLSL2017074138$AMGEN$$73$YR$E$M$Y$$$20200819$$MD$CO$CO
135622336$13562233$6$F$20170217$20200922$20170519$20200924$EXP$$FR-ROCHE-1937102$ROCHE$$82$YR$$M$Y$78$KG$20200924$$MD$FR$FR
135622502$13562250$2$F$20160603$20171206$20170519$20171214$EXP$$JP-ASTRAZENECA-2016SE60261$ASTRAZENECA$$26111$DY$$M$Y$$$20171214$$MD$JP$JP
135624135$13562413$5$F$2014$20200908$20170519$20200911$EXP$$US-ASTRAZENECA-2017SE51144$ASTRAZENECA$$63$YR$$F$Y$81.6$KG$20200911$$$US$US
135625495$13562549$5$F$$20200910$20170519$20200922$EXP$$CA-APOTEX-2017AP011966$APOTEX$$64$YR$$M$Y$74$KG$20200922$$CN$CA$CA
135629661$13562966$1$I$$20170508$20170519$20170519$EXP$$KR-ROCHE-1933928$ROCHE$WOO C, SEO S, KIM S, JANG S, PARK K, SONG J, LEE B, RICHARDS M, BAYLISS R, LEE D, CHOI J. DIFFERENTIAL PROTEIN STABILITY AND CLINICAL RESPONSES OF EML4?ALK FUSION VARIANTS TO VARIOUS ALK INHIBITORS IN ADVANCED ALK?REARRANGED NON?SMALL CELL LUNG CANCER. ANNALS OF ONCOLOGY 2017 APR 01?28 (4):791?797.$$$$$Y$$$20170519$$HP$KR$KR
1356322110$13563221$10$F$20170130$20200727$20170519$20200804$EXP$$PHHY2017US071664$NOVARTIS$$32$YR$$F$Y$$$20200804$$MD$US$US
135634656$13563465$6$F$20170506$20180227$20170519$20180312$EXP$$GB-JNJFOC-20170515856$JANSSEN$$7$YR$C$F$Y$21.4$KG$20180312$$MD$GB$GB
135637217$13563721$7$F$$20200720$20170519$20200729$PER$$CA-AMGEN-CANSP2017074123$AMGEN$$52$YR$A$F$Y$$$20200729$$HP$CA$CA
135638284$13563828$4$F$20170502$20181114$20170519$20181120$EXP$$BE-JNJFOC-20170503376$PHARMACYCLICS$$62$YR$A$M$Y$81$KG$20181120$$MD$BE$BE
135638292$13563829$2$F$20170503$20170612$20170519$20170620$EXP$$US-JNJFOC-20170512430$PHARMACYCLICS$$62$YR$A$M$Y$66.8$KG$20170620$$MD$US$US
135638368$13563836$8$F$20170515$20170802$20170519$20170807$EXP$$TR-JNJFOC-20170515226$PHARMACYCLICS$$5$YR$C$M$Y$13.5$KG$20170807$$MD$TR$TR
135638505$13563850$5$F$20170427$20200804$20170519$20200814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003459$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20200814$$MD$US$US
135639683$13563968$3$F$$20200928$20170519$20200929$PER$$US-AMGEN-USASP2017073883$AMGEN$$69$YR$E$M$Y$$$20200929$$MD$US$US
135645247$13564524$7$F$20200810$20200903$20170519$20200908$EXP$$US-TAKEDA-2017MPI004445$TAKEDA$$78$YR$$F$Y$$$20200908$$CN$US$US
135646462$13564646$2$F$20160615$20181128$20170519$20181206$EXP$$JP-ASTRAZENECA-2016SE65797$ASTRAZENECA$$28532$DY$$F$Y$$$20181206$$MD$JP$JP
135646869$13564686$9$F$$20200806$20170519$20200807$EXP$$CA-ABBVIE-17K-028-1975999-00$ABBVIE$$$$$F$Y$$$20200807$$MD$CA$CA
135647304$13564730$4$F$$20200925$20170519$20200929$PER$$US-PFIZER INC-2017074991$PFIZER$$70$YR$$M$Y$$$20200929$$MD$US$US
135649073$13564907$3$F$20170509$20170523$20170519$20170531$EXP$$AU-JNJFOC-20170512398$JANSSEN$$61$YR$A$M$Y$107$KG$20170531$$MD$AU$AU
135654745$13565474$5$F$20170425$20200528$20170519$20200825$PER$$US-BIOGEN-2017BI00403588$BIOGEN$LIN J, GEE R, WATSON K, BUU M, DAY J, TESI?ROCHA C. CASE REPORT: TREATMENT WITH NUSINERSEN AND GENE THERAPY IN A CHILD WITH SMA AFTER DEVELOPMENT OF COMMUNICATING HYDROCEPHALUS. 2020 MDA CLINICAL + SCIENTIFIC CONFERENCE. 2020?.$4$MON$$F$Y$9.98$KG$20200825$$MD$US$US
1356589511$13565895$11$F$$20200813$20170520$20200826$EXP$$GB-MACLEODS PHARMACEUTICALS US LTD-MAC2017005022$MACLEODS$$$$$$Y$$$20200826$$CN$GB$GB
1356643116$13566431$16$F$20170517$20200810$20170521$20200814$EXP$$NL-ABBVIE-17K-114-1976327-00$ABBVIE$$78$YR$$M$Y$65$KG$20200813$$CN$NL$NL
135675711$13567571$1$I$20150212$20150213$20170522$20170522$EXP$$JP-ROCHE-1540948$ROCHE$$67$YR$$F$Y$42$KG$20170522$$MD$JP$JP
135677251$13567725$1$I$20160920$20160927$20170522$20170522$EXP$$IT-JNJFOC-20170516506$JANSSEN$$57$YR$A$F$Y$$$20170522$$MD$IT$IT
135678462$13567846$2$F$$20170509$20170522$20200914$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-044245$BRISTOL MYERS SQUIBB$YANES DA, MOSSER?GOLDFARB JL. A CUTANEOUS LUPUS ERYTHEMATOSUS?LIKE ERUPTION INDUCED BY HYDROXYUREA. PEDIATRIC DERMATOLOGY. 2017?34:E30?E31$14$YR$$F$Y$$$20200914$$MD$US$US
135683317$13568331$7$F$201610$20200629$20170522$20200710$EXP$$US-AEGERION PHARMACEUTICAL, INC-AEGR003170$AEGERION$$44$YR$$F$Y$63$KG$20200710$$MD$US$US
135684935$13568493$5$F$201801$20200914$20170522$20200917$EXP$$US-SA-2017SA091642$SANOFI AVENTIS$$$$$$Y$$$20200917$$CN$US$US
135685946$13568594$6$F$20170512$20181119$20170522$20181126$EXP$$US-JNJFOC-20170518584$PHARMACYCLICS$$58$YR$A$F$Y$$$20181126$$MD$US$US
135690422$13569042$2$F$20160505$20200422$20170522$20200428$EXP$$BE-JNJFOC-20160506431$JOHNSON AND JOHNSON$$49$YR$$F$Y$87$KG$20200428$$MD$BE$BE
135690433$13569043$3$F$20161018$20170518$20170522$20200821$EXP$$CO-JNJFOC-20170519685$JOHNSON AND JOHNSON$$48$YR$A$F$Y$69$KG$20200821$$HP$CO$CO
135693512$13569351$2$F$20151231$20181015$20170522$20181019$EXP$$KR-ASTRAZENECA-2016SE00063$ASTRAZENECA$$17377$DY$$F$Y$$$20181019$$MD$KR$KR
135701166$13570116$6$F$19960126$20200910$20170522$20200917$EXP$$US-BIOGEN-2017BI00405582$BIOGEN$$24$YR$$F$Y$$$20200917$$CN$US$US
135709801$13570980$1$I$20170517$20170518$20170523$20170523$EXP$$CA-ASTRAZENECA-2017SE53329$ASTRAZENECA$$71$YR$$F$Y$$$20170523$$MD$CA$CA
135709812$13570981$2$F$20161018$20170614$20170523$20170620$EXP$$BE-ASTRAZENECA-2017SE31958$ASTRAZENECA$$64$YR$$M$Y$107.6$KG$20170620$$MD$BE$BE
135713608$13571360$8$F$2009$20200629$20170523$20200703$PER$$CA-AMGEN-CANSP2017077269$AMGEN$$61$YR$A$F$Y$$$20200703$$CN$CA$CA
135733992$13573399$2$F$20170512$20170523$20170523$20170530$EXP$$CA-PFIZER INC-2017218584$PFIZER$$56$YR$$F$Y$$$20170530$$MD$CA$CA
135734125$13573412$5$F$201611$20200803$20170523$20200805$EXP$$US-PFIZER INC-2017226046$PFIZER$$76$YR$$F$Y$$$20200805$$HP$US$US
135739173$13573917$3$F$20170421$20170512$20170523$20170524$EXP$$GB-CELGENEUS-GBR-20170410308$CELGENE$$49$YR$$F$Y$$$20170524$$HP$GB$GB
135739366$13573936$6$F$$20200904$20170523$20200907$EXP$$PHHY2016CO161301$NOVARTIS$$$$$F$Y$96$KG$20200907$$CN$COUNTRY NOT SPECIFIED$CO
135741138$13574113$8$F$$20200824$20170523$20200827$EXP$$SE-009507513-1705SWE011101$MERCK$GUERRIERI D, RAPP E, ROMAN M, DRUID H, KRONSTRAND R.. POSTMORTEM AND TOXICOLOGICAL FINDINGS IN A SERIES OF FURANYLFENTANYL?RELATED DEATHS. J ANAL TOXICOL. 2017?1?8$26$YR$$M$Y$$$20200827$$$COUNTRY NOT SPECIFIED$SE
135741341$13574134$1$I$20160315$20160316$20170523$20170523$EXP$$RU-ASTRAZENECA-2016SE29243$ASTRAZENECA$$24080$DY$$F$Y$$$20170523$$MD$RU$RU
135748862$13574886$2$F$20170419$20180420$20170523$20180423$EXP$$KR-ASTRAZENECA-2017SE41770$ASTRAZENECA$$68$YR$$M$Y$64.9$KG$20180423$$MD$KR$KR
135754617$13575461$7$F$$20200625$20170524$20200701$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-012089$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20200701$$CN$GB$GB
135759485$13575948$5$F$2017$20200720$20170524$20200723$PER$$US-PFIZER INC-2017223345$PFIZER$$74$YR$$F$Y$$$20200723$$HP$US$US
135760436$13576043$6$F$201910$20200824$20170524$20200825$PER$$US-PFIZER INC-2017227779$PFIZER$$75$YR$$F$Y$83.91$KG$20200825$$CN$US$US
1357620112$13576201$12$F$$20200811$20170524$20200821$EXP$$US-ACTELION-A-US2017-150370$ACTELION$$$$$F$Y$107.03$KG$20200821$$PH$US$US
135768872$13576887$2$F$20170518$20170530$20170524$20170605$EXP$$FR-ASTRAZENECA-2017SE53829$ASTRAZENECA$$27036$DY$$M$Y$76$KG$20170605$$MD$FR$FR
135771262$13577126$2$F$20170207$20200902$20170524$20200904$EXP$$CH-ABBVIE-17P-151-1984666-00$ABBVIE$$73$YR$$F$Y$50$KG$20200904$$PH$CH$CH
1357731510$13577315$10$F$201205$20200713$20170524$20200716$EXP$$US-JAZZ-2014-US-009104$JAZZ$$57$YR$$M$Y$90.7$KG$20200716$$MD$US$US
135773651$13577365$1$I$20160603$20160603$20170524$20170524$EXP$$JP-ASTRAZENECA-2016SE61617$ASTRAZENECA$$20946$DY$$M$Y$$$20170524$$MD$JP$JP
135776852$13577685$2$F$$20170510$20170524$20200914$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-045404$BRISTOL MYERS SQUIBB$ZINN DJ, GRIMES AB, LIN H, ECKSTEIN O, ALLEN CE, ET AL.. HYDROXYUREA: A NEW OLD THERAPY FOR LANGERHANS CELL HISTIOCYTOSIS.. BLOOD. 2016?128:2462?5$48$YR$$F$Y$$$20200914$$HP$US$US
135776922$13577692$2$F$$20170510$20170524$20200914$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-045180$BRISTOL MYERS SQUIBB$ZINN DJ, GRIMES AB, LIN H, ECKSTEIN O, ALLEN CE, ET AL.. HYDROXYUREA: A NEW OLD THERAPY FOR LANGERHANS CELL HISTIOCYTOSIS.. BLOOD. 2016?128:2462?5$9$YR$$M$Y$$$20200914$$HP$US$US
135778852$13577885$2$F$20170404$20170727$20170524$20170801$EXP$$US-ASTRAZENECA-2017SE36198$ASTRAZENECA$$59$YR$$F$Y$58.5$KG$20170801$$MD$US$US
135779913$13577991$3$F$20170327$20170919$20170524$20170921$EXP$$FR-ASTRAZENECA-2017SE35464$ASTRAZENECA$$48$YR$$M$Y$89$KG$20170921$$MD$FR$FR
1357802412$13578024$12$F$201904$20200909$20170524$20200915$EXP$$PHHY2017BR073853$NOVARTIS$$62$YR$$F$Y$54$KG$20200915$$CN$COUNTRY NOT SPECIFIED$BR
1357807711$13578077$11$F$20170424$20191016$20170524$20191025$EXP$$FR-ABBVIE-17P-056-1965707-00$ABBVIE$$64$YR$$F$Y$46$KG$20191025$$MD$FR$FR
135780798$13578079$8$F$20170505$20200814$20170524$20200820$PER$$US-ACTELION-A-NJ2017-154302$ACTELION$$64$YR$$F$Y$$$20200820$$HP$US$US
135782222$13578222$2$F$$20170510$20170524$20200921$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-045417$BRISTOL MYERS SQUIBB$ZINN DJ, GRIMES AB, LIN H, ECKSTEIN O, ALLEN CE, ET AL.. HYDROXYUREA: A NEW OLD THERAPY FOR LANGERHANS CELL HISTIOCYTOSIS.. BLOOD. 2016?128:2462?5$59$YR$$F$Y$$$20200921$$HP$US$US
135782658$13578265$8$F$$20200807$20170524$20200811$PER$$US-PFIZER INC-2017225456$PFIZER$$66$YR$$F$Y$71.67$KG$20200811$$CN$US$US
135788013$13578801$3$F$2015$20200617$20170524$20200820$PER$$US-JAZZ-2017-US-005256$JAZZ$$$$$F$Y$$$20200820$$HP$US$US
135788762$13578876$2$F$$20200508$20170524$20200820$PER$$US-JAZZ-2017-US-005130$JAZZ$$$$$M$Y$$$20200820$$$US$US
135789666$13578966$6$F$201909$20200922$20170524$20200925$EXP$$US-JAZZ-2017-US-005038$JAZZ$$46$YR$$F$Y$$$20200925$$HP$US$US
135792416$13579241$6$F$2017$20200715$20170525$20200724$EXP$$US-BIOGEN-2017BI00391183$BIOGEN$$$$$M$Y$$$20200724$$MD$US$US
135795687$13579568$7$F$20170502$20200910$20170525$20200918$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-043071$BRISTOL MYERS SQUIBB$$63$YR$$F$Y$$$20200918$$HP$FR$FR
135801023$13580102$3$F$$20200706$20170525$20200714$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-1214$ORION$$$$$F$Y$$$20200714$$MD$CA$CA
135804503$13580450$3$F$2015$20200813$20170525$20200819$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0403$ORION$$59$YR$$F$Y$$$20200819$$MD$CA$CA
135805592$13580559$2$F$$20170516$20170525$20200909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-043343$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200909$$PH$US$US
135807932$13580793$2$F$$20171207$20170525$20171222$EXP$$JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2017R1-141432$RANBAXY$KITSIRIPANT C, KAMATA K, KANAMORI R, YAMAGUCHI K, OZAKI M, NOMURA M. POSTOPERATIVE MANAGEMENT WITH DEXMEDETOMIDINE IN A PREGNANT PATIENT WHO UNDERWENT AVM NIDUS REMOVAL: A CASE REPORT. JA CLIN REP. 2017?3(17):4 PAGES$32$YR$$F$Y$$$20171222$$HP$JP$JP
135811283$13581128$3$F$$20200722$20170525$20200724$PER$$US-PFIZER INC-2017228170$PFIZER$$84$YR$$M$Y$$$20200724$$CN$US$US
135818287$13581828$7$F$2017$20200826$20170525$20200907$EXP$$DK-UCBSA-2017019498$UCB$$$$$M$Y$65$KG$20200907$$HP$DK$DK
135818953$13581895$3$F$20140404$20200902$20170525$20200914$PER$$US-JNJFOC-20170523061$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200914$$CN$US$US
135821491$13582149$1$I$20160611$20160613$20170525$20170525$EXP$$ES-ASTRAZENECA-2016SE78517$ASTRAZENECA$$25862$DY$$F$Y$$$20170525$$MD$ES$ES
135822201$13582220$1$I$20160622$20160622$20170525$20170525$EXP$$FR-ASTRAZENECA-2016SE69113$ASTRAZENECA$$27408$DY$$M$Y$$$20170525$$MD$FR$FR
135822932$13582293$2$F$$20200818$20170525$20200820$PER$$US-PFIZER INC-2017223352$PFIZER$$76$YR$$F$Y$$$20200820$$CN$US$US
1358230219$13582302$19$F$20170501$20200828$20170525$20200901$EXP$$AU-SA-2017SA095064$SANOFI AVENTIS$$$$$$Y$$$20200901$$HP$AU$AU
135823188$13582318$8$F$20151215$20200714$20170525$20200716$PER$$US-PFIZER INC-2017227092$PFIZER$$55$YR$$F$Y$64.85$KG$20200716$$LW$US$US
135824244$13582424$4$F$20161212$20180730$20170525$20180803$EXP$$JP-ASTRAZENECA-2016SF33424$ASTRAZENECA$$26378$DY$$M$Y$$$20180803$$MD$JP$JP
135825253$13582525$3$F$20160330$20171014$20170525$20171019$EXP$$US-ASTRAZENECA-2016SE37641$ASTRAZENECA$$46$YR$$M$Y$58$KG$20171019$$MD$US$US
135828803$13582880$3$F$$20200714$20170525$20200720$EXP$$PHHY2017PT075268$NOVARTIS$$86$YR$$F$Y$$$20200720$$HP$PT$PT
135829002$13582900$2$F$201705$20200714$20170525$20200722$PER$$US-009507513-1705USA013059$MERCK$$15$YR$$F$Y$81.18$KG$20200722$$MD$US$US
135829953$13582995$3$F$20170211$20170523$20170525$20200806$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-045459$BRISTOL MYERS SQUIBB$$30$YR$$F$Y$$$20200806$$HP$CN$CN
135833542$13583354$2$F$20170116$20200917$20170525$20200930$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-043586$BRISTOL MYERS SQUIBB$$26$YR$$F$Y$50$KG$20200930$$MD$FR$FR
135838481$13583848$1$I$$20170515$20170526$20170526$EXP$$US-ROCHE-1938169$ROCHE$YEH M, ZHOU H, ADAMS A, ITUARTE P, LI N, LIU I AND HAIGH P THE RELATIONSHIP OF PARATHYROIDECTOMY AND BISPHOSPHONATES WITH FRACTURE RISK IN PRIMARY HYPERPARATHYROIDISM AN OBSERVATIONAL STUDY.. ANN.INTERN.MED 2016 JUN 07?164(11):715?723.$$$$$Y$$$20170526$$MD$US$US
135841056$13584105$6$F$1996$20200904$20170526$20200915$PER$$US-BIOGEN-2017BI00405625$BIOGEN$$$$$F$Y$$$20200915$$CN$US$US
135847293$13584729$3$F$20170418$20200629$20170526$20200701$PER$$US-BIOGEN-2017BI00405187$BIOGEN$$55$YR$$F$Y$$$20200701$$CN$US$US
135851822$13585182$2$F$201702$20200904$20170526$20200910$PER$$US-009507513-1705USA007925$MERCK$$72$YR$$M$Y$$$20200910$$CN$US$US
135854178$13585417$8$F$201703$20200805$20170526$20200911$PER$$US-INCYTE CORPORATION-2017IN004005$INCYTE$$$$$$Y$$$20200911$$CN$US$US
135863823$13586382$3$F$20170417$20170804$20170526$20170810$EXP$$CN-ASTRAZENECA-2017SE55954$ASTRAZENECA$$24077$DY$$F$Y$$$20170810$$MD$CN$CN
135864243$13586424$3$F$20170515$20171204$20170526$20171211$EXP$$UA-ASTRAZENECA-2017SE52420$ASTRAZENECA$$21056$DY$$F$Y$$$20171211$$MD$UA$UA
135864512$13586451$2$F$20150702$20200917$20170526$20200928$EXP$$US-NOVOPROD-546759$NOVO NORDISK$$55$YR$$F$Y$108.8$KG$20200928$$LW$US$US
135864572$13586457$2$F$20160519$20171220$20170526$20171222$EXP$$GB-ASTRAZENECA-2016SE55686$ASTRAZENECA$$18262$DY$$F$Y$$$20171222$$MD$GB$GB
135865143$13586514$3$F$20151128$20200910$20170526$20200918$EXP$$US-LUNDBECK-DKLU2031776$LUNDBECK$$45$YR$$F$Y$$$20200918$$CN$US$US
135867092$13586709$2$F$20160703$20171030$20170526$20171102$EXP$$PL-ASTRAZENECA-2016SE74795$ASTRAZENECA$$23252$DY$$M$Y$$$20171102$$MD$PL$PL
135872734$13587273$4$F$20170420$20200810$20170526$20200820$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-05794$VIFOR$$78$YR$$F$Y$70.82$KG$20200820$$PH$US$US
135876196$13587619$6$F$20170322$20200915$20170526$20200917$EXP$$CA-TAKEDA-2017TUS008487$TAKEDA$$42$YR$$M$Y$$$20200917$$CN$CA$CA
1358785415$13587854$15$F$20170515$20200824$20170527$20200901$EXP$$NL-ABBVIE-17P-114-1973894-00$ABBVIE$$69$YR$$M$Y$78$KG$20200831$$CN$NL$NL
1358798312$13587983$12$F$$20200824$20170527$20200919$PER$$JP-AMGEN-JPNCT2017081695$AMGEN$$$$$M$Y$67.2$KG$20200918$$MD$JP$JP
135885652$13588565$2$F$20170428$20200722$20170529$20200729$EXP$$US-ROCHE-1938683$ROCHE$$22$YR$$M$Y$51.2$KG$20200729$$MD$US$US
135895597$13589559$7$F$20170217$20200917$20170529$20200928$EXP$ST20170631$FR-ACCORD-052117$ACCORD$$82$YR$$M$Y$78$KG$20200928$$HP$FR$FR
135899805$13589980$5$F$201705$20200820$20170530$20200827$EXP$$PHHY2017CA079140$NOVARTIS$$51$YR$$F$Y$$$20200827$$CN$COUNTRY NOT SPECIFIED$CA
135905855$13590585$5$F$20180319$20200729$20170529$20200807$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003545$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$63$KG$20200807$$MD$US$US
135909186$13590918$6$F$20161125$20200708$20170530$20200713$EXP$$DE-CELGENEUS-DEU-2016118289$CELGENE$$70$YR$$M$Y$$$20200713$$MD$DE$DE
135911713$13591171$3$F$20161022$20180730$20170529$20180801$EXP$$CL-ASTRAZENECA-2016SF12632$ASTRAZENECA$$27627$DY$$F$Y$$$20180801$$MD$CL$CL
135916792$13591679$2$F$20170516$20170606$20170530$20170609$EXP$$CN-ROCHE-1936866$ROCHE$$44$YR$$M$Y$67$KG$20170609$$MD$CN$CN
135920751$13592075$1$I$20170426$20170428$20170530$20170530$EXP$$FR-JNJFOC-20170501336$JANSSEN$$56$YR$A$M$Y$$$20170530$$MD$FR$FR
135921302$13592130$2$F$20170407$20170526$20170529$20170802$EXP$$CA-ASTRAZENECA-2017SE37651$ASTRAZENECA$$55$YR$$F$Y$$$20170802$$MD$CA$CA
135924804$13592480$4$F$$20200617$20170530$20200702$EXP$DE-EMA-20170703-PSEVHUMANWTDD-122217984$DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2017-00266$ALKEM$$54$YR$$F$Y$$$20200702$$HP$GB$GB
135924872$13592487$2$F$20170521$20170601$20170530$20170606$EXP$$FR-JNJFOC-20170525984$PHARMACYCLICS$$66$YR$E$M$Y$74$KG$20170606$$MD$FR$FR
135928387$13592838$7$F$20130919$20200727$20170530$20200806$EXP$GB-MHRA-ADR 23836748$GB-TORRENT-00014939$TORRENT$$55$YR$A$M$Y$$$20200806$$CN$GB$GB
1359290227$13592902$27$F$2017$20200915$20170530$20200923$EXP$$CA-CELLTRION INC.-2017CA006873$CELLTRION$$$$$$Y$$$20200923$$HP$CA$CA
135936573$13593657$3$F$$20200810$20170530$20200812$EXP$$CA-ROCHE-1939740$ROCHE$$$$$F$Y$$$20200812$$HP$CA$CA
135937302$13593730$2$F$20160331$20170530$20170530$20170607$EXP$$DE-ASTRAZENECA-2016SE82515$ASTRAZENECA$$842$MON$$M$Y$$$20170607$$MD$DE$DE
135938742$13593874$2$F$$20200818$20170530$20200901$EXP$$US-AUROBINDO-AUR-APL-2017-34389$AUROBINDO$$76$YR$$M$Y$$$20200901$$HP$US$US
135940821$13594082$1$I$20131008$20170526$20170530$20170530$EXP$$DE-ROCHE-1940924$ROCHE$$60$YR$$F$Y$$$20170530$$MD$DE$DE
1359427431$13594274$31$F$2017$20200817$20170530$20200824$EXP$$US-ACTELION-A-NJ2017-154486$ACTELION$$61$YR$$F$Y$95.24$KG$20200824$$HP$US$US
135942825$13594282$5$F$20170510$20200806$20170530$20200818$EXP$$US-ACTELION-A-US2017-154408$ACTELION$$64$YR$$F$Y$$$20200818$$HP$US$US
135942869$13594286$9$F$20150418$20200728$20170530$20200807$EXP$$US-ACTELION-A-NJ2015-125272$ACTELION$$30$YR$$F$Y$72.11$KG$20200807$$MD$US$US
135943422$13594342$2$F$201705$20200918$20170530$20200922$PER$$US-AMGEN-USASL2017079036$AMGEN$$60$YR$A$F$Y$$$20200922$$MD$US$US
135944777$13594477$7$F$2012$20200629$20170530$20200706$PER$$CA-AMGEN-CANSP2017081646$AMGEN$$35$YR$A$F$Y$$$20200706$$HP$CA$CA
135946977$13594697$7$F$2014$20200708$20170530$20200709$PER$$US-PFIZER INC-2017231733$PFIZER$$61$YR$$F$Y$$$20200709$$LW$US$US
135950064$13595006$4$F$20160907$20180420$20170531$20180427$EXP$$US-ASTRAZENECA-2016SF04605$ASTRAZENECA$$29069$DY$$F$Y$$$20180427$$MD$US$US
135951691$13595169$1$I$20160531$20160603$20170531$20170531$EXP$$JP-ASTRAZENECA-2016SE61525$ASTRAZENECA$$24046$DY$$M$Y$$$20170531$$MD$JP$JP
135969346$13596934$6$F$20170217$20200917$20170531$20200923$EXP$$FR-AUROBINDO-AUR-APL-2017-34638$AUROBINDO$$82$YR$$M$Y$78$KG$20200923$$MD$FR$FR
135984004$13598400$4$F$20170521$20170817$20170531$20170823$EXP$$AU-JNJFOC-20170521614$JANSSEN$$71$YR$E$F$Y$$$20170823$$MD$AU$AU
135984012$13598401$2$F$$20200826$20170531$20200909$EXP$$CA-JNJFOC-20170523969$JOHNSON AND JOHNSON$$75$YR$E$M$Y$96.16$KG$20200909$$HP$CA$CA
135987422$13598742$2$F$20160710$20170612$20170531$20170614$EXP$$DE-ASTRAZENECA-2016SE74923$ASTRAZENECA$$924$MON$$F$Y$$$20170614$$MD$DE$DE
135988652$13598865$2$F$20170501$20170720$20170531$20170726$EXP$$US-JNJFOC-20170508512$PHARMACYCLICS$$73$YR$E$M$Y$$$20170726$$MD$US$US
135989024$13598902$4$F$2016$20200723$20170531$20200727$EXP$$CA-PFIZER INC-2016364480$PFIZER$$61$YR$$M$Y$$$20200727$$HP$CA$CA
135989663$13598966$3$F$20170322$20180211$20170531$20180219$EXP$$CN-ASTRAZENECA-2017SE33288$ASTRAZENECA$$18645$DY$$M$Y$$$20180219$$MD$CN$CN
135989951$13598995$1$I$20161022$20161022$20170531$20170531$EXP$$JP-ASTRAZENECA-2016SF12855$ASTRAZENECA$$24722$DY$$M$Y$$$20170531$$MD$JP$JP
135990054$13599005$4$F$$20200720$20170531$20200724$EXP$$US-ASTRAZENECA-2017SE56838$ASTRAZENECA$$$$$M$Y$97.5$KG$20200724$$$US$US
135992155$13599215$5$F$20170519$20200729$20170531$20200812$EXP$$US-INCYTE CORPORATION-2017IN004103$INCYTE$$$$$$Y$$$20200812$$CN$US$US
135992202$13599220$2$F$20151024$20200924$20170531$20200930$EXP$$US-BAYER-2017-018200$BAYER$$76$YR$E$M$Y$$$20200930$$CN$US$US
135993002$13599300$2$F$20150316$20200728$20170531$20200806$EXP$$US-BAYER-2017-047009$BAYER$$66$YR$E$M$Y$153.13$KG$20200806$$CN$US$US
135993042$13599304$2$F$201308$20200903$20170531$20200911$EXP$$US-BAYER-2017-052770$BAYER$$59$YR$A$M$Y$$$20200911$$CN$US$US
135996835$13599683$5$F$2017$20200910$20170601$20200918$EXP$$US-BIOGEN-2017BI00394394$BIOGEN$$67$YR$$M$Y$$$20200918$$CN$US$US
135996946$13599694$6$F$20170517$20200907$20170601$20200913$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-046485$BRISTOL MYERS SQUIBB$ONOYAMA T, ET AL. THREE CASES OF SUSPECTED NIVOLUMAB?RELATED CHOLANGITIS. 118TH CHUGOKU REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2018?21$75$YR$$M$Y$62$KG$20200913$$MD$JP$JP
135998491$13599849$1$I$20160930$20161003$20170601$20170601$EXP$$GB-ASTRAZENECA-2016SF05332$ASTRAZENECA$$9836$DY$$F$Y$$$20170601$$MD$GB$GB
136000481$13600048$1$I$20160713$20160713$20170601$20170601$EXP$$RU-ASTRAZENECA-2016SE76007$ASTRAZENECA$$25784$DY$$M$Y$$$20170601$$MD$RU$RU
1360033117$13600331$17$F$201705$20200914$20170601$20200918$PER$$US-PFIZER INC-2017234774$PFIZER$$76$YR$$M$Y$64$KG$20200918$$MD$US$US
1360040813$13600408$13$F$201704$20200910$20170601$20200915$PER$$US-PFIZER INC-2017236083$PFIZER$$55$YR$$M$Y$122$KG$20200915$$HP$US$US
1360044510$13600445$10$F$2016$20200702$20170601$20200706$PER$$US-PFIZER INC-2017241351$PFIZER$$74$YR$$F$Y$88$KG$20200706$$MD$US$US
136008362$13600836$2$F$$20200810$20170601$20200818$EXP$$IT-AUROBINDO-AUR-APL-2017-34828$AUROBINDO$$$$I$$Y$$$20200818$$HP$IT$IT
136008372$13600837$2$F$$20200810$20170601$20200819$EXP$$IT-AUROBINDO-AUR-APL-2017-34826$AUROBINDO$$$$I$$Y$$$20200819$$HP$IT$IT
136008402$13600840$2$F$$20200810$20170601$20200818$EXP$$IT-AUROBINDO-AUR-APL-2017-34863$AUROBINDO$$$$I$F$Y$$$20200818$$HP$IT$IT
136008462$13600846$2$F$$20200810$20170601$20200820$EXP$$IT-AUROBINDO-AUR-APL-2017-34865$AUROBINDO$$$$I$$Y$$$20200820$$HP$IT$IT
136008502$13600850$2$F$$20200810$20170601$20200821$EXP$$IT-AUROBINDO-AUR-APL-2017-34866$AUROBINDO$$$$I$$Y$$$20200821$$HP$IT$IT
136012502$13601250$2$F$20170519$20171228$20170601$20180104$EXP$$FR-JNJFOC-20170526295$JANSSEN$$59$YR$A$M$Y$94$KG$20180104$$MD$FR$FR
136013997$13601399$7$F$$20200824$20170601$20200831$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK082517$GLAXOSMITHKLINE$$$$$M$Y$$$20200831$$CN$CA$CA
136016153$13601615$3$F$$20200806$20170601$20200818$EXP$$US-DRREDDYS-USA/USA/17/0091015$DR REDDYS$CONWAY M, NOBLE J, PEYMAN G. CENTRAL SEROUS CHORIORETINOPATHY IN POSTMENOPAUSAL WOMEN RECEIVING EXOGENOUS TESTOSTERONE. RETIN CASES BRIEF REP. 2017?11(2):95?9.$55$YR$A$F$Y$$$20200818$$MD$US$US
1360172112$13601721$12$F$20170517$20200818$20170601$20200820$EXP$$CA-TAKEDA-2017TUS011439$TAKEDA$$17$YR$$F$Y$$$20200820$$MD$CA$CA
136023101$13602310$1$I$20170418$20170419$20170601$20170601$EXP$$IN-ASTRAZENECA-2017SE41496$ASTRAZENECA$$24792$DY$$M$Y$$$20170601$$MD$IN$IN
136024142$13602414$2$F$20161108$20200719$20170601$20200727$EXP$$US-BAYER-2017-059384$BAYER$$63$YR$A$M$Y$$$20200727$$CN$US$US
1360252112$13602521$12$F$201705$20200709$20170601$20200713$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-047783$BRISTOL MYERS SQUIBB$$50$YR$$F$Y$$$20200713$$MD$CA$CA
136025862$13602586$2$F$20170521$20181122$20170601$20181127$EXP$$FR-JNJFOC-20170523931$JANSSEN$$63$YR$A$F$Y$46$KG$20181127$$MD$FR$FR
136025922$13602592$2$F$20160521$20170612$20170601$20170614$EXP$$US-ASTRAZENECA-2016SE56251$ASTRAZENECA$$21401$DY$$M$Y$97$KG$20170614$$MD$US$US
136026922$13602692$2$F$20161128$20180108$20170601$20180116$EXP$$US-ASTRAZENECA-2017SE01987$ASTRAZENECA$$64$YR$$M$Y$61$KG$20180116$$MD$US$US
136027436$13602743$6$F$20170531$20170718$20170601$20170720$EXP$$UA-ASTRAZENECA-2017SE57918$ASTRAZENECA$$15018$DY$$M$Y$76$KG$20170720$$MD$UA$UA
1360370621$13603706$21$F$20150923$20200722$20170602$20200724$EXP$$CA-ROCHE-1638435$ROCHE$$70$YR$$F$Y$73$KG$20200724$$CN$CA$CA
136057352$13605735$2$F$$20200810$20170602$20200818$EXP$$IT-AUROBINDO-AUR-APL-2017-34824$AUROBINDO$$$$I$$Y$$$20200818$$HP$IT$IT
136058192$13605819$2$F$$20200810$20170602$20200820$EXP$$IT-AUROBINDO-AUR-APL-2017-34827$AUROBINDO$$$$I$$Y$$$20200820$$HP$IT$IT
1360598610$13605986$10$F$2017$20200819$20170602$20200821$EXP$$US-PFIZER INC-2017242220$PFIZER$$76$YR$$F$Y$66$KG$20200821$$MD$US$US
1360809419$13608094$19$F$20170524$20200730$20170602$20200804$EXP$$AU-SA-2017SA098145$SANOFI AVENTIS$$$$$$Y$$$20200804$$HP$AU$AU
136084329$13608432$9$F$20161203$20180810$20170602$20190214$EXP$$IT-JNJFOC-20170522283$JANSSEN$$43$YR$A$M$Y$76$KG$20190214$$MD$IT$IT
1360851111$13608511$11$F$2020$20200728$20170602$20200904$PER$$US-INCYTE CORPORATION-2017IN004081$INCYTE$$$$$$Y$$$20200904$$CN$US$US
136087536$13608753$6$F$20170516$20200710$20170602$20200722$EXP$$US-JNJFOC-20170529699$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200722$$HP$US$US
136089012$13608901$2$F$20160212$20200702$20170602$20200710$EXP$$GB-ASTRAZENECA-2016SE24923$ASTRAZENECA$$17678$DY$$F$Y$$$20200710$$MD$GB$GB
136090573$13609057$3$F$20160819$20200917$20170602$20200924$EXP$$US-TESARO, INC-US-2016TSO00247$GLAXOSMITHKLINE$$66$YR$$F$Y$61.68$KG$20200924$$MD$US$US
136090802$13609080$2$F$20170517$20170606$20170602$20170614$EXP$$CA-JNJFOC-20170527425$PHARMACYCLICS$$68$YR$E$$Y$76$KG$20170614$$MD$CA$CA
136099182$13609918$2$F$20170503$20170522$20170603$20200814$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-045573$BRISTOL MYERS SQUIBB$$29$YR$$F$Y$55$KG$20200814$$PH$US$US
136108139$13610813$9$F$20150618$20200723$20170605$20200731$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-1627$ORION$$50$YR$$F$Y$$$20200731$$HP$CA$CA
136113114$13611311$4$F$20160129$20200710$20170605$20200713$PER$$US-PFIZER INC-2017023806$PFIZER$$69$YR$$F$Y$$$20200713$$LW$US$US
136113543$13611354$3$F$201603$20200630$20170605$20200701$PER$$US-PFIZER INC-2017067710$PFIZER$$60$YR$$F$Y$$$20200701$$LW$US$US
136115722$13611572$2$F$20150705$20200903$20170605$20200909$EXP$$US-BAYER-2017-066514$BAYER$$70$YR$E$F$Y$$$20200909$$LW$US$US
1361216810$13612168$10$F$2016$20200908$20170605$20200909$EXP$$US-PFIZER INC-2017242256$PFIZER$$72$YR$$F$Y$$$20200909$$CN$US$US
136123961$13612396$1$I$20160708$20160712$20170605$20170605$EXP$$KR-ASTRAZENECA-2016SE75231$ASTRAZENECA$$27320$DY$$M$Y$$$20170605$$MD$KR$KR
136131595$13613159$5$F$20170328$20200715$20170605$20200727$EXP$$CO-INCYTE CORPORATION-2017IN004298$INCYTE$$$$$$Y$$$20200727$$CN$CO$CO
1361331722$13613317$22$F$20180216$20200710$20170605$20200723$EXP$$US-ACTELION-A-US2017-154708$ACTELION$$40$YR$$F$Y$58.96$KG$20200723$$HP$US$US
136135574$13613557$4$F$20170529$20180111$20170605$20180608$EXP$$IN-ASTRAZENECA-2017SE57727$ASTRAZENECA$$20602$DY$$F$Y$$$20180608$$MD$IN$IN
136135822$13613582$2$F$20170505$20170601$20170605$20200910$EXP$$GB-ASTRAZENECA-2017SE55677$ASTRAZENECA$$63$YR$$F$Y$94.7$KG$20200910$$MD$GB$GB
1361409510$13614095$10$F$20170508$20200807$20170606$20200827$EXP$$JP-009507513-1705JPN000803J$MERCK$$62$YR$$M$Y$62$KG$20200827$$CN$JP$JP
1361431728$13614317$28$F$2017$20200723$20170606$20200804$EXP$$CA-ROCHE-1942935$ROCHE$$63$YR$$M$Y$$$20200803$$MD$CA$CA
136145382$13614538$2$F$$20200821$20170606$20200904$EXP$$ZA-LUPIN (EUROPE) LIMITED-2017-02693$LUPIN$$$$$F$Y$$$20200904$$CN$ZA$ZA
1361456113$13614561$13$F$20170425$20190807$20170606$20200817$EXP$$JP-009507513-1704JPN002445J$MERCK$$69$YR$$M$Y$81$KG$20200817$$MD$JP$JP
136146183$13614618$3$F$20170525$20170606$20170606$20170614$EXP$$CA-PFIZER INC-2017240932$PFIZER$$72$YR$$M$Y$$$20170614$$MD$CA$CA
136146941$13614694$1$I$20160925$20161013$20170606$20170606$EXP$$US-JNJFOC-20161013260$JANSSEN$$66$YR$E$M$Y$$$20170606$$MD$US$US
136147056$13614705$6$F$20170518$20171229$20170606$20180104$EXP$$CN-JNJFOC-20170526621$JANSSEN$$70$YR$E$M$Y$80$KG$20180104$$MD$CN$CN
136147433$13614743$3$F$201612$20200714$20170606$20200717$EXP$$GB-ROCHE-1932326$ROCHE$$$$$F$Y$$$20200717$$MD$GB$GB
136151744$13615174$4$F$20161223$20200824$20170606$20200902$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-074593$BRISTOL MYERS SQUIBB$KOBAYASHI T, IWAMA S, YASUDA Y, OKADA N, OKUJI T, ITO M, ET AL. PITUITARY DYSFUNCTION INDUCED BY IMMUNE CHECKPOINT INHIBITORS IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN BOTH MALIGNANT MELANOMA AND NON?SMALL CELL LUNG CARCINOMA: A PROSPECTIVE STUDY. JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2020?8(2)$49$YR$$F$Y$$$20200902$$MD$JP$JP
136153723$13615372$3$F$$20200706$20170606$20200707$PER$$US-PFIZER INC-2017244309$PFIZER$$55$YR$$M$Y$$$20200707$$HP$US$US
136154189$13615418$9$F$201003$20200921$20170606$20200924$PER$$US-PFIZER INC-2016305780$PFIZER$$38$YR$$F$Y$113$KG$20200924$$MD$US$US
136154819$13615481$9$F$$20200805$20170606$20200818$EXP$$JP-PFIZER INC-2016487880$PFIZER$HIRAI, I.. COMBINATION CISPLATIN?EPIRUBICIN?PACLITAXEL THERAPY FOR METASTATIC EXTRAMAMMARY PAGET^S DISEASE. ONCOLOGIST. 2019?24(6):394?396$65$YR$$M$Y$$$20200818$$HP$JP$JP
136156512$13615651$2$F$20160719$20170609$20170606$20170616$EXP$$VN-ASTRAZENECA-2016SE91142$ASTRAZENECA$$30515$DY$$M$Y$$$20170616$$MD$VN$VN
136156862$13615686$2$F$$20200727$20170606$20200729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-049463$BRISTOL MYERS SQUIBB$$$$$$Y$$$20200729$$PH$JP$JP
136160181$13616018$1$I$20170517$20170522$20170606$20170606$EXP$$US-ASTRAZENECA-2017SE54835$ASTRAZENECA$$$$$F$Y$$$20170606$$MD$US$US
136160403$13616040$3$F$20160512$20170616$20170606$20170621$EXP$$IT-ASTRAZENECA-2016SE55736$ASTRAZENECA$$840$MON$$M$Y$63$KG$20170621$$MD$IT$IT
136164854$13616485$4$F$2017$20200629$20170606$20200706$PER$$US-SA-2016SA068859$SANOFI AVENTIS$$$$$$Y$$$20200706$$CN$US$US
136176684$13617668$4$F$20170511$20200911$20170606$20200921$EXP$$US-SA-2017SA007278$SANOFI AVENTIS$$81$YR$$F$Y$$$20200921$$CN$US$US
136179015$13617901$5$F$20170526$20180404$20170606$20180413$EXP$$US-JNJFOC-20170528208$JANSSEN$$23$YR$A$F$Y$63.96$KG$20180413$$MD$US$US
136187222$13618722$2$F$201609$20200817$20170606$20200821$EXP$$US-BAYER-2017-044047$BAYER$$90$YR$E$F$Y$$$20200821$$CN$US$US
136187976$13618797$6$F$20170914$20200806$20170606$20200818$EXP$$US-ACTELION-A-US2017-153450$ACTELION$$64$YR$$F$Y$71.66$KG$20200818$$HP$US$US
136196924$13619692$4$F$201303$20200904$20170606$20200915$PER$$US-BIOGEN-2013BI046231$BIOGEN$$41$YR$$F$Y$41.31$KG$20200915$$CN$US$US
136196972$13619697$2$F$$20200803$20170606$20200811$PER$$US-BIOGEN-2017BI00411003$BIOGEN$$$$$F$Y$$$20200811$$CN$US$US
136203751$13620375$1$I$201703$20170524$20170607$20170607$EXP$$US-ASTRAZENECA-2017SE56828$ASTRAZENECA$$843$MON$$M$Y$72.6$KG$20170607$$$US$US
136204852$13620485$2$F$20170414$20170727$20170607$20170728$EXP$$FR-ASTRAZENECA-2017SE59269$ASTRAZENECA$$56$YR$$F$Y$69$KG$20170728$$MD$FR$FR
136205002$13620500$2$F$20160620$20170613$20170607$20170614$EXP$$FR-ASTRAZENECA-2016SE68517$ASTRAZENECA$$19774$DY$$M$Y$$$20170614$$MD$FR$FR
136211274$13621127$4$F$20150820$20200725$20170607$20200801$EXP$$DE-ACCORD-052336$ACCORD$$67$YR$E$M$Y$$$20200801$$HP$DE$DE
1362235010$13622350$10$F$201704$20200724$20170607$20200728$EXP$$PHHY2017DE056752$NOVARTIS$$$$E$M$Y$120$KG$20200728$$HP$DE$DE
1362284214$13622842$14$F$20160919$20200514$20170607$20200520$EXP$$PHHY2016CA134077$NOVARTIS$$84$YR$$F$Y$$$20200520$$CN$COUNTRY NOT SPECIFIED$CA
1362284610$13622846$10$F$20170601$20200804$20170607$20200810$EXP$$PHEH2017US017009$NOVARTIS$$10$YR$$M$Y$33.7$KG$20200810$$MD$US$US
136229931$13622993$1$I$20170426$20170605$20170607$20170607$EXP$$RU-ASTRAZENECA-2017SE59414$ASTRAZENECA$$20935$DY$$F$Y$$$20170608$$MD$RU$RU
136233054$13623305$4$F$20170421$20200711$20170607$20200715$EXP$$US-GLAXOSMITHKLINE-US2017GSK069550$GLAXOSMITHKLINE$$66$YR$$F$Y$74.8$KG$20200715$$MD$US$US
1362366835$13623668$35$F$2017$20200711$20170608$20200721$EXP$$CA-ROCHE-1944331$ROCHE$$72$YR$$M$Y$$$20200721$$MD$CA$CA
136240553$13624055$3$F$2016$20200220$20170607$20200807$PER$$US-PURDUE-USA-2016-0135033$PURDUE$$$$$F$Y$$$20200807$$MD$US$US
136243011$13624301$1$I$20161021$20161021$20170608$20170608$EXP$$JP-ASTRAZENECA-2016SF11826$ASTRAZENECA$$22070$DY$$M$Y$$$20170608$$MD$JP$JP
136245482$13624548$2$F$$20200825$20170608$20200827$PER$$US-PFIZER INC-2017244538$PFIZER$$$$A$F$Y$$$20200827$$MD$US$US
136263242$13626324$2$F$2004$20200708$20170607$20200710$PER$$US-JNJFOC-20170415957$JOHNSON AND JOHNSON$$$$$M$Y$$$20200710$$CN$US$US
1362723414$13627234$14$F$201704$20200708$20170607$20200710$EXP$$US-PFIZER INC-2017247556$PFIZER$$80$YR$$F$Y$65.32$KG$20200710$$CN$US$US
136273817$13627381$7$F$202004$20200721$20170608$20200723$EXP$$US-PFIZER INC-2017240661$PFIZER$$59$YR$$F$Y$70$KG$20200723$$HP$US$US
136285385$13628538$5$F$2016$20200814$20170607$20200909$PER$$US-LUNDBECK-DKLU2027398$LUNDBECK$$67$YR$$F$Y$$$20200909$$CN$US$US
136285584$13628558$4$F$20170323$20200817$20170608$20200821$EXP$$JP-BAYER-2017-103942$BAYER$$54$YR$A$F$Y$28.4$KG$20200821$$MD$JP$JP
136285972$13628597$2$F$20170331$20171017$20170607$20171023$EXP$$NL-ASTRAZENECA-2017SE35906$ASTRAZENECA$$804$MON$$F$Y$$$20171023$$MD$NL$NL
136292327$13629232$7$F$20140929$20200826$20170608$20200908$EXP$$JP-INCYTE CORPORATION-2014IN003463$INCYTE$$$$$$Y$$$20200908$$MD$JP$JP
136294584$13629458$4$F$$20200924$20170608$20200930$PER$$US-AMGEN-USASP2017085062$AMGEN$$63$YR$A$F$Y$$$20200930$$MD$US$US
136296056$13629605$6$F$201705$20200916$20170608$20200923$EXP$$US-INCYTE CORPORATION-2017IN004319$INCYTE$$$$$$Y$$$20200923$$CN$US$US
136298781$13629878$1$I$20170413$20170504$20170608$20170608$EXP$$DE-JNJFOC-20170513712$JANSSEN$$43$YR$A$M$Y$$$20170608$$MD$DE$DE
136344604$13634460$4$F$20150825$20171128$20170609$20171205$EXP$$US-ASTRAZENECA-2017SE59493$ASTRAZENECA$$67$YR$$M$Y$53.1$KG$20171205$$MD$US$US
136362212$13636221$2$F$20150409$20200805$20170609$20200813$EXP$$US-BAYER-2017-070580$BAYER$$52$YR$A$M$Y$$$20200813$$CN$US$US
136363551$13636355$1$I$20170216$20170221$20170609$20170609$EXP$$CA-PFIZER INC-2017093855$PFIZER$$56$YR$$F$Y$$$20170609$$MD$CA$CA
136363732$13636373$2$F$201305$20200803$20170609$20200812$EXP$$US-BAYER-2017-073140$BAYER$$75$YR$E$M$Y$$$20200812$$CN$US$US
136370363$13637036$3$F$$20190626$20170609$20190709$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK085504$GLAXOSMITHKLINE$$$$$F$Y$$$20190709$$CN$CA$CA
136376436$13637643$6$F$2017$20200701$20170609$20200716$EXP$$US-MALLINCKRODT-T201700411$MALLINCKRODT$$55$YR$$F$Y$96$KG$20200716$$CN$US$US
136377736$13637773$6$F$201704$20200721$20170609$20200723$EXP$$AR-PFIZER INC-2017251331$PFIZER$$48$YR$$F$Y$$$20200723$$CN$AR$AR
136380541$13638054$1$I$20161108$20161108$20170609$20170609$EXP$$JP-ASTRAZENECA-2016SF18546$ASTRAZENECA$$29108$DY$$M$Y$$$20170609$$MD$JP$JP
136381325$13638132$5$F$2007$20200710$20170609$20200717$EXP$$US-SA-2017SA102947$SANOFI AVENTIS$$$$$$Y$$$20200717$$MD$US$US
136382677$13638267$7$F$20170820$20200701$20170609$20200706$PER$$US-PFIZER INC-2017250536$PFIZER$$59$YR$$F$Y$$$20200706$$HP$US$US
1363842116$13638421$16$F$$20200914$20170609$20200918$PER$$CA-AMGEN-CANSP2017086096$AMGEN$$47$YR$A$F$Y$79$KG$20200918$$PH$CA$CA
136385401$13638540$1$I$20170308$20170317$20170609$20170609$EXP$$DE-ASTRAZENECA-2017SE29434$ASTRAZENECA$$74$YR$$M$Y$90$KG$20170609$$MD$DE$DE
1363911612$13639116$12$F$20170302$20200630$20170609$20200708$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-019766$BRISTOL MYERS SQUIBB$$71$YR$$M$Y$$$20200708$$CN$CA$CA
136405214$13640521$4$F$20170517$20200914$20170611$20200917$EXP$$DE-CELGENEUS-DEU-20170507267$CELGENE$$56$YR$$M$Y$77$KG$20200917$$MD$DE$DE
136415405$13641540$5$F$20170530$20180801$20170612$20180807$EXP$$FR-JNJFOC-20170603861$JANSSEN$$61$YR$A$M$Y$60$KG$20180807$$MD$FR$FR
136415446$13641544$6$F$20170606$20170718$20170612$20170725$EXP$$JP-JNJFOC-20170606286$JANSSEN$$89$YR$E$M$Y$81.5$KG$20170725$$MD$JP$JP
136416494$13641649$4$F$20161208$20200731$20170612$20200805$EXP$$FR-ROCHE-1873119$ROCHE$$69$YR$$M$Y$66$KG$20200805$$MD$FR$FR
136419079$13641907$9$F$2017$20200902$20170612$20200904$EXP$$US-PFIZER INC-2017254194$PFIZER$$68$YR$$F$Y$57$KG$20200904$$CN$US$US
136428302$13642830$2$F$$20200707$20170612$20200709$PER$$US-BIOGEN-2017BI00412744$BIOGEN$$$$$M$Y$$$20200709$$CN$US$US
1364330611$13643306$11$F$20170503$20200629$20170612$20200703$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-050190$BRISTOL MYERS SQUIBB$YANAI S, ET AL.. CLINICOPATHOLOGICAL CHARACTERISTICS OF NIVOLUMAB?RELATED ENTERITIS. THE 96TH CONGRESS OF THE JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY HELD ON 1 T. 2018?60(S?2):6?2$56$YR$$M$Y$78$KG$20200703$$MD$JP$JP
136434332$13643433$2$F$20160801$20170609$20170612$20170615$EXP$$KR-ASTRAZENECA-2016SE83616$ASTRAZENECA$$15353$DY$$M$Y$$$20170615$$MD$KR$KR
136434627$13643462$7$F$20161114$20200914$20170612$20200917$EXP$$CA-PFIZER INC-2016386409$PFIZER$$83$YR$$M$Y$$$20200917$$HP$CA$CA
136435322$13643532$2$F$20160420$20180614$20170612$20180622$EXP$$US-ASTRAZENECA-2016SE54216$ASTRAZENECA$$25074$DY$$M$Y$$$20180622$$MD$US$US
136436654$13643665$4$F$20170502$20200818$20170612$20200821$EXP$$US-INCYTE CORPORATION-2017IN003472$INCYTE$$$$$$Y$$$20200821$$CN$US$US
136454468$13645446$8$F$$20200720$20170612$20200723$EXP$$US-ARIAD PHARMACEUTICALS, INC-2017US008050$TAKEDA$$$$$F$Y$$$20200723$$CN$US$US
136455562$13645556$2$F$2020$20200717$20170613$20200721$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-051420$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200721$$CN$US$US
1364559114$13645591$14$F$20060510$20200108$20170613$20200807$EXP$$PHEH2017US017860$NOVARTIS$$30$YR$$F$Y$56.69$KG$20200807$$CN$US$US
136462551$13646255$1$I$20170524$20170607$20170613$20170613$EXP$$US-ASTRAZENECA-2017SE60424$ASTRAZENECA$$42$YR$$F$Y$64.2$KG$20170613$$MD$US$US
1364639110$13646391$10$F$201705$20200908$20170613$20200914$EXP$$US-ASTELLAS-2017US021136$ASTELLAS$$70$YR$$M$Y$$$20200914$$CN$US$US
1364647210$13646472$10$F$$20200917$20170613$20200921$PER$$US-PFIZER INC-2017250850$PFIZER$$67$YR$$M$Y$113$KG$20200921$$MD$US$US
136470302$13647030$2$F$$20200821$20170613$20200903$EXP$$ZA-LUPIN PHARMACEUTICALS INC.-2017-02968$LUPIN$$$$$F$Y$$$20200903$$CN$ZA$ZA
136472528$13647252$8$F$20161216$20200812$20170613$20200817$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN088088$VIIV$$31$YR$$M$Y$$$20200817$$CN$JP$JP
136474925$13647492$5$F$201706$20200724$20170613$20200728$PER$$US-PFIZER INC-2017255621$PFIZER$$61$YR$$F$Y$113$KG$20200728$$HP$US$US
136475471$13647547$1$I$20170517$20170522$20170613$20170613$EXP$$US-PFIZER INC-2017241348$PFIZER$$$$$F$Y$$$20170613$$MD$US$US
136483222$13648322$2$F$$20200910$20170613$20200918$EXP$$CA-BAYER-2017-106449$BAYER$$24$YR$A$F$Y$63.99$KG$20200918$$HP$US$CA
136484893$13648489$3$F$20170309$20200711$20170613$20200720$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-021713$BRISTOL MYERS SQUIBB$$57$YR$$M$Y$56.24$KG$20200720$$HP$US$US
136484951$13648495$1$I$20170413$20170607$20170613$20170613$EXP$$US-PFIZER INC-2017252089$PFIZER$$70$YR$$F$Y$66.32$KG$20170613$$HP$US$US
136485494$13648549$4$F$20170601$20171221$20170613$20180102$EXP$$RS-ASTRAZENECA-2017SE60695$ASTRAZENECA$$53$YR$$M$Y$92$KG$20180102$$MD$RS$RS
136485657$13648565$7$F$$20200923$20170613$20200930$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-087026$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200930$$CN$CA$CA
136496324$13649632$4$F$$20171017$20170614$20171030$EXP$$PT-ROCHE-1946629$ROCHE$$$$$M$Y$$$20171030$$MD$PT$PT
136499727$13649972$7$F$201807$20200909$20170614$20200918$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003772$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20200918$$MD$US$US
1365009110$13650091$10$F$$20200818$20170614$20200820$EXP$$US-PFIZER INC-2017024216$PFIZER$$69$YR$$F$Y$$$20200820$$MD$US$US
136501137$13650113$7$F$$20200923$20170614$20200925$EXP$$US-PFIZER INC-2017258576$PFIZER$$90$YR$$M$Y$104$KG$20200925$$HP$US$US
136508572$13650857$2$F$$20170606$20170614$20200914$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-050632$BRISTOL MYERS SQUIBB$$11$YR$$M$Y$$$20200914$$HP$US$US
1365101222$13651012$22$F$2017$20200819$20170614$20200902$EXP$$US-INCYTE CORPORATION-2017IN004526$INCYTE$$$$$$Y$$$20200902$$CN$US$US
136520754$13652075$4$F$20170531$20170823$20170614$20170831$EXP$$TW-JNJFOC-20170603912$JANSSEN$$54$YR$A$M$Y$64$KG$20170831$$HP$TW$TW
1365209518$13652095$18$F$20170505$20200702$20170614$20200708$EXP$$HK-CELGENEUS-HKG-20170600522$CELGENE$$67$YR$$F$Y$56$KG$20200708$$MD$HK$HK
1365216712$13652167$12$F$2017$20200819$20170614$20200825$EXP$$CA-PFIZER INC-2017231448$PFIZER$$30$YR$$M$Y$$$20200825$$CN$CA$CA
136523677$13652367$7$F$20170612$20180416$20170614$20180418$EXP$$BR-ASTRAZENECA-2017SE62083$ASTRAZENECA$$28231$DY$$M$Y$$$20180418$$MD$BR$BR
136532232$13653223$2$F$20170307$20180804$20170614$20180809$EXP$$KR-ASTRAZENECA-2017SE31864$ASTRAZENECA$$26670$DY$$F$Y$$$20180809$$MD$KR$KR
136553393$13655339$3$F$2016$20200709$20170615$20200715$EXP$$US-SA-2016SA205445$SANOFI AVENTIS$$59$YR$$F$Y$$$20200715$$CN$US$US
136555084$13655508$4$F$$20200902$20170615$20200904$PER$$US-PFIZER INC-2017262769$PFIZER$$60$YR$$F$Y$$$20200904$$CN$US$US
1365605131$13656051$31$F$2017$20200904$20170615$20200930$EXP$$CA-CELLTRION INC.-2017CA006338$CELLTRION$$$$$$Y$$$20201001$$HP$CA$CA
136561227$13656122$7$F$2007$20200727$20170615$20200805$EXP$$US-BIOGEN-2017BI00418037$BIOGEN$$$$$F$Y$$$20200805$$CN$US$US
136562111$13656211$1$I$20160608$20160618$20170615$20170615$EXP$$PL-ASTRAZENECA-2016SE69347$ASTRAZENECA$$22974$DY$$F$Y$$$20170615$$MD$PL$PL
136564788$13656478$8$F$20170416$20200727$20170615$20200813$EXP$$ES-CELGENEUS-ESP-20170511080$CELGENE$$66$YR$$M$Y$$$20200813$$MD$ES$ES
136565967$13656596$7$F$20170123$20200813$20170615$20200818$EXP$$PHHY2017CA040049$NOVARTIS$$67$YR$$F$Y$86.5$KG$20200818$$MD$CA$CA
136566957$13656695$7$F$$20200904$20170615$20200908$EXP$$CA-PFIZER INC-2017233771$PFIZER$$79$YR$$F$Y$75$KG$20200908$$MD$CA$CA
136568523$13656852$3$F$20170521$20180112$20170615$20180119$EXP$$ES-ASTRAZENECA-2017SE55834$ASTRAZENECA$$25035$DY$$M$Y$$$20180119$$MD$ES$ES
136568578$13656857$8$F$201703$20200618$20170615$20200701$EXP$$US-ACTELION-A-NJ2017-154815$ACTELION$$22$YR$$F$Y$77.1$KG$20200701$$HP$US$US
136569261$13656926$1$I$20161122$20161128$20170615$20170615$EXP$$TW-ASTRAZENECA-2016SF28498$ASTRAZENECA$$27811$DY$$M$Y$$$20170615$$MD$TW$TW
136569782$13656978$2$F$2013$20200923$20170615$20200930$EXP$$US-BAYER-2017-048543$BAYER$$71$YR$E$F$Y$$$20200930$$CN$US$US
136569832$13656983$2$F$20161031$20170801$20170615$20170815$EXP$$JP-JNJFOC-20161108896$JANSSEN$$69$YR$E$M$Y$73.3$KG$20170815$$MD$JP$JP
1365715410$13657154$10$F$$20200811$20170615$20200817$EXP$$CA-SA-2017SA105779$SANOFI AVENTIS$$$$$$Y$$$20200817$$MD$CA$CA
136571822$13657182$2$F$20170606$20170613$20170615$20170622$EXP$$FR-JNJFOC-20170606924$JANSSEN$$62$YR$A$F$Y$60$KG$20170622$$MD$FR$FR
136572131$13657213$1$I$20160602$20160609$20170615$20170615$EXP$$ES-ASTRAZENECA-2016SE62021$ASTRAZENECA$$19441$DY$$M$Y$$$20170615$$MD$ES$ES
136572761$13657276$1$I$20170609$20170609$20170615$20170615$EXP$$IT-JNJFOC-20170611564$JANSSEN$$66$YR$E$F$Y$$$20170615$$HP$IT$IT
136572842$13657284$2$F$20170609$20170616$20170615$20170620$EXP$$ES-ASTRAZENECA-2017SE62179$ASTRAZENECA$$21420$DY$$F$Y$54$KG$20170620$$MD$ES$ES
136573734$13657373$4$F$20160808$20171117$20170615$20171120$EXP$$DE-ASTRAZENECA-2016SE90738$ASTRAZENECA$$61$YR$$M$Y$$$20171120$$MD$DE$DE
136574078$13657407$8$F$2016$20200817$20170615$20200827$EXP$$CA-ASCEND THERAPEUTICS-2022092$ASCEND$MYLAN LABS MFR NO: 2018M1079696??PATIENT NO : P08500ES ?STUDY IDENTIFICATION FOR EUDRACT:??EUDRACT NO:  PSP?019$43$YR$$F$Y$$$20200827$$CN$CA$CA
136574393$13657439$3$F$20170601$20200731$20170615$20200813$EXP$$CA-INCYTE CORPORATION-2017IN004587$INCYTE$$$$$$Y$$$20200813$$MD$CA$CA
1365749538$13657495$38$F$20170527$20200810$20170615$20200817$EXP$$CA-CELGENEUS-CAN-20170603374$CELGENE$$42$YR$$F$Y$$$20200817$$MD$CA$CA
136576355$13657635$5$F$$20200707$20170615$20200710$EXP$$US-JAZZ-2017-US-007605$JAZZ$$$$$F$Y$$$20200710$$MD$US$US
136577546$13657754$6$F$20121012$20200904$20170615$20200914$PER$$US-AMGEN-USASP2017087761$AMGEN$$65$YR$E$F$Y$78.92$KG$20200914$$MD$US$US
136580918$13658091$8$F$20170511$20200731$20170616$20200807$EXP$$CA-ROCHE-1951394$ROCHE$$54$YR$$M$Y$$$20200807$$HP$CA$CA
136582323$13658232$3$F$20160406$20171115$20170616$20180129$EXP$$JP-ASTRAZENECA-2016SE42107$ASTRAZENECA$$68$YR$$M$Y$52.7$KG$20180129$$MD$JP$JP
136583272$13658327$2$F$$20200916$20170616$20200924$EXP$$CA-ASTRAZENECA-2015SE93138$ASTRAZENECA$$70$YR$$M$Y$$$20200924$$CN$CA$CA
136586662$13658666$2$F$20160923$20180719$20170616$20180727$EXP$$JP-ASTRAZENECA-2016SF02371$ASTRAZENECA$$51$YR$$M$Y$54$KG$20180727$$MD$JP$JP
136589757$13658975$7$F$201612$20191202$20170616$20200721$EXP$$US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-17-01975$HIKMA$$70$YR$$F$Y$$$20200721$$CN$US$US
136590673$13659067$3$F$201511$20200710$20170616$20200721$EXP$$US-BAXALTA-2017BLT005488AA$SHIRE$$62$YR$$F$Y$$$20200721$$CN$US$US
136597622$13659762$2$F$$20200616$20170616$20200715$PER$$US-ELI_LILLY_AND_COMPANY-US201706004086$ELI LILLY AND CO$$$$$M$Y$$$20200715$$PH$US$US
1366009424$13660094$24$F$20170606$20200909$20170616$20200930$EXP$$CA-CELLTRION INC.-2017CA007824$CELLTRION$$$$$$Y$$$20201001$$HP$CA$CA
136604565$13660456$5$F$20170520$20190828$20170616$20200717$EXP$$US-ASTRAZENECA-2017SE58738$ASTRAZENECA$$74$YR$$M$Y$95.6$KG$20200717$$MD$NL$NL
136609254$13660925$4$F$20160618$20200910$20170616$20200922$EXP$$US-JNJFOC-20170613961$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200922$$CN$US$US
136616626$13661662$6$F$20170421$20171006$20170616$20171011$EXP$$JP-ASTRAZENECA-2017SE42934$ASTRAZENECA$$19198$DY$$M$Y$$$20171011$$MD$JP$JP
136618114$13661811$4$F$201703$20200909$20170616$20200915$EXP$$PHJP2017JP019319$NOVARTIS$$62$YR$$M$Y$$$20200915$$CN$JP$JP
136621914$13662191$4$F$20161130$20200923$20170616$20200928$EXP$$JP-ARIAD PHARMACEUTICALS, INC-2017JP008412$TAKEDA$$77$YR$$F$Y$43$KG$20200928$$MD$JP$JP
136629037$13662903$7$F$20161123$20200702$20170619$20200707$PER$$PHHY2017US087819$NOVARTIS$$40$YR$$F$Y$$$20200708$$MD$US$US
136635344$13663534$4$F$2017$20200804$20170619$20200805$EXP$$US-PFIZER INC-2017263301$PFIZER$$66$YR$$F$Y$$$20200805$$HP$US$US
136636044$13663604$4$F$$20200923$20170619$20200928$PER$$US-PFIZER INC-2017263384$PFIZER$$58$YR$$M$Y$$$20200928$$MD$US$US
1366364913$13663649$13$F$$20200811$20170619$20200818$EXP$$PHEH2017US018501$NOVARTIS$$$$$M$Y$$$20200818$$CN$US$US
136642436$13664243$6$F$20170609$20181009$20170619$20181015$EXP$$FR-JNJFOC-20170609835$JANSSEN$$54$YR$A$M$Y$90$KG$20181015$$MD$FR$FR
136642888$13664288$8$F$20160701$20200709$20170619$20200716$EXP$$US-PFIZER INC-2017260916$PFIZER$$2$YR$$M$Y$$$20200716$$HP$US$US
136652332$13665233$2$F$2015$20200916$20170619$20200923$EXP$$US-VERTEX PHARMACEUTICALS-2016-000537$VERTEX$$$$$F$Y$$$20200923$$PH$US$US
136654812$13665481$2$F$201405$20200819$20170619$20200824$EXP$$US-BAYER-2017-084091$BAYER$$71$YR$E$M$Y$$$20200824$$CN$US$US
136656481$13665648$1$I$20160703$20160705$20170619$20170619$EXP$$US-ASTRAZENECA-2016SE73374$ASTRAZENECA$$21497$DY$$M$Y$$$20170619$$MD$US$US
136658172$13665817$2$F$$20200629$20170619$20200706$EXP$$CA-APOTEX-2017AP012958$APOTEX$$68$YR$$M$Y$$$20200706$$HP$CA$CA
1366596016$13665960$16$F$20170415$20200826$20170619$20200829$EXP$$PHHY2017CO090376$NOVARTIS$$49$YR$$F$Y$53$KG$20200829$$MD$CO$CO
136672673$13667267$3$F$201109$20200907$20170619$20200916$EXP$$FR-BIOGEN-2011BI039107$BIOGEN$MAILLART E. FINGOLIMOD TO TREAT SEVERE MULTIPLE SCLEROSIS AFTER NATALIZUMAB?ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY: A VALID OPTION?. MULTIPLE SCLEROSIS. 2013 DEC 23?.$46$YR$$F$Y$$$20200916$$MD$FR$FR
136673703$13667370$3$F$20170607$20180205$20170620$20180207$EXP$$CA-ASTRAZENECA-2017SE62060$ASTRAZENECA$$29$YR$$F$Y$$$20180207$$MD$CA$CA
136674644$13667464$4$F$$20200914$20170620$20200917$EXP$$CA-ROCHE-1950692$ROCHE$$67$YR$$F$Y$76$KG$20200917$$MD$CA$CA
136677121$13667712$1$I$20161122$20161122$20170620$20170620$EXP$$US-ASTRAZENECA-2016SF24562$ASTRAZENECA$$60$YR$$M$Y$100.9$KG$20170620$$MD$US$US
136678593$13667859$3$F$20170225$20170807$20170620$20170809$EXP$$IT-ASTRAZENECA-2017SE22020$ASTRAZENECA$$739$MON$$M$Y$$$20170809$$MD$IT$IT
136680064$13668006$4$F$$20200824$20170620$20200826$EXP$$CA-ROCHE-1951972$ROCHE$$35$YR$$F$Y$$$20200826$$HP$CA$CA
136681363$13668136$3$F$201705$20200818$20170620$20200826$PER$$US-PFIZER INC-2017267823$PFIZER$$62$YR$$F$Y$$$20200826$$HP$US$US
136682013$13668201$3$F$$20200903$20170620$20200907$PER$$US-PFIZER INC-2017265443$PFIZER$$57$YR$$F$Y$$$20200907$$HP$US$US
136692314$13669231$4$F$20170323$20200817$20170620$20200819$EXP$$US-PFIZER INC-2017266939$PFIZER$$67$YR$$F$Y$$$20200819$$CN$US$US
136693211$13669321$1$I$201409$20170616$20170620$20170620$EXP$$PHHY2017AU090286$NOVARTIS$$39$YR$$F$Y$$$20170620$$MD$AU$AU
136693356$13669335$6$F$20160622$20200702$20170620$20200710$PER$$PHHY2016US113074$NOVARTIS$$28$YR$$M$Y$$$20200710$$MD$US$US
136704113$13670411$3$F$$20200831$20170620$20200909$EXP$$CA-APOTEX-2017AP013180$APOTEX$$43$YR$$F$Y$$$20200909$$CN$CA$CA
136705392$13670539$2$F$20170529$20200625$20170620$20200701$EXP$$PHHY2017FR088876$NOVARTIS$$9$YR$$F$Y$$$20200701$$MD$FR$FR
136709593$13670959$3$F$2016$20200717$20170620$20200722$PER$$US-PFIZER INC-2017258372$PFIZER$$56$YR$$F$Y$77$KG$20200722$$HP$US$US
136713362$13671336$2$F$$20170605$20170620$20200803$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-053771$BRISTOL MYERS SQUIBB$ADAMS CB, VOLLMAN KE, LEVENTHAL EL, ACQUISTO NM. EMERGENT PEDIATRIC ANTICOAGULATION REVERSAL USING A 4?FACTOR PROTHROMBIN COMPLEX CONCENTRATE. AMERICAN JOURNAL OF EMERGENCY MEDICINE. 2016?34:1182 E1?2$9$YR$$F$Y$$$20200803$$HP$US$US
1367152615$13671526$15$F$201804$20200818$20170620$20200824$EXP$$US-ACTELION-A-NJ2017-155432$ACTELION$$55$YR$$M$Y$127.89$KG$20200824$$HP$US$US
136717876$13671787$6$F$20170312$20200727$20170620$20200803$PER$$US-BIOGEN-2017BI00418063$BIOGEN$$55$YR$$F$Y$$$20200803$$CN$US$US
136718671$13671867$1$I$20160422$20160426$20170620$20170620$EXP$$US-ASTRAZENECA-2016SE45948$ASTRAZENECA$$25277$DY$$M$Y$$$20170620$$MD$US$US
136719515$13671951$5$F$$20200913$20170621$20200915$PER$$US-PFIZER INC-2017265290$PFIZER$$$$A$F$Y$$$20200915$$HP$US$US
136725901$13672590$1$I$20170612$20170614$20170621$20170621$EXP$$GB-ASTRAZENECA-2017SE62754$ASTRAZENECA$$17964$DY$$M$Y$$$20170621$$MD$GB$GB
1367300513$13673005$13$F$20170306$20200928$20170621$20200930$EXP$$PHHY2017DE037337$NOVARTIS$$77$YR$$F$Y$82$KG$20200930$$HP$DE$DE
136745903$13674590$3$F$$20200630$20170621$20200710$EXP$$CA-APOTEX-2017AP012975$APOTEX$$52$YR$$F$Y$$$20200710$$CN$CA$CA
136752352$13675235$2$F$$20200729$20170621$20200810$EXP$$CA-APOTEX-2017AP013056$APOTEX$$67$YR$$F$Y$$$20200810$$HP$CA$CA
1367533412$13675334$12$F$20110426$20200624$20170621$20200706$EXP$$GB-MYLANLABS-2016M1043301$MYLAN$$48$YR$$M$Y$$$20200706$$HP$GB$GB
1367540214$13675402$14$F$$20200831$20170621$20200909$EXP$$CA-APOTEX-2017AP012984$APOTEX$$42$YR$$F$Y$$$20200909$$CN$CA$CA
136755127$13675512$7$F$20170428$20170926$20170621$20171003$EXP$$JP-JNJFOC-20170612839$JANSSEN$$29$YR$A$F$Y$44.3$KG$20171003$$MD$JP$JP
136755219$13675521$9$F$20170415$20200921$20170621$20200923$EXP$$US-PFIZER INC-2016284224$PFIZER$$75$YR$$F$Y$$$20200923$$MD$US$US
136760292$13676029$2$F$20170612$20200811$20170622$20200817$PER$$US-BIOGEN-2017BI00418486$BIOGEN$$57$YR$$F$Y$$$20200817$$CN$US$US
136763156$13676315$6$F$20160301$20200702$20170622$20200707$PER$$PHHY2017US088044$NOVARTIS$$37$YR$$F$Y$$$20200708$$MD$US$US
136764353$13676435$3$F$20161001$20180808$20170622$20180813$EXP$$JP-ASTRAZENECA-2016SF08921$ASTRAZENECA$$23724$DY$$M$Y$$$20180813$$MD$JP$JP
136764682$13676468$2$F$20151119$20170728$20170622$20170804$EXP$$SG-ASTRAZENECA-2016SE16962$ASTRAZENECA$$16116$DY$$M$Y$$$20170804$$MD$SG$SG
136765023$13676502$3$F$$20200901$20170622$20200905$EXP$$CA-TEVA-780631ACC$TEVA$$56$YR$A$F$Y$$$20200905$$MD$CA$CA
136767027$13676702$7$F$20180404$20200708$20170622$20200710$PER$$US-PFIZER INC-2017270929$PFIZER$$57$YR$$F$Y$99.77$KG$20200710$$CN$US$US
136767297$13676729$7$F$200607$20200708$20170622$20200710$EXP$$US-PFIZER INC-2017271245$PFIZER$$75$YR$$F$Y$55.33$KG$20200710$$MD$US$US
136767742$13676774$2$F$$20170606$20170622$20200914$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-054239$BRISTOL MYERS SQUIBB$HALAWI R, BEYDOUN H, CAPPELLINI MD, FERLA V, TAHER A. HEMATOLOGIC MALIGNANCIES IN THALASSEMIA: ADDING NEW CASES TO THE REPERTOIRE. AMERICAN JOURNAL OF HEMATOLOGY. 2017?92:E68?70$36$YR$$M$Y$$$20200914$$HP$US$US
136767832$13676783$2$F$$20170606$20170622$20200915$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-054705$BRISTOL MYERS SQUIBB$HALAWI R, BEYDOUN H, CAPPELLINI MD, FERLA V, TAHER A. HEMATOLOGIC MALIGNANCIES IN THALASSEMIA: ADDING NEW CASES TO THE REPERTOIRE. AMERICAN JOURNAL OF HEMATOLOGY. 2017?92:E68?70$34$YR$$M$Y$$$20200915$$HP$US$US
136769355$13676935$5$F$20190514$20200702$20170622$20200710$PER$$PHHY2017US088057$NOVARTIS$$70$YR$$F$Y$$$20200710$$MD$US$US
136777142$13677714$2$F$20161211$20170706$20170622$20170707$EXP$$GB-ASTRAZENECA-2016SF31784$ASTRAZENECA$$21218$DY$$F$Y$$$20170707$$MD$GB$GB
136782299$13678229$9$F$2017$20200922$20170622$20200928$EXP$$PHHY2016CA012252$NOVARTIS$$$$$F$Y$$$20200928$$CN$COUNTRY NOT SPECIFIED$CA
136787033$13678703$3$F$2017$20200706$20170622$20200716$PER$$US-SA-2017SA029275$SANOFI AVENTIS$$$$$$Y$$$20200716$$PH$US$US
136800052$13680005$2$F$20170604$20170626$20170622$20170628$EXP$$CA-PFIZER INC-2017267818$PFIZER$$60$YR$$M$Y$$$20170628$$MD$CA$CA
136800256$13680025$6$F$20160926$20200807$20170622$20200813$EXP$$PHHY2017DE052506$NOVARTIS$$$$E$M$Y$74$KG$20200813$$HP$DE$DE
136801105$13680110$5$F$2017$20171002$20170622$20171010$EXP$$US-ABBVIE-17P-163-2004202-00$ABBVIE$$59$YR$$F$Y$$$20171010$$CN$US$US
136804305$13680430$5$F$$20200713$20170623$20200720$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-053927$BRISTOL MYERS SQUIBB$$$$$M$Y$97.5$KG$20200720$$CN$US$US
1368122112$13681221$12$F$20170513$20200803$20170623$20200813$EXP$$JP-UNITED THERAPEUTICS-UNT-2017-009354$UNITED THERAPEUTICS$$27$YR$$F$Y$56$KG$20200813$$CN$JP$JP
136812958$13681295$8$F$201803$20200827$20170623$20200831$PER$$US-PFIZER INC-2017273490$PFIZER$$69$YR$$F$Y$81$KG$20200831$$CN$US$US
136814422$13681442$2$F$$20170609$20170623$20200803$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-055318$BRISTOL MYERS SQUIBB$LEE JK, ING C. PROTHROMBIN COMPLEX CONCENTRATE AND METHYLENE BLUE FOR TREATMENT OF COAGULOPATHY AND VASOPLEGIA IN A PEDIATRIC HEART TRANSPLANT PATIENT. A AND A CASE REPORTS. 2016?6(5):127?9$7$YR$$F$Y$23.5$KG$20200803$$MD$US$US
136815132$13681513$2$F$20160420$20171219$20170623$20171221$EXP$$GB-ASTRAZENECA-2016SE56330$ASTRAZENECA$$19082$DY$$M$Y$$$20171221$$MD$GB$GB
136820064$13682006$4$F$201412$20200812$20170623$20200819$EXP$$US-BAYER-2016-218177$BAYER$$85$YR$E$F$Y$$$20200819$$CN$US$US
136829884$13682988$4$F$20170502$20180322$20170623$20180330$EXP$$FR-JNJFOC-20170510040$PHARMACYCLICS$$85$YR$E$F$Y$$$20180330$$MD$FR$FR
136830039$13683003$9$F$20170423$20200807$20170623$20200819$EXP$$JP-INCYTE CORPORATION-2017IN004757$INCYTE$$$$$$Y$$$20200819$$MD$JP$JP
136831607$13683160$7$F$20161210$20200720$20170623$20200730$EXP$$JP-ACTELION-A-CH2016-147529$ACTELION$$47$YR$$M$Y$86$KG$20200730$$MD$JP$JP
136832892$13683289$2$F$201501$20200713$20170623$20200717$EXP$$US-BAYER-2017-103648$BAYER$$51$YR$A$M$Y$$$20200717$$CN$US$US
136834707$13683470$7$F$20160422$20200901$20170623$20200904$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN094777$VIIV$$50$YR$$M$Y$$$20200904$$CN$JP$JP
136842496$13684249$6$F$$20200810$20170623$20200821$EXP$$PT-AUROBINDO-AUR-APL-2012-05137$AUROBINDO$$32$YR$$M$Y$$$20200821$$HP$PT$PT
136856036$13685603$6$F$20170524$20200825$20170623$20200902$EXP$$AE-APOPHARMA-2017AP013294$CHIESI$$14$YR$T$M$Y$42$KG$20200902$$MD$OM$OM
136856271$13685627$1$I$20170320$20170324$20170623$20170623$EXP$$BG-ASTRAZENECA-2017SE32064$ASTRAZENECA$$864$MON$$M$Y$$$20170623$$MD$BG$BG
136868121$13686812$1$I$20170515$20170518$20170623$20170623$EXP$$CA-ASTRAZENECA-2017SE53340$ASTRAZENECA$$48$YR$$F$Y$$$20170623$$MD$CA$CA
136869163$13686916$3$F$20170520$20200806$20170623$20200812$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-045296$BRISTOL MYERS SQUIBB$$43$YR$$M$Y$47$KG$20200812$$HP$FR$FR
136871243$13687124$3$F$20170613$20180926$20170623$20181002$EXP$$IE-JNJFOC-20170615307$JANSSEN$$71$YR$E$F$Y$62$KG$20181002$$MD$IE$IE
136872524$13687252$4$F$$20200629$20170623$20200703$EXP$$US-009507513-1706USA007451$MERCK$$30$YR$$F$Y$163.27$KG$20200703$$CN$US$US
136873013$13687301$3$F$2012$20200827$20170623$20200901$EXP$$US-JAZZ-2017-US-007918$JAZZ$$$$$M$Y$$$20200901$$CN$US$US
1368813718$13688137$18$F$2019$20200723$20170626$20200727$EXP$$US-PFIZER INC-2017276014$PFIZER$$81$YR$$F$Y$61$KG$20200727$$CN$US$US
136886423$13688642$3$F$20161212$20200915$20170626$20200924$EXP$$US-BIOGEN-2017BI00420986$BIOGEN$$43$YR$$F$Y$$$20200924$$MD$US$US
1368918211$13689182$11$F$201705$20200624$20170626$20200803$EXP$$US-INCYTE CORPORATION-2017IN004844$INCYTE$$$$$$Y$$$20200803$$CN$US$US
136902931$13690293$1$I$20170530$20170602$20170626$20170626$EXP$$CA-PFIZER INC-2017250914$PFIZER$$68$YR$$M$Y$$$20170626$$MD$CA$CA
136916243$13691624$3$F$20170601$20180516$20170626$20180522$EXP$IT-MINISAL02-414417$IT-TEVA-780267ACC$TEVA$$68$YR$$F$Y$80$KG$20180522$$MD$IT$IT
1369169412$13691694$12$F$201706$20200817$20170626$20200823$PER$$US-ACTELION-A-US2017-155808$ACTELION$$35$YR$$F$Y$$$20200823$$MD$US$US
136916957$13691695$7$F$$20200717$20170626$20200730$EXP$$US-ACTELION-A-NJ2017-155767$ACTELION$$$$$F$Y$71.2$KG$20200730$$HP$US$US
136923348$13692334$8$F$20170116$20200131$20170627$20200203$EXP$$BR-ASTRAZENECA-2017SE05443$ASTRAZENECA$$24170$DY$$M$Y$$$20200203$$MD$BR$BR
136923468$13692346$8$F$20161116$20200811$20170627$20200817$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-056211$BRISTOL MYERS SQUIBB$YANAGISAWA H.. A CASE OF MALIGNANT MELANOMA ON THE LEFT THIGH IN WHICH EATING DISORDER WAS CAUSED BY GASTRITIS AFTER SWITCHING NIVOLUMAB TO IPILIMUMAB. PROGRAM AND ABSTRACTS OF THE 33RD ANNUAL MEETING OF THE JAPANESE SKIN CANCER SOC. 2017?D?5?4:161 ? 161$54$YR$$F$Y$46$KG$20200817$$MD$JP$JP
1369276529$13692765$29$F$201108$20200909$20170627$20200917$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-056337$BRISTOL MYERS SQUIBB$$58$YR$$F$Y$$$20200917$$CN$CA$CA
136932123$13693212$3$F$$20200731$20170627$20200807$EXP$$US-ASTELLAS-2017US024664$ASTELLAS$$$$$M$Y$$$20200807$$CN$US$US
136933502$13693350$2$F$20150215$20200827$20170627$20200904$EXP$$US-JNJFOC-20170427778$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200904$$CN$US$US
136934774$13693477$4$F$20170623$20171025$20170627$20171102$EXP$$FR-ASTRAZENECA-2017SE66210$ASTRAZENECA$$71$YR$$F$Y$57$KG$20171102$$MD$FR$FR
136936257$13693625$7$F$2017$20200626$20170627$20200708$EXP$$US-INCYTE CORPORATION-2017IN004847$INCYTE$$$$$$Y$$$20200708$$CN$US$US
136940088$13694008$8$F$20170417$20171130$20170627$20171208$EXP$$BE-JNJFOC-20170423042$JANSSEN$$49$YR$A$F$Y$56.3$KG$20171208$$MD$BE$BE
136940732$13694073$2$F$201705$20200702$20170627$20200708$PER$$US-ELI_LILLY_AND_COMPANY-US201706008381$ELI LILLY AND CO$$70$YR$$F$Y$$$20200708$$CN$US$US
136946652$13694665$2$F$$20170619$20170627$20200803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-056893$BRISTOL MYERS SQUIBB$$56$YR$$M$Y$$$20200803$$MD$US$US
136947692$13694769$2$F$20160622$20171213$20170627$20171221$EXP$$JP-ASTRAZENECA-2016SE71069$ASTRAZENECA$$25438$DY$$M$Y$$$20171221$$MD$JP$JP
136947943$13694794$3$F$20170512$20170731$20170627$20170814$EXP$$US-JNJFOC-20170622065$JANSSEN$$85$YR$E$M$Y$106.2$KG$20170814$$MD$US$US
136948314$13694831$4$F$20170613$20180503$20170627$20180515$EXP$$ES-JNJFOC-20170613494$JANSSEN$$72$YR$E$M$Y$74$KG$20180515$$MD$ES$ES
136948375$13694837$5$F$2017$20170727$20170627$20170811$EXP$$US-JNJFOC-20170619079$JANSSEN$$73$YR$E$M$Y$90.4$KG$20170811$$HP$US$US
136950806$13695080$6$F$20190326$20200626$20170627$20200701$EXP$$US-JAZZ-2017-US-007977$JAZZ$$41$YR$$F$Y$$$20200701$$HP$US$US
1369592922$13695929$22$F$20170109$20200617$20170628$20200701$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-060431$BRISTOL MYERS SQUIBB$$80$YR$$F$Y$$$20200701$$HP$AU$AU
136966386$13696638$6$F$20170605$20200729$20170628$20200802$EXP$$PHHO2017GB009128$NOVARTIS$$74$YR$$M$Y$114$KG$20200802$$HP$GB$GB
136969462$13696946$2$F$20170407$20170620$20170628$20200915$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-055675$BRISTOL MYERS SQUIBB$$78$YR$$M$Y$$$20200915$$CN$US$US
136974316$13697431$6$F$20170611$20190904$20170628$20190906$EXP$$CN-ASTRAZENECA-2017SE65712$ASTRAZENECA$$24344$DY$$M$Y$45$KG$20190906$$MD$CN$CN
136977766$13697776$6$F$20170617$20170918$20170628$20170922$EXP$$HU-JNJFOC-20170623056$JANSSEN$$59$YR$A$M$Y$78$KG$20170922$$MD$HU$HU
136988735$13698873$5$F$20170605$20170918$20170628$20200724$EXP$$GB-BAYER-2017-123740$BAYER$$50$YR$A$F$Y$$$20200724$$HP$GB$GB
136989512$13698951$2$F$$20170613$20170628$20200810$EXP$$MY-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-057083$BRISTOL MYERS SQUIBB$GAN SP, ONG SG.. ANTITHROMBOTIC EFFECTS OF HYDROXYCHLOROQUINE IN A PREGNANT PATIENT WITH ANTIPHOSPHOLIPID SYNDROME AND RECURRENT VENOUS THROMBOEMBOLISM.. MEDICAL JOURNAL OF MALAYSIA. 2017?72(2):124?5$23$YR$$F$Y$$$20200810$$MD$MY$MY
136989685$13698968$5$F$20161028$20180503$20170628$20180514$EXP$$FR-JNJFOC-20161100335$JANSSEN$$57$YR$A$F$Y$50$KG$20180514$$MD$FR$FR
1369901828$13699018$28$F$2017$20200918$20170628$20200922$EXP$$US-INCYTE CORPORATION-2017IN004363$INCYTE$$$$$$Y$$$20200922$$CN$US$US
136991091$13699109$1$I$20160903$20160908$20170628$20170628$EXP$$FR-ASTRAZENECA-2016SE97366$ASTRAZENECA$$26369$DY$$M$Y$$$20170628$$MD$FR$FR
137001315$13700131$5$F$2017$20200727$20170629$20200801$EXP$$US-ABBVIE-17K-163-2021674-00$ABBVIE$$54$YR$$F$Y$86.71$KG$20200801$$CN$US$US
137002513$13700251$3$F$$20200626$20170629$20200709$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-144195$RANBAXY$VAN SANFORD C, OBEIDAT AZ, HAGEN M, ZABETI A. A CASE OF FATAL INVASIVE ASPERGILLOSIS IN A PATIENT WITH NEUROSARCOIDOSIS TREATED WITH INFLIXIMAB. INT J NEUROSCI. 2019?129(6):619?622$55$YR$$F$Y$$$20200709$$MD$US$US
137004622$13700462$2$F$$20170626$20170629$20200825$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-057170$BRISTOL MYERS SQUIBB$$10$DEC$$F$Y$$$20200825$$MD$JP$JP
137009637$13700963$7$F$201705$20200924$20170629$20200928$EXP$$FR-PFIZER INC-2017281651$PFIZER$$89$YR$$F$Y$$$20200928$$MD$FR$FR
137010042$13701004$2$F$$20200831$20170629$20200902$PER$$US-PFIZER INC-2017281219$PFIZER$$$$$F$Y$$$20200902$$CN$US$US
137018161$13701816$1$I$20170515$20170518$20170629$20170629$EXP$$CA-PFIZER INC-2017230223$PFIZER$$48$YR$$F$Y$$$20170629$$MD$CA$CA
137018302$13701830$2$F$20170619$20200724$20170629$20200729$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-057788$BRISTOL MYERS SQUIBB$$48$YR$$F$Y$111.7$KG$20200729$$HP$US$US
137024374$13702437$4$F$201612$20200914$20170629$20200918$EXP$$CA-ABBVIE-17K-028-1873857-00$ABBVIE$$19$YR$$F$Y$$$20200918$$CN$CA$CA
137030283$13703028$3$F$20170420$20171229$20170629$20180101$EXP$$TW-ASTRAZENECA-2017SE35857$ASTRAZENECA$$19012$DY$$M$Y$$$20180101$$MD$TW$TW
137031049$13703104$9$F$20170615$20200910$20170629$20200922$EXP$$US-INCYTE CORPORATION-2017IN004986$INCYTE$$$$$$Y$$$20200922$$CN$US$US
1370316010$13703160$10$F$2017$20200729$20170629$20200803$EXP$$US-PFIZER INC-2017142637$PFIZER$$78$YR$$F$Y$$$20200803$$CN$US$US
137041213$13704121$3$F$20161103$20200717$20170630$20200724$EXP$$PHHY2017CA094802$NOVARTIS$$28$YR$$M$Y$$$20200724$$CN$CA$CA
137045743$13704574$3$F$20170508$20170705$20170630$20170710$EXP$$US-ROCHE-1955398$ROCHE$$77$YR$$M$Y$72$KG$20170710$$MD$US$US
137045872$13704587$2$F$20170626$20170705$20170630$20170707$EXP$$RU-ASTRAZENECA-2017SE67185$ASTRAZENECA$$22024$DY$$M$Y$$$20170707$$MD$RU$RU
137046641$13704664$1$I$201210$20170620$20170630$20170630$EXP$$LU-ROCHE-1953238$ROCHE$$29$YR$$F$Y$$$20170630$$MD$LU$LU
137048736$13704873$6$F$$20200915$20170630$20200924$EXP$$CA-APOTEX-2017AP013514$APOTEX$$85$YR$$M$Y$$$20200924$$CN$CA$CA
137054755$13705475$5$F$201704$20200706$20170630$20200713$EXP$$US-ASTELLAS-2016US043314$ASTELLAS$$68$YR$$M$Y$$$20200713$$CN$US$US
137056112$13705611$2$F$20160101$20200902$20170630$20200909$EXP$$US-BAYER-2017-060555$BAYER$$64$YR$A$M$Y$$$20200909$$CN$US$US
137057313$13705731$3$F$20170518$20180418$20170630$20180425$EXP$$US-JNJFOC-20170522001$PHARMACYCLICS$$69$YR$E$M$Y$$$20180425$$MD$US$US
137061214$13706121$4$F$20170615$20180918$20170630$20180920$EXP$$FR-JNJFOC-20170623244$JANSSEN$$60$YR$A$M$Y$$$20180920$$MD$FR$FR
137062682$13706268$2$F$$20200831$20170630$20200903$PER$$US-PFIZER INC-2017279212$PFIZER$$65$YR$$F$Y$$$20200903$$CN$US$US
1370644810$13706448$10$F$20170520$20200828$20170630$20200901$EXP$$CA-TAKEDA-2017TUS013681$TAKEDA$$66$YR$$M$Y$75$KG$20200901$$MD$CA$CA
137078398$13707839$8$F$$20200925$20170630$20200929$EXP$$US-PFIZER INC-2017284135$PFIZER$$71$YR$$F$Y$$$20200929$$MD$US$US
137080682$13708068$2$F$$20170615$20170630$20200810$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-057367$BRISTOL MYERS SQUIBB$AL?RABADI L, AYALON R, BONEGIO RG, BALLARD JE, FUJII AM, HENDERSON JM, ET AL. PREGNANCY IN A PATIENT WITH PRIMARY MEMBRANOUS NEPHROPATHY AND CIRCULATING ANTI?PLA2R ANTIBODIES: A CASE REPORT. AMERICAN JOURNAL OF KIDNEY DISEASES. 2016?67(5):775?8$39$YR$$F$Y$$$20200810$$MD$US$US
137081142$13708114$2$F$$20170617$20170630$20200807$EXP$$AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-057342$BRISTOL MYERS SQUIBB$SHEE A, FRACALOSSI N. MATERNAL CHRONIC HEPATITIS B AND ENTECAVIR THERAPY ASSOCIATED WITH MECONIUM PERITONITIS IN A NEONATE. JOURNAL OF CLINICAL NEONATOLOGY. 2017?6:106?8$29$YR$$F$Y$$$20200807$$MD$AU$AU
1370812911$13708129$11$F$$20200925$20170630$20200929$EXP$$US-PFIZER INC-2017284228$PFIZER$$86$YR$$M$Y$$$20200929$$MD$US$US
137083623$13708362$3$F$20170623$20171108$20170630$20171114$EXP$$US-JNJFOC-20170627648$PHARMACYCLICS$$71$YR$E$M$Y$$$20171114$$MD$US$US
137085843$13708584$3$F$20160517$20180330$20170630$20180404$EXP$$GR-JNJFOC-20160623304$JANSSEN$$64$YR$A$M$Y$95$KG$20180404$$MD$GR$GR
1370864114$13708641$14$F$2017$20200814$20170630$20200822$EXP$$US-ACTELION-A-NJ2017-155060$ACTELION$$62$YR$$F$Y$78.46$KG$20200822$$HP$US$US
1370864911$13708649$11$F$20170619$20200630$20170630$20200714$EXP$$US-ACTELION-A-NJ2016-147274$ACTELION$$42$YR$$F$Y$85.71$KG$20200714$$HP$US$US
137086555$13708655$5$F$$20200820$20170630$20200825$EXP$$US-ACTELION-A-NJ2017-156012$ACTELION$$$$$F$Y$63.49$KG$20200825$$MD$US$US
1370906117$13709061$17$F$2017$20200915$20170701$20200922$EXP$$NL-ABBVIE-16K-114-1806540-00$ABBVIE$$$$$M$Y$81$KG$20200922$$HP$NL$NL
1370917816$13709178$16$F$20170613$20200910$20170702$20200918$EXP$$GB-MYLANLABS-2017M1039719$MYLAN$$39$YR$$M$Y$$$20200918$$CN$GB$GB
137097081$13709708$1$I$20120727$20120730$20170703$20170703$EXP$$ZA-ACTELION-A-CH2012-69414$ACTELION$$55$YR$A$F$Y$$$20170703$$HP$ZA$ZA
1371030413$13710304$13$F$20171006$20200730$20170703$20200811$EXP$$US-ACTELION-A-NJ2017-156026$ACTELION$$58$YR$$F$Y$49.43$KG$20200811$$HP$US$US
1371054610$13710546$10$F$$20200722$20170703$20200728$EXP$$GB-UCBSA-2017025195$UCB$$$$$F$Y$61$KG$20200728$$CN$GB$GB
1371148724$13711487$24$F$2017$20200918$20170703$20200927$EXP$$CA-CELLTRION INC.-2017CA008553$CELLTRION$$$$$$Y$$$20200928$$HP$CA$CA
1371149815$13711498$15$F$20170613$20200715$20170703$20200723$EXP$$CA-CELLTRION INC.-2017CA006285$CELLTRION$$$$$$Y$$$20200723$$HP$CA$CA
137116382$13711638$2$F$20170514$20170713$20170703$20170717$EXP$$FR-ASTRAZENECA-2017SE52395$ASTRAZENECA$$71$YR$$F$Y$63$KG$20170717$$MD$FR$FR
137126901$13712690$1$I$$20170623$20170703$20170703$EXP$$CA-MYLANLABS-2017M1039960$MYLAN$$$$$$Y$$$20170630$$CN$CA$CA
137126981$13712698$1$I$$20170623$20170703$20170703$EXP$$CA-MYLANLABS-2017M1039944$MYLAN$$$$$$Y$$$20170630$$CN$CA$CA
1371299611$13712996$11$F$20170613$20200727$20170704$20200731$EXP$$PHHY2017CA095439$NOVARTIS$$63$YR$$F$Y$$$20200731$$MD$CA$CA
137137435$13713743$5$F$$20200908$20170704$20200916$EXP$$CA-APOTEX-2017AP013628$APOTEX$$$$$$Y$$$20200916$$CN$CA$CA
137140615$13714061$5$F$20170629$20180517$20170704$20180525$EXP$$US-ASTRAZENECA-2017SE68686$ASTRAZENECA$$70$YR$$M$Y$$$20180525$$MD$US$US
137147892$13714789$2$F$20131017$20200903$20170704$20200914$PER$$US-JNJFOC-20170511470$JOHNSON AND JOHNSON$$40$YR$A$F$Y$$$20200914$$HP$US$US
137152601$13715260$1$I$20170529$20170605$20170704$20170704$EXP$$IT-JNJFOC-20170605339$JANSSEN$$68$YR$E$F$Y$63$KG$20170704$$CN$IT$IT
137153426$13715342$6$F$20111105$20200626$20170704$20200702$PER$$US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-036538$BOEHRINGER INGELHEIM$$73$YR$$M$Y$61.68$KG$20200702$$MD$US$US
137155812$13715581$2$F$$20200727$20170705$20200803$EXP$$DE-AUROBINDO-AUR-APL-2017-36766$AUROBINDO$$44$YR$$M$Y$$$20200803$$HP$DE$DE
137166912$13716691$2$F$20140422$20200916$20170705$20200925$EXP$$US-BAYER-2017-045436$BAYER$$34$YR$A$F$Y$72.64$KG$20200925$$CN$US$US
137167652$13716765$2$F$201406$20200817$20170705$20200820$EXP$$US-BAYER-2017-065842$BAYER$$75$YR$E$F$Y$$$20200820$$CN$US$US
137169822$13716982$2$F$20140131$20200628$20170705$20200710$EXP$$US-BAYER-2017-022807$BAYER$$86$YR$E$F$Y$100.1$KG$20200710$$CN$US$US
137170988$13717098$8$F$$20200801$20170705$20200814$EXP$$ES-VALIDUS PHARMACEUTICALS LLC-EE-2016VAL000771$VALIDUS$$$$$$Y$$$20200814$$HP$ES$ES
137178392$13717839$2$F$20170629$20170712$20170705$20170713$EXP$$US-ASTRAZENECA-2017SE68776$ASTRAZENECA$$46$YR$$M$Y$63.6$KG$20170713$$MD$US$US
137182773$13718277$3$F$201507$20200722$20170705$20200731$PER$$US-JNJFOC-20170628870$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200731$$CN$US$US
137183372$13718337$2$F$20150124$20200809$20170705$20200818$EXP$$US-JNJFOC-20170334654$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20200818$$CN$US$US
137184233$13718423$3$F$$20200907$20170705$20200908$EXP$$PHHY2017GR093936$NOVARTIS$$77$YR$$F$Y$$$20200908$$HP$GR$GR
137184754$13718475$4$F$201706$20200804$20170705$20200805$EXP$$US-PFIZER INC-2017285587$PFIZER$$67$YR$$F$Y$51.26$KG$20200805$$MD$US$US
137194035$13719403$5$F$$20180430$20170705$20180502$EXP$$CZ-PFIZER INC-2017286064$PFIZER$HANOUSEK, J.. PLASMACYTIC POST?TRANSPLANT LYMPHOPROLIFERATIVE DISORDER ? CASE REPORT. EUROPEAN ONCOLOGY AND HAEMATOLOGY. 2017?13 (1):80?82$43$YR$$F$Y$$$20180502$$MD$CZ$CZ
137211282$13721128$2$F$20160928$20180308$20170706$20180314$EXP$$JP-ASTRAZENECA-2016SF17675$ASTRAZENECA$$26627$DY$$F$Y$43$KG$20180314$$MD$JP$JP
137223162$13722316$2$F$20161006$20200820$20170706$20200825$EXP$$US-BAYER-2017-115195$BAYER$$86$YR$E$F$Y$$$20200825$$CN$US$US
137244692$13724469$2$F$201705$20200922$20170706$20200924$EXP$$CA-PFIZER INC-2017285010$PFIZER$$61$YR$$F$Y$$$20200924$$MD$CA$CA
137245251$13724525$1$I$$20170623$20170706$20170706$EXP$$CA-MYLANLABS-2017M1040235$MYLAN$$$$$$Y$$$20170706$$CN$CA$CA
137254991$13725499$1$I$$20170706$20170707$20170707$EXP$$HK-ROCHE-1960453$ROCHE$$$$$$Y$$$20170707$$MD$HK$HK
137255445$13725544$5$F$20170608$20200728$20170706$20200804$PER$$US-PFIZER INC-2017288640$PFIZER$$62$YR$$F$Y$$$20200804$$CN$US$US
137256801$13725680$1$I$$20161128$20170707$20170707$EXP$$GR-ROCHE-1926084$ROCHE$VASSILIOU V, KALOGEROPOULOU C, CHRISTOPOULOS C, SOLOMOU E, LEOTSINIDES M AND KARDAMAKIS D COMBINATION IBANDRONATE AND RADIOTHERAPY FOR THE TREATMENT OF BONE METASTASES: CLINICAL EVALUATION AND RADIOLOGIC ASSESSMENT. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS 2007 JAN 01?67 (1):264?272.$$$$$Y$$$20170707$$MD$GR$GR
137260485$13726048$5$F$20140617$20200707$20170707$20200709$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK103895$GLAXOSMITHKLINE$$52$YR$$M$Y$$$20200709$$CN$CA$CA
137263163$13726316$3$F$20161107$20200702$20170707$20200715$EXP$$US-BAYER-2017-093491$BAYER$$62$YR$A$M$Y$$$20200715$$CN$US$US
137265096$13726509$6$F$20160725$20200715$20170707$20200721$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN102802$VIIV$$$$$M$Y$$$20200721$$CN$JP$JP
137268223$13726822$3$F$20130912$20200906$20170707$20200918$EXP$$US-JNJFOC-20170522276$JOHNSON AND JOHNSON$$90$YR$E$F$Y$$$20200918$$CN$US$US
137270073$13727007$3$F$$20200907$20170707$20200914$EXP$$DE-AUROBINDO-AUR-APL-2017-36861$AUROBINDO$$$$A$F$Y$87$KG$20200914$$HP$DE$DE
137278011$13727801$1$I$20170327$20170327$20170707$20170707$EXP$$CZ-BAXTER-2017BAX027007$BAXTER$$33$YR$$F$Y$58$KG$20170706$$HP$CZ$CZ
137278493$13727849$3$F$201608$20200802$20170707$20200810$EXP$$US-JNJFOC-20170414325$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200810$$CN$US$US
137278923$13727892$3$F$201404$20200728$20170707$20200731$PER$$US-JNJFOC-20170414107$JOHNSON AND JOHNSON$$86$YR$E$F$Y$77.63$KG$20200731$$CN$US$US
137278983$13727898$3$F$20160204$20200715$20170707$20200717$PER$$US-JNJFOC-20170413543$JOHNSON AND JOHNSON$$63$YR$$M$Y$$$20200717$$LW$US$US
137279572$13727957$2$F$2007$20200731$20170707$20200805$PER$$US-JNJFOC-20150713762$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20200805$$CN$US$US
137280539$13728053$9$F$$20200728$20170707$20200730$PER$$US-PFIZER INC-2017293324$PFIZER$$73$YR$$M$Y$98$KG$20200730$$MD$US$US
137280705$13728070$5$F$$20200810$20170707$20200812$PER$$US-PFIZER INC-2017293896$PFIZER$$81$YR$$F$Y$55$KG$20200812$$CN$US$US
137282052$13728205$2$F$20160930$20200917$20170707$20200921$PER$$US-JNJFOC-20170600013$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200921$$CN$US$US
137282353$13728235$3$F$20150818$20200902$20170707$20200914$PER$$US-JNJFOC-20170624389$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200914$$CN$US$US
137282473$13728247$3$F$2016$20200714$20170707$20200727$EXP$$US-JNJFOC-20170624832$JOHNSON AND JOHNSON$$9$DEC$E$F$Y$66.5$KG$20200727$$CN$US$US
137283013$13728301$3$F$201507$20200802$20170707$20200805$PER$$US-JNJFOC-20170621760$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200805$$CN$US$US
137283282$13728328$2$F$20150630$20200721$20170707$20200724$PER$$US-JNJFOC-20170624735$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200724$$CN$US$US
137283323$13728332$3$F$201607$20200804$20170707$20200806$PER$$US-JNJFOC-20170625484$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200806$$CN$US$US
137283553$13728355$3$F$20160515$20200827$20170707$20200901$PER$$US-JNJFOC-20170625888$JOHNSON AND JOHNSON$$47$YR$A$M$Y$$$20200901$$LW$US$US
1372836610$13728366$10$F$20151202$20200917$20170707$20200918$PER$$US-AMGEN-USANI2017101679$AMGEN$$73$YR$E$M$Y$$$20200918$$MD$US$US
137284323$13728432$3$F$20170310$20200917$20170707$20200928$PER$$US-JNJFOC-20170625909$JOHNSON AND JOHNSON$$90$YR$E$M$Y$$$20200928$$CN$US$US
137286374$13728637$4$F$20140809$20200914$20170707$20200917$PER$$US-JNJFOC-20170625643$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200917$$CN$US$US
137286973$13728697$3$F$20160820$20200721$20170707$20200731$PER$$US-JNJFOC-20170626842$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200731$$CN$US$US
137287072$13728707$2$F$20150719$20200806$20170707$20200811$PER$$US-JNJFOC-20170516123$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200811$$CN$US$US
137287713$13728771$3$F$20150729$20200913$20170707$20200924$EXP$$US-JNJFOC-20170627878$JOHNSON AND JOHNSON$$57$YR$A$F$Y$70.31$KG$20200924$$LW$US$US
137287794$13728779$4$F$20150823$20200803$20170707$20200812$EXP$$US-JNJFOC-20170628168$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20200812$$CN$US$US
137288845$13728884$5$F$$20200903$20170707$20200907$PER$$US-PFIZER INC-2017294637$PFIZER$$68$YR$$F$Y$$$20200907$$MD$US$US
1372947311$13729473$11$F$20170519$20180731$20170707$20200817$EXP$$JP-009507513-1705JPN002864J$MERCK$$62$YR$$M$Y$65$KG$20200817$$CN$JP$JP
137294922$13729492$2$F$20130709$20200826$20170707$20200831$PER$$US-JNJFOC-20160922309$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200831$$CN$US$US
137297383$13729738$3$F$2015$20200630$20170707$20200706$PER$$US-JNJFOC-20170407871$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200706$$CN$US$US
137297623$13729762$3$F$201503$20200818$20170707$20200821$PER$$US-JNJFOC-20170413247$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200821$$CN$US$US
137298053$13729805$3$F$20141022$20200802$20170707$20200805$PER$$US-JNJFOC-20170505471$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200805$$CN$US$US
137298093$13729809$3$F$20150120$20200818$20170707$20200821$PER$$US-JNJFOC-20170505781$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200821$$CN$US$US
137298113$13729811$3$F$20140117$20200813$20170707$20200817$PER$$US-JNJFOC-20170505561$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200817$$CN$US$US
137298212$13729821$2$F$20150528$20200726$20170707$20200730$PER$$US-JNJFOC-20170220820$JOHNSON AND JOHNSON$$51$YR$A$M$Y$$$20200730$$CN$US$US
137298583$13729858$3$F$20150902$20200901$20170707$20200914$PER$$US-JNJFOC-20170507284$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200914$$CN$US$US
137298622$13729862$2$F$20150223$20200709$20170707$20200713$PER$$US-JNJFOC-20170505947$JOHNSON AND JOHNSON$$75$YR$$F$Y$$$20200713$$CN$US$US
137298722$13729872$2$F$20161018$20200804$20170707$20200807$PER$$US-JNJFOC-20170504911$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200807$$CN$US$US
137298762$13729876$2$F$20141019$20200804$20170707$20200807$PER$$US-JNJFOC-20170426024$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20200807$$CN$US$US
137298955$13729895$5$F$201411$20200628$20170707$20200707$EXP$$US-JNJFOC-20170509696$JOHNSON AND JOHNSON$$80$YR$$M$Y$$$20200707$$CN$US$US
137299103$13729910$3$F$20140626$20200730$20170707$20200803$PER$$US-JNJFOC-20170509162$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200803$$CN$US$US
137299643$13729964$3$F$20150512$20200706$20170707$20200717$EXP$$US-JNJFOC-20170511887$JOHNSON AND JOHNSON$$81$YR$$M$Y$95.34$KG$20200717$$CN$US$US
137299863$13729986$3$F$20161107$20200702$20170707$20200709$PER$$US-JNJFOC-20170515256$JOHNSON AND JOHNSON$$62$YR$$M$Y$$$20200709$$LW$US$US
137299993$13729999$3$F$20150515$20200927$20170707$20200930$PER$$US-JNJFOC-20170515503$JOHNSON AND JOHNSON$$85$YR$E$M$Y$$$20200930$$CN$US$US
137300013$13730001$3$F$20150513$20200804$20170707$20200807$PER$$US-JNJFOC-20170515738$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200807$$CN$US$US
137300133$13730013$3$F$20121125$20200803$20170707$20200806$PER$$US-JNJFOC-20170516164$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200806$$CN$US$US
137300581$13730058$1$I$$20170623$20170707$20170707$EXP$$CA-MYLANLABS-2017M1040954$MYLAN$$$$$$Y$$$20170707$$CN$CA$CA
137300693$13730069$3$F$20140526$20200805$20170707$20200813$PER$$US-JNJFOC-20170518794$JOHNSON AND JOHNSON$$54$YR$A$F$Y$$$20200813$$CN$US$US
137300883$13730088$3$F$20150518$20200914$20170707$20200925$EXP$$US-JNJFOC-20170520184$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200925$$CN$US$US
137301443$13730144$3$F$20160504$20200728$20170707$20200731$PER$$US-JNJFOC-20170521695$JOHNSON AND JOHNSON$$76$YR$E$F$Y$$$20200731$$CN$US$US
137301674$13730167$4$F$20130702$20200906$20170707$20200918$EXP$$US-JNJFOC-20170522581$JOHNSON AND JOHNSON$$56$YR$A$F$Y$$$20200918$$CN$US$US
137301812$13730181$2$F$201701$20200927$20170707$20200930$PER$$US-JNJFOC-20170418441$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20200930$$CN$US$US
137302082$13730208$2$F$20160723$20200805$20170707$20200807$PER$$US-JNJFOC-20170430444$JOHNSON AND JOHNSON$$75$YR$E$F$Y$51.59$KG$20200807$$CN$US$US
137302363$13730236$3$F$2014$20200903$20170707$20200914$PER$$US-JNJFOC-20170526522$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200914$$CN$US$US
137302383$13730238$3$F$20150524$20200825$20170707$20200901$PER$$US-JNJFOC-20170525102$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200901$$HP$US$US
137302483$13730248$3$F$20150421$20200816$20170707$20200820$PER$$US-JNJFOC-20170526200$JOHNSON AND JOHNSON$$41$YR$A$F$Y$$$20200820$$CN$US$US
137303574$13730357$4$F$20160606$20200709$20170707$20200720$EXP$$US-JNJFOC-20170602080$JOHNSON AND JOHNSON$$81$YR$$M$Y$$$20200720$$CN$US$US
137303592$13730359$2$F$201608$20200906$20170707$20200914$PER$$US-JNJFOC-20170307003$JOHNSON AND JOHNSON$$52$YR$A$F$Y$$$20200914$$CN$US$US
137303612$13730361$2$F$20170114$20200723$20170707$20200728$PER$$US-JNJFOC-20170529765$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20200728$$CN$US$US
137303702$13730370$2$F$20160412$20200908$20170707$20200914$PER$$US-JNJFOC-20170411098$JOHNSON AND JOHNSON$$58$YR$A$F$Y$$$20200914$$CN$US$US
137303772$13730377$2$F$20150727$20200923$20170707$20200930$PER$$US-JNJFOC-20170404067$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200930$$CN$US$US
137304232$13730423$2$F$20150405$20200906$20170707$20200914$PER$$US-JNJFOC-20170409567$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200914$$HP$US$US
137304353$13730435$3$F$20140513$20200811$20170707$20200813$PER$$US-JNJFOC-20170603940$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200813$$CN$US$US
137304432$13730443$2$F$20150409$20200805$20170707$20200807$PER$$US-JNJFOC-20170409663$JOHNSON AND JOHNSON$$52$YR$A$M$Y$$$20200807$$CN$US$US
137304513$13730451$3$F$20150427$20200830$20170707$20200902$EXP$$US-JNJFOC-20170501017$JOHNSON AND JOHNSON$$73$YR$E$M$Y$$$20200902$$CN$US$US
137304962$13730496$2$F$20170519$20180404$20170707$20180409$EXP$$US-JNJFOC-20170701805$JANSSEN$$63$YR$A$F$Y$47$KG$20180409$$MD$US$US
137305453$13730545$3$F$20130613$20200719$20170707$20200722$PER$$US-JNJFOC-20170605292$JOHNSON AND JOHNSON$$75$YR$E$F$Y$$$20200722$$CN$US$US
137305532$13730553$2$F$201305$20200803$20170707$20200805$PER$$US-JNJFOC-20170413746$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200805$$CN$US$US
137305913$13730591$3$F$20151001$20200812$20170707$20200817$PER$$US-JNJFOC-20170607140$JOHNSON AND JOHNSON$$91$YR$E$M$Y$$$20200817$$CN$US$US
137305964$13730596$4$F$20140505$20200715$20170707$20200717$PER$$US-JNJFOC-20170606153$JOHNSON AND JOHNSON$$85$YR$$F$Y$$$20200717$$CN$US$US
137306343$13730634$3$F$20161103$20200913$20170707$20200924$EXP$$US-JNJFOC-20170607535$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200924$$CN$US$US
137306363$13730636$3$F$201501$20200924$20170707$20200929$PER$$US-JNJFOC-20170607569$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200929$$CN$US$US
137306493$13730649$3$F$20140611$20200805$20170707$20200817$EXP$$US-JNJFOC-20170608671$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200817$$CN$US$US
137306525$13730652$5$F$201506$20200730$20170707$20200806$EXP$$US-JNJFOC-20170609202$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20200806$$CN$US$US
137306683$13730668$3$F$20130304$20200809$20170707$20200817$PER$$US-JNJFOC-20170609417$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200817$$CN$US$US
137307273$13730727$3$F$2015$20200914$20170707$20200917$PER$$US-JNJFOC-20170429662$JOHNSON AND JOHNSON$$61$YR$A$M$Y$$$20200917$$LW$US$US
137307333$13730733$3$F$201512$20200721$20170707$20200730$EXP$$US-JNJFOC-20170430658$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200730$$CN$US$US
137307425$13730742$5$F$201510$20200803$20170707$20200812$EXP$$US-JNJFOC-20170430638$JOHNSON AND JOHNSON$$75$YR$E$F$Y$56.3$KG$20200812$$CN$US$US
137307593$13730759$3$F$201507$20200622$20170707$20200702$EXP$$US-JNJFOC-20170500636$JOHNSON AND JOHNSON$$63$YR$$F$Y$67.3$KG$20200702$$CN$US$US
137307753$13730775$3$F$20160622$20200716$20170707$20200721$PER$$US-JNJFOC-20170500960$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200721$$HP$US$US
137307913$13730791$3$F$20160221$20200713$20170707$20200717$PER$$US-JNJFOC-20170608911$JOHNSON AND JOHNSON$$64$YR$$M$Y$$$20200717$$CN$US$US
137307993$13730799$3$F$20150718$20200624$20170707$20200707$EXP$$US-JNJFOC-20170608963$JOHNSON AND JOHNSON$$72$YR$$M$Y$$$20200707$$CN$US$US
137308543$13730854$3$F$20150519$20200820$20170707$20200826$PER$$US-JNJFOC-20170610934$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200826$$CN$US$US
137308592$13730859$2$F$20130520$20200902$20170707$20200909$PER$$US-JNJFOC-20170125947$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20200909$$CN$US$US
137308953$13730895$3$F$20161220$20200804$20170707$20200807$PER$$US-JNJFOC-20170502256$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200807$$CN$US$US
137309082$13730908$2$F$201602$20200729$20170707$20200803$PER$$US-JNJFOC-20170408271$JOHNSON AND JOHNSON$$82$YR$E$M$Y$91.25$KG$20200803$$CN$US$US
137309092$13730909$2$F$20150624$20200910$20170707$20200915$PER$$US-JNJFOC-20170506292$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200915$$CN$US$US
137309165$13730916$5$F$20141203$20200713$20170707$20200716$PER$$US-JNJFOC-20170613895$JOHNSON AND JOHNSON$$91$YR$$F$Y$$$20200716$$CN$US$US
137309173$13730917$3$F$20150605$20200927$20170707$20200929$PER$$US-JNJFOC-20170613373$JOHNSON AND JOHNSON$$70$YR$E$F$Y$77.11$KG$20200929$$CN$US$US
137309213$13730921$3$F$201510$20200712$20170707$20200715$PER$$US-JNJFOC-20170613558$JOHNSON AND JOHNSON$$42$YR$$F$Y$$$20200715$$CN$US$US
137309272$13730927$2$F$201405$20200819$20170707$20200824$PER$$US-JNJFOC-20170500973$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200824$$CN$US$US
137309353$13730935$3$F$20150306$20200730$20170707$20200805$PER$$US-JNJFOC-20170613546$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200805$$CN$US$US
137309403$13730940$3$F$20150830$20200629$20170707$20200710$EXP$$US-JNJFOC-20170613614$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200710$$CN$US$US
137309653$13730965$3$F$201507$20200714$20170707$20200720$PER$$US-JNJFOC-20170502670$JOHNSON AND JOHNSON$$52$YR$$F$Y$$$20200720$$CN$US$US
137310384$13731038$4$F$20140801$20200918$20170707$20200928$EXP$$US-JNJFOC-20170614299$JOHNSON AND JOHNSON$$49$YR$A$F$Y$151.5$KG$20200928$$CN$US$US
137310403$13731040$3$F$201412$20200702$20170707$20200715$EXP$$US-JNJFOC-20170615331$JOHNSON AND JOHNSON$$46$YR$$F$Y$$$20200715$$CN$US$US
137310433$13731043$3$F$20121004$20200901$20170707$20200914$PER$$US-JNJFOC-20170615587$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200914$$CN$US$US
137310533$13731053$3$F$20160518$20200708$20170707$20200714$PER$$US-JNJFOC-20170615548$JOHNSON AND JOHNSON$$59$YR$$F$Y$$$20200714$$CN$US$US
137311733$13731173$3$F$20161006$20200820$20170707$20200824$PER$$US-JNJFOC-20170610887$JOHNSON AND JOHNSON$$86$YR$E$F$Y$$$20200824$$CN$US$US
137312542$13731254$2$F$20140620$20200903$20170707$20200909$PER$$US-JNJFOC-20161020273$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20200909$$HP$US$US
137312622$13731262$2$F$20140212$20200903$20170707$20200916$EXP$$US-JNJFOC-20161020269$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20200916$$CN$US$US
137312972$13731297$2$F$201504$20200916$20170707$20200918$PER$$US-JNJFOC-20170516064$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20200918$$CN$US$US
137313052$13731305$2$F$201501$20200713$20170707$20200716$PER$$US-JNJFOC-20170528977$JOHNSON AND JOHNSON$$51$YR$$M$Y$$$20200716$$CN$US$US
137313132$13731313$2$F$20140909$20200824$20170707$20200907$EXP$$US-JNJFOC-20170521816$JOHNSON AND JOHNSON$$91$YR$E$F$Y$$$20200907$$CN$US$US
137314013$13731401$3$F$201606$20200812$20170707$20200817$PER$$US-JNJFOC-20170622246$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200817$$CN$US$US
137316325$13731632$5$F$20160415$20180108$20170707$20180112$EXP$$FI-ASTRAZENECA-2016SE43784$ASTRAZENECA$$27880$DY$$F$Y$$$$$MD$FI$FI
137316683$13731668$3$F$20160905$20171205$20170707$20171208$EXP$$MX-ASTRAZENECA-2016SE96379$ASTRAZENECA$$25707$DY$$M$Y$$$20171208$$MD$MX$MX
137317653$13731765$3$F$20170309$20180111$20170707$20180113$EXP$$IN-ASTRAZENECA-2017SE26130$ASTRAZENECA$$21252$DY$$M$Y$$$20180113$$MD$IN$IN
137323273$13732327$3$F$20170428$20200922$20170707$20200930$PER$$US-SA-2017SA081562$SANOFI AVENTIS$$$$$$Y$$$20200930$$HP$US$US
137323462$13732346$2$F$201704$20200922$20170707$20200930$PER$$US-SA-2017SA086515$SANOFI AVENTIS$$$$$$Y$$$20200930$$CN$US$US
137324222$13732422$2$F$2017$20200810$20170707$20200814$EXP$$US-SA-2017SA109413$SANOFI AVENTIS$$65$YR$$F$Y$65.7$KG$20200814$$CN$US$US
137324303$13732430$3$F$20180124$20200624$20170707$20200703$PER$$US-SA-2017SA110141$SANOFI AVENTIS$$$$$$Y$$$20200703$$CN$US$US
137326286$13732628$6$F$20170314$20200918$20170707$20200928$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-056330$BRISTOL MYERS SQUIBB$$71$YR$$M$Y$$$20200928$$CN$US$US
137335888$13733588$8$F$20170519$20200629$20170707$20200813$EXP$$JP-009507513-1705JPN003237J$MERCK$$56$YR$$M$Y$48$KG$20200813$$MD$JP$JP
137337334$13733733$4$F$20160701$20200713$20170707$20200720$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-070585$BRISTOL MYERS SQUIBB$$85$YR$$M$Y$$$20200720$$HP$CA$CA
137339692$13733969$2$F$20150220$20200903$20170708$20200911$EXP$$FR-009507513-1706FRA009602$MERCK$$$$$F$Y$2.27$KG$20200911$$HP$FR$FR
137340282$13734028$2$F$$20200625$20170708$20200703$EXP$$IT-009507513-1702ITA006085$MERCK$$65$YR$$F$Y$$$20200703$$CN$IT$IT
137360174$13736017$4$F$$20200828$20170710$20200908$EXP$$CA-ROCHE-1960411$ROCHE$$47$YR$$M$Y$$$20200909$$HP$CA$CA
137363692$13736369$2$F$20170228$20200918$20170710$20200923$EXP$$ES-PFIZER INC-2017293733$PFIZER$$59$YR$$F$Y$$$20200923$$MD$ES$ES
137375302$13737530$2$F$2016$20170807$20170710$20170811$EXP$CH-SM-2017-05438$CH-PFIZER INC-2017292057$PFIZER$$$$$F$Y$1.95$KG$20170811$$MD$CH$CH
137376373$13737637$3$F$20150309$20200427$20170710$20200710$EXP$$US-SAOL THERAPEUTICS-2016SAO00770$SAOL THERAPEUTICS$$50$YR$$M$Y$81.63$KG$20200710$$MD$US$US
1373823914$13738239$14$F$20161020$20200811$20170710$20200814$EXP$$CA-TAKEDA-2016TUS019347$TAKEDA$$35$YR$$F$Y$$$20200814$$MD$CA$CA
137405422$13740542$2$F$$20200629$20170711$20200708$PER$$FR-LUPIN PHARMACEUTICALS INC.-2017-01892$LUPIN$$49$YR$$M$Y$$$20200708$$HP$FR$FR
137407649$13740764$9$F$2017$20200730$20170711$20200807$EXP$$NL-ABBVIE-17K-114-2033753-00$ABBVIE$$68$YR$$M$Y$65$KG$20200806$$CN$NL$NL
137408745$13740874$5$F$$20200713$20170711$20200717$PER$$US-PFIZER INC-2017300469$PFIZER$$74$YR$$F$Y$$$20200717$$HP$US$US
1374154212$13741542$12$F$20170609$20200806$20170711$20200807$PER$$US-PFIZER INC-2017294654$PFIZER$$69$YR$$F$Y$$$20200807$$PH$US$US
137417676$13741767$6$F$20170601$20200908$20170711$20200910$PER$$US-PFIZER INC-2017296776$PFIZER$$74$YR$$M$Y$$$20200910$$CN$US$US
137425999$13742599$9$F$201707$20200722$20170711$20200723$EXP$$US-PFIZER INC-2017296205$PFIZER$$54$YR$$F$Y$47$KG$20200723$$CN$US$US
1374261319$13742613$19$F$$20200924$20170711$20200929$PER$$US-PFIZER INC-2017300984$PFIZER$$69$YR$$M$Y$80$KG$20200929$$MD$US$US
1374262142$13742621$42$F$2017$20200728$20170711$20200804$EXP$$PHHY2017CA101173$NOVARTIS$$43$YR$$F$Y$$$20200804$$HP$CA$CA
137427272$13742727$2$F$20150201$20200804$20170711$20200812$EXP$$US-MYLANLABS-2017M1040203$MYLAN$$66$YR$$M$Y$73$KG$20200812$$CN$US$US
137427721$13742772$1$I$20170701$20170705$20170711$20170711$EXP$$IT-JNJFOC-20170704660$JANSSEN$$51$YR$A$F$Y$$$20170711$$MD$IT$IT
137428332$13742833$2$F$20161013$20170721$20170711$20170727$EXP$$JP-ASTRAZENECA-2016SF09643$ASTRAZENECA$$26786$DY$$M$Y$$$20170727$$MD$JP$JP
137429415$13742941$5$F$20170324$20200917$20170711$20200922$EXP$DE-EMA-DD-20180502-HJAINP-152713$DE-DSJP-DSE-2017-121014$DAIICHI$$74$YR$$F$Y$60$KG$20200922$$MD$DE$DE
137430349$13743034$9$F$20160615$20200714$20170711$20200727$EXP$$JP-INCYTE CORPORATION-2017IN005448$INCYTE$$$$$$Y$$$20200727$$MD$JP$JP
1374353120$13743531$20$F$20181027$20200702$20170711$20200716$EXP$$US-ACTELION-A-NJ2017-156445$ACTELION$$49$YR$$F$Y$113.83$KG$20200716$$HP$US$US
137441354$13744135$4$F$20131101$20200626$20170712$20200701$EXP$$US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-038307$BOEHRINGER INGELHEIM$$76$YR$$F$Y$90.71$KG$20200701$$MD$US$US
137443927$13744392$7$F$$20200805$20170712$20200817$EXP$$US-ASTRAZENECA-2017SE70772$ASTRAZENECA$$$$$M$Y$105.7$KG$20200817$$$US$US
137444881$13744488$1$I$20170608$20170707$20170712$20170712$EXP$$ES-ROCHE-1961549$ROCHE$$83$YR$$M$Y$68$KG$20170712$$MD$ES$ES
137446304$13744630$4$F$20170629$20180711$20170712$20180718$EXP$$CN-ROCHE-1957787$ROCHE$$64$YR$$F$Y$62$KG$20180718$$MD$CN$CN
137450214$13745021$4$F$20170604$20200707$20170712$20200709$PER$$US-PFIZER INC-2017301265$PFIZER$$76$YR$$M$Y$$$20200709$$CN$US$US
137453032$13745303$2$F$20170704$20170704$20170712$20200915$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-059786$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20200915$$CN$BR$BR
137454312$13745431$2$F$20130912$20200906$20170712$20200914$EXP$$US-BAYER-2017-098515$BAYER$$90$YR$E$F$Y$$$20200914$$CN$US$US
137457052$13745705$2$F$20170705$20170814$20170712$20170818$EXP$$UA-ASTRAZENECA-2017SE71416$ASTRAZENECA$$40$YR$$M$Y$62$KG$20170818$$MD$UA$UA
1374596414$13745964$14$F$2017$20200814$20170712$20200821$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK107373$GLAXOSMITHKLINE$$56$YR$$F$Y$$$20200821$$CN$CA$CA
1374631720$13746317$20$F$2017$20200806$20170712$20200813$EXP$$CA-CELLTRION INC.-2017CA004502$CELLTRION$$$$$$Y$$$20200813$$HP$CA$CA
1374677936$13746779$36$F$20170629$20200824$20170712$20200825$EXP$$US-ACTELION-A-NJ2017-156416$ACTELION$$68$YR$$F$Y$56.69$KG$20200825$$HP$US$US
137470958$13747095$8$F$20170225$20181207$20170712$20181210$EXP$$PL-ASTRAZENECA-2017SE27111$ASTRAZENECA$$24160$DY$$F$Y$$$20181210$$MD$PL$PL
137471372$13747137$2$F$20170610$20170731$20170712$20170809$EXP$$BR-JNJFOC-20170611316$JANSSEN$$80$YR$E$M$Y$71.4$KG$20170809$$MD$BR$BR
137471385$13747138$5$F$20170321$20200826$20170712$20200910$EXP$$FR-JNJFOC-20170702453$JOHNSON AND JOHNSON$$58$YR$A$F$Y$117$KG$20200910$$MD$FR$FR
1374715110$13747151$10$F$2017$20200629$20170712$20200706$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-010765$BRISTOL MYERS SQUIBB$MORIGUCHI S. USAGE EXPERIENCE OF NIVOLUMAB IN IWATE PREFECTURE. I?O CASE CONFERENCE FOR LUNG CANCER IN IWATE. 2017?G1964$69$YR$$M$Y$62$KG$20200706$$MD$JP$JP
137472831$13747283$1$I$20160721$20160721$20170712$20170712$EXP$$JP-ASTRAZENECA-2016SE79803$ASTRAZENECA$$21385$DY$$M$Y$$$20170712$$MD$JP$JP
137485446$13748544$6$F$20170329$20200629$20170713$20200707$EXP$FR-AFSSAPS-RN20170874$PHHY2017FR070254$NOVARTIS$$43$YR$$M$Y$$$20200707$$HP$FR$FR
137487317$13748731$7$F$201703$20200908$20170713$20200910$EXP$$AT-ELI_LILLY_AND_COMPANY-AT201706013544$ELI LILLY AND CO$$31$YR$$M$Y$$$20200910$$MD$AT$AT
137487332$13748733$2$F$201612$20200907$20170713$20200917$EXP$$DE-ELI_LILLY_AND_COMPANY-DE201707000179$ELI LILLY AND CO$$30$YR$$F$Y$87$KG$20200917$$MD$DE$DE
137491428$13749142$8$F$20170607$20200731$20170713$20200806$EXP$$US-ASTELLAS-2017US026936$ASTELLAS$$64$YR$$M$Y$$$20200806$$CN$US$US
137493812$13749381$2$F$$20200910$20170713$20200911$PER$$US-ELI_LILLY_AND_COMPANY-US201706009921$ELI LILLY AND CO$$$$$M$Y$$$20200911$$CN$US$US
137495475$13749547$5$F$2010$20200916$20170713$20200921$EXP$$US-PFIZER INC-2017300447$PFIZER$$60$YR$$F$Y$61.69$KG$20200921$$MD$US$US
137502585$13750258$5$F$$20200701$20170713$20200707$EXP$$JP-BAUSCH-BL-2017-021208$BAUSCH AND LOMB$TAKAHASHI S, HAYAKAWA M, ISOGAWA M, TOGASHI T, TAMURA Y, IGARASHI M, NAITO M, AOYAGI Y. A CASE OF IGG4?RELATED DISEASE DIAGNOSED 8 YEARS AFTER LOW?DOSE STEROID THERAPY FOR PALPEBRAL EDEMA. ENDOSCOPIC FORUM FOR DIGESTIVE DISEASE. 2017?33(1):27?34.$54$YR$$F$Y$56$KG$20200707$$MD$JP$JP
137527793$13752779$3$F$20170522$20200213$20170713$20200226$EXP$$US-JNJFOC-20170526555$JOHNSON AND JOHNSON$$70$YR$$M$Y$67$KG$20200226$$MD$US$US
137533545$13753354$5$F$20170702$20171102$20170713$20171110$EXP$$US-JNJFOC-20170707907$PHARMACYCLICS$$64$YR$A$F$Y$53$KG$20171110$$MD$US$US
1375339517$13753395$17$F$2017$20200917$20170713$20200923$EXP$$US-JAZZ-2017-US-009041$JAZZ$$12$YR$$M$Y$$$20200923$$HP$US$US
137534644$13753464$4$F$20170514$20200707$20170713$20200714$EXP$$IT-009507513-1707ITA001859$MERCK$$71$YR$$M$Y$$$20200714$$CN$IT$IT
137542562$13754256$2$F$$20200731$20170714$20200808$EXP$$FR-AUROBINDO-AUR-APL-2014-09085$AUROBINDO$$83$YR$$F$Y$$$20200808$$HP$FR$FR
137547002$13754700$2$F$$20170705$20170714$20200805$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-062998$BRISTOL MYERS SQUIBB$DERHAM AM, CHEN E, BUNYA VY, O^MALLEY RE. BILATERAL HERPETIC KERATITIS AFTER BILATERAL INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE MACULAR DEGENERATION. CORNEA. 2017?36(7):878?9$66$YR$$M$Y$$$20200805$$MD$US$US
137551432$13755143$2$F$20200717$20200727$20170714$20200807$EXP$$US-ELI_LILLY_AND_COMPANY-US201707001425$ELI LILLY AND CO$$64$YR$$F$Y$$$20200807$$CN$US$US
137553934$13755393$4$F$$20200915$20170714$20200917$EXP$$US-PFIZER INC-2017304923$PFIZER$$51$YR$$F$Y$$$20200917$$HP$US$US
137556151$13755615$1$I$20170709$20170712$20170714$20170714$EXP$$US-ASTRAZENECA-2017SE72210$ASTRAZENECA$$46$YR$$M$Y$63.6$KG$20170714$$MD$US$US
137557202$13755720$2$F$20170323$20200630$20170714$20200706$EXP$$US-ROCHE-1936007$ROCHE$$75$YR$$F$Y$103$KG$20200706$$MD$US$US
137558023$13755802$3$F$20170327$20200630$20170714$20200706$EXP$$US-ROCHE-1940794$ROCHE$$74$YR$$F$Y$117.4$KG$20200706$$MD$US$US
137560177$13756017$7$F$20110801$20200824$20170714$20200826$PER$$US-PFIZER INC-2017307193$PFIZER$$47$YR$$F$Y$145$KG$20200826$$LW$US$US
137561763$13756176$3$F$20170703$20180807$20170714$20180809$EXP$$CA-ASTRAZENECA-2017SE70073$ASTRAZENECA$$37$YR$$F$Y$$$20180809$$MD$CA$CA
137562203$13756220$3$F$20170630$20171013$20170714$20171018$EXP$$AU-JNJFOC-20170704129$JANSSEN$$67$YR$E$F$Y$80.3$KG$20171018$$MD$AU$AU
137562215$13756221$5$F$20170707$20170919$20170714$20170928$EXP$$UA-JNJFOC-20170706409$JANSSEN$$57$YR$A$F$Y$104$KG$20170928$$MD$UA$UA
137562783$13756278$3$F$20160108$20180329$20170714$20180412$EXP$$CA-JNJFOC-20160111677$PHARMACYCLICS$$77$YR$E$F$Y$65$KG$20180412$$MD$CA$CA
137564204$13756420$4$F$20170609$20170727$20170714$20200717$EXP$$US-ASTRAZENECA-2017SE65303$ASTRAZENECA$$57$YR$$M$Y$49.2$KG$20200717$$$AT$AT
1375690716$13756907$16$F$$20200914$20170714$20200916$EXP$$NO-009507513-1706NOR010798$MERCK$$43$YR$$F$Y$$$20200916$$HP$NO$NO
137573467$13757346$7$F$$20200907$20170715$20200911$PER$$DE-AMGEN-DEUNI2017106186$AMGEN$HORNEFF, G.. UPDATE ON MALIGNANCIES IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS IN THE GERMAN BIKER REGISTRY. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2016?34 (6):1113?1120$16$YR$T$F$Y$$$20200911$$HP$DE$DE
137573632$13757363$2$F$$20200803$20170716$20200806$PER$$US-BIOGEN-2017BI00430341$BIOGEN$$$$$F$Y$$$20200806$$CN$US$US
137575708$13757570$8$F$19960610$20200807$20170717$20200816$PER$$US-BIOGEN-2017BI00430541$BIOGEN$$40$YR$$F$Y$$$20200816$$CN$US$US
1375780011$13757800$11$F$2016$20200626$20170717$20200703$EXP$$US-ABBVIE-17K-163-2037686-00$ABBVIE$$63$YR$$F$Y$88.53$KG$20200703$$CN$US$US
137578102$13757810$2$F$$20200828$20170717$20200904$EXP$$CA-ROCHE-1962285$ROCHE$$$$$F$Y$$$20200904$$MD$CA$CA
137584183$13758418$3$F$$20200812$20170717$20200817$PER$$US-PFIZER INC-2017302499$PFIZER$$58$YR$$F$Y$$$20200817$$CN$US$US
137584335$13758433$5$F$20170613$20200825$20170717$20200901$PER$$US-ELI_LILLY_AND_COMPANY-US201706011831$ELI LILLY AND CO$$54$YR$$M$Y$$$20200901$$CN$US$US
137590812$13759081$2$F$20170607$20170908$20170717$20170913$EXP$$CA-PFIZER INC-2017269122$PFIZER$$29$YR$$F$Y$$$20170913$$MD$CA$CA
137594024$13759402$4$F$$20200914$20170717$20200916$PER$$US-PFIZER INC-2017307582$PFIZER$$71$YR$$F$Y$$$20200916$$MD$US$US
137599672$13759967$2$F$$20200806$20170717$20200811$EXP$$US-SA-2017SA128054$SANOFI AVENTIS$$$$$$Y$$$20200811$$CN$US$US
137600399$13760039$9$F$2018$20200901$20170717$20200908$EXP$$PHHY2017BR059556$NOVARTIS$$$$$F$Y$88$KG$20200908$$HP$BR$BR
137602203$13760220$3$F$20170706$20171124$20170717$20171128$EXP$$GB-JNJFOC-20170705190$PHARMACYCLICS$$84$YR$E$F$Y$$$20171128$$MD$GB$GB
137602452$13760245$2$F$20161005$20190529$20170717$20190531$EXP$$GB-ASTRAZENECA-2016SF09314$ASTRAZENECA$$20620$DY$$F$Y$$$20190531$$MD$GB$GB
137603475$13760347$5$F$20170617$20180805$20170717$20180813$EXP$$IL-ASTRAZENECA-2017SE64248$ASTRAZENECA$$70$YR$$M$Y$61$KG$20180813$$MD$IL$IL
137612835$13761283$5$F$201403$20200416$20170717$20200421$EXP$$PHHY2015CR008160$NOVARTIS$$17$YR$$F$Y$56.7$KG$20200421$$CN$COUNTRY NOT SPECIFIED$CR
1376137211$13761372$11$F$20170708$20200904$20170717$20200907$EXP$$US-PFIZER INC-2017307777$PFIZER$$79$YR$$F$Y$66.67$KG$20200907$$CN$US$US
137614724$13761472$4$F$$20200629$20170717$20200706$PER$$CA-AMGEN-CANSP2017105360$AMGEN$$66$YR$E$F$Y$$$20200706$$HP$CA$CA
137623536$13762353$6$F$20170703$20200817$20170718$20200819$EXP$$US-PFIZER INC-2017301253$PFIZER$$59$YR$$M$Y$61$KG$20200819$$CN$US$US
137625094$13762509$4$F$$20200727$20170718$20200729$PER$$US-PFIZER INC-2017310100$PFIZER$$68$YR$$F$Y$120$KG$20200729$$CN$US$US
137625982$13762598$2$F$$20200715$20170718$20200717$EXP$$US-PFIZER INC-2017310927$PFIZER$$$$$F$Y$$$20200717$$CN$US$US
137628412$13762841$2$F$$20200821$20170718$20200903$EXP$$JP-LUPIN PHARMACEUTICALS INC.-2017-03780$LUPIN$$80$YR$$F$Y$$$20200903$$HP$JP$JP
137628877$13762887$7$F$201701$20200714$20170718$20200718$EXP$$TR-ABBVIE-17P-161-2034719-00$ABBVIE$$78$YR$$M$Y$90$KG$20200717$$HP$TR$TR
1376349612$13763496$12$F$$20200707$20170718$20200709$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK094878$GLAXOSMITHKLINE$$$$$F$Y$117$KG$20200709$$CN$BR$BR
137636526$13763652$6$F$201109$20200723$20170718$20200724$EXP$$US-ELI_LILLY_AND_COMPANY-US201706013580$ELI LILLY AND CO$$28$YR$$M$Y$103$KG$20200724$$CN$US$US
137638182$13763818$2$F$20160419$20170713$20170718$20170720$EXP$$HU-JNJFOC-20170619275$JANSSEN$$73$YR$E$F$Y$70.5$KG$20170720$$MD$HU$HU
137641085$13764108$5$F$20170401$20200220$20170718$20200714$PER$$US-VANDA PHARMACEUTICALS, INC-2017TASUS001655$VANDA PHARMACEUTICALS$$70$YR$$F$Y$$$20200714$$HP$US$US
137641114$13764111$4$F$$20200221$20170718$20200714$PER$$US-VANDA PHARMACEUTICALS, INC-2017TASUS001658$VANDA PHARMACEUTICALS$$$$$F$Y$$$20200714$$MD$US$US
1376449215$13764492$15$F$20170418$20200828$20170718$20200910$EXP$$JP-INCYTE CORPORATION-2017IN005474$INCYTE$$$$$$Y$$$20200910$$MD$JP$JP
137651003$13765100$3$F$$20200702$20170718$20200709$EXP$$PHHY2017PT105233$NOVARTIS$$65$YR$$F$Y$$$20200709$$HP$PT$PT
137654664$13765466$4$F$2017$20200820$20170718$20200828$EXP$$US-BIOGEN-2017BI00431177$BIOGEN$$$$$F$Y$$$20200828$$CN$US$US
137655028$13765502$8$F$$20200918$20170718$20200922$EXP$$US-PFIZER INC-2017310535$PFIZER$$76$YR$$F$Y$$$20200922$$CN$US$US
1376554214$13765542$14$F$2017$20200724$20170718$20200729$EXP$$CA-TAKEDA-2017TUS014962$TAKEDA$$70$YR$$F$Y$$$20200729$$MD$CA$CA
137656321$13765632$1$I$20160725$20160812$20170718$20170718$EXP$$UA-ASTRAZENECA-2016SE87392$ASTRAZENECA$$19400$DY$$M$Y$$$20170718$$MD$UA$UA
137661012$13766101$2$F$20170603$20200706$20170719$20200716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004648$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$$$20200716$$MD$US$US
137661731$13766173$1$I$20170707$20170710$20170719$20170719$EXP$$US-ASTRAZENECA-2017SE71475$ASTRAZENECA$$$$$F$Y$$$20170719$$MD$US$US
137662642$13766264$2$F$$20200803$20170719$20200814$PER$$US-009507513-1707USA002769$MERCK$$$$$F$Y$$$20200814$$MD$US$US
137671671$13767167$1$I$20170715$20170717$20170719$20170719$EXP$$CA-ASTRAZENECA-2017SE73456$ASTRAZENECA$$57$YR$$F$Y$$$20170719$$MD$CA$CA
137675333$13767533$3$F$20170702$20200629$20170719$20200707$EXP$$US-BIOGEN-2017BI00432446$BIOGEN$$62$YR$$M$Y$$$20200707$$HP$US$US
137678688$13767868$8$F$$20200721$20170719$20200723$PER$$US-PFIZER INC-2017307754$PFIZER$$66$YR$$F$Y$77$KG$20200723$$MD$US$US
137679844$13767984$4$F$201602$20200821$20170719$20200903$EXP$$IN-INCYTE CORPORATION-2016IN000807$INCYTE$$$$$$Y$$$20200903$$CN$IN$IN
137690477$13769047$7$F$20170707$20200902$20170719$20200911$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004623$ACADIA PHARMACEUTICALS$$76$YR$$F$Y$$$20200911$$CN$US$US
1376927715$13769277$15$F$201607$20200805$20170719$20200818$EXP$$US-ACTELION-A-US2016-140274$ACTELION$$65$YR$$F$Y$$$20200818$$PH$US$US
137692935$13769293$5$F$201706$20200818$20170719$20200824$EXP$$US-ACTELION-A-US2017-156646$ACTELION$$63$YR$$M$Y$106.58$KG$20200824$$HP$US$US
137693321$13769332$1$I$20170630$20170713$20170719$20170719$EXP$$US-JNJFOC-20170712099$PHARMACYCLICS$$79$YR$E$M$Y$97$KG$20170719$$MD$US$US
1376951511$13769515$11$F$2018$20200706$20170719$20200707$EXP$$US-PFIZER INC-2017311811$PFIZER$$92$YR$$F$Y$60$KG$20200707$$HP$US$US
137697308$13769730$8$F$20170707$20200721$20170719$20200728$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-07704$VIFOR$$85$YR$$M$Y$$$20200728$$CN$US$US
137697593$13769759$3$F$20170710$20170810$20170719$20170814$EXP$$UA-JNJFOC-20170713881$PHARMACYCLICS$$76$YR$E$M$Y$$$20170814$$MD$UA$UA
137702315$13770231$5$F$2017$20200903$20170719$20200909$PER$$US-JAZZ-2017-US-008551$JAZZ$$$$$F$Y$$$20200909$$HP$US$US
1377049111$13770491$11$F$$20200914$20170719$20200921$EXP$$NL-ABBVIE-17P-114-1948344-00$ABBVIE$$$$$M$Y$72.6$KG$20200921$$CN$COUNTRY NOT SPECIFIED$US
137709219$13770921$9$F$$20200830$20170720$20200906$PER$$BR-AMGEN-BRASP2012011603$AMGEN$$49$YR$A$F$Y$65$KG$20200906$$CN$BR$BR
137709348$13770934$8$F$$20200810$20170720$20200817$EXP$$SE-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-143798$RANBAXY$$26$YR$$M$Y$$$20200817$$HP$NL$SE
137713097$13771309$7$F$20170616$20200831$20170720$20200910$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004663$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20200910$$MD$US$US
137719663$13771966$3$F$20170212$20170913$20170720$20170918$EXP$$BR-JNJFOC-20170329641$JANSSEN$$58$YR$A$F$Y$85$KG$20170918$$MD$BR$BR
1377200413$13772004$13$F$201701$20200820$20170720$20200827$EXP$$PHHY2017CO068332$NOVARTIS$$72$YR$$F$Y$76$KG$20200827$$CN$COUNTRY NOT SPECIFIED$CO
1377208518$13772085$18$F$$20200916$20170720$20200924$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091773$BRISTOL MYERS SQUIBB$$$$$F$Y$83$KG$20200924$$CN$CA$CA
137722406$13772240$6$F$2000$20200218$20170720$20200701$EXP$$US-JNJFOC-20170714833$JOHNSON AND JOHNSON$$$$$M$Y$64.47$KG$20200701$$CN$US$US
137739251$13773925$1$I$20121022$20130121$20170720$20170720$EXP$$AU-PFIZER INC-1574331$PFIZER$$43$YR$$F$Y$$$20170720$$PH$AU$AU
137744564$13774456$4$F$20140812$20200809$20170721$20200818$EXP$$US-BAYER-2017-087071$BAYER$$62$YR$A$M$Y$$$20200818$$CN$US$US
137747024$13774702$4$F$201501$20200720$20170721$20200729$EXP$$US-JNJFOC-20170704450$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200729$$CN$US$US
137747982$13774798$2$F$201703$20180309$20170720$20180314$EXP$$CZ-BAXTER-2017BAX028504$BAXTER$$42$YR$$F$Y$81$KG$20180314$$MD$CZ$CZ
1377497022$13774970$22$F$20080604$20200903$20170720$20200909$EXP$$PHHY2017CA105523$NOVARTIS$$56$YR$$F$Y$$$20200909$$CN$COUNTRY NOT SPECIFIED$CA
137758842$13775884$2$F$20150519$20200820$20170721$20200826$EXP$$US-BAYER-2017-115413$BAYER$$72$YR$E$M$Y$$$20200826$$CN$US$US
137759141$13775914$1$I$20170417$20170511$20170720$20170720$EXP$$GB-JNJFOC-20170514398$JANSSEN$$73$YR$E$M$Y$82$KG$20170720$$HP$GB$GB
137759334$13775933$4$F$20170719$20171027$20170721$20171030$EXP$$CA-ASTRAZENECA-2017SE74461$ASTRAZENECA$$73$YR$$M$Y$$$20171030$$MD$CA$CA
1377646310$13776463$10$F$20170711$20200810$20170720$20200817$EXP$$CA-ACTELION-A-US2017-155264$ACTELION$$43$YR$$F$Y$$$20200817$$HP$CA$CA
137766034$13776603$4$F$$20200915$20170721$20200916$EXP$$US-PFIZER INC-2017312234$PFIZER$$59$YR$$F$Y$$$20200916$$MD$US$US
137766504$13776650$4$F$20170301$20180629$20170721$20180702$EXP$$TH-ASTRAZENECA-2017SE24471$ASTRAZENECA$$20605$DY$$F$Y$$$20180702$$MD$TH$TH
137772934$13777293$4$F$20170713$20171114$20170721$20171120$EXP$$US-JNJFOC-20170716463$PHARMACYCLICS$$76$YR$E$M$Y$102.1$KG$20171120$$MD$US$US
137782761$13778276$1$I$20170306$20170308$20170721$20170721$EXP$$CA-ASTRAZENECA-2017SE25391$ASTRAZENECA$$71$YR$$M$Y$$$20170721$$MD$CA$CA
137783242$13778324$2$F$20140526$20200805$20170721$20200814$EXP$$US-BAYER-2017-096588$BAYER$$54$YR$A$F$Y$$$20200814$$CN$US$US
137786174$13778617$4$F$20160531$20170914$20170721$20170915$EXP$$TW-ASTRAZENECA-2016SE58689$ASTRAZENECA$$18232$DY$$F$Y$35$KG$20170915$$MD$TW$TW
1377871511$13778715$11$F$20161019$20200918$20170721$20200923$EXP$$PHHY2016DE149291$NOVARTIS$$29$YR$$F$Y$94$KG$20200923$$CN$DE$DE
137787548$13778754$8$F$20170302$20200702$20170721$20200709$EXP$$PHHY2016ZA126695$NOVARTIS$$19$YR$$F$Y$44.5$KG$20200709$$MD$ZA$ZA
137788548$13778854$8$F$2017$20200713$20170721$20200716$PER$$US-PFIZER INC-2017314776$PFIZER$$48$YR$$F$Y$$$20200716$$HP$US$US
137789008$13778900$8$F$20170714$20200722$20170721$20200724$EXP$$US-PFIZER INC-2017315871$PFIZER$$59$YR$$F$Y$$$20200724$$CN$US$US
137795802$13779580$2$F$20170519$20180309$20170721$20180315$EXP$$CZ-BAXTER-2017BAX028507$BAXTER$$25$YR$$M$Y$64$KG$20180315$$MD$CZ$CZ
1377990120$13779901$20$F$20170625$20200721$20170723$20200723$EXP$$PHHY2017DE100273$NOVARTIS$$77$YR$$F$Y$50$KG$20200723$$HP$DE$DE
137801683$13780168$3$F$2012$20200626$20170724$20200702$EXP$$CO-ABBVIE-17K-036-2047932-00$ABBVIE$$57$YR$$F$Y$50$KG$20200702$$CN$CO$CO
137806486$13780648$6$F$2017$20200911$20170724$20200917$PER$$US-PFIZER INC-2017317884$PFIZER$$71$YR$$F$Y$82$KG$20200917$$CN$US$US
137811553$13781155$3$F$20170222$20170913$20170724$20180323$EXP$$KR-ASTRAZENECA-2017SE20655$ASTRAZENECA$$64$YR$$M$Y$56.7$KG$20180323$$MD$KR$KR
137816033$13781603$3$F$$20200821$20170724$20200904$EXP$$ZA-LUPIN (EUROPE) LIMITED-2017-03879$LUPIN$$$$$M$Y$$$20200904$$CN$ZA$ZA
137817254$13781725$4$F$201501$20200720$20170724$20200804$EXP$$US-BAYER-2017-131960$BAYER$$80$YR$E$F$Y$$$20200804$$CN$US$US
137825482$13782548$2$F$20170703$20170912$20170724$20170925$EXP$$US-JNJFOC-20170709377$JANSSEN$$69$YR$E$M$Y$111.4$KG$20170925$$HP$US$US
137829642$13782964$2$F$$20170711$20170724$20200909$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-065876$BRISTOL MYERS SQUIBB$$7$YR$$M$Y$$$20200909$$CN$CH$CH
137833672$13783367$2$F$20170718$20170814$20170724$20170816$EXP$$US-ASTRAZENECA-2017SE74218$ASTRAZENECA$$20104$DY$$F$Y$88$KG$20170816$$MD$US$US
137833951$13783395$1$I$20170715$20170717$20170724$20170724$EXP$$CA-PFIZER INC-2017315394$PFIZER$$57$YR$$F$Y$$$20170724$$MD$CA$CA
137834932$13783493$2$F$20170719$20170726$20170724$20170727$EXP$$CA-ASTRAZENECA-2017SE74847$ASTRAZENECA$$65$YR$$M$Y$$$20170727$$MD$CA$CA
137835572$13783557$2$F$20170718$20170815$20170724$20170818$EXP$$CA-ASTRAZENECA-2017SE74998$ASTRAZENECA$$76$YR$$F$Y$$$20170818$$MD$CA$CA
137835803$13783580$3$F$20170720$20171011$20170724$20171016$EXP$$CA-ASTRAZENECA-2017SE74961$ASTRAZENECA$$72$YR$$F$Y$$$20171016$$MD$CA$CA
137836822$13783682$2$F$$20170711$20170724$20200909$EXP$$CH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-065902$BRISTOL MYERS SQUIBB$$48$YR$$M$Y$$$20200909$$CN$CH$CH
1378406014$13784060$14$F$20170601$20200814$20170724$20200819$EXP$$PHHY2017US106657$NOVARTIS$$29$YR$$F$Y$59$KG$20200819$$HP$US$US
1378419011$13784190$11$F$20170601$20200623$20170724$20200707$EXP$$US-ACTELION-A-NJ2017-155263$ACTELION$$69$YR$$F$Y$$$20200707$$HP$US$US
137847117$13784711$7$F$20170704$20200913$20170725$20200921$EXP$$CN-ASTRAZENECA-2017SE74636$ASTRAZENECA$$24630$DY$$M$Y$$$20200921$$MD$CN$CN
137862634$13786263$4$F$20170331$20200814$20170725$20200819$EXP$$FR-ROCHE-1967178$ROCHE$$66$YR$$M$Y$123$KG$20200819$$MD$FR$FR
137864434$13786443$4$F$20170313$20170925$20170725$20171003$EXP$$RU-ASTRAZENECA-2017SE28183$ASTRAZENECA$$58$YR$$F$Y$49$KG$20171003$$MD$RU$RU
137888813$13788881$3$F$20170722$20170728$20170725$20170802$EXP$$KR-ROCHE-1967953$ROCHE$$71$YR$$M$Y$79.2$KG$20170802$$MD$KR$KR
137894648$13789464$8$F$20170605$20200816$20170725$20200820$EXP$$CZ-BIOGEN-2017BI00432523$BIOGEN$VANECKOVA M, MARTINKOVA A, TUPY R, FIEDLER J, STETKAROVA I, MEDOVA E, VACHOVA M, GRUNERMELOVA M, MELUZINOVA E, ADAMKOVA J, KUBALE J, TALABOVA M, HORAKOVA D, HAVRDOVA E, MARKOVA J. THE SPECTRUM OF MRI FINDINGS OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN PATIENTS WITH MULTIPLE SCLEROSIS IN THE CZECH REPUBLIC. DOI: 10.14735/AMCSNN2019381. CESK SLOV NEUROL N. 2019?82(4):381?390.$48$YR$$F$Y$$$20200820$$MD$CZ$CZ
137899483$13789948$3$F$$20200713$20170725$20200715$PER$$US-PFIZER INC-2017320377$PFIZER$$69$YR$$F$Y$68.04$KG$20200715$$HP$US$US
137902582$13790258$2$F$20170702$20171122$20170725$20171127$EXP$$US-JNJFOC-20170713311$PHARMACYCLICS$$66$YR$E$F$Y$77.11$KG$20171127$$MD$US$US
137904033$13790403$3$F$20170714$20170814$20170725$20200708$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-065704$BRISTOL MYERS SQUIBB$$65$YR$$F$Y$67.6$KG$20200708$$HP$US$US
1379042816$13790428$16$F$20170502$20190128$20170725$20200812$EXP$$JP-009507513-1705JPN000546J$MERCK$$63$YR$$M$Y$63$KG$20200812$$CN$JP$JP
137910722$13791072$2$F$20170721$20170727$20170725$20170728$EXP$$CA-ASTRAZENECA-2017SE75476$ASTRAZENECA$$67$YR$$M$Y$$$20170728$$MD$CA$CA
137912895$13791289$5$F$20170721$20180118$20170725$20180122$EXP$$RU-ASTRAZENECA-2017SE75633$ASTRAZENECA$$76$YR$$M$Y$60$KG$20180122$$MD$RU$RU
137914802$13791480$2$F$20170510$20181030$20170725$20181105$EXP$$TW-ASTRAZENECA-2017SE51112$ASTRAZENECA$$25607$DY$$M$Y$$$20181105$$MD$TW$TW
137914853$13791485$3$F$20160618$20171023$20170725$20171030$EXP$$KR-ASTRAZENECA-2017SE75335$ASTRAZENECA$$29607$DY$$M$Y$58$KG$20171030$$MD$KR$KR
137924074$13792407$4$F$$20200805$20170725$20200806$PER$$US-BIOGEN-2017BI00433486$BIOGEN$$$$$F$Y$$$20200806$$CN$US$US
137931315$13793131$5$F$20170712$20171023$20170726$20171030$EXP$$CA-JNJFOC-20170715514$JANSSEN$$69$YR$E$M$Y$74$KG$20171030$$MD$CA$CA
137934432$13793443$2$F$20161213$20170726$20170726$20170803$EXP$$TW-ASTRAZENECA-2016SF32406$ASTRAZENECA$$50$YR$$M$Y$55$KG$20170803$$MD$TW$TW
137938081$13793808$1$I$20170719$20170720$20170726$20170726$EXP$$US-JNJFOC-20170717596$JANSSEN$$69$YR$E$F$Y$83$KG$20170726$$MD$US$US
137941485$13794148$5$F$$20200828$20170726$20200902$EXP$$CA-PFIZER INC-2017317576$PFIZER$$54$YR$$F$Y$$$20200902$$CN$CA$CA
137943355$13794335$5$F$2017$20200717$20170726$20200721$EXP$$US-PFIZER INC-2017102747$PFIZER$$30$YR$$F$Y$83.91$KG$20200721$$CN$US$US
137944033$13794403$3$F$20170714$20170809$20170726$20170817$EXP$$JP-JNJFOC-20170714615$JANSSEN$$60$YR$A$F$Y$52.2$KG$20170817$$MD$JP$JP
137947173$13794717$3$F$20170718$20170804$20170726$20170811$EXP$$JP-ROCHE-1968561$ROCHE$$60$YR$$F$Y$$$20170811$$MD$JP$JP
1379472517$13794725$17$F$201704$20200813$20170726$20200820$EXP$$US-TESARO, INC.-US-2017TSO00166$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20200820$$CN$US$US
137951406$13795140$6$F$201509$20200728$20170726$20200811$PER$$JP-AMGEN-JPNSP2017112884$AMGEN$HORIUCHI K., NAKAYAMA R., KIKUTA K., ET. AL.. DENOSUMAB THERAPY IN UNRESECTABLE BONE GIANT CELL TUMOUR OF THE TRUNK.. J. JPN. ORTHOP. ASSOC/ THE 50TH ANNUAL MUSCULOSKELETAL TUMOR MEETING OF THE JOA.. 2017?91(6):S1399$30$YR$A$F$Y$48$KG$20200811$$MD$JP$JP
137954606$13795460$6$F$20130225$20191216$20170726$20191224$EXP$$PHHY2013CA009735$NOVARTIS$$76$YR$$F$Y$$$20191224$$CN$CA$CA
1379597811$13795978$11$F$20160616$20200828$20170726$20200831$EXP$$PHHY2016CO089099$NOVARTIS$$36$YR$$F$Y$76$KG$20200831$$MD$CO$CO
137963123$13796312$3$F$20170705$20180511$20170726$20180518$EXP$$US-JNJFOC-20170714534$PHARMACYCLICS$$69$YR$E$M$Y$99$KG$20180518$$MD$US$US
137970312$13797031$2$F$20141025$20170724$20170727$20170801$EXP$$JP-ROCHE-1483843$ROCHE$, SOWA?OSAKO J, NAKAI T, OHYAMA A, KAWAGUCHI T, TSURUTA D, OHSAWA M AND HIRATA K. ALECTINIB?INDUCED ERYTHEMA MULTIFORME AND SUCCESSFUL RECHALLENGE WITH ALECTINIB IN A PATIENT WITH ANAPLASTIC LYMPHOMA KINASE?REARRANGED LUNG CANCER.. CASE REPORTS IN ONCOLOGY. 2016?9:826?832.$39$YR$$F$Y$49$KG$20170801$$MD$JP$JP
137973267$13797326$7$F$$20200918$20170727$20200924$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2195$ORION$$65$YR$$M$Y$$$20200924$$HP$CA$CA
137974372$13797437$2$F$$20200729$20170727$20200811$EXP$$US-LUPIN PHARMACEUTICALS INC.-2017-00800$LUPIN$$55$YR$$F$Y$$$20200811$$HP$US$US
1379794011$13797940$11$F$20170411$20200908$20170727$20200911$EXP$$US-ROCHE-1965568$ROCHE$$65$YR$$M$Y$75.6$KG$20200911$$MD$US$US
137979886$13797988$6$F$201711$20200707$20170727$20200723$EXP$$US-PFIZER INC-2017103918$PFIZER$$69$YR$$F$Y$69$KG$20200723$$HP$US$US
137980713$13798071$3$F$$20200629$20170727$20200701$PER$$US-PFIZER INC-2017322148$PFIZER$$65$YR$$F$Y$$$20200701$$CN$US$US
137980786$13798078$6$F$$20200814$20170727$20200819$PER$$US-PFIZER INC-2017323069$PFIZER$$76$YR$$F$Y$$$20200819$$MD$US$US
137984583$13798458$3$F$201704$20200810$20170727$20200820$EXP$$BR-BIOGEN-2017BI00438533$BIOGEN$$51$YR$$F$Y$$$20200820$$CN$BR$BR
138007832$13800783$2$F$20170716$20170804$20170727$20170811$EXP$$US-JNJFOC-20170715763$JANSSEN$$55$YR$A$F$Y$86$KG$20170811$$MD$US$US
1380081612$13800816$12$F$20170710$20200813$20170727$20200818$EXP$$PHHY2017CA108258$NOVARTIS$$63$YR$$F$Y$$$20200818$$CN$CA$CA
138008258$13800825$8$F$2016$20200717$20170727$20200818$EXP$$PHHY2017CO107370$NOVARTIS$$58$YR$$M$Y$65$KG$20200818$$CN$COUNTRY NOT SPECIFIED$CO
138010023$13801002$3$F$20170715$20171006$20170727$20171011$EXP$$NZ-JNJFOC-20170715187$JANSSEN$$46$YR$A$M$Y$$$20171011$$MD$NZ$NZ
138011054$13801105$4$F$20170225$20180429$20170727$20180507$EXP$$QA-ASTRAZENECA-2017SE41283$ASTRAZENECA$$19838$DY$$M$Y$$$20180507$$MD$QA$QA
138013462$13801346$2$F$20170329$20170802$20170727$20170804$EXP$$QA-ASTRAZENECA-2017SE27329$ASTRAZENECA$$19842$DY$$M$Y$$$20170804$$MD$QA$QA
138014912$13801491$2$F$20170707$20180424$20170727$20180502$EXP$$AU-ASTRAZENECA-2017SE75577$ASTRAZENECA$$24534$DY$$F$Y$$$20180502$$MD$AU$AU
1380187812$13801878$12$F$201810$20200722$20170727$20200801$EXP$$PHHY2017ZA108027$NOVARTIS$$23$YR$$M$Y$67.8$KG$20200801$$MD$ZA$ZA
138019992$13801999$2$F$$20200715$20170727$20200721$EXP$$PT-CELLTRION INC.-2017PT009813$CELLTRION$$$$$$Y$$$20200722$$MD$PT$PT
138022607$13802260$7$F$20170922$20200625$20170727$20200701$PER$$US-ACTELION-A-US2017-157219$ACTELION$$58$YR$$F$Y$126.98$KG$20200701$$MD$US$US
138031544$13803154$4$F$$20200912$20170728$20200921$EXP$$US-ROCHE-1970820$ROCHE$$$$$$Y$$$20200921$$HP$US$US
138036531$13803653$1$I$20170722$20170727$20170728$20170728$EXP$$CA-ASTRAZENECA-2017SE76900$ASTRAZENECA$$58$YR$$F$Y$$$20170728$$MD$CA$CA
138037772$13803777$2$F$2015$20191207$20170728$20200727$PER$$US-ABBVIE-16P-163-1715434-00$ABBVIE$$$$$F$Y$65.83$KG$20200727$$CN$US$US
138039764$13803976$4$F$20170724$20180112$20170728$20180119$EXP$$CN-ASTRAZENECA-2017SE76794$ASTRAZENECA$$25731$DY$$F$Y$$$20180118$$MD$CN$CN
138042285$13804228$5$F$2020$20200914$20170728$20200919$EXP$$US-ABBVIE-17P-163-2023227-00$ABBVIE$$$$$M$Y$67.65$KG$20200919$$CN$US$US
138052052$13805205$2$F$$20200824$20170728$20200826$PER$$US-PFIZER INC-2017326010$PFIZER$$47$YR$$M$Y$$$20200826$$CN$US$US
1380529913$13805299$13$F$201610$20200629$20170728$20200703$PER$$CA-AMGEN-CANSP2017112357$AMGEN$$65$YR$E$F$Y$$$20200703$$CN$CA$CA
1380530611$13805306$11$F$2010$20200914$20170728$20200921$PER$$CA-AMGEN-CANSP2016034387$AMGEN$$46$YR$A$F$Y$$$20200921$$MD$CA$CA
1380555217$13805552$17$F$2016$20200726$20170728$20200730$EXP$$PHHY2016CA065812$NOVARTIS$$77$YR$$F$Y$$$20200730$$MD$CA$CA
138057254$13805725$4$F$201704$20200813$20170728$20200820$PER$$US-AMGEN-USASP2017107811$AMGEN$$87$YR$E$F$Y$$$20200820$$MD$US$US
138062195$13806219$5$F$20150624$20200803$20170728$20200812$EXP$$US-JNJFOC-20170720551$JOHNSON AND JOHNSON$$64$YR$A$F$Y$73.09$KG$20200812$$CN$US$US
138066413$13806641$3$F$$20200721$20170728$20200723$EXP$$CA-PFIZER INC-2017324042$PFIZER$$67$YR$$F$Y$$$20200723$$MD$CA$CA
138074113$13807411$3$F$20170718$20170830$20170728$20170901$EXP$$US-ASTRAZENECA-2017SE76847$ASTRAZENECA$$70$YR$$M$Y$$$20170901$$MD$US$US
138074943$13807494$3$F$20170703$20200624$20170728$20200702$EXP$$US-JNJFOC-20170714538$JOHNSON AND JOHNSON$A PHASE 1 STUDY OF PF?06840003, AN ORAL INDOLEAMINE 2,3?DIOXYGENASE 1 (IDO1) INHIBITOR IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA. INVESTIGATIONAL NEW DRUGS. 2020?.$69$YR$$M$Y$68.06$KG$20200702$$$COUNTRY NOT SPECIFIED$US
138075783$13807578$3$F$20170720$20171003$20170728$20171011$EXP$$IT-ABBVIE-17P-083-2051889-00$ABBVIE$$70$YR$$M$Y$$$20171011$$MD$IT$IT
138103915$13810391$5$F$$20200709$20170728$20200710$PER$$US-PFIZER INC-2017328114$PFIZER$$79$YR$$F$Y$$$20200710$$CN$US$US
138104606$13810460$6$F$20170710$20200727$20170728$20200805$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-063325$BRISTOL MYERS SQUIBB$$56$YR$$M$Y$61.6$KG$20200805$$HP$CA$CA
138130936$13813093$6$F$$20200909$20170729$20200916$EXP$NO-009507513-1706NOR010798$NO-ACCORD-056450$ACCORD$$43$YR$$F$Y$51$KG$20200916$$MD$NO$NO
138133271$13813327$1$I$$20170715$20170729$20170729$EXP$$JP-MYLANLABS-2017M1046080$MYLAN$TERUKINA J, TAKAMATSU M, ENOMOTO T, BABA H.. ANESTHETIC MANAGEMENT OF ABDOMINAL RADICAL TRACHELECTOMY FOR UTERINE CERVICAL CANCER DURING PREGNANCY.. J?ANESTH. 2017?31(3):467?471$$$$$Y$$$20170728$$HP$JP$JP
138135544$13813554$4$F$$20200812$20170731$20200820$EXP$$JP-ROCHE-1969463$ROCHE$, MATSUMURA K, MARUI Y, YOZA N, ET AL. A CASE OF UTERINE CARCINOSARCOMA RAPIDLY PROGRESSING 12 YEARS AFTER RENAL TRANSPLANT. JAPANESE JOURNAL OF UROLOGIC SURGERY. 2020?33(5): P.550./ THE 61ST KANAGAWA REGINAL MEETING OF JAPANESE UROLOGICAL ASSOCIATION. ?:141?.$53$YR$$F$Y$$$20200820$$MD$JP$JP
138136591$13813659$1$I$20170725$20170726$20170731$20170731$EXP$$ES-ASTRAZENECA-2017SE76687$ASTRAZENECA$$23318$DY$$M$Y$75$KG$20170731$$MD$ES$ES
138140562$13814056$2$F$$20200727$20170731$20200728$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-067947$BRISTOL MYERS SQUIBB$$50$YR$$F$Y$$$20200728$$MD$JP$JP
138142927$13814292$7$F$$20200715$20170731$20200716$EXP$$US-PFIZER INC-2017327586$PFIZER$$63$YR$$F$Y$69.39$KG$20200716$$CN$US$US
138144507$13814450$7$F$20170720$20181022$20170731$20181105$EXP$$US-JNJFOC-20170717589$JANSSEN$$62$YR$A$F$Y$64.86$KG$20181105$$MD$US$US
138144954$13814495$4$F$2012$20200505$20170731$20200727$EXP$$US-PURDUE PHARMA-USA-2015-0122307$PURDUE$$$$$M$Y$$$20200727$$CN$US$US
138149424$13814942$4$F$$20200727$20170731$20200731$EXP$IT-MINISAL02-419429$IT-MYLANLABS-2017M1044250$MYLAN$$59$YR$$M$Y$$$20200731$$MD$IT$IT
138151102$13815110$2$F$$20200713$20170731$20200716$PER$$US-BIOGEN-2017BI00436653$BIOGEN$$$$$M$Y$$$20200716$$CN$US$US
138154034$13815403$4$F$20170720$20170912$20170731$20170919$EXP$$KR-PFIZER INC-2017326225$PFIZER$$62$YR$$M$Y$$$20170919$$MD$KR$KR
138155303$13815530$3$F$201706$20200812$20170731$20200819$EXP$$GB-MYLANLABS-2017M1044600$MYLAN$$64$YR$$M$Y$$$20200819$$CN$GB$GB
1381605320$13816053$20$F$$20200629$20170731$20200707$EXP$$CA-PFIZER INC-2017329621$PFIZER$$65$YR$$F$Y$$$20200707$$MD$CA$CA
138163438$13816343$8$F$20170704$20200914$20170731$20200925$EXP$$FR-BIOGEN-2017BI00430503$BIOGEN$MOLINIER?FRENKEL V, CREANGE A, BELDI?FERCHIOU A, WAHAB A, DUCHMANN M, HODEL J, PATRY I, DELFAU?LARUE M. HIGH EFFECTOR?MEMORY CD8+ T?CELL LEVELS CORRELATE WITH HIGH PML RISK IN NATALIZUMAB?TREATED PATIENTS. DOI.ORG/10.1016/J.MSARD.2020.102470. MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2020?46:1?7.$62$YR$$F$Y$$$20200925$$MD$FR$FR
138170103$13817010$3$F$$20200706$20170731$20200707$PER$$US-JNJFOC-20170714138$JOHNSON AND JOHNSON$$$$$M$Y$$$20200707$$LW$US$US
138171804$13817180$4$F$$20200811$20170731$20200816$EXP$$PHHY2017AR110414$NOVARTIS$$$$$M$Y$$$20200816$$CN$COUNTRY NOT SPECIFIED$AR
1381746119$13817461$19$F$20170207$20200918$20170731$20200921$EXP$$PHHY2017DE070638$NOVARTIS$$54$YR$$F$Y$57$KG$20200921$$CN$DE$DE
138191452$13819145$2$F$$20200914$20170801$20200923$EXP$$NL-AUROBINDO-AUR-APL-2017-37178$AUROBINDO$$39$YR$$F$Y$124$KG$20200923$$HP$NL$NL
138192883$13819288$3$F$20140507$20200710$20170801$20200722$EXP$$US-JNJFOC-20170725102$JOHNSON AND JOHNSON$$74$YR$$M$Y$115.77$KG$20200722$$HP$US$US
138197744$13819774$4$F$201509$20200831$20170801$20200903$PER$$US-JNJFOC-20170724152$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200903$$CN$US$US
138202445$13820244$5$F$$20200623$20170801$20200701$EXP$$IT-AUROBINDO-AUR-APL-2017-37903$AUROBINDO$$59$YR$$M$Y$$$20200701$$HP$IT$IT
1382061915$13820619$15$F$$20200803$20170801$20200814$EXP$$NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-146576$RANBAXY$$53$YR$$F$Y$$$20200814$$HP$NL$NO
138206862$13820686$2$F$$20200701$20170801$20200707$EXP$$PHHY2017PT111062$NOVARTIS$$51$YR$$M$Y$$$20200708$$HP$PT$PT
138209822$13820982$2$F$$20200902$20170801$20200910$EXP$$US-MYLANLABS-2017M1046611$MYLAN$CHOWDHURY M, AZARI BM, DESAI NR, AHMAD T. A NOVEL TREATMENT FOR A RARE CAUSE OF CARDIOGENIC SHOCK. JACC?CASE?REP 2020?2(10):1461?1465.$37$YR$$F$Y$$$20200910$$MD$US$US
1382142618$13821426$18$F$2015$20200903$20170801$20200908$EXP$$ES-009507513-1707ESP012411$MERCK$SANTACROCE R, RUIZ BENNASAR C, SANCHO JARAIZ JR, FIORI F, SARCHIONE F, ANGELINI F, ET AL.. A MATTER OF LIFE AND DEATH: SUBSTANCE?CAUSED AND SUBSTANCE RELATED FATALITIES IN LBIZA IN 2015. HUMAN PSYCHOPHARMACOLOGY CLIN EXP. 2017?32(3):E2592$40$YR$$M$Y$$$20200908$$MD$IT$ES
138221013$13822101$3$F$$20200721$20170801$20200724$PER$$US-PFIZER INC-2017243999$PFIZER$$72$YR$$F$Y$63.49$KG$20200724$$CN$US$US
1382214214$13822142$14$F$$20200914$20170801$20200922$EXP$$CA-PFIZER INC-2016163871$PFIZER$$46$YR$$F$Y$$$20200922$$HP$CA$CA
138222572$13822257$2$F$20170311$20180314$20170801$20180316$EXP$$FR-ASTRAZENECA-2017SE28562$ASTRAZENECA$$56$YR$$F$Y$69$KG$20180316$$MD$FR$FR
138224141$13822414$1$I$20161221$20161228$20170801$20170801$EXP$$JP-ASTRAZENECA-2016SF37832$ASTRAZENECA$$61$YR$$M$Y$49.3$KG$20170801$$MD$JP$JP
138227576$13822757$6$F$20190222$20200820$20170801$20200827$EXP$$PHHY2017CO110240$NOVARTIS$$11$YR$$F$Y$26.5$KG$20200827$$HP$CO$CO
1382354215$13823542$15$F$$20200703$20170802$20200709$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2252$ORION$$65$YR$$F$Y$$$20200709$$MD$CA$CA
138243742$13824374$2$F$20150729$20200913$20170802$20200923$EXP$$US-BAYER-2017-127020$BAYER$$57$YR$A$F$Y$70.31$KG$20200923$$CN$US$US
138251347$13825134$7$F$20151225$20200827$20170802$20200909$EXP$$JP-EISAI MEDICAL RESEARCH-EC-2016-020341$EISAI$$75$YR$E$M$Y$65$KG$20200909$$MD$JP$JP
13825291115$13825291$115$F$201305$20200917$20170802$20200926$EXP$$PHHY2013CA176263$NOVARTIS$$56$YR$$M$Y$$$20200926$$MD$CA$CA
138253503$13825350$3$F$20170731$20170808$20170802$20170814$EXP$$KR-ASTRAZENECA-2017SE78595$ASTRAZENECA$$45$YR$$M$Y$$$20170814$$MD$KR$KR
138254083$13825408$3$F$20170724$20170816$20170802$20170823$EXP$$TR-JNJFOC-20170728858$PHARMACYCLICS$$80$YR$E$F$Y$$$20170823$$MD$TR$TR
138256493$13825649$3$F$20170722$20170913$20170802$20170921$EXP$$ES-JNJFOC-20170720023$JANSSEN$$49$YR$A$M$Y$125$KG$20170921$$MD$ES$ES
138257522$13825752$2$F$20150718$20200624$20170802$20200708$EXP$$US-BAYER-2017-113087$BAYER$$72$YR$E$M$Y$$$20200708$$CN$US$US
138261167$13826116$7$F$20170724$20200915$20170802$20200918$EXP$$JP-ARIAD PHARMACEUTICALS, INC-2017JP008640$TAKEDA$$33$YR$$M$Y$$$20200918$$MD$JP$JP
1382632436$13826324$36$F$201708$20200910$20170802$20200918$EXP$$CA-CELLTRION INC.-2017CA009950$CELLTRION$$$$$$Y$$$20200918$$HP$CA$CA
138281423$13828142$3$F$2017$20200727$20170803$20200730$EXP$$CA-ABBVIE-17K-028-1990699-00$ABBVIE$$$$$F$Y$$$20200730$$MD$CA$CA
138281892$13828189$2$F$20160905$20180426$20170803$20180504$EXP$$UA-ASTRAZENECA-2016SF08609$ASTRAZENECA$$22128$DY$$M$Y$$$20180504$$MD$UA$UA
138282611$13828261$1$I$$20170621$20170803$20170803$EXP$$ES-ROCHE-1954507$ROCHE$$71$YR$$M$Y$$$20170803$$MD$ES$BR
138282892$13828289$2$F$201412$20171227$20170803$20180108$EXP$$JP-ROCHE-1972215$ROCHE$$67$YR$$M$Y$49$KG$20180108$$MD$JP$JP
138286453$13828645$3$F$2016$20200908$20170803$20200910$PER$$US-BIOGEN-2017BI00438693$BIOGEN$$$$$F$Y$$$20200910$$CN$US$US
138287925$13828792$5$F$20170726$20170925$20170803$20170929$EXP$$RU-ASTRAZENECA-2017SE77981$ASTRAZENECA$$66$YR$$M$Y$78$KG$20170929$$MD$RU$RU
138288058$13828805$8$F$20150410$20200713$20170803$20200717$EXP$$JP-ASTELLAS-2017JP001686$ASTELLAS$$44$YR$$F$Y$$$20200717$$MD$JP$JP
138293776$13829377$6$F$$20200807$20170803$20200811$EXP$$US-PFIZER INC-2017334117$PFIZER$$67$YR$$F$Y$86$KG$20200811$$MD$US$US
138295964$13829596$4$F$20160623$20171120$20170803$20171127$EXP$$FR-ASTRAZENECA-2016SE78669$ASTRAZENECA$$60$YR$$M$Y$72$KG$20171127$$MD$FR$FR
1383001714$13830017$14$F$2017$20200901$20170803$20200909$EXP$$NL-ABBVIE-17K-114-2057715-00$ABBVIE$$80$YR$$F$Y$50$KG$20200908$$HP$NL$NL
138301834$13830183$4$F$20170530$20200703$20170803$20200708$PER$$US-SA-2017SA102519$SANOFI AVENTIS$$$$$$Y$$$20200708$$HP$US$US
138302633$13830263$3$F$20200516$20200630$20170803$20200708$PER$$US-SA-2017SA119214$SANOFI AVENTIS$$$$$$Y$$$20200708$$CN$US$US
138308833$13830883$3$F$20170722$20170811$20170803$20170818$EXP$$US-JNJFOC-20170728909$PHARMACYCLICS$$75$YR$E$F$Y$112.8$KG$20170818$$MD$US$US
138313361$13831336$1$I$20161124$20161125$20170803$20170803$EXP$$JP-ASTRAZENECA-2016SF26003$ASTRAZENECA$$61$YR$$M$Y$62$KG$20170803$$MD$JP$JP
138313742$13831374$2$F$20200714$20200715$20170803$20200721$PER$$US-BAYER-2017-141743$BAYER$$50$YR$A$F$Y$$$20200721$$CN$US$US
138329664$13832966$4$F$$20200713$20170803$20200715$PER$$US-PFIZER INC-2017333417$PFIZER$$70$YR$$F$Y$$$20200715$$HP$US$US
1383299910$13832999$10$F$201712$20200807$20170803$20200811$PER$$US-PFIZER INC-2017250530$PFIZER$$58$YR$$M$Y$120.2$KG$20200811$$CN$US$US
1383363815$13833638$15$F$20180112$20200707$20170804$20200714$EXP$$CA-OTSUKA-2017_008104$OTSUKA$$30$YR$$F$Y$88.43$KG$20200714$$CN$CA$CA
138336703$13833670$3$F$20170215$20170912$20170804$20170919$EXP$$TW-PFIZER INC-2017333698$PFIZER$$67$YR$$M$Y$$$20170919$$MD$TW$TW
138343165$13834316$5$F$20170713$20200921$20170804$20200924$PER$$US-PFIZER INC-2017332790$PFIZER$$69$YR$$M$Y$78$KG$20200924$$CN$US$US
138347634$13834763$4$F$20170623$20200701$20170804$20200714$EXP$$US-INCYTE CORPORATION-2017IN006177$INCYTE$$$$$$Y$$$20200714$$CN$US$US
1383526611$13835266$11$F$201707$20200917$20170804$20200924$EXP$$NL-ABBVIE-17K-114-2060766-00$ABBVIE$$76$YR$$M$Y$60$KG$20200924$$HP$NL$NL
138353776$13835377$6$F$20170109$20180525$20170804$20200922$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-004531$BRISTOL MYERS SQUIBB$$69$YR$$M$Y$$$20200922$$MD$JP$JP
138355813$13835581$3$F$20160817$20180420$20170804$20180423$EXP$$CA-ASTRAZENECA-2016SE89810$ASTRAZENECA$$74$YR$$F$Y$$$20180423$$MD$CA$CA
138355894$13835589$4$F$20170718$20180125$20170804$20180201$EXP$$IT-JNJFOC-20170718637$JANSSEN$$83$YR$E$M$Y$83$KG$20180201$$MD$IT$IT
138355986$13835598$6$F$20170725$20171124$20170804$20171128$EXP$$IT-JNJFOC-20170802434$JANSSEN$$46$YR$A$F$Y$59$KG$20171128$$MD$IT$IT
138356007$13835600$7$F$20170726$20181019$20170804$20181024$EXP$$BR-JNJFOC-20170728410$PHARMACYCLICS$$61$YR$A$M$Y$66.5$KG$20181024$$MD$BR$BR
138356062$13835606$2$F$20170603$20200915$20170804$20200916$EXP$$US-ASTELLAS-2017US023131$ASTELLAS$$33$YR$$F$Y$$$20200916$$MD$US$US
138356671$13835667$1$I$20150908$20150910$20170804$20170804$EXP$$BR-JNJFOC-20150912206$JANSSEN$$67$YR$E$M$Y$68.2$KG$20170804$$MD$BR$BR
138358712$13835871$2$F$20160605$20180919$20170804$20180921$EXP$$US-ASTRAZENECA-2016SE61421$ASTRAZENECA$$51$YR$$M$Y$59$KG$20180921$$MD$US$US
138359481$13835948$1$I$20160810$20160815$20170804$20170804$EXP$$US-ASTRAZENECA-2016SE87748$ASTRAZENECA$$82$YR$$M$Y$81.6$KG$20170804$$MD$US$US
138363247$13836324$7$F$201904$20200810$20170804$20200816$EXP$$PHHY2017BR113598$NOVARTIS$$38$YR$$M$Y$100$KG$20200816$$CN$COUNTRY NOT SPECIFIED$BR
138363902$13836390$2$F$2017$20200828$20170804$20200904$EXP$$US-ELI_LILLY_AND_COMPANY-US201707010120$ELI LILLY AND CO$$$$$M$Y$95.24$KG$20200904$$HP$US$US
138364612$13836461$2$F$2011$20200609$20170804$20200820$PER$$US-JAZZ-2013-US-003158$JAZZ$$41$YR$$F$Y$70.3$KG$20200820$$$US$US
1383650719$13836507$19$F$20190401$20200722$20170804$20200730$EXP$$CA-CELLTRION INC.-2017CA010079$CELLTRION$$$$$$Y$$$20200730$$HP$CA$CA
138381661$13838166$1$I$20170302$20170306$20170807$20170807$EXP$$PE-ASTRAZENECA-2017SE24629$ASTRAZENECA$$22732$DY$$F$Y$$$20170807$$MD$PE$PE
138381832$13838183$2$F$20170728$20200828$20170807$20200909$EXP$$AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-043643$BOEHRINGER INGELHEIM$BOTTARO F, MARGAN M, DUBOSCQ C, CERESETTO J, EXPERIENCE WITH IDARUCIZUMAB AS A REVERSE AGENT OF DABIGATRAN. MEDICINA (BUENOS AIRES). 2020? 80:4: 405?410.$78$YR$E$$Y$$$20200904$$HP$AR$AR
138384357$13838435$7$F$20170802$20180618$20170807$20180625$EXP$$AU-ROCHE-1972716$ROCHE$$38$YR$$F$Y$68.1$KG$20180625$$MD$AU$AU
138386366$13838636$6$F$2017$20200908$20170807$20200915$EXP$$PHHY2017CO113587$NOVARTIS$$59$YR$$F$Y$76$KG$20200915$$CN$CO$CO
138393675$13839367$5$F$20170725$20200901$20170807$20200908$EXP$$JP-ASTELLAS-2017JP014893AA$ASTELLAS$$76$YR$$M$Y$$$20200908$$MD$JP$JP
138394313$13839431$3$F$20170124$20200825$20170807$20200903$EXP$$DE-BIOGEN-2017BI00442096$BIOGEN$$67$YR$$F$Y$$$20200903$$CN$DE$DE
138394675$13839467$5$F$2017$20200805$20170807$20200812$EXP$$US-BIOGEN-2017BI00442175$BIOGEN$$$$$F$Y$$$20200812$$CN$US$US
138396212$13839621$2$F$20160906$20200727$20170807$20200730$EXP$$PL-PFIZER INC-2016435605$PFIZER$$64$YR$$M$Y$83$KG$20200730$$MD$PL$PL
138396815$13839681$5$F$$20200629$20170807$20200701$EXP$$IT-PFIZER INC-2017332772$PFIZER$MUCCIOLI, L.. LONG TERM FOLLOW?UP OF RECURRENT STATUS EPILEPTICUS AND STROKE?LIKE EPISODES IN A MELAS FAMILY. EPILEPSY AND BEHAVIOR. 2019?101:10.1016/J.YEBEH.2019.08.033$29$YR$$M$Y$$$20200701$$HP$IT$IT
138400894$13840089$4$F$20170720$20190503$20170807$20190509$EXP$$US-JNJFOC-20170719865$PHARMACYCLICS$$56$YR$A$M$Y$102$KG$20190509$$MD$US$US
138401032$13840103$2$F$20170727$20170929$20170807$20171009$EXP$$US-JNJFOC-20170804289$PHARMACYCLICS$$$$E$M$Y$$$20171009$$MD$US$US
138401183$13840118$3$F$$20200912$20170807$20200921$EXP$$US-ROCHE-1974925$ROCHE$$$$$$Y$$$20200921$$HP$US$US
138402193$13840219$3$F$$20200912$20170807$20200923$EXP$$US-ROCHE-1974964$ROCHE$$$$$M$Y$$$20200923$$HP$US$US
138402203$13840220$3$F$$20200912$20170807$20200921$EXP$$US-ROCHE-1974962$ROCHE$$$$$$Y$$$20200921$$HP$US$US
138402243$13840224$3$F$$20200912$20170807$20200924$EXP$$US-ROCHE-1974963$ROCHE$$$$$$Y$$$20200924$$HP$US$US
138402313$13840231$3$F$$20200912$20170807$20200922$EXP$$US-ROCHE-1974961$ROCHE$$$$$$Y$$$20200922$$HP$US$US
138402562$13840256$2$F$20150120$20200818$20170807$20200824$EXP$$US-BAYER-2017-086957$BAYER$$67$YR$E$M$Y$$$20200824$$CN$US$US
138403291$13840329$1$I$20161027$20161028$20170807$20170807$EXP$$JP-ASTRAZENECA-2016SF14394$ASTRAZENECA$$29776$DY$$F$Y$$$20170807$$MD$JP$JP
138405668$13840566$8$F$2017$20200723$20170807$20200805$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-08040$VIFOR$$90$YR$$F$Y$63.56$KG$20200805$$CN$US$US
138406242$13840624$2$F$20170730$20170831$20170807$20170901$EXP$$US-ASTRAZENECA-2017SE79638$ASTRAZENECA$$53$YR$$M$Y$$$20170901$$MD$US$US
138406749$13840674$9$F$20170513$20181024$20170807$20200817$EXP$$JP-009507513-1705JPN002344J$MERCK$$71$YR$$F$Y$49$KG$20200817$$CN$JP$JP
138407041$13840704$1$I$20160530$20160822$20170807$20170807$EXP$$BR-JNJFOC-20160824130$JANSSEN$$67$YR$E$F$Y$50.5$KG$20170807$$MD$BR$BR
138407051$13840705$1$I$20151020$20151110$20170807$20170807$EXP$$AR-JNJFOC-20151116229$JANSSEN$$67$YR$E$F$Y$110$KG$20170807$$MD$AR$AR
138407481$13840748$1$I$20161014$20170407$20170807$20170807$EXP$$PH-JNJFOC-20170411259$JANSSEN$$82$YR$E$M$Y$57$KG$20170807$$MD$PH$PH
138407501$13840750$1$I$20160610$20160609$20170807$20170807$EXP$$JP-JNJFOC-20160611440$JANSSEN$$75$YR$E$M$Y$71.4$KG$20170807$$MD$JP$JP
138407511$13840751$1$I$20150901$20161011$20170807$20170807$EXP$$US-JNJFOC-20161014352$JANSSEN$$75$YR$E$M$Y$75.8$KG$20170807$$MD$US$US
138407521$13840752$1$I$20160930$20170627$20170807$20170807$EXP$$CZ-JNJFOC-20170704714$JANSSEN$$71$YR$E$M$Y$89$KG$20170807$$MD$CZ$CZ
138407531$13840753$1$I$20131126$20170509$20170807$20170807$EXP$$CO-JNJFOC-20170515296$JANSSEN$$68$YR$E$M$Y$92.8$KG$20170807$$MD$CO$CO
138407541$13840754$1$I$20160523$20160524$20170807$20170807$EXP$$JP-JNJFOC-20160527525$JANSSEN$$78$YR$E$F$Y$47$KG$20170807$$MD$JP$JP
138407551$13840755$1$I$20160707$20160811$20170807$20170807$EXP$$DK-JNJFOC-20160813297$JANSSEN$$72$YR$E$M$Y$75.9$KG$20170807$$MD$DK$DK
138407561$13840756$1$I$20151119$20151126$20170807$20170807$EXP$$NL-JNJFOC-20151127283$JANSSEN$$68$YR$E$M$Y$118$KG$20170807$$MD$NL$NL
138413402$13841340$2$F$20170213$20170928$20170807$20171002$EXP$$CA-ASTRAZENECA-2017SE17176$ASTRAZENECA$$76$YR$$F$Y$$$20171002$$MD$CA$CA
138414392$13841439$2$F$$20200914$20170807$20200924$EXP$$US-TEVA-794128USA$TEVA$AZARI B. A NOVEL TREATMENT FOR A RARE CAUSE OF CARDIOGENIC SHOCK.. JACC: CASE REPORTS 2. 2020 AUG?10:1461?1465.$37$YR$A$F$Y$$$20200924$$HP$US$US
138423722$13842372$2$F$20150905$20200622$20170808$20200706$EXP$$US-BAYER-2017-112203$BAYER$$71$YR$E$F$Y$$$20200706$$CN$US$US
138427722$13842772$2$F$20160617$20200914$20170808$20200924$EXP$$IT-AUROBINDO-AUR-APL-2017-38569$AUROBINDO$$44$YR$$F$Y$$$20200924$$MD$IT$IT
138428922$13842892$2$F$$20170714$20170808$20200806$EXP$$JP-009507513-1707JPN002177J$MERCK$$$$$$Y$$$20200806$$CN$JP$JP
1384296012$13842960$12$F$20170725$20200908$20170808$20200923$EXP$$US-ROCHE-1969438$ROCHE$$71$YR$$F$Y$$$20200924$$MD$US$US
1384328934$13843289$34$F$2017$20200909$20170808$20200921$EXP$$CA-ROCHE-1964253$ROCHE$$77$YR$$F$Y$$$20200921$$MD$CA$CA
138433062$13843306$2$F$$20200902$20170808$20200914$EXP$$ES-AUROBINDO-AUR-APL-2009-01181$AUROBINDO$$63$YR$$M$Y$$$20200914$$HP$US$ES
1384383317$13843833$17$F$20160825$20200721$20170808$20200729$EXP$$PHHY2016CA118687$NOVARTIS$$75$YR$$M$Y$$$20200729$$HP$CA$CA
138438636$13843863$6$F$20170802$20170927$20170808$20171003$EXP$$KR-PFIZER INC-2017340240$PFIZER$$62$YR$$M$Y$$$20171003$$MD$KR$KR
138438845$13843884$5$F$$20200623$20170808$20200701$EXP$$IT-SA-2017SA143750$SANOFI AVENTIS$SACCO M, CARAFA M, DI PALO M, MASSARI V, NANNOLA O, PICCENNA L, ET AL. WHEN THERE IS TOO MUCH MEDICATION: A VERY SERIOUS METABOLIC?LACTIC ACIDOSIS BY METFORMIN IN PATIENT IN MULTIPLE DRUG THERAPY. XXII NATIONAL CONGRESS OF THE SCIENTIFIC SOCIETY FADOI. SORRENTO. ITALIAN JOURNAL OF MEDICINE. 2017?11(S1):151$$$$$Y$$$20200701$$MD$IT$IT
138439274$13843927$4$F$20170621$20180627$20170808$20180704$EXP$$GB-ROCHE-1963432$ROCHE$$55$YR$$F$Y$60.2$KG$20180704$$MD$GB$GB
138440404$13844040$4$F$20130524$20200702$20170808$20200715$EXP$$US-JNJFOC-20170805186$JOHNSON AND JOHNSON$$64$YR$$M$Y$$$20200715$$HP$US$US
138440852$13844085$2$F$20170803$20180308$20170808$20180309$EXP$$ES-ASTRAZENECA-2017SE80037$ASTRAZENECA$$20027$DY$$M$Y$68$KG$20180309$$MD$ES$ES
138443201$13844320$1$I$20160215$20160216$20170808$20170808$EXP$$BE-JNJFOC-20160216035$JANSSEN$$47$YR$A$M$Y$80$KG$20170808$$MD$BE$BE
138443251$13844325$1$I$20160620$20160621$20170808$20170808$EXP$$FR-JNJFOC-20160623112$JANSSEN$$72$YR$E$M$Y$80$KG$20170808$$MD$FR$FR
138443261$13844326$1$I$20140921$20141022$20170808$20170808$EXP$$GB-JNJFOC-20141017484$JANSSEN$$71$YR$E$M$Y$68$KG$20170808$$MD$GB$GB
138443281$13844328$1$I$20141001$20150529$20170808$20170808$EXP$$CA-JNJFOC-20150603999$JANSSEN$$71$YR$E$M$Y$81.4$KG$20170808$$MD$CA$CA
138443301$13844330$1$I$20160418$20160422$20170808$20170808$EXP$$CA-JNJFOC-20160424663$JANSSEN$$69$YR$E$M$Y$86.8$KG$20170808$$MD$CA$CA
138443351$13844335$1$I$20160721$20160802$20170808$20170808$EXP$$BR-JNJFOC-20160807887$JANSSEN$$73$YR$E$M$Y$86.2$KG$20170808$$MD$BR$BR
138443891$13844389$1$I$20150622$20150622$20170808$20170808$EXP$$KR-JNJFOC-20150620879$JANSSEN$$71$YR$E$M$Y$64$KG$20170808$$MD$KR$KR
138443901$13844390$1$I$20160526$20161026$20170808$20170808$EXP$$RO-JNJFOC-20161100900$JANSSEN$$50$YR$A$M$Y$97$KG$20170808$$MD$RO$RO
138443921$13844392$1$I$20160425$20160427$20170808$20170808$EXP$$US-JNJFOC-20160500626$JANSSEN$$73$YR$E$M$Y$51$KG$20170808$$MD$US$US
138444526$13844452$6$F$201610$20200819$20170808$20200826$EXP$$US-ASTELLAS-2017US030877$ASTELLAS$$74$YR$$M$Y$$$20200826$$CN$US$US
138445001$13844500$1$I$20140828$20140923$20170808$20170808$EXP$$IL-JNJFOC-20140926023$JANSSEN$$73$YR$E$M$Y$80$KG$20170808$$MD$IL$IL
138445829$13844582$9$F$$20200916$20170808$20200923$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-067794$BRISTOL MYERS SQUIBB$$52$YR$$F$Y$$$20200923$$CN$CA$CA
1384474811$13844748$11$F$201803$20200811$20170808$20200813$EXP$$US-PFIZER INC-2017340658$PFIZER$$75$YR$$F$Y$71$KG$20200813$$CN$US$US
1384494212$13844942$12$F$20170614$20200901$20170808$20200907$EXP$$PHHY2017DE092066$NOVARTIS$$54$YR$$M$Y$69$KG$20200907$$MD$DE$DE
138456962$13845696$2$F$20170722$20200727$20170808$20200805$EXP$$US-SHIRE-US201717336$SHIRE$$55$YR$$M$Y$73.9$KG$20200805$$HP$US$US
1384584116$13845841$16$F$$20200916$20170808$20200924$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070102$BRISTOL MYERS SQUIBB$$59$YR$$F$Y$68$KG$20200924$$MD$CA$CA
1384640310$13846403$10$F$$20200917$20170808$20200925$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070150$BRISTOL MYERS SQUIBB$$43$YR$$M$Y$$$20200925$$MD$CA$CA
138464545$13846454$5$F$20170729$20171215$20170808$20171218$EXP$$FR-JNJFOC-20170802442$JANSSEN$$67$YR$E$F$Y$54$KG$20171218$$MD$FR$FR
1384699724$13846997$24$F$20170501$20200728$20170808$20200804$EXP$$CA-CELLTRION INC.-2017CA004103$CELLTRION$$$$$$Y$$$20200804$$HP$CA$CA
138475972$13847597$2$F$20170130$20200225$20170809$20200807$PER$$US-PURDUE-USA-2017-0136373$PURDUE$$60$YR$$F$Y$$$20200807$$CN$US$US
138484182$13848418$2$F$202004$20200512$20170809$20200807$PER$$US-PURDUE-USA-2017-0139946$PURDUE$$56$YR$$M$Y$$$20200807$$CN$US$US
138490973$13849097$3$F$20170222$20171025$20170809$20171027$EXP$$GB-ASTRAZENECA-2017SE24119$ASTRAZENECA$$24076$DY$$F$Y$$$20171027$$MD$GB$GB
138494176$13849417$6$F$201702$20200630$20170809$20200708$EXP$$US-BIOGEN-2017BI00443088$BIOGEN$$25$YR$$F$Y$$$20200708$$CN$US$US
138494583$13849458$3$F$20130420$20200703$20170809$20200713$EXP$$PHHY2013SK060513$NOVARTIS$$30$YR$$F$Y$55$KG$20200713$$MD$SK$SK
138501542$13850154$2$F$$20200909$20170809$20200914$EXP$$MX-PFIZER INC-2017328382$PFIZER$GUILLERMO, J.. TUBERCULOSIS ASSOCIATED FATAL HEMOPHAGOCYTIC SYNDROME IN A PATIENT WITH LYMPHOMA TREATED WITH FLUDARABINE. LEUKEMIA AND LYMPHOMA. 1998?28 (5?6):599?602$31$YR$$F$Y$$$20200914$$HP$MX$MX
138501929$13850192$9$F$$20200914$20170809$20200921$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070656$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200921$$MD$CA$CA
138505703$13850570$3$F$$20200826$20170810$20200902$EXP$$US-BIOGEN-2016BI00288491$BIOGEN$$$$$F$Y$$$20200902$$CN$US$US
138507307$13850730$7$F$20170703$20200902$20170809$20200907$EXP$$US-PFIZER INC-2017338601$PFIZER$$66$YR$$M$Y$$$20200907$$MD$US$US
138508685$13850868$5$F$2017$20200728$20170809$20200804$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK122286$GLAXOSMITHKLINE$$$$$F$Y$$$20200804$$CN$CA$CA
1385095610$13850956$10$F$$20200917$20170809$20200923$EXP$$US-INCYTE CORPORATION-2017IN006279$INCYTE$$$$$$Y$$$20200923$$CN$US$US
138512805$13851280$5$F$$20200922$20170809$20200930$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-069845$BRISTOL MYERS SQUIBB$$67$YR$$F$Y$$$20200930$$HP$CA$CA
1385138923$13851389$23$F$$20200921$20170809$20200929$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-069714$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200929$$CN$CA$CA
138514922$13851492$2$F$20170806$20170808$20170809$20170815$EXP$$KR-ASTRAZENECA-2017SE80379$ASTRAZENECA$$36$YR$$M$Y$$$20170815$$MD$KR$KR
138518532$13851853$2$F$$20200714$20170810$20200724$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004665$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20200724$$HP$US$US
138526116$13852611$6$F$2016$20200814$20170809$20200818$PER$$US-PFIZER INC-2017342147$PFIZER$$72$YR$$F$Y$$$20200818$$MD$US$US
138528766$13852876$6$F$$20200818$20170809$20200826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-069854$BRISTOL MYERS SQUIBB$$64$YR$$F$Y$$$20200826$$HP$CA$CA
138528789$13852878$9$F$$20200819$20170809$20200826$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070080$BRISTOL MYERS SQUIBB$$25$YR$$M$Y$$$20200826$$CN$CA$CA
1385296413$13852964$13$F$$20200710$20170809$20200715$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070668$BRISTOL MYERS SQUIBB$$65$YR$$F$Y$$$20200715$$HP$CA$CA
138532868$13853286$8$F$20140415$20200728$20170810$20200729$EXP$$PHHY2015CH027229$NOVARTIS$$43$YR$$F$Y$$$20200729$$MD$CH$CH
138535883$13853588$3$F$20150921$20180124$20170809$20180201$EXP$$CO-JNJFOC-20170515251$JANSSEN$$75$YR$E$M$Y$70.5$KG$20180201$$MD$CO$CO
138535901$13853590$1$I$20150706$20150715$20170809$20170809$EXP$$DK-JNJFOC-20150716277$JANSSEN$$65$YR$E$M$Y$94$KG$20170809$$MD$DK$DK
138535911$13853591$1$I$20150326$20170615$20170809$20170809$EXP$$CA-JNJFOC-20170620195$JANSSEN$$82$YR$E$M$Y$81.9$KG$20170809$$MD$CA$CA
138535921$13853592$1$I$20150313$20150407$20170809$20170809$EXP$$NL-JNJFOC-20150409824$JANSSEN$$67$YR$E$M$Y$85$KG$20170809$$MD$NL$NL
138538121$13853812$1$I$20150723$20150727$20170810$20170810$EXP$$DK-JNJFOC-20150722761$JANSSEN$$78$YR$E$F$Y$66$KG$20170810$$MD$DK$DK
138542673$13854267$3$F$20161020$20171115$20170809$20171120$EXP$$PT-ASTRAZENECA-2016SF17694$ASTRAZENECA$$25390$DY$$M$Y$$$20171120$$MD$PT$PT
1385428218$13854282$18$F$$20200818$20170809$20200820$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070658$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200820$$CN$CA$CA
138546837$13854683$7$F$$20200917$20170810$20200924$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070666$BRISTOL MYERS SQUIBB$$59$YR$$F$Y$$$20200924$$MD$CA$CA
138553313$13855331$3$F$20160517$20200729$20170810$20200806$PER$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-04998$VIFOR$$71$YR$$F$Y$51.76$KG$20200806$$HP$US$US
138554571$13855457$1$I$20150506$20150515$20170810$20170810$EXP$$BR-JNJFOC-20150514687$JANSSEN$$70$YR$E$F$Y$69$KG$20170810$$MD$BR$BR
138554611$13855461$1$I$20160412$20160426$20170810$20170810$EXP$$DK-JNJFOC-20160427865$JANSSEN$$67$YR$E$M$Y$81$KG$20170810$$MD$DK$DK
138554987$13855498$7$F$$20200630$20170810$20200703$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070302$BRISTOL MYERS SQUIBB$$39$YR$$F$Y$$$20200703$$CN$CA$CA
138555083$13855508$3$F$20161111$20180102$20170810$20180110$EXP$$PH-ASTRAZENECA-2017SE35884$ASTRAZENECA$$23338$DY$$F$Y$$$20180110$$MD$PH$PH
138556983$13855698$3$F$20131231$20200713$20170810$20200724$EXP$$US-SA-2017SA138887$SANOFI AVENTIS$KANTARJIAN HM, DEANGELO DJ, ADVANI AS, STELLJES M, KEBRIAEI P, CASSADAY RD ET AL.. HEPATIC ADVERSE EVENT PROFILE OF INOTUZUMAB OZOGAMICIN IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA: RESULTS FROM THE OPEN?LABEL, RANDOMIZED, PHASE 3 INO?VATE STUDY.. LANCET HAEMATOL. 2017?4(8):E387?98$$$$$Y$$$20200724$$MD$ES$ES
138560313$13856031$3$F$20161027$20190521$20170810$20190529$EXP$$CA-ASTRAZENECA-2016SF14242$ASTRAZENECA$$897$MON$$M$Y$81.9$KG$20190529$$MD$CA$CA
138561023$13856102$3$F$20170803$20171013$20170810$20171016$EXP$$CA-ASTRAZENECA-2017SE80013$ASTRAZENECA$$64$YR$$F$Y$$$20171016$$MD$CA$CA
138561191$13856119$1$I$20170331$20170407$20170810$20170810$EXP$$FR-JNJFOC-20170413376$JANSSEN$$54$YR$A$M$Y$60$KG$20170810$$MD$FR$FR
138563148$13856314$8$F$201509$20200714$20170810$20200727$EXP$$US-ACTELION-A-NJ2015-125446$ACTELION$$64$YR$$F$Y$$$20200727$$HP$US$US
1385631818$13856318$18$F$$20200720$20170810$20200721$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070219$BRISTOL MYERS SQUIBB$$23$YR$$F$Y$$$20200721$$MD$CA$CA
1385764314$13857643$14$F$$20200914$20170811$20200925$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052306$BRISTOL MYERS SQUIBB$$85$YR$$M$Y$$$20200925$$MD$CA$CA
1385782120$13857821$20$F$20160927$20200721$20170811$20200728$EXP$$FR-ROCHE-1964926$ROCHE$$69$YR$$M$Y$80$KG$20200729$$MD$FR$FR
138583762$13858376$2$F$201603$20200720$20170811$20200727$EXP$$US-BIOGEN-2017BI00444859$BIOGEN$$25$YR$$F$Y$$$20200727$$CN$US$US
138584525$13858452$5$F$20161101$20200814$20170811$20200819$EXP$$CA-TAKEDA-2017TUS016499$TAKEDA$$73$YR$$M$Y$$$20200819$$HP$CA$CA
138592078$13859207$8$F$$20200914$20170811$20200918$PER$$CA-AMGEN-CANSP2017119169$AMGEN$$$$$F$Y$$$20200918$$HP$CA$CA
1385959410$13859594$10$F$$20200731$20170811$20200804$EXP$$US-PFIZER INC-2017346502$PFIZER$$75$YR$$F$Y$$$20200804$$MD$US$US
1385980010$13859800$10$F$20170422$20180417$20170811$20200819$EXP$$JP-009507513-1705JPN002053J$MERCK$$66$YR$$M$Y$44$KG$20200819$$CN$JP$JP
138599282$13859928$2$F$20170403$20200910$20170811$20200924$EXP$$FR-GLAXOSMITHKLINE-FR2017GSK124917$GLAXOSMITHKLINE$$39$YR$$F$Y$$$20200924$$HP$FR$FR
138600963$13860096$3$F$20170803$20170814$20170811$20170823$EXP$$ES-JNJFOC-20170804159$PHARMACYCLICS$$75$YR$E$F$Y$80.7$KG$20170823$$MD$ES$ES
1386022810$13860228$10$F$$20200430$20170811$20200505$EXP$$PHHY2017CR116421$NOVARTIS$$$$$F$Y$56$KG$20200505$$MD$CR$CR
138608765$13860876$5$F$20150616$20200827$20170811$20200902$PER$$US-JNJFOC-20170808845$JOHNSON AND JOHNSON$$68$YR$E$F$Y$72.46$KG$20200902$$CN$US$US
138608881$13860888$1$I$$20170731$20170811$20170811$EXP$$CA-JNJFOC-20170804216$JANSSEN$BOUMEDIEN F, ADAM JP, AKKOUR K, LE?TARTE N, PROVENCHER DM. SINGLE AGENT TRABECTEDIN IN HEAVILY PRETREATED PATIENTS WITH RECURRENT OVARIAN CANCER (ROC). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER MAY?2015?VOL.33,NO.15,SUPPL 1. BOUMEDIEN F, ADAM JP, AKKOUR K, LE?TARTE N, PROVENCHER DM. SINGLE AGENT TRABECTEDIN IN HEAVILY PRETREATED PATIENTS WITH RECURRENT OVARIAN CANCER (ROC). ANNUAL MEETING OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, ASCO MAY?2015?ISSN: 0732?183X. ADAM JP, BOUMEDIEN F, LE TN$$$$F$Y$$$20170811$$MD$CA$CA
1386097510$13860975$10$F$201712$20200707$20170811$20200717$EXP$$PHHY2017CR116440$NOVARTIS$$64$YR$$F$Y$65$KG$20200717$$MD$CR$CR
138612765$13861276$5$F$20170728$20181022$20170811$20181105$EXP$$PL-JNJFOC-20170802839$JANSSEN$$41$YR$A$M$Y$106$KG$20181105$$MD$PL$PL
1386150615$13861506$15$F$20170707$20200623$20170811$20200817$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-061135$BRISTOL MYERS SQUIBB$$82$YR$$M$Y$$$20200817$$HP$DE$DE
138630035$13863003$5$F$$20200714$20170814$20200723$EXP$$CA-TEVA-794600ACC$TEVA$$31$YR$$F$Y$52$KG$20200723$$HP$CA$CA
1386335815$13863358$15$F$20170411$20200811$20170814$20200813$EXP$$US-PFIZER INC-2017346562$PFIZER$$60$YR$$F$Y$48$KG$20200813$$MD$US$US
1386339210$13863392$10$F$$20200709$20170814$20200710$EXP$$US-PFIZER INC-2017349552$PFIZER$$57$YR$$F$Y$52$KG$20200710$$CN$US$US
138635697$13863569$7$F$2015$20200914$20170814$20200915$EXP$$US-PFIZER INC-2017351029$PFIZER$$69$YR$$M$Y$83$KG$20200915$$CN$US$US
138643124$13864312$4$F$20170721$20170808$20170814$20181220$EXP$$DE-JNJFOC-20170808253$JANSSEN$$46$YR$A$M$Y$139$KG$20181220$$HP$DE$DE
138644892$13864489$2$F$$20200821$20170814$20200904$EXP$$ZA-LUPIN (EUROPE) LIMITED-2017-04428$LUPIN$$$$$F$Y$$$20200904$$CN$ZA$ZA
138645141$13864514$1$I$20150526$20150701$20170814$20170814$EXP$$DE-JNJFOC-20150704576$JANSSEN$$79$YR$E$M$Y$107$KG$20170814$$MD$DE$DE
138645151$13864515$1$I$20151216$20151217$20170814$20170814$EXP$$JP-JNJFOC-20151220728$JANSSEN$$$$E$F$Y$$$20170814$$MD$JP$JP
138646373$13864637$3$F$20120223$20200812$20170814$20200817$PER$$US-JNJFOC-20170808742$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200817$$CN$US$US
138646972$13864697$2$F$$20170802$20170814$20200803$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-072332$BRISTOL MYERS SQUIBB$KASAHARA K, GOTOH Y, KUROYANAGI Y, NAGANO C. WARFARIN?INDUCED TOXIC EPIDERMAL NECROLYSIS IN COMBINATION THERAPY OF HENOCH?SCHONLEIN PURPURA NEPHRITIS: A CASE REPORT. BMC NEPHROLOGY. 2017?18:237$3$YR$$F$Y$$$20200803$$HP$JP$JP
138647846$13864784$6$F$20170802$20171121$20170814$20171127$EXP$$BE-JNJFOC-20170808928$JANSSEN$$39$YR$A$F$Y$91$KG$20171127$$MD$BE$BE
1386495811$13864958$11$F$20150818$20200629$20170814$20200707$EXP$$CA-PFIZER INC-2015286770$PFIZER$$40$YR$$F$Y$$$20200707$$HP$CA$CA
138652454$13865245$4$F$201906$20200826$20170814$20200904$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003689$ACADIA PHARMACEUTICALS$$68$YR$$F$Y$$$20200904$$CN$US$US
138656112$13865611$2$F$20160608$20200430$20170814$20200819$PER$$US-AEGERION PHARMACEUTICAL, INC-AEGR003209$AEGERION$$82$YR$$F$Y$$$20200819$$MD$US$US
138656182$13865618$2$F$20170216$20200430$20170814$20200819$PER$$US-AEGERION PHARMACEUTICAL, INC-AEGR003137$AEGERION$$69$YR$$F$Y$$$20200819$$MD$US$US
138657032$13865703$2$F$20160719$20171114$20170814$20171122$EXP$$GB-ASTRAZENECA-2016SE78821$ASTRAZENECA$$28841$DY$$F$Y$$$20171122$$MD$GB$GB
138657363$13865736$3$F$$20200910$20170814$20200923$EXP$$JP-JNJFOC-20170810579$JOHNSON AND JOHNSON$TANAKA N, YAMAKAGE M, GUSHMEN T, SEKIYAMA H, NAKATSUKA H, MASUDA R, YAMAURA K. ADVERSE EVENTS IN PAIN TREATMENT SETTING DURING 2016: A REPORT ON ADVERSE EVENTS FROM THE COMMITTEE ON SAFETY OF THE JSPC. JOURNAL OF JAPAN SOCIETY OF PAIN CLINICIANS. 2020?27 (2):133?142.$$$$$Y$$$20200923$$MD$JP$JP
1386598748$13865987$48$F$20161116$20200826$20170814$20200902$EXP$$PHHY2016CA159803$NOVARTIS$$45$YR$$F$Y$$$20200902$$PH$CA$CA
1386653111$13866531$11$F$20170321$20200820$20170814$20200903$EXP$$DE-INCYTE CORPORATION-2017IN006709$INCYTE$$$$$$Y$$$20200903$$MD$DE$DE
138667122$13866712$2$F$20170809$20170811$20170814$20170817$EXP$$US-ASTRAZENECA-2017SE81610$ASTRAZENECA$$31$YR$$F$Y$80.7$KG$20170817$$MD$US$US
138669762$13866976$2$F$201705$20200818$20170814$20200828$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003765$ACADIA PHARMACEUTICALS$$87$YR$$F$Y$54$KG$20200828$$HP$US$US
138671662$13867166$2$F$2020$20200706$20170814$20200731$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004541$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20200731$$CN$US$US
138673262$13867326$2$F$$20200725$20170814$20200819$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004716$ACADIA PHARMACEUTICALS$$$$$M$Y$66$KG$20200819$$MD$US$US
138673488$13867348$8$F$2018$20200716$20170814$20200724$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004708$ACADIA PHARMACEUTICALS$$$$$F$Y$63$KG$20200724$$MD$US$US
138673503$13867350$3$F$2017$20200713$20170814$20200723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004584$ACADIA PHARMACEUTICALS$$86$YR$$M$Y$$$20200723$$MD$US$US
138676573$13867657$3$F$201704$20200706$20170814$20200716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003313$ACADIA PHARMACEUTICALS$$66$YR$$M$Y$$$20200716$$MD$US$US
138676847$13867684$7$F$2017$20200801$20170814$20200826$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003337$ACADIA PHARMACEUTICALS$$75$YR$$M$Y$$$20200826$$CN$US$US
138676902$13867690$2$F$20200728$20200806$20170814$20200814$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003402$ACADIA PHARMACEUTICALS$$84$YR$$M$Y$$$20200814$$CN$US$US
138677017$13867701$7$F$2017$20200807$20170814$20200901$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003448$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20200901$$CN$US$US
138678483$13867848$3$F$201705$20200910$20170814$20200918$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003564$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20200918$$MD$US$US
138679174$13867917$4$F$20190802$20200811$20170814$20200821$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004243$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$$$20200821$$CN$US$US
138679506$13867950$6$F$2019$20200626$20170814$20200706$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004397$ACADIA PHARMACEUTICALS$$70$YR$$F$Y$$$20200706$$MD$US$US
138679722$13867972$2$F$$20200611$20170814$20200706$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004456$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20200706$$CN$US$US
138679983$13867998$3$F$20171129$20200828$20170814$20200907$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004519$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$76$KG$20200907$$CN$US$US
138681814$13868181$4$F$20151015$20200831$20170814$20200903$EXP$$CA-ROCHE-1644511$ROCHE$$60$YR$$F$Y$85$KG$20200903$$HP$CA$CA
138691227$13869122$7$F$$20200707$20170815$20200712$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2464$ORION$$$$$F$Y$$$20200712$$HP$CA$CA
1386912811$13869128$11$F$$20200723$20170815$20200729$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2456$ORION$$79$YR$$F$Y$$$20200729$$MD$CA$CA
138691325$13869132$5$F$$20200723$20170815$20200729$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2455$ORION$$65$YR$$F$Y$$$20200729$$HP$CA$CA
138691942$13869194$2$F$$20200827$20170815$20200903$EXP$DK-TAKEDA-2016TUS015248$DK-MYLANLABS-2017M1048484$MYLAN$$22$YR$$F$Y$$$20200903$$CN$DK$DK
138692592$13869259$2$F$20170427$20200820$20170815$20200825$EXP$$PL-PFIZER INC-2017337807$PFIZER$$70$YR$$F$Y$63$KG$20200825$$HP$PL$PL
138692683$13869268$3$F$20160202$20200904$20170815$20200917$EXP$$JP-INCYTE CORPORATION-2017IN003439$INCYTE$$$$$$Y$$$20200917$$MD$JP$JP
1386928821$13869288$21$F$2017$20200917$20170815$20200922$EXP$$CA-PFIZER INC-2017117209$PFIZER$$54$YR$$M$Y$110$KG$20200922$$HP$CA$CA
138692974$13869297$4$F$20170724$20171011$20170815$20171018$EXP$$AU-ROCHE-1969337$ROCHE$$55$YR$$M$Y$83.2$KG$20171018$$MD$AU$AU
138693272$13869327$2$F$20160308$20200213$20170815$20200819$PER$$US-AEGERION PHARMACEUTICAL, INC-AEGR002999$AEGERION$$63$YR$$M$Y$$$20200819$$MD$US$US
138694283$13869428$3$F$20160314$20200630$20170815$20200710$EXP$$JP-ACTELION-A-CH2017-157830$ACTELION$$48$YR$$F$Y$$$20200710$$MD$JP$JP
138695215$13869521$5$F$20170203$20170808$20170815$20200717$EXP$$DE-GLAXOSMITHKLINE-DE2017GSK123778$GLAXOSMITHKLINE$$59$YR$$F$Y$100$KG$20200717$$MD$DE$DE
1386965810$13869658$10$F$2017$20200904$20170815$20200910$EXP$$PHHY2016CA101833$NOVARTIS$$67$YR$$M$Y$$$20200910$$MD$CA$CA
138698001$13869800$1$I$20140227$20140325$20170815$20170815$EXP$$CA-JNJFOC-20140400477$JANSSEN$$70$YR$E$M$Y$66$KG$20170815$$MD$CA$CA
1386990916$13869909$16$F$201705$20200805$20170815$20200807$EXP$$US-PFIZER INC-2017346173$PFIZER$$67$YR$$F$Y$$$20200807$$CN$US$US
138700011$13870001$1$I$20160914$20160928$20170815$20170815$EXP$$JP-JNJFOC-20161003611$JANSSEN$$76$YR$E$M$Y$53$KG$20170815$$MD$JP$JP
138700873$13870087$3$F$201007$20200902$20170815$20200908$EXP$$US-EMD SERONO-7024515$EMD SERONO INC$$56$YR$A$F$Y$$$20200908$$CN$US$US
138702001$13870200$1$I$20140717$20140930$20170815$20170815$EXP$$CO-JNJFOC-20141003104$JANSSEN$$59$YR$A$F$Y$61$KG$20170815$$MD$CO$CO
138702011$13870201$1$I$20160603$20160603$20170815$20170815$EXP$$JP-JNJFOC-20160606430$JANSSEN$$81$YR$E$M$Y$57.6$KG$20170815$$MD$JP$JP
138702631$13870263$1$I$20160714$20160805$20170815$20170815$EXP$$JP-JNJFOC-20160809083$JANSSEN$$77$YR$E$M$Y$66.2$KG$20170815$$MD$JP$JP
138702641$13870264$1$I$20141114$20160202$20170815$20170815$EXP$$JP-JNJFOC-20160205097$JANSSEN$$70$YR$E$M$Y$58$KG$20170815$$MD$JP$JP
138702651$13870265$1$I$20151217$20151222$20170815$20170815$EXP$$JP-JNJFOC-20151222878$JANSSEN$$81$YR$E$M$Y$64$KG$20170815$$MD$JP$JP
138702661$13870266$1$I$20151016$20151016$20170815$20170815$EXP$$JP-JNJFOC-20151016838$JANSSEN$$70$YR$E$M$Y$68.5$KG$20170815$$MD$JP$JP
1387027610$13870276$10$F$$20200914$20170815$20200921$EXP$$CA-PFIZER INC-2017350057$PFIZER$$$$$F$Y$$$20200921$$CN$CA$CA
138708532$13870853$2$F$$20200915$20170816$20200927$EXP$$CA-APOTEX-2017AP016474$APOTEX$$61$YR$$F$Y$72$KG$20200927$$CN$CA$CA
138708713$13870871$3$F$20170520$20200702$20170816$20200707$EXP$$PHHY2017CO118273$NOVARTIS$$18$YR$$M$Y$48$KG$20200707$$CN$COUNTRY NOT SPECIFIED$CO
138711244$13871124$4$F$201608$20200722$20170816$20200728$EXP$$US-SA-2016SA156063$SANOFI AVENTIS$$$$$$Y$$$20200728$$CN$US$US
138711662$13871166$2$F$20160913$20190705$20170816$20190711$EXP$$PE-ASTRAZENECA-2016SE98605$ASTRAZENECA$$22814$DY$$F$Y$$$20190711$$MD$PE$PE
138713052$13871305$2$F$20130304$20200809$20170816$20200817$EXP$$US-BAYER-2017-112923$BAYER$$66$YR$E$M$Y$$$20200817$$HP$US$US
138714062$13871406$2$F$20160518$20200708$20170816$20200717$EXP$$US-BAYER-2017-117945$BAYER$$59$YR$A$F$Y$$$20200717$$CN$US$US
138715704$13871570$4$F$2016$20200219$20170816$20200810$PER$$US-ALLERGAN-1709471US$ALLERGAN$$64$YR$$F$Y$$$20200810$$MD$US$US
138717165$13871716$5$F$20170806$20170929$20170816$20171006$EXP$$US-JNJFOC-20170812482$PHARMACYCLICS$$66$YR$E$M$Y$142.5$KG$20171006$$MD$US$US
138717713$13871771$3$F$20161001$20171018$20170816$20171019$EXP$$HK-ASTRAZENECA-2016SF04911$ASTRAZENECA$$17857$DY$$M$Y$$$20171020$$MD$HK$HK
138718671$13871867$1$I$20170625$20170814$20170816$20170816$EXP$GB-MHRA-EYC 00163404$GB-ROCHE-1979042$ROCHE$$51$YR$$M$Y$80$KG$20170816$$MD$GB$GB
138722291$13872229$1$I$20150725$20151015$20170816$20170816$EXP$$SE-JNJFOC-20151015929$JANSSEN$$70$YR$E$M$Y$82$KG$20170816$$MD$SE$SE
138722391$13872239$1$I$20141104$20141113$20170816$20170816$EXP$$JP-JNJFOC-20141113766$JANSSEN$$67$YR$E$M$Y$53$KG$20170816$$MD$JP$JP
138722401$13872240$1$I$20141117$20141219$20170816$20170816$EXP$$JP-JNJFOC-20141217659$JANSSEN$$77$YR$E$M$Y$55$KG$20170816$$MD$JP$JP
138722411$13872241$1$I$20150415$20150416$20170816$20170816$EXP$$CZ-JNJFOC-20150417654$JANSSEN$$66$YR$E$F$Y$68$KG$20170816$$MD$CZ$CZ
1387265311$13872653$11$F$20170519$20200813$20170816$20200819$EXP$$AU-SA-2017SA120140$SANOFI AVENTIS$$$$$$Y$$$20200819$$MD$AU$AU
138727373$13872737$3$F$20170809$20190211$20170816$20190215$EXP$$CA-PFIZER INC-2017351933$PFIZER$$60$YR$$F$Y$$$20190215$$MD$CA$CA
1387278919$13872789$19$F$20160927$20200721$20170816$20200729$EXP$$FR-ABBVIE-17P-056-2041692-00$ABBVIE$$69$YR$$M$Y$83$KG$20200729$$MD$FR$FR
138729051$13872905$1$I$$20170802$20170816$20170816$EXP$$DE-ACCORD-057016$ACCORD$$$$$F$Y$$$20170816$$CN$DE$DE
138732332$13873233$2$F$200807$20200915$20170816$20200920$EXP$$PHHY2017AU119219$NOVARTIS$$55$YR$$F$Y$$$20200920$$HP$AU$AU
138734152$13873415$2$F$$20200915$20170816$20200924$EXP$$CA-APOTEX-2017AP016504$APOTEX$$78$YR$$M$Y$$$20200924$$HP$CA$CA
1387415310$13874153$10$F$20170706$20200818$20170816$20200824$EXP$$US-ACTELION-A-US2017-157990$ACTELION$$41$YR$$M$Y$86.17$KG$20200824$$PH$US$US
138741557$13874155$7$F$201808$20200729$20170816$20200811$EXP$$US-ACTELION-A-NJ2017-158162$ACTELION$$62$YR$$M$Y$$$20200811$$PH$US$US
138742824$13874282$4$F$$20180306$20170816$20200908$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-072446$BRISTOL MYERS SQUIBB$$$$$M$Y$83.9$KG$20200908$$CN$US$US
138754578$13875457$8$F$$20200703$20170817$20200710$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2015-0556$ORION$$40$YR$$F$Y$$$20200710$$MD$CA$CA
138755056$13875505$6$F$20160816$20200902$20170817$20200910$EXP$$CA-TAKEDA-2017TUS016250$TAKEDA$$53$YR$$F$Y$60$KG$20200910$$MD$CA$CA
138755277$13875527$7$F$$20200918$20170817$20200925$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2509$ORION$$$$$F$Y$$$20200925$$MD$CA$CA
138756514$13875651$4$F$$20180726$20170817$20200805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-074015$BRISTOL MYERS SQUIBB$TSUJII Y, HAYASHI Y, KAWAI N, YAMADA T, YAMAMOTO K, HAYASHI S, ET AL.. RISK OF PERFORATION IN BALLOON DILATION ASSOCIATED WITH STEROID INJECTION FOR PREVENTING ESOPHAGEAL STRICTURE AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION. ENDOSCOPY INTERNATIONAL OPEN. 2017?05:E573?9$61$YR$$M$Y$$$20200805$$MD$JP$JP
138756524$13875652$4$F$$20180726$20170817$20200805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-074017$BRISTOL MYERS SQUIBB$TSUJII Y, HAYASHI Y, KAWAI N, YAMADA T, YAMAMOTO K, HAYASHI S, ET AL. RISK OF PERFORATION IN BALLOON DILATION ASSOCIATED WITH STEROID INJECTION FOR PREVENTING ESOPHAGEAL STRICTURE AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION. ENDOSCOPY INTERNATIONAL OPEN. 2017?05:E573?9$74$YR$$M$Y$$$20200805$$MD$JP$JP
138756533$13875653$3$F$$20180416$20170817$20200805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-074016$BRISTOL MYERS SQUIBB$TSUJII Y, HAYASHI Y, KAWAI N, YAMADA T, YAMAMOTO K, HAYASHI S, ET AL.. RISK OF PERFORATION IN BALLOON DILATION ASSOCIATED WITH STEROID INJECTION FOR PREVENTING ESOPHAGEAL STRICTURE AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION.. ENDOSCOPY INTERNATIONAL OPEN.. 2017?05:E573?9$75$YR$$F$Y$$$20200805$$MD$JP$JP
138756544$13875654$4$F$$20180726$20170817$20200805$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-074018$BRISTOL MYERS SQUIBB$TSUJII Y, HAYASHI Y, KAWAI N, YAMADA T, YAMAMOTO K, HAYASHI S, ET AL.. RISK OF PERFORATION IN BALLOON DILATION ASSOCIATED WITH STEROID INJECTION FOR PREVENTING ESOPHAGEAL STRICTURE AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION.. ENDOSCOPY INTERNATIONAL OPEN.. 2017?05:E573?9$68$YR$$M$Y$$$20200805$$MD$JP$JP
138756554$13875655$4$F$$20180726$20170817$20200804$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-073344$BRISTOL MYERS SQUIBB$TSUJII Y, HAYASHI Y, KAWAI N, YAMADA T, YAMAMOTO K, HAYASHI S. RISK OF PERFORATION IN BALLOON DILATION ASSOCIATED WITH STEROID INJECTION FOR PREVENTING ESOPHAGEAL STRICTURE AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION. ENDOSCOPY INTERNATIONAL OPEN. 2017?5:E573?9$70$YR$$M$Y$$$20200804$$MD$JP$JP
1387576721$13875767$21$F$2017$20200918$20170817$20200924$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-0878$ORION$$54$YR$$M$Y$110$KG$20200924$$MD$CA$CA
138761432$13876143$2$F$$20200713$20170817$20200716$PER$$US-PFIZER INC-2017353713$PFIZER$$63$YR$$F$Y$$$20200716$$HP$US$US
138766887$13876688$7$F$$20200713$20170817$20200724$EXP$$NO-ROCHE-1978381$ROCHE$$$$$$Y$$$20200724$$HP$NO$NO
138768849$13876884$9$F$20170701$20200727$20170817$20200729$EXP$$AU-ROCHE-1959481$ROCHE$$74$YR$$M$Y$103$KG$20200729$$MD$AU$AU
138769052$13876905$2$F$20140611$20200805$20170817$20200814$EXP$$US-BAYER-2017-112826$BAYER$$71$YR$E$M$Y$$$20200814$$CN$US$US
138769774$13876977$4$F$$20200820$20170817$20200828$EXP$$NL-JNJFOC-20170813043$JOHNSON AND JOHNSON$$$$$M$Y$4$KG$20200828$$MD$NL$NL
138773514$13877351$4$F$201707$20200901$20170817$20200910$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK103316$GLAXOSMITHKLINE$$48$YR$$M$Y$$$20200909$$CN$CA$CA
138774923$13877492$3$F$$20200708$20170817$20200709$PER$$US-PFIZER INC-2017089929$PFIZER$$74$YR$$F$Y$86$KG$20200709$$HP$US$US
138778715$13877871$5$F$20161114$20200710$20170817$20200722$EXP$$US-JNJFOC-20170813712$JOHNSON AND JOHNSON$$68$YR$E$M$Y$90.8$KG$20200722$$HP$US$US
138780678$13878067$8$F$20170810$20171026$20170817$20171031$EXP$$AR-JNJFOC-20170811762$PHARMACYCLICS$$74$YR$E$M$Y$102$KG$20171031$$MD$AR$AR
138799196$13879919$6$F$20170717$20180208$20170818$20180213$EXP$$AT-JNJFOC-20170716263$JANSSEN$$84$YR$E$F$Y$$$20180213$$MD$AT$AT
138801943$13880194$3$F$20170808$20171228$20170818$20180101$EXP$$CA-ASTRAZENECA-2017SE81643$ASTRAZENECA$$66$YR$$F$Y$$$20180101$$MD$CA$CA
138805642$13880564$2$F$20160316$20200713$20170818$20200722$EXP$$CA-ROCHE-1743894$ROCHE$$52$YR$$F$Y$$$20200722$$HP$CA$CA
138807562$13880756$2$F$20140730$20200806$20170818$20200818$EXP$$US-JNJFOC-20170707478$JOHNSON AND JOHNSON$$74$YR$E$M$Y$$$20200818$$CN$US$US
138808292$13880829$2$F$20170315$20200813$20170818$20200814$EXP$$US-TESARO, INC.-US-2017TSO00077$GLAXOSMITHKLINE$$84$YR$$F$Y$$$20200814$$MD$US$US
138808373$13880837$3$F$$20200902$20170818$20200903$EXP$$US-PFIZER INC-2017355318$PFIZER$$69$YR$$F$Y$$$20200903$$CN$US$US
138811563$13881156$3$F$20170529$20170822$20170818$20170828$EXP$$US-JNJFOC-20170604508$PHARMACYCLICS$$70$YR$E$M$Y$$$20170828$$MD$US$US
138811733$13881173$3$F$20170809$20171128$20170818$20171205$EXP$$US-JNJFOC-20170815240$PHARMACYCLICS$$67$YR$E$M$Y$$$20171205$$MD$US$US
138813424$13881342$4$F$$20200819$20170818$20200819$PER$$US-PFIZER INC-2017355635$PFIZER$$64$YR$$F$Y$$$20200819$$MD$US$US
138815677$13881567$7$F$201708$20200806$20170818$20200810$EXP$$US-SA-2017SA146572$SANOFI AVENTIS$$$$$$Y$$$20200810$$CN$US$US
1388165410$13881654$10$F$201708$20200713$20170818$20200724$EXP$$PHHY2016CA103571$NOVARTIS$$58$YR$$M$Y$$$20200724$$CN$COUNTRY NOT SPECIFIED$CA
138816832$13881683$2$F$$20200915$20170818$20200925$EXP$$CA-APOTEX-2017AP016554$APOTEX$$77$YR$$M$Y$$$20200925$$CN$CA$CA
138818261$13881826$1$I$$20170808$20170818$20170818$EXP$$PHHY2017IL118038$NOVARTIS$$60$YR$$M$Y$$$20170818$$CN$IL$IL
1388227012$13882270$12$F$201707$20200715$20170818$20200721$EXP$$US-TAKEDA-2017MPI007056$TAKEDA$$62$YR$$M$Y$106$KG$20200721$$MD$US$US
138823262$13882326$2$F$$20170817$20170818$20170829$EXP$$US-IMPAX LABORATORIES, INC-2017-IPXL-02422$IMPAX$SANFORD EL, HICKEY T, LU J.. ACUTE TAKOTSUBO CARDIOMYOPATHY DURING ELECTIVE HERNIA REPAIR IN A PATIENT WITH PREVIOUSLY RESECTED PHEOCHROMOCYTOMA. J CARDIOTHORAC VASC ANESTH.. 2015?29(6):1596?8$81$YR$$F$Y$73$KG$20170829$$MD$US$US
138823691$13882369$1$I$20170103$20170104$20170818$20170818$EXP$$BR-ASTRAZENECA-2017SE01110$ASTRAZENECA$$28511$DY$$M$Y$$$20170818$$MD$BR$BR
138826451$13882645$1$I$20161214$20161215$20170818$20170818$EXP$$GB-ASTRAZENECA-2016SF33067$ASTRAZENECA$$51$YR$$M$Y$88.8$KG$20170818$$MD$GB$GB
138845302$13884530$2$F$$20170816$20170821$20200910$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-074526$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200910$$CN$US$US
138846152$13884615$2$F$20170815$20170823$20170821$20170824$EXP$$CA-ASTRAZENECA-2017SE84630$ASTRAZENECA$$69$YR$$M$Y$$$20170824$$MD$CA$CA
138850611$13885061$1$I$20161230$20170103$20170821$20170821$EXP$$MY-ASTRAZENECA-2017SE00568$ASTRAZENECA$$21352$DY$$M$Y$$$20170821$$MD$MY$MY
138854295$13885429$5$F$$20200812$20170821$20200813$PER$$US-PFIZER INC-2017355600$PFIZER$$64$YR$$F$Y$$$20200813$$MD$US$US
138859051$13885905$1$I$20170721$20170807$20170821$20170821$EXP$$DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-147679$RANBAXY$$17$YR$$M$Y$65$KG$20170821$$HP$DE$DE
138860065$13886006$5$F$2017$20200729$20170821$20200803$EXP$$US-SA-2017SA136389$SANOFI AVENTIS$$$$$$Y$$$20200803$$CN$US$US
1388606123$13886061$23$F$2017$20200708$20170821$20200717$EXP$$PHHY2017CA034529$NOVARTIS$$72$YR$$M$Y$$$20200717$$CN$CA$CA
138866384$13886638$4$F$20170722$20171221$20170821$20171228$EXP$$KR-JNJFOC-20170725737$PHARMACYCLICS$$51$YR$A$F$Y$54$KG$20171228$$MD$KR$KR
138871271$13887127$1$I$20140223$20140303$20170821$20170821$EXP$$US-ASTRAZENECA-2014SE15372$ASTRAZENECA$SOORAJ JOHN , SCOTT J. ANTONIA, TREVOR A. ROSE, ROBERT P. SEIFERT, BARBARA A. CENTENO, AARON S. WAGNER,  BEN C. CREELAN. PROGRESSIVE HYPOVENTILATION DUE TO MIXED CD8+ AND CD4+ LYMPHOCYTIC POLYMYOSITIS FOLLOWING TREMELIMUMAB ? DURVALUMAB TREATMENT. JOURNAL FOR IMMUNOTHERAPY OF CANCER 2017? 5(54):1?6.$64$YR$$F$Y$56.4$KG$20170821$$MD$US$US
138885961$13888596$1$I$20161130$20161130$20170822$20170822$EXP$$BR-ASTRAZENECA-2016SF28898$ASTRAZENECA$$28477$DY$$M$Y$$$20170822$$MD$BR$BR
138899222$13889922$2$F$20170809$20170822$20170822$20170829$EXP$$GB-ASTRAZENECA-2017SE82716$ASTRAZENECA$$23215$DY$$M$Y$$$20170829$$MD$GB$GB
1389081220$13890812$20$F$2017$20200917$20170822$20200924$EXP$$CA-CELLTRION INC.-2017CA004234$CELLTRION$$$$$$Y$$$20200924$$HP$CA$CA
1389154113$13891541$13$F$$20200811$20170822$20200824$EXP$$PHEH2017US026455$NOVARTIS$$$$$M$Y$$$20200824$$LW$US$US
138921103$13892110$3$F$20161018$20200904$20170822$20200916$EXP$$US-JNJFOC-20170813594$JOHNSON AND JOHNSON$$46$YR$A$F$Y$$$20200916$$HP$US$US
1389347314$13893473$14$F$201707$20200729$20170822$20200810$EXP$$DE-BIOGEN-2017BI00445458$BIOGEN$STANKOFF B, GARCIA J, HENDEL?CHAVEZ H, DE?GOER M, L^HONNEUR A, DUBESSY A, TAOUFIK Y. PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY ON DIMETHYL FUMARATE WITH PRESERVED LYMPHOCYTE COUNT BUT DEEP T?CELLS EXHAUSTION. DOI: 10.1177/1352458520942201. MULTIPLE SCLEROSIS JOURNAL. 2020?1?5.$75$YR$$F$Y$$$20200810$$MD$FR$DE
1389395013$13893950$13$F$$20200229$20170822$20200312$EXP$$US-ACTELION-A-NJ2017-158373$ACTELION$$$$$F$Y$56.24$KG$20200312$$HP$US$US
138940803$13894080$3$F$20170804$20200619$20170822$20200702$EXP$$US-JNJFOC-20170818899$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200702$$HP$US$US
138945032$13894503$2$F$$20200804$20170823$20200814$EXP$$GB-BEH-2017082951$CSL BEHRING$PHB BOLTON?MAGGS (ED) D POLES ET AL. ON BEHALF OF THE SERIOUS HAZARDS OF TRANSFUSION (SHOT) STEERING GROUP. ANNUAL SHOT REPORT 2016. THE 2016 ANNUAL SHOT REPORT. 2017$$$N$$Y$$$20200814$$MD$GB$GB
138948482$13894848$2$F$20170521$20200727$20170823$20200805$PER$$CO-AMGEN-COLCT2017119486$AMGEN$$63$YR$A$F$Y$42$KG$20200804$$HP$CO$CO
138957975$13895797$5$F$20170708$20200720$20170823$20200728$EXP$$PHHY2017DE117595$NOVARTIS$$$$E$M$Y$84$KG$20200728$$MD$DE$DE
138958143$13895814$3$F$20140327$20200802$20170823$20200816$EXP$$PHHY2017CA123306$NOVARTIS$$52$YR$$F$Y$$$20200816$$MD$CA$CA
1389581816$13895818$16$F$20170719$20200730$20170823$20200807$EXP$$PHHY2017CO114250$NOVARTIS$$71$YR$$F$Y$61$KG$20200807$$CN$COUNTRY NOT SPECIFIED$CO
138959104$13895910$4$F$201912$20200917$20170823$20200922$PER$$US-AMGEN-USASL2017124310$AMGEN$$61$YR$A$F$Y$$$20200922$$MD$US$US
138962759$13896275$9$F$20170522$20200624$20170823$20200703$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005124$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20200703$$MD$US$US
138968571$13896857$1$I$20161214$20161214$20170823$20170823$EXP$$JP-ASTRAZENECA-2016SF32415$ASTRAZENECA$$77$YR$$F$Y$38.8$KG$20170823$$MD$JP$JP
138973462$13897346$2$F$20161204$20190102$20170823$20190110$EXP$$MY-ASTRAZENECA-2016SF29275$ASTRAZENECA$$28249$DY$$M$Y$$$20190110$$MD$MY$MY
138976771$13897677$1$I$20161205$20161207$20170823$20170823$EXP$$CN-JNJFOC-20161208205$JANSSEN$$42$YR$A$F$Y$74$KG$20170823$$MD$CN$CN
138979362$13897936$2$F$20170817$20171013$20170823$20171019$EXP$$SG-ASTRAZENECA-2017SE84544$ASTRAZENECA$$54$YR$$M$Y$$$20171019$$MD$SG$SG
138987696$13898769$6$F$20090608$20200714$20170824$20200717$EXP$$JP-GLAXOSMITHKLINE-JP2017JPN128187$GLAXOSMITHKLINE$$$$$M$Y$$$20200717$$CN$JP$JP
138989066$13898906$6$F$20090608$20200714$20170824$20200717$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN128187$VIIV$$$$$M$Y$$$20200717$$CN$JP$JP
138993443$13899344$3$F$201701$20200904$20170823$20200911$EXP$$US-JAZZ-2017-US-008240$JAZZ$$34$YR$$F$Y$$$20200911$$HP$US$US
139000892$13900089$2$F$$20170815$20170823$20200909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-073858$BRISTOL MYERS SQUIBB$$$$$F$Y$53.97$KG$20200909$$CN$US$US
139002384$13900238$4$F$20170818$20180125$20170824$20180131$EXP$$CA-ASTRAZENECA-2017SE86098$ASTRAZENECA$$69$YR$$M$Y$$$20180131$$MD$CA$CA
139002477$13900247$7$F$201705$20200709$20170823$20200714$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-068263$BRISTOL MYERS SQUIBB$$85$YR$$F$Y$75$KG$20200714$$MD$CA$CA
1390025310$13900253$10$F$$20200804$20170824$20200810$EXP$$CA-PFIZER INC-2017363631$PFIZER$$$$C$F$Y$$$20200810$$MD$CA$CA
139002823$13900282$3$F$20140820$20200727$20170824$20200803$EXP$$US-JNJFOC-20170820425$JOHNSON AND JOHNSON$$64$YR$A$M$Y$$$20200803$$CN$US$US
1390045814$13900458$14$F$20170821$20200925$20170824$20200929$PER$$US-PFIZER INC-2017363382$PFIZER$$69$YR$$F$Y$$$20200929$$CN$US$US
139008032$13900803$2$F$20170320$20171010$20170824$20171019$EXP$$GB-JNJFOC-20170419503$PHARMACYCLICS$$68$YR$E$M$Y$$$20171019$$MD$GB$GB
139009572$13900957$2$F$$20190904$20170824$20200830$PER$$US-ENDO PHARMACEUTICALS INC-2017-002814$ENDO$$$$$M$Y$113.4$KG$20200830$$CN$US$US
139010621$13901062$1$I$20161031$20161201$20170824$20170824$EXP$$US-JNJFOC-20161201898$JANSSEN$$64$YR$A$M$Y$91.4$KG$20170824$$MD$US$US
139012181$13901218$1$I$20170721$20170809$20170824$20170824$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-147967$RANBAXY$$$$$$Y$$$20170824$$HP$GB$GB
139015091$13901509$1$I$20170821$20170823$20170824$20170824$EXP$$CA-ASTRAZENECA-2017SE86414$ASTRAZENECA$$46$YR$$F$Y$$$20170824$$MD$CA$CA
139015375$13901537$5$F$20170819$20171102$20170824$20171108$EXP$$CA-ASTRAZENECA-2017SE86410$ASTRAZENECA$$73$YR$$F$Y$$$20171108$$MD$CA$CA
139016435$13901643$5$F$$20200810$20170824$20200818$EXP$$PHHY2017CA124481$NOVARTIS$$34$YR$$M$Y$$$20200818$$MD$CA$CA
139017202$13901720$2$F$$20200908$20170824$20200915$EXP$$PHHY2017CA124492$NOVARTIS$$51$YR$$F$Y$$$20200915$$CN$CA$CA
139018093$13901809$3$F$20161223$20180109$20170824$20180113$EXP$$SE-ASTRAZENECA-2017SE00925$ASTRAZENECA$$22156$DY$$M$Y$$$20180113$$MD$SE$SE
1390233543$13902335$43$F$20170329$20200908$20170824$20200927$EXP$$CA-ROCHE-1981757$ROCHE$$60$YR$$F$Y$$$20200928$$HP$CA$CA
139030354$13903035$4$F$201708$20200622$20170824$20200703$EXP$$US-CIPLA LTD.-2017US14663$CIPLA$$$$$$Y$$$20200703$$PH$US$US
1390312514$13903125$14$F$$20200909$20170824$20200915$EXP$$CA-APOTEX-2017AP016854$APOTEX$$74$YR$$F$Y$$$20200915$$HP$CA$CA
139038672$13903867$2$F$$20200812$20170824$20200814$PER$$US-BIOGEN-2017BI00449759$BIOGEN$$$$$M$Y$$$20200814$$CN$US$US
139038753$13903875$3$F$20170323$20200917$20170824$20200929$EXP$$GB-TAKEDA-2017TUS015227$TAKEDA$$$$A$F$Y$$$20200929$$MD$GB$GB
139043783$13904378$3$F$20170814$20171115$20170825$20171116$EXP$$CA-ASTRAZENECA-2017SE83202$ASTRAZENECA$$72$YR$$F$Y$$$20171117$$MD$CA$CA
139043997$13904399$7$F$20170707$20181203$20170825$20200807$EXP$$JP-009507513-1708JPN002142J$MERCK$$86$YR$$M$Y$48$KG$20200807$$CN$JP$JP
139045347$13904534$7$F$20170502$20200702$20170825$20200710$PER$$PHHY2017US088088$NOVARTIS$$40$YR$$F$Y$$$20200710$$MD$US$US
1390455312$13904553$12$F$20170630$20200702$20170825$20200710$EXP$$PHHY2017US122224$NOVARTIS$$50$YR$$F$Y$$$20200710$$MD$US$US
139048783$13904878$3$F$20170821$20180910$20170825$20180918$EXP$$CA-ASTRAZENECA-2017SE86121$ASTRAZENECA$$73$YR$$M$Y$$$20180918$$MD$CA$CA
139050083$13905008$3$F$20170727$20200728$20170825$20200804$EXP$$US-ROCHE-1983073$ROCHE$$54$YR$$M$Y$97.61$KG$20200803$$CN$US$US
1390506117$13905061$17$F$20170126$20200902$20170825$20200908$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-0668$ORION$$56$YR$$M$Y$100.4$KG$20200908$$MD$CA$CA
139060197$13906019$7$F$20170720$20200702$20170825$20200706$PER$$PHHY2017US121057$NOVARTIS$$20$YR$$F$Y$$$20200706$$MD$US$US
139060315$13906031$5$F$$20200825$20170825$20200826$EXP$$US-PFIZER INC-2017363963$PFIZER$$70$YR$$F$Y$88.44$KG$20200826$$CN$US$US
139061134$13906113$4$F$2017$20200722$20170825$20200729$EXP$$US-SA-2017SA129905$SANOFI AVENTIS$$$$$$Y$$$20200729$$HP$US$US
1390614616$13906146$16$F$20170803$20200714$20170825$20200721$EXP$$DE-SA-2017SA152949$SANOFI AVENTIS$$$$$$Y$$$20200721$$MD$DE$DE
139063624$13906362$4$F$20170710$20191024$20170825$20200722$EXP$$PHHY2017CO108158$NOVARTIS$$75$YR$$M$Y$68$KG$20200722$$CN$CO$CO
139064502$13906450$2$F$20170515$20200729$20170825$20200903$PER$$US-HERON THERAPEUTICS, INC-HRTX-2017-000174$HERON$$$$$F$Y$$$20200903$$HP$US$US
139070012$13907001$2$F$$20200908$20170825$20200921$PER$$US-ELI_LILLY_AND_COMPANY-US201708009294$ELI LILLY AND CO$$$$$F$Y$$$20200921$$CN$US$US
1390879615$13908796$15$F$20120822$20200831$20170827$20200907$EXP$$PHHY2012CA074290$NOVARTIS$$57$YR$$F$Y$$$20200908$$MD$CA$CA
139087998$13908799$8$F$2015$20200706$20170827$20200710$EXP$$PHHY2016CO073530$NOVARTIS$$64$YR$$F$Y$160$KG$20200711$$MD$CO$CO
139094042$13909404$2$F$20170803$20200821$20170828$20200903$EXP$$ZA-LUPIN PHARMACEUTICALS INC.-2017-04836$LUPIN$$80$YR$$M$Y$$$20200903$$CN$ZA$ZA
1390941223$13909412$23$F$$20200914$20170828$20200917$PER$$CA-AMGEN-CANSP2017128000$AMGEN$$59$YR$A$M$Y$66$KG$20200917$$CN$CA$CA
139101012$13910101$2$F$20170503$20170922$20170828$20170922$EXP$$GB-ASTRAZENECA-2017SE54974$ASTRAZENECA$$18544$DY$$M$Y$$$20170922$$MD$GB$GB
139106627$13910662$7$F$201708$20200921$20170828$20200923$EXP$$CA-PFIZER INC-2017307172$PFIZER$$60$YR$$F$Y$$$20200923$$MD$CA$CA
1391119010$13911190$10$F$20170510$20200728$20170828$20200730$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-075235$BRISTOL MYERS SQUIBB$NARUSE T, ET AL. 2 CASES OF COLITIS REQUIRING EMERGENCY SURGERY DUE TO INVOLVEMENT OF IPILIMUMAB. 125TH HOKURIKU DIVISION MEETING OF THE JAPANESE SOCIETY OF GASTROENTEROLOGY. 2017?37$75$YR$$M$Y$55$KG$20200730$$MD$JP$JP
139113543$13911354$3$F$$20200714$20170828$20200721$EXP$$PHHY2017US124877$NOVARTIS$$59$YR$$F$Y$$$20200721$$HP$US$US
139125438$13912543$8$F$$20200914$20170828$20200917$PER$$CA-AMGEN-CANSP2017127722$AMGEN$$$$$F$Y$$$20200917$$HP$CA$CA
139126056$13912605$6$F$2017$20200708$20170828$20200713$EXP$$PHHY2017CA118987$NOVARTIS$$$$$F$Y$$$20200713$$CN$COUNTRY NOT SPECIFIED$CA
1391285320$13912853$20$F$20170815$20200727$20170828$20200804$EXP$$PHHY2017CA038696$NOVARTIS$$65$YR$$M$Y$$$20200804$$HP$CA$CA
1391294735$13912947$35$F$201902$20200731$20170828$20200814$EXP$$US-ACTELION-A-NJ2017-158327$ACTELION$$59$YR$$F$Y$86.17$KG$20200814$$HP$US$US
139134666$13913466$6$F$$20200629$20170829$20200703$PER$$CA-AMGEN-CANSP2017129066$AMGEN$$62$YR$A$F$Y$$$20200703$$HP$CA$CA
139136765$13913676$5$F$201610$20200706$20170829$20200710$PER$$US-AMGEN-USASP2017128312$AMGEN$$74$YR$E$M$Y$90$KG$20200710$$HP$US$US
139161953$13916195$3$F$20161103$20180111$20170829$20180113$EXP$$US-ASTRAZENECA-2016SF17185$ASTRAZENECA$$20528$DY$$M$Y$$$20180113$$MD$US$US
139164892$13916489$2$F$201708$20200727$20170829$20200805$EXP$$PHHY2017CA124510$NOVARTIS$$60$YR$$F$Y$$$20200805$$CN$COUNTRY NOT SPECIFIED$CA
1391653712$13916537$12$F$20170808$20200914$20170829$20200917$EXP$$PHHY2017DE119593$NOVARTIS$$71$YR$$F$Y$59$KG$20200918$$HP$DE$DE
1391656412$13916564$12$F$$20200826$20170829$20200902$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076470$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200902$$CN$GB$GB
139166933$13916693$3$F$20170720$20171016$20170829$20171018$EXP$$CN-JNJFOC-20170819215$PHARMACYCLICS$$77$YR$E$M$Y$70$KG$20171018$$CN$CN$CN
139171617$13917161$7$F$201609$20200901$20170829$20200903$EXP$$US-PFIZER INC-2017368800$PFIZER$$61$YR$$M$Y$64$KG$20200903$$MD$US$US
139172645$13917264$5$F$20170702$20200914$20170829$20200915$PER$$CN-AMGEN-CHNCT2017130531$AMGEN$$69$YR$E$M$Y$59$KG$20200915$$MD$CN$CN
139174833$13917483$3$F$201609$20200916$20170829$20200922$PER$$US-JNJFOC-20170825189$JOHNSON AND JOHNSON$$89$YR$E$F$Y$$$20200922$$CN$US$US
139174842$13917484$2$F$20170821$20171115$20170829$20171120$EXP$$FR-JNJFOC-20170824594$JANSSEN$$57$YR$A$F$Y$59.6$KG$20171120$$MD$FR$FR
139175485$13917548$5$F$20150213$20200630$20170829$20200708$EXP$$ES-PFIZER INC-2015109699$PFIZER$GOURD, E.. INOTUZUMAB OZOGAMICIN IN ACUTE LYMPHOBLASTIC LEUKAEMIA. THE LANCET ONCOLOGY. 2019?20(5):E248$46$YR$$M$Y$$$20200708$$HP$GB$ES
1391785110$13917851$10$F$$20200819$20170829$20200820$EXP$$US-PFIZER INC-2017366939$PFIZER$$62$YR$$M$Y$71.66$KG$20200820$$CN$US$US
139182092$13918209$2$F$2017$20200706$20170829$20200716$PER$$US-SA-2017SA034838$SANOFI AVENTIS$$$$$$Y$$$20200716$$CN$US$US
139183583$13918358$3$F$20170818$20170828$20170829$20170908$EXP$$CA-PFIZER INC-2017368964$PFIZER$$69$YR$$M$Y$$$20170908$$MD$CA$CA
1391835910$13918359$10$F$$20200914$20170829$20200922$EXP$$CA-PFIZER INC-2017375529$PFIZER$$$$$F$Y$$$20200922$$HP$CA$CA
139196017$13919601$7$F$201708$20200922$20170830$20200925$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2127$ORION$$60$YR$$F$Y$$$20200925$$MD$CA$CA
139208923$13920892$3$F$201709$20191008$20170830$20191022$EXP$$PHHY2017BR126086$NOVARTIS$$66$YR$$F$Y$72$KG$20191022$$CN$COUNTRY NOT SPECIFIED$BR
139210072$13921007$2$F$20160528$20200906$20170830$20200911$EXP$$US-BAYER-2017-131034$BAYER$$81$YR$E$M$Y$$$20200911$$CN$US$US
139212313$13921231$3$F$$20200714$20170830$20200715$EXP$$CA-PFIZER INC-2017364651$PFIZER$$82$YR$$F$Y$$$20200715$$HP$CA$CA
139213475$13921347$5$F$2017$20200807$20170830$20200811$EXP$$US-PFIZER INC-2017369720$PFIZER$$33$YR$$M$Y$$$20200811$$MD$US$US
139218116$13921811$6$F$20170824$20180314$20170830$20180316$EXP$$PL-JNJFOC-20170825909$JANSSEN$$45$YR$A$F$Y$62.2$KG$20180316$$MD$PL$PL
139219073$13921907$3$F$20170809$20190123$20170830$20190201$EXP$$US-JNJFOC-20170820442$PHARMACYCLICS$$80$YR$E$F$Y$$$20190201$$MD$US$US
139220282$13922028$2$F$20170814$20171117$20170830$20171121$EXP$$CA-CELGENEUS-CAN-20170808487$CELGENE$$72$YR$$F$Y$$$20171121$$MD$CA$CA
139221261$13922126$1$I$$20170825$20170830$20170830$EXP$$US-PFIZER INC-2017370897$PFIZER$$50$YR$$M$Y$$$20170830$$HP$US$US
139223156$13922315$6$F$20170807$20181025$20170830$20181029$EXP$$PHHO2017ES012208$SANDOZ$$51$YR$$M$Y$$$20181029$$HP$ES$ES
139229178$13922917$8$F$20170209$20200831$20170830$20200911$EXP$$JP-INCYTE CORPORATION-2017IN002303$INCYTE$$$$$$Y$$$20200911$$MD$JP$JP
139234056$13923405$6$F$$20200917$20170831$20200924$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2662$ORION$$$$$F$Y$$$20200924$$MD$CA$CA
139237739$13923773$9$F$20170823$20200707$20170831$20200710$PER$$US-PFIZER INC-2017373086$PFIZER$$69$YR$$F$Y$82$KG$20200710$$HP$US$US
1392462912$13924629$12$F$20170709$20180821$20170831$20180831$EXP$$KR-JNJFOC-20170824292$JANSSEN$$79$YR$E$M$Y$$$20180831$$MD$KR$KR
139247186$13924718$6$F$2016$20200901$20170831$20200910$EXP$$US-BIOGEN-2017BI00452675$BIOGEN$$$$$M$Y$$$20200910$$CN$US$US
139247354$13924735$4$F$20170814$20171115$20170831$20171122$EXP$$CA-PFIZER INC-2017365744$PFIZER$$72$YR$$F$Y$$$20171122$$MD$CA$CA
139248571$13924857$1$I$20170720$20170720$20170831$20170831$EXP$$CA-ASTRAZENECA-2017SE74590$ASTRAZENECA$$65$YR$$M$Y$$$20170831$$MD$CA$CA
139250754$13925075$4$F$20170726$20200706$20170831$20200715$EXP$$JP-ACTELION-A-CH2017-157917$ACTELION$$65$YR$$F$Y$51$KG$20200715$$MD$JP$JP
139251619$13925161$9$F$20170801$20180705$20170831$20180713$EXP$$TR-JNJFOC-20170802672$PHARMACYCLICS$$12$YR$C$F$Y$35$KG$20180713$$MD$TR$TR
139262566$13926256$6$F$$20200629$20170831$20200706$EXP$$CA-PFIZER INC-2017375036$PFIZER$$62$YR$$F$Y$$$20200706$$MD$CA$CA
139269506$13926950$6$F$20130502$20200901$20170901$20200904$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN132845$VIIV$$51$YR$$M$Y$$$20200904$$CN$JP$JP
139269966$13926996$6$F$20130502$20200901$20170901$20200904$EXP$$JP-GLAXOSMITHKLINE-JP2017JPN132845$GLAXOSMITHKLINE$$51$YR$$M$Y$$$20200904$$CN$JP$JP
1392762511$13927625$11$F$201306$20200715$20170831$20200717$EXP$$US-JAZZ-JPI-P-033507$JAZZ$$55$YR$$M$Y$113.29$KG$20200717$$HP$US$US
139282032$13928203$2$F$$20200623$20170901$20200708$EXP$US-MLMSERVICE-20170817-0854704-1$US-ALKEM LABORATORIES LIMITED-US-ALKEM-2017-00567$ALKEM$$59$YR$$F$Y$$$20200708$$HP$GB$US
139285222$13928522$2$F$201705$20200722$20170901$20200803$EXP$$BR-JNJFOC-20170512594$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20200803$$CN$BR$BR
139286365$13928636$5$F$$20200824$20170901$20200826$EXP$$US-PFIZER INC-2017372710$PFIZER$SIDLAK, A.. INTRATHECAL BUPIVACAINE AND MORPHINE TOXICITY LEADING TO TRANSIENT HYPOTENSION AND DELAYED STATUS EPILEPTICUS. AMERICAN JOURNAL OF EMERGENCY MEDICINE. 2020?38(5):1046.E5?1046.E7$74$YR$$F$Y$$$20200826$$MD$US$US
139294093$13929409$3$F$20170726$20191217$20170901$20191220$EXP$$ES-ROCHE-1974143$ROCHE$$86$YR$$M$Y$89.1$KG$20191220$$MD$ES$ES
139296576$13929657$6$F$$20200723$20170901$20200803$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2687$ORION$$62$YR$$M$Y$113$KG$20200803$$MD$CA$CA
139296615$13929661$5$F$$20200703$20170901$20200708$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2691$ORION$$62$YR$$F$Y$$$20200708$$MD$CA$CA
1392968210$13929682$10$F$$20200918$20170901$20200923$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2697$ORION$$67$YR$$F$Y$$$20200923$$MD$CA$CA
139296842$13929684$2$F$20170809$20170814$20170901$20170913$EXP$$CA-CELGENEUS-CAN-20170809329$CELGENE$$76$YR$$F$Y$$$20170913$$MD$CA$CA
139298309$13929830$9$F$20150123$20200908$20170901$20200922$EXP$$CA-ROCHE-1987377$ROCHE$$26$YR$$F$Y$$$20200922$$MD$CA$CA
139299093$13929909$3$F$20170819$20171206$20170901$20171213$EXP$$CA-PFIZER INC-2017370522$PFIZER$$72$YR$$F$Y$$$20171213$$MD$CA$CA
139300004$13930000$4$F$20170817$20180323$20170901$20180330$EXP$$FR-JNJFOC-20170821817$JANSSEN$$69$YR$E$F$Y$69$KG$20180330$$MD$FR$FR
139300026$13930002$6$F$20170814$20180315$20170901$20180323$EXP$$ES-JNJFOC-20170815312$JANSSEN$$75$YR$E$M$Y$77$KG$20180323$$MD$ES$ES
139301013$13930101$3$F$20160505$20180115$20170901$20180117$EXP$$PL-ASTRAZENECA-2016SE54838$ASTRAZENECA$$27597$DY$$F$Y$$$20180117$$MD$PL$PL
139302494$13930249$4$F$20170817$20171101$20170901$20171110$EXP$$KR-JNJFOC-20170824040$JANSSEN$$26$YR$A$F$Y$58$KG$20171110$$MD$KR$KR
1393030024$13930300$24$F$20160517$20200729$20170901$20200805$EXP$$PHHY2016CA076948$NOVARTIS$$70$YR$$M$Y$$$20200805$$HP$CA$CA
139304857$13930485$7$F$20170707$20200918$20170901$20200928$EXP$$IN-INCYTE CORPORATION-2017IN007203$INCYTE$$$$$$Y$$$20200928$$CN$IN$IN
1393058872$13930588$72$F$2014$20200710$20170901$20200722$EXP$$JP-JNJFOC-20170827690$JOHNSON AND JOHNSON$$50$YR$A$M$Y$117$KG$20200722$$CN$JP$JP
139309785$13930978$5$F$201704$20200804$20170902$20200807$EXP$$US-JAZZ-2017-US-011332$JAZZ$$50$YR$$F$Y$$$20200807$$HP$US$US
139313823$13931382$3$F$$20200911$20170903$20200923$EXP$$JP-ROCHE-1975173$ROCHE$$71$YR$$F$Y$$$20200923$$MD$JP$JP
139315503$13931550$3$F$20170804$20200828$20170904$20200903$EXP$$GB-ASTRAZENECA-2017SE88838$ASTRAZENECA$$16480$DY$$F$Y$$$20200904$$MD$GB$GB
139318233$13931823$3$F$$20171102$20170904$20200807$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-077067$BRISTOL MYERS SQUIBB$$$$$F$Y$43.08$KG$20200807$$CN$US$US
139328001$13932800$1$I$20170720$20170724$20170904$20170904$EXP$$GB-ASTRAZENECA-2017SE75867$ASTRAZENECA$$19300$DY$$M$Y$84$KG$20170904$$MD$GB$GB
139328444$13932844$4$F$$20200706$20170904$20200803$PER$$CA-AMGEN-CANSP2017133050$AMGEN$$66$YR$E$M$Y$$$20200803$$CN$CA$CA
139328504$13932850$4$F$20170820$20170925$20170904$20170927$EXP$$US-JNJFOC-20170821136$JANSSEN$$68$YR$E$F$Y$92$KG$20170927$$MD$US$US
139328578$13932857$8$F$$20200910$20170904$20200918$EXP$$CA-APOTEX-2017AP017314$APOTEX$$58$YR$$F$Y$$$20200918$$CN$CA$CA
139329681$13932968$1$I$20170214$20170222$20170904$20170904$EXP$$US-JNJFOC-20170222481$JANSSEN$$71$YR$E$M$Y$87$KG$20170904$$MD$US$US
139348402$13934840$2$F$$20200810$20170905$20200813$EXP$$CA-ROCHE-1984386$ROCHE$$68$YR$$F$Y$61$KG$20200813$$HP$CA$CA
1393499321$13934993$21$F$20161024$20200921$20170905$20200928$EXP$$GB-MYLANLABS-2016M1046300$MYLAN$$54$YR$$F$Y$$$20200928$$CN$GB$GB
139355815$13935581$5$F$201708$20200808$20170905$20200817$EXP$$PHHY2017IN130503$NOVARTIS$$29$YR$$M$Y$63$KG$20200817$$MD$IN$IN
139362792$13936279$2$F$201404$20200630$20170905$20200715$EXP$$US-BAYER-2017-128208$BAYER$$78$YR$E$M$Y$$$20200715$$CN$US$US
1393654215$13936542$15$F$201708$20200710$20170905$20200717$EXP$$US-INCYTE CORPORATION-2017IN007200$INCYTE$$$$$$Y$$$20200717$$CN$US$US
139367764$13936776$4$F$$20200629$20170905$20200702$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078918$BRISTOL MYERS SQUIBB$MISHRA R, GOEL B, VAKDE T. LINEZOLID INDUCED THROMBOCYTOPENIA, LACTIC ACIDOSIS, HYPOGLYCEMIA AND WARFARIN TOXICITY. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2017?195:19?24$59$YR$$F$Y$$$20200702$$HP$US$US
139367905$13936790$5$F$2019$20200901$20170905$20200908$EXP$$US-ASTELLAS-2017US034990$ASTELLAS$$$$$M$Y$$$20200908$$CN$US$US
139370009$13937000$9$F$201707$20200810$20170905$20200812$PER$$US-PFIZER INC-2017378579$PFIZER$$68$YR$$M$Y$80$KG$20200812$$MD$US$US
139370202$13937020$2$F$$20200713$20170905$20200716$PER$$US-PFIZER INC-2017379023$PFIZER$$73$YR$$M$Y$$$20200716$$MD$US$US
1393798010$13937980$10$F$20170824$20200903$20170905$20200908$EXP$$JP-ARIAD PHARMACEUTICALS, INC-2017JP008841$TAKEDA$$81$YR$$M$Y$47$KG$20200908$$MD$JP$JP
1393849411$13938494$11$F$201606$20200729$20170905$20200804$EXP$$DE-ABBVIE-17K-062-2092047-00$ABBVIE$$71$YR$$M$Y$$$20200803$$MD$DE$DE
1393852617$13938526$17$F$20170824$20200915$20170905$20200918$EXP$$US-CELGENEUS-USA-20170808539$CELGENE$$34$YR$$F$Y$53$KG$20200918$$HP$US$US
139391324$13939132$4$F$201512$20170828$20170906$20200706$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-077464$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200706$$CN$US$US
139392305$13939230$5$F$$20200807$20170906$20200819$EXP$$CA-APOTEX-2017AP017490$APOTEX$$77$YR$$F$Y$$$20200819$$CN$CA$CA
139394145$13939414$5$F$20170630$20180926$20170906$20181003$EXP$$FI-ROCHE-1986346$ROCHE$$76$YR$$F$Y$65$KG$20181003$$MD$FI$FI
1394017212$13940172$12$F$20170512$20200805$20170906$20200812$EXP$$JP-ACTELION-A-CH2017-158996$ACTELION$$62$YR$$F$Y$87$KG$20200812$$MD$JP$JP
1394020132$13940201$32$F$201708$20200716$20170906$20200724$EXP$$US-INCYTE CORPORATION-2017IN007324$INCYTE$$$$$$Y$$$20200724$$CN$US$US
139403658$13940365$8$F$201706$20200622$20170906$20200703$EXP$$US-INCYTE CORPORATION-2017IN007335$INCYTE$$$$$$Y$$$20200703$$CN$US$US
139405087$13940508$7$F$20160718$20200924$20170906$20200928$PER$$US-PFIZER INC-2016356709$PFIZER$$53$YR$$M$Y$95$KG$20200928$$CN$US$US
1394052618$13940526$18$F$201503$20200910$20170906$20200918$EXP$$PHHY2015CA034068$NOVARTIS$$39$YR$$F$Y$$$20200918$$CN$COUNTRY NOT SPECIFIED$CA
1394052919$13940529$19$F$20150206$20200618$20170906$20200623$EXP$$PHHY2009CA05245$NOVARTIS$$38$YR$$M$Y$$$20200623$$CN$COUNTRY NOT SPECIFIED$CA
139409843$13940984$3$F$20170726$20200817$20170906$20200819$EXP$$US-PFIZER INC-2017380990$PFIZER$$85$YR$$F$Y$$$20200819$$CN$US$US
139412813$13941281$3$F$20170902$20171008$20170906$20171016$EXP$$AU-ASTRAZENECA-2017SE90587$ASTRAZENECA$$70$YR$$M$Y$109.5$KG$20171016$$MD$AU$AU
139413122$13941312$2$F$20170811$20171002$20170906$20171005$EXP$$BE-ASTRAZENECA-2017SE83337$ASTRAZENECA$$68$YR$$M$Y$76$KG$20171005$$MD$BE$BE
139414693$13941469$3$F$20170824$20200813$20170906$20200814$EXP$$US-TESARO, INC.-US-2017TSO02622$GLAXOSMITHKLINE$$69$YR$$F$Y$$$20200814$$MD$US$US
139420772$13942077$2$F$20170825$20171009$20170907$20171013$EXP$$US-JNJFOC-20170903914$JANSSEN$$14$YR$T$M$Y$$$20171013$$MD$US$US
139422143$13942214$3$F$$20200915$20170906$20200918$EXP$$US-JAZZ-2017-US-011448$JAZZ$$$$$F$Y$$$20200918$$HP$US$US
139430542$13943054$2$F$20170807$20200629$20170907$20200706$EXP$$PHHY2017FR129726$NOVARTIS$$63$YR$$M$Y$75$KG$20200706$$HP$FR$FR
139431392$13943139$2$F$20170809$20170913$20170907$20170921$EXP$$IT-JNJFOC-20170814994$PHARMACYCLICS$$82$YR$E$M$Y$$$20170921$$MD$IT$IT
139436094$13943609$4$F$20170718$20180509$20170907$20200707$EXP$$GB-AMGEN-GBRCT2017132758$AMGEN$$72$YR$E$F$Y$83.2$KG$20200707$$HP$GB$GB
139436392$13943639$2$F$$20200821$20170907$20200903$EXP$$ZA-LUPIN PHARMACEUTICALS INC.-2017-05149$LUPIN$$$$$F$Y$$$20200903$$CN$ZA$ZA
139437442$13943744$2$F$20170727$20171010$20170907$20171017$EXP$$US-ASTRAZENECA-2017SE90133$ASTRAZENECA$$24214$DY$$F$Y$$$20171017$$MD$US$US
139439135$13943913$5$F$$20200629$20170907$20200703$EXP$$US-AUROBINDO-AUR-APL-2017-39746$AUROBINDO$$59$YR$$F$Y$$$20200703$$HP$US$US
1394424310$13944243$10$F$20170902$20181108$20170907$20181112$EXP$$JP-ASTRAZENECA-2017SE90841$ASTRAZENECA$$25664$DY$$M$Y$$$20181112$$MD$JP$JP
1394478310$13944783$10$F$20190507$20200730$20170907$20200806$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-080301$BRISTOL MYERS SQUIBB$$81$YR$$M$Y$$$20200806$$CN$US$US
139454856$13945485$6$F$20181228$20200802$20170907$20200806$PER$$US-PFIZER INC-2017383404$PFIZER$$46$YR$$F$Y$$$20200806$$CN$US$US
139459485$13945948$5$F$2014$20200724$20170907$20200729$EXP$$US-UCBSA-2017022802$UCB$$30$YR$$M$Y$68$KG$20200729$$CN$US$US
139460652$13946065$2$F$20161103$20200913$20170907$20200923$EXP$$US-BAYER-2017-112546$BAYER$$70$YR$E$M$Y$$$20200923$$CN$US$US
139461272$13946127$2$F$2017$20200824$20170907$20200917$PER$$US-EISAI MEDICAL RESEARCH-EC-2017-029141$EISAI$$67$YR$E$M$Y$$$20200917$$CN$US$US
139463948$13946394$8$F$20170905$20180418$20170907$20180420$EXP$$CN-ASTRAZENECA-2017SE91068$ASTRAZENECA$$25087$DY$$M$Y$$$20180420$$MD$CN$CN
1394639710$13946397$10$F$$20200720$20170907$20200730$EXP$$CA-APOTEX-2017AP017455$APOTEX$$60$YR$$F$Y$$$20200730$$CN$US$CA
1394651313$13946513$13$F$201704$20200713$20170907$20200724$EXP$$US-ACTELION-A-US2017-153449$ACTELION$$57$YR$$F$Y$81.18$KG$20200724$$HP$US$US
139467372$13946737$2$F$20170704$20171027$20170907$20171108$EXP$$CA-PFIZER INC-2017301822$PFIZER$$57$YR$$M$Y$$$20171108$$MD$CA$CA
139469247$13946924$7$F$2017$20200908$20170907$20200914$EXP$$US-JAZZ-2017-US-011492$JAZZ$$$$$M$Y$$$20200914$$CN$US$US
1394718723$13947187$23$F$201608$20200827$20170907$20200901$EXP$$JP-UNITED THERAPEUTICS-UNT-2016-012695$UNITED THERAPEUTICS$$35$YR$$F$Y$72.6$KG$20200901$$CN$JP$JP
139472115$13947211$5$F$20170902$20191104$20170907$20191107$EXP$$CA-ASTRAZENECA-2017SE91281$ASTRAZENECA$$66$YR$$F$Y$$$20191107$$MD$CA$CA
139473065$13947306$5$F$20161014$20200708$20170907$20200709$EXP$$CA-ROCHE-1875144$ROCHE$$56$YR$$M$Y$$$20200709$$MD$CA$CA
139473283$13947328$3$F$201706$20171123$20170908$20171201$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-079751$BRISTOL MYERS SQUIBB$$91$YR$$M$Y$71$KG$20171201$$MD$CA$CA
139473802$13947380$2$F$$20200803$20170908$20200805$PER$$US-009507513-1709USA000554$MERCK$$$$$$Y$$$20200805$$MD$US$US
139483885$13948388$5$F$20170901$20200831$20170908$20200907$EXP$$CN-ASTELLAS-2017US035865$ASTELLAS$$61$YR$$F$Y$43$KG$20200907$$MD$CN$CN
139484065$13948406$5$F$20170123$20180726$20170908$20190824$EXP$$GB-TEVA-803945ACC$TEVA$$32$YR$$F$Y$66.2$KG$20190825$$MD$GB$GB
139491828$13949182$8$F$2015$20200910$20170908$20200918$EXP$$JP-UNITED THERAPEUTICS-UNT-2015-008541$UNITED THERAPEUTICS$$31$YR$$M$Y$68.9$KG$20200918$$CN$JP$JP
139493842$13949384$2$F$$20200813$20170908$20200818$EXP$$US-JAZZ-2017-US-009429$JAZZ$$$$$F$Y$$$20200818$$HP$US$US
139495162$13949516$2$F$2017$20200528$20170908$20200820$PER$$US-JAZZ-2017-US-008872$JAZZ$$$$$M$Y$$$20200820$$MD$US$US
139498942$13949894$2$F$2016$20200706$20170908$20200717$EXP$$US-INCYTE CORPORATION-2017IN007434$INCYTE$$$$$$Y$$$20200717$$CN$US$US
139499273$13949927$3$F$20170810$20180607$20170908$20180615$EXP$$CA-CELGENEUS-CAN-20170809328$CELGENE$$54$YR$$F$Y$$$20180615$$MD$CA$CA
139502531$13950253$1$I$20170826$20170901$20170908$20170908$EXP$$CA-PFIZER INC-2017384734$PFIZER$$57$YR$$F$Y$57.1$KG$20170908$$MD$CA$CA
1395070921$13950709$21$F$20170707$20200831$20170908$20200910$EXP$$JP-009507513-1708JPN001278J$MERCK$$77$YR$$F$Y$67.4$KG$20200910$$CN$JP$JP
139514585$13951458$5$F$20161222$20200717$20170908$20200723$EXP$$US-JAZZ-2017-US-008862$JAZZ$$33$YR$$F$Y$$$20200723$$HP$US$US
1395151611$13951516$11$F$20170806$20190314$20170908$20190319$EXP$$FR-JNJFOC-20170828592$PHARMACYCLICS$$16$YR$T$M$Y$55$KG$20190319$$MD$FR$FR
139517262$13951726$2$F$20170818$20170926$20170908$20171004$EXP$$US-JNJFOC-20170907212$JANSSEN$$74$YR$E$M$Y$$$20171004$$MD$US$US
139528104$13952810$4$F$20170314$20200609$20170911$20200702$PER$$US-TEVA-756021USA$TEVA$$57$YR$$M$Y$$$20200702$$MD$US$US
139536783$13953678$3$F$$20200717$20170911$20200721$PER$$US-PFIZER INC-2017390632$PFIZER$$71$YR$$M$Y$90.72$KG$20200721$$MD$US$US
139565471$13956547$1$I$201511$20160128$20170912$20170912$EXP$$PHHY2016BR013674$NOVARTIS$$63$YR$$F$Y$53$KG$20170912$$MD$BR$BR
139566712$13956671$2$F$201709$20170906$20170911$20200914$EXP$$AU-JNJFOC-20170905341$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20200914$$CN$AU$AU
139567639$13956763$9$F$20170815$20200819$20170911$20200825$EXP$$PHHY2017CA133691$NOVARTIS$$70$YR$$F$Y$52$KG$20200826$$HP$CA$CA
139570832$13957083$2$F$$20200713$20170911$20200717$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-078738$BRISTOL MYERS SQUIBB$$81$YR$$F$Y$57.15$KG$20200717$$CN$US$US
139571559$13957155$9$F$201912$20200630$20170911$20200701$EXP$$US-PFIZER INC-2017388761$PFIZER$$76$YR$$F$Y$86$KG$20200701$$MD$US$US
139573072$13957307$2$F$20170327$20190116$20170911$20190125$EXP$$US-JNJFOC-20170404023$PHARMACYCLICS$CHENG C, WORONOW D, NAYERNAMA A, WROBLEWSKI T, JONES SC. IBRUTINIB?ASSOCIATED VENTRICULAR ARRHYTHMIA IN THE FDA ADVERSE EVENT REPORTING SYSTEM.. LEUKEMIA + LYMPHOMA 2018?59 (NO 12):3016?3017.$72$YR$E$M$Y$100.3$KG$20190125$$MD$US$US
139573649$13957364$9$F$20180329$20200923$20170911$20200926$EXP$$PHHY2017CA132557$NOVARTIS$$57$YR$$F$Y$$$20200926$$MD$CA$CA
139579455$13957945$5$F$$20200825$20170912$20200903$EXP$$CA-APOTEX-2017AP017756$APOTEX$$46$YR$$F$Y$$$20200903$$HP$CA$CA
139579948$13957994$8$F$$20200918$20170912$20200930$EXP$$CA-APOTEX-2017AP017733$APOTEX$$37$YR$$F$Y$$$20200930$$CN$CA$CA
139582275$13958227$5$F$$20200825$20170912$20200907$EXP$$CA-APOTEX-2017AP017824$APOTEX$$79$YR$$F$Y$$$20200907$$CN$CA$CA
139583632$13958363$2$F$$20200713$20170912$20200716$PER$$US-PFIZER INC-2017390917$PFIZER$$65$YR$$F$Y$$$20200716$$HP$US$US
139583748$13958374$8$F$$20200701$20170912$20200702$PER$$US-PFIZER INC-2016444428$PFIZER$$76$YR$$F$Y$92$KG$20200702$$MD$US$US
139598654$13959865$4$F$201707$20200629$20170912$20200703$PER$$CA-AMGEN-CANSP2017136465$AMGEN$$49$YR$A$F$Y$$$20200703$$HP$CA$CA
139601132$13960113$2$F$20150306$20200730$20170912$20200811$EXP$$US-BAYER-2017-117336$BAYER$$56$YR$A$M$Y$$$20200811$$CN$US$US
139603342$13960334$2$F$20160820$20200721$20170912$20200729$EXP$$US-BAYER-2017-126534$BAYER$$68$YR$E$F$Y$$$20200729$$CN$US$US
139604432$13960443$2$F$$20200227$20170912$20200928$PER$$US-ALLERGAN-1723193US$ALLERGAN$$$$$F$Y$$$20200928$$HP$US$US
139604853$13960485$3$F$$20191017$20170912$20200928$PER$$US-FRI-1000075876$ALLERGAN$$$$$M$Y$74.83$KG$20200928$$CN$US$US
139610073$13961007$3$F$20170406$20200710$20170912$20200722$EXP$$US-JNJFOC-20170909028$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200722$$HP$US$US
1396111913$13961119$13$F$2017$20200825$20170912$20200901$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-080601$BRISTOL MYERS SQUIBB$IWADOU S, ET AL. A CASE OF LUNG ADENOSQUAMOUS CARCINOMA WITH DRUG?INDUCED ORGANISING PNEUMONIA DUE TO NIVOLUMAB AFTER ACHIEVING A CLINICAL RESPONSE. THE 44TH ULTRASOUND CONFERENCE OF DOPPLER IMAGING AND NEW TECHNOLOGY. 2017?15$62$YR$$M$Y$53.5$KG$20200901$$MD$JP$JP
139613741$13961374$1$I$20170727$20170908$20170912$20170912$EXP$$CA-JNJFOC-20170908085$PHARMACYCLICS$$58$YR$A$M$Y$100$KG$20170912$$MD$CA$CA
139620043$13962004$3$F$20170818$20200727$20170912$20200807$EXP$$US-AKORN PHARMACEUTICALS-2017AKN01096$AKORN$$22$YR$$F$Y$$$20200807$$CN$US$US
139624574$13962457$4$F$20160909$20200914$20170913$20200922$EXP$$US-ASTRAZENECA-2017SE91693$ASTRAZENECA$$74$YR$$F$Y$62.1$KG$20200922$$$US$US
139624594$13962459$4$F$20160611$20200812$20170913$20200817$EXP$$JP-009507513-1709JPN000651J$MERCK$$57$YR$$F$Y$53$KG$20200817$$CN$JP$JP
139629795$13962979$5$F$$20200807$20170913$20200819$EXP$$CA-APOTEX-2017AP017777$APOTEX$$55$YR$$F$Y$$$20200819$$HP$CA$CA
139631289$13963128$9$F$201708$20200911$20170913$20200915$EXP$$US-PFIZER INC-2017231807$PFIZER$$70$YR$$F$Y$95$KG$20200915$$HP$US$US
139631357$13963135$7$F$$20200717$20170913$20200720$PER$$US-PFIZER INC-2017395939$PFIZER$$56$YR$$M$Y$79$KG$20200720$$MD$US$US
1396380419$13963804$19$F$20170825$20200828$20170913$20200904$EXP$$PHHY2017CA129367$NOVARTIS$$65$YR$$M$Y$$$20200904$$PH$CA$CA
139644185$13964418$5$F$20170905$20200630$20170913$20200709$PER$$PL-AMGEN-POLCT2017138190$AMGEN$$78$YR$E$F$Y$55$KG$20200708$$MD$PL$PL
139644532$13964453$2$F$20170819$20170914$20170913$20170918$EXP$$CA-ASTRAZENECA-2017SE86088$ASTRAZENECA$$71$YR$$M$Y$$$20170918$$MD$CA$CA
139650942$13965094$2$F$201701$20190924$20170913$20200903$PER$$US-PERRIGO-17US001444$PERRIGO$$52$YR$$F$Y$49.89$KG$20200903$$CN$US$US
139654205$13965420$5$F$$20200807$20170913$20200819$EXP$$CA-APOTEX-2017AP017881$APOTEX$$54$YR$$F$Y$74$KG$20200819$$CN$CA$CA
139659761$13965976$1$I$20170719$20170830$20170913$20170913$EXP$$CA-JNJFOC-20170911729$JANSSEN$$71$YR$E$M$Y$$$20170913$$MD$CA$CA
139664222$13966422$2$F$20170909$20180105$20170913$20180108$EXP$$CA-ASTRAZENECA-2017SE93409$ASTRAZENECA$$71$YR$$M$Y$$$20180108$$MD$CA$CA
139674374$13967437$4$F$$20200904$20170914$20200908$PER$$US-PFIZER INC-2017394958$PFIZER$$$$A$F$Y$$$20200908$$CN$US$US
139675555$13967555$5$F$$20200826$20170914$20200905$EXP$$CA-APOTEX-2017AP017891$APOTEX$$63$YR$$F$Y$$$20200905$$CN$CA$CA
139678352$13967835$2$F$20150830$20200629$20170914$20200714$EXP$$US-BAYER-2017-117000$BAYER$$71$YR$E$M$Y$$$20200714$$CN$US$US
139679662$13967966$2$F$20160125$20200805$20170914$20200824$EXP$AT-BAGAGES-174087$AT-ALLERGAN-1751930US$ALLERGAN$$$$$M$Y$$$20200824$$CN$AT$AT
139682352$13968235$2$F$20170911$20171011$20170914$20171016$EXP$$NZ-JNJFOC-20170911017$JANSSEN$$53$YR$A$F$Y$95$KG$20171016$$MD$NZ$NZ
139691473$13969147$3$F$2018$20200908$20170914$20200918$EXP$$US-ASTELLAS-2017US012476$ASTELLAS$$68$YR$$M$Y$$$20200918$$CN$US$US
139694963$13969496$3$F$20170710$20200803$20170914$20200810$EXP$$US-ASTELLAS-2017US028855$ASTELLAS$$81$YR$$M$Y$$$20200810$$CN$US$US
139698062$13969806$2$F$201709$20200714$20170914$20200715$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-081865$BRISTOL MYERS SQUIBB$$5$DEC$$M$Y$$$20200715$$MD$JP$JP
1396980912$13969809$12$F$$20200825$20170914$20200903$EXP$$CA-APOTEX-2017AP018054$APOTEX$$67$YR$$F$Y$$$20200903$$CN$CA$CA
139699634$13969963$4$F$20170118$20200915$20170914$20200921$EXP$$JP-ARIAD PHARMACEUTICALS, INC-2017JP007645$TAKEDA$$48$YR$$M$Y$48$KG$20200921$$MD$JP$JP
139700444$13970044$4$F$201507$20200624$20170914$20200702$EXP$$US-ASTRAZENECA-2016SF24329$ASTRAZENECA$$728$MON$$F$Y$121.6$KG$20200702$$$US$US
1397048223$13970482$23$F$20170403$20190729$20170914$20190906$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-080933$BRISTOL MYERS SQUIBB$$66$YR$$M$Y$68$KG$20190906$$CN$DE$DE
139707748$13970774$8$F$$20200126$20170914$20200702$EXP$$BE-SA-2017SA166875$SANOFI AVENTIS$$$$$$Y$$$20200702$$MD$BE$BE
139711593$13971159$3$F$20161230$20200812$20170914$20200821$EXP$$US-ASTELLAS-2017US002370$ASTELLAS$$76$YR$$M$Y$$$20200821$$CN$US$US
1397123119$13971231$19$F$2015$20200902$20170914$20200911$EXP$$US-ASTELLAS-2017US014871$ASTELLAS$$79$YR$$M$Y$$$20200911$$CN$US$US
139715392$13971539$2$F$20170818$20180510$20170914$20180518$EXP$$US-ASTRAZENECA-2017SE85860$ASTRAZENECA$$$$$F$Y$$$20180518$$MD$US$US
139726372$13972637$2$F$20170101$20200115$20170914$20200915$PER$$US-ASTELLAS-2016US049573$ASTELLAS$$78$YR$$M$Y$$$20200915$$CN$US$US
139733181$13973318$1$I$$20170904$20170915$20170915$EXP$$US-ROCHE-1992358$ROCHE$TRACE A, HOANG K, MCMONAGLE J AND USATINE R. SEVERE RIGHT HIP PAIN.. JOURNAL OF FAMILY PRACTICE. 2017?66(6):395?397.$63$YR$$F$Y$$$20170915$$MD$US$US
139738164$13973816$4$F$20170820$20200708$20170915$20200710$EXP$$AU-ABBVIE-17P-008-2096651-00$ABBVIE$$76$YR$$M$Y$74$KG$20200710$$MD$AU$AU
139748824$13974882$4$F$$20200630$20170915$20200706$EXP$CA-MLMSERVICE-20170830-0873392-1$CA-JNJFOC-20170904498$JOHNSON AND JOHNSON$MAXIME G, DAZE Y, MIREAULT P, CRAHES M. TOXIC MYOCARDITIS CAUSED BY ACETAMINOPHEN IN A MULTIDRUG OVERDOSE. AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY. 2017 DEC?38 (4):349?352.$18$YR$$F$Y$$$20200706$$HP$CA$CA
139749294$13974929$4$F$$20180621$20170915$20200908$EXP$$CA-APOTEX-2017AP018008$APOTEX$$$$$M$Y$$$20200908$$CN$CA$CA
139749552$13974955$2$F$201505$20190909$20170915$20200710$EXP$$US-SAOL THERAPEUTICS-0500176565$SAOL THERAPEUTICS$$59$YR$$M$Y$$$20200710$$CN$US$US
139751358$13975135$8$F$2016$20200814$20170915$20200819$EXP$$US-SA-2017SA168498$SANOFI AVENTIS$$$$$$Y$$$20200819$$HP$US$US
139751587$13975158$7$F$$20200918$20170915$20200930$EXP$$CA-APOTEX-2017AP018001$APOTEX$$$$$F$Y$$$20200930$$CN$CA$CA
1397621617$13976216$17$F$20170827$20200704$20170915$20200707$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-077567$BRISTOL MYERS SQUIBB$$57$YR$$F$Y$55$KG$20200707$$HP$ES$ES
1397663113$13976631$13$F$201709$20200915$20170915$20200925$EXP$$PHHY2017BR116847$NOVARTIS$$42$YR$$F$Y$72$KG$20200925$$HP$BR$BR
139771952$13977195$2$F$20160311$20170922$20170915$20170925$EXP$$TW-ASTRAZENECA-2016SE28745$ASTRAZENECA$$22030$DY$$F$Y$$$20170925$$MD$TW$TW
1397725112$13977251$12$F$20160512$20200903$20170915$20200911$EXP$$PHHY2016CA067704$NOVARTIS$$51$YR$$M$Y$$$20200911$$HP$CA$CA
139776804$13977680$4$F$20160831$20200906$20170915$20200915$EXP$GB-MHRA-ADR 24151631$GB-ACCORD-058486$ACCORD$$83$YR$E$F$Y$49.2$KG$20200915$$HP$GB$GB
139781832$13978183$2$F$20170902$20170907$20170915$20170918$EXP$$JP-PFIZER INC-2017390353$PFIZER$$70$YR$$M$Y$$$20170918$$MD$JP$JP
139784652$13978465$2$F$20170905$20200219$20170915$20200304$EXP$$FR-JNJFOC-20170911166$JOHNSON AND JOHNSON$$76$YR$$M$Y$$$20200304$$MD$FR$FR
139789602$13978960$2$F$$20200708$20170914$20200714$EXP$$US-ASTELLAS-2017US006004$ASTELLAS$$$$$M$Y$$$20200714$$CN$US$US
139798024$13979802$4$F$201905$20200725$20170914$20200731$EXP$$US-ASTELLAS-2017US025795$ASTELLAS$$61$YR$$M$Y$$$20200731$$CN$US$US
139798293$13979829$3$F$$20200827$20170914$20200907$EXP$$US-ASTELLAS-2017US011440$ASTELLAS$$$$$M$Y$$$20200907$$CN$US$US
1398017612$13980176$12$F$201709$20200818$20170914$20200826$EXP$$US-ASTELLAS-2017US027619$ASTELLAS$$85$YR$$M$Y$$$20200826$$CN$US$US
139805112$13980511$2$F$2014$20200630$20170918$20200706$EXP$$CA-ABBVIE-17K-028-2100679-00$ABBVIE$$$$$M$Y$$$20200706$$CN$CA$CA
139806806$13980680$6$F$$20200716$20170918$20200719$EXP$$ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-050658$BOEHRINGER INGELHEIM$AMARILLA LANZAS I, FERNANDEZ MOSTEIRIN N, CALVO VINAS J, SANCHO VAL L, CUESTA GALLARDO I, GAVIN SEBASTIAN O. A MULTICENTER EXPERIENCE WITH IDARUCIZUMAB ^IN REAL WORLD^ AS REVERSAL ANTICOAGULATION OF DABIGATRAN. 2020 JUL?.$81$YR$$M$Y$$$20200720$$MD$ES$ES
139807088$13980708$8$F$201709$20200706$20170918$20200709$PER$$US-AMGEN-USASL2017140116$AMGEN$$56$YR$A$F$Y$$$20200709$$MD$US$US
139813346$13981334$6$F$201706$20200812$20170918$20200817$PER$$US-PFIZER INC-2017244111$PFIZER$$24$YR$$F$Y$73$KG$20200817$$MD$US$US
139817566$13981756$6$F$20170913$20180105$20170918$20180112$EXP$$CN-ASTRAZENECA-2017SE94706$ASTRAZENECA$$25782$DY$$F$Y$$$20180113$$MD$CN$CN
139818417$13981841$7$F$$20200817$20170918$20200819$EXP$$US-PFIZER INC-2017401296$PFIZER$$74$YR$$F$Y$$$20200819$$CN$US$US
139821242$13982124$2$F$2016$20200706$20170918$20200711$EXP$$PHHY2016CA070862$NOVARTIS$$45$YR$$F$Y$$$20200712$$CN$COUNTRY NOT SPECIFIED$CA
139822994$13982299$4$F$20160628$20180924$20170918$20180926$EXP$$US-ROCHE-1788319$ROCHE$$75$YR$$M$Y$66.5$KG$20180926$$MD$US$US
139823855$13982385$5$F$201708$20200630$20170918$20200706$PER$$US-PFIZER INC-2017399331$PFIZER$$67$YR$$M$Y$79$KG$20200706$$HP$US$US
139824792$13982479$2$F$20170714$20171019$20170918$20171031$EXP$$FR-VANDA PHARMACEUTICALS, INC-2017TASFR001785$VANDA PHARMACEUTICALS$$39$YR$$F$Y$44.5$KG$20171031$$HP$FR$FR
139826982$13982698$2$F$20170905$20170920$20170918$20170928$EXP$$NZ-JNJFOC-20170913761$PHARMACYCLICS$$81$YR$E$M$Y$$$20170928$$MD$NZ$NZ
139832502$13983250$2$F$20170713$20200914$20170918$20200916$EXP$$PHHY2017ES136549$NOVARTIS$$84$YR$$M$Y$63$KG$20200916$$HP$ES$ES
1398335110$13983351$10$F$$20200814$20170918$20200818$EXP$$US-PFIZER INC-2017397457$PFIZER$$72$YR$$F$Y$$$20200818$$CN$US$US
139841935$13984193$5$F$$20200707$20170918$20200709$EXP$$CA-ROCHE-1993146$ROCHE$$$$$F$Y$$$20200709$$HP$CA$CA
139842428$13984242$8$F$20170705$20200917$20170918$20200918$EXP$$GB-PFIZER INC-2017404056$PFIZER$$83$YR$$F$Y$$$20200918$$HP$GB$GB
139842474$13984247$4$F$$20200713$20170918$20200721$PER$$US-SA-2017SA171335$SANOFI AVENTIS$$$$$$Y$$$20200721$$CN$US$US
139845895$13984589$5$F$20170908$20171116$20170918$20200716$EXP$$FR-CELGENEUS-FRA-20170902956$CELGENE$$73$YR$$M$Y$76$KG$20200716$$HP$FR$FR
139850483$13985048$3$F$20170828$20200818$20170919$20200821$PER$$US-AMGEN-USACT2017131158$AMGEN$$67$YR$E$F$Y$112$KG$20200821$$HP$US$US
139854393$13985439$3$F$20170705$20200905$20170919$20200911$EXP$$GB-AUROBINDO-AUR-APL-2017-40139$AUROBINDO$$83$YR$$F$Y$$$20200911$$HP$GB$GB
139854827$13985482$7$F$201702$20200904$20170919$20200916$EXP$$CA-ROCHE-1991029$ROCHE$$53$YR$$F$Y$41$KG$20200916$$MD$CA$CA
139857392$13985739$2$F$2017$20190809$20170919$20200924$PER$$US-ENDO PHARMACEUTICALS INC-2017-002648$ENDO$$$$$F$Y$$$20200924$$CN$US$US
139860753$13986075$3$F$$20200716$20170919$20200717$PER$$US-PFIZER INC-2017401739$PFIZER$$52$YR$$F$Y$$$20200717$$MD$US$US
139866343$13986634$3$F$$20200702$20170919$20200714$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK144375$GLAXOSMITHKLINE$$$$$M$Y$$$20200714$$MD$CA$CA
1398694112$13986941$12$F$20170306$20191003$20170919$20200925$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-024485$BRISTOL MYERS SQUIBB$$70$YR$$M$Y$$$20200925$$HP$FR$FR
139874642$13987464$2$F$20170810$20171002$20170919$20171004$EXP$$KR-PFIZER INC-2017366755$PFIZER$$63$YR$$M$Y$$$20171004$$MD$KR$KR
139877502$13987750$2$F$20170914$20171106$20170919$20171108$EXP$$CA-ASTRAZENECA-2017SE94834$ASTRAZENECA$$72$YR$$M$Y$$$20171109$$MD$CA$CA
139878563$13987856$3$F$20150321$20200824$20170919$20200904$EXP$$JP-INCYTE CORPORATION-2017IN007648$INCYTE$$$$$$Y$$$20200904$$MD$JP$JP
1398794912$13987949$12$F$20180605$20200804$20170919$20200811$EXP$$PHHY2017CR079583$NOVARTIS$$39$YR$$M$Y$108$KG$20200811$$CN$COUNTRY NOT SPECIFIED$CR
139879571$13987957$1$I$201106$20170914$20170919$20170919$EXP$$US-ALLERGAN-1752985US$ALLERGAN$$67$YR$$F$Y$$$20170919$$LW$US$US
139882562$13988256$2$F$20170123$20180206$20170919$20180216$EXP$$GB-MYLANLABS-2017M1057056$MYLAN$$$$$$Y$$$20180214$$MD$GB$GB
1398828919$13988289$19$F$$20200915$20170919$20200923$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-083265$BRISTOL MYERS SQUIBB$$59$YR$$M$Y$66$KG$20200923$$MD$CA$CA
1398852618$13988526$18$F$201709$20200921$20170919$20200922$EXP$$CA-PFIZER INC-2017397126$PFIZER$$71$YR$$M$Y$$$20200922$$HP$CA$CA
1398872712$13988727$12$F$2017$20200724$20170919$20200729$EXP$$CA-TAKEDA-2017TUS017710$TAKEDA$$73$YR$$M$Y$$$20200729$$HP$CA$CA
139888773$13988877$3$F$$20200915$20170919$20200921$EXP$$CA-TEVA-807464ACC$TEVA$$8$YR$C$M$Y$28$KG$20200921$$PH$CA$CA
139891312$13989131$2$F$20170301$20200914$20170920$20200922$EXP$$ES-ROCHE-1995267$ROCHE$$61$YR$$F$Y$$$20200922$$MD$ES$ES
139892175$13989217$5$F$20170626$20200918$20170920$20200925$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-082123$BRISTOL MYERS SQUIBB$$76$YR$$F$Y$$$20200925$$MD$DE$DE
139899413$13989941$3$F$$20200807$20170920$20200813$EXP$$SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-082535$BRISTOL MYERS SQUIBB$FARKAS F, MISTRIK M, SIMANBKOVA I, SOPKO L, SLEZAIKOVA K, BEITOROVA A.. NEW TRENDS IN PH TREATMENT + ACUTE TREATMENT OF LYMPHOBLASTIC LEUKEMIA. ONKOLOGIA. 2017?12(3):210?2$24$YR$$M$Y$$$20200813$$MD$SK$SK
139902635$13990263$5$F$2015$20200721$20170920$20200728$EXP$$US-GLAXOSMITHKLINE-US2017GSK145436$GLAXOSMITHKLINE$$$$$F$Y$$$20200728$$CN$US$US
139906769$13990676$9$F$$20200901$20170920$20200904$PER$$US-PFIZER INC-2017403277$PFIZER$$78$YR$$M$Y$116$KG$20200904$$CN$US$US
139907225$13990722$5$F$20161117$20200813$20170920$20200820$EXP$$FR-ROCHE-1890305$ROCHE$$76$YR$$F$Y$56$KG$20200820$$MD$FR$FR
1399089310$13990893$10$F$$20200714$20170920$20200715$EXP$$US-PFIZER INC-2017405466$PFIZER$$75$YR$$F$Y$$$20200715$$MD$US$US
139928803$13992880$3$F$$20200714$20170920$20200715$PER$$US-BIOGEN-2017BI00457629$BIOGEN$$$$$F$Y$$$20200715$$CN$US$US
139930322$13993032$2$F$$20200713$20170920$20200716$PER$$US-PFIZER INC-2017403729$PFIZER$$55$YR$$F$Y$$$20200716$$MD$US$US
139932112$13993211$2$F$201408$20200803$20170920$20200812$EXP$$US-JNJFOC-20170725035$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200812$$CN$US$US
139933914$13993391$4$F$20170908$20180403$20170920$20180404$EXP$$ES-JNJFOC-20170915668$JANSSEN$$23$YR$A$M$Y$103$KG$20180404$$MD$ES$ES
139937304$13993730$4$F$2007$20200908$20170920$20200909$EXP$$US-TAKEDA-2017TUS019566$TAKEDA$$$$$M$Y$$$20200909$$CN$US$US
139947052$13994705$2$F$$20170911$20170921$20200915$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-084507$BRISTOL MYERS SQUIBB$HUIBREGTSE KE, VO KT, DUBOIS SG, FETZKO S, NEUHAUS J, BATRA V, MARIS JM, ET AL. INCIDENCE AND RISK FACTORS FOR SECONDARY MALIGNANCY IN PATIENTS WITH NEUROBLASTOMA AFTER TREATMENT WITH (131)I?METAIODOBENZYLGUANIDINE. EUROPEAN JOURNAL OF CANCER. 2016?66:144?52$$$$F$Y$$$20200915$$HP$US$US
1399490616$13994906$16$F$201709$20200910$20170921$20200918$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2903$ORION$$71$YR$$M$Y$$$20200918$$MD$CA$CA
139953111$13995311$1$I$20170910$20170914$20170921$20170921$EXP$$US-ASTRAZENECA-2017SE94547$ASTRAZENECA$$63$YR$$F$Y$$$20170921$$MD$US$US
139954486$13995448$6$F$$20200721$20170921$20200731$EXP$$CA-APOTEX-2017AP018261$APOTEX$$$$$F$Y$$$20200731$$CN$CA$CA
1399570913$13995709$13$F$201709$20200825$20170921$20200827$EXP$$US-PFIZER INC-2017409502$PFIZER$$81$YR$$M$Y$113$KG$20200827$$HP$US$US
139957372$13995737$2$F$$20190517$20170921$20190521$PER$$US-PFIZER INC-2017407946$PFIZER$$68$YR$$F$Y$$$20190521$$MD$US$US
1399582412$13995824$12$F$201412$20200903$20170921$20200912$EXP$$PHHY2015CA002165$NOVARTIS$$64$YR$$M$Y$$$20200912$$MD$CA$CA
139960972$13996097$2$F$201702$20200227$20170921$20200922$PER$$US-AMARIN PHARMA, INC.-2017AMR000057$AMARIN$$68$YR$E$M$Y$101.24$KG$20200914$$CN$US$US
139965662$13996566$2$F$20170806$20180621$20170921$20180625$EXP$$CA-CELGENEUS-CAN-20170905493$CELGENE$$66$YR$$F$Y$$$20180625$$HP$CA$CA
139970134$13997013$4$F$$20200929$20170921$20200930$EXP$$CA-PFIZER INC-2017399047$PFIZER$$66$YR$$M$Y$$$20200930$$CN$CA$CA
139974463$13997446$3$F$20150426$20200914$20170921$20200925$EXP$$US-JNJFOC-20170920002$JOHNSON AND JOHNSON$$84$YR$E$F$Y$$$20200925$$CN$US$US
139977956$13997795$6$F$20170825$20200422$20170921$20200430$EXP$$US-JNJFOC-20170912327$JOHNSON AND JOHNSON$$69$YR$$M$Y$$$20200430$$MD$US$US
139982125$13998212$5$F$202006$20200716$20170921$20200730$PER$$US-ACTELION-A-NJ2017-159783$ACTELION$$38$YR$$M$Y$$$20200730$$MD$US$US
139988932$13998893$2$F$201709$20200828$20170922$20200905$EXP$$PHHY2017CA138383$NOVARTIS$$35$YR$$F$Y$$$20200905$$HP$CA$CA
139994512$13999451$2$F$$20170911$20170922$20200803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-081548$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200803$$CN$US$US
139998773$13999877$3$F$20150809$20200805$20170922$20200811$PER$$US-JNJFOC-20170808115$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200811$$CN$US$US
139999053$13999905$3$F$20150812$20200812$20170922$20200817$PER$$US-JNJFOC-20170808278$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20200817$$CN$US$US
139999103$13999910$3$F$201505$20200729$20170922$20200806$EXP$$US-JNJFOC-20170808428$JOHNSON AND JOHNSON$$55$YR$A$M$Y$$$20200806$$CN$US$US
139999143$13999914$3$F$20150929$20200901$20170922$20200902$PER$$US-JNJFOC-20170808082$JOHNSON AND JOHNSON$$49$YR$A$M$Y$$$20200902$$LW$US$US
139999203$13999920$3$F$201312$20200714$20170922$20200717$PER$$US-JNJFOC-20170808803$JOHNSON AND JOHNSON$$83$YR$$F$Y$$$20200717$$CN$US$US
139999573$13999957$3$F$20140605$20200924$20170922$20200929$PER$$US-JNJFOC-20170811728$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200929$$CN$US$US
139999643$13999964$3$F$20140711$20200819$20170922$20200901$EXP$$US-JNJFOC-20170810787$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200901$$CN$US$US
139999783$13999978$3$F$2015$20200809$20170922$20200813$PER$$US-JNJFOC-20170811461$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200813$$CN$US$US
140000183$14000018$3$F$201602$20200917$20170922$20200922$PER$$US-JNJFOC-20170811852$JOHNSON AND JOHNSON$$43$YR$A$F$Y$$$20200922$$CN$US$US
140000823$14000082$3$F$201704$20200728$20170922$20200731$PER$$US-JNJFOC-20170814195$JOHNSON AND JOHNSON$$65$YR$E$M$Y$$$20200731$$CN$US$US
140001304$14000130$4$F$20150325$20200628$20170922$20200702$PER$$US-JNJFOC-20170814168$JOHNSON AND JOHNSON$$79$YR$$F$Y$$$20200702$$CN$US$US
140001543$14000154$3$F$201512$20200915$20170922$20200918$PER$$US-JNJFOC-20170815072$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200918$$CN$US$US
140002163$14000216$3$F$20150428$20200709$20170922$20200713$PER$$PR-JNJFOC-20170824303$JOHNSON AND JOHNSON$$72$YR$$M$Y$$$20200713$$CN$US$PR
140002203$14000220$3$F$20140910$20200827$20170922$20200902$PER$$US-JNJFOC-20170826020$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200902$$CN$US$US
140002476$14000247$6$F$20170215$20200720$20170922$20200731$EXP$$US-JNJFOC-20170826963$JOHNSON AND JOHNSON$$91$YR$E$M$Y$79.45$KG$20200731$$CN$US$US
140002802$14000280$2$F$20150724$20200924$20170922$20200928$PER$$US-JNJFOC-20170801511$JOHNSON AND JOHNSON$$69$YR$E$M$Y$116.68$KG$20200928$$HP$US$US
140002842$14000284$2$F$201703$20200812$20170922$20200817$PER$$US-JNJFOC-20170817509$JOHNSON AND JOHNSON$$87$YR$E$M$Y$$$20200817$$CN$US$US
140003103$14000310$3$F$20150910$20200818$20170922$20200821$PER$$US-JNJFOC-20170828510$JOHNSON AND JOHNSON$$51$YR$A$F$Y$$$20200821$$CN$US$US
140003565$14000356$5$F$20170905$20171113$20170922$20171120$EXP$$JP-JNJFOC-20170915330$JANSSEN$$59$YR$A$M$Y$53.3$KG$20171120$$MD$JP$JP
140004113$14000411$3$F$201409$20200913$20170922$20200917$PER$$US-JNJFOC-20170700024$JOHNSON AND JOHNSON$$97$YR$E$F$Y$$$20200917$$CN$US$US
140004493$14000449$3$F$20150711$20200914$20170922$20200917$PER$$US-JNJFOC-20170701266$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200917$$CN$US$US
140005313$14000531$3$F$20130807$20200810$20170922$20200813$PER$$US-JNJFOC-20170705718$JOHNSON AND JOHNSON$$71$YR$E$M$Y$88.08$KG$20200813$$CN$US$US
140006105$14000610$5$F$$20200803$20170922$20200803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-083955$BRISTOL MYERS SQUIBB$$$$$F$Y$68$KG$20200803$$CN$US$US
140006314$14000631$4$F$20131211$20200727$20170922$20200731$PER$$US-JNJFOC-20170710442$JOHNSON AND JOHNSON$$58$YR$A$F$Y$67.19$KG$20200731$$CN$US$US
140006623$14000662$3$F$20150831$20200625$20170922$20200708$EXP$$US-JNJFOC-20170711153$JOHNSON AND JOHNSON$$87$YR$$F$Y$$$20200708$$CN$US$US
140006733$14000673$3$F$20150106$20200824$20170922$20200831$PER$$US-JNJFOC-20170711647$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200831$$CN$US$US
140006762$14000676$2$F$20160708$20200816$20170922$20200820$PER$$US-JNJFOC-20170711728$JOHNSON AND JOHNSON$$70$YR$E$M$Y$$$20200820$$HP$US$US
140006873$14000687$3$F$20160521$20200708$20170922$20200713$PER$$US-JNJFOC-20170701272$JOHNSON AND JOHNSON$$64$YR$$F$Y$$$20200713$$CN$US$US
140006943$14000694$3$F$20140616$20200730$20170922$20200804$PER$$US-JNJFOC-20170711814$JOHNSON AND JOHNSON$$78$YR$E$M$Y$85.26$KG$20200804$$CN$US$US
140008073$14000807$3$F$20121230$20200903$20170922$20200914$PER$$US-JNJFOC-20170709591$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20200914$$CN$US$US
140008623$14000862$3$F$20150413$20200927$20170922$20200928$PER$$US-JNJFOC-20170716772$JOHNSON AND JOHNSON$$68$YR$E$M$Y$108.86$KG$20200928$$LW$US$US
140008913$14000891$3$F$20170819$20171107$20170922$20171114$EXP$$CA-PFIZER INC-2017370459$PFIZER$$71$YR$$M$Y$$$20171114$$MD$CA$CA
140009723$14000972$3$F$2016$20200913$20170922$20200915$PER$$US-JNJFOC-20170718722$JOHNSON AND JOHNSON$$8$DEC$E$M$Y$$$20200915$$CN$US$US
140009913$14000991$3$F$201506$20200910$20170922$20200915$PER$$US-JNJFOC-20170719232$JOHNSON AND JOHNSON$$84$YR$E$M$Y$$$20200915$$CN$US$US
140009983$14000998$3$F$20140223$20200910$20170922$20200915$PER$$US-JNJFOC-20170719035$JOHNSON AND JOHNSON$$68$YR$E$M$Y$$$20200915$$CN$US$US
140010082$14001008$2$F$20170123$20170921$20170922$20170925$EXP$$FR-ASTRAZENECA-2017SE09017$ASTRAZENECA$$58$YR$$M$Y$65$KG$20170925$$MD$FR$FR
140010383$14001038$3$F$201506$20200628$20170922$20200702$PER$$US-JNJFOC-20170719892$JOHNSON AND JOHNSON$$86$YR$$F$Y$77.8$KG$20200702$$CN$US$US
140011183$14001118$3$F$20150804$20200630$20170922$20200706$PER$$US-JNJFOC-20170722726$JOHNSON AND JOHNSON$$66$YR$$F$Y$$$20200706$$CN$US$US
140011893$14001189$3$F$201508$20200913$20170922$20200918$PER$$US-JNJFOC-20170726341$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200918$$CN$US$US
140011973$14001197$3$F$20150629$20200915$20170922$20200918$PER$$US-JNJFOC-20170726243$JOHNSON AND JOHNSON$$63$YR$A$M$Y$$$20200918$$CN$US$US
140012073$14001207$3$F$20160418$20200715$20170922$20200729$EXP$$US-JNJFOC-20170726316$JOHNSON AND JOHNSON$$74$YR$E$F$Y$$$20200729$$CN$US$US
140012113$14001211$3$F$20160808$20200817$20170922$20200820$PER$$US-JNJFOC-20170728413$JOHNSON AND JOHNSON$$79$YR$E$F$Y$49.94$KG$20200820$$CN$US$US
140012153$14001215$3$F$20160415$20200715$20170922$20200727$EXP$$US-JNJFOC-20170726654$JOHNSON AND JOHNSON$$60$YR$A$F$Y$$$20200727$$CN$US$US
140012612$14001261$2$F$201607$20200804$20170922$20200813$EXP$$US-BAYER-2017-124818$BAYER$$81$YR$E$M$Y$$$20200813$$CN$US$US
140012743$14001274$3$F$20141101$20200825$20170922$20200827$PER$$US-JNJFOC-20170801471$JOHNSON AND JOHNSON$$88$YR$E$M$Y$$$20200827$$CN$US$US
140012773$14001277$3$F$201508$20200729$20170922$20200805$EXP$$US-JNJFOC-20170801408$JOHNSON AND JOHNSON$$75$YR$E$M$Y$$$20200805$$CN$US$US
140012823$14001282$3$F$201511$20200831$20170922$20200902$PER$$US-JNJFOC-20170801564$JOHNSON AND JOHNSON$$79$YR$E$F$Y$$$20200902$$CN$US$US
140012853$14001285$3$F$20150604$20200820$20170922$20200826$PER$$US-JNJFOC-20170801397$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200826$$CN$US$US
140013283$14001328$3$F$20161210$20200809$20170922$20200813$PER$$US-JNJFOC-20170802824$JOHNSON AND JOHNSON$$73$YR$E$F$Y$$$20200813$$CN$US$US
140013372$14001337$2$F$20150720$20200823$20170922$20200827$PER$$US-JNJFOC-20170700070$JOHNSON AND JOHNSON$$29$YR$A$F$Y$$$20200827$$CN$US$US
140013963$14001396$3$F$20150908$20200903$20170922$20200914$PER$$US-JNJFOC-20170805160$JOHNSON AND JOHNSON$$80$YR$E$M$Y$$$20200914$$CN$US$US
140014753$14001475$3$F$20160507$20200709$20170922$20200713$PER$$PR-JNJFOC-20170901354$JOHNSON AND JOHNSON$$91$YR$$M$Y$$$20200713$$CN$US$US
140015223$14001522$3$F$201403$20200805$20170922$20200817$EXP$$US-JNJFOC-20170903979$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200817$$CN$US$US
140015243$14001524$3$F$20150902$20200825$20170922$20200827$PER$$US-JNJFOC-20170904347$JOHNSON AND JOHNSON$$36$YR$A$F$Y$$$20200827$$CN$US$US
140016385$14001638$5$F$20170817$20200713$20170922$20200717$EXP$$PHJP2017JP028738$NOVARTIS$$83$YR$$M$Y$59.9$KG$20200717$$PH$JP$JP
140016392$14001639$2$F$201404$20200630$20170922$20200706$PER$$US-JNJFOC-20170628937$JOHNSON AND JOHNSON$$78$YR$$M$Y$$$20200706$$CN$US$US
140016455$14001645$5$F$20160925$20200831$20170922$20200915$EXP$$US-JNJFOC-20170901189$JOHNSON AND JOHNSON$$72$YR$E$M$Y$$$20200915$$CN$US$US
140016803$14001680$3$F$201409$20200805$20170922$20200807$PER$$US-JNJFOC-20170905330$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200807$$CN$US$US
140017093$14001709$3$F$201510$20200708$20170922$20200717$EXP$$US-JNJFOC-20170906165$JOHNSON AND JOHNSON$$75$YR$$M$Y$$$20200717$$CN$US$US
140017723$14001772$3$F$20140916$20200910$20170922$20200914$PER$$US-JNJFOC-20170907703$JOHNSON AND JOHNSON$$50$YR$A$F$Y$$$20200914$$CN$US$US
140017732$14001773$2$F$20160207$20200913$20170922$20200915$PER$$US-JNJFOC-20170714440$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200915$$HP$US$US
140018302$14001830$2$F$20170103$20200921$20170922$20200923$PER$$US-JNJFOC-20170711792$JOHNSON AND JOHNSON$$94$YR$E$F$Y$47.2$KG$20200923$$CN$US$US
140019244$14001924$4$F$20160820$20200923$20170922$20200929$PER$$US-JNJFOC-20170911295$JOHNSON AND JOHNSON$$70$YR$E$F$Y$$$20200929$$CN$US$US
140019763$14001976$3$F$2013$20200712$20170922$20200716$PER$$US-JNJFOC-20170912468$JOHNSON AND JOHNSON$$47$YR$$M$Y$$$20200716$$CN$US$US
140019853$14001985$3$F$20140409$20200902$20170922$20200909$PER$$US-JNJFOC-20170912458$JOHNSON AND JOHNSON$$69$YR$E$F$Y$$$20200909$$CN$US$US
140020644$14002064$4$F$201509$20200817$20170922$20200824$PER$$US-JNJFOC-20170914002$JOHNSON AND JOHNSON$$64$YR$A$F$Y$$$20200824$$CN$US$US
140020763$14002076$3$F$20150928$20200903$20170922$20200914$PER$$US-JNJFOC-20170915397$JOHNSON AND JOHNSON$$84$YR$E$M$Y$99.88$KG$20200914$$CN$VI$VI
140020793$14002079$3$F$20140409$20200802$20170922$20200806$PER$$US-JNJFOC-20170915685$JOHNSON AND JOHNSON$$74$YR$E$M$Y$87.17$KG$20200806$$CN$US$US
140020993$14002099$3$F$20150106$20200903$20170922$20200914$PER$$US-JNJFOC-20170915166$JOHNSON AND JOHNSON$$85$YR$E$F$Y$$$20200914$$CN$US$US
140021273$14002127$3$F$20151020$20200730$20170922$20200804$PER$$US-JNJFOC-20170915000$JOHNSON AND JOHNSON$$59$YR$A$F$Y$$$20200804$$CN$US$US
140021434$14002143$4$F$$20200714$20170922$20200727$EXP$$US-JNJFOC-20170915672$JOHNSON AND JOHNSON$$$$$F$Y$$$20200727$$CN$US$US
140021633$14002163$3$F$20130422$20200826$20170922$20200831$PER$$US-JNJFOC-20170913334$JOHNSON AND JOHNSON$$71$YR$E$F$Y$$$20200831$$CN$US$US
140023254$14002325$4$F$20161019$20200629$20170922$20200706$PER$$US-JNJFOC-20170919930$JOHNSON AND JOHNSON$$74$YR$$M$Y$$$20200706$$CN$US$US
140023302$14002330$2$F$201609$20200708$20170922$20200713$PER$$US-JNJFOC-20170716662$JOHNSON AND JOHNSON$$37$YR$$F$Y$66.56$KG$20200713$$CN$US$US
140023392$14002339$2$F$20150905$20200803$20170922$20200807$PER$$US-JNJFOC-20170907745$JOHNSON AND JOHNSON$$80$YR$E$F$Y$$$20200807$$CN$US$US
140023503$14002350$3$F$201504$20200707$20170922$20200716$EXP$$US-JNJFOC-20170919602$JOHNSON AND JOHNSON$$57$YR$$F$Y$$$20200716$$LW$US$US
140023704$14002370$4$F$201604$20200915$20170922$20200929$EXP$$US-JNJFOC-20170819963$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200929$$LW$US$US
140024103$14002410$3$F$201610$20200729$20170922$20200803$PER$$US-JNJFOC-20170820081$JOHNSON AND JOHNSON$$73$YR$E$F$Y$44.5$KG$20200803$$CN$US$US
140024116$14002411$6$F$$20200710$20170922$20200715$EXP$$US-JAZZ-2017-US-012296$JAZZ$$$$$F$Y$$$20200715$$MD$US$US
140024164$14002416$4$F$20160321$20200816$20170922$20200827$EXP$$US-JNJFOC-20170820061$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20200827$$LW$US$US
140024283$14002428$3$F$20161018$20200810$20170922$20200813$PER$$US-JNJFOC-20170820780$JOHNSON AND JOHNSON$$63$YR$A$M$Y$134.38$KG$20200813$$LW$US$US
140024722$14002472$2$F$20150918$20200727$20170922$20200731$PER$$US-JNJFOC-20170817489$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20200731$$CN$US$US
140024793$14002479$3$F$20150824$20200811$20170922$20200814$PER$$US-JNJFOC-20170821294$JOHNSON AND JOHNSON$$55$YR$A$F$Y$$$20200814$$CN$US$US
140024963$14002496$3$F$201502$20200914$20170922$20200917$PER$$US-JNJFOC-20170817707$JOHNSON AND JOHNSON$$87$YR$E$F$Y$$$20200917$$CN$US$US
140025173$14002517$3$F$20141118$20200917$20170922$20200921$PER$$US-JNJFOC-20170817575$JOHNSON AND JOHNSON$$88$YR$E$F$Y$$$20200921$$CN$US$US
140025553$14002555$3$F$20130429$20200707$20170922$20200713$PER$$US-JNJFOC-20170816895$JOHNSON AND JOHNSON$$39$YR$$F$Y$$$20200713$$CN$US$US
140025863$14002586$3$F$20160104$20200727$20170922$20200731$PER$$US-JNJFOC-20170819407$JOHNSON AND JOHNSON$$68$YR$E$F$Y$65.83$KG$20200731$$CN$US$US
140026793$14002679$3$F$201609$20200805$20170922$20200811$PER$$US-JNJFOC-20170821955$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200811$$CN$US$US
140027792$14002779$2$F$20160528$20200906$20170922$20200914$PER$$US-JNJFOC-20170703738$JOHNSON AND JOHNSON$$81$YR$E$M$Y$$$20200914$$CN$US$US
140045217$14004521$7$F$20170915$20200914$20170922$20200915$PER$$CN-AMGEN-CHNCT2017142082$AMGEN$$69$YR$E$M$Y$54.5$KG$20200915$$MD$CN$CN
140047122$14004712$2$F$20170901$20190116$20170922$20190124$EXP$$PL-ASTRAZENECA-2017SE96192$ASTRAZENECA$$24571$DY$$F$Y$$$20190124$$MD$PL$PL
140048859$14004885$9$F$201709$20200928$20170922$20200930$PER$$US-PFIZER INC-2017409285$PFIZER$$82$YR$$F$Y$72$KG$20200930$$MD$US$US
140052727$14005272$7$F$201703$20200716$20170922$20200721$EXP$$JP-PFIZER INC-2017407371$PFIZER$$81$YR$$F$Y$35$KG$20200721$$MD$JP$JP
140058281$14005828$1$I$201106$20170914$20170923$20170923$EXP$$US-TEVA-808939USA$TEVA$$66$YR$$F$Y$$$20170924$$LW$US$US
140064613$14006461$3$F$2015$20200916$20170925$20200921$EXP$$CA-ABBVIE-17K-028-2013063-00$ABBVIE$$$$$M$Y$$$20200921$$CN$CA$CA
140065032$14006503$2$F$20160628$20200914$20170925$20200923$EXP$$ES-ROCHE-1998193$ROCHE$$54$YR$$F$Y$$$20200923$$PH$ES$ES
140066972$14006697$2$F$$20170919$20170925$20200803$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-085006$BRISTOL MYERS SQUIBB$MUTO T, ET AL.. A CASE OF DELAYED PERFORATION AND MEDIASTINAL ABSCESS DUE TO STEROIDAL LOCAL INJECTION TO PREVENT STENOSIS AFTER ESOPHAGEAL ESD (ENDOSCOPIC SUBMUCOSAL DISSECTION). THE JAPANESE SOCIETY OF GASTROENTEROLOGY. 2017?34$70$YR$$M$Y$$$20200803$$MD$JP$JP
140068094$14006809$4$F$20171107$20200715$20170925$20200716$PER$$US-PFIZER INC-2017409445$PFIZER$$70$YR$$F$Y$87.09$KG$20200716$$HP$US$US
140068223$14006822$3$F$$20200903$20170925$20200907$PER$$US-PFIZER INC-2017409596$PFIZER$$53$YR$$F$Y$$$20200907$$MD$US$US
140070263$14007026$3$F$201707$20200724$20170925$20200806$EXP$$US-LUPIN PHARMACEUTICALS INC.-2017-04741$LUPIN$$62$YR$$M$Y$65.76$KG$20200806$$CN$US$US
1400739319$14007393$19$F$20140122$20200630$20170925$20200716$EXP$$PHHY2014CA014290$NOVARTIS$$66$YR$$M$Y$$$20200716$$HP$CA$CA
140085702$14008570$2$F$201707$20200709$20170925$20200716$EXP$$FR-INDIVIOR LIMITED-INDV-104691-2017$RECKITT BENCKISER$$29$YR$$M$Y$$$20200716$$MD$FR$FR
140088392$14008839$2$F$20170914$20171106$20170925$20171113$EXP$$CA-PFIZER INC-2017407766$PFIZER$$72$YR$$M$Y$$$20171113$$MD$CA$CA
140088866$14008886$6$F$20161110$20200911$20170925$20200922$EXP$$JP-INCYTE CORPORATION-2017IN006183$INCYTE$$$$$$Y$$$20200922$$MD$JP$JP
1400908031$14009080$31$F$20170206$20200908$20170925$20200918$EXP$$CA-CELLTRION INC.-2017CA012486$CELLTRION$$$$$$Y$$$20200918$$HP$CA$CA
140090983$14009098$3$F$20160211$20200813$20170925$20200814$PER$$US-PFIZER INC-2016586541$PFIZER$$47$YR$$F$Y$105$KG$20200814$$LW$US$US
140093582$14009358$2$F$201612$20200622$20170925$20200703$EXP$$US-BAYER-2017-156838$BAYER$$59$YR$A$F$Y$$$20200703$$CN$US$US
140097963$14009796$3$F$20170703$20200825$20170925$20200828$EXP$$PHHY2017MX138556$NOVARTIS$$22$YR$$F$Y$$$20200828$$MD$MX$MX
140102504$14010250$4$F$20170917$20171031$20170926$20171113$EXP$$IT-ROCHE-1995785$ROCHE$$59$YR$$M$Y$80$KG$20171113$$MD$IT$IT
140102653$14010265$3$F$20170721$20200828$20170926$20200907$EXP$$AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-041597$BOEHRINGER INGELHEIM$BOTTARAO F, MARGAN M, DUBOSCQ C, CERESETTO J, EXPERIENCE WITH IDARUCIZUMAB AS A REVERSE AGENT OF DABIGATRAN. MEDICINA (BUENOS AIRES). 2020? 80:4: 405?410.$90$YR$E$M$Y$70$KG$20200831$$HP$AR$AR
1401060913$14010609$13$F$20170914$20200715$20170926$20200724$EXP$$JP-009507513-1709JPN001275J$MERCK$$77$YR$$M$Y$40$KG$20200724$$CN$JP$JP
140111024$14011102$4$F$20170803$20200731$20170926$20200804$PER$$US-PFIZER INC-2017413356$PFIZER$$76$YR$$F$Y$77.11$KG$20200804$$CN$US$US
140115113$14011511$3$F$2017$20200903$20170926$20200923$PER$$US-AMGEN-USASP2017143717$AMGEN$$53$YR$A$F$Y$$$20200923$$MD$US$US
140116824$14011682$4$F$20170920$20171102$20170926$20171105$EXP$$CA-ASTRAZENECA-2017SE97522$ASTRAZENECA$$65$YR$$M$Y$$$20171106$$MD$CA$CA
140119406$14011940$6$F$20170914$20171129$20170926$20171204$EXP$$BR-JNJFOC-20170922099$PHARMACYCLICS$$18$YR$T$M$Y$76$KG$20171204$$MD$BR$BR
140120323$14012032$3$F$20170521$20200529$20170926$20200903$PER$$US-CIPLA LTD.-2017US09615$CIPLA$$$$$$Y$$$20200903$$CN$US$US
140120734$14012073$4$F$20170904$20200916$20170926$20200922$EXP$$PHHO2017DE012712$NOVARTIS$$58$YR$$M$Y$75$KG$20200922$$HP$DE$DE
140121564$14012156$4$F$20170308$20200205$20170926$20200803$EXP$$DE-JNJFOC-20170924654$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20200803$$MD$DE$DE
140122379$14012237$9$F$20170914$20200730$20170926$20200813$EXP$$US-INCYTE CORPORATION-2017IN007902$INCYTE$$$$$$Y$$$20200813$$CN$US$US
1401228920$14012289$20$F$201612$20200910$20170926$20200914$EXP$$US-PFIZER INC-2017413442$PFIZER$$55$YR$$F$Y$95$KG$20200914$$MD$US$US
140123403$14012340$3$F$201707$20200828$20170926$20200907$EXP$$AR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-052257$BOEHRINGER INGELHEIM$BOTTARO F, MARGAN M, EXPERIENCE WITH IDARUCIZUMAB AS A REVERSE AGENT OF DABIGATRAN. MEDICINA (BUENOS AIRES). 2020? 80(4): 405?410.$90$YR$E$M$Y$70$KG$20200904$$HP$AR$AR
140124602$14012460$2$F$20170905$20200730$20170926$20200807$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005514$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20200807$$MD$US$US
140131802$14013180$2$F$20160831$20190328$20170926$20190402$EXP$$BE-ASTRAZENECA-2016SE93791$ASTRAZENECA$$21857$DY$$M$Y$$$20190402$$MD$BE$BE
140135572$14013557$2$F$$20200728$20170926$20200811$EXP$E2B_01129117$CA-VALIDUS PHARMACEUTICALS LLC-CA-2017VAL001374$VALIDUS$$$$$$Y$$$20200811$$HP$CA$CA
140143783$14014378$3$F$20170817$20180301$20170927$20180314$EXP$$ES-ROCHE-1984497$ROCHE$$52$YR$$M$Y$107$KG$20180314$$MD$ES$ES
1401468710$14014687$10$F$$20200706$20170927$20200715$EXP$$CA-AUROBINDO-AUR-APL-2017-38862$AUROBINDO$$50$YR$$F$Y$79$KG$20200715$$HP$CA$CA
140149873$14014987$3$F$20170108$20200603$20170927$20200901$PER$$US-CIPLA LTD.-2017US01626$CIPLA$$$$$$Y$$$20200901$$CN$US$US
140150003$14015000$3$F$201601$20200529$20170927$20200903$PER$$US-CIPLA LTD.-2017US01475$CIPLA$$$$$$Y$$$20200903$$CN$US$US
140155015$14015501$5$F$2017$20200903$20170927$20200910$EXP$$US-009507513-1709USA011797$MERCK$$$$$F$Y$$$20200910$$CN$US$US
140155179$14015517$9$F$201611$20200824$20170927$20200825$EXP$$US-PFIZER INC-2017149574$PFIZER$$81$YR$$F$Y$56$KG$20200825$$MD$US$US
140156193$14015619$3$F$20150823$20200803$20170927$20200813$EXP$$US-BAYER-2017-127059$BAYER$$87$YR$E$M$Y$$$20200813$$CN$US$US
140158162$14015816$2$F$$20200622$20170927$20200701$PER$$PT-EISAI MEDICAL RESEARCH-EC-2014-001161$EISAI$ALMEIDA J, LOPES A, BARBOSA M. A CASE REPORT OF DELAYED HYPERSENSITIVITY TO ALL PPIS. REVISTA PORTUGUESA DE IMUNOALERGOLOGIA. 2016?24(1):31?36.$$$$F$Y$$$20200701$$MD$PT$PT
1401583429$14015834$29$F$20170929$20200625$20170927$20200709$EXP$$US-ACTELION-A-NJ2017-159993$ACTELION$$38$YR$$F$Y$107.03$KG$20200709$$MD$US$US
140162152$14016215$2$F$20160926$20200716$20170927$20200724$PER$$US-SA-2016SA184704$SANOFI AVENTIS$$47$YR$$M$Y$$$20200724$$CN$US$US
140162372$14016237$2$F$201610$20200819$20170927$20200825$PER$$US-SA-2016SA198367$SANOFI AVENTIS$$50$YR$$M$Y$$$20200825$$HP$US$US
140163612$14016361$2$F$201703$20200811$20170927$20200821$PER$$US-SA-2017SA041714$SANOFI AVENTIS$$34$YR$$M$Y$$$20200821$$HP$US$US
140165252$14016525$2$F$20170807$20200708$20170927$20200714$EXP$$US-SA-2017SA151315$SANOFI AVENTIS$$58$YR$$F$Y$$$20200714$$CN$US$US
140169092$14016909$2$F$$20200728$20170927$20200812$EXP$E2B_01129117$CA-VALIDUS PHARMACEUTICALS LLC-CA-2017VAL001377$VALIDUS$$$$$$Y$$$20200812$$HP$CA$CA
140170583$14017058$3$F$20170315$20171017$20170927$20200818$EXP$$DE-TEVA-805849GER$TEVA$$65$YR$E$M$Y$90$KG$20200818$$MD$DE$DE
140170752$14017075$2$F$20170912$20170929$20170927$20171006$EXP$$IT-JNJFOC-20170918984$JANSSEN$$61$YR$A$M$Y$129$KG$20171006$$CN$IT$IT
140172036$14017203$6$F$20170919$20200807$20170927$20200812$EXP$$PHHY2017US139531$NOVARTIS$$68$YR$$F$Y$55.8$KG$20200812$$MD$US$US
140178695$14017869$5$F$20161101$20200901$20170928$20200907$PER$$ZA-AMGEN-ZAFSP2017146883$AMGEN$$57$YR$A$M$Y$80$KG$20200907$$MD$ZA$ZA
140193562$14019356$2$F$$20200715$20170928$20200727$EXP$$US-INCYTE CORPORATION-2017IN007948$INCYTE$$$$$$Y$$$20200727$$CN$US$US
140195374$14019537$4$F$20170412$20200727$20170928$20200801$PER$$PHHY2017US139764$NOVARTIS$$35$YR$$F$Y$$$20200801$$MD$US$US
140197432$14019743$2$F$20160906$20171006$20170928$20171013$EXP$$JP-ASTRAZENECA-2016SE96076$ASTRAZENECA$$20491$DY$$F$Y$$$20171013$$MD$JP$JP
140198951$14019895$1$I$20170908$20170908$20170928$20170928$EXP$$US-JNJFOC-20170912352$PHARMACYCLICS$$70$YR$E$M$Y$109$KG$20170928$$MD$US$US
140201574$14020157$4$F$20151106$20200729$20170928$20200805$EXP$$US-JNJFOC-20170928210$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20200805$$CN$US$US
140202025$14020202$5$F$2016$20200925$20170928$20200929$EXP$$US-PFIZER INC-2017418113$PFIZER$$76$YR$$F$Y$70.31$KG$20200929$$MD$US$US
140203827$14020382$7$F$$20200909$20170928$20200918$EXP$$CA-APOTEX-2017AP018741$APOTEX$$$$$F$Y$61$KG$20200918$$CN$CA$CA
140213343$14021334$3$F$$20200910$20170928$20200922$EXP$$US-INCYTE CORPORATION-2017IN008071$INCYTE$$$$$$Y$$$20200922$$CN$US$US
1402215521$14022155$21$F$20180212$20200713$20170928$20200724$EXP$$US-ACTELION-A-NJ2017-160202$ACTELION$$41$YR$$F$Y$77.1$KG$20200724$$MD$US$US
140225151$14022515$1$I$$20170926$20170929$20170929$EXP$$FR-AUROBINDO-AUR-APL-2017-41339$AUROBINDO$$$$A$F$Y$$$20170929$$MD$FR$FR
140225323$14022532$3$F$20170906$20171206$20170929$20171218$EXP$$KR-PFIZER INC-2017398261$PFIZER$$76$YR$$F$Y$$$20171218$$MD$KR$KR
140228062$14022806$2$F$201512$20200715$20170928$20200727$PER$$US-SA-2016SA187573$SANOFI AVENTIS$$56$YR$$F$Y$$$20200727$$CN$US$US
140229822$14022982$2$F$$20200717$20170928$20200723$PER$$US-SA-2016SA193551$SANOFI AVENTIS$$$$$$Y$$$20200723$$CN$US$US
140229846$14022984$6$F$20161011$20200804$20170928$20200810$PER$$US-SA-2016SA193569$SANOFI AVENTIS$$$$$$Y$$$20200810$$HP$US$US
140230434$14023043$4$F$$20200803$20170929$20200804$EXP$$US-PFIZER INC-2017416858$PFIZER$$64$YR$$M$Y$99$KG$20200804$$CN$US$US
140231422$14023142$2$F$2017$20180328$20170929$20180404$EXP$$TJ-JNJFOC-20170925930$JANSSEN$$31$YR$A$M$Y$52$KG$20180404$$HP$TJ$TJ
140232273$14023227$3$F$$20200821$20170928$20200831$PER$$US-SA-2016SA202625$SANOFI AVENTIS$$$$$$Y$$$20200831$$CN$US$US
140233163$14023316$3$F$20170925$20180328$20170929$20180405$EXP$$US-ASTRAZENECA-2017SE98694$ASTRAZENECA$$25437$DY$$F$Y$66.7$KG$20180405$$MD$US$US
140235152$14023515$2$F$20161118$20200827$20170928$20200901$PER$$US-SA-2016SA216231$SANOFI AVENTIS$$$$$$Y$$$20200901$$HP$US$US
140238713$14023871$3$F$20170926$20190312$20170929$20190320$EXP$$CA-ASTRAZENECA-2017SE99020$ASTRAZENECA$$49$YR$$F$Y$$$20190320$$MD$CA$CA
140238725$14023872$5$F$20170925$20190221$20170929$20190222$EXP$$ES-ASTRAZENECA-2017SE97703$ASTRAZENECA$$21777$DY$$M$Y$$$20190222$$MD$ES$ES
140239513$14023951$3$F$$20200628$20170928$20200707$PER$$US-SA-2016SA228099$SANOFI AVENTIS$$$$$$Y$$$20200707$$MD$US$US
1402407323$14024073$23$F$20171101$20200908$20170929$20200924$EXP$$CA-CELLTRION INC.-2017CA012918$CELLTRION$$$$$$Y$$$20200924$$HP$CA$CA
140241166$14024116$6$F$20170913$20171204$20170929$20171207$EXP$$BR-ASTRAZENECA-2017SE98690$ASTRAZENECA$$63$YR$$M$Y$55$KG$20171207$$MD$BR$BR
140242292$14024229$2$F$20170922$20191202$20170929$20191211$EXP$$US-JNJFOC-20170925421$JOHNSON AND JOHNSON$$61$YR$$F$Y$87$KG$20191211$$MD$US$US
140243063$14024306$3$F$20161209$20200730$20170929$20200806$EXP$$US-JNJFOC-20170929474$JOHNSON AND JOHNSON$$78$YR$E$F$Y$$$20200806$$CN$US$US
140244742$14024474$2$F$20200916$20200916$20170928$20200922$PER$$US-SA-2017SA008556$SANOFI AVENTIS$$68$YR$$M$Y$$$20200922$$CN$US$US
140244778$14024477$8$F$201912$20200921$20170928$20200928$EXP$$US-SA-2017SA008573$SANOFI AVENTIS$$$$$$Y$$$20200928$$CN$US$US
140245532$14024553$2$F$20161201$20200724$20170928$20200729$PER$$US-SA-2017SA012969$SANOFI AVENTIS$$$$$$Y$$$20200729$$CN$US$US
140246743$14024674$3$F$$20200831$20170928$20200903$PER$$US-SA-2017SA018913$SANOFI AVENTIS$$$$$$Y$$$20200903$$CN$US$US
140248729$14024872$9$F$2017$20200902$20170928$20200908$EXP$$US-SA-2017SA021632$SANOFI AVENTIS$$$$$$Y$$$20200908$$CN$US$US
140248874$14024887$4$F$20170918$20171128$20170929$20171204$EXP$$CA-PFIZER INC-2017419195$PFIZER$$30$YR$$F$Y$$$20171204$$MD$CA$CA
140249686$14024968$6$F$20170201$20200914$20170928$20200921$PER$$US-SA-2017SA024676$SANOFI AVENTIS$$$$$$Y$$$20200921$$PH$US$US
140250331$14025033$1$I$20170919$20170921$20170929$20170929$EXP$$FR-JNJFOC-20170923194$JANSSEN$$44$YR$A$F$Y$98.3$KG$20170929$$MD$FR$FR
140253149$14025314$9$F$20170316$20200702$20170929$20200706$PER$$PHHY2017US072114$NOVARTIS$$35$YR$$M$Y$$$20200706$$MD$US$US
140257183$14025718$3$F$20170313$20200722$20170929$20200731$PER$$US-SA-2017SA045573$SANOFI AVENTIS$$$$$$Y$$$20200731$$PH$US$US
140261822$14026182$2$F$$20200810$20170929$20200818$EXP$$IT-AUROBINDO-AUR-APL-2017-41063$AUROBINDO$$73$YR$$M$Y$$$20200818$$HP$IT$IT
1402649230$14026492$30$F$20200729$20200806$20170929$20200819$EXP$$US-ACTELION-A-US2017-160243$ACTELION$$63$YR$$F$Y$53.06$KG$20200819$$HP$US$US
1402690312$14026903$12$F$201701$20200908$20170929$20200916$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-085161$BRISTOL MYERS SQUIBB$$54$YR$$M$Y$$$20200916$$HP$DE$DE
140273636$14027363$6$F$201608$20191105$20170929$20191112$EXP$$PHHY2016CA096981$NOVARTIS$$81$YR$$M$Y$$$20191112$$MD$CA$CA
140275253$14027525$3$F$$20200810$20170929$20200819$EXP$$IT-AUROBINDO-AUR-APL-2017-41309$AUROBINDO$$79$YR$$F$Y$$$20200819$$HP$IT$IT
140276248$14027624$8$F$$20200827$20170929$20200828$EXP$$US-PFIZER INC-2017419897$PFIZER$$72$YR$$F$Y$47.17$KG$20200828$$MD$US$US
140276464$14027646$4$F$$20200922$20170929$20200925$PER$$US-PFIZER INC-2017419492$PFIZER$$$$A$F$Y$$$20200925$$HP$US$US
1402772115$14027721$15$F$20140811$20200817$20170929$20200819$EXP$$IE-MYLANLABS-2016M1042375$MYLAN$$36$YR$$M$Y$$$20200819$$MD$IE$IE
140277925$14027792$5$F$201702$20200803$20170929$20200810$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-005567$BOEHRINGER INGELHEIM$SEKINE R, HASEGAWA M, SUZUKI T, YAZAWA M, ICHIKAWA D, KOIKE J, ETAL. A CASE OF NINTEDANIB?INDUCED NEPHROTIC SYNDROME. THE JAPANESE JOURNAL OF NEPHROLOGY. 2017 SEP?59(6):914.$68$YR$$M$Y$$$20200810$$MD$JP$JP
1402780625$14027806$25$F$2017$20200928$20170929$20200929$EXP$$US-PFIZER INC-2017419766$PFIZER$$76$YR$$F$Y$100$KG$20200929$$CN$US$US
140278943$14027894$3$F$201612$20200629$20170929$20200703$PER$$US-VERTEX PHARMACEUTICALS-2017-005324$VERTEX$$15$YR$$F$Y$$$20200703$$CN$US$US
140285395$14028539$5$F$20170315$20200908$20170930$20200911$PER$$US-SA-2017SA051245$SANOFI AVENTIS$$$$$$Y$$$20200911$$CN$US$US
140285592$14028559$2$F$201703$20200923$20170930$20200930$PER$$US-SA-2017SA054124$SANOFI AVENTIS$$37$YR$$F$Y$$$20200930$$CN$US$US
140286822$14028682$2$F$201701$20200922$20170930$20200929$PER$$US-SA-2017SA065888$SANOFI AVENTIS$$$$$$Y$$$20200929$$CN$US$US
140288126$14028812$6$F$$20200804$20170930$20200807$PER$$US-SA-2017SA105082$SANOFI AVENTIS$$$$$$Y$$$20200807$$CN$US$US
140289169$14028916$9$F$201704$20200713$20170930$20200715$PER$$US-SA-2017SA095436$SANOFI AVENTIS$$$$$$Y$$$20200715$$CN$US$US
140289682$14028968$2$F$2020$20200909$20170930$20200915$PER$$US-SA-2017SA075616$SANOFI AVENTIS$$$$$$Y$$$20200915$$CN$US$US
140291332$14029133$2$F$202006$20200728$20170930$20200803$PER$$US-SA-2017SA120630$SANOFI AVENTIS$$$$$$Y$$$20200803$$CN$US$US
140292282$14029228$2$F$20170411$20200825$20170930$20200902$PER$$US-SA-2017SA085260$SANOFI AVENTIS$$$$$$Y$$$20200902$$CN$US$US
140293093$14029309$3$F$$20200923$20170930$20200930$PER$$US-SA-2017SA088210$SANOFI AVENTIS$$$$$$Y$$$20200930$$CN$US$US
140297494$14029749$4$F$201706$20200723$20170930$20200730$PER$$US-SA-2017SA132508$SANOFI AVENTIS$$$$$$Y$$$20200730$$CN$US$US
140299373$14029937$3$F$$20180410$20171002$20180423$EXP$$PHHY2017GR140789$NOVARTIS$$81$YR$$F$Y$$$20180423$$HP$GR$GR
140300996$14030099$6$F$20180615$20200917$20170930$20200921$PER$$US-SA-2017SA154841$SANOFI AVENTIS$$$$$$Y$$$20200921$$MD$US$US
140301955$14030195$5$F$20170405$20200817$20171001$20200821$EXP$$US-SA-2017SA062965$SANOFI AVENTIS$$$$$$Y$$$20200821$$CN$US$US
140306606$14030660$6$F$20170926$20180201$20171002$20180202$EXP$$CA-ASTRAZENECA-2017SE99442$ASTRAZENECA$$71$YR$$M$Y$$$20180202$$MD$CA$CA
140308752$14030875$2$F$202001$20200724$20171002$20200730$PER$$US-009507513-1709USA009825$MERCK$$54$YR$$F$Y$$$20200730$$CN$US$US
140314862$14031486$2$F$20170927$20200720$20171003$20200722$PER$$US-AMGEN-USASP2017147459$AMGEN$$60$YR$A$F$Y$$$20200722$$MD$US$US
140318988$14031898$8$F$201708$20200818$20171002$20200923$PER$$US-INCYTE CORPORATION-2017IN007113$INCYTE$$$$$$Y$$$20200923$$CN$US$US
140320831$14032083$1$I$20170901$20170920$20171002$20171002$EXP$$PL-PFIZER INC-2017412604$PFIZER$$67$YR$$F$Y$$$20171002$$MD$PL$PL
140324809$14032480$9$F$20180518$20200716$20171002$20200720$PER$$US-PFIZER INC-2017422042$PFIZER$$53$YR$$F$Y$$$20200720$$HP$US$US
140330813$14033081$3$F$20170906$20200730$20171002$20200807$EXP$$US-BIOGEN-2017BI00465050$BIOGEN$$39$YR$$M$Y$$$20200807$$CN$US$US
140330882$14033088$2$F$$20200909$20171003$20200915$PER$$US-PFIZER INC-2017423759$PFIZER$$61$YR$$F$Y$$$20200915$$CN$US$US
1403309112$14033091$12$F$2017$20200709$20171002$20200709$EXP$$US-PFIZER INC-2017422132$PFIZER$$76$YR$$F$Y$95$KG$20200709$$MD$US$US
1403319712$14033197$12$F$$20200728$20171003$20200729$PER$$US-PFIZER INC-2016356970$PFIZER$$69$YR$$F$Y$91$KG$20200729$$CN$US$US
140333683$14033368$3$F$20141229$20200702$20171003$20200710$PER$$PHHY2017US141399$NOVARTIS$$34$YR$$F$Y$$$20200711$$MD$US$US
140334314$14033431$4$F$20161205$20200723$20171003$20200729$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-017645$BRISTOL MYERS SQUIBB$$60$YR$$F$Y$$$20200729$$MD$DE$DE
140337792$14033779$2$F$$20200810$20171003$20200820$EXP$$IT-AUROBINDO-AUR-APL-2017-41308$AUROBINDO$$79$YR$$M$Y$$$20200820$$HP$IT$IT
140337822$14033782$2$F$$20200810$20171003$20200818$EXP$$IT-AUROBINDO-AUR-APL-2017-41303$AUROBINDO$$83$YR$$F$Y$$$20200818$$HP$IT$IT
140337842$14033784$2$F$$20200803$20171003$20200812$EXP$$FR-AUROBINDO-AUR-APL-2015-07279$AUROBINDO$$61$YR$$F$Y$$$20200812$$HP$FR$FR
140337872$14033787$2$F$$20200810$20171003$20200819$EXP$$IT-AUROBINDO-AUR-APL-2017-41307$AUROBINDO$$80$YR$$F$Y$$$20200819$$HP$IT$IT
140343382$14034338$2$F$20161227$20171002$20171003$20171005$EXP$$CA-ASTRAZENECA-2016SF37733$ASTRAZENECA$$65$YR$$F$Y$$$20171005$$MD$CA$CA
140350956$14035095$6$F$2010$20200728$20171003$20200731$EXP$$US-PFIZER INC-2016009780$PFIZER$$65$YR$$F$Y$77$KG$20200731$$MD$US$US
140351193$14035119$3$F$20161004$20190514$20171003$20190521$EXP$$US-ASTRAZENECA-2016SF05433$ASTRAZENECA$$20498$DY$$M$Y$$$20190521$$MD$US$US
140351754$14035175$4$F$20170828$20171213$20171003$20171222$EXP$$CZ-JNJFOC-20170931368$PHARMACYCLICS$$70$YR$E$M$Y$$$20171222$$MD$CZ$CZ
140352634$14035263$4$F$20170927$20171102$20171003$20171109$EXP$$CA-PFIZER INC-2017426196$PFIZER$$71$YR$$M$Y$$$20171109$$MD$CA$CA
140354277$14035427$7$F$20160928$20190521$20171003$20200908$EXP$$PHHY2017CA032939$NOVARTIS$$80$YR$$F$Y$$$20200908$$HP$CA$CA
140366548$14036654$8$F$20170929$20200826$20171003$20200901$EXP$$AR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-087894$BRISTOL MYERS SQUIBB$$43$YR$$F$Y$49.7$KG$20200901$$HP$AR$AR
140367525$14036752$5$F$20190329$20200818$20171003$20200827$EXP$$US-BIOGEN-2017BI00465593$BIOGEN$$68$YR$$F$Y$$$20200827$$HP$US$US
140375052$14037505$2$F$$20170923$20171004$20200918$EXP$$TR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-087967$BRISTOL MYERS SQUIBB$BEKSAC K, ORGUL G, OZYUNCU O, YURDAKOK M, ALTUNDAG K, BEKSAC MS. CHEMOTHERAPY DURING PREGNANCY: CASES OF HODGKIN^S AND NON?HODGKIN^S LYMPHOMA, CHRONIC MYELOID LEUKEMIA, BREAST CANCER, NASOPHARYNGEAL CANCER, AND CHORIOCARCINOMA. ONCOLOGY RESEARCH AND TREATMENT. 2017?40:441?5$26$YR$$F$Y$$$20200918$$MD$TR$TR
1403792113$14037921$13$F$$20190220$20171004$20190302$EXP$$ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-151216$RANBAXY$$76$YR$$F$Y$$$20190302$$HP$ES$ES
140382675$14038267$5$F$$20200909$20171004$20200915$EXP$$CA-ASTRAZENECA-2015SE67103$ASTRAZENECA$$66$YR$$M$Y$$$20200915$$CN$CA$CA
1403842913$14038429$13$F$20170922$20200713$20171004$20200723$EXP$$JP-009507513-1710JPN000176J$MERCK$MORITA E, SAKAMOTO N, ONUKI T, SAITO K, YOSHIZUMI N, UCHIYAMA A, ET AL.. 30. A CASE OF OESOPHAGITIS AND ENTERITIS DURING PEMBROLIZUMAB THERAPY FOR PDL1?POSITIVE SQUAMOUS CELL CARCINOMA OF LUNG. THE 181ST MEETING OF KANTO BRANCH OF THE JAPAN LUNG CANCER SOCIETY. 2018$68$YR$$M$Y$76$KG$20200723$$HP$JP$JP
140385611$14038561$1$I$20170809$20170927$20171004$20171004$EXP$$US-JNJFOC-20170931136$PHARMACYCLICS$$71$YR$E$M$Y$78.5$KG$20171004$$MD$US$US
140386476$14038647$6$F$20170920$20171106$20171004$20200113$EXP$$CA-CELGENEUS-CAN-20170908695$CELGENE$$65$YR$$M$Y$$$20200113$$HP$CA$CA
1403879612$14038796$12$F$20170626$20200706$20171004$20200709$EXP$$IT-SA-2017SA180869$SANOFI AVENTIS$$$$$$Y$$$20200709$$HP$IT$IT
140391651$14039165$1$I$20170527$20170530$20171004$20171004$EXP$$GB-ASTRAZENECA-2017SE57456$ASTRAZENECA$$$$$M$Y$63.3$KG$20171004$$MD$GB$GB
140392621$14039262$1$I$20170606$20170926$20171004$20171004$EXP$$FR-JNJFOC-20170928412$JANSSEN$$65$YR$A$M$Y$61$KG$20171004$$MD$FR$FR
140394017$14039401$7$F$201702$20200701$20171004$20200707$PER$$US-ASTRAZENECA-2017SE98909$ASTRAZENECA$$879$MON$$F$Y$63.5$KG$20200708$$$US$US
140396112$14039611$2$F$$20170925$20171004$20200915$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-088349$BRISTOL MYERS SQUIBB$WU B, JUG R, LUEDKE C, SU P, REHDER C, MCCALL C, ET AL. LINEAGE SWITCH BETWEEN B?LYMPHOBLASTIC LEUKEMIA AND ACUTE MYELOID LEUKEMIA INTERMEDIATED BY ^OCCULT^ MYELODYSPLASTIC NEOPLASM: TWO CASES OF ADULT PATIENTS WITH EVIDENCE OF GENOMIC INSTABILITY AND CLONAL SELECTION BY CHEMOTHERAPY. AMERICAN JOURNAL OF CLINICAL PATHOLOGY. 2017?148:136?47$23$YR$$M$Y$$$20200915$$MD$CN$CN
140396344$14039634$4$F$201708$20200811$20171004$20200813$PER$$US-JAZZ-2017-US-012732$JAZZ$$70$YR$$F$Y$$$20200813$$MD$US$US
1404027618$14040276$18$F$20170810$20200626$20171004$20200709$EXP$$US-ACTELION-A-NJ2017-158255$ACTELION$$66$YR$$F$Y$75.74$KG$20200709$$HP$US$US
1404037322$14040373$22$F$201809$20200813$20171004$20200821$EXP$$US-ACTELION-A-NJ2016-138829$ACTELION$$53$YR$$F$Y$87.08$KG$20200821$$HP$US$US
140430032$14043003$2$F$$20200903$20171004$20200908$EXP$$GB-GILEAD-2017-0296371$GILEAD$$12$YR$T$F$Y$$$20200908$$HP$US$GB
140437532$14043753$2$F$20160204$20200816$20171004$20200819$EXP$$US-BAYER-2016-124365$BAYER$$75$YR$E$F$Y$89.36$KG$20200819$$HP$US$US
1404422125$14044221$25$F$201707$20200902$20171004$20200923$EXP$$CA-CELLTRION INC.-2017CA004414$CELLTRION$$$$$$Y$$$20200923$$HP$CA$CA
140460272$14046027$2$F$20170930$20200908$20171005$20200909$PER$$US-PFIZER INC-2017426633$PFIZER$$83$YR$$F$Y$$$20200909$$CN$US$US
1404630327$14046303$27$F$20171225$20200910$20171005$20200917$EXP$$US-TESARO, INC-US-2017TSO02047$GLAXOSMITHKLINE$$61$YR$$F$Y$37.91$KG$20200917$$CN$US$US
140466344$14046634$4$F$20170919$20200707$20171005$20200717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005670$ACADIA PHARMACEUTICALS$$82$YR$$F$Y$$$20200717$$HP$US$US
1404687917$14046879$17$F$20150327$20200306$20171005$20200605$EXP$$PHHY2015CA039204$NOVARTIS$$71$YR$$F$Y$$$20200605$$MD$CA$CA
140474987$14047498$7$F$20170914$20180730$20171005$20180802$EXP$$CN-ASTRAZENECA-2017SE94818$ASTRAZENECA$$22106$DY$$F$Y$$$20180802$$MD$CN$CN
140476784$14047678$4$F$20170805$20200629$20171005$20200706$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-005598$BOEHRINGER INGELHEIM$$59$YR$$M$Y$73.2$KG$20200706$$MD$JP$JP
1404774510$14047745$10$F$201312$20200910$20171005$20200914$EXP$$US-PFIZER INC-2017428305$PFIZER$$65$YR$$M$Y$73$KG$20200914$$MD$US$US
140479082$14047908$2$F$20130920$20200908$20171005$20200914$PER$$US-JNJFOC-20170925522$JOHNSON AND JOHNSON$$77$YR$E$F$Y$$$20200914$$CN$US$US
140480353$14048035$3$F$20141107$20200928$20171005$20200930$PER$$US-JNJFOC-20170929782$JOHNSON AND JOHNSON$$81$YR$E$F$Y$$$20200930$$CN$US$US
140483134$14048313$4$F$20160919$20200901$20171005$20200907$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-113572$BRISTOL MYERS SQUIBB$2017$49$YR$$F$Y$47.5$KG$20200907$$MD$JP$JP
140493477$14049347$7$F$20170317$20200727$20171005$20200730$EXP$$BR-TAKEDA-2017TUS015433$TAKEDA$$25$YR$$M$Y$$$20200730$$CN$BR$BR
1405158010$14051580$10$F$2016$20200806$20171005$20200810$EXP$$US-PFIZER INC-2017425962$PFIZER$$73$YR$$F$Y$92$KG$20200810$$MD$US$US
140517541$14051754$1$I$20170925$20170925$20171006$20171006$EXP$$US-CELGENEUS-USA-20170908360$CELGENE$$66$YR$$M$Y$83.9$KG$20171006$$HP$US$US
140519745$14051974$5$F$$20200831$20171006$20200902$EXP$$US-PFIZER INC-2017426123$PFIZER$$47$YR$$F$Y$$$20200902$$MD$US$US
140527242$14052724$2$F$2014$20200923$20171005$20200928$PER$$US-JNJFOC-20170919380$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200928$$CN$US$US
140529473$14052947$3$F$20170122$20200927$20171005$20200930$PER$$US-JNJFOC-20170923740$JOHNSON AND JOHNSON$$47$YR$A$F$Y$$$20200930$$CN$US$US
140530963$14053096$3$F$20161202$20200917$20171005$20200922$PER$$US-JNJFOC-20170925535$JOHNSON AND JOHNSON$$66$YR$E$M$Y$$$20200922$$CN$US$US
140531752$14053175$2$F$20150924$20200825$20171005$20200831$PER$$US-JNJFOC-20170925919$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200831$$HP$US$US
140537982$14053798$2$F$20170105$20171006$20171006$20171013$EXP$$GB-ASTRAZENECA-2017SE11238$ASTRAZENECA$$69$YR$$F$Y$60.9$KG$20171013$$MD$GB$GB
140538403$14053840$3$F$$20200723$20171006$20200804$EXP$$CA-APOTEX-2017AP019129$APOTEX$$$$$F$Y$$$20200804$$CN$CA$CA
140549923$14054992$3$F$$20200721$20171006$20200726$EXP$$TR-009507513-1709TUR013878$MERCK$$56$YR$$F$Y$$$20200726$$HP$TR$GB
140558683$14055868$3$F$20170925$20180213$20171006$20180222$EXP$$US-JNJFOC-20170929283$PHARMACYCLICS$$75$YR$E$F$Y$49.9$KG$20180222$$MD$US$US
140559086$14055908$6$F$20170925$20180221$20171006$20180302$EXP$$US-JNJFOC-20171003137$PHARMACYCLICS$$52$YR$A$M$Y$103.5$KG$20180302$$MD$US$US
140559103$14055910$3$F$20170922$20171012$20171006$20171020$EXP$$US-JNJFOC-20171003958$PHARMACYCLICS$$86$YR$E$F$Y$51.1$KG$20171020$$MD$US$US
140561734$14056173$4$F$20170118$20180509$20171006$20180515$EXP$$US-JNJFOC-20171000061$JANSSEN$$51$YR$A$F$Y$106$KG$20180515$$MD$US$US
140565792$14056579$2$F$20170217$20171010$20171006$20171018$EXP$$PL-JNJFOC-20170323821$PHARMACYCLICS$$92$YR$E$M$Y$$$20171018$$MD$PL$PL
140568251$14056825$1$I$$20171003$20171006$20171006$EXP$$GB-PFIZER INC-2017430264$PFIZER$GREYSTOKE, A.. SELECT?3: A PHASE I STUDY OF SELUMETINIB IN COMBINATION WITH PLATINUM?DOUBLET CHEMOTHERAPY FOR ADVANCED NSCLC IN THE FIRST?LINE SETTING. BRITISH JOURNAL OF CANCER. 2017?117(7):938? 946$$$$$Y$$$20171006$$HP$GB$GB
140570002$14057000$2$F$201409$20200805$20171006$20200813$EXP$$US-BAYER-2017-172259$BAYER$$83$YR$E$M$Y$$$20200813$$HP$US$US
140578381$14057838$1$I$20170420$20170421$20171006$20171006$EXP$$FR-ASTRAZENECA-2017SE42634$ASTRAZENECA$$56$YR$$F$Y$59.8$KG$20171006$$MD$FR$FR
140579131$14057913$1$I$20160301$20160301$20171006$20171006$EXP$$RO-ASTRAZENECA-2016SE22950$ASTRAZENECA$$79$YR$$M$Y$72$KG$20171006$$MD$RO$RO
140580625$14058062$5$F$20170914$20200720$20171006$20200728$EXP$$DE-EISAI MEDICAL RESEARCH-EC-2017-031516$EISAI$$42$YR$A$F$Y$70$KG$20200728$$MD$DE$DE
140606892$14060689$2$F$2007$20200921$20171007$20200929$EXP$$NL-AUROBINDO-AUR-APL-2017-06852$AUROBINDO$$35$YR$$F$Y$$$20200929$$HP$NL$NL
140606955$14060695$5$F$201708$20200701$20171007$20200714$EXP$$GB-AUROBINDO-AUR-APL-2017-41262$AUROBINDO$$78$YR$$M$Y$86$KG$20200715$$CN$GB$GB
140608206$14060820$6$F$$20200729$20171009$20200810$EXP$$CA-APOTEX-2017AP019295$APOTEX$$68$YR$$M$Y$$$20200810$$CN$CA$CA
140609422$14060942$2$F$$20200826$20171007$20200904$EXP$$SE-AUROBINDO-AUR-APL-2017-41612$AUROBINDO$$$$$$Y$$$20200904$$HP$SE$SE
140609432$14060943$2$F$$20200826$20171007$20200903$EXP$$SE-AUROBINDO-AUR-APL-2017-41611$AUROBINDO$$$$$$Y$$$20200903$$HP$SE$SE
140609452$14060945$2$F$$20200826$20171007$20200905$EXP$$SE-AUROBINDO-AUR-APL-2017-41610$AUROBINDO$$$$$$Y$$$20200905$$HP$SE$SE
140609922$14060992$2$F$$20200820$20171007$20200828$EXP$$US-AUROBINDO-AUR-APL-2017-41291$AUROBINDO$MULTIPLE DRUGS:PANCYTOPENIA, PULMONARY EMBOLI AND CONSTIPATION: 2 CASE REPORTS. 2017$49$YR$$F$Y$$$20200828$$MD$US$US
140615372$14061537$2$F$$20200723$20171009$20200729$EXP$$CA-ROCHE-2004854$ROCHE$$13$YR$$$Y$$$20200729$$HP$CA$CA
140620805$14062080$5$F$20130601$20200918$20171009$20200925$PER$$US-PFIZER INC-2017427392$PFIZER$$58$YR$$F$Y$$$20200925$$LW$US$US
140621475$14062147$5$F$201603$20200701$20171009$20200706$PER$$US-PFIZER INC-2017428754$PFIZER$$68$YR$$F$Y$$$20200706$$HP$US$US
140627447$14062744$7$F$20170925$20200914$20171009$20200922$PER$$CA-AMGEN-CANSP2017146523$AMGEN$$59$YR$A$F$Y$$$20200922$$CN$CA$CA
140639903$14063990$3$F$20161202$20200917$20171009$20200925$EXP$$US-BAYER-2017-184727$BAYER$$66$YR$E$M$Y$$$20200925$$HP$US$US
140644024$14064402$4$F$20170926$20180721$20171009$20180731$EXP$$BE-JNJFOC-20171004483$JANSSEN$$60$YR$A$F$Y$61$KG$20180731$$MD$BE$BE
140644038$14064403$8$F$20170930$20181008$20171009$20181016$EXP$$KR-JNJFOC-20171000300$JANSSEN$$64$YR$A$M$Y$$$20181016$$MD$KR$KR
140649393$14064939$3$F$20170929$20200908$20171009$20200915$PER$$PHEH2017US032455$NOVARTIS$$56$YR$$F$Y$$$20200915$$CN$COUNTRY NOT SPECIFIED$US
140652624$14065262$4$F$2016$20200917$20171009$20200924$EXP$$PHHY2016AR112258$NOVARTIS$$$$$F$Y$$$20200924$$CN$COUNTRY NOT SPECIFIED$AR
1406536918$14065369$18$F$201709$20200710$20171009$20200716$EXP$$US-INCYTE CORPORATION-2017IN008376$INCYTE$$$$$$Y$$$20200716$$CN$US$US
140661742$14066174$2$F$20170929$20171013$20171009$20171020$EXP$$ES-ASTRAZENECA-2017SF00343$ASTRAZENECA$$18924$DY$$M$Y$69$KG$20171020$$MD$ES$ES
140662638$14066263$8$F$20180108$20190527$20171009$20200914$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-089244$BRISTOL MYERS SQUIBB$$70$YR$$F$Y$$$20200914$$CN$CA$CA
140662648$14066264$8$F$201608$20200914$20171010$20200923$PER$$CA-AMGEN-CANSP2017151683$AMGEN$$59$YR$A$F$Y$$$20200923$$HP$CA$CA
140662992$14066299$2$F$20171004$20171016$20171009$20171024$EXP$$ES-JNJFOC-20171006569$PHARMACYCLICS$$63$YR$A$M$Y$$$20171024$$MD$ES$ES
140663074$14066307$4$F$$20200722$20171010$20200805$EXP$$TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-151630$RANBAXY$$56$YR$$F$Y$$$20200806$$HP$NL$TR
140663113$14066311$3$F$20170724$20171101$20171009$20171108$EXP$$UA-JNJFOC-20170807033$PHARMACYCLICS$$71$YR$E$M$Y$$$20171108$$MD$UA$UA
140664071$14066407$1$I$20170623$20170707$20171009$20171009$EXP$$AT-JNJFOC-20170708182$JANSSEN$$45$YR$A$F$Y$65$KG$20171009$$MD$AT$AT
140669524$14066952$4$F$20170515$20200518$20171009$20200813$EXP$$US-NAPPMUNDI-USA-2017-0141034$PURDUE$$61$YR$$M$Y$54.42$KG$20200813$$CN$US$US
1406729410$14067294$10$F$20170726$20200622$20171009$20200706$EXP$$US-ACTELION-A-US2017-158953$ACTELION$$70$YR$$F$Y$61.22$KG$20200706$$HP$US$US
140678481$14067848$1$I$20161229$20161230$20171010$20171010$EXP$$GB-ASTRAZENECA-2017SE00185$ASTRAZENECA$$69$YR$$F$Y$62.6$KG$20171010$$MD$GB$GB
140680693$14068069$3$F$20171006$20181114$20171010$20181116$EXP$$CA-ASTRAZENECA-2017SF02637$ASTRAZENECA$$67$YR$$M$Y$$$20181116$$MD$CA$CA
140681175$14068117$5$F$$20200729$20171010$20200810$EXP$$CA-APOTEX-2017AP019305$APOTEX$$47$YR$$F$Y$$$20200810$$CN$CA$CA
140682267$14068226$7$F$20170721$20200917$20171010$20200921$EXP$$CA-TAKEDA-2017TUS015717$TAKEDA$$45$YR$$F$Y$$$20200921$$HP$CA$CA
140685515$14068551$5$F$201301$20200825$20171010$20200827$PER$$US-PFIZER INC-2017434198$PFIZER$$34$YR$$F$Y$$$20200827$$LW$US$US
140687232$14068723$2$F$$20200831$20171010$20200901$PER$$US-PFIZER INC-2017434885$PFIZER$$52$YR$$F$Y$$$20200901$$CN$US$US
140687258$14068725$8$F$$20200707$20171010$20200709$PER$$US-PFIZER INC-2017434767$PFIZER$$75$YR$$M$Y$124$KG$20200709$$MD$US$US
140688493$14068849$3$F$20121115$20200918$20171010$20200925$PER$$US-PFIZER INC-2017421331$PFIZER$$51$YR$$F$Y$$$20200925$$LW$US$US
1406897020$14068970$20$F$20180326$20200917$20171010$20200925$EXP$$CA-CELLTRION INC.-2017CA013585$CELLTRION$$$$$$Y$$$20200925$$HP$CA$CA
1406912312$14069123$12$F$20170925$20200730$20171010$20200802$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-088508$BRISTOL MYERS SQUIBB$$64$YR$$M$Y$$$20200802$$HP$FR$FR
140692997$14069299$7$F$20170927$20200915$20171010$20200925$EXP$$ES-PFIZER INC-2017423431$PFIZER$$54$YR$$F$Y$94.7$KG$20200925$$HP$ES$ES
140694567$14069456$7$F$2015$20200731$20171010$20200807$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK154893$GLAXOSMITHKLINE$$73$YR$$F$Y$$$20200807$$CN$CA$CA
140695142$14069514$2$F$2017$20200713$20171010$20200716$EXP$$US-SA-2017SA193916$SANOFI AVENTIS$$$$$M$Y$$$20200716$$CN$US$US
140695253$14069525$3$F$20141118$20200720$20171010$20200724$PER$$US-JNJFOC-20171008068$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200724$$CN$US$US
1406955912$14069559$12$F$2015$20200706$20171010$20200713$EXP$$US-ABBVIE-17K-163-1936422-00$ABBVIE$$$$$F$Y$78.09$KG$20200713$$CN$US$US
140697794$14069779$4$F$20171003$20180709$20171010$20180712$EXP$$IT-JNJFOC-20171004094$JANSSEN$$49$YR$A$F$Y$$$20180712$$MD$IT$IT
140700565$14070056$5$F$$20200909$20171011$20200924$EXP$$CA-ALVOGEN-2017-ALVOGEN-093730$ALVOGEN$$66$YR$$M$Y$$$20200924$$CN$CA$CA
140704775$14070477$5$F$$20200729$20171011$20200810$EXP$$CA-APOTEX-2017AP019401$APOTEX$$64$YR$$M$Y$$$20200810$$CN$CA$CA
1407060317$14070603$17$F$2017$20200624$20171010$20200706$EXP$$US-INCYTE CORPORATION-2017IN008377$INCYTE$$$$$$Y$$$20200706$$CN$US$US
140706272$14070627$2$F$20161020$20200630$20171011$20200706$EXP$$US-ROCHE-1896468$ROCHE$$66$YR$$F$Y$109.8$KG$20200706$$MD$US$US
140706373$14070637$3$F$$20200827$20171010$20200901$EXP$$CA-PFIZER INC-2017219025$PFIZER$$51$YR$$M$Y$$$20200901$$HP$CA$CA
140714263$14071426$3$F$2017$20200727$20171010$20200803$PER$$US-SA-2017SA122460$SANOFI AVENTIS$$$$$$Y$$$20200803$$CN$US$US
140715242$14071524$2$F$20170608$20200622$20171010$20200702$EXP$$US-SA-2017SA132590$SANOFI AVENTIS$$42$YR$$F$Y$75.3$KG$20200702$$CN$US$US
140717147$14071714$7$F$2017$20200824$20171010$20200907$EXP$$US-SA-2017SA152119$SANOFI AVENTIS$$$$$$Y$$$20200907$$PH$US$US
140719042$14071904$2$F$20180316$20200709$20171010$20200717$EXP$$US-SA-2017SA141618$SANOFI AVENTIS$$64$YR$$M$Y$$$20200717$$CN$US$US
140719852$14071985$2$F$2017$20200910$20171010$20200915$EXP$$US-SA-2017SA145378$SANOFI AVENTIS$$60$YR$$F$Y$$$20200915$$HP$US$US
140720043$14072004$3$F$2017$20200803$20171010$20200806$EXP$$US-SA-2017SA154039$SANOFI AVENTIS$$51$YR$$M$Y$$$20200806$$HP$US$US
140720704$14072070$4$F$2017$20200827$20171010$20200903$PER$$US-SA-2017SA157758$SANOFI AVENTIS$$$$$$Y$$$20200903$$PH$US$US
140721066$14072106$6$F$2017$20200821$20171010$20200901$PER$$US-SA-2017SA160185$SANOFI AVENTIS$$$$$$Y$$$20200901$$CN$US$US
140723613$14072361$3$F$2017$20200813$20171010$20200819$EXP$$US-SA-2017SA184187$SANOFI AVENTIS$$79$YR$$F$Y$$$20200819$$CN$US$US
140724482$14072448$2$F$2017$20200625$20171010$20200702$EXP$$US-SA-2017SA164896$SANOFI AVENTIS$$62$YR$$F$Y$$$20200702$$CN$US$US
140724786$14072478$6$F$$20200718$20171010$20200723$PER$$US-SA-2017SA166206$SANOFI AVENTIS$$$$$$Y$$$20200723$$CN$US$US
140726016$14072601$6$F$20170830$20200706$20171010$20200714$PER$$US-SA-2017SA171745$SANOFI AVENTIS$$$$$$Y$$$20200714$$CN$US$US
140728592$14072859$2$F$$20190517$20171010$20190604$PER$$US-JNJFOC-20170922293$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20190604$$MD$US$US
140741742$14074174$2$F$201512$20200915$20171010$20200924$EXP$$US-BAYER-2017-159180$BAYER$$76$YR$E$M$Y$$$20200924$$CN$US$US
140741872$14074187$2$F$20150908$20200903$20171010$20200909$EXP$$US-BAYER-2017-150708$BAYER$$80$YR$E$M$Y$$$20200909$$CN$US$US
140747214$14074721$4$F$20170908$20171221$20171011$20171229$EXP$$CA-JNJFOC-20171002576$JANSSEN$$77$YR$E$M$Y$72.7$KG$20171229$$MD$CA$CA
140749695$14074969$5$F$2017$20200821$20171010$20200826$EXP$$AT-ELI_LILLY_AND_COMPANY-AT201709012026$ELI LILLY AND CO$$55$YR$$F$Y$64$KG$20200826$$MD$AT$AT
140757344$14075734$4$F$$20200727$20171011$20200728$PER$$US-PFIZER INC-2017429866$PFIZER$$$$$F$Y$$$20200728$$HP$US$US
140759189$14075918$9$F$$20200716$20171011$20200720$PER$$US-PFIZER INC-2017263335$PFIZER$$63$YR$$F$Y$$$20200720$$MD$US$US
140759324$14075932$4$F$20170903$20171212$20171011$20171218$EXP$$IT-JNJFOC-20170911844$PHARMACYCLICS$$59$YR$A$M$Y$108$KG$20171218$$MD$IT$IT
140762314$14076231$4$F$20171225$20200717$20171011$20200724$EXP$$CA-PFIZER INC-2017416857$PFIZER$$79$YR$$F$Y$$$20200724$$CN$CA$CA
140764172$14076417$2$F$20170906$20180329$20171011$20180403$EXP$$IT-ASTRAZENECA-2017SE91766$ASTRAZENECA$$908$MON$$F$Y$$$20180403$$MD$IT$IT
140764632$14076463$2$F$20170821$20200925$20171011$20200930$PER$$DE-AMGEN-DEUCT2017151075$AMGEN$$79$YR$E$F$Y$59.4$KG$20200929$$HP$DE$DE
140764694$14076469$4$F$$20200727$20171011$20200806$EXP$$CA-ACTELION-A-US2017-160537$ACTELION$$$$$F$Y$81.63$KG$20200806$$MD$CA$CA
140764768$14076476$8$F$20170807$20200714$20171011$20200727$EXP$$US-ACTELION-A-US2017-160401$ACTELION$$61$YR$$F$Y$$$20200727$$HP$US$US
140765462$14076546$2$F$2015$20200421$20171011$20200720$EXP$$US-NAPPMUNDI-USA-2017-0141113$PURDUE$$$$$M$Y$$$20200720$$CN$US$US
140765846$14076584$6$F$20150925$20200824$20171011$20200907$EXP$$JP-INCYTE CORPORATION-2016IN008205$INCYTE$$$$$$Y$$$20200907$$MD$JP$JP
140766701$14076670$1$I$201211$20170929$20171011$20171011$EXP$$US-LANNETT COMPANY, INC.-US-2017LAN001081$LANNETT$BELLISTON S, SUNDARARAJAN J, HAMMOND N, NEWELL K, LYNCH S. REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME IN ASSOCIATION WITH FINGOLIMOD USE. INT?J?NEUROSCI. 2017?127(9):831?834$39$YR$$F$Y$$$20171011$$HP$US$US
140769527$14076952$7$F$20171008$20200715$20171011$20200724$EXP$$US-BIOGEN-2017BI00470479$BIOGEN$$55$YR$$F$Y$$$20200724$$CN$US$US
140774055$14077405$5$F$20170202$20200630$20171012$20200709$EXP$$US-ROCHE-1990966$ROCHE$$57$YR$$F$Y$61.2$KG$20200709$$MD$US$US
140774975$14077497$5$F$$20200826$20171012$20200901$EXP$$CA-ROCHE-2004886$ROCHE$$8$YR$$$Y$$$20200901$$MD$CA$CA
140782775$14078277$5$F$20140215$20200918$20171012$20200924$PER$$US-PFIZER INC-2017423544$PFIZER$$52$YR$$F$Y$81$KG$20200924$$LW$US$US
140788212$14078821$2$F$$20200911$20171012$20200921$EXP$$CA-APOTEX-2017AP019541$APOTEX$$85$YR$$M$Y$$$20200921$$CN$CA$CA
140794709$14079470$9$F$2017$20200729$20171012$20200731$EXP$$US-PFIZER INC-2017438795$PFIZER$$64$YR$$F$Y$$$20200731$$CN$US$US
140797782$14079778$2$F$20170929$20171010$20171012$20171019$EXP$$DE-JNJFOC-20171003936$JANSSEN$$37$YR$A$M$Y$$$20171019$$MD$DE$DE
140803282$14080328$2$F$201612$20200721$20171012$20200724$EXP$$US-JAZZ-2017-US-013083$JAZZ$$39$YR$$F$Y$$$20200724$$HP$US$US
140804126$14080412$6$F$2011$20200806$20171012$20200813$EXP$$US-JAZZ-JPI-P-032171$JAZZ$$$$$F$Y$89.8$KG$20200813$$CN$US$US
140813005$14081300$5$F$20170926$20180202$20171012$20180209$EXP$$CA-CELGENEUS-CAN-20171000284$CELGENE$$71$YR$$M$Y$$$20180209$$HP$CA$CA
140824681$14082468$1$I$20170926$20171005$20171013$20171013$EXP$$US-ASTRAZENECA-2017SF01428$ASTRAZENECA$$17670$DY$$M$Y$118$KG$20171013$$MD$US$US
140829594$14082959$4$F$$20200709$20171012$20200720$PER$$JP-AMGEN-JPNSP2017155156$AMGEN$HAYAMI  A.. LESSONS FROM FINDINGS ON RENAL BIOPSY, NO.64 TOKYO RENAL BIOPSY CONFERENCE? A CASE OF END STAGE RENAL FAILURE RESULTED FROM OXALATE NEPHROPATHY DEVELOPED DURING CHEMOTHERAPY INCLUDING MOLECULAR TARGETED DRUGS FOR RECURRENT LARGE INTESTINE CARCINOMA WITH 2 LARGE/SMALL INTESTINAL RESECTIONS. KIDNEY AND DIALYSIS. 2020?88(4):559?66$68$YR$E$M$Y$50.8$KG$20200719$$MD$JP$JP
140832187$14083218$7$F$20170704$20200821$20171012$20200825$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-005392$BOEHRINGER INGELHEIM$$77$YR$$M$Y$55.4$KG$20200825$$MD$JP$JP
140837503$14083750$3$F$$20200721$20171013$20200805$EXP$US-MLMSERVICE-20170502-0710329-1$US-CIPLA LTD.-2017US18003$CIPLA$BANKER K, RUEKERT L, HASAN S.. COMPULSIVE GABAPENTIN ABUSE DESPITE LACK OF DESIRABLE EFFECTS: A CASE REPORT. JOURNAL OF SUBSTANCE USE.. 2017?1 TO 3$$$$$Y$$$20200805$$PH$US$US
140853843$14085384$3$F$20170925$20171023$20171013$20171030$EXP$$DE-ASTRAZENECA-2017SF01637$ASTRAZENECA$$872$MON$$M$Y$$$20171030$$MD$DE$DE
140879094$14087909$4$F$20171012$20181204$20171013$20181207$EXP$$KR-ASTRAZENECA-2017SF04602$ASTRAZENECA$$818$MON$$M$Y$$$20181207$$MD$KR$KR
140885761$14088576$1$I$20161021$20161025$20171013$20171013$EXP$$AR-JNJFOC-20161022820$JANSSEN$$48$YR$A$M$Y$80$KG$20171013$$MD$AR$AR
140888525$14088852$5$F$$20200919$20171014$20200925$EXP$$NL-AUROBINDO-AUR-APL-2017-07943$AUROBINDO$$77$YR$$M$Y$$$20200925$$MD$NL$NL
140906693$14090669$3$F$2017$20200820$20171015$20200831$PER$$US-SA-2017SA138179$SANOFI AVENTIS$$$$$$Y$$$20200831$$CN$US$US
140908822$14090882$2$F$$20200916$20171015$20200923$EXP$$US-ROCHE-2008493$ROCHE$$$$$F$Y$70.37$KG$20200924$$CN$US$US
140918513$14091851$3$F$20170605$20180921$20171016$20180926$EXP$$FI-BAYER-2017-111611$BAYER$$69$YR$E$F$Y$71$KG$20180926$$MD$FI$FI
1409190322$14091903$22$F$20170731$20200908$20171016$20200914$EXP$$PHHY2017AR151832$NOVARTIS$$44$YR$$M$Y$$$20200914$$CN$COUNTRY NOT SPECIFIED$AR
140919578$14091957$8$F$$20200814$20171016$20200818$PER$$US-PFIZER INC-2017443091$PFIZER$$67$YR$$F$Y$75.75$KG$20200818$$CN$US$US
140921215$14092121$5$F$20170915$20200722$20171016$20200727$EXP$$FR-ROCHE-2006995$ROCHE$$69$YR$$F$Y$$$20200727$$MD$FR$FR
140924232$14092423$2$F$20171008$20200626$20171016$20200703$EXP$$CO-ASTELLAS-2017US041061$ASTELLAS$$87$YR$$M$Y$$$20200703$$CN$CO$CO
140925462$14092546$2$F$2011$20200714$20171016$20200728$EXP$PT-EMA-DD-20200709-KAKWANI_D-153802$PT-JNJFOC-20171010305$JOHNSON AND JOHNSON$JASMINS L, ANDRADE C, FIGUEIRA R, FARIA G, PEREIRA V. INFLIXIMAB?INDUCED LUPUS: A CASE REPORT. GE PORT J GASTROENTEROL. 2017 NOV 19?24:84?88.$48$YR$A$F$Y$$$20200728$$MD$PT$PT
140930232$14093023$2$F$20120223$20200812$20171016$20200817$EXP$$US-BAYER-2017-155281$BAYER$$78$YR$E$M$Y$$$20200817$$CN$US$US
140933025$14093302$5$F$20171005$20171212$20171016$20171218$EXP$$DE-JNJFOC-20171008194$JANSSEN$$30$YR$A$M$Y$80$KG$20171218$$MD$DE$DE
140933031$14093303$1$I$20170329$20170414$20171016$20171016$EXP$$KR-JNJFOC-20170415475$JANSSEN$$31$YR$A$M$Y$83$KG$20171016$$MD$KR$KR
140934118$14093411$8$F$20170718$20200708$20171016$20200717$EXP$$JP-JNJFOC-20171013915$JOHNSON AND JOHNSON$$34$YR$$M$Y$64$KG$20200717$$HP$JP$JP
140962177$14096217$7$F$2017$20200923$20171017$20200930$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2708$ORION$$78$YR$$F$Y$$$20200930$$MD$CA$CA
140968414$14096841$4$F$20170924$20191108$20171017$20191115$EXP$$KR-ASTRAZENECA-2017SE99540$ASTRAZENECA$$61$YR$$M$Y$$$20191115$$MD$KR$KR
140991582$14099158$2$F$2017$20200718$20171017$20200724$EXP$$GB-AUROBINDO-AUR-APL-2017-41705$AUROBINDO$$78$YR$$M$Y$$$20200724$$HP$GB$GB
141000272$14100027$2$F$$20200806$20171017$20200813$EXP$$US-SA-2017SA194945$SANOFI AVENTIS$$$$$$Y$$$20200813$$CN$US$US
141002724$14100272$4$F$20170926$20190612$20171017$20190626$PER$$CA-BEH-2017084400$CSL BEHRING$$79$YR$E$M$Y$$$20190626$$HP$CA$CA
1410030312$14100303$12$F$2017$20200813$20171017$20200826$EXP$$US-INCYTE CORPORATION-2017IN008712$INCYTE$$$$$$Y$$$20200826$$CN$US$US
1410037133$14100371$33$F$2017$20200723$20171017$20200806$EXP$$US-ACTELION-A-NJ2017-159078$ACTELION$$70$YR$$F$Y$54.42$KG$20200806$$HP$US$US
141005343$14100534$3$F$20171016$20180507$20171017$20180515$EXP$$CA-ASTRAZENECA-2017SF05617$ASTRAZENECA$$79$YR$$M$Y$62.2$KG$20180515$$MD$CA$CA
141008452$14100845$2$F$20160605$20171025$20171018$20171030$EXP$$KR-ASTRAZENECA-2016SE61547$ASTRAZENECA$$29594$DY$$M$Y$$$20171030$$MD$KR$KR
141009892$14100989$2$F$20160602$20190806$20171018$20190808$EXP$$JP-ASTRAZENECA-2016SE60239$ASTRAZENECA$$18175$DY$$F$Y$$$20190808$$MD$JP$JP
141016172$14101617$2$F$201701$20180522$20171018$20200716$EXP$$FR-SHIRE-FR201725024$SHIRE$$$$$$Y$$$20200716$$HP$FR$FR
141016972$14101697$2$F$20171012$20171012$20171018$20200810$PER$$PHEH2017US033652$NOVARTIS$$$$$$Y$$$20200810$$PH$US$US
1410194510$14101945$10$F$20171023$20200731$20171018$20200813$EXP$$CO-INCYTE CORPORATION-2017IN008831$INCYTE$$$$$$Y$$$20200814$$CN$CO$CO
141020435$14102043$5$F$2017$20200714$20171018$20200716$EXP$$DE-EISAI MEDICAL RESEARCH-EC-2017-032099$EISAI$$57$YR$A$F$Y$60$KG$20200716$$MD$DE$DE
141020872$14102087$2$F$2017$20200708$20171018$20200717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005819$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$88$KG$20200717$$MD$US$US
141022397$14102239$7$F$2017$20200921$20171018$20200923$PER$$US-EISAI MEDICAL RESEARCH-EC-2017-030986$EISAI$$73$YR$E$F$Y$71$KG$20200923$$CN$US$US
141024881$14102488$1$I$20171005$20171012$20171018$20171018$EXP$$RU-PFIZER INC-2017445175$PFIZER$$66$YR$$M$Y$$$20171018$$MD$RU$RU
141030322$14103032$2$F$$20171011$20171018$20200915$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-093296$BRISTOL MYERS SQUIBB$JANAKIRAM M, VERMA A, WANG Y, BUDHATHOKI A, SUAREZ LONDONO J, MURAKHOVSKAYA I, ET AL. ACCELERATED LEUKEMIC TRANSFORMATION AFTER HAPLO?IDENTICAL TRANSPLANTATION FOR HYDROXYUREA?TREATED SICKLE CELL DISEASE. LEUKEMIA AND LYMPHOMA. 2017?59(1):241?4$31$YR$$F$Y$$$20200915$$HP$US$US
141032304$14103230$4$F$20161226$20200922$20171018$20200924$EXP$$CA-PFIZER INC-2016582274$PFIZER$$54$YR$$F$Y$$$20200924$$MD$CA$CA
141032896$14103289$6$F$2017$20200811$20171018$20200825$EXP$$CA-INTERCEPT-PMOCA2017000951$INTERCEPT PHARMACEUTICALS$$60$YR$$F$Y$$$20200825$$CN$CA$CA
1410390113$14103901$13$F$20171003$20200805$20171018$20200814$EXP$$CO-ASTELLAS-2017US041734$ASTELLAS$$32$YR$$F$Y$43$KG$20200814$$CN$CO$CO
1410426110$14104261$10$F$20171002$20181113$20171018$20181120$EXP$$KR-JNJFOC-20171016531$PHARMACYCLICS$$50$YR$A$M$Y$$$20181120$$MD$KR$KR
141048994$14104899$4$F$20171014$20171113$20171018$20171116$EXP$$JP-ASTRAZENECA-2017SF05181$ASTRAZENECA$$22814$DY$$M$Y$$$20171116$$MD$JP$JP
141060564$14106056$4$F$20170921$20171013$20171018$20180611$EXP$$FR-ASTRAZENECA-2017SF05098$ASTRAZENECA$$67$YR$$M$Y$50$KG$20180611$$MD$FR$FR
141065768$14106576$8$F$$20200824$20171019$20200826$PER$$US-PFIZER INC-2017447585$PFIZER$$73$YR$$F$Y$63.5$KG$20200826$$HP$US$US
141073282$14107328$2$F$20150831$20200625$20171019$20200708$EXP$$US-BAYER-2017-136315$BAYER$$87$YR$E$F$Y$$$20200708$$CN$US$US
141073993$14107399$3$F$20170905$20200817$20171019$20200828$EXP$$JP-TAKEDA-2017MPI007944$TAKEDA$SAHARA N, KOBAYASHI S.. A CASE OF DRUG?INDUCED MYOCARDIAL DISORDER DUE TO BORTEZOMIB, WHICH WAS SUCCESSFULLY TREATED WITH IXAZOMIB.PROCEEDINGS OF THE 12TH REGINAL MEETING OF KANTO?KOSHINETSU BRANCH. THE JAPANESE SOCIETY OF HEMATOLOGY. 2020?16$66$YR$$M$Y$$$20200828$$MD$JP$JP
141074125$14107412$5$F$2014$20200914$20171019$20200920$EXP$$BR-PFIZER INC-2017440925$PFIZER$$57$YR$$F$Y$$$20200920$$CN$BR$BR
141076845$14107684$5$F$20171008$20171207$20171019$20171218$EXP$$PL-JNJFOC-20171012651$JANSSEN$$57$YR$A$F$Y$46$KG$20171218$$MD$PL$PL
141080566$14108056$6$F$20171005$20190703$20171019$20190716$EXP$$FR-JNJFOC-20171011346$JOHNSON AND JOHNSON$$30$YR$$F$Y$56.7$KG$20190716$$MD$FR$FR
141080702$14108070$2$F$20150815$20200625$20171019$20200701$EXP$$US-BAYER-2015-455843$BAYER$$86$YR$E$F$Y$58.97$KG$20200701$$CN$US$US
141081954$14108195$4$F$20170926$20190314$20171019$20190315$EXP$$KR-ASTRAZENECA-2017SF04978$ASTRAZENECA$$727$MON$$M$Y$75.5$KG$20190315$$MD$KR$KR
141082665$14108266$5$F$20170914$20180330$20171019$20180406$EXP$$UA-ASTRAZENECA-2017SE94289$ASTRAZENECA$$23830$DY$$M$Y$115$KG$20180406$$MD$UA$UA
141084446$14108444$6$F$20171003$20171129$20171019$20171207$EXP$$US-JNJFOC-20171017679$PHARMACYCLICS$$68$YR$E$M$Y$$$20171207$$MD$US$US
141085241$14108524$1$I$20170604$20171013$20171019$20171019$EXP$$CA-CELGENEUS-CAN-20171004180$CELGENE$$60$YR$$M$Y$$$20171019$$MD$CA$CA
141088338$14108833$8$F$20200819$20200821$20171019$20200823$EXP$$US-ACTELION-A-NJ2017-161079$ACTELION$$76$YR$$F$Y$$$20200823$$MD$US$US
141094064$14109406$4$F$20171014$20180112$20171019$20180116$EXP$$CA-ASTRAZENECA-2017SF06182$ASTRAZENECA$$30$YR$$F$Y$$$20180116$$MD$CA$CA
141096655$14109665$5$F$201805$20200624$20171020$20200701$EXP$$US-BIOGEN-2017BI00473026$BIOGEN$$64$YR$$M$Y$95.34$KG$20200701$$CN$US$US
141105342$14110534$2$F$20171010$20171019$20171020$20171027$EXP$$US-JNJFOC-20171016201$JANSSEN$$63$YR$A$F$Y$$$20171027$$MD$US$US
1411065419$14110654$19$F$20170330$20200916$20171020$20200922$EXP$$PHHY2017CA152622$NOVARTIS$$62$YR$$M$Y$$$20200922$$CN$CA$CA
141107598$14110759$8$F$$20200901$20171020$20200911$EXP$$CA-APOTEX-2017AP019857$APOTEX$$50$YR$$M$Y$$$20200911$$CN$CA$CA
141109618$14110961$8$F$2017$20200817$20171020$20200819$EXP$$US-PFIZER INC-2017451044$PFIZER$$65$YR$$F$Y$81$KG$20200819$$MD$US$US
1411123414$14111234$14$F$20170917$20200620$20171020$20200623$EXP$$PHHO2017IT013299$NOVARTIS$$76$YR$$M$Y$85$KG$20200623$$MD$IT$IT
1411133213$14111332$13$F$20170925$20200622$20171020$20200624$EXP$$PHHO2017FR011620$NOVARTIS$$23$YR$$M$Y$108$KG$20200624$$MD$FR$FR
1411160613$14111606$13$F$2017$20200909$20171020$20200919$EXP$$US-INCYTE CORPORATION-2017IN008839$INCYTE$$$$$$Y$$$20200920$$CN$US$US
141118852$14111885$2$F$201409$20200913$20171020$20200924$EXP$$US-BAYER-2017-127864$BAYER$$97$YR$E$F$Y$$$20200924$$CN$US$US
141118944$14111894$4$F$20160714$20190711$20171020$20190718$EXP$$GR-ASTRAZENECA-2016SE79266$ASTRAZENECA$$65$YR$$F$Y$$$20190718$$MD$GR$GR
141120714$14112071$4$F$20170613$20200821$20171020$20200826$EXP$$KR-TAKEDA-2017TUS021914$TAKEDA$$76$YR$$F$Y$51$KG$20200826$$MD$KR$KR
1411212325$14112123$25$F$20170927$20191018$20171020$20191023$EXP$$TR-JNJFOC-20170928641$JOHNSON AND JOHNSON$$15$YR$$F$Y$53$KG$20191023$$MD$TR$TR
1411224023$14112240$23$F$20170731$20200715$20171020$20200728$EXP$$US-ACTELION-A-US2017-156120$ACTELION$$79$YR$$F$Y$76.64$KG$20200728$$HP$US$US
1411230712$14112307$12$F$20180208$20200623$20171020$20200707$EXP$$US-ACTELION-A-NJ2017-161251$ACTELION$$75$YR$$F$Y$$$20200707$$HP$US$US
1411231219$14112312$19$F$20180605$20200618$20171020$20200701$EXP$$US-ACTELION-A-US2017-161309$ACTELION$$86$YR$$F$Y$$$20200701$$HP$US$US
141129093$14112909$3$F$20170919$20171102$20171022$20200804$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-094388$BRISTOL MYERS SQUIBB$$81$YR$$F$Y$$$20200804$$MD$JP$JP
141139404$14113940$4$F$20171010$20200901$20171023$20200909$EXP$$JP-SHIRE-JP201726938$SHIRE$C MORIWAKI, Y OKUMURA, Y HAYASHI,ET AL.. DEVELOPMENT OF NEPHROTIC SYNDROME DURING BYPASS THERAPY ACCOMPANIED BY INHIBITOR?POSITIVE HEMOPHILIA B :A CASE REPORT. JAPAN PEDIATRIC SOCIETY JOURNAL. 2020?124(8):1251?1256$2$YR$$M$Y$12.3$KG$20200909$$MD$JP$JP
141142461$14114246$1$I$20170810$20171011$20171023$20171023$EXP$$CA-CELGENEUS-CAN-20171004669$CELGENE$$54$YR$$F$Y$$$20171023$$HP$CA$CA
141150743$14115074$3$F$201707$20200626$20171023$20200710$PER$$US-NEUROCRINE BIOSCIENCES INC.-2017NBI00578$NEUROCRINE BIOSCIENCES$$63$YR$A$F$Y$$$20200710$$CN$US$US
141153094$14115309$4$F$20171010$20200726$20171023$20200803$EXP$$US-PFIZER INC-2017445522$PFIZER$$68$YR$$F$Y$$$20200803$$MD$US$US
141159193$14115919$3$F$20170905$20171220$20171023$20171229$EXP$$DE-JNJFOC-20171016091$JANSSEN$$63$YR$A$F$Y$75$KG$20171229$$MD$DE$DE
141161381$14116138$1$I$20170802$20171006$20171023$20171023$EXP$$PL-PFIZER INC-2017440467$PFIZER$$64$YR$$M$Y$$$20171023$$MD$PL$PL
1411618525$14116185$25$F$20200613$20200624$20171023$20200708$EXP$$US-ACTELION-A-NJ2017-161363$ACTELION$$55$YR$$F$Y$61.22$KG$20200708$$PH$US$US
141161977$14116197$7$F$20200618$20200715$20171023$20200728$PER$$US-ACTELION-A-US2017-161124$ACTELION$$69$YR$$F$Y$$$20200728$$HP$US$US
141164842$14116484$2$F$20171014$20171128$20171023$20171206$EXP$$ES-ASTRAZENECA-2017SF07300$ASTRAZENECA$$16505$DY$$F$Y$80.5$KG$20171206$$MD$ES$ES
1411662635$14116626$35$F$201711$20200708$20171023$20200722$EXP$$US-ACTELION-A-US2017-161157$ACTELION$$27$YR$$F$Y$72.56$KG$20200722$$HP$US$US
1411696512$14116965$12$F$$20200924$20171023$20200928$EXP$$US-PFIZER INC-2017456628$PFIZER$$60$YR$$M$Y$$$20200928$$MD$US$US
141170289$14117028$9$F$$20200710$20171023$20200713$EXP$$US-ARIAD PHARMACEUTICALS, INC-2017US008967$TAKEDA$$$$$M$Y$174.61$KG$20200713$$CN$US$US
141173386$14117338$6$F$$20200820$20171023$20200824$EXP$$US-ALLERGAN-1760085US$ALLERGAN$BENSEN PB, RUTHERFORD CC, GARDNER TB. SYSTEMIC BOTULISM TOXICITY CAUSED BY PYLORIC BOTOX INJECTION TO TREAT GASTROPARESIS. CASE REPORTS IN GASTROENTEROLOGY. 2020?14:373?6$$$$F$Y$$$20200824$$MD$US$US
141180068$14118006$8$F$201710$20200811$20171024$20200819$EXP$$DE-BIOGEN-2017BI00474608$BIOGEN$$40$YR$$M$Y$$$20200819$$CN$DE$DE
1411890620$14118906$20$F$201705$20200720$20171024$20200727$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-051789$BRISTOL MYERS SQUIBB$$73$YR$$F$Y$$$20200727$$CN$CA$CA
141195904$14119590$4$F$$20200811$20171024$20200821$EXP$$CA-APOTEX-2017AP020045$APOTEX$$52$YR$$F$Y$$$20200821$$CN$CA$CA
141204162$14120416$2$F$20160914$20200805$20171024$20200817$EXP$$US-JNJFOC-20171014547$JOHNSON AND JOHNSON$$79$YR$E$F$Y$77.18$KG$20200817$$CN$US$US
141206042$14120604$2$F$20170920$20171025$20171024$20171030$EXP$$KR-PFIZER INC-2017413096$PFIZER$$57$YR$$M$Y$$$20171030$$MD$KR$KR
1412066221$14120662$21$F$2017$20200903$20171024$20200916$EXP$$US-INCYTE CORPORATION-2017IN008873$INCYTE$$$$$$Y$$$20200916$$CN$US$US
1412080625$14120806$25$F$20170812$20200707$20171024$20200710$PER$$PHHO2017US012668$NOVARTIS$$17$YR$$F$Y$50$KG$20200710$$MD$US$US
141208825$14120882$5$F$2010$20200720$20171024$20200724$EXP$$US-ABBVIE-17K-163-2029925-00$ABBVIE$$78$YR$$M$Y$$$20200724$$CN$US$US
141209613$14120961$3$F$20170925$20171110$20171024$20171117$EXP$$FR-JNJFOC-20171002198$PHARMACYCLICS$$86$YR$E$F$Y$$$20171117$$MD$FR$FR
141211012$14121101$2$F$20170609$20200821$20171024$20200827$PER$$US-SA-2017SA107301$SANOFI AVENTIS$$$$$$Y$$$20200827$$PH$US$US
141211283$14121128$3$F$20170822$20200820$20171024$20200827$PER$$US-SA-2017SA157923$SANOFI AVENTIS$$$$$$Y$$$20200827$$PH$US$US
141211686$14121168$6$F$20110606$20200717$20171024$20200720$EXP$$US-PFIZER INC-2017452824$PFIZER$$53$YR$$M$Y$98.41$KG$20200720$$MD$US$US
141213356$14121335$6$F$20170928$20181113$20171024$20181116$EXP$$KR-ASTRAZENECA-2017SE99074$ASTRAZENECA$$865$MON$$F$Y$$$20181116$$MD$KR$KR
141217782$14121778$2$F$20161129$20171103$20171024$20171106$EXP$$IT-JNJFOC-20161206383$JANSSEN$$64$YR$A$F$Y$92$KG$20171106$$MD$IT$IT
141227214$14122721$4$F$$20200727$20171024$20200729$PER$$US-BIOGEN-2017BI00465181$BIOGEN$$$$$F$Y$$$20200729$$CN$US$US
141231964$14123196$4$F$20171016$20180814$20171025$20180817$EXP$$SG-ASTRAZENECA-2017SF06317$ASTRAZENECA$$54$YR$$M$Y$$$20180817$$MD$SG$SG
1412326210$14123262$10$F$2017$20200919$20171025$20200924$EXP$GB-EMA-DD-20171221-TIWARIEVPROD-134905$GB-AUROBINDO-AUR-APL-2017-42336$AUROBINDO$$83$YR$$F$Y$$$20200924$$CN$GB$GB
141236042$14123604$2$F$201312$20200714$20171025$20200722$EXP$$US-BAYER-2017-154641$BAYER$$83$YR$E$F$Y$$$20200722$$CN$US$US
141240322$14124032$2$F$201609$20200805$20171025$20200813$EXP$$US-BAYER-2017-163932$BAYER$$78$YR$E$F$Y$$$20200813$$CN$US$US
141244923$14124492$3$F$20170912$20200727$20171025$20200730$EXP$$US-EISAI MEDICAL RESEARCH-EC-2017-031232$EISAI$$52$YR$A$F$Y$78.2$KG$20200730$$MD$US$US
141245773$14124577$3$F$$20200710$20171025$20200713$PER$$US-PFIZER INC-2017459040$PFIZER$$62$YR$$F$Y$$$20200713$$MD$US$US
141247522$14124752$2$F$20160712$20171031$20171025$20171106$EXP$$JP-ASTRAZENECA-2016SE80753$ASTRAZENECA$$29877$DY$$F$Y$$$20171106$$MD$JP$JP
141248333$14124833$3$F$201603$20200813$20171025$20200819$EXP$$CZ-GILEAD-2017-0300852$GILEAD$MELICHARKOVA, K ET AL. CUSTOMIZED, OR RANDOMIZED TRIALS FOR RELAPSED REFRACTORY PEDIATRIC BURKITT LYMPHOMAS? A RETROSPECTIVE ANALYSIS OF TWO CLINICAL CASES WITH COMPREHENSIVE MOLECULAR PROFILING ? POSSIBLE EXPLANATION FOR DIFFERENT TREATMENT OUTCOMES AFTER SIMILAR TARGETED THERAPIES. 6TH INTERNATIONAL SYMPOSIUM ON CHILDHOOD, ADOLESCENT AND YOUNG ADULT NON?HODGKIN. 2018?UNK:UNK$3$YR$C$M$Y$$$20200819$$MD$CZ$CZ
141251063$14125106$3$F$20170721$20200902$20171025$20200907$EXP$$PHHY2017CR155131$NOVARTIS$$71$YR$$F$Y$63$KG$20200907$$HP$CR$CR
141251182$14125118$2$F$$20200715$20171025$20200722$EXP$$PL-GILEAD-2017-0298255$GILEAD$PULA B, DLUGOSZ?DANECKA M, SALOMON?PERZYNSKI A, SZYMCZYK A, SUBOCZ E, BUDZISZEWSKA BK, RYBKA J, GIL L, WASZCZUK?GAJDA A, ET AL. EFFICACY OF HIGH?DOSE CORTICOSTEROID?BASED TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH P53 ABNORMALITIES IN THE ERA OF B?CELL RECEPTOR. ADVANCES IN MEDICAL SCIENCES. 2020?65(2):371?377. DOI:10.1016/J.ADVMS.2020.06.002$$$A$$Y$$$20200722$$MD$PL$PL
141252232$14125223$2$F$$20200729$20171025$20200811$EXP$$ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-093102$BRISTOL MYERS SQUIBB$OTEYZA JGD, OTEYZA GGD. SEVERE COMPLICATION DURING STRABISMUS SURGERY. ARCHIVOS DE LA SOCIEDAD ESPANOLA DE OFTALMOLOGIA. 2016?91(4):198?203$$$$M$Y$$$20200811$$HP$ES$ES
141254213$14125421$3$F$20171004$20171130$20171025$20171208$EXP$$ES-JNJFOC-20171016752$JANSSEN$$58$YR$A$M$Y$$$20171208$$MD$ES$ES
141258842$14125884$2$F$20171016$20180411$20171025$20180419$EXP$$DE-JNJFOC-20171026961$JANSSEN$$66$YR$E$F$Y$68$KG$20180419$$MD$DE$DE
141265252$14126525$2$F$20170909$20200619$20171025$20200702$PER$$US-NEUROCRINE BIOSCIENCES INC.-2017NBI00972$NEUROCRINE BIOSCIENCES$$61$YR$A$F$Y$$$20200702$$CN$US$US
141270014$14127001$4$F$20161108$20200831$20171026$20200908$EXP$$JP-ARIAD PHARMACEUTICALS, INC-2016JP007385$TAKEDA$KUSABA K.. TWO CASES OF PHILADELPHIA?POSITIVE LEUKAEMIA WITH T315I MUTATION TREATED WITH PONATINIB AFTER ALLOGENEIC TRANSPLANT. PS2:22?4$34$YR$$M$Y$$$20200908$$MD$JP$JP
141275742$14127574$2$F$$20200821$20171026$20200903$EXP$$ZA-LUPIN PHARMACEUTICALS INC.-2017-06116$LUPIN$$$$$M$Y$$$20200903$$CN$ZA$ZA
141279273$14127927$3$F$201710$20200807$20171026$20200811$PER$$US-PFIZER INC-2017460974$PFIZER$$70$YR$$F$Y$58$KG$20200811$$CN$US$US
141281245$14128124$5$F$$20200808$20171026$20200819$EXP$$CA-APOTEX-2017AP020227$APOTEX$$70$YR$$F$Y$$$20200819$$CN$CA$CA
141282075$14128207$5$F$$20200918$20171026$20200930$EXP$$CA-APOTEX-2017AP020228$APOTEX$$67$YR$$F$Y$$$20200930$$CN$CA$CA
141282174$14128217$4$F$20171016$20171024$20171026$20200710$EXP$$CO-ORPHAN EUROPE-2031531$RECORDATI$$30$MON$$M$Y$13$KG$20200710$$HP$CO$CO
141282299$14128229$9$F$$20200808$20171026$20200821$EXP$$CA-APOTEX-2017AP020204$APOTEX$$54$YR$$F$Y$83$KG$20200821$$HP$CA$CA
141289011$14128901$1$I$20170927$20171012$20171026$20171026$EXP$$CA-CELGENEUS-CAN-20171004667$CELGENE$$71$YR$$M$Y$$$20171026$$HP$CA$CA
141290273$14129027$3$F$20130807$20200810$20171026$20200818$EXP$$US-BAYER-2017-132226$BAYER$$71$YR$E$M$Y$88.08$KG$20200818$$HP$US$US
1412906010$14129060$10$F$$20200910$20171026$20200921$EXP$$CA-APOTEX-2017AP020166$APOTEX$$33$YR$$F$Y$$$20200921$$CN$CA$CA
141291622$14129162$2$F$20150325$20200628$20171026$20200708$EXP$$US-BAYER-2017-158472$BAYER$$79$YR$E$F$Y$$$20200708$$CN$US$US
141293342$14129334$2$F$20140409$20200802$20171026$20200812$EXP$$US-BAYER-2017-178626$BAYER$$74$YR$E$M$Y$87.17$KG$20200812$$CN$US$US
141293492$14129349$2$F$201405$20200723$20171026$20200731$EXP$$US-JNJFOC-20171028211$JOHNSON AND JOHNSON$$72$YR$E$F$Y$$$20200731$$CN$US$US
141293952$14129395$2$F$20171010$20200731$20171026$20200809$EXP$$BR-BIOMARINAP-BR-2017-115727$BIOMARIN$$2$YR$$F$Y$11$KG$20200809$$HP$BR$BR
141294683$14129468$3$F$20171020$20200121$20171026$20200129$EXP$$CA-ASTRAZENECA-2017SF08733$ASTRAZENECA$$64$YR$$F$Y$$$20200129$$MD$CA$CA
141297842$14129784$2$F$20171018$20171108$20171026$20171110$EXP$$RU-ASTRAZENECA-2017SF08656$ASTRAZENECA$$21427$DY$$M$Y$$$20171110$$MD$RU$RU
141313502$14131350$2$F$20171018$20171103$20171026$20171110$EXP$$UA-JNJFOC-20170818308$PHARMACYCLICS$$68$YR$E$F$Y$65$KG$20171110$$MD$UA$UA
141313523$14131352$3$F$20171017$20171114$20171026$20171115$EXP$$US-JNJFOC-20171028561$PHARMACYCLICS$$72$YR$E$F$Y$69$KG$20171115$$MD$US$US
141316163$14131616$3$F$20170902$20191107$20171026$20191111$EXP$$CA-CELGENEUS-CAN-20171006549$CELGENE$$66$YR$$F$Y$$$20191111$$MD$CA$CA
141316973$14131697$3$F$20171013$20200914$20171026$20200923$EXP$$US-INCYTE CORPORATION-2017IN009051$INCYTE$$$$$$Y$$$20200923$$CN$US$US
141318942$14131894$2$F$$20200625$20171026$20200702$EXP$$CA-BAXTER-2017BAX036275$BAXTER$$20$YR$$M$Y$66$KG$20200702$$MD$CA$CA
141319513$14131951$3$F$20171012$20200714$20171026$20200720$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-093315$BRISTOL MYERS SQUIBB$$69$YR$$M$Y$$$20200720$$HP$US$US
141322412$14132241$2$F$20170906$20171201$20171027$20171206$EXP$$KR-ASTRAZENECA-2017SE92847$ASTRAZENECA$$920$MON$$F$Y$$$20171206$$MD$KR$KR
141323107$14132310$7$F$20171007$20180326$20171027$20200807$EXP$$JP-009507513-1710JPN002764J$MERCK$$69$YR$$F$Y$36$KG$20200807$$CN$JP$JP
141331021$14133102$1$I$20160903$20160912$20171027$20171027$EXP$$UA-ASTRAZENECA-2016SE96943$ASTRAZENECA$$25535$DY$$F$Y$$$20171027$$MD$UA$UA
141332713$14133271$3$F$20171023$20171031$20171026$20171106$EXP$$JP-ASTRAZENECA-2017SF08250$ASTRAZENECA$$21397$DY$$M$Y$$$20171106$$MD$JP$JP
141333142$14133314$2$F$20170925$20200710$20171027$20200715$EXP$$GR-ROCHE-2014221$ROCHE$$80$YR$$M$Y$71$KG$20200716$$MD$GR$GR
141337075$14133707$5$F$20171015$20200727$20171027$20200728$EXP$$US-PFIZER INC-2017460741$PFIZER$$64$YR$$F$Y$74.84$KG$20200728$$HP$US$US
141337976$14133797$6$F$20170529$20190807$20171026$20200707$EXP$$US-TESARO, INC.-US-2017TSO00872$GLAXOSMITHKLINE$$60$YR$$F$Y$$$20200707$$CN$US$US
141341408$14134140$8$F$2017$20200722$20171026$20200803$EXP$$US-TESARO, INC.-US-2017TSO01778$GLAXOSMITHKLINE$$70$YR$$F$Y$57$KG$20200803$$CN$US$US
141341656$14134165$6$F$20150701$20200702$20171027$20200709$EXP$$PHHY2017AU042419$NOVARTIS$$37$YR$$F$Y$$$20200709$$MD$AU$AU
141351059$14135105$9$F$20170811$20200908$20171027$20200920$EXP$$US-ROCHE-2010390$ROCHE$$$$$F$Y$$$20200921$$MD$US$US
141356453$14135645$3$F$20171017$20190116$20171027$20190124$EXP$$PL-ASTRAZENECA-2017SF07406$ASTRAZENECA$$24617$DY$$F$Y$$$20190124$$MD$PL$PL
141360703$14136070$3$F$$20200803$20171027$20200813$EXP$$CA-APOTEX-2017AP020163$APOTEX$$$$$F$Y$$$20200813$$HP$CA$CA
141362225$14136222$5$F$$20200831$20171027$20200908$EXP$$CA-APOTEX-2017AP020162$APOTEX$$$$$F$Y$$$20200908$$CN$CA$CA
141365382$14136538$2$F$20171014$20171121$20171027$20171130$EXP$$CA-PFIZER INC-2017458941$PFIZER$$30$YR$$F$Y$$$20171130$$MD$CA$CA
1413677413$14136774$13$F$201802$20200904$20171027$20200910$EXP$$US-JAZZ-2017-US-013896$JAZZ$$18$YR$$M$Y$117.9$KG$20200910$$CN$US$US
141370874$14137087$4$F$$20200803$20171027$20200814$EXP$$CA-APOTEX-2017AP020201$APOTEX$$47$YR$$F$Y$$$20200814$$CN$CA$CA
141370904$14137090$4$F$$20200820$20171027$20200828$EXP$$CA-APOTEX-2017AP020189$APOTEX$$70$YR$$F$Y$$$20200828$$HP$CA$CA
141372566$14137256$6$F$201705$20200806$20171027$20200807$EXP$$US-PFIZER INC-2017288858$PFIZER$$61$YR$$M$Y$93$KG$20200807$$CN$US$US
141374682$14137468$2$F$201506$20200910$20171027$20200916$EXP$$US-BAYER-2017-142528$BAYER$$84$YR$E$M$Y$$$20200916$$CN$US$US
141378474$14137847$4$F$$20200703$20171027$20200709$EXP$$PHHY2017CO157430$NOVARTIS$$$$$M$Y$80$KG$20200709$$CN$COUNTRY NOT SPECIFIED$CO
141379973$14137997$3$F$20171019$20180207$20171027$20180212$EXP$$AU-JNJFOC-20171031182$PHARMACYCLICS$$71$YR$E$F$Y$65$KG$20180212$$MD$AU$AU
141381452$14138145$2$F$20170925$20170925$20171027$20171107$EXP$$ES-PFIZER INC-2017459276$PFIZER$$59$YR$$M$Y$$$20171107$$MD$ES$ES
141386831$14138683$1$I$20170713$20171017$20171027$20171027$EXP$$CA-CELGENEUS-CAN-20171005240$CELGENE$$77$YR$$M$Y$$$20171027$$MD$CA$CA
141388404$14138840$4$F$202006$20200701$20171027$20200717$PER$$US-ACTELION-A-US2017-161580$ACTELION$$33$YR$$M$Y$$$20200717$$MD$US$US
141389463$14138946$3$F$20161115$20190207$20171027$20190220$EXP$$PT-JNJFOC-20161212433$JANSSEN$$72$YR$E$M$Y$80$KG$20190220$$MD$PT$PT
141391871$14139187$1$I$20171016$20171019$20171028$20171028$EXP$$GB-ROCHE-2012286$ROCHE$$82$YR$$M$Y$68.9$KG$20171028$$MD$GB$GB
141393892$14139389$2$F$20160816$20200914$20171028$20200924$EXP$$IT-AUROBINDO-AUR-APL-2017-42699$AUROBINDO$$49$YR$$F$Y$$$20200924$$MD$IT$IT
141397093$14139709$3$F$20170628$20200707$20171029$20200715$EXP$$GB-MYLANLABS-2017M1039793$MYLAN$$49$YR$$M$Y$$$20200715$$MD$GB$GB
1414069217$14140692$17$F$$20200915$20171030$20200917$EXP$$US-PFIZER INC-2017454746$PFIZER$$68$YR$$F$Y$$$20200917$$MD$US$US
141407063$14140706$3$F$$20200702$20171030$20200706$PER$$US-PFIZER INC-2017467360$PFIZER$$81$YR$$F$Y$$$20200706$$MD$US$US
141409819$14140981$9$F$201710$20191125$20171030$20191202$EXP$$PHHY2017CA158576$NOVARTIS$$62$YR$$F$Y$$$20191202$$CN$COUNTRY NOT SPECIFIED$CA
141412182$14141218$2$F$20171019$20171105$20171030$20171110$EXP$$IL-JNJFOC-20171031238$PHARMACYCLICS$$65$YR$A$M$Y$$$20171110$$MD$IL$IL
141414032$14141403$2$F$2016$20200913$20171030$20200916$EXP$$US-BAYER-2017-142257$BAYER$$8$DEC$E$M$Y$$$20200916$$HP$US$US
141417782$14141778$2$F$20170413$20171030$20171030$20171102$EXP$$IT-JNJFOC-20171029794$PHARMACYCLICS$$80$YR$E$F$Y$55$KG$20171102$$MD$IT$IT
141421962$14142196$2$F$20160819$20171016$20171030$20200910$EXP$$BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001791$BRISTOL MYERS SQUIBB$$32$YR$$F$Y$$$20200910$$CN$BR$BR
1414270220$14142702$20$F$20180702$20200902$20171030$20200909$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-031856$BRISTOL MYERS SQUIBB$$79$YR$$F$Y$$$20200909$$HP$CA$CA
141427152$14142715$2$F$$20171219$20171030$20171229$EXP$$JP-JNJFOC-20171032770$JANSSEN$FUJIWARA Y. THE PHASE I DOMESTIC STUDY OF IPATASERTIB FOR PATIENTS WITH PROGRESSIVE?RECURRENT SOLID TUMOUR INCLUDING CASTRATION?RESISTANT PROSTATE CANCER. CLINICAL ONCOLOGY 2017:1102. TAKAHASHI S, FUJIWARA Y, MATSUBARA N, TOMOMATSU J, IWASA S, YAMASAKI A, ET AL. PHASE 1 STUDY OF IPATASERTIB (AKT INHIBITOR) FOR INVESTIGATING SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), EFFICACY, AND BIOMARKERS IN JAPANESE PATIENTS (PTS) WITH SOLID TUMORS INCLUDING CASTRATION?RESISTANT PROSTATE CANCER (CRPC). ANNA$$$$M$Y$$$20171229$$MD$JP$JP
141427885$14142788$5$F$20171020$20171114$20171030$20171117$EXP$$CA-PFIZER INC-2017465141$PFIZER$$64$YR$$F$Y$$$20171117$$MD$CA$CA
141430863$14143086$3$F$20130101$20200706$20171030$20200708$EXP$$PHHY2017FR155930$NOVARTIS$$32$YR$$F$Y$$$20200708$$HP$COUNTRY NOT SPECIFIED$FR
141431231$14143123$1$I$$20171016$20171030$20171030$EXP$$FI-ROCHE-2012960$ROCHE$JOENSUU T, JOENSUU G, KAIREMO K, KILJUNEN T, RIENER M, AALTONEN A, ALA?OPAS M, KANGASMAKI A AND ALANKO T MULTIMODAL PRIMARY TREATMENT OF METASTATIC PROSTATE CANCER WITH ANDROGEN DEPRIVATION AND RADIATION.. ANTICANCER RESEARCH 2016?36 (12):6439?6447.$$$$$Y$$$20171030$$MD$FI$FI
1414319613$14143196$13$F$2017$20200623$20171030$20200707$EXP$$US-ACTELION-A-US2017-161574$ACTELION$$67$YR$$M$Y$79.37$KG$20200707$$HP$US$US
141432062$14143206$2$F$20171014$20200824$20171030$20200825$EXP$$US-ACTELION-A-NJ2017-161528$ACTELION$$57$YR$$F$Y$$$20200825$$MD$US$US
141432272$14143227$2$F$$20200706$20171030$20200710$EXP$$US-ARIAD PHARMACEUTICALS, INC-2016US006582$TAKEDA$$$$$M$Y$$$20200710$$CN$US$US
141432747$14143274$7$F$201610$20200910$20171030$20200915$EXP$$US-SA-2017SA203592$SANOFI AVENTIS$$$$$$Y$$$20200915$$HP$US$US
141445132$14144513$2$F$2015$20200716$20171031$20200729$EXP$$US-CIPLA LTD.-2017US18788$CIPLA$BERGMANN S. PROACTIVE USE OF ELTROMBOPAG BEFORE THE ONSET OF CLINICAL BLEEDING IN TWO CHILDREN WITH IMMUNE THROMBOCYTOPENIA AND LIFESTYLE RESTRICTIONS. CLINICAL CASE REPORTS. 2017?5 (10):1660 TO 1663$$$$$Y$$$20200729$$HP$US$US
141445203$14144520$3$F$20170925$20180426$20171031$20200914$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-094718$BRISTOL MYERS SQUIBB$$65$YR$$F$Y$$$20200914$$CN$US$US
141447211$14144721$1$I$$20171017$20171031$20171031$EXP$$SG-ROCHE-2010641$ROCHE$$$$$$Y$$$20171031$$MD$SG$SG
141449513$14144951$3$F$$20200708$20171031$20200715$EXP$$US-BIOGEN-2017BI00477880$BIOGEN$$$$$F$Y$$$20200715$$CN$US$US
141449873$14144987$3$F$$20200803$20171031$20200811$EXP$$CA-APOTEX-2017AP020310$APOTEX$$$$$F$Y$$$20200811$$CN$CA$CA
141457042$14145704$2$F$201302$20200717$20171031$20200729$EXP$$US-NOVOPROD-570062$NOVO NORDISK$$70$YR$$M$Y$102.04$KG$20200730$$LW$US$US
141460698$14146069$8$F$20171014$20191029$20171031$20191104$EXP$$US-ROCHE-2010256$ROCHE$$64$YR$$F$Y$100.1$KG$20191104$$MD$US$US
141461486$14146148$6$F$$20200727$20171031$20200729$EXP$$GB-ABBVIE-17P-167-2146039-00$ABBVIE$$$$$F$Y$$$20200729$$HP$GB$GB
141461871$14146187$1$I$201710$20171026$20171031$20171031$EXP$$IT-JNJFOC-20171031905$JANSSEN$$66$YR$E$F$Y$$$20171031$$MD$IT$IT
1414648610$14146486$10$F$20160414$20200727$20171031$20200801$PER$$PHHY2016US143493$NOVARTIS$$29$YR$$F$Y$$$20200801$$MD$US$US
141466598$14146659$8$F$20110923$20200720$20171031$20200722$EXP$$US-PFIZER INC-2016284919$PFIZER$$57$YR$$F$Y$74.83$KG$20200722$$MD$US$US
141469191$14146919$1$I$20161110$20161201$20171031$20171031$EXP$$KR-JNJFOC-20161200187$JANSSEN$$58$YR$A$M$Y$84.3$KG$20171031$$MD$KR$KR
141469201$14146920$1$I$20170704$20170823$20171031$20171031$EXP$$KR-JNJFOC-20170819108$JANSSEN$$29$YR$A$M$Y$73.2$KG$20171031$$MD$KR$KR
141469211$14146921$1$I$20160616$20160617$20171031$20171031$EXP$$KR-JNJFOC-20160617226$JANSSEN$$63$YR$A$M$Y$76.9$KG$20171031$$MD$KR$KR
141474884$14147488$4$F$$20200113$20171101$20200715$EXP$$CA-ROCHE-2013417$ROCHE$$69$YR$$M$Y$$$20200715$$HP$CA$CA
1414782414$14147824$14$F$20170413$20200805$20171031$20200811$EXP$$CA-TAKEDA-2017TUS005050$TAKEDA$$28$YR$$M$Y$$$20200811$$MD$CA$CA
141480886$14148088$6$F$$20200806$20171101$20200807$PER$$US-PFIZER INC-2017469475$PFIZER$$75$YR$$F$Y$$$20200807$$MD$US$US
141481225$14148122$5$F$$20200623$20171101$20200701$EXP$$IT-BAUSCH-BL-2017-030014$BAUSCH AND LOMB$SACCO M, CARAFA M, DI PALO M, MASSARI V, NANNOLA O, PICCENNA L, MORELLA P. WHEN THERE IS A DRUG TOO: A VERY STRONG LACTIC?METABOLIC ACIDOSIS FROM METFORMIN IN A PATIENT IN MULTIPLE PHARMACOLOGICAL THERAPY. ITALIAN JOURNAL OF MEDICINE. 2017?11(S1):151.$59$YR$$M$Y$$$20200702$$MD$IT$IT
141491252$14149125$2$F$2011$20200908$20171101$20200911$EXP$$ZA-PFIZER INC-2017465678$PFIZER$$25$YR$$M$Y$80$KG$20200911$$MD$ZA$ZA
1414946319$14149463$19$F$20171013$20200902$20171101$20200910$EXP$$PHHY2017CA159299$NOVARTIS$$60$YR$$M$Y$$$20200910$$HP$CA$CA
141495162$14149516$2$F$201508$20200913$20171101$20200924$EXP$$US-BAYER-2017-147221$BAYER$$80$YR$E$F$Y$$$20200924$$HP$US$US
141495618$14149561$8$F$20171014$20191029$20171101$20191106$EXP$$US-ABBVIE-17P-163-2132770-00$ABBVIE$$64$YR$$F$Y$100.1$KG$20191106$$MD$US$US
141496822$14149682$2$F$20170727$20171226$20171101$20180102$EXP$$AR-JNJFOC-20171000005$JANSSEN$$83$YR$E$M$Y$73.1$KG$20180102$$MD$AR$AR
141497299$14149729$9$F$201509$20200903$20171101$20200910$EXP$$BR-ALEXION-A201711575$ALEXION$$22$YR$$F$Y$54$KG$20200910$$CN$BR$BR
1414974029$14149740$29$F$20170926$20191104$20171101$20191111$EXP$$PHHY2017CA143435$NOVARTIS$$11$YR$$M$Y$$$20191112$$CN$CA$CA
141498513$14149851$3$F$2016$20200713$20171101$20200721$EXP$$US-SA-2016SA128709$SANOFI AVENTIS$$46$YR$$F$Y$$$20200721$$CN$US$US
141501886$14150188$6$F$201506$20200826$20171101$20200908$EXP$$JP-INCYTE CORPORATION-2015IN003030$INCYTE$$$$$$Y$$$20200908$$MD$JP$JP
141505723$14150572$3$F$20171001$20171229$20171101$20180104$EXP$$UA-ASTRAZENECA-2017SF00886$ASTRAZENECA$$14788$DY$$M$Y$$$20180104$$MD$UA$UA
141507438$14150743$8$F$20171019$20200717$20171102$20200728$EXP$$US-ROCHE-2016445$ROCHE$$53$YR$$F$Y$82.67$KG$20200728$$MD$US$US
141507584$14150758$4$F$$20200703$20171102$20200714$EXP$$CA-ABBVIE-17K-028-2145793-00$ABBVIE$$$$$M$Y$$$20200714$$CN$CA$CA
141511242$14151124$2$F$$20200710$20171102$20200720$EXP$$CA-APOTEX-2017AP020468$APOTEX$$28$YR$$F$Y$$$20200720$$CN$CA$CA
141518862$14151886$2$F$20170722$20200206$20171102$20200214$EXP$$PHHY2017CO142376$NOVARTIS$$51$YR$$F$Y$77$KG$20200214$$CN$COUNTRY NOT SPECIFIED$CO
141521863$14152186$3$F$$20200909$20171102$20200916$EXP$$CA-APOTEX-2017AP020467$APOTEX$$43$YR$$M$Y$104$KG$20200916$$CN$CA$CA
141523982$14152398$2$F$201709$20200722$20171102$20200728$EXP$$US-SA-2017SA212095$SANOFI AVENTIS$$$$$$Y$$$20200728$$CN$US$US
141525232$14152523$2$F$20151001$20200812$20171102$20200818$EXP$$US-BAYER-2017-112214$BAYER$$91$YR$E$M$Y$$$20200818$$HP$US$US
141525515$14152551$5$F$20171028$20180725$20171102$20180726$EXP$$DE-ASTRAZENECA-2017SF10872$ASTRAZENECA$$71$YR$$F$Y$$$20180726$$MD$DE$DE
141526274$14152627$4$F$20151107$20200802$20171102$20200807$EXP$$US-JNJFOC-20171035099$JOHNSON AND JOHNSON$$73$YR$E$F$Y$67.22$KG$20200807$$HP$US$US
141526691$14152669$1$I$20171017$20171019$20171102$20171102$EXP$$PL-PFIZER INC-2017466616$PFIZER$$67$YR$$F$Y$$$20171102$$MD$PL$PL
141527232$14152723$2$F$$20200729$20171102$20200731$EXP$$US-PFIZER INC-2017471629$PFIZER$$$$$F$Y$$$20200731$$CN$US$US
141528961$14152896$1$I$20160126$20160128$20171102$20171102$EXP$$US-JNJFOC-20160124286$PHARMACYCLICS$$68$YR$E$F$Y$89.9$KG$20171102$$MD$US$US
141529112$14152911$2$F$20170925$20200826$20171102$20200901$EXP$$DE-CELGENEUS-DEU-20170907046$CELGENE$$77$YR$$M$Y$97$KG$20200901$$MD$DE$DE
141530447$14153044$7$F$$20200806$20171102$20200810$EXP$$US-PFIZER INC-2017469998$PFIZER$$75$YR$$F$Y$$$20200810$$MD$US$US
141531244$14153124$4$F$20171017$20200721$20171102$20200728$PER$$US-AMGEN-USASP2017163251$AMGEN$$72$YR$E$F$Y$$$20200728$$HP$US$US
141531762$14153176$2$F$20161101$20200824$20171102$20200907$EXP$$IT-INCYTE CORPORATION-2017IN009147$INCYTE$$$$$$Y$$$20200907$$HP$IT$IT
141540184$14154018$4$F$20171005$20171222$20171102$20171228$EXP$$NZ-JNJFOC-20171013481$JANSSEN$$41$YR$A$M$Y$70.3$KG$20171228$$MD$NZ$NZ
141541095$14154109$5$F$20200204$20200706$20171102$20200709$EXP$$US-TAKEDA-2017MPI009450$TAKEDA$$70$YR$$F$Y$$$20200709$$HP$US$US
1415444317$14154443$17$F$201705$20200707$20171102$20200709$PER$$US-PFIZER INC-2017474104$PFIZER$$78$YR$$M$Y$$$20200709$$MD$US$US
1415452716$14154527$16$F$2016$20200811$20171102$20200819$EXP$$US-ACTELION-A-NJ2017-158827$ACTELION$$61$YR$$F$Y$99.32$KG$20200819$$HP$US$US
1415453125$14154531$25$F$20180101$20200622$20171102$20200706$EXP$$US-ACTELION-A-US2017-153036$ACTELION$$69$YR$$F$Y$$$20200706$$HP$US$US
141549802$14154980$2$F$20170626$20200630$20171102$20200714$EXP$$US-CIPLA LTD.-2017US13841$CIPLA$$$$$$Y$$$20200714$$CN$US$US
1415499812$14154998$12$F$$20200914$20171103$20200918$PER$$CA-AMGEN-CANSP2017164903$AMGEN$$66$YR$E$M$Y$$$20200918$$HP$CA$CA
141550631$14155063$1$I$20160504$20160509$20171103$20171103$EXP$$US-ASTRAZENECA-2016SE50259$ASTRAZENECA$$60$YR$$F$Y$56.8$KG$20171103$$MD$US$US
141552382$14155238$2$F$20171024$20171027$20171103$20200811$PER$$PHEH2017US035648$NOVARTIS$$$$$$Y$$$20200811$$PH$US$US
1415570116$14155701$16$F$20170307$20200903$20171103$20200912$EXP$DE-EMA-DD-20171214-KUMARNVEVHP-104458$PHHY2017DE069415$NOVARTIS$$59$YR$$M$Y$100$KG$20200912$$HP$DE$DE
141559078$14155907$8$F$20170321$20181003$20171103$20200814$EXP$$JP-009507513-1703JPN002075J$MERCK$$70$YR$$M$Y$53$KG$20200814$$CN$JP$JP
141561162$14156116$2$F$20171022$20171023$20171103$20200914$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-095945$BRISTOL MYERS SQUIBB$$69$YR$$F$Y$$$20200914$$CN$US$US
1415621214$14156212$14$F$2014$20200707$20171103$20200716$EXP$$IT-AUROBINDO-AUR-APL-2017-42792$AUROBINDO$$45$YR$$M$Y$$$20200717$$HP$IT$IT
141563173$14156317$3$F$2017$20200911$20171103$20200915$PER$$US-PFIZER INC-2017471874$PFIZER$$66$YR$$F$Y$54$KG$20200915$$HP$US$US
141564634$14156463$4$F$2013$20200720$20171103$20200725$PER$$CA-AMGEN-CANSP2017163488$AMGEN$$41$YR$A$M$Y$$$20200725$$HP$CA$CA
141565794$14156579$4$F$$20200804$20171103$20200811$EXP$$PHHY2017MX161021$NOVARTIS$$$$$F$Y$71$KG$20200811$$MD$MX$MX
1415674010$14156740$10$F$20131028$20200810$20171103$20200812$EXP$$PHHY2015NL047937$NOVARTIS$NEW J, LE K, WONG KA, CHOI SJ, DANH CL, HALL JD ET. AL.. A CASE OF ACUTE RENAL FAILURE AND RHABDOMYOLYSIS ASSOCIATED WITH THE CONCOMITANT USE OF TICAGRELOR ROSUVASTATIN AND LOSARTAN. JSM INTERN MED. 2017?2(1):1004$78$YR$$M$Y$$$20200812$$HP$NL$NL
141572902$14157290$2$F$20171024$20180830$20171103$20180906$EXP$$US-JNJFOC-20171035137$JANSSEN$$13$YR$C$F$Y$$$20180906$$MD$US$US
141575185$14157518$5$F$20170909$20190715$20171103$20190719$EXP$$PHHO2017ES012873$NOVARTIS$$66$YR$$F$Y$55$KG$20190719$$MD$ES$ES
141577914$14157791$4$F$20171002$20200818$20171103$20200821$EXP$$JP-EISAI MEDICAL RESEARCH-EC-2017-032743$EISAI$ARAI A. LENVATINIB ADMINISTRATION EXPERIENCES FOR PERICARDIAL METASTASES OF THYROID CANCER PRESENTING CARDIAC TAMPONADE. J JPN ENDOCR SURG. 2019?36(S?3):S354?S354.$58$YR$A$M$Y$$$20200821$$MD$JP$JP
1415804020$14158040$20$F$2017$20200811$20171103$20200818$EXP$$CA-PFIZER INC-2017472395$PFIZER$$57$YR$$F$Y$$$20200818$$HP$CA$CA
1415807714$14158077$14$F$20171026$20200623$20171105$20200710$EXP$$CA-ROCHE-2019446$ROCHE$$68$YR$$F$Y$76$KG$20200710$$HP$CA$CA
141581227$14158122$7$F$20180516$20200812$20171103$20200817$PER$$US-PFIZER INC-2017472533$PFIZER$$73$YR$$F$Y$81.63$KG$20200817$$CN$US$US
141583106$14158310$6$F$20171020$20171127$20171103$20171201$EXP$$US-JNJFOC-20171033972$JANSSEN$$70$YR$E$F$Y$69.9$KG$20171201$$MD$US$US
141583208$14158320$8$F$20200902$20200904$20171103$20200908$EXP$$CA-PFIZER INC-2017249904$PFIZER$$66$YR$$M$Y$$$20200908$$HP$CA$CA
141586292$14158629$2$F$201710$20200709$20171106$20200711$PER$$US-BIOGEN-2017BI00479206$BIOGEN$$37$YR$$M$Y$$$20200711$$CN$US$US
141587582$14158758$2$F$201405$20200723$20171103$20200730$EXP$$US-BAYER-2017-206752$BAYER$$72$YR$E$F$Y$$$20200730$$CN$US$US
141588492$14158849$2$F$20160521$20190408$20171103$20190412$EXP$$IL-ASTRAZENECA-2016SE54755$ASTRAZENECA$$20023$DY$$M$Y$75$KG$20190412$$MD$IL$IL
141589303$14158930$3$F$20130731$20200714$20171103$20200722$EXP$$GR-CELGENEUS-GRC-20171100454$CELGENE$$73$YR$$F$Y$74$KG$20200722$$MD$GR$GR
141591266$14159126$6$F$$20200629$20171103$20200708$PER$$CA-AMGEN-CANSP2017165285$AMGEN$$61$YR$A$F$Y$$$20200708$$HP$CA$CA
141591565$14159156$5$F$20160809$20200909$20171106$20200911$EXP$$CA-TAKEDA-2016TUS014207$TAKEDA$$38$YR$$F$Y$$$20200911$$MD$CA$CA
141598694$14159869$4$F$$20200729$20171106$20200810$EXP$$CA-APOTEX-2017AP020540$APOTEX$$$$$F$Y$$$20200810$$CN$CA$CA
141600604$14160060$4$F$20170308$20180508$20171106$20180511$EXP$$CA-ASTRAZENECA-2017SE25595$ASTRAZENECA$$70$YR$$M$Y$$$20180511$$MD$CA$CA
1416052216$14160522$16$F$201601$20200729$20171106$20200805$EXP$$PHHY2017CA072611$NOVARTIS$$54$YR$$F$Y$53.51$KG$20200805$$CN$COUNTRY NOT SPECIFIED$CA
141605415$14160541$5$F$$20200702$20171104$20200715$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-153818$RANBAXY$$59$YR$$M$Y$$$20200715$$HP$NL$IT
141612592$14161259$2$F$20171031$20180226$20171106$20180302$EXP$$US-JNJFOC-20171101719$JANSSEN$$5$YR$C$F$Y$17$KG$20180302$$MD$US$US
141615632$14161563$2$F$20171021$20171109$20171106$20171117$EXP$$US-JNJFOC-20171030461$JANSSEN$$90$YR$E$M$Y$80$KG$20171117$$MD$US$US
141616382$14161638$2$F$20170526$20200826$20171106$20200925$PER$$US-LUNDBECK-DKLU2032243$LUNDBECK$$53$YR$$M$Y$$$20200925$$CN$US$US
141617444$14161744$4$F$$20200505$20171106$20200810$EXP$$CA-ROCHE-2014675$ROCHE$$$$$M$Y$89$KG$20200811$$HP$CA$CA
141619712$14161971$2$F$201511$20200831$20171106$20200903$EXP$$US-BAYER-2017-148765$BAYER$$79$YR$E$F$Y$$$20200903$$CN$US$US
141620872$14162087$2$F$20171013$20200730$20171106$20200807$EXP$$BR-BIOMARINAP-BR-2017-115968$BIOMARIN$$13$YR$$F$Y$36$KG$20200807$$MD$BR$BR
141621133$14162113$3$F$20170716$20200806$20171106$20200812$EXP$$US-SA-2017SA213924$SANOFI AVENTIS$$$$$$Y$$$20200812$$MD$US$US
141621885$14162188$5$F$20171023$20200807$20171106$20200812$PER$$US-CELGENEUS-USA-20171100264$CELGENE$$74$YR$$M$Y$84.44$KG$20200812$$HP$US$US
141621942$14162194$2$F$20141101$20200825$20171106$20200828$EXP$$US-BAYER-2017-148777$BAYER$$88$YR$E$M$Y$$$20200828$$CN$US$US
141624753$14162475$3$F$20171021$20171128$20171106$20171201$EXP$$PL-ASTRAZENECA-2017SF08633$ASTRAZENECA$$26042$DY$$M$Y$$$20171201$$MD$PL$PL
141630657$14163065$7$F$20171031$20200629$20171107$20200706$EXP$$CA-ROCHE-2019461$ROCHE$$48$YR$$M$Y$$$20200706$$MD$CA$CA
141633274$14163327$4$F$2015$20200721$20171106$20200723$PER$$US-PFIZER INC-2017477536$PFIZER$$79$YR$$F$Y$63$KG$20200723$$CN$US$US
1416336810$14163368$10$F$20171024$20200828$20171107$20200902$EXP$$CA-TAKEDA-2017TUS023074$TAKEDA$$87$YR$$M$Y$$$20200902$$HP$CA$CA
141636305$14163630$5$F$201612$20190225$20171107$20200703$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-098426$BRISTOL MYERS SQUIBB$WANG C, PARKER J, FEAGIN W, HEERSINK M, PARKER J. CORNEAL ULCERATION ASSOCIATED WITH NIVOLUMAB USE. AMERICAN JOURNAL OF OPHTHALMOLOGY CASE REPORTS. 2019?14:26?7$80$YR$$F$Y$$$20200703$$HP$US$US
141639133$14163913$3$F$20160518$20180803$20171107$20180809$EXP$$US-ASTRAZENECA-2016SE50072$ASTRAZENECA$$25665$DY$$M$Y$$$20180809$$MD$US$US
141648456$14164845$6$F$20170713$20200729$20171107$20200803$EXP$$PHHY2017DE159071$NOVARTIS$$80$YR$$M$Y$95$KG$20200803$$MD$DE$DE
141648672$14164867$2$F$20171104$20171212$20171107$20171220$EXP$$JP-ASTRAZENECA-2017SF12405$ASTRAZENECA$$25674$DY$$M$Y$$$20171220$$MD$JP$JP
141650012$14165001$2$F$$20171107$20171107$20171115$EXP$$US-DRREDDYS-USA/USA/17/0094376$DR REDDYS$JENSEN A, HAAS R. REFRACTORY HYPOTENSION IN A PATIENT WITH A HISTORY OF ANABOLIC STEROID ABUSE TAKING AN ANGIOTENSIN?II RECEPTOR BLOCKER: A CASE REPORT.. AANA J. 2017?85(5):340?4.$55$YR$$M$Y$97$KG$20171115$$HP$COUNTRY NOT SPECIFIED$US
141651382$14165138$2$F$201507$20200710$20171107$20200714$EXP$$FR-PFIZER INC-2016026280$PFIZER$$71$YR$$M$Y$63$KG$20200714$$MD$FR$FR
141651788$14165178$8$F$$20180624$20171107$20200812$EXP$$PHHY2017IT162575$NOVARTIS$$16$YR$$F$Y$$$20200812$$HP$IT$IT
141653566$14165356$6$F$20180104$20200916$20171107$20200923$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK091406$GLAXOSMITHKLINE$$55$YR$$F$Y$$$20200923$$CN$CA$CA
141654429$14165442$9$F$20181126$20200814$20171107$20200820$EXP$$CA-ROCHE-2017774$ROCHE$$60$YR$$F$Y$$$20200820$$HP$CA$CA
141654565$14165456$5$F$20171024$20180706$20171107$20180903$EXP$$US-JNJFOC-20171035560$JANSSEN$$7$YR$C$F$Y$26.1$KG$20180903$$HP$US$US
141657672$14165767$2$F$2017$20200825$20171107$20200827$PER$$US-009507513-1710USA013074$MERCK$$8$YR$$M$Y$$$20200827$$MD$US$US
141666635$14166663$5$F$20171101$20200820$20171107$20200821$PER$$US-AMGEN-USACT2017166872$AMGEN$$72$YR$E$F$Y$87$KG$20200821$$HP$US$US
141667212$14166721$2$F$20171020$20171107$20171107$20171115$EXP$$US-JNJFOC-20171105580$PHARMACYCLICS$$71$YR$E$F$Y$65$KG$20171115$$MD$US$US
1416720121$14167201$21$F$20171028$20180925$20171108$20180928$EXP$$DE-ROCHE-2018649$ROCHE$$68$YR$$M$Y$95$KG$20180928$$MD$DE$DE
141672583$14167258$3$F$2017$20200903$20171107$20200915$EXP$$US-ELI_LILLY_AND_COMPANY-US201710012150$ELI LILLY AND CO$$61$YR$$F$Y$$$20200915$$CN$US$US
141676165$14167616$5$F$20171030$20200919$20171107$20200923$EXP$$SG-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-098261$BRISTOL MYERS SQUIBB$$71$YR$$M$Y$61.1$KG$20200923$$HP$SG$SG
141681473$14168147$3$F$20160601$20200625$20171107$20200702$PER$$US-SA-2017SA097235$SANOFI AVENTIS$$$$$$Y$$$20200702$$CN$US$US
141685353$14168535$3$F$2016$20200813$20171107$20200820$PER$$US-SA-2017SA175637$SANOFI AVENTIS$$$$$$Y$$$20200820$$CN$US$US
141685427$14168542$7$F$2016$20200827$20171108$20200902$EXP$$JP-UNITED THERAPEUTICS-UNT-2016-010052$UNITED THERAPEUTICS$$30$YR$$M$Y$75.2$KG$20200902$$HP$JP$JP
141685503$14168550$3$F$$20200914$20171107$20200921$PER$$US-SA-2017SA178580$SANOFI AVENTIS$$$$$$Y$$$20200921$$CN$US$US
141686543$14168654$3$F$$20200706$20171107$20200710$PER$$US-SA-2017SA197505$SANOFI AVENTIS$$$$$$Y$$$20200710$$CN$US$US
141690525$14169052$5$F$$20200914$20171108$20200916$EXP$$US-PFIZER INC-2017480435$PFIZER$$77$YR$$F$Y$63.05$KG$20200916$$MD$US$US
141690662$14169066$2$F$20170819$20190830$20171107$20190904$EXP$$CA-CELGENEUS-CAN-20171007950$CELGENE$$71$YR$$M$Y$$$20190904$$MD$CA$CA
1416917412$14169174$12$F$20171020$20200717$20171107$20200730$EXP$$US-ACTELION-A-NJ2017-162166$ACTELION$$54$YR$$M$Y$89.34$KG$20200730$$HP$US$US
141692842$14169284$2$F$20171026$20200824$20171108$20200831$EXP$$PHHY2017CA162378$NOVARTIS$$56$YR$$F$Y$$$20200831$$HP$CA$CA
141696103$14169610$3$F$$20200728$20171108$20200806$EXP$$CA-APOTEX-2017AP020661$APOTEX$$54$YR$$F$Y$$$20200806$$CN$CA$CA
141709163$14170916$3$F$$20200803$20171108$20200803$PER$$US-BIOGEN-2017BI00479030$BIOGEN$$$$$M$Y$$$20200803$$CN$US$US
141709543$14170954$3$F$20171024$20190307$20171108$20190308$EXP$$ES-ASTRAZENECA-2017SF09329$ASTRAZENECA$$24854$DY$$F$Y$51.5$KG$20190308$$MD$ES$ES
141709702$14170970$2$F$20170904$20180809$20171108$20180817$EXP$$IT-JNJFOC-20170907216$JANSSEN$$60$YR$A$F$Y$$$20180817$$MD$IT$IT
141711146$14171114$6$F$20171115$20200911$20171108$20200922$EXP$$US-INCYTE CORPORATION-2017IN009507$INCYTE$$$$$$Y$$$20200922$$CN$US$US
141713233$14171323$3$F$2006$20200831$20171108$20200904$EXP$$US-SA-2016SA120399$SANOFI AVENTIS$$$$$$Y$$$20200904$$CN$US$US
141713822$14171382$2$F$201710$20200803$20171108$20200805$EXP$$JP-SA-2017SA214474$SANOFI AVENTIS$$$$$$Y$$$20200806$$MD$JP$JP
141717745$14171774$5$F$20170705$20200917$20171108$20200924$PER$$US-SA-2017SA123231$SANOFI AVENTIS$$$$$$Y$$$20200924$$CN$US$US
141719777$14171977$7$F$2014$20200629$20171108$20200707$EXP$$US-009507513-1710USA005692$MERCK$$$$$M$Y$113.38$KG$20200707$$CN$US$US
141724729$14172472$9$F$20051030$20200921$20171109$20200925$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3452$ORION$$14$YR$$F$Y$$$20200925$$MD$CA$CA
141727142$14172714$2$F$$20200903$20171109$20200915$EXP$$AT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-059467$BOEHRINGER INGELHEIM$BAUMANN?DURCHSCHEIN F, CASE REPORT: BILIARY PANCREATITIS WITH ACUTE CHOLANGITIS IN A PATIENT UNDER ANTICOAGULANT TREATMENT WITH DABIGATRAN. ELECTRONIC JOURNAL OF THE INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2017? 28:3: 233?236.$75$YR$E$M$Y$$$20200915$$HP$AT$AT
141727892$14172789$2$F$201708$20200828$20171109$20200907$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005242$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$86$KG$20200907$$MD$US$US
141728282$14172828$2$F$$20200902$20171109$20200911$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005262$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20200911$$MD$US$US
141728652$14172865$2$F$$20200619$20171109$20200714$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005316$ACADIA PHARMACEUTICALS$$$$$F$Y$43$KG$20200714$$MD$US$US
141733016$14173301$6$F$2018$20200825$20171109$20200918$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005403$ACADIA PHARMACEUTICALS$$71$YR$$F$Y$72$KG$20200918$$MD$US$US
1417351715$14173517$15$F$2017$20200804$20171109$20200810$EXP$$US-PFIZER INC-2017479956$PFIZER$$73$YR$$M$Y$102$KG$20200810$$CN$US$US
141735867$14173586$7$F$2010$20200924$20171109$20200928$EXP$$US-PFIZER INC-2017482056$PFIZER$$63$YR$$F$Y$63$KG$20200928$$CN$US$US
141737683$14173768$3$F$$20200707$20171109$20200721$EXP$$PHJP2017JP032805$NOVARTIS$$65$YR$$M$Y$$$20200721$$CN$COUNTRY NOT SPECIFIED$JP
141741008$14174100$8$F$$20200616$20171109$20200723$PER$$US-INCYTE CORPORATION-2017IN009603$INCYTE$$$$$$Y$$$20200723$$CN$US$US
1417424017$14174240$17$F$20180207$20200812$20171109$20200820$EXP$$CA-CELLTRION INC.-2017CA013523$CELLTRION$$$$$$Y$$$20200820$$HP$CA$CA
141744174$14174417$4$F$201710$20200727$20171109$20200806$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006084$ACADIA PHARMACEUTICALS$$81$YR$$M$Y$$$20200806$$MD$US$US
1417457412$14174574$12$F$20171024$20200828$20171109$20200904$EXP$$CA-PFIZER INC-2017480638$PFIZER$$87$YR$$M$Y$$$20200904$$MD$CA$CA
141750864$14175086$4$F$20171025$20200915$20171109$20200929$EXP$$CA-JNJFOC-20171107016$JOHNSON AND JOHNSON$$45$YR$A$F$Y$$$20200929$$CN$CA$CA
141751453$14175145$3$F$2014$20200629$20171109$20200710$EXP$$US-JNJFOC-20171106563$JOHNSON AND JOHNSON$$84$YR$$M$Y$$$20200710$$LW$US$US
141759713$14175971$3$F$20171027$20180718$20171109$20180719$EXP$$CA-CELGENEUS-CAN-20171101269$CELGENE$$60$YR$$F$Y$$$20180719$$MD$CA$CA
141760871$14176087$1$I$$20171031$20171109$20171109$EXP$$ES-JNJFOC-20171100086$JANSSEN$PEREZ?DE?LIS M, RETAMOZO S, FLORES?CHAVEZ A, KOSTOV B, PEREZ?ALVAREZ R, BRITO?ZERON P, ET AL. AUTOIMMUNE DISEASES INDUCED BY BIOLOGICAL AGENTS. A REVIEW OF 12,731 CASES (BIOGEAS REGISTRY). EXPERT OPINION ON DRUG SAFETY 2017?16 (11):1255?1271.$$$$$Y$$$20171109$$HP$ES$ES
1417613117$14176131$17$F$20171019$20200623$20171109$20200707$EXP$$US-ACTELION-A-NJ2017-162029$ACTELION$$39$YR$$F$Y$$$20200707$$PH$US$US
141763155$14176315$5$F$20171021$20200917$20171109$20200925$EXP$$US-TESARO, INC.-US-2017TSO03473$GLAXOSMITHKLINE$$48$YR$$F$Y$53.06$KG$20200925$$MD$US$US
141764818$14176481$8$F$20170126$20200806$20171109$20200809$EXP$DE-EMA-DD-20171206-SGALIPALLIP-141231$PHHY2016DE183065$NOVARTIS$$80$YR$$F$Y$71$KG$20200809$$MD$DE$DE
1417708311$14177083$11$F$2015$20200817$20171110$20200819$PER$$US-PFIZER INC-2017482199$PFIZER$$59$YR$$F$Y$114$KG$20200819$$CN$US$US
141775302$14177530$2$F$20160613$20171117$20171110$20171124$EXP$$RU-ASTRAZENECA-2016SE86380$ASTRAZENECA$$14774$DY$$M$Y$$$20171124$$MD$RU$RU
141775999$14177599$9$F$2017$20200814$20171110$20200824$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004971$ACADIA PHARMACEUTICALS$$71$YR$$M$Y$$$20200824$$MD$US$US
141778932$14177893$2$F$201708$20200807$20171110$20200901$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005235$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20200901$$CN$US$US
141779016$14177901$6$F$20161213$20200716$20171110$20200722$PER$$PHEH2017US035650$NOVARTIS$$$$A$M$Y$118.3$KG$20200722$$HP$US$US
141779074$14177907$4$F$201708$20200706$20171110$20200716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005237$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$54$KG$20200716$$MD$US$US
141780044$14178004$4$F$201707$20200706$20171110$20200716$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005346$ACADIA PHARMACEUTICALS$$80$YR$$F$Y$$$20200716$$MD$US$US
141781014$14178101$4$F$20200315$20200911$20171110$20200921$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005884$ACADIA PHARMACEUTICALS$$95$YR$$F$Y$$$20200921$$MD$US$US
141781627$14178162$7$F$20170823$20200728$20171110$20200807$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005410$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20200807$$CN$US$US
1417819711$14178197$11$F$2017$20200720$20171110$20200730$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005827$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20200730$$MD$US$US
141782102$14178210$2$F$201708$20200826$20171110$20200904$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005431$ACADIA PHARMACEUTICALS$$83$YR$$F$Y$$$20200904$$MD$US$US
141783252$14178325$2$F$2016$20200721$20171110$20200727$PER$$AR-AMGEN-ARGSP2017168958$AMGEN$$57$YR$A$F$Y$$$20200727$$CN$AR$AR
141784412$14178441$2$F$20170531$20171120$20171110$20200803$PER$$US-AMGEN-USACT2017167129$AMGEN$$67$YR$E$F$Y$$$20200803$$MD$US$US
141784722$14178472$2$F$2017$20200814$20171111$20200824$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005750$ACADIA PHARMACEUTICALS$$60$YR$$F$Y$$$20200824$$MD$US$US
141787809$14178780$9$F$20171108$20200820$20171110$20200821$EXP$$US-EISAI MEDICAL RESEARCH-EC-2017-032962$EISAI$$71$YR$$F$Y$94.71$KG$20200821$$MD$US$US
141789542$14178954$2$F$20170730$20171110$20171110$20171115$EXP$$CN-ASTRAZENECA-2017SE80895$ASTRAZENECA$$30829$DY$$M$Y$$$20171115$$MD$CN$CN
141789821$14178982$1$I$20170515$20171108$20171110$20171110$EXP$$GB-JNJFOC-20171109726$PHARMACYCLICS$$67$YR$E$M$Y$75.6$KG$20171110$$MD$GB$GB
1417925711$14179257$11$F$20171026$20190130$20171110$20190207$EXP$$US-JNJFOC-20171101097$PHARMACYCLICS$$74$YR$E$F$Y$$$20190207$$MD$US$US
1417941511$14179415$11$F$2018$20200831$20171110$20200902$PER$$US-PFIZER INC-2017486666$PFIZER$$56$YR$$M$Y$82$KG$20200902$$MD$US$US
141794531$14179453$1$I$20171103$20171106$20171110$20171110$EXP$$CA-ASTRAZENECA-2017SF13161$ASTRAZENECA$$59$YR$$M$Y$$$20171110$$MD$CA$CA
141796033$14179603$3$F$20180228$20200713$20171110$20200723$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006062$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$$$20200723$$CN$US$US
141796416$14179641$6$F$20151117$20200811$20171110$20200812$EXP$$PHHO2015BE019839$NOVARTIS$$62$YR$$F$Y$82$KG$20200812$$HP$BE$BE
141799981$14179998$1$I$20171003$20171004$20171110$20171110$EXP$$JP-PFIZER INC-2017438505$PFIZER$$70$YR$$M$Y$66$KG$20171110$$MD$JP$JP
1418080910$14180809$10$F$20181010$20200813$20171110$20200818$EXP$$US-ACTELION-A-NJ2017-153307$ACTELION$$74$YR$$F$Y$$$20200818$$HP$US$US
1418085312$14180853$12$F$20180815$20200729$20171110$20200811$PER$$US-ACTELION-A-NJ2017-162433$ACTELION$$67$YR$$M$Y$105.22$KG$20200811$$HP$US$US
141812913$14181291$3$F$$20171124$20171112$20171207$EXP$IT-MINISAL02-434443$IT-TEVA-822998ACC$TEVA$PARRETTA E, SOTTOSANTI L, SPORTIELLO L, RAFANIELLO C, POTENZA S, D AMATO S.$53$YR$$F$Y$$$20171207$$HP$IT$IT
141813588$14181358$8$F$2017$20200922$20171113$20200926$EXP$$PHHY2017CA076896$NOVARTIS$$37$YR$$M$Y$$$20200926$$CN$COUNTRY NOT SPECIFIED$CA
141815908$14181590$8$F$$20200914$20171113$20200921$PER$$CA-AMGEN-CANSP2017170158$AMGEN$$48$YR$A$F$Y$$$20200920$$CN$CA$CA
141820761$14182076$1$I$20170818$20171030$20171113$20171113$EXP$$IT-ROCHE-2017520$ROCHE$$24$YR$$M$Y$61$KG$20171113$$MD$IT$IT
141824287$14182428$7$F$20171105$20200716$20171113$20200723$EXP$IT-EMA-DD-20171211-NGEVHPROD-130221$PHHY2017IT166920$NOVARTIS$$57$YR$$F$Y$$$20200723$$HP$IT$IT
141825723$14182572$3$F$$20200921$20171113$20200922$PER$$US-PFIZER INC-2017488372$PFIZER$$48$YR$$F$Y$$$20200922$$CN$US$US
141830462$14183046$2$F$201510$20200708$20171113$20200720$EXP$$US-BAYER-2017-172791$BAYER$$75$YR$E$M$Y$$$20200720$$CN$US$US
141830952$14183095$2$F$20170507$20180810$20171113$20180824$EXP$$AU-JNJFOC-20171100434$JANSSEN$$20$YR$A$M$Y$71.3$KG$20180824$$MD$AU$AU
141835531$14183553$1$I$20170928$20171110$20171113$20171113$EXP$$US-ASTRAZENECA-2017SF15223$ASTRAZENECA$$925$MON$$M$Y$69$KG$20171113$$MD$US$US
141846521$14184652$1$I$20170707$20171103$20171113$20171113$EXP$$CA-CELGENEUS-CAN-20171101276$CELGENE$$59$YR$$M$Y$$$20171113$$MD$CA$CA
141847462$14184746$2$F$20171106$20200709$20171114$20200722$EXP$$GB-ASTELLAS-2017US046568$ASTELLAS$$9$YR$$F$Y$$$20200722$$MD$GB$GB
141848462$14184846$2$F$20171031$20200831$20171113$20200909$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-098682$BRISTOL MYERS SQUIBB$$52$YR$$M$Y$87.1$KG$20200909$$HP$US$US
1418488210$14184882$10$F$$20200622$20171113$20200721$PER$$US-ACTELION-A-NJ2017-162507$ACTELION$$$$$F$Y$81.63$KG$20200721$$HP$US$US
1418504713$14185047$13$F$$20200720$20171113$20200723$PER$$CA-AMGEN-CANSP2017169967$AMGEN$$60$YR$A$F$Y$$$20200723$$CN$CA$CA
141850619$14185061$9$F$$20200914$20171113$20200917$PER$$CA-AMGEN-CANSP2017170005$AMGEN$$61$YR$A$F$Y$$$20200917$$HP$CA$CA
141856318$14185631$8$F$$20200720$20171114$20200804$PER$$CA-AMGEN-CANSP2017170118$AMGEN$$66$YR$E$F$Y$$$20200804$$HP$CA$CA
1418585425$14185854$25$F$201605$20200727$20171114$20200730$EXP$$CA-ROCHE-1758973$ROCHE$$77$YR$$M$Y$80$KG$20200730$$CN$CA$CA
141862613$14186261$3$F$$20200811$20171114$20200818$EXP$$CA-IPCA LABORATORIES LIMITED-IPC-2017-CA-003493$IPCA$J. CHU. INTRACRANIAL HEMORRHAGE AS INITIAL PRESENTATION OF CEREBRAL VENOUS SINUS THROMBOSIS: A CASE SERIES OF  OUR PATIENTS. EUROPEAN STROKE JOURNAL. 4(1S):452$$$$$Y$$$20200818$$$COUNTRY NOT SPECIFIED$CA
141870625$14187062$5$F$2017$20200921$20171114$20200924$PER$$US-PFIZER INC-2017487172$PFIZER$$68$YR$$F$Y$$$20200924$$HP$US$US
141870724$14187072$4$F$$20200911$20171114$20200915$PER$$US-PFIZER INC-2017316074$PFIZER$$66$YR$$F$Y$$$20200915$$MD$US$US
141871364$14187136$4$F$$20200629$20171114$20200706$PER$$CA-AMGEN-CANSP2017170029$AMGEN$$64$YR$A$F$Y$$$20200706$$CN$CA$CA
141871392$14187139$2$F$$20200810$20171114$20200812$PER$$US-PFIZER INC-2017488492$PFIZER$$64$YR$$F$Y$$$20200812$$CN$US$US
1418715624$14187156$24$F$2017$20200916$20171114$20200918$EXP$$JP-ABBVIE-17K-087-2112255-00$ABBVIE$KAKINUMA T, KINOSHITA F, NODA K, ET AL. A CASE OF THERAPY INTERVENTION WITH CARBIDOPA HYDRATE?LEVODOPA MIXT VIA JEJUNUM ADMINISTRATION IN THIS HOSPITAL. THE 28TH ANNUAL MEETING OF THE JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES. 2018?1569?1569.$75$YR$$F$Y$$$20200918$$CN$COUNTRY NOT SPECIFIED$JP
141876992$14187699$2$F$20171108$20180214$20171114$20180219$EXP$$RU-ASTRAZENECA-2017SF15119$ASTRAZENECA$$28035$DY$$M$Y$$$20180219$$MD$RU$RU
141879514$14187951$4$F$20170918$20200908$20171114$20200910$EXP$$PHHY2017CO151669$NOVARTIS$$47$YR$$F$Y$56$KG$20200910$$CN$CO$CO
1418810013$14188100$13$F$2017$20200617$20171114$20200727$EXP$$US-INCYTE CORPORATION-2017IN004186$INCYTE$$$$$$Y$$$20200727$$CN$US$US
141883452$14188345$2$F$201710$20200818$20171114$20200821$EXP$$US-ABBVIE-17P-163-2149107-00$ABBVIE$$70$YR$$M$Y$79.45$KG$20200821$$CN$US$US
1418865014$14188650$14$F$$20200720$20171114$20200723$PER$$CA-AMGEN-CANSP2017170056$AMGEN$$59$YR$A$F$Y$$$20200723$$MD$CA$CA
141886704$14188670$4$F$$20200914$20171114$20200917$PER$$CA-AMGEN-CANSP2017170073$AMGEN$$$$$F$Y$$$20200917$$HP$CA$CA
1418942910$14189429$10$F$20171017$20200625$20171115$20200702$EXP$$US-ROCHE-2019577$ROCHE$$53$YR$$F$Y$59.02$KG$20200702$$CN$US$US
141897416$14189741$6$F$20171105$20200716$20171115$20200721$EXP$$IT-ROCHE-2023186$ROCHE$$57$YR$$F$Y$$$20200721$$MD$IT$IT
141899346$14189934$6$F$2016$20200827$20171115$20200831$EXP$$US-PFIZER INC-2017488434$PFIZER$$58$YR$$F$Y$49.89$KG$20200831$$HP$US$US
141902788$14190278$8$F$20171004$20200710$20171115$20200714$EXP$$PHHO2017US015416$NOVARTIS$$61$YR$$F$Y$77$KG$20200714$$HP$US$US
141903557$14190355$7$F$20161212$20180322$20171115$20200716$EXP$$RU-CELGENEUS-RUS-2016125360$CELGENE$$85$YR$$M$Y$60$KG$20200716$$HP$RU$RU
141905531$14190553$1$I$20171009$20171111$20171115$20171115$EXP$$DE-JNJFOC-20171115744$JANSSEN$$73$YR$E$F$Y$$$20171115$$MD$DE$DE
141908259$14190825$9$F$$20200914$20171115$20200918$EXP$$CA-PFIZER INC-2017490362$PFIZER$$61$YR$$F$Y$$$20200918$$CN$CA$CA
141910404$14191040$4$F$$20200710$20171115$20200715$EXP$$US-PFIZER INC-2017486208$PFIZER$$66$YR$$F$Y$61$KG$20200715$$CN$US$US
141910568$14191056$8$F$$20200720$20171115$20200804$EXP$$CA-PFIZER INC-2017490913$PFIZER$$66$YR$$F$Y$$$20200804$$HP$CA$CA
141917962$14191796$2$F$201911$20200807$20171115$20200814$EXP$$BR-BIOGEN-2017BI00483386$BIOGEN$$78$YR$$F$Y$$$20200814$$CN$BR$BR
141920251$14192025$1$I$20170704$20171103$20171115$20171115$EXP$$CA-CELGENEUS-CAN-20171101691$CELGENE$$57$YR$$M$Y$$$20171115$$MD$CA$CA
141921626$14192162$6$F$201709$20200709$20171115$20200716$EXP$$US-ROCHE-2021825$ROCHE$$49$YR$$F$Y$53.57$KG$20200716$$CN$US$US
141934865$14193486$5$F$$20200706$20171115$20200708$EXP$$US-LUNDBECK-DKLU2039999$LUNDBECK$$3$YR$$F$Y$$$20200709$$MD$US$US
141936566$14193656$6$F$20171019$20200720$20171116$20200724$PER$$CA-AMGEN-CANSP2017171692$AMGEN$$63$YR$A$F$Y$$$20200724$$HP$CA$CA
141936624$14193662$4$F$20170803$20200716$20171115$20200812$EXP$$US-INCYTE CORPORATION-2017IN007891$INCYTE$$$$$$Y$$$20200812$$MD$US$US
141940698$14194069$8$F$20171015$20200616$20171116$20200623$EXP$$PHHO2017DE014414$NOVARTIS$$66$YR$$M$Y$83$KG$20200623$$HP$DE$DE
141940832$14194083$2$F$20170510$20200713$20171116$20200720$EXP$$BR-TAKEDA-2017TUS023003$TAKEDA$$54$YR$$F$Y$$$20200720$$CN$BR$BR
141941342$14194134$2$F$201709$20200811$20171116$20200819$EXP$$US-ROCHE-2026479$ROCHE$$52$YR$$M$Y$65.83$KG$20200819$$CN$US$US
141942405$14194240$5$F$20171108$20200721$20171116$20200723$EXP$$US-PFIZER INC-2017487959$PFIZER$$66$YR$$F$Y$55$KG$20200723$$HP$US$US
141943175$14194317$5$F$2017$20200731$20171116$20200804$PER$$US-PFIZER INC-2017264943$PFIZER$$57$YR$$F$Y$76$KG$20200804$$HP$US$US
141944173$14194417$3$F$$20200928$20171116$20200930$PER$$US-PFIZER INC-2017490783$PFIZER$$63$YR$$F$Y$$$20200930$$CN$US$US
141944294$14194429$4$F$$20200902$20171116$20200904$PER$$US-PFIZER INC-2017493101$PFIZER$$$$$F$Y$$$20200904$$MD$US$US
141945144$14194514$4$F$$20200713$20171116$20200716$PER$$US-PFIZER INC-2017492926$PFIZER$$49$YR$$M$Y$$$20200716$$CN$US$US
141946923$14194692$3$F$$20200730$20171116$20200810$EXP$$CA-APOTEX-2017AP019600$APOTEX$$$$$F$Y$$$20200810$$CN$CA$CA
141949412$14194941$2$F$$20171102$20171116$20200915$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-103645$BRISTOL MYERS SQUIBB$GLASSER CL, LEE A, ESLIN D, MARKS L, MODAK S, GLADE BENDER JLG.. EPIGENETIC COMBINATION THERAPY FOR CHILDREN WITH SECONDARY MYELODYSPLASTIC SYNDROME (MDS)/ACUTE MYELOID LEUKEMIA (AML) AND CONCURRENT SOLID TUMOR RELAPSE. JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY. 2017?39(7):560?4$15$YR$$F$Y$$$20200915$$MD$US$US
141950477$14195047$7$F$20171104$20200728$20171116$20200803$EXP$$CL-SA-2017SA221612$SANOFI AVENTIS$$$$$$Y$$$20200803$$HP$CL$CL
141955074$14195507$4$F$$20200914$20171116$20200918$EXP$$CA-PFIZER INC-2017492781$PFIZER$$$$$F$Y$$$20200918$$HP$CA$CA
141960001$14196000$1$I$20171025$20171109$20171116$20171116$EXP$$PL-JNJFOC-20171112626$JANSSEN$$50$YR$A$F$Y$54$KG$20171116$$MD$PL$PL
141960041$14196004$1$I$20170403$20170411$20171116$20171116$EXP$$CH-JNJFOC-20170414458$JANSSEN$$67$YR$E$F$Y$65$KG$20171116$$MD$CH$CH
141960052$14196005$2$F$20171005$20171115$20171116$20171127$EXP$$US-JNJFOC-20171107823$JANSSEN$$67$YR$E$F$Y$56.7$KG$20171127$$MD$US$US
141963193$14196319$3$F$20171031$20171219$20171116$20171229$EXP$$US-JNJFOC-20171117326$PHARMACYCLICS$$86$YR$E$F$Y$$$20171229$$MD$US$US
1419658317$14196583$17$F$$20200720$20171116$20200727$EXP$$CA-PFIZER INC-2017494347$PFIZER$$59$YR$$F$Y$$$20200727$$HP$CA$CA
141977002$14197700$2$F$20171106$20171115$20171116$20171117$EXP$$JP-ASTRAZENECA-2017SF14214$ASTRAZENECA$$23887$DY$$M$Y$$$20171117$$MD$JP$JP
141978562$14197856$2$F$20170126$20180928$20171117$20181004$EXP$$US-ASTRAZENECA-2017SE11208$ASTRAZENECA$$25305$DY$$M$Y$$$20181004$$MD$US$US
141978891$14197889$1$I$20160601$20160602$20171117$20171117$EXP$$RU-ASTRAZENECA-2016SE61247$ASTRAZENECA$$52$YR$$M$Y$56$KG$20171117$$MD$RU$RU
1419864716$14198647$16$F$$20200723$20171117$20200728$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3616$ORION$$60$YR$$F$Y$$$20200728$$MD$CA$CA
141986885$14198688$5$F$$20200707$20171117$20200713$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3639$ORION$$57$YR$$M$Y$$$20200713$$MD$CA$CA
141986906$14198690$6$F$$20200706$20171117$20200714$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3643$ORION$$61$YR$$F$Y$$$20200714$$MD$CA$CA
141987436$14198743$6$F$$20200827$20171117$20200831$EXP$$US-PFIZER INC-2017490290$PFIZER$$62$YR$$M$Y$65.77$KG$20200831$$CN$US$US
141989607$14198960$7$F$$20200804$20171117$20200806$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3659$ORION$$66$YR$$F$Y$$$20200806$$HP$CA$CA
141989712$14198971$2$F$201603$20200918$20171117$20200925$EXP$$CO-ASTELLAS-2017US046791$ASTELLAS$$44$YR$$F$Y$$$20200925$$CN$CO$CO
141990094$14199009$4$F$20171108$20181120$20171117$20181122$EXP$$CN-ASTRAZENECA-2017SF15346$ASTRAZENECA$$20062$DY$$M$Y$$$20181122$$MD$CN$CN
141995652$14199565$2$F$20170827$20200820$20171117$20200826$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-102347$BRISTOL MYERS SQUIBB$$61$YR$$F$Y$86$KG$20200826$$HP$US$US
141995943$14199594$3$F$$20200805$20171117$20200806$EXP$$CA-ABBVIE-17K-028-2166089-00$ABBVIE$$$$$M$Y$75$KG$20200806$$CN$CA$CA
141997082$14199708$2$F$20160325$20180111$20171117$20180119$EXP$$JP-AMGEN-JPNNI2017154542$AMGEN$$75$YR$E$F$Y$51$KG$20180118$$MD$JP$JP
141998201$14199820$1$I$20171101$20171103$20171117$20171117$EXP$$US-JNJFOC-20171116555$JANSSEN$$70$YR$E$M$Y$79$KG$20171117$$MD$US$US
141999547$14199954$7$F$20160323$20191118$20171117$20200803$EXP$$DE-JNJFOC-20160622158$JOHNSON AND JOHNSON$$3$DEC$A$F$Y$58$KG$20200803$$MD$DE$DE
142001154$14200115$4$F$20150205$20200821$20171117$20200825$EXP$$US-PFIZER INC-2017479954$PFIZER$$91$YR$$F$Y$63$KG$20200825$$HP$US$US
142011832$14201183$2$F$20171114$20171117$20171117$20171129$EXP$$US-ASTRAZENECA-2017SF17081$ASTRAZENECA$$$$$$Y$$$20171129$$MD$US$US
142012744$14201274$4$F$1989$20200810$20171117$20200812$PER$$US-PFIZER INC-2017488227$PFIZER$$40$YR$$M$Y$72.56$KG$20200812$$CN$US$US
142017481$14201748$1$I$20160413$20160413$20171117$20171117$EXP$$UA-ASTRAZENECA-2016SE39723$ASTRAZENECA$$23627$DY$$M$Y$$$20171117$$MD$UA$UA
142020199$14202019$9$F$2017$20200728$20171117$20200801$EXP$$CA-TAKEDA-2017TUS023635$TAKEDA$$52$YR$$F$Y$$$20200801$$HP$CA$CA
142021706$14202170$6$F$20170520$20200720$20171117$20200728$EXP$$PHHY2017IN076604$NOVARTIS$$53$YR$$F$Y$$$20200729$$HP$IN$IN
1420232511$14202325$11$F$$20200720$20171117$20200731$EXP$$US-ACTELION-A-NJ2015-123875$ACTELION$$$$$F$Y$63.49$KG$20200731$$HP$US$US
142025243$14202524$3$F$20171113$20200909$20171117$20200917$EXP$$US-ABBVIE-17K-163-2162242-00$ABBVIE$$82$YR$$F$Y$$$20200917$$CN$US$US
1420317212$14203172$12$F$20171106$20190527$20171120$20200807$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-103042$BRISTOL MYERS SQUIBB$$36$YR$$F$Y$$$20200807$$HP$DE$DE
142037423$14203742$3$F$201711$20200922$20171120$20200928$PER$$US-PFIZER INC-2017497436$PFIZER$$62$YR$$F$Y$$$20200928$$CN$US$US
142041456$14204145$6$F$$20200701$20171120$20200702$PER$$US-PFIZER INC-2017499630$PFIZER$$74$YR$$F$Y$$$20200702$$MD$US$US
142041644$14204164$4$F$$20200917$20171120$20200923$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3688$ORION$$$$$F$Y$$$20200923$$HP$CA$CA
142041694$14204169$4$F$20171113$20171227$20171120$20180101$EXP$$GB-ROCHE-2025737$ROCHE$$53$YR$$M$Y$117$KG$20180101$$MD$GB$GB
142042553$14204255$3$F$$20200722$20171120$20200729$EXP$$US-ELI_LILLY_AND_COMPANY-US201711002515$ELI LILLY AND CO$$$$$M$Y$$$20200729$$CN$US$US
142042912$14204291$2$F$201706$20200727$20171120$20200731$EXP$$DE-SHIRE-DE201728823$SHIRE$$$$$$Y$$$20200731$$MD$DE$DE
142043183$14204318$3$F$20161202$20200808$20171120$20200813$EXP$$JP-ASTELLAS-2017JP021972$ASTELLAS$$$$$M$Y$$$20200813$$MD$JP$JP
1420447611$14204476$11$F$201703$20200915$20171120$20200928$EXP$$AR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-070316$BRISTOL MYERS SQUIBB$$72$YR$$F$Y$$$20200928$$CN$AR$AR
142045793$14204579$3$F$20171011$20180712$20171120$20180719$EXP$$AT-JNJFOC-20171028665$JANSSEN$$78$YR$E$F$Y$74$KG$20180719$$MD$AT$AT
142046164$14204616$4$F$201711$20200903$20171120$20200904$EXP$$US-PFIZER INC-2017495880$PFIZER$$78$YR$$F$Y$65.3$KG$20200904$$CN$US$US
142050007$14205000$7$F$198910$20200803$20171120$20200805$EXP$$US-PFIZER INC-2015240283$PFIZER$$34$YR$$M$Y$$$20200805$$CN$US$US
142050372$14205037$2$F$2017$20200814$20171120$20200824$EXP$$IT-ELI_LILLY_AND_COMPANY-IT201710012671$ELI LILLY AND CO$$84$YR$$F$Y$$$20200824$$MD$IT$IT
142051032$14205103$2$F$201609$20200916$20171120$20200925$EXP$$US-BAYER-2017-165449$BAYER$$89$YR$E$F$Y$$$20200925$$CN$US$US
142052981$14205298$1$I$20170815$20171113$20171120$20171120$EXP$$US-ASTRAZENECA-2017SF16103$ASTRAZENECA$$$$$M$Y$$$20171120$$MD$US$US
142058749$14205874$9$F$20170710$20200828$20171120$20200903$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-104941$BRISTOL MYERS SQUIBB$KAWATA S.,ET AL. A CASE OF SIMULTANEOUS TYPE 1 DIABETES MELLITUS AND ABNORMAL THYROID FUNCTION AFTER TREATMENT WITH NIVOLUMAB, AN ANTI?PD?I ANTIBODY DRUG, FOR HODGKIN^S LYMPHOMA. 61ST ANNUAL MEETING OF THE JAPAN DIABETES SOCIETY. 2018?61(S?1):S174$55$YR$$M$Y$60$KG$20200903$$HP$JP$JP
142059734$14205973$4$F$20171102$20200818$20171120$20200820$EXP$FR-AFSSAPS-CN20171530$PHHY2017FR170956$NOVARTIS$$62$YR$$F$Y$80$KG$20200820$$HP$FR$FR
142062966$14206296$6$F$20170915$20200501$20171120$20200914$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-102142$BRISTOL MYERS SQUIBB$$10$YR$$F$Y$$$20200914$$MD$US$US
142064086$14206408$6$F$$20200904$20171120$20200908$EXP$$US-PFIZER INC-2017498067$PFIZER$$82$YR$$F$Y$76$KG$20200908$$HP$US$US
1420656412$14206564$12$F$201710$20200709$20171120$20200714$EXP$$NL-ABBVIE-17K-114-2164922-00$ABBVIE$$55$YR$$M$Y$90$KG$20200714$$CN$NL$NL
142068236$14206823$6$F$20171105$20200715$20171121$20200729$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-154837$RANBAXY$$57$YR$A$F$Y$$$20200730$$HP$NL$IT
142069903$14206990$3$F$$20200814$20171121$20200824$EXP$$CA-APOTEX-2017AP021270$APOTEX$$60$YR$$F$Y$47$KG$20200824$$CN$CA$CA
142078834$14207883$4$F$20171016$20200807$20171121$20200812$PER$$PHHY2017US169042$NOVARTIS$$58$YR$$M$Y$82.1$KG$20200812$$HP$US$US
142085198$14208519$8$F$20171002$20191001$20171121$20200817$EXP$$PHHY2017CA162242$NOVARTIS$$61$YR$$M$Y$101.2$KG$20200817$$MD$CA$CA
142087094$14208709$4$F$20170519$20200820$20171121$20200901$EXP$$US-JNJFOC-20171028876$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200901$$LW$US$US
142087183$14208718$3$F$20161207$20200714$20171121$20200717$PER$$US-JNJFOC-20171029649$JOHNSON AND JOHNSON$$43$YR$$F$Y$119.86$KG$20200717$$CN$US$US
142087793$14208779$3$F$20160715$20200823$20171121$20200827$PER$$US-JNJFOC-20171030018$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200827$$LW$US$US
142088963$14208896$3$F$20150810$20200730$20171121$20200803$PER$$US-JNJFOC-20171034168$JOHNSON AND JOHNSON$$71$YR$E$M$Y$$$20200803$$CN$US$US
142089313$14208931$3$F$20160927$20200701$20171121$20200706$PER$$US-JNJFOC-20171035124$JOHNSON AND JOHNSON$$89$YR$$F$Y$$$20200706$$CN$US$US
142089503$14208950$3$F$201511$20200702$20171121$20200707$PER$$US-JNJFOC-20171101537$JOHNSON AND JOHNSON$$85$YR$$M$Y$$$20200707$$CN$US$US
142089564$14208956$4$F$201505$20200908$20171121$20200914$PER$$US-JNJFOC-20171100284$JOHNSON AND JOHNSON$$60$YR$A$M$Y$$$20200914$$CN$US$US
142089713$14208971$3$F$201410$20200924$20171121$20200929$PER$$US-JNJFOC-20171101164$JOHNSON AND JOHNSON$$76$YR$E$M$Y$$$20200929$$LW$US$US
142089823$14208982$3$F$201609$20200804$20171121$20200811$PER$$US-JNJFOC-20171101583$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200811$$LW$US$US
142089853$14208985$3$F$20141230$20200727$20171121$20200731$PER$$PR-JNJFOC-20171100458$JOHNSON AND JOHNSON$$67$YR$E$M$Y$$$20200731$$CN$US$US
142090074$14209007$4$F$201412$20200901$20171121$20200914$PER$$US-JNJFOC-20171103778$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20200914$$CN$US$US
142090084$14209008$4$F$20160130$20200906$20171121$20200914$PER$$US-JNJFOC-20171103580$JOHNSON AND JOHNSON$$81$YR$E$M$Y$98.06$KG$20200914$$CN$US$US
142090173$14209017$3$F$20151109$20200721$20171121$20200724$PER$$US-JNJFOC-20171103833$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200724$$CN$US$US
142090234$14209023$4$F$201603$20200701$20171121$20200707$PER$$US-JNJFOC-20171100401$JOHNSON AND JOHNSON$$58$YR$$F$Y$$$20200707$$CN$US$US
142090293$14209029$3$F$20160510$20200924$20171121$20200930$PER$$US-JNJFOC-20171102147$JOHNSON AND JOHNSON$$65$YR$E$F$Y$$$20200930$$CN$US$US
142090453$14209045$3$F$20131025$20200712$20171121$20200715$PER$$US-JNJFOC-20171103825$JOHNSON AND JOHNSON$$84$YR$$M$Y$$$20200715$$CN$US$US
142090673$14209067$3$F$20161208$20200810$20171121$20200819$EXP$$US-JNJFOC-20171104451$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200819$$CN$US$US
142090733$14209073$3$F$201511$20200625$20171121$20200708$EXP$$US-JNJFOC-20171104572$JOHNSON AND JOHNSON$$58$YR$$M$Y$$$20200708$$CN$US$US
142092053$14209205$3$F$20151116$20200712$20171121$20200720$PER$$US-JNJFOC-20171113129$JOHNSON AND JOHNSON$$77$YR$E$M$Y$$$20200720$$HP$US$US
142092863$14209286$3$F$20131030$20200830$20171121$20200911$EXP$$US-JNJFOC-20171117742$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200911$$CN$US$US
142093853$14209385$3$F$20141025$20200727$20171121$20200731$PER$$US-JNJFOC-20170929535$JOHNSON AND JOHNSON$$83$YR$E$F$Y$$$20200731$$CN$US$US
142094663$14209466$3$F$20170201$20200726$20171121$20200731$PER$$US-JNJFOC-20171000134$JOHNSON AND JOHNSON$$82$YR$E$M$Y$$$20200731$$CN$US$US
142094803$14209480$3$F$20161120$20200723$20171121$20200730$PER$$US-JNJFOC-20171001745$JOHNSON AND JOHNSON$$26$YR$A$F$Y$$$20200730$$CN$US$US
142094954$14209495$4$F$201311$20200629$20171121$20200706$PER$$US-JNJFOC-20171001749$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20200706$$CN$US$US
142095753$14209575$3$F$20170401$20200902$20171121$20200909$EXP$$US-JNJFOC-20171007538$JOHNSON AND JOHNSON$$83$YR$E$M$Y$$$20200909$$CN$US$US
142096003$14209600$3$F$2013$20200812$20171121$20200814$PER$$US-JNJFOC-20171008836$JOHNSON AND JOHNSON$$5$DEC$A$F$Y$$$20200814$$CN$US$US
142096043$14209604$3$F$201510$20200910$20171121$20200915$PER$$US-JNJFOC-20171008939$JOHNSON AND JOHNSON$$73$YR$E$M$Y$86.18$KG$20200915$$CN$US$US
142097163$14209716$3$F$20160929$20200713$20171121$20200716$PER$$US-JNJFOC-20171013851$JOHNSON AND JOHNSON$$82$YR$$M$Y$$$20200716$$CN$US$US
142097323$14209732$3$F$20170105$20200706$20171121$20200710$PER$$US-JNJFOC-20171012901$JOHNSON AND JOHNSON$$27$YR$$F$Y$$$20200710$$LW$US$US
142097503$14209750$3$F$20161201$20200701$20171121$20200706$PER$$US-JNJFOC-20171015522$JOHNSON AND JOHNSON$$73$YR$$F$Y$$$20200706$$CN$US$US
142098096$14209809$6$F$$20200830$20171121$20200903$PER$$US-PFIZER INC-2017499435$PFIZER$$11$YR$$F$Y$$$20200903$$MD$US$US
142098997$14209899$7$F$$20200714$20171121$20200717$PER$$US-PFIZER INC-2017502141$PFIZER$$62$YR$$F$Y$$$20200717$$MD$US$US
142099453$14209945$3$F$20151019$20200701$20171121$20200706$PER$$US-JNJFOC-20171016426$JOHNSON AND JOHNSON$$67$YR$$F$Y$$$20200706$$CN$US$US
142099563$14209956$3$F$201510$20200916$20171121$20200929$EXP$$US-JNJFOC-20171016451$JOHNSON AND JOHNSON$$62$YR$A$F$Y$$$20200929$$CN$US$US
142099813$14209981$3$F$201409$20200811$20171121$20200817$PER$$US-JNJFOC-20171017686$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200817$$CN$US$US
142099893$14209989$3$F$201510$20200806$20171121$20200818$EXP$$US-JNJFOC-20171018555$JOHNSON AND JOHNSON$$86$YR$E$M$Y$78.09$KG$20200818$$CN$US$US
142100023$14210002$3$F$20151018$20200802$20171121$20200805$PER$$US-JNJFOC-20171019415$JOHNSON AND JOHNSON$$48$YR$A$F$Y$$$20200805$$CN$US$US
142100083$14210008$3$F$20140118$20200628$20171121$20200702$PER$$US-JNJFOC-20171019018$JOHNSON AND JOHNSON$$85$YR$$F$Y$$$20200702$$CN$US$US
142100142$14210014$2$F$20141128$20200623$20171121$20200707$EXP$$US-JNJFOC-20171019223$JOHNSON AND JOHNSON$$71$YR$$M$Y$$$20200707$$CN$US$US
142103057$14210305$7$F$2016$20200708$20171121$20200715$EXP$$US-JAZZ-2017-US-015325$JAZZ$$$$$M$Y$$$20200715$$MD$US$US
142103763$14210376$3$F$20161201$20200818$20171121$20200820$PER$$US-JNJFOC-20171114349$JOHNSON AND JOHNSON$$78$YR$E$M$Y$$$20200820$$CN$US$US
142104214$14210421$4$F$20161020$20200910$20171121$20200914$PER$$US-JNJFOC-20171114963$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20200914$$LW$US$US
142109482$14210948$2$F$201408$20200917$20171121$20200923$PER$$US-JNJFOC-20171001539$JOHNSON AND JOHNSON$$53$YR$A$M$Y$$$20200923$$CN$US$US
142109654$14210965$4$F$20151019$20200920$20171121$20200928$PER$$US-JNJFOC-20171011220$JOHNSON AND JOHNSON$$82$YR$E$M$Y$108$KG$20200928$$CN$US$US
142109753$14210975$3$F$201605$20200803$20171121$20200811$PER$$US-JNJFOC-20171011209$JOHNSON AND JOHNSON$$62$YR$A$F$Y$89$KG$20200811$$HP$US$US
142110653$14211065$3$F$2016$20171113$20171121$20200904$EXP$$US-BAUSCH-BL-2017-031576$BAUSCH AND LOMB$$53$YR$$F$Y$28.6$KG$20200904$$CN$US$US
142110883$14211088$3$F$20140906$20200828$20171121$20200910$EXP$$JP-INCYTE CORPORATION-2015IN000748$INCYTE$$$$$$Y$$$20200910$$MD$JP$JP
142111279$14211127$9$F$20161220$20200623$20171121$20200706$EXP$$JP-INCYTE CORPORATION-2017IN006563$INCYTE$$$$$$Y$$$20200706$$MD$JP$JP
142112654$14211265$4$F$$20200720$20171121$20200723$EXP$$PHHY2017PT170242$NOVARTIS$$85$YR$$F$Y$$$20200723$$HP$PT$PT
142117522$14211752$2$F$$20200808$20171122$20200820$EXP$$CA-APOTEX-2017AP021335$APOTEX$$33$YR$$M$Y$$$20200820$$CN$CA$CA
142120953$14212095$3$F$20170915$20180228$20171122$20180312$EXP$$JP-JNJFOC-20171026830$JANSSEN$$74$YR$E$M$Y$78.41$KG$20180312$$MD$JP$JP
142121073$14212107$3$F$20140922$20200915$20171122$20200921$PER$$US-JNJFOC-20171122251$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200921$$CN$US$US
142121565$14212156$5$F$201711$20200824$20171122$20200903$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006245$ACADIA PHARMACEUTICALS$$84$YR$$F$Y$$$20200903$$MD$US$US
142124883$14212488$3$F$$20200629$20171121$20200703$PER$$CA-AMGEN-CANSP2017173378$AMGEN$$75$YR$E$F$Y$$$20200703$$HP$CA$CA
142129763$14212976$3$F$20171108$20171201$20171121$20200918$EXP$$DE-BEH-2017085101$CSL BEHRING$$52$YR$A$F$Y$$$20200918$$HP$DE$DE
142131912$14213191$2$F$$20171113$20171122$20200810$PER$$PHEH2017US036893$NOVARTIS$$$$$M$Y$$$20200810$$MD$US$US
142135862$14213586$2$F$2017$20200622$20171122$20200701$EXP$$US-BIOGEN-2017BI00476618$BIOGEN$$$$$F$Y$91.25$KG$20200701$$CN$US$US
142136442$14213644$2$F$20141230$20200727$20171122$20200804$EXP$$PR-BAYER-2017-214157$BAYER$$67$YR$E$M$Y$$$20200804$$CN$US$US
142137461$14213746$1$I$20170906$20170916$20171122$20171122$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-155186$RANBAXY$$77$YR$$F$Y$65$KG$20171122$$HP$GB$GB
142137784$14213778$4$F$201710$20200724$20171122$20200902$PER$$US-INCYTE CORPORATION-2017IN009832$INCYTE$$$$$$Y$$$20200902$$CN$US$US
142142293$14214229$3$F$201512$20200816$20171122$20200826$EXP$$US-BIOGEN-2017BI00486638$BIOGEN$$49$YR$$F$Y$$$20200826$$CN$US$US
142143203$14214320$3$F$201611$20200622$20171122$20200702$EXP$$JP-NOVOPROD-573904$NOVO NORDISK$HIRROSHI NAKAMA, ET.AL. A CASE OF ADRENALINE?PREDOMINANT PARAGANGLIOMA DIAGNOSED WITH A STATE OF SHOCK AFTER GLUCAGON INJECTION. HYPERTENSION RESEARCH. 2020?43:473?475$75$YR$$F$Y$$$20200702$$MD$JP$JP
142144068$14214406$8$F$2016$20200728$20171122$20200803$PER$$US-PFIZER INC-2017498989$PFIZER$$55$YR$$F$Y$58$KG$20200803$$MD$US$US
1421450711$14214507$11$F$201903$20200827$20171122$20200831$EXP$$US-PFIZER INC-2017501645$PFIZER$$54$YR$$F$Y$83$KG$20200831$$MD$US$US
142145654$14214565$4$F$201906$20200814$20171122$20200818$EXP$$US-PFIZER INC-2017501593$PFIZER$$80$YR$$F$Y$78$KG$20200818$$CN$US$US
142146861$14214686$1$I$$20151011$20171122$20171122$EXP$$IL-JNJFOC-20151008270$JANSSEN$$54$YR$A$M$Y$76$KG$20171122$$MD$IL$IL
142146871$14214687$1$I$20160129$20160207$20171122$20171122$EXP$$IL-JNJFOC-20160206751$JANSSEN$$62$YR$A$M$Y$72$KG$20171122$$MD$IL$IL
142152241$14215224$1$I$20170130$20170201$20171122$20171122$EXP$$IL-JNJFOC-20170200200$JANSSEN$$72$YR$E$F$Y$84$KG$20171122$$MD$IL$IL
142152302$14215230$2$F$$20161130$20171122$20171122$EXP$$IL-JNJFOC-20161130454$JANSSEN$$78$YR$E$M$Y$60$KG$20171122$$MD$IL$IL
142152331$14215233$1$I$20170111$20170112$20171122$20171122$EXP$$IT-JNJFOC-20170111287$JANSSEN$$60$YR$A$F$Y$95$KG$20171122$$MD$IT$IT
142152361$14215236$1$I$20170110$20170112$20171122$20171122$EXP$$IT-JNJFOC-20170111411$JANSSEN$$75$YR$E$M$Y$78$KG$20171122$$CN$IT$IT
142154052$14215405$2$F$20171111$20171229$20171122$20180103$EXP$$US-JNJFOC-20171118691$JANSSEN$$49$YR$A$M$Y$61$KG$20180103$$MD$US$US
142156586$14215658$6$F$20170909$20180330$20171122$20180404$EXP$$MY-JNJFOC-20171114824$JANSSEN$$57$YR$A$F$Y$97$KG$20180404$$MD$MY$MY
142157523$14215752$3$F$$20200921$20171122$20200925$EXP$$PHHY2016PA111994$NOVARTIS$$$$$F$Y$$$20200926$$CN$COUNTRY NOT SPECIFIED$PA
142164052$14216405$2$F$20170918$20180118$20171122$20180122$EXP$$CA-ASTRAZENECA-2017SE95763$ASTRAZENECA$$30$YR$$F$Y$$$20180122$$MD$CA$CA
142164672$14216467$2$F$$20200724$20171122$20200729$EXP$$CA-BIOMARINAP-CA-2017-113995$BIOMARIN$$3$YR$$M$Y$15.9$KG$20200729$$MD$CA$CA
142164974$14216497$4$F$20171022$20180418$20171122$20180524$EXP$$US-JNJFOC-20171031122$JANSSEN$$64$YR$A$F$Y$73.6$KG$20180524$$MD$US$US
142166284$14216628$4$F$2015$20200904$20171122$20200911$EXP$$US-ABBVIE-17P-163-2169581-00$ABBVIE$$$$$M$Y$131.1$KG$20200911$$MD$US$US
1421687010$14216870$10$F$$20200629$20171122$20200706$PER$$CA-AMGEN-CANSP2017174939$AMGEN$$$$$F$Y$$$20200705$$HP$CA$CA
142173941$14217394$1$I$20170203$20170203$20171123$20171123$EXP$$JP-ASTRAZENECA-2017SE13357$ASTRAZENECA$$22470$DY$$M$Y$39.8$KG$20171123$$MD$JP$JP
142176139$14217613$9$F$2007$20200804$20171123$20200806$PER$$US-PFIZER INC-2017392521$PFIZER$$70$YR$$F$Y$67.59$KG$20200806$$HP$US$US
142176344$14217634$4$F$$20200903$20171123$20200907$PER$$US-PFIZER INC-2017500204$PFIZER$$67$YR$$F$Y$$$20200907$$MD$US$US
1421781911$14217819$11$F$$20200914$20171123$20200921$PER$$CA-AMGEN-CANSP2017175088$AMGEN$$77$YR$E$F$Y$$$20200921$$HP$CA$CA
142179529$14217952$9$F$201711$20200720$20171123$20200724$EXP$$US-ROCHE-2023818$ROCHE$$54$YR$$M$Y$99.88$KG$20200724$$CN$US$US
142179574$14217957$4$F$$20200717$20171123$20200727$EXP$$CA-APOTEX-2017AP021473$APOTEX$$$$$F$Y$$$20200727$$CN$CA$CA
142180142$14218014$2$F$20171114$20171123$20171123$20171127$EXP$$GB-ASTRAZENECA-2017SF17055$ASTRAZENECA$$25881$DY$$M$Y$93.2$KG$20171127$$MD$GB$GB
142189633$14218963$3$F$$20200729$20171123$20200807$EXP$$US-JNJFOC-20171011339$JOHNSON AND JOHNSON$$$$A$M$Y$99.88$KG$20200807$$CN$US$US
142192472$14219247$2$F$$20200728$20171123$20200731$PER$$US-JNJFOC-20171030732$JOHNSON AND JOHNSON$$$$A$M$Y$$$20200731$$CN$US$US
142195113$14219511$3$F$$20200204$20171123$20200701$EXP$$US-JNJFOC-20171124729$JOHNSON AND JOHNSON$$$$$M$Y$65.83$KG$20200701$$CN$US$US
1421965717$14219657$17$F$20190730$20200702$20171123$20200707$PER$$US-PFIZER INC-2017505171$PFIZER$$62$YR$$F$Y$91$KG$20200707$$MD$US$US
142196768$14219676$8$F$2007$20200910$20171123$20200910$PER$$US-PFIZER INC-2017503866$PFIZER$$31$YR$$F$Y$82$KG$20200910$$MD$US$US
142203892$14220389$2$F$20160620$20171119$20171124$20200807$EXP$$CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-106327$BRISTOL MYERS SQUIBB$$37$YR$$F$Y$$$20200807$$HP$CN$CN
142206122$14220612$2$F$$20171116$20171124$20200803$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-104538$BRISTOL MYERS SQUIBB$GUTIERREZ?AGUIRRE K.I, STEWART MW, SLUZEVICH JC. SCLEROMYXEDEMA WITH RETINAL VASCULITIS AND MASCULAR EDEMA. RETINAL CASES BRIEF REP. 2017?11 (4):319?22$64$YR$$F$Y$$$20200803$$MD$US$US
1422061611$14220616$11$F$2016$20200723$20171124$20200730$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-008349$BRISTOL MYERS SQUIBB$$63$YR$$F$Y$$$20200730$$HP$CA$CA
142208491$14220849$1$I$20171113$20171116$20171124$20171124$EXP$$US-ASTRAZENECA-2017SF16597$ASTRAZENECA$$20986$DY$$F$Y$59.2$KG$20171124$$MD$US$US
142208621$14220862$1$I$20171113$20171116$20171124$20171124$EXP$$US-ASTRAZENECA-2017SF17116$ASTRAZENECA$$20986$DY$$F$Y$59.2$KG$20171124$$MD$US$US
142209331$14220933$1$I$20171010$20171012$20171124$20171124$EXP$$BE-JNJFOC-20171017740$JANSSEN$$81$YR$E$M$Y$75$KG$20171124$$MD$BE$BE
142209584$14220958$4$F$20171122$20190329$20171124$20190401$EXP$$UA-ASTRAZENECA-2017SF19067$ASTRAZENECA$$25343$DY$$M$Y$$$20190401$$MD$UA$UA
142209863$14220986$3$F$$20200803$20171124$20200810$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-103577$BRISTOL MYERS SQUIBB$LI L, PATEL J, BUEHLER?BOTA T, BOTA J, PARR K. SYMPTOMATIC IMPROVEMENT OF KELOID WITH 5?FLUOROURACIL INJECTIONS.. JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS. 2017?18(2):S85$62$YR$$F$Y$$$20200810$$HP$US$US
142210099$14221009$9$F$20171012$20190404$20171124$20190411$EXP$$PL-ASTRAZENECA-2017SF14393$ASTRAZENECA$$23436$DY$$F$Y$$$20190411$$MD$PL$PL
142212174$14221217$4$F$20171116$20200717$20171124$20200721$PER$$US-PFIZER INC-2017502511$PFIZER$$23$YR$$F$Y$$$20200721$$HP$US$US
142216208$14221620$8$F$202004$20200811$20171124$20200819$EXP$$US-ACTELION-A-US2016-133806$ACTELION$$78$YR$$F$Y$81.63$KG$20200819$$HP$US$US
142218853$14221885$3$F$20170310$20200702$20171124$20200710$EXP$$JP-VIFOR (INTERNATIONAL) INC.-VIT-2017-12885$VIFOR$$77$YR$$F$Y$48.4$KG$20200710$$MD$JP$JP
142222867$14222286$7$F$$20200629$20171124$20200706$PER$$CA-AMGEN-CANSP2017175431$AMGEN$$$$$F$Y$$$20200706$$HP$CA$CA
142227683$14222768$3$F$201511$20200715$20171124$20200717$PER$$US-JNJFOC-20171118548$JOHNSON AND JOHNSON$$67$YR$$M$Y$$$20200717$$CN$US$US
142227873$14222787$3$F$20151204$20200707$20171124$20200716$EXP$$US-JNJFOC-20171117340$JOHNSON AND JOHNSON$$61$YR$$F$Y$$$20200716$$CN$US$US
142228593$14222859$3$F$20140514$20200827$20171124$20200902$PER$$US-JNJFOC-20171120445$JOHNSON AND JOHNSON$$82$YR$E$F$Y$$$20200902$$CN$US$US
142233193$14223319$3$F$$20200827$20171124$20200907$PER$$PHEH2017US037984$NOVARTIS$$$$$F$Y$$$20200907$$HP$US$US
142233415$14223341$5$F$20171110$20180116$20171124$20180119$EXP$$ES-ROCHE-2025948$ROCHE$$55$YR$$F$Y$46.3$KG$20180119$$MD$ES$ES
1422413913$14224139$13$F$201707$20200903$20171126$20200914$EXP$$US-TESARO, INC-US-2017TSO02024$GLAXOSMITHKLINE$$88$YR$$F$Y$$$20200914$$CN$US$US
142242042$14224204$2$F$20171110$20180921$20171126$20180927$EXP$$CA-CELGENEUS-CAN-20171106040$CELGENE$$72$YR$$F$Y$$$20180927$$MD$CA$CA
142242694$14224269$4$F$$20200907$20171126$20200908$EXP$$PHHY2017AT173177$NOVARTIS$$14$YR$$M$Y$$$20200908$$HP$AT$AT
1422428711$14224287$11$F$$20200914$20171126$20200917$PER$$CA-AMGEN-CANSP2017175535$AMGEN$$55$YR$A$F$Y$$$20200917$$CN$CA$CA
142244387$14224438$7$F$20171116$20200914$20171127$20200919$PER$$CA-AMGEN-CANSP2017175422$AMGEN$$74$YR$E$F$Y$$$20200919$$CN$CA$CA
142245543$14224554$3$F$$20200712$20171127$20200713$PER$$US-BIOGEN-2017BI00486678$BIOGEN$$$$$M$Y$$$20200713$$CN$US$US
142248964$14224896$4$F$$20200804$20171127$20200810$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-2375$ORION$$67$YR$$F$Y$$$20200810$$MD$CA$CA
142253254$14225325$4$F$2015$20200707$20171127$20200709$EXP$$US-PFIZER INC-2017216859$PFIZER$$83$YR$$F$Y$118.8$KG$20200709$$CN$US$US
142254113$14225411$3$F$20171102$20200923$20171127$20200928$EXP$$US-PFIZER INC-2017508118$PFIZER$$80$YR$$F$Y$67$KG$20200928$$CN$US$US
142254886$14225488$6$F$201709$20200914$20171127$20200916$PER$$US-PFIZER INC-2017508620$PFIZER$$65$YR$$F$Y$64$KG$20200916$$CN$US$US
1422606813$14226068$13$F$2017$20200803$20171127$20200806$EXP$$CZ-SA-2017SA233899$SANOFI AVENTIS$$$$$$Y$$$20200806$$MD$CZ$CZ
142262853$14226285$3$F$$20200629$20171127$20200706$EXP$$CA-PFIZER INC-2017503742$PFIZER$$75$YR$$F$Y$$$20200706$$MD$CA$CA
142262874$14226287$4$F$$20200803$20171127$20200805$EXP$$CA-PFIZER INC-2017334003$PFIZER$$67$YR$$F$Y$$$20200805$$HP$CA$CA
142266777$14226677$7$F$$20200629$20171127$20200707$EXP$$CA-PFIZER INC-2017507919$PFIZER$$$$$F$Y$$$20200707$$CN$CA$CA
142269753$14226975$3$F$20141121$20200923$20171127$20200928$PER$$US-JNJFOC-20171125741$JOHNSON AND JOHNSON$$67$YR$E$F$Y$$$20200928$$CN$US$US
142270323$14227032$3$F$20170822$20180724$20171127$20180803$EXP$$TW-JNJFOC-20170821602$JANSSEN$$34$YR$A$F$Y$92$KG$20180803$$MD$TW$TW
1422705510$14227055$10$F$$20200629$20171127$20200707$EXP$$CA-PFIZER INC-2017506816$PFIZER$$$$$F$Y$$$20200707$$HP$CA$CA
142271452$14227145$2$F$20171102$20180618$20171127$20180628$EXP$$FR-JNJFOC-20171122286$JANSSEN$$70$YR$E$F$Y$$$20180628$$MD$FR$FR
142271462$14227146$2$F$20171120$20171215$20171127$20171219$EXP$$RU-JNJFOC-20171124690$JANSSEN$$51$YR$A$F$Y$52$KG$20171219$$MD$RU$RU
142272425$14227242$5$F$20160410$20171218$20171127$20200731$PER$$AU-AMGEN-AUSCT2017175588$AMGEN$$57$YR$A$F$Y$60$KG$20200731$$MD$AU$AU
1422731811$14227318$11$F$$20200914$20171127$20200922$EXP$$CA-PFIZER INC-2017506298$PFIZER$$77$YR$$F$Y$$$20200922$$CN$CA$CA
142276262$14227626$2$F$$20171228$20171127$20180105$EXP$$PHHY2017PL170934$SANDOZ$$57$YR$$F$Y$56$KG$20180105$$HP$PL$PL
142281027$14228102$7$F$$20200810$20171127$20200817$PER$$US-ACTELION-A-NJ2017-163246$ACTELION$$$$$F$Y$73.92$KG$20200817$$HP$US$US
1422850413$14228504$13$F$201612$20200702$20171128$20200707$EXP$$NL-ABBVIE-16K-114-1715586-00$ABBVIE$$58$YR$$M$Y$80$KG$20200707$$CN$NL$NL
142287963$14228796$3$F$$20200703$20171128$20200708$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3816$ORION$$75$YR$$F$Y$$$20200708$$MD$CA$CA
142291214$14229121$4$F$201711$20200818$20171128$20200826$EXP$$JP-UNITED THERAPEUTICS-UNT-2017-016286$UNITED THERAPEUTICS$$38$YR$$M$Y$90$KG$20200826$$CN$JP$JP
142293809$14229380$9$F$20171120$20200723$20171128$20200727$EXP$$US-PFIZER INC-2017510814$PFIZER$$65$YR$$M$Y$91$KG$20200727$$CN$US$US
142300492$14230049$2$F$$20171114$20171128$20200803$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-103525$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200803$$HP$US$US
142300932$14230093$2$F$20171120$20171130$20171128$20171205$EXP$$IT-JNJFOC-20171126359$JANSSEN$$79$YR$E$F$Y$$$20171205$$MD$IT$IT
1423077811$14230778$11$F$$20200914$20171128$20200921$EXP$$CA-PFIZER INC-2017510773$PFIZER$$55$YR$$F$Y$$$20200921$$CN$CA$CA
1423215419$14232154$19$F$2017$20200721$20171128$20200728$EXP$$CA-CELLTRION INC.-2017CA005325$CELLTRION$$$$$$Y$$$20200729$$HP$CA$CA
142323454$14232345$4$F$201709$20200820$20171128$20200825$EXP$$CA-OTSUKA-2017_018459$OTSUKA$$57$YR$$F$Y$$$20200825$$HP$CA$CA
142329487$14232948$7$F$20171118$20180821$20171129$20180828$EXP$$DK-JNJFOC-20171125230$JANSSEN$$83$YR$E$M$Y$83$KG$20180828$$MD$DK$DK
142330201$14233020$1$I$20171111$20171116$20171129$20171129$EXP$$GB-ROCHE-2027922$ROCHE$$55$YR$$M$Y$$$20171129$$HP$GB$GB
1423323918$14233239$18$F$$20200806$20171128$20200815$PER$$US-ACTELION-A-US2017-163048$ACTELION$$$$$M$Y$67.57$KG$20200815$$HP$US$US
142336393$14233639$3$F$20160130$20200906$20171129$20200910$EXP$$US-BAYER-2017-214632$BAYER$$81$YR$E$M$Y$98.06$KG$20200910$$HP$US$US
142336654$14233665$4$F$20170502$20200925$20171128$20200930$EXP$$DK-CELGENEUS-DNK-20170505325$CELGENE$$73$YR$$M$Y$62.5$KG$20200930$$MD$DK$DK
142338033$14233803$3$F$201608$20200917$20171129$20200921$EXP$$US-PFIZER INC-2017508126$PFIZER$$51$YR$$F$Y$122.4$KG$20200921$$CN$US$US
142344014$14234401$4$F$$20200803$20171129$20200804$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-107188$BRISTOL MYERS SQUIBB$ONODA Y, ET AL. A CASE OF DIFFUSE ASTROCYTOMA COMPLICATED WITH SERIOUS DRUG?INDUCED NEUTROPENIA DURING THE EARLY STAGE OF TREATMENT.. NEUROSURGERY KINKI 2017 AUTUMN MEETING. 2017?52$63$YR$$F$Y$$$20200804$$MD$JP$JP
142345854$14234585$4$F$$20200806$20171129$20200812$EXP$$US-ROCHE-2029611$ROCHE$$$$$F$Y$$$20200812$$CN$US$US
142346684$14234668$4$F$20171109$20180115$20171129$20180123$EXP$$AU-ROCHE-2028040$ROCHE$$59$YR$$M$Y$80.6$KG$20180123$$MD$AU$AU
142350022$14235002$2$F$$20200818$20171129$20200826$EXP$$CA-APOTEX-2017AP021644$APOTEX$$$$$F$Y$$$20200826$$CN$CA$CA
142350335$14235033$5$F$$20200825$20171129$20200903$EXP$$CA-APOTEX-2017AP021680$APOTEX$$60$YR$$F$Y$$$20200903$$CN$CA$CA
142350386$14235038$6$F$$20200720$20171129$20200728$EXP$$CA-APOTEX-2017AP021663$APOTEX$$56$YR$$F$Y$$$20200728$$CN$CA$CA
142350405$14235040$5$F$$20200831$20171129$20200909$EXP$$CA-APOTEX-2017AP021690$APOTEX$$80$YR$$F$Y$$$20200909$$CN$CA$CA
142352869$14235286$9$F$20170403$20200806$20171129$20200908$EXP$$GB-ASPEN-GLO2017GB007654$ASPEN$$76$YR$$F$Y$69.9$KG$20200908$$HP$GB$GB
142354263$14235426$3$F$$20200807$20171129$20200819$EXP$$CA-APOTEX-2017AP021710$APOTEX$$$$$M$Y$$$20200819$$CN$CA$CA
1423543014$14235430$14$F$$20200910$20171129$20200918$EXP$$CA-APOTEX-2017AP021569$APOTEX$$54$YR$$F$Y$90$KG$20200918$$CN$CA$CA
142354334$14235433$4$F$$20200709$20171129$20200717$EXP$$CA-APOTEX-2017AP021665$APOTEX$$57$YR$$M$Y$$$20200717$$HP$CA$CA
1423593112$14235931$12$F$$20200723$20171129$20200803$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3893$ORION$$65$YR$$F$Y$$$20200803$$MD$CA$CA
142359725$14235972$5$F$$20200917$20171129$20200923$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3852$ORION$$35$YR$$F$Y$$$20200923$$MD$CA$CA
142362116$14236211$6$F$$20200706$20171129$20200709$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2017-3856$ORION$$$$$F$Y$$$20200709$$HP$CA$CA
142366143$14236614$3$F$20171119$20171214$20171129$20171222$EXP$$US-ASTRAZENECA-2017SF19012$ASTRAZENECA$$19589$DY$$F$Y$51.5$KG$20171222$$MD$US$US
142366541$14236654$1$I$20101124$20171115$20171129$20171129$EXP$$PHHY2017HU170606$NOVARTIS$$48$YR$$F$Y$$$20171129$$CN$COUNTRY NOT SPECIFIED$HU
142367697$14236769$7$F$201612$20200801$20171129$20200804$EXP$$US-PFIZER INC-2017502146$PFIZER$$48$YR$$F$Y$61$KG$20200804$$CN$US$US
1423678411$14236784$11$F$20170124$20200716$20171129$20200730$EXP$$US-ACTELION-A-US2017-152585$ACTELION$$61$YR$$F$Y$74.83$KG$20200730$$HP$US$US
142372292$14237229$2$F$20171122$20171205$20171129$20171207$EXP$$FR-JNJFOC-20171134636$JANSSEN$$68$YR$E$M$Y$$$20171207$$MD$FR$FR
142375032$14237503$2$F$20170205$20200902$20171129$20200908$PER$$US-JAZZ-2017-US-001755$JAZZ$$51$YR$$F$Y$$$20200908$$HP$US$US
142381032$14238103$2$F$$20200914$20171130$20200923$EXP$$IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2017R1-147107$RANBAXY$SHAREEF J, JOSEPH J, ADITHI K. A SINGLE CASE REPORT ON HYPONATREMIA SEIZURE INDUCED BY ACETYLCHOLINESTERASE INHIBITORS. INT J PHARM PHARMACEUT SCI. 2017?9(7):165?166$50$YR$$M$Y$$$20200923$$HP$IN$IN
142381583$14238158$3$F$20171120$20171204$20171130$20171207$EXP$$US-ASTRAZENECA-2017SF20102$ASTRAZENECA$$29710$DY$$F$Y$$$20171207$$MD$US$US
142384077$14238407$7$F$$20200824$20171130$20200903$EXP$$CA-APOTEX-2017AP021637$APOTEX$$46$YR$$F$Y$$$20200903$$HP$CA$CA
1423849723$14238497$23$F$201711$20200805$20171130$20200812$EXP$$CA-CELLTRION INC.-2017CA016468$CELLTRION$$$$$$Y$$$20200812$$HP$CA$CA
1423907815$14239078$15$F$20170621$20200722$20171130$20200731$EXP$$CA-ROCHE-2031070$ROCHE$$41$YR$$F$Y$129$KG$20200731$$MD$CA$CA
142390984$14239098$4$F$20170311$20180725$20171130$20180731$EXP$$US-ASTRAZENECA-2017SE27422$ASTRAZENECA$$65$YR$$M$Y$78.8$KG$20180731$$MD$US$US
142392364$14239236$4$F$20171103$20180122$20171130$20180223$EXP$$CN-ASTRAZENECA-2017SF21654$ASTRAZENECA$$21673$DY$$M$Y$$$20180223$$MD$CN$CN
142392442$14239244$2$F$201509$20200817$20171130$20200824$EXP$$US-BAYER-2017-178479$BAYER$$64$YR$A$F$Y$$$20200824$$CN$US$US
1423955918$14239559$18$F$2010$20200626$20171130$20200703$EXP$$US-009507513-1711USA008545$MERCK$$$$$F$Y$169.16$KG$20200703$$CN$US$US
142404689$14240468$9$F$20171109$20190422$20171130$20200715$EXP$$TR-CELGENEUS-TUR-20171108201$CELGENE$$74$YR$$F$Y$51.2$KG$20200715$$HP$TR$TR
142405274$14240527$4$F$20171109$20180115$20171130$20180123$EXP$$AU-ABBVIE-17P-008-2168018-00$ABBVIE$$59$YR$$M$Y$80.6$KG$20180123$$MD$AU$AU
1424113416$14241134$16$F$200510$20200921$20171130$20200923$PER$$US-PFIZER INC-2017512800$PFIZER$$37$YR$$F$Y$70$KG$20200923$$CN$US$US
142416625$14241662$5$F$20170623$20200729$20171201$20200804$EXP$$DE-UCBSA-2017047918$UCB$$$$A$M$Y$$$20200804$$MD$DE$DE
142417494$14241749$4$F$20171127$20200724$20171201$20200802$EXP$$US-BIOGEN-2017BI00489747$BIOGEN$KARAM C, MOSHE?LILIE O, VISSER A, CHAHIN N, RAGOLE T, DIMITROVA D. NUSINERSEN IN ADULT PATIENTS WITH SPINAL MUSCULAR ATROPHY: OBSERVATIONS FROM A SINGLE CENTER. DOI: 10.1212/WNL.0000000000009914. NEUROLOGY. 2020 JUL 14?95:.$30$YR$$F$Y$$$20200802$$MD$US$US
1424183117$14241831$17$F$20171024$20200814$20171201$20200823$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-106977$BRISTOL MYERS SQUIBB$$75$YR$$M$Y$88$KG$20200823$$HP$FR$FR
142419474$14241947$4$F$$20200803$20171201$20200813$EXP$$CA-APOTEX-2017AP021741$APOTEX$$44$YR$$F$Y$$$20200813$$CN$CA$CA
142428177$14242817$7$F$20171201$20200707$20171201$20200709$EXP$$JP-ABBVIE-17K-087-2181140-00$ABBVIE$$76$YR$$M$Y$66$KG$20200709$$PH$JP$JP
142431357$14243135$7$F$$20200824$20171201$20200902$EXP$$CA-APOTEX-2017AP021933$APOTEX$$36$YR$$F$Y$$$20200902$$HP$CA$CA
142431622$14243162$2$F$20170201$20200726$20171201$20200804$EXP$$US-BAYER-2017-189642$BAYER$$82$YR$E$M$Y$$$20200804$$CN$US$US
142433361$14243336$1$I$20161209$20161222$20171201$20171201$EXP$$PL-ASTRAZENECA-2016SF36840$ASTRAZENECA$$24196$DY$$F$Y$$$20171201$$MD$PL$PL
1424340212$14243402$12$F$20171118$20200727$20171201$20200804$EXP$$CA-CELLTRION INC.-2017CA016041$CELLTRION$$$$$$Y$$$20200804$$HP$CA$CA
1424348812$14243488$12$F$$20200724$20171201$20200728$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-105151$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200728$$CN$GB$GB
142442384$14244238$4$F$20171128$20171214$20171201$20171219$EXP$$IL-JNJFOC-20171136434$PHARMACYCLICS$$65$YR$A$M$Y$98$KG$20171219$$MD$IL$IL
1424484615$14244846$15$F$202005$20200709$20171201$20200722$EXP$$US-ACTELION-A-NJ2017-163489$ACTELION$$66$YR$$F$Y$74.83$KG$20200722$$PH$US$US
142450232$14245023$2$F$$20200709$20171202$20200710$EXP$$CA-ROCHE-2029484$ROCHE$$34$YR$$M$Y$$$20200710$$HP$CA$CA
1424521511$14245215$11$F$20171128$20200716$20171202$20200720$EXP$$ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-064210$BOEHRINGER INGELHEIM$AMARILLA LANZAS I, FERNANDEZ MOSTEIRIN N, CALVO VINAS J, SANCHO VAL L, CUESTA GALLARDO I, GAVIN SEBASTIAN O. A MULTICENTER EXPERIENCE WITH IDARUCIZUMAB ^IN REAL WORLD^AS REVERSAL ANTICOAGULATION OF DABIGATRAN. 2020 JUL?.$82$YR$$F$Y$60$KG$20200720$$MD$ES$ES
142452421$14245242$1$I$$20171124$20171202$20171202$EXP$IT-MINISAL02-436699$IT-AUROBINDO-AUR-APL-2017-44107$AUROBINDO$$53$YR$$F$Y$$$20171202$$HP$IT$IT
142456116$14245611$6$F$20121001$20200806$20171203$20200808$PER$$US-BIOGEN-2015BI066854$BIOGEN$$46$YR$$F$Y$64$KG$20200808$$CN$US$US
142460347$14246034$7$F$$20200707$20171204$20200709$EXP$$CA-ORION CORPORATION ORION PHARMA-TREX2016-0973$ORION$$33$YR$$F$Y$$$20200709$$MD$CA$CA
142461992$14246199$2$F$2016$20200729$20171204$20200807$EXP$FR-AFSSAPS-PC20160886$FR-009507513-1711FRA013096$MERCK$$68$YR$$M$Y$$$20200807$$PH$FR$FR
142462632$14246263$2$F$201304$20200810$20171204$20200820$EXP$$FR-ROCHE-1476904$ROCHE$$39$YR$$F$Y$43$KG$20200820$$HP$FR$FR
1424668228$14246682$28$F$20170213$20200814$20171204$20200824$EXP$$US-PFIZER INC-2017512614$PFIZER$$64$YR$$F$Y$$$20200824$$MD$US$US
142468133$14246813$3$F$$20200730$20171204$20200803$PER$$US-PFIZER INC-2017516556$PFIZER$$46$YR$$F$Y$$$20200803$$CN$US$US
142470293$14247029$3$F$201710$20200827$20171204$20200904$EXP$$PHHY2017DE173671$NOVARTIS$$$$A$M$Y$93$KG$20200904$$HP$DE$DE
142474324$14247432$4$F$$20200924$20171204$20200929$EXP$$US-PFIZER INC-2017516568$PFIZER$BUTANI, L.. PRIMARY RENAL LYMPHOMA PRESENTING AS END?STAGE RENAL DISEASE. CASE REPORTS IN MEDICINE. 2017?10.1155/2017/9210648$12$YR$$M$Y$$$20200929$$MD$US$US
142475275$14247527$5$F$20170913$20180524$20171204$20180601$EXP$$US-JNJFOC-20170918153$JANSSEN$$64$YR$A$F$Y$71$KG$20180601$$MD$US$US
142475422$14247542$2$F$201510$20200921$20171204$20200928$EXP$$US-BAYER-2017-191674$BAYER$$74$YR$E$F$Y$$$20200928$$CN$US$US
142475904$14247590$4$F$$20200623$20171204$20200707$EXP$$JP-JNJFOC-20171137437$JOHNSON AND JOHNSON$$$$$$Y$$$20200707$$MD$JP$JP
142479742$14247974$2$F$20150810$20200730$20171204$20200811$EXP$$US-BAYER-2017-211072$BAYER$$71$YR$E$M$Y$$$20200811$$CN$US$US
142484572$14248457$2$F$20160619$20171201$20171204$20171207$EXP$$BE-ASTRAZENECA-2016SE69426$ASTRAZENECA$$18469$DY$$F$Y$$$20171207$$MD$BE$BE
142485982$14248598$2$F$20170903$20181106$20171204$20181112$EXP$$CA-CELGENEUS-CAN-20171108861$CELGENE$$66$YR$$M$Y$$$20181112$$MD$CA$CA
142488252$14248825$2$F$201710$20200630$20171204$20200702$EXP$$US-PFIZER INC-2017516604$PFIZER$$49$YR$$F$Y$$$20200702$$CN$US$US
142490246$14249024$6$F$20170523$20200729$20171204$20200803$EXP$$MX-ABBVIE-17P-107-2178838-00$ABBVIE$$56$YR$$F$Y$50$KG$20200803$$MD$MX$MX
142498343$14249834$3$F$$20200624$20171205$20200703$EXP$$FR-MACLEODS PHARMACEUTICALS US LTD-MAC2017006436$MACLEODS$$$$$$Y$$$20200703$$CN$IN$FR
142499004$14249900$4$F$20170601$20200219$20171205$20200817$EXP$$GB-UCBSA-2017046433$UCB$$37$YR$$F$Y$$$20200817$$HP$GB$GB
1425019915$14250199$15$F$20130513$20200923$20171205$20200927$EXP$$IT-ROCHE-1703806$ROCHE$$58$YR$$F$Y$88$KG$20200928$$MD$IT$IT
142503532$14250353$2$F$$20200717$20171205$20200725$EXP$$US-ACCORD-061650$ACCORD$BUTANI L, DUCORE J. PRIMARY RENAL LYMPHOMA PRESENTING AS END?STAGE RENAL DISEASE. CASE REPORTS IN MEDICINE. 2017?ARTICLE NUMBER 9210648.$12$YR$$M$Y$$$20200725$$MD$US$US
1425078715$14250787$15$F$201804$20200908$20171205$20200910$EXP$$US-PFIZER INC-2017517877$PFIZER$$71$YR$$F$Y$$$20200910$$CN$US$US
142514004$14251400$4$F$201512$20200716$20171205$20200728$EXP$$US-JNJFOC-20171202589$JOHNSON AND JOHNSON$$79$YR$E$M$Y$$$20200728$$CN$US$US
1425148525$14251485$25$F$201709$20200707$20171205$20200722$EXP$$US-ACTELION-A-NJ2017-163595$ACTELION$$49$YR$$F$Y$136.05$KG$20200722$$HP$US$US
142518863$14251886$3$F$$20200909$20171205$20200918$EXP$$CA-APOTEX-2017AP021869$APOTEX$$56$YR$$F$Y$75$KG$20200918$$CN$CA$CA
142520496$14252049$6$F$$20200909$20171205$20200921$EXP$$CA-APOTEX-2017AP021830$APOTEX$$31$YR$$F$Y$52$KG$20200921$$MD$CA$CA
1425234027$14252340$27$F$20170925$20200811$20171205$20200813$EXP$$US-SA-2017SA207805$SANOFI AVENTIS$$$$$$Y$$$20200813$$HP$US$US
142524222$14252422$2$F$20160427$20200624$20171205$20200706$EXP$$US-BAYER-2017-221961$BAYER$$70$YR$E$M$Y$$$20200706$$CN$US$US
142529887$14252988$7$F$$20181001$20171205$20200914$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-108872$BRISTOL MYERS SQUIBB$$$$$F$Y$102$KG$20200914$$HP$US$US
142530123$14253012$3$F$20170103$20200921$20171205$20200930$EXP$DE-BFARM-17395069$DE-BAYER-2017-215754$BAYER$$61$YR$A$F$Y$60$KG$20200930$$HP$DE$DE
1425310417$14253104$17$F$20170911$20200817$20171206$20200820$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-110429$BRISTOL MYERS SQUIBB$SUMI K, ET AL.. A CASE OF MYELITIS AND POLYRADICULITIS DEVELOPED AFTER THE NIVOLUMAB THERAPY. 221ST KYUSYU REGIONAL MEETING OF THE JAPANESE SOCIETY OF NEUROLOGY. 2018?39$74$YR$$M$Y$63.3$KG$20200820$$MD$JP$JP
142532932$14253293$2$F$20171127$20171209$20171205$20171214$EXP$$US-JNJFOC-20171204304$PHARMACYCLICS$$72$YR$E$M$Y$$$20171214$$MD$US$US
142535434$14253543$4$F$$20200701$20171206$20200708$EXP$$FR-AUROBINDO-AUR-APL-2017-44386$AUROBINDO$$8$YR$$M$Y$$$20200708$$HP$FR$FR
142541601$14254160$1$I$20171117$20171123$20171206$20171206$EXP$$CA-ASTRAZENECA-2017SF19634$ASTRAZENECA$$63$YR$$M$Y$$$20171206$$MD$CA$CA
142544242$14254424$2$F$20150622$20200618$20171205$20200701$EXP$$US-JNJFOC-20171101729$JOHNSON AND JOHNSON$$72$YR$$M$Y$$$20200701$$MD$US$US
142545546$14254554$6$F$201509$20200728$20171206$20200730$PER$$US-PFIZER INC-2017520603$PFIZER$$56$YR$$F$Y$$$20200730$$HP$US$US
142546753$14254675$3$F$$20200630$20171206$20200707$EXP$$US-ASTELLAS-2017US050633$ASTELLAS$$$$$M$Y$$$20200707$$CN$US$US
142552801$14255280$1$I$20171122$20171128$20171206$20171206$EXP$$CA-CELGENEUS-CAN-20171108898$CELGENE$$70$YR$$F$Y$$$20171206$$MD$CA$CA
142557686$14255768$6$F$20171103$20180720$20171206$20180726$EXP$$US-JNJFOC-20171135010$JANSSEN$$67$YR$E$M$Y$118.5$KG$20180726$$MD$US$US
142558145$14255814$5$F$20171108$20180227$20171206$20180309$EXP$$NZ-JNJFOC-20171111899$JANSSEN$$32$YR$A$M$Y$112.6$KG$20180309$$MD$NZ$NZ
142559856$14255985$6$F$$20200713$20171206$20200715$EXP$$JP-PFIZER INC-2017514616$PFIZER$SUZUKI, K.. VORINOSTAT AND BORTEZOMIB COMBINED INTENSIVE CHEMOTHERAPY FOR CHILDREN WITH KMT2A (MLL)?REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA.. PEDIATRIC BLOOD AND CANCER. 2017?64 (SUPPL 4):S90$1$YR$$F$Y$$$20200715$$HP$JP$JP
142560283$14256028$3$F$$20180709$20171206$20180711$EXP$$PL-PFIZER INC-2017512067$PFIZER$STERNAL, S.. CLINICAL ANALYSIS OF KLEBSIELLA PNEUMONIAE KPC INFECTION IN INTENSIVE CARE UNIT ? SERIES OF 7 CASE REPORTS.. PRZEGLAD LEKARSKI. 2017?9:445?449$72$YR$$F$Y$$$20180711$$HP$PL$PL
142560402$14256040$2$F$$20200817$20171206$20200825$EXP$$CA-ASTRAZENECA-2017SF22857$ASTRAZENECA$$40$YR$$F$Y$$$20200825$$CN$CA$CA
142560583$14256058$3$F$20151013$20200727$20171206$20200804$EXP$$PHHY2015BR124888$NOVARTIS$$51$YR$$F$Y$96$KG$20200804$$MD$BR$BR
142561143$14256114$3$F$$20171127$20171206$20200707$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-107575$BRISTOL MYERS SQUIBB$$$$$M$Y$51.7$KG$20200707$$CN$US$US
1425616516$14256165$16$F$201604$20200625$20171206$20200709$EXP$$US-ACTELION-A-NJ2017-160191$ACTELION$$59$YR$$M$Y$93.88$KG$20200709$$HP$US$US
142563155$14256315$5$F$20171128$20191010$20171206$20191017$EXP$$AT-JNJFOC-20171206213$JOHNSON AND JOHNSON$$73$YR$$M$Y$86$KG$20191017$$MD$AT$AT
1425644013$14256440$13$F$20170201$20200904$20171206$20200908$EXP$$DE-PFIZER INC-2017517405$PFIZER$$63$YR$$M$Y$$$20200908$$CN$DE$DE
142565495$14256549$5$F$20171201$20190214$20171206$20200715$EXP$$FR-CELGENEUS-FRA-20171200773$CELGENE$$85$YR$$F$Y$48$KG$20200715$$HP$FR$FR
142565761$14256576$1$I$20170810$20171201$20171206$20171206$EXP$$US-PFIZER INC-2017518439$PFIZER$$62$YR$$M$Y$76$KG$20171206$$HP$US$US
142578717$14257871$7$F$$20200714$20171207$20200716$PER$$US-AMGEN-USASP2017180861$AMGEN$$63$YR$A$M$Y$$$20200716$$CN$US$US
142580431$14258043$1$I$20171030$20171106$20171207$20171207$EXP$$US-ASTRAZENECA-2017SF13025$ASTRAZENECA$$58$YR$$F$Y$$$20171207$$MD$US$US
142582353$14258235$3$F$20160715$20160715$20171207$20180124$EXP$$IT-ASTRAZENECA-2016SE77789$ASTRAZENECA$$758$MON$$M$Y$$$20180124$$MD$IT$IT
142585302$14258530$2$F$$20200714$20171207$20200716$PER$$US-PFIZER INC-2017522435$PFIZER$$72$YR$$M$Y$$$20200716$$MD$US$US
142587614$14258761$4$F$$20200718$20171207$20200724$EXP$$GB-AUROBINDO-AUR-APL-2017-44836$AUROBINDO$$58$YR$$M$Y$$$20200724$$MD$GB$GB
142588131$14258813$1$I$20171118$20171121$20171207$20171207$EXP$$US-ASTRAZENECA-2017SF19019$ASTRAZENECA$$19478$DY$$F$Y$62.6$KG$20171207$$MD$US$US
142588773$14258877$3$F$$20200910$20171207$20200921$EXP$$CA-APOTEX-2017AP021983$APOTEX$$$$$M$Y$132$KG$20200921$$CN$CA$CA
142591883$14259188$3$F$20171125$20180302$20171207$20180309$EXP$$US-JNJFOC-20171133015$JANSSEN$$64$YR$A$F$Y$83.92$KG$20180309$$MD$US$US
1425925211$14259252$11$F$$20200804$20171207$20200812$EXP$$US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-BI-057471$BOEHRINGER INGELHEIM$$$$$M$Y$$$20200812$$CN$US$US
142592992$14259299$2$F$20171120$20171204$20171207$20171214$EXP$$ZA-JNJFOC-20171136597$JANSSEN$$69$YR$E$M$Y$81.6$KG$20171214$$MD$ZA$ZA
142596362$14259636$2$F$20161209$20200730$20171207$20200811$EXP$$US-BAYER-2017-187981$BAYER$$78$YR$E$F$Y$$$20200811$$CN$US$US
142599677$14259967$7$F$201709$20200915$20171207$20200923$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-09983$VIFOR$$67$YR$$F$Y$$$20200923$$CN$US$US
142600325$14260032$5$F$2017$20180103$20171207$20200715$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-09276$VIFOR$$67$YR$E$M$Y$88.98$KG$20200715$$CN$US$US
142601203$14260120$3$F$20150701$20200818$20171207$20200826$EXP$$US-ASTRAZENECA-2017SF22063$ASTRAZENECA$$20269$DY$$F$Y$73.9$KG$20200826$$$US$US
142601805$14260180$5$F$20170904$20200818$20171207$20200825$EXP$$US-ASTELLAS-2017US050697$ASTELLAS$$83$YR$$M$Y$$$20200825$$MD$US$US
142601942$14260194$2$F$20160606$20180502$20171207$20180510$EXP$$BE-ASTRAZENECA-2016SE73880$ASTRAZENECA$$21356$DY$$M$Y$$$20180510$$MD$BE$BE
142604931$14260493$1$I$20161110$20161118$20171207$20171207$EXP$$DE-JNJFOC-20161121605$JANSSEN$$56$YR$A$M$Y$80$KG$20171207$$MD$DE$DE
142607714$14260771$4$F$20171113$20200730$20171207$20200807$EXP$$BR-BIOMARINAP-BR-2017-116270$BIOMARIN$$13$YR$$F$Y$36$KG$20200807$$MD$BR$BR
142612472$14261247$2$F$20170824$20200908$20171208$20200914$EXP$$PHHY2017DE179279$NOVARTIS$$$$A$M$Y$63$KG$20200914$$CN$DE$DE
142617014$14261701$4$F$$20200915$20171208$20200924$EXP$$CA-APOTEX-2017AP022104$APOTEX$$81$YR$$M$Y$$$20200924$$CN$CA$CA
142617376$14261737$6$F$$20200918$20171208$20200930$EXP$$CA-APOTEX-2017AP022150$APOTEX$$47$YR$$F$Y$121$KG$20200930$$HP$CA$CA
142618085$14261808$5$F$201602$20200818$20171208$20200828$EXP$$NL-AUROBINDO-AUR-APL-2017-44219$AUROBINDO$$56$YR$$M$Y$78$KG$20200828$$MD$NL$NL
142618343$14261834$3$F$$20200915$20171208$20200929$EXP$$CA-APOTEX-2017AP022094$APOTEX$$70$YR$$F$Y$$$20200929$$CN$CA$CA
142619884$14261988$4$F$20200912$20200914$20171208$20200917$EXP$$US-ARIAD PHARMACEUTICALS, INC-2017US008572$TAKEDA$$40$YR$$F$Y$$$20200917$$HP$US$US
142623071$14262307$1$I$20160506$20160511$20171208$20171208$EXP$$JP-ASTRAZENECA-2016SE51451$ASTRAZENECA$$25391$DY$$M$Y$$$20171208$$MD$JP$JP
142625687$14262568$7$F$20191029$20200827$20171208$20200902$PER$$US-PFIZER INC-2017522169$PFIZER$$70$YR$$F$Y$81.65$KG$20200902$$CN$US$US
142625858$14262585$8$F$20130822$20200124$20171208$20200914$PER$$JP-AMGEN-JPNCT2017182950$AMGEN$$64$YR$A$M$Y$64$KG$20200913$$HP$JP$JP
142626277$14262627$7$F$2017$20200713$20171208$20200714$EXP$$US-PFIZER INC-2017520662$PFIZER$$68$YR$$F$Y$$$20200714$$CN$US$US
142628284$14262828$4$F$$20200915$20171208$20200925$EXP$$CA-APOTEX-2017AP022086$APOTEX$$59$YR$$F$Y$$$20200925$$CN$CA$CA
142638125$14263812$5$F$20171109$20200908$20171208$20200922$EXP$$US-ROCHE-2032121$ROCHE$$$$$$Y$$$20200922$$MD$US$US
142638552$14263855$2$F$20171124$20171215$20171208$20171218$EXP$$US-ASTRAZENECA-2017SF20641$ASTRAZENECA$$77$YR$$M$Y$$$20171218$$MD$ES$ES
142641262$14264126$2$F$20171203$20171214$20171208$20171220$EXP$$CA-ASTRAZENECA-2017SF24496$ASTRAZENECA$$69$YR$$F$Y$$$20171220$$MD$CA$CA
142641846$14264184$6$F$20170530$20200810$20171208$20200816$EXP$GB-CELGENE-GBR-20170605850$PHHY2017GB180222$NOVARTIS$$76$YR$$F$Y$69.9$KG$20200816$$HP$GB$GB
142642872$14264287$2$F$2013$20200710$20171208$20200921$PER$$US-JAZZ-2013-US-000336$JAZZ$$$$$F$Y$60.77$KG$20200921$$MD$US$US
142643324$14264332$4$F$$20200825$20171208$20200828$EXP$$US-JAZZ-2013-US-000516$JAZZ$$$$$F$Y$$$20200828$$HP$US$US
1426433516$14264335$16$F$2017$20200908$20171208$20200915$EXP$$CA-TAKEDA-2017TUS021165$TAKEDA$$45$YR$$F$Y$$$20200915$$HP$CA$CA
142645462$14264546$2$F$2017$20200605$20171208$20200820$PER$$US-JAZZ-2017-US-013095$JAZZ$$$$$M$Y$$$20200820$$MD$US$US
142645953$14264595$3$F$2017$20200708$20171208$20200713$EXP$$US-JAZZ-2017-US-012393$JAZZ$$$$$F$Y$$$20200713$$MD$US$US
142647395$14264739$5$F$201812$20200915$20171208$20200923$EXP$$US-VIFOR (INTERNATIONAL) INC.-VIT-2017-09259$VIFOR$$78$YR$$M$Y$$$20200923$$CN$US$US
142653142$14265314$2$F$$20171129$20171208$20200803$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-109817$BRISTOL MYERS SQUIBB$KIM TK, LEE JH, LEE MY.. MACULAR INFARCTION FOLLOWING INTRAVITREAL TRIAMCINOLONE INJECTION FOR TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION.. ACTA OPHTHALMOLOGICA. 2015?93(S255)$75$YR$$M$Y$$$20200803$$HP$KR$KR
1426554618$14265546$18$F$20171119$20200805$20171208$20200815$EXP$$US-ACTELION-A-US2017-163878$ACTELION$$29$YR$$F$Y$68.03$KG$20200815$$HP$US$US
142656685$14265668$5$F$20170530$20200808$20171208$20200814$EXP$$GB-BAUSCH-BL-2017-032426$BAUSCH AND LOMB$$76$YR$$F$Y$69.9$KG$20200814$$HP$GB$GB
142658881$14265888$1$I$20170826$20171124$20171209$20171209$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-156153$RANBAXY$$85$YR$$F$Y$$$20171209$$HP$GB$GB
142658961$14265896$1$I$$20171124$20171209$20171209$EXP$$IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2017RR-155889$RANBAXY$$53$YR$$F$Y$$$20171209$$HP$IT$IT
142659859$14265985$9$F$20171031$20200707$20171209$20200713$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-109691$BRISTOL MYERS SQUIBB$$76$YR$$F$Y$94$KG$20200713$$HP$NL$NL
142662372$14266237$2$F$$20200707$20171210$20200710$EXP$$PHHY2017CA181128$NOVARTIS$$$$$F$Y$$$20200711$$CN$COUNTRY NOT SPECIFIED$CA
1426665810$14266658$10$F$20170907$20200709$20171211$20200713$EXP$$NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-112180$BRISTOL MYERS SQUIBB$HAANEN J, CARBONNEL F, ROBERT C, KERR K, PETERS S, LARKIN J, ET AL. ESMO GUIDELINE IMMUNOTHERAPY. ANN ONCOL. 2017?28(4):IV119?42$68$YR$$M$Y$71$KG$20200713$$MD$NL$NL
142674796$14267479$6$F$20170802$20200914$20171211$20200925$EXP$$DE-AUROBINDO-AUR-APL-2017-45133$AUROBINDO$$55$YR$$F$Y$$$20200925$$MD$JP$DE
142680361$14268036$1$I$20160718$20160804$20171211$20171211$EXP$$FR-ASTRAZENECA-2016SE84453$ASTRAZENECA$$19192$DY$$F$Y$$$20171211$$MD$FR$FR
142680763$14268076$3$F$2017$20200902$20171211$20200907$PER$$US-PFIZER INC-2017526826$PFIZER$$46$YR$$F$Y$$$20200907$$HP$US$US
142680974$14268097$4$F$20171104$20200831$20171211$20200905$EXP$$PHHY2017DE178865$NOVARTIS$$76$YR$$F$Y$91$KG$20200905$$HP$DE$DE
142682645$14268264$5$F$$20200623$20171211$20200701$EXP$$FR-MYLANLABS-2017M1076865$MYLAN$$8$YR$$M$Y$$$20200701$$HP$FR$FR
142683562$14268356$2$F$201607$20200924$20171211$20200930$EXP$$US-BAYER-2017-215742$BAYER$$62$YR$A$M$Y$$$20200930$$CN$US$US
1426839720$14268397$20$F$20170404$20200903$20171211$20200927$EXP$$CA-CELLTRION INC.-2017CA004546$CELLTRION$$$$$$Y$$$20200927$$HP$CA$CA
142689404$14268940$4$F$201703$20200914$20171211$20200915$EXP$$PT-BAYER-2017-231473$BAYER$$29$YR$A$F$Y$86$KG$20200915$$HP$US$PT
142691693$14269169$3$F$20171122$20171221$20171211$20171229$EXP$$GB-PFIZER INC-2017513570$PFIZER$$64$YR$$F$Y$64.2$KG$20171229$$MD$GB$GB
142695852$14269585$2$F$$20200804$20171211$20200810$EXP$$US-OTSUKA-2017_014107$OTSUKA$$$$$M$Y$$$20200810$$CN$US$US
142704602$14270460$2$F$2010$20200906$20171211$20200914$EXP$$US-OTSUKA-BMS-2016-090492$OTSUKA$$$$$F$Y$$$20200914$$CN$US$US
142709293$14270929$3$F$201604$20200824$20171211$20200831$EXP$FR-AFSSAPS-ST20160980$FR-OTSUKA-2016_022162$OTSUKA$$37$YR$$M$Y$$$20200831$$HP$FR$FR
1427117010$14271170$10$F$20170201$20200908$20171211$20200911$EXP$$DE-MYLANLABS-2017M1076437$MYLAN$$63$YR$$M$Y$$$20200911$$CN$DE$DE
142711781$14271178$1$I$20101124$20171204$20171211$20171211$EXP$$HU-PFIZER INC-2017521328$PFIZER$$48$YR$$F$Y$$$20171211$$MD$HU$HU
142713042$14271304$2$F$20171022$20180404$20171211$20180413$EXP$$US-JNJFOC-20171035575$JANSSEN$$74$YR$E$M$Y$61.04$KG$20180413$$MD$US$US
1427193513$14271935$13$F$20171127$20200921$20171212$20200923$PER$$US-EISAI MEDICAL RESEARCH-EC-2017-033880$EISAI$$71$YR$E$F$Y$85.4$KG$20200923$$MD$US$US
142722398$14272239$8$F$201411$20180801$20171211$20180809$EXP$$HU-TEVA-2017-HU-829097$TEVA$$$$$F$Y$$$20180809$$HP$HU$HU
1427241912$14272419$12$F$2004$20200813$20171211$20200817$EXP$$PHHY2017BR178335$NOVARTIS$$56$YR$$F$Y$59$KG$20200818$$MD$BR$BR
142730476$14273047$6$F$20171011$20200704$20171212$20200707$EXP$$PHHO2017GB013384$NOVARTIS$$40$YR$$M$Y$83$KG$20200707$$HP$GB$GB
142730663$14273066$3$F$$20200624$20171212$20200703$EXP$FR-MLMSERVICE-20171121-0972707-1$FR-LUPIN PHARMACEUTICALS INC.-2017-07059$LUPIN$$8$YR$$M$Y$$$20200703$$HP$FR$FR
142752652$14275265$2$F$20141025$20200727$20171211$20200730$EXP$$US-BAYER-2017-188718$BAYER$$83$YR$E$F$Y$$$20200730$$CN$US$US
142753684$14275368$4$F$2011$20200915$20171211$20200921$EXP$$CA-OTSUKA-2016_025145$OTSUKA$$$$$F$Y$$$20200921$$CN$CA$CA
142758982$14275898$2$F$20150824$20200811$20171212$20200817$EXP$$US-BAYER-2017-162842$BAYER$$55$YR$A$F$Y$$$20200817$$CN$US$US
142764602$14276460$2$F$20170705$20200905$20171212$20200917$EXP$$GB-MACLEODS PHARMACEUTICALS US LTD-MAC2017006458$MACLEODS$$$$$$Y$$$20200917$$CN$GB$GB
142768655$14276865$5$F$20131030$20200821$20171211$20200824$EXP$$NL-OTSUKA-2015_017504$OTSUKA$$18$YR$$M$Y$130$KG$20200824$$CN$NL$NL
142772854$14277285$4$F$$20200806$20171212$20200813$EXP$$IE-ROCHE-2030666$ROCHE$ABKUR T, SAEED M, AHMED S, MCARTHUR R, LEAHY M, O^LEARY H AND O^KEEFE D. PNEUMOCYSTIS JIROVECI PROPHYLAXIS IN PATIENTS UNDERGOING BENDAMUSTINE TREATMENT: THE NEED FOR A STANDARDIZED PROTOCOL.. CLINICAL CASE REPORTS 2015 APR?3 (4):255?259.$71$YR$$F$Y$$$20200813$$HP$IE$IE
142775944$14277594$4$F$20171130$20200826$20171212$20200831$EXP$$PHHO2017BE016512$NOVARTIS$$65$YR$$F$Y$67$KG$20200831$$HP$BE$BE
142776982$14277698$2$F$$20200701$20171212$20200707$EXP$$PHHY2017ES182403$NOVARTIS$$63$YR$$F$Y$$$20200708$$HP$ES$ES
1427783013$14277830$13$F$$20200810$20171212$20200819$EXP$$NL-MYLANLABS-2017M1078532$MYLAN$$67$YR$$M$Y$$$20200819$$MD$NL$NL
142782553$14278255$3$F$$20200713$20171212$20200717$PER$$US-PFIZER INC-2017528959$PFIZER$$55$YR$$F$Y$$$20200717$$MD$US$US
142791513$14279151$3$F$20171204$20200726$20171212$20200803$EXP$$US-EMD SERONO-E2B_90000619$EMD SERONO INC$$27$YR$A$F$Y$$$20200803$$CN$US$US
142796804$14279680$4$F$20101201$20200722$20171213$20200728$EXP$$US-BIOGEN-2010BI042672$BIOGEN$$49$YR$$F$Y$$$20200728$$MD$US$US
142799797$14279979$7$F$20191216$20200818$20171212$20200824$EXP$$US-ACTELION-A-US2017-160930$ACTELION$$78$YR$$F$Y$73.47$KG$20200824$$HP$US$US
142803054$14280305$4$F$$20200819$20171212$20200824$EXP$$US-JAZZ-2017-US-016379$JAZZ$$$$$M$Y$$$20200824$$HP$US$US
142805017$14280501$7$F$20171202$20200803$20171213$20200809$EXP$$PHHY2017CA181737$NOVARTIS$$57$YR$$M$Y$$$20200809$$CN$CA$CA
1428054315$14280543$15$F$2017$20200805$20171213$20200816$EXP$$PHEH2017US034480$NOVARTIS$$114$YR$$F$Y$88.45$KG$20200816$$CN$US$US
142806941$14280694$1$I$$20171201$20171213$20171213$EXP$$ES-ROCHE-2035754$ROCHE$$$$$$Y$$$20171213$$PH$ES$ES
142813237$14281323$7$F$201801$20200612$20171213$20200721$PER$$US-INCYTE CORPORATION-2017IN010436$INCYTE$$$$$$Y$$$20200722$$CN$US$US
142819962$14281996$2$F$20170627$20190121$20171213$20190123$EXP$$ES-ASTRAZENECA-2017SE67004$ASTRAZENECA$$22380$DY$$M$Y$$$20190123$$MD$ES$ES
142823974$14282397$4$F$20171128$20180105$20171213$20180108$EXP$$JP-ASTRAZENECA-2017SF25812$ASTRAZENECA$$26$YR$$F$Y$$$20180108$$MD$JP$JP
142824004$14282400$4$F$20180901$20200917$20171213$20200929$EXP$$US-BIOGEN-2017BI00495703$BIOGEN$$62$YR$$F$Y$$$20200929$$CN$US$US
142830144$14283014$4$F$201710$20200722$20171213$20200724$PER$$US-PFIZER INC-2017486691$PFIZER$$64$YR$$F$Y$72$KG$20200724$$CN$US$US
1428312113$14283121$13$F$20171008$20200805$20171213$20200817$EXP$$US-ACTELION-A-US2016-130798$ACTELION$$38$YR$$F$Y$49.89$KG$20200817$$PH$US$US
142833759$14283375$9$F$2015$20200803$20171213$20200807$PER$$US-BIOGEN-2017BI00443465$BIOGEN$$44$YR$$F$Y$$$20200807$$CN$US$US
1428402914$14284029$14$F$2017$20200818$20171214$20200821$EXP$$CA-TAKEDA-2017TUS022963$TAKEDA$$70$YR$$M$Y$$$20200821$$HP$CA$CA
142853474$14285347$4$F$201812$20200902$20171214$20200903$EXP$$US-PFIZER INC-2017463691$PFIZER$$60$YR$$F$Y$146$KG$20200903$$CN$US$US
142856451$14285645$1$I$20170826$20171130$20171214$20171214$EXP$GB-MHRA-EYC 00168528$GB-ROCHE-2034724$ROCHE$$85$YR$$F$Y$$$20171214$$HP$GB$GB
142867972$14286797$2$F$20171010$20200722$20171214$20200731$EXP$$BR-BIOGEN-2017BI00484016$BIOGEN$$32$YR$$M$Y$$$20200731$$CN$BR$BR
142870687$14287068$7$F$20171002$20200622$20171214$20200701$EXP$$BE-ASPEN-GLO2017BE008311$ASPEN$$71$YR$$F$Y$$$20200701$$MD$BE$BE
142871859$14287185$9$F$2009$20200925$20171214$20200929$EXP$$GR-BAXTER-2017BAX042267$BAXTER$$62$YR$$F$Y$$$20200929$$MD$GR$GR
142873399$14287339$9$F$20161227$20200724$20171214$20200803$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033939$BRISTOL MYERS SQUIBB$$56$YR$$M$Y$$$20200803$$HP$DE$DE
1428796618$14287966$18$F$20141009$20200811$20171214$20200819$EXP$$PHEH2017US039766$NOVARTIS$$0$DY$$F$Y$$$20200820$$LW$US$US
142881113$14288111$3$F$2017$20200707$20171214$20200713$EXP$$CA-UCBSA-2017049999$UCB$$42$YR$$F$Y$$$20200713$$CN$CA$CA
142881215$14288121$5$F$20171107$20200602$20171214$20200610$EXP$$US-ASTRAZENECA-2017SF24745$ASTRAZENECA$$56$YR$$M$Y$105.8$KG$20200610$$MD$US$US
142881734$14288173$4$F$20160520$20200915$20171214$20200924$EXP$$DE-TEVA-2017-DE-830623$TEVA$$67$YR$E$F$Y$71$KG$20200924$$MD$DE$DE
142883392$14288339$2$F$20171110$20171201$20171214$20200709$EXP$$NL-TEVA-2017-NL-833567$TEVA$$55$YR$$F$Y$$$20200709$$CN$NL$NL
142885062$14288506$2$F$$20200826$20171214$20200902$EXP$$PHEH2017US040110$NOVARTIS$$$$$F$Y$$$20200902$$MD$US$US
142887972$14288797$2$F$2017$20200714$20171215$20200717$PER$$US-AMGEN-USASP2017185243$AMGEN$$52$YR$A$M$Y$$$20200717$$MD$US$US
142888314$14288831$4$F$20171211$20181219$20171215$20181221$EXP$$RU-ASTRAZENECA-2017SF27476$ASTRAZENECA$$25404$DY$$M$Y$$$20181221$$MD$RU$RU
142890244$14289024$4$F$20171204$20200707$20171215$20200708$PER$$US-PFIZER INC-2017530080$PFIZER$$46$YR$$M$Y$$$20200708$$HP$US$US
142893336$14289333$6$F$$20200709$20171215$20200710$PER$$US-PFIZER INC-2017535606$PFIZER$$84$YR$$F$Y$$$20200710$$CN$US$US
142895018$14289501$8$F$20170223$20200819$20171214$20200824$EXP$$US-ACTELION-A-NJ2017-164095$ACTELION$$71$YR$$F$Y$51.25$KG$20200824$$HP$US$US
142904172$14290417$2$F$201606$20171219$20171215$20171227$EXP$$HU-JNJFOC-20171213245$JANSSEN$$62$YR$A$$Y$$$20171227$$HP$HU$HU
142908433$14290843$3$F$20160810$20180109$20171215$20180112$EXP$$US-JNJFOC-20160812210$JANSSEN$$30$YR$A$F$Y$90.7$KG$20180112$$MD$US$US
1429089913$14290899$13$F$2017$20200918$20171215$20200928$EXP$$CA-ROCHE-2038011$ROCHE$$60$YR$$M$Y$$$20200929$$CN$CA$CA
1429104710$14291047$10$F$$20200810$20171215$20200819$EXP$$NL-AUROBINDO-AUR-APL-2017-45494$AUROBINDO$$67$YR$$M$Y$$$20200819$$HP$NL$NL
142915893$14291589$3$F$20171211$20171218$20171215$20171220$EXP$$CA-ASTRAZENECA-2017SF26776$ASTRAZENECA$$72$YR$$M$Y$$$20171220$$MD$CA$CA
142919452$14291945$2$F$20160624$20200728$20171215$20200730$EXP$$US-ABBVIE-16P-163-1670299-00$ABBVIE$$81$YR$$M$Y$67.65$KG$20200730$$MD$US$US
1429209818$14292098$18$F$201706$20200916$20171215$20200924$EXP$$CA-CELLTRION INC.-2017CA011035$CELLTRION$$$$$$Y$$$20200924$$HP$CA$CA
142923752$14292375$2$F$20171204$20180214$20171215$20180222$EXP$$US-ASTRAZENECA-2017SF28206$ASTRAZENECA$$52$YR$$F$Y$$$20180222$$MD$US$US
142924018$14292401$8$F$20171129$20200812$20171215$20200820$PER$$JP-AMGEN-JPNSP2017185808$AMGEN$HIRAI K.? IMAMURA S.? HIRAI A. ET AL.. EFFECTS OF EVOLOCUMAB ON CAROTID INTIMA?MEDIA THICKNESS AND CLINICAL PARAMETERS IN PATIENTS TAKING A STATIN. JOURNAL OF CLINICAL MEDICINE. 2020?9 (7):1?15$55$YR$A$M$Y$96$KG$20200820$$MD$JP$JP
1429284721$14292847$21$F$$20200811$20171215$20200818$EXP$$LT-PFIZER INC-2017532771$PFIZER$ABRAMAVICIUS, S.. CISPLATIN?INDUCED SUDDEN CARDIAC DEATH WITH HEMODYNAMIC COLLAPSE: A SEVERE ADVERSE DRUG REACTION. MEDICINE. 2017?96 (48)$53$YR$$F$Y$$$20200818$$MD$LT$LT
1429291411$14292914$11$F$20170523$20200731$20171215$20200811$EXP$$JP-009507513-1706JPN000831J$MERCK$$54$YR$$F$Y$44$KG$20200811$$CN$JP$JP
142929673$14292967$3$F$20171122$20200707$20171215$20200713$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-107059$BRISTOL MYERS SQUIBB$$76$YR$$F$Y$95.7$KG$20200713$$HP$CA$CA
142932051$14293205$1$I$20171122$20171208$20171215$20171215$EXP$$CA-CELGENEUS-CAN-20171203032$CELGENE$$70$YR$$F$Y$$$20171215$$CN$SE$CA
1429337715$14293377$15$F$20170829$20200923$20171215$20200930$PER$$US-BIOGEN-2017BI00464888$BIOGEN$$56$YR$$M$Y$76.19$KG$20200930$$CN$US$US
142934567$14293456$7$F$20170414$20200911$20171215$20200922$EXP$$JP-INCYTE CORPORATION-2017IN010510$INCYTE$$$$$$Y$$$20200922$$MD$JP$JP
142937713$14293771$3$F$201707$20180111$20171216$20180125$EXP$$SI-MACLEODS PHARMACEUTICALS US LTD-MAC2017006721$MACLEODS$$$$$$Y$$$20180125$$CN$SI$SI
142950094$14295009$4$F$$20200709$20171218$20200715$PER$$US-AMGEN-USASP2017183978$AMGEN$$70$YR$E$F$Y$$$20200714$$MD$US$US
142951881$14295188$1$I$201411$20171203$20171218$20171218$EXP$$HU-CIPLA LTD.-2017HU24847$CIPLA$$$$$$Y$$$20171218$$HP$GB$HU
142954404$14295440$4$F$201608$20200715$20171218$20200716$PER$$US-PFIZER INC-2017536902$PFIZER$$57$YR$$F$Y$72.57$KG$20200716$$CN$US$US
1429594114$14295941$14$F$20160514$20200714$20171218$20200729$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-072361$BRISTOL MYERS SQUIBB$URATA T, ET AL. A CASE OF MALIGNANT MELANOMA IN WHICH GRADE 4 HEPATIC FUNCTION DISORDER DEVELOPED BY ADMINISTERING IPILIMUMAB AFTER NIVOLUMAB WAS USED. THE 33RD ANNUAL MEETING OF THE JAPANESE SKIN CANCER SOCIETY. 2017?159 ? 159$56$YR$$M$Y$74$KG$20200729$$MD$JP$JP
142963052$14296305$2$F$2017$20200715$20171218$20200727$EXP$$CA-JNJFOC-20171220451$JOHNSON AND JOHNSON$$55$YR$A$M$Y$84.9$KG$20200727$$HP$CA$CA
142966367$14296636$7$F$20140101$20200721$20171218$20200730$EXP$$PT-AUROBINDO-AUR-APL-2017-46073$AUROBINDO$$39$YR$$M$Y$$$20200730$$HP$PT$PT
142970015$14297001$5$F$$20200824$20171218$20200831$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK192701$GLAXOSMITHKLINE$$64$YR$$F$Y$69$KG$20200831$$CN$CA$CA
142971644$14297164$4$F$201709$20180116$20171218$20200701$EXP$$GR-JNJFOC-20171218517$JOHNSON AND JOHNSON$$49$YR$$M$Y$82$KG$20200701$$CN$GR$GR
142972432$14297243$2$F$20171102$20171214$20171218$20171219$EXP$$CA-CELGENEUS-CAN-20171104625$CELGENE$$58$YR$$F$Y$$$20171219$$MD$CA$CA
142973102$14297310$2$F$2017$20200722$20171218$20200724$EXP$$US-PFIZER INC-2017536717$PFIZER$$66$YR$$F$Y$85.73$KG$20200724$$HP$US$US
1429771412$14297714$12$F$20171206$20181204$20171218$20190211$EXP$$ZA-ASTRAZENECA-2017SF24921$ASTRAZENECA$$24446$DY$$F$Y$$$20190211$$MD$ZA$ZA
142977311$14297731$1$I$20170829$20171002$20171218$20171218$EXP$$PL-ASTRAZENECA-2017SF00101$ASTRAZENECA$$22208$DY$$M$Y$$$20171218$$MD$PL$PL
142979023$14297902$3$F$2017$20171225$20171218$20180102$EXP$$HU-PFIZER INC-2017530130$PFIZER$$62$YR$$$Y$$$20180102$$MD$HU$HU
142983643$14298364$3$F$2016$20200902$20171218$20200908$EXP$$PHHY2017CO185705$NOVARTIS$$$$$F$Y$48$KG$20200908$$CN$COUNTRY NOT SPECIFIED$CO
142984342$14298434$2$F$$20200715$20171218$20200722$EXP$$CA-UCBSA-2017050707$UCB$$74$YR$$M$Y$$$20200722$$HP$CA$CA
142984603$14298460$3$F$$20200715$20171218$20200720$EXP$$CA-UCBSA-2017050715$UCB$$52$YR$$F$Y$$$20200720$$HP$CA$CA
1429848212$14298482$12$F$$20200819$20171218$20200824$EXP$$US-ACTELION-A-NJ2017-164177$ACTELION$$$$$F$Y$88.89$KG$20200824$$HP$US$US
1429853211$14298532$11$F$20200611$20200624$20171218$20200708$EXP$$US-ACTELION-A-NJ2017-164344$ACTELION$$75$YR$$F$Y$$$20200708$$HP$US$US
142987592$14298759$2$F$20170201$20200709$20171218$20200715$PER$$US-BIOGEN-2017BI00495397$BIOGEN$$58$YR$$F$Y$$$20200715$$CN$US$US
142988284$14298828$4$F$20150225$20200814$20171218$20200819$PER$$US-BIOGEN-2015BI033148$BIOGEN$$57$YR$$F$Y$$$20200819$$CN$US$US
142990524$14299052$4$F$$20200715$20171218$20200721$EXP$$CA-UCBSA-2017050856$UCB$$74$YR$$M$Y$$$20200721$$HP$CA$CA
1429942519$14299425$19$F$20151203$20200812$20171219$20200815$EXP$$CA-ROCHE-1622005$ROCHE$$64$YR$$F$Y$$$20200815$$MD$CA$CA
142999694$14299969$4$F$20171212$20180206$20171219$20180212$EXP$$US-ASTRAZENECA-2017SF27281$ASTRAZENECA$$72$YR$$F$Y$68.3$KG$20180212$$MD$GB$GB
143002966$14300296$6$F$$20200904$20171219$20200908$PER$$US-PFIZER INC-2017534888$PFIZER$$$$E$F$Y$$$20200908$$MD$US$US
143003173$14300317$3$F$20171207$20200730$20171219$20200810$EXP$$CA-ROCHE-2041428$ROCHE$$10$YR$$M$Y$$$20200810$$MD$CA$CA
143004344$14300434$4$F$20171214$20171231$20171219$20180103$EXP$$IL-ASTRAZENECA-2017SF28391$ASTRAZENECA$$31028$DY$$M$Y$$$20180103$$MD$IL$IL
143010165$14301016$5$F$2005$20200810$20171219$20200813$PER$$US-PFIZER INC-2017534684$PFIZER$$36$YR$$M$Y$79.38$KG$20200813$$CN$US$US
143011724$14301172$4$F$20171104$20180117$20171219$20180122$EXP$$IL-JNJFOC-20171109380$PHARMACYCLICS$$73$YR$E$F$Y$52$KG$20180122$$MD$IL$IL
143011988$14301198$8$F$201407$20200701$20171219$20200710$EXP$$GB-AUROBINDO-AUR-APL-2017-45902$AUROBINDO$$70$YR$$F$Y$$$20200710$$HP$GB$GB
143012312$14301231$2$F$$20200917$20171219$20200928$EXP$$CA-APOTEX-2017AP022577$APOTEX$$$$$M$Y$$$20200928$$CN$CA$CA
143028245$14302824$5$F$20171108$20190307$20171219$20190315$EXP$$TW-ASTRAZENECA-2017SF27899$ASTRAZENECA$$19308$DY$$M$Y$$$20190315$$MD$TW$TW
143029524$14302952$4$F$20171215$20171227$20171219$20171229$EXP$$JP-ASTRAZENECA-2017SF28554$ASTRAZENECA$$22674$DY$$M$Y$$$20171229$$MD$JP$JP
143030946$14303094$6$F$2016$20200709$20171219$20200717$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006743$ACADIA PHARMACEUTICALS$$74$YR$$F$Y$$$20200717$$MD$US$US
143030978$14303097$8$F$20171205$20200918$20171219$20200924$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-111224$BRISTOL MYERS SQUIBB$$72$YR$$M$Y$57$KG$20200924$$HP$DE$DE
143031212$14303121$2$F$20171201$20200828$20171219$20200831$EXP$$JP-BAYER-2017-239824$BAYER$$80$YR$E$M$Y$53$KG$20200831$$MD$JP$JP
143032663$14303266$3$F$201612$20190125$20171219$20190130$EXP$$GR-MYLANLABS-2017M1079325$MYLAN$THEODOROU E.. THE CLINICAL EXPERIENCE OF IL?17 INHIBITION IN GREECE.. 9^^ ANNUAL SCIENTIFIC CONGRESS OF SCIENTIFIC SOCIETY FOR MUSCULOSKELETAL HEALTH.. 2017$29$YR$$M$Y$$$20190130$$HP$GR$GR
143038629$14303862$9$F$20160909$20200706$20171219$20200714$EXP$$JP-UNITED THERAPEUTICS-UNT-2017-017770$UNITED THERAPEUTICS$$33$YR$$F$Y$41$KG$20200714$$CN$JP$JP
143038645$14303864$5$F$20170628$20190729$20171219$20200928$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-113398$BRISTOL MYERS SQUIBB$$$$A$F$Y$$$20200928$$MD$DE$DE
143042443$14304244$3$F$$20200912$20171219$20200921$EXP$$PT-MYLANLABS-2017M1079456$MYLAN$VAZ R, BARROS F, TAVARES I, BUSTROFF M, FERREIRA I, PESTANA M ET ALL. GANCICLOVIR?RESISTANT CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANTATION.. CLIN. KIDNEY J.. 2014?7(2):210?3$61$YR$$F$Y$$$20200921$$HP$PT$PT
143052822$14305282$2$F$$20200723$20171219$20200727$EXP$$PT-OTSUKA-DJ201406873$OTSUKA$$44$YR$$F$Y$$$20200727$$MD$PT$PT
143058011$14305801$1$I$20171201$20171207$20171219$20171219$EXP$$CA-CELGENEUS-CAN-20171202855$CELGENE$$70$YR$$M$Y$$$20171219$$MD$CA$CA
143058541$14305854$1$I$20171202$20171211$20171219$20171219$EXP$$CA-CELGENEUS-CAN-20171204138$CELGENE$$72$YR$$F$Y$$$20171219$$MD$CA$CA
1430589024$14305890$24$F$2014$20200803$20171219$20200814$EXP$$US-ACTELION-A-NJ2017-164316$ACTELION$$72$YR$$F$Y$84.35$KG$20200814$$HP$US$US
143060074$14306007$4$F$$20200713$20171219$20200720$EXP$$JP-BAUSCH-BL-2017-034024$BAUSCH AND LOMB$SUZUKI K, MURAMATSU H, OKUNO Y, NARITA K, KITAZAWA H, HUANG Y. VORINOSTAT AND BORTEZOMIB COMBINED INTENSIVE CHEMOTHERAPY FOR CHILDREN WITH KMT2A (MLL)?REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA. PEDIATRIC BLOOD AND CANCER. 2017?64(4):S90. DOI:10.1002/PBC.26872$1$YR$$F$Y$$$20200720$$MD$JP$JP
143067886$14306788$6$F$20171203$20180330$20171220$20200929$EXP$$JP-NEUROCRINE BIOSCIENCES INC.-2017NBI01941$NEUROCRINE BIOSCIENCES$$47$YR$A$M$Y$85$KG$20200929$$MD$JP$JP
143069738$14306973$8$F$$20200917$20171220$20200928$EXP$$CA-APOTEX-2017AP022582$APOTEX$$54$YR$$M$Y$$$20200928$$CN$CA$CA
143070553$14307055$3$F$$20200720$20171220$20200728$EXP$$CA-APOTEX-2017AP022586$APOTEX$$$$$M$Y$$$20200728$$CN$CA$CA
143071548$14307154$8$F$$20200714$20171220$20200722$EXP$$CA-APOTEX-2017AP022542$APOTEX$$67$YR$$M$Y$$$20200722$$CN$CA$CA
143071986$14307198$6$F$20170808$20200908$20171220$20200922$EXP$$US-ROCHE-2042500$ROCHE$$61$YR$$F$Y$94.9$KG$20200922$$MD$US$US
143078113$14307811$3$F$$20200629$20171220$20200708$EXP$$CA-UCBSA-2017051039$UCB$$52$YR$$F$Y$$$20200708$$HP$CA$CA
143081969$14308196$9$F$20170508$20200902$20171220$20200910$EXP$$PHHY2017DE095752$NOVARTIS$$$$A$F$Y$80$KG$20200910$$MD$DE$DE
1430821310$14308213$10$F$20171109$20200731$20171220$20200814$EXP$$US-ACTELION-A-NJ2016-141045$ACTELION$$76$YR$$F$Y$53.06$KG$20200814$$HP$US$US
1430839415$14308394$15$F$20171123$20200814$20171220$20200818$EXP$$CA-TAKEDA-2017TUS025842$TAKEDA$$50$YR$$F$Y$$$20200818$$MD$CA$CA
143084582$14308458$2$F$20171024$20200914$20171220$20200919$EXP$$ES-AUROBINDO-AUR-APL-2017-45587$AUROBINDO$$69$YR$$M$Y$$$20200919$$CN$ES$ES
143084862$14308486$2$F$20171003$20171220$20171220$20171227$EXP$$ES-PFIZER INC-2017436158$PFIZER$$67$YR$$M$Y$$$20171227$$MD$ES$ES
143084974$14308497$4$F$$20190831$20171220$20190913$EXP$$DE-AUROBINDO-AUR-APL-2017-46532$AUROBINDO$$$$$$Y$$$20190913$$HP$DE$DE
1430861610$14308616$10$F$$20200805$20171220$20200814$EXP$$NL-009507513-1712NLD010064$MERCK$GODSCHALX?DEKKER JA, SIEGERS HP. REDUCTION OF PARKINSONISM AND PSYCHOSIS WITH MIRTAZAPINE: A CASE REPORT.. PHARMACOPSYCHIATRY. 2014?47(3):81?3$67$YR$$M$Y$$$20200814$$HP$NL$NL
143091102$14309110$2$F$2010$20200710$20171220$20200720$EXP$$US-BIOGEN-2017BI00499272$BIOGEN$$$$$F$Y$$$20200720$$CN$US$US
143096832$14309683$2$F$20101124$20180726$20171220$20180804$EXP$$HU-TEVA-2017-HU-832102$TEVA$$48$YR$$F$Y$$$20180804$$MD$HU$HU
1430974410$14309744$10$F$20171210$20180220$20171220$20180228$EXP$$AU-ABBVIE-17P-008-2191432-00$ABBVIE$$72$YR$$F$Y$88.1$KG$20180228$$MD$AU$AU
1430974661$14309746$61$F$2017$20200828$20171220$20200923$EXP$$CA-CELLTRION INC.-2017CA009441$CELLTRION$$$$$$Y$$$20200923$$HP$CA$CA
143098133$14309813$3$F$20141121$20200728$20171220$20200804$EXP$$US-JNJFOC-20171225143$JOHNSON AND JOHNSON$$56$YR$A$M$Y$$$20200804$$CN$US$US
1430984414$14309844$14$F$20170828$20200910$20171220$20200918$EXP$$CA-CELLTRION INC.-2017CA011855$CELLTRION$$$$$$Y$$$20200918$$HP$CA$CA
143098882$14309888$2$F$20171204$20180219$20171220$20180222$EXP$$RU-JNJFOC-20171221060$JANSSEN$$70$YR$E$F$Y$66$KG$20180222$$MD$RU$RU
143100174$14310017$4$F$20170925$20200713$20171220$20200722$EXP$$FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-104377$BRISTOL MYERS SQUIBB$$58$YR$$F$Y$65$KG$20200722$$HP$FR$FR
143100706$14310070$6$F$201502$20200714$20171220$20200722$EXP$$AT-MYLANLABS-2017M1079499$MYLAN$TROBISCH A, MARTERER R, GORKIEWICZ G, FLASCHBERGER S, LACKNER H, SEIDEL M ET. AL. INVASIVE MUCORMYCOSIS DURING TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKAEMIA?SUCCESSFUL MANAGEMENT OF TWO LIFE?THREATENING DISEASES.. SUPPORTIVE CARE IN CANCER.. 2019$5$YR$$M$Y$$$20200722$$HP$AT$AT
143102857$14310285$7$F$201710$20200706$20171220$20200713$EXP$$DE-MYLANLABS-2017M1079476$MYLAN$$$$A$M$Y$93$KG$20200713$$HP$DE$DE
143106476$14310647$6$F$$20180516$20171220$20180523$EXP$$PL-MYLANLABS-2017M1079813$MYLAN$$57$YR$$F$Y$56$KG$20180522$$HP$PL$PL
143106884$14310688$4$F$$20200701$20171220$20200703$PER$$US-BIOGEN-2017BI00496851$BIOGEN$$$$$M$Y$$$20200703$$CN$US$US
143118081$14311808$1$I$$20171206$20171221$20171221$EXP$$PL-CIPLA LTD.-2017PL24968$CIPLA$$$$$$Y$$$20171221$$HP$GB$PL
143119231$14311923$1$I$2017$20171206$20171221$20171221$EXP$$HU-ALVOGEN-2017-ALVOGEN-094586$ALVOGEN$$62$YR$$$Y$$$20171221$$MD$HU$HU
143120614$14312061$4$F$$20200909$20171221$20200911$EXP$$CA-TAKEDA-2017TUS026369$TAKEDA$$82$YR$$M$Y$$$20200911$$MD$CA$CA
1431215612$14312156$12$F$2010$20200309$20171221$20200806$PER$$US-AMGEN-USASP2017187639$AMGEN$$63$YR$A$F$Y$88$KG$20200806$$MD$US$US
1431215711$14312157$11$F$$20200914$20171221$20200917$PER$$CA-AMGEN-CANSP2016084874$AMGEN$$51$YR$A$F$Y$$$20200917$$MD$CA$CA
1431241713$14312417$13$F$20160101$20200914$20171221$20200923$EXP$$DE-AUROBINDO-AUR-APL-2017-45285$AUROBINDO$$78$YR$$M$Y$$$20200923$$MD$DE$DE
143125279$14312527$9$F$20200328$20200728$20171221$20200729$EXP$$US-TAKEDA-2017MPI011584$TAKEDA$$73$YR$$F$Y$$$20200729$$HP$US$US
143128147$14312814$7$F$2016$20200701$20171221$20200719$EXP$$PHHY2016BR123971$NOVARTIS$$48$YR$$F$Y$69$KG$20200719$$MD$BR$BR
143129374$14312937$4$F$$20200729$20171221$20200805$EXP$$PT-MYLANLABS-2017M1079480$MYLAN$$60$YR$$M$Y$$$20200805$$HP$PT$PT
143130348$14313034$8$F$201711$20200902$20171221$20200903$PER$$US-PFIZER INC-2017544728$PFIZER$$78$YR$$F$Y$72$KG$20200903$$CN$US$US
143142533$14314253$3$F$$20190902$20171221$20190906$EXP$$PHHY2014DE184981$SANDOZ$REICHLE A, WALPINSKI I, VOGELHUBER M, KLEBL F, WIEST R, SCHULZ U ET AL. COMBINED ANTI?INFLAMMATORY, IMMUNE?MODULATORY AND ANGIOSTATIC THERAPY IN PRETREATED PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: IMPACT OF TREATMENT AND DISEASE RELATED PARAMETERS ON OVERALL SURVIVAL.. ONKOLOGIE. 2013?36 (SUP7):69$$$$$Y$$$20190906$$HP$DE$DE
143143004$14314300$4$F$20171216$20181213$20171221$20181217$EXP$$AU-JNJFOC-20171227046$PHARMACYCLICS$$61$YR$A$M$Y$$$20181217$$MD$AU$AU
143144111$14314411$1$I$20101124$20171206$20171221$20171221$EXP$$HU-CIPLA LTD.-2017HU24820$CIPLA$$$$$$Y$$$20171221$$HP$GB$HU
143146569$14314656$9$F$201411$20180724$20171221$20181228$EXP$$PHHY2017HU168012$NOVARTIS$$$$$F$Y$$$20181228$$HP$HU$HU
143149073$14314907$3$F$2016$20200901$20171221$20200914$PER$$US-JNJFOC-20171226143$JOHNSON AND JOHNSON$$68$YR$E$F$Y$$$20200914$$CN$US$US
143153421$14315342$1$I$20170826$20171206$20171221$20171221$EXP$GB-MHRA-EYC 00168528$GB-TEVA-2017-GB-833847$TEVA$$85$YR$$F$Y$$$20171221$$HP$GB$GB
1431537112$14315371$12$F$201702$20200710$20171221$20200723$EXP$$US-ACTELION-A-NJ2017-150070$ACTELION$$65$YR$$F$Y$56.69$KG$20200723$$HP$US$US
143153855$14315385$5$F$20170728$20200703$20171221$20200709$EXP$$PHHO2017CA011384$NOVARTIS$$58$YR$$M$Y$77$KG$20200709$$HP$CA$CA
143156076$14315607$6$F$20150223$20200706$20171221$20200715$EXP$$JP-UNITED THERAPEUTICS-UNT-2015-010730$UNITED THERAPEUTICS$$53$YR$$F$Y$49.8$KG$20200715$$CN$JP$JP
143157908$14315790$8$F$2016$20200706$20171221$20200708$EXP$$PHHY2017FR189924$NOVARTIS$$57$YR$$M$Y$59$KG$20200708$$HP$FR$FR
143160889$14316088$9$F$20160731$20200714$20171222$20200722$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-115125$BRISTOL MYERS SQUIBB$MIZUNO K, ET AL.. REAL WORLD DATA OF LIVER INJURY INDUCED BY IMMUNE CHECKPOINT INHIBITORS IN JAPANESE PATIENTS WITH ADVANCED MALIGNANCIES. J.GASTROENTEROL.. 2020?55:653?661$80$YR$$F$Y$45$KG$20200722$$MD$JP$JP
143166353$14316635$3$F$20171217$20180117$20171222$20180125$EXP$$KR-ASTRAZENECA-2017SF29305$ASTRAZENECA$$932$MON$$M$Y$$$20180125$$MD$KR$KR
1431664328$14316643$28$F$20171205$20200916$20171222$20200929$EXP$$GB-ASPEN-GLO2017GB008662$ASPEN$$77$YR$$M$Y$90.6$KG$20200929$$MD$GB$GB
143168004$14316800$4$F$$20200803$20171222$20200806$PER$$US-PFIZER INC-2017542735$PFIZER$$62$YR$$F$Y$$$20200806$$MD$US$US
143168703$14316870$3$F$201502$20200706$20171222$20200714$EXP$$JP-UNITED THERAPEUTICS-UNT-2015-002838$UNITED THERAPEUTICS$$52$YR$$F$Y$58$KG$20200714$$CN$JP$JP
143176729$14317672$9$F$20171217$20180711$20171222$20200916$EXP$$US-TESARO, INC.-US-2017TSO04532$GLAXOSMITHKLINE$$49$YR$$F$Y$$$20200916$$CN$US$US
143177672$14317767$2$F$20171201$20180115$20171222$20180118$EXP$$CA-CELGENEUS-CAN-20171204694$CELGENE$$70$YR$$M$Y$$$20180118$$MD$CA$CA
143177793$14317779$3$F$20170208$20200713$20171222$20200714$EXP$ES-AEMPS-304239$ES-PFIZER INC-2017544267$PFIZER$$36$YR$$F$Y$$$20200714$$MD$ES$ES
1431802223$14318022$23$F$20180109$20200708$20171222$20200715$EXP$$CA-PFIZER INC-2017539652$PFIZER$$21$YR$$F$Y$$$20200715$$HP$CA$CA
143186332$14318633$2$F$$20200910$20171222$20200918$EXP$$CA-ASTRAZENECA-2017SF28031$ASTRAZENECA$$56$YR$$M$Y$$$20200918$$CN$CA$CA
143187556$14318755$6$F$201610$20200810$20171222$20200817$EXP$$HU-MYLANLABS-2017M1080005$MYLAN$$73$YR$$$Y$$$20200817$$MD$HU$HU
143189731$14318973$1$I$20171209$20171211$20171222$20171222$EXP$$US-JNJFOC-20171228060$JANSSEN$$56$YR$A$F$Y$52.8$KG$20171222$$HP$US$US
143190184$14319018$4$F$20171108$20180118$20171222$20180119$EXP$$NL-ASTRAZENECA-2017SF13923$ASTRAZENECA$$58$YR$$M$Y$98.4$KG$20180119$$MD$NL$NL
1431904212$14319042$12$F$20150818$20200716$20171222$20200730$EXP$$US-ACTELION-A-NJ2017-164483$ACTELION$$52$YR$$F$Y$109.3$KG$20200730$$HP$US$US
143191386$14319138$6$F$20161108$20200817$20171222$20200819$EXP$$PHHY2017DE016440$NOVARTIS$$73$YR$$F$Y$81$KG$20200819$$CN$DE$DE
143191682$14319168$2$F$201606$20171219$20171222$20180103$EXP$$HU-MYLANLABS-2017M1080413$MYLAN$$62$YR$$$Y$$$20180103$$MD$HU$HU
143196794$14319679$4$F$201712$20200818$20171222$20200820$EXP$$US-PFIZER INC-2017544940$PFIZER$$69$YR$$F$Y$$$20200820$$MD$US$US
143201233$14320123$3$F$$20200714$20171222$20200722$EXP$$US-BAYER-2017-178979$BAYER$$79$YR$E$F$Y$$$20200722$$CN$US$US
143209665$14320966$5$F$2017$20200828$20171223$20200904$EXP$$US-ABBVIE-17K-163-2007575-00$ABBVIE$$61$YR$$F$Y$$$20200904$$CN$US$US
1432117714$14321177$14$F$20160610$20200902$20171223$20200910$EXP$$ES-AUROBINDO-AUR-APL-2017-46608$AUROBINDO$MIRTAZAPINE OVERDOSE ACUTE NECROTISING PANCREATITIS: CASE REPORT. 2018$83$YR$$F$Y$62$KG$20200910$$HP$ES$ES
143212785$14321278$5$F$201707$20200727$20171223$20200729$EXP$NL-LRB-00254512$PHHY2017NL193086$NOVARTIS$$79$YR$$M$Y$73$KG$20200729$$HP$NL$NL
143214142$14321414$2$F$2017$20200818$20171223$20200901$EXP$$RO-GLENMARK PHARMACEUTICALS-2017GMK030162$GLENMARK$$$$$$Y$$$20200901$$MD$RO$RO
143216913$14321691$3$F$2017$20200917$20171224$20200921$PER$$US-BIOGEN-2017BI00496793$BIOGEN$$44$YR$$F$Y$$$20200921$$CN$US$US
143220242$14322024$2$F$$20180712$20171225$20180713$EXP$$PK-ROCHE-2044224$ROCHE$$57$YR$$F$Y$$$20180713$$CN$PK$PK
143220343$14322034$3$F$$20171219$20171225$20200707$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-116446$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20200707$$CN$US$US
143221369$14322136$9$F$20171210$20180220$20171225$20180227$EXP$$AU-ROCHE-2039988$ROCHE$$72$YR$$F$Y$88.1$KG$20180227$$MD$AU$AU
1432223710$14322237$10$F$2017$20200914$20171225$20200921$EXP$$PHHY2017CA054784$NOVARTIS$$29$YR$$M$Y$$$20200921$$MD$CA$CA
143223584$14322358$4$F$2016$20180910$20171225$20180919$EXP$$PHHY2017PL193026$SANDOZ$$67$YR$$F$Y$$$20180919$$HP$PL$PL
143230562$14323056$2$F$20160830$20200722$20171226$20200724$PER$$US-BIOGEN-2016BI00286068$BIOGEN$$44$YR$$F$Y$74.91$KG$20200724$$CN$US$US
143233842$14323384$2$F$20171218$20180102$20171226$20180104$EXP$$CA-ASTRAZENECA-2017SF30218$ASTRAZENECA$$64$YR$$F$Y$$$20180105$$MD$CA$CA
143238078$14323807$8$F$20170911$20181107$20171226$20181115$EXP$$BE-JNJFOC-20171213491$JANSSEN$$12$YR$C$F$Y$38.5$KG$20181115$$MD$BE$BE
143238679$14323867$9$F$20180113$20200909$20171226$20200915$EXP$$CL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-114684$BRISTOL MYERS SQUIBB$$69$YR$$F$Y$$$20200915$$CN$CL$CL
143239614$14323961$4$F$20160811$20200701$20171226$20200709$EXP$NL-LRB-00252906$PHHY2017NL192585$NOVARTIS$$73$YR$$F$Y$$$20200709$$HP$NL$NL
143242443$14324244$3$F$20171205$20200731$20171226$20200804$EXP$$PHHO2017US017170$NOVARTIS$$73$YR$$M$Y$92.2$KG$20200804$$HP$US$US
143242843$14324284$3$F$20171026$20171228$20171226$20180103$EXP$$US-JNJFOC-20171100931$PHARMACYCLICS$$66$YR$E$M$Y$92.4$KG$20180103$$MD$US$US
1432443814$14324438$14$F$20171126$20200206$20171226$20200220$EXP$$US-JNJFOC-20171200142$JOHNSON AND JOHNSON$$73$YR$$M$Y$67$KG$20200220$$MD$US$US
143244912$14324491$2$F$20171215$20180110$20171226$20180119$EXP$$JP-JNJFOC-20171228872$JANSSEN$$76$YR$E$M$Y$58$KG$20180119$$MD$JP$JP
143245507$14324550$7$F$20160921$20200720$20171226$20200724$EXP$$GR-MYLANLABS-2017M1077734$MYLAN$PATOULIAS D, MICHAILIDIS T, KERYTTOPOULOS P, PAPATOLIOS T, PAPADOPOULOS R.. RHABDOMYOLYSIS INDUCED BY COADMINISTRATION OF FUSIDIC ACID AND ATORVASTATIN: A CASE REPORT AND COMPREHENSIVE REVIEW OF THE LITERATURE.. CASE REP NEPHROL.. 2017?2017:2187264$79$YR$$F$Y$$$20200724$$MD$GR$GR
143246575$14324657$5$F$20171204$20180125$20171226$20180131$EXP$$HR-ASTRAZENECA-2017SF29854$ASTRAZENECA$$64$YR$$M$Y$95$KG$20180131$$MD$HR$HR
143251801$14325180$1$I$20160815$20160822$20171226$20171226$EXP$$FR-ASTRAZENECA-2016SE90040$ASTRAZENECA$$28351$DY$$F$Y$$$20171226$$MD$FR$FR
143253524$14325352$4$F$20171002$20200706$20171226$20200710$EXP$$PHHY2017BE191731$NOVARTIS$$71$YR$$F$Y$$$20200710$$HP$BE$BE
143254515$14325451$5$F$201608$20200720$20171226$20200723$EXP$$US-JAZZ-2016-US-024548$JAZZ$$67$YR$$M$Y$$$20200723$$HP$COUNTRY NOT SPECIFIED$US
1432573912$14325739$12$F$201707$20200902$20171226$20200908$EXP$NL-LRB-00254512$NL-MYLANLABS-2017M1081878$MYLAN$$79$YR$$M$Y$73$KG$20200908$$CN$NL$NL
143257936$14325793$6$F$20161229$20180423$20171226$20180507$EXP$PT-EMA-DD-20171208-DPRABHAKAR9P-133044$PT-MYLANLABS-2017M1081916$MYLAN$$58$YR$$F$Y$$$20180507$$CN$PT$PT
1432618213$14326182$13$F$20171206$20200821$20171227$20200825$PER$$US-PFIZER INC-2017544766$PFIZER$$75$YR$$F$Y$$$20200825$$HP$US$US
143270305$14327030$5$F$20171201$20200714$20171227$20200715$EXP$$KR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-118067$BRISTOL MYERS SQUIBB$$65$YR$$M$Y$67$KG$20200715$$MD$KR$KR
143271845$14327184$5$F$20171221$20200715$20171227$20200723$EXP$$PHHY2017CA046691$NOVARTIS$$29$YR$$F$Y$51.5$KG$20200723$$HP$CA$CA
1432723724$14327237$24$F$201709$20200730$20171227$20200807$EXP$$CA-CELLTRION INC.-2017CA013052$CELLTRION$$$$$$Y$$$20200807$$HP$CA$CA
143274221$14327422$1$I$$20171212$20171227$20171227$EXP$$PL-AUROBINDO-AUR-APL-2017-47241$AUROBINDO$$57$YR$$F$Y$56$KG$20171227$$CN$NL$PL
143275586$14327558$6$F$$20200921$20171227$20200925$PER$$US-PFIZER INC-2017545204$PFIZER$$50$YR$$F$Y$$$20200925$$CN$US$US
1432798522$14327985$22$F$201610$20200730$20171227$20200807$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-073536$BRISTOL MYERS SQUIBB$$64$YR$$F$Y$$$20200807$$CN$CA$CA
143280173$14328017$3$F$201705$20200824$20171227$20200831$EXP$$FR-ABBVIE-17P-056-2204627-00$ABBVIE$$85$YR$$F$Y$$$20200831$$HP$FR$FR
143282029$14328202$9$F$20161205$20200708$20171227$20200717$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN198629$VIIV$$$$$F$Y$$$20200717$$CN$JP$JP
143283762$14328376$2$F$$20200804$20171227$20200806$PER$$US-PFIZER INC-2017548649$PFIZER$$62$YR$$F$Y$$$20200806$$MD$US$US
1432848016$14328480$16$F$2018$20200828$20171227$20200904$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK162592$GLAXOSMITHKLINE$$$$$F$Y$86$KG$20200904$$CN$BR$BR
143288924$14328892$4$F$201709$20200811$20171227$20200814$PER$$US-PFIZER INC-2017546768$PFIZER$$70$YR$$F$Y$$$20200814$$MD$US$US
143291304$14329130$4$F$$20200925$20171227$20200930$EXP$$CA-PFIZER INC-2017546675$PFIZER$$51$YR$$F$Y$$$20200930$$HP$CA$CA
143293622$14329362$2$F$2017$20200824$20171227$20200904$EXP$$RO-GLENMARK PHARMACEUTICALS-2017GMK030251$GLENMARK$$$$$$Y$$$20200904$$MD$RO$RO
143293974$14329397$4$F$20171218$20180212$20171227$20180213$EXP$$CA-ASTRAZENECA-2017SF30184$ASTRAZENECA$$66$YR$$F$Y$$$20180213$$MD$CA$CA
1432968511$14329685$11$F$20170201$20200831$20171227$20200904$EXP$$PHHY2017DE194647$NOVARTIS$$63$YR$$M$Y$$$20200904$$HP$DE$DE
143299482$14329948$2$F$20170810$20171220$20171227$20171228$EXP$$PHEH2017US041627$SANDOZ$$62$YR$$M$Y$76$KG$20171228$$CN$US$US
143300737$14330073$7$F$$20200907$20171227$20200916$EXP$$BE-MYLANLABS-2017M1082168$MYLAN$SMETS GJ, LOYSON T, VAN PAESSCHEN W, DEMAEREL P, NACKAERTS K. POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME POSSIBLY INDUCED BY PEMETREXED MAINTENANCE THERAPY FOR LUNG CANCER.. ACTA CLINICA BELGICA:INTERNATIONAL JOURNAL OF CLINICAL AND LABORATORY MEDICIN.. 2018?73 (5):382?88$59$YR$$F$Y$$$20200916$$MD$BE$BE
143303033$14330303$3$F$20160614$20181219$20171227$20200821$EXP$$BE-TAKEDA-2017TUS027371$TAKEDA$$48$YR$$M$Y$92$KG$20200821$$MD$BE$BE
143305183$14330518$3$F$20161229$20180209$20171227$20180221$EXP$$PT-BAUSCH-BL-2017-035242$BAUSCH AND LOMB$$58$YR$$F$Y$$$20180221$$MD$PT$PT
143309453$14330945$3$F$20171111$20200623$20171228$20200707$EXP$$IT-MACLEODS PHARMACEUTICALS US LTD-MAC2017007516$MACLEODS$$$$$$Y$$$20200707$$HP$IT$IT
1433140019$14331400$19$F$2017$20200720$20171228$20200727$EXP$$CA-CELLTRION INC.-2017CA012620$CELLTRION$$$$$$Y$$$20200728$$HP$CA$CA
143314406$14331440$6$F$20171003$20200731$20171228$20200807$EXP$$US-ROCHE-2020625$ROCHE$$79$YR$$M$Y$81.2$KG$20200807$$MD$US$US
143314892$14331489$2$F$$20200903$20171228$20200913$EXP$$US-ELI_LILLY_AND_COMPANY-US201712010436$ELI LILLY AND CO$$$$$F$Y$$$20200913$$CN$US$US
143314982$14331498$2$F$$20200729$20171228$20200729$EXP$$TH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-116612$BRISTOL MYERS SQUIBB$KEOROCHANA N, KUNASUNTIWARAKUL S, TREESIT I, CHOONTANOM N. THE EFFICACY OF PREOPERATIVE POSTERIOR SUBTENON INJECTION OF TRIAMEINOLONE ACETONIDE IN NONINFECTIOUS UVEITIC PATIENTS WITH SECONDARY GLAUCOMA UNDERGOING TRABECULECTOMY. CLINICAL OPHTHALMOLOGY. 2017?11:2057?63$$$$$Y$$$20200729$$HP$TH$TH
1433161415$14331614$15$F$201707$20200813$20171228$20200821$EXP$$CA-CELLTRION INC.-2017CA009239$CELLTRION$$$$$$Y$$$20200821$$HP$CA$CA
143319812$14331981$2$F$201504$20200707$20171228$20200717$EXP$$US-BAYER-2017-181797$BAYER$$57$YR$A$F$Y$$$20200717$$LW$US$US
143319987$14331998$7$F$20171220$20180531$20171228$20180608$EXP$$GB-JNJFOC-20171233441$PHARMACYCLICS$$61$YR$A$M$Y$64.4$KG$20180608$$MD$GB$GB
1433206913$14332069$13$F$20170118$20200901$20171228$20200907$EXP$$DE-AUROBINDO-AUR-APL-2017-47223$AUROBINDO$$44$YR$$F$Y$64$KG$20200907$$CN$DE$DE
143321346$14332134$6$F$20160316$20200708$20171228$20200714$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN198663$VIIV$$$$$M$Y$$$20200714$$CN$JP$JP
143323882$14332388$2$F$$20200729$20171228$20200730$EXP$$TH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-119014$BRISTOL MYERS SQUIBB$KEOROCHANA N, KUNASUNTIWARAKUL S, TREESIT I, CHOONTANOM N. THE EFFICACY OF PREOPERATIVE POSTERIOR SUBTENON INJECTION OF TRIAMEINOLONE ACETONIDE IN NONINFECTIOUS UVEITIC PATIENTS WITH SECONDARY GLAUCOMA UNDERGOING TRABECULECTOMY. CLINICAL OPHTHALMOLOGY. 2017?11:2057?63$$$$$Y$$$20200730$$HP$TH$TH
143324639$14332463$9$F$20171212$20180928$20171228$20181003$EXP$$JP-ROCHE-2045780$ROCHE$$44$YR$$F$Y$50$KG$20181003$$MD$JP$JP
143325353$14332535$3$F$20171216$20200916$20171228$20200923$EXP$$PHHO2017US017226$NOVARTIS$$49$YR$$M$Y$71.66$KG$20200923$$HP$US$US
143325663$14332566$3$F$20171105$20180404$20171228$20180416$EXP$$AU-JNJFOC-20171227045$JANSSEN$$68$YR$E$F$Y$65$KG$20180416$$MD$AU$AU
143327792$14332779$2$F$20160101$20180109$20171228$20180122$EXP$$NL-JNJFOC-20171226939$JANSSEN$$67$YR$E$$Y$$$20180122$$CN$NL$NL
143329687$14332968$7$F$201206$20200818$20171228$20200826$PER$$PHEH2017US041609$NOVARTIS$$58$YR$$F$Y$$$20200826$$CN$COUNTRY NOT SPECIFIED$U